Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_002528.7(NTHL1):c.275G>A (p.Arg92His)	NTHL1|TSC2	R92H	Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis 3|not specified|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000647900	16	2096208	16	2046207	647900	644067	rs145644817	NC_000016.10:2046206:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002528.7(NTHL1):c.244C>T (p.Gln82Ter)	NTHL1|TSC2	Q82*	Inherited polyposis and early onset colorectal cancer - germline testing|Hereditary cancer-predisposing syndrome|not provided|Familial adenomatous polyposis 3	VCV000192319	16	2096239	16	2046238	192319	190112	rs150766139	NC_000016.10:2046237:G:A	single nucleotide variant	nonsense|intron variant	Conflicting classifications of pathogenicity	May 5, 2025	criteria provided, conflicting classifications							
NM_002528.7(NTHL1):c.74G>A (p.Arg25Lys)	NTHL1|TSC2	R25K	Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000708448	16	2097751	16	2047750	708448	726486	rs2302172	NC_000016.10:2047749:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 28, 2025	criteria provided, conflicting classifications							
NC_000016.10:g.2047954G>C	TSC2		not provided	VCV002645966	16	2097955	16	2047954	2645966	2810847	rs577046175	NC_000016.10:2047953:G:C	single nucleotide variant		Benign	Oct 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.-87A>G	TSC2		Tuberous sclerosis syndrome	VCV000318301	16	2098009	16	2048008	318301	340847	rs886051785	NC_000016.10:2048007:A:G	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.-85G>C	TSC2		Tuberous sclerosis syndrome	VCV000318302	16	2098011	16	2048010	318302	324601	rs540716235	NC_000016.10:2048009:G:C	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.-82G>T	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000885578	16	2098014	16	2048013	885578	874842	rs1391750751	NC_000016.10:2048012:G:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	May 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.-72T>A	LOC130058210|TSC2		not provided|Tuberous sclerosis syndrome	VCV000885579	16	2098024	16	2048023	885579	874843	rs543752709	NC_000016.10:2048022:T:A	single nucleotide variant	5 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.-65G>C	LOC130058210|TSC2		not provided|Tuberous sclerosis syndrome	VCV000318303	16	2098031	16	2048030	318303	342251	rs563544506	NC_000016.10:2048029:G:C	single nucleotide variant	5 prime UTR variant	Benign/Likely benign	Jun 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.-48C>G	LOC130058210|TSC2		not provided	VCV001243273	16	2098048	16	2048047	1243273	1234045	rs1022290518	NC_000016.10:2048046:C:G	single nucleotide variant	5 prime UTR variant	Benign	Jul 10, 2015	criteria provided, single submitter							
NM_000548.5(TSC2):c.-45G>T	LOC130058210|TSC2		not specified	VCV000506728	16	2098051	16	2048050	506728	506127	rs947662369	NC_000016.10:2048049:G:T	single nucleotide variant	5 prime UTR variant	Likely benign	Jan 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.-40C>T	LOC130058210|TSC2		not specified	VCV000383242	16	2098056	16	2048055	383242	374031	rs1057521563	NC_000016.10:2048054:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Feb 5, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.-38C>T	LOC130058210|TSC2		not specified	VCV000207701	16	2098058	16	2048057	207701	203077	rs796053481	NC_000016.10:2048056:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Apr 2, 2013	criteria provided, single submitter							
NM_000548.5(TSC2):c.-36G>A	LOC130058210|TSC2		not specified	VCV000507556	16	2098060	16	2048059	507556	505650	rs903216714	NC_000016.10:2048058:G:A	single nucleotide variant	5 prime UTR variant	Likely benign	Jan 2, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.-34G>A	LOC130058210|TSC2		not specified|Tuberous sclerosis syndrome	VCV000378770	16	2098062	16	2048061	378770	374716	rs559641280	NC_000016.10:2048060:G:A	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 13, 2018	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.-30+1G>A	LOC130058210|TSC2		Tuberous sclerosis 2	VCV003706705	16	2098067	16	2048066	3706705	3836277		NC_000016.10:2048065:G:A	single nucleotide variant	splice donor variant	Uncertain significance	Apr 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.-30+1G>C	LOC130058210|TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000207767	16	2098067	16	2048066	207767	203078	rs587778004	NC_000016.10:2048065:G:C	single nucleotide variant	splice donor variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.-30+1G>T	LOC130058210|TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000133423	16	2098067	16	2048066	133423	137162	rs587778004	NC_000016.10:2048065:G:T	single nucleotide variant	splice donor variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.-30+2T>C	LOC130058210|TSC2		Hereditary cancer-predisposing syndrome|not specified	VCV000207788	16	2098068	16	2048067	207788	203079	rs796053514	NC_000016.10:2048066:T:C	single nucleotide variant	splice donor variant	Conflicting classifications of pathogenicity	Aug 6, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.-30+5G>T	LOC130058210|TSC2		not specified	VCV000373780	16	2098071	16	2048070	373780	360243	rs991520392	NC_000016.10:2048069:G:T	single nucleotide variant	intron variant	Uncertain significance	Dec 7, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.-30+134C>T	LOC130058210|TSC2		not provided	VCV000677387	16	2098200	16	2048199	677387	668664	rs568457786	NC_000016.10:2048198:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.-30+192G>C	TSC2		not specified	VCV003896149	16	2098258	16	2048257	3896149	4012020		NC_000016.10:2048256:G:C	single nucleotide variant	5 prime UTR variant|intron variant	Uncertain significance	Apr 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.-29-18C>T	TSC2		not specified	VCV000513656	16	2098570	16	2048569	513656	506129	rs1319033169	NC_000016.10:2048568:C:T	single nucleotide variant	intron variant	Likely benign	Nov 27, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.-29-17C>T	TSC2		not specified	VCV000509764	16	2098571	16	2048570	509764	505143	rs201044312	NC_000016.10:2048569:C:T	single nucleotide variant	intron variant	Likely benign	Mar 16, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.-29-10G>C	TSC2		not specified|not provided|Tuberous sclerosis syndrome	VCV000137734	16	2098578	16	2048577	137734	141437	rs28537973	NC_000016.10:2048576:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.-29-7T>G	TSC2		Tuberous sclerosis 2	VCV001709570	16	2098581	16	2048580	1709570	1707924	rs1567379910	NC_000016.10:2048579:T:G	single nucleotide variant	intron variant	Uncertain significance	Jun 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.-13G>T	TSC2		Tuberous sclerosis syndrome	VCV003386154	16	2098604	16	2048603	3386154	3545295		NC_000016.10:2048602:G:T	single nucleotide variant	5 prime UTR variant|synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.-5C>T	TSC2	S10F	Hereditary cancer-predisposing syndrome	VCV002626428	16	2098612	16	2048611	2626428	2794194	rs1423798557	NC_000016.10:2048610:C:T	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.-4C>G	TSC2		Hereditary cancer-predisposing syndrome	VCV003974646	16	2098613	16	2048612	3974646	4086469		NC_000016.10:2048611:C:G	single nucleotide variant	5 prime UTR variant|synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.-4C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000825358	16	2098613	16	2048612	825358	812459	rs1596233597	NC_000016.10:2048611:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Uncertain significance	Feb 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.-3A>T	TSC2	T11S	Hereditary cancer-predisposing syndrome	VCV003232158	16	2098614	16	2048613	3232158	3391959	rs2150969451	NC_000016.10:2048612:A:T	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.-1C>G	TSC2		Hereditary cancer-predisposing syndrome	VCV003974639	16	2098616	16	2048615	3974639	4086462		NC_000016.10:2048614:C:G	single nucleotide variant	5 prime UTR variant|synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 25, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1A>G (p.Met1Val)	TSC2	M12V, M1V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001368130	16	2098617	16	2048616	1368130	1424668	rs1055443730	NC_000016.10:2048615:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2T>A (p.Met1Lys)	TSC2	M12K, M1K	Tuberous sclerosis 2	VCV001378864	16	2098618	16	2048617	1378864	1408055	rs2084667702	NC_000016.10:2048616:T:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|intron variant	Likely pathogenic	Feb 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2T>C (p.Met1Thr)	TSC2	M12T, M1T	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001002972	16	2098618	16	2048617	1002972	996680	rs2084667702	NC_000016.10:2048616:T:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3G>T (p.Met1Ile)	TSC2	M1I, M12I	not provided	VCV000593812	16	2098619	16	2048618	593812	584875	rs397515208	NC_000016.10:2048617:G:T	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|intron variant	Likely pathogenic	Sep 12, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3G>A (p.Met1Ile)	TSC2	M1I, M12I	Tuberous sclerosis 2	VCV000065284	16	2098619	16	2048618	65284	76216	rs397515208	NC_000016.10:2048617:G:A	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|intron variant	Likely pathogenic	Mar 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4G>A (p.Ala2Thr)	TSC2	A2T, A13T	Tuberous sclerosis 2	VCV001929319	16	2098620	16	2048619	1929319	1984329	rs769400464	NC_000016.10:2048618:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4G>C (p.Ala2Pro)	TSC2	A13P, A2P	Hereditary cancer-predisposing syndrome	VCV001744709	16	2098620	16	2048619	1744709	1809489	rs769400464	NC_000016.10:2048618:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4G>T (p.Ala2Ser)	TSC2	A2S, A13S	Tuberous sclerosis 2	VCV001369100	16	2098620	16	2048619	1369100	1417990	rs769400464	NC_000016.10:2048618:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Mar 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5C>A (p.Ala2Asp)	TSC2	A2D, A13D	Tuberous sclerosis 2	VCV003637168	16	2098621	16	2048620	3637168	3771322		NC_000016.10:2048619:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5C>T (p.Ala2Val)	TSC2	A13V, A2V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000852633	16	2098621	16	2048620	852633	843300	rs2084668501	NC_000016.10:2048619:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.6C>G (p.Ala2=)	TSC2		Tuberous sclerosis 2	VCV002822357	16	2098622	16	2048621	2822357	2982160	rs1367421033	NC_000016.10:2048620:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Feb 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.9A>G (p.Lys3=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001674584	16	2098625	16	2048624	1674584	1532590	rs2150969793	NC_000016.10:2048623:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.10C>T (p.Pro4Ser)	TSC2	P4S, P15S	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002916828	16	2098626	16	2048625	2916828	3076890	rs2150969834	NC_000016.10:2048624:C:T	single nucleotide variant	intron variant|missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.11C>T (p.Pro4Leu)	TSC2	P4L, P15L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000658500	16	2098627	16	2048626	658500	644125	rs147206318	NC_000016.10:2048625:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Aug 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.12A>G (p.Pro4=)	TSC2		Tuberous sclerosis 2	VCV002873020	16	2098628	16	2048627	2873020	3034894	rs762387565	NC_000016.10:2048626:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.13A>G (p.Thr5Ala)	TSC2	T5A, T16A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049728	16	2098629	16	2048628	49728	58890	rs45517093	NC_000016.10:2048627:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign/Likely benign	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.16A>T (p.Ser6Cys)	TSC2	S6C, S17C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000856629	16	2098632	16	2048631	856629	843302	rs1555494544	NC_000016.10:2048630:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.16A>G (p.Ser6Gly)	TSC2	S6G, S17G	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535932	16	2098632	16	2048631	535932	529804	rs1555494544	NC_000016.10:2048630:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.17G>C (p.Ser6Thr)	TSC2	S17T, S6T	Tuberous sclerosis 2	VCV001468757	16	2098633	16	2048632	1468757	1359116	rs758239066	NC_000016.10:2048631:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.17G>A (p.Ser6Asn)	TSC2	S6N, S17N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000230395	16	2098633	16	2048632	230395	235088	rs758239066	NC_000016.10:2048631:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Apr 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.18C>T (p.Ser6=)	TSC2		Tuberous sclerosis 2	VCV003716599	16	2098634	16	2048633	3716599	3849004		NC_000016.10:2048632:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.20A>C (p.Lys7Thr)	TSC2	K7T, K18T	Tuberous sclerosis 2	VCV000943258	16	2098636	16	2048635	943258	937272	rs137854215	NC_000016.10:2048634:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.20A>G (p.Lys7Arg)	TSC2	K7R, K18R	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049194	16	2098636	16	2048635	49194	58356	rs137854215	NC_000016.10:2048634:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.22G>C (p.Asp8His)	TSC2	D19H, D8H	Hereditary cancer-predisposing syndrome	VCV003974667	16	2098638	16	2048637	3974667	4086490		NC_000016.10:2048636:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.22G>A (p.Asp8Asn)	TSC2	D19N, D8N	Tuberous sclerosis 2	VCV000644667	16	2098638	16	2048637	644667	644126	rs1596233815	NC_000016.10:2048636:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.24T>C (p.Asp8=)	TSC2		Tuberous sclerosis 2	VCV004071348	16	2098640	16	2048639	4071348	4185196		NC_000016.10:2048638:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	Apr 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.25T>G (p.Ser9Ala)	TSC2	S20A, S9A	Hereditary cancer-predisposing syndrome	VCV003232120	16	2098641	16	2048640	3232120	3391921	rs2150970332	NC_000016.10:2048639:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.26C>G (p.Ser9Ter)	TSC2	S9*, S20*	Tuberous sclerosis 2	VCV000065313	16	2098642	16	2048641	65313	76245	rs397515228	NC_000016.10:2048640:C:G	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Oct 9, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.27A>C (p.Ser9=)	TSC2		Tuberous sclerosis 2	VCV002112887	16	2098643	16	2048642	2112887	2168169	rs1555494555	NC_000016.10:2048641:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Mar 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.27A>G (p.Ser9=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467971	16	2098643	16	2048642	467971	465702	rs1555494555	NC_000016.10:2048641:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.28G>C (p.Gly10Arg)	TSC2	G21R, G10R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002847717	16	2098644	16	2048643	2847717	3008789	rs2150970435	NC_000016.10:2048642:G:C	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.29G>T (p.Gly10Val)	TSC2	G10V, G21V	Tuberous sclerosis 2	VCV000937943	16	2098645	16	2048644	937943	937273	rs2084671697	NC_000016.10:2048643:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.30C>A (p.Gly10=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564647	16	2098646	16	2048645	2564647	2733803	rs876659726	NC_000016.10:2048644:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.30C>G (p.Gly10=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000702471	16	2098646	16	2048645	702471	693802	rs876659726	NC_000016.10:2048644:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.30C>T (p.Gly10=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000232373	16	2098646	16	2048645	232373	235089	rs876659726	NC_000016.10:2048644:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.31T>G (p.Leu11Val)	TSC2	L11V, L22V	Hereditary cancer-predisposing syndrome	VCV002564648	16	2098647	16	2048646	2564648	2733804	rs978517404	NC_000016.10:2048645:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.31T>C (p.Leu11=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536078	16	2098647	16	2048646	536078	530073	rs978517404	NC_000016.10:2048645:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.33G>A (p.Leu11=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000787557	16	2098649	16	2048648	787557	714794	rs1190907341	NC_000016.10:2048647:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.36G>T (p.Lys12Asn)	TSC2	K12N, K23N	Hereditary cancer-predisposing syndrome	VCV000824096	16	2098652	16	2048651	824096	812460	rs1596233951	NC_000016.10:2048650:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.36G>A (p.Lys12=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000752950	16	2098652	16	2048651	752950	770657	rs1596233951	NC_000016.10:2048650:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.37G>A (p.Glu13Lys)	TSC2	E13K, E24K	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000486676	16	2098653	16	2048652	486676	477282	rs1555494586	NC_000016.10:2048651:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.39G>T (p.Glu13Asp)	TSC2	E13D, E24D	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001060157	16	2098655	16	2048654	1060157	1049412	rs766814650	NC_000016.10:2048653:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Dec 12, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.41A>G (p.Lys14Arg)	TSC2	K14R, K25R	not provided|not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001395321	16	2098657	16	2048656	1395321	1412334	rs1263108967	NC_000016.10:2048655:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Feb 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.42G>A (p.Lys14=)	TSC2		Tuberous sclerosis 2	VCV002796246	16	2098658	16	2048657	2796246	2954784	rs2548348958	NC_000016.10:2048656:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.44T>G (p.Phe15Cys)	TSC2	F15C, F26C	Hereditary cancer-predisposing syndrome	VCV002564649	16	2098660	16	2048659	2564649	2733805	rs2150970912	NC_000016.10:2048658:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.45T>G (p.Phe15Leu)	TSC2	F15L, F26L	Hereditary cancer-predisposing syndrome	VCV001741816	16	2098661	16	2048660	1741816	1801460	rs2548349074	NC_000016.10:2048659:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 29, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.48G>A (p.Lys16=)	TSC2		Tuberous sclerosis 2	VCV002090689	16	2098664	16	2048663	2090689	2148493	rs2084674938	NC_000016.10:2048662:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Mar 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.48G>C (p.Lys16Asn)	TSC2	K16N, K27N	Tuberous sclerosis 2	VCV001024015	16	2098664	16	2048663	1024015	1011922	rs2084674938	NC_000016.10:2048662:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.49A>T (p.Ile17Phe)	TSC2	I17F, I28F	Tuberous sclerosis 2	VCV002713806	16	2098665	16	2048664	2713806	2872229	rs1274194851	NC_000016.10:2048663:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.49A>G (p.Ile17Val)	TSC2	I17V, I28V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825353	16	2098665	16	2048664	825353	812461	rs1274194851	NC_000016.10:2048663:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.50T>G (p.Ile17Ser)	TSC2	I17S, I28S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002564650	16	2098666	16	2048665	2564650	2733806	rs2548349184	NC_000016.10:2048664:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.51T>G (p.Ile17Met)	TSC2	I17M, I28M	Hereditary cancer-predisposing syndrome	VCV003232187	16	2098667	16	2048666	3232187	3391988	rs2150971085	NC_000016.10:2048665:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Oct 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.51T>C (p.Ile17=)	TSC2		Tuberous sclerosis 2	VCV001651043	16	2098667	16	2048666	1651043	1578418	rs2150971085	NC_000016.10:2048665:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Nov 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.52C>G (p.Leu18Val)	TSC2	L18V, L29V	Tuberous sclerosis 2	VCV002851598	16	2098668	16	2048667	2851598	3006275	rs1596234078	NC_000016.10:2048666:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.52C>T (p.Leu18=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825626	16	2098668	16	2048667	825626	812462	rs1596234078	NC_000016.10:2048666:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.54G>C (p.Leu18=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001612322	16	2098670	16	2048669	1612322	1601405	rs2150971145	NC_000016.10:2048668:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.54G>A (p.Leu18=)	TSC2		Tuberous sclerosis 2	VCV001563446	16	2098670	16	2048669	1563446	1619950	rs2150971145	NC_000016.10:2048668:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.54G>T (p.Leu18=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001138624	16	2098670	16	2048669	1138624	1125004	rs2150971145	NC_000016.10:2048668:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.55T>C (p.Leu19=)	TSC2		Tuberous sclerosis 2	VCV001099897	16	2098671	16	2048670	1099897	1103598	rs2150971171	NC_000016.10:2048669:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.58G>A (p.Gly20Arg)	TSC2	G31R, G20R	Hereditary cancer-predisposing syndrome	VCV000826046	16	2098674	16	2048673	826046	812463	rs1596234105	NC_000016.10:2048672:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 30, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.59G>A (p.Gly20Glu)	TSC2	G20E, G31E	Hereditary cancer-predisposing syndrome	VCV003329491	16	2098675	16	2048674	3329491	3489083		NC_000016.10:2048673:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.59G>T (p.Gly20Val)	TSC2	G20V, G31V	Tuberous sclerosis 2	VCV001367292	16	2098675	16	2048674	1367292	1405013	rs2150971313	NC_000016.10:2048673:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.60A>C (p.Gly20=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000718709	16	2098676	16	2048675	718709	726487	rs1060504108	NC_000016.10:2048674:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.60A>G (p.Gly20=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000413713	16	2098676	16	2048675	413713	401392	rs1060504108	NC_000016.10:2048674:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.61C>G (p.Leu21Val)	TSC2	L21V, L32V	Tuberous sclerosis 2	VCV001721602	16	2098677	16	2048676	1721602	1772936	rs2084676177	NC_000016.10:2048675:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.61C>A (p.Leu21Met)	TSC2	L21M, L32M	Tuberous sclerosis 2	VCV001016158	16	2098677	16	2048676	1016158	1011923	rs2084676177	NC_000016.10:2048675:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.63G>A (p.Leu21=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002449974	16	2098679	16	2048678	2449974	2429599	rs2150971432	NC_000016.10:2048677:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jan 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.64G>A (p.Gly22Arg)	TSC2	G22R, G33R	Tuberous sclerosis 2	VCV002893054	16	2098680	16	2048679	2893054	3055562	rs1479698846	NC_000016.10:2048678:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	Nov 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.65G>C (p.Gly22Ala)	TSC2	G22A, G33A	Tuberous sclerosis 2	VCV001020511	16	2098681	16	2048680	1020511	1011924	rs2084676497	NC_000016.10:2048679:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.68C>T (p.Thr23Ile)	TSC2	T34I, T23I	Tuberous sclerosis 2	VCV003705264	16	2098684	16	2048683	3705264	3846043		NC_000016.10:2048682:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.70C>A (p.Pro24Thr)	TSC2	P24T, P35T	Tuberous sclerosis 2|not provided	VCV000569456	16	2098686	16	2048685	569456	567710	rs1567380585	NC_000016.10:2048684:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.71C>G (p.Pro24Arg)	TSC2	P35R, P24R	Hereditary cancer-predisposing syndrome	VCV002564737	16	2098687	16	2048686	2564737	2733893	rs868467487	NC_000016.10:2048685:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.71C>A (p.Pro24Gln)	TSC2	P35Q, P24Q	Tuberous sclerosis 2	VCV001044406	16	2098687	16	2048686	1044406	1032423	rs868467487	NC_000016.10:2048685:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.71C>T (p.Pro24Leu)	TSC2	P35L, P24L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000936546	16	2098687	16	2048686	936546	937274	rs868467487	NC_000016.10:2048685:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.72G>C (p.Pro24=)	TSC2		Tuberous sclerosis 2	VCV001118876	16	2098688	16	2048687	1118876	1103599	rs754121475	NC_000016.10:2048686:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 4, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.72G>A (p.Pro24=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000755021	16	2098688	16	2048687	755021	770658	rs754121475	NC_000016.10:2048686:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.74G>T (p.Arg25Met)	TSC2	R25M, R36M	Tuberous sclerosis 2	VCV002706786	16	2098690	16	2048689	2706786	2870359	rs759867905	NC_000016.10:2048688:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.74G>A (p.Arg25Lys)	TSC2	R25K, R36K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535934	16	2098690	16	2048689	535934	529527	rs759867905	NC_000016.10:2048688:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Jan 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.75G>A (p.Arg25=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001149053	16	2098691	16	2048690	1149053	1145888	rs2150971828	NC_000016.10:2048689:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.76C>T (p.Pro26Ser)	TSC2	P26S, P37S	Tuberous sclerosis 2	VCV002712351	16	2098692	16	2048691	2712351	2868191	rs2150971861	NC_000016.10:2048690:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.77C>T (p.Pro26Leu)	TSC2	P26L, P37L	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000451829	16	2098693	16	2048692	451829	445509	rs1555494636	NC_000016.10:2048691:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.79A>G (p.Asn27Asp)	TSC2	N38D, N27D	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000886606	16	2098695	16	2048694	886606	874844	rs2084677815	NC_000016.10:2048693:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.81T>A (p.Asn27Lys)	TSC2	N27K, N38K	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV002564651	16	2098697	16	2048696	2564651	2733807	rs2548350127	NC_000016.10:2048695:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.82C>T (p.Pro28Ser)	TSC2	P39S, P28S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002854426	16	2098698	16	2048697	2854426	3006964	rs200480606	NC_000016.10:2048696:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.82C>G (p.Pro28Ala)	TSC2	P28A, P39A	Tuberous sclerosis 2	VCV002708239	16	2098698	16	2048697	2708239	2874404	rs200480606	NC_000016.10:2048696:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.82C>A (p.Pro28Thr)	TSC2	P28T, P39T	Tuberous sclerosis 2	VCV000952356	16	2098698	16	2048697	952356	927606	rs200480606	NC_000016.10:2048696:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 13, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.83C>T (p.Pro28Leu)	TSC2	P28L, P39L	Hereditary cancer-predisposing syndrome	VCV003462634	16	2098699	16	2048698	3462634	3621653		NC_000016.10:2048697:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.83C>G (p.Pro28Arg)	TSC2	P28R, P39R	Isolated focal cortical dysplasia type II	VCV003240659	16	2098699	16	2048698	3240659	3399645	rs1057522105	NC_000016.10:2048697:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.83C>A (p.Pro28His)	TSC2	P28H, P39H	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000385045	16	2098699	16	2048698	385045	374717	rs1057522105	NC_000016.10:2048697:C:A	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.84C>G (p.Pro28=)	TSC2		Tuberous sclerosis 2	VCV004071313	16	2098700	16	2048699	4071313	4185161		NC_000016.10:2048698:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	Apr 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.84C>T (p.Pro28=)	TSC2		Tuberous sclerosis 2	VCV004071281	16	2098700	16	2048699	4071281	4185129		NC_000016.10:2048698:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	Apr 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.85A>G (p.Arg29Gly)	TSC2	R29G, R40G	Tuberous sclerosis 2	VCV002009321	16	2098701	16	2048700	2009321	2073685	rs752830086	NC_000016.10:2048699:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.86G>C (p.Arg29Thr)	TSC2	R40T, R29T	Tuberous sclerosis 2	VCV000944814	16	2098702	16	2048701	944814	927607	rs1567380695	NC_000016.10:2048700:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.86G>A (p.Arg29Lys)	TSC2	R29K, R40K	Tuberous sclerosis 2	VCV000572351	16	2098702	16	2048701	572351	569579	rs1567380695	NC_000016.10:2048700:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.87G>A (p.Arg29=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001536751	16	2098703	16	2048702	1536751	1533035	rs1010489256	NC_000016.10:2048701:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.87G>T (p.Arg29Ser)	TSC2	R29S, R40S	Tuberous sclerosis 2	VCV001014307	16	2098703	16	2048702	1014307	1011925	rs1010489256	NC_000016.10:2048701:G:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.89C>G (p.Ser30Cys)	TSC2	S30C, S41C	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000576521	16	2098705	16	2048704	576521	569581	rs1425163522	NC_000016.10:2048703:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Aug 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.90T>C (p.Ser30=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003628285	16	2098706	16	2048705	3628285	3758807		NC_000016.10:2048704:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.92C>T (p.Ala31Val)	TSC2	A31V, A42V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000577837	16	2098708	16	2048707	577837	573745	rs1567380741	NC_000016.10:2048706:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.93A>G (p.Ala31=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003811362	16	2098709	16	2048708	3811362	3928603		NC_000016.10:2048707:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.94G>C (p.Glu32Gln)	TSC2	E32Q, E43Q	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001767178	16	2098710	16	2048709	1767178	1821520	rs2084679567	NC_000016.10:2048708:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.94G>A (p.Glu32Lys)	TSC2	E32K, E43K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000971297	16	2098710	16	2048709	971297	957664	rs2084679567	NC_000016.10:2048708:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.95A>T (p.Glu32Val)	TSC2	E43V, E32V	Hereditary cancer-predisposing syndrome	VCV003462569	16	2098711	16	2048710	3462569	3621588		NC_000016.10:2048709:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.95A>G (p.Glu32Gly)	TSC2	E43G, E32G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000863431	16	2098711	16	2048710	863431	843303	rs1482573368	NC_000016.10:2048709:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.96G>A (p.Glu32=)	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000589718	16	2098712	16	2048711	589718	580062	rs1567380772	NC_000016.10:2048710:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Aug 21, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.97G>A (p.Gly33Ser)	TSC2	G33S, G44S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486639	16	2098713	16	2048712	486639	477410	rs370230541	NC_000016.10:2048711:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Sep 18, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.98G>A (p.Gly33Asp)	TSC2	G33D, G44D	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535900	16	2098714	16	2048713	535900	529505	rs1352220583	NC_000016.10:2048712:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Nov 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.100A>G (p.Lys34Glu)	TSC2	K34E, K45E	Tuberous sclerosis 2	VCV001022994	16	2098716	16	2048715	1022994	1011926	rs2084680573	NC_000016.10:2048714:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.101A>G (p.Lys34Arg)	TSC2	K34R, K45R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486619	16	2098717	16	2048716	486619	477900	rs777988634	NC_000016.10:2048715:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.101A>C (p.Lys34Thr)	TSC2	K34T, K45T	not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000207654	16	2098717	16	2048716	207654	203081	rs777988634	NC_000016.10:2048715:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.102A>C (p.Lys34Asn)	TSC2	K34N, K45N	not provided	VCV002443651	16	2098718	16	2048717	2443651	2417386	rs2150972734	NC_000016.10:2048716:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.103C>G (p.Gln35Glu)	TSC2	Q35E, Q46E	Hereditary cancer-predisposing syndrome	VCV003329481	16	2098719	16	2048718	3329481	3489073		NC_000016.10:2048717:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.105G>A (p.Gln35=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001146375	16	2098721	16	2048720	1146375	1145889	rs2150972829	NC_000016.10:2048719:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.106A>G (p.Thr36Ala)	TSC2	T36A, T47A	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207655	16	2098722	16	2048721	207655	203082	rs757113497	NC_000016.10:2048720:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.107C>T (p.Thr36Met)	TSC2	T36M, T47M	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001061710	16	2098723	16	2048722	1061710	1049413	rs376280172	NC_000016.10:2048721:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Sep 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.108G>A (p.Thr36=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000413639	16	2098724	16	2048723	413639	401393	rs781075483	NC_000016.10:2048722:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.109G>T (p.Glu37Ter)	TSC2	E37*, E48*	Tuberous sclerosis 2	VCV002430255	16	2098725	16	2048724	2430255	2403763	rs2150972985	NC_000016.10:2048723:G:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Apr 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.109G>A (p.Glu37Lys)	TSC2	E37K, E48K	Tuberous sclerosis 2	VCV002060718	16	2098725	16	2048724	2060718	2106948	rs2150972985	NC_000016.10:2048723:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.110A>T (p.Glu37Val)	TSC2	E37V, E48V	Tuberous sclerosis 2	VCV002100646	16	2098726	16	2048725	2100646	2154662	rs2548351211	NC_000016.10:2048724:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.111G>A (p.Glu37=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003811311	16	2098727	16	2048726	3811311	3928552		NC_000016.10:2048725:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.113T>A (p.Phe38Tyr)	TSC2	F38Y, F49Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001058082	16	2098729	16	2048728	1058082	1049414	rs745604417	NC_000016.10:2048727:T:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.113T>C (p.Phe38Ser)	TSC2	F38S, F49S	Tuberous sclerosis 2	VCV001009038	16	2098729	16	2048728	1009038	996681	rs745604417	NC_000016.10:2048727:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 24, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.114T>A (p.Phe38Leu)	TSC2	F38L, F49L	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578778	16	2098730	16	2048729	3578778	3708200		NC_000016.10:2048728:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.114T>C (p.Phe38=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413717	16	2098730	16	2048729	413717	401119	rs1060504110	NC_000016.10:2048728:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.115A>G (p.Ile39Val)	TSC2	I50V, I39V	Tuberous sclerosis 2	VCV002109843	16	2098731	16	2048730	2109843	2163718	rs1265165657	NC_000016.10:2048729:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Aug 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.116T>A (p.Ile39Asn)	TSC2	I39N, I50N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002711109	16	2098732	16	2048731	2711109	2878561	rs184437554	NC_000016.10:2048730:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.116T>C (p.Ile39Thr)	TSC2	I39T, I50T	Tuberous sclerosis 2	VCV000405979	16	2098732	16	2048731	405979	401124	rs184437554	NC_000016.10:2048730:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Benign	Sep 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.117C>T (p.Ile39=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974616	16	2098733	16	2048732	3974616	4086439		NC_000016.10:2048731:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.117C>A (p.Ile39=)	TSC2		Tuberous sclerosis 2	VCV001670761	16	2098733	16	2048732	1670761	1605068	rs2150973249	NC_000016.10:2048731:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.118A>T (p.Ile40Phe)	TSC2	I40F, I51F	Tuberous sclerosis 2	VCV002061346	16	2098734	16	2048733	2061346	2124038	rs2084683845	NC_000016.10:2048732:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.118A>G (p.Ile40Val)	TSC2	I40V, I51V	Tuberous sclerosis 2	VCV000856562	16	2098734	16	2048733	856562	843306	rs2084683845	NC_000016.10:2048732:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 3, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.119T>C (p.Ile40Thr)	TSC2	I40T, I51T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000141455	16	2098735	16	2048734	141455	151169	rs587781758	NC_000016.10:2048733:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.120C>A (p.Ile40=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462636	16	2098736	16	2048735	3462636	3621655		NC_000016.10:2048734:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.121A>G (p.Thr41Ala)	TSC2	T41A, T52A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001379252	16	2098737	16	2048736	1379252	1486481	rs1596234558	NC_000016.10:2048735:A:G	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.121A>T (p.Thr41Ser)	TSC2	T41S, T52S	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000655432	16	2098737	16	2048736	655432	644128	rs1596234558	NC_000016.10:2048735:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.122C>A (p.Thr41Asn)	TSC2	T41N, T52N	Hereditary cancer-predisposing syndrome	VCV001755126	16	2098738	16	2048737	1755126	1822215	rs1385450866	NC_000016.10:2048736:C:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Nov 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.122C>T (p.Thr41Ile)	TSC2	T52I, T41I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001043681	16	2098738	16	2048737	1043681	1032424	rs1385450866	NC_000016.10:2048736:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.123C>T (p.Thr41=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413678	16	2098739	16	2048738	413678	401394	rs1060504100	NC_000016.10:2048737:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.124G>A (p.Ala42Thr)	TSC2	A42T, A53T	Tuberous sclerosis 2	VCV001915555	16	2098740	16	2048739	1915555	1970591	rs1229322782	NC_000016.10:2048738:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.125C>G (p.Ala42Gly)	TSC2	A42G, A53G	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|not provided|Hereditary cancer-predisposing syndrome	VCV002679345	16	2098741	16	2048740	2679345	2836922	rs199562226	NC_000016.10:2048739:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.125C>T (p.Ala42Val)	TSC2	A42V, A53V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001442644	16	2098741	16	2048740	1442644	1375408	rs199562226	NC_000016.10:2048739:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.126G>C (p.Ala42=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001595307	16	2098742	16	2048741	1595307	1590947	rs886043548	NC_000016.10:2048740:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.126G>A (p.Ala42=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000287010	16	2098742	16	2048741	287010	271247	rs886043548	NC_000016.10:2048740:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Apr 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.127G>A (p.Glu43Lys)	TSC2	E43K, E54K	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000864308	16	2098743	16	2048742	864308	843307	rs2084685904	NC_000016.10:2048741:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.129A>G (p.Glu43=)	TSC2		Tuberous sclerosis 2	VCV001652282	16	2098745	16	2048744	1652282	1664195	rs1295533489	NC_000016.10:2048743:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.130A>G (p.Ile44Val)	TSC2	I44V, I55V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486649	16	2098746	16	2048745	486649	477256	rs1555494697	NC_000016.10:2048744:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.131T>C (p.Ile44Thr)	TSC2	I44T, I55T	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535920	16	2098747	16	2048746	535920	529511	rs1190102918	NC_000016.10:2048745:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.132A>G (p.Ile44Met)	TSC2	I44M, I55M	Tuberous sclerosis 2|not provided	VCV000207778	16	2098748	16	2048747	207778	203083	rs796053508	NC_000016.10:2048746:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.133C>G (p.Leu45Val)	TSC2	L45V, L56V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000639412	16	2098749	16	2048748	639412	644129	rs1555494707	NC_000016.10:2048747:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.133C>T (p.Leu45=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000467861	16	2098749	16	2048748	467861	465994	rs1555494707	NC_000016.10:2048747:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.134T>C (p.Leu45Pro)	TSC2	L45P, L56P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000951243	16	2098750	16	2048749	951243	927608	rs1383831944	NC_000016.10:2048748:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.134T>G (p.Leu45Arg)	TSC2	L45R, L56R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000467862	16	2098750	16	2048749	467862	465703	rs1383831944	NC_000016.10:2048748:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.135G>A (p.Leu45=)	TSC2		Tuberous sclerosis 2	VCV002764907	16	2098751	16	2048750	2764907	2928673	rs1555494715	NC_000016.10:2048749:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Oct 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.135G>C (p.Leu45=)	TSC2		Tuberous sclerosis 2	VCV001537423	16	2098751	16	2048750	1537423	1597016	rs1555494715	NC_000016.10:2048749:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.135G>T (p.Leu45=)	TSC2		Tuberous sclerosis 2	VCV000536089	16	2098751	16	2048750	536089	529812	rs1555494715	NC_000016.10:2048749:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 19, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.136A>T (p.Arg46Ter)	TSC2	R46*, R57*	Tuberous sclerosis 2	VCV000050188	16	2098752	16	2048751	50188	59350	rs137854266	NC_000016.10:2048750:A:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Pathogenic	Apr 9, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+1G>T	TSC2		Tuberous sclerosis 2	VCV004072022	16	2098755	16	2048754	4072022	4185894		NC_000016.10:2048753:G:T	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Oct 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+2T>C	TSC2		not provided|Tuberous sclerosis 2	VCV000049155	16	2098756	16	2048755	49155	58317	rs137854226	NC_000016.10:2048754:T:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Aug 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.138+4A>G	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001052020	16	2098758	16	2048757	1052020	1049415	rs779611259	NC_000016.10:2048756:A:G	single nucleotide variant	intron variant	Uncertain significance	Apr 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.138+5G>C	TSC2		Tuberous sclerosis 2	VCV001069935	16	2098759	16	2048758	1069935	1063522	rs45481400	NC_000016.10:2048757:G:C	single nucleotide variant	intron variant	Pathogenic	May 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+5G>A	TSC2		not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Neoplasm	VCV000050192	16	2098759	16	2048758	50192	59354	rs45481400	NC_000016.10:2048757:G:A	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Jul 8, 2025	criteria provided, multiple submitters, no conflicts				Uncertain significance	Mar 4, 2025	criteria provided, single submitter	
NM_000548.5(TSC2):c.138+6T>C	TSC2		Tuberous sclerosis 2	VCV000651316	16	2098760	16	2048759	651316	652934	rs1252109762	NC_000016.10:2048758:T:C	single nucleotide variant	intron variant	Likely benign	Nov 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+7G>A	TSC2		Tuberous sclerosis 2	VCV000793940	16	2098761	16	2048760	793940	788177	rs1596234900	NC_000016.10:2048759:G:A	single nucleotide variant	intron variant	Likely benign	Jan 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+10C>A	TSC2		Tuberous sclerosis 2	VCV004071091	16	2098764	16	2048763	4071091	4184939		NC_000016.10:2048762:C:A	single nucleotide variant	intron variant	Likely benign	Apr 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+10C>T	TSC2		Tuberous sclerosis 2	VCV002803535	16	2098764	16	2048763	2803535	2967216	rs748932830	NC_000016.10:2048762:C:T	single nucleotide variant	intron variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+10C>G	TSC2		Tuberous sclerosis 2	VCV000406023	16	2098764	16	2048763	406023	401130	rs748932830	NC_000016.10:2048762:C:G	single nucleotide variant	intron variant	Uncertain significance	Nov 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+11T>G	TSC2		Tuberous sclerosis 2	VCV003650317	16	2098765	16	2048764	3650317	3784892		NC_000016.10:2048763:T:G	single nucleotide variant	intron variant	Likely benign	Apr 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+12A>C	TSC2		Tuberous sclerosis 2	VCV003660929	16	2098766	16	2048765	3660929	3790588		NC_000016.10:2048764:A:C	single nucleotide variant	intron variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+13C>T	TSC2		Tuberous sclerosis 2	VCV001565859	16	2098767	16	2048766	1565859	1590448	rs2084692975	NC_000016.10:2048765:C:T	single nucleotide variant	intron variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+14C>T	TSC2		Tuberous sclerosis 2	VCV001626621	16	2098768	16	2048767	1626621	1583624	rs201204330	NC_000016.10:2048766:C:T	single nucleotide variant	intron variant	Likely benign	Aug 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+14C>G	TSC2		not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000137736	16	2098768	16	2048767	137736	141439	rs201204330	NC_000016.10:2048766:C:G	single nucleotide variant	intron variant	Benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.138+15T>A	TSC2		Tuberous sclerosis 2	VCV001675004	16	2098769	16	2048768	1675004	1597182	rs1168013718	NC_000016.10:2048767:T:A	single nucleotide variant	intron variant	Likely benign	Nov 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+16G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000514347	16	2098770	16	2048769	514347	505438	rs1555494744	NC_000016.10:2048768:G:A	single nucleotide variant	intron variant	Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.138+17T>A	TSC2		Tuberous sclerosis 2	VCV002807905	16	2098771	16	2048770	2807905	2971546	rs2150974664	NC_000016.10:2048769:T:A	single nucleotide variant	intron variant	Likely benign	Jun 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+18G>A	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001590021	16	2098772	16	2048771	1590021	1576567	rs966402370	NC_000016.10:2048770:G:A	single nucleotide variant	intron variant	Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.138+19T>G	TSC2		Tuberous sclerosis 2	VCV001660096	16	2098773	16	2048772	1660096	1606467	rs1185810797	NC_000016.10:2048771:T:G	single nucleotide variant	intron variant	Likely benign	Dec 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+19T>C	TSC2		Tuberous sclerosis 2	VCV001658953	16	2098773	16	2048772	1658953	1640498	rs1185810797	NC_000016.10:2048771:T:C	single nucleotide variant	intron variant	Likely benign	Aug 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+20C>T	TSC2		Tuberous sclerosis 2	VCV001538098	16	2098774	16	2048773	1538098	1619324	rs45517092	NC_000016.10:2048772:C:T	single nucleotide variant	intron variant	Likely benign	Mar 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+20C>G	TSC2		not provided|Tuberous sclerosis 2|not specified	VCV000049758	16	2098774	16	2048773	49758	58920	rs45517092	NC_000016.10:2048772:C:G	single nucleotide variant	intron variant	Benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.138+211T>C	TSC2		not provided	VCV000677676	16	2098965	16	2048964	677676	668352	rs3211962	NC_000016.10:2048963:T:C	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.138+263C>A	TSC2		not provided	VCV001190971	16	2099017	16	2049016	1190971	1181344	rs147607620	NC_000016.10:2049015:C:A	single nucleotide variant	intron variant	Likely benign	Jul 9, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-160A>G	TSC2		not provided	VCV001190062	16	2100241	16	2050240	1190062	1181345	rs529566060	NC_000016.10:2050239:A:G	single nucleotide variant	intron variant	Likely benign	Jun 25, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-20C>T	TSC2		Tuberous sclerosis 2	VCV002833880	16	2100381	16	2050380	2833880	2998820	rs779808076	NC_000016.10:2050379:C:T	single nucleotide variant	intron variant	Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139-20C>A	TSC2		Tuberous sclerosis 2	VCV002197874	16	2100381	16	2050380	2197874	1924035	rs779808076	NC_000016.10:2050379:C:A	single nucleotide variant	intron variant	Likely benign	Apr 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-17C>G	TSC2		Tuberous sclerosis 2	VCV002017725	16	2100384	16	2050383	2017725	2065366	rs748987903	NC_000016.10:2050382:C:G	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-17C>T	TSC2		Tuberous sclerosis 2	VCV001567594	16	2100384	16	2050383	1567594	1591754	rs748987903	NC_000016.10:2050382:C:T	single nucleotide variant	intron variant	Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139-16T>C	TSC2		Tuberous sclerosis 2	VCV001999628	16	2100385	16	2050384	1999628	2057562	rs2150994521	NC_000016.10:2050383:T:C	single nucleotide variant	intron variant	Likely benign	May 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-15T>A	TSC2		Tuberous sclerosis 2	VCV001552462	16	2100386	16	2050385	1552462	1586541	rs563094714	NC_000016.10:2050384:T:A	single nucleotide variant	intron variant	Likely benign	Aug 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-15T>G	TSC2		Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2	VCV000517101	16	2100386	16	2050385	517101	505144	rs563094714	NC_000016.10:2050384:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.139-14T>G	TSC2		Tuberous sclerosis 2	VCV001627695	16	2100387	16	2050386	1627695	1530913	rs1366210687	NC_000016.10:2050385:T:G	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-13C>A	TSC2		Tuberous sclerosis 2	VCV002806376	16	2100388	16	2050387	2806376	2971308	rs2150994586	NC_000016.10:2050386:C:A	single nucleotide variant	intron variant	Likely benign	Aug 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-13C>T	TSC2		Tuberous sclerosis 2	VCV001934613	16	2100388	16	2050387	1934613	1985738	rs2150994586	NC_000016.10:2050386:C:T	single nucleotide variant	intron variant	Likely benign	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-12A>G	TSC2		Tuberous sclerosis 2	VCV003609641	16	2100389	16	2050388	3609641	3744506		NC_000016.10:2050387:A:G	single nucleotide variant	intron variant	Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139-11T>A	TSC2		Tuberous sclerosis 2	VCV003692713	16	2100390	16	2050389	3692713	3828211		NC_000016.10:2050388:T:A	single nucleotide variant	intron variant	Likely benign	Apr 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-10C>T	TSC2		Tuberous sclerosis 2	VCV000706468	16	2100391	16	2050390	706468	695680	rs996641937	NC_000016.10:2050389:C:T	single nucleotide variant	intron variant	Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139-8C>G	TSC2		Tuberous sclerosis 2	VCV001610639	16	2100393	16	2050392	1610639	1585457	rs1382083945	NC_000016.10:2050391:C:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-8C>T	TSC2		Tuberous sclerosis 2	VCV001081646	16	2100393	16	2050392	1081646	1081765	rs1382083945	NC_000016.10:2050391:C:T	single nucleotide variant	intron variant	Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139-6C>T	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000413623	16	2100395	16	2050394	413623	400744	rs778516569	NC_000016.10:2050393:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139-6C>G	TSC2		Tuberous sclerosis 2	VCV000406000	16	2100395	16	2050394	406000	400588	rs778516569	NC_000016.10:2050393:C:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-5T>G	TSC2		Tuberous sclerosis 2	VCV002122407	16	2100396	16	2050395	2122407	2173832	rs2548371649	NC_000016.10:2050394:T:G	single nucleotide variant	intron variant	Likely benign	Apr 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.139-4C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001595947	16	2100397	16	2050396	1595947	1569522	rs747561824	NC_000016.10:2050395:C:T	single nucleotide variant	intron variant	Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139-4C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001088558	16	2100397	16	2050396	1088558	1081766	rs747561824	NC_000016.10:2050395:C:G	single nucleotide variant	intron variant	Likely benign	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139-2A>G	TSC2		Tuberous sclerosis 2	VCV000863043	16	2100399	16	2050398	863043	852636	rs2084954667	NC_000016.10:2050397:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Nov 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139-1G>A	TSC2		Tuberous sclerosis 2	VCV000579576	16	2100400	16	2050399	579576	569583	rs1567386603	NC_000016.10:2050398:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.139G>T (p.Glu47Ter)	TSC2	E47*, E58*	not provided	VCV000448720	16	2100401	16	2050400	448720	441776	rs1555495676	NC_000016.10:2050399:G:T	single nucleotide variant	nonsense|5 prime UTR variant	Pathogenic	Feb 20, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.140A>G (p.Glu47Gly)	TSC2	E47G, E58G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003649458	16	2100402	16	2050401	3649458	3777420		NC_000016.10:2050400:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.141A>G (p.Glu47=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001561963	16	2100403	16	2050402	1561963	1608502	rs137854133	NC_000016.10:2050401:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.141A>T (p.Glu47Asp)	TSC2	E47D, E58D	Tuberous sclerosis 2	VCV000049157	16	2100403	16	2050402	49157	58319	rs137854133	NC_000016.10:2050401:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.142C>G (p.Leu48Val)	TSC2	L48V, L59V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV001511595	16	2100404	16	2050403	1511595	1459076	rs1486839704	NC_000016.10:2050402:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Sep 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.143T>G (p.Leu48Arg)	TSC2	L48R, L59R	Tuberous sclerosis 2	VCV003637169	16	2100405	16	2050404	3637169	3771323		NC_000016.10:2050403:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.143T>A (p.Leu48Gln)	TSC2	L48Q, L59Q	Hereditary cancer-predisposing syndrome	VCV002564652	16	2100405	16	2050404	2564652	2733808	rs2150995062	NC_000016.10:2050403:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.145A>G (p.Ser49Gly)	TSC2	S49G, S60G	Tuberous sclerosis 2	VCV003637170	16	2100407	16	2050406	3637170	3771324		NC_000016.10:2050405:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.146G>A (p.Ser49Asn)	TSC2	S60N, S49N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001028340	16	2100408	16	2050407	1028340	1018040	rs2084956276	NC_000016.10:2050406:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.147C>T (p.Ser49=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467875	16	2100409	16	2050408	467875	465705	rs1555495692	NC_000016.10:2050407:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.148A>C (p.Met50Leu)	TSC2	M1L, M50L, M61L	Hereditary cancer-predisposing syndrome	VCV002626407	16	2100410	16	2050409	2626407	2794173	rs140618379	NC_000016.10:2050408:A:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.148A>G (p.Met50Val)	TSC2	M50V, M61V, M1V	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2	VCV000237966	16	2100410	16	2050409	237966	242204	rs140618379	NC_000016.10:2050408:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.149T>G (p.Met50Arg)	TSC2	M50R, M61R, M1R	Hereditary cancer-predisposing syndrome	VCV003462619	16	2100411	16	2050410	3462619	3621638		NC_000016.10:2050409:T:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.149T>C (p.Met50Thr)	TSC2	M50T, M61T, M1T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000406067	16	2100411	16	2050410	406067	401135	rs1060500955	NC_000016.10:2050409:T:C	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Uncertain significance	Jun 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.151G>C (p.Glu51Gln)	TSC2	E2Q, E51Q, E62Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000837852	16	2100413	16	2050412	837852	843308	rs910205065	NC_000016.10:2050411:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.152A>C (p.Glu51Ala)	TSC2	E51A, E2A, E62A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000207736	16	2100414	16	2050413	207736	203084	rs772617064	NC_000016.10:2050412:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.153A>T (p.Glu51Asp)	TSC2	E51D, E2D, E62D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000819437	16	2100415	16	2050414	819437	812464	rs746366461	NC_000016.10:2050413:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.153A>C (p.Glu51Asp)	TSC2	E51D, E62D, E2D	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000577058	16	2100415	16	2050414	577058	569584	rs746366461	NC_000016.10:2050413:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.153A>G (p.Glu51=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000514502	16	2100415	16	2050414	514502	505445	rs746366461	NC_000016.10:2050413:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.154T>G (p.Cys52Gly)	TSC2	C52G, C3G, C63G	Hereditary cancer-predisposing syndrome	VCV002626422	16	2100416	16	2050415	2626422	2794188	rs2084958377	NC_000016.10:2050414:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.154T>C (p.Cys52Arg)	TSC2	C3R, C52R, C63R	Tuberous sclerosis 2	VCV001005708	16	2100416	16	2050415	1005708	996682	rs2084958377	NC_000016.10:2050414:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.156T>C (p.Cys52=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002707230	16	2100418	16	2050417	2707230	2866921	rs2548372094	NC_000016.10:2050416:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.156T>G (p.Cys52Trp)	TSC2	C52W, C3W, C63W	Hereditary cancer-predisposing syndrome	VCV001775492	16	2100418	16	2050417	1775492	1830689	rs2548372094	NC_000016.10:2050416:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.160C>G (p.Leu54Val)	TSC2	L5V, L65V, L54V	Tuberous sclerosis 2	VCV001499930	16	2100422	16	2050421	1499930	1385750	rs1394176023	NC_000016.10:2050420:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.160C>T (p.Leu54Phe)	TSC2	L54F, L5F, L65F	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000852430	16	2100422	16	2050421	852430	843309	rs1394176023	NC_000016.10:2050420:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.161T>G (p.Leu54Arg)	TSC2	L5R, L54R, L65R	Tuberous sclerosis 2	VCV002130977	16	2100423	16	2050422	2130977	2186272	rs2150995490	NC_000016.10:2050421:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.161T>C (p.Leu54Pro)	TSC2	L54P, L65P, L5P	Hereditary cancer-predisposing syndrome	VCV001776584	16	2100423	16	2050422	1776584	1833860	rs2150995490	NC_000016.10:2050421:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.162C>G (p.Leu54=)	TSC2		Tuberous sclerosis 2	VCV004071358	16	2100424	16	2050423	4071358	4185206		NC_000016.10:2050422:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	Apr 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.162C>T (p.Leu54=)	TSC2		Tuberous sclerosis 2	VCV004071214	16	2100424	16	2050423	4071214	4185062		NC_000016.10:2050422:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	Apr 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.163A>C (p.Asn55His)	TSC2	N66H, N55H, N6H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000846708	16	2100425	16	2050424	846708	843310	rs2084958940	NC_000016.10:2050423:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.164A>T (p.Asn55Ile)	TSC2	N6I, N66I, N55I	Hereditary cancer-predisposing syndrome	VCV000819747	16	2100426	16	2050425	819747	812465	rs1555495709	NC_000016.10:2050424:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 7, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.164A>G (p.Asn55Ser)	TSC2	N55S, N6S, N66S	Tuberous sclerosis 2|not provided	VCV000535994	16	2100426	16	2050425	535994	530078	rs1555495709	NC_000016.10:2050424:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.165C>G (p.Asn55Lys)	TSC2	N55K, N66K, N6K	Tuberous sclerosis syndrome	VCV003071583	16	2100427	16	2050426	3071583	3233849	rs1596245687	NC_000016.10:2050425:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.165C>T (p.Asn55=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000819736	16	2100427	16	2050426	819736	812466	rs1596245687	NC_000016.10:2050425:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.166A>G (p.Asn56Asp)	TSC2	N56D, N67D, N7D	Hereditary cancer-predisposing syndrome	VCV003811334	16	2100428	16	2050427	3811334	3928575		NC_000016.10:2050426:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.167A>T (p.Asn56Ile)	TSC2	N56I, N67I, N7I	Tuberous sclerosis 2	VCV000943085	16	2100429	16	2050428	943085	937275	rs144165984	NC_000016.10:2050427:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.167A>G (p.Asn56Ser)	TSC2	N56S, N67S, N7S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000161398	16	2100429	16	2050428	161398	171186	rs144165984	NC_000016.10:2050427:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Benign/Likely benign	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.168T>C (p.Asn56=)	TSC2		Tuberous sclerosis 2	VCV004071259	16	2100430	16	2050429	4071259	4185107		NC_000016.10:2050428:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.168T>A (p.Asn56Lys)	TSC2	N7K, N67K, N56K	Hereditary cancer-predisposing syndrome	VCV002564653	16	2100430	16	2050429	2564653	2733809	rs2150995697	NC_000016.10:2050428:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.169C>T (p.Arg57Cys)	TSC2	R57C, R68C, R8C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000535903	16	2100431	16	2050430	535903	529814	rs1430159201	NC_000016.10:2050429:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.170G>A (p.Arg57His)	TSC2	R57H, R68H, R8H	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000064932	16	2100432	16	2050431	64932	75862	rs397514949	NC_000016.10:2050430:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Apr 24, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.172A>G (p.Ile58Val)	TSC2	I58V, I9V, I69V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000834857	16	2100434	16	2050433	834857	843311	rs2084960700	NC_000016.10:2050432:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.174C>T (p.Ile58=)	TSC2		Tuberous sclerosis 2	VCV001598190	16	2100436	16	2050435	1598190	1660796	rs2150995862	NC_000016.10:2050434:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.174C>A (p.Ile58=)	TSC2		Tuberous sclerosis 2	VCV001101925	16	2100436	16	2050435	1101925	1103601	rs2150995862	NC_000016.10:2050434:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Apr 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.175C>A (p.Arg59=)	TSC2		Tuberous sclerosis 2	VCV001414284	16	2100437	16	2050436	1414284	1358307	rs1015282988	NC_000016.10:2050435:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.175C>T (p.Arg59Trp)	TSC2	R10W, R59W, R70W	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000659055	16	2100437	16	2050436	659055	644130	rs1015282988	NC_000016.10:2050435:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.176G>C (p.Arg59Pro)	TSC2	R59P, R70P, R10P	Tuberous sclerosis 2	VCV000535933	16	2100438	16	2050437	535933	529819	rs1161261925	NC_000016.10:2050436:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 11, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.176G>A (p.Arg59Gln)	TSC2	R59Q, R10Q, R70Q	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000486661	16	2100438	16	2050437	486661	477258	rs1161261925	NC_000016.10:2050436:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.177G>C (p.Arg59=)	TSC2		Tuberous sclerosis 2	VCV002037150	16	2100439	16	2050438	2037150	2097642	rs2150995969	NC_000016.10:2050437:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.177G>T (p.Arg59=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001779966	16	2100439	16	2050438	1779966	1838618	rs2150995969	NC_000016.10:2050437:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 1, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.177G>A (p.Arg59=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001779956	16	2100439	16	2050438	1779956	1838608	rs2150995969	NC_000016.10:2050437:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Sep 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.178A>T (p.Met60Leu)	TSC2	M11L, M71L, M60L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001507492	16	2100440	16	2050439	1507492	1351951	rs1053960780	NC_000016.10:2050438:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.178A>G (p.Met60Val)	TSC2	M60V, M71V, M11V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000854678	16	2100440	16	2050439	854678	843312	rs1053960780	NC_000016.10:2050438:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 29, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.181A>G (p.Ile61Val)	TSC2	I61V, I12V, I72V	Tuberous sclerosis 2	VCV000942160	16	2100443	16	2050442	942160	937276	rs2084961446	NC_000016.10:2050441:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 17, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.181A>T (p.Ile61Leu)	TSC2	I12L, I61L, I72L	Tuberous sclerosis 2	VCV000839588	16	2100443	16	2050442	839588	843313	rs2084961446	NC_000016.10:2050441:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 17, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.183A>G (p.Ile61Met)	TSC2	I12M, I61M, I72M	Autism spectrum disorder|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001007004	16	2100445	16	2050444	1007004	996683	rs2084961841	NC_000016.10:2050443:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 25, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.185G>C (p.Gly62Ala)	TSC2	G13A, G62A, G73A	Hereditary cancer-predisposing syndrome	VCV003232092	16	2100447	16	2050446	3232092	3385632	rs397515045	NC_000016.10:2050445:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.185G>A (p.Gly62Glu)	TSC2	G62E, G13E, G73E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000065064	16	2100447	16	2050446	65064	75994	rs397515045	NC_000016.10:2050445:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Feb 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.186G>A (p.Gly62=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001781659	16	2100448	16	2050447	1781659	1839005	rs200912369	NC_000016.10:2050446:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	Feb 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.187C>T (p.Gln63Ter)	TSC2	Q63*, Q74*, Q14*	Tuberous sclerosis 2	VCV000065057	16	2100449	16	2050448	65057	75987	rs397515039	NC_000016.10:2050447:C:T	single nucleotide variant	nonsense|5 prime UTR variant	Pathogenic	Jul 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.188A>G (p.Gln63Arg)	TSC2	Q14R, Q63R, Q74R	Tuberous sclerosis 2	VCV002695172	16	2100450	16	2050449	2695172	2854032	rs2150996390	NC_000016.10:2050448:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.188A>T (p.Gln63Leu)	TSC2	Q14L, Q74L, Q63L	Tuberous sclerosis 2	VCV001490442	16	2100450	16	2050449	1490442	1433511	rs2150996390	NC_000016.10:2050448:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	May 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.189G>T (p.Gln63His)	TSC2	Q14H, Q63H, Q74H	Tuberous sclerosis syndrome	VCV003071292	16	2100451	16	2050450	3071292	3228873	rs2150996416	NC_000016.10:2050449:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.189G>C (p.Gln63His)	TSC2	Q63H, Q14H, Q74H	Hereditary cancer-predisposing syndrome	VCV001782249	16	2100451	16	2050450	1782249	1842633	rs2150996416	NC_000016.10:2050449:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 14, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.190A>C (p.Ile64Leu)	TSC2	I15L, I64L, I75L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001782466	16	2100452	16	2050451	1782466	1842850	rs397515081	NC_000016.10:2050450:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.190A>T (p.Ile64Phe)	TSC2	I75F, I15F, I64F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000645136	16	2100452	16	2050451	645136	644131	rs397515081	NC_000016.10:2050450:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.190A>G (p.Ile64Val)	TSC2	I64V, I15V, I75V	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000065108	16	2100452	16	2050451	65108	76039	rs397515081	NC_000016.10:2050450:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jul 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.192T>G (p.Ile64Met)	TSC2	I15M, I64M, I75M	Hereditary cancer-predisposing syndrome	VCV003462643	16	2100454	16	2050453	3462643	3621662		NC_000016.10:2050452:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.193T>C (p.Cys65Arg)	TSC2	C65R, C16R, C76R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406100	16	2100455	16	2050454	406100	401136	rs1060500965	NC_000016.10:2050453:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.194G>A (p.Cys65Tyr)	TSC2	C16Y, C65Y, C76Y	Tuberous sclerosis 2	VCV001053841	16	2100456	16	2050455	1053841	1049416	rs1299377997	NC_000016.10:2050454:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.195T>C (p.Cys65=)	TSC2		Tuberous sclerosis 2	VCV001094582	16	2100457	16	2050456	1094582	1081767	rs764177596	NC_000016.10:2050455:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Apr 1, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.196G>C (p.Glu66Gln)	TSC2	E17Q, E66Q, E77Q	Ovarian cancer	VCV002445248	16	2100458	16	2050457	2445248	2418975	rs45517094	NC_000016.10:2050456:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Jan 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.196G>A (p.Glu66Lys)	TSC2	E17K, E77K, E66K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002061642	16	2100458	16	2050457	2061642	2120790	rs45517094	NC_000016.10:2050456:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.198A>C (p.Glu66Asp)	TSC2	E17D, E66D, E77D	Tuberous sclerosis 2	VCV002859055	16	2100460	16	2050459	2859055	3025270	rs1596245865	NC_000016.10:2050458:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.198A>G (p.Glu66=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000793109	16	2100460	16	2050459	793109	785179	rs1596245865	NC_000016.10:2050458:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.199G>T (p.Val67Phe)	TSC2	V67F, V18F, V78F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000840287	16	2100461	16	2050460	840287	843314	rs774506901	NC_000016.10:2050459:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.199G>A (p.Val67Ile)	TSC2	V67I, V18I, V78I	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535927	16	2100461	16	2050460	535927	529529	rs774506901	NC_000016.10:2050459:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Nov 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.200T>G (p.Val67Gly)	TSC2	V18G, V67G, V78G	Hereditary cancer-predisposing syndrome	VCV003232099	16	2100462	16	2050461	3232099	3385639	rs2084964913	NC_000016.10:2050460:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.201C>G (p.Val67=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001636802	16	2100463	16	2050462	1636802	1612091	rs45460096	NC_000016.10:2050461:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.201C>A (p.Val67=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001135918	16	2100463	16	2050462	1135918	1125005	rs45460096	NC_000016.10:2050461:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	May 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.201C>T (p.Val67=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050100	16	2100463	16	2050462	50100	59262	rs45460096	NC_000016.10:2050461:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.202G>A (p.Ala68Thr)	TSC2	A19T, A79T, A68T	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000966947	16	2100464	16	2050463	966947	957665	rs767626323	NC_000016.10:2050462:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.202G>C (p.Ala68Pro)	TSC2	A68P, A19P, A79P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000570657	16	2100464	16	2050463	570657	573751	rs767626323	NC_000016.10:2050462:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.203C>T (p.Ala68Val)	TSC2	A68V, A79V, A19V	Tuberous sclerosis 2	VCV002120989	16	2100465	16	2050464	2120989	2184041	rs2548373159	NC_000016.10:2050463:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.203C>G (p.Ala68Gly)	TSC2	A19G, A68G, A79G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV001784866	16	2100465	16	2050464	1784866	1843511	rs2548373159	NC_000016.10:2050463:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jun 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.204A>G (p.Ala68=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001785024	16	2100466	16	2050465	1785024	1843669	rs2548373174	NC_000016.10:2050464:A:G	single nucleotide variant	5 prime UTR variant|synonymous variant|non-coding transcript variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.205A>G (p.Lys69Glu)	TSC2	K69E, K80E, K20E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535919	16	2100467	16	2050466	535919	530079	rs45517095	NC_000016.10:2050465:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.206A>G (p.Lys69Arg)	TSC2	K20R, K69R, K80R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001785341	16	2100468	16	2050467	1785341	1840138	rs756020849	NC_000016.10:2050466:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	May 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.208A>C (p.Thr70Pro)	TSC2	T21P, T70P, T81P	Tuberous sclerosis 2	VCV001920007	16	2100470	16	2050469	1920007	1978919	rs2548373235	NC_000016.10:2050468:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.209C>T (p.Thr70Ile)	TSC2	T70I, T81I, T21I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002455202	16	2100471	16	2050470	2455202	2427278	rs1013995962	NC_000016.10:2050469:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.209C>A (p.Thr70Asn)	TSC2	T21N, T81N, T70N	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000810703	16	2100471	16	2050470	810703	797272	rs1013995962	NC_000016.10:2050469:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.209C>G (p.Thr70Ser)	TSC2	T81S, T70S, T21S	Tuberous sclerosis 2	VCV000663039	16	2100471	16	2050470	663039	644132	rs1013995962	NC_000016.10:2050469:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.210C>T (p.Thr70=)	TSC2		Tuberous sclerosis 2	VCV004071245	16	2100472	16	2050471	4071245	4185093		NC_000016.10:2050470:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.210C>G (p.Thr70=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001137067	16	2100472	16	2050471	1137067	1125006	rs2084966494	NC_000016.10:2050470:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.211A>G (p.Lys71Glu)	TSC2	K71E, K82E, K22E	Hereditary cancer-predisposing syndrome	VCV001786213	16	2100473	16	2050472	1786213	1846965	rs2084966690	NC_000016.10:2050471:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.213G>C (p.Lys71Asn)	TSC2	K82N, K71N, K22N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001786560	16	2100475	16	2050474	1786560	1843930	rs766200310	NC_000016.10:2050473:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.213G>A (p.Lys71=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000820791	16	2100475	16	2050474	820791	812467	rs766200310	NC_000016.10:2050473:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.213G>T (p.Lys71Asn)	TSC2	K71N, K22N, K82N	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000207740	16	2100475	16	2050474	207740	203085	rs766200310	NC_000016.10:2050473:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.214A>G (p.Lys72Glu)	TSC2	K23E, K72E, K83E	Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV001015368	16	2100476	16	2050475	1015368	1011927	rs2084967199	NC_000016.10:2050474:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.215A>G (p.Lys72Arg)	TSC2	K72R, K23R, K83R	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000467927	16	2100477	16	2050476	467927	465708	rs1489623582	NC_000016.10:2050475:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.216A>C (p.Lys72Asn)	TSC2	K72N, K83N, K23N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001346754	16	2100478	16	2050477	1346754	1456716	rs1201047547	NC_000016.10:2050476:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.216A>G (p.Lys72=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001127511	16	2100478	16	2050477	1127511	1125007	rs1201047547	NC_000016.10:2050476:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.217T>G (p.Phe73Val)	TSC2	F24V, F73V, F84V	not provided|Tuberous sclerosis 2	VCV000840098	16	2100479	16	2050478	840098	843315	rs1596245977	NC_000016.10:2050477:T:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.217T>C (p.Phe73Leu)	TSC2	F84L, F73L, F24L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000820853	16	2100479	16	2050478	820853	812468	rs1596245977	NC_000016.10:2050477:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.220G>T (p.Glu74Ter)	TSC2	E85*, E74*, E25*	Hereditary cancer-predisposing syndrome	VCV001787749	16	2100482	16	2050481	1787749	1850729	rs2150997192	NC_000016.10:2050480:G:T	single nucleotide variant	nonsense|5 prime UTR variant	Pathogenic	Jan 26, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.221A>G (p.Glu74Gly)	TSC2	E74G, E25G, E85G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001046113	16	2100483	16	2050482	1046113	1032425	rs2084968438	NC_000016.10:2050481:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Aug 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.222A>G (p.Glu74=)	TSC2		Tuberous sclerosis 2	VCV001154531	16	2100484	16	2050483	1154531	1145890	rs2150997246	NC_000016.10:2050482:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant	Likely benign	Jul 7, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.223G>C (p.Glu75Gln)	TSC2	E86Q, E75Q, E26Q	Tuberous sclerosis 2	VCV001046676	16	2100485	16	2050484	1046676	1032426	rs145470784	NC_000016.10:2050483:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Uncertain significance	Oct 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.223G>A (p.Glu75Lys)	TSC2	E75K, E26K, E86K	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000161399	16	2100485	16	2050484	161399	171187	rs145470784	NC_000016.10:2050483:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.225G>A (p.Glu75=)	TSC2		not provided	VCV003572144	16	2100487	16	2050486	3572144	3731045		NC_000016.10:2050485:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+1G>A	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000626196	16	2100488	16	2050487	626196	614413	rs1567387207	NC_000016.10:2050486:G:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.225+2T>G	TSC2		Tuberous sclerosis syndrome	VCV003236656	16	2100489	16	2050488	3236656	3395776	rs397515105	NC_000016.10:2050487:T:G	single nucleotide variant	splice donor variant	Pathogenic	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+2T>C	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000834629	16	2100489	16	2050488	834629	851653	rs397515105	NC_000016.10:2050487:T:C	single nucleotide variant	splice donor variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.225+2T>A	TSC2		Tuberous sclerosis 2	VCV000065138	16	2100489	16	2050488	65138	76069	rs397515105	NC_000016.10:2050487:T:A	single nucleotide variant	splice donor variant	Pathogenic	Nov 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+3A>T	TSC2		Tuberous sclerosis 2	VCV002812128	16	2100490	16	2050489	2812128	2965521	rs1060500963	NC_000016.10:2050488:A:T	single nucleotide variant	intron variant	Likely benign	Nov 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+3A>G	TSC2		Tuberous sclerosis 2	VCV000406095	16	2100490	16	2050489	406095	400590	rs1060500963	NC_000016.10:2050488:A:G	single nucleotide variant	intron variant	Likely benign	Aug 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+4G>C	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002028686	16	2100491	16	2050490	2028686	2085321	rs201901739	NC_000016.10:2050489:G:C	single nucleotide variant	intron variant	Uncertain significance	Feb 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.225+4G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000406047	16	2100491	16	2050490	406047	401139	rs201901739	NC_000016.10:2050489:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.225+5G>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406046	16	2100492	16	2050491	406046	401397	rs778371172	NC_000016.10:2050490:G:T	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.225+7T>C	TSC2		Tuberous sclerosis 2	VCV000758553	16	2100494	16	2050493	758553	776278	rs1596246066	NC_000016.10:2050492:T:C	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.225+10T>A	TSC2		Tuberous sclerosis 2	VCV001146991	16	2100497	16	2050496	1146991	1145891	rs2150997561	NC_000016.10:2050495:T:A	single nucleotide variant	intron variant	Likely benign	Aug 31, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+12C>T	TSC2		Tuberous sclerosis 2	VCV001601909	16	2100499	16	2050498	1601909	1633035	rs886038352	NC_000016.10:2050497:C:T	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+12C>A	TSC2		not specified|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000256623	16	2100499	16	2050498	256623	255482	rs886038352	NC_000016.10:2050497:C:A	single nucleotide variant	intron variant	Likely benign	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.225+14G>A	TSC2		Tuberous sclerosis 2	VCV002778749	16	2100501	16	2050500	2778749	2943786	rs1406190529	NC_000016.10:2050499:G:A	single nucleotide variant	intron variant	Likely benign	Sep 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+14G>T	TSC2		Tuberous sclerosis 2	VCV002113650	16	2100501	16	2050500	2113650	2161185	rs1406190529	NC_000016.10:2050499:G:T	single nucleotide variant	intron variant	Likely benign	Apr 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+16T>C	TSC2		Tuberous sclerosis 2	VCV002130961	16	2100503	16	2050502	2130961	2186256	rs2150997719	NC_000016.10:2050501:T:C	single nucleotide variant	intron variant	Likely benign	Apr 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+16T>A	TSC2		Tuberous sclerosis 2	VCV001619019	16	2100503	16	2050502	1619019	1548794	rs2150997719	NC_000016.10:2050501:T:A	single nucleotide variant	intron variant	Likely benign	Nov 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+18A>G	TSC2		Tuberous sclerosis 2	VCV002138901	16	2100505	16	2050504	2138901	1878572	rs1402832502	NC_000016.10:2050503:A:G	single nucleotide variant	intron variant	Likely benign	Dec 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+19G>C	TSC2		Tuberous sclerosis 2	VCV001548706	16	2100506	16	2050505	1548706	1658073	rs980875984	NC_000016.10:2050504:G:C	single nucleotide variant	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+19G>A	TSC2		not specified|Tuberous sclerosis 2	VCV000509671	16	2100506	16	2050505	509671	506133	rs980875984	NC_000016.10:2050504:G:A	single nucleotide variant	intron variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.225+20C>T	TSC2		Tuberous sclerosis 2	VCV002129475	16	2100507	16	2050506	2129475	2190899	rs747834120	NC_000016.10:2050505:C:T	single nucleotide variant	intron variant	Likely benign	May 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.225+20C>G	TSC2		Tuberous sclerosis 2	VCV001435403	16	2100507	16	2050506	1435403	1422377	rs747834120	NC_000016.10:2050505:C:G	single nucleotide variant	intron variant	Likely benign	Sep 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-338C>T	TSC2		not provided	VCV000680816	16	2103005	16	2053004	680816	667384	rs2516735	NC_000016.10:2053003:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-82C>T	TSC2		not provided	VCV000673418	16	2103261	16	2053260	673418	668359	rs7185742	NC_000016.10:2053259:C:T	single nucleotide variant	intron variant	Likely benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.226-74G>A	TSC2		Hereditary cancer-predisposing syndrome	VCV002626410	16	2103269	16	2053268	2626410	2794176	rs2548394738	NC_000016.10:2053267:G:A	single nucleotide variant	intron variant	Uncertain significance	Jun 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-20G>A	TSC2		Tuberous sclerosis 2	VCV001650142	16	2103323	16	2053322	1650142	1601854	rs753647216	NC_000016.10:2053321:G:A	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.226-19T>C	TSC2		Tuberous sclerosis 2	VCV004071033	16	2103324	16	2053323	4071033	4184881		NC_000016.10:2053322:T:C	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-19T>G	TSC2		Tuberous sclerosis 2	VCV001668076	16	2103324	16	2053323	1668076	1569941	rs938983644	NC_000016.10:2053322:T:G	single nucleotide variant	intron variant	Likely benign	Nov 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-18C>A	TSC2		Tuberous sclerosis 2	VCV002073076	16	2103325	16	2053324	2073076	2127148	rs2151025462	NC_000016.10:2053323:C:A	single nucleotide variant	intron variant	Likely benign	Jan 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-18C>T	TSC2		Tuberous sclerosis 2	VCV001586477	16	2103325	16	2053324	1586477	1562635	rs2151025462	NC_000016.10:2053323:C:T	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.226-17C>G	TSC2		Tuberous sclerosis 2	VCV002765027	16	2103326	16	2053325	2765027	2928793	rs1356531469	NC_000016.10:2053324:C:G	single nucleotide variant	intron variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-17C>T	TSC2		Tuberous sclerosis 2	VCV001530775	16	2103326	16	2053325	1530775	1635247	rs1356531469	NC_000016.10:2053324:C:T	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.226-16C>T	TSC2		Tuberous sclerosis 2	VCV002813605	16	2103327	16	2053326	2813605	2969555	rs2151025516	NC_000016.10:2053325:C:T	single nucleotide variant	intron variant	Likely benign	Aug 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-15C>T	TSC2		Tuberous sclerosis 2	VCV001598154	16	2103328	16	2053327	1598154	1660760	rs759316470	NC_000016.10:2053326:C:T	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.226-14T>C	TSC2		Tuberous sclerosis 2	VCV003664221	16	2103329	16	2053328	3664221	3795380		NC_000016.10:2053327:T:C	single nucleotide variant	intron variant	Likely benign	Sep 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-14T>A	TSC2		Tuberous sclerosis 2	VCV002182113	16	2103329	16	2053328	2182113	1909639	rs2151025566	NC_000016.10:2053327:T:A	single nucleotide variant	intron variant	Likely benign	Jan 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-13C>T	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000256624	16	2103330	16	2053329	256624	255483	rs886038353	NC_000016.10:2053328:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.226-11G>A	TSC2		Tuberous sclerosis 2	VCV002700530	16	2103332	16	2053331	2700530	2855529	rs1380316959	NC_000016.10:2053330:G:A	single nucleotide variant	intron variant	Likely benign	Dec 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-10C>T	TSC2		Tuberous sclerosis 2	VCV003726606	16	2103333	16	2053332	3726606	3855096		NC_000016.10:2053331:C:T	single nucleotide variant	intron variant	Likely benign	Dec 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-9T>C	TSC2		Tuberous sclerosis 2	VCV002870995	16	2103334	16	2053333	2870995	3037377	rs2548395850	NC_000016.10:2053332:T:C	single nucleotide variant	intron variant	Likely benign	Dec 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-8G>A	TSC2		Tuberous sclerosis 2	VCV001020408	16	2103335	16	2053334	1020408	1011928	rs2085356308	NC_000016.10:2053333:G:A	single nucleotide variant	intron variant	Uncertain significance	Sep 17, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-7G>C	TSC2		Tuberous sclerosis 2	VCV000536106	16	2103336	16	2053335	536106	529513	rs1555496912	NC_000016.10:2053334:G:C	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.226-6T>A	TSC2		Tuberous sclerosis 2	VCV002767373	16	2103337	16	2053336	2767373	2922947	rs765069074	NC_000016.10:2053335:T:A	single nucleotide variant	intron variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-6T>C	TSC2		Tuberous sclerosis 1	VCV000627569	16	2103337	16	2053336	627569	615924	rs765069074	NC_000016.10:2053335:T:C	single nucleotide variant	intron variant	Uncertain significance	Jan 30, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-5G>C	TSC2		Tuberous sclerosis 2	VCV000744874	16	2103338	16	2053337	744874	760283	rs1596258779	NC_000016.10:2053336:G:C	single nucleotide variant	intron variant	Likely benign	Feb 1, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-5G>A	TSC2		Tuberous sclerosis 2	VCV000701664	16	2103338	16	2053337	701664	690132	rs1596258779	NC_000016.10:2053336:G:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-4A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000318304	16	2103339	16	2053338	318304	334156	rs886051786	NC_000016.10:2053337:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.226-3C>G	TSC2		Tuberous sclerosis 2	VCV003777070	16	2103340	16	2053339	3777070	3893210		NC_000016.10:2053338:C:G	single nucleotide variant	intron variant	Likely pathogenic		criteria provided, single submitter							
NM_000548.5(TSC2):c.226-3C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002067232	16	2103340	16	2053339	2067232	2118625	rs2151025824	NC_000016.10:2053338:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.226-2A>G	TSC2		Tuberous sclerosis 2	VCV000049200	16	2103341	16	2053340	49200	58362	rs45517096	NC_000016.10:2053339:A:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Sep 3, 2013	criteria provided, single submitter							
NM_000548.5(TSC2):c.226-1G>A	TSC2		TSC2-related disorder|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000065180	16	2103342	16	2053341	65180	76111	rs397515134	NC_000016.10:2053340:G:A	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.226C>T (p.His76Tyr)	TSC2	H76Y, H87Y, H27Y	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207787	16	2103343	16	2053342	207787	203086	rs574779350	NC_000016.10:2053341:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.228C>T (p.His76=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000049202	16	2103345	16	2053344	49202	58364	rs45517097	NC_000016.10:2053343:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.229G>T (p.Ala77Ser)	TSC2	A77S, A88S, A28S	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000968409	16	2103346	16	2053345	968409	957666	rs777459404	NC_000016.10:2053344:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.229G>A (p.Ala77Thr)	TSC2	A77T, A88T, A28T	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000576940	16	2103346	16	2053345	576940	567726	rs777459404	NC_000016.10:2053344:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 21, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.231A>G (p.Ala77=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001651724	16	2103348	16	2053347	1651724	1547173	rs2151026046	NC_000016.10:2053346:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.231A>C (p.Ala77=)	TSC2		not provided|Tuberous sclerosis 2	VCV001111873	16	2103348	16	2053347	1111873	1103602	rs2151026046	NC_000016.10:2053346:A:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.233T>A (p.Val78Glu)	TSC2	V29E, V89E, V78E	Tuberous sclerosis 2	VCV002838690	16	2103350	16	2053349	2838690	2999792	rs1163221525	NC_000016.10:2053348:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.233T>C (p.Val78Ala)	TSC2	V78A, V89A, V29A	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000642759	16	2103350	16	2053349	642759	644133	rs1163221525	NC_000016.10:2053348:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.234G>A (p.Val78=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000753532	16	2103351	16	2053350	753532	770659	rs1347487177	NC_000016.10:2053349:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.235G>A (p.Glu79Lys)	TSC2	E30K, E90K, E79K	not provided|Tuberous sclerosis 2	VCV001382405	16	2103352	16	2053351	1382405	1434834	rs2151026169	NC_000016.10:2053350:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.236A>C (p.Glu79Ala)	TSC2	E30A, E79A, E90A	Tuberous sclerosis 2	VCV001720812	16	2103353	16	2053352	1720812	1774794	rs2085359439	NC_000016.10:2053351:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.236A>T (p.Glu79Val)	TSC2	E30V, E90V, E79V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000964182	16	2103353	16	2053352	964182	949220	rs2085359439	NC_000016.10:2053351:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.237A>G (p.Glu79=)	TSC2		Tuberous sclerosis 2	VCV003642879	16	2103354	16	2053353	3642879	3765650		NC_000016.10:2053352:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Feb 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.237A>T (p.Glu79Asp)	TSC2	E79D, E30D, E90D	Tuberous sclerosis 2	VCV000565882	16	2103354	16	2053353	565882	570017	rs1567394781	NC_000016.10:2053352:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 10, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.238G>A (p.Ala80Thr)	TSC2	A91T, A31T, A80T	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000942914	16	2103355	16	2053354	942914	937277	rs2085359793	NC_000016.10:2053353:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.239C>T (p.Ala80Val)	TSC2	A80V, A91V, A31V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000656547	16	2103356	16	2053355	656547	644134	rs142580483	NC_000016.10:2053354:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.240A>G (p.Ala80=)	TSC2		Tuberous sclerosis 2	VCV004071049	16	2103357	16	2053356	4071049	4184897		NC_000016.10:2053355:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.240A>T (p.Ala80=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001790850	16	2103357	16	2053356	1790850	1851211	rs1596258909	NC_000016.10:2053355:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Sep 27, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.241C>T (p.Leu81Phe)	TSC2	L32F, L92F, L81F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV001790993	16	2103358	16	2053357	1790993	1851354	rs2548396461	NC_000016.10:2053356:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.242T>C (p.Leu81Pro)	TSC2	L32P, L81P, L92P	Tuberous sclerosis 2	VCV002706024	16	2103359	16	2053358	2706024	2877349	rs2548396479	NC_000016.10:2053357:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.243C>T (p.Leu81=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564732	16	2103360	16	2053359	2564732	2733888	rs751068235	NC_000016.10:2053358:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.243C>G (p.Leu81=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001082909	16	2103360	16	2053359	1082909	1081768	rs751068235	NC_000016.10:2053358:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.244T>C (p.Trp82Arg)	TSC2	W82R, W93R, W33R	Tuberous sclerosis 2	VCV000237991	16	2103361	16	2053360	237991	242205	rs878854083	NC_000016.10:2053359:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 12, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.245G>A (p.Trp82Ter)	TSC2	W82*, W33*, W93*	Tuberous sclerosis 2	VCV000064913	16	2103362	16	2053361	64913	75843	rs397514933	NC_000016.10:2053360:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.246G>A (p.Trp82Ter)	TSC2	W82*, W33*, W93*	Tuberous sclerosis 2	VCV000580963	16	2103363	16	2053362	580963	570028	rs1567394860	NC_000016.10:2053361:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 17, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.247A>G (p.Lys83Glu)	TSC2	K83E, K34E, K94E	Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome	VCV001791884	16	2103364	16	2053363	1791884	1845317	rs2085361160	NC_000016.10:2053362:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.248A>C (p.Lys83Thr)	TSC2	K34T, K94T, K83T	Hereditary cancer-predisposing syndrome	VCV001792036	16	2103365	16	2053364	1792036	1845469	rs1267562998	NC_000016.10:2053363:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.248A>G (p.Lys83Arg)	TSC2	K34R, K83R, K94R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000821352	16	2103365	16	2053364	821352	812469	rs1267562998	NC_000016.10:2053363:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.249G>A (p.Lys83=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001078329	16	2103366	16	2053365	1078329	1081769	rs1202653675	NC_000016.10:2053364:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.250G>A (p.Ala84Thr)	TSC2	A84T, A95T, A35T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001792378	16	2103367	16	2053366	1792378	1841966	rs2151026510	NC_000016.10:2053365:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.251C>A (p.Ala84Glu)	TSC2	A35E, A84E, A95E	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001473079	16	2103368	16	2053367	1473079	1501324	rs35660529	NC_000016.10:2053366:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.251C>T (p.Ala84Val)	TSC2	A84V, A35V, A95V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000049212	16	2103368	16	2053367	49212	58374	rs35660529	NC_000016.10:2053366:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.252G>C (p.Ala84=)	TSC2		Tuberous sclerosis 2	VCV002081512	16	2103369	16	2053368	2081512	2139447	rs1316543957	NC_000016.10:2053367:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Mar 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.252G>A (p.Ala84=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000766727	16	2103369	16	2053368	766727	770660	rs1316543957	NC_000016.10:2053367:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.253G>A (p.Val85Ile)	TSC2	V36I, V85I, V96I	not provided	VCV003369761	16	2103370	16	2053369	3369761	3528952		NC_000016.10:2053368:G:A	single nucleotide variant	missense variant|non-coding transcript variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.255C>T (p.Val85=)	TSC2		not provided|not specified|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049572	16	2103372	16	2053371	49572	58734	rs45517098	NC_000016.10:2053370:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.256G>A (p.Ala86Thr)	TSC2	A86T, A37T, A97T	not provided|TSC2-related disorder|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000574849	16	2103373	16	2053372	574849	569588	rs1190158836	NC_000016.10:2053371:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.257C>A (p.Ala86Glu)	TSC2	A97E, A86E, A37E	Tuberous sclerosis 2	VCV002704963	16	2103374	16	2053373	2704963	2863375	rs1369594860	NC_000016.10:2053372:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	Dec 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.257C>T (p.Ala86Val)	TSC2	A86V, A97V, A37V	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000578585	16	2103374	16	2053373	578585	573753	rs1369594860	NC_000016.10:2053372:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.258G>T (p.Ala86=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001793505	16	2103375	16	2053374	1793505	1845631	rs397514912	NC_000016.10:2053373:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jun 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.258G>C (p.Ala86=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000318305	16	2103375	16	2053374	318305	342258	rs397514912	NC_000016.10:2053373:G:C	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.258G>A (p.Ala86=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000064887	16	2103375	16	2053374	64887	75817	rs397514912	NC_000016.10:2053373:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.260A>T (p.Asp87Val)	TSC2	D87V, D98V, D38V	Tuberous sclerosis 2	VCV003637171	16	2103377	16	2053376	3637171	3771325		NC_000016.10:2053375:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.261T>A (p.Asp87Glu)	TSC2	D98E, D38E, D87E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000861838	16	2103378	16	2053377	861838	843316	rs1555496967	NC_000016.10:2053376:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.261T>C (p.Asp87=)	TSC2		Tuberous sclerosis 2	VCV000536059	16	2103378	16	2053377	536059	529829	rs1555496967	NC_000016.10:2053376:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.262C>G (p.Leu88Val)	TSC2	L99V, L88V, L39V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002626449	16	2103379	16	2053378	2626449	2794215	rs45485999	NC_000016.10:2053377:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.262C>T (p.Leu88=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000049217	16	2103379	16	2053378	49217	58379	rs45485999	NC_000016.10:2053377:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.263T>G (p.Leu88Arg)	TSC2	L99R, L88R, L39R	Hereditary cancer-predisposing syndrome	VCV002564654	16	2103380	16	2053379	2564654	2733810	rs2548397140	NC_000016.10:2053378:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.264G>T (p.Leu88=)	TSC2		Tuberous sclerosis 2	VCV002020109	16	2103381	16	2053380	2020109	2083149	rs1466279830	NC_000016.10:2053379:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Nov 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.264G>C (p.Leu88=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001794315	16	2103381	16	2053380	1794315	1852061	rs1466279830	NC_000016.10:2053379:G:C	single nucleotide variant	non-coding transcript variant|intron variant|synonymous variant|5 prime UTR variant	Likely benign	Apr 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.264G>A (p.Leu88=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000762237	16	2103381	16	2053380	762237	770661	rs1466279830	NC_000016.10:2053379:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.265T>C (p.Leu89=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001918204	16	2103382	16	2053381	1918204	1978415	rs1336362677	NC_000016.10:2053380:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.267G>T (p.Leu89Phe)	TSC2	L100F, L40F, L89F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001794674	16	2103384	16	2053383	1794674	1852419	rs1286845026	NC_000016.10:2053382:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.268C>G (p.Gln90Glu)	TSC2	Q101E, Q41E, Q90E	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003073488	16	2103385	16	2053384	3073488	3234444	rs45517099	NC_000016.10:2053383:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.268C>A (p.Gln90Lys)	TSC2	Q101K, Q90K, Q41K	Hereditary cancer-predisposing syndrome	VCV001794775	16	2103385	16	2053384	1794775	1848984	rs45517099	NC_000016.10:2053383:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.268C>T (p.Gln90Ter)	TSC2	Q90*, Q41*, Q101*	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049738	16	2103385	16	2053384	49738	58900	rs45517099	NC_000016.10:2053383:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.269A>G (p.Gln90Arg)	TSC2	Q101R, Q90R, Q41R	Hereditary cancer-predisposing syndrome	VCV003462536	16	2103386	16	2053385	3462536	3621556		NC_000016.10:2053384:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.269A>T (p.Gln90Leu)	TSC2	Q101L, Q41L, Q90L	Tuberous sclerosis 2	VCV002117572	16	2103386	16	2053385	2117572	2183213	rs2151027126	NC_000016.10:2053384:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.270G>T (p.Gln90His)	TSC2	Q41H, Q90H, Q101H	Tuberous sclerosis 2	VCV002095850	16	2103387	16	2053386	2095850	2149767	rs779310889	NC_000016.10:2053385:G:T	single nucleotide variant	missense variant|intron variant	Benign	Feb 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.270G>A (p.Gln90=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000467958	16	2103387	16	2053386	467958	465713	rs779310889	NC_000016.10:2053385:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.271C>T (p.Pro91Ser)	TSC2	P91S, P102S, P42S	TSC2-related disorder|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000535967	16	2103388	16	2053387	535967	530085	rs1555496979	NC_000016.10:2053386:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.271C>A (p.Pro91Thr)	TSC2	P91T, P102T, P42T	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467960	16	2103388	16	2053387	467960	465135	rs1555496979	NC_000016.10:2053386:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.272C>T (p.Pro91Leu)	TSC2	P91L, P102L, P42L	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2	VCV000049225	16	2103389	16	2053388	49225	58387	rs45482691	NC_000016.10:2053387:C:T	single nucleotide variant	missense variant|intron variant	Benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.273G>T (p.Pro91=)	TSC2		Tuberous sclerosis 2	VCV001555869	16	2103390	16	2053389	1555869	1626743	rs772296140	NC_000016.10:2053388:G:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.273G>A (p.Pro91=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000413680	16	2103390	16	2053389	413680	400746	rs772296140	NC_000016.10:2053388:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.274G>T (p.Glu92Ter)	TSC2	E103*, E43*, E92*	not provided	VCV003911794	16	2103391	16	2053390	3911794	4025769		NC_000016.10:2053389:G:T	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant|intron variant	Pathogenic	Feb 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.274G>C (p.Glu92Gln)	TSC2	E103Q, E43Q, E92Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001795544	16	2103391	16	2053390	1795544	1854203	rs1325855418	NC_000016.10:2053389:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.275A>T (p.Glu92Val)	TSC2	E92V, E103V, E43V	Tuberous sclerosis 2|not specified|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000050116	16	2103392	16	2053391	50116	59278	rs137853994	NC_000016.10:2053390:A:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.276G>T (p.Glu92Asp)	TSC2	E103D, E43D, E92D	Tuberous sclerosis 2	VCV002000996	16	2103393	16	2053392	2000996	2061500	rs1271369775	NC_000016.10:2053391:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.276G>A (p.Glu92=)	TSC2		Tuberous sclerosis 2	VCV001107008	16	2103393	16	2053392	1107008	1103603	rs1271369775	NC_000016.10:2053391:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.277C>G (p.Arg93Gly)	TSC2	R44G, R93G, R104G	Tuberous sclerosis 2	VCV003637172	16	2103394	16	2053393	3637172	3771326		NC_000016.10:2053392:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.277C>T (p.Arg93Trp)	TSC2	R93W, R104W, R44W	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000467968	16	2103394	16	2053393	467968	465715	rs760688660	NC_000016.10:2053392:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.278G>A (p.Arg93Gln)	TSC2	R93Q, R44Q, R104Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II	VCV000467970	16	2103395	16	2053394	467970	465998	rs1222477746	NC_000016.10:2053393:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.279G>T (p.Arg93=)	TSC2		Tuberous sclerosis 2	VCV003721559	16	2103396	16	2053395	3721559	3850060		NC_000016.10:2053394:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Sep 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.281C>A (p.Pro94Gln)	TSC2	P45Q, P94Q, P105Q	Hereditary cancer-predisposing syndrome	VCV003329501	16	2103398	16	2053397	3329501	3489093		NC_000016.10:2053396:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.281C>G (p.Pro94Arg)	TSC2	P105R, P45R, P94R	Tuberous sclerosis 2	VCV002125891	16	2103398	16	2053397	2125891	2185060	rs200045926	NC_000016.10:2053396:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.281C>T (p.Pro94Leu)	TSC2	P94L, P105L, P45L	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided|Hereditary cancer-predisposing syndrome	VCV000406038	16	2103398	16	2053397	406038	401140	rs200045926	NC_000016.10:2053396:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.282G>T (p.Pro94=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001670583	16	2103399	16	2053398	1670583	1604890	rs145624233	NC_000016.10:2053397:G:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.282G>A (p.Pro94=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000238001	16	2103399	16	2053398	238001	242206	rs145624233	NC_000016.10:2053397:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.283C>T (p.Leu95=)	TSC2		Tuberous sclerosis 2	VCV002057007	16	2103400	16	2053399	2057007	2105829	rs1257472165	NC_000016.10:2053398:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Aug 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.284T>C (p.Leu95Pro)	TSC2	L46P, L95P, L106P	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001523409	16	2103401	16	2053400	1523409	1350578	rs2085369170	NC_000016.10:2053399:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.284T>G (p.Leu95Arg)	TSC2	L106R, L46R, L95R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001002608	16	2103401	16	2053400	1002608	996684	rs2085369170	NC_000016.10:2053399:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.286G>A (p.Glu96Lys)	TSC2	E107K, E47K, E96K	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001057665	16	2103403	16	2053402	1057665	1049417	rs2151027724	NC_000016.10:2053401:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.287A>G (p.Glu96Gly)	TSC2	E107G, E96G, E47G	Tuberous sclerosis 2	VCV001352607	16	2103404	16	2053403	1352607	1505816	rs2085369532	NC_000016.10:2053402:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.288G>A (p.Glu96=)	TSC2		Tuberous sclerosis 2	VCV004071336	16	2103405	16	2053404	4071336	4185184		NC_000016.10:2053403:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.289G>A (p.Ala97Thr)	TSC2	A108T, A48T, A97T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001024008	16	2103406	16	2053405	1024008	1011929	rs1446873736	NC_000016.10:2053404:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.289G>C (p.Ala97Pro)	TSC2	A48P, A97P, A108P	Tuberous sclerosis 2	VCV000646376	16	2103406	16	2053405	646376	644135	rs1446873736	NC_000016.10:2053404:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 22, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.290C>T (p.Ala97Val)	TSC2	A48V, A108V, A97V	Tuberous sclerosis 2	VCV003713139	16	2103407	16	2053406	3713139	3841403		NC_000016.10:2053405:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.290C>A (p.Ala97Asp)	TSC2	A97D, A108D, A48D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002071933	16	2103407	16	2053406	2071933	2123310	rs2151027838	NC_000016.10:2053405:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.291C>G (p.Ala97=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238003	16	2103408	16	2053407	238003	242207	rs137933794	NC_000016.10:2053406:C:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.292C>G (p.Arg98Gly)	TSC2	R109G, R49G, R98G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001797787	16	2103409	16	2053408	1797787	1854703	rs372321790	NC_000016.10:2053407:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.292C>A (p.Arg98=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413705	16	2103409	16	2053408	413705	400591	rs372321790	NC_000016.10:2053407:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.292C>T (p.Arg98Trp)	TSC2	R98W, R109W, R49W	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000065223	16	2103409	16	2053408	65223	76155	rs372321790	NC_000016.10:2053407:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.293G>T (p.Arg98Leu)	TSC2	R109L, R98L, R49L	Neoplasm	VCV003258002	16	2103410	16	2053409	3258002	3416761		NC_000016.10:2053408:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant							Uncertain significance	Mar 4, 2025	criteria provided, single submitter	
NM_000548.5(TSC2):c.293G>C (p.Arg98Pro)	TSC2	R98P, R109P, R49P	Tuberous sclerosis 2	VCV001481191	16	2103410	16	2053409	1481191	1451629	rs1478204355	NC_000016.10:2053408:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.293G>A (p.Arg98Gln)	TSC2	R98Q, R109Q, R49Q	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000643234	16	2103410	16	2053409	643234	644136	rs1478204355	NC_000016.10:2053408:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.294G>A (p.Arg98=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified|not provided	VCV001809593	16	2103411	16	2053410	1809593	1866597	rs2085370771	NC_000016.10:2053409:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.294G>C (p.Arg98=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001543372	16	2103411	16	2053410	1543372	1632829	rs2085370771	NC_000016.10:2053409:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.297C>T (p.His99=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000467983	16	2103414	16	2053413	467983	465815	rs752498350	NC_000016.10:2053412:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.298G>A (p.Ala100Thr)	TSC2	A111T, A100T, A51T	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000950341	16	2103415	16	2053414	950341	927609	rs369314296	NC_000016.10:2053413:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.299C>T (p.Ala100Val)	TSC2	A100V, A111V, A51V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|not specified	VCV000467984	16	2103416	16	2053415	467984	466000	rs375824753	NC_000016.10:2053414:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.300G>C (p.Ala100=)	TSC2		Tuberous sclerosis 2	VCV003727292	16	2103417	16	2053416	3727292	3861517		NC_000016.10:2053415:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Dec 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.300G>T (p.Ala100=)	TSC2		Tuberous sclerosis 2	VCV001545043	16	2103417	16	2053416	1545043	1644449	rs45517100	NC_000016.10:2053415:G:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.300G>A (p.Ala100=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050170	16	2103417	16	2053416	50170	59332	rs45517100	NC_000016.10:2053415:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.301G>T (p.Val101Leu)	TSC2	V101L, V52L, V112L	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000664080	16	2103418	16	2053417	664080	644137	rs878854089	NC_000016.10:2053416:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.301G>A (p.Val101Met)	TSC2	V101M, V112M, V52M	not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238006	16	2103418	16	2053417	238006	242208	rs878854089	NC_000016.10:2053416:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.302T>G (p.Val101Gly)	TSC2	V112G, V101G, V52G	Hereditary cancer-predisposing syndrome	VCV002564655	16	2103419	16	2053418	2564655	2733811	rs2085372909	NC_000016.10:2053417:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.302T>C (p.Val101Ala)	TSC2	V101A, V112A, V52A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001015478	16	2103419	16	2053418	1015478	1011930	rs2085372909	NC_000016.10:2053417:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.303G>A (p.Val101=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001799138	16	2103420	16	2053419	1799138	1854748	rs2151028329	NC_000016.10:2053418:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Dec 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.304C>T (p.Leu102=)	TSC2		Tuberous sclerosis 2	VCV002845994	16	2103421	16	2053420	2845994	3008354	rs2151028347	NC_000016.10:2053419:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Mar 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.305T>C (p.Leu102Pro)	TSC2	L102P, L113P, L53P	not provided	VCV004083272	16	2103422	16	2053421	4083272	4195957		NC_000016.10:2053420:T:C	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.306G>A (p.Leu102=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329463	16	2103423	16	2053422	3329463	3489055		NC_000016.10:2053421:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Apr 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.306G>T (p.Leu102=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001799482	16	2103423	16	2053422	1799482	1855090	rs2151028373	NC_000016.10:2053421:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Dec 2, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.307G>T (p.Ala103Ser)	TSC2	A103S, A54S, A114S	Tuberous sclerosis 2	VCV002055169	16	2103424	16	2053423	2055169	2105287	rs2151028402	NC_000016.10:2053422:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.307G>A (p.Ala103Thr)	TSC2	A103T, A114T, A54T	Tuberous sclerosis 2	VCV001425907	16	2103424	16	2053423	1425907	1428280	rs2151028402	NC_000016.10:2053422:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.308C>G (p.Ala103Gly)	TSC2	A103G, A114G, A54G	Tuberous sclerosis 2	VCV001379701	16	2103425	16	2053424	1379701	1483080	rs1555497043	NC_000016.10:2053423:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.308C>T (p.Ala103Val)	TSC2	A103V, A114V, A54V	Tuberous sclerosis 2	VCV000467989	16	2103425	16	2053424	467989	465816	rs1555497043	NC_000016.10:2053423:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.309T>A (p.Ala103=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462664	16	2103426	16	2053425	3462664	3621683		NC_000016.10:2053424:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Nov 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.309T>C (p.Ala103=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329516	16	2103426	16	2053425	3329516	3489108		NC_000016.10:2053424:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	May 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.310C>T (p.Leu104=)	TSC2		Tuberous sclerosis 2	VCV001111849	16	2103427	16	2053426	1111849	1103604	rs1596259554	NC_000016.10:2053425:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.310C>G (p.Leu104Val)	TSC2	L115V, L104V, L55V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000662673	16	2103427	16	2053426	662673	644138	rs1596259554	NC_000016.10:2053425:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.311T>C (p.Leu104Pro)	TSC2	L104P, L115P, L55P	Tuberous sclerosis 2	VCV000859124	16	2103428	16	2053427	859124	843317	rs2085373985	NC_000016.10:2053426:T:C	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Apr 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.312G>C (p.Leu104=)	TSC2		Tuberous sclerosis 2	VCV004071107	16	2103429	16	2053428	4071107	4184955		NC_000016.10:2053427:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.313C>T (p.Leu105=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002186018	16	2103430	16	2053429	2186018	1921230	rs2151028526	NC_000016.10:2053428:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.315G>A (p.Leu105=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811275	16	2103432	16	2053431	3811275	3928517		NC_000016.10:2053430:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Feb 26, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.316A>C (p.Lys106Gln)	TSC2	K106Q, K117Q, K57Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449958	16	2103433	16	2053432	2449958	203087	rs1555497046	NC_000016.10:2053431:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.317A>G (p.Lys106Arg)	TSC2	K106R, K117R, K57R	Tuberous sclerosis 2	VCV001490413	16	2103434	16	2053433	1490413	1433482	rs1567395686	NC_000016.10:2053432:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.317A>C (p.Lys106Thr)	TSC2	K106T, K57T, K117T	Tuberous sclerosis 2	VCV000576517	16	2103434	16	2053433	576517	567729	rs1567395686	NC_000016.10:2053432:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.318G>A (p.Lys106=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001026926	16	2103435	16	2053434	1026926	1011931	rs756890243	NC_000016.10:2053433:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.319G>A (p.Ala107Thr)	TSC2	A107T, A118T, A58T	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003071013	16	2103436	16	2053435	3071013	3228597	rs1403848498	NC_000016.10:2053434:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.320C>T (p.Ala107Val)	TSC2	A118V, A107V, A58V	Tuberous sclerosis 2	VCV001400336	16	2103437	16	2053436	1400336	1440563	rs2085374926	NC_000016.10:2053435:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 3, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.320C>A (p.Ala107Asp)	TSC2	A107D, A118D, A58D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000951599	16	2103437	16	2053436	951599	927610	rs2085374926	NC_000016.10:2053435:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.321C>T (p.Ala107=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001120594	16	2103438	16	2053437	1120594	1125008	rs1280933774	NC_000016.10:2053436:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.322A>C (p.Ile108Leu)	TSC2	I108L, I119L, I59L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564656	16	2103439	16	2053438	2564656	2733812	rs955754399	NC_000016.10:2053437:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.322A>G (p.Ile108Val)	TSC2	I108V, I119V, I59V	Tuberous sclerosis 2	VCV000467996	16	2103439	16	2053438	467996	465822	rs955754399	NC_000016.10:2053437:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.323T>C (p.Ile108Thr)	TSC2	I108T, I119T, I59T	Tuberous sclerosis 2	VCV000950316	16	2103440	16	2053439	950316	927611	rs1233900284	NC_000016.10:2053438:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.324C>T (p.Ile108=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000413748	16	2103441	16	2053440	413748	400748	rs973500815	NC_000016.10:2053439:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.325G>T (p.Val109Leu)	TSC2	V120L, V109L, V60L	Tuberous sclerosis syndrome	VCV002774666	16	2103442	16	2053441	2774666	2935393	rs369932305	NC_000016.10:2053440:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.325G>A (p.Val109Met)	TSC2	V109M, V120M, V60M	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207698	16	2103442	16	2053441	207698	203088	rs369932305	NC_000016.10:2053440:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.327G>T (p.Val109=)	TSC2		Tuberous sclerosis 2	VCV001919165	16	2103444	16	2053443	1919165	1971605	rs754348511	NC_000016.10:2053442:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Apr 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.327G>A (p.Val109=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000413736	16	2103444	16	2053443	413736	401401	rs754348511	NC_000016.10:2053442:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.328C>T (p.Gln110Ter)	TSC2	Q110*, Q121*, Q61*	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000423588	16	2103445	16	2053444	423588	409476	rs1064796511	NC_000016.10:2053443:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Feb 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.329A>C (p.Gln110Pro)	TSC2	Q110P, Q121P, Q61P	Tuberous sclerosis 2	VCV001352090	16	2103446	16	2053445	1352090	1482626	rs2085376654	NC_000016.10:2053444:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.329A>G (p.Gln110Arg)	TSC2	Q121R, Q61R, Q110R	Tuberous sclerosis 2	VCV000950213	16	2103446	16	2053445	950213	927612	rs2085376654	NC_000016.10:2053444:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.330G>A (p.Gln110=)	TSC2		Tuberous sclerosis 2	VCV001114196	16	2103447	16	2053446	1114196	1103605	rs1203856960	NC_000016.10:2053445:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.331G>T (p.Gly111Trp)	TSC2	G111W, G122W, G62W	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000823605	16	2103448	16	2053447	823605	812470	rs1266039524	NC_000016.10:2053446:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.332G>A (p.Gly111Glu)	TSC2	G111E, G122E, G62E	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003240651	16	2103449	16	2053448	3240651	3399637	rs1488640964	NC_000016.10:2053447:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.333G>A (p.Gly111=)	TSC2		Tuberous sclerosis 2	VCV001645346	16	2103450	16	2053449	1645346	1652645	rs1198874350	NC_000016.10:2053448:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.333G>C (p.Gly111=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468004	16	2103450	16	2053449	468004	465138	rs1198874350	NC_000016.10:2053448:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.334C>G (p.Gln112Glu)	TSC2	Q123E, Q112E, Q63E	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000823644	16	2103451	16	2053450	823644	812471	rs397515308	NC_000016.10:2053449:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.335A>T (p.Gln112Leu)	TSC2	Q123L, Q112L, Q63L	Tuberous sclerosis 2	VCV003639647	16	2103452	16	2053451	3639647	3764992		NC_000016.10:2053450:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.335A>C (p.Gln112Pro)	TSC2	Q63P, Q123P, Q112P	Hereditary cancer-predisposing syndrome	VCV002564657	16	2103452	16	2053451	2564657	2733813	rs2151029133	NC_000016.10:2053450:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.336G>A (p.Gln112=)	TSC2		Tuberous sclerosis 2	VCV002832231	16	2103453	16	2053452	2832231	2994615	rs2151029157	NC_000016.10:2053451:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Pathogenic	Oct 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+1G>T	TSC2	V64L, V113L	Tuberous sclerosis 2	VCV002109602	16	2103454	16	2053453	2109602	2163477	rs45517102	NC_000016.10:2053452:G:T	single nucleotide variant	missense variant|5 prime UTR variant|splice donor variant|intron variant	Pathogenic/Likely pathogenic	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.336+1G>C	TSC2	V113L, V64L	Tuberous sclerosis 2	VCV000535935	16	2103454	16	2053453	535935	530087	rs45517102	NC_000016.10:2053452:G:C	single nucleotide variant	missense variant|5 prime UTR variant|splice donor variant|intron variant	Pathogenic	Sep 9, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+1G>A	TSC2	V113I, V64I	Tuberous sclerosis 2|not provided	VCV000050064	16	2103454	16	2053453	50064	59226	rs45517102	NC_000016.10:2053452:G:A	single nucleotide variant	missense variant|5 prime UTR variant|splice donor variant|intron variant	Pathogenic	Feb 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.336+2T>G	TSC2	V113G, V64G	not provided	VCV000050065	16	2103455	16	2053454	50065	59227	rs45505995	NC_000016.10:2053453:T:G	single nucleotide variant	missense variant|5 prime UTR variant|splice donor variant|intron variant	Pathogenic	Jun 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+4A>G	TSC2	R114G, R65G	Tuberous sclerosis 2	VCV003658567	16	2103457	16	2053456	3658567	3796988		NC_000016.10:2053455:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+5G>C	TSC2		not provided|Tuberous sclerosis 2	VCV000388832	16	2103458	16	2053457	388832	374726	rs1057523242	NC_000016.10:2053456:G:C	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.336+6G>A	TSC2		Tuberous sclerosis 2	VCV000949831	16	2103459	16	2053458	949831	941120	rs2085379244	NC_000016.10:2053457:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+7C>A	TSC2		Tuberous sclerosis 2	VCV000760658	16	2103460	16	2053459	760658	776284	rs1199855368	NC_000016.10:2053458:C:A	single nucleotide variant	intron variant	Likely benign	Sep 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+8C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000390659	16	2103461	16	2053460	390659	374727	rs779174834	NC_000016.10:2053459:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.336+10A>G	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000133424	16	2103463	16	2053462	133424	137163	rs587778005	NC_000016.10:2053461:A:G	single nucleotide variant	intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.336+11G>T	TSC2		Tuberous sclerosis 2	VCV001568856	16	2103464	16	2053463	1568856	1634457	rs983337757	NC_000016.10:2053462:G:T	single nucleotide variant	intron variant	Likely benign	Apr 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+13G>A	TSC2	A68T, A117T	Tuberous sclerosis 2	VCV002918960	16	2103466	16	2053465	2918960	3077707	rs2548399478	NC_000016.10:2053464:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Jun 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+14C>G	TSC2	A68G, A117G	Tuberous sclerosis 2	VCV002979913	16	2103467	16	2053466	2979913	3134677	rs570065416	NC_000016.10:2053465:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Sep 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+14C>T	TSC2		not specified|not provided|Tuberous sclerosis 2	VCV000512755	16	2103467	16	2053466	512755	505652	rs570065416	NC_000016.10:2053465:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.336+15G>A	TSC2		Tuberous sclerosis 2	VCV001666853	16	2103468	16	2053467	1666853	1622278	rs777904257	NC_000016.10:2053466:G:A	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+15G>C	TSC2		Tuberous sclerosis 2	VCV001615561	16	2103468	16	2053467	1615561	1547503	rs777904257	NC_000016.10:2053466:G:C	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+16A>G	TSC2	T69A, T118A	Tuberous sclerosis 2	VCV002899132	16	2103469	16	2053468	2899132	3057313	rs2151029490	NC_000016.10:2053467:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Sep 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+17C>T	TSC2		Tuberous sclerosis 2	VCV001631061	16	2103470	16	2053469	1631061	1543473	rs754295761	NC_000016.10:2053468:C:T	single nucleotide variant	intron variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+18G>A	TSC2		Tuberous sclerosis 2	VCV001551375	16	2103471	16	2053470	1551375	1551154	rs2085381541	NC_000016.10:2053469:G:A	single nucleotide variant	intron variant	Likely benign	Dec 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+18G>T	TSC2		Tuberous sclerosis 2	VCV001537672	16	2103471	16	2053470	1537672	1649951	rs2085381541	NC_000016.10:2053469:G:T	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+19C>T	TSC2		Tuberous sclerosis 2	VCV002810105	16	2103472	16	2053471	2810105	2968633	rs2151029584	NC_000016.10:2053470:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+19C>A	TSC2		Tuberous sclerosis 2	VCV001658950	16	2103472	16	2053471	1658950	1640495	rs2151029584	NC_000016.10:2053470:C:A	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+32C>T	TSC2		not provided	VCV000049809	16	2103485	16	2053484	49809	58971	rs45517103	NC_000016.10:2053483:C:T	single nucleotide variant	intron variant	Likely benign	Aug 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+33G>A	TSC2		not provided	VCV003898137	16	2103486	16	2053485	3898137	4013978		NC_000016.10:2053484:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.336+33G>T	TSC2		not provided|Tuberous sclerosis 2|not specified	VCV000049810	16	2103486	16	2053485	49810	58972	rs45517104	NC_000016.10:2053484:G:T	single nucleotide variant	intron variant	Benign/Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.336+61C>T	TSC2		not specified|not provided	VCV000064987	16	2103514	16	2053513	64987	75917	rs397514989	NC_000016.10:2053512:C:T	single nucleotide variant	intron variant	Likely benign	Mar 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.336+233T>C	TSC2		not provided	VCV000133428	16	2103686	16	2053685	133428	137167	rs144712953	NC_000016.10:2053684:T:C	single nucleotide variant	intron variant	Likely benign	Jun 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-26G>C	TSC2		not specified	VCV000256628	16	2104271	16	2054270	256628	255484	rs182543432	NC_000016.10:2054269:G:C	single nucleotide variant	intron variant	Benign		criteria provided, single submitter							
NM_000548.5(TSC2):c.337-20C>T	TSC2		Tuberous sclerosis 2	VCV002029251	16	2104277	16	2054276	2029251	2082043	rs376175375	NC_000016.10:2054275:C:T	single nucleotide variant	intron variant	Likely benign	Sep 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-20C>G	TSC2		Tuberous sclerosis 2	VCV001627663	16	2104277	16	2054276	1627663	1530881	rs376175375	NC_000016.10:2054275:C:G	single nucleotide variant	intron variant	Likely benign	Nov 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-19C>T	TSC2		Tuberous sclerosis 2	VCV004071157	16	2104278	16	2054277	4071157	4185005		NC_000016.10:2054276:C:T	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-19C>G	TSC2		Tuberous sclerosis 2	VCV002084275	16	2104278	16	2054277	2084275	2133164	rs1450147983	NC_000016.10:2054276:C:G	single nucleotide variant	intron variant	Likely benign	Jan 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-18T>C	TSC2		Tuberous sclerosis 2	VCV001589407	16	2104279	16	2054278	1589407	1607429	rs2151039421	NC_000016.10:2054277:T:C	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.337-17G>T	TSC2		Tuberous sclerosis 2	VCV002194763	16	2104280	16	2054279	2194763	1932606	rs1259615174	NC_000016.10:2054278:G:T	single nucleotide variant	intron variant	Likely benign	Aug 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-17G>A	TSC2		Tuberous sclerosis 2	VCV001654682	16	2104280	16	2054279	1654682	1580311	rs1259615174	NC_000016.10:2054278:G:A	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.337-16T>C	TSC2		Tuberous sclerosis 2	VCV001993502	16	2104281	16	2054280	1993502	2049289	rs771627218	NC_000016.10:2054279:T:C	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.337-15G>C	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001631478	16	2104282	16	2054281	1631478	1597282	rs772983704	NC_000016.10:2054280:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.337-14G>C	TSC2		Tuberous sclerosis 2	VCV002115632	16	2104283	16	2054282	2115632	2182571	rs2151039593	NC_000016.10:2054281:G:C	single nucleotide variant	intron variant	Likely benign	Mar 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-13C>G	TSC2		Tuberous sclerosis 2	VCV002104464	16	2104284	16	2054283	2104464	2162227	rs2151039623	NC_000016.10:2054282:C:G	single nucleotide variant	intron variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-13C>T	TSC2		Tuberous sclerosis 2	VCV002003248	16	2104284	16	2054283	2003248	2055167	rs2151039623	NC_000016.10:2054282:C:T	single nucleotide variant	intron variant	Likely benign	Jun 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-12T>A	TSC2		Tuberous sclerosis 2	VCV001621937	16	2104285	16	2054284	1621937	1593140	rs2151039655	NC_000016.10:2054283:T:A	single nucleotide variant	intron variant	Likely benign	Aug 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-8G>A	TSC2		Tuberous sclerosis 2	VCV004071047	16	2104289	16	2054288	4071047	4184895		NC_000016.10:2054287:G:A	single nucleotide variant	intron variant	Likely benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-8G>C	TSC2		Tuberous sclerosis 2	VCV002873910	16	2104289	16	2054288	2873910	3040730	rs2085494215	NC_000016.10:2054287:G:C	single nucleotide variant	intron variant	Likely benign	Dec 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-7T>C	TSC2		Tuberous sclerosis 2	VCV002828985	16	2104290	16	2054289	2828985	2983651	rs2548412607	NC_000016.10:2054288:T:C	single nucleotide variant	intron variant	Uncertain significance	Jan 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-6C>T	TSC2		Tuberous sclerosis 2	VCV002896491	16	2104291	16	2054290	2896491	3052732	rs760230326	NC_000016.10:2054289:C:T	single nucleotide variant	intron variant	Likely benign	Aug 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-6C>G	TSC2		Tuberous sclerosis 2	VCV000774116	16	2104291	16	2054290	774116	778284	rs760230326	NC_000016.10:2054289:C:G	single nucleotide variant	intron variant	Likely benign	Apr 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-5T>C	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001730767	16	2104292	16	2054291	1730767	1785755	rs2548412653	NC_000016.10:2054290:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.337-4T>A	TSC2		Hereditary cancer-predisposing syndrome	VCV003462640	16	2104293	16	2054292	3462640	3621659		NC_000016.10:2054291:T:A	single nucleotide variant	intron variant	Likely benign	Oct 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-3T>C	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000468009	16	2104294	16	2054293	468009	465718	rs770515822	NC_000016.10:2054292:T:C	single nucleotide variant	intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.337-2A>C	TSC2		Tuberous sclerosis 2	VCV002113612	16	2104295	16	2054294	2113612	2161147	rs397515316	NC_000016.10:2054293:A:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Mar 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.337-1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000065038	16	2104296	16	2054295	65038	75968	rs45517105	NC_000016.10:2054294:G:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.337-1G>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049253	16	2104296	16	2054295	49253	58415	rs45517105	NC_000016.10:2054294:G:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.337G>T (p.Gly113Cys)	TSC2	G113C, G124C, G143C, G64C, G76C, G94C	not provided	VCV003364233	16	2104297	16	2054296	3364233	3523440		NC_000016.10:2054295:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.338G>A (p.Gly113Asp)	TSC2	G113D, G124D, G143D, G64D, G76D, G94D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001720337	16	2104298	16	2054297	1720337	1779375	rs2151039913	NC_000016.10:2054296:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.339C>A (p.Gly113=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001563204	16	2104299	16	2054298	1563204	1556202	rs368451664	NC_000016.10:2054297:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.339C>T (p.Gly113=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207699	16	2104299	16	2054298	207699	203089	rs368451664	NC_000016.10:2054297:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.340G>A (p.Glu114Lys)	TSC2	E114K, E125K, E77K, E65K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000065349	16	2104300	16	2054299	65349	76283	rs397515021	NC_000016.10:2054298:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.340G>T (p.Glu114Ter)	TSC2	E114*, E65*, E125*, E77*	Tuberous sclerosis 2	VCV000065033	16	2104300	16	2054299	65033	75963	rs397515021	NC_000016.10:2054298:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.342G>A (p.Glu114=)	TSC2		Tuberous sclerosis 2	VCV004071260	16	2104302	16	2054301	4071260	4185108		NC_000016.10:2054300:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.342G>T (p.Glu114Asp)	TSC2	E77D, E65D, E114D, E125D, E95D, E144D	Hereditary cancer-predisposing syndrome	VCV001731365	16	2104302	16	2054301	1731365	1795738	rs1555497542	NC_000016.10:2054300:G:T	single nucleotide variant	missense variant|intron variant	Likely benign	Feb 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.342G>C (p.Glu114Asp)	TSC2	E114D, E125D, E77D, E65D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468014	16	2104302	16	2054301	468014	465829	rs1555497542	NC_000016.10:2054300:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.343C>A (p.Arg115Ser)	TSC2	R66S, R78S, R115S, R126S, R145S, R96S	Tuberous sclerosis 2	VCV002706325	16	2104303	16	2054302	2706325	2873779	rs1256047792	NC_000016.10:2054301:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.343C>T (p.Arg115Cys)	TSC2	R115C, R126C, R78C, R66C	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000647485	16	2104303	16	2054302	647485	644139	rs1256047792	NC_000016.10:2054301:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.344G>T (p.Arg115Leu)	TSC2	R78L, R66L, R115L, R126L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000823785	16	2104304	16	2054303	823785	812473	rs764529584	NC_000016.10:2054302:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.344G>C (p.Arg115Pro)	TSC2	R66P, R78P, R126P, R115P	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000823784	16	2104304	16	2054303	823784	812472	rs764529584	NC_000016.10:2054302:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.344G>A (p.Arg115His)	TSC2	R115H, R66H, R78H, R126H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000468016	16	2104304	16	2054303	468016	465140	rs764529584	NC_000016.10:2054302:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.345T>C (p.Arg115=)	TSC2		Tuberous sclerosis 2	VCV004071197	16	2104305	16	2054304	4071197	4185045		NC_000016.10:2054303:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	May 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.345T>G (p.Arg115=)	TSC2		Hereditary cancer-predisposing syndrome|not provided	VCV002564658	16	2104305	16	2054304	2564658	2733814	rs2548412985	NC_000016.10:2054303:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.346T>G (p.Leu116Val)	TSC2	L127V, L116V, L97V, L146V, L79V, L67V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002119578	16	2104306	16	2054305	2119578	2180058	rs751923657	NC_000016.10:2054304:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.346T>C (p.Leu116=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468017	16	2104306	16	2054305	468017	465143	rs751923657	NC_000016.10:2054304:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.347T>C (p.Leu116Ser)	TSC2	L116S, L146S, L127S, L97S, L67S, L79S	Hereditary cancer-predisposing syndrome	VCV001731841	16	2104307	16	2054306	1731841	1792744	rs2548413068	NC_000016.10:2054305:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.348G>A (p.Leu116=)	TSC2		Tuberous sclerosis 2	VCV001564738	16	2104308	16	2054307	1564738	1567692	rs2151040222	NC_000016.10:2054306:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.350G>A (p.Gly117Glu)	TSC2	G80E, G117E, G68E, G128E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000823868	16	2104310	16	2054309	823868	812474	rs1596264690	NC_000016.10:2054308:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.351G>C (p.Gly117=)	TSC2		Tuberous sclerosis 2	VCV002894645	16	2104311	16	2054310	2894645	3056285	rs1555497554	NC_000016.10:2054309:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.351G>A (p.Gly117=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536045	16	2104311	16	2054310	536045	529539	rs1555497554	NC_000016.10:2054309:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.352G>A (p.Val118Ile)	TSC2	V118I, V129I, V81I, V69I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000573256	16	2104312	16	2054311	573256	573761	rs878854094	NC_000016.10:2054310:G:A	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.352G>T (p.Val118Phe)	TSC2	V118F, V129F, V69F, V81F	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000238019	16	2104312	16	2054311	238019	242209	rs878854094	NC_000016.10:2054310:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.353T>A (p.Val118Asp)	TSC2	V118D, V69D, V81D, V148D, V99D, V129D	Hereditary cancer-predisposing syndrome	VCV002626427	16	2104313	16	2054312	2626427	2794193	rs2548413255	NC_000016.10:2054311:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.354C>A (p.Val118=)	TSC2		Tuberous sclerosis 2	VCV002014532	16	2104314	16	2054313	2014532	2075028	rs762228318	NC_000016.10:2054312:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.354C>T (p.Val118=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000732414	16	2104314	16	2054313	732414	740013	rs762228318	NC_000016.10:2054312:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.354C>G (p.Val118=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000289837	16	2104314	16	2054313	289837	274074	rs762228318	NC_000016.10:2054312:C:G	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.355C>T (p.Leu119Phe)	TSC2	L119F, L130F, L70F, L82F	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000823927	16	2104315	16	2054314	823927	812475	rs1596264734	NC_000016.10:2054313:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.356T>A (p.Leu119His)	TSC2	L119H, L82H, L100H, L130H, L149H, L70H	Hereditary cancer-predisposing syndrome	VCV003329527	16	2104316	16	2054315	3329527	3489119		NC_000016.10:2054314:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.356T>G (p.Leu119Arg)	TSC2	L119R, L130R, L82R, L70R	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000468024	16	2104316	16	2054315	468024	466010	rs1477548902	NC_000016.10:2054314:T:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.357C>T (p.Leu119=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000759744	16	2104317	16	2054316	759744	770662	rs1168763677	NC_000016.10:2054315:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.357C>G (p.Leu119=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000486645	16	2104317	16	2054316	486645	477411	rs1168763677	NC_000016.10:2054315:C:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.358A>G (p.Arg120Gly)	TSC2	R120G, R150G, R101G, R83G, R131G, R71G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003711531	16	2104318	16	2054317	3711531	3841093		NC_000016.10:2054316:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.358A>C (p.Arg120=)	TSC2		Tuberous sclerosis 2	VCV003672187	16	2104318	16	2054317	3672187	3805244		NC_000016.10:2054316:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.358A>T (p.Arg120Ter)	TSC2	R120*, R131*, R71*, R83*	not provided|Tuberous sclerosis 2	VCV000429805	16	2104318	16	2054317	429805	422076	rs1131691602	NC_000016.10:2054316:A:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.359G>A (p.Arg120Lys)	TSC2	R131K, R120K, R71K, R83K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001485795	16	2104319	16	2054318	1485795	1472142	rs2151040587	NC_000016.10:2054317:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.362C>A (p.Ala121Asp)	TSC2	A121D, A132D, A102D, A84D, A72D, A151D	Tuberous sclerosis 2	VCV002123074	16	2104322	16	2054321	2123074	2180968	rs767755750	NC_000016.10:2054320:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.362C>T (p.Ala121Val)	TSC2	A121V, A132V, A72V, A84V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001016743	16	2104322	16	2054321	1016743	1011932	rs767755750	NC_000016.10:2054320:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.362C>G (p.Ala121Gly)	TSC2	A121G, A132G, A72G, A84G	not provided|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207766	16	2104322	16	2054321	207766	203090	rs767755750	NC_000016.10:2054320:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.363C>A (p.Ala121=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329508	16	2104323	16	2054322	3329508	3489100		NC_000016.10:2054321:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	May 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.363C>G (p.Ala121=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001733476	16	2104323	16	2054322	1733476	1793097	rs45517106	NC_000016.10:2054321:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	May 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.363C>T (p.Ala121=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000049530	16	2104323	16	2054322	49530	58692	rs45517106	NC_000016.10:2054321:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.364C>A (p.Leu122Ile)	TSC2	L103I, L122I, L133I, L152I, L73I, L85I	Tuberous sclerosis syndrome	VCV003075077	16	2104324	16	2054323	3075077	3234729	rs1175373447	NC_000016.10:2054322:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.364C>T (p.Leu122Phe)	TSC2	L73F, L122F, L133F, L85F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000663246	16	2104324	16	2054323	663246	644140	rs1175373447	NC_000016.10:2054322:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 24, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.365T>G (p.Leu122Arg)	TSC2	L103R, L133R, L122R, L85R, L152R, L73R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462682	16	2104325	16	2054324	3462682	3621701		NC_000016.10:2054323:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Nov 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.365T>C (p.Leu122Pro)	TSC2	L122P, L133P, L152P, L103P, L73P, L85P	Tuberous sclerosis 2	VCV002186523	16	2104325	16	2054324	2186523	1917868	rs756263581	NC_000016.10:2054323:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.365T>A (p.Leu122His)	TSC2	L73H, L122H, L133H, L85H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000664431	16	2104325	16	2054324	664431	644141	rs756263581	NC_000016.10:2054323:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.366C>G (p.Leu122=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001733757	16	2104326	16	2054325	1733757	1789507	rs1397677711	NC_000016.10:2054324:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jan 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.366C>T (p.Leu122=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486698	16	2104326	16	2054325	486698	477288	rs1397677711	NC_000016.10:2054324:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.367T>C (p.Phe123Leu)	TSC2	F86L, F134L, F104L, F123L, F153L, F74L	Tuberous sclerosis 2	VCV002066166	16	2104327	16	2054326	2066166	2128851	rs2548413950	NC_000016.10:2054325:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.368T>C (p.Phe123Ser)	TSC2	F123S, F153S, F134S, F74S, F86S, F104S	Hereditary cancer-predisposing syndrome	VCV001733956	16	2104328	16	2054327	1733956	1789706	rs2548413976	NC_000016.10:2054326:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.369C>T (p.Phe123=)	TSC2		Tuberous sclerosis 2	VCV001636080	16	2104329	16	2054328	1636080	1644105	rs1567399252	NC_000016.10:2054327:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.369C>G (p.Phe123Leu)	TSC2	F123L, F74L, F134L, F86L	Tuberous sclerosis 2	VCV000567814	16	2104329	16	2054328	567814	567733	rs1567399252	NC_000016.10:2054327:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.370T>C (p.Phe124Leu)	TSC2	F87L, F124L, F135L, F75L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000648180	16	2104330	16	2054329	648180	644142	rs547231441	NC_000016.10:2054328:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.372T>C (p.Phe124=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000733797	16	2104332	16	2054331	733797	740014	rs753922923	NC_000016.10:2054330:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.373A>C (p.Lys125Gln)	TSC2	K88Q, K136Q, K155Q, K106Q, K125Q, K76Q	Hereditary cancer-predisposing syndrome	VCV001734451	16	2104333	16	2054332	1734451	1786870	rs1397640702	NC_000016.10:2054331:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.374A>G (p.Lys125Arg)	TSC2	K125R, K136R, K76R, K88R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000468038	16	2104334	16	2054333	468038	465151	rs767059758	NC_000016.10:2054332:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.375G>A (p.Lys125=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000576899	16	2104335	16	2054334	576899	570036	rs778928295	NC_000016.10:2054333:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.375G>C (p.Lys125Asn)	TSC2	K125N, K76N, K136N, K88N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486657	16	2104335	16	2054334	486657	477273	rs778928295	NC_000016.10:2054333:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.376G>A (p.Val126Ile)	TSC2	V126I, V137I, V77I, V89I	Tuberous sclerosis 2	VCV001022346	16	2104336	16	2054335	1022346	1011933	rs1458070269	NC_000016.10:2054334:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.376G>T (p.Val126Phe)	TSC2	V77F, V89F, V126F, V137F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000967345	16	2104336	16	2054335	967345	957667	rs1458070269	NC_000016.10:2054334:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.377T>C (p.Val126Ala)	TSC2	V126A, V77A, V89A, V137A	Tuberous sclerosis 2	VCV000843821	16	2104337	16	2054336	843821	843319	rs2085502098	NC_000016.10:2054335:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.378C>G (p.Val126=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001126477	16	2104338	16	2054337	1126477	1125009	rs1222534983	NC_000016.10:2054336:C:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.378C>T (p.Val126=)	TSC2		not provided|Hereditary cancer-predisposing syndrome	VCV000824209	16	2104338	16	2054337	824209	812476	rs1222534983	NC_000016.10:2054336:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.379A>G (p.Ile127Val)	TSC2	I90V, I127V, I138V, I78V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000945542	16	2104339	16	2054338	945542	927613	rs1207714822	NC_000016.10:2054337:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.380T>C (p.Ile127Thr)	TSC2	I127T, I108T, I78T, I138T, I157T, I90T	Tuberous sclerosis 2	VCV002695439	16	2104340	16	2054339	2695439	2854298	rs2151041304	NC_000016.10:2054338:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.381C>T (p.Ile127=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002894656	16	2104341	16	2054340	2894656	3056296	rs2085502591	NC_000016.10:2054339:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.381C>G (p.Ile127Met)	TSC2	I127M, I138M, I78M, I90M	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV001309559	16	2104341	16	2054340	1309559	1300258	rs2085502591	NC_000016.10:2054339:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.382A>G (p.Lys128Glu)	TSC2	K109E, K158E, K79E, K128E, K139E, K91E	Tuberous sclerosis 2	VCV002122388	16	2104342	16	2054341	2122388	2173813	rs2085502766	NC_000016.10:2054340:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.382A>C (p.Lys128Gln)	TSC2	K109Q, K128Q, K158Q, K79Q, K139Q, K91Q	Tuberous sclerosis 2	VCV002055038	16	2104342	16	2054341	2055038	2109039	rs2085502766	NC_000016.10:2054340:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.383A>C (p.Lys128Thr)	TSC2	K109T, K139T, K91T, K128T, K158T, K79T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002497445	16	2104343	16	2054342	2497445	2472528	rs2151041424	NC_000016.10:2054341:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.384G>A (p.Lys128=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000765240	16	2104344	16	2054343	765240	770663	rs748095129	NC_000016.10:2054342:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.384G>T (p.Lys128Asn)	TSC2	K128N, K139N, K79N, K91N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000578706	16	2104344	16	2054343	578706	573765	rs748095129	NC_000016.10:2054342:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.385G>T (p.Asp129Tyr)	TSC2	D129Y, D92Y, D80Y, D140Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535996	16	2104345	16	2054344	535996	529556	rs771961048	NC_000016.10:2054343:G:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.386A>T (p.Asp129Val)	TSC2	D129V, D80V, D92V, D140V	Tuberous sclerosis 2	VCV000535986	16	2104346	16	2054345	535986	529515	rs1555497612	NC_000016.10:2054344:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.387T>A (p.Asp129Glu)	TSC2	D80E, D92E, D140E, D129E	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001443754	16	2104347	16	2054346	1443754	1487754	rs1202650869	NC_000016.10:2054345:T:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.388T>C (p.Tyr130His)	TSC2	Y130H, Y160H, Y141H, Y93H, Y111H, Y81H	Tuberous sclerosis 2	VCV002130946	16	2104348	16	2054347	2130946	2186241	rs1567399451	NC_000016.10:2054346:T:C	single nucleotide variant	missense variant|intron variant	Benign	Apr 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.390C>T (p.Tyr130=)	TSC2		Tuberous sclerosis 2	VCV001673646	16	2104350	16	2054349	1673646	1648946	rs2151041690	NC_000016.10:2054348:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.391C>T (p.Pro131Ser)	TSC2	P142S, P82S, P94S, P131S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001384186	16	2104351	16	2054350	1384186	1447782	rs777398393	NC_000016.10:2054349:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 7, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.391C>G (p.Pro131Ala)	TSC2	P142A, P82A, P94A, P131A	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000962260	16	2104351	16	2054350	962260	949221	rs777398393	NC_000016.10:2054349:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 24, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.391C>A (p.Pro131Thr)	TSC2	P131T, P142T, P82T, P94T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000238032	16	2104351	16	2054350	238032	242210	rs777398393	NC_000016.10:2054349:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.392C>A (p.Pro131His)	TSC2	P82H, P131H, P161H, P142H, P94H, P112H	Tuberous sclerosis 2	VCV003637173	16	2104352	16	2054351	3637173	3771327		NC_000016.10:2054350:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.392C>G (p.Pro131Arg)	TSC2	P131R, P142R, P94R, P82R	Tuberous sclerosis 2	VCV000946772	16	2104352	16	2054351	946772	927614	rs1487984678	NC_000016.10:2054350:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 7, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.392C>T (p.Pro131Leu)	TSC2	P131L, P142L, P94L, P82L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000655701	16	2104352	16	2054351	655701	644143	rs1487984678	NC_000016.10:2054350:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.393T>G (p.Pro131=)	TSC2		Tuberous sclerosis 2	VCV001987674	16	2104353	16	2054352	1987674	2040321	rs2151041812	NC_000016.10:2054351:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jun 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.393T>C (p.Pro131=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001128596	16	2104353	16	2054352	1128596	1125010	rs2151041812	NC_000016.10:2054351:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.394T>C (p.Ser132Pro)	TSC2	S132P, S95P, S143P, S83P	Tuberous sclerosis 2	VCV000578878	16	2104354	16	2054353	578878	570037	rs1191673224	NC_000016.10:2054352:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 25, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.395C>G (p.Ser132Cys)	TSC2	S132C, S143C, S95C, S83C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000050034	16	2104355	16	2054354	50034	59196	rs137854391	NC_000016.10:2054353:C:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.396C>T (p.Ser132=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413624	16	2104356	16	2054355	413624	400595	rs1060504083	NC_000016.10:2054354:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.397A>G (p.Asn133Asp)	TSC2	N114D, N133D, N144D, N163D, N84D, N96D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003386155	16	2104357	16	2054356	3386155	3545296		NC_000016.10:2054355:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.398A>C (p.Asn133Thr)	TSC2	N144T, N133T, N96T, N84T	Tuberous sclerosis 2	VCV000948345	16	2104358	16	2054357	948345	927615	rs1265446222	NC_000016.10:2054356:A:C	single nucleotide variant	missense variant|intron variant	Benign	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.399C>A (p.Asn133Lys)	TSC2	N96K, N84K, N133K, N144K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000845277	16	2104359	16	2054358	845277	843320	rs746704620	NC_000016.10:2054357:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.399C>T (p.Asn133=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000536035	16	2104359	16	2054358	536035	529517	rs746704620	NC_000016.10:2054357:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.400G>T (p.Glu134Ter)	TSC2	E145*, E85*, E134*, E97*	Tuberous sclerosis 2	VCV000803147	16	2104360	16	2054359	803147	791531	rs1555497641	NC_000016.10:2054358:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.400G>A (p.Glu134Lys)	TSC2	E134K, E85K, E97K, E145K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468058	16	2104360	16	2054359	468058	465719	rs1555497641	NC_000016.10:2054358:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.401A>G (p.Glu134Gly)	TSC2	E145G, E97G, E134G, E85G	Tuberous sclerosis 2	VCV001471725	16	2104361	16	2054360	1471725	1388752	rs2151042080	NC_000016.10:2054359:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.403G>A (p.Asp135Asn)	TSC2	D98N, D146N, D135N, D86N	Tuberous sclerosis 2	VCV001356117	16	2104363	16	2054362	1356117	1354412	rs770439945	NC_000016.10:2054361:G:A	single nucleotide variant	missense variant|intron variant	Benign	Aug 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.404A>G (p.Asp135Gly)	TSC2	D135G, D146G, D86G, D98G	Tuberous sclerosis 2	VCV000999227	16	2104364	16	2054363	999227	996685	rs2085506301	NC_000016.10:2054362:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.405C>A (p.Asp135Glu)	TSC2	D165E, D135E, D116E, D86E, D146E, D98E	Hereditary cancer-predisposing syndrome	VCV003329497	16	2104365	16	2054364	3329497	3489089		NC_000016.10:2054363:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.405C>T (p.Asp135=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000793712	16	2104365	16	2054364	793712	785180	rs1005115266	NC_000016.10:2054363:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.406C>T (p.Leu136Phe)	TSC2	L136F, L87F, L147F, L99F	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000640127	16	2104366	16	2054365	640127	644144	rs1350803240	NC_000016.10:2054364:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.408T>G (p.Leu136=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000468064	16	2104368	16	2054367	468064	465833	rs1037058497	NC_000016.10:2054366:T:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.409C>T (p.His137Tyr)	TSC2	H88Y, H100Y, H148Y, H137Y	Tuberous sclerosis 2	VCV000657404	16	2104369	16	2054368	657404	644145	rs1596265133	NC_000016.10:2054367:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 24, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.410A>G (p.His137Arg)	TSC2	H137R, H148R, H88R, H100R	Tuberous sclerosis 2	VCV000049283	16	2104370	16	2054369	49283	58445	rs45517107	NC_000016.10:2054368:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.411C>G (p.His137Gln)	TSC2	H148Q, H100Q, H137Q, H88Q	Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV001518879	16	2104371	16	2054370	1518879	1343072	rs776129896	NC_000016.10:2054369:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.411C>T (p.His137=)	TSC2		not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468066	16	2104371	16	2054370	468066	465153	rs776129896	NC_000016.10:2054369:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.412G>C (p.Glu138Gln)	TSC2	E168Q, E101Q, E138Q, E149Q, E119Q, E89Q	Tuberous sclerosis 2	VCV001979361	16	2104372	16	2054371	1979361	2034740	rs1173061992	NC_000016.10:2054370:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.412G>A (p.Glu138Lys)	TSC2	E89K, E149K, E101K, E138K	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000648101	16	2104372	16	2054371	648101	644146	rs1173061992	NC_000016.10:2054370:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.412G>T (p.Glu138Ter)	TSC2	E138*, E149*, E89*, E101*	not provided	VCV000489046	16	2104372	16	2054371	489046	482090	rs1173061992	NC_000016.10:2054370:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 10, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.413A>T (p.Glu138Val)	TSC2	E119V, E101V, E149V, E89V, E138V, E168V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001738137	16	2104373	16	2054372	1738137	1797373	rs2151042580	NC_000016.10:2054371:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.413A>G (p.Glu138Gly)	TSC2	E101G, E138G, E149G, E89G	not provided|Tuberous sclerosis 2	VCV001309506	16	2104373	16	2054372	1309506	1300205	rs2151042580	NC_000016.10:2054371:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.414A>G (p.Glu138=)	TSC2		Tuberous sclerosis 2	VCV004071257	16	2104374	16	2054373	4071257	4185105		NC_000016.10:2054372:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	May 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.416G>T (p.Arg139Met)	TSC2	R150M, R102M, R120M, R139M, R169M, R90M	Tuberous sclerosis 2	VCV001963029	16	2104376	16	2054375	1963029	2020580	rs2085508015	NC_000016.10:2054374:G:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.416G>A (p.Arg139Lys)	TSC2	R139K, R102K, R90K, R150K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000953112	16	2104376	16	2054375	953112	949222	rs2085508015	NC_000016.10:2054374:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.417G>T (p.Arg139Ser)	TSC2	R120S, R169S, R90S, R102S, R150S, R139S	Hereditary cancer-predisposing syndrome	VCV003462614	16	2104377	16	2054376	3462614	3621633		NC_000016.10:2054375:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.418C>G (p.Leu140Val)	TSC2	L103V, L140V, L151V, L91V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692500	16	2104378	16	2054377	1692500	1684940	rs1555497657	NC_000016.10:2054376:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.418C>T (p.Leu140=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000480842	16	2104378	16	2054377	480842	477418	rs1555497657	NC_000016.10:2054376:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.419T>C (p.Leu140Pro)	TSC2	L103P, L140P, L151P, L91P	Tuberous sclerosis 2|not provided	VCV001303529	16	2104379	16	2054378	1303529	1293806	rs2151042793	NC_000016.10:2054377:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.420G>A (p.Leu140=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000232927	16	2104380	16	2054379	232927	235091	rs876660078	NC_000016.10:2054378:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.421G>A (p.Glu141Lys)	TSC2	E152K, E92K, E141K, E122K, E104K, E171K	Tuberous sclerosis 2	VCV003637174	16	2104381	16	2054380	3637174	3771328		NC_000016.10:2054379:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.421G>C (p.Glu141Gln)	TSC2	E141Q, E122Q, E171Q, E104Q, E152Q, E92Q	Tuberous sclerosis 2	VCV002844167	16	2104381	16	2054380	2844167	3007808	rs1060500924	NC_000016.10:2054379:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.421G>T (p.Glu141Ter)	TSC2	E141*, E92*, E104*, E152*	Tuberous sclerosis 2	VCV000405985	16	2104381	16	2054380	405985	401148	rs1060500924	NC_000016.10:2054379:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 27, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.422A>G (p.Glu141Gly)	TSC2	E152G, E92G, E104G, E141G	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis	VCV001462284	16	2104382	16	2054381	1462284	1507611	rs1446616583	NC_000016.10:2054380:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.423G>A (p.Glu141=)	TSC2		Tuberous sclerosis 2	VCV002098522	16	2104383	16	2054382	2098522	2157718	rs2151042934	NC_000016.10:2054381:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.424G>A (p.Val142Ile)	TSC2	V105I, V123I, V142I, V153I, V172I, V93I	Tuberous sclerosis 2	VCV002437383	16	2104384	16	2054383	2437383	2411314	rs2151043003	NC_000016.10:2054382:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.424G>C (p.Val142Leu)	TSC2	V153L, V93L, V142L, V105L	Tuberous sclerosis 2	VCV001354799	16	2104384	16	2054383	1354799	1434384	rs2151043003	NC_000016.10:2054382:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.425T>A (p.Val142Asp)	TSC2	V123D, V172D, V105D, V142D, V153D, V93D	Tuberous sclerosis 2	VCV002757249	16	2104385	16	2054384	2757249	2921020	rs2151043024	NC_000016.10:2054383:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.428T>A (p.Phe143Tyr)	TSC2	F106Y, F124Y, F143Y, F154Y, F173Y, F94Y	Tuberous sclerosis syndrome	VCV003074031	16	2104388	16	2054387	3074031	3231167	rs2151043120	NC_000016.10:2054386:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.429C>T (p.Phe143=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000388146	16	2104389	16	2054388	388146	377127	rs137854406	NC_000016.10:2054387:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.429C>G (p.Phe143Leu)	TSC2	F143L, F106L, F154L, F94L	Tuberous sclerosis 2|See cases|not specified|Hereditary cancer-predisposing syndrome	VCV000049898	16	2104389	16	2054388	49898	59060	rs137854406	NC_000016.10:2054387:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.431A>T (p.Lys144Met)	TSC2	K107M, K125M, K144M, K155M, K174M, K95M	Tuberous sclerosis 2|not provided	VCV002502037	16	2104391	16	2054390	2502037	2534249	rs769286175	NC_000016.10:2054389:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.431A>C (p.Lys144Thr)	TSC2	K174T, K107T, K144T, K155T, K125T, K95T	Tuberous sclerosis 2	VCV002095796	16	2104391	16	2054390	2095796	2149713	rs769286175	NC_000016.10:2054389:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.431A>G (p.Lys144Arg)	TSC2	K144R, K95R, K155R, K107R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome	VCV000207700	16	2104391	16	2054390	207700	203091	rs769286175	NC_000016.10:2054389:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.432G>A (p.Lys144=)	TSC2		Tuberous sclerosis 2	VCV001608833	16	2104392	16	2054391	1608833	1573703	rs2085509615	NC_000016.10:2054390:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.432G>C (p.Lys144Asn)	TSC2	K144N, K95N, K155N, K107N	Tuberous sclerosis 2	VCV001035884	16	2104392	16	2054391	1035884	1032427	rs2085509615	NC_000016.10:2054390:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.433G>T (p.Ala145Ser)	TSC2	A175S, A156S, A96S, A108S, A145S, A126S	Tuberous sclerosis 2	VCV002834478	16	2104393	16	2054392	2834478	2991745	rs774892845	NC_000016.10:2054391:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.433G>A (p.Ala145Thr)	TSC2	A145T, A156T, A108T, A96T	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486622	16	2104393	16	2054392	486622	477275	rs774892845	NC_000016.10:2054391:G:A	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.434C>G (p.Ala145Gly)	TSC2	A108G, A145G, A156G, A96G	Tuberous sclerosis 2	VCV001364277	16	2104394	16	2054393	1364277	1386216	rs1596265255	NC_000016.10:2054392:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.434C>T (p.Ala145Val)	TSC2	A156V, A108V, A145V, A96V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000824815	16	2104394	16	2054393	824815	812477	rs1596265255	NC_000016.10:2054392:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.435C>T (p.Ala145=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001595919	16	2104395	16	2054394	1595919	1569494	rs762200040	NC_000016.10:2054393:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.436C>T (p.Leu146Phe)	TSC2	L97F, L109F, L157F, L146F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001386898	16	2104396	16	2054395	1386898	1381263	rs997604465	NC_000016.10:2054394:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.436C>G (p.Leu146Val)	TSC2	L109V, L146V, L157V, L97V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001016534	16	2104396	16	2054395	1016534	1011934	rs997604465	NC_000016.10:2054394:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.437T>C (p.Leu146Pro)	TSC2	L127P, L146P, L157P, L176P, L109P, L97P	Tuberous sclerosis 2	VCV002133408	16	2104397	16	2054396	2133408	2190097	rs397514996	NC_000016.10:2054395:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.438C>T (p.Leu146=)	TSC2		Tuberous sclerosis 2	VCV001095517	16	2104398	16	2054397	1095517	1081770	rs2151043440	NC_000016.10:2054396:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 16, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.439A>C (p.Thr147Pro)	TSC2	T98P, T128P, T147P, T158P, T110P, T177P	Tuberous sclerosis 2|not provided	VCV002747342	16	2104399	16	2054398	2747342	2908102	rs1596265301	NC_000016.10:2054397:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.439A>G (p.Thr147Ala)	TSC2	T147A, T158A, T98A, T110A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000664782	16	2104399	16	2054398	664782	644147	rs1596265301	NC_000016.10:2054397:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.440C>T (p.Thr147Ile)	TSC2	T110I, T147I, T158I, T98I	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001004052	16	2104400	16	2054399	1004052	996686	rs1555497690	NC_000016.10:2054398:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.440C>A (p.Thr147Lys)	TSC2	T147K, T158K, T98K, T110K	Tuberous sclerosis 2	VCV000535892	16	2104400	16	2054399	535892	530089	rs1555497690	NC_000016.10:2054398:C:A	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Mar 5, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.441A>G (p.Thr147=)	TSC2		Tuberous sclerosis 2	VCV002138808	16	2104401	16	2054400	2138808	1878481	rs1403910231	NC_000016.10:2054399:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	Dec 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.442G>C (p.Asp148His)	TSC2	D159H, D99H, D111H, D148H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001505646	16	2104402	16	2054401	1505646	1437213	rs2151043628	NC_000016.10:2054400:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 25, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.444C>T (p.Asp148=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824900	16	2104404	16	2054403	824900	812478	rs767968378	NC_000016.10:2054402:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.445A>G (p.Asn149Asp)	TSC2	N149D, N100D, N160D, N112D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238050	16	2104405	16	2054404	238050	242211	rs878854107	NC_000016.10:2054403:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.446A>G (p.Asn149Ser)	TSC2	N149S, N112S, N160S, N100S	not provided|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000480817	16	2104406	16	2054405	480817	477423	rs1029118280	NC_000016.10:2054404:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.447T>C (p.Asn149=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001136091	16	2104407	16	2054406	1136091	1125011	rs750717653	NC_000016.10:2054405:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.448G>A (p.Gly150Arg)	TSC2	M1I, G131R, G150R, G161R, G180R, G101R, G113R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002485512	16	2104408	16	2054407	2485512	2459394	rs2151043819	NC_000016.10:2054406:G:A	single nucleotide variant	missense variant|5 prime UTR variant|initiator_codon_variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.449G>A (p.Gly150Glu)	TSC2	G113E, G131E, G150E, G161E, G180E, G2R, G101E	Tuberous sclerosis 2	VCV002060508	16	2104409	16	2054408	2060508	2106739	rs2151043854	NC_000016.10:2054407:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.450G>A (p.Gly150=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000387280	16	2104410	16	2054409	387280	375096	rs372000734	NC_000016.10:2054408:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.453A>T (p.Arg151Ser)	TSC2	R162S, R102S, R114S, R151S	Tuberous sclerosis 2	VCV001515956	16	2104413	16	2054412	1515956	1407234	rs2151043990	NC_000016.10:2054411:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.453A>G (p.Arg151=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001119502	16	2104413	16	2054412	1119502	1103606	rs2151043990	NC_000016.10:2054411:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.454C>T (p.His152Tyr)	TSC2	H182Y, H103Y, H115Y, H133Y, H152Y, H163Y	Tuberous sclerosis 2	VCV003670479	16	2104414	16	2054413	3670479	3799888		NC_000016.10:2054412:C:T	single nucleotide variant	missense variant|5 prime UTR variant|synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.454C>G (p.His152Asp)	TSC2	H152D, H115D, H103D, H163D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000065379	16	2104414	16	2054413	65379	76313	rs397515285	NC_000016.10:2054412:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.456C>T (p.His152=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000703427	16	2104416	16	2054415	703427	693803	rs1596265401	NC_000016.10:2054414:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.457A>G (p.Ile153Val)	TSC2	I153V, I104V, I116V, I164V	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486705	16	2104417	16	2054416	486705	477905	rs1555497700	NC_000016.10:2054415:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.458T>A (p.Ile153Asn)	TSC2	I153N, I183N, I164N, S5T, I104N, I134N, I116N	Hereditary cancer-predisposing syndrome	VCV001741708	16	2104418	16	2054417	1741708	1805151	rs2151044174	NC_000016.10:2054416:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.459C>G (p.Ile153Met)	TSC2	I153M, I164M, I183M, I134M, S5*, I104M, I116M	Tuberous sclerosis 2	VCV002132963	16	2104419	16	2054418	2132963	2191802	rs2151044207	NC_000016.10:2054417:C:G	single nucleotide variant	missense variant|nonsense|intron variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.459C>A (p.Ile153=)	TSC2	S5*	Hereditary cancer-predisposing syndrome	VCV001741756	16	2104419	16	2054418	1741756	1805199	rs2151044207	NC_000016.10:2054417:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|nonsense|non-coding transcript variant|intron variant	Likely benign	May 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.461C>A (p.Thr154Asn)	TSC2	T165N, T117N, T184N, P6T, T135N, T105N, T154N	Hereditary cancer-predisposing syndrome	VCV003974607	16	2104421	16	2054420	3974607	4086430		NC_000016.10:2054419:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 31, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.461C>G (p.Thr154Ser)	TSC2	T117S, T184S, P6A, T105S, T135S, T154S, T165S	Tuberous sclerosis 2	VCV002723928	16	2104421	16	2054420	2723928	2881840	rs1215092245	NC_000016.10:2054419:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.461C>T (p.Thr154Ile)	TSC2	T154I, T117I, T105I, T165I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535890	16	2104421	16	2054420	535890	530091	rs1215092245	NC_000016.10:2054419:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.462C>T (p.Thr154=)	TSC2		Tuberous sclerosis 2	VCV001639198	16	2104422	16	2054421	1639198	1525927	rs2151044315	NC_000016.10:2054420:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.464A>G (p.Tyr155Cys)	TSC2	Y155C, Y166C, Y106C, Y118C	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000535937	16	2104424	16	2054423	535937	530094	rs755177576	NC_000016.10:2054422:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.465C>T (p.Tyr155=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065152	16	2104425	16	2054424	65152	76083	rs45444196	NC_000016.10:2054423:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.466T>C (p.Leu156=)	TSC2		Tuberous sclerosis 2	VCV002003509	16	2104426	16	2054425	2003509	2055428	rs2151044466	NC_000016.10:2054424:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.467T>C (p.Leu156Ser)	TSC2	L156S, L167S, L186S, L107S, W8R, L119S, L137S	Hereditary cancer-predisposing syndrome	VCV001742391	16	2104427	16	2054426	1742391	1798592	rs2548417898	NC_000016.10:2054425:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.467T>G (p.Leu156Trp)	TSC2	L107W, L119W, L137W, L156W, L167W, L186W, W8G	Tuberous sclerosis 2	VCV001720789	16	2104427	16	2054426	1720789	1774771	rs2548417898	NC_000016.10:2054425:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.468G>A (p.Leu156=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000845249	16	2104428	16	2054427	845249	843322	rs2085514413	NC_000016.10:2054426:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.470A>G (p.Glu157Gly)	TSC2	E157G, E108G, E120G, E168G	Tuberous sclerosis 2	VCV001487289	16	2104430	16	2054429	1487289	1485183	rs2085514800	NC_000016.10:2054428:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.471G>A (p.Glu157=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001161529	16	2104431	16	2054430	1161529	1145892	rs1449885781	NC_000016.10:2054429:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.472G>T (p.Glu158Ter)	TSC2	E109*, R9S, E169*, E188*, E121*, E139*, E158*	Tuberous sclerosis 2	VCV002105554	16	2104432	16	2054431	2105554	2169906	rs1596265482	NC_000016.10:2054430:G:T	single nucleotide variant	nonsense|missense variant|intron variant	Pathogenic	Sep 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.472G>A (p.Glu158Lys)	TSC2	E109K, E121K, E158K, E169K	Tuberous sclerosis 2	VCV000666143	16	2104432	16	2054431	666143	644148	rs1596265482	NC_000016.10:2054430:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.473A>G (p.Glu158Gly)	TSC2	E169G, E158G, E121G, E109G	Tuberous sclerosis 2	VCV000952784	16	2104433	16	2054432	952784	927616	rs2085515389	NC_000016.10:2054431:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.474A>G (p.Glu158=)	TSC2	K10R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002018417	16	2104434	16	2054433	2018417	2072501	rs2151044701	NC_000016.10:2054432:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|missense variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.474A>C (p.Glu158Asp)	TSC2	E169D, K10T, E109D, E121D, E139D, E188D, E158D	Hereditary cancer-predisposing syndrome	VCV001742813	16	2104434	16	2054433	1742813	1808896	rs2151044701	NC_000016.10:2054432:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.475G>A (p.Glu159Lys)	TSC2	E110K, E170K, E122K, E140K, E159K, E189K	Hereditary cancer-predisposing syndrome	VCV001742892	16	2104435	16	2054434	1742892	1808973	rs1555497714	NC_000016.10:2054433:G:A	single nucleotide variant	missense variant|synonymous variant|intron variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.475G>T (p.Glu159Ter)	TSC2	E159*, E170*, E110*, E122*	Tuberous sclerosis 2	VCV000535913	16	2104435	16	2054434	535913	529848	rs1555497714	NC_000016.10:2054433:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 15, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.476A>G (p.Glu159Gly)	TSC2	E140G, E122G, E159G, S11G, E110G, E170G, E189G	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002815777	16	2104436	16	2054435	2815777	2966612	rs1555497716	NC_000016.10:2054434:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.476A>T (p.Glu159Val)	TSC2	E159V, E110V, E170V, E122V	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536005	16	2104436	16	2054435	536005	529518	rs1555497716	NC_000016.10:2054434:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.477G>A (p.Glu159=)	TSC2	S11N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003462691	16	2104437	16	2054436	3462691	3621710		NC_000016.10:2054435:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|missense variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.478C>G (p.Leu160Val)	TSC2	L160V, L171V, L111V, L123V	not provided	VCV000049319	16	2104438	16	2054437	49319	58481	rs45517109	NC_000016.10:2054436:C:G	single nucleotide variant	missense variant|intron variant	Likely pathogenic	May 10, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.479T>C (p.Leu160Pro)	TSC2	L123P, L171P, L190P, L160P, L111P, L141P, W12R	Tuberous sclerosis 2	VCV002108645	16	2104439	16	2054438	2108645	2170403	rs1555497725	NC_000016.10:2054437:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.479T>G (p.Leu160Arg)	TSC2	L111R, L123R, L160R, L171R	Tuberous sclerosis 2	VCV001437245	16	2104439	16	2054438	1437245	1513861	rs1555497725	NC_000016.10:2054437:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.479T>A (p.Leu160Gln)	TSC2	L160Q, L111Q, L123Q, L171Q	Tuberous sclerosis 2	VCV000468112	16	2104439	16	2054438	468112	465835	rs1555497725	NC_000016.10:2054437:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.481G>A (p.Ala161Thr)	TSC2	A172T, A161T, A124T, A112T	Tuberous sclerosis 2	VCV001492917	16	2104441	16	2054440	1492917	1515753	rs1157976261	NC_000016.10:2054439:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+1G>A	TSC2		Tuberous sclerosis 2|Focal cortical dysplasia|Cortical tubers	VCV001077128	16	2104442	16	2054441	1077128	1065770	rs45488500	NC_000016.10:2054440:G:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Mar 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.481+1G>T	TSC2		Tuberous sclerosis syndrome	VCV000049321	16	2104442	16	2054441	49321	58483	rs45488500	NC_000016.10:2054440:G:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jun 15, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+3G>T	TSC2		Tuberous sclerosis 2	VCV003641947	16	2104444	16	2054443	3641947	3772669		NC_000016.10:2054442:G:T	single nucleotide variant	intron variant	Uncertain significance	Feb 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+3G>C	TSC2		Tuberous sclerosis 2	VCV002701119	16	2104444	16	2054443	2701119	2865959	rs2085516860	NC_000016.10:2054442:G:C	single nucleotide variant	intron variant	Uncertain significance	Mar 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+4G>C	TSC2		Tuberous sclerosis 2	VCV003623650	16	2104445	16	2054444	3623650	3751450		NC_000016.10:2054443:G:C	single nucleotide variant	intron variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+4G>A	TSC2		Tuberous sclerosis 2	VCV002032252	16	2104445	16	2054444	2032252	2086310	rs2151045013	NC_000016.10:2054443:G:A	single nucleotide variant	intron variant	Uncertain significance	Oct 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+5G>C	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000828016	16	2104446	16	2054445	828016	816331	rs137854135	NC_000016.10:2054444:G:C	single nucleotide variant	intron variant	Uncertain significance		criteria provided, single submitter							
NM_000548.5(TSC2):c.481+5G>A	TSC2		Tuberous sclerosis 2	VCV000064988	16	2104446	16	2054445	64988	75918	rs137854135	NC_000016.10:2054444:G:A	single nucleotide variant	intron variant	Pathogenic	Apr 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+5G>T	TSC2		not provided	VCV000049825	16	2104446	16	2054445	49825	58987	rs137854135	NC_000016.10:2054444:G:T	single nucleotide variant	intron variant	Pathogenic	Feb 1, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+7G>C	TSC2		Tuberous sclerosis 2	VCV003730299	16	2104448	16	2054447	3730299	3862365		NC_000016.10:2054446:G:C	single nucleotide variant	intron variant	Likely benign	Apr 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+7G>T	TSC2		Tuberous sclerosis 2	VCV001136844	16	2104448	16	2054447	1136844	1125012	rs752730339	NC_000016.10:2054446:G:T	single nucleotide variant	intron variant	Likely benign	Aug 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+8C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000238063	16	2104449	16	2054448	238063	242212	rs758228838	NC_000016.10:2054447:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.481+9C>T	TSC2		not specified|not provided|Tuberous sclerosis 2	VCV000468114	16	2104450	16	2054449	468114	465155	rs201026150	NC_000016.10:2054448:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.481+10A>G	TSC2		Tuberous sclerosis 2	VCV000765363	16	2104451	16	2054450	765363	776147	rs1196443311	NC_000016.10:2054449:A:G	single nucleotide variant	intron variant	Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.481+10A>C	TSC2		Tuberous sclerosis 2	VCV000468113	16	2104451	16	2054450	468113	465836	rs1196443311	NC_000016.10:2054449:A:C	single nucleotide variant	intron variant	Likely benign	Oct 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+11C>G	TSC2		Tuberous sclerosis 2	VCV002819550	16	2104452	16	2054451	2819550	2987905	rs975536162	NC_000016.10:2054450:C:G	single nucleotide variant	intron variant	Likely benign	Dec 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+11C>A	TSC2		Tuberous sclerosis 2	VCV001587381	16	2104452	16	2054451	1587381	1541897	rs975536162	NC_000016.10:2054450:C:A	single nucleotide variant	intron variant	Likely benign	May 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+11C>T	TSC2		Tuberous sclerosis 2	VCV001547816	16	2104452	16	2054451	1547816	1624890	rs975536162	NC_000016.10:2054450:C:T	single nucleotide variant	intron variant	Likely benign	Oct 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+12C>T	TSC2		Tuberous sclerosis 2|not specified|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000516772	16	2104453	16	2054452	516772	505149	rs777645015	NC_000016.10:2054451:C:T	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.481+14T>C	TSC2		Tuberous sclerosis 2	VCV002723509	16	2104455	16	2054454	2723509	2885298	rs1160412532	NC_000016.10:2054453:T:C	single nucleotide variant	intron variant	Likely benign	Feb 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+14T>G	TSC2		Tuberous sclerosis 2	VCV001609972	16	2104455	16	2054454	1609972	1550928	rs1160412532	NC_000016.10:2054453:T:G	single nucleotide variant	intron variant	Likely benign	May 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+15G>A	TSC2		Tuberous sclerosis 2	VCV002020386	16	2104456	16	2054455	2020386	2079571	rs2548418832	NC_000016.10:2054454:G:A	single nucleotide variant	intron variant	Likely benign	Jul 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+16G>C	TSC2		Tuberous sclerosis 2	VCV002785116	16	2104457	16	2054456	2785116	2948418	rs2151045362	NC_000016.10:2054455:G:C	single nucleotide variant	intron variant	Likely benign	Feb 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+18T>C	TSC2		Tuberous sclerosis 2	VCV002186829	16	2104459	16	2054458	2186829	1918174	rs1360550363	NC_000016.10:2054457:T:C	single nucleotide variant	intron variant	Likely benign	Nov 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.481+19T>G	TSC2		Tuberous sclerosis 2	VCV002031556	16	2104460	16	2054459	2031556	2089461	rs2548418934	NC_000016.10:2054458:T:G	single nucleotide variant	intron variant	Likely benign	Sep 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-268G>A	TSC2		not provided	VCV001219298	16	2105135	16	2055134	1219298	1209276	rs141986802	NC_000016.10:2055133:G:A	single nucleotide variant	intron variant	Likely benign	Jul 9, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-114T>C	TSC2		not provided	VCV000676697	16	2105289	16	2055288	676697	668665	rs77037371	NC_000016.10:2055287:T:C	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-68C>G	TSC2		not provided	VCV000049958	16	2105335	16	2055334	49958	59120	rs2516734	NC_000016.10:2055333:C:G	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-27C>T	TSC2		not provided	VCV000065374	16	2105376	16	2055375	65374	76308	rs200473689	NC_000016.10:2055374:C:T	single nucleotide variant	intron variant	Likely benign	Jul 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-20T>C	TSC2		Tuberous sclerosis 2	VCV001623266	16	2105383	16	2055382	1623266	1540468	rs548831116	NC_000016.10:2055381:T:C	single nucleotide variant	intron variant	Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-20T>A	TSC2		not specified|not provided|Tuberous sclerosis 2	VCV000516773	16	2105383	16	2055382	516773	506135	rs548831116	NC_000016.10:2055381:T:A	single nucleotide variant	intron variant	Benign/Likely benign	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-19G>A	TSC2		Tuberous sclerosis 2	VCV003692218	16	2105384	16	2055383	3692218	3831605		NC_000016.10:2055382:G:A	single nucleotide variant	intron variant	Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-18C>T	TSC2		Tuberous sclerosis 2	VCV002162862	16	2105385	16	2055384	2162862	1891279	rs1400003245	NC_000016.10:2055383:C:T	single nucleotide variant	intron variant	Likely benign	Dec 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-17C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000383812	16	2105386	16	2055385	383812	375100	rs201589515	NC_000016.10:2055384:C:T	single nucleotide variant	intron variant	Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-16G>A	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001599284	16	2105387	16	2055386	1599284	1609366	rs200647260	NC_000016.10:2055385:G:A	single nucleotide variant	intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-14C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001614650	16	2105389	16	2055388	1614650	1663924	rs757054946	NC_000016.10:2055387:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-14C>A	TSC2		Tuberous sclerosis 2	VCV001358137	16	2105389	16	2055388	1358137	1460436	rs757054946	NC_000016.10:2055387:C:A	single nucleotide variant	intron variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-13G>T	TSC2		Tuberous sclerosis 2	VCV002150895	16	2105390	16	2055389	2150895	1888391	rs1221885368	NC_000016.10:2055388:G:T	single nucleotide variant	intron variant	Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-13G>C	TSC2		Tuberous sclerosis 2	VCV001659063	16	2105390	16	2055389	1659063	1640608	rs1221885368	NC_000016.10:2055388:G:C	single nucleotide variant	intron variant	Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-13G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001587391	16	2105390	16	2055389	1587391	1541906	rs1221885368	NC_000016.10:2055388:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.482-11T>C	TSC2		Tuberous sclerosis 2	VCV002082328	16	2105392	16	2055391	2082328	2132514	rs2151058085	NC_000016.10:2055390:T:C	single nucleotide variant	intron variant	Likely benign	Oct 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-10T>A	TSC2		Tuberous sclerosis syndrome	VCV003073781	16	2105393	16	2055392	3073781	3232651	rs2548432795	NC_000016.10:2055391:T:A	single nucleotide variant	intron variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-9C>T	TSC2		Tuberous sclerosis 2	VCV003716519	16	2105394	16	2055393	3716519	3848924		NC_000016.10:2055392:C:T	single nucleotide variant	intron variant	Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-9C>A	TSC2		Tuberous sclerosis 2	VCV002847708	16	2105394	16	2055393	2847708	3008780	rs1060504096	NC_000016.10:2055392:C:A	single nucleotide variant	intron variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-9C>G	TSC2		Tuberous sclerosis 2	VCV000413663	16	2105394	16	2055393	413663	400607	rs1060504096	NC_000016.10:2055392:C:G	single nucleotide variant	intron variant	Likely benign	Jun 5, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-7C>T	TSC2		Tuberous sclerosis 2	VCV002713106	16	2105396	16	2055395	2713106	2879252	rs2085648892	NC_000016.10:2055394:C:T	single nucleotide variant	intron variant	Likely benign	Aug 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-7C>A	TSC2		Tuberous sclerosis 2	VCV001038056	16	2105396	16	2055395	1038056	1032428	rs2085648892	NC_000016.10:2055394:C:A	single nucleotide variant	intron variant	Uncertain significance	Feb 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-7C>G	TSC2		Tuberous sclerosis 2	VCV001004859	16	2105396	16	2055395	1004859	996687	rs2085648892	NC_000016.10:2055394:C:G	single nucleotide variant	intron variant	Uncertain significance	Apr 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-6C>G	TSC2		Tuberous sclerosis 2	VCV002103113	16	2105397	16	2055396	2103113	2158417	rs1372293593	NC_000016.10:2055395:C:G	single nucleotide variant	intron variant	Uncertain significance	Feb 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-6C>A	TSC2		Tuberous sclerosis 2	VCV002036351	16	2105397	16	2055396	2036351	2090407	rs1372293593	NC_000016.10:2055395:C:A	single nucleotide variant	intron variant	Uncertain significance	Oct 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-5C>G	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000998803	16	2105398	16	2055397	998803	996688	rs397515071	NC_000016.10:2055396:C:G	single nucleotide variant	intron variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-5C>T	TSC2		Tuberous sclerosis 2	VCV000065096	16	2105398	16	2055397	65096	76027	rs397515071	NC_000016.10:2055396:C:T	single nucleotide variant	intron variant	Likely benign	Aug 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-4C>G	TSC2		Hereditary cancer-predisposing syndrome	VCV003232177	16	2105399	16	2055398	3232177	3391978	rs780938957	NC_000016.10:2055397:C:G	single nucleotide variant	intron variant	Likely benign	Sep 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-4C>A	TSC2		Hereditary cancer-predisposing syndrome	VCV001743379	16	2105399	16	2055398	1743379	1805525	rs780938957	NC_000016.10:2055397:C:A	single nucleotide variant	intron variant	Uncertain significance	May 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-4C>T	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000766539	16	2105399	16	2055398	766539	776117	rs780938957	NC_000016.10:2055397:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.482-3C>T	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049957	16	2105400	16	2055399	49957	59119	rs1800720	NC_000016.10:2055398:C:T	single nucleotide variant	intron variant	Benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.482-1G>A	TSC2		not provided	VCV000449786	16	2105402	16	2055401	449786	445511	rs137854306	NC_000016.10:2055400:G:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Feb 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.482-1G>C	TSC2		Tuberous sclerosis 2	VCV000049826	16	2105402	16	2055401	49826	58988	rs137854306	NC_000016.10:2055400:G:C	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Jan 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.482C>G (p.Ala161Gly)	TSC2	A124G, A172G, A112G, A161G	Tuberous sclerosis 2	VCV000649299	16	2105403	16	2055402	649299	644149	rs45481496	NC_000016.10:2055401:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.482C>T (p.Ala161Val)	TSC2	A161V, A112V, A172V, A124V	Tuberous sclerosis 2	VCV000049324	16	2105403	16	2055402	49324	58486	rs45481496	NC_000016.10:2055401:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 5, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.483T>G (p.Ala161=)	TSC2		Tuberous sclerosis 2	VCV003699917	16	2105404	16	2055403	3699917	3830201		NC_000016.10:2055402:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jun 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.484G>T (p.Asp162Tyr)	TSC2	D173Y, D192Y, D125Y, D113Y, D162Y, D143Y	Hereditary cancer-predisposing syndrome	VCV001743568	16	2105405	16	2055404	1743568	1801915	rs1257721773	NC_000016.10:2055403:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.484G>A (p.Asp162Asn)	TSC2	D162N, D113N, D173N, D125N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535868	16	2105405	16	2055404	535868	530095	rs1257721773	NC_000016.10:2055403:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.486C>G (p.Asp162Glu)	TSC2	D113E, D173E, D125E, D192E, D162E, D143E	Hereditary cancer-predisposing syndrome	VCV001743689	16	2105407	16	2055406	1743689	1802035	rs45473598	NC_000016.10:2055405:C:G	single nucleotide variant	missense variant|intron variant	Likely benign	Apr 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.486C>T (p.Asp162=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049328	16	2105407	16	2055406	49328	58490	rs45473598	NC_000016.10:2055405:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.487T>A (p.Phe163Ile)	TSC2	F174I, F144I, F114I, F126I, F163I, F193I	Tuberous sclerosis 2	VCV002757947	16	2105408	16	2055407	2757947	2914790	rs2548433174	NC_000016.10:2055406:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.488T>C (p.Phe163Ser)	TSC2	F114S, F174S, F126S, F163S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000663005	16	2105409	16	2055408	663005	644150	rs1596270677	NC_000016.10:2055407:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.490G>C (p.Val164Leu)	TSC2	V115L, V175L, V145L, V194L, V127L, V164L	Hereditary cancer-predisposing syndrome	VCV003811368	16	2105411	16	2055410	3811368	3928609		NC_000016.10:2055409:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.490G>A (p.Val164Ile)	TSC2	V145I, V175I, V115I, V164I, V194I, V127I	Hereditary cancer-predisposing syndrome	VCV002449979	16	2105411	16	2055410	2449979	2425936	rs1596270687	NC_000016.10:2055409:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.491T>C (p.Val164Ala)	TSC2	V175A, V115A, V127A, V164A, V145A, V194A	Hereditary cancer-predisposing syndrome	VCV003462657	16	2105412	16	2055411	3462657	3621676		NC_000016.10:2055410:T:C	single nucleotide variant	intron variant|missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.492C>T (p.Val164=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468120	16	2105413	16	2055412	468120	466011	rs1424637610	NC_000016.10:2055411:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.493C>T (p.Leu165=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000198098	16	2105414	16	2055413	198098	195259	rs758521946	NC_000016.10:2055412:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.494T>C (p.Leu165Pro)	TSC2	L128P, L165P, L176P, L146P, L116P, L195P	Hereditary cancer-predisposing syndrome	VCV003811332	16	2105415	16	2055414	3811332	3928573		NC_000016.10:2055413:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.494T>A (p.Leu165Gln)	TSC2	L128Q, L176Q, L165Q, L195Q, L116Q, L146Q	Hereditary cancer-predisposing syndrome	VCV003462645	16	2105415	16	2055414	3462645	3621664		NC_000016.10:2055413:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.495G>A (p.Leu165=)	TSC2		Tuberous sclerosis 2	VCV001627648	16	2105416	16	2055415	1627648	1530866	rs2151058683	NC_000016.10:2055414:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.496C>A (p.Gln166Lys)	TSC2	Q147K, Q177K, Q196K, Q166K, Q117K, Q129K	Tuberous sclerosis 2	VCV002700135	16	2105417	16	2055416	2700135	2858987	rs45517111	NC_000016.10:2055415:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.496C>T (p.Gln166Ter)	TSC2	Q166*, Q177*, Q117*, Q129*	Tuberous sclerosis 2|not provided	VCV000049819	16	2105417	16	2055416	49819	58981	rs45517111	NC_000016.10:2055415:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.497A>G (p.Gln166Arg)	TSC2	Q129R, Q147R, Q166R, Q196R, Q177R, Q117R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001744511	16	2105418	16	2055417	1744511	1809292	rs954041989	NC_000016.10:2055416:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.498G>A (p.Gln166=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001744581	16	2105419	16	2055418	1744581	1809362	rs2085655247	NC_000016.10:2055417:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Dec 6, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.499T>C (p.Trp167Arg)	TSC2	W167R, W118R, W130R, W178R	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000486635	16	2105420	16	2055419	486635	477296	rs1555498118	NC_000016.10:2055418:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 25, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.500G>A (p.Trp167Ter)	TSC2	W167*, W178*, W118*, W130*	not provided|Tuberous sclerosis 2	VCV000430129	16	2105421	16	2055420	430129	422077	rs1131691794	NC_000016.10:2055419:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.501G>A (p.Trp167Ter)	TSC2	W130*, W178*, W118*, W167*	Lymphangiomyomatosis	VCV000930277	16	2105422	16	2055421	930277	919615	rs755728007	NC_000016.10:2055420:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.501G>C (p.Trp167Cys)	TSC2	W167C, W118C, W178C, W130C	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000468130	16	2105422	16	2055421	468130	465841	rs755728007	NC_000016.10:2055420:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.502A>T (p.Met168Leu)	TSC2	M149L, M179L, M119L, M14L, M168L, M131L, M198L	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001744879	16	2105423	16	2055422	1744879	1805725	rs779566253	NC_000016.10:2055421:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.502A>G (p.Met168Val)	TSC2	M179V, M168V, M119V, M131V	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001047698	16	2105423	16	2055422	1047698	1032429	rs779566253	NC_000016.10:2055421:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.502A>C (p.Met168Leu)	TSC2	M119L, M131L, M168L, M179L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000961978	16	2105423	16	2055422	961978	949224	rs779566253	NC_000016.10:2055421:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.503T>C (p.Met168Thr)	TSC2	M168T, M131T, M179T, M119T	Tuberous sclerosis 2	VCV000468132	16	2105424	16	2055423	468132	466012	rs1555498124	NC_000016.10:2055422:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.504G>A (p.Met168Ile)	TSC2	M198I, M119I, M168I, M179I, M131I, M14I, M149I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001745015	16	2105425	16	2055424	1745015	1805861	rs748692173	NC_000016.10:2055423:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 9, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.504G>T (p.Met168Ile)	TSC2	M168I, M179I, M119I, M131I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000578409	16	2105425	16	2055424	578409	569590	rs748692173	NC_000016.10:2055423:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.505G>A (p.Asp169Asn)	TSC2	D132N, D169N, D180N, D120N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000952666	16	2105426	16	2055425	952666	927617	rs2085657148	NC_000016.10:2055424:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 17, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.506A>C (p.Asp169Ala)	TSC2	D180A, D150A, D169A, D199A, D120A, D132A, D15A	Tuberous sclerosis 2	VCV002708235	16	2105427	16	2055426	2708235	2874400	rs2151058974	NC_000016.10:2055425:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.507T>C (p.Asp169=)	TSC2		Tuberous sclerosis 2	VCV002037979	16	2105428	16	2055427	2037979	2090739	rs1257599991	NC_000016.10:2055426:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Dec 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.508G>T (p.Val170Phe)	TSC2	V170F, V121F, V133F, V181F, V151F, V16F, V200F	Hereditary cancer-predisposing syndrome	VCV003811299	16	2105429	16	2055428	3811299	3928540		NC_000016.10:2055427:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 31, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.508G>A (p.Val170Ile)	TSC2	V133I, V170I, V181I, V121I	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000643303	16	2105429	16	2055428	643303	644151	rs1596270815	NC_000016.10:2055427:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.509T>C (p.Val170Ala)	TSC2	V170A, V133A, V181A, V121A	Tuberous sclerosis 2	VCV000834477	16	2105430	16	2055429	834477	843323	rs2085658266	NC_000016.10:2055428:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.512G>T (p.Gly171Val)	TSC2	G134V, G17V, G182V, G171V, G201V, G122V, G152V	Tuberous sclerosis 2	VCV002095346	16	2105433	16	2055432	2095346	2153252	rs983899092	NC_000016.10:2055431:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.512G>A (p.Gly171Asp)	TSC2	G182D, G122D, G134D, G171D	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000664555	16	2105433	16	2055432	664555	644152	rs983899092	NC_000016.10:2055431:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.513C>T (p.Gly171=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003811341	16	2105434	16	2055433	3811341	3928582		NC_000016.10:2055432:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.514T>G (p.Leu172Val)	TSC2	L135V, L172V, L202V, L18V, L153V, L183V, L123V	Hereditary cancer-predisposing syndrome	VCV002564659	16	2105435	16	2055434	2564659	2733815	rs2548433945	NC_000016.10:2055433:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.516G>C (p.Leu172Phe)	TSC2	L123F, L153F, L183F, L172F, L135F, L18F, L202F	Tuberous sclerosis 2	VCV002797016	16	2105437	16	2055436	2797016	2951670	rs772641112	NC_000016.10:2055435:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.516G>A (p.Leu172=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825501	16	2105437	16	2055436	825501	812479	rs772641112	NC_000016.10:2055435:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.517T>C (p.Ser173Pro)	TSC2	S124P, S136P, S154P, S173P, S184P, S19P, S203P	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003074954	16	2105438	16	2055437	3074954	3234606	rs2151059325	NC_000016.10:2055436:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.517T>G (p.Ser173Ala)	TSC2	S136A, S173A, S184A, S124A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001423090	16	2105438	16	2055437	1423090	1425369	rs2151059325	NC_000016.10:2055436:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.518C>T (p.Ser173Phe)	TSC2	S124F, S136F, S184F, S173F	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000949320	16	2105439	16	2055438	949320	927618	rs773662047	NC_000016.10:2055437:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.519C>G (p.Ser173=)	TSC2		Tuberous sclerosis 2	VCV002713395	16	2105440	16	2055439	2713395	2875693	rs2151059384	NC_000016.10:2055438:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	May 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.521C>T (p.Ser174Leu)	TSC2	S174L, S137L, S185L, S125L	not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000468149	16	2105442	16	2055441	468149	466015	rs747538587	NC_000016.10:2055440:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.522G>C (p.Ser174=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001080163	16	2105443	16	2055442	1080163	1081771	rs2085660429	NC_000016.10:2055441:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.522G>A (p.Ser174=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000856671	16	2105443	16	2055442	856671	843324	rs2085660429	NC_000016.10:2055441:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.523G>C (p.Glu175Gln)	TSC2	E138Q, E175Q, E186Q, E126Q	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001035715	16	2105444	16	2055443	1035715	1032430	rs1555498151	NC_000016.10:2055442:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 8, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.523G>A (p.Glu175Lys)	TSC2	E175K, E138K, E126K, E186K	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535939	16	2105444	16	2055443	535939	529850	rs1555498151	NC_000016.10:2055442:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.525A>G (p.Glu175=)	TSC2		Tuberous sclerosis 2	VCV001545081	16	2105446	16	2055445	1545081	1644487	rs1173197942	NC_000016.10:2055444:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 26, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.528C>T (p.Phe176=)	TSC2		Tuberous sclerosis 2	VCV002895225	16	2105449	16	2055448	2895225	3049314	rs2151059657	NC_000016.10:2055447:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jul 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.528C>A (p.Phe176Leu)	TSC2	F139L, F176L, F187L, F127L	Tuberous sclerosis 2	VCV001354572	16	2105449	16	2055448	1354572	1434157	rs2151059657	NC_000016.10:2055447:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.529C>A (p.Leu177Ile)	TSC2	L158I, L207I, L128I, L140I, L177I, L23I, L188I	Tuberous sclerosis 2	VCV003637175	16	2105450	16	2055449	3637175	3771329		NC_000016.10:2055448:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.529C>T (p.Leu177Phe)	TSC2	L140F, L128F, L177F, L188F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000850642	16	2105450	16	2055449	850642	843325	rs867879148	NC_000016.10:2055448:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 27, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.530T>G (p.Leu177Arg)	TSC2	L177R, L140R, L207R, L128R, L158R, L188R, L23R	Hereditary cancer-predisposing syndrome	VCV002564660	16	2105451	16	2055450	2564660	2733816	rs2085662752	NC_000016.10:2055449:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.532C>T (p.Leu178=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468158	16	2105453	16	2055452	468158	465721	rs1465941679	NC_000016.10:2055451:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.533T>C (p.Leu178Pro)	TSC2	L189P, L129P, L141P, L178P	Tuberous sclerosis 2	VCV001516755	16	2105454	16	2055453	1516755	1495528	rs1266917945	NC_000016.10:2055452:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.535G>T (p.Val179Leu)	TSC2	V130L, V142L, V160L, V179L, V190L, V209L, V25L	not provided	VCV001878906	16	2105456	16	2055455	1878906	1935658	rs777105764	NC_000016.10:2055454:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.535G>A (p.Val179Met)	TSC2	V179M, V130M, V142M, V190M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468165	16	2105456	16	2055455	468165	465845	rs777105764	NC_000016.10:2055454:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.537G>A (p.Val179=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001620506	16	2105458	16	2055457	1620506	1581332	rs2151059968	NC_000016.10:2055456:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.538C>A (p.Leu180Met)	TSC2	L180M, L131M, L143M, L191M	Tuberous sclerosis 2	VCV000581190	16	2105459	16	2055458	581190	570039	rs45485591	NC_000016.10:2055457:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.538C>G (p.Leu180Val)	TSC2	L180V, L191V, L131V, L143V	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome	VCV000049846	16	2105459	16	2055458	49846	59008	rs45485591	NC_000016.10:2055457:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.539T>C (p.Leu180Pro)	TSC2	L131P, L143P, L161P, L180P, L191P, L210P, L26P	Tuberous sclerosis 2	VCV003391019	16	2105460	16	2055459	3391019	3550104		NC_000016.10:2055458:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.539T>A (p.Leu180Gln)	TSC2	L143Q, L180Q, L131Q, L191Q	Hereditary cancer-predisposing syndrome	VCV000825700	16	2105460	16	2055459	825700	812480	rs1567403610	NC_000016.10:2055458:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.539T>G (p.Leu180Arg)	TSC2	L180R, L131R, L143R, L191R	Tuberous sclerosis 2	VCV000569291	16	2105460	16	2055459	569291	569596	rs1567403610	NC_000016.10:2055458:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 29, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.540G>T (p.Leu180=)	TSC2		Tuberous sclerosis 2	VCV002698921	16	2105461	16	2055460	2698921	2855212	rs1567403619	NC_000016.10:2055459:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Nov 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.540G>A (p.Leu180=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000871456	16	2105461	16	2055460	871456	860215	rs1567403619	NC_000016.10:2055459:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.541G>A (p.Val181Met)	TSC2	V144M, V181M, V192M, V132M	Tuberous sclerosis 2	VCV001401120	16	2105462	16	2055461	1401120	1379108	rs2151060118	NC_000016.10:2055460:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.542T>C (p.Val181Ala)	TSC2	V132A, V144A, V162A, V27A, V181A, V192A, V211A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002497446	16	2105463	16	2055462	2497446	2472529	rs982250014	NC_000016.10:2055461:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.544A>G (p.Asn182Asp)	TSC2	N182D, N133D, N145D, N193D, N212D, N28D, N163D	Tuberous sclerosis 2	VCV001924667	16	2105465	16	2055464	1924667	1980114	rs2151060213	NC_000016.10:2055463:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.545A>T (p.Asn182Ile)	TSC2	N145I, N193I, N133I, N182I	Tuberous sclerosis 2	VCV000834514	16	2105466	16	2055465	834514	843326	rs1016698636	NC_000016.10:2055464:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 12, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.546C>T (p.Asn182=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001534805	16	2105467	16	2055466	1534805	1617321	rs2085665682	NC_000016.10:2055465:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.547T>C (p.Leu183=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462561	16	2105468	16	2055467	3462561	3621581		NC_000016.10:2055466:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Oct 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.549G>T (p.Leu183Phe)	TSC2	L134F, L146F, L164F, L183F, L194F, L213F, L29F	Hereditary cancer-predisposing syndrome	VCV003232197	16	2105470	16	2055469	3232197	3391998	rs1415519717	NC_000016.10:2055468:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.549G>A (p.Leu183=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002044666	16	2105470	16	2055469	2044666	2096091	rs1415519717	NC_000016.10:2055468:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.549G>C (p.Leu183Phe)	TSC2	L183F, L194F, L134F, L146F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535997	16	2105470	16	2055469	535997	529563	rs1415519717	NC_000016.10:2055468:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.551T>A (p.Val184Asp)	TSC2	V135D, V147D, V184D, V195D	Tuberous sclerosis 2	VCV001068227	16	2105472	16	2055471	1068227	1056292	rs2085667006	NC_000016.10:2055470:T:A	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Jan 7, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.551T>G (p.Val184Gly)	TSC2	V195G, V147G, V184G, V135G	Tuberous sclerosis 2	VCV000938837	16	2105472	16	2055471	938837	937278	rs2085667006	NC_000016.10:2055470:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 16, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.552C>G (p.Val184=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001908685	16	2105473	16	2055472	1908685	1958987	rs199991910	NC_000016.10:2055471:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.552C>T (p.Val184=)	TSC2		not specified|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000318306	16	2105473	16	2055472	318306	340849	rs199991910	NC_000016.10:2055471:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.554A>G (p.Lys185Arg)	TSC2	K136R, K148R, K166R, K185R, K196R, K215R, K31R	Tuberous sclerosis 2	VCV003615450	16	2105475	16	2055474	3615450	3749281		NC_000016.10:2055473:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.554A>C (p.Lys185Thr)	TSC2	K148T, K136T, K196T, K185T	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001416380	16	2105475	16	2055474	1416380	1383202	rs2151060565	NC_000016.10:2055473:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.558C>A (p.Phe186Leu)	TSC2	F137L, F149L, F186L, F197L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001021704	16	2105479	16	2055478	1021704	1011935	rs775642056	NC_000016.10:2055477:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.558C>T (p.Phe186=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000413628	16	2105479	16	2055478	413628	401402	rs775642056	NC_000016.10:2055477:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.559A>C (p.Asn187His)	TSC2	N138H, N168H, N187H, N150H, N217H, N33H, N198H	Hereditary cancer-predisposing syndrome	VCV001748522	16	2105480	16	2055479	1748522	1806770	rs2151060666	NC_000016.10:2055478:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.560A>G (p.Asn187Ser)	TSC2	N187S, N138S, N150S, N198S	Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis	VCV000184186	16	2105481	16	2055480	184186	184112	rs45505405	NC_000016.10:2055479:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.561T>C (p.Asn187=)	TSC2		Tuberous sclerosis 2	VCV002915623	16	2105482	16	2055481	2915623	3074173	rs2151060729	NC_000016.10:2055480:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.563G>T (p.Ser188Ile)	TSC2	S139I, S188I, S199I, S169I, S218I, S151I, S34I	Hereditary cancer-predisposing syndrome	VCV003974657	16	2105484	16	2055483	3974657	4086480		NC_000016.10:2055482:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.563G>C (p.Ser188Thr)	TSC2	S139T, S218T, S151T, S188T, S199T, S169T, S34T	Tuberous sclerosis 2	VCV002800026	16	2105484	16	2055483	2800026	2955964	rs2151060769	NC_000016.10:2055482:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.563G>A (p.Ser188Asn)	TSC2	S139N, S169N, S151N, S188N, S218N, S199N, S34N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001748790	16	2105484	16	2055483	1748790	1803243	rs2151060769	NC_000016.10:2055482:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.564C>T (p.Ser188=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001146616	16	2105485	16	2055484	1146616	1145893	rs2151060790	NC_000016.10:2055483:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.566G>C (p.Cys189Ser)	TSC2	C140S, C152S, C200S, C189S	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000825884	16	2105487	16	2055486	825884	812481	rs764218079	NC_000016.10:2055485:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.566G>A (p.Cys189Tyr)	TSC2	C189Y, C200Y, C140Y, C152Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000238088	16	2105487	16	2055486	238088	242213	rs764218079	NC_000016.10:2055485:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.567T>A (p.Cys189Ter)	TSC2	C189*, C200*, C140*, C152*	Tuberous sclerosis 2	VCV000839179	16	2105488	16	2055487	839179	843327	rs2085669104	NC_000016.10:2055486:T:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 11, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.570C>T (p.Tyr190=)	TSC2		Tuberous sclerosis 2	VCV001103802	16	2105491	16	2055490	1103802	1103607	rs397515099	NC_000016.10:2055489:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.571C>G (p.Leu191Val)	TSC2	L154V, L202V, L142V, L191V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000825921	16	2105492	16	2055491	825921	812482	rs1555498201	NC_000016.10:2055490:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.571C>T (p.Leu191Phe)	TSC2	L191F, L202F, L154F, L142F	Tuberous sclerosis 2	VCV000535954	16	2105492	16	2055491	535954	530100	rs1555498201	NC_000016.10:2055490:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.572T>A (p.Leu191His)	TSC2	L142H, L191H, L37H, L154H, L202H, L172H, L221H	Tuberous sclerosis 2	VCV002720316	16	2105493	16	2055492	2720316	2880827	rs2151061041	NC_000016.10:2055491:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.572T>C (p.Leu191Pro)	TSC2	L142P, L172P, L221P, L154P, L37P, L191P, L202P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002095794	16	2105493	16	2055492	2095794	2149711	rs2151061041	NC_000016.10:2055491:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.573C>G (p.Leu191=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000198097	16	2105494	16	2055493	198097	195258	rs397515059	NC_000016.10:2055492:C:G	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.573C>T (p.Leu191=)	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000065080	16	2105494	16	2055493	65080	76011	rs397515059	NC_000016.10:2055492:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.574G>A (p.Asp192Asn)	TSC2	D192N, D203N, D155N, D143N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535962	16	2105495	16	2055494	535962	529853	rs1284679649	NC_000016.10:2055493:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.576C>A (p.Asp192Glu)	TSC2	D143E, D155E, D173E, D192E, D203E, D222E, D38E	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003069223	16	2105497	16	2055496	3069223	3229850	rs761704292	NC_000016.10:2055495:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.576C>G (p.Asp192Glu)	TSC2	D143E, D155E, D192E, D38E, D203E, D173E, D222E	Tuberous sclerosis 2	VCV003009594	16	2105497	16	2055496	3009594	3180285	rs761704292	NC_000016.10:2055495:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.576C>T (p.Asp192=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2	VCV000413654	16	2105497	16	2055496	413654	400749	rs761704292	NC_000016.10:2055495:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.577G>C (p.Glu193Gln)	TSC2	E144Q, E156Q, E223Q, E174Q, E193Q, E204Q, E39Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV001749603	16	2105498	16	2055497	1749603	1810523	rs45517112	NC_000016.10:2055496:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.577G>A (p.Glu193Lys)	TSC2	E193K, E156K, E144K, E204K	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207702	16	2105498	16	2055497	207702	203092	rs45517112	NC_000016.10:2055496:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.577G>T (p.Glu193Ter)	TSC2	E193*, E156*, E144*, E204*	not provided|Tuberous sclerosis 2	VCV000050039	16	2105498	16	2055497	50039	59201	rs45517112	NC_000016.10:2055496:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.578A>G (p.Glu193Gly)	TSC2	E204G, E156G, E144G, E193G	Tuberous sclerosis 2	VCV001375875	16	2105499	16	2055498	1375875	1470261	rs2085672813	NC_000016.10:2055497:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.578A>C (p.Glu193Ala)	TSC2	E204A, E144A, E156A, E193A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000840262	16	2105499	16	2055498	840262	843328	rs2085672813	NC_000016.10:2055497:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.579G>A (p.Glu193=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000751868	16	2105500	16	2055499	751868	770664	rs1192379518	NC_000016.10:2055498:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.581A>G (p.Tyr194Cys)	TSC2	Y194C, Y145C, Y157C, Y205C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486684	16	2105502	16	2055501	486684	477424	rs1555498219	NC_000016.10:2055500:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.582C>G (p.Tyr194Ter)	TSC2	Y194*, Y205*, Y145*, Y157*	Tuberous sclerosis 2	VCV000952313	16	2105503	16	2055502	952313	927619	rs750174170	NC_000016.10:2055501:C:G	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 14, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.582C>T (p.Tyr194=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000825996	16	2105503	16	2055502	825996	812483	rs750174170	NC_000016.10:2055501:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.583A>G (p.Ile195Val)	TSC2	I195V, I158V, I146V, I206V	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207703	16	2105504	16	2055503	207703	203093	rs148325559	NC_000016.10:2055502:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.585C>G (p.Ile195Met)	TSC2	I195M, I146M, I158M, I206M	Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000581042	16	2105506	16	2055505	581042	570042	rs397515309	NC_000016.10:2055504:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.585C>T (p.Ile195=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000536097	16	2105506	16	2055505	536097	529519	rs397515309	NC_000016.10:2055504:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.585C>A (p.Ile195=)	TSC2		not specified	VCV000065051	16	2105506	16	2055505	65051	75981	rs397515309	NC_000016.10:2055504:C:A	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Aug 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.586G>T (p.Ala196Ser)	TSC2	A177S, A226S, A196S, A147S, A159S, A207S, A42S	Hereditary cancer-predisposing syndrome	VCV002564718	16	2105507	16	2055506	2564718	2733874	rs45517113	NC_000016.10:2055505:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.586G>A (p.Ala196Thr)	TSC2	A196T, A147T, A159T, A207T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000049953	16	2105507	16	2055506	49953	59115	rs45517113	NC_000016.10:2055505:G:A	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.587C>A (p.Ala196Glu)	TSC2	A147E, A177E, A226E, A196E, A159E, A42E, A207E	Hereditary cancer-predisposing syndrome	VCV003974691	16	2105508	16	2055507	3974691	4086514		NC_000016.10:2055506:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.587C>T (p.Ala196Val)	TSC2	A159V, A147V, A207V, A196V	Tuberous sclerosis 2	VCV000654311	16	2105508	16	2055507	654311	644153	rs1596271211	NC_000016.10:2055506:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.588A>T (p.Ala196=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003232198	16	2105509	16	2055508	3232198	3391999	rs941407136	NC_000016.10:2055507:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.588A>G (p.Ala196=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002626412	16	2105509	16	2055508	2626412	2794178	rs941407136	NC_000016.10:2055507:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.590G>A (p.Arg197Lys)	TSC2	R148K, R160K, R197K, R208K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001062844	16	2105511	16	2055510	1062844	1049418	rs754505860	NC_000016.10:2055509:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.591G>A (p.Arg197=)	TSC2		Tuberous sclerosis 2	VCV004071327	16	2105512	16	2055511	4071327	4185175		NC_000016.10:2055510:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	May 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.593T>C (p.Met198Thr)	TSC2	M198T, M149T, M161T, M209T	Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049375	16	2105514	16	2055513	49375	58537	rs45517114	NC_000016.10:2055512:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.594G>A (p.Met198Ile)	TSC2	M161I, M149I, M209I, M198I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000857885	16	2105515	16	2055514	857885	843329	rs1452242351	NC_000016.10:2055513:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.595G>A (p.Val199Ile)	TSC2	V150I, V162I, V180I, V229I, V199I, V210I, V45I	Hereditary cancer-predisposing syndrome	VCV003974641	16	2105516	16	2055515	3974641	4086464		NC_000016.10:2055514:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.595G>C (p.Val199Leu)	TSC2	V199L, V150L, V210L, V162L	Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000135378	16	2105516	16	2055515	135378	139117	rs587778733	NC_000016.10:2055514:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.596T>A (p.Val199Asp)	TSC2	V150D, V162D, V180D, V199D, V210D, V229D, V45D	Tuberous sclerosis 2	VCV002437384	16	2105517	16	2055516	2437384	2411315	rs1555498243	NC_000016.10:2055515:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 5, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.596T>C (p.Val199Ala)	TSC2	V199A, V162A, V210A, V150A	Tuberous sclerosis 2	VCV000468169	16	2105517	16	2055516	468169	466020	rs1555498243	NC_000016.10:2055515:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.598C>T (p.Gln200Ter)	TSC2	Q200*, Q151*, Q163*, Q211*	Tuberous sclerosis syndrome	VCV000049376	16	2105519	16	2055518	49376	58538	rs45517115	NC_000016.10:2055517:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 17, 2015	criteria provided, single submitter							
NM_000548.5(TSC2):c.599A>T (p.Gln200Leu)	TSC2	Q200L, Q163L, Q151L, Q211L, Q230L, Q46L, Q181L	Tuberous sclerosis 2	VCV002005995	16	2105520	16	2055519	2005995	2072941	rs2085677930	NC_000016.10:2055518:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.599A>G (p.Gln200Arg)	TSC2	Q163R, Q211R, Q151R, Q200R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000958434	16	2105520	16	2055519	958434	949225	rs2085677930	NC_000016.10:2055518:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.599+1G>C	TSC2		Tuberous sclerosis 2	VCV003393429	16	2105521	16	2055520	3393429	3552505		NC_000016.10:2055519:G:C	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic		criteria provided, single submitter							
NM_000548.5(TSC2):c.599+1G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049377	16	2105521	16	2055520	49377	58539	rs45460895	NC_000016.10:2055519:G:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.599+2T>A	TSC2		Tuberous sclerosis 2	VCV002130841	16	2105522	16	2055521	2130841	2186136	rs45484992	NC_000016.10:2055520:T:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Jul 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+2T>C	TSC2		Hereditary cancer-predisposing syndrome	VCV001750906	16	2105522	16	2055521	1750906	1800635	rs45484992	NC_000016.10:2055520:T:C	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Aug 17, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+2T>G	TSC2		Tuberous sclerosis 2	VCV000049876	16	2105522	16	2055521	49876	59038	rs45484992	NC_000016.10:2055520:T:G	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Feb 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+3A>T	TSC2		not specified	VCV000448739	16	2105523	16	2055522	448739	441777	rs397514899	NC_000016.10:2055521:A:T	single nucleotide variant	intron variant	Uncertain significance	Jan 31, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+3A>G	TSC2		Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000064873	16	2105523	16	2055522	64873	75802	rs397514899	NC_000016.10:2055521:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 17, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.599+4A>G	TSC2		Tuberous sclerosis 2	VCV000065188	16	2105524	16	2055523	65188	76120	rs397515140	NC_000016.10:2055522:A:G	single nucleotide variant	intron variant	Uncertain significance	Jan 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+5G>C	TSC2		Tuberous sclerosis 2	VCV000049878	16	2105525	16	2055524	49878	59040	rs45463996	NC_000016.10:2055523:G:C	single nucleotide variant	intron variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+5G>A	TSC2		Tuberous sclerosis 2	VCV000049877	16	2105525	16	2055524	49877	59039	rs45463996	NC_000016.10:2055523:G:A	single nucleotide variant	intron variant	Likely pathogenic	Jul 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+6A>G	TSC2		Tuberous sclerosis 2	VCV001005236	16	2105526	16	2055525	1005236	996689	rs2085679383	NC_000016.10:2055524:A:G	single nucleotide variant	intron variant	Uncertain significance	Nov 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+7A>G	TSC2		Tuberous sclerosis 2	VCV002864181	16	2105527	16	2055526	2864181	3026546	rs1345035201	NC_000016.10:2055525:A:G	single nucleotide variant	intron variant	Likely benign	Oct 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+8A>G	TSC2		Tuberous sclerosis 2	VCV001132026	16	2105528	16	2055527	1132026	1125013	rs2151062239	NC_000016.10:2055526:A:G	single nucleotide variant	intron variant	Likely benign	Jun 1, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+9A>G	TSC2		Tuberous sclerosis 2	VCV002984777	16	2105529	16	2055528	2984777	3146389	rs2548437341	NC_000016.10:2055527:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.599+10G>T	TSC2		Tuberous sclerosis 2	VCV000792774	16	2105530	16	2055529	792774	787921	rs1037449903	NC_000016.10:2055528:G:T	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.599+10G>C	TSC2		Tuberous sclerosis 2|not specified	VCV000388112	16	2105530	16	2055529	388112	375104	rs1037449903	NC_000016.10:2055528:G:C	single nucleotide variant	intron variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.599+11A>C	TSC2		Tuberous sclerosis 2	VCV002701372	16	2105531	16	2055530	2701372	2862366	rs2085680412	NC_000016.10:2055529:A:C	single nucleotide variant	intron variant	Likely benign	Dec 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+13T>C	TSC2		Tuberous sclerosis 2	VCV002821226	16	2105533	16	2055532	2821226	2988302	rs2151062385	NC_000016.10:2055531:T:C	single nucleotide variant	intron variant	Likely benign	Dec 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+13T>G	TSC2		Tuberous sclerosis 2	VCV002789793	16	2105533	16	2055532	2789793	2949635	rs2151062385	NC_000016.10:2055531:T:G	single nucleotide variant	intron variant	Uncertain significance	Nov 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+14T>G	TSC2		Tuberous sclerosis 2	VCV003663805	16	2105534	16	2055533	3663805	3798396		NC_000016.10:2055532:T:G	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+14T>C	TSC2		Tuberous sclerosis 2	VCV003650058	16	2105534	16	2055533	3650058	3788054		NC_000016.10:2055532:T:C	single nucleotide variant	intron variant	Likely benign	Apr 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+14T>A	TSC2		Tuberous sclerosis 2	VCV002823386	16	2105534	16	2055533	2823386	2985751	rs771515880	NC_000016.10:2055532:T:A	single nucleotide variant	intron variant	Likely benign	Dec 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+15G>T	TSC2		Tuberous sclerosis 2	VCV002761262	16	2105535	16	2055534	2761262	2925028	rs2151062449	NC_000016.10:2055533:G:T	single nucleotide variant	intron variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+17G>C	TSC2		not specified|Tuberous sclerosis 2	VCV000207704	16	2105537	16	2055536	207704	203094	rs533989586	NC_000016.10:2055535:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.599+20C>T	TSC2		Tuberous sclerosis 2	VCV002174786	16	2105540	16	2055539	2174786	1900925	rs746167724	NC_000016.10:2055538:C:T	single nucleotide variant	intron variant	Likely benign	Mar 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.599+241G>T	TSC2		not provided	VCV000677865	16	2105761	16	2055760	677865	668183	rs534820975	NC_000016.10:2055759:G:T	single nucleotide variant	intron variant	Likely benign	Jun 17, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.599+327G>A	TSC2		not provided	VCV000668572	16	2105847	16	2055846	668572	667385	rs28735816	NC_000016.10:2055845:G:A	single nucleotide variant	intron variant	Likely benign	Jun 19, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-180C>A	TSC2		not provided	VCV001694774	16	2106017	16	2056016	1694774	1687206	rs537423263	NC_000016.10:2056015:C:A	single nucleotide variant	intron variant	Likely benign	May 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-145C>T	TSC2		Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV003602200	16	2106052	16	2056051	3602200	3734872		NC_000016.10:2056050:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Oct 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.600-124G>A	TSC2		Tuberous sclerosis 2	VCV001700636	16	2106073	16	2056072	1700636	1693031	rs2151069014	NC_000016.10:2056071:G:A	single nucleotide variant	intron variant	Pathogenic	Aug 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-84C>T	TSC2		not provided	VCV000049409	16	2106113	16	2056112	49409	58571	rs35364892	NC_000016.10:2056111:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.600-20G>C	TSC2		Tuberous sclerosis 2	VCV001628107	16	2106177	16	2056176	1628107	1584675	rs1011228500	NC_000016.10:2056175:G:C	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.600-18G>C	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001673777	16	2106179	16	2056178	1673777	1649077	rs199683502	NC_000016.10:2056177:G:C	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.600-18G>A	TSC2		Tuberous sclerosis 2	VCV001622011	16	2106179	16	2056178	1622011	1593214	rs199683502	NC_000016.10:2056177:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.600-17C>T	TSC2		Tuberous sclerosis 2	VCV004071308	16	2106180	16	2056179	4071308	4185156		NC_000016.10:2056178:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	May 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-16T>C	TSC2		Tuberous sclerosis 2	VCV002758241	16	2106181	16	2056180	2758241	2910340	rs2548449228	NC_000016.10:2056179:T:C	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.600-15C>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001672837	16	2106182	16	2056181	1672837	1531284	rs369708731	NC_000016.10:2056180:C:A	single nucleotide variant	intron variant	Likely benign	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.600-15C>T	TSC2		Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000065102	16	2106182	16	2056181	65102	76033	rs369708731	NC_000016.10:2056180:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.600-14G>T	TSC2		Tuberous sclerosis 2	VCV002757715	16	2106183	16	2056182	2757715	2917587	rs1229656999	NC_000016.10:2056181:G:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.600-14G>A	TSC2		Tuberous sclerosis 2	VCV001572935	16	2106183	16	2056182	1572935	1573302	rs1229656999	NC_000016.10:2056181:G:A	single nucleotide variant	intron variant	Likely benign	Nov 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-13G>A	TSC2		Tuberous sclerosis 2	VCV004071232	16	2106184	16	2056183	4071232	4185080		NC_000016.10:2056182:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	May 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-13G>C	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049901	16	2106184	16	2056183	49901	59063	rs45517116	NC_000016.10:2056182:G:C	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.600-11G>A	TSC2		Tuberous sclerosis syndrome	VCV003072412	16	2106186	16	2056185	3072412	3230853	rs1346678348	NC_000016.10:2056184:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Jul 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-11G>T	TSC2		Tuberous sclerosis 2	VCV002068016	16	2106186	16	2056185	2068016	2129405	rs1346678348	NC_000016.10:2056184:G:T	single nucleotide variant	intron variant	Uncertain significance	Dec 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-10C>T	TSC2		Tuberous sclerosis 2	VCV000536098	16	2106187	16	2056186	536098	529865	rs1555498511	NC_000016.10:2056185:C:T	single nucleotide variant	intron variant	Likely benign	Nov 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-9T>C	TSC2		Tuberous sclerosis 2	VCV001922931	16	2106188	16	2056187	1922931	1979677	rs1265270587	NC_000016.10:2056186:T:C	single nucleotide variant	intron variant	Likely benign	Dec 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-9T>A	TSC2		Tuberous sclerosis 2	VCV001397072	16	2106188	16	2056187	1397072	1414946	rs1265270587	NC_000016.10:2056186:T:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-8C>G	TSC2		Tuberous sclerosis 2	VCV002031524	16	2106189	16	2056188	2031524	2089429	rs755164905	NC_000016.10:2056187:C:G	single nucleotide variant	intron variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-7C>T	TSC2		Tuberous sclerosis 2	VCV001153505	16	2106190	16	2056189	1153505	1145894	rs2151070585	NC_000016.10:2056188:C:T	single nucleotide variant	intron variant	Likely benign	Mar 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-5T>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000753126	16	2106192	16	2056191	753126	776148	rs779176291	NC_000016.10:2056190:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.600-4G>A	TSC2		Tuberous sclerosis 2	VCV002111198	16	2106193	16	2056192	2111198	2167767	rs976201466	NC_000016.10:2056191:G:A	single nucleotide variant	intron variant	Likely benign	May 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-4G>T	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001631094	16	2106193	16	2056192	1631094	1543506	rs976201466	NC_000016.10:2056191:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.600-3C>G	TSC2		Tuberous sclerosis 2	VCV003721949	16	2106194	16	2056193	3721949	3860053		NC_000016.10:2056192:C:G	single nucleotide variant	5 prime UTR variant|intron variant	Pathogenic	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-2A>T	TSC2		Tuberous sclerosis 2	VCV001028343	16	2106195	16	2056194	1028343	1018041	rs45468592	NC_000016.10:2056193:A:T	single nucleotide variant	5 prime UTR variant|splice acceptor variant	Pathogenic	Nov 3, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-2A>G	TSC2		Tuberous sclerosis 2	VCV000049903	16	2106195	16	2056194	49903	59065	rs45468592	NC_000016.10:2056193:A:G	single nucleotide variant	5 prime UTR variant|splice acceptor variant	Likely pathogenic	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.600-1G>A	TSC2		Tuberous sclerosis 2	VCV000049902	16	2106196	16	2056195	49902	59064	rs45517117	NC_000016.10:2056194:G:A	single nucleotide variant	5 prime UTR variant|splice acceptor variant	Pathogenic	Mar 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.600G>C (p.Gln200His)	TSC2	Q211H, Q200H, Q151H, Q163H, Q181H, Q230H, Q46H	Hereditary cancer-predisposing syndrome	VCV000826133	16	2106197	16	2056196	826133	812484	rs1596275209	NC_000016.10:2056195:G:C	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Uncertain significance	Oct 15, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.601A>G (p.Met201Val)	TSC2	M152V, M201V, M164V, M1V, M212V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000946307	16	2106198	16	2056197	946307	927620	rs1596275224	NC_000016.10:2056196:A:G	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.601A>T (p.Met201Leu)	TSC2	M201L, M212L, M164L, M1L, M152L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000826136	16	2106198	16	2056197	826136	812485	rs1596275224	NC_000016.10:2056196:A:T	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.602T>C (p.Met201Thr)	TSC2	M152T, M164T, M1T, M201T, M212T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001426403	16	2106199	16	2056198	1426403	1451010	rs2151070731	NC_000016.10:2056197:T:C	single nucleotide variant	missense variant|initiator_codon_variant	Uncertain significance	Feb 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.603G>C (p.Met201Ile)	TSC2	M201I, M212I, M164I, M1I, M152I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049882	16	2106200	16	2056199	49882	59044	rs45506197	NC_000016.10:2056198:G:C	single nucleotide variant	missense variant|initiator_codon_variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.605T>C (p.Ile202Thr)	TSC2	I165T, I213T, I153T, I183T, I232T, I2T, I202T, I48T	Tuberous sclerosis 2	VCV002186161	16	2106202	16	2056201	2186161	1921373	rs2548449804	NC_000016.10:2056200:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.606C>A (p.Ile202=)	TSC2		Tuberous sclerosis 2	VCV004071282	16	2106203	16	2056202	4071282	4185130		NC_000016.10:2056201:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.606C>T (p.Ile202=)	TSC2		Tuberous sclerosis 2	VCV001669890	16	2106203	16	2056202	1669890	1582568	rs2151070786	NC_000016.10:2056201:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.609T>C (p.Cys203=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000797147	16	2106206	16	2056205	797147	785181	rs1596275256	NC_000016.10:2056204:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.610C>G (p.Leu204Val)	TSC2	L155V, L167V, L4V, L204V, L215V, L50V, L185V, L234V	Hereditary cancer-predisposing syndrome	VCV003811355	16	2106207	16	2056206	3811355	3928596		NC_000016.10:2056205:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.610C>T (p.Leu204=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001654704	16	2106207	16	2056206	1654704	1580333	rs1439997904	NC_000016.10:2056205:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.611T>C (p.Leu204Pro)	TSC2	L155P, L167P, L185P, L204P, L215P, L234P, L4P, L50P	Hereditary cancer-predisposing syndrome	VCV003232199	16	2106208	16	2056207	3232199	3392000	rs2548449890	NC_000016.10:2056206:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.612G>A (p.Leu204=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003232200	16	2106209	16	2056208	3232200	3392001	rs2548449920	NC_000016.10:2056207:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.612G>C (p.Leu204=)	TSC2		Tuberous sclerosis 2	VCV002109927	16	2106209	16	2056208	2109927	2160047	rs2548449920	NC_000016.10:2056207:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Mar 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.613C>T (p.Leu205=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000761294	16	2106210	16	2056209	761294	770665	rs1596275276	NC_000016.10:2056208:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.613C>G (p.Leu205Val)	TSC2	L156V, L205V, L5V, L168V, L216V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis	VCV000645392	16	2106210	16	2056209	645392	644154	rs1596275276	NC_000016.10:2056208:C:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.614T>C (p.Leu205Pro)	TSC2	L168P, L5P, L156P, L205P, L216P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000859992	16	2106211	16	2056210	859992	843330	rs2085789314	NC_000016.10:2056209:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.615G>C (p.Leu205=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001126547	16	2106212	16	2056211	1126547	1125014	rs1596275291	NC_000016.10:2056210:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.615G>A (p.Leu205=)	TSC2		Tuberous sclerosis 2	VCV000755217	16	2106212	16	2056211	755217	770666	rs1596275291	NC_000016.10:2056210:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.616T>C (p.Cys206Arg)	TSC2	C6R, C169R, C206R, C217R, C157R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000648964	16	2106213	16	2056212	648964	644155	rs1596275305	NC_000016.10:2056211:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.617G>A (p.Cys206Tyr)	TSC2	C157Y, C169Y, C206Y, C217Y, C6Y	Tuberous sclerosis 2	VCV001057872	16	2106214	16	2056213	1057872	1049419	rs2085790261	NC_000016.10:2056212:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.618C>G (p.Cys206Trp)	TSC2	C206W, C169W, C157W, C6W, C187W, C217W, C236W, C52W	Hereditary cancer-predisposing syndrome	VCV003974681	16	2106215	16	2056214	3974681	4086504		NC_000016.10:2056213:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.618C>T (p.Cys206=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000413697	16	2106215	16	2056214	413697	400751	rs45498496	NC_000016.10:2056213:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.619G>A (p.Val207Ile)	TSC2	V207I, V218I, V158I, V7I, V170I	not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000516774	16	2106216	16	2056215	516774	506137	rs139929314	NC_000016.10:2056214:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.621C>T (p.Val207=)	TSC2		Tuberous sclerosis 2	VCV003673396	16	2106218	16	2056217	3673396	3804233		NC_000016.10:2056216:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Sep 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.622C>A (p.Arg208=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000847475	16	2106219	16	2056218	847475	843331	rs374410454	NC_000016.10:2056217:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.622C>T (p.Arg208Trp)	TSC2	R208W, R159W, R219W, R8W, R171W	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000065103	16	2106219	16	2056218	65103	76034	rs374410454	NC_000016.10:2056217:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.623G>A (p.Arg208Gln)	TSC2	R171Q, R219Q, R159Q, R208Q, R8Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000826262	16	2106220	16	2056219	826262	812486	rs368386966	NC_000016.10:2056218:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.624G>A (p.Arg208=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002757040	16	2106221	16	2056220	2757040	2920811	rs2085792359	NC_000016.10:2056219:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.624G>T (p.Arg208=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001752441	16	2106221	16	2056220	1752441	1804296	rs2085792359	NC_000016.10:2056219:G:T	single nucleotide variant	5 prime UTR variant|synonymous variant|non-coding transcript variant	Likely benign	Sep 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.627C>T (p.Thr209=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not provided	VCV000386986	16	2106224	16	2056223	386986	375105	rs776293094	NC_000016.10:2056222:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.628G>T (p.Ala210Ser)	TSC2	A56S, A10S, A240S, A173S, A191S, A210S, A221S, A161S	Hereditary cancer-predisposing syndrome	VCV003329466	16	2106225	16	2056224	3329466	3489058		NC_000016.10:2056223:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.628G>C (p.Ala210Pro)	TSC2	A161P, A10P, A210P, A173P, A221P	Tuberous sclerosis 2|not provided	VCV001514042	16	2106225	16	2056224	1514042	1491857	rs147196739	NC_000016.10:2056223:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.628G>A (p.Ala210Thr)	TSC2	A210T, A221T, A161T, A173T, A10T	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184164	16	2106225	16	2056224	184164	184113	rs147196739	NC_000016.10:2056223:G:A	single nucleotide variant	missense variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.629C>A (p.Ala210Glu)	TSC2	A161E, A191E, A56E, A10E, A173E, A210E, A221E, A240E	Hereditary cancer-predisposing syndrome	VCV002626445	16	2106226	16	2056225	2626445	2794211	rs764925296	NC_000016.10:2056224:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.629C>G (p.Ala210Gly)	TSC2	A10G, A221G, A210G, A161G, A173G	not provided|Tuberous sclerosis 2	VCV001504144	16	2106226	16	2056225	1504144	1337020	rs764925296	NC_000016.10:2056224:C:G	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.629C>T (p.Ala210Val)	TSC2	A210V, A161V, A173V, A221V, A10V	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000187388	16	2106226	16	2056225	187388	184114	rs764925296	NC_000016.10:2056224:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.630G>C (p.Ala210=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001129277	16	2106227	16	2056226	1129277	1125015	rs567756494	NC_000016.10:2056225:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.630G>A (p.Ala210=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238089	16	2106227	16	2056226	238089	242214	rs567756494	NC_000016.10:2056225:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.632C>A (p.Ser211Tyr)	TSC2	S174Y, S162Y, S11Y, S211Y, S222Y	Tuberous sclerosis 2	VCV000652977	16	2106229	16	2056228	652977	644156	rs878854120	NC_000016.10:2056227:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.632C>T (p.Ser211Phe)	TSC2	S211F, S222F, S11F, S174F, S162F	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000238090	16	2106229	16	2056228	238090	242215	rs878854120	NC_000016.10:2056227:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.633C>T (p.Ser211=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000724810	16	2106230	16	2056229	724810	740015	rs762659998	NC_000016.10:2056228:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.633C>G (p.Ser211=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536108	16	2106230	16	2056229	536108	529867	rs762659998	NC_000016.10:2056228:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.635C>G (p.Ser212Cys)	TSC2	S212C, S163C, S193C, S223C, S12C, S175C, S242C, S58C	Tuberous sclerosis 2	VCV002794747	16	2106232	16	2056231	2794747	2954582	rs2085795216	NC_000016.10:2056230:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.635C>T (p.Ser212Phe)	TSC2	S12F, S223F, S163F, S175F, S212F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000965610	16	2106232	16	2056231	965610	957668	rs2085795216	NC_000016.10:2056230:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.636T>C (p.Ser212=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001161083	16	2106233	16	2056232	1161083	1145895	rs2151071330	NC_000016.10:2056231:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.637G>A (p.Val213Met)	TSC2	V213M, V176M, V224M, V13M, V164M	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000405991	16	2106234	16	2056233	405991	401152	rs1060500927	NC_000016.10:2056232:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.639G>A (p.Val213=)	TSC2		Tuberous sclerosis 2	VCV001920801	16	2106236	16	2056235	1920801	1971944	rs2151071369	NC_000016.10:2056234:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Sep 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.640G>A (p.Asp214Asn)	TSC2	D14N, D165N, D177N, D195N, D214N, D225N, D244N, D60N	Hereditary cancer-predisposing syndrome	VCV003232201	16	2106237	16	2056236	3232201	3392002	rs2151071392	NC_000016.10:2056235:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.642C>G (p.Asp214Glu)	TSC2	D14E, D165E, D177E, D195E, D214E, D225E, D244E, D60E	Hereditary cancer-predisposing syndrome	VCV003232202	16	2106239	16	2056238	3232202	3392003	rs763726222	NC_000016.10:2056237:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.642C>T (p.Asp214=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001134549	16	2106239	16	2056238	1134549	1125016	rs763726222	NC_000016.10:2056237:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.643A>G (p.Ile215Val)	TSC2	I215V, I15V, I178V, I166V, I226V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000648100	16	2106240	16	2056239	648100	644157	rs1293515155	NC_000016.10:2056238:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.644T>C (p.Ile215Thr)	TSC2	I215T, I166T, I178T, I15T, I226T	Tuberous sclerosis 2	VCV000468170	16	2106241	16	2056240	468170	465156	rs1555498571	NC_000016.10:2056239:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.646G>C (p.Glu216Gln)	TSC2	E167Q, E227Q, E16Q, E179Q, E216Q	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000647602	16	2106243	16	2056242	647602	644159	rs45517118	NC_000016.10:2056241:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.646G>T (p.Glu216Ter)	TSC2	E216*, E227*, E179*, E16*, E167*	Tuberous sclerosis 2	VCV000049380	16	2106243	16	2056242	49380	58542	rs45517118	NC_000016.10:2056241:G:T	single nucleotide variant	nonsense	Pathogenic	Dec 15, 2014	criteria provided, single submitter							
NM_000548.5(TSC2):c.646G>A (p.Glu216Lys)	TSC2	E216K, E179K, E167K, E16K, E227K	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000049379	16	2106243	16	2056242	49379	58541	rs45517118	NC_000016.10:2056241:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.647A>T (p.Glu216Val)	TSC2	E16V, E62V, E246V, E167V, E179V, E197V, E216V, E227V	Tuberous sclerosis 2	VCV003651309	16	2106244	16	2056243	3651309	3777987		NC_000016.10:2056242:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.648G>A (p.Glu216=)	TSC2		Tuberous sclerosis 2	VCV002018109	16	2106245	16	2056244	2018109	2076026	rs2548450950	NC_000016.10:2056243:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+1G>C	TSC2		Tuberous sclerosis 2	VCV003220903	16	2106246	16	2056245	3220903	3380113	rs45488893	NC_000016.10:2056244:G:C	single nucleotide variant	splice donor variant	Pathogenic	Jan 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+1G>A	TSC2		Tuberous sclerosis 2	VCV000049410	16	2106246	16	2056245	49410	58572	rs45488893	NC_000016.10:2056244:G:A	single nucleotide variant	splice donor variant	Pathogenic	May 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+4A>G	TSC2		Tuberous sclerosis 2	VCV001449711	16	2106249	16	2056248	1449711	1416767	rs2151071557	NC_000016.10:2056247:A:G	single nucleotide variant	intron variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+5G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001520074	16	2106250	16	2056249	1520074	1516070	rs2085796888	NC_000016.10:2056248:G:A	single nucleotide variant	intron variant	Uncertain significance	Jun 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+5G>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000842558	16	2106250	16	2056249	842558	852093	rs2085796888	NC_000016.10:2056248:G:C	single nucleotide variant	intron variant	Uncertain significance	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+6T>C	TSC2		Tuberous sclerosis 2|not provided	VCV000452900	16	2106251	16	2056250	452900	445512	rs372007135	NC_000016.10:2056249:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.648+7G>T	TSC2		Tuberous sclerosis 2	VCV001632645	16	2106252	16	2056251	1632645	1631171	rs1216419213	NC_000016.10:2056250:G:T	single nucleotide variant	intron variant	Likely benign	Jan 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+7G>C	TSC2		Tuberous sclerosis 2	VCV001110433	16	2106252	16	2056251	1110433	1103608	rs1216419213	NC_000016.10:2056250:G:C	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+8C>G	TSC2		Tuberous sclerosis 2	VCV002899409	16	2106253	16	2056252	2899409	3057590	rs1596275557	NC_000016.10:2056251:C:G	single nucleotide variant	intron variant	Likely benign	Nov 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+8C>T	TSC2		Tuberous sclerosis 2	VCV002056989	16	2106253	16	2056252	2056989	2105811	rs1596275557	NC_000016.10:2056251:C:T	single nucleotide variant	intron variant	Likely benign	May 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+9C>G	TSC2		Tuberous sclerosis 2	VCV000727760	16	2106254	16	2056253	727760	744895	rs756588732	NC_000016.10:2056252:C:G	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+9C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000413693	16	2106254	16	2056253	413693	400636	rs756588732	NC_000016.10:2056252:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+10T>C	TSC2		Tuberous sclerosis 2	VCV001083170	16	2106255	16	2056254	1083170	1081772	rs2151071693	NC_000016.10:2056253:T:C	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+11C>T	TSC2		Tuberous sclerosis 2	VCV002147790	16	2106256	16	2056255	2147790	1877102	rs371896390	NC_000016.10:2056254:C:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+11C>G	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001655810	16	2106256	16	2056255	1655810	1529057	rs371896390	NC_000016.10:2056254:C:G	single nucleotide variant	intron variant	Likely benign	Aug 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+12C>T	TSC2		Tuberous sclerosis 2	VCV002911563	16	2106257	16	2056256	2911563	3075544	rs2151071734	NC_000016.10:2056255:C:T	single nucleotide variant	intron variant	Likely benign	Apr 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+12C>A	TSC2		Tuberous sclerosis 2	VCV001557340	16	2106257	16	2056256	1557340	1561999	rs2151071734	NC_000016.10:2056255:C:A	single nucleotide variant	intron variant	Likely benign	Mar 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+13C>A	TSC2		Tuberous sclerosis 2	VCV001607160	16	2106258	16	2056257	1607160	1572470	rs2151071760	NC_000016.10:2056256:C:A	single nucleotide variant	intron variant	Likely benign	May 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+13C>T	TSC2		Tuberous sclerosis 2	VCV001537130	16	2106258	16	2056257	1537130	1596723	rs2151071760	NC_000016.10:2056256:C:T	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+14C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000388609	16	2106259	16	2056258	388609	375111	rs941595244	NC_000016.10:2056257:C:T	single nucleotide variant	intron variant	Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+16C>A	TSC2		Tuberous sclerosis 2	VCV003671058	16	2106261	16	2056260	3671058	3804494		NC_000016.10:2056259:C:A	single nucleotide variant	intron variant	Likely benign	Jun 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+17C>T	TSC2		Tuberous sclerosis 2	VCV002724319	16	2106262	16	2056261	2724319	2892119	rs755431618	NC_000016.10:2056260:C:T	single nucleotide variant	intron variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+17C>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|not specified	VCV000385872	16	2106262	16	2056261	385872	374032	rs755431618	NC_000016.10:2056260:C:A	single nucleotide variant	intron variant	Likely benign	Jan 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+18C>A	TSC2		Tuberous sclerosis 2	VCV003666584	16	2106263	16	2056262	3666584	3802410		NC_000016.10:2056261:C:A	single nucleotide variant	intron variant	Likely benign	Oct 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+18C>T	TSC2		Tuberous sclerosis 2	VCV001601839	16	2106263	16	2056262	1601839	1523782	rs2151071875	NC_000016.10:2056261:C:T	single nucleotide variant	intron variant	Likely benign	Jun 20, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+19C>G	TSC2		Tuberous sclerosis 2	VCV001583109	16	2106264	16	2056263	1583109	1535347	rs1196860918	NC_000016.10:2056262:C:G	single nucleotide variant	intron variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+19C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000507751	16	2106264	16	2056263	507751	505659	rs1196860918	NC_000016.10:2056262:C:T	single nucleotide variant	intron variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.648+20A>C	TSC2		Tuberous sclerosis 2	VCV003016096	16	2106265	16	2056264	3016096	3171220	rs2151071929	NC_000016.10:2056263:A:C	single nucleotide variant	intron variant	Likely benign	Oct 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+20A>G	TSC2		not provided	VCV001319396	16	2106265	16	2056264	1319396	1309649	rs2151071929	NC_000016.10:2056263:A:G	single nucleotide variant	intron variant	Uncertain significance	Nov 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+117C>G	TSC2		not provided	VCV000049884	16	2106362	16	2056361	49884	59046	rs45460197	NC_000016.10:2056360:C:G	single nucleotide variant	intron variant	Likely benign	Aug 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.648+162C>T	TSC2		not provided	VCV001223510	16	2106407	16	2056406	1223510	1211331	rs573404958	NC_000016.10:2056405:C:T	single nucleotide variant	intron variant	Likely benign	Jul 8, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-198A>G	TSC2		not provided	VCV001208907	16	2106447	16	2056446	1208907	1198737	rs187353366	NC_000016.10:2056445:A:G	single nucleotide variant	intron variant	Likely benign	Jul 8, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-35G>T	TSC2		not specified	VCV000256636	16	2106610	16	2056609	256636	255485	rs112305151	NC_000016.10:2056608:G:T	single nucleotide variant	intron variant	Likely benign		criteria provided, single submitter							
NM_000548.5(TSC2):c.649-30A>T	TSC2		Tuberous sclerosis 2	VCV001696449	16	2106615	16	2056614	1696449	1688851	rs2151076571	NC_000016.10:2056613:A:T	single nucleotide variant	intron variant	Uncertain significance	Jun 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-20G>T	TSC2		Tuberous sclerosis 2	VCV001649684	16	2106625	16	2056624	1649684	1535940	rs377558380	NC_000016.10:2056623:G:T	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-20G>A	TSC2		not specified|Tuberous sclerosis 2	VCV000378771	16	2106625	16	2056624	378771	377135	rs377558380	NC_000016.10:2056623:G:A	single nucleotide variant	intron variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-19C>T	TSC2		Tuberous sclerosis 2	VCV003703643	16	2106626	16	2056625	3703643	3845723		NC_000016.10:2056624:C:T	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-18C>A	TSC2		Tuberous sclerosis 2	VCV001641402	16	2106627	16	2056626	1641402	1520336	rs771537061	NC_000016.10:2056625:C:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-18C>T	TSC2		not provided|Tuberous sclerosis 2	VCV001268776	16	2106627	16	2056626	1268776	1261207	rs771537061	NC_000016.10:2056625:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-17G>A	TSC2		Tuberous sclerosis 2	VCV001659337	16	2106628	16	2056627	1659337	1543066	rs757405342	NC_000016.10:2056626:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-16T>C	TSC2		Tuberous sclerosis 2	VCV001616296	16	2106629	16	2056628	1616296	1526486	rs1417361912	NC_000016.10:2056627:T:C	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-15C>T	TSC2		Tuberous sclerosis 2	VCV004071273	16	2106630	16	2056629	4071273	4185121		NC_000016.10:2056628:C:T	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-15C>G	TSC2		Tuberous sclerosis 2	VCV002116464	16	2106630	16	2056629	2116464	2165179	rs1367018977	NC_000016.10:2056628:C:G	single nucleotide variant	intron variant	Likely benign	Mar 31, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-13C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692511	16	2106632	16	2056631	1692511	1684951	rs1290261668	NC_000016.10:2056630:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.649-12C>T	TSC2		Tuberous sclerosis syndrome	VCV003070320	16	2106633	16	2056632	3070320	3231808	rs1596277751	NC_000016.10:2056631:C:T	single nucleotide variant	intron variant	Likely benign	Apr 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-12C>A	TSC2		not provided	VCV000668270	16	2106633	16	2056632	668270	668185	rs1596277751	NC_000016.10:2056631:C:A	single nucleotide variant	intron variant	Likely benign	May 7, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-11C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003386158	16	2106634	16	2056633	3386158	3545299		NC_000016.10:2056632:C:T	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-11C>G	TSC2		Tuberous sclerosis 2	VCV001645842	16	2106634	16	2056633	1645842	1565446	rs1254475243	NC_000016.10:2056632:C:G	single nucleotide variant	intron variant	Likely benign	Jul 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-9C>T	TSC2		Tuberous sclerosis 2	VCV001097305	16	2106636	16	2056635	1097305	1081773	rs781099543	NC_000016.10:2056634:C:T	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-9C>G	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2	VCV000468172	16	2106636	16	2056635	468172	465160	rs781099543	NC_000016.10:2056634:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-8T>C	TSC2		Tuberous sclerosis 2	VCV001104656	16	2106637	16	2056636	1104656	1103609	rs769803918	NC_000016.10:2056635:T:C	single nucleotide variant	intron variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-7C>A	TSC2		Tuberous sclerosis 2	VCV000655563	16	2106638	16	2056637	655563	652935	rs1596277822	NC_000016.10:2056636:C:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-6C>T	TSC2		Tuberous sclerosis 2	VCV001111185	16	2106639	16	2056638	1111185	1103610	rs1323228446	NC_000016.10:2056637:C:T	single nucleotide variant	intron variant	Likely benign	Apr 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-5A>T	TSC2		Tuberous sclerosis 2	VCV000468171	16	2106640	16	2056639	468171	466022	rs1555498745	NC_000016.10:2056638:A:T	single nucleotide variant	intron variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.649-4C>T	TSC2		Tuberous sclerosis 2	VCV000536043	16	2106641	16	2056640	536043	529524	rs1329743344	NC_000016.10:2056639:C:T	single nucleotide variant	intron variant	Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-1G>A	TSC2		Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000547825	16	2106644	16	2056643	547825	538095	rs794727906	NC_000016.10:2056642:G:A	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Apr 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649-1G>C	TSC2		not provided	VCV000198742	16	2106644	16	2056643	198742	195902	rs794727906	NC_000016.10:2056642:G:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jul 31, 2014	criteria provided, single submitter							
NM_000548.5(TSC2):c.649G>A (p.Val217Ile)	TSC2	V168I, V180I, V17I, V217I, V228I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001517166	16	2106645	16	2056644	1517166	1515326	rs1567407896	NC_000016.10:2056643:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.649G>C (p.Val217Leu)	TSC2	V217L, V168L, V17L, V228L, V180L	Tuberous sclerosis 2	VCV000578739	16	2106645	16	2056644	578739	569598	rs1567407896	NC_000016.10:2056643:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.651C>T (p.Val217=)	TSC2		Tuberous sclerosis 2|not provided	VCV002897707	16	2106647	16	2056646	2897707	3057181	rs780004703	NC_000016.10:2056645:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.651C>A (p.Val217=)	TSC2		Tuberous sclerosis 2	VCV001564774	16	2106647	16	2056646	1564774	1567728	rs780004703	NC_000016.10:2056645:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.651C>G (p.Val217=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000705854	16	2106647	16	2056646	705854	693804	rs780004703	NC_000016.10:2056645:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.653C>T (p.Ser218Phe)	TSC2	S169F, S181F, S18F, S248F, S64F, S229F, S199F, S218F	Tuberous sclerosis 2	VCV002700184	16	2106649	16	2056648	2700184	2859036	rs2151077490	NC_000016.10:2056647:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.654C>T (p.Ser218=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000826476	16	2106650	16	2056649	826476	812487	rs1353074849	NC_000016.10:2056648:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.655C>A (p.Leu219Met)	TSC2	L182M, L219M, L65M, L170M, L19M, L230M, L200M, L249M	Hereditary cancer-predisposing syndrome	VCV003462678	16	2106651	16	2056650	3462678	3621697		NC_000016.10:2056649:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.655C>G (p.Leu219Val)	TSC2	L219V, L230V, L182V, L170V, L19V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001462978	16	2106651	16	2056650	1462978	1511415	rs369046625	NC_000016.10:2056649:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.655C>T (p.Leu219=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000486700	16	2106651	16	2056650	486700	477429	rs369046625	NC_000016.10:2056649:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.656T>C (p.Leu219Pro)	TSC2	L219P, L182P, L170P, L230P, L19P	not provided|Tuberous sclerosis 2	VCV000065337	16	2106652	16	2056651	65337	76270	rs397515249	NC_000016.10:2056650:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.657G>A (p.Leu219=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000378891	16	2106653	16	2056652	378891	374729	rs768570301	NC_000016.10:2056651:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.658C>G (p.Gln220Glu)	TSC2	Q220E, Q183E, Q20E, Q171E, Q231E	Tuberous sclerosis 2	VCV000565941	16	2106654	16	2056653	565941	570043	rs45517119	NC_000016.10:2056652:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.658C>T (p.Gln220Ter)	TSC2	Q220*, Q183*, Q20*, Q171*, Q231*	Tuberous sclerosis 2|not provided	VCV000049411	16	2106654	16	2056653	49411	58573	rs45517119	NC_000016.10:2056652:C:T	single nucleotide variant	nonsense	Pathogenic	May 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.659A>C (p.Gln220Pro)	TSC2	Q171P, Q183P, Q201P, Q20P, Q220P, Q231P, Q250P, Q66P	Tuberous sclerosis 2	VCV003624963	16	2106655	16	2056654	3624963	3754911		NC_000016.10:2056653:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|splice acceptor variant	Uncertain significance	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.661G>C (p.Val221Leu)	TSC2	V172L, V184L, V202L, V217L, V21L, V221L, V232L, V251L, V67L	not provided	VCV002645967	16	2106657	16	2056656	2645967	2810848	rs1567408059	NC_000016.10:2056655:G:C	single nucleotide variant	non-coding transcript variant|5 prime UTR variant|missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.661G>A (p.Val221Met)	TSC2	V221M, V184M, V21M, V172M, V232M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000572608	16	2106657	16	2056656	572608	570045	rs1567408059	NC_000016.10:2056655:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.663G>A (p.Val221=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207768	16	2106659	16	2056658	207768	203095	rs774115464	NC_000016.10:2056657:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.664C>T (p.Leu222=)	TSC2		Tuberous sclerosis 2	VCV001136813	16	2106660	16	2056659	1136813	1125017	rs2151077923	NC_000016.10:2056658:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.665T>C (p.Leu222Pro)	TSC2	L222P, L173P, L22P, L233P, L185P	Tuberous sclerosis 2	VCV000049381	16	2106661	16	2056660	49381	58543	rs45517120	NC_000016.10:2056659:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.666G>A (p.Leu222=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000755023	16	2106662	16	2056661	755023	770667	rs761351907	NC_000016.10:2056660:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.667G>C (p.Asp223His)	TSC2	D174H, D186H, D204H, D219H, D223H, D234H, D23H, D253H, D69H	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003069224	16	2106663	16	2056662	3069224	3229851	rs45517121	NC_000016.10:2056661:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.667G>A (p.Asp223Asn)	TSC2	D234N, D186N, D23N, D174N, D223N	Tuberous sclerosis 2	VCV001503518	16	2106663	16	2056662	1503518	1401235	rs45517121	NC_000016.10:2056661:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.668A>G (p.Asp223Gly)	TSC2	D223G, D219G, D234G, D23G, D69G, D174G, D186G, D204G, D253G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001951013	16	2106664	16	2056663	1951013	2017616	rs2151078058	NC_000016.10:2056662:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.669C>T (p.Asp223=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000413651	16	2106665	16	2056664	413651	400638	rs35501344	NC_000016.10:2056663:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.670G>T (p.Ala224Ser)	TSC2	A175S, A224S, A24S, A235S, A187S	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000953929	16	2106666	16	2056665	953929	949226	rs772558666	NC_000016.10:2056664:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.670G>A (p.Ala224Thr)	TSC2	A224T, A187T, A235T, A175T, A24T	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000468173	16	2106666	16	2056665	468173	465165	rs772558666	NC_000016.10:2056664:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.671C>A (p.Ala224Asp)	TSC2	A187D, A175D, A24D, A254D, A205D, A224D, A235D, A70D, A220D	Hereditary cancer-predisposing syndrome	VCV002449952	16	2106667	16	2056666	2449952	2429578	rs2151078164	NC_000016.10:2056665:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.671C>T (p.Ala224Val)	TSC2	A235V, A175V, A187V, A224V, A24V	Tuberous sclerosis 2	VCV001475105	16	2106667	16	2056666	1475105	1404015	rs2151078164	NC_000016.10:2056665:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.672C>A (p.Ala224=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV003578782	16	2106668	16	2056667	3578782	3708202		NC_000016.10:2056666:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.672C>T (p.Ala224=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000413682	16	2106668	16	2056667	413682	400645	rs138897064	NC_000016.10:2056666:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.673G>T (p.Val225Leu)	TSC2	V225L, V25L, V176L, V188L, V236L	Tuberous sclerosis 2	VCV000565802	16	2106669	16	2056668	565802	570048	rs142919353	NC_000016.10:2056667:G:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.673G>A (p.Val225Met)	TSC2	V225M, V188M, V176M, V25M, V236M	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000406017	16	2106669	16	2056668	406017	400649	rs142919353	NC_000016.10:2056667:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.674T>A (p.Val225Glu)	TSC2	V176E, V188E, V225E, V236E, V25E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001014369	16	2106670	16	2056669	1014369	1011937	rs1437259556	NC_000016.10:2056668:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.674T>C (p.Val225Ala)	TSC2	V236A, V225A, V176A, V188A, V25A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000826600	16	2106670	16	2056669	826600	812488	rs1437259556	NC_000016.10:2056668:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.675G>A (p.Val225=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001090574	16	2106671	16	2056670	1090574	1081774	rs2085881355	NC_000016.10:2056669:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.676G>C (p.Val226Leu)	TSC2	V226L, V237L, V26L, V177L, V189L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000952237	16	2106672	16	2056671	952237	927621	rs2085881555	NC_000016.10:2056670:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.678C>A (p.Val226=)	TSC2		Tuberous sclerosis 2	VCV003659211	16	2106674	16	2056673	3659211	3794208		NC_000016.10:2056672:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jul 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.678C>G (p.Val226=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462603	16	2106674	16	2056673	3462603	3621622		NC_000016.10:2056672:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.678C>T (p.Val226=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001141701	16	2106674	16	2056673	1141701	1145896	rs2151078413	NC_000016.10:2056672:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.679T>C (p.Cys227Arg)	TSC2	C27R, C190R, C227R, C178R, C208R, C223R, C73R, C238R, C257R	Tuberous sclerosis 2	VCV002709728	16	2106675	16	2056674	2709728	2874626	rs753197543	NC_000016.10:2056673:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.679T>G (p.Cys227Gly)	TSC2	C178G, C190G, C227G, C238G, C27G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001002815	16	2106675	16	2056674	1002815	996690	rs753197543	NC_000016.10:2056673:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.681C>T (p.Cys227=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049892	16	2106677	16	2056676	49892	59054	rs45443205	NC_000016.10:2056675:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.683A>G (p.Tyr228Cys)	TSC2	Y179C, Y191C, Y228C, Y239C, Y28C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001011903	16	2106679	16	2056678	1011903	996691	rs2085882405	NC_000016.10:2056677:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.684C>T (p.Tyr228=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000697851	16	2106680	16	2056679	697851	688536	rs397515034	NC_000016.10:2056678:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.685A>G (p.Asn229Asp)	TSC2	N180D, N210D, N229D, N240D, N29D, N259D, N75D, N192D, N225D	Tuberous sclerosis 2	VCV003637176	16	2106681	16	2056680	3637176	3771330		NC_000016.10:2056679:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.686A>G (p.Asn229Ser)	TSC2	N229S, N180S, N192S, N240S, N29S	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000468174	16	2106682	16	2056681	468174	465168	rs1555498800	NC_000016.10:2056680:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.687C>G (p.Asn229Lys)	TSC2	N229K, N240K, N180K, N192K, N29K	Tuberous sclerosis 2	VCV000560665	16	2106683	16	2056682	560665	551737	rs1555498802	NC_000016.10:2056681:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.687C>T (p.Asn229=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486696	16	2106683	16	2056682	486696	477280	rs1555498802	NC_000016.10:2056681:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.688T>A (p.Cys230Ser)	TSC2	C193S, C241S, C230S, C30S, C181S	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000937549	16	2106684	16	2056683	937549	937279	rs1043187800	NC_000016.10:2056682:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.688T>C (p.Cys230Arg)	TSC2	C181R, C193R, C30R, C230R, C241R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000852299	16	2106684	16	2056683	852299	843332	rs1043187800	NC_000016.10:2056682:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.689G>A (p.Cys230Tyr)	TSC2	C76Y, C226Y, C241Y, C193Y, C181Y, C211Y, C230Y, C260Y, C30Y	Hereditary cancer-predisposing syndrome	VCV001756039	16	2106685	16	2056684	1756039	1812217	rs1238176703	NC_000016.10:2056683:G:A	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.690C>A (p.Cys230Ter)	TSC2	C211*, C226*, C30*, C181*, C241*, C260*, C193*, C230*, C76*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002836723	16	2106686	16	2056685	2836723	3002495	rs2151078845	NC_000016.10:2056684:C:A	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jul 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.690C>T (p.Cys230=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001756105	16	2106686	16	2056685	1756105	1812283	rs2151078845	NC_000016.10:2056684:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jun 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.691C>T (p.Leu231=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468175	16	2106687	16	2056686	468175	465169	rs1555498820	NC_000016.10:2056685:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.692T>C (p.Leu231Pro)	TSC2	L182P, L194P, L212P, L227P, L231P, L242P, L261P, L31P, L77P	not provided	VCV003898807	16	2106688	16	2056687	3898807	4014647		NC_000016.10:2056686:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.693G>A (p.Leu231=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000826716	16	2106689	16	2056688	826716	812489	rs764417359	NC_000016.10:2056687:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.694C>T (p.Pro232Ser)	TSC2	P232S, P183S, P243S, P32S, P195S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406031	16	2106690	16	2056689	406031	401406	rs751846529	NC_000016.10:2056688:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.695C>G (p.Pro232Arg)	TSC2	P232R, P262R, P78R, P213R, P32R, P183R, P195R, P228R, P243R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001756316	16	2106691	16	2056690	1756316	1812494	rs760100924	NC_000016.10:2056689:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.695C>T (p.Pro232Leu)	TSC2	P232L, P183L, P195L, P243L, P32L	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486620	16	2106691	16	2056690	486620	477283	rs760100924	NC_000016.10:2056689:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.696G>T (p.Pro232=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449988	16	2106692	16	2056691	2449988	2425945	rs539797467	NC_000016.10:2056690:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.696G>A (p.Pro232=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000405990	16	2106692	16	2056691	405990	401155	rs539797467	NC_000016.10:2056690:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.697G>T (p.Ala233Ser)	TSC2	A233S, A184S, A196S, A33S, A244S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000576838	16	2106693	16	2056692	576838	573775	rs1567408479	NC_000016.10:2056691:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.698C>G (p.Ala233Gly)	TSC2	A233G, A196G, A33G, A184G, A244G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468176	16	2106694	16	2056693	468176	465171	rs1555498839	NC_000016.10:2056692:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.699T>G (p.Ala233=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001096109	16	2106695	16	2056694	1096109	1081775	rs1596278327	NC_000016.10:2056693:T:G	single nucleotide variant	synonymous variant	Likely benign	Aug 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.699T>C (p.Ala233=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000756868	16	2106695	16	2056694	756868	770668	rs1596278327	NC_000016.10:2056693:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.700G>A (p.Glu234Lys)	TSC2	E215K, E34K, E185K, E230K, E264K, E80K, E197K, E234K, E245K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003329531	16	2106696	16	2056695	3329531	3489123		NC_000016.10:2056694:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.700G>C (p.Glu234Gln)	TSC2	E234Q, E197Q, E34Q, E185Q, E245Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000640709	16	2106696	16	2056695	640709	644160	rs397515018	NC_000016.10:2056694:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.702G>A (p.Glu234=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974675	16	2106698	16	2056697	3974675	4086498		NC_000016.10:2056696:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	May 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.703A>C (p.Ser235Arg)	TSC2	S235R, S216R, S246R, S35R, S186R, S231R, S81R, S198R, S265R	Tuberous sclerosis 2	VCV003637177	16	2106699	16	2056698	3637177	3771331		NC_000016.10:2056697:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.703A>G (p.Ser235Gly)	TSC2	S235G, S186G, S35G, S198G, S246G	Tuberous sclerosis 2	VCV000570728	16	2106699	16	2056698	570728	573778	rs1567408536	NC_000016.10:2056697:A:G	single nucleotide variant	missense variant	Uncertain significance	May 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.704G>C (p.Ser235Thr)	TSC2	S235T, S186T, S246T, S35T, S198T	not provided|Hereditary cancer-predisposing syndrome	VCV000486692	16	2106700	16	2056699	486692	477434	rs397514957	NC_000016.10:2056698:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.704G>A (p.Ser235Asn)	TSC2	S235N, S186N, S246N, S198N, S35N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000064942	16	2106700	16	2056699	64942	75872	rs397514957	NC_000016.10:2056698:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.705C>A (p.Ser235Arg)	TSC2	S186R, S246R, S198R, S216R, S265R, S231R, S235R, S35R, S81R	Tuberous sclerosis 2	VCV002743755	16	2106701	16	2056700	2743755	2907108	rs2151079388	NC_000016.10:2056699:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.706C>T (p.Leu236Phe)	TSC2	L36F, L217F, L247F, L266F, L187F, L199F, L232F, L236F, L82F	Tuberous sclerosis 2	VCV001904511	16	2106702	16	2056701	1904511	1964743	rs2548461968	NC_000016.10:2056700:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.706C>G (p.Leu236Val)	TSC2	L232V, L266V, L199V, L247V, L236V, L36V, L82V, L187V, L217V	Hereditary cancer-predisposing syndrome	VCV001756987	16	2106702	16	2056701	1756987	1818992	rs2548461968	NC_000016.10:2056700:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.707T>C (p.Leu236Pro)	TSC2	L187P, L236P, L247P, L36P, L199P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000826824	16	2106703	16	2056702	826824	812490	rs1596278377	NC_000016.10:2056701:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.708C>T (p.Leu236=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184237	16	2106704	16	2056703	184237	184115	rs756121647	NC_000016.10:2056702:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.709C>G (p.Pro237Ala)	TSC2	P188A, P37A, P248A, P237A, P200A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000934777	16	2106705	16	2056704	934777	937280	rs1555498859	NC_000016.10:2056703:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.709C>T (p.Pro237Ser)	TSC2	P237S, P37S, P188S, P248S, P200S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486675	16	2106705	16	2056704	486675	477445	rs1555498859	NC_000016.10:2056703:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.710C>A (p.Pro237Gln)	TSC2	P248Q, P200Q, P188Q, P237Q, P37Q	Tuberous sclerosis 2	VCV000850970	16	2106706	16	2056705	850970	843333	rs139060277	NC_000016.10:2056704:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.710C>G (p.Pro237Arg)	TSC2	P237R, P188R, P200R, P37R, P248R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486659	16	2106706	16	2056705	486659	477300	rs139060277	NC_000016.10:2056704:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.710C>T (p.Pro237Leu)	TSC2	P237L, P37L, P248L, P188L, P200L	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207769	16	2106706	16	2056705	207769	203096	rs139060277	NC_000016.10:2056704:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.711G>A (p.Pro237=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000468177	16	2106707	16	2056706	468177	465173	rs189380607	NC_000016.10:2056705:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.712C>G (p.Leu238Val)	TSC2	L38V, L201V, L249V, L268V, L84V, L189V, L219V, L234V, L238V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV002497450	16	2106708	16	2056707	2497450	2472533	rs1287428578	NC_000016.10:2056706:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.712C>T (p.Leu238=)	TSC2		Tuberous sclerosis 2	VCV001611239	16	2106708	16	2056707	1611239	1640314	rs1287428578	NC_000016.10:2056706:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.713T>G (p.Leu238Arg)	TSC2	L268R, L38R, L84R, L234R, L189R, L201R, L249R, L219R, L238R	Hereditary cancer-predisposing syndrome	VCV002449997	16	2106709	16	2056708	2449997	2425954	rs768623382	NC_000016.10:2056707:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.713T>C (p.Leu238Pro)	TSC2	L201P, L38P, L189P, L249P, L238P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000653663	16	2106709	16	2056708	653663	644161	rs768623382	NC_000016.10:2056707:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.714G>A (p.Leu238=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462586	16	2106710	16	2056709	3462586	3621605		NC_000016.10:2056708:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jul 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.716T>C (p.Phe239Ser)	TSC2	F190S, F202S, F239S, F250S, F39S	not provided	VCV001306820	16	2106712	16	2056711	1306820	1295770	rs778544723	NC_000016.10:2056710:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.716T>G (p.Phe239Cys)	TSC2	F239C, F202C, F190C, F39C, F250C	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207705	16	2106712	16	2056711	207705	203097	rs778544723	NC_000016.10:2056710:T:G	single nucleotide variant	missense variant	Benign/Likely benign	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.717C>T (p.Phe239=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001081093	16	2106713	16	2056712	1081093	1081776	rs1567408727	NC_000016.10:2056711:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.717C>A (p.Phe239Leu)	TSC2	F250L, F39L, F202L, F190L, F239L	Tuberous sclerosis 2	VCV000845033	16	2106713	16	2056712	845033	843334	rs1567408727	NC_000016.10:2056711:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.717C>G (p.Phe239Leu)	TSC2	F239L, F190L, F202L, F39L, F250L	Hereditary cancer-predisposing syndrome|not provided	VCV000623882	16	2106713	16	2056712	623882	613026	rs1567408727	NC_000016.10:2056711:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.718A>C (p.Ile240Leu)	TSC2	I236L, I251L, I221L, I86L, I203L, I240L, I191L, I270L, I40L	Tuberous sclerosis 2	VCV002771867	16	2106714	16	2056713	2771867	2927853	rs796053482	NC_000016.10:2056712:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.718A>T (p.Ile240Phe)	TSC2	I240F, I191F, I251F, I40F, I203F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406122	16	2106714	16	2056713	406122	400753	rs796053482	NC_000016.10:2056712:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.718A>G (p.Ile240Val)	TSC2	I240V, I203V, I40V, I191V, I251V	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207706	16	2106714	16	2056713	207706	203098	rs796053482	NC_000016.10:2056712:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.719T>C (p.Ile240Thr)	TSC2	I240T, I251T, I270T, I191T, I40T, I86T, I203T, I221T, I236T	Hereditary cancer-predisposing syndrome	VCV003811363	16	2106715	16	2056714	3811363	3928604		NC_000016.10:2056713:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.720C>T (p.Ile240=)	TSC2		Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000049909	16	2106716	16	2056715	49909	59071	rs45517123	NC_000016.10:2056714:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.721G>C (p.Val241Leu)	TSC2	V241L, V252L, V192L, V204L, V41L	not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535999	16	2106717	16	2056716	535999	529868	rs200943828	NC_000016.10:2056715:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.721G>A (p.Val241Ile)	TSC2	V241I, V41I, V192I, V204I, V252I	not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Intellectual disability	VCV000389984	16	2106717	16	2056716	389984	375115	rs200943828	NC_000016.10:2056715:G:A	single nucleotide variant	missense variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.722T>C (p.Val241Ala)	TSC2	V192A, V204A, V241A, V252A, V41A	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001056341	16	2106718	16	2056717	1056341	1049420	rs888878542	NC_000016.10:2056716:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.723T>G (p.Val241=)	TSC2		Tuberous sclerosis 2	VCV002010429	16	2106719	16	2056718	2010429	2067093	rs2151080112	NC_000016.10:2056717:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jun 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.724A>G (p.Thr242Ala)	TSC2	T193A, T205A, T223A, T238A, T242A, T253A, T272A, T42A, T88A	Isolated focal cortical dysplasia type II	VCV002679324	16	2106720	16	2056719	2679324	2836901	rs1596278522	NC_000016.10:2056718:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.725C>A (p.Thr242Asn)	TSC2	T193N, T205N, T242N, T253N, T42N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001055573	16	2106721	16	2056720	1055573	1049421	rs1007232729	NC_000016.10:2056719:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.725C>T (p.Thr242Ile)	TSC2	T205I, T193I, T42I, T242I, T253I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000641675	16	2106721	16	2056720	641675	644162	rs1007232729	NC_000016.10:2056719:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.726C>T (p.Thr242=)	TSC2		Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000256637	16	2106722	16	2056721	256637	255486	rs570051626	NC_000016.10:2056720:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.727C>G (p.Leu243Val)	TSC2	L243V, L194V, L43V, L254V, L206V	Tuberous sclerosis 2	VCV000238091	16	2106723	16	2056722	238091	242216	rs796053502	NC_000016.10:2056721:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.727C>T (p.Leu243Phe)	TSC2	L243F, L206F, L43F, L194F, L254F	not provided	VCV000207770	16	2106723	16	2056722	207770	203099	rs796053502	NC_000016.10:2056721:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2014	criteria provided, single submitter							
NM_000548.5(TSC2):c.728T>C (p.Leu243Pro)	TSC2	L206P, L224P, L243P, L194P, L239P, L254P, L43P, L273P, L89P	Tuberous sclerosis 2	VCV002846749	16	2106724	16	2056723	2846749	3014924	rs2151080318	NC_000016.10:2056722:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Apr 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.729C>T (p.Leu243=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000754615	16	2106725	16	2056724	754615	770669	rs45473698	NC_000016.10:2056723:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.729C>G (p.Leu243=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|not specified	VCV000049382	16	2106725	16	2056724	49382	58544	rs45473698	NC_000016.10:2056723:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.730T>C (p.Cys244Arg)	TSC2	C244R, C255R, C207R, C195R, C44R	not provided	VCV000049896	16	2106726	16	2056725	49896	59058	rs137854101	NC_000016.10:2056724:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.733C>G (p.Arg245Gly)	TSC2	R245G, R208G, R45G, R196G, R256G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468178	16	2106729	16	2056728	468178	465847	rs375574283	NC_000016.10:2056727:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.733C>T (p.Arg245Cys)	TSC2	R245C, R208C, R256C, R196C, R45C	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000405992	16	2106729	16	2056728	405992	400650	rs375574283	NC_000016.10:2056727:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.734G>T (p.Arg245Leu)	TSC2	R208L, R226L, R245L, R256L, R91L, R196L, R275L, R241L, R45L	Tuberous sclerosis 2	VCV002708257	16	2106730	16	2056729	2708257	2874422	rs397515011	NC_000016.10:2056728:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.734G>C (p.Arg245Pro)	TSC2	R208P, R241P, R245P, R275P, R91P, R226P, R196P, R256P, R45P	Hereditary cancer-predisposing syndrome	VCV001758448	16	2106730	16	2056729	1758448	1822965	rs397515011	NC_000016.10:2056728:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.734G>A (p.Arg245His)	TSC2	R245H, R208H, R256H, R45H, R196H	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000065021	16	2106730	16	2056729	65021	75951	rs397515011	NC_000016.10:2056728:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.735C>T (p.Arg245=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000413669	16	2106731	16	2056730	413669	401158	rs763419528	NC_000016.10:2056729:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.736A>G (p.Thr246Ala)	TSC2	T246A, T197A, T209A, T257A, T46A	Hereditary cancer-predisposing syndrome|not specified|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000049384	16	2106732	16	2056731	49384	58546	rs137854123	NC_000016.10:2056730:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.739A>T (p.Ile247Phe)	TSC2	I198F, I210F, I228F, I243F, I247F, I258F, I277F, I47F, I93F	Hereditary cancer-predisposing syndrome	VCV003232203	16	2106735	16	2056734	3232203	3392004	rs774526017	NC_000016.10:2056733:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.739A>G (p.Ile247Val)	TSC2	I247V, I210V, I198V, I47V, I258V	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000318307	16	2106735	16	2056734	318307	340850	rs774526017	NC_000016.10:2056733:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.740T>C (p.Ile247Thr)	TSC2	I210T, I228T, I243T, I258T, I277T, I47T, I198T, I247T, I93T	Hereditary cancer-predisposing syndrome	VCV003974668	16	2106736	16	2056735	3974668	4086491		NC_000016.10:2056734:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.741C>T (p.Ile247=)	TSC2		Tuberous sclerosis 2	VCV001082735	16	2106737	16	2056736	1082735	1081777	rs2151080723	NC_000016.10:2056735:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.743A>C (p.Asn248Thr)	TSC2	N199T, N211T, N229T, N244T, N248T, N259T, N278T, N48T, N94T	Tuberous sclerosis 2|not provided	VCV002505834	16	2106739	16	2056738	2505834	2670798	rs762104739	NC_000016.10:2056737:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.743A>G (p.Asn248Ser)	TSC2	N248S, N211S, N259S, N48S, N199S	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000536104	16	2106739	16	2056738	536104	529526	rs762104739	NC_000016.10:2056737:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.743A>T (p.Asn248Ile)	TSC2	N248I, N259I, N199I, N211I, N48I	Tuberous sclerosis 2	VCV000405965	16	2106739	16	2056738	405965	400661	rs762104739	NC_000016.10:2056737:A:T	single nucleotide variant	missense variant	Benign	Mar 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.744C>T (p.Asn248=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000413752	16	2106740	16	2056739	413752	401409	rs767565673	NC_000016.10:2056738:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.745G>T (p.Val249Phe)	TSC2	V230F, V260F, V279F, V200F, V212F, V245F, V95F, V249F, V49F	Tuberous sclerosis 2	VCV003703510	16	2106741	16	2056740	3703510	3845591		NC_000016.10:2056739:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.745G>A (p.Val249Ile)	TSC2	V249I, V200I, V260I, V49I, V212I	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000579851	16	2106741	16	2056740	579851	567736	rs750649974	NC_000016.10:2056739:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.745G>C (p.Val249Leu)	TSC2	V249L, V212L, V49L, V260L, V200L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000570781	16	2106741	16	2056740	570781	567740	rs750649974	NC_000016.10:2056739:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.746T>C (p.Val249Ala)	TSC2	V200A, V260A, V249A, V49A, V212A	Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000643020	16	2106742	16	2056741	643020	644163	rs1596278719	NC_000016.10:2056740:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.747C>G (p.Val249=)	TSC2		Tuberous sclerosis 2	VCV003643045	16	2106743	16	2056742	3643045	3775917		NC_000016.10:2056741:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.747C>T (p.Val249=)	TSC2		Tuberous sclerosis 2	VCV002131597	16	2106743	16	2056742	2131597	2189585	rs2151080943	NC_000016.10:2056741:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Oct 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.748A>G (p.Lys250Glu)	TSC2	K201E, K50E, K213E, K250E, K261E	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|not provided	VCV000855925	16	2106744	16	2056743	855925	843335	rs2085894886	NC_000016.10:2056742:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.749A>C (p.Lys250Thr)	TSC2	K201T, K213T, K231T, K246T, K250T, K261T, K280T, K50T, K96T	not provided	VCV003389691	16	2106745	16	2056744	3389691	3548814		NC_000016.10:2056743:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.749A>G (p.Lys250Arg)	TSC2	K201R, K250R, K261R, K50R, K213R	Tuberous sclerosis 2	VCV001378871	16	2106745	16	2056744	1378871	1408062	rs2151081016	NC_000016.10:2056743:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.750G>A (p.Lys250=)	TSC2		Tuberous sclerosis 2	VCV002745675	16	2106746	16	2056745	2745675	2903868	rs2151081051	NC_000016.10:2056744:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.751G>C (p.Glu251Gln)	TSC2	E202Q, E232Q, E247Q, E262Q, E97Q, E251Q, E214Q, E281Q, E51Q	Tuberous sclerosis 2	VCV002859719	16	2106747	16	2056746	2859719	3018479	rs1114167465	NC_000016.10:2056745:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.751G>A (p.Glu251Lys)	TSC2	E251K, E262K, E51K, E214K, E202K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000468179	16	2106747	16	2056746	468179	465175	rs1114167465	NC_000016.10:2056745:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.751G>T (p.Glu251Ter)	TSC2	E251*, E214*, E262*, E51*, E202*	Hereditary cancer-predisposing syndrome	VCV000427994	16	2106747	16	2056746	427994	419866	rs1114167465	NC_000016.10:2056745:G:T	single nucleotide variant	nonsense	Pathogenic	Jul 1, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.753G>A (p.Glu251=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000233330	16	2106749	16	2056748	233330	235092	rs876660338	NC_000016.10:2056747:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.754C>A (p.Leu252Ile)	TSC2	L252I, L203I, L52I, L215I, L263I	Tuberous sclerosis 2	VCV000566158	16	2106750	16	2056749	566158	567741	rs766770734	NC_000016.10:2056748:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.756C>G (p.Leu252=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000765243	16	2106752	16	2056751	765243	770670	rs1026303888	NC_000016.10:2056750:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.756C>T (p.Leu252=)	TSC2		Tuberous sclerosis 2	VCV000759536	16	2106752	16	2056751	759536	770671	rs1026303888	NC_000016.10:2056750:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.758G>A (p.Cys253Tyr)	TSC2	C216Y, C253Y, C264Y, C53Y, C204Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000741184	16	2106754	16	2056753	741184	754977	rs766547457	NC_000016.10:2056752:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.758G>T (p.Cys253Phe)	TSC2	C253F, C264F, C216F, C53F, C204F	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468180	16	2106754	16	2056753	468180	465724	rs766547457	NC_000016.10:2056752:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.759C>T (p.Cys253=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000389500	16	2106755	16	2056754	389500	374043	rs45517125	NC_000016.10:2056753:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.759C>A (p.Cys253Ter)	TSC2	C253*, C53*, C204*, C216*, C264*	not provided|Tuberous sclerosis 2	VCV000049914	16	2106755	16	2056754	49914	59076	rs45517125	NC_000016.10:2056753:C:A	single nucleotide variant	nonsense	Pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.760G>A (p.Glu254Lys)	TSC2	E254K, E205K, E217K, E265K, E54K	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000065231	16	2106756	16	2056755	65231	76163	rs45517126	NC_000016.10:2056754:G:A	single nucleotide variant	missense variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.762G>A (p.Glu254=)	TSC2		Tuberous sclerosis 2	VCV001103393	16	2106758	16	2056757	1103393	1103611	rs2151081395	NC_000016.10:2056756:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.764C>G (p.Pro255Arg)	TSC2	P101R, P206R, P218R, P236R, P251R, P255R, P266R, P285R, P55R	Tuberous sclerosis syndrome	VCV003071843	16	2106760	16	2056759	3071843	3232021	rs2085896951	NC_000016.10:2056758:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.764C>A (p.Pro255His)	TSC2	P266H, P55H, P206H, P255H, P218H	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001489100	16	2106760	16	2056759	1489100	1498592	rs2085896951	NC_000016.10:2056758:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.767G>C (p.Cys256Ser)	TSC2	C102S, C252S, C256S, C207S, C56S, C237S, C286S, C219S, C267S	Hereditary cancer-predisposing syndrome	VCV003811378	16	2106763	16	2056762	3811378	3928619		NC_000016.10:2056761:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.767G>A (p.Cys256Tyr)	TSC2	C102Y, C207Y, C219Y, C237Y, C252Y, C256Y, C267Y, C286Y, C56Y	Tuberous sclerosis 2	VCV001717029	16	2106763	16	2056762	1717029	1775854	rs1567409304	NC_000016.10:2056761:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.767G>T (p.Cys256Phe)	TSC2	C256F, C219F, C56F, C207F, C267F	Tuberous sclerosis 2	VCV000582395	16	2106763	16	2056762	582395	570053	rs1567409304	NC_000016.10:2056761:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.768C>G (p.Cys256Trp)	TSC2	C207W, C256W, C267W, C56W, C219W	Tuberous sclerosis 2	VCV001406798	16	2106764	16	2056763	1406798	1486856	rs45517127	NC_000016.10:2056762:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.768C>T (p.Cys256=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468181	16	2106764	16	2056763	468181	465179	rs45517127	NC_000016.10:2056762:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.770G>A (p.Trp257Ter)	TSC2	W103*, W253*, W257*, W208*, W220*, W268*, W238*, W57*, W287*	not provided|Tuberous sclerosis 2	VCV002137758	16	2106766	16	2056765	2137758	1871367	rs2151081778	NC_000016.10:2056764:G:A	single nucleotide variant	nonsense	Pathogenic	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.772A>C (p.Lys258Gln)	TSC2	K221Q, K254Q, K258Q, K58Q, K209Q, K269Q, K288Q, K104Q, K239Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002110378	16	2106768	16	2056767	2110378	2170842	rs2151081843	NC_000016.10:2056766:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.774G>A (p.Lys258=)	TSC2		Tuberous sclerosis 2|TSC2-related disorder	VCV002630731	16	2106770	16	2056769	2630731	2796486	rs137854875	NC_000016.10:2056768:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.774+1G>T	TSC2		Tuberous sclerosis 2	VCV000065237	16	2106771	16	2056770	65237	76169	rs45517128	NC_000016.10:2056769:G:T	single nucleotide variant	splice donor variant	Pathogenic	Mar 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000049919	16	2106771	16	2056770	49919	59081	rs45517128	NC_000016.10:2056769:G:A	single nucleotide variant	splice donor variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.774+2T>C	TSC2		not provided	VCV002500640	16	2106772	16	2056771	2500640	2523538	rs45517129	NC_000016.10:2056770:T:C	single nucleotide variant	splice donor variant	Pathogenic	Oct 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+2T>A	TSC2		not provided	VCV000049385	16	2106772	16	2056771	49385	58547	rs45517129	NC_000016.10:2056770:T:A	single nucleotide variant	splice donor variant	Pathogenic	Nov 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+3G>A	TSC2		Tuberous sclerosis 2	VCV002711514	16	2106773	16	2056772	2711514	2875116	rs2151081990	NC_000016.10:2056771:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.774+3G>C	TSC2		Tuberous sclerosis 2	VCV001413892	16	2106773	16	2056772	1413892	1361795	rs2151081990	NC_000016.10:2056771:G:C	single nucleotide variant	intron variant	Uncertain significance	Nov 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+4G>T	TSC2		Tuberous sclerosis 2	VCV002025271	16	2106774	16	2056773	2025271	2084474	rs1244859914	NC_000016.10:2056772:G:T	single nucleotide variant	intron variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+4G>C	TSC2		Tuberous sclerosis 2	VCV001396074	16	2106774	16	2056773	1396074	1350853	rs1244859914	NC_000016.10:2056772:G:C	single nucleotide variant	intron variant	Uncertain significance	Dec 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+4G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000468182	16	2106774	16	2056773	468182	465182	rs1244859914	NC_000016.10:2056772:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.774+5G>A	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578783	16	2106775	16	2056774	3578783	3708203		NC_000016.10:2056773:G:A	single nucleotide variant	intron variant	Uncertain significance	Jun 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+6G>C	TSC2		Tuberous sclerosis 2	VCV002770894	16	2106776	16	2056775	2770894	2923868	rs2151082068	NC_000016.10:2056774:G:C	single nucleotide variant	intron variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+6G>T	TSC2		Tuberous sclerosis 2	VCV002127885	16	2106776	16	2056775	2127885	2185762	rs2151082068	NC_000016.10:2056774:G:T	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.774+12G>C	TSC2		Tuberous sclerosis 2	VCV003003376	16	2106782	16	2056781	3003376	3161082	rs1299521085	NC_000016.10:2056780:G:C	single nucleotide variant	intron variant	Likely benign	Jan 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+12G>A	TSC2		Tuberous sclerosis 2	VCV001616963	16	2106782	16	2056781	1616963	1579966	rs1299521085	NC_000016.10:2056780:G:A	single nucleotide variant	intron variant	Likely benign	Jun 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+13A>G	TSC2		Tuberous sclerosis 2	VCV002132474	16	2106783	16	2056782	2132474	2186475	rs2151082224	NC_000016.10:2056781:A:G	single nucleotide variant	intron variant	Likely benign	May 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+15A>C	TSC2		Tuberous sclerosis 2	VCV002827482	16	2106785	16	2056784	2827482	2983434	rs747841616	NC_000016.10:2056783:A:C	single nucleotide variant	intron variant	Likely benign	Jan 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+15A>T	TSC2		Tuberous sclerosis 2	VCV001661899	16	2106785	16	2056784	1661899	1576781	rs747841616	NC_000016.10:2056783:A:T	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+17T>G	TSC2		Tuberous sclerosis 2	VCV003704347	16	2106787	16	2056786	3704347	3839097		NC_000016.10:2056785:T:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+18G>A	TSC2		Tuberous sclerosis 2	VCV001998899	16	2106788	16	2056787	1998899	2060692	rs2151082344	NC_000016.10:2056786:G:A	single nucleotide variant	intron variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+19C>T	TSC2		Tuberous sclerosis 2	VCV002031244	16	2106789	16	2056788	2031244	2078886	rs2151082365	NC_000016.10:2056787:C:T	single nucleotide variant	intron variant	Likely benign	May 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.774+20T>C	TSC2		Tuberous sclerosis 2	VCV002912587	16	2106790	16	2056789	2912587	3070699	rs1291650358	NC_000016.10:2056788:T:C	single nucleotide variant	intron variant	Likely benign	Dec 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-19C>T	TSC2		Tuberous sclerosis 2	VCV003704011	16	2107087	16	2057086	3704011	3842211		NC_000016.10:2057085:C:T	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-19C>G	TSC2		Tuberous sclerosis 2	VCV003656079	16	2107087	16	2057086	3656079	3782946		NC_000016.10:2057085:C:G	single nucleotide variant	intron variant	Likely benign	Jun 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-18A>G	TSC2		Tuberous sclerosis 2	VCV002024245	16	2107088	16	2057087	2024245	2077022	rs1415572593	NC_000016.10:2057086:A:G	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-17C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000378772	16	2107089	16	2057088	378772	377144	rs137854299	NC_000016.10:2057087:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-16G>T	TSC2		Tuberous sclerosis 2	VCV003687408	16	2107090	16	2057089	3687408	3830669		NC_000016.10:2057088:G:T	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-16G>A	TSC2		Tuberous sclerosis 2	VCV001588123	16	2107090	16	2057089	1588123	1574666	rs1359566041	NC_000016.10:2057088:G:A	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-16G>C	TSC2		not specified|Tuberous sclerosis 2	VCV000509482	16	2107090	16	2057089	509482	505446	rs1359566041	NC_000016.10:2057088:G:C	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-14A>G	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001643743	16	2107092	16	2057091	1643743	1651481	rs969379684	NC_000016.10:2057090:A:G	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-13T>C	TSC2		Tuberous sclerosis 2	VCV004071456	16	2107093	16	2057092	4071456	4185303		NC_000016.10:2057091:T:C	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-12T>C	TSC2		not provided|Tuberous sclerosis 2	VCV001249656	16	2107094	16	2057093	1249656	1241281	rs753920940	NC_000016.10:2057092:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-11G>A	TSC2		Tuberous sclerosis 2	VCV002186765	16	2107095	16	2057094	2186765	1918110	rs2548472058	NC_000016.10:2057093:G:A	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-11G>T	TSC2		Tuberous sclerosis 2	VCV002159785	16	2107095	16	2057094	2159785	1886861	rs2548472058	NC_000016.10:2057093:G:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-10T>A	TSC2		Tuberous sclerosis syndrome	VCV003071030	16	2107096	16	2057095	3071030	3228613	rs1555499018	NC_000016.10:2057094:T:A	single nucleotide variant	intron variant	Uncertain significance	May 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-10T>G	TSC2		Tuberous sclerosis 2	VCV000468183	16	2107096	16	2057095	468183	465731	rs1555499018	NC_000016.10:2057094:T:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-9G>C	TSC2		Tuberous sclerosis 2	VCV001573449	16	2107097	16	2057096	1573449	1637164	rs1596280442	NC_000016.10:2057095:G:C	single nucleotide variant	intron variant	Likely benign	Aug 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-9G>A	TSC2		Tuberous sclerosis 2	VCV000760911	16	2107097	16	2057096	760911	776150	rs1596280442	NC_000016.10:2057095:G:A	single nucleotide variant	intron variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-7C>G	TSC2		Renal cyst|Tuberous sclerosis 2	VCV001158828	16	2107099	16	2057098	1158828	1145897	rs368164133	NC_000016.10:2057097:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.775-6T>C	TSC2		Tuberous sclerosis 2	VCV002842803	16	2107100	16	2057099	2842803	2997509	rs2548472221	NC_000016.10:2057098:T:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-5C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536051	16	2107101	16	2057100	536051	530102	rs181827303	NC_000016.10:2057099:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.775-5C>T	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238092	16	2107101	16	2057100	238092	242217	rs181827303	NC_000016.10:2057099:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.775-4G>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003462650	16	2107102	16	2057101	3462650	3621669		NC_000016.10:2057100:G:T	single nucleotide variant	intron variant	Likely benign	Oct 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-4G>A	TSC2		Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184603	16	2107102	16	2057101	184603	184116	rs754957491	NC_000016.10:2057100:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-3C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002061659	16	2107103	16	2057102	2061659	2120807	rs397514909	NC_000016.10:2057101:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.775-3C>A	TSC2		Tuberous sclerosis 2	VCV000936335	16	2107103	16	2057102	936335	940347	rs397514909	NC_000016.10:2057101:C:A	single nucleotide variant	intron variant	Uncertain significance	Sep 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-3C>G	TSC2		not provided	VCV000064883	16	2107103	16	2057102	64883	75813	rs397514909	NC_000016.10:2057101:C:G	single nucleotide variant	intron variant	Uncertain significance	Dec 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-2A>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001705534	16	2107104	16	2057103	1705534	1701619	rs2548472327	NC_000016.10:2057102:A:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Jun 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.775-1G>C	TSC2		Tuberous sclerosis 2	VCV000983048	16	2107105	16	2057104	983048	971039	rs45454192	NC_000016.10:2057103:G:C	single nucleotide variant	splice acceptor variant	Pathogenic	Feb 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.775-1G>A	TSC2		Tuberous sclerosis 2	VCV000049984	16	2107105	16	2057104	49984	59146	rs45454192	NC_000016.10:2057103:G:A	single nucleotide variant	splice acceptor variant	Likely pathogenic	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.777G>C (p.Leu259=)	TSC2		Tuberous sclerosis 2	VCV003724889	16	2107108	16	2057107	3724889	3854668		NC_000016.10:2057106:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.778A>T (p.Met260Leu)	TSC2	M60L, M223L, M211L, M271L, M260L	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000951791	16	2107109	16	2057108	951791	927622	rs2085953921	NC_000016.10:2057107:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.779T>C (p.Met260Thr)	TSC2	M106T, M211T, M223T, M241T, M256T, M260T, M271T, M290T, M60T	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003073473	16	2107110	16	2057109	3073473	3234429	rs2548472429	NC_000016.10:2057108:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.781C>G (p.Arg261Gly)	TSC2	R261G, R212G, R224G, R272G, R61G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Isolated focal cortical dysplasia type II	VCV000468184	16	2107112	16	2057111	468184	466026	rs45517130	NC_000016.10:2057110:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.781C>T (p.Arg261Trp)	TSC2	R261W, R61W, R212W, R272W, R224W	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000049386	16	2107112	16	2057111	49386	58548	rs45517130	NC_000016.10:2057110:C:T	single nucleotide variant	missense variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.782G>T (p.Arg261Leu)	TSC2	R224L, R261L, R212L, R272L, R61L	Tuberous sclerosis 2	VCV001465757	16	2107113	16	2057112	1465757	1353989	rs45502703	NC_000016.10:2057111:G:T	single nucleotide variant	missense variant	Likely benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.782G>A (p.Arg261Gln)	TSC2	R261Q, R61Q, R212Q, R224Q, R272Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000207771	16	2107113	16	2057112	207771	203100	rs45502703	NC_000016.10:2057111:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.783G>A (p.Arg261=)	TSC2		Tuberous sclerosis 2	VCV004071341	16	2107114	16	2057113	4071341	4185189		NC_000016.10:2057112:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.785A>T (p.Asn262Ile)	TSC2	N213I, N225I, N262I, N273I, N62I	Tuberous sclerosis 2	VCV001000421	16	2107116	16	2057115	1000421	996692	rs2085955900	NC_000016.10:2057114:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.786C>T (p.Asn262=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001097230	16	2107117	16	2057116	1097230	1081778	rs1485087555	NC_000016.10:2057115:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.786C>A (p.Asn262Lys)	TSC2	N213K, N225K, N262K, N273K, N62K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001005689	16	2107117	16	2057116	1005689	996693	rs1485087555	NC_000016.10:2057115:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.787C>T (p.Leu263Phe)	TSC2	L63F, L274F, L226F, L263F, L214F	not provided|Tuberous sclerosis 2	VCV001449154	16	2107118	16	2057117	1449154	1338909	rs2151086992	NC_000016.10:2057116:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.788T>C (p.Leu263Pro)	TSC2	L109P, L226P, L244P, L274P, L214P, L263P, L259P, L293P, L63P	Tuberous sclerosis 2	VCV002770424	16	2107119	16	2057118	2770424	2927274	rs2548472706	NC_000016.10:2057117:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.789C>G (p.Leu263=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811320	16	2107120	16	2057119	3811320	3928561		NC_000016.10:2057118:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.789C>T (p.Leu263=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001139818	16	2107120	16	2057119	1139818	1125018	rs1478468856	NC_000016.10:2057118:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.790C>T (p.Leu264Phe)	TSC2	L227F, L215F, L264F, L275F, L64F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000965517	16	2107121	16	2057120	965517	957669	rs2085956949	NC_000016.10:2057119:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.791T>C (p.Leu264Pro)	TSC2	L264P, L64P, L215P, L227P, L275P	not provided	VCV000049921	16	2107122	16	2057121	49921	59083	rs45517131	NC_000016.10:2057120:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 26, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.792T>C (p.Leu264=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001761285	16	2107123	16	2057122	1761285	1813593	rs2548472881	NC_000016.10:2057121:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	May 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.793G>T (p.Gly265Cys)	TSC2	G265C, G276C, G295C, G111C, G216C, G246C, G228C, G261C, G65C	Hereditary cancer-predisposing syndrome	VCV002455151	16	2107124	16	2057123	2455151	2430900	rs1567410457	NC_000016.10:2057122:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.793G>A (p.Gly265Ser)	TSC2	G265S, G276S, G65S, G228S, G216S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000573729	16	2107124	16	2057123	573729	570058	rs1567410457	NC_000016.10:2057122:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.794G>T (p.Gly265Val)	TSC2	G276V, G65V, G216V, G228V, G265V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001522362	16	2107125	16	2057124	1522362	1369306	rs1188591008	NC_000016.10:2057123:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.795C>T (p.Gly265=)	TSC2		Tuberous sclerosis 2	VCV004071178	16	2107126	16	2057125	4071178	4185026		NC_000016.10:2057124:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.796A>G (p.Thr266Ala)	TSC2	T217A, T229A, T266A, T277A, T66A	Tuberous sclerosis 2	VCV001053400	16	2107127	16	2057126	1053400	1049422	rs1433069377	NC_000016.10:2057125:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.797C>T (p.Thr266Ile)	TSC2	T112I, T217I, T229I, T247I, T262I, T266I, T277I, T296I, T66I	Tuberous sclerosis 2	VCV001718044	16	2107128	16	2057127	1718044	1772020	rs2548473078	NC_000016.10:2057126:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.798C>T (p.Thr266=)	TSC2		Tuberous sclerosis 2	VCV002735616	16	2107129	16	2057128	2735616	2901637	rs1172338384	NC_000016.10:2057127:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.798C>A (p.Thr266=)	TSC2		Tuberous sclerosis 2	VCV001147611	16	2107129	16	2057128	1147611	1145898	rs1172338384	NC_000016.10:2057127:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.801C>A (p.His267Gln)	TSC2	H113Q, H230Q, H297Q, H248Q, H263Q, H278Q, H67Q, H218Q, H267Q	Tuberous sclerosis 2	VCV002709399	16	2107132	16	2057131	2709399	2878145	rs2548473179	NC_000016.10:2057130:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.801C>T (p.His267=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001761682	16	2107132	16	2057131	1761682	1823624	rs2548473179	NC_000016.10:2057130:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.802C>G (p.Leu268Val)	TSC2	L219V, L268V, L279V, L68V, L231V	Tuberous sclerosis 2	VCV001443512	16	2107133	16	2057132	1443512	1384458	rs1396943042	NC_000016.10:2057131:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.802C>T (p.Leu268=)	TSC2		Tuberous sclerosis 2	VCV001101430	16	2107133	16	2057132	1101430	1103612	rs1396943042	NC_000016.10:2057131:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.803T>G (p.Leu268Arg)	TSC2	L231R, L268R, L279R, L219R, L68R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000861909	16	2107134	16	2057133	861909	843336	rs2085959207	NC_000016.10:2057132:T:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.804G>C (p.Leu268=)	TSC2		Tuberous sclerosis 2	VCV003644141	16	2107135	16	2057134	3644141	3779995		NC_000016.10:2057133:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Mar 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.804G>A (p.Leu268=)	TSC2		Tuberous sclerosis 2	VCV001062597	16	2107135	16	2057134	1062597	1049423	rs2151087245	NC_000016.10:2057133:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.805G>A (p.Gly269Ser)	TSC2	G220S, G232S, G269S, G280S, G69S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000827429	16	2107136	16	2057135	827429	812491	rs1596280654	NC_000016.10:2057134:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.806G>C (p.Gly269Ala)	TSC2	G220A, G299A, G69A, G265A, G280A, G115A, G232A, G269A, G250A	Tuberous sclerosis 2	VCV002759865	16	2107137	16	2057136	2759865	2924918	rs1435458884	NC_000016.10:2057135:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.807C>A (p.Gly269=)	TSC2		Tuberous sclerosis 2	VCV000759381	16	2107138	16	2057137	759381	770672	rs1297815371	NC_000016.10:2057136:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.807C>T (p.Gly269=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000468185	16	2107138	16	2057137	468185	465186	rs1297815371	NC_000016.10:2057136:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.808C>T (p.His270Tyr)	TSC2	H221Y, H233Y, H251Y, H116Y, H270Y, H70Y, H266Y, H281Y, H300Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001761936	16	2107139	16	2057138	1761936	1823878	rs2548473393	NC_000016.10:2057137:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.809A>G (p.His270Arg)	TSC2	H116R, H221R, H233R, H251R, H266R, H270R, H281R, H300R, H70R	Hereditary cancer-predisposing syndrome	VCV003232204	16	2107140	16	2057139	3232204	3392005	rs2548473424	NC_000016.10:2057138:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.810C>T (p.His270=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000756447	16	2107141	16	2057140	756447	770673	rs1596280678	NC_000016.10:2057139:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.811A>G (p.Ser271Gly)	TSC2	S271G, S234G, S71G, S222G, S282G	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000468186	16	2107142	16	2057141	468186	465848	rs1555499071	NC_000016.10:2057140:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.812G>A (p.Ser271Asn)	TSC2	S301N, S282N, S117N, S252N, S267N, S222N, S234N, S271N, S71N	Hereditary cancer-predisposing syndrome	VCV003462680	16	2107143	16	2057142	3462680	3621699		NC_000016.10:2057141:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.813C>A (p.Ser271Arg)	TSC2	S117R, S271R, S71R, S252R, S267R, S222R, S282R, S234R, S301R	Tuberous sclerosis 2	VCV002861009	16	2107144	16	2057143	2861009	3022339	rs752676212	NC_000016.10:2057142:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.813C>G (p.Ser271Arg)	TSC2	S222R, S234R, S271R, S282R, S71R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001692513	16	2107144	16	2057143	1692513	1684953	rs752676212	NC_000016.10:2057142:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.813C>T (p.Ser271=)	TSC2		Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536079	16	2107144	16	2057143	536079	529565	rs752676212	NC_000016.10:2057142:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.814G>T (p.Ala272Ser)	TSC2	A272S, A223S, A283S, A72S, A235S	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000576842	16	2107145	16	2057144	576842	569617	rs373818076	NC_000016.10:2057143:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.814G>A (p.Ala272Thr)	TSC2	A272T, A235T, A223T, A72T, A283T	not specified|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238093	16	2107145	16	2057144	238093	242218	rs373818076	NC_000016.10:2057143:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.815C>T (p.Ala272Val)	TSC2	A118V, A223V, A235V, A253V, A268V, A272V, A283V, A302V, A72V	Hereditary cancer-predisposing syndrome	VCV003232205	16	2107146	16	2057145	3232205	3392006	rs2085961158	NC_000016.10:2057144:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.815C>A (p.Ala272Asp)	TSC2	A118D, A235D, A272D, A223D, A283D, A253D, A302D, A268D, A72D	Tuberous sclerosis 2	VCV002780309	16	2107146	16	2057145	2780309	2944049	rs2085961158	NC_000016.10:2057144:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.816C>G (p.Ala272=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001109614	16	2107147	16	2057146	1109614	1103613	rs917246659	NC_000016.10:2057145:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.816C>T (p.Ala272=)	TSC2		Tuberous sclerosis 2	VCV001096779	16	2107147	16	2057146	1096779	1081779	rs917246659	NC_000016.10:2057145:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.816C>A (p.Ala272=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536066	16	2107147	16	2057146	536066	529875	rs917246659	NC_000016.10:2057145:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.817A>G (p.Ile273Val)	TSC2	I224V, I236V, I273V, I284V, I73V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001062374	16	2107148	16	2057147	1062374	1049424	rs1357428836	NC_000016.10:2057146:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.818T>C (p.Ile273Thr)	TSC2	I269T, I303T, I73T, I119T, I273T, I284T, I236T, I224T, I254T	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001998524	16	2107149	16	2057148	1998524	2050445	rs1366677287	NC_000016.10:2057147:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 26, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.819C>A (p.Ile273=)	TSC2		Tuberous sclerosis 2	VCV002863230	16	2107150	16	2057149	2863230	3019417	rs2548473706	NC_000016.10:2057148:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	May 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.820T>A (p.Tyr274Asn)	TSC2	Y225N, Y274N, Y285N, Y74N, Y237N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000827513	16	2107151	16	2057150	827513	812492	rs367642937	NC_000016.10:2057149:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.820T>G (p.Tyr274Asp)	TSC2	Y274D, Y225D, Y237D, Y285D, Y74D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405958	16	2107151	16	2057150	405958	400668	rs367642937	NC_000016.10:2057149:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.821A>G (p.Tyr274Cys)	TSC2	Y274C, Y225C, Y237C, Y285C, Y74C	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000480835	16	2107152	16	2057151	480835	477307	rs1305592691	NC_000016.10:2057150:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.822C>T (p.Tyr274=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001108440	16	2107153	16	2057152	1108440	1103614	rs1347972318	NC_000016.10:2057151:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.823A>G (p.Asn275Asp)	TSC2	N226D, N121D, N238D, N256D, N75D, N271D, N275D, N286D, N305D	Hereditary cancer-predisposing syndrome	VCV002450006	16	2107154	16	2057153	2450006	2425963	rs2548473910	NC_000016.10:2057152:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.824A>G (p.Asn275Ser)	TSC2	N271S, N305S, N121S, N238S, N275S, N226S, N256S, N286S, N75S	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002911186	16	2107155	16	2057154	2911186	3078539	rs2151087703	NC_000016.10:2057153:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.825C>T (p.Asn275=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001762652	16	2107156	16	2057155	1762652	1817050	rs45468594	NC_000016.10:2057154:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.826A>C (p.Met276Leu)	TSC2	M122L, M272L, M276L, M76L, M239L, M257L, M287L, M306L, M227L	Hereditary cancer-predisposing syndrome	VCV002564661	16	2107157	16	2057156	2564661	2733817	rs1238874343	NC_000016.10:2057155:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.826A>G (p.Met276Val)	TSC2	M227V, M239V, M276V, M287V, M76V	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001303670	16	2107157	16	2057156	1303670	1293947	rs1238874343	NC_000016.10:2057155:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.827T>C (p.Met276Thr)	TSC2	M276T, M287T, M227T, M239T, M76T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000581815	16	2107158	16	2057157	581815	567753	rs1281538226	NC_000016.10:2057156:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.828G>T (p.Met276Ile)	TSC2	M239I, M276I, M287I, M76I, M227I	Tuberous sclerosis 2	VCV000846454	16	2107159	16	2057158	846454	843337	rs1318274503	NC_000016.10:2057157:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.828G>A (p.Met276Ile)	TSC2	M276I, M227I, M239I, M287I, M76I	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468187	16	2107159	16	2057158	468187	466028	rs1318274503	NC_000016.10:2057157:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.829T>A (p.Cys277Ser)	TSC2	C123S, C228S, C240S, C258S, C273S, C277S, C288S, C307S, C77S	Hereditary cancer-predisposing syndrome	VCV003232207	16	2107160	16	2057159	3232207	3392008	rs2548474148	NC_000016.10:2057158:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.829T>G (p.Cys277Gly)	TSC2	C240G, C258G, C228G, C273G, C277G, C288G, C307G, C77G, C123G	Hereditary cancer-predisposing syndrome	VCV001762812	16	2107160	16	2057159	1762812	1817210	rs2548474148	NC_000016.10:2057158:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.830G>T (p.Cys277Phe)	TSC2	C77F, C240F, C277F, C288F, C228F	Tuberous sclerosis 2	VCV001519589	16	2107161	16	2057160	1519589	1434083	rs1216101095	NC_000016.10:2057159:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.831C>G (p.Cys277Trp)	TSC2	C277W, C240W, C288W, C77W, C228W	Tuberous sclerosis 2|not specified	VCV000448740	16	2107162	16	2057161	448740	441778	rs1057523424	NC_000016.10:2057160:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.831C>T (p.Cys277=)	TSC2		Hereditary cancer-predisposing syndrome|not specified	VCV000389430	16	2107162	16	2057161	389430	374045	rs1057523424	NC_000016.10:2057160:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.832C>T (p.His278Tyr)	TSC2	H229Y, H241Y, H278Y, H289Y, H78Y	Tuberous sclerosis 2	VCV001001347	16	2107163	16	2057162	1001347	996694	rs2085965079	NC_000016.10:2057161:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.833A>G (p.His278Arg)	TSC2	H278R, H289R, H241R, H229R, H78R	Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238094	16	2107164	16	2057163	238094	242219	rs397515266	NC_000016.10:2057162:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.834C>T (p.His278=)	TSC2		Tuberous sclerosis 2	VCV000759079	16	2107165	16	2057164	759079	770674	rs1596280873	NC_000016.10:2057163:C:T	single nucleotide variant	synonymous variant	Likely benign	May 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.835C>T (p.Leu279Phe)	TSC2	L125F, L230F, L279F, L290F, L275F, L260F, L79F, L242F, L309F	Hereditary cancer-predisposing syndrome	VCV003974609	16	2107166	16	2057165	3974609	4086432		NC_000016.10:2057164:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.836T>A (p.Leu279His)	TSC2	L125H, L230H, L275H, L242H, L260H, L309H, L79H, L279H, L290H	Tuberous sclerosis 2	VCV002719540	16	2107167	16	2057166	2719540	2870176	rs2548474345	NC_000016.10:2057165:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.836T>C (p.Leu279Pro)	TSC2	L125P, L230P, L242P, L260P, L275P, L279P, L290P, L309P, L79P	Tuberous sclerosis 2	VCV001720950	16	2107167	16	2057166	1720950	1774932	rs2548474345	NC_000016.10:2057165:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.837C>T (p.Leu279=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000184662	16	2107168	16	2057167	184662	184117	rs746694709	NC_000016.10:2057166:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.838A>G (p.Met280Val)	TSC2	M80V, M231V, M280V, M243V, M291V	Tuberous sclerosis 2	VCV000646434	16	2107169	16	2057168	646434	644164	rs1596280903	NC_000016.10:2057167:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.839T>G (p.Met280Arg)	TSC2	M231R, M310R, M261R, M280R, M243R, M291R, M80R, M126R, M276R	Tuberous sclerosis 2	VCV002857579	16	2107170	16	2057169	2857579	3021476	rs2548474408	NC_000016.10:2057168:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.839T>A (p.Met280Lys)	TSC2	M243K, M261K, M276K, M291K, M80K, M126K, M231K, M280K, M310K	Hereditary cancer-predisposing syndrome	VCV002564662	16	2107170	16	2057169	2564662	2733818	rs2548474408	NC_000016.10:2057168:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.839T>C (p.Met280Thr)	TSC2	M261T, M291T, M126T, M231T, M243T, M310T, M80T, M276T, M280T	Hereditary cancer-predisposing syndrome|not provided	VCV002564634	16	2107170	16	2057169	2564634	2733790	rs2548474408	NC_000016.10:2057168:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Jul 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.843G>A (p.Glu281=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002121267	16	2107174	16	2057173	2121267	2180449	rs2151088094	NC_000016.10:2057172:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.843G>T (p.Glu281Asp)	TSC2	E232D, E244D, E281D, E292D, E81D	Tuberous sclerosis 2	VCV001700567	16	2107174	16	2057173	1700567	1692960	rs2151088094	NC_000016.10:2057172:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.844G>A (p.Asp282Asn)	TSC2	D282N, D293N, D312N, D245N, D263N, D278N, D128N, D233N, D82N	Tuberous sclerosis 2	VCV002118393	16	2107175	16	2057174	2118393	2176175	rs1192271452	NC_000016.10:2057173:G:A	single nucleotide variant	missense variant	Benign	Mar 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.844G>T (p.Asp282Tyr)	TSC2	D245Y, D282Y, D293Y, D233Y, D82Y	Tuberous sclerosis 2	VCV001346833	16	2107175	16	2057174	1346833	1452946	rs1192271452	NC_000016.10:2057173:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.846C>T (p.Asp282=)	TSC2		Tuberous sclerosis 2	VCV004071246	16	2107177	16	2057176	4071246	4185094		NC_000016.10:2057175:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.846C>G (p.Asp282Glu)	TSC2	D128E, D245E, D233E, D293E, D312E, D263E, D278E, D282E, D82E	Tuberous sclerosis 2	VCV002698830	16	2107177	16	2057176	2698830	2855121	rs587778734	NC_000016.10:2057175:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.846C>A (p.Asp282Glu)	TSC2	D282E, D82E, D233E, D245E, D293E	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135379	16	2107177	16	2057176	135379	139118	rs587778734	NC_000016.10:2057175:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.847A>G (p.Arg283Gly)	TSC2	R246G, R83G, R283G, R294G, R234G	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000665722	16	2107178	16	2057177	665722	644165	rs1596280931	NC_000016.10:2057176:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848G>A (p.Arg283Lys)	TSC2	R246K, R83K, R234K, R283K, R294K	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001348115	16	2107179	16	2057178	1348115	1459346	rs1255519055	NC_000016.10:2057177:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.848+1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000049922	16	2107180	16	2057179	49922	59084	rs45466296	NC_000016.10:2057178:G:A	single nucleotide variant	splice donor variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+2T>A	TSC2		Hereditary cancer-predisposing syndrome	VCV001763543	16	2107181	16	2057180	1763543	1824267	rs1555499119	NC_000016.10:2057179:T:A	single nucleotide variant	splice donor variant	Likely pathogenic	Nov 2, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+2T>G	TSC2		not provided	VCV000448741	16	2107181	16	2057180	448741	441779	rs1555499119	NC_000016.10:2057179:T:G	single nucleotide variant	splice donor variant	Pathogenic	Sep 9, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+3G>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003462617	16	2107182	16	2057181	3462617	3621636		NC_000016.10:2057180:G:T	single nucleotide variant	intron variant	Uncertain significance	Sep 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+4A>G	TSC2		Hereditary cancer-predisposing syndrome	VCV003974671	16	2107183	16	2057182	3974671	4086494		NC_000016.10:2057181:A:G	single nucleotide variant	intron variant	Uncertain significance	May 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+5G>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000885645	16	2107184	16	2057183	885645	876634	rs1370989559	NC_000016.10:2057182:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.848+5G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468188	16	2107184	16	2057183	468188	465851	rs1370989559	NC_000016.10:2057182:G:A	single nucleotide variant	intron variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+6T>C	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001970874	16	2107185	16	2057184	1970874	2025714	rs2548474698	NC_000016.10:2057183:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+7G>A	TSC2		not provided|Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049399	16	2107186	16	2057185	49399	58561	rs45442896	NC_000016.10:2057184:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+9G>A	TSC2		Tuberous sclerosis 2	VCV001077827	16	2107188	16	2057187	1077827	1081780	rs1158054515	NC_000016.10:2057186:G:A	single nucleotide variant	intron variant	Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+10G>A	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001126406	16	2107189	16	2057188	1126406	1125019	rs1405925936	NC_000016.10:2057187:G:A	single nucleotide variant	intron variant	Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+12G>C	TSC2		Tuberous sclerosis 2	VCV003654187	16	2107191	16	2057190	3654187	3782338		NC_000016.10:2057189:G:C	single nucleotide variant	intron variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+12G>T	TSC2		Tuberous sclerosis 2	VCV002708420	16	2107191	16	2057190	2708420	2874585	rs1456160330	NC_000016.10:2057189:G:T	single nucleotide variant	intron variant	Likely benign	Jan 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+12G>A	TSC2		Tuberous sclerosis 2	VCV001673261	16	2107191	16	2057190	1673261	1595448	rs1456160330	NC_000016.10:2057189:G:A	single nucleotide variant	intron variant	Likely benign	May 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+13G>C	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578784	16	2107192	16	2057191	3578784	3708204		NC_000016.10:2057190:G:C	single nucleotide variant	intron variant	Uncertain significance	May 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+13G>A	TSC2		Tuberous sclerosis 2	VCV001649189	16	2107192	16	2057191	1649189	1662841	rs1402619251	NC_000016.10:2057190:G:A	single nucleotide variant	intron variant	Likely benign	Oct 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+13G>T	TSC2		not specified|Tuberous sclerosis 2	VCV000507163	16	2107192	16	2057191	507163	505669	rs1402619251	NC_000016.10:2057190:G:T	single nucleotide variant	intron variant	Likely benign	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+14G>A	TSC2		Tuberous sclerosis 2	VCV003623626	16	2107193	16	2057192	3623626	3751426		NC_000016.10:2057191:G:A	single nucleotide variant	intron variant	Likely benign	Mar 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+14G>T	TSC2		Tuberous sclerosis 2	VCV003019953	16	2107193	16	2057192	3019953	3182820	rs1160175015	NC_000016.10:2057191:G:T	single nucleotide variant	intron variant	Likely benign	Oct 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+15T>G	TSC2		Tuberous sclerosis 2	VCV002156964	16	2107194	16	2057193	2156964	1883240	rs2548474946	NC_000016.10:2057192:T:G	single nucleotide variant	intron variant	Likely benign	May 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+16G>C	TSC2		Tuberous sclerosis 2	VCV002113150	16	2107195	16	2057194	2113150	2164438	rs1567411045	NC_000016.10:2057193:G:C	single nucleotide variant	intron variant	Likely benign	Mar 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+19G>T	TSC2		Tuberous sclerosis 2	VCV002856137	16	2107198	16	2057197	2856137	3007390	rs1044793633	NC_000016.10:2057196:G:T	single nucleotide variant	intron variant	Likely benign	Apr 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+19G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000517981	16	2107198	16	2057197	517981	505160	rs1044793633	NC_000016.10:2057196:G:A	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+20C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000508689	16	2107199	16	2057198	508689	505161	rs1459744028	NC_000016.10:2057197:C:T	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+113A>G	TSC2		not provided	VCV000676019	16	2107292	16	2057291	676019	668362	rs56077830	NC_000016.10:2057290:A:G	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+143G>T	TSC2		not provided	VCV001253034	16	2107322	16	2057321	1253034	1242978	rs78160478	NC_000016.10:2057320:G:T	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+276C>G	TSC2		not provided	VCV000669642	16	2107455	16	2057454	669642	668364	rs60154230	NC_000016.10:2057453:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Oct 11, 2019	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.848+281C>A	TSC2		Tuberous sclerosis 2	VCV003614496	16	2107460	16	2057459	3614496	3749191		NC_000016.10:2057458:C:A	single nucleotide variant	intron variant	Likely benign	Nov 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.848+281C>T	TSC2		Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049923	16	2107460	16	2057459	49923	59085	rs45517132	NC_000016.10:2057458:C:T	single nucleotide variant	intron variant	Pathogenic	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.849-323G>A	TSC2		not provided	VCV001223449	16	2108425	16	2058424	1223449	1211270	rs113694289	NC_000016.10:2058423:G:A	single nucleotide variant	intron variant	Likely benign	Jun 28, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-19C>T	TSC2		Tuberous sclerosis 2	VCV001584110	16	2108729	16	2058728	1584110	1528556	rs2151104623	NC_000016.10:2058727:C:T	single nucleotide variant	intron variant	Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.849-18T>C	TSC2		Tuberous sclerosis 2	VCV002782233	16	2108730	16	2058729	2782233	2944675	rs1464990066	NC_000016.10:2058728:T:C	single nucleotide variant	intron variant	Likely benign	Nov 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-17C>A	TSC2		Tuberous sclerosis 2	VCV001662761	16	2108731	16	2058730	1662761	1555567	rs45517133	NC_000016.10:2058729:C:A	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-17C>T	TSC2		Tuberous sclerosis 2	VCV000049400	16	2108731	16	2058730	49400	58562	rs45517133	NC_000016.10:2058729:C:T	single nucleotide variant	intron variant	Likely benign	Jul 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-16T>C	TSC2		Tuberous sclerosis 2	VCV001666081	16	2108732	16	2058731	1666081	1655810	rs1355739947	NC_000016.10:2058730:T:C	single nucleotide variant	intron variant	Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.849-14G>T	TSC2		Tuberous sclerosis 2	VCV004071099	16	2108734	16	2058733	4071099	4184947		NC_000016.10:2058732:G:T	single nucleotide variant	intron variant	Likely benign	May 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-13G>A	TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000318308	16	2108735	16	2058734	318308	324604	rs886051787	NC_000016.10:2058733:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.849-12G>A	TSC2		Tuberous sclerosis 2	VCV001604872	16	2108736	16	2058735	1604872	1624026	rs2151104844	NC_000016.10:2058734:G:A	single nucleotide variant	intron variant	Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.849-11A>G	TSC2		Tuberous sclerosis 2	VCV002808517	16	2108737	16	2058736	2808517	2968319	rs1442386641	NC_000016.10:2058735:A:G	single nucleotide variant	intron variant	Likely benign	Aug 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-10A>G	TSC2		Tuberous sclerosis 2	VCV000965826	16	2108738	16	2058737	965826	960839	rs1596288175	NC_000016.10:2058736:A:G	single nucleotide variant	intron variant	Uncertain significance	Feb 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-10A>T	TSC2		Tuberous sclerosis 2	VCV000743696	16	2108738	16	2058737	743696	760420	rs1596288175	NC_000016.10:2058736:A:T	single nucleotide variant	intron variant	Likely benign	Jan 29, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-9C>T	TSC2		Tuberous sclerosis 2	VCV001135897	16	2108739	16	2058738	1135897	1125020	rs1353108408	NC_000016.10:2058737:C:T	single nucleotide variant	intron variant	Likely benign	May 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-8A>T	TSC2		Tuberous sclerosis 2	VCV003645909	16	2108740	16	2058739	3645909	3780484		NC_000016.10:2058738:A:T	single nucleotide variant	intron variant	Likely benign	Mar 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-8A>G	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000281378	16	2108740	16	2058739	281378	265615	rs765336852	NC_000016.10:2058738:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.849-7C>G	TSC2		not provided	VCV003257370	16	2108741	16	2058740	3257370	3416124		NC_000016.10:2058739:C:G	single nucleotide variant	intron variant	Uncertain significance	Aug 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-7C>T	TSC2		Tuberous sclerosis 2	VCV002826086	16	2108741	16	2058740	2826086	2979479	rs2548493776	NC_000016.10:2058739:C:T	single nucleotide variant	intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-6T>G	TSC2		Tuberous sclerosis 2|not specified	VCV000256638	16	2108742	16	2058741	256638	255487	rs886038358	NC_000016.10:2058740:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.849-4T>G	TSC2		Tuberous sclerosis 2	VCV001990540	16	2108744	16	2058743	1990540	2044479	rs752614339	NC_000016.10:2058742:T:G	single nucleotide variant	intron variant	Likely benign	Feb 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-4T>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000234027	16	2108744	16	2058743	234027	235093	rs752614339	NC_000016.10:2058742:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.849-3T>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535929	16	2108745	16	2058744	535929	530107	rs45489591	NC_000016.10:2058743:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.849-2A>C	TSC2		Tuberous sclerosis 2	VCV002701409	16	2108746	16	2058745	2701409	2862403	rs45517134	NC_000016.10:2058744:A:C	single nucleotide variant	splice acceptor variant	Pathogenic	Dec 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.849-1G>C	TSC2		Tuberous sclerosis 2	VCV000065091	16	2108747	16	2058746	65091	76022	rs45506396	NC_000016.10:2058745:G:C	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.849-1G>A	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000049388	16	2108747	16	2058746	49388	58550	rs45506396	NC_000016.10:2058745:G:A	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Oct 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.849A>C (p.Arg283Ser)	TSC2	R83S, R234S, R294S, R283S, R246S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000651988	16	2108748	16	2058747	651988	644166	rs1596288325	NC_000016.10:2058746:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.850G>A (p.Ala284Thr)	TSC2	A247T, A280T, A295T, A314T, A130T, A265T, A284T, A84T, A235T	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV002626435	16	2108749	16	2058748	2626435	2794201	rs2086222827	NC_000016.10:2058747:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.851C>A (p.Ala284Asp)	TSC2	A235D, A130D, A265D, A295D, A284D, A84D, A247D, A280D, A314D	Tuberous sclerosis 2	VCV001983672	16	2108750	16	2058749	1983672	2042827	rs1195702502	NC_000016.10:2058748:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.851C>T (p.Ala284Val)	TSC2	A247V, A84V, A235V, A284V, A295V	Tuberous sclerosis 2	VCV001496332	16	2108750	16	2058749	1496332	1359364	rs1195702502	NC_000016.10:2058748:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.851C>G (p.Ala284Gly)	TSC2	A235G, A247G, A284G, A295G, A84G	Tuberous sclerosis 2	VCV001007888	16	2108750	16	2058749	1007888	996695	rs1195702502	NC_000016.10:2058748:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.852C>G (p.Ala284=)	TSC2		Tuberous sclerosis 2	VCV002756334	16	2108751	16	2058750	2756334	2914479	rs1555499631	NC_000016.10:2058749:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jun 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.852C>T (p.Ala284=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468190	16	2108751	16	2058750	468190	465737	rs1555499631	NC_000016.10:2058749:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.853T>G (p.Tyr285Asp)	TSC2	Y131D, Y236D, Y248D, Y266D, Y285D, Y281D, Y296D, Y315D, Y85D	Tuberous sclerosis 2	VCV002769305	16	2108752	16	2058751	2769305	2923580	rs2151105378	NC_000016.10:2058750:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.853T>C (p.Tyr285His)	TSC2	Y248H, Y281H, Y285H, Y85H, Y131H, Y236H, Y266H, Y296H, Y315H	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002156333	16	2108752	16	2058751	2156333	1886005	rs2151105378	NC_000016.10:2058750:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.854A>G (p.Tyr285Cys)	TSC2	Y315C, Y236C, Y248C, Y285C, Y296C, Y131C, Y266C, Y281C, Y85C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001763805	16	2108753	16	2058752	1763805	1820671	rs2548494072	NC_000016.10:2058751:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.855C>G (p.Tyr285Ter)	TSC2	Y236*, Y248*, Y285*, Y296*, Y85*	not provided	VCV001330490	16	2108754	16	2058753	1330490	1321169	rs794726983	NC_000016.10:2058752:C:G	single nucleotide variant	nonsense	Pathogenic	Feb 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.855C>T (p.Tyr285=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000193602	16	2108754	16	2058753	193602	190765	rs794726983	NC_000016.10:2058752:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.856A>C (p.Met286Leu)	TSC2	M282L, M286L, M297L, M267L, M132L, M237L, M249L, M86L, M316L	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002829520	16	2108755	16	2058754	2829520	2980349	rs1800748	NC_000016.10:2058753:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.856A>T (p.Met286Leu)	TSC2	M132L, M237L, M249L, M297L, M316L, M282L, M267L, M286L, M86L	Hereditary cancer-predisposing syndrome	VCV002564640	16	2108755	16	2058754	2564640	2733796	rs1800748	NC_000016.10:2058753:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.856A>G (p.Met286Val)	TSC2	M286V, M249V, M86V, M297V, M237V	not specified|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000050009	16	2108755	16	2058754	50009	59171	rs1800748	NC_000016.10:2058753:A:G	single nucleotide variant	missense variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.857T>C (p.Met286Thr)	TSC2	M286T, M297T, M249T, M86T, M237T	not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000050010	16	2108756	16	2058755	50010	59172	rs45517136	NC_000016.10:2058754:T:C	single nucleotide variant	missense variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.859G>A (p.Glu287Lys)	TSC2	E287K, E250K, E238K, E87K, E298K	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000567506	16	2108758	16	2058757	567506	569620	rs397515300	NC_000016.10:2058756:G:A	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.861G>A (p.Glu287=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome	VCV000385281	16	2108760	16	2058759	385281	375116	rs192567788	NC_000016.10:2058758:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.861G>C (p.Glu287Asp)	TSC2	E287D, E238D, E250D, E87D, E298D	Hereditary cancer-predisposing syndrome|not specified|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000238095	16	2108760	16	2058759	238095	242220	rs192567788	NC_000016.10:2058758:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.862G>T (p.Asp288Tyr)	TSC2	D134Y, D88Y, D269Y, D284Y, D299Y, D318Y, D239Y, D251Y, D288Y	Tuberous sclerosis 2|not specified	VCV002836373	16	2108761	16	2058760	2836373	2992360	rs1555499648	NC_000016.10:2058759:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.862G>A (p.Asp288Asn)	TSC2	D288N, D299N, D88N, D251N, D239N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535879	16	2108761	16	2058760	535879	529877	rs1555499648	NC_000016.10:2058759:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.864C>G (p.Asp288Glu)	TSC2	D288E, D251E, D239E, D299E, D88E	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535930	16	2108763	16	2058762	535930	529567	rs780887572	NC_000016.10:2058761:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.864C>T (p.Asp288=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000413646	16	2108763	16	2058762	413646	401414	rs780887572	NC_000016.10:2058761:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.865G>C (p.Ala289Pro)	TSC2	A270P, A252P, A285P, A289P, A319P, A89P, A135P, A300P, A240P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV002134313	16	2108764	16	2058763	2134313	2187032	rs750060649	NC_000016.10:2058762:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.865G>A (p.Ala289Thr)	TSC2	A289T, A89T, A252T, A240T, A300T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000842589	16	2108764	16	2058763	842589	843338	rs750060649	NC_000016.10:2058762:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.866C>A (p.Ala289Glu)	TSC2	A135E, A300E, A319E, A270E, A285E, A289E, A89E, A240E, A252E	Tuberous sclerosis 2	VCV002745522	16	2108765	16	2058764	2745522	2907580	rs755631210	NC_000016.10:2058763:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.866C>T (p.Ala289Val)	TSC2	A289V, A240V, A252V, A300V, A89V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207707	16	2108765	16	2058764	207707	203101	rs755631210	NC_000016.10:2058763:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.867G>C (p.Ala289=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001538123	16	2108766	16	2058765	1538123	1619349	rs375163125	NC_000016.10:2058764:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.867G>T (p.Ala289=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468191	16	2108766	16	2058765	468191	465741	rs375163125	NC_000016.10:2058764:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.867G>A (p.Ala289=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000230383	16	2108766	16	2058765	230383	235094	rs375163125	NC_000016.10:2058764:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.868C>T (p.Pro290Ser)	TSC2	P136S, P253S, P290S, P286S, P241S, P271S, P301S, P320S, P90S	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578785	16	2108767	16	2058766	3578785	3708205		NC_000016.10:2058765:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.869C>G (p.Pro290Arg)	TSC2	P136R, P241R, P253R, P271R, P286R, P290R, P301R, P320R, P90R	Hereditary cancer-predisposing syndrome	VCV003232209	16	2108768	16	2058767	3232209	3392010	rs2151106083	NC_000016.10:2058766:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.869C>T (p.Pro290Leu)	TSC2	P290L, P90L, P241L, P253L, P301L	Tuberous sclerosis 2	VCV001468326	16	2108768	16	2058767	1468326	1362570	rs2151106083	NC_000016.10:2058766:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.870C>T (p.Pro290=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001594258	16	2108769	16	2058768	1594258	1568262	rs1166082765	NC_000016.10:2058767:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.871C>A (p.Leu291Met)	TSC2	L272M, L287M, L291M, L137M, L242M, L254M, L302M, L321M, L91M	Hereditary cancer-predisposing syndrome	VCV003462592	16	2108770	16	2058769	3462592	3621611		NC_000016.10:2058768:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.871C>G (p.Leu291Val)	TSC2	L242V, L302V, L254V, L291V, L91V	Tuberous sclerosis 2	VCV001521514	16	2108770	16	2058769	1521514	1347409	rs45517137	NC_000016.10:2058768:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.871C>T (p.Leu291=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049391	16	2108770	16	2058769	49391	58553	rs45517137	NC_000016.10:2058768:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.873G>A (p.Leu291=)	TSC2		Tuberous sclerosis 2	VCV002695776	16	2108772	16	2058771	2695776	2864463	rs2151106237	NC_000016.10:2058770:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.874C>T (p.Leu292=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000760127	16	2108773	16	2058772	760127	770675	rs1031153520	NC_000016.10:2058771:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.875T>C (p.Leu292Pro)	TSC2	L292P, L255P, L303P, L243P, L92P	Tuberous sclerosis 2	VCV000049933	16	2108774	16	2058773	49933	59095	rs45517138	NC_000016.10:2058772:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.876G>T (p.Leu292=)	TSC2		Tuberous sclerosis 2	VCV003019434	16	2108775	16	2058774	3019434	3171942	rs2151106335	NC_000016.10:2058773:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.878G>A (p.Arg293Lys)	TSC2	R304K, R256K, R293K, R244K, R93K	Tuberous sclerosis 2	VCV001522364	16	2108777	16	2058776	1522364	1369308	rs2151106417	NC_000016.10:2058775:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.879A>T (p.Arg293Ser)	TSC2	R323S, R256S, R289S, R139S, R304S, R244S, R274S, R293S, R93S	Hereditary cancer-predisposing syndrome	VCV002454942	16	2108778	16	2058777	2454942	2430691	rs369222477	NC_000016.10:2058776:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.879A>G (p.Arg293=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000701704	16	2108778	16	2058777	701704	688537	rs369222477	NC_000016.10:2058776:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.880G>A (p.Gly294Arg)	TSC2	G294R, G245R, G305R, G257R, G94R	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000049402	16	2108779	16	2058778	49402	58564	rs45517139	NC_000016.10:2058777:G:A	single nucleotide variant	missense variant	Pathogenic	Oct 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.883G>C (p.Ala295Pro)	TSC2	A258P, A306P, A325P, A246P, A276P, A95P, A141P, A291P, A295P	Tuberous sclerosis 2	VCV002746311	16	2108782	16	2058781	2746311	2911821	rs2151106561	NC_000016.10:2058780:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.884C>A (p.Ala295Asp)	TSC2	A258D, A295D, A246D, A306D, A95D	Tuberous sclerosis 2	VCV001513132	16	2108783	16	2058782	1513132	1472187	rs1596288578	NC_000016.10:2058781:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 16, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.884C>T (p.Ala295Val)	TSC2	A258V, A95V, A246V, A306V, A295V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000822773	16	2108783	16	2058782	822773	812493	rs1596288578	NC_000016.10:2058781:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.885C>T (p.Ala295=)	TSC2		not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000511557	16	2108784	16	2058783	511557	505166	rs778296481	NC_000016.10:2058782:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.886G>T (p.Val296Leu)	TSC2	V96L, V296L, V259L, V307L, V247L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000849839	16	2108785	16	2058784	849839	843339	rs747237113	NC_000016.10:2058783:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.886G>A (p.Val296Met)	TSC2	V296M, V307M, V96M, V247M, V259M	Tuberous sclerosis 2|Cortical tubers|Hereditary cancer-predisposing syndrome|not provided|Lymphangiomyomatosis	VCV000374159	16	2108785	16	2058784	374159	360985	rs747237113	NC_000016.10:2058783:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.888G>A (p.Val296=)	TSC2		Tuberous sclerosis 2	VCV003693313	16	2108787	16	2058786	3693313	3824648		NC_000016.10:2058785:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	May 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.890T>G (p.Phe297Cys)	TSC2	F297C, F248C, F260C, F308C, F97C	not provided	VCV000593080	16	2108789	16	2058788	593080	584144	rs1567415441	NC_000016.10:2058787:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.891T>G (p.Phe297Leu)	TSC2	F278L, F97L, F293L, F308L, F143L, F260L, F297L, F327L, F248L	Hereditary cancer-predisposing syndrome	VCV001765128	16	2108790	16	2058789	1765128	1824622	rs2151106824	NC_000016.10:2058788:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.893T>C (p.Phe298Ser)	TSC2	F298S, F309S, F249S, F261S, F98S	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000283532	16	2108792	16	2058791	283532	267769	rs747310967	NC_000016.10:2058790:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.895G>T (p.Val299Leu)	TSC2	V262L, V329L, V280L, V310L, V99L, V145L, V250L, V295L, V299L	Hereditary cancer-predisposing syndrome	VCV002397674	16	2108794	16	2058793	2397674	2378964	rs2151106890	NC_000016.10:2058792:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.897G>A (p.Val299=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000945310	16	2108796	16	2058795	945310	927623	rs1382139812	NC_000016.10:2058794:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.898G>T (p.Gly300Cys)	TSC2	G100C, G251C, G281C, G146C, G296C, G311C, G330C, G263C, G300C	Tuberous sclerosis 2	VCV001999465	16	2108797	16	2058796	1999465	2057399	rs2151107014	NC_000016.10:2058795:G:T	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.899G>A (p.Gly300Asp)	TSC2	G263D, G330D, G100D, G146D, G281D, G311D, G251D, G300D, G296D	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578786	16	2108798	16	2058797	3578786	3708206		NC_000016.10:2058796:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.900C>T (p.Gly300=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000952707	16	2108799	16	2058798	952707	927624	rs1415187475	NC_000016.10:2058797:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.901A>T (p.Met301Leu)	TSC2	M282L, M252L, M297L, M301L, M312L, M101L, M147L, M264L, M331L	Tuberous sclerosis 2	VCV003686513	16	2108800	16	2058799	3686513	3812656		NC_000016.10:2058798:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.901A>C (p.Met301Leu)	TSC2	M264L, M301L, M252L, M101L, M312L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001037501	16	2108800	16	2058799	1037501	1032431	rs1356498946	NC_000016.10:2058798:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.901A>G (p.Met301Val)	TSC2	M101V, M252V, M264V, M312V, M301V	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000742825	16	2108800	16	2058799	742825	754978	rs1356498946	NC_000016.10:2058798:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.902T>A (p.Met301Lys)	TSC2	M101K, M147K, M252K, M264K, M282K, M297K, M301K, M312K, M331K	Tuberous sclerosis syndrome	VCV003070881	16	2108801	16	2058800	3070881	3230637	rs1060500949	NC_000016.10:2058799:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.902T>C (p.Met301Thr)	TSC2	M301T, M252T, M264T, M312T, M101T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406052	16	2108801	16	2058800	406052	401417	rs1060500949	NC_000016.10:2058799:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.905C>T (p.Ala302Val)	TSC2	A283V, A102V, A253V, A302V, A332V, A148V, A298V, A313V, A265V	Hereditary cancer-predisposing syndrome	VCV001765623	16	2108804	16	2058803	1765623	1821263	rs2151107275	NC_000016.10:2058802:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.905C>G (p.Ala302Gly)	TSC2	A253G, A302G, A265G, A102G, A313G	Tuberous sclerosis 2	VCV001351427	16	2108804	16	2058803	1351427	1407776	rs2151107275	NC_000016.10:2058802:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.906T>C (p.Ala302=)	TSC2		Tuberous sclerosis 2	VCV001621067	16	2108805	16	2058804	1621067	1615315	rs2151107335	NC_000016.10:2058803:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.907C>G (p.Leu303Val)	TSC2	L103V, L254V, L266V, L303V, L314V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001004114	16	2108806	16	2058805	1004114	996696	rs1060500943	NC_000016.10:2058804:C:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.907C>T (p.Leu303Phe)	TSC2	L303F, L103F, L254F, L314F, L266F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000406080	16	2108806	16	2058805	406080	400755	rs1060500943	NC_000016.10:2058804:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.907C>A (p.Leu303Ile)	TSC2	L303I, L103I, L266I, L254I, L314I	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406034	16	2108806	16	2058805	406034	401161	rs1060500943	NC_000016.10:2058804:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.909C>G (p.Leu303=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232210	16	2108808	16	2058807	3232210	3392011	rs1433197017	NC_000016.10:2058806:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.909C>T (p.Leu303=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001129353	16	2108808	16	2058807	1129353	1125021	rs1433197017	NC_000016.10:2058806:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.910T>C (p.Trp304Arg)	TSC2	W304R, W315R, W267R, W104R, W255R	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|TSC2-related disorder|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000065143	16	2108809	16	2058808	65143	76074	rs397515108	NC_000016.10:2058807:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.911G>T (p.Trp304Leu)	TSC2	W104L, W150L, W255L, W267L, W285L, W300L, W304L, W315L, W334L	not provided	VCV001707363	16	2108810	16	2058809	1707363	1705672	rs45517140	NC_000016.10:2058808:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.911G>A (p.Trp304Ter)	TSC2	W304*, W255*, W104*, W267*, W315*	Tuberous sclerosis 2|TSC2-related disorder	VCV000049405	16	2108810	16	2058809	49405	58567	rs45517140	NC_000016.10:2058808:G:A	single nucleotide variant	nonsense	Pathogenic	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.912G>A (p.Trp304Ter)	TSC2	W304*, W267*, W255*, W104*, W315*	Tuberous sclerosis 2	VCV000064852	16	2108811	16	2058810	64852	75781	rs397514884	NC_000016.10:2058809:G:A	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.913G>A (p.Gly305Arg)	TSC2	G305R, G316R, G256R, G268R, G105R	Tuberous sclerosis 2	VCV000574339	16	2108812	16	2058811	574339	569621	rs1567415674	NC_000016.10:2058810:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.914G>T (p.Gly305Val)	TSC2	G105V, G316V, G256V, G268V, G305V	Tuberous sclerosis 2	VCV001372234	16	2108813	16	2058812	1372234	1443479	rs770137362	NC_000016.10:2058811:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.916G>C (p.Ala306Pro)	TSC2	A152P, A257P, A269P, A106P, A317P, A336P, A287P, A302P, A306P	Tuberous sclerosis 2	VCV003637178	16	2108815	16	2058814	3637178	3771332		NC_000016.10:2058813:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.916G>T (p.Ala306Ser)	TSC2	A152S, A302S, A317S, A257S, A269S, A306S, A287S, A106S, A336S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001973970	16	2108815	16	2058814	1973970	2026667	rs1215705768	NC_000016.10:2058813:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.917C>T (p.Ala306Val)	TSC2	A106V, A257V, A269V, A306V, A317V	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001022711	16	2108816	16	2058815	1022711	1011938	rs2086235107	NC_000016.10:2058814:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.918C>A (p.Ala306=)	TSC2		Tuberous sclerosis 2	VCV001673752	16	2108817	16	2058816	1673752	1649052	rs2151107825	NC_000016.10:2058815:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.918C>T (p.Ala306=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001093935	16	2108817	16	2058816	1093935	1081781	rs2151107825	NC_000016.10:2058815:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.919C>T (p.His307Tyr)	TSC2	H107Y, H258Y, H270Y, H307Y, H318Y	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV001304177	16	2108818	16	2058817	1304177	1294452	rs1279645051	NC_000016.10:2058816:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.921C>A (p.His307Gln)	TSC2	H337Q, H270Q, H303Q, H153Q, H258Q, H288Q, H107Q, H307Q, H318Q	Tuberous sclerosis 2	VCV002057881	16	2108820	16	2058819	2057881	2113168	rs878854121	NC_000016.10:2058818:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.921C>T (p.His307=)	TSC2		Tuberous sclerosis 2	VCV001148660	16	2108820	16	2058819	1148660	1145899	rs878854121	NC_000016.10:2058818:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.921C>G (p.His307Gln)	TSC2	H307Q, H258Q, H107Q, H270Q, H318Q	TSC2-related disorder|not provided|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000238096	16	2108820	16	2058819	238096	242221	rs878854121	NC_000016.10:2058818:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 31, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.922C>T (p.Arg308Trp)	TSC2	R308W, R108W, R259W, R271W, R319W	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000405962	16	2108821	16	2058820	405962	400669	rs201144475	NC_000016.10:2058819:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.922C>G (p.Arg308Gly)	TSC2	R308G, R319G, R108G, R271G, R259G	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000041750	16	2108821	16	2058820	41750	50189	rs201144475	NC_000016.10:2058819:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.923G>T (p.Arg308Leu)	TSC2	R271L, R319L, R154L, R304L, R108L, R259L, R289L, R308L, R338L	Hereditary cancer-predisposing syndrome	VCV002449989	16	2108822	16	2058821	2449989	2425946	rs1213252028	NC_000016.10:2058820:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.923G>A (p.Arg308Gln)	TSC2	R308Q, R108Q, R259Q, R319Q, R271Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000823124	16	2108822	16	2058821	823124	812494	rs1213252028	NC_000016.10:2058820:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.924G>T (p.Arg308=)	TSC2		Tuberous sclerosis 2	VCV003702892	16	2108823	16	2058822	3702892	3838943		NC_000016.10:2058821:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.925C>G (p.Leu309Val)	TSC2	L272V, L260V, L305V, L309V, L320V, L109V, L155V, L290V, L339V	Hereditary cancer-predisposing syndrome	VCV003329498	16	2108824	16	2058823	3329498	3489090		NC_000016.10:2058822:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.925C>T (p.Leu309Phe)	TSC2	L309F, L109F, L260F, L272F, L320F	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000468192	16	2108824	16	2058823	468192	466039	rs1258567486	NC_000016.10:2058822:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.926T>C (p.Leu309Pro)	TSC2	L109P, L260P, L272P, L309P, L320P	not provided	VCV001201412	16	2108825	16	2058824	1201412	1191766	rs75348431	NC_000016.10:2058823:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.926T>A (p.Leu309His)	TSC2	L309H, L260H, L272H, L109H, L320H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000757415	16	2108825	16	2058824	757415	770676	rs75348431	NC_000016.10:2058823:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.927C>A (p.Leu309=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564663	16	2108826	16	2058825	2564663	2733819	rs79786059	NC_000016.10:2058824:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.927C>T (p.Leu309=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000823140	16	2108826	16	2058825	823140	812495	rs79786059	NC_000016.10:2058824:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.927C>G (p.Leu309=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000757416	16	2108826	16	2058825	757416	770677	rs79786059	NC_000016.10:2058824:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.929A>C (p.Tyr310Ser)	TSC2	Y261S, Y310S, Y340S, Y110S, Y156S, Y291S, Y273S, Y306S, Y321S	Hereditary cancer-predisposing syndrome	VCV003462697	16	2108828	16	2058827	3462697	3617823		NC_000016.10:2058826:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.929A>T (p.Tyr310Phe)	TSC2	Y310F, Y321F, Y110F, Y273F, Y261F	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000577044	16	2108828	16	2058827	577044	570063	rs878854122	NC_000016.10:2058826:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.929A>G (p.Tyr310Cys)	TSC2	Y310C, Y321C, Y110C, Y261C, Y273C	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000238097	16	2108828	16	2058827	238097	242222	rs878854122	NC_000016.10:2058826:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.930T>C (p.Tyr310=)	TSC2		Tuberous sclerosis syndrome	VCV003073661	16	2108829	16	2058828	3073661	3232531	rs886041758	NC_000016.10:2058827:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Oct 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.930T>A (p.Tyr310Ter)	TSC2	Y310*, Y110*, Y261*, Y273*, Y321*	not provided	VCV000280581	16	2108829	16	2058828	280581	264608	rs886041758	NC_000016.10:2058827:T:A	single nucleotide variant	nonsense	Pathogenic	Aug 1, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.931T>C (p.Ser311Pro)	TSC2	S111P, S262P, S307P, S311P, S322P, S341P, S157P, S274P, S292P	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001766569	16	2108830	16	2058829	1766569	1824812	rs775590764	NC_000016.10:2058828:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.931T>A (p.Ser311Thr)	TSC2	S111T, S262T, S274T, S311T, S322T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001009767	16	2108830	16	2058829	1009767	996697	rs775590764	NC_000016.10:2058828:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.932C>T (p.Ser311Phe)	TSC2	S274F, S311F, S111F, S322F, S262F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000839234	16	2108831	16	2058830	839234	843341	rs1475672414	NC_000016.10:2058829:C:T	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.932C>G (p.Ser311Cys)	TSC2	S322C, S262C, S274C, S311C, S111C	Tuberous sclerosis 2|not provided	VCV000661997	16	2108831	16	2058830	661997	644167	rs1475672414	NC_000016.10:2058829:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.933T>A (p.Ser311=)	TSC2		Tuberous sclerosis 2	VCV004071254	16	2108832	16	2058831	4071254	4185102		NC_000016.10:2058830:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.933T>G (p.Ser311=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000793984	16	2108832	16	2058831	793984	785182	rs1596289005	NC_000016.10:2058830:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.934C>T (p.Leu312Phe)	TSC2	L312F, L263F, L112F, L275F, L323F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000405963	16	2108833	16	2058832	405963	400759	rs755368431	NC_000016.10:2058831:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.934C>G (p.Leu312Val)	TSC2	L312V, L323V, L112V, L263V, L275V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000186143	16	2108833	16	2058832	186143	184118	rs755368431	NC_000016.10:2058831:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.936C>A (p.Leu312=)	TSC2		Tuberous sclerosis 2	VCV004071058	16	2108835	16	2058834	4071058	4184906		NC_000016.10:2058833:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.936C>G (p.Leu312=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001158102	16	2108835	16	2058834	1158102	1145900	rs2086239603	NC_000016.10:2058833:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.936C>T (p.Leu312=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001142488	16	2108835	16	2058834	1142488	1145901	rs2086239603	NC_000016.10:2058833:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.937A>T (p.Arg313Trp)	TSC2	R264W, R276W, R324W, R113W, R313W	Tuberous sclerosis 2	VCV001044390	16	2108836	16	2058835	1044390	1032432	rs2086239979	NC_000016.10:2058834:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.938G>A (p.Arg313Lys)	TSC2	R294K, R313K, R113K, R159K, R264K, R276K, R343K, R309K, R324K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001766768	16	2108837	16	2058836	1766768	1825011	rs2151108833	NC_000016.10:2058835:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 16, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.939G>C (p.Arg313Ser)	TSC2	R324S, R264S, R276S, R313S, R113S, R294S, R159S, R309S, R343S	Tuberous sclerosis 2	VCV003637179	16	2108838	16	2058837	3637179	3771333		NC_000016.10:2058836:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.941A>G (p.Asn314Ser)	TSC2	N314S, N325S, N265S, N114S, N277S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238098	16	2108840	16	2058839	238098	242223	rs878854123	NC_000016.10:2058838:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.942C>G (p.Asn314Lys)	TSC2	N277K, N314K, N265K, N325K, N114K, N310K, N160K, N295K, N344K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002823751	16	2108841	16	2058840	2823751	2982264	rs2086241050	NC_000016.10:2058839:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.943T>G (p.Ser315Ala)	TSC2	S161A, S296A, S315A, S278A, S311A, S115A, S266A, S326A, S345A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002108442	16	2108842	16	2058841	2108442	2159856	rs949801715	NC_000016.10:2058840:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.944C>G (p.Ser315Trp)	TSC2	S161W, S266W, S115W, S278W, S311W, S326W, S296W, S315W, S345W	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001766985	16	2108843	16	2058842	1766985	1825227	rs202082319	NC_000016.10:2058841:C:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.944C>T (p.Ser315Leu)	TSC2	S315L, S326L, S266L, S278L, S115L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000187173	16	2108843	16	2058842	187173	184119	rs202082319	NC_000016.10:2058841:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.945G>T (p.Ser315=)	TSC2		Tuberous sclerosis 2	VCV001612867	16	2108844	16	2058843	1612867	1663018	rs763948768	NC_000016.10:2058842:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.945G>A (p.Ser315=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000256639	16	2108844	16	2058843	256639	255488	rs763948768	NC_000016.10:2058842:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.947C>T (p.Pro316Leu)	TSC2	P327L, P267L, P316L, P116L, P279L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000651445	16	2108846	16	2058845	651445	644168	rs751490043	NC_000016.10:2058844:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.947C>A (p.Pro316Gln)	TSC2	P316Q, P327Q, P279Q, P267Q, P116Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000238099	16	2108846	16	2058845	238099	242224	rs751490043	NC_000016.10:2058844:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.948G>T (p.Pro316=)	TSC2		Tuberous sclerosis 2	VCV002112035	16	2108847	16	2058846	2112035	2160856	rs45517141	NC_000016.10:2058845:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	May 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.948G>A (p.Pro316=)	TSC2		Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified	VCV000049395	16	2108847	16	2058846	49395	58557	rs45517141	NC_000016.10:2058845:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.950C>T (p.Thr317Ile)	TSC2	T117I, T280I, T328I, T268I, T317I	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000660174	16	2108849	16	2058848	660174	644169	rs1596289105	NC_000016.10:2058847:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.951A>G (p.Thr317=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486633	16	2108850	16	2058849	486633	477285	rs767275578	NC_000016.10:2058848:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.953C>T (p.Ser318Phe)	TSC2	S318F, S269F, S329F, S118F, S281F	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000406116	16	2108852	16	2058851	406116	400760	rs1060500970	NC_000016.10:2058850:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.954T>C (p.Ser318=)	TSC2		Tuberous sclerosis 2	VCV002830267	16	2108853	16	2058852	2830267	2997745	rs1328588034	NC_000016.10:2058851:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.954T>A (p.Ser318=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000480821	16	2108853	16	2058852	480821	477311	rs1328588034	NC_000016.10:2058851:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.955G>A (p.Val319Met)	TSC2	V319M, V119M, V330M, V270M, V282M	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II	VCV000468193	16	2108854	16	2058853	468193	465190	rs1432086775	NC_000016.10:2058852:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.956T>A (p.Val319Glu)	TSC2	V319E, V282E, V270E, V330E, V119E	not specified	VCV000448742	16	2108855	16	2058854	448742	441780	rs1555499785	NC_000016.10:2058853:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.957G>A (p.Val319=)	TSC2		Tuberous sclerosis 2	VCV003672865	16	2108856	16	2058855	3672865	3805002		NC_000016.10:2058854:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.957G>T (p.Val319=)	TSC2		Tuberous sclerosis 2	VCV001557789	16	2108856	16	2058855	1557789	1540808	rs2086246062	NC_000016.10:2058854:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.960G>A (p.Leu320=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001137052	16	2108859	16	2058858	1137052	1125022	rs1131825	NC_000016.10:2058857:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.960G>T (p.Leu320Phe)	TSC2	L320F, L331F, L120F, L271F, L283F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049408	16	2108859	16	2058858	49408	58570	rs1131825	NC_000016.10:2058857:G:T	single nucleotide variant	missense variant	Uncertain significance	May 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.961C>T (p.Pro321Ser)	TSC2	P121S, P167S, P317S, P321S, P351S, P272S, P284S, P332S, P302S	Tuberous sclerosis 2	VCV003637180	16	2108860	16	2058859	3637180	3771334		NC_000016.10:2058858:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.961C>A (p.Pro321Thr)	TSC2	P284T, P302T, P272T, P321T, P121T, P167T, P332T, P317T, P351T	Tuberous sclerosis 2	VCV002024516	16	2108860	16	2058859	2024516	2077293	rs2151109725	NC_000016.10:2058858:C:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.962C>T (p.Pro321Leu)	TSC2	P121L, P321L, P284L, P332L, P272L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001409002	16	2108861	16	2058860	1409002	1496791	rs2151109772	NC_000016.10:2058859:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.965C>T (p.Ser322Leu)	TSC2	S273L, S285L, S333L, S122L, S322L	Tuberous sclerosis 2	VCV000852080	16	2108864	16	2058863	852080	843342	rs1345813917	NC_000016.10:2058862:C:T	single nucleotide variant	missense variant	Benign	Nov 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.966A>C (p.Ser322=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001157948	16	2108865	16	2058864	1157948	1145902	rs1236668149	NC_000016.10:2058863:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.967T>C (p.Phe323Leu)	TSC2	F323L, F286L, F123L, F169L, F304L, F319L, F353L, F274L, F334L	Tuberous sclerosis 2	VCV003637181	16	2108866	16	2058865	3637181	3771335		NC_000016.10:2058864:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.968T>G (p.Phe323Cys)	TSC2	F334C, F274C, F319C, F353C, F123C, F323C, F169C, F286C, F304C	Hereditary cancer-predisposing syndrome	VCV002564622	16	2108867	16	2058866	2564622	2733778	rs2548496968	NC_000016.10:2058865:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.969T>C (p.Phe323=)	TSC2		Tuberous sclerosis 2	VCV003619576	16	2108868	16	2058867	3619576	3756599		NC_000016.10:2058866:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.969T>G (p.Phe323Leu)	TSC2	F274L, F286L, F123L, F323L, F334L	Tuberous sclerosis 2	VCV001365680	16	2108868	16	2058867	1365680	1402547	rs2151109944	NC_000016.10:2058866:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.970T>C (p.Tyr324His)	TSC2	Y170H, Y324H, Y335H, Y305H, Y124H, Y275H, Y287H, Y320H, Y354H	Tuberous sclerosis 2	VCV002009593	16	2108869	16	2058868	2009593	2073957	rs2086247823	NC_000016.10:2058867:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.970T>G (p.Tyr324Asp)	TSC2	Y275D, Y287D, Y324D, Y124D, Y335D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000951298	16	2108869	16	2058868	951298	927625	rs2086247823	NC_000016.10:2058867:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.972C>T (p.Tyr324=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001638123	16	2108871	16	2058870	1638123	1560027	rs45517143	NC_000016.10:2058869:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.972C>A (p.Tyr324Ter)	TSC2	Y324*, Y124*, Y287*, Y335*, Y275*	Tuberous sclerosis 2	VCV000049946	16	2108871	16	2058870	49946	59108	rs45517143	NC_000016.10:2058869:C:A	single nucleotide variant	nonsense	Pathogenic	Aug 9, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.973C>T (p.Gln325Ter)	TSC2	Q325*, Q336*, Q276*, Q288*, Q125*	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000065130	16	2108872	16	2058871	65130	76061	rs397515097	NC_000016.10:2058870:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.974A>C (p.Gln325Pro)	TSC2	Q288P, Q125P, Q276P, Q325P, Q336P	Tuberous sclerosis 2	VCV000862284	16	2108873	16	2058872	862284	843343	rs2086248990	NC_000016.10:2058871:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.975G>C (p.Gln325His)	TSC2	Q325H, Q125H, Q276H, Q288H, Q336H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000566277	16	2108874	16	2058873	566277	569622	rs1567416259	NC_000016.10:2058872:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+1G>C	TSC2		Tuberous sclerosis 2	VCV003649418	16	2108875	16	2058874	3649418	3777380		NC_000016.10:2058873:G:C	single nucleotide variant	splice donor variant	Pathogenic	Apr 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+1G>T	TSC2		Tuberous sclerosis 2	VCV000064960	16	2108875	16	2058874	64960	75890	rs137854200	NC_000016.10:2058873:G:T	single nucleotide variant	splice donor variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+1G>A	TSC2		Tuberous sclerosis 2	VCV000049948	16	2108875	16	2058874	49948	59110	rs137854200	NC_000016.10:2058873:G:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+2T>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001074350	16	2108876	16	2058875	1074350	1063524	rs2151110209	NC_000016.10:2058874:T:C	single nucleotide variant	splice donor variant	Pathogenic	Jun 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+3A>G	TSC2		Tuberous sclerosis 2	VCV003017902	16	2108877	16	2058876	3017902	3171717	rs1131692179	NC_000016.10:2058875:A:G	single nucleotide variant	intron variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+5G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001768081	16	2108879	16	2058878	1768081	1825514	rs45458600	NC_000016.10:2058877:G:A	single nucleotide variant	intron variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+5G>C	TSC2		Tuberous sclerosis 2	VCV000065140	16	2108879	16	2058878	65140	76071	rs45458600	NC_000016.10:2058877:G:C	single nucleotide variant	intron variant	Uncertain significance	Oct 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+6G>A	TSC2		Tuberous sclerosis 2	VCV002850032	16	2108880	16	2058879	2850032	3005987	rs2151110322	NC_000016.10:2058878:G:A	single nucleotide variant	intron variant	Uncertain significance	Mar 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+7C>A	TSC2		Tuberous sclerosis 2	VCV000755240	16	2108881	16	2058880	755240	776482	rs372463702	NC_000016.10:2058879:C:A	single nucleotide variant	intron variant	Likely benign	Jan 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+7C>G	TSC2		not provided	VCV000738891	16	2108881	16	2058880	738891	760286	rs372463702	NC_000016.10:2058879:C:G	single nucleotide variant	intron variant	Likely benign	Jun 4, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+7C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000381254	16	2108881	16	2058880	381254	375122	rs372463702	NC_000016.10:2058879:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.975+8G>T	TSC2		Tuberous sclerosis 2	VCV001109107	16	2108882	16	2058881	1109107	1103615	rs137853984	NC_000016.10:2058880:G:T	single nucleotide variant	intron variant	Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+8G>A	TSC2		Tuberous sclerosis 2|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000049890	16	2108882	16	2058881	49890	59052	rs137853984	NC_000016.10:2058880:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+9G>T	TSC2		Tuberous sclerosis 2	VCV004071241	16	2108883	16	2058882	4071241	4185089		NC_000016.10:2058881:G:T	single nucleotide variant	intron variant	Likely benign	May 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+12T>C	TSC2		Tuberous sclerosis 2	VCV002840078	16	2108886	16	2058885	2840078	3003300	rs2548497374	NC_000016.10:2058884:T:C	single nucleotide variant	intron variant	Likely benign	Jun 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+13C>G	TSC2		Tuberous sclerosis 2	VCV001618805	16	2108887	16	2058886	1618805	1580938	rs200564575	NC_000016.10:2058885:C:G	single nucleotide variant	intron variant	Likely benign	Nov 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+13C>T	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000064946	16	2108887	16	2058886	64946	75876	rs200564575	NC_000016.10:2058885:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+14T>C	TSC2		Tuberous sclerosis 2	VCV002857299	16	2108888	16	2058887	2857299	3024792	rs2548497406	NC_000016.10:2058886:T:C	single nucleotide variant	intron variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+15G>C	TSC2		Tuberous sclerosis 2	VCV002760662	16	2108889	16	2058888	2760662	2921841	rs753334357	NC_000016.10:2058887:G:C	single nucleotide variant	intron variant	Likely benign	Sep 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+15G>A	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001670887	16	2108889	16	2058888	1670887	1605194	rs753334357	NC_000016.10:2058887:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+15G>T	TSC2		not provided|Tuberous sclerosis 2	VCV001551817	16	2108889	16	2058888	1551817	1520428	rs753334357	NC_000016.10:2058887:G:T	single nucleotide variant	intron variant	Likely benign	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+16T>C	TSC2		not specified|Tuberous sclerosis 2	VCV000511400	16	2108890	16	2058889	511400	505671	rs769084318	NC_000016.10:2058888:T:C	single nucleotide variant	intron variant	Likely benign	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+17G>A	TSC2		Tuberous sclerosis 2	VCV003668582	16	2108891	16	2058890	3668582	3803107		NC_000016.10:2058889:G:A	single nucleotide variant	intron variant	Likely benign	Sep 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+19G>A	TSC2		Tuberous sclerosis 2	VCV002048830	16	2108893	16	2058892	2048830	2114473	rs909473730	NC_000016.10:2058891:G:A	single nucleotide variant	intron variant	Likely benign	Jan 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+19G>T	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001584741	16	2108893	16	2058892	1584741	1560892	rs909473730	NC_000016.10:2058891:G:T	single nucleotide variant	intron variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.975+20C>T	TSC2		Tuberous sclerosis 2	VCV002813416	16	2108894	16	2058893	2813416	2969366	rs2151110614	NC_000016.10:2058892:C:T	single nucleotide variant	intron variant	Likely benign	Nov 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+45C>G	TSC2		Tuberous sclerosis 2	VCV001696450	16	2108919	16	2058918	1696450	1688852	rs373276095	NC_000016.10:2058917:C:G	single nucleotide variant	intron variant	Uncertain significance	Jun 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.975+214T>C	TSC2		not provided	VCV001197916	16	2109088	16	2059087	1197916	1188329	rs183097117	NC_000016.10:2059086:T:C	single nucleotide variant	intron variant	Likely benign	Jul 8, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-100C>G	TSC2		not provided|not specified|Tuberous sclerosis 2	VCV000675047	16	2110571	16	2060570	675047	668366	rs2074968	NC_000016.10:2060569:C:G	single nucleotide variant	intron variant	Benign	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.976-63G>A	TSC2		not provided	VCV000049906	16	2110608	16	2060607	49906	59068	rs12927333	NC_000016.10:2060606:G:A	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.976-44G>A	TSC2		not provided	VCV000675803	16	2110627	16	2060626	675803	668369	rs188449241	NC_000016.10:2060625:G:A	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-20T>C	TSC2		Tuberous sclerosis 2	VCV002796578	16	2110651	16	2060650	2796578	2955116	rs397515259	NC_000016.10:2060649:T:C	single nucleotide variant	intron variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-19G>A	TSC2		Tuberous sclerosis 2	VCV002121731	16	2110652	16	2060651	2121731	2176925	rs2151133698	NC_000016.10:2060650:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-18G>T	TSC2		Tuberous sclerosis 2	VCV002000373	16	2110653	16	2060652	2000373	2051007	rs2151133746	NC_000016.10:2060651:G:T	single nucleotide variant	intron variant	Uncertain significance	May 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-17C>T	TSC2		Tuberous sclerosis 2	VCV002097067	16	2110654	16	2060653	2097067	2153676	rs2151133787	NC_000016.10:2060652:C:T	single nucleotide variant	intron variant	Likely benign	Feb 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-17C>A	TSC2		Tuberous sclerosis 2	VCV001549882	16	2110654	16	2060653	1549882	1538836	rs2151133787	NC_000016.10:2060652:C:A	single nucleotide variant	intron variant	Likely benign	May 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-16C>G	TSC2		Tuberous sclerosis 2	VCV002994804	16	2110655	16	2060654	2994804	3148650	rs773016098	NC_000016.10:2060653:C:G	single nucleotide variant	intron variant	Likely benign	Jul 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-16C>T	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001588724	16	2110655	16	2060654	1588724	1641050	rs773016098	NC_000016.10:2060653:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.976-15G>C	TSC2		Tuberous sclerosis 2	VCV002149059	16	2110656	16	2060655	2149059	1877507	rs45517150	NC_000016.10:2060654:G:C	single nucleotide variant	intron variant	Likely benign	Feb 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-15G>A	TSC2		TSC2-related disorder|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome	VCV000049396	16	2110656	16	2060655	49396	58558	rs45517150	NC_000016.10:2060654:G:A	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.976-14G>C	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001588414	16	2110657	16	2060656	1588414	1574957	rs397515186	NC_000016.10:2060655:G:C	single nucleotide variant	intron variant	Likely benign	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.976-13G>A	TSC2		Tuberous sclerosis 2	VCV002005401	16	2110658	16	2060657	2005401	2052165	rs2151133923	NC_000016.10:2060656:G:A	single nucleotide variant	intron variant	Likely benign	Feb 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-12C>T	TSC2		Tuberous sclerosis 2	VCV001404932	16	2110659	16	2060658	1404932	1405693	rs760262673	NC_000016.10:2060657:C:T	single nucleotide variant	intron variant	Likely benign	Aug 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-11T>C	TSC2		Tuberous sclerosis 2	VCV004071108	16	2110660	16	2060659	4071108	4184956		NC_000016.10:2060658:T:C	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-10C>G	TSC2		Tuberous sclerosis 2	VCV001510970	16	2110661	16	2060660	1510970	1377785	rs765990217	NC_000016.10:2060659:C:G	single nucleotide variant	intron variant	Uncertain significance	Dec 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-10C>T	TSC2		Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000468194	16	2110661	16	2060660	468194	466041	rs765990217	NC_000016.10:2060659:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.976-10C>A	TSC2		not provided	VCV000431920	16	2110661	16	2060660	431920	426150	rs765990217	NC_000016.10:2060659:C:A	single nucleotide variant	intron variant	Likely pathogenic	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.976-9G>T	TSC2		Tuberous sclerosis 2	VCV002129560	16	2110662	16	2060661	2129560	2190984	rs367613848	NC_000016.10:2060660:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.976-9G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468195	16	2110662	16	2060661	468195	466045	rs367613848	NC_000016.10:2060660:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.976-8T>C	TSC2		Tuberous sclerosis 2	VCV001126503	16	2110663	16	2060662	1126503	1125024	rs2151134100	NC_000016.10:2060661:T:C	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.976-6T>A	TSC2		Tuberous sclerosis 2	VCV000852421	16	2110665	16	2060664	852421	852639	rs2086516048	NC_000016.10:2060663:T:A	single nucleotide variant	intron variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-5T>C	TSC2		Tuberous sclerosis 2	VCV001396965	16	2110666	16	2060665	1396965	1414839	rs2086516322	NC_000016.10:2060664:T:C	single nucleotide variant	intron variant	Uncertain significance	Jul 26, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-5T>A	TSC2		Tuberous sclerosis 2	VCV000847258	16	2110666	16	2060665	847258	851655	rs2086516322	NC_000016.10:2060664:T:A	single nucleotide variant	intron variant	Uncertain significance	Dec 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000382887	16	2110668	16	2060667	382887	377149	rs45517151	NC_000016.10:2060666:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.976-3C>G	TSC2		Hereditary cancer-predisposing syndrome	VCV000049904	16	2110668	16	2060667	49904	59066	rs45517151	NC_000016.10:2060666:C:G	single nucleotide variant	intron variant	Uncertain significance	Mar 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.976-1G>A	TSC2		Tuberous sclerosis 2	VCV000049397	16	2110670	16	2060669	49397	58559	rs45451199	NC_000016.10:2060668:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.978C>T (p.Ala326=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974625	16	2110673	16	2060672	3974625	4086448		NC_000016.10:2060671:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Mar 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.978C>G (p.Ala326=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000758668	16	2110673	16	2060672	758668	770678	rs1294670888	NC_000016.10:2060671:C:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.979A>G (p.Met327Val)	TSC2	M127V, M278V, M290V, M327V, M338V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001007500	16	2110674	16	2060673	1007500	996698	rs754596133	NC_000016.10:2060672:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.980T>G (p.Met327Arg)	TSC2	M327R, M278R, M290R, M323R, M308R, M338R, M357R, M127R, M173R	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV003892741	16	2110675	16	2060674	3892741	4008627		NC_000016.10:2060673:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.981G>A (p.Met327Ile)	TSC2	M278I, M327I, M173I, M357I, M127I, M290I, M308I, M323I, M338I	Hereditary cancer-predisposing syndrome	VCV003974662	16	2110676	16	2060675	3974662	4086485		NC_000016.10:2060674:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.982G>A (p.Ala328Thr)	TSC2	A128T, A174T, A279T, A291T, A309T, A324T, A328T, A339T, A358T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV003069225	16	2110677	16	2060676	3069225	3229852	rs45517152	NC_000016.10:2060675:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.983C>T (p.Ala328Val)	TSC2	A291V, A324V, A339V, A358V, A128V, A174V, A279V, A309V, A328V	Tuberous sclerosis 2	VCV002850925	16	2110678	16	2060677	2850925	3013280	rs2151134572	NC_000016.10:2060676:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.984A>C (p.Ala328=)	TSC2		Tuberous sclerosis 2	VCV002868812	16	2110679	16	2060678	2868812	3031001	rs2548519531	NC_000016.10:2060677:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.985T>A (p.Cys329Ser)	TSC2	C280S, C329S, C340S, C129S, C292S	Tuberous sclerosis 2	VCV001444218	16	2110680	16	2060679	1444218	1388183	rs2086518199	NC_000016.10:2060678:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.985T>C (p.Cys329Arg)	TSC2	C129R, C292R, C329R, C340R, C280R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000860699	16	2110680	16	2060679	860699	843344	rs2086518199	NC_000016.10:2060678:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.986G>A (p.Cys329Tyr)	TSC2	C129Y, C280Y, C292Y, C329Y, C340Y	Tuberous sclerosis 2	VCV001011619	16	2110681	16	2060680	1011619	996699	rs2086518389	NC_000016.10:2060679:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.988C>A (p.Pro330Thr)	TSC2	P311T, P326T, P341T, P176T, P281T, P130T, P330T, P293T, P360T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003637182	16	2110683	16	2060682	3637182	3771336		NC_000016.10:2060681:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.988C>T (p.Pro330Ser)	TSC2	P281S, P293S, P341S, P130S, P330S	Tuberous sclerosis 2	VCV001437183	16	2110683	16	2060682	1437183	1435753	rs2151134701	NC_000016.10:2060681:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.989C>G (p.Pro330Arg)	TSC2	P176R, P281R, P326R, P330R, P130R, P293R, P311R, P341R, P360R	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002912254	16	2110684	16	2060683	2912254	3073411	rs140910086	NC_000016.10:2060682:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.989C>T (p.Pro330Leu)	TSC2	P330L, P281L, P130L, P341L, P293L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000405950	16	2110684	16	2060683	405950	401165	rs140910086	NC_000016.10:2060682:C:T	single nucleotide variant	missense variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.990G>C (p.Pro330=)	TSC2		Tuberous sclerosis 2	VCV002032959	16	2110685	16	2060684	2032959	2079320	rs752141469	NC_000016.10:2060683:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.990G>A (p.Pro330=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000468196	16	2110685	16	2060684	468196	465853	rs752141469	NC_000016.10:2060683:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.991A>G (p.Asn331Asp)	TSC2	N331D, N131D, N294D, N282D, N342D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406128	16	2110686	16	2060685	406128	400763	rs1060500974	NC_000016.10:2060684:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 21, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.992A>G (p.Asn331Ser)	TSC2	N177S, N312S, N327S, N131S, N294S, N282S, N331S, N342S, N361S	Tuberous sclerosis 2	VCV003637183	16	2110687	16	2060686	3637183	3771337		NC_000016.10:2060685:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.993C>G (p.Asn331Lys)	TSC2	N131K, N282K, N331K, N177K, N294K, N312K, N342K, N327K, N361K	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001768665	16	2110688	16	2060687	1768665	1829074	rs45517153	NC_000016.10:2060686:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.993C>T (p.Asn331=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049969	16	2110688	16	2060687	49969	59131	rs45517153	NC_000016.10:2060686:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.994G>T (p.Glu332Ter)	TSC2	E132*, E313*, E332*, E178*, E283*, E328*, E295*, E343*, E362*	Tuberous sclerosis 2	VCV001998350	16	2110689	16	2060688	1998350	2054131	rs911600402	NC_000016.10:2060687:G:T	single nucleotide variant	nonsense	Pathogenic	May 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.994G>C (p.Glu332Gln)	TSC2	E132Q, E283Q, E295Q, E332Q, E343Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001694775	16	2110689	16	2060688	1694775	1687207	rs911600402	NC_000016.10:2060687:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.994G>A (p.Glu332Lys)	TSC2	E332K, E343K, E283K, E132K, E295K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468197	16	2110689	16	2060688	468197	465858	rs911600402	NC_000016.10:2060687:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.995A>T (p.Glu332Val)	TSC2	E178V, E132V, E283V, E295V, E328V, E313V, E332V, E343V, E362V	Hereditary cancer-predisposing syndrome	VCV002564664	16	2110690	16	2060689	2564664	2733820	rs2151135068	NC_000016.10:2060688:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.995A>G (p.Glu332Gly)	TSC2	E132G, E178G, E283G, E295G, E313G, E328G, E332G, E343G, E362G	Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II	VCV002413025	16	2110690	16	2060689	2413025	2401752	rs2151135068	NC_000016.10:2060688:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.996G>T (p.Glu332Asp)	TSC2	E132D, E178D, E295D, E343D, E362D, E283D, E313D, E328D, E332D	Hereditary cancer-predisposing syndrome	VCV002626431	16	2110691	16	2060690	2626431	2794197	rs757788971	NC_000016.10:2060689:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.996G>C (p.Glu332Asp)	TSC2	E343D, E295D, E132D, E283D, E332D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000823584	16	2110691	16	2060690	823584	812496	rs757788971	NC_000016.10:2060689:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.996G>A (p.Glu332=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536070	16	2110691	16	2060690	536070	529881	rs757788971	NC_000016.10:2060689:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.997G>A (p.Val333Met)	TSC2	V133M, V284M, V296M, V333M, V344M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001018136	16	2110692	16	2060691	1018136	1011939	rs1336741146	NC_000016.10:2060690:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.997G>T (p.Val333Leu)	TSC2	V333L, V284L, V344L, V133L, V296L	not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000468198	16	2110692	16	2060691	468198	465859	rs1336741146	NC_000016.10:2060690:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.998T>C (p.Val333Ala)	TSC2	V344A, V133A, V333A, V284A, V296A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000823592	16	2110693	16	2060692	823592	812497	rs781423177	NC_000016.10:2060691:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.999G>T (p.Val333=)	TSC2		Tuberous sclerosis 2	VCV001089604	16	2110694	16	2060693	1089604	1081783	rs746177025	NC_000016.10:2060692:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.999G>A (p.Val333=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001085218	16	2110694	16	2060693	1085218	1081782	rs746177025	NC_000016.10:2060692:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1000G>A (p.Val334Met)	TSC2	V134M, V285M, V297M, V334M, V345M	Tuberous sclerosis 2	VCV001001995	16	2110695	16	2060694	1001995	996700	rs2086521360	NC_000016.10:2060693:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1001T>C (p.Val334Ala)	TSC2	V334A, V297A, V345A, V134A, V285A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000065217	16	2110696	16	2060695	65217	76149	rs45484892	NC_000016.10:2060694:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1002G>T (p.Val334=)	TSC2		Tuberous sclerosis syndrome	VCV003074167	16	2110697	16	2060696	3074167	3231303	rs2151135280	NC_000016.10:2060695:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Oct 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1002G>A (p.Val334=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002711375	16	2110697	16	2060696	2711375	2878827	rs2151135280	NC_000016.10:2060695:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1004C>T (p.Ser335Phe)	TSC2	S335F, S135F, S286F, S298F, S346F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207709	16	2110699	16	2060698	207709	203102	rs45517144	NC_000016.10:2060697:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 7, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1004C>G (p.Ser335Cys)	TSC2	S335C, S298C, S135C, S346C, S286C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000049653	16	2110699	16	2060698	49653	58815	rs45517144	NC_000016.10:2060697:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1005C>T (p.Ser335=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000748557	16	2110700	16	2060699	748557	754979	rs397514924	NC_000016.10:2060698:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1005C>G (p.Ser335=)	TSC2		Tuberous sclerosis 2	VCV000064903	16	2110700	16	2060699	64903	75833	rs397514924	NC_000016.10:2060698:C:G	single nucleotide variant	synonymous variant	Benign	May 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1006T>C (p.Tyr336His)	TSC2	Y136H, Y287H, Y299H, Y347H, Y336H	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000935044	16	2110701	16	2060700	935044	937282	rs2086522579	NC_000016.10:2060699:T:C	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1007A>T (p.Tyr336Phe)	TSC2	Y136F, Y287F, Y299F, Y336F, Y347F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000647762	16	2110702	16	2060701	647762	644171	rs780378198	NC_000016.10:2060700:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1007A>G (p.Tyr336Cys)	TSC2	Y336C, Y287C, Y299C, Y136C, Y347C	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535893	16	2110702	16	2060701	535893	530113	rs780378198	NC_000016.10:2060700:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1010A>T (p.Glu337Val)	TSC2	E288V, E300V, E337V, E137V, E348V	Tuberous sclerosis 2	VCV000639561	16	2110705	16	2060704	639561	644172	rs1596298246	NC_000016.10:2060703:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1011G>C (p.Glu337Asp)	TSC2	E183D, E288D, E300D, E318D, E337D, E348D, E367D, E137D, E333D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV002876774	16	2110706	16	2060705	2876774	3036044	rs2151135622	NC_000016.10:2060704:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1012A>G (p.Ile338Val)	TSC2	I289V, I301V, I334V, I368V, I138V, I184V, I319V, I338V, I349V	Hereditary cancer-predisposing syndrome	VCV003974666	16	2110707	16	2060706	3974666	4086489		NC_000016.10:2060705:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1013T>G (p.Ile338Ser)	TSC2	I138S, I334S, I184S, I319S, I338S, I289S, I349S, I368S, I301S	Hereditary cancer-predisposing syndrome	VCV001737354	16	2110708	16	2060707	1737354	1790553	rs2151135695	NC_000016.10:2060706:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1014C>T (p.Ile338=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001110160	16	2110709	16	2060708	1110160	1103616	rs1250621196	NC_000016.10:2060707:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1014C>G (p.Ile338Met)	TSC2	I301M, I338M, I349M, I138M, I289M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000822012	16	2110709	16	2060708	822012	812498	rs1250621196	NC_000016.10:2060707:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1015G>C (p.Val339Leu)	TSC2	V339L, V302L, V139L, V350L, V290L	Tuberous sclerosis 2	VCV000577552	16	2110710	16	2060709	577552	570064	rs559727962	NC_000016.10:2060708:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1015G>A (p.Val339Ile)	TSC2	V339I, V302I, V350I, V290I, V139I	TSC2-related disorder|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000535974	16	2110710	16	2060709	535974	529885	rs559727962	NC_000016.10:2060708:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1017C>T (p.Val339=)	TSC2		Tuberous sclerosis syndrome	VCV003386159	16	2110712	16	2060711	3386159	3545300		NC_000016.10:2060710:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1017C>G (p.Val339=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003069559	16	2110712	16	2060711	3069559	3230184	rs1327205698	NC_000016.10:2060710:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1017C>A (p.Val339=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001747085	16	2110712	16	2060711	1747085	1802836	rs1327205698	NC_000016.10:2060710:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 18, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1018C>G (p.Leu340Val)	TSC2	L303V, L140V, L186V, L340V, L336V, L351V, L291V, L321V, L370V	Tuberous sclerosis 2	VCV002089964	16	2110713	16	2060712	2089964	2155634	rs2151135855	NC_000016.10:2060711:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1018C>T (p.Leu340=)	TSC2		Tuberous sclerosis 2	VCV001124604	16	2110713	16	2060712	1124604	1125025	rs2151135855	NC_000016.10:2060711:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1019T>C (p.Leu340Pro)	TSC2	L340P, L351P, L140P, L291P, L303P	Tuberous sclerosis 2	VCV000065264	16	2110714	16	2060713	65264	76196	rs397515192	NC_000016.10:2060712:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1020G>A (p.Leu340=)	TSC2		Tuberous sclerosis 2	VCV004071135	16	2110715	16	2060714	4071135	4184983		NC_000016.10:2060713:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1020G>T (p.Leu340=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002564624	16	2110715	16	2060714	2564624	2733780	rs2151135941	NC_000016.10:2060713:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1022C>T (p.Ser341Phe)	TSC2	S292F, S304F, S341F, S352F, S141F	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000847500	16	2110717	16	2060716	847500	843346	rs2086524884	NC_000016.10:2060715:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1023C>T (p.Ser341=)	TSC2		Tuberous sclerosis 2	VCV001110718	16	2110718	16	2060717	1110718	1103617	rs2086525075	NC_000016.10:2060716:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1024A>C (p.Ile342Leu)	TSC2	I142L, I188L, I293L, I305L, I323L, I338L, I342L, I353L, I372L	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV002679336	16	2110719	16	2060718	2679336	2836913	rs1060500913	NC_000016.10:2060717:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1024A>T (p.Ile342Phe)	TSC2	I142F, I293F, I305F, I342F, I353F	not provided	VCV001315477	16	2110719	16	2060718	1315477	1305737	rs1060500913	NC_000016.10:2060717:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1024A>G (p.Ile342Val)	TSC2	I342V, I293V, I142V, I305V, I353V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome	VCV000405948	16	2110719	16	2060718	405948	400673	rs1060500913	NC_000016.10:2060717:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1029C>A (p.Thr343=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000378773	16	2110724	16	2060723	378773	375128	rs45468201	NC_000016.10:2060722:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1029C>T (p.Thr343=)	TSC2		Tuberous sclerosis 2	VCV000049137	16	2110724	16	2060723	49137	58299	rs45468201	NC_000016.10:2060722:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1030A>G (p.Arg344Gly)	TSC2	R325G, R340G, R344G, R144G, R295G, R307G, R374G, R190G, R355G	Hereditary cancer-predisposing syndrome	VCV003811346	16	2110725	16	2060724	3811346	3928587		NC_000016.10:2060723:A:G	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Uncertain significance	Jan 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1031G>A (p.Arg344Lys)	TSC2	R144K, R307K, R355K, R374K, R190K, R325K, R340K, R295K, R344K	Tuberous sclerosis 2	VCV001974167	16	2110726	16	2060725	1974167	2023103	rs2151136294	NC_000016.10:2060724:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1032G>A (p.Arg344=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000391321	16	2110727	16	2060726	391321	374731	rs1057524033	NC_000016.10:2060725:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1033C>T (p.Leu345Phe)	TSC2	L345F, L356F, L145F, L296F, L308F	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000065196	16	2110728	16	2060727	65196	76128	rs397515146	NC_000016.10:2060726:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1034T>G (p.Leu345Arg)	TSC2	L345R, L145R, L296R, L356R, L308R	not provided	VCV000049138	16	2110729	16	2060728	49138	58300	rs45451295	NC_000016.10:2060727:T:G	single nucleotide variant	missense variant	Uncertain significance	May 23, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1035C>T (p.Leu345=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000764379	16	2110730	16	2060729	764379	770679	rs1476429068	NC_000016.10:2060728:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1035C>A (p.Leu345=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467837	16	2110730	16	2060729	467837	466048	rs1476429068	NC_000016.10:2060728:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1036A>C (p.Ile346Leu)	TSC2	I297L, I357L, I376L, I146L, I192L, I342L, I346L, I309L, I327L	Tuberous sclerosis 2	VCV003637184	16	2110731	16	2060730	3637184	3771338		NC_000016.10:2060729:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Benign	Apr 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1036A>T (p.Ile346Phe)	TSC2	I309F, I346F, I357F, I297F, I146F	Tuberous sclerosis 2	VCV000647936	16	2110731	16	2060730	647936	644173	rs768760795	NC_000016.10:2060729:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1036A>G (p.Ile346Val)	TSC2	I346V, I309V, I357V, I146V, I297V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406037	16	2110731	16	2060730	406037	401427	rs768760795	NC_000016.10:2060729:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1037T>C (p.Ile346Thr)	TSC2	I146T, I192T, I297T, I309T, I327T, I342T, I346T, I357T, I376T	Tuberous sclerosis syndrome	VCV003069226	16	2110732	16	2060731	3069226	3229853	rs2151136498	NC_000016.10:2060730:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1037T>A (p.Ile346Asn)	TSC2	I192N, I327N, I146N, I357N, I297N, I376N, I309N, I342N, I346N	Tuberous sclerosis 2	VCV002732728	16	2110732	16	2060731	2732728	2894056	rs2151136498	NC_000016.10:2060730:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Sep 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1038C>T (p.Ile346=)	TSC2		Tuberous sclerosis 2	VCV001643746	16	2110733	16	2060732	1643746	1651484	rs2086528091	NC_000016.10:2060731:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1038C>G (p.Ile346Met)	TSC2	I357M, I297M, I346M, I146M, I309M	Tuberous sclerosis 2	VCV000951592	16	2110733	16	2060732	951592	927626	rs2086528091	NC_000016.10:2060731:C:G	single nucleotide variant	missense variant	Uncertain significance	May 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1039A>G (p.Lys347Glu)	TSC2	K147E, K298E, K310E, K358E, K347E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000822067	16	2110734	16	2060733	822067	812499	rs1337295642	NC_000016.10:2060732:A:G	single nucleotide variant	missense variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1040A>G (p.Lys347Arg)	TSC2	K347R, K310R, K147R, K298R, K358R	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000064956	16	2110735	16	2060734	64956	75886	rs367963898	NC_000016.10:2060733:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1041G>A (p.Lys347=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002626458	16	2110736	16	2060735	2626458	2794224	rs1460919356	NC_000016.10:2060734:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1044G>A (p.Lys348=)	TSC2		Tuberous sclerosis 2	VCV001149819	16	2110739	16	2060738	1149819	1145903	rs2086529149	NC_000016.10:2060737:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1045T>C (p.Tyr349His)	TSC2	Y149H, Y312H, Y360H, Y349H, Y300H	Tuberous sclerosis 2	VCV001046206	16	2110740	16	2060739	1046206	1032433	rs2086529367	NC_000016.10:2060738:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1046A>T (p.Tyr349Phe)	TSC2	Y300F, Y149F, Y360F, Y312F, Y349F	Tuberous sclerosis 2	VCV000842128	16	2110741	16	2060740	842128	843347	rs1060500916	NC_000016.10:2060739:A:T	single nucleotide variant	missense variant	Uncertain significance	May 1, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1046A>G (p.Tyr349Cys)	TSC2	Y349C, Y360C, Y149C, Y312C, Y300C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000405959	16	2110741	16	2060740	405959	400771	rs1060500916	NC_000016.10:2060739:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1047T>C (p.Tyr349=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467841	16	2110742	16	2060741	467841	466049	rs1042628888	NC_000016.10:2060740:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1048A>T (p.Arg350Trp)	TSC2	R313W, R361W, R350W, R301W, R150W	Tuberous sclerosis 2	VCV001512441	16	2110743	16	2060742	1512441	1478691	rs2086530276	NC_000016.10:2060741:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1049G>A (p.Arg350Lys)	TSC2	R150K, R301K, R350K, R361K, R313K	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000950473	16	2110744	16	2060743	950473	927627	rs1567423240	NC_000016.10:2060742:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1050G>A (p.Arg350=)	TSC2		Tuberous sclerosis 2	VCV001118191	16	2110745	16	2060744	1118191	1103618	rs1371264521	NC_000016.10:2060743:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1051A>G (p.Lys351Glu)	TSC2	K151E, K302E, K314E, K351E, K362E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001019495	16	2110746	16	2060745	1019495	1011940	rs2086530884	NC_000016.10:2060744:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1052A>G (p.Lys351Arg)	TSC2	K351R, K151R, K314R, K362R, K302R	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000486650	16	2110747	16	2060746	486650	477312	rs748109163	NC_000016.10:2060745:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1053G>A (p.Lys351=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001622322	16	2110748	16	2060747	1622322	1561169	rs2151137077	NC_000016.10:2060746:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1054G>A (p.Glu352Lys)	TSC2	E315K, E352K, E152K, E303K, E363K	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000665304	16	2110749	16	2060748	665304	644174	rs1596298442	NC_000016.10:2060747:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1056G>C (p.Glu352Asp)	TSC2	E198D, E303D, E348D, E352D, E152D, E315D, E333D, E363D, E382D	Tuberous sclerosis 2	VCV003677812	16	2110751	16	2060750	3677812	3814130		NC_000016.10:2060749:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1057C>T (p.Leu353Phe)	TSC2	L153F, L316F, L353F, L304F, L364F	Tuberous sclerosis 2	VCV000835104	16	2110752	16	2060751	835104	843348	rs902767624	NC_000016.10:2060750:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1057C>G (p.Leu353Val)	TSC2	L353V, L364V, L153V, L304V, L316V	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000651839	16	2110752	16	2060751	651839	644175	rs902767624	NC_000016.10:2060750:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1058T>A (p.Leu353His)	TSC2	L199H, L304H, L153H, L316H, L383H, L334H, L349H, L353H, L364H	Hereditary cancer-predisposing syndrome	VCV002449965	16	2110753	16	2060752	2449965	2429590	rs2151137215	NC_000016.10:2060751:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1058T>C (p.Leu353Pro)	TSC2	L153P, L353P, L304P, L316P, L364P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001420485	16	2110753	16	2060752	1420485	1403093	rs2151137215	NC_000016.10:2060751:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1059C>A (p.Leu353=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001132323	16	2110754	16	2060753	1132323	1125026	rs796053472	NC_000016.10:2060752:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1059C>G (p.Leu353=)	TSC2		Hereditary cancer-predisposing syndrome	VCV000818293	16	2110754	16	2060753	818293	812500	rs796053472	NC_000016.10:2060752:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 12, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1059C>T (p.Leu353=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000207653	16	2110754	16	2060753	207653	203103	rs796053472	NC_000016.10:2060752:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1060C>T (p.Gln354Ter)	TSC2	Q354*, Q154*, Q305*, Q365*, Q317*	not provided|Tuberous sclerosis 2	VCV000049656	16	2110755	16	2060754	49656	58818	rs45469896	NC_000016.10:2060753:C:T	single nucleotide variant	nonsense	Pathogenic	Aug 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1061A>G (p.Gln354Arg)	TSC2	Q305R, Q317R, Q350R, Q384R, Q154R, Q354R, Q365R, Q200R, Q335R	Tuberous sclerosis 2	VCV002826162	16	2110756	16	2060755	2826162	2979555	rs1394071689	NC_000016.10:2060754:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1061A>T (p.Gln354Leu)	TSC2	Q350L, Q365L, Q305L, Q317L, Q335L, Q154L, Q200L, Q354L, Q384L	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002197582	16	2110756	16	2060755	2197582	1927163	rs1394071689	NC_000016.10:2060754:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1062G>C (p.Gln354His)	TSC2	Q305H, Q154H, Q317H, Q354H, Q365H	Tuberous sclerosis 2	VCV000951957	16	2110757	16	2060756	951957	927628	rs771943476	NC_000016.10:2060755:G:C	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1062G>A (p.Gln354=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000758973	16	2110757	16	2060756	758973	770680	rs771943476	NC_000016.10:2060755:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1063G>A (p.Val355Met)	TSC2	V201M, V336M, V355M, V366M, V306M, V351M, V155M, V318M, V385M	Tuberous sclerosis 2	VCV003706147	16	2110758	16	2060757	3706147	3839600		NC_000016.10:2060756:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1063G>T (p.Val355Leu)	TSC2	V155L, V306L, V318L, V201L, V366L, V385L, V351L, V355L, V336L	Hereditary cancer-predisposing syndrome	VCV001781112	16	2110758	16	2060757	1781112	1839380	rs2151137395	NC_000016.10:2060756:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1064T>G (p.Val355Gly)	TSC2	V155G, V201G, V306G, V318G, V336G, V351G, V355G, V366G, V385G	Tuberous sclerosis 2	VCV001721227	16	2110759	16	2060758	1721227	1772561	rs2548521939	NC_000016.10:2060757:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1065G>A (p.Val355=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002153207	16	2110760	16	2060759	2153207	1882069	rs2151137423	NC_000016.10:2060758:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 25, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1066G>C (p.Val356Leu)	TSC2	V356L, V319L, V367L, V156L, V307L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000135370	16	2110761	16	2060760	135370	139109	rs587778728	NC_000016.10:2060759:G:C	single nucleotide variant	missense variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1068G>A (p.Val356=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001547887	16	2110763	16	2060762	1547887	1537705	rs760584946	NC_000016.10:2060761:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1069G>C (p.Ala357Pro)	TSC2	A308P, A320P, A338P, A203P, A357P, A368P, A157P, A353P, A387P	Hereditary cancer-predisposing syndrome	VCV003462693	16	2110764	16	2060763	3462693	3621712		NC_000016.10:2060762:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1069G>A (p.Ala357Thr)	TSC2	A157T, A320T, A368T, A308T, A353T, A387T, A203T, A338T, A357T	Tuberous sclerosis 2	VCV002134181	16	2110764	16	2060763	2134181	2186900	rs2151137517	NC_000016.10:2060762:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1070C>A (p.Ala357Glu)	TSC2	A157E, A320E, A368E, A357E, A308E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001044925	16	2110765	16	2060764	1044925	1032434	rs150195368	NC_000016.10:2060763:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1070C>T (p.Ala357Val)	TSC2	A357V, A308V, A320V, A157V, A368V	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000041724	16	2110765	16	2060764	41724	50163	rs150195368	NC_000016.10:2060763:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1071G>T (p.Ala357=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001783657	16	2110766	16	2060765	1783657	1839753	rs776395163	NC_000016.10:2060764:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1071G>A (p.Ala357=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000237958	16	2110766	16	2060765	237958	242225	rs776395163	NC_000016.10:2060764:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1073G>T (p.Trp358Leu)	TSC2	W158L, W204L, W309L, W321L, W339L, W354L, W358L, W369L, W388L	Tuberous sclerosis 2	VCV003066179	16	2110768	16	2060767	3066179	3226192	rs2151137617	NC_000016.10:2060766:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1074G>C (p.Trp358Cys)	TSC2	W321C, W354C, W204C, W339C, W158C, W358C, W369C, W388C, W309C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002497440	16	2110769	16	2060768	2497440	2472523	rs1229561585	NC_000016.10:2060767:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 3, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1074G>A (p.Trp358Ter)	TSC2	W158*, W309*, W321*, W358*, W369*	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001074283	16	2110769	16	2060768	1074283	1063525	rs1229561585	NC_000016.10:2060767:G:A	single nucleotide variant	nonsense	Pathogenic	Jan 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1075G>A (p.Asp359Asn)	TSC2	D359N, D322N, D159N, D310N, D370N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001045515	16	2110770	16	2060769	1045515	1032435	rs2086534058	NC_000016.10:2060768:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1077C>A (p.Asp359Glu)	TSC2	D159E, D322E, D205E, D359E, D355E, D370E, D310E, D340E, D389E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001785123	16	2110772	16	2060771	1785123	1843768	rs1555500558	NC_000016.10:2060770:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1077C>T (p.Asp359=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000511330	16	2110772	16	2060771	511330	505673	rs1555500558	NC_000016.10:2060770:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1078A>T (p.Ile360Phe)	TSC2	I160F, I206F, I341F, I311F, I323F, I360F, I390F, I356F, I371F	Hereditary cancer-predisposing syndrome	VCV001785398	16	2110773	16	2060772	1785398	1840195	rs1555500560	NC_000016.10:2060771:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1078A>G (p.Ile360Val)	TSC2	I360V, I311V, I160V, I323V, I371V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467842	16	2110773	16	2060772	467842	465742	rs1555500560	NC_000016.10:2060771:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1080T>C (p.Ile360=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001147691	16	2110775	16	2060774	1147691	1145904	rs2086534827	NC_000016.10:2060773:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1080T>G (p.Ile360Met)	TSC2	I311M, I360M, I371M, I160M, I323M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000969552	16	2110775	16	2060774	969552	957670	rs2086534827	NC_000016.10:2060773:T:G	single nucleotide variant	missense variant	Uncertain significance	May 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1081C>A (p.Leu361Met)	TSC2	L207M, L312M, L324M, L357M, L372M, L161M, L342M, L361M, L391M	Hereditary cancer-predisposing syndrome	VCV003462575	16	2110776	16	2060775	3462575	3621594		NC_000016.10:2060774:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1081C>T (p.Leu361=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001692475	16	2110776	16	2060775	1692475	1684915	rs796053483	NC_000016.10:2060774:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 7, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1081C>G (p.Leu361Val)	TSC2	L361V, L161V, L372V, L312V, L324V	Hereditary cancer-predisposing syndrome|Autism spectrum disorder|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000207710	16	2110776	16	2060775	207710	203104	rs796053483	NC_000016.10:2060774:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1083G>A (p.Leu361=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000391560	16	2110778	16	2060777	391560	374732	rs1057524138	NC_000016.10:2060776:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1084C>G (p.Leu362Val)	TSC2	L162V, L325V, L362V, L373V, L208V, L343V, L358V, L313V, L392V	Hereditary cancer-predisposing syndrome	VCV003462638	16	2110779	16	2060778	3462638	3621657		NC_000016.10:2060777:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1085T>C (p.Leu362Pro)	TSC2	L362P, L313P, L325P, L373P, L162P	not provided|Tuberous sclerosis 2	VCV000049140	16	2110780	16	2060779	49140	58302	rs137854345	NC_000016.10:2060778:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1086G>C (p.Leu362=)	TSC2		Tuberous sclerosis 2	VCV001530370	16	2110781	16	2060780	1530370	1582155	rs1416323572	NC_000016.10:2060779:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1086G>A (p.Leu362=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001103173	16	2110781	16	2060780	1103173	1103619	rs1416323572	NC_000016.10:2060779:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1088A>T (p.Asn363Ile)	TSC2	N363I, N314I, N163I, N374I, N326I	Tuberous sclerosis 2	VCV000578764	16	2110783	16	2060782	578764	567759	rs1567423658	NC_000016.10:2060781:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1088A>G (p.Asn363Ser)	TSC2	N363S, N163S, N326S, N374S, N314S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000575343	16	2110783	16	2060782	575343	567757	rs1567423658	NC_000016.10:2060781:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1089C>T (p.Asn363=)	TSC2		Tuberous sclerosis 2	VCV002899282	16	2110784	16	2060783	2899282	3057463	rs1346577037	NC_000016.10:2060782:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Sep 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1090A>G (p.Ile364Val)	TSC2	I164V, I364V, I375V, I315V, I327V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000942740	16	2110785	16	2060784	942740	937283	rs2086536512	NC_000016.10:2060783:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1091T>C (p.Ile364Thr)	TSC2	I210T, I327T, I345T, I360T, I315T, I164T, I364T, I375T, I394T	Hereditary cancer-predisposing syndrome	VCV003462613	16	2110786	16	2060785	3462613	3621632		NC_000016.10:2060784:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1091T>G (p.Ile364Ser)	TSC2	I164S, I210S, I315S, I327S, I345S, I360S, I364S, I375S, I394S	Hereditary cancer-predisposing syndrome|not provided	VCV003232071	16	2110786	16	2060785	3232071	3385611	rs2151138290	NC_000016.10:2060784:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1092C>T (p.Ile364=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001159179	16	2110787	16	2060786	1159179	1145905	rs2151138326	NC_000016.10:2060785:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1093A>G (p.Ile365Val)	TSC2	I365V, I165V, I316V, I376V, I328V	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000429535	16	2110788	16	2060787	429535	422078	rs370403197	NC_000016.10:2060786:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1094T>C (p.Ile365Thr)	TSC2	I165T, I211T, I316T, I328T, I346T, I361T, I365T, I376T, I395T	not provided	VCV001722991	16	2110789	16	2060788	1722991	1780493	rs2151138380	NC_000016.10:2060787:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1095C>G (p.Ile365Met)	TSC2	I316M, I365M, I165M, I328M, I376M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000952344	16	2110790	16	2060789	952344	927629	rs757135168	NC_000016.10:2060788:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1095C>T (p.Ile365=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184699	16	2110790	16	2060789	184699	184120	rs757135168	NC_000016.10:2060788:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1096G>C (p.Glu366Gln)	TSC2	E366Q, E329Q, E166Q, E317Q, E377Q	not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535916	16	2110791	16	2060790	535916	529888	rs45517148	NC_000016.10:2060789:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1096G>A (p.Glu366Lys)	TSC2	E366K, E166K, E377K, E317K, E329K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000207711	16	2110791	16	2060790	207711	203105	rs45517148	NC_000016.10:2060789:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1096G>T (p.Glu366Ter)	TSC2	E366*, E329*, E166*, E317*, E377*	Tuberous sclerosis 2|not provided	VCV000012400	16	2110791	16	2060790	12400	27439	rs45517148	NC_000016.10:2060789:G:T	single nucleotide variant	nonsense	Pathogenic	Jan 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1097A>G (p.Glu366Gly)	TSC2	E212G, E347G, E396G, E317G, E362G, E166G, E329G, E366G, E377G	Hereditary cancer-predisposing syndrome	VCV003974621	16	2110792	16	2060791	3974621	4086444		NC_000016.10:2060790:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1097A>C (p.Glu366Ala)	TSC2	E166A, E317A, E329A, E366A, E396A, E212A, E347A, E362A, E377A	Hereditary cancer-predisposing syndrome	VCV001790864	16	2110792	16	2060791	1790864	1851225	rs2151138526	NC_000016.10:2060790:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1098A>G (p.Glu366=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003069227	16	2110793	16	2060792	3069227	3229854	rs113071226	NC_000016.10:2060791:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1099C>T (p.Arg367Trp)	TSC2	R167W, R378W, R330W, R318W, R367W	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000805693	16	2110794	16	2060793	805693	793570	rs757844109	NC_000016.10:2060792:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1100G>T (p.Arg367Leu)	TSC2	R167L, R318L, R330L, R367L, R378L	Tuberous sclerosis 2	VCV001024808	16	2110795	16	2060794	1024808	1011941	rs1800725	NC_000016.10:2060793:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1100G>C (p.Arg367Pro)	TSC2	R367P, R167P, R378P, R318P, R330P	not provided|Tuberous sclerosis 2	VCV000064859	16	2110795	16	2060794	64859	75788	rs1800725	NC_000016.10:2060793:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1100G>A (p.Arg367Gln)	TSC2	R367Q, R318Q, R378Q, R330Q, R167Q	not provided|Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000041725	16	2110795	16	2060794	41725	50164	rs1800725	NC_000016.10:2060793:G:A	single nucleotide variant	missense variant	Benign	Sep 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1101G>C (p.Arg367=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000467843	16	2110796	16	2060795	467843	465192	rs45517149	NC_000016.10:2060794:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1101G>A (p.Arg367=)	TSC2		Tuberous sclerosis 2|not provided	VCV000050161	16	2110796	16	2060795	50161	59323	rs45517149	NC_000016.10:2060794:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1102C>T (p.Leu368Phe)	TSC2	L368F, L331F, L379F, L168F, L319F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000567076	16	2110797	16	2060796	567076	570069	rs1567423904	NC_000016.10:2060795:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1103T>C (p.Leu368Pro)	TSC2	L168P, L364P, L214P, L319P, L349P, L398P, L331P, L368P, L379P	Hereditary cancer-predisposing syndrome	VCV001793110	16	2110798	16	2060797	1793110	1848623	rs2151138758	NC_000016.10:2060796:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1104C>T (p.Leu368=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001554924	16	2110799	16	2060798	1554924	1564668	rs1352216421	NC_000016.10:2060797:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1105C>G (p.Leu369Val)	TSC2	L169V, L320V, L365V, L215V, L332V, L350V, L399V, L380V, L369V	Tuberous sclerosis 2	VCV003637185	16	2110800	16	2060799	3637185	3771339		NC_000016.10:2060798:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1105C>T (p.Leu369Phe)	TSC2	L320F, L215F, L350F, L380F, L169F, L332F, L365F, L369F, L399F	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002151168	16	2110800	16	2060799	2151168	1884736	rs1195544121	NC_000016.10:2060798:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1105C>A (p.Leu369Ile)	TSC2	L169I, L320I, L332I, L369I, L380I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000999848	16	2110800	16	2060799	999848	996702	rs1195544121	NC_000016.10:2060798:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1108C>T (p.Gln370Ter)	TSC2	Q381*, Q333*, Q170*, Q321*, Q370*	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000647290	16	2110803	16	2060802	647290	644176	rs1596298721	NC_000016.10:2060801:C:T	single nucleotide variant	nonsense	Pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1110G>A (p.Gln370=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|not specified	VCV000049141	16	2110805	16	2060804	49141	58303	rs1800742	NC_000016.10:2060803:G:A	single nucleotide variant	synonymous variant	Benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1111C>T (p.Gln371Ter)	TSC2	Q371*, Q171*, Q334*, Q382*, Q322*	Tuberous sclerosis 2|not provided	VCV000049142	16	2110806	16	2060805	49142	58304	rs45469099	NC_000016.10:2060804:C:T	single nucleotide variant	nonsense	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1112A>C (p.Gln371Pro)	TSC2	Q334P, Q352P, Q171P, Q382P, Q322P, Q217P, Q367P, Q371P, Q401P	Tuberous sclerosis 2	VCV002741729	16	2110807	16	2060806	2741729	2896480	rs1555500581	NC_000016.10:2060805:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1112A>G (p.Gln371Arg)	TSC2	Q371R, Q171R, Q322R, Q382R, Q334R	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000453076	16	2110807	16	2060806	453076	445513	rs1555500581	NC_000016.10:2060805:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 23, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1113G>A (p.Gln371=)	TSC2		Tuberous sclerosis 2	VCV002964284	16	2110808	16	2060807	2964284	3124188	rs571767462	NC_000016.10:2060806:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1113G>T (p.Gln371His)	TSC2	Q171H, Q371H, Q367H, Q401H, Q217H, Q322H, Q382H, Q334H, Q352H	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001975421	16	2110808	16	2060807	1975421	2026828	rs571767462	NC_000016.10:2060806:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1113G>C (p.Gln371His)	TSC2	Q322H, Q371H, Q171H, Q334H, Q382H	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000960741	16	2110808	16	2060807	960741	949229	rs571767462	NC_000016.10:2060806:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1114C>T (p.Leu372Phe)	TSC2	L323F, L335F, L353F, L368F, L383F, L172F, L218F, L372F, L402F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002697835	16	2110809	16	2060808	2697835	2861397	rs2151139076	NC_000016.10:2060807:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1115T>C (p.Leu372Pro)	TSC2	L372P, L172P, L323P, L383P, L335P	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000405972	16	2110810	16	2060809	405972	400681	rs1060500919	NC_000016.10:2060808:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 31, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1116C>T (p.Leu372=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000137735	16	2110811	16	2060810	137735	141438	rs587780973	NC_000016.10:2060809:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1117C>A (p.Gln373Lys)	TSC2	Q173K, Q324K, Q336K, Q373K, Q384K	Tuberous sclerosis 2	VCV001061060	16	2110812	16	2060811	1061060	1049425	rs45458694	NC_000016.10:2060810:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1117C>T (p.Gln373Ter)	TSC2	Q373*, Q324*, Q336*, Q384*, Q173*	not provided	VCV000049759	16	2110812	16	2060811	49759	58921	rs45458694	NC_000016.10:2060810:C:T	single nucleotide variant	nonsense	Pathogenic	May 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1118A>G (p.Gln373Arg)	TSC2	Q373R, Q324R, Q336R, Q173R, Q384R	Tuberous sclerosis 2	VCV000570588	16	2110813	16	2060812	570588	573779	rs397515131	NC_000016.10:2060811:A:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119G>C (p.Gln373His)	TSC2	Q373H, Q173H, Q384H, Q324H, Q336H	not provided	VCV000390324	16	2110814	16	2060813	390324	374054	rs1057523727	NC_000016.10:2060812:G:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 29, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+3G>A	TSC2		Tuberous sclerosis 2	VCV000961608	16	2110817	16	2060816	961608	960141	rs79668097	NC_000016.10:2060815:G:A	single nucleotide variant	intron variant	Uncertain significance	Feb 26, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+3G>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000643731	16	2110817	16	2060816	643731	652522	rs79668097	NC_000016.10:2060815:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1119+4G>C	TSC2		Tuberous sclerosis 2	VCV002693662	16	2110818	16	2060817	2693662	2853795	rs2151139421	NC_000016.10:2060816:G:C	single nucleotide variant	intron variant	Uncertain significance	May 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+5G>A	TSC2		Tuberous sclerosis 2	VCV002819755	16	2110819	16	2060818	2819755	2988110	rs2086542949	NC_000016.10:2060817:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+5G>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001054533	16	2110819	16	2060818	1054533	1049426	rs2086542949	NC_000016.10:2060817:G:C	single nucleotide variant	intron variant	Uncertain significance	Apr 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1119+5G>T	TSC2		Tuberous sclerosis 2	VCV000960023	16	2110819	16	2060818	960023	960142	rs2086542949	NC_000016.10:2060817:G:T	single nucleotide variant	intron variant	Uncertain significance	Oct 9, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+6G>T	TSC2		Tuberous sclerosis 2	VCV001525497	16	2110820	16	2060819	1525497	1359955	rs397515305	NC_000016.10:2060818:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1119+6G>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000655451	16	2110820	16	2060819	655451	652943	rs397515305	NC_000016.10:2060818:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1119+6G>C	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2	VCV000064948	16	2110820	16	2060819	64948	75878	rs397515305	NC_000016.10:2060818:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1119+7T>G	TSC2		Lymphangiomyomatosis	VCV000931277	16	2110821	16	2060820	931277	920352	rs778981693	NC_000016.10:2060819:T:G	single nucleotide variant	intron variant	Uncertain significance	Jan 9, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+8G>C	TSC2		Tuberous sclerosis 2	VCV001614182	16	2110822	16	2060821	1614182	1612769	rs1377444061	NC_000016.10:2060820:G:C	single nucleotide variant	intron variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+8G>T	TSC2		Tuberous sclerosis 2	VCV000758919	16	2110822	16	2060821	758919	776285	rs1377444061	NC_000016.10:2060820:G:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1119+9G>T	TSC2		Tuberous sclerosis 2	VCV001641069	16	2110823	16	2060822	1641069	1520004	rs748164142	NC_000016.10:2060821:G:T	single nucleotide variant	intron variant	Likely benign	Jun 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+9G>A	TSC2		Tuberous sclerosis 2	VCV001127700	16	2110823	16	2060822	1127700	1125027	rs748164142	NC_000016.10:2060821:G:A	single nucleotide variant	intron variant	Likely benign	Jan 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+10G>A	TSC2		Tuberous sclerosis 2	VCV002030025	16	2110824	16	2060823	2030025	2089217	rs772040527	NC_000016.10:2060822:G:A	single nucleotide variant	intron variant	Likely benign	Sep 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+10G>C	TSC2		Tuberous sclerosis 2	VCV001112692	16	2110824	16	2060823	1112692	1103620	rs772040527	NC_000016.10:2060822:G:C	single nucleotide variant	intron variant	Likely benign	Jul 7, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+11G>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV001577214	16	2110825	16	2060824	1577214	1640071	rs1026151983	NC_000016.10:2060823:G:C	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1119+11G>T	TSC2		Tuberous sclerosis 2	VCV001561359	16	2110825	16	2060824	1561359	1554784	rs1026151983	NC_000016.10:2060823:G:T	single nucleotide variant	intron variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+12G>A	TSC2		Tuberous sclerosis 2	VCV002069577	16	2110826	16	2060825	2069577	2129666	rs777825025	NC_000016.10:2060824:G:A	single nucleotide variant	intron variant	Likely benign	Mar 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+13C>T	TSC2		Tuberous sclerosis 2	VCV002060500	16	2110827	16	2060826	2060500	2106731	rs2151139799	NC_000016.10:2060825:C:T	single nucleotide variant	intron variant	Likely benign	Oct 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+14A>G	TSC2		Tuberous sclerosis 2	VCV002188509	16	2110828	16	2060827	2188509	1918553	rs950674352	NC_000016.10:2060826:A:G	single nucleotide variant	intron variant	Likely benign	Nov 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+15G>A	TSC2		Tuberous sclerosis 2	VCV003649415	16	2110829	16	2060828	3649415	3777377		NC_000016.10:2060827:G:A	single nucleotide variant	intron variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+18G>C	TSC2		Tuberous sclerosis 2	VCV003729271	16	2110832	16	2060831	3729271	3858601		NC_000016.10:2060830:G:C	single nucleotide variant	intron variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+18G>A	TSC2		Tuberous sclerosis 2	VCV002070594	16	2110832	16	2060831	2070594	2119827	rs746899769	NC_000016.10:2060830:G:A	single nucleotide variant	intron variant	Likely benign	Sep 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+19C>T	TSC2		Tuberous sclerosis 2	VCV001603875	16	2110833	16	2060832	1603875	1644942	rs2151140026	NC_000016.10:2060831:C:T	single nucleotide variant	intron variant	Likely benign	Nov 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+19C>G	TSC2		Tuberous sclerosis 2	VCV001349022	16	2110833	16	2060832	1349022	1479033	rs2151140026	NC_000016.10:2060831:C:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+20T>C	TSC2		Tuberous sclerosis 2	VCV002168229	16	2110834	16	2060833	2168229	1899545	rs2151140077	NC_000016.10:2060832:T:C	single nucleotide variant	intron variant	Likely benign	Jul 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+129G>T	TSC2		Tuberous sclerosis 2	VCV000930216	16	2110943	16	2060942	930216	918535	rs1001221917	NC_000016.10:2060941:G:T	single nucleotide variant	intron variant	Pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1119+233C>T	TSC2		not provided	VCV000677388	16	2111047	16	2061046	677388	668668	rs139167052	NC_000016.10:2061045:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-93T>C	TSC2		not specified|Tuberous sclerosis 2|not provided	VCV000049143	16	2111779	16	2061778	49143	58305	rs17135764	NC_000016.10:2061777:T:C	single nucleotide variant	intron variant	Benign	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-20C>T	TSC2		Tuberous sclerosis 2	VCV001651955	16	2111852	16	2061851	1651955	1613181	rs2086675709	NC_000016.10:2061850:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-19A>G	TSC2		Tuberous sclerosis 2	VCV002855437	16	2111853	16	2061852	2855437	3013945	rs2548535878	NC_000016.10:2061851:A:G	single nucleotide variant	intron variant	Likely benign	Apr 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-19A>T	TSC2		Tuberous sclerosis 2	VCV002018573	16	2111853	16	2061852	2018573	2072656	rs2548535878	NC_000016.10:2061851:A:T	single nucleotide variant	intron variant	Likely benign	Apr 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-17C>T	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not provided|not specified|Tuberous sclerosis 2	VCV000378774	16	2111855	16	2061854	378774	374734	rs201704675	NC_000016.10:2061853:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-16G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000386457	16	2111856	16	2061855	386457	377151	rs768241936	NC_000016.10:2061854:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-15T>G	TSC2		Tuberous sclerosis 2	VCV002699451	16	2111857	16	2061856	2699451	2861725	rs2548535969	NC_000016.10:2061855:T:G	single nucleotide variant	intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-15T>C	TSC2		Tuberous sclerosis 2	VCV002194137	16	2111857	16	2061856	2194137	1926337	rs2548535969	NC_000016.10:2061855:T:C	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-14G>A	TSC2		Tuberous sclerosis 2	VCV004071200	16	2111858	16	2061857	4071200	4185048		NC_000016.10:2061856:G:A	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-14G>T	TSC2		Tuberous sclerosis 2	VCV003690033	16	2111858	16	2061857	3690033	3820331		NC_000016.10:2061856:G:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-12C>G	TSC2		Tuberous sclerosis 2	VCV003697310	16	2111860	16	2061859	3697310	3822410		NC_000016.10:2061858:C:G	single nucleotide variant	intron variant	Likely benign	Oct 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-12C>T	TSC2		Tuberous sclerosis 2	VCV002428138	16	2111860	16	2061859	2428138	1951175	rs773688581	NC_000016.10:2061858:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-12C>A	TSC2		Tuberous sclerosis 2	VCV002006598	16	2111860	16	2061859	2006598	2069692	rs773688581	NC_000016.10:2061858:C:A	single nucleotide variant	intron variant	Likely benign	Jun 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-11T>C	TSC2		Tuberous sclerosis 2	VCV002723274	16	2111861	16	2061860	2723274	2885064	rs2086676901	NC_000016.10:2061859:T:C	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-10G>A	TSC2		Tuberous sclerosis 2	VCV001437515	16	2111862	16	2061861	1437515	1514131	rs2151153517	NC_000016.10:2061860:G:A	single nucleotide variant	intron variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-9G>A	TSC2		Tuberous sclerosis 2	VCV002886313	16	2111863	16	2061862	2886313	3054027	rs2151153539	NC_000016.10:2061861:G:A	single nucleotide variant	intron variant	Likely benign	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-9G>C	TSC2		Tuberous sclerosis 2	VCV001152629	16	2111863	16	2061862	1152629	1145906	rs2151153539	NC_000016.10:2061861:G:C	single nucleotide variant	intron variant	Likely benign	Sep 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-7A>G	TSC2		Tuberous sclerosis 2	VCV002809256	16	2111865	16	2061864	2809256	2975052	rs1459785336	NC_000016.10:2061863:A:G	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-6C>T	TSC2		Tuberous sclerosis 2	VCV000719192	16	2111866	16	2061865	719192	731052	rs1327886668	NC_000016.10:2061864:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1120-5T>C	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000480819	16	2111867	16	2061866	480819	477313	rs896351318	NC_000016.10:2061865:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1120-4G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001797555	16	2111868	16	2061867	1797555	1854473	rs2151153688	NC_000016.10:2061866:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 14, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1120-3C>T	TSC2		Tuberous sclerosis 2	VCV000939574	16	2111869	16	2061868	939574	940348	rs1349958011	NC_000016.10:2061867:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120-1G>A	TSC2		Hereditary cancer-predisposing syndrome	VCV000818377	16	2111871	16	2061870	818377	815611	rs1596303216	NC_000016.10:2061869:G:A	single nucleotide variant	splice acceptor variant	Uncertain significance	Nov 20, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1120A>G (p.Thr374Ala)	TSC2	T374A, T220A, T325A, T370A, T404A, T355A, T385A, T174A, T337A	Tuberous sclerosis 2	VCV002106323	16	2111872	16	2061871	2106323	2162790	rs2086678793	NC_000016.10:2061870:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1121C>A (p.Thr374Asn)	TSC2	T374N, T404N, T325N, T337N, T355N, T370N, T385N, T174N, T220N	Hereditary cancer-predisposing syndrome	VCV003811270	16	2111873	16	2061872	3811270	3928512		NC_000016.10:2061871:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1121C>T (p.Thr374Ile)	TSC2	T337I, T404I, T325I, T370I, T220I, T174I, T355I, T374I, T385I	Tuberous sclerosis 2	VCV002765830	16	2111873	16	2061872	2765830	2922704	rs1440918649	NC_000016.10:2061871:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1121C>G (p.Thr374Ser)	TSC2	T374S, T174S, T337S, T385S, T325S	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467845	16	2111873	16	2061872	467845	465749	rs1440918649	NC_000016.10:2061871:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1122C>T (p.Thr374=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232072	16	2111874	16	2061873	3232072	3385612	rs1555500988	NC_000016.10:2061872:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Sep 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1122C>G (p.Thr374=)	TSC2		not provided|Tuberous sclerosis 2	VCV000502423	16	2111874	16	2061873	502423	493847	rs1555500988	NC_000016.10:2061872:C:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1125G>A (p.Leu375=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974695	16	2111877	16	2061876	3974695	4086518		NC_000016.10:2061875:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	May 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1125G>C (p.Leu375Phe)	TSC2	L175F, L338F, L221F, L326F, L375F, L405F, L371F, L386F, L356F	Tuberous sclerosis 2	VCV002757669	16	2111877	16	2061876	2757669	2917541	rs2548536334	NC_000016.10:2061875:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1126G>A (p.Asp376Asn)	TSC2	D376N, D387N, D176N, D339N, D327N	Tuberous sclerosis 2	VCV000406132	16	2111878	16	2061877	406132	400775	rs1060500976	NC_000016.10:2061876:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1128C>G (p.Asp376Glu)	TSC2	D339E, D357E, D376E, D406E, D176E, D372E, D387E, D222E, D327E	Tuberous sclerosis 2|not provided	VCV002799067	16	2111880	16	2061879	2799067	2962344	rs1183791367	NC_000016.10:2061878:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1128C>T (p.Asp376=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000749875	16	2111880	16	2061879	749875	754980	rs1183791367	NC_000016.10:2061878:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1129A>G (p.Ser377Gly)	TSC2	S177G, S328G, S377G, S407G, S223G, S340G, S358G, S373G, S388G	Hereditary cancer-predisposing syndrome	VCV003462516	16	2111881	16	2061880	3462516	3621536		NC_000016.10:2061879:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1129A>T (p.Ser377Cys)	TSC2	S177C, S223C, S328C, S340C, S358C, S373C, S377C, S388C, S407C	Hereditary cancer-predisposing syndrome	VCV003232073	16	2111881	16	2061880	3232073	3385613	rs2086679931	NC_000016.10:2061879:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1130G>A (p.Ser377Asn)	TSC2	S177N, S328N, S340N, S388N, S377N	Tuberous sclerosis 2	VCV001037307	16	2111882	16	2061881	1037307	1032436	rs2086680090	NC_000016.10:2061880:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1131C>G (p.Ser377Arg)	TSC2	S177R, S328R, S340R, S377R, S388R	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001002448	16	2111883	16	2061882	1002448	996703	rs201525586	NC_000016.10:2061881:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 25, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1131C>T (p.Ser377=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207656	16	2111883	16	2061882	207656	203106	rs201525586	NC_000016.10:2061881:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1132C>G (p.Pro378Ala)	TSC2	P178A, P329A, P378A, P341A, P389A	Tuberous sclerosis 2	VCV001438227	16	2111884	16	2061883	1438227	1355080	rs2151154104	NC_000016.10:2061882:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1133C>G (p.Pro378Arg)	TSC2	P378R, P178R, P329R, P341R, P389R	not provided|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000237959	16	2111885	16	2061884	237959	242226	rs45517154	NC_000016.10:2061883:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1133C>T (p.Pro378Leu)	TSC2	P378L, P178L, P341L, P329L, P389L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050164	16	2111885	16	2061884	50164	59326	rs45517154	NC_000016.10:2061883:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1134G>A (p.Pro378=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000287554	16	2111886	16	2061885	287554	271791	rs754343186	NC_000016.10:2061884:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1137G>T (p.Glu379Asp)	TSC2	E179D, E330D, E409D, E225D, E342D, E360D, E375D, E379D, E390D	Hereditary cancer-predisposing syndrome	VCV003974692	16	2111889	16	2061888	3974692	4086515		NC_000016.10:2061887:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1137G>A (p.Glu379=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000374981	16	2111889	16	2061888	374981	361881	rs1057519260	NC_000016.10:2061887:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1138C>G (p.Leu380Val)	TSC2	L410V, L376V, L380V, L180V, L391V, L331V, L343V, L226V, L361V	Tuberous sclerosis 2	VCV002863367	16	2111890	16	2061889	2863367	3029443	rs2151154287	NC_000016.10:2061888:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1138C>T (p.Leu380Phe)	TSC2	L331F, L343F, L180F, L391F, L380F	Tuberous sclerosis 2	VCV001474641	16	2111890	16	2061889	1474641	1503728	rs2151154287	NC_000016.10:2061888:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1140C>G (p.Leu380=)	TSC2		not provided	VCV003341752	16	2111892	16	2061891	3341752	3500986		NC_000016.10:2061890:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1140C>T (p.Leu380=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001731126	16	2111892	16	2061891	1731126	1795500	rs2548536724	NC_000016.10:2061890:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant|5 prime UTR variant	Likely benign	Oct 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1141A>G (p.Arg381Gly)	TSC2	R181G, R332G, R344G, R381G, R392G	Tuberous sclerosis 2	VCV001504716	16	2111893	16	2061892	1504716	1417467	rs759952396	NC_000016.10:2061891:A:G	single nucleotide variant	missense variant	Benign	Jun 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1142G>T (p.Arg381Met)	TSC2	R181M, R392M, R332M, R344M, R381M	Tuberous sclerosis 2	VCV001395744	16	2111894	16	2061893	1395744	1425143	rs45465395	NC_000016.10:2061892:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1142G>A (p.Arg381Lys)	TSC2	R381K, R181K, R344K, R332K, R392K	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049673	16	2111894	16	2061893	49673	58835	rs45465395	NC_000016.10:2061892:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 6, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1143G>A (p.Arg381=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|not specified	VCV000049666	16	2111895	16	2061894	49666	58828	rs45517155	NC_000016.10:2061893:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1144A>T (p.Thr382Ser)	TSC2	T182S, T382S, T345S, T393S, T333S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000969843	16	2111896	16	2061895	969843	957671	rs2086683040	NC_000016.10:2061894:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1145C>T (p.Thr382Ile)	TSC2	T382I, T393I, T333I, T182I, T345I	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome	VCV000596501	16	2111897	16	2061896	596501	587562	rs758511419	NC_000016.10:2061895:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1146C>T (p.Thr382=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001573773	16	2111898	16	2061897	1573773	1538977	rs887128869	NC_000016.10:2061896:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1146C>A (p.Thr382=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000739245	16	2111898	16	2061897	739245	754981	rs887128869	NC_000016.10:2061896:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1147A>G (p.Ile383Val)	TSC2	I229V, I334V, I183V, I379V, I383V, I394V, I346V, I364V, I413V	Tuberous sclerosis 2	VCV002714295	16	2111899	16	2061898	2714295	2868832	rs2548536908	NC_000016.10:2061897:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1149C>T (p.Ile383=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001080835	16	2111901	16	2061900	1080835	1081784	rs764246333	NC_000016.10:2061899:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1149C>G (p.Ile383Met)	TSC2	I183M, I334M, I346M, I394M, I383M	Tuberous sclerosis 2	VCV000835338	16	2111901	16	2061900	835338	843349	rs764246333	NC_000016.10:2061899:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1150G>A (p.Val384Ile)	TSC2	V384I, V335I, V395I, V184I, V347I	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000064844	16	2111902	16	2061901	64844	75773	rs397514881	NC_000016.10:2061900:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1151T>C (p.Val384Ala)	TSC2	V184A, V414A, V380A, V395A, V335A, V347A, V384A, V230A, V365A	Hereditary cancer-predisposing syndrome	VCV002564637	16	2111903	16	2061902	2564637	2733793	rs397515214	NC_000016.10:2061901:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1153C>G (p.His385Asp)	TSC2	H185D, H385D, H348D, H336D, H396D	Tuberous sclerosis 2	VCV000651758	16	2111905	16	2061904	651758	644177	rs1410290642	NC_000016.10:2061903:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1154A>G (p.His385Arg)	TSC2	H385R, H348R, H396R, H336R, H185R	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486691	16	2111906	16	2061905	486691	477320	rs757353933	NC_000016.10:2061904:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1155T>C (p.His385=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001143351	16	2111907	16	2061906	1143351	1145907	rs2151154815	NC_000016.10:2061905:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1157A>G (p.Asp386Gly)	TSC2	D382G, D397G, D349G, D386G, D186G, D337G, D416G, D232G, D367G	Tuberous sclerosis 2	VCV002128026	16	2111909	16	2061908	2128026	2182029	rs2151154884	NC_000016.10:2061907:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1158C>A (p.Asp386Glu)	TSC2	D186E, D232E, D337E, D349E, D367E, D382E, D386E, D397E, D416E	Tuberous sclerosis 2	VCV002437381	16	2111910	16	2061909	2437381	2411312	rs2151154909	NC_000016.10:2061908:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1158C>T (p.Asp386=)	TSC2		Tuberous sclerosis 2	VCV001551526	16	2111910	16	2061909	1551526	1551305	rs2151154909	NC_000016.10:2061908:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1159C>G (p.Leu387Val)	TSC2	L187V, L233V, L368V, L398V, L338V, L387V, L383V, L350V, L417V	Tuberous sclerosis 2	VCV002834937	16	2111911	16	2061910	2834937	3001989	rs1307333182	NC_000016.10:2061909:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1159C>T (p.Leu387=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002113954	16	2111911	16	2061910	2113954	2171849	rs1307333182	NC_000016.10:2061909:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1161G>A (p.Leu387=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001656662	16	2111913	16	2061912	1656662	1562047	rs781336082	NC_000016.10:2061911:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1161G>C (p.Leu387=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000739923	16	2111913	16	2061912	739923	754982	rs781336082	NC_000016.10:2061911:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1164G>T (p.Leu388Phe)	TSC2	L339F, L384F, L388F, L399F, L188F, L234F, L369F, L351F, L418F	Hereditary cancer-predisposing syndrome	VCV002564666	16	2111916	16	2061915	2564666	2733822	rs1416852086	NC_000016.10:2061914:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1164G>A (p.Leu388=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001086816	16	2111916	16	2061915	1086816	1081785	rs1416852086	NC_000016.10:2061914:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1165A>G (p.Thr389Ala)	TSC2	T189A, T235A, T340A, T385A, T370A, T389A, T400A, T419A, T352A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV002626460	16	2111917	16	2061916	2626460	2794226	rs2151155127	NC_000016.10:2061915:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1166C>A (p.Thr389Asn)	TSC2	T370N, T400N, T189N, T235N, T340N, T352N, T385N, T389N, T419N	Hereditary cancer-predisposing syndrome	VCV001738222	16	2111918	16	2061917	1738222	1797458	rs2548537306	NC_000016.10:2061916:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1167C>T (p.Thr389=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413643	16	2111919	16	2061918	413643	401168	rs745774782	NC_000016.10:2061917:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1168A>T (p.Thr390Ser)	TSC2	T353S, T190S, T390S, T341S, T401S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000943012	16	2111920	16	2061919	943012	937284	rs2086688013	NC_000016.10:2061918:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1169C>T (p.Thr390Met)	TSC2	T190M, T390M, T401M, T341M, T353M	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000818478	16	2111921	16	2061920	818478	812501	rs1596303442	NC_000016.10:2061919:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1170G>T (p.Thr390=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001592827	16	2111922	16	2061921	1592827	1620382	rs376144933	NC_000016.10:2061920:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1170G>A (p.Thr390=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184142	16	2111922	16	2061921	184142	184121	rs376144933	NC_000016.10:2061920:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1171G>T (p.Val391Leu)	TSC2	V402L, V237L, V387L, V391L, V191L, V354L, V342L, V372L, V421L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002840325	16	2111923	16	2061922	2840325	3000149	rs1555501071	NC_000016.10:2061921:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1171G>A (p.Val391Met)	TSC2	V391M, V191M, V354M, V402M, V342M	Tuberous sclerosis 2	VCV000467846	16	2111923	16	2061922	467846	465866	rs1555501071	NC_000016.10:2061921:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1172T>A (p.Val391Glu)	TSC2	V237E, V354E, V372E, V421E, V342E, V391E, V402E, V387E, V191E	Hereditary cancer-predisposing syndrome	VCV001739949	16	2111924	16	2061923	1739949	1794395	rs1414372155	NC_000016.10:2061922:T:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 29, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1172T>C (p.Val391Ala)	TSC2	V391A, V342A, V191A, V354A, V402A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000580592	16	2111924	16	2061923	580592	569624	rs1414372155	NC_000016.10:2061922:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1173G>A (p.Val391=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001981029	16	2111925	16	2061924	1981029	2035099	rs2151155361	NC_000016.10:2061923:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1174G>A (p.Glu392Lys)	TSC2	E192K, E343K, E373K, E388K, E355K, E238K, E392K, E422K, E403K	Hereditary cancer-predisposing syndrome	VCV001740364	16	2111926	16	2061925	1740364	1791395	rs2086689181	NC_000016.10:2061924:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1175A>G (p.Glu392Gly)	TSC2	E192G, E238G, E343G, E355G, E373G, E388G, E392G, E403G, E422G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV003386161	16	2111927	16	2061926	3386161	3545302		NC_000016.10:2061925:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1175A>C (p.Glu392Ala)	TSC2	E192A, E238A, E343A, E355A, E373A, E388A, E392A, E403A, E422A	Tuberous sclerosis syndrome	VCV003386160	16	2111927	16	2061926	3386160	3545301		NC_000016.10:2061925:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1176G>T (p.Glu392Asp)	TSC2	E238D, E343D, E355D, E192D, E373D, E392D, E388D, E422D, E403D	Tuberous sclerosis 2	VCV002842959	16	2111928	16	2061927	2842959	2993831	rs2151155407	NC_000016.10:2061926:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1177G>T (p.Glu393Ter)	TSC2	E193*, E344*, E356*, E393*, E404*	Tuberous sclerosis 2	VCV000974587	16	2111929	16	2061928	974587	962881	rs2086689358	NC_000016.10:2061927:G:T	single nucleotide variant	nonsense	Pathogenic	Dec 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1179G>C (p.Glu393Asp)	TSC2	E393D, E239D, E356D, E389D, E404D, E423D, E193D, E344D, E374D	Hereditary cancer-predisposing syndrome	VCV001741582	16	2111931	16	2061930	1741582	1805025	rs2151155465	NC_000016.10:2061929:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1179G>A (p.Glu393=)	TSC2		Tuberous sclerosis 2	VCV001107765	16	2111931	16	2061930	1107765	1103621	rs2151155465	NC_000016.10:2061929:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1180C>A (p.Leu394Met)	TSC2	L357M, L194M, L345M, L394M, L405M	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001471872	16	2111932	16	2061931	1471872	1388899	rs1409309186	NC_000016.10:2061930:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1180C>T (p.Leu394=)	TSC2		Tuberous sclerosis 2	VCV001130927	16	2111932	16	2061931	1130927	1125028	rs1409309186	NC_000016.10:2061930:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1180C>G (p.Leu394Val)	TSC2	L394V, L194V, L405V, L345V, L357V	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535881	16	2111932	16	2061931	535881	529906	rs1409309186	NC_000016.10:2061930:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1181T>C (p.Leu394Pro)	TSC2	L194P, L240P, L345P, L357P, L375P, L390P, L394P, L405P, L424P	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003073971	16	2111933	16	2061932	3073971	3232841	rs2548537534	NC_000016.10:2061931:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1182G>A (p.Leu394=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467847	16	2111934	16	2061933	467847	465868	rs779951754	NC_000016.10:2061932:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1184G>A (p.Cys395Tyr)	TSC2	C195Y, C346Y, C395Y, C406Y, C358Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000655467	16	2111936	16	2061935	655467	644178	rs1026632436	NC_000016.10:2061934:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1186G>A (p.Asp396Asn)	TSC2	D407N, D196N, D359N, D347N, D396N	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000951403	16	2111938	16	2061937	951403	927630	rs1596303501	NC_000016.10:2061936:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1186G>C (p.Asp396His)	TSC2	D396H, D196H, D347H, D359H, D407H	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000818533	16	2111938	16	2061937	818533	812502	rs1596303501	NC_000016.10:2061936:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1187A>T (p.Asp396Val)	TSC2	D396V, D196V, D359V, D347V, D407V	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000486658	16	2111939	16	2061938	486658	477323	rs1365616275	NC_000016.10:2061937:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1188C>G (p.Asp396Glu)	TSC2	D377E, D396E, D426E, D347E, D359E, D392E, D196E, D242E, D407E	Tuberous sclerosis 2	VCV002754311	16	2111940	16	2061939	2754311	2913753	rs748989730	NC_000016.10:2061938:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1189C>T (p.Gln397Ter)	TSC2	Q197*, Q348*, Q393*, Q408*, Q427*, Q243*, Q360*, Q378*, Q397*	Tuberous sclerosis 2	VCV002011701	16	2111941	16	2061940	2011701	2070930	rs2151155696	NC_000016.10:2061939:C:T	single nucleotide variant	nonsense	Pathogenic	Jul 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1191G>C (p.Gln397His)	TSC2	Q408H, Q348H, Q397H, Q197H, Q360H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001038908	16	2111943	16	2061942	1038908	1032437	rs2086690848	NC_000016.10:2061941:G:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1192A>G (p.Asn398Asp)	TSC2	N198D, N244D, N349D, N361D, N379D, N394D, N398D, N409D, N428D	Tuberous sclerosis syndrome	VCV003075052	16	2111944	16	2061943	3075052	3234704	rs2548537658	NC_000016.10:2061942:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1194C>G (p.Asn398Lys)	TSC2	N361K, N244K, N379K, N349K, N409K, N198K, N394K, N398K, N428K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001745604	16	2111946	16	2061945	1745604	1802656	rs369172347	NC_000016.10:2061944:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1194C>T (p.Asn398=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000413661	16	2111946	16	2061945	413661	401171	rs369172347	NC_000016.10:2061944:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1195G>A (p.Glu399Lys)	TSC2	E199K, E350K, E362K, E410K, E399K	Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000862651	16	2111947	16	2061946	862651	843350	rs773920155	NC_000016.10:2061945:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1195G>T (p.Glu399Ter)	TSC2	E399*, E410*, E350*, E362*, E199*	Tuberous sclerosis 2|not provided	VCV000280323	16	2111947	16	2061946	280323	264660	rs773920155	NC_000016.10:2061945:G:T	single nucleotide variant	nonsense	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1196A>T (p.Glu399Val)	TSC2	E199V, E245V, E350V, E362V, E380V, E395V, E399V, E410V, E429V	Hereditary cancer-predisposing syndrome	VCV003232074	16	2111948	16	2061947	3232074	3385614	rs2548537750	NC_000016.10:2061946:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1199T>A (p.Phe400Tyr)	TSC2	F200Y, F246Y, F363Y, F396Y, F400Y, F351Y, F411Y, F381Y, F430Y	Hereditary cancer-predisposing syndrome	VCV003811312	16	2111951	16	2061950	3811312	3928553		NC_000016.10:2061949:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1200C>T (p.Phe400=)	TSC2		Tuberous sclerosis 2	VCV002032850	16	2111952	16	2061951	2032850	2079211	rs2548537813	NC_000016.10:2061950:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1202A>G (p.His401Arg)	TSC2	H352R, H401R, H412R, H364R, H201R	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001513680	16	2111954	16	2061953	1513680	1468869	rs2086691569	NC_000016.10:2061952:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1202A>C (p.His401Pro)	TSC2	H201P, H352P, H364P, H401P, H412P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|not specified	VCV001301335	16	2111954	16	2061953	1301335	1291618	rs2086691569	NC_000016.10:2061952:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1203C>T (p.His401=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000486607	16	2111955	16	2061954	486607	477325	rs199665674	NC_000016.10:2061953:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1204G>C (p.Gly402Arg)	TSC2	G202R, G248R, G353R, G365R, G383R, G398R, G402R, G413R, G432R	Tuberous sclerosis 2	VCV003605473	16	2111956	16	2061955	3605473	3736888		NC_000016.10:2061954:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1204G>T (p.Gly402Trp)	TSC2	G365W, G402W, G202W, G413W, G353W	not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000933939	16	2111956	16	2061955	933939	937285	rs771561593	NC_000016.10:2061954:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1204G>A (p.Gly402Arg)	TSC2	G402R, G365R, G202R, G353R, G413R	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000467848	16	2111956	16	2061955	467848	465752	rs771561593	NC_000016.10:2061954:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1205G>A (p.Gly402Glu)	TSC2	G353E, G365E, G402E, G413E, G202E	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000818583	16	2111957	16	2061956	818583	812503	rs777172185	NC_000016.10:2061955:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1205G>T (p.Gly402Val)	TSC2	G402V, G353V, G413V, G365V, G202V	Tuberous sclerosis 2|not provided	VCV000449637	16	2111957	16	2061956	449637	445514	rs777172185	NC_000016.10:2061955:G:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1206G>C (p.Gly402=)	TSC2		Tuberous sclerosis 2	VCV002011281	16	2111958	16	2061957	2011281	2074355	rs558873383	NC_000016.10:2061956:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1206G>A (p.Gly402=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000765973	16	2111958	16	2061957	765973	770681	rs558873383	NC_000016.10:2061956:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1208C>G (p.Ser403Cys)	TSC2	S203C, S403C, S414C, S354C, S366C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001450285	16	2111960	16	2061959	1450285	1436165	rs1555501098	NC_000016.10:2061958:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1208C>T (p.Ser403Phe)	TSC2	S403F, S203F, S414F, S366F, S354F	Tuberous sclerosis 2	VCV000467849	16	2111960	16	2061959	467849	465872	rs1555501098	NC_000016.10:2061958:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1210C>T (p.Gln404Ter)	TSC2	Q404*, Q367*, Q204*, Q355*, Q415*	TSC2-related disorder|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049676	16	2111962	16	2061961	49676	58838	rs45457701	NC_000016.10:2061960:C:T	single nucleotide variant	nonsense	Pathogenic	Mar 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1212G>A (p.Gln404=)	TSC2		Tuberous sclerosis 2	VCV000467850	16	2111964	16	2061963	467850	465754	rs1156766051	NC_000016.10:2061962:G:A	single nucleotide variant	synonymous variant	Likely benign	May 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1213G>A (p.Glu405Lys)	TSC2	E205K, E356K, E386K, E401K, E251K, E405K, E416K, E368K, E435K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002912555	16	2111965	16	2061964	2912555	3070668	rs765622787	NC_000016.10:2061963:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1213G>T (p.Glu405Ter)	TSC2	E356*, E251*, E401*, E405*, E205*, E386*, E416*, E368*, E435*	Tuberous sclerosis 2	VCV002838404	16	2111965	16	2061964	2838404	3002904	rs765622787	NC_000016.10:2061963:G:T	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Feb 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1213G>C (p.Glu405Gln)	TSC2	E405Q, E368Q, E356Q, E205Q, E416Q	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000237961	16	2111965	16	2061964	237961	242228	rs765622787	NC_000016.10:2061963:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1214A>G (p.Glu405Gly)	TSC2	E405G, E368G, E416G, E205G, E356G	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000467851	16	2111966	16	2061965	467851	465195	rs1057518321	NC_000016.10:2061964:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1214A>T (p.Glu405Val)	TSC2	E405V, E368V, E356V, E205V, E416V	not specified	VCV000373277	16	2111966	16	2061965	373277	360163	rs1057518321	NC_000016.10:2061964:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.1215G>T (p.Glu405Asp)	TSC2	E205D, E251D, E356D, E368D, E386D, E401D, E405D, E416D, E435D	Isolated focal cortical dysplasia type II	VCV003240652	16	2111967	16	2061966	3240652	3399638	rs2151156348	NC_000016.10:2061965:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1215G>A (p.Glu405=)	TSC2		Tuberous sclerosis 2	VCV001135185	16	2111967	16	2061966	1135185	1125029	rs2151156348	NC_000016.10:2061965:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1216A>G (p.Arg406Gly)	TSC2	R357G, R406G, R206G, R417G, R369G	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV001395138	16	2111968	16	2061967	1395138	1412152	rs2151156367	NC_000016.10:2061966:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1217G>A (p.Arg406Lys)	TSC2	R357K, R406K, R417K, R206K, R369K	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000947212	16	2111969	16	2061968	947212	927631	rs2086693907	NC_000016.10:2061967:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1218A>G (p.Arg406=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002449948	16	2111970	16	2061969	2449948	2429574	rs2548538158	NC_000016.10:2061968:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1219T>C (p.Tyr407His)	TSC2	Y418H, Y388H, Y207H, Y358H, Y370H, Y407H, Y437H, Y253H, Y403H	Hereditary cancer-predisposing syndrome	VCV001752537	16	2111971	16	2061970	1752537	1804392	rs45517156	NC_000016.10:2061969:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1220A>G (p.Tyr407Cys)	TSC2	Y207C, Y358C, Y370C, Y407C, Y418C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001009538	16	2111972	16	2061971	1009538	996704	rs1596303621	NC_000016.10:2061970:A:G	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1220A>T (p.Tyr407Phe)	TSC2	Y207F, Y358F, Y407F, Y418F, Y370F	Tuberous sclerosis 2	VCV000946811	16	2111972	16	2061971	946811	927632	rs1596303621	NC_000016.10:2061970:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1221C>G (p.Tyr407Ter)	TSC2	Y207*, Y253*, Y358*, Y370*, Y388*, Y403*, Y407*, Y418*, Y437*	Tuberous sclerosis 2	VCV003065267	16	2111973	16	2061972	3065267	3225290	rs397514897	NC_000016.10:2061971:C:G	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Mar 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1221C>T (p.Tyr407=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000706536	16	2111973	16	2061972	706536	693805	rs397514897	NC_000016.10:2061971:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1221C>A (p.Tyr407Ter)	TSC2	Y407*, Y370*, Y207*, Y358*, Y418*	Isolated focal cortical dysplasia type II	VCV000064871	16	2111973	16	2061972	64871	75800	rs397514897	NC_000016.10:2061971:C:A	single nucleotide variant	nonsense	Likely pathogenic	Apr 6, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1223T>G (p.Phe408Cys)	TSC2	F408C, F359C, F208C, F371C, F419C	Tuberous sclerosis 2	VCV000467852	16	2111975	16	2061974	467852	465196	rs1555501123	NC_000016.10:2061973:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1225G>C (p.Glu409Gln)	TSC2	E390Q, E409Q, E439Q, E209Q, E420Q, E372Q, E405Q, E255Q, E360Q	Hereditary cancer-predisposing syndrome	VCV002449977	16	2111977	16	2061976	2449977	2429602	rs2548538325	NC_000016.10:2061975:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1228C>G (p.Leu410Val)	TSC2	L256V, L410V, L210V, L391V, L361V, L406V, L373V, L421V, L440V	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002003058	16	2111980	16	2061979	2003058	2058417	rs528727637	NC_000016.10:2061978:C:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1228C>T (p.Leu410=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001131377	16	2111980	16	2061979	1131377	1125030	rs528727637	NC_000016.10:2061978:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1229T>C (p.Leu410Pro)	TSC2	L210P, L361P, L373P, L410P, L421P	not provided	VCV001306061	16	2111981	16	2061980	1306061	1297332	rs137854298	NC_000016.10:2061979:T:C	single nucleotide variant	missense variant	Uncertain significance	May 16, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1229T>G (p.Leu410Arg)	TSC2	L410R, L361R, L421R, L210R, L373R	Tuberous sclerosis 2|not provided	VCV000049680	16	2111981	16	2061980	49680	58842	rs137854298	NC_000016.10:2061979:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 14, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1230G>C (p.Leu410=)	TSC2		Tuberous sclerosis 2	VCV001609135	16	2111982	16	2061981	1609135	1574005	rs2151156690	NC_000016.10:2061980:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1230G>A (p.Leu410=)	TSC2		Tuberous sclerosis 2	VCV001086691	16	2111982	16	2061981	1086691	1081786	rs2151156690	NC_000016.10:2061980:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1231G>A (p.Val411Met)	TSC2	V211M, V257M, V362M, V374M, V392M, V407M, V411M, V422M, V441M	Tuberous sclerosis 2	VCV001719629	16	2111983	16	2061982	1719629	1772285	rs1567428822	NC_000016.10:2061981:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1231G>T (p.Val411Leu)	TSC2	V411L, V422L, V211L, V374L, V362L	Tuberous sclerosis 2	VCV000566861	16	2111983	16	2061982	566861	567770	rs1567428822	NC_000016.10:2061981:G:T	single nucleotide variant	missense variant	Uncertain significance	May 10, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1233G>A (p.Val411=)	TSC2		Tuberous sclerosis 2	VCV000841440	16	2111985	16	2061984	841440	843351	rs2086697274	NC_000016.10:2061983:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1234G>C (p.Glu412Gln)	TSC2	E212Q, E423Q, E363Q, E375Q, E412Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000818664	16	2111986	16	2061985	818664	812504	rs1596303713	NC_000016.10:2061984:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1235A>G (p.Glu412Gly)	TSC2	E412G, E363G, E375G, E423G, E212G	Tuberous sclerosis 2	VCV000467853	16	2111987	16	2061986	467853	465874	rs137854026	NC_000016.10:2061985:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1236G>C (p.Glu412Asp)	TSC2	E258D, E363D, E442D, E393D, E212D, E408D, E412D, E375D, E423D	Tuberous sclerosis 2	VCV003637186	16	2111988	16	2061987	3637186	3771340		NC_000016.10:2061986:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1236G>A (p.Glu412=)	TSC2		Tuberous sclerosis 2	VCV000747882	16	2111988	16	2061987	747882	754983	rs1596303728	NC_000016.10:2061986:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1237A>G (p.Arg413Gly)	TSC2	R364G, R413G, R376G, R213G, R424G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001463594	16	2111989	16	2061988	1463594	1508157	rs2151156876	NC_000016.10:2061987:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1239A>T (p.Arg413Ser)	TSC2	R376S, R364S, R213S, R413S, R424S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000663123	16	2111991	16	2061990	663123	644179	rs1596303739	NC_000016.10:2061989:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1240T>A (p.Cys414Ser)	TSC2	C214S, C365S, C377S, C414S, C425S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001307109	16	2111992	16	2061991	1307109	1296058	rs1057523509	NC_000016.10:2061990:T:A	single nucleotide variant	missense variant	Uncertain significance	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1240T>G (p.Cys414Gly)	TSC2	C414G, C214G, C365G, C425G, C377G	not provided|Tuberous sclerosis 2	VCV000389695	16	2111992	16	2061991	389695	377162	rs1057523509	NC_000016.10:2061990:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1242T>A (p.Cys414Ter)	TSC2	C214*, C260*, C444*, C425*, C365*, C377*, C395*, C410*, C414*	Tuberous sclerosis 2	VCV003672893	16	2111994	16	2061993	3672893	3805030		NC_000016.10:2061992:T:A	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	May 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1242T>C (p.Cys414=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564720	16	2111994	16	2061993	2564720	2733876	rs2151156989	NC_000016.10:2061992:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Apr 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1242T>G (p.Cys414Trp)	TSC2	C425W, C414W, C214W, C365W, C377W	Tuberous sclerosis 2	VCV001425310	16	2111994	16	2061993	1425310	1431549	rs2151156989	NC_000016.10:2061992:T:G	single nucleotide variant	missense variant	Uncertain significance	May 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1244C>T (p.Ala415Val)	TSC2	A415V, A366V, A426V, A215V, A378V	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184138	16	2111996	16	2061995	184138	184122	rs374936223	NC_000016.10:2061994:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1245G>T (p.Ala415=)	TSC2		Tuberous sclerosis 2	VCV004071126	16	2111997	16	2061996	4071126	4184974		NC_000016.10:2061995:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1245G>C (p.Ala415=)	TSC2		Tuberous sclerosis 2	VCV001140429	16	2111997	16	2061996	1140429	1125031	rs757325185	NC_000016.10:2061995:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 14, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1245G>A (p.Ala415=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184607	16	2111997	16	2061996	184607	184123	rs757325185	NC_000016.10:2061995:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1246G>A (p.Asp416Asn)	TSC2	D216N, D367N, D379N, D416N, D427N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001018552	16	2111998	16	2061997	1018552	1011942	rs45517157	NC_000016.10:2061996:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1247A>G (p.Asp416Gly)	TSC2	D379G, D412G, D397G, D416G, D427G, D216G, D262G, D367G, D446G	Tuberous sclerosis 2	VCV003637187	16	2111999	16	2061998	3637187	3771341		NC_000016.10:2061997:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Benign	May 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1247A>C (p.Asp416Ala)	TSC2	D427A, D216A, D367A, D416A, D379A	Tuberous sclerosis 2	VCV000648357	16	2111999	16	2061998	648357	644180	rs117111015	NC_000016.10:2061997:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1248C>G (p.Asp416Glu)	TSC2	D416E, D427E, D379E, D367E, D216E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001472576	16	2112000	16	2061999	1472576	1397958	rs1555501144	NC_000016.10:2061998:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1248C>T (p.Asp416=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467854	16	2112000	16	2061999	467854	465880	rs1555501144	NC_000016.10:2061998:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1249C>T (p.Gln417Ter)	TSC2	Q417*, Q380*, Q217*, Q368*, Q428*	Tuberous sclerosis 2	VCV000050175	16	2112001	16	2062000	50175	59337	rs45517158	NC_000016.10:2061999:C:T	single nucleotide variant	nonsense	Pathogenic	Nov 1, 2016	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1250A>C (p.Gln417Pro)	TSC2	Q380P, Q263P, Q398P, Q413P, Q217P, Q368P, Q417P, Q447P, Q428P	Hereditary cancer-predisposing syndrome	VCV002564635	16	2112002	16	2062001	2564635	2733791	rs2548538774	NC_000016.10:2062000:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1251G>C (p.Gln417His)	TSC2	Q217H, Q263H, Q368H, Q380H, Q398H, Q413H, Q417H, Q428H, Q447H	Hereditary cancer-predisposing syndrome	VCV003232075	16	2112003	16	2062002	3232075	3385615	rs2548538815	NC_000016.10:2062001:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1254G>A (p.Arg418=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811289	16	2112006	16	2062005	3811289	3928530		NC_000016.10:2062004:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1254G>T (p.Arg418Ser)	TSC2	R218S, R369S, R381S, R418S, R429S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001018899	16	2112006	16	2062005	1018899	1011943	rs767670580	NC_000016.10:2062004:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1255C>T (p.Pro419Ser)	TSC2	P419S, P219S, P370S, P382S, P430S	Tuberous sclerosis 2	VCV000050176	16	2112007	16	2062006	50176	59338	rs45517159	NC_000016.10:2062005:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 17, 2012	criteria provided, single submitter							
NM_000548.5(TSC2):c.1256C>A (p.Pro419His)	TSC2	P219H, P265H, P370H, P382H, P400H, P415H, P419H, P430H, P449H	not provided	VCV003253422	16	2112008	16	2062007	3253422	3412216	rs1237876686	NC_000016.10:2062006:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1256C>T (p.Pro419Leu)	TSC2	P419L, P219L, P430L, P370L, P382L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000572759	16	2112008	16	2062007	572759	573783	rs1237876686	NC_000016.10:2062006:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1257+1G>C	TSC2		Tuberous sclerosis 2	VCV000656920	16	2112010	16	2062009	656920	652945	rs397515066	NC_000016.10:2062008:G:C	single nucleotide variant	splice donor variant	Pathogenic	Oct 6, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+1G>A	TSC2		Tuberous sclerosis 2	VCV000065089	16	2112010	16	2062009	65089	76020	rs397515066	NC_000016.10:2062008:G:A	single nucleotide variant	splice donor variant	Pathogenic	May 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1257+2T>G	TSC2		not provided	VCV000064864	16	2112011	16	2062010	64864	75793	rs45509697	NC_000016.10:2062009:T:G	single nucleotide variant	splice donor variant	Pathogenic	Jun 28, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+2T>C	TSC2		Tuberous sclerosis 2	VCV000049683	16	2112011	16	2062010	49683	58845	rs45509697	NC_000016.10:2062009:T:C	single nucleotide variant	splice donor variant	Pathogenic	Jan 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+5G>A	TSC2		Tuberous sclerosis 2	VCV001679283	16	2112014	16	2062013	1679283	1671206	rs2151157428	NC_000016.10:2062012:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 23, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1257+6A>G	TSC2		Tuberous sclerosis 2	VCV001432933	16	2112015	16	2062014	1432933	1493507	rs2151157450	NC_000016.10:2062013:A:G	single nucleotide variant	intron variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+7C>T	TSC2		Tuberous sclerosis 2	VCV000766699	16	2112016	16	2062015	766699	776122	rs1596303823	NC_000016.10:2062014:C:T	single nucleotide variant	intron variant	Likely benign	Mar 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+8C>T	TSC2		Tuberous sclerosis 2	VCV002868618	16	2112017	16	2062016	2868618	3030807	rs767392684	NC_000016.10:2062015:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1257+8C>G	TSC2		Tuberous sclerosis 2	VCV000467855	16	2112017	16	2062016	467855	465759	rs767392684	NC_000016.10:2062015:C:G	single nucleotide variant	intron variant	Likely benign	Feb 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+8C>A	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified	VCV000318309	16	2112017	16	2062016	318309	340851	rs767392684	NC_000016.10:2062015:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1257+9C>G	TSC2		Tuberous sclerosis 2	VCV002917557	16	2112018	16	2062017	2917557	3074799	rs1166139497	NC_000016.10:2062016:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1257+9C>A	TSC2		Tuberous sclerosis 2	VCV001657015	16	2112018	16	2062017	1657015	1562399	rs1166139497	NC_000016.10:2062016:C:A	single nucleotide variant	intron variant	Likely benign	May 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+9C>T	TSC2		Tuberous sclerosis 2	VCV001082560	16	2112018	16	2062017	1082560	1081787	rs1166139497	NC_000016.10:2062016:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1257+10C>G	TSC2		not provided|Tuberous sclerosis 2	VCV000536056	16	2112019	16	2062018	536056	529528	rs756063576	NC_000016.10:2062017:C:G	single nucleotide variant	intron variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1257+10C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000515792	16	2112019	16	2062018	515792	506141	rs756063576	NC_000016.10:2062017:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1257+11C>T	TSC2		Tuberous sclerosis 2	VCV003669963	16	2112020	16	2062019	3669963	3803189		NC_000016.10:2062018:C:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+12T>C	TSC2		Tuberous sclerosis 2	VCV003688789	16	2112021	16	2062020	3688789	3830759		NC_000016.10:2062019:T:C	single nucleotide variant	intron variant	Likely benign	Sep 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+13C>G	TSC2		Tuberous sclerosis 2	VCV001558288	16	2112022	16	2062021	1558288	1594877	rs780010894	NC_000016.10:2062020:C:G	single nucleotide variant	intron variant	Likely benign	May 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+14C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000207657	16	2112023	16	2062022	207657	203107	rs748972223	NC_000016.10:2062021:C:T	single nucleotide variant	intron variant	Benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1257+15T>C	TSC2		Tuberous sclerosis 2	VCV002031104	16	2112024	16	2062023	2031104	2078746	rs2548539301	NC_000016.10:2062022:T:C	single nucleotide variant	intron variant	Likely benign	Sep 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+16G>A	TSC2		Tuberous sclerosis 2	VCV002011396	16	2112025	16	2062024	2011396	2070625	rs2548539312	NC_000016.10:2062023:G:A	single nucleotide variant	intron variant	Uncertain significance	Sep 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+17G>T	TSC2		Tuberous sclerosis 2|not specified	VCV000378775	16	2112026	16	2062025	378775	377164	rs369939081	NC_000016.10:2062024:G:T	single nucleotide variant	intron variant	Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1257+18G>C	TSC2		Tuberous sclerosis 2	VCV002194679	16	2112027	16	2062026	2194679	1932522	rs2151157676	NC_000016.10:2062025:G:C	single nucleotide variant	intron variant	Likely benign	Sep 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+18G>A	TSC2		Tuberous sclerosis 2	VCV001561318	16	2112027	16	2062026	1561318	1554743	rs2151157676	NC_000016.10:2062025:G:A	single nucleotide variant	intron variant	Likely benign	Jan 26, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1257+20G>A	TSC2		Tuberous sclerosis 2|not provided	VCV000452279	16	2112029	16	2062028	452279	445515	rs1436234038	NC_000016.10:2062027:G:A	single nucleotide variant	intron variant	Uncertain significance	Nov 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1257+172C>G	TSC2		Isolated focal cortical dysplasia type II	VCV002679347	16	2112181	16	2062180	2679347	2836924	rs2548541065	NC_000016.10:2062179:C:G	single nucleotide variant	intron variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258-20A>G	TSC2		Tuberous sclerosis 2	VCV001552789	16	2112478	16	2062477	1552789	1639394	rs2151162687	NC_000016.10:2062476:A:G	single nucleotide variant	intron variant	Likely benign	Jul 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258-19C>T	TSC2		Tuberous sclerosis 2	VCV001573497	16	2112479	16	2062478	1573497	1637212	rs1235654050	NC_000016.10:2062477:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-18C>G	TSC2		Tuberous sclerosis 2	VCV002737732	16	2112480	16	2062479	2737732	2899379	rs778741704	NC_000016.10:2062478:C:G	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258-18C>T	TSC2		not provided|Tuberous sclerosis 2	VCV001537241	16	2112480	16	2062479	1537241	1596834	rs778741704	NC_000016.10:2062478:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-17G>C	TSC2		Tuberous sclerosis 2	VCV002129347	16	2112481	16	2062480	2129347	2190771	rs752327718	NC_000016.10:2062479:G:C	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-17G>A	TSC2		Tuberous sclerosis 2	VCV001571833	16	2112481	16	2062480	1571833	1625156	rs752327718	NC_000016.10:2062479:G:A	single nucleotide variant	intron variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-16G>T	TSC2		Tuberous sclerosis 2|not specified	VCV000385079	16	2112482	16	2062481	385079	374735	rs979174870	NC_000016.10:2062480:G:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-15C>T	TSC2		Tuberous sclerosis 2	VCV001596355	16	2112483	16	2062482	1596355	1633438	rs2151162848	NC_000016.10:2062481:C:T	single nucleotide variant	intron variant	Likely benign	Apr 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258-13C>T	TSC2		Tuberous sclerosis 2	VCV002724812	16	2112485	16	2062484	2724812	2888740	rs2548544672	NC_000016.10:2062483:C:T	single nucleotide variant	intron variant	Likely benign	Feb 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258-10C>T	TSC2		Tuberous sclerosis 2	VCV001087684	16	2112488	16	2062487	1087684	1081788	rs794727093	NC_000016.10:2062486:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-10C>G	TSC2		not provided|not specified|Tuberous sclerosis 2	VCV000194182	16	2112488	16	2062487	194182	191345	rs794727093	NC_000016.10:2062486:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1258-9T>G	TSC2		Tuberous sclerosis 2	VCV000752331	16	2112489	16	2062488	752331	776152	rs377188047	NC_000016.10:2062487:T:G	single nucleotide variant	intron variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-8T>G	TSC2		Tuberous sclerosis 2|not provided	VCV000798611	16	2112490	16	2062489	798611	787995	rs1175574879	NC_000016.10:2062488:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 24, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1258-7T>C	TSC2		Tuberous sclerosis 2	VCV002873151	16	2112491	16	2062490	2873151	3035025	rs1447629115	NC_000016.10:2062489:T:C	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-6T>C	TSC2		Tuberous sclerosis 2	VCV003643938	16	2112492	16	2062491	3643938	3779792		NC_000016.10:2062490:T:C	single nucleotide variant	intron variant	Likely benign	Mar 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258-6T>A	TSC2		Isolated focal cortical dysplasia type II	VCV002679327	16	2112492	16	2062491	2679327	2836904	rs2548544809	NC_000016.10:2062490:T:A	single nucleotide variant	intron variant	Uncertain significance	Oct 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258-5G>A	TSC2		Tuberous sclerosis 2|not provided	VCV000795553	16	2112493	16	2062492	795553	788028	rs925954967	NC_000016.10:2062491:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1258-5G>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome	VCV000413674	16	2112493	16	2062492	413674	401172	rs925954967	NC_000016.10:2062491:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1258-4A>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002746021	16	2112494	16	2062493	2746021	2904214	rs2086763634	NC_000016.10:2062492:A:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1258-4A>G	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001085420	16	2112494	16	2062493	1085420	1081789	rs2086763634	NC_000016.10:2062492:A:G	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-3C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002200826	16	2112495	16	2062494	2200826	1927787	rs45517161	NC_000016.10:2062493:C:T	single nucleotide variant	intron variant	Uncertain significance	Apr 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258-3C>A	TSC2		Tuberous sclerosis 2	VCV000569693	16	2112495	16	2062494	569693	567772	rs45517161	NC_000016.10:2062493:C:A	single nucleotide variant	intron variant	Uncertain significance	Jan 28, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258-3C>G	TSC2		Tuberous sclerosis 2	VCV000049148	16	2112495	16	2062494	49148	58310	rs45517161	NC_000016.10:2062493:C:G	single nucleotide variant	intron variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258-2A>G	TSC2		not provided|Tuberous sclerosis 2	VCV001028339	16	2112496	16	2062495	1028339	1018042	rs45517160	NC_000016.10:2062494:A:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258G>C (p.Glu420Gln)	TSC2	E371Q, E420Q, E266Q, E401Q, E220Q, E383Q, E416Q, E450Q, E431Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001762397	16	2112498	16	2062497	1762397	1816796	rs796053484	NC_000016.10:2062496:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1258G>A (p.Glu420Lys)	TSC2	E420K, E371K, E220K, E383K, E431K	Tuberous sclerosis 2	VCV000467856	16	2112498	16	2062497	467856	466053	rs796053484	NC_000016.10:2062496:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1258G>T (p.Glu420Ter)	TSC2	E420*, E371*, E220*, E383*, E431*	Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000207712	16	2112498	16	2062497	207712	203108	rs796053484	NC_000016.10:2062496:G:T	single nucleotide variant	nonsense	Pathogenic	Jul 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1260G>A (p.Glu420=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486686	16	2112500	16	2062499	486686	477286	rs876658585	NC_000016.10:2062498:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1260G>T (p.Glu420Asp)	TSC2	E420D, E431D, E383D, E220D, E371D	Hereditary cancer-predisposing syndrome	VCV000230470	16	2112500	16	2062499	230470	235095	rs876658585	NC_000016.10:2062498:G:T	single nucleotide variant	missense variant	Uncertain significance	May 7, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1261T>C (p.Ser421Pro)	TSC2	S221P, S432P, S267P, S384P, S421P, S372P, S402P, S417P, S451P	Tuberous sclerosis 2	VCV002843417	16	2112501	16	2062500	2843417	3004072	rs2086765786	NC_000016.10:2062499:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1261T>A (p.Ser421Thr)	TSC2	S221T, S372T, S384T, S421T, S432T	Tuberous sclerosis 2	VCV000948447	16	2112501	16	2062500	948447	927633	rs2086765786	NC_000016.10:2062499:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1262C>G (p.Ser421Cys)	TSC2	S221C, S267C, S372C, S384C, S402C, S417C, S421C, S432C, S451C	Hereditary cancer-predisposing syndrome	VCV003232076	16	2112502	16	2062501	3232076	3385616	rs2151163260	NC_000016.10:2062500:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1262C>T (p.Ser421Phe)	TSC2	S221F, S372F, S384F, S432F, S421F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001367720	16	2112502	16	2062501	1367720	1401570	rs2151163260	NC_000016.10:2062500:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1263C>G (p.Ser421=)	TSC2		Tuberous sclerosis 2	VCV002831362	16	2112503	16	2062502	2831362	3000962	rs1199113125	NC_000016.10:2062501:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jan 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1263C>T (p.Ser421=)	TSC2		Tuberous sclerosis 2	VCV002022785	16	2112503	16	2062502	2022785	2076849	rs1199113125	NC_000016.10:2062501:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1265C>T (p.Ser422Phe)	TSC2	S222F, S373F, S385F, S422F, S433F	not provided|Tuberous sclerosis 2	VCV001311983	16	2112505	16	2062504	1311983	1302514	rs2151163315	NC_000016.10:2062503:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1266C>A (p.Ser422=)	TSC2		Tuberous sclerosis 2	VCV003716447	16	2112506	16	2062505	3716447	3848853		NC_000016.10:2062504:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Sep 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1266C>G (p.Ser422=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462690	16	2112506	16	2062505	3462690	3621709		NC_000016.10:2062504:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1266C>T (p.Ser422=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001764223	16	2112506	16	2062505	1764223	1817350	rs1476279884	NC_000016.10:2062504:C:T	single nucleotide variant	non-coding transcript variant|intron variant|synonymous variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Mar 23, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1267C>T (p.Leu423Phe)	TSC2	L223F, L434F, L374F, L386F, L423F	Tuberous sclerosis 2	VCV001523329	16	2112507	16	2062506	1523329	1350498	rs746586340	NC_000016.10:2062505:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1267C>A (p.Leu423Ile)	TSC2	L423I, L434I, L223I, L374I, L386I	Tuberous sclerosis 2	VCV000966161	16	2112507	16	2062506	966161	957672	rs746586340	NC_000016.10:2062505:C:A	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1268T>C (p.Leu423Pro)	TSC2	L453P, L374P, L419P, L423P, L434P, L223P, L386P, L404P, L269P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001764666	16	2112508	16	2062507	1764666	1814487	rs2548545163	NC_000016.10:2062506:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1269C>G (p.Leu423=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002626413	16	2112509	16	2062508	2626413	2794179	rs1323588796	NC_000016.10:2062507:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jun 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1269C>A (p.Leu423=)	TSC2		Tuberous sclerosis 2	VCV002012458	16	2112509	16	2062508	2012458	2063964	rs1323588796	NC_000016.10:2062507:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Jun 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1269C>T (p.Leu423=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001138070	16	2112509	16	2062508	1138070	1125033	rs1323588796	NC_000016.10:2062507:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1270C>T (p.Leu424=)	TSC2		Tuberous sclerosis 2	VCV003620664	16	2112510	16	2062509	3620664	3759854		NC_000016.10:2062508:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Oct 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1270C>A (p.Leu424Met)	TSC2	L224M, L270M, L375M, L387M, L405M, L420M, L424M, L435M, L454M	Tuberous sclerosis syndrome	VCV003075334	16	2112510	16	2062509	3075334	3232901	rs1053117188	NC_000016.10:2062508:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1271T>C (p.Leu424Pro)	TSC2	L454P, L420P, L224P, L375P, L387P, L424P, L270P, L405P, L435P	Tuberous sclerosis 2	VCV002714950	16	2112511	16	2062510	2714950	2875950	rs1468287623	NC_000016.10:2062509:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Benign	Jun 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1271T>G (p.Leu424Arg)	TSC2	L224R, L424R, L375R, L387R, L435R	Tuberous sclerosis 2	VCV001396729	16	2112511	16	2062510	1396729	1418480	rs1468287623	NC_000016.10:2062509:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1273A>T (p.Asn425Tyr)	TSC2	N225Y, N376Y, N436Y, N388Y, N425Y	not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000649712	16	2112513	16	2062512	649712	644181	rs1186443300	NC_000016.10:2062511:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1274A>G (p.Asn425Ser)	TSC2	N225S, N271S, N376S, N388S, N406S, N421S, N425S, N436S, N455S	Tuberous sclerosis 2	VCV001719466	16	2112514	16	2062513	1719466	1772122	rs2548545321	NC_000016.10:2062512:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1275C>G (p.Asn425Lys)	TSC2	N421K, N225K, N271K, N376K, N388K, N406K, N436K, N455K, N425K	Hereditary cancer-predisposing syndrome	VCV002564727	16	2112515	16	2062514	2564727	2733883	rs878854076	NC_000016.10:2062513:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|intron variant	Uncertain significance	May 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1275C>T (p.Asn425=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001641145	16	2112515	16	2062514	1641145	1520080	rs878854076	NC_000016.10:2062513:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1275C>A (p.Asn425Lys)	TSC2	N425K, N388K, N225K, N436K, N376K	Tuberous sclerosis 2	VCV000237962	16	2112515	16	2062514	237962	242229	rs878854076	NC_000016.10:2062513:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1276C>G (p.Leu426Val)	TSC2	L389V, L426V, L377V, L437V, L226V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001043051	16	2112516	16	2062515	1043051	1032438	rs45478593	NC_000016.10:2062514:C:G	single nucleotide variant	missense variant	Benign/Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1276C>T (p.Leu426=)	TSC2		not specified|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000049150	16	2112516	16	2062515	49150	58312	rs45478593	NC_000016.10:2062514:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1278G>C (p.Leu426=)	TSC2		Tuberous sclerosis 2	VCV003061195	16	2112518	16	2062517	3061195	3193701	rs749771063	NC_000016.10:2062516:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	May 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1278G>A (p.Leu426=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001133911	16	2112518	16	2062517	1133911	1125034	rs749771063	NC_000016.10:2062516:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1279A>G (p.Ile427Val)	TSC2	I227V, I378V, I390V, I427V, I438V	Tuberous sclerosis 2	VCV000951014	16	2112519	16	2062518	951014	927634	rs1202399787	NC_000016.10:2062517:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1281C>T (p.Ile427=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001095758	16	2112521	16	2062520	1095758	1081790	rs45478892	NC_000016.10:2062519:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1281C>G (p.Ile427Met)	TSC2	I427M, I227M, I378M, I390M, I438M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000064940	16	2112521	16	2062520	64940	75870	rs45478892	NC_000016.10:2062519:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1281C>A (p.Ile427=)	TSC2		not specified|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000049685	16	2112521	16	2062520	49685	58847	rs45478892	NC_000016.10:2062519:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1284C>T (p.Ser428=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001080211	16	2112524	16	2062523	1080211	1081791	rs1325874616	NC_000016.10:2062522:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1284C>G (p.Ser428=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000730150	16	2112524	16	2062523	730150	740016	rs1325874616	NC_000016.10:2062522:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1285T>C (p.Tyr429His)	TSC2	Y380H, Y410H, Y429H, Y229H, Y275H, Y392H, Y425H, Y440H, Y459H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001768960	16	2112525	16	2062524	1768960	1825960	rs2151163734	NC_000016.10:2062523:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1285T>A (p.Tyr429Asn)	TSC2	Y392N, Y440N, Y429N, Y229N, Y380N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001487315	16	2112525	16	2062524	1487315	1485208	rs2151163734	NC_000016.10:2062523:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1286A>T (p.Tyr429Phe)	TSC2	Y440F, Y392F, Y425F, Y229F, Y380F, Y429F, Y275F, Y410F, Y459F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002126572	16	2112526	16	2062525	2126572	2181872	rs774727624	NC_000016.10:2062524:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1286A>G (p.Tyr429Cys)	TSC2	Y429C, Y229C, Y392C, Y440C, Y380C	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000467858	16	2112526	16	2062525	467858	465882	rs774727624	NC_000016.10:2062524:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1287T>C (p.Tyr429=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002058987	16	2112527	16	2062526	2058987	2106513	rs45493394	NC_000016.10:2062525:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant|intron variant	Likely benign	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1287T>A (p.Tyr429Ter)	TSC2	Y429*, Y392*, Y440*, Y229*, Y380*	not provided	VCV000451112	16	2112527	16	2062526	451112	445516	rs45493394	NC_000016.10:2062525:T:A	single nucleotide variant	nonsense	Pathogenic	Aug 1, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1288A>G (p.Arg430Gly)	TSC2	R426G, R430G, R460G, R393G, R411G, R441G, R230G, R276G, R381G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001987775	16	2112528	16	2062527	1987775	2040422	rs2548545731	NC_000016.10:2062526:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1289G>T (p.Arg430Ile)	TSC2	R426I, R441I, R276I, R381I, R393I, R411I, R230I, R430I, R460I	Hereditary cancer-predisposing syndrome	VCV002564667	16	2112529	16	2062528	2564667	2733823	rs2086770532	NC_000016.10:2062527:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant|splice acceptor variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1289G>C (p.Arg430Thr)	TSC2	R430T, R230T, R393T, R441T, R381T	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000944536	16	2112529	16	2062528	944536	927635	rs2086770532	NC_000016.10:2062527:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1290A>C (p.Arg430Ser)	TSC2	R230S, R276S, R381S, R393S, R411S, R426S, R430S, R441S, R460S	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003075458	16	2112530	16	2062529	3075458	3233025	rs2548545805	NC_000016.10:2062528:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1291G>C (p.Ala431Pro)	TSC2	A231P, A382P, A394P, A431P, A442P	Tuberous sclerosis 2	VCV001024143	16	2112531	16	2062530	1024143	1011944	rs2086770794	NC_000016.10:2062529:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1292C>T (p.Ala431Val)	TSC2	A431V, A382V, A442V, A231V, A394V	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis	VCV000207708	16	2112532	16	2062531	207708	203109	rs202187148	NC_000016.10:2062530:C:T	single nucleotide variant	missense variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1293G>T (p.Ala431=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000237963	16	2112533	16	2062532	237963	242230	rs45517162	NC_000016.10:2062531:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1293G>A (p.Ala431=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050181	16	2112533	16	2062532	50181	59343	rs45517162	NC_000016.10:2062531:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1294C>T (p.Gln432Ter)	TSC2	Q432*, Q443*, Q395*, Q383*, Q232*	Tuberous sclerosis 2|not provided|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000427991	16	2112534	16	2062533	427991	419867	rs1114167462	NC_000016.10:2062532:C:T	single nucleotide variant	nonsense	Pathogenic	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1295A>G (p.Gln432Arg)	TSC2	Q232R, Q278R, Q383R, Q395R, Q413R, Q428R, Q432R, Q443R, Q462R	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis	VCV002679343	16	2112535	16	2062534	2679343	2836920	rs2151163930	NC_000016.10:2062533:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1297T>C (p.Ser433Pro)	TSC2	S233P, S414P, S463P, S384P, S396P, S279P, S429P, S433P, S444P	Tuberous sclerosis 2	VCV003631192	16	2112537	16	2062536	3631192	3763002		NC_000016.10:2062535:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Benign	Aug 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1297T>G (p.Ser433Ala)	TSC2	S384A, S396A, S444A, S233A, S433A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000663616	16	2112537	16	2062536	663616	644182	rs1335355737	NC_000016.10:2062535:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1298C>A (p.Ser433Tyr)	TSC2	S433Y, S233Y, S384Y, S396Y, S444Y	Tuberous sclerosis 2	VCV000568370	16	2112538	16	2062537	568370	567773	rs397515187	NC_000016.10:2062536:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1298C>T (p.Ser433Phe)	TSC2	S433F, S233F, S384F, S396F, S444F	not provided	VCV000418667	16	2112538	16	2062537	418667	409478	rs397515187	NC_000016.10:2062536:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1298C>G (p.Ser433Cys)	TSC2	S433C, S384C, S396C, S444C, S233C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065257	16	2112538	16	2062537	65257	76189	rs397515187	NC_000016.10:2062536:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1299C>T (p.Ser433=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413744	16	2112539	16	2062538	413744	400778	rs993220492	NC_000016.10:2062537:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1300A>G (p.Ile434Val)	TSC2	I385V, I397V, I430V, I415V, I445V, I464V, I234V, I280V, I434V	Hereditary cancer-predisposing syndrome	VCV003974608	16	2112540	16	2062539	3974608	4086431		NC_000016.10:2062538:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1303C>A (p.His435Asn)	TSC2	H235N, H446N, H386N, H435N, H398N	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000660330	16	2112543	16	2062542	660330	644184	rs760896048	NC_000016.10:2062541:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1303C>T (p.His435Tyr)	TSC2	H435Y, H386Y, H398Y, H446Y, H235Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified	VCV000383175	16	2112543	16	2062542	383175	374738	rs760896048	NC_000016.10:2062541:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1304A>G (p.His435Arg)	TSC2	H235R, H398R, H446R, H386R, H435R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001441967	16	2112544	16	2062543	1441967	1382041	rs1555501389	NC_000016.10:2062542:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1304A>C (p.His435Pro)	TSC2	H398P, H235P, H446P, H386P, H435P	Tuberous sclerosis 2	VCV000940907	16	2112544	16	2062543	940907	937286	rs1555501389	NC_000016.10:2062542:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1304A>T (p.His435Leu)	TSC2	H435L, H398L, H235L, H386L, H446L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535964	16	2112544	16	2062543	535964	529573	rs1555501389	NC_000016.10:2062542:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1305C>G (p.His435Gln)	TSC2	H398Q, H435Q, H465Q, H281Q, H416Q, H235Q, H431Q, H386Q, H446Q	Hereditary cancer-predisposing syndrome	VCV001769498	16	2112545	16	2062544	1769498	1835933	rs766461065	NC_000016.10:2062543:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1305C>T (p.His435=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413696	16	2112545	16	2062544	413696	401178	rs766461065	NC_000016.10:2062543:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1306C>T (p.Pro436Ser)	TSC2	P387S, P447S, P236S, P436S, P399S, P417S, P432S, P282S, P466S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002149449	16	2112546	16	2062545	2149449	1873967	rs1489429320	NC_000016.10:2062544:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1306C>G (p.Pro436Ala)	TSC2	P236A, P387A, P399A, P436A, P447A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001015972	16	2112546	16	2062545	1015972	1011945	rs1489429320	NC_000016.10:2062544:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1306C>A (p.Pro436Thr)	TSC2	P436T, P447T, P387T, P399T, P236T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000818862	16	2112546	16	2062545	818862	812505	rs1489429320	NC_000016.10:2062544:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1307C>A (p.Pro436Gln)	TSC2	P387Q, P236Q, P436Q, P447Q, P399Q	Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV001376226	16	2112547	16	2062546	1376226	1466759	rs796053485	NC_000016.10:2062545:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1307C>G (p.Pro436Arg)	TSC2	P236R, P387R, P399R, P436R, P447R	Tuberous sclerosis 2	VCV000863911	16	2112547	16	2062546	863911	843352	rs796053485	NC_000016.10:2062545:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1307C>T (p.Pro436Leu)	TSC2	P436L, P447L, P236L, P387L, P399L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000207713	16	2112547	16	2062546	207713	203110	rs796053485	NC_000016.10:2062545:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1308G>C (p.Pro436=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000696884	16	2112548	16	2062547	696884	684580	rs753764275	NC_000016.10:2062546:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1308G>T (p.Pro436=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000500981	16	2112548	16	2062547	500981	492405	rs753764275	NC_000016.10:2062546:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1308G>A (p.Pro436=)	TSC2		Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000378776	16	2112548	16	2062547	378776	377167	rs753764275	NC_000016.10:2062546:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1309G>C (p.Ala437Pro)	TSC2	A388P, A437P, A448P, A237P, A400P	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000818865	16	2112549	16	2062548	818865	812506	rs764967942	NC_000016.10:2062547:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1310C>T (p.Ala437Val)	TSC2	A237V, A283V, A388V, A400V, A418V, A433V, A437V, A448V, A467V	not provided	VCV002571884	16	2112550	16	2062549	2571884	2736831	rs2151164422	NC_000016.10:2062548:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1311C>T (p.Ala437=)	TSC2		Tuberous sclerosis 2	VCV002969921	16	2112551	16	2062550	2969921	3129012	rs752435039	NC_000016.10:2062549:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant|non-coding transcript variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1311C>G (p.Ala437=)	TSC2		Tuberous sclerosis 2	VCV002858100	16	2112551	16	2062550	2858100	3018146	rs752435039	NC_000016.10:2062549:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1311C>A (p.Ala437=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000467859	16	2112551	16	2062550	467859	465197	rs752435039	NC_000016.10:2062549:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1312A>C (p.Lys438Gln)	TSC2	K419Q, K434Q, K468Q, K238Q, K438Q, K449Q, K284Q, K389Q, K401Q	Hereditary cancer-predisposing syndrome	VCV002564668	16	2112552	16	2062551	2564668	2733824	rs2548546522	NC_000016.10:2062550:A:C	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1313A>G (p.Lys438Arg)	TSC2	K238R, K401R, K468R, K438R, K284R, K389R, K419R, K434R, K449R	Tuberous sclerosis 2	VCV003701379	16	2112553	16	2062552	3701379	3826627		NC_000016.10:2062551:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1314G>A (p.Lys438=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413644	16	2112554	16	2062553	413644	400779	rs201584852	NC_000016.10:2062552:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1316A>G (p.Asp439Gly)	TSC2	D239G, D285G, D390G, D402G, D420G, D435G, D439G, D450G, D469G	not provided	VCV001710845	16	2112556	16	2062555	1710845	1709256	rs2548546586	NC_000016.10:2062554:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1317C>A (p.Asp439Glu)	TSC2	D439E, D450E, D390E, D239E, D402E	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000467860	16	2112557	16	2062556	467860	466055	rs777457815	NC_000016.10:2062555:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1317C>T (p.Asp439=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000387550	16	2112557	16	2062556	387550	377170	rs777457815	NC_000016.10:2062555:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1318G>A (p.Gly440Ser)	TSC2	G440S, G391S, G403S, G240S, G451S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|not specified|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000041726	16	2112558	16	2062557	41726	50165	rs45484298	NC_000016.10:2062556:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1319G>A (p.Gly440Asp)	TSC2	G391D, G436D, G286D, G470D, G240D, G403D, G421D, G440D, G451D	Hereditary cancer-predisposing syndrome	VCV003974605	16	2112559	16	2062558	3974605	4086428		NC_000016.10:2062557:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 18, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1319G>C (p.Gly440Ala)	TSC2	G240A, G391A, G403A, G440A, G451A	Hereditary cancer-predisposing syndrome	VCV001692477	16	2112559	16	2062558	1692477	1684917	rs2151164566	NC_000016.10:2062557:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1320C>A (p.Gly440=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001157359	16	2112560	16	2062559	1157359	1145908	rs983982198	NC_000016.10:2062558:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 3, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1320C>G (p.Gly440=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413757	16	2112560	16	2062559	413757	401182	rs983982198	NC_000016.10:2062558:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1321T>C (p.Trp441Arg)	TSC2	W241R, W287R, W392R, W404R, W422R, W437R, W441R, W452R, W471R	not provided	VCV003363973	16	2112561	16	2062560	3363973	3523182		NC_000016.10:2062559:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1322G>A (p.Trp441Ter)	TSC2	W441*, W404*, W452*, W241*, W392*	Tuberous sclerosis 2	VCV000012407	16	2112562	16	2062561	12407	27446	rs45515894	NC_000016.10:2062560:G:A	single nucleotide variant	nonsense	Pathogenic	Apr 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1323G>C (p.Trp441Cys)	TSC2	W241C, W422C, W392C, W404C, W452C, W437C, W287C, W441C, W471C	Hereditary cancer-predisposing syndrome	VCV003811367	16	2112563	16	2062562	3811367	3928608		NC_000016.10:2062561:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 25, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1325T>G (p.Ile442Ser)	TSC2	I442S, I405S, I453S, I242S, I393S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000252492	16	2112565	16	2062564	252492	247113	rs879255344	NC_000016.10:2062563:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1326T>G (p.Ile442Met)	TSC2	I405M, I242M, I393M, I442M, I453M	Tuberous sclerosis 2	VCV000861959	16	2112566	16	2062565	861959	843353	rs2086776250	NC_000016.10:2062564:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1327C>G (p.Gln443Glu)	TSC2	Q243E, Q394E, Q424E, Q443E, Q473E, Q454E, Q289E, Q406E, Q439E	Tuberous sclerosis 2	VCV002138111	16	2112567	16	2062566	2138111	1868266	rs2151164702	NC_000016.10:2062565:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1327C>T (p.Gln443Ter)	TSC2	Q243*, Q394*, Q406*, Q443*, Q454*	Tuberous sclerosis 2	VCV001696844	16	2112567	16	2062566	1696844	1689241	rs2151164702	NC_000016.10:2062565:C:T	single nucleotide variant	nonsense	Pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1328A>C (p.Gln443Pro)	TSC2	Q443P, Q394P, Q439P, Q406P, Q454P, Q473P, Q243P, Q289P, Q424P	Tuberous sclerosis 2	VCV003683281	16	2112568	16	2062567	3683281	3812007		NC_000016.10:2062566:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1328A>G (p.Gln443Arg)	TSC2	Q394R, Q289R, Q406R, Q424R, Q439R, Q454R, Q243R, Q443R, Q473R	Tuberous sclerosis 2	VCV003637188	16	2112568	16	2062567	3637188	3771342		NC_000016.10:2062566:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1329G>A (p.Gln443=)	TSC2		Tuberous sclerosis 2	VCV001591587	16	2112569	16	2062568	1591587	1577703	rs1459924996	NC_000016.10:2062567:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 14, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1329G>C (p.Gln443His)	TSC2	Q443H, Q243H, Q394H, Q406H, Q454H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000572766	16	2112569	16	2062568	572766	567775	rs1459924996	NC_000016.10:2062567:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Nov 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1330A>C (p.Asn444His)	TSC2	N407H, N455H, N244H, N395H, N444H	Tuberous sclerosis 2	VCV001467683	16	2112570	16	2062569	1467683	1462065	rs2151164750	NC_000016.10:2062568:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1332C>A (p.Asn444Lys)	TSC2	N244K, N290K, N395K, N407K, N425K, N440K, N444K, N455K, N474K	not provided|Tuberous sclerosis 2	VCV002497989	16	2112572	16	2062571	2497989	2473071	rs535984356	NC_000016.10:2062570:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1332C>T (p.Asn444=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified|not provided	VCV000256618	16	2112572	16	2062571	256618	255489	rs535984356	NC_000016.10:2062570:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1332C>G (p.Asn444Lys)	TSC2	N444K, N244K, N395K, N407K, N455K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II	VCV000207714	16	2112572	16	2062571	207714	203111	rs535984356	NC_000016.10:2062570:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1333C>T (p.Leu445=)	TSC2		Tuberous sclerosis 2	VCV004071326	16	2112573	16	2062572	4071326	4185174		NC_000016.10:2062571:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1333C>G (p.Leu445Val)	TSC2	L245V, L456V, L396V, L475V, L291V, L426V, L441V, L445V, L408V	Hereditary cancer-predisposing syndrome	VCV003974699	16	2112573	16	2062572	3974699	4086522		NC_000016.10:2062571:C:G	single nucleotide variant	5 prime UTR variant|missense variant|non-coding transcript variant	Uncertain significance	Jun 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1335G>A (p.Leu445=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811353	16	2112575	16	2062574	3811353	3928594		NC_000016.10:2062573:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 31, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1335G>T (p.Leu445=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001087856	16	2112575	16	2062574	1087856	1081792	rs2151164864	NC_000016.10:2062573:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1337A>G (p.Gln446Arg)	TSC2	Q397R, Q409R, Q246R, Q292R, Q427R, Q457R, Q442R, Q446R, Q476R	Tuberous sclerosis 2	VCV002919220	16	2112577	16	2062576	2919220	3075144	rs1259157214	NC_000016.10:2062575:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1338G>A (p.Gln446=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001666733	16	2112578	16	2062577	1666733	1622158	rs2151165007	NC_000016.10:2062576:G:A	single nucleotide variant	synonymous variant	Likely benign	May 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1339G>T (p.Ala447Ser)	TSC2	A293S, A410S, A443S, A458S, A398S, A447S, A247S, A428S, A477S	Hereditary cancer-predisposing syndrome	VCV003462655	16	2112579	16	2062578	3462655	3621674		NC_000016.10:2062577:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1339G>A (p.Ala447Thr)	TSC2	A398T, A458T, A247T, A410T, A447T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000640712	16	2112579	16	2062578	640712	644185	rs1408196847	NC_000016.10:2062577:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1340C>A (p.Ala447Glu)	TSC2	A447E, A247E, A293E, A477E, A428E, A458E, A398E, A410E, A443E	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV002859297	16	2112580	16	2062579	2859297	3021911	rs45486591	NC_000016.10:2062578:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1340C>G (p.Ala447Gly)	TSC2	A447G, A247G, A398G, A458G, A410G	Tuberous sclerosis 2	VCV000535865	16	2112580	16	2062579	535865	529530	rs45486591	NC_000016.10:2062578:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1340C>T (p.Ala447Val)	TSC2	A447V, A247V, A410V, A398V, A458V	not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000041727	16	2112580	16	2062579	41727	50166	rs45486591	NC_000016.10:2062578:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1341G>T (p.Ala447=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001138694	16	2112581	16	2062580	1138694	1125035	rs141609319	NC_000016.10:2062579:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1341G>A (p.Ala447=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000386855	16	2112581	16	2062580	386855	375132	rs141609319	NC_000016.10:2062579:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1342C>T (p.Leu448=)	TSC2		Tuberous sclerosis 2	VCV002003740	16	2112582	16	2062581	2003740	2051797	rs1413875392	NC_000016.10:2062580:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jun 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1342C>G (p.Leu448Val)	TSC2	L448V, L399V, L459V, L248V, L411V	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000513426	16	2112582	16	2062581	513426	505172	rs1413875392	NC_000016.10:2062580:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1343T>C (p.Leu448Pro)	TSC2	L448P, L248P, L399P, L411P, L459P	Tuberous sclerosis 2	VCV000065281	16	2112583	16	2062582	65281	76213	rs397515206	NC_000016.10:2062581:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 7, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1345A>T (p.Met449Leu)	TSC2	M449L, M249L, M400L, M412L, M460L	not provided|Tuberous sclerosis 2	VCV000535924	16	2112585	16	2062584	535924	529574	rs1555501441	NC_000016.10:2062583:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1346T>G (p.Met449Arg)	TSC2	M412R, M460R, M249R, M449R, M400R	Tuberous sclerosis 2	VCV001517825	16	2112586	16	2062585	1517825	1420727	rs1057520875	NC_000016.10:2062584:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1346T>C (p.Met449Thr)	TSC2	M249T, M400T, M412T, M449T, M460T	Tuberous sclerosis 2	VCV001360058	16	2112586	16	2062585	1360058	1473931	rs1057520875	NC_000016.10:2062584:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1346T>A (p.Met449Lys)	TSC2	M449K, M400K, M249K, M412K, M460K	not provided|Tuberous sclerosis 2	VCV000380647	16	2112586	16	2062585	380647	374055	rs1057520875	NC_000016.10:2062584:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1347G>A (p.Met449Ile)	TSC2	M249I, M400I, M460I, M412I, M449I	Tuberous sclerosis 2	VCV000852892	16	2112587	16	2062586	852892	843356	rs45443091	NC_000016.10:2062585:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1348G>A (p.Glu450Lys)	TSC2	E250K, E296K, E2K, E401K, E413K, E431K, E446K, E450K, E461K, E480K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV003074972	16	2112588	16	2062587	3074972	3234624	rs45491095	NC_000016.10:2062586:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1348G>T (p.Glu450Ter)	TSC2	E450*, E250*, E461*, E401*, E413*	Tuberous sclerosis 2	VCV000049651	16	2112588	16	2062587	49651	58813	rs45491095	NC_000016.10:2062586:G:T	single nucleotide variant	nonsense	Pathogenic	Sep 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1350G>T (p.Glu450Asp)	TSC2	E450D, E431D, E480D, E296D, E2D, E413D, E250D, E401D, E446D, E461D	Tuberous sclerosis 2	VCV003637189	16	2112590	16	2062589	3637189	3771343		NC_000016.10:2062588:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1352G>A (p.Arg451Lys)	TSC2	R251K, R451K, R462K, R402K, R414K	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000647792	16	2112592	16	2062591	647792	644186	rs749780677	NC_000016.10:2062590:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1353A>G (p.Arg451=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467863	16	2112593	16	2062592	467863	466063	rs1555501456	NC_000016.10:2062591:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1354T>A (p.Phe452Ile)	TSC2	F252I, F298I, F403I, F415I, F433I, F448I, F452I, F463I, F482I, F4I	Tuberous sclerosis 2	VCV001721053	16	2112594	16	2062593	1721053	1775035	rs2548547453	NC_000016.10:2062592:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1355T>G (p.Phe452Cys)	TSC2	F252C, F298C, F403C, F415C, F433C, F448C, F452C, F463C, F482C, F4C	not specified	VCV003339448	16	2112595	16	2062594	3339448	3498714		NC_000016.10:2062593:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1355T>A (p.Phe452Tyr)	TSC2	F403Y, F452Y, F4Y, F298Y, F463Y, F482Y, F415Y, F433Y, F252Y, F448Y	Tuberous sclerosis 2	VCV002862159	16	2112595	16	2062594	2862159	3025810	rs2548547470	NC_000016.10:2062593:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1356C>T (p.Phe452=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002455125	16	2112596	16	2062595	2455125	2430874	rs769147552	NC_000016.10:2062594:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1356C>G (p.Phe452Leu)	TSC2	F403L, F452L, F463L, F252L, F415L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001042948	16	2112596	16	2062595	1042948	1032439	rs769147552	NC_000016.10:2062594:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1356C>A (p.Phe452Leu)	TSC2	F452L, F403L, F252L, F415L, F463L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000467864	16	2112596	16	2062595	467864	465200	rs769147552	NC_000016.10:2062594:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1359C>G (p.Phe453Leu)	TSC2	F416L, F453L, F5L, F299L, F404L, F253L, F434L, F449L, F464L, F483L	Hereditary cancer-predisposing syndrome	VCV003974656	16	2112599	16	2062598	3974656	4086479		NC_000016.10:2062597:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1359C>T (p.Phe453=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001568108	16	2112599	16	2062598	1568108	1657616	rs2151165435	NC_000016.10:2062597:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1360A>T (p.Arg454Trp)	TSC2	R405W, R450W, R6W, R254W, R300W, R417W, R465W, R435W, R454W, R484W	Hereditary cancer-predisposing syndrome	VCV001770827	16	2112600	16	2062599	1770827	1826527	rs2086780236	NC_000016.10:2062598:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1360A>C (p.Arg454=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001770822	16	2112600	16	2062599	1770822	1826522	rs2086780236	NC_000016.10:2062598:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Feb 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1360A>G (p.Arg454Gly)	TSC2	R405G, R454G, R254G, R465G, R417G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000947102	16	2112600	16	2062599	947102	927636	rs2086780236	NC_000016.10:2062598:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361G>A (p.Arg454Lys)	TSC2	R254K, R300K, R405K, R417K, R435K, R450K, R454K, R465K, R484K, R6K	Tuberous sclerosis 2	VCV003609734	16	2112601	16	2062600	3609734	3744598		NC_000016.10:2062599:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Mar 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+1G>T	TSC2		Tuberous sclerosis 2|not provided	VCV000871457	16	2112602	16	2062601	871457	860216	rs45517164	NC_000016.10:2062600:G:T	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Mar 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361+1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000049693	16	2112602	16	2062601	49693	58855	rs45517164	NC_000016.10:2062600:G:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361+2T>C	TSC2		Tuberous sclerosis 2	VCV000065150	16	2112603	16	2062602	65150	76081	rs397515301	NC_000016.10:2062601:T:C	single nucleotide variant	splice donor variant	Likely pathogenic		criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+3A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000572928	16	2112604	16	2062603	572928	569625	rs1567431655	NC_000016.10:2062602:A:G	single nucleotide variant	intron variant	Uncertain significance	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361+4G>A	TSC2		Tuberous sclerosis 2	VCV000951110	16	2112605	16	2062604	951110	941121	rs2086781300	NC_000016.10:2062603:G:A	single nucleotide variant	intron variant	Uncertain significance	Mar 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+5G>C	TSC2		Tuberous sclerosis 2	VCV003729282	16	2112606	16	2062605	3729282	3858612		NC_000016.10:2062604:G:C	single nucleotide variant	intron variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+5G>T	TSC2		Tuberous sclerosis 2	VCV002008898	16	2112606	16	2062605	2008898	2062971	rs2086781791	NC_000016.10:2062604:G:T	single nucleotide variant	intron variant	Uncertain significance	Jun 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+5G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000839758	16	2112606	16	2062605	839758	851657	rs2086781791	NC_000016.10:2062604:G:A	single nucleotide variant	intron variant	Uncertain significance	Sep 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361+6G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001023016	16	2112607	16	2062606	1023016	1011946	rs1596305980	NC_000016.10:2062605:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1361+7G>T	TSC2		Tuberous sclerosis 2	VCV000757177	16	2112608	16	2062607	757177	776485	rs1248857340	NC_000016.10:2062606:G:T	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361+8G>A	TSC2		Tuberous sclerosis 2	VCV001145785	16	2112609	16	2062608	1145785	1145909	rs1596306003	NC_000016.10:2062607:G:A	single nucleotide variant	intron variant	Likely benign	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361+8G>T	TSC2		Tuberous sclerosis 2	VCV000794826	16	2112609	16	2062608	794826	788035	rs1596306003	NC_000016.10:2062607:G:T	single nucleotide variant	intron variant	Likely benign	Aug 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+9T>C	TSC2		Tuberous sclerosis 2	VCV000467866	16	2112610	16	2062609	467866	465203	rs1041094432	NC_000016.10:2062608:T:C	single nucleotide variant	intron variant	Likely benign	Oct 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+10C>T	TSC2		Tuberous sclerosis 2	VCV000766381	16	2112611	16	2062610	766381	776154	rs1023095335	NC_000016.10:2062609:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361+11C>T	TSC2		Tuberous sclerosis 2	VCV001935602	16	2112612	16	2062611	1935602	1993189	rs2548547776	NC_000016.10:2062610:C:T	single nucleotide variant	intron variant	Likely benign	Dec 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+13C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified	VCV000516775	16	2112614	16	2062613	516775	505455	rs900870796	NC_000016.10:2062612:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1361+14T>C	TSC2		Tuberous sclerosis 2	VCV003693665	16	2112615	16	2062614	3693665	3821381		NC_000016.10:2062613:T:C	single nucleotide variant	intron variant	Likely benign	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+14T>A	TSC2		Tuberous sclerosis 2	VCV002134959	16	2112615	16	2062614	2134959	2190367	rs2548547824	NC_000016.10:2062613:T:A	single nucleotide variant	intron variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+15G>A	TSC2		Tuberous sclerosis 2	VCV001642518	16	2112616	16	2062615	1642518	1552616	rs1252164517	NC_000016.10:2062614:G:A	single nucleotide variant	intron variant	Likely benign	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+16T>G	TSC2		not provided|Tuberous sclerosis 2|not specified	VCV000137737	16	2112617	16	2062616	137737	141440	rs45502491	NC_000016.10:2062615:T:G	single nucleotide variant	intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361+17A>G	TSC2		Tuberous sclerosis 2	VCV003729704	16	2112618	16	2062617	3729704	3862482		NC_000016.10:2062616:A:G	single nucleotide variant	intron variant	Likely benign	Jan 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+18G>A	TSC2		Tuberous sclerosis 2	VCV002057037	16	2112619	16	2062618	2057037	2105859	rs140223009	NC_000016.10:2062617:G:A	single nucleotide variant	intron variant	Likely benign	Jan 7, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+18G>T	TSC2		Tuberous sclerosis 2	VCV001556605	16	2112619	16	2062618	1556605	1592749	rs140223009	NC_000016.10:2062617:G:T	single nucleotide variant	intron variant	Likely benign	Jul 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+18G>C	TSC2		not specified|not provided|Tuberous sclerosis 2	VCV000137738	16	2112619	16	2062618	137738	141441	rs140223009	NC_000016.10:2062617:G:C	single nucleotide variant	intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1361+19C>T	TSC2		Tuberous sclerosis 2	VCV002846207	16	2112620	16	2062619	2846207	3008567	rs1254535320	NC_000016.10:2062618:C:T	single nucleotide variant	intron variant	Likely benign	Mar 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+20C>T	TSC2		Tuberous sclerosis 2	VCV002144387	16	2112621	16	2062620	2144387	1876291	rs538626543	NC_000016.10:2062619:C:T	single nucleotide variant	intron variant	Likely benign	Aug 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1361+20C>G	TSC2		Tuberous sclerosis 2|not specified|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000380234	16	2112621	16	2062620	380234	374056	rs538626543	NC_000016.10:2062619:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1362-32C>G	TSC2		Tuberous sclerosis 2|not provided	VCV000049703	16	2112941	16	2062940	49703	58865	rs45517166	NC_000016.10:2062939:C:G	single nucleotide variant	intron variant	Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1362-20A>G	TSC2		Tuberous sclerosis 2	VCV002175217	16	2112953	16	2062952	2175217	1897594	rs1390894171	NC_000016.10:2062951:A:G	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1362-18C>T	TSC2		Tuberous sclerosis 2	VCV002133892	16	2112955	16	2062954	2133892	2188438	rs1453977523	NC_000016.10:2062953:C:T	single nucleotide variant	intron variant	Likely benign	May 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-17A>C	TSC2		Tuberous sclerosis 2	VCV003012408	16	2112956	16	2062955	3012408	3173997	rs2151170088	NC_000016.10:2062954:A:C	single nucleotide variant	intron variant	Likely benign	Dec 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-17A>G	TSC2		Tuberous sclerosis 2	VCV002819454	16	2112956	16	2062955	2819454	2987809	rs2151170088	NC_000016.10:2062954:A:G	single nucleotide variant	intron variant	Likely benign	Jan 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-16G>A	TSC2		Tuberous sclerosis 2	VCV001550146	16	2112957	16	2062956	1550146	1659082	rs1174276562	NC_000016.10:2062955:G:A	single nucleotide variant	intron variant	Likely benign	Jul 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-15G>T	TSC2		Tuberous sclerosis 2	VCV002166735	16	2112958	16	2062957	2166735	1895578	rs1360683344	NC_000016.10:2062956:G:T	single nucleotide variant	intron variant	Likely benign	Sep 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-15G>C	TSC2		Tuberous sclerosis 2	VCV001628516	16	2112958	16	2062957	1628516	1648160	rs1360683344	NC_000016.10:2062956:G:C	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1362-13T>C	TSC2		Tuberous sclerosis 2	VCV001541982	16	2112960	16	2062959	1541982	1545736	rs2151170217	NC_000016.10:2062958:T:C	single nucleotide variant	intron variant	Likely benign	Aug 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-12G>C	TSC2		Tuberous sclerosis 2	VCV004071297	16	2112961	16	2062960	4071297	4185145		NC_000016.10:2062959:G:C	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-12G>A	TSC2		Tuberous sclerosis 2	VCV002795478	16	2112961	16	2062960	2795478	2961351	rs1466410459	NC_000016.10:2062959:G:A	single nucleotide variant	intron variant	Likely benign	Sep 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-10C>G	TSC2		Tuberous sclerosis 2	VCV000770320	16	2112963	16	2062962	770320	778187	rs45446697	NC_000016.10:2062961:C:G	single nucleotide variant	intron variant	Likely benign	May 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-10C>T	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000389376	16	2112963	16	2062962	389376	377173	rs45446697	NC_000016.10:2062961:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1362-10C>A	TSC2		TSC2-related disorder|Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000050185	16	2112963	16	2062962	50185	59347	rs45446697	NC_000016.10:2062961:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1362-9G>T	TSC2		Tuberous sclerosis 2	VCV002831208	16	2112964	16	2062963	2831208	2991009	rs763842281	NC_000016.10:2062962:G:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-9G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000318310	16	2112964	16	2062963	318310	324612	rs763842281	NC_000016.10:2062962:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1362-8T>C	TSC2		Tuberous sclerosis 2	VCV001552699	16	2112965	16	2062964	1552699	1639304	rs2151170386	NC_000016.10:2062963:T:C	single nucleotide variant	intron variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-7C>A	TSC2		Tuberous sclerosis 2	VCV001434131	16	2112966	16	2062965	1434131	1497829	rs1555501647	NC_000016.10:2062964:C:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-7C>T	TSC2		Tuberous sclerosis 2	VCV001138408	16	2112966	16	2062965	1138408	1125036	rs1555501647	NC_000016.10:2062964:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1362-7C>G	TSC2		Tuberous sclerosis 2	VCV000535963	16	2112966	16	2062965	535963	529582	rs1555501647	NC_000016.10:2062964:C:G	single nucleotide variant	intron variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-6C>A	TSC2		Tuberous sclerosis 2	VCV001508764	16	2112967	16	2062966	1508764	1439975	rs2086820146	NC_000016.10:2062965:C:A	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-6C>T	TSC2		Tuberous sclerosis 2	VCV000963493	16	2112967	16	2062966	963493	960143	rs2086820146	NC_000016.10:2062965:C:T	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-5C>G	TSC2		Tuberous sclerosis 2	VCV000535993	16	2112968	16	2062967	535993	529583	rs372424945	NC_000016.10:2062966:C:G	single nucleotide variant	intron variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-5C>T	TSC2		Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000413673	16	2112968	16	2062967	413673	401200	rs372424945	NC_000016.10:2062966:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1362-4G>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413645	16	2112969	16	2062968	413645	400780	rs397515145	NC_000016.10:2062967:G:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1362-4G>A	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065195	16	2112969	16	2062968	65195	76127	rs397515145	NC_000016.10:2062967:G:A	single nucleotide variant	intron variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1362-3C>T	TSC2		Tuberous sclerosis 2	VCV003641080	16	2112970	16	2062969	3641080	3768798		NC_000016.10:2062968:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-3C>G	TSC2		Tuberous sclerosis 2	VCV002743878	16	2112970	16	2062969	2743878	2907231	rs2151170598	NC_000016.10:2062968:C:G	single nucleotide variant	intron variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-2A>G	TSC2		Tuberous sclerosis 2	VCV000050186	16	2112971	16	2062970	50186	59348	rs45517165	NC_000016.10:2062969:A:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Aug 31, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362-1G>A	TSC2		Tuberous sclerosis 2	VCV002736283	16	2112972	16	2062971	2736283	2894975	rs2151170644	NC_000016.10:2062970:G:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Mar 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1362G>A (p.Arg454=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001770866	16	2112973	16	2062972	1770866	1826566	rs374252944	NC_000016.10:2062971:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1362G>C (p.Arg454Ser)	TSC2	R454S, R254S, R417S, R405S, R465S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000406041	16	2112973	16	2062972	406041	400684	rs374252944	NC_000016.10:2062971:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1363A>G (p.Ser455Gly)	TSC2	S301G, S418G, S436G, S455G, S255G, S406G, S466G, S7G, S451G, S485G	Tuberous sclerosis 2	VCV002120817	16	2112974	16	2062973	2120817	2183869	rs2548552395	NC_000016.10:2062972:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1364G>A (p.Ser455Asn)	TSC2	S455N, S255N, S418N, S406N, S466N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000570246	16	2112975	16	2062974	570246	569629	rs1567432782	NC_000016.10:2062973:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1365C>T (p.Ser455=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000207658	16	2112976	16	2062975	207658	203112	rs34567401	NC_000016.10:2062974:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1366G>C (p.Glu456Gln)	TSC2	E407Q, E419Q, E256Q, E486Q, E456Q, E467Q, E302Q, E437Q, E452Q, E8Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002713362	16	2112977	16	2062976	2713362	2875660	rs397515142	NC_000016.10:2062975:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1366G>A (p.Glu456Lys)	TSC2	E456K, E256K, E419K, E407K, E467K	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000065190	16	2112977	16	2062976	65190	76122	rs397515142	NC_000016.10:2062975:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Dec 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1367A>G (p.Glu456Gly)	TSC2	E456G, E407G, E419G, E256G, E467G	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000231820	16	2112978	16	2062977	231820	235096	rs876659386	NC_000016.10:2062976:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1368G>C (p.Glu456Asp)	TSC2	E407D, E256D, E419D, E467D, E456D	Tuberous sclerosis 2	VCV001518397	16	2112979	16	2062978	1518397	1508790	rs2151170835	NC_000016.10:2062977:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1369T>C (p.Ser457Pro)	TSC2	S257P, S303P, S420P, S453P, S487P, S468P, S408P, S9P, S438P, S457P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002882066	16	2112980	16	2062979	2882066	3034255	rs2151170866	NC_000016.10:2062978:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1369T>A (p.Ser457Thr)	TSC2	S408T, S468T, S257T, S420T, S457T	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001469768	16	2112980	16	2062979	1469768	1375611	rs2151170866	NC_000016.10:2062978:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1370C>T (p.Ser457Phe)	TSC2	S408F, S468F, S457F, S257F, S420F	Tuberous sclerosis 2	VCV000864206	16	2112981	16	2062980	864206	843357	rs1278503244	NC_000016.10:2062979:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1370C>A (p.Ser457Tyr)	TSC2	S457Y, S257Y, S408Y, S420Y, S468Y	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000467867	16	2112981	16	2062980	467867	465764	rs1278503244	NC_000016.10:2062979:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1371C>G (p.Ser457=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413657	16	2112982	16	2062981	413657	401201	rs1060504093	NC_000016.10:2062980:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1372C>A (p.Arg458=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003675803	16	2112983	16	2062982	3675803	3813419		NC_000016.10:2062981:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1372C>T (p.Arg458Ter)	TSC2	R458*, R469*, R258*, R409*, R421*	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049153	16	2112983	16	2062982	49153	58315	rs45517169	NC_000016.10:2062981:C:T	single nucleotide variant	nonsense	Pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1373G>C (p.Arg458Pro)	TSC2	R10P, R258P, R304P, R409P, R421P, R439P, R454P, R458P, R469P, R488P	Hereditary cancer-predisposing syndrome|not provided	VCV003232077	16	2112984	16	2062983	3232077	3385617	rs878854077	NC_000016.10:2062982:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1373G>A (p.Arg458Gln)	TSC2	R458Q, R409Q, R469Q, R258Q, R421Q	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000237964	16	2112984	16	2062983	237964	242231	rs878854077	NC_000016.10:2062982:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1374A>G (p.Arg458=)	TSC2		Tuberous sclerosis 2	VCV004071081	16	2112985	16	2062984	4071081	4184929		NC_000016.10:2062983:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1375G>A (p.Gly459Ser)	TSC2	G11S, G259S, G410S, G455S, G489S, G305S, G422S, G470S, G440S, G459S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002699378	16	2112986	16	2062985	2699378	2865501	rs1567432890	NC_000016.10:2062984:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1375G>T (p.Gly459Cys)	TSC2	G459C, G259C, G410C, G422C, G470C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000582621	16	2112986	16	2062985	582621	567777	rs1567432890	NC_000016.10:2062984:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1376G>A (p.Gly459Asp)	TSC2	G459D, G410D, G422D, G470D, G259D	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000318311	16	2112987	16	2062986	318311	340852	rs886051788	NC_000016.10:2062985:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1377C>A (p.Gly459=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001561116	16	2112988	16	2062987	1561116	1641523	rs45517170	NC_000016.10:2062986:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1377C>G (p.Gly459=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000759787	16	2112988	16	2062987	759787	770682	rs45517170	NC_000016.10:2062986:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1377C>T (p.Gly459=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2	VCV000049154	16	2112988	16	2062987	49154	58316	rs45517170	NC_000016.10:2062986:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1378G>C (p.Ala460Pro)	TSC2	A423P, A460P, A12P, A306P, A471P, A260P, A411P, A441P, A456P, A490P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449951	16	2112989	16	2062988	2449951	2429577	rs137854154	NC_000016.10:2062987:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1378G>A (p.Ala460Thr)	TSC2	A460T, A423T, A411T, A471T, A260T	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified	VCV000049660	16	2112989	16	2062988	49660	58822	rs137854154	NC_000016.10:2062987:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1380C>A (p.Ala460=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001157925	16	2112991	16	2062990	1157925	1145910	rs1060504113	NC_000016.10:2062989:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1380C>T (p.Ala460=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000413723	16	2112991	16	2062990	413723	400690	rs1060504113	NC_000016.10:2062989:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1381G>C (p.Val461Leu)	TSC2	V261L, V424L, V461L, V472L, V412L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000937432	16	2112992	16	2062991	937432	937287	rs796053486	NC_000016.10:2062990:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1381G>A (p.Val461Met)	TSC2	V461M, V261M, V412M, V472M, V424M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000207715	16	2112992	16	2062991	207715	203113	rs796053486	NC_000016.10:2062990:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1382T>C (p.Val461Ala)	TSC2	V261A, V412A, V461A, V472A, V424A	not provided|Tuberous sclerosis 2	VCV000952267	16	2112993	16	2062992	952267	927637	rs2086823656	NC_000016.10:2062991:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1383G>A (p.Val461=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000413712	16	2112994	16	2062993	413712	401202	rs760393399	NC_000016.10:2062992:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1384C>G (p.Arg462Gly)	TSC2	R413G, R425G, R473G, R262G, R462G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000648636	16	2112995	16	2062994	648636	644187	rs397515261	NC_000016.10:2062993:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1384C>T (p.Arg462Cys)	TSC2	R462C, R413C, R425C, R473C, R262C	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000065350	16	2112995	16	2062994	65350	76284	rs397515261	NC_000016.10:2062993:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1385G>C (p.Arg462Pro)	TSC2	R262P, R443P, R462P, R14P, R425P, R473P, R308P, R413P, R458P, R492P	Tuberous sclerosis 2	VCV002779962	16	2112996	16	2062995	2779962	2947158	rs45494392	NC_000016.10:2062994:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1385G>A (p.Arg462His)	TSC2	R462H, R262H, R413H, R425H, R473H	Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000050193	16	2112996	16	2062995	50193	59355	rs45494392	NC_000016.10:2062994:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1386C>T (p.Arg462=)	TSC2		Tuberous sclerosis 2	VCV004071158	16	2112997	16	2062996	4071158	4185006		NC_000016.10:2062995:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1387A>G (p.Ile463Val)	TSC2	I463V, I414V, I474V, I263V, I426V	not specified|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049674	16	2112998	16	2062997	49674	58836	rs45517171	NC_000016.10:2062996:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1388T>A (p.Ile463Asn)	TSC2	I463N, I474N, I263N, I414N, I426N	Tuberous sclerosis 2	VCV000937992	16	2112999	16	2062998	937992	937288	rs1060500940	NC_000016.10:2062997:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1388T>G (p.Ile463Ser)	TSC2	I463S, I263S, I426S, I414S, I474S	Tuberous sclerosis 2	VCV000406027	16	2112999	16	2062998	406027	400783	rs1060500940	NC_000016.10:2062997:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1389C>A (p.Ile463=)	TSC2		Tuberous sclerosis 2	VCV001092630	16	2113000	16	2062999	1092630	1081793	rs1188230416	NC_000016.10:2062998:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 31, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1389C>G (p.Ile463Met)	TSC2	I426M, I463M, I474M, I263M, I414M	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000837633	16	2113000	16	2062999	837633	843358	rs1188230416	NC_000016.10:2062998:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1390A>C (p.Lys464Gln)	TSC2	K427Q, K475Q, K264Q, K415Q, K464Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000662892	16	2113001	16	2063000	662892	644188	rs1555501694	NC_000016.10:2062999:A:C	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1390A>G (p.Lys464Glu)	TSC2	K464E, K264E, K415E, K427E, K475E	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000467868	16	2113001	16	2063000	467868	465885	rs1555501694	NC_000016.10:2062999:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1391A>C (p.Lys464Thr)	TSC2	K415T, K464T, K494T, K16T, K445T, K264T, K310T, K427T, K460T, K475T	Tuberous sclerosis 2	VCV002856468	16	2113002	16	2063001	2856468	3007720	rs1033108057	NC_000016.10:2063000:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1391A>G (p.Lys464Arg)	TSC2	K415R, K264R, K464R, K427R, K475R	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000848781	16	2113002	16	2063001	848781	843359	rs1033108057	NC_000016.10:2063000:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1392G>A (p.Lys464=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003013131	16	2113003	16	2063002	3013131	3181224	rs2548553445	NC_000016.10:2063001:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1392G>C (p.Lys464Asn)	TSC2	K16N, K445N, K475N, K415N, K427N, K460N, K264N, K464N, K310N, K494N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002765852	16	2113003	16	2063002	2765852	2922726	rs2548553445	NC_000016.10:2063001:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1393G>T (p.Val465Leu)	TSC2	V17L, V265L, V311L, V416L, V428L, V446L, V461L, V465L, V476L, V495L	Tuberous sclerosis syndrome	VCV003069228	16	2113004	16	2063003	3069228	3229855	rs758874054	NC_000016.10:2063002:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1393G>A (p.Val465Met)	TSC2	V476M, V265M, V416M, V465M, V428M	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000848903	16	2113004	16	2063003	848903	843360	rs758874054	NC_000016.10:2063002:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1395G>A (p.Val465=)	TSC2		Tuberous sclerosis 2	VCV001083342	16	2113006	16	2063005	1083342	1081794	rs2151171914	NC_000016.10:2063004:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1396C>T (p.Leu466=)	TSC2		Tuberous sclerosis 2	VCV002830929	16	2113007	16	2063006	2830929	2990730	rs2151171934	NC_000016.10:2063005:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jan 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1397T>G (p.Leu466Arg)	TSC2	L466R, L266R, L429R, L477R, L417R	not provided	VCV000050195	16	2113008	16	2063007	50195	59357	rs45481199	NC_000016.10:2063006:T:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 14, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1397T>C (p.Leu466Pro)	TSC2	L466P, L266P, L429P, L417P, L477P	Tuberous sclerosis 2	VCV000050194	16	2113008	16	2063007	50194	59356	rs45481199	NC_000016.10:2063006:T:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 6, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1398G>C (p.Leu466=)	TSC2		Tuberous sclerosis 2	VCV004071148	16	2113009	16	2063008	4071148	4184996		NC_000016.10:2063007:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1398G>A (p.Leu466=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000237965	16	2113009	16	2063008	237965	242232	rs200702857	NC_000016.10:2063007:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1400A>G (p.Asp467Gly)	TSC2	D467G, D267G, D418G, D430G, D478G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406133	16	2113011	16	2063010	406133	400784	rs1060500977	NC_000016.10:2063009:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1401C>A (p.Asp467Glu)	TSC2	D313E, D418E, D430E, D448E, D497E, D19E, D467E, D267E, D463E, D478E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003637190	16	2113012	16	2063011	3637190	3771344		NC_000016.10:2063010:C:A	single nucleotide variant	non-coding transcript variant|intron variant|missense variant	Uncertain significance	Feb 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1401C>T (p.Asp467=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000467869	16	2113012	16	2063011	467869	465888	rs1433989426	NC_000016.10:2063010:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1402G>A (p.Val468Met)	TSC2	V419M, V268M, V468M, V479M, V431M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000655172	16	2113013	16	2063012	655172	644189	rs1158055650	NC_000016.10:2063011:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1404G>C (p.Val468=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001652494	16	2113015	16	2063014	1652494	1664407	rs778247396	NC_000016.10:2063013:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1404G>A (p.Val468=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001089230	16	2113015	16	2063014	1089230	1081795	rs778247396	NC_000016.10:2063013:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1404G>T (p.Val468=)	TSC2		Hereditary cancer-predisposing syndrome	VCV000486699	16	2113015	16	2063014	486699	477327	rs778247396	NC_000016.10:2063013:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 18, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1405C>T (p.Leu469=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000819126	16	2113016	16	2063015	819126	812507	rs1596307389	NC_000016.10:2063014:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1406T>C (p.Leu469Pro)	TSC2	L315P, L420P, L432P, L480P, L21P, L450P, L469P, L269P, L465P, L499P	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV002768404	16	2113017	16	2063016	2768404	2929572	rs2151172242	NC_000016.10:2063015:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1407G>C (p.Leu469=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001692479	16	2113018	16	2063017	1692479	1684919	rs1458720483	NC_000016.10:2063016:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Sep 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1407G>A (p.Leu469=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001115980	16	2113018	16	2063017	1115980	1103622	rs1458720483	NC_000016.10:2063016:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1410C>G (p.Ser470=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002454332	16	2113021	16	2063020	2454332	2434001	rs2151172357	NC_000016.10:2063019:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1410C>T (p.Ser470=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001089162	16	2113021	16	2063020	1089162	1081796	rs2151172357	NC_000016.10:2063019:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1411T>C (p.Phe471Leu)	TSC2	F422L, F452L, F471L, F271L, F317L, F434L, F23L, F467L, F482L, F501L	Tuberous sclerosis 2	VCV002965136	16	2113022	16	2063021	2965136	3117703	rs2548554065	NC_000016.10:2063020:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1411T>G (p.Phe471Val)	TSC2	F317V, F471V, F482V, F501V, F23V, F434V, F271V, F422V, F452V, F467V	Hereditary cancer-predisposing syndrome	VCV002564669	16	2113022	16	2063021	2564669	2733825	rs2548554065	NC_000016.10:2063020:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1412T>G (p.Phe471Cys)	TSC2	F271C, F434C, F471C, F452C, F317C, F501C, F23C, F422C, F467C, F482C	Hereditary cancer-predisposing syndrome	VCV002564670	16	2113023	16	2063022	2564670	2733826	rs2151172398	NC_000016.10:2063021:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1413T>C (p.Phe471=)	TSC2		Tuberous sclerosis 2	VCV003704671	16	2113024	16	2063023	3704671	3835538		NC_000016.10:2063022:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1414G>T (p.Val472Leu)	TSC2	V24L, V272L, V318L, V423L, V435L, V453L, V468L, V472L, V483L, V502L	Hereditary cancer-predisposing syndrome	VCV003232078	16	2113025	16	2063024	3232078	3385618	rs2151172422	NC_000016.10:2063023:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1415T>C (p.Val472Ala)	TSC2	V24A, V272A, V318A, V423A, V435A, V453A, V468A, V472A, V483A, V502A	Hereditary cancer-predisposing syndrome	VCV003232079	16	2113026	16	2063025	3232079	3385619	rs2151172463	NC_000016.10:2063024:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1415T>G (p.Val472Gly)	TSC2	V483G, V272G, V423G, V472G, V435G	Tuberous sclerosis 2	VCV001489567	16	2113026	16	2063025	1489567	1495173	rs2151172463	NC_000016.10:2063024:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1416G>A (p.Val472=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000819159	16	2113027	16	2063026	819159	812508	rs1596307406	NC_000016.10:2063025:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1417C>T (p.Leu473=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001103056	16	2113028	16	2063027	1103056	1103623	rs1321215329	NC_000016.10:2063026:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1417C>G (p.Leu473Val)	TSC2	L473V, L424V, L436V, L484V, L273V	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467870	16	2113028	16	2063027	467870	465212	rs1321215329	NC_000016.10:2063026:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1418T>C (p.Leu473Pro)	TSC2	L273P, L424P, L436P, L473P, L484P	Hereditary cancer-predisposing syndrome|not provided	VCV001308796	16	2113029	16	2063028	1308796	1300824	rs2086830486	NC_000016.10:2063027:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1418T>A (p.Leu473Gln)	TSC2	L484Q, L273Q, L424Q, L436Q, L473Q	Tuberous sclerosis 2	VCV000849129	16	2113029	16	2063028	849129	843361	rs2086830486	NC_000016.10:2063027:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1419G>C (p.Leu473=)	TSC2		Tuberous sclerosis 2	VCV003645438	16	2113030	16	2063029	3645438	3783853		NC_000016.10:2063028:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1419G>T (p.Leu473=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV001939247	16	2113030	16	2063029	1939247	2000704	rs1365563478	NC_000016.10:2063028:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Sep 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1420C>G (p.Leu474Val)	TSC2	L26V, L274V, L320V, L437V, L485V, L425V, L474V, L470V, L455V, L504V	Hereditary cancer-predisposing syndrome	VCV003329507	16	2113031	16	2063030	3329507	3489099		NC_000016.10:2063029:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1422C>G (p.Leu474=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811325	16	2113033	16	2063032	3811325	3928566		NC_000016.10:2063031:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jan 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1422C>T (p.Leu474=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000760000	16	2113033	16	2063032	760000	770683	rs565646854	NC_000016.10:2063031:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1423A>G (p.Ile475Val)	TSC2	I275V, I426V, I438V, I475V, I486V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II	VCV001009685	16	2113034	16	2063033	1009685	996705	rs1196710568	NC_000016.10:2063032:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1425C>T (p.Ile475=)	TSC2		Tuberous sclerosis 2	VCV001559567	16	2113036	16	2063035	1559567	1542158	rs1596307430	NC_000016.10:2063034:C:T	single nucleotide variant	synonymous variant	Likely benign	May 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1425C>G (p.Ile475Met)	TSC2	I438M, I475M, I275M, I426M, I486M	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000654039	16	2113036	16	2063035	654039	644190	rs1596307430	NC_000016.10:2063034:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1426A>C (p.Asn476His)	TSC2	N276H, N322H, N457H, N427H, N472H, N476H, N506H, N439H, N487H, N28H	Tuberous sclerosis 2	VCV002106627	16	2113037	16	2063036	2106627	2159336	rs2151172872	NC_000016.10:2063035:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1427A>G (p.Asn476Ser)	TSC2	N427S, N439S, N472S, N487S, N322S, N476S, N28S, N506S, N276S, N457S	Hereditary cancer-predisposing syndrome	VCV003974601	16	2113038	16	2063037	3974601	4086424		NC_000016.10:2063036:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1427A>C (p.Asn476Thr)	TSC2	N427T, N439T, N476T, N276T, N487T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001515504	16	2113038	16	2063037	1515504	1505369	rs2086831741	NC_000016.10:2063036:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1428C>T (p.Asn476=)	TSC2		Tuberous sclerosis 2	VCV001668737	16	2113039	16	2063038	1668737	1634111	rs2151172933	NC_000016.10:2063037:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1429A>G (p.Arg477Gly)	TSC2	R277G, R29G, R323G, R428G, R440G, R458G, R473G, R477G, R488G, R507G	Tuberous sclerosis 2	VCV001714163	16	2113040	16	2063039	1714163	1773434	rs2548554590	NC_000016.10:2063038:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1430G>A (p.Arg477Lys)	TSC2	R277K, R323K, R428K, R477K, R29K, R440K, R458K, R473K, R488K, R507K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003637191	16	2113041	16	2063040	3637191	3771345		NC_000016.10:2063039:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1431G>A (p.Arg477=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003811327	16	2113042	16	2063041	3811327	3928568		NC_000016.10:2063040:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1432C>A (p.Gln478Lys)	TSC2	Q324K, Q429K, Q278K, Q441K, Q478K, Q508K, Q459K, Q474K, Q30K, Q489K	Tuberous sclerosis 2	VCV002851543	16	2113043	16	2063042	2851543	3006220	rs121964862	NC_000016.10:2063041:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1432C>G (p.Gln478Glu)	TSC2	Q441E, Q429E, Q278E, Q478E, Q489E	Hereditary cancer-predisposing syndrome	VCV000819200	16	2113043	16	2063042	819200	812509	rs121964862	NC_000016.10:2063041:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1432C>T (p.Gln478Ter)	TSC2	Q478*, Q489*, Q429*, Q441*, Q278*	Tuberous sclerosis 2|not provided	VCV000012399	16	2113043	16	2063042	12399	27438	rs121964862	NC_000016.10:2063041:C:T	single nucleotide variant	nonsense	Pathogenic	Feb 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1433A>T (p.Gln478Leu)	TSC2	Q474L, Q278L, Q459L, Q508L, Q30L, Q324L, Q441L, Q429L, Q478L, Q489L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449998	16	2113044	16	2063043	2449998	2425955	rs1555501733	NC_000016.10:2063042:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1433A>G (p.Gln478Arg)	TSC2	Q478R, Q489R, Q441R, Q278R, Q429R	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467871	16	2113044	16	2063043	467871	465771	rs1555501733	NC_000016.10:2063042:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1434G>T (p.Gln478His)	TSC2	Q278H, Q474H, Q429H, Q478H, Q489H, Q30H, Q324H, Q441H, Q459H, Q508H	Tuberous sclerosis 2	VCV003637192	16	2113045	16	2063044	3637192	3771346		NC_000016.10:2063043:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1434G>A (p.Gln478=)	TSC2		Tuberous sclerosis 2	VCV000467872	16	2113045	16	2063044	467872	465216	rs1555501735	NC_000016.10:2063043:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1435T>C (p.Phe479Leu)	TSC2	F279L, F430L, F490L, F442L, F479L	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001428927	16	2113046	16	2063045	1428927	1457891	rs2151173141	NC_000016.10:2063044:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1437C>T (p.Phe479=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811336	16	2113048	16	2063047	3811336	3928577		NC_000016.10:2063046:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1437C>G (p.Phe479Leu)	TSC2	F442L, F509L, F430L, F479L, F490L, F460L, F475L, F279L, F31L, F325L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002199714	16	2113048	16	2063047	2199714	1924560	rs2086832508	NC_000016.10:2063046:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1439A>G (p.Tyr480Cys)	TSC2	Y431C, Y443C, Y280C, Y480C, Y491C	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000955674	16	2113050	16	2063049	955674	949231	rs2086832697	NC_000016.10:2063048:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1440T>C (p.Tyr480=)	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000381057	16	2113051	16	2063050	381057	375141	rs45514794	NC_000016.10:2063049:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1440T>G (p.Tyr480Ter)	TSC2	Y480*, Y443*, Y431*, Y491*, Y280*	Tuberous sclerosis 2	VCV000049158	16	2113051	16	2063050	49158	58320	rs45514794	NC_000016.10:2063049:T:G	single nucleotide variant	nonsense	Pathogenic	Jun 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1441G>A (p.Glu481Lys)	TSC2	E481K, E492K, E327K, E432K, E281K, E444K, E462K, E477K, E33K, E511K	Hereditary cancer-predisposing syndrome	VCV003811305	16	2113052	16	2063051	3811305	3928546		NC_000016.10:2063050:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1442A>G (p.Glu481Gly)	TSC2	E432G, E327G, E33G, E462G, E477G, E281G, E511G, E444G, E481G, E492G	Tuberous sclerosis 2	VCV001953438	16	2113053	16	2063052	1953438	2010998	rs2151173333	NC_000016.10:2063051:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443G>T (p.Glu481Asp)	TSC2	E281D, E33D, E432D, E444D, E511D, E327D, E477D, E462D, E481D, E492D	Tuberous sclerosis 2	VCV002760443	16	2113054	16	2063053	2760443	2921623	rs137854876	NC_000016.10:2063052:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Likely pathogenic	Jul 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443G>A (p.Glu481=)	TSC2		Tuberous sclerosis 2	VCV000049743	16	2113054	16	2063053	49743	58905	rs137854876	NC_000016.10:2063052:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jul 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+1G>A	TSC2		Tuberous sclerosis 2|not provided	VCV002121635	16	2113055	16	2063054	2121635	2176829	rs397515257	NC_000016.10:2063053:G:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Feb 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+1G>T	TSC2		Tuberous sclerosis 2	VCV000065346	16	2113055	16	2063054	65346	76279	rs397515257	NC_000016.10:2063053:G:T	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Dec 12, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+2T>C	TSC2		Tuberous sclerosis 2	VCV002107068	16	2113056	16	2063055	2107068	2170122	rs397515064	NC_000016.10:2063054:T:C	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Nov 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+2T>A	TSC2		not provided|Tuberous sclerosis 2	VCV001333076	16	2113056	16	2063055	1333076	1323832	rs397515064	NC_000016.10:2063054:T:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic	Nov 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+3G>T	TSC2		Tuberous sclerosis 2	VCV003655087	16	2113057	16	2063056	3655087	3789230		NC_000016.10:2063055:G:T	single nucleotide variant	intron variant	Uncertain significance	May 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+3G>A	TSC2		Tuberous sclerosis 2	VCV002041181	16	2113057	16	2063056	2041181	2095203	rs1433599550	NC_000016.10:2063055:G:A	single nucleotide variant	intron variant	Likely benign	Aug 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+4C>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001612155	16	2113058	16	2063057	1612155	1535783	rs45517172	NC_000016.10:2063056:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1443+4C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001021118	16	2113058	16	2063057	1021118	1011947	rs45517172	NC_000016.10:2063056:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1443+4C>T	TSC2		not provided|Hereditary cancer-predisposing syndrome|Dystonia, early-onset, and/or spastic paraplegia|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000049742	16	2113058	16	2063057	49742	58904	rs45517172	NC_000016.10:2063056:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1443+5G>C	TSC2		not provided|Tuberous sclerosis 2	VCV000489133	16	2113059	16	2063058	489133	482091	rs1057521562	NC_000016.10:2063057:G:C	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+5G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II	VCV000383238	16	2113059	16	2063058	383238	377174	rs1057521562	NC_000016.10:2063057:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 28, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1443+7G>A	TSC2		Tuberous sclerosis 2	VCV000467873	16	2113061	16	2063060	467873	465889	rs950216832	NC_000016.10:2063059:G:A	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+8T>A	TSC2		Tuberous sclerosis 2	VCV002837932	16	2113062	16	2063061	2837932	2992650	rs1412278532	NC_000016.10:2063060:T:A	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+8T>G	TSC2		Tuberous sclerosis 2	VCV002714208	16	2113062	16	2063061	2714208	2868746	rs1412278532	NC_000016.10:2063060:T:G	single nucleotide variant	intron variant	Likely benign	Jan 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+9C>T	TSC2		Tuberous sclerosis 2	VCV004071274	16	2113063	16	2063062	4071274	4185122		NC_000016.10:2063061:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+9C>G	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001664740	16	2113063	16	2063062	1664740	1557103	rs2151173612	NC_000016.10:2063061:C:G	single nucleotide variant	intron variant	Likely benign	Oct 20, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+10C>G	TSC2		Tuberous sclerosis 2	VCV001611703	16	2113064	16	2063063	1611703	1552219	rs1222870951	NC_000016.10:2063062:C:G	single nucleotide variant	intron variant	Likely benign	Oct 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+10C>T	TSC2		Tuberous sclerosis 2	VCV001156154	16	2113064	16	2063063	1156154	1145911	rs1222870951	NC_000016.10:2063062:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+11A>G	TSC2		Tuberous sclerosis 2	VCV003681552	16	2113065	16	2063064	3681552	3811573		NC_000016.10:2063063:A:G	single nucleotide variant	intron variant	Likely benign	May 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+12G>C	TSC2		Tuberous sclerosis 2	VCV001544909	16	2113066	16	2063065	1544909	1644315	rs771129412	NC_000016.10:2063064:G:C	single nucleotide variant	intron variant	Likely benign	Jan 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+13G>A	TSC2		Tuberous sclerosis 2	VCV001626212	16	2113067	16	2063066	1626212	1575426	rs1215320121	NC_000016.10:2063065:G:A	single nucleotide variant	intron variant	Likely benign	Mar 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+14C>A	TSC2		not specified|Tuberous sclerosis 2	VCV000507068	16	2113068	16	2063067	507068	505457	rs753454333	NC_000016.10:2063066:C:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+14C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000378777	16	2113068	16	2063067	378777	375143	rs753454333	NC_000016.10:2063066:C:T	single nucleotide variant	intron variant	Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+15G>A	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not specified|Tuberous sclerosis 2	VCV000378778	16	2113069	16	2063068	378778	377176	rs182743311	NC_000016.10:2063067:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+16G>A	TSC2		Tuberous sclerosis 2	VCV002713880	16	2113070	16	2063069	2713880	2872303	rs371644025	NC_000016.10:2063068:G:A	single nucleotide variant	intron variant	Likely benign	Jan 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+16G>T	TSC2		Tuberous sclerosis 2	VCV001572638	16	2113070	16	2063069	1572638	1658257	rs371644025	NC_000016.10:2063068:G:T	single nucleotide variant	intron variant	Likely benign	Nov 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+18C>G	TSC2		Tuberous sclerosis 2	VCV003693390	16	2113072	16	2063071	3693390	3824725		NC_000016.10:2063070:C:G	single nucleotide variant	intron variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+18C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not specified|not provided	VCV000064938	16	2113072	16	2063071	64938	75868	rs375947241	NC_000016.10:2063070:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+19G>A	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001586898	16	2113073	16	2063072	1586898	1628838	rs1219381067	NC_000016.10:2063071:G:A	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1443+65T>G	TSC2		not provided	VCV001194899	16	2113119	16	2063118	1194899	1185070	rs115599333	NC_000016.10:2063117:T:G	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+255C>T	TSC2		not provided	VCV000679777	16	2113309	16	2063308	679777	667386	rs116134738	NC_000016.10:2063307:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1443+256G>A	TSC2		not provided	VCV000679761	16	2113310	16	2063309	679761	668190	rs114236708	NC_000016.10:2063308:G:A	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-283G>A	TSC2		not provided	VCV001190662	16	2113990	16	2063989	1190662	1181346	rs575523507	NC_000016.10:2063988:G:A	single nucleotide variant	intron variant	Likely benign	Jul 6, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-273G>A	TSC2		not provided	VCV003340835	16	2114000	16	2063999	3340835	3500074		NC_000016.10:2063998:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-232C>T	TSC2		not provided	VCV000676866	16	2114041	16	2064040	676866	668669	rs4335770	NC_000016.10:2064039:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-201G>A	TSC2		not provided	VCV000677255	16	2114072	16	2064071	677255	668671	rs60763712	NC_000016.10:2064070:G:A	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-151C>T	TSC2		not provided	VCV000677677	16	2114122	16	2064121	677677	667390	rs116269447	NC_000016.10:2064120:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-100A>G	TSC2		not provided	VCV001206859	16	2114173	16	2064172	1206859	1198738	rs114861515	NC_000016.10:2064171:A:G	single nucleotide variant	intron variant	Likely benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-29G>T	TSC2		Hereditary cancer-predisposing syndrome	VCV001692480	16	2114244	16	2064243	1692480	1684920	rs778300365	NC_000016.10:2064242:G:T	single nucleotide variant	intron variant	Likely benign	Feb 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-20C>T	TSC2		Tuberous sclerosis 2	VCV002708665	16	2114253	16	2064252	2708665	2870956	rs2548568988	NC_000016.10:2064251:C:T	single nucleotide variant	intron variant	Likely benign	Jan 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-19C>T	TSC2		Tuberous sclerosis 2	VCV003695008	16	2114254	16	2064253	3695008	3825046		NC_000016.10:2064252:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-17C>T	TSC2		Tuberous sclerosis 2	VCV004071298	16	2114256	16	2064255	4071298	4185146		NC_000016.10:2064254:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-17C>G	TSC2		Tuberous sclerosis 2	VCV002744871	16	2114256	16	2064255	2744871	2897034	rs757560701	NC_000016.10:2064254:C:G	single nucleotide variant	intron variant	Likely benign	Jul 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-16C>T	TSC2		Tuberous sclerosis 2	VCV004071133	16	2114257	16	2064256	4071133	4184981		NC_000016.10:2064255:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-15C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002799967	16	2114258	16	2064257	2799967	2955905	rs781524288	NC_000016.10:2064256:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-15C>G	TSC2		Tuberous sclerosis 2	VCV002199363	16	2114258	16	2064257	2199363	1927630	rs781524288	NC_000016.10:2064256:C:G	single nucleotide variant	intron variant	Likely benign	Jul 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-14T>C	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050126	16	2114259	16	2064258	50126	59288	rs45517173	NC_000016.10:2064257:T:C	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-13T>C	TSC2		not provided|Tuberous sclerosis 2	VCV000049744	16	2114260	16	2064259	49744	58906	rs45447093	NC_000016.10:2064258:T:C	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-12G>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001624689	16	2114261	16	2064260	1624689	1629308	rs566516726	NC_000016.10:2064259:G:A	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-10G>T	TSC2		Tuberous sclerosis 2	VCV004071092	16	2114263	16	2064262	4071092	4184940		NC_000016.10:2064261:G:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-10G>A	TSC2		Tuberous sclerosis 2	VCV003616755	16	2114263	16	2064262	3616755	3749722		NC_000016.10:2064261:G:A	single nucleotide variant	intron variant	Likely benign	May 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-9C>A	TSC2		Tuberous sclerosis 2	VCV002018551	16	2114264	16	2064263	2018551	2072634	rs780055493	NC_000016.10:2064262:C:A	single nucleotide variant	intron variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-9C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000467874	16	2114264	16	2064263	467874	465221	rs780055493	NC_000016.10:2064262:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-8C>T	TSC2		Tuberous sclerosis 2	VCV000738623	16	2114265	16	2064264	738623	760423	rs749236601	NC_000016.10:2064263:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-7T>G	TSC2		Tuberous sclerosis 2	VCV003640539	16	2114266	16	2064265	3640539	3772124		NC_000016.10:2064264:T:G	single nucleotide variant	intron variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-7T>C	TSC2		Tuberous sclerosis 2	VCV001150482	16	2114266	16	2064265	1150482	1145912	rs2151188110	NC_000016.10:2064264:T:C	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-6G>T	TSC2		Tuberous sclerosis 2	VCV002123999	16	2114267	16	2064266	2123999	2174127	rs2548569250	NC_000016.10:2064265:G:T	single nucleotide variant	intron variant	Uncertain significance	Apr 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-5T>A	TSC2		Tuberous sclerosis 2	VCV001002343	16	2114268	16	2064267	1002343	996706	rs2087005659	NC_000016.10:2064266:T:A	single nucleotide variant	intron variant	Uncertain significance	Feb 11, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-4G>A	TSC2		Tuberous sclerosis 2	VCV004071021	16	2114269	16	2064268	4071021	4184869		NC_000016.10:2064267:G:A	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-4G>T	TSC2		Tuberous sclerosis 2	VCV002004154	16	2114269	16	2064268	2004154	2062089	rs2548569301	NC_000016.10:2064267:G:T	single nucleotide variant	intron variant	Likely benign	Jun 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-3C>A	TSC2		Tuberous sclerosis 2	VCV001961448	16	2114270	16	2064269	1961448	2020294	rs1484617931	NC_000016.10:2064268:C:A	single nucleotide variant	intron variant	Uncertain significance	Oct 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444-3C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001399112	16	2114270	16	2064269	1399112	1450408	rs1484617931	NC_000016.10:2064268:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-2A>G	TSC2		Tuberous sclerosis 2|not provided	VCV000049633	16	2114271	16	2064270	49633	58795	rs45517174	NC_000016.10:2064269:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Dec 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1444-1G>A	TSC2		Tuberous sclerosis 2	VCV000050127	16	2114272	16	2064271	50127	59289	rs45515902	NC_000016.10:2064270:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444G>A (p.Glu482Lys)	TSC2	E282K, E328K, E34K, E433K, E445K, E463K, E478K, E482K, E493K, E512K	Tuberous sclerosis 2	VCV001720774	16	2114273	16	2064272	1720774	1776956	rs1308965961	NC_000016.10:2064271:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1444G>C (p.Glu482Gln)	TSC2	E282Q, E482Q, E433Q, E493Q, E445Q	not provided|Tuberous sclerosis 2	VCV000944549	16	2114273	16	2064272	944549	927639	rs1308965961	NC_000016.10:2064271:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1446G>A (p.Glu482=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001128971	16	2114275	16	2064274	1128971	1125037	rs2151188264	NC_000016.10:2064273:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1447G>C (p.Glu483Gln)	TSC2	E446Q, E494Q, E434Q, E483Q, E283Q	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001424794	16	2114276	16	2064275	1424794	1353301	rs397515297	NC_000016.10:2064274:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1447G>T (p.Glu483Ter)	TSC2	E483*, E434*, E494*, E283*, E446*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000064885	16	2114276	16	2064275	64885	75815	rs397515297	NC_000016.10:2064274:G:T	single nucleotide variant	nonsense	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1449G>T (p.Glu483Asp)	TSC2	E283D, E329D, E35D, E483D, E434D, E464D, E513D, E446D, E479D, E494D	Hereditary cancer-predisposing syndrome	VCV003974650	16	2114278	16	2064277	3974650	4086473		NC_000016.10:2064276:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 11, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1449G>C (p.Glu483Asp)	TSC2	E329D, E446D, E464D, E479D, E513D, E283D, E35D, E494D, E434D, E483D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001772871	16	2114278	16	2064277	1772871	1836714	rs768511587	NC_000016.10:2064276:G:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1449G>A (p.Glu483=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000705328	16	2114278	16	2064277	705328	693806	rs768511587	NC_000016.10:2064276:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1450C>T (p.Leu484=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV001146384	16	2114279	16	2064278	1146384	1145913	rs2087007486	NC_000016.10:2064277:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1452G>C (p.Leu484=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811342	16	2114281	16	2064280	3811342	3928583		NC_000016.10:2064279:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1452G>A (p.Leu484=)	TSC2		Tuberous sclerosis 2	VCV001094797	16	2114281	16	2064280	1094797	1081797	rs2087007660	NC_000016.10:2064279:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1453A>G (p.Ile485Val)	TSC2	I436V, I285V, I496V, I515V, I37V, I466V, I481V, I485V, I331V, I448V	Hereditary cancer-predisposing syndrome	VCV001772993	16	2114282	16	2064281	1772993	1836836	rs2151188401	NC_000016.10:2064280:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1453A>T (p.Ile485Phe)	TSC2	I285F, I436F, I485F, I448F, I496F	Tuberous sclerosis 2	VCV001441338	16	2114282	16	2064281	1441338	1358607	rs2151188401	NC_000016.10:2064280:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1454T>A (p.Ile485Asn)	TSC2	I285N, I436N, I448N, I485N, I496N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001022250	16	2114283	16	2064282	1022250	1011948	rs774265657	NC_000016.10:2064281:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1455T>A (p.Ile485=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003649739	16	2114284	16	2064283	3649739	3777701		NC_000016.10:2064282:T:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1455T>C (p.Ile485=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000514829	16	2114284	16	2064283	514829	505173	rs1239743041	NC_000016.10:2064282:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1456A>T (p.Asn486Tyr)	TSC2	N437Y, N497Y, N332Y, N482Y, N486Y, N449Y, N286Y, N38Y, N467Y, N516Y	Hereditary cancer-predisposing syndrome	VCV001773056	16	2114285	16	2064284	1773056	1832951	rs2548569650	NC_000016.10:2064283:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1457A>T (p.Asn486Ile)	TSC2	N486I, N449I, N437I, N497I, N286I	Tuberous sclerosis 2	VCV000049788	16	2114286	16	2064285	49788	58950	rs45486599	NC_000016.10:2064284:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1458C>T (p.Asn486=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000819267	16	2114287	16	2064286	819267	812510	rs200532154	NC_000016.10:2064285:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1458C>G (p.Asn486Lys)	TSC2	N486K, N286K, N497K, N449K, N437K	not specified|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000041728	16	2114287	16	2064286	41728	50167	rs200532154	NC_000016.10:2064285:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1459T>A (p.Ser487Thr)	TSC2	S468T, S483T, S287T, S39T, S487T, S498T, S517T, S333T, S438T, S450T	Hereditary cancer-predisposing syndrome	VCV001773110	16	2114288	16	2064287	1773110	1833005	rs2548569776	NC_000016.10:2064286:T:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1460C>G (p.Ser487Ter)	TSC2	S287*, S333*, S39*, S438*, S450*, S468*, S483*, S487*, S498*, S517*	Tuberous sclerosis 2	VCV003362709	16	2114289	16	2064288	3362709	3521918		NC_000016.10:2064287:C:G	single nucleotide variant	nonsense|5 prime UTR variant|non-coding transcript variant	Pathogenic	Sep 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1460C>T (p.Ser487Leu)	TSC2	S450L, S438L, S487L, S498L, S287L	Tuberous sclerosis 2	VCV001449690	16	2114289	16	2064288	1449690	1416746	rs2151188579	NC_000016.10:2064287:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1461A>G (p.Ser487=)	TSC2		Tuberous sclerosis 2	VCV004071036	16	2114290	16	2064289	4071036	4184884		NC_000016.10:2064288:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1461A>C (p.Ser487=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811350	16	2114290	16	2064289	3811350	3928591		NC_000016.10:2064288:A:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1461A>T (p.Ser487=)	TSC2		Tuberous sclerosis 2	VCV003006820	16	2114290	16	2064289	3006820	3161941	rs2548569798	NC_000016.10:2064288:A:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Sep 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1462G>A (p.Val488Met)	TSC2	V451M, V484M, V488M, V288M, V499M, V40M, V439M, V334M, V469M, V518M	Tuberous sclerosis 2	VCV002726921	16	2114291	16	2064290	2726921	2886111	rs2151188599	NC_000016.10:2064289:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1463T>C (p.Val488Ala)	TSC2	V488A, V288A, V499A, V451A, V439A	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000568181	16	2114292	16	2064291	568181	567779	rs760205499	NC_000016.10:2064290:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1464G>C (p.Val488=)	TSC2		Tuberous sclerosis 2	VCV000799235	16	2114293	16	2064292	799235	785183	rs1596311870	NC_000016.10:2064291:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1466T>G (p.Val489Gly)	TSC2	V519G, V335G, V440G, V485G, V500G, V289G, V452G, V470G, V489G, V41G	Tuberous sclerosis 2	VCV003637193	16	2114295	16	2064294	3637193	3771347		NC_000016.10:2064293:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1467C>T (p.Val489=)	TSC2		Tuberous sclerosis 2	VCV003669547	16	2114296	16	2064295	3669547	3792754		NC_000016.10:2064294:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1467C>G (p.Val489=)	TSC2		Tuberous sclerosis 2	VCV002127387	16	2114296	16	2064295	2127387	2174925	rs2151188723	NC_000016.10:2064294:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1468A>G (p.Ile490Val)	TSC2	I490V, I290V, I441V, I453V, I501V	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000049159	16	2114297	16	2064296	49159	58321	rs45517175	NC_000016.10:2064295:A:G	single nucleotide variant	missense variant	Uncertain significance	May 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1469T>C (p.Ile490Thr)	TSC2	I441T, I520T, I42T, I490T, I501T, I290T, I336T, I453T, I486T, I471T	Tuberous sclerosis 2	VCV002747062	16	2114298	16	2064297	2747062	2907822	rs2548570094	NC_000016.10:2064296:T:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1470C>T (p.Ile490=)	TSC2		Tuberous sclerosis 2	VCV004071136	16	2114299	16	2064298	4071136	4184984		NC_000016.10:2064297:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1470C>A (p.Ile490=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000745186	16	2114299	16	2064298	745186	754984	rs753344988	NC_000016.10:2064297:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1470C>G (p.Ile490Met)	TSC2	I441M, I290M, I490M, I453M, I501M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000654316	16	2114299	16	2064298	654316	644191	rs753344988	NC_000016.10:2064297:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1472C>T (p.Ser491Leu)	TSC2	S491L, S442L, S454L, S291L, S502L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406025	16	2114301	16	2064300	406025	401207	rs45517176	NC_000016.10:2064299:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1473G>C (p.Ser491=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001773414	16	2114302	16	2064301	1773414	1833308	rs764767361	NC_000016.10:2064300:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1473G>T (p.Ser491=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001631745	16	2114302	16	2064301	1631745	1597547	rs764767361	NC_000016.10:2064300:G:T	single nucleotide variant	synonymous variant	Likely benign	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1473G>A (p.Ser491=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000392976	16	2114302	16	2064301	392976	375158	rs764767361	NC_000016.10:2064300:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1474C>T (p.Gln492Ter)	TSC2	Q492*, Q503*, Q455*, Q443*, Q292*	not provided|Tuberous sclerosis 2	VCV000405998	16	2114303	16	2064302	405998	400786	rs1060500931	NC_000016.10:2064301:C:T	single nucleotide variant	nonsense	Pathogenic	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1476G>C (p.Gln492His)	TSC2	Q292H, Q443H, Q455H, Q492H, Q503H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000973205	16	2114305	16	2064304	973205	961580	rs1596311941	NC_000016.10:2064303:G:C	single nucleotide variant	missense variant	Uncertain significance	May 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1476G>A (p.Gln492=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000819289	16	2114305	16	2064304	819289	812511	rs1596311941	NC_000016.10:2064303:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1477C>T (p.Leu493Phe)	TSC2	L493F, L293F, L504F, L444F, L456F	not provided|Tuberous sclerosis 2	VCV000207716	16	2114306	16	2064305	207716	203114	rs45517177	NC_000016.10:2064304:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1477C>G (p.Leu493Val)	TSC2	L493V, L444V, L456V, L504V, L293V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049161	16	2114306	16	2064305	49161	58323	rs45517177	NC_000016.10:2064304:C:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1478T>C (p.Leu493Pro)	TSC2	L493P, L293P, L456P, L444P, L504P	Tuberous sclerosis 2	VCV000065045	16	2114307	16	2064306	65045	75975	rs397515029	NC_000016.10:2064305:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1479C>G (p.Leu493=)	TSC2		Tuberous sclerosis 2	VCV000799338	16	2114308	16	2064307	799338	785184	rs137854145	NC_000016.10:2064306:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1479C>T (p.Leu493=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049635	16	2114308	16	2064307	49635	58797	rs137854145	NC_000016.10:2064306:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1480T>C (p.Ser494Pro)	TSC2	S494P, S445P, S457P, S294P, S505P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467876	16	2114309	16	2064308	467876	465779	rs1555502412	NC_000016.10:2064307:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1481C>A (p.Ser494Tyr)	TSC2	S294Y, S505Y, S340Y, S445Y, S46Y, S524Y, S475Y, S494Y, S457Y, S490Y	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001773574	16	2114310	16	2064309	1773574	1830080	rs751984707	NC_000016.10:2064308:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1481C>T (p.Ser494Phe)	TSC2	S494F, S457F, S505F, S294F, S445F	not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000423778	16	2114310	16	2064309	423778	409479	rs751984707	NC_000016.10:2064308:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1482C>T (p.Ser494=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001133493	16	2114311	16	2064310	1133493	1125038	rs549189961	NC_000016.10:2064309:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 12, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1482C>G (p.Ser494=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000819338	16	2114311	16	2064310	819338	812512	rs549189961	NC_000016.10:2064309:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1483C>T (p.His495Tyr)	TSC2	H458Y, H495Y, H506Y, H295Y, H446Y	Tuberous sclerosis 2	VCV001372634	16	2114312	16	2064311	1372634	1440012	rs2087013241	NC_000016.10:2064310:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1483C>G (p.His495Asp)	TSC2	H295D, H446D, H495D, H458D, H506D	Tuberous sclerosis 2	VCV000836131	16	2114312	16	2064311	836131	843362	rs2087013241	NC_000016.10:2064310:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1485C>T (p.His495=)	TSC2		Tuberous sclerosis 2|not provided	VCV001694776	16	2114314	16	2064313	1694776	1687208	rs2151189170	NC_000016.10:2064312:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1486A>T (p.Ile496Phe)	TSC2	I447F, I296F, I48F, I492F, I496F, I507F, I342F, I477F, I459F, I526F	Hereditary cancer-predisposing syndrome	VCV003329505	16	2114315	16	2064314	3329505	3489097		NC_000016.10:2064313:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1486A>G (p.Ile496Val)	TSC2	I447V, I477V, I48V, I459V, I526V, I296V, I342V, I492V, I496V, I507V	Tuberous sclerosis 2	VCV002131757	16	2114315	16	2064314	2131757	2189745	rs1211121251	NC_000016.10:2064313:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1486A>C (p.Ile496Leu)	TSC2	I296L, I507L, I447L, I459L, I496L	Tuberous sclerosis 2	VCV000952746	16	2114315	16	2064314	952746	927640	rs1211121251	NC_000016.10:2064313:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1487T>A (p.Ile496Asn)	TSC2	I342N, I526N, I459N, I477N, I48N, I296N, I447N, I492N, I496N, I507N	Hereditary cancer-predisposing syndrome	VCV002564671	16	2114316	16	2064315	2564671	2733827	rs2548570491	NC_000016.10:2064314:T:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1488C>T (p.Ile496=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000740203	16	2114317	16	2064316	740203	754985	rs1596312013	NC_000016.10:2064315:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1489C>T (p.Pro497Ser)	TSC2	P297S, P497S, P508S, P527S, P343S, P460S, P478S, P448S, P493S, P49S	Tuberous sclerosis 2	VCV003637194	16	2114318	16	2064317	3637194	3771348		NC_000016.10:2064316:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1489C>A (p.Pro497Thr)	TSC2	P297T, P493T, P343T, P508T, P527T, P448T, P478T, P497T, P460T, P49T	Tuberous sclerosis 2	VCV003002068	16	2114318	16	2064317	3002068	3157245	rs2548570569	NC_000016.10:2064316:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1490C>A (p.Pro497His)	TSC2	P448H, P497H, P508H, P460H, P297H	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|TSC2-related disorder|Hereditary cancer-predisposing syndrome	VCV000660968	16	2114319	16	2064318	660968	644192	rs1484576810	NC_000016.10:2064317:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1490C>T (p.Pro497Leu)	TSC2	P460L, P297L, P497L, P448L, P508L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000643571	16	2114319	16	2064318	643571	644193	rs1484576810	NC_000016.10:2064317:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1491C>G (p.Pro497=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536086	16	2114320	16	2064319	536086	529912	rs781367910	NC_000016.10:2064318:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1491C>T (p.Pro497=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000413658	16	2114320	16	2064319	413658	400695	rs781367910	NC_000016.10:2064318:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1492G>A (p.Glu498Lys)	TSC2	E498K, E449K, E298K, E461K, E509K	Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000064986	16	2114321	16	2064320	64986	75916	rs45517178	NC_000016.10:2064319:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1492G>T (p.Glu498Ter)	TSC2	E498*, E449*, E461*, E298*, E509*	Tuberous sclerosis 2	VCV000049637	16	2114321	16	2064320	49637	58799	rs45517178	NC_000016.10:2064319:G:T	single nucleotide variant	nonsense	Pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1494G>A (p.Glu498=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000486618	16	2114323	16	2064322	486618	477452	rs780112077	NC_000016.10:2064321:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1495G>C (p.Asp499His)	TSC2	D299H, D510H, D462H, D499H, D450H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000951812	16	2114324	16	2064323	951812	927641	rs1555502438	NC_000016.10:2064322:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1495G>A (p.Asp499Asn)	TSC2	D499N, D299N, D450N, D462N, D510N	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000467877	16	2114324	16	2064323	467877	465892	rs1555502438	NC_000016.10:2064322:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1496A>G (p.Asp499Gly)	TSC2	D299G, D345G, D450G, D462G, D480G, D495G, D499G, D510G, D51G, D529G	Hereditary cancer-predisposing syndrome	VCV003232080	16	2114325	16	2064324	3232080	3385620	rs749434353	NC_000016.10:2064323:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1497T>G (p.Asp499Glu)	TSC2	D299E, D450E, D462E, D499E, D510E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001024862	16	2114326	16	2064325	1024862	1011949	rs1354915682	NC_000016.10:2064324:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1498A>G (p.Lys500Glu)	TSC2	K451E, K511E, K300E, K500E, K463E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001499419	16	2114327	16	2064326	1499419	1389122	rs2151189527	NC_000016.10:2064325:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1501G>A (p.Asp501Asn)	TSC2	D482N, D512N, D301N, D497N, D531N, D347N, D452N, D464N, D501N, D53N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001774028	16	2114330	16	2064329	1774028	1827134	rs2151189570	NC_000016.10:2064328:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1502A>T (p.Asp501Val)	TSC2	D301V, D452V, D464V, D501V, D512V	not provided	VCV001326828	16	2114331	16	2064330	1326828	1317187	rs2151189595	NC_000016.10:2064329:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1503C>T (p.Asp501=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001141225	16	2114332	16	2064331	1141225	1145914	rs2087016490	NC_000016.10:2064330:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1504C>A (p.His502Asn)	TSC2	H302N, H502N, H453N, H465N, H513N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000836730	16	2114333	16	2064332	836730	843363	rs1567437505	NC_000016.10:2064331:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1504C>T (p.His502Tyr)	TSC2	H502Y, H465Y, H513Y, H302Y, H453Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000569655	16	2114333	16	2064332	569655	567787	rs1567437505	NC_000016.10:2064331:C:T	single nucleotide variant	missense variant	Uncertain significance	May 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1506C>T (p.His502=)	TSC2		Tuberous sclerosis 2	VCV003009625	16	2114335	16	2064334	3009625	3180316	rs2548570951	NC_000016.10:2064333:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1506C>A (p.His502Gln)	TSC2	H348Q, H498Q, H54Q, H453Q, H483Q, H502Q, H532Q, H302Q, H465Q, H513Q	Hereditary cancer-predisposing syndrome	VCV001774086	16	2114335	16	2064334	1774086	1827192	rs2548570951	NC_000016.10:2064333:C:A	single nucleotide variant	missense variant	Uncertain significance	May 19, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1507C>G (p.Gln503Glu)	TSC2	Q303E, Q454E, Q466E, Q503E, Q514E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001001714	16	2114336	16	2064335	1001714	996707	rs397514929	NC_000016.10:2064334:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1507C>T (p.Gln503Ter)	TSC2	Q503*, Q303*, Q466*, Q514*, Q454*	not provided	VCV000064909	16	2114336	16	2064335	64909	75839	rs397514929	NC_000016.10:2064334:C:T	single nucleotide variant	nonsense	Pathogenic	Dec 17, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1508A>G (p.Gln503Arg)	TSC2	Q503R, Q303R, Q466R, Q454R, Q514R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000572117	16	2114337	16	2064336	572117	570073	rs1567437568	NC_000016.10:2064335:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1509G>C (p.Gln503His)	TSC2	Q349H, Q503H, Q514H, Q533H, Q303H, Q454H, Q499H, Q55H, Q466H, Q484H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001774140	16	2114338	16	2064337	1774140	1827246	rs2151189853	NC_000016.10:2064336:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1509G>A (p.Gln503=)	TSC2		Tuberous sclerosis 2	VCV001125210	16	2114338	16	2064337	1125210	1125039	rs2151189853	NC_000016.10:2064336:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1510G>T (p.Val504Phe)	TSC2	V515F, V467F, V304F, V455F, V504F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001518722	16	2114339	16	2064338	1518722	1509115	rs768707639	NC_000016.10:2064337:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1512C>A (p.Val504=)	TSC2		Tuberous sclerosis 2	VCV000759625	16	2114341	16	2064340	759625	770684	rs146359990	NC_000016.10:2064339:C:A	single nucleotide variant	synonymous variant	Likely benign	May 5, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1512C>T (p.Val504=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000732708	16	2114341	16	2064340	732708	740017	rs146359990	NC_000016.10:2064339:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1512C>G (p.Val504=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000141670	16	2114341	16	2064340	141670	151384	rs146359990	NC_000016.10:2064339:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1513C>G (p.Arg505Gly)	TSC2	R505G, R456G, R468G, R305G, R516G	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467878	16	2114342	16	2064341	467878	466064	rs45517179	NC_000016.10:2064340:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1513C>T (p.Arg505Ter)	TSC2	R505*, R305*, R468*, R516*, R456*	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000012396	16	2114342	16	2064341	12396	27435	rs45517179	NC_000016.10:2064340:C:T	single nucleotide variant	nonsense	Pathogenic	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1514G>A (p.Arg505Gln)	TSC2	R505Q, R456Q, R468Q, R305Q, R516Q	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000064996	16	2114343	16	2064342	64996	75926	rs376285784	NC_000016.10:2064341:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1517A>G (p.Lys506Arg)	TSC2	K306R, K506R, K517R, K536R, K457R, K352R, K469R, K502R, K487R, K58R	Tuberous sclerosis 2	VCV002796531	16	2114346	16	2064345	2796531	2955069	rs2548571150	NC_000016.10:2064344:A:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1518G>T (p.Lys506Asn)	TSC2	K487N, K517N, K536N, K306N, K457N, K502N, K506N, K58N, K352N, K469N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449990	16	2114347	16	2064346	2449990	2425947	rs2548571166	NC_000016.10:2064345:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1519C>G (p.Leu507Val)	TSC2	L353V, L488V, L458V, L503V, L537V, L307V, L59V, L470V, L507V, L518V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002861923	16	2114348	16	2064347	2861923	3029285	rs2087019774	NC_000016.10:2064346:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1519C>T (p.Leu507=)	TSC2		Tuberous sclerosis 2	VCV002754135	16	2114348	16	2064347	2754135	2916603	rs2087019774	NC_000016.10:2064346:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1520T>C (p.Leu507Pro)	TSC2	L507P, L458P, L307P, L470P, L518P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000860604	16	2114349	16	2064348	860604	843364	rs1413063599	NC_000016.10:2064347:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1521G>A (p.Leu507=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001534363	16	2114350	16	2064349	1534363	1647931	rs2151190089	NC_000016.10:2064348:G:A	single nucleotide variant	synonymous variant	Likely benign	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1521G>T (p.Leu507=)	TSC2		Tuberous sclerosis 2	VCV001127752	16	2114350	16	2064349	1127752	1125040	rs2151190089	NC_000016.10:2064348:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 1, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1522G>C (p.Ala508Pro)	TSC2	A308P, A459P, A489P, A504P, A508P, A60P, A519P, A538P, A354P, A471P	Tuberous sclerosis 2	VCV002706252	16	2114351	16	2064350	2706252	2877577	rs2087020192	NC_000016.10:2064349:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1522G>T (p.Ala508Ser)	TSC2	A504S, A508S, A519S, A538S, A354S, A489S, A60S, A308S, A459S, A471S	Hereditary cancer-predisposing syndrome	VCV002587623	16	2114351	16	2064350	2587623	2763961	rs2087020192	NC_000016.10:2064349:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1522G>A (p.Ala508Thr)	TSC2	A308T, A459T, A471T, A519T, A508T	Tuberous sclerosis 2	VCV001034894	16	2114351	16	2064350	1034894	1032440	rs2087020192	NC_000016.10:2064349:G:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1523C>A (p.Ala508Asp)	TSC2	A508D, A354D, A519D, A308D, A538D, A60D, A459D, A471D, A489D, A504D	Tuberous sclerosis 2	VCV002835640	16	2114352	16	2064351	2835640	2995472	rs1336558090	NC_000016.10:2064350:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Apr 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1523C>T (p.Ala508Val)	TSC2	A354V, A471V, A489V, A504V, A519V, A459V, A60V, A308V, A508V, A538V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002146440	16	2114352	16	2064351	2146440	1873544	rs1336558090	NC_000016.10:2064350:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1524C>G (p.Ala508=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811373	16	2114353	16	2064352	3811373	3928614		NC_000016.10:2064351:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Mar 7, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1524C>T (p.Ala508=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001639799	16	2114353	16	2064352	1639799	1571219	rs2151190194	NC_000016.10:2064351:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1525A>G (p.Thr509Ala)	TSC2	T509A, T460A, T309A, T472A, T520A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001413068	16	2114354	16	2064353	1413068	1356665	rs1042656602	NC_000016.10:2064352:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1526C>G (p.Thr509Ser)	TSC2	T309S, T460S, T472S, T509S, T520S	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001056722	16	2114355	16	2064354	1056722	1049427	rs2151190252	NC_000016.10:2064353:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1527C>T (p.Thr509=)	TSC2		Tuberous sclerosis 2	VCV004071187	16	2114356	16	2064355	4071187	4185035		NC_000016.10:2064354:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1527C>A (p.Thr509=)	TSC2		Tuberous sclerosis 2	VCV002010416	16	2114356	16	2064355	2010416	2067080	rs2151190276	NC_000016.10:2064354:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jun 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1527C>G (p.Thr509=)	TSC2		Tuberous sclerosis 2	VCV001082094	16	2114356	16	2064355	1082094	1081798	rs2151190276	NC_000016.10:2064354:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 22, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1528C>T (p.Gln510Ter)	TSC2	Q310*, Q356*, Q461*, Q473*, Q491*, Q506*, Q510*, Q521*, Q540*, Q62*	Lymphangiomyomatosis	VCV001810234	16	2114357	16	2064356	1810234	1867236	rs2151190319	NC_000016.10:2064355:C:T	single nucleotide variant	nonsense	Pathogenic	Oct 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1529A>G (p.Gln510Arg)	TSC2	Q310R, Q461R, Q473R, Q510R, Q521R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000819461	16	2114358	16	2064357	819461	812514	rs1596312182	NC_000016.10:2064356:A:G	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1529A>C (p.Gln510Pro)	TSC2	Q521P, Q461P, Q473P, Q310P, Q510P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000819460	16	2114358	16	2064357	819460	812513	rs1596312182	NC_000016.10:2064356:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1530G>A (p.Gln510=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002199782	16	2114359	16	2064358	2199782	1924629	rs1360209954	NC_000016.10:2064357:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1530G>C (p.Gln510His)	TSC2	Q510H, Q461H, Q310H, Q473H, Q521H	Tuberous sclerosis 2	VCV001482036	16	2114359	16	2064358	1482036	1445272	rs1360209954	NC_000016.10:2064357:G:C	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1533G>C (p.Leu511Phe)	TSC2	L311F, L357F, L462F, L474F, L492F, L507F, L511F, L522F, L541F, L63F	Tuberous sclerosis 2	VCV001720529	16	2114362	16	2064361	1720529	1776711	rs771932622	NC_000016.10:2064360:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1533G>A (p.Leu511=)	TSC2		Tuberous sclerosis 2	VCV001616222	16	2114362	16	2064361	1616222	1526412	rs771932622	NC_000016.10:2064360:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1533G>T (p.Leu511Phe)	TSC2	L462F, L522F, L311F, L474F, L511F	Tuberous sclerosis 2	VCV000655069	16	2114362	16	2064361	655069	644194	rs771932622	NC_000016.10:2064360:G:T	single nucleotide variant	missense variant	Benign	Nov 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1534C>A (p.Leu512Met)	TSC2	L475M, L493M, L508M, L542M, L512M, L64M, L358M, L463M, L312M, L523M	Hereditary cancer-predisposing syndrome	VCV002497443	16	2114363	16	2064362	2497443	2472526	rs772834557	NC_000016.10:2064361:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1534C>T (p.Leu512=)	TSC2		Tuberous sclerosis 2	VCV001926186	16	2114363	16	2064362	1926186	1980335	rs772834557	NC_000016.10:2064361:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1534C>G (p.Leu512Val)	TSC2	L512V, L523V, L463V, L312V, L475V	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207717	16	2114363	16	2064362	207717	203115	rs772834557	NC_000016.10:2064361:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1536G>A (p.Leu512=)	TSC2		Tuberous sclerosis 2	VCV004071310	16	2114365	16	2064364	4071310	4185158		NC_000016.10:2064363:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1536G>C (p.Leu512=)	TSC2		Tuberous sclerosis 2	VCV001565484	16	2114365	16	2064364	1565484	1621556	rs2151190487	NC_000016.10:2064363:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1537G>A (p.Val513Met)	TSC2	V476M, V513M, V524M, V359M, V464M, V543M, V313M, V509M, V494M, V65M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002751313	16	2114366	16	2064365	2751313	2908609	rs2548571584	NC_000016.10:2064364:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1539G>A (p.Val513=)	TSC2		Tuberous sclerosis 2	VCV004071055	16	2114368	16	2064367	4071055	4184903		NC_000016.10:2064366:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1539G>T (p.Val513=)	TSC2		Tuberous sclerosis 2	VCV001540115	16	2114368	16	2064367	1540115	1544733	rs2087022460	NC_000016.10:2064366:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1540G>C (p.Asp514His)	TSC2	D314H, D495H, D66H, D514H, D544H, D477H, D360H, D465H, D510H, D525H	Tuberous sclerosis 2	VCV003668084	16	2114369	16	2064368	3668084	3792589		NC_000016.10:2064367:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1541A>G (p.Asp514Gly)	TSC2	D477G, D514G, D314G, D465G, D525G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001046824	16	2114370	16	2064369	1046824	1032441	rs2087022663	NC_000016.10:2064368:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1542C>T (p.Asp514=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692481	16	2114371	16	2064370	1692481	1684921	rs2151190617	NC_000016.10:2064369:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1542C>G (p.Asp514Glu)	TSC2	D525E, D314E, D477E, D465E, D514E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001462576	16	2114371	16	2064370	1462576	1432979	rs2151190617	NC_000016.10:2064369:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1543C>T (p.Leu515=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000065170	16	2114372	16	2064371	65170	76101	rs35896166	NC_000016.10:2064370:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1545G>A (p.Leu515=)	TSC2		Tuberous sclerosis 2	VCV003003337	16	2114374	16	2064373	3003337	3164871	rs2548571705	NC_000016.10:2064372:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1545G>C (p.Leu515=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001774924	16	2114374	16	2064373	1774924	1833509	rs2548571705	NC_000016.10:2064372:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1546G>T (p.Ala516Ser)	TSC2	A467S, A527S, A316S, A479S, A516S	Tuberous sclerosis 2	VCV001496366	16	2114375	16	2064374	1496366	1359398	rs2151190732	NC_000016.10:2064373:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1547C>T (p.Ala516Val)	TSC2	A467V, A516V, A316V, A479V, A527V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001443337	16	2114376	16	2064375	1443337	1384283	rs2151190764	NC_000016.10:2064374:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1548A>G (p.Ala516=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001108022	16	2114377	16	2064376	1108022	1103624	rs2151190793	NC_000016.10:2064375:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1549G>C (p.Glu517Gln)	TSC2	E468Q, E498Q, E547Q, E317Q, E480Q, E363Q, E513Q, E517Q, E69Q, E528Q	Hereditary cancer-predisposing syndrome	VCV001775001	16	2114378	16	2064377	1775001	1833586	rs1555502518	NC_000016.10:2064376:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1549G>T (p.Glu517Ter)	TSC2	E517*, E528*, E468*, E317*, E480*	Tuberous sclerosis 2	VCV000467879	16	2114378	16	2064377	467879	465227	rs1555502518	NC_000016.10:2064376:G:T	single nucleotide variant	nonsense	Pathogenic	Jun 22, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1551G>A (p.Glu517=)	TSC2		Tuberous sclerosis 2	VCV002737843	16	2114380	16	2064379	2737843	2899490	rs1567437828	NC_000016.10:2064378:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1553G>T (p.Gly518Val)	TSC2	G318V, G469V, G481V, G518V, G529V	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000819497	16	2114382	16	2064381	819497	812515	rs1229407025	NC_000016.10:2064380:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1554C>A (p.Gly518=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000726632	16	2114383	16	2064382	726632	740018	rs1274545629	NC_000016.10:2064381:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1555T>G (p.Cys519Gly)	TSC2	C470G, C319G, C482G, C519G, C530G	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000963958	16	2114384	16	2064383	963958	949232	rs1156554876	NC_000016.10:2064382:T:G	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1556G>C (p.Cys519Ser)	TSC2	C319S, C470S, C530S, C365S, C519S, C549S, C482S, C500S, C515S, C71S	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002852190	16	2114385	16	2064384	2852190	3016518	rs2151191042	NC_000016.10:2064383:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1557C>T (p.Cys519=)	TSC2		Tuberous sclerosis syndrome	VCV003071821	16	2114386	16	2064385	3071821	3234086	rs2548571987	NC_000016.10:2064384:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jun 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1559A>C (p.His520Pro)	TSC2	H320P, H366P, H471P, H483P, H501P, H516P, H520P, H531P, H550P, H72P	Hereditary cancer-predisposing syndrome	VCV003232081	16	2114388	16	2064387	3232081	3385621	rs1220672669	NC_000016.10:2064386:A:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1559A>G (p.His520Arg)	TSC2	H471R, H520R, H320R, H483R, H531R	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000846290	16	2114388	16	2064387	846290	843365	rs1220672669	NC_000016.10:2064386:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1560C>G (p.His520Gln)	TSC2	H471Q, H483Q, H520Q, H531Q, H320Q	Tuberous sclerosis 2	VCV000834343	16	2114389	16	2064388	834343	843366	rs1596312329	NC_000016.10:2064387:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1560C>T (p.His520=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000759033	16	2114389	16	2064388	759033	770685	rs1596312329	NC_000016.10:2064387:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1561A>G (p.Thr521Ala)	TSC2	T484A, T532A, T321A, T521A, T472A	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000850751	16	2114390	16	2064389	850751	843367	rs1279109316	NC_000016.10:2064388:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1562C>T (p.Thr521Ile)	TSC2	T502I, T321I, T517I, T472I, T484I, T521I, T532I, T551I, T367I, T73I	Hereditary cancer-predisposing syndrome	VCV002626418	16	2114391	16	2064390	2626418	2794184	rs1378972928	NC_000016.10:2064389:C:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1562C>G (p.Thr521Arg)	TSC2	T484R, T321R, T472R, T521R, T532R	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000846105	16	2114391	16	2064390	846105	843368	rs1378972928	NC_000016.10:2064389:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1563A>G (p.Thr521=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001775306	16	2114392	16	2064391	1775306	1830503	rs1464352573	NC_000016.10:2064390:A:G	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jun 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1563A>T (p.Thr521=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001624713	16	2114392	16	2064391	1624713	1629332	rs1464352573	NC_000016.10:2064390:A:T	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1564C>G (p.His522Asp)	TSC2	H522D, H473D, H533D, H322D, H485D	Tuberous sclerosis 2	VCV001387023	16	2114393	16	2064392	1387023	1381388	rs397514991	NC_000016.10:2064391:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1564C>T (p.His522Tyr)	TSC2	H522Y, H533Y, H322Y, H473Y, H485Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000064992	16	2114393	16	2064392	64992	75922	rs397514991	NC_000016.10:2064391:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1565A>G (p.His522Arg)	TSC2	H522R, H322R, H533R, H473R, H485R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486677	16	2114394	16	2064393	486677	477459	rs397515147	NC_000016.10:2064392:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1566C>A (p.His522Gln)	TSC2	H368Q, H552Q, H74Q, H473Q, H503Q, H518Q, H533Q, H485Q, H522Q, H322Q	Tuberous sclerosis 2	VCV002852110	16	2114395	16	2064394	2852110	3016438	rs876659982	NC_000016.10:2064393:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Dec 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1566C>G (p.His522Gln)	TSC2	H368Q, H533Q, H552Q, H74Q, H473Q, H518Q, H322Q, H485Q, H503Q, H522Q	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002813045	16	2114395	16	2064394	2813045	2972847	rs876659982	NC_000016.10:2064393:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1566C>T (p.His522=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000232771	16	2114395	16	2064394	232771	235097	rs876659982	NC_000016.10:2064393:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1567C>T (p.His523Tyr)	TSC2	H523Y, H534Y, H474Y, H486Y, H323Y	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000581779	16	2114396	16	2064395	581779	573787	rs1567438108	NC_000016.10:2064394:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1569C>G (p.His523Gln)	TSC2	H323Q, H474Q, H486Q, H523Q, H534Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001005663	16	2114398	16	2064397	1005663	996708	rs1420211177	NC_000016.10:2064396:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1569C>T (p.His523=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000755664	16	2114398	16	2064397	755664	770686	rs1420211177	NC_000016.10:2064396:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1572C>G (p.Phe524Leu)	TSC2	F475L, F324L, F535L, F487L, F524L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001470313	16	2114401	16	2064400	1470313	1372275	rs2151191560	NC_000016.10:2064399:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1574A>G (p.Asn525Ser)	TSC2	N525S, N536S, N488S, N325S, N476S	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000049681	16	2114403	16	2064402	49681	58843	rs45457694	NC_000016.10:2064401:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1575C>T (p.Asn525=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413668	16	2114404	16	2064403	413668	400700	rs1060504098	NC_000016.10:2064402:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1577G>A (p.Ser526Asn)	TSC2	S526N, S477N, S537N, S326N, S489N	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405944	16	2114406	16	2064405	405944	400789	rs376573446	NC_000016.10:2064404:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1577G>C (p.Ser526Thr)	TSC2	S526T, S477T, S537T, S326T, S489T	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000207659	16	2114406	16	2064405	207659	203117	rs376573446	NC_000016.10:2064404:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1578C>A (p.Ser526Arg)	TSC2	S326R, S372R, S477R, S489R, S507R, S522R, S526R, S537R, S556R, S78R	Hereditary cancer-predisposing syndrome	VCV003232082	16	2114407	16	2064406	3232082	3385622	rs34012042	NC_000016.10:2064405:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1578C>T (p.Ser526=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049162	16	2114407	16	2064406	49162	58324	rs34012042	NC_000016.10:2064405:C:T	single nucleotide variant	synonymous variant	Benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1579C>T (p.Leu527=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001129728	16	2114408	16	2064407	1129728	1125041	rs762173463	NC_000016.10:2064406:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1581G>A (p.Leu527=)	TSC2		Tuberous sclerosis 2	VCV002090574	16	2114410	16	2064409	2090574	2148378	rs2151191739	NC_000016.10:2064408:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1582C>G (p.Leu528Val)	TSC2	L374V, L479V, L491V, L80V, L328V, L509V, L528V, L558V, L524V, L539V	Tuberous sclerosis 2	VCV002752998	16	2114411	16	2064410	2752998	2908996	rs2151191760	NC_000016.10:2064409:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1583T>C (p.Leu528Pro)	TSC2	L528P, L328P, L491P, L539P, L479P	Tuberous sclerosis 2|not provided	VCV000064901	16	2114412	16	2064411	64901	75831	rs397514922	NC_000016.10:2064410:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1584G>A (p.Leu528=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000704768	16	2114413	16	2064412	704768	693807	rs1478821497	NC_000016.10:2064411:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1585G>A (p.Asp529Asn)	TSC2	D329N, D529N, D492N, D525N, D540N, D559N, D375N, D480N, D510N, D81N	Hereditary cancer-predisposing syndrome	VCV003974651	16	2114414	16	2064413	3974651	4086474		NC_000016.10:2064412:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 11, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1585G>C (p.Asp529His)	TSC2	D559H, D81H, D480H, D492H, D510H, D540H, D525H, D529H, D329H, D375H	Tuberous sclerosis 2	VCV003675909	16	2114414	16	2064413	3675909	3813525		NC_000016.10:2064412:G:C	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1585G>T (p.Asp529Tyr)	TSC2	D529Y, D540Y, D492Y, D329Y, D480Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000591296	16	2114414	16	2064413	591296	582289	rs1567438280	NC_000016.10:2064412:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1588A>G (p.Ile530Val)	TSC2	I530V, I493V, I330V, I541V, I481V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000187099	16	2114417	16	2064416	187099	184124	rs786203470	NC_000016.10:2064415:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1589T>C (p.Ile530Thr)	TSC2	I493T, I330T, I530T, I541T, I481T	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001481581	16	2114418	16	2064417	1481581	1367099	rs2151191974	NC_000016.10:2064416:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1590C>T (p.Ile530=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462637	16	2114419	16	2064418	3462637	3621656		NC_000016.10:2064417:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Sep 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1590C>A (p.Ile530=)	TSC2		Tuberous sclerosis 2	VCV002816651	16	2114419	16	2064418	2816651	2984153	rs2151191998	NC_000016.10:2064417:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1590C>G (p.Ile530Met)	TSC2	I330M, I481M, I493M, I530M, I541M	Tuberous sclerosis 2	VCV001058628	16	2114419	16	2064418	1058628	1049428	rs2151191998	NC_000016.10:2064417:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1591A>T (p.Ile531Phe)	TSC2	I331F, I377F, I531F, I494F, I512F, I527F, I542F, I83F, I482F, I561F	Hereditary cancer-predisposing syndrome	VCV003462540	16	2114420	16	2064419	3462540	3621560		NC_000016.10:2064418:A:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1591A>G (p.Ile531Val)	TSC2	I482V, I531V, I542V, I494V, I331V	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000864062	16	2114420	16	2064419	864062	843370	rs1309168496	NC_000016.10:2064418:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1593C>A (p.Ile531=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232083	16	2114422	16	2064421	3232083	3385623	rs45517180	NC_000016.10:2064420:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1593C>G (p.Ile531Met)	TSC2	I531M, I331M, I482M, I542M, I494M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000421682	16	2114422	16	2064421	421682	409480	rs45517180	NC_000016.10:2064420:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1593C>T (p.Ile531=)	TSC2		not provided|not specified|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000049163	16	2114422	16	2064421	49163	58325	rs45517180	NC_000016.10:2064420:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1594G>C (p.Glu532Gln)	TSC2	E332Q, E483Q, E532Q, E543Q, E495Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000838403	16	2114423	16	2064422	838403	843371	rs149222396	NC_000016.10:2064421:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1594G>A (p.Glu532Lys)	TSC2	E532K, E483K, E332K, E495K, E543K	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207718	16	2114423	16	2064422	207718	203118	rs149222396	NC_000016.10:2064421:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1596G>A (p.Glu532=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000760197	16	2114425	16	2064424	760197	770687	rs756466484	NC_000016.10:2064423:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1599G>T (p.Lys533Asn)	TSC2	K333N, K379N, K484N, K496N, K514N, K529N, K533N, K544N, K563N, K85N	not provided	VCV004083472	16	2114428	16	2064427	4083472	4196157		NC_000016.10:2064426:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Mar 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599G>A (p.Lys533=)	TSC2		Tuberous sclerosis 2	VCV000049686	16	2114428	16	2064427	49686	58848	rs1555502589	NC_000016.10:2064426:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Apr 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+1G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000049646	16	2114429	16	2064428	49646	58808	rs45517182	NC_000016.10:2064427:G:A	single nucleotide variant	splice donor variant	Pathogenic	Aug 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1599+2T>G	TSC2		Tuberous sclerosis 2	VCV002741633	16	2114430	16	2064429	2741633	2896384	rs45517183	NC_000016.10:2064428:T:G	single nucleotide variant	splice donor variant	Pathogenic	Nov 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+2T>C	TSC2		Hereditary cancer-predisposing syndrome	VCV000049647	16	2114430	16	2064429	49647	58809	rs45517183	NC_000016.10:2064428:T:C	single nucleotide variant	splice donor variant	Pathogenic	Feb 17, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+3G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001776049	16	2114431	16	2064430	1776049	1827848	rs2548573185	NC_000016.10:2064429:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1599+4A>T	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV003578788	16	2114432	16	2064431	3578788	3708210		NC_000016.10:2064430:A:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1599+4A>C	TSC2		Tuberous sclerosis 2	VCV001700634	16	2114432	16	2064431	1700634	1693028	rs2151192256	NC_000016.10:2064430:A:C	single nucleotide variant	intron variant	Pathogenic	Aug 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+5G>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001709027	16	2114433	16	2064432	1709027	1707381	rs397515100	NC_000016.10:2064431:G:C	single nucleotide variant	intron variant	Uncertain significance	May 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1599+5G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000065133	16	2114433	16	2064432	65133	76064	rs397515100	NC_000016.10:2064431:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 10, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1599+7G>A	TSC2		Tuberous sclerosis 2	VCV001636596	16	2114435	16	2064434	1636596	1558503	rs1261800438	NC_000016.10:2064433:G:A	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1599+8C>A	TSC2		Tuberous sclerosis 2	VCV000536032	16	2114436	16	2064435	536032	530121	rs780311327	NC_000016.10:2064434:C:A	single nucleotide variant	intron variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1599+8C>T	TSC2		Tuberous sclerosis 2	VCV000467881	16	2114436	16	2064435	467881	465232	rs780311327	NC_000016.10:2064434:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1599+9C>A	TSC2		Tuberous sclerosis 2	VCV002779374	16	2114437	16	2064436	2779374	2937071	rs776274603	NC_000016.10:2064435:C:A	single nucleotide variant	intron variant	Likely benign	Dec 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+9C>T	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000467883	16	2114437	16	2064436	467883	466070	rs776274603	NC_000016.10:2064435:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1599+10G>A	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000237967	16	2114438	16	2064437	237967	242233	rs376692777	NC_000016.10:2064436:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1599+12T>C	TSC2		Tuberous sclerosis 2	VCV001672503	16	2114440	16	2064439	1672503	1616758	rs554900745	NC_000016.10:2064438:T:C	single nucleotide variant	intron variant	Likely benign	Mar 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+13G>T	TSC2		Tuberous sclerosis 2	VCV002753497	16	2114441	16	2064440	2753497	2919864	rs2087038678	NC_000016.10:2064439:G:T	single nucleotide variant	intron variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+14T>C	TSC2		Tuberous sclerosis 2	VCV002727980	16	2114442	16	2064441	2727980	2889318	rs2087038956	NC_000016.10:2064440:T:C	single nucleotide variant	intron variant	Likely benign	Feb 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+15A>T	TSC2		Tuberous sclerosis 2	VCV003647624	16	2114443	16	2064442	3647624	3780917		NC_000016.10:2064441:A:T	single nucleotide variant	intron variant	Likely benign	Mar 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+16C>A	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001585597	16	2114444	16	2064443	1585597	1540113	rs45517181	NC_000016.10:2064442:C:A	single nucleotide variant	intron variant	Likely benign	Jan 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1599+16C>T	TSC2		Tuberous sclerosis 2	VCV000049164	16	2114444	16	2064443	49164	58326	rs45517181	NC_000016.10:2064442:C:T	single nucleotide variant	intron variant	Likely benign	Dec 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+17C>G	TSC2		Tuberous sclerosis 2	VCV002750766	16	2114445	16	2064444	2750766	2915829	rs1438908951	NC_000016.10:2064443:C:G	single nucleotide variant	intron variant	Likely benign	Aug 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+17C>A	TSC2		Tuberous sclerosis 2	VCV001577948	16	2114445	16	2064444	1577948	1522376	rs1438908951	NC_000016.10:2064443:C:A	single nucleotide variant	intron variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+17C>T	TSC2		Tuberous sclerosis 2	VCV001565992	16	2114445	16	2064444	1565992	1655930	rs1438908951	NC_000016.10:2064443:C:T	single nucleotide variant	intron variant	Likely benign	Aug 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+18C>G	TSC2		Tuberous sclerosis 2	VCV002080506	16	2114446	16	2064445	2080506	2135739	rs758214726	NC_000016.10:2064444:C:G	single nucleotide variant	intron variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+18C>T	TSC2		Tuberous sclerosis 2	VCV001588557	16	2114446	16	2064445	1588557	1640884	rs758214726	NC_000016.10:2064444:C:T	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+19G>A	TSC2		not specified|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000207660	16	2114447	16	2064446	207660	203119	rs777632769	NC_000016.10:2064445:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1599+20G>A	TSC2		Tuberous sclerosis 2	VCV002913875	16	2114448	16	2064447	2913875	3073729	rs2548573536	NC_000016.10:2064446:G:A	single nucleotide variant	intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+162C>T	TSC2		not provided	VCV001193172	16	2114590	16	2064589	1193172	1185071	rs74819416	NC_000016.10:2064588:C:T	single nucleotide variant	intron variant	Likely benign	Jun 21, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1599+216T>G	TSC2		not provided	VCV001292780	16	2114644	16	2064643	1292780	1282586	rs17654678	NC_000016.10:2064642:T:G	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-310C>T	TSC2		not provided	VCV000680979	16	2115210	16	2065209	680979	668373	rs146267799	NC_000016.10:2065208:C:T	single nucleotide variant	intron variant	Benign	Jun 20, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-238C>T	TSC2		not provided	VCV001199552	16	2115282	16	2065281	1199552	1191767	rs139061979	NC_000016.10:2065280:C:T	single nucleotide variant	intron variant	Likely benign	Jul 2, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-64T>G	TSC2		not provided	VCV001210543	16	2115456	16	2065455	1210543	1200542	rs553684075	NC_000016.10:2065454:T:G	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1600-39C>T	TSC2		not provided|not specified	VCV000049695	16	2115481	16	2065480	49695	58857	rs45477195	NC_000016.10:2065479:C:T	single nucleotide variant	intron variant	Benign	Jun 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1600-19C>T	TSC2		Tuberous sclerosis 2	VCV002806813	16	2115501	16	2065500	2806813	2967902	rs1397268426	NC_000016.10:2065499:C:T	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1600-19C>A	TSC2		Tuberous sclerosis 2	VCV001669534	16	2115501	16	2065500	1669534	1665788	rs1397268426	NC_000016.10:2065499:C:A	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-19C>G	TSC2		Tuberous sclerosis 2	VCV001641637	16	2115501	16	2065500	1641637	1586035	rs1397268426	NC_000016.10:2065499:C:G	single nucleotide variant	intron variant	Likely benign	Dec 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-18C>G	TSC2		Tuberous sclerosis 2	VCV002154925	16	2115502	16	2065501	2154925	1885891	rs2151205529	NC_000016.10:2065500:C:G	single nucleotide variant	intron variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-18C>T	TSC2		Tuberous sclerosis 2	VCV001529918	16	2115502	16	2065501	1529918	1665274	rs2151205529	NC_000016.10:2065500:C:T	single nucleotide variant	intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-16G>C	TSC2		Tuberous sclerosis 2	VCV001938572	16	2115504	16	2065503	1938572	1994002	rs2151205564	NC_000016.10:2065502:G:C	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-14C>G	TSC2		Tuberous sclerosis 2	VCV001537046	16	2115506	16	2065505	1537046	1533330	rs45517185	NC_000016.10:2065504:C:G	single nucleotide variant	intron variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-14C>A	TSC2		Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2	VCV000207661	16	2115506	16	2065505	207661	203120	rs45517185	NC_000016.10:2065504:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1600-14C>T	TSC2		not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050139	16	2115506	16	2065505	50139	59301	rs45517185	NC_000016.10:2065504:C:T	single nucleotide variant	intron variant	Benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1600-13C>G	TSC2		Tuberous sclerosis syndrome	VCV000318312	16	2115507	16	2065506	318312	340853	rs1800712	NC_000016.10:2065505:C:G	single nucleotide variant	intron variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-11T>G	TSC2		not provided	VCV001306943	16	2115509	16	2065508	1306943	1295892	rs2151205759	NC_000016.10:2065507:T:G	single nucleotide variant	intron variant	Uncertain significance	Jul 9, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-10C>G	TSC2		Tuberous sclerosis 2	VCV001659448	16	2115510	16	2065509	1659448	1543177	rs768188836	NC_000016.10:2065508:C:G	single nucleotide variant	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-10C>T	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000237968	16	2115510	16	2065509	237968	242234	rs768188836	NC_000016.10:2065508:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1600-9T>C	TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000285953	16	2115511	16	2065510	285953	270190	rs886043268	NC_000016.10:2065509:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1600-8C>G	TSC2		Tuberous sclerosis 2	VCV001155144	16	2115512	16	2065511	1155144	1145915	rs1555503101	NC_000016.10:2065510:C:G	single nucleotide variant	intron variant	Likely benign	Nov 1, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-8C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000536027	16	2115512	16	2065511	536027	529585	rs1555503101	NC_000016.10:2065510:C:T	single nucleotide variant	intron variant	Likely benign	Oct 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1600-7T>C	TSC2		Tuberous sclerosis 2	VCV000754210	16	2115513	16	2065512	754210	776124	rs1459453778	NC_000016.10:2065511:T:C	single nucleotide variant	intron variant	Likely benign	Jan 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-5C>T	TSC2		Tuberous sclerosis 2	VCV001651047	16	2115515	16	2065514	1651047	1578422	rs1426258365	NC_000016.10:2065513:C:T	single nucleotide variant	intron variant	Likely benign	Nov 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-5C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001156491	16	2115515	16	2065514	1156491	1145916	rs1426258365	NC_000016.10:2065513:C:G	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1600-4A>G	TSC2		Tuberous sclerosis 2	VCV002707743	16	2115516	16	2065515	2707743	2877775	rs1164295969	NC_000016.10:2065514:A:G	single nucleotide variant	intron variant	Likely benign	Jan 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-4A>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000705844	16	2115516	16	2065515	705844	695682	rs1164295969	NC_000016.10:2065514:A:C	single nucleotide variant	intron variant	Likely benign	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1600-3A>G	TSC2		Tuberous sclerosis 2	VCV000049696	16	2115517	16	2065516	49696	58858	rs45517186	NC_000016.10:2065515:A:G	single nucleotide variant	intron variant	Uncertain significance	Aug 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-2A>G	TSC2		Hereditary cancer-predisposing syndrome	VCV000427997	16	2115518	16	2065517	427997	419868	rs1114167466	NC_000016.10:2065516:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Nov 19, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600-1G>C	TSC2		Tuberous sclerosis 2	VCV002130573	16	2115519	16	2065518	2130573	2187701	rs45517184	NC_000016.10:2065517:G:C	single nucleotide variant	splice acceptor variant	Pathogenic	Nov 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1600G>A (p.Val534Met)	TSC2	V334M, V497M, V485M, V534M, V545M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000651678	16	2115520	16	2065519	651678	644196	rs587778729	NC_000016.10:2065518:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1600G>T (p.Val534Leu)	TSC2	V534L, V497L, V545L, V334L, V485L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000135371	16	2115520	16	2065519	135371	139110	rs587778729	NC_000016.10:2065518:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1601T>G (p.Val534Gly)	TSC2	V534G, V485G, V497G, V545G, V334G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome	VCV000406006	16	2115521	16	2065520	406006	401438	rs924098595	NC_000016.10:2065519:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1602G>A (p.Val534=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001602487	16	2115522	16	2065521	1602487	1557444	rs2151206157	NC_000016.10:2065520:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1603A>T (p.Met535Leu)	TSC2	M535L, M335L, M486L, M498L, M546L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000566422	16	2115523	16	2065522	566422	569633	rs1309598467	NC_000016.10:2065521:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1604T>C (p.Met535Thr)	TSC2	M535T, M1T, M381T, M486T, M531T, M546T, M335T, M498T, M516T, M565T, M87T	Hereditary cancer-predisposing syndrome	VCV003462661	16	2115524	16	2065523	3462661	3621680		NC_000016.10:2065522:T:C	single nucleotide variant	non-coding transcript variant|missense variant|initiator_codon_variant	Uncertain significance	Nov 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1604T>A (p.Met535Lys)	TSC2	M1K, M335K, M381K, M486K, M498K, M516K, M531K, M535K, M546K, M565K, M87K	Tuberous sclerosis 2	VCV001718160	16	2115524	16	2065523	1718160	1778520	rs2151206261	NC_000016.10:2065522:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1605G>A (p.Met535Ile)	TSC2	M335I, M486I, M498I, M535I, M546I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001058274	16	2115525	16	2065524	1058274	1049430	rs2151206304	NC_000016.10:2065523:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1606G>A (p.Ala536Thr)	TSC2	A487T, A532T, A536T, A566T, A336T, A517T, A547T, A2T, A382T, A499T, A88T	Tuberous sclerosis 2	VCV001928404	16	2115526	16	2065525	1928404	1991171	rs2087223499	NC_000016.10:2065524:G:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1606G>T (p.Ala536Ser)	TSC2	A2S, A336S, A382S, A532S, A547S, A499S, A517S, A536S, A566S, A88S, A487S	Hereditary cancer-predisposing syndrome	VCV001776299	16	2115526	16	2065525	1776299	1837529	rs2087223499	NC_000016.10:2065524:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1607C>T (p.Ala536Val)	TSC2	A536V, A336V, A487V, A499V, A547V	Hereditary cancer-predisposing syndrome	VCV000049165	16	2115527	16	2065526	49165	58327	rs45517187	NC_000016.10:2065525:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1608C>G (p.Ala536=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001641559	16	2115528	16	2065527	1641559	1585957	rs2151206478	NC_000016.10:2065526:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1608C>T (p.Ala536=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001130627	16	2115528	16	2065527	1130627	1125042	rs2151206478	NC_000016.10:2065526:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1609C>G (p.Arg537Gly)	TSC2	R488G, R500G, R548G, R337G, R537G	Tuberous sclerosis 2	VCV001479104	16	2115529	16	2065528	1479104	1426475	rs142257684	NC_000016.10:2065527:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1609C>A (p.Arg537Ser)	TSC2	R537S, R500S, R548S, R337S, R488S	Tuberous sclerosis 2	VCV000406103	16	2115529	16	2065528	406103	401210	rs142257684	NC_000016.10:2065527:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1609C>T (p.Arg537Cys)	TSC2	R537C, R337C, R488C, R548C, R500C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|not specified	VCV000064976	16	2115529	16	2065528	64976	75906	rs142257684	NC_000016.10:2065527:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1610G>C (p.Arg537Pro)	TSC2	R500P, R337P, R548P, R488P, R537P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000944322	16	2115530	16	2065529	944322	927642	rs372681603	NC_000016.10:2065528:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1610G>T (p.Arg537Leu)	TSC2	R537L, R337L, R488L, R548L, R500L	Tuberous sclerosis 2	VCV000570127	16	2115530	16	2065529	570127	569636	rs372681603	NC_000016.10:2065528:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1610G>A (p.Arg537His)	TSC2	R537H, R548H, R488H, R337H, R500H	Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000207719	16	2115530	16	2065529	207719	203121	rs372681603	NC_000016.10:2065528:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1611C>A (p.Arg537=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462660	16	2115531	16	2065530	3462660	3621679		NC_000016.10:2065529:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1611C>T (p.Arg537=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049166	16	2115531	16	2065530	49166	58328	rs45469702	NC_000016.10:2065529:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1613C>G (p.Ser538Cys)	TSC2	S338C, S501C, S549C, S489C, S538C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000640565	16	2115533	16	2065532	640565	644197	rs201334685	NC_000016.10:2065531:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1613C>T (p.Ser538Phe)	TSC2	S538F, S338F, S549F, S489F, S501F	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000237969	16	2115533	16	2065532	237969	242235	rs201334685	NC_000016.10:2065531:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1614C>A (p.Ser538=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811326	16	2115534	16	2065533	3811326	3928567		NC_000016.10:2065532:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1614C>T (p.Ser538=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001139114	16	2115534	16	2065533	1139114	1125043	rs759762459	NC_000016.10:2065532:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1615C>G (p.Leu539Val)	TSC2	L339V, L490V, L539V, L550V, L502V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001434060	16	2115535	16	2065534	1434060	1497758	rs2087226024	NC_000016.10:2065533:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1615C>T (p.Leu539Phe)	TSC2	L490F, L539F, L339F, L502F, L550F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000844959	16	2115535	16	2065534	844959	843372	rs2087226024	NC_000016.10:2065533:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1616T>C (p.Leu539Pro)	TSC2	L339P, L490P, L502P, L520P, L91P, L385P, L535P, L569P, L550P, L5P, L539P	Tuberous sclerosis 2	VCV001996149	16	2115536	16	2065535	1996149	2056659	rs2087226212	NC_000016.10:2065534:T:C	single nucleotide variant	missense variant	Uncertain significance	May 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1617C>T (p.Leu539=)	TSC2		Tuberous sclerosis 2	VCV001158154	16	2115537	16	2065536	1158154	1145917	rs1596317183	NC_000016.10:2065535:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1617C>A (p.Leu539=)	TSC2		Tuberous sclerosis 2	VCV000795349	16	2115537	16	2065536	795349	785185	rs1596317183	NC_000016.10:2065535:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1617C>G (p.Leu539=)	TSC2		Tuberous sclerosis 2	VCV000758412	16	2115537	16	2065536	758412	770688	rs1596317183	NC_000016.10:2065535:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1618T>C (p.Ser540Pro)	TSC2	S386P, S491P, S536P, S6P, S540P, S551P, S570P, S503P, S92P, S340P, S521P	Tuberous sclerosis 2	VCV001980299	16	2115538	16	2065537	1980299	2042071	rs765448103	NC_000016.10:2065536:T:C	single nucleotide variant	missense variant	Benign	Dec 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1619C>T (p.Ser540Phe)	TSC2	S340F, S540F, S491F, S503F, S551F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000951196	16	2115539	16	2065538	951196	927643	rs1296271407	NC_000016.10:2065537:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1620C>A (p.Ser540=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232084	16	2115540	16	2065539	3232084	3385624	rs2151207054	NC_000016.10:2065538:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1620C>T (p.Ser540=)	TSC2		Tuberous sclerosis 2	VCV001570915	16	2115540	16	2065539	1570915	1646143	rs2151207054	NC_000016.10:2065538:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1621C>T (p.Pro541Ser)	TSC2	P341S, P492S, P504S, P541S, P552S	Tuberous sclerosis 2|not provided	VCV001021758	16	2115541	16	2065540	1021758	1011950	rs1596317209	NC_000016.10:2065539:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1621C>G (p.Pro541Ala)	TSC2	P341A, P492A, P552A, P541A, P504A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000819678	16	2115541	16	2065540	819678	812516	rs1596317209	NC_000016.10:2065539:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1621C>A (p.Pro541Thr)	TSC2	P504T, P341T, P541T, P552T, P492T	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000641429	16	2115541	16	2065540	641429	644198	rs1596317209	NC_000016.10:2065539:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1622C>T (p.Pro541Leu)	TSC2	P387L, P522L, P341L, P492L, P504L, P541L, P571L, P537L, P552L, P7L, P93L	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001776630	16	2115542	16	2065541	1776630	1833906	rs752953762	NC_000016.10:2065540:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1622C>A (p.Pro541Gln)	TSC2	P541Q, P492Q, P504Q, P552Q, P341Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406013	16	2115542	16	2065541	406013	400701	rs752953762	NC_000016.10:2065540:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1622C>G (p.Pro541Arg)	TSC2	P541R, P341R, P504R, P552R, P492R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000318313	16	2115542	16	2065541	318313	342264	rs752953762	NC_000016.10:2065540:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1623A>T (p.Pro541=)	TSC2		Tuberous sclerosis 2	VCV002978600	16	2115543	16	2065542	2978600	3131206	rs2151207212	NC_000016.10:2065541:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1623A>G (p.Pro541=)	TSC2		Tuberous sclerosis 2	VCV002828437	16	2115543	16	2065542	2828437	2986956	rs2151207212	NC_000016.10:2065541:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1624C>G (p.Pro542Ala)	TSC2	P542A, P553A, P342A, P493A, P505A	Tuberous sclerosis 2	VCV001494844	16	2115544	16	2065543	1494844	1344986	rs891347695	NC_000016.10:2065542:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1624C>T (p.Pro542Ser)	TSC2	P342S, P493S, P505S, P542S, P553S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001000572	16	2115544	16	2065543	1000572	996709	rs891347695	NC_000016.10:2065542:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1624C>A (p.Pro542Thr)	TSC2	P542T, P493T, P553T, P342T, P505T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000486694	16	2115544	16	2065543	486694	477293	rs891347695	NC_000016.10:2065542:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1625C>A (p.Pro542His)	TSC2	P542H, P493H, P342H, P505H, P553H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001507442	16	2115545	16	2065544	1507442	1449732	rs764191178	NC_000016.10:2065543:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1625C>T (p.Pro542Leu)	TSC2	P542L, P342L, P493L, P553L, P505L	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000535951	16	2115545	16	2065544	535951	529587	rs764191178	NC_000016.10:2065543:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 31, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1625C>G (p.Pro542Arg)	TSC2	P542R, P553R, P342R, P505R, P493R	Tuberous sclerosis 2	VCV000406040	16	2115545	16	2065544	406040	401440	rs764191178	NC_000016.10:2065543:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.1626C>G (p.Pro542=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001128670	16	2115546	16	2065545	1128670	1125044	rs376234285	NC_000016.10:2065544:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1626C>T (p.Pro542=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000819696	16	2115546	16	2065545	819696	812517	rs376234285	NC_000016.10:2065544:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1626C>A (p.Pro542=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000382718	16	2115546	16	2065545	382718	377178	rs376234285	NC_000016.10:2065544:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1627C>G (p.Pro543Ala)	TSC2	P343A, P389A, P506A, P524A, P543A, P554A, P494A, P539A, P573A, P95A, P9A	Tuberous sclerosis 2	VCV002057227	16	2115547	16	2065546	2057227	2106049	rs1060500944	NC_000016.10:2065545:C:G	single nucleotide variant	missense variant	Uncertain significance	May 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1627C>T (p.Pro543Ser)	TSC2	P543S, P494S, P506S, P554S, P343S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000406036	16	2115547	16	2065546	406036	401446	rs1060500944	NC_000016.10:2065545:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1628C>T (p.Pro543Leu)	TSC2	P543L, P506L, P554L, P343L, P494L	not provided|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000049671	16	2115548	16	2065547	49671	58833	rs45517188	NC_000016.10:2065546:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1629G>T (p.Pro543=)	TSC2		Tuberous sclerosis 2	VCV002119189	16	2115549	16	2065548	2119189	2183536	rs750309571	NC_000016.10:2065547:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1629G>A (p.Pro543=)	TSC2		Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467885	16	2115549	16	2065548	467885	466072	rs750309571	NC_000016.10:2065547:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1632G>T (p.Glu544Asp)	TSC2	E544D, E507D, E555D, E344D, E495D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000049672	16	2115552	16	2065551	49672	58834	rs137854075	NC_000016.10:2065550:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1633C>A (p.Leu545Met)	TSC2	L526M, L556M, L391M, L97M, L345M, L496M, L545M, L11M, L508M, L541M, L575M	Hereditary cancer-predisposing syndrome	VCV003462666	16	2115553	16	2065552	3462666	3621685		NC_000016.10:2065551:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1633C>G (p.Leu545Val)	TSC2	L496V, L508V, L556V, L345V, L545V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000819714	16	2115553	16	2065552	819714	812518	rs1060504103	NC_000016.10:2065551:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1633C>T (p.Leu545=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413690	16	2115553	16	2065552	413690	401448	rs1060504103	NC_000016.10:2065551:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1634T>C (p.Leu545Pro)	TSC2	L345P, L391P, L508P, L541P, L97P, L496P, L526P, L545P, L11P, L556P, L575P	Tuberous sclerosis 2	VCV002768975	16	2115554	16	2065553	2768975	2923250	rs2543470611	NC_000016.10:2065552:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1635G>C (p.Leu545=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001091923	16	2115555	16	2065554	1091923	1081799	rs755923499	NC_000016.10:2065553:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1635G>A (p.Leu545=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000746137	16	2115555	16	2065554	746137	754986	rs755923499	NC_000016.10:2065553:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1636G>T (p.Glu546Ter)	TSC2	E346*, E557*, E497*, E509*, E546*	Tuberous sclerosis 2	VCV000842141	16	2115556	16	2065555	842141	843373	rs2087230941	NC_000016.10:2065554:G:T	single nucleotide variant	nonsense	Pathogenic	Jul 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1640A>G (p.Glu547Gly)	TSC2	E347G, E547G, E498G, E510G, E558G	Tuberous sclerosis 2	VCV000837680	16	2115560	16	2065559	837680	843374	rs2087231131	NC_000016.10:2065558:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1642A>G (p.Arg548Gly)	TSC2	R511G, R548G, R559G, R348G, R499G	Tuberous sclerosis 2|not provided	VCV001381112	16	2115562	16	2065561	1381112	1499954	rs565375272	NC_000016.10:2065560:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1642A>C (p.Arg548=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000467886	16	2115562	16	2065561	467886	466076	rs565375272	NC_000016.10:2065560:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1643G>A (p.Arg548Lys)	TSC2	R100K, R14K, R348K, R394K, R499K, R511K, R529K, R544K, R548K, R559K, R578K	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003071333	16	2115563	16	2065562	3071333	3228914	rs748938385	NC_000016.10:2065561:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1643G>C (p.Arg548Thr)	TSC2	R548T, R348T, R499T, R511T, R559T	Hereditary cancer-predisposing syndrome|TSC2-related disorder|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000535863	16	2115563	16	2065562	535863	529532	rs748938385	NC_000016.10:2065561:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1644G>A (p.Arg548=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001777114	16	2115564	16	2065563	1777114	1831006	rs1447854292	NC_000016.10:2065562:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1646A>C (p.Asp549Ala)	TSC2	D395A, D579A, D15A, D500A, D512A, D530A, D560A, D545A, D549A, D101A, D349A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002096145	16	2115566	16	2065565	2096145	2146296	rs1170792905	NC_000016.10:2065564:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1646A>T (p.Asp549Val)	TSC2	D349V, D500V, D512V, D549V, D560V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001510964	16	2115566	16	2065565	1510964	1377779	rs1170792905	NC_000016.10:2065564:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1646A>G (p.Asp549Gly)	TSC2	D549G, D500G, D349G, D560G, D512G	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000467887	16	2115566	16	2065565	467887	465784	rs1170792905	NC_000016.10:2065564:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1648G>A (p.Val550Met)	TSC2	V501M, V513M, V550M, V561M, V350M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001357890	16	2115568	16	2065567	1357890	1367785	rs2087232543	NC_000016.10:2065566:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1650G>A (p.Val550=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001777252	16	2115570	16	2065569	1777252	1831144	rs2151208305	NC_000016.10:2065568:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1651G>A (p.Ala551Thr)	TSC2	A17T, A351T, A502T, A514T, A532T, A562T, A551T, A581T, A103T, A397T, A547T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462600	16	2115571	16	2065570	3462600	3621619		NC_000016.10:2065569:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1651G>T (p.Ala551Ser)	TSC2	A551S, A351S, A562S, A514S, A502S	Tuberous sclerosis 2	VCV000535943	16	2115571	16	2065570	535943	529588	rs149877669	NC_000016.10:2065569:G:T	single nucleotide variant	missense variant	Benign	Jul 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1652C>T (p.Ala551Val)	TSC2	A502V, A351V, A514V, A562V, A551V	not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000840573	16	2115572	16	2065571	840573	843375	rs1465307943	NC_000016.10:2065570:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1653C>A (p.Ala551=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232086	16	2115573	16	2065572	3232086	3385626	rs202171361	NC_000016.10:2065571:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1653C>G (p.Ala551=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000755276	16	2115573	16	2065572	755276	770689	rs202171361	NC_000016.10:2065571:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1653C>T (p.Ala551=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000486599	16	2115573	16	2065572	486599	477298	rs202171361	NC_000016.10:2065571:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1654G>T (p.Ala552Ser)	TSC2	A398S, A552S, A104S, A18S, A352S, A533S, A548S, A503S, A563S, A515S, A582S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001936373	16	2115574	16	2065573	1936373	1986204	rs777121421	NC_000016.10:2065572:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1654G>A (p.Ala552Thr)	TSC2	A552T, A563T, A352T, A503T, A515T	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000486688	16	2115574	16	2065573	486688	477328	rs777121421	NC_000016.10:2065572:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1655C>A (p.Ala552Glu)	TSC2	A352E, A503E, A515E, A552E, A563E	Hereditary cancer-predisposing syndrome	VCV001692482	16	2115575	16	2065574	1692482	1684922	rs1555503231	NC_000016.10:2065573:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1655C>T (p.Ala552Val)	TSC2	A552V, A352V, A515V, A563V, A503V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486680	16	2115575	16	2065574	486680	477461	rs1555503231	NC_000016.10:2065573:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1656A>G (p.Ala552=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000064851	16	2115576	16	2065575	64851	75780	rs373515515	NC_000016.10:2065574:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1658A>G (p.Tyr553Cys)	TSC2	Y553C, Y504C, Y516C, Y353C, Y564C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000576263	16	2115578	16	2065577	576263	569640	rs1319281731	NC_000016.10:2065576:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1659C>A (p.Tyr553Ter)	TSC2	Y105*, Y19*, Y353*, Y399*, Y504*, Y516*, Y534*, Y549*, Y553*, Y564*, Y583*	Tuberous sclerosis 2	VCV002444425	16	2115579	16	2065578	2444425	2418157	rs1358358656	NC_000016.10:2065577:C:A	single nucleotide variant	nonsense	Likely pathogenic	Feb 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1659C>G (p.Tyr553Ter)	TSC2	Y399*, Y504*, Y534*, Y549*, Y564*, Y19*, Y353*, Y583*, Y516*, Y105*, Y553*	Tuberous sclerosis 2	VCV002027350	16	2115579	16	2065578	2027350	2081423	rs1358358656	NC_000016.10:2065577:C:G	single nucleotide variant	nonsense	Pathogenic	Aug 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1659C>T (p.Tyr553=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467888	16	2115579	16	2065578	467888	465785	rs1358358656	NC_000016.10:2065577:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1660T>C (p.Ser554Pro)	TSC2	S565P, S517P, S554P, S354P, S505P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000819741	16	2115580	16	2065579	819741	812519	rs1596317415	NC_000016.10:2065578:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1660T>A (p.Ser554Thr)	TSC2	S505T, S565T, S517T, S354T, S554T	Tuberous sclerosis 2	VCV000665739	16	2115580	16	2065579	665739	644199	rs1596317415	NC_000016.10:2065578:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1661C>G (p.Ser554Trp)	TSC2	S554W, S565W, S505W, S106W, S20W, S400W, S517W, S354W, S535W, S550W, S584W	Tuberous sclerosis 2	VCV002692907	16	2115581	16	2065580	2692907	2863734	rs45471596	NC_000016.10:2065579:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1661C>T (p.Ser554Leu)	TSC2	S554L, S505L, S565L, S517L, S354L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207720	16	2115581	16	2065580	207720	203122	rs45471596	NC_000016.10:2065579:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1661C>A (p.Ser554Ter)	TSC2	S554*, S354*, S565*, S505*, S517*	Tuberous sclerosis 2	VCV000050145	16	2115581	16	2065580	50145	59307	rs45471596	NC_000016.10:2065579:C:A	single nucleotide variant	nonsense	Pathogenic	May 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1662G>C (p.Ser554=)	TSC2		Tuberous sclerosis 2	VCV003727057	16	2115582	16	2065581	3727057	3851678		NC_000016.10:2065580:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1662G>A (p.Ser554=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000486623	16	2115582	16	2065581	486623	477909	rs775617895	NC_000016.10:2065580:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1663G>T (p.Ala555Ser)	TSC2	A355S, A506S, A518S, A555S, A566S	Tuberous sclerosis 2	VCV001055291	16	2115583	16	2065582	1055291	1049431	rs763183991	NC_000016.10:2065581:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1663G>C (p.Ala555Pro)	TSC2	A506P, A555P, A355P, A518P, A566P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000840867	16	2115583	16	2065582	840867	843376	rs763183991	NC_000016.10:2065581:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1665C>T (p.Ala555=)	TSC2		Tuberous sclerosis 2	VCV001565030	16	2115585	16	2065584	1565030	1567984	rs2151208963	NC_000016.10:2065583:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1666T>C (p.Ser556Pro)	TSC2	S402P, S537P, S108P, S507P, S556P, S567P, S586P, S22P, S519P, S356P, S552P	Tuberous sclerosis 2	VCV002102647	16	2115586	16	2065585	2102647	2151366	rs2151208996	NC_000016.10:2065584:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1667C>T (p.Ser556Phe)	TSC2	S519F, S567F, S556F, S356F, S507F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000857607	16	2115587	16	2065586	857607	843377	rs2087235893	NC_000016.10:2065585:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1668C>T (p.Ser556=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001541606	16	2115588	16	2065587	1541606	1631489	rs764091433	NC_000016.10:2065586:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1668C>G (p.Ser556=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000237970	16	2115588	16	2065587	237970	242236	rs764091433	NC_000016.10:2065586:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1669T>C (p.Leu557=)	TSC2		Tuberous sclerosis 2	VCV004071208	16	2115589	16	2065588	4071208	4185056		NC_000016.10:2065587:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1669T>G (p.Leu557Val)	TSC2	L109V, L357V, L403V, L538V, L23V, L520V, L553V, L587V, L557V, L508V, L568V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449993	16	2115589	16	2065588	2449993	2425950	rs2151209140	NC_000016.10:2065587:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1669T>A (p.Leu557Met)	TSC2	L403M, L508M, L520M, L538M, L553M, L557M, L568M, L587M, L109M, L23M, L357M	Tuberous sclerosis 2	VCV001719288	16	2115589	16	2065588	1719288	1774592	rs2151209140	NC_000016.10:2065587:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1670T>G (p.Leu557Trp)	TSC2	L538W, L553W, L357W, L403W, L587W, L109W, L520W, L568W, L23W, L508W, L557W	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002086696	16	2115590	16	2065589	2086696	2140737	rs751618728	NC_000016.10:2065588:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1670T>C (p.Leu557Ser)	TSC2	L109S, L520S, L553S, L557S, L568S, L538S, L23S, L403S, L508S, L357S, L587S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001777682	16	2115590	16	2065589	1777682	1828184	rs751618728	NC_000016.10:2065588:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1671G>A (p.Leu557=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000940003	16	2115591	16	2065590	940003	937289	rs761975891	NC_000016.10:2065589:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1673A>T (p.Glu558Val)	TSC2	E558V, E569V, E509V, E521V, E358V	Tuberous sclerosis 2	VCV000863714	16	2115593	16	2065592	863714	843378	rs1596317476	NC_000016.10:2065591:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1673A>G (p.Glu558Gly)	TSC2	E521G, E558G, E569G, E358G, E509G	Tuberous sclerosis 2	VCV000647663	16	2115593	16	2065592	647663	644200	rs1596317476	NC_000016.10:2065591:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1674G>T (p.Glu558Asp)	TSC2	E509D, E521D, E588D, E24D, E358D, E558D, E110D, E554D, E569D, E404D, E539D	Hereditary cancer-predisposing syndrome	VCV003974613	16	2115594	16	2065593	3974613	4086436		NC_000016.10:2065592:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1675G>T (p.Asp559Tyr)	TSC2	D559Y, D359Y, D522Y, D570Y, D510Y	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486617	16	2115595	16	2065594	486617	477910	rs1555503254	NC_000016.10:2065593:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1676A>T (p.Asp559Val)	TSC2	D510V, D522V, D570V, D559V, D359V	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000819765	16	2115596	16	2065595	819765	812521	rs767619776	NC_000016.10:2065594:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1676A>G (p.Asp559Gly)	TSC2	D359G, D510G, D522G, D570G, D559G	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000819764	16	2115596	16	2065595	819764	812520	rs767619776	NC_000016.10:2065594:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1677T>C (p.Asp559=)	TSC2		Tuberous sclerosis 2	VCV000467889	16	2115597	16	2065596	467889	466077	rs1555503256	NC_000016.10:2065595:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 16, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1678G>A (p.Val560Met)	TSC2	V560M, V523M, V511M, V571M, V360M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided	VCV000065075	16	2115598	16	2065597	65075	76006	rs141631268	NC_000016.10:2065596:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1679T>C (p.Val560Ala)	TSC2	V560A, V523A, V571A, V360A, V511A	Hereditary cancer-predisposing syndrome	VCV000819770	16	2115599	16	2065598	819770	812522	rs1596317536	NC_000016.10:2065597:T:C	single nucleotide variant	missense variant	Uncertain significance	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1680G>C (p.Val560=)	TSC2		Tuberous sclerosis 2	VCV001159644	16	2115600	16	2065599	1159644	1145918	rs1247485772	NC_000016.10:2065598:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1683G>T (p.Lys561Asn)	TSC2	K361N, K407N, K512N, K572N, K113N, K27N, K524N, K542N, K557N, K561N, K591N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002564673	16	2115603	16	2065602	2564673	2733829	rs2087238377	NC_000016.10:2065601:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1683G>A (p.Lys561=)	TSC2		Tuberous sclerosis 2	VCV001613919	16	2115603	16	2065602	1613919	1536674	rs2087238377	NC_000016.10:2065601:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1684A>T (p.Thr562Ser)	TSC2	T114S, T408S, T562S, T513S, T525S, T543S, T573S, T362S, T28S, T558S, T592S	Hereditary cancer-predisposing syndrome	VCV003462588	16	2115604	16	2065603	3462588	3621607		NC_000016.10:2065602:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1685C>T (p.Thr562Ile)	TSC2	T362I, T573I, T513I, T562I, T525I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000819833	16	2115605	16	2065604	819833	812523	rs1463643429	NC_000016.10:2065603:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 10, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1686A>T (p.Thr562=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000486654	16	2115606	16	2065605	486654	477463	rs755900760	NC_000016.10:2065604:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1688C>T (p.Ala563Val)	TSC2	A29V, A409V, A514V, A574V, A593V, A115V, A363V, A559V, A563V, A526V, A544V	Tuberous sclerosis 2	VCV002000619	16	2115608	16	2065607	2000619	2061123	rs2151209815	NC_000016.10:2065606:C:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1688C>A (p.Ala563Asp)	TSC2	A29D, A526D, A593D, A115D, A363D, A514D, A544D, A559D, A574D, A409D, A563D	Hereditary cancer-predisposing syndrome	VCV001778052	16	2115608	16	2065607	1778052	1837984	rs2151209815	NC_000016.10:2065606:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1689C>T (p.Ala563=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486612	16	2115609	16	2065608	486612	477330	rs779858018	NC_000016.10:2065607:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1690G>C (p.Val564Leu)	TSC2	V515L, V527L, V575L, V364L, V564L	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001489716	16	2115610	16	2065609	1489716	1495322	rs147072281	NC_000016.10:2065608:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1690G>A (p.Val564Ile)	TSC2	V564I, V527I, V364I, V575I, V515I	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467890	16	2115610	16	2065609	467890	466079	rs147072281	NC_000016.10:2065608:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1692C>T (p.Val564=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001084512	16	2115612	16	2065611	1084512	1081800	rs2151210021	NC_000016.10:2065610:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1693C>T (p.Leu565=)	TSC2		Tuberous sclerosis 2	VCV000797029	16	2115613	16	2065612	797029	785186	rs878854078	NC_000016.10:2065611:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1693C>G (p.Leu565Val)	TSC2	L565V, L576V, L365V, L516V, L528V	Tuberous sclerosis 2	VCV000237971	16	2115613	16	2065612	237971	242237	rs878854078	NC_000016.10:2065611:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1694T>C (p.Leu565Pro)	TSC2	L365P, L516P, L528P, L565P, L576P	Tuberous sclerosis 2	VCV001054895	16	2115614	16	2065613	1054895	1049432	rs2087239987	NC_000016.10:2065612:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1694T>A (p.Leu565Gln)	TSC2	L365Q, L516Q, L528Q, L565Q, L576Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001015142	16	2115614	16	2065613	1015142	1011951	rs2087239987	NC_000016.10:2065612:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1695G>A (p.Leu565=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001778221	16	2115615	16	2065614	1778221	1838153	rs1260065398	NC_000016.10:2065613:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1696G>A (p.Gly566Arg)	TSC2	G517R, G566R, G366R, G529R, G577R	Tuberous sclerosis 2	VCV000647810	16	2115616	16	2065615	647810	644201	rs1596317594	NC_000016.10:2065614:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1698G>C (p.Gly566=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232088	16	2115618	16	2065617	3232088	3385628	rs2543476579	NC_000016.10:2065616:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1698G>A (p.Gly566=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002729521	16	2115618	16	2065617	2729521	2893434	rs2543476579	NC_000016.10:2065616:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1699C>T (p.Leu567Phe)	TSC2	L567F, L367F, L578F, L518F, L530F	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000855554	16	2115619	16	2065618	855554	843379	rs2087240694	NC_000016.10:2065617:C:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1701T>C (p.Leu567=)	TSC2		Tuberous sclerosis 2	VCV002030852	16	2115621	16	2065620	2030852	2082355	rs2543476743	NC_000016.10:2065619:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1702C>T (p.Leu568=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002561942	16	2115622	16	2065621	2561942	2724313	rs778399398	NC_000016.10:2065620:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1702C>G (p.Leu568Val)	TSC2	L120V, L34V, L368V, L414V, L519V, L531V, L549V, L564V, L568V, L579V, L598V	Tuberous sclerosis 2	VCV001714858	16	2115622	16	2065621	1714858	1777859	rs778399398	NC_000016.10:2065620:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1703T>C (p.Leu568Pro)	TSC2	L120P, L34P, L368P, L414P, L519P, L531P, L549P, L564P, L568P, L579P, L598P	Hereditary cancer-predisposing syndrome	VCV003232089	16	2115623	16	2065622	3232089	3385629	rs2151210367	NC_000016.10:2065621:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1706T>A (p.Val569Asp)	TSC2	V121D, V550D, V35D, V415D, V569D, V599D, V369D, V520D, V532D, V565D, V580D	Tuberous sclerosis 2	VCV002847970	16	2115626	16	2065625	2847970	3005213	rs2543477178	NC_000016.10:2065624:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1707C>G (p.Val569=)	TSC2		Tuberous sclerosis 2	VCV002003176	16	2115627	16	2065626	2003176	2055096	rs1379203110	NC_000016.10:2065625:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1707C>T (p.Val569=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001128625	16	2115627	16	2065626	1128625	1125045	rs1379203110	NC_000016.10:2065625:C:T	single nucleotide variant	synonymous variant	Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1708A>G (p.Ile570Val)	TSC2	I570V, I581V, I533V, I370V, I521V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000065315	16	2115628	16	2065627	65315	76247	rs397515230	NC_000016.10:2065626:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1710C>T (p.Ile570=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001081625	16	2115630	16	2065629	1081625	1081801	rs1470229525	NC_000016.10:2065628:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1710C>A (p.Ile570=)	TSC2		Hereditary cancer-predisposing syndrome	VCV000819905	16	2115630	16	2065629	819905	812524	rs1470229525	NC_000016.10:2065628:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 21, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1711C>G (p.Leu571Val)	TSC2	L371V, L522V, L601V, L37V, L534V, L567V, L123V, L552V, L417V, L571V, L582V	Hereditary cancer-predisposing syndrome	VCV003974654	16	2115631	16	2065630	3974654	4086477		NC_000016.10:2065629:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1711C>T (p.Leu571Phe)	TSC2	L371F, L571F, L582F, L522F, L534F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000650497	16	2115631	16	2065630	650497	644202	rs1596317641	NC_000016.10:2065629:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1713T>G (p.Leu571=)	TSC2		Tuberous sclerosis 2	VCV001673107	16	2115633	16	2065632	1673107	1531553	rs2151210746	NC_000016.10:2065631:T:G	single nucleotide variant	synonymous variant	Likely benign	Sep 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1713T>C (p.Leu571=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001085312	16	2115633	16	2065632	1085312	1081802	rs2151210746	NC_000016.10:2065631:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1714C>G (p.Gln572Glu)	TSC2	Q38E, Q535E, Q572E, Q602E, Q372E, Q418E, Q523E, Q568E, Q124E, Q553E, Q583E	Tuberous sclerosis 2	VCV002852178	16	2115634	16	2065633	2852178	3016506	rs2087242404	NC_000016.10:2065632:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1714C>T (p.Gln572Ter)	TSC2	Q535*, Q572*, Q583*, Q372*, Q523*	Tuberous sclerosis 2	VCV000943529	16	2115634	16	2065633	943529	937290	rs2087242404	NC_000016.10:2065632:C:T	single nucleotide variant	nonsense	Pathogenic	Oct 9, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1715A>C (p.Gln572Pro)	TSC2	Q372P, Q572P, Q583P, Q523P, Q535P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000819892	16	2115635	16	2065634	819892	812525	rs1596317664	NC_000016.10:2065633:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1716G>A (p.Gln572=)	TSC2		Tuberous sclerosis 2	VCV000064893	16	2115636	16	2065635	64893	75823	rs397514917	NC_000016.10:2065634:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Mar 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+1G>A	TSC2		Hereditary cancer-predisposing syndrome|not provided	VCV000050147	16	2115637	16	2065636	50147	59309	rs45517190	NC_000016.10:2065635:G:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Mar 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1716+3G>T	TSC2		Tuberous sclerosis 2	VCV003664217	16	2115639	16	2065638	3664217	3795376		NC_000016.10:2065637:G:T	single nucleotide variant	intron variant	Uncertain significance	Sep 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+3G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001399308	16	2115639	16	2065638	1399308	1450602	rs1596317691	NC_000016.10:2065637:G:A	single nucleotide variant	intron variant	Uncertain significance	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1716+3G>C	TSC2		Tuberous sclerosis 2	VCV000645827	16	2115639	16	2065638	645827	652524	rs1596317691	NC_000016.10:2065637:G:C	single nucleotide variant	intron variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+4G>T	TSC2		Tuberous sclerosis 2	VCV003641059	16	2115640	16	2065639	3641059	3768777		NC_000016.10:2065638:G:T	single nucleotide variant	intron variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+4G>C	TSC2		Tuberous sclerosis 2	VCV002836914	16	2115640	16	2065639	2836914	2999293	rs2151211033	NC_000016.10:2065638:G:C	single nucleotide variant	intron variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+5G>C	TSC2		Tuberous sclerosis 2	VCV000664388	16	2115641	16	2065640	664388	652706	rs1596317714	NC_000016.10:2065639:G:C	single nucleotide variant	intron variant	Pathogenic	Feb 7, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+7G>A	TSC2		Tuberous sclerosis 2	VCV000701684	16	2115643	16	2065642	701684	690134	rs1204839285	NC_000016.10:2065641:G:A	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1716+9T>G	TSC2		Tuberous sclerosis 2	VCV003641060	16	2115645	16	2065644	3641060	3768778		NC_000016.10:2065643:T:G	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1716+10C>T	TSC2		Tuberous sclerosis 2	VCV000759576	16	2115646	16	2065645	759576	776126	rs45464995	NC_000016.10:2065644:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1716+10C>G	TSC2		Tuberous sclerosis 2	VCV000703398	16	2115646	16	2065645	703398	695683	rs45464995	NC_000016.10:2065644:C:G	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1716+13C>G	TSC2		Tuberous sclerosis 2	VCV002808535	16	2115649	16	2065648	2808535	2968337	rs2151211284	NC_000016.10:2065647:C:G	single nucleotide variant	intron variant	Likely benign	Jan 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+14A>G	TSC2		Tuberous sclerosis 2	VCV003673193	16	2115650	16	2065649	3673193	3804030		NC_000016.10:2065648:A:G	single nucleotide variant	intron variant	Likely benign	Jun 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+15C>G	TSC2		Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001377816	16	2115651	16	2065650	1377816	1469621	rs199964793	NC_000016.10:2065649:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1716+15C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000391660	16	2115651	16	2065650	391660	377182	rs199964793	NC_000016.10:2065649:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1716+16G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000050146	16	2115652	16	2065651	50146	59308	rs45517189	NC_000016.10:2065650:G:A	single nucleotide variant	intron variant	Likely benign	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1716+18G>A	TSC2		Tuberous sclerosis 2	VCV002897734	16	2115654	16	2065653	2897734	3067115	rs1288971785	NC_000016.10:2065652:G:A	single nucleotide variant	intron variant	Likely benign	Oct 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+20C>T	TSC2		Tuberous sclerosis 2	VCV001569272	16	2115656	16	2065655	1569272	1603820	rs781703479	NC_000016.10:2065654:C:T	single nucleotide variant	intron variant	Likely benign	Dec 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+48C>G	TSC2		not specified	VCV000256619	16	2115684	16	2065683	256619	255490	rs200355157	NC_000016.10:2065682:C:G	single nucleotide variant	intron variant	Likely benign		criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+82T>C	TSC2		not provided	VCV000670875	16	2115718	16	2065717	670875	668191	rs144949495	NC_000016.10:2065716:T:C	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+183A>G	TSC2		not provided	VCV000677145	16	2115819	16	2065818	677145	668375	rs8063461	NC_000016.10:2065817:A:G	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+221T>C	TSC2		not provided	VCV001272882	16	2115857	16	2065856	1272882	1262347	rs13331020	NC_000016.10:2065855:T:C	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1716+263G>A	TSC2		not provided	VCV002576058	16	2115899	16	2065898	2576058	2740955	rs748920796	NC_000016.10:2065897:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-67A>G	TSC2		not provided	VCV001217832	16	2120390	16	2070389	1217832	1207815	rs182404389	NC_000016.10:2070388:A:G	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-55T>C	TSC2		not provided|not specified|Tuberous sclerosis 2	VCV000065157	16	2120402	16	2070401	65157	76088	rs7187438	NC_000016.10:2070400:T:C	single nucleotide variant	intron variant	Benign	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-30G>A	TSC2		not provided	VCV000049619	16	2120427	16	2070426	49619	58781	rs45500703	NC_000016.10:2070425:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-20G>A	TSC2		Tuberous sclerosis 2	VCV001548431	16	2120437	16	2070436	1548431	1657799	rs1555505006	NC_000016.10:2070435:G:A	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-20G>T	TSC2		not specified|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000512894	16	2120437	16	2070436	512894	505459	rs1555505006	NC_000016.10:2070435:G:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-19C>T	TSC2		Tuberous sclerosis 2	VCV001569540	16	2120438	16	2070437	1569540	1559511	rs2151277025	NC_000016.10:2070436:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-18T>C	TSC2		Tuberous sclerosis 2	VCV002771405	16	2120439	16	2070438	2771405	2933421	rs2088110659	NC_000016.10:2070437:T:C	single nucleotide variant	intron variant	Likely benign	May 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-17G>A	TSC2		Tuberous sclerosis 2	VCV001636083	16	2120440	16	2070439	1636083	1644108	rs2151277082	NC_000016.10:2070438:G:A	single nucleotide variant	intron variant	Likely benign	Mar 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-17G>C	TSC2		Tuberous sclerosis 2	VCV001543613	16	2120440	16	2070439	1543613	1557768	rs2151277082	NC_000016.10:2070438:G:C	single nucleotide variant	intron variant	Likely benign	Sep 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-16C>T	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not specified|Tuberous sclerosis 2	VCV000049617	16	2120441	16	2070440	49617	58779	rs45517191	NC_000016.10:2070439:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-15G>C	TSC2		Tuberous sclerosis 2	VCV003723914	16	2120442	16	2070441	3723914	3860730		NC_000016.10:2070440:G:C	single nucleotide variant	intron variant	Likely benign	Oct 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-15G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000385069	16	2120442	16	2070441	385069	374741	rs372949465	NC_000016.10:2070440:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-15G>T	TSC2		Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|not specified	VCV000207662	16	2120442	16	2070441	207662	203123	rs372949465	NC_000016.10:2070440:G:T	single nucleotide variant	intron variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-14T>C	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001582247	16	2120443	16	2070442	1582247	1662310	rs780658386	NC_000016.10:2070441:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-13C>T	TSC2		Tuberous sclerosis 2	VCV001546328	16	2120444	16	2070443	1546328	1526178	rs2151277233	NC_000016.10:2070442:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-12C>T	TSC2		Tuberous sclerosis 2	VCV002098045	16	2120445	16	2070444	2098045	2146901	rs2151277263	NC_000016.10:2070443:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-12C>G	TSC2		Tuberous sclerosis 2	VCV001622384	16	2120445	16	2070444	1622384	1561231	rs2151277263	NC_000016.10:2070443:C:G	single nucleotide variant	intron variant	Likely benign	Jul 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-11T>C	TSC2		Tuberous sclerosis 2	VCV001559852	16	2120446	16	2070445	1559852	1542442	rs2151277310	NC_000016.10:2070444:T:C	single nucleotide variant	intron variant	Likely benign	Oct 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-10C>G	TSC2		Tuberous sclerosis 2	VCV003014575	16	2120447	16	2070446	3014575	3171011	rs377168627	NC_000016.10:2070445:C:G	single nucleotide variant	intron variant	Likely benign	Feb 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-10C>T	TSC2		Tuberous sclerosis 2	VCV000413650	16	2120447	16	2070446	413650	400703	rs377168627	NC_000016.10:2070445:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-8C>T	TSC2		Tuberous sclerosis 2	VCV002915619	16	2120449	16	2070448	2915619	3074169	rs755425128	NC_000016.10:2070447:C:T	single nucleotide variant	intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-8C>A	TSC2		Tuberous sclerosis 2	VCV001089911	16	2120449	16	2070448	1089911	1081803	rs755425128	NC_000016.10:2070447:C:A	single nucleotide variant	intron variant	Likely benign	May 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-8C>G	TSC2		Tuberous sclerosis 2	VCV000413733	16	2120449	16	2070448	413733	400706	rs755425128	NC_000016.10:2070447:C:G	single nucleotide variant	intron variant	Likely benign	Feb 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-6C>G	TSC2		Tuberous sclerosis 2	VCV001375688	16	2120451	16	2070450	1375688	1470076	rs1596335934	NC_000016.10:2070449:C:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-6C>T	TSC2		not provided|Tuberous sclerosis 2	VCV000765582	16	2120451	16	2070450	765582	776156	rs1596335934	NC_000016.10:2070449:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-5T>C	TSC2		Tuberous sclerosis 2	VCV002131867	16	2120452	16	2070451	2131867	2189855	rs2088113456	NC_000016.10:2070450:T:C	single nucleotide variant	intron variant	Likely benign	Dec 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-5T>A	TSC2		Tuberous sclerosis 2	VCV001015688	16	2120452	16	2070451	1015688	1011952	rs2088113456	NC_000016.10:2070450:T:A	single nucleotide variant	intron variant	Uncertain significance	May 29, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-4G>A	TSC2		Tuberous sclerosis 2	VCV002864501	16	2120453	16	2070452	2864501	3023265	rs2151277463	NC_000016.10:2070451:G:A	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717-3C>A	TSC2		Hereditary cancer-predisposing syndrome	VCV001778645	16	2120454	16	2070453	1778645	1834616	rs2151277529	NC_000016.10:2070452:C:A	single nucleotide variant	intron variant	Likely pathogenic	Jun 15, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-3C>T	TSC2		Tuberous sclerosis 2	VCV001365567	16	2120454	16	2070453	1365567	1402437	rs2151277529	NC_000016.10:2070452:C:T	single nucleotide variant	intron variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-2A>T	TSC2		not provided	VCV004055801	16	2120455	16	2070454	4055801	4169741		NC_000016.10:2070453:A:T	single nucleotide variant	splice acceptor variant	Pathogenic	Jan 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-2A>C	TSC2		Tuberous sclerosis 2	VCV000803148	16	2120455	16	2070454	803148	791532	rs1596335963	NC_000016.10:2070453:A:C	single nucleotide variant	splice acceptor variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-1G>C	TSC2		Hereditary cancer-predisposing syndrome	VCV001778644	16	2120456	16	2070455	1778644	1834615	rs45517192	NC_000016.10:2070454:G:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Sep 22, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1717-1G>A	TSC2		Tuberous sclerosis 2	VCV000049618	16	2120456	16	2070455	49618	58780	rs45517192	NC_000016.10:2070454:G:A	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717A>C (p.Thr573Pro)	TSC2	T125P, T373P, T39P, T419P, T524P, T536P, T554P, T569P, T573P, T584P, T603P	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV002679339	16	2120457	16	2070456	2679339	2836916	rs748396290	NC_000016.10:2070455:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1717A>G (p.Thr573Ala)	TSC2	T554A, T569A, T39A, T536A, T603A, T373A, T419A, T524A, T573A, T584A, T125A	Hereditary cancer-predisposing syndrome	VCV001778647	16	2120457	16	2070456	1778647	1834618	rs748396290	NC_000016.10:2070455:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1718C>G (p.Thr573Ser)	TSC2	T39S, T524S, T536S, T569S, T573S, T125S, T419S, T584S, T603S, T373S, T554S	Hereditary cancer-predisposing syndrome	VCV003329462	16	2120458	16	2070457	3329462	3489054		NC_000016.10:2070456:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1718C>T (p.Thr573Ile)	TSC2	T573I, T373I, T536I, T584I, T524I	Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000406026	16	2120458	16	2070457	406026	401452	rs773304374	NC_000016.10:2070456:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1719C>G (p.Thr573=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002757157	16	2120459	16	2070458	2757157	2920928	rs2151277677	NC_000016.10:2070457:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1719C>T (p.Thr573=)	TSC2		Tuberous sclerosis 2	VCV001158996	16	2120459	16	2070458	1158996	1145919	rs2151277677	NC_000016.10:2070457:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1720A>G (p.Lys574Glu)	TSC2	K525E, K537E, K574E, K585E, K374E	Tuberous sclerosis 2	VCV001408304	16	2120460	16	2070459	1408304	1421951	rs2088115626	NC_000016.10:2070458:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1720A>T (p.Lys574Ter)	TSC2	K374*, K525*, K537*, K574*, K585*	not provided	VCV000987350	16	2120460	16	2070459	987350	975434	rs2088115626	NC_000016.10:2070458:A:T	single nucleotide variant	nonsense	Pathogenic	Oct 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1721A>G (p.Lys574Arg)	TSC2	K574R, K525R, K537R, K374R, K585R	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405989	16	2120461	16	2070460	405989	401211	rs1060500926	NC_000016.10:2070459:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1722G>A (p.Lys574=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000819937	16	2120462	16	2070461	819937	812526	rs1596336026	NC_000016.10:2070460:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1723C>T (p.Leu575=)	TSC2		Tuberous sclerosis 2	VCV001106944	16	2120463	16	2070462	1106944	1103625	rs1419122104	NC_000016.10:2070461:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1723C>G (p.Leu575Val)	TSC2	L375V, L526V, L538V, L575V, L586V	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000957252	16	2120463	16	2070462	957252	949233	rs1419122104	NC_000016.10:2070461:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1724T>G (p.Leu575Arg)	TSC2	L127R, L421R, L586R, L41R, L556R, L571R, L575R, L375R, L526R, L538R, L605R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001778838	16	2120464	16	2070463	1778838	1831422	rs1567456901	NC_000016.10:2070462:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1724T>C (p.Leu575Pro)	TSC2	L575P, L375P, L586P, L526P, L538P	Tuberous sclerosis 2	VCV000573399	16	2120464	16	2070463	573399	569642	rs1567456901	NC_000016.10:2070462:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1725G>T (p.Leu575=)	TSC2		Tuberous sclerosis 2	VCV001582134	16	2120465	16	2070464	1582134	1654095	rs747173035	NC_000016.10:2070463:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1725G>A (p.Leu575=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467891	16	2120465	16	2070464	467891	466086	rs747173035	NC_000016.10:2070463:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1726T>C (p.Tyr576His)	TSC2	Y539H, Y557H, Y576H, Y527H, Y128H, Y422H, Y572H, Y376H, Y42H, Y587H, Y606H	Tuberous sclerosis 2	VCV002693565	16	2120466	16	2070465	2693565	2853698	rs2151277938	NC_000016.10:2070464:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1726T>G (p.Tyr576Asp)	TSC2	Y128D, Y42D, Y572D, Y422D, Y527D, Y539D, Y376D, Y587D, Y557D, Y576D, Y606D	Hereditary cancer-predisposing syndrome	VCV001778873	16	2120466	16	2070465	1778873	1831457	rs2151277938	NC_000016.10:2070464:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1728C>G (p.Tyr576Ter)	TSC2	Y128*, Y376*, Y42*, Y422*, Y527*, Y539*, Y557*, Y572*, Y576*, Y587*, Y606*	not provided	VCV002682993	16	2120468	16	2070467	2682993	2844020	rs966102111	NC_000016.10:2070466:C:G	single nucleotide variant	nonsense|non-coding transcript variant	Likely pathogenic	Mar 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1728C>T (p.Tyr576=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000516776	16	2120468	16	2070467	516776	506145	rs966102111	NC_000016.10:2070466:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1729A>T (p.Thr577Ser)	TSC2	T528S, T540S, T377S, T577S, T588S	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000843352	16	2120469	16	2070468	843352	843380	rs1204749633	NC_000016.10:2070467:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1729A>G (p.Thr577Ala)	TSC2	T577A, T528A, T540A, T377A, T588A	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000819923	16	2120469	16	2070468	819923	812527	rs1204749633	NC_000016.10:2070467:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1730C>A (p.Thr577Asn)	TSC2	T377N, T129N, T540N, T558N, T423N, T43N, T528N, T573N, T577N, T588N, T607N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449959	16	2120470	16	2070469	2449959	2429584	rs770895919	NC_000016.10:2070468:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1730C>T (p.Thr577Ile)	TSC2	T577I, T377I, T588I, T528I, T540I	Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467892	16	2120470	16	2070469	467892	466089	rs770895919	NC_000016.10:2070468:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1731C>A (p.Thr577=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001778986	16	2120471	16	2070470	1778986	1831570	rs144122318	NC_000016.10:2070469:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 9, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1731C>T (p.Thr577=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000413667	16	2120471	16	2070470	413667	400791	rs144122318	NC_000016.10:2070469:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1731C>G (p.Thr577=)	TSC2		Hereditary cancer-predisposing syndrome|not specified	VCV000256620	16	2120471	16	2070470	256620	255491	rs144122318	NC_000016.10:2070469:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1732C>T (p.Leu578=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001147336	16	2120472	16	2070471	1147336	1145920	rs1204972424	NC_000016.10:2070470:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1732C>G (p.Leu578Val)	TSC2	L378V, L529V, L589V, L541V, L578V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001036242	16	2120472	16	2070471	1036242	1032442	rs1204972424	NC_000016.10:2070470:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1734G>C (p.Leu578=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002843177	16	2120474	16	2070473	2843177	2994049	rs2151278251	NC_000016.10:2070472:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1734G>T (p.Leu578=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001635489	16	2120474	16	2070473	1635489	1523951	rs2151278251	NC_000016.10:2070472:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1735C>A (p.Pro579Thr)	TSC2	P590T, P530T, P579T, P379T, P542T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000941133	16	2120475	16	2070474	941133	937291	rs45517196	NC_000016.10:2070473:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1735C>T (p.Pro579Ser)	TSC2	P579S, P590S, P379S, P530S, P542S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000185164	16	2120475	16	2070474	185164	184125	rs45517196	NC_000016.10:2070473:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1735C>G (p.Pro579Ala)	TSC2	P579A, P530A, P542A, P590A, P379A	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000049621	16	2120475	16	2070474	49621	58783	rs45517196	NC_000016.10:2070473:C:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1736C>G (p.Pro579Arg)	TSC2	P131R, P379R, P425R, P45R, P530R, P542R, P560R, P575R, P579R, P590R, P609R	Hereditary cancer-predisposing syndrome	VCV003232090	16	2120476	16	2070475	3232090	3385630	rs1471786715	NC_000016.10:2070474:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1736C>T (p.Pro579Leu)	TSC2	P131L, P575L, P609L, P530L, P379L, P45L, P542L, P560L, P579L, P425L, P590L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001779077	16	2120476	16	2070475	1779077	1831661	rs1471786715	NC_000016.10:2070474:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1738G>A (p.Ala580Thr)	TSC2	A380T, A531T, A591T, A543T, A580T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000659231	16	2120478	16	2070477	659231	644203	rs1596336167	NC_000016.10:2070476:G:A	single nucleotide variant	missense variant	Uncertain significance	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1739C>T (p.Ala580Val)	TSC2	A380V, A580V, A531V, A591V, A543V	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001365354	16	2120479	16	2070478	1365354	1402224	rs765043471	NC_000016.10:2070477:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1739C>G (p.Ala580Gly)	TSC2	A580G, A543G, A591G, A380G, A531G	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535878	16	2120479	16	2070478	535878	530127	rs765043471	NC_000016.10:2070477:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1740A>G (p.Ala580=)	TSC2		Tuberous sclerosis 2	VCV001646643	16	2120480	16	2070479	1646643	1599667	rs1057522755	NC_000016.10:2070478:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1740A>C (p.Ala580=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000387283	16	2120480	16	2070479	387283	374059	rs1057522755	NC_000016.10:2070478:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Mar 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1741A>T (p.Ser581Cys)	TSC2	S532C, S544C, S581C, S381C, S592C	Tuberous sclerosis 2	VCV001408964	16	2120481	16	2070480	1408964	1496753	rs2151278580	NC_000016.10:2070479:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1742G>T (p.Ser581Ile)	TSC2	S381I, S532I, S544I, S581I, S592I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000959206	16	2120482	16	2070481	959206	949234	rs45517197	NC_000016.10:2070480:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1742G>A (p.Ser581Asn)	TSC2	S581N, S381N, S592N, S544N, S532N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000050153	16	2120482	16	2070481	50153	59315	rs45517197	NC_000016.10:2070480:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1743C>G (p.Ser581Arg)	TSC2	S577R, S427R, S532R, S562R, S133R, S381R, S544R, S581R, S592R, S47R, S611R	Hereditary cancer-predisposing syndrome|not provided	VCV001779235	16	2120483	16	2070482	1779235	1828450	rs775195398	NC_000016.10:2070481:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1743C>T (p.Ser581=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000819986	16	2120483	16	2070482	819986	812528	rs775195398	NC_000016.10:2070481:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1743C>A (p.Ser581Arg)	TSC2	S581R, S532R, S544R, S592R, S381R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000318314	16	2120483	16	2070482	318314	334158	rs775195398	NC_000016.10:2070481:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1744C>A (p.His582Asn)	TSC2	H134N, H382N, H428N, H48N, H533N, H545N, H563N, H578N, H582N, H593N, H612N	not provided	VCV004074398	16	2120484	16	2070483	4074398	4187666		NC_000016.10:2070482:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1744C>T (p.His582Tyr)	TSC2	H428Y, H563Y, H582Y, H533Y, H545Y, H134Y, H578Y, H612Y, H382Y, H48Y, H593Y	Tuberous sclerosis 2	VCV002698625	16	2120484	16	2070483	2698625	2854916	rs1385373190	NC_000016.10:2070482:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Oct 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1744C>G (p.His582Asp)	TSC2	H533D, H593D, H545D, H582D, H382D	Tuberous sclerosis 2	VCV000665753	16	2120484	16	2070483	665753	644204	rs1385373190	NC_000016.10:2070482:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1745A>G (p.His582Arg)	TSC2	H545R, H382R, H533R, H582R, H593R	Tuberous sclerosis 2	VCV001432735	16	2120485	16	2070484	1432735	1480990	rs2088124334	NC_000016.10:2070483:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1745A>T (p.His582Leu)	TSC2	H533L, H593L, H382L, H545L, H582L	Tuberous sclerosis 2	VCV000935375	16	2120485	16	2070484	935375	937292	rs2088124334	NC_000016.10:2070483:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1746C>A (p.His582Gln)	TSC2	H382Q, H593Q, H582Q, H533Q, H545Q	Tuberous sclerosis 2	VCV001473790	16	2120486	16	2070485	1473790	1387786	rs876658921	NC_000016.10:2070484:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1746C>T (p.His582=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000231042	16	2120486	16	2070485	231042	235098	rs876658921	NC_000016.10:2070484:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1747G>T (p.Ala583Ser)	TSC2	A49S, A534S, A579S, A583S, A594S, A383S, A564S, A613S, A135S, A429S, A546S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564730	16	2120487	16	2070486	2564730	2733886	rs1800729	NC_000016.10:2070485:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1747G>A (p.Ala583Thr)	TSC2	A583T, A383T, A546T, A594T, A534T	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not specified|Hereditary cancer-predisposing syndrome	VCV000041729	16	2120487	16	2070486	41729	50168	rs1800729	NC_000016.10:2070485:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1748C>G (p.Ala583Gly)	TSC2	A429G, A49G, A534G, A579G, A594G, A564G, A583G, A613G, A135G, A383G, A546G	Hereditary cancer-predisposing syndrome	VCV003811369	16	2120488	16	2070487	3811369	3928610		NC_000016.10:2070486:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1748C>T (p.Ala583Val)	TSC2	A383V, A546V, A583V, A534V, A594V	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000839663	16	2120488	16	2070487	839663	843381	rs763863196	NC_000016.10:2070486:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1749C>T (p.Ala583=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232091	16	2120489	16	2070488	3232091	3385631	rs2151278875	NC_000016.10:2070487:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1751C>G (p.Thr584Arg)	TSC2	T595R, T547R, T384R, T535R, T584R	Hereditary cancer-predisposing syndrome	VCV000819976	16	2120491	16	2070490	819976	812529	rs751147419	NC_000016.10:2070489:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1751C>T (p.Thr584Met)	TSC2	T584M, T535M, T547M, T595M, T384M	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207663	16	2120491	16	2070490	207663	203124	rs751147419	NC_000016.10:2070489:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1752G>T (p.Thr584=)	TSC2		Tuberous sclerosis 2	VCV001161147	16	2120492	16	2070491	1161147	1145921	rs141285742	NC_000016.10:2070490:G:T	single nucleotide variant	synonymous variant	Likely benign	May 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1752G>C (p.Thr584=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000760717	16	2120492	16	2070491	760717	770690	rs141285742	NC_000016.10:2070490:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1752G>A (p.Thr584=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065018	16	2120492	16	2070491	65018	75948	rs141285742	NC_000016.10:2070490:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1753C>G (p.Arg585Gly)	TSC2	R385G, R548G, R585G, R596G, R536G	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000855124	16	2120493	16	2070492	855124	843382	rs370324876	NC_000016.10:2070491:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1753C>T (p.Arg585Cys)	TSC2	R585C, R536C, R596C, R548C, R385C	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000406014	16	2120493	16	2070492	406014	401455	rs370324876	NC_000016.10:2070491:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1754G>T (p.Arg585Leu)	TSC2	R581L, R615L, R536L, R548L, R137L, R385L, R566L, R596L, R431L, R51L, R585L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002882512	16	2120494	16	2070493	2882512	3043113	rs397515063	NC_000016.10:2070492:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1754G>A (p.Arg585His)	TSC2	R585H, R385H, R536H, R548H, R596H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065084	16	2120494	16	2070493	65084	76015	rs397515063	NC_000016.10:2070492:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1755T>C (p.Arg585=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001142318	16	2120495	16	2070494	1142318	1145922	rs755484371	NC_000016.10:2070493:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1756G>C (p.Val586Leu)	TSC2	V549L, V567L, V582L, V138L, V586L, V597L, V386L, V432L, V52L, V537L, V616L	Tuberous sclerosis 2	VCV002962203	16	2120496	16	2070495	2962203	3126915	rs779425782	NC_000016.10:2070494:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jun 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1756G>A (p.Val586Met)	TSC2	V432M, V52M, V549M, V537M, V567M, V597M, V386M, V582M, V586M, V616M, V138M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002819237	16	2120496	16	2070495	2819237	2977763	rs779425782	NC_000016.10:2070494:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1757T>G (p.Val586Gly)	TSC2	V138G, V52G, V537G, V386G, V549G, V616G, V567G, V597G, V432G, V582G, V586G	Tuberous sclerosis 2	VCV002847469	16	2120497	16	2070496	2847469	3012389	rs2088127954	NC_000016.10:2070495:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1757T>A (p.Val586Glu)	TSC2	V386E, V537E, V549E, V586E, V597E	Tuberous sclerosis 2	VCV001687477	16	2120497	16	2070496	1687477	1679770	rs2088127954	NC_000016.10:2070495:T:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1757T>C (p.Val586Ala)	TSC2	V597A, V549A, V386A, V537A, V586A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000836342	16	2120497	16	2070496	836342	843383	rs2088127954	NC_000016.10:2070495:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1758G>T (p.Val586=)	TSC2		Tuberous sclerosis 2	VCV001099983	16	2120498	16	2070497	1099983	1103626	rs1555505092	NC_000016.10:2070496:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1758G>A (p.Val586=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000486666	16	2120498	16	2070497	486666	477331	rs1555505092	NC_000016.10:2070496:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1759T>C (p.Tyr587His)	TSC2	Y587H, Y538H, Y598H, Y387H, Y550H	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535882	16	2120499	16	2070498	535882	529602	rs1555505094	NC_000016.10:2070497:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1760A>G (p.Tyr587Cys)	TSC2	Y387C, Y587C, Y538C, Y550C, Y598C	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000655995	16	2120500	16	2070499	655995	644205	rs1487642536	NC_000016.10:2070498:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1761T>G (p.Tyr587Ter)	TSC2	Y587*, Y538*, Y387*, Y598*, Y550*	not provided	VCV000620479	16	2120501	16	2070500	620479	611816	rs753179817	NC_000016.10:2070499:T:G	single nucleotide variant	nonsense	Pathogenic	Aug 7, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1761T>C (p.Tyr587=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536092	16	2120501	16	2070500	536092	529915	rs753179817	NC_000016.10:2070499:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1762G>T (p.Glu588Ter)	TSC2	E388*, E588*, E599*, E539*, E551*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000846684	16	2120502	16	2070501	846684	843384	rs1596336374	NC_000016.10:2070500:G:T	single nucleotide variant	nonsense	Pathogenic	Nov 18, 2019	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1762G>A (p.Glu588Lys)	TSC2	E539K, E551K, E588K, E388K, E599K	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000659073	16	2120502	16	2070501	659073	644206	rs1596336374	NC_000016.10:2070500:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1763A>T (p.Glu588Val)	TSC2	E140V, E599V, E618V, E388V, E434V, E551V, E588V, E539V, E54V, E569V, E584V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001779619	16	2120503	16	2070502	1779619	1838272	rs2151279468	NC_000016.10:2070501:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1763A>G (p.Glu588Gly)	TSC2	E388G, E539G, E551G, E588G, E599G	not provided	VCV001703971	16	2120503	16	2070502	1703971	1696448	rs2151279468	NC_000016.10:2070501:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1764G>A (p.Glu588=)	TSC2		Tuberous sclerosis 2	VCV002839823	16	2120504	16	2070503	2839823	2993260	rs2088130143	NC_000016.10:2070502:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1764G>C (p.Glu588Asp)	TSC2	E539D, E551D, E588D, E599D, E388D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000954201	16	2120504	16	2070503	954201	949235	rs2088130143	NC_000016.10:2070502:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1765A>T (p.Met589Leu)	TSC2	M540L, M589L, M600L, M389L, M552L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000838978	16	2120505	16	2070504	838978	843385	rs1567457356	NC_000016.10:2070503:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1765A>G (p.Met589Val)	TSC2	M589V, M552V, M389V, M600V, M540V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000578229	16	2120505	16	2070504	578229	570076	rs1567457356	NC_000016.10:2070503:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1766T>C (p.Met589Thr)	TSC2	M141T, M619T, M435T, M55T, M570T, M389T, M552T, M585T, M540T, M589T, M600T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001779692	16	2120506	16	2070505	1779692	1838345	rs796053487	NC_000016.10:2070504:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 20, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1766T>G (p.Met589Arg)	TSC2	M389R, M600R, M552R, M589R, M540R	Tuberous sclerosis 2	VCV000969402	16	2120506	16	2070505	969402	957673	rs796053487	NC_000016.10:2070504:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1766T>A (p.Met589Lys)	TSC2	M589K, M389K, M540K, M552K, M600K	not provided|Tuberous sclerosis 2	VCV000207721	16	2120506	16	2070505	207721	203125	rs796053487	NC_000016.10:2070504:T:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1767G>C (p.Met589Ile)	TSC2	M141I, M389I, M585I, M552I, M435I, M570I, M589I, M619I, M540I, M55I, M600I	Tuberous sclerosis 2	VCV002692896	16	2120507	16	2070506	2692896	2863723	rs1227923469	NC_000016.10:2070505:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1767G>A (p.Met589Ile)	TSC2	M389I, M435I, M552I, M589I, M540I, M55I, M585I, M619I, M141I, M570I, M600I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002062242	16	2120507	16	2070506	2062242	2117515	rs1227923469	NC_000016.10:2070505:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1768C>T (p.Leu590=)	TSC2		Tuberous sclerosis 2	VCV000752731	16	2120508	16	2070507	752731	770691	rs758824621	NC_000016.10:2070506:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1770G>A (p.Leu590=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002454268	16	2120510	16	2070509	2454268	2424157	rs778109774	NC_000016.10:2070508:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1770G>T (p.Leu590=)	TSC2		Tuberous sclerosis 2	VCV000793733	16	2120510	16	2070509	793733	785187	rs778109774	NC_000016.10:2070508:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1770G>C (p.Leu590=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000757322	16	2120510	16	2070509	757322	770692	rs778109774	NC_000016.10:2070508:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1771G>C (p.Val591Leu)	TSC2	V57L, V587L, V554L, V572L, V391L, V437L, V542L, V621L, V143L, V591L, V602L	Tuberous sclerosis 2	VCV002816663	16	2120511	16	2070510	2816663	2984165	rs984275273	NC_000016.10:2070509:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1771G>A (p.Val591Ile)	TSC2	V591I, V602I, V391I, V542I, V554I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000467894	16	2120511	16	2070510	467894	465788	rs984275273	NC_000016.10:2070509:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 16, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1772T>G (p.Val591Gly)	TSC2	V542G, V554G, V572G, V587G, V591G, V621G, V437G, V143G, V391G, V57G, V602G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001779825	16	2120512	16	2070511	1779825	1838477	rs2151279869	NC_000016.10:2070510:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1773C>T (p.Val591=)	TSC2		Tuberous sclerosis 2	VCV000797746	16	2120513	16	2070512	797746	785188	rs1596336485	NC_000016.10:2070511:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1773C>G (p.Val591=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000764108	16	2120513	16	2070512	764108	770693	rs1596336485	NC_000016.10:2070511:C:G	single nucleotide variant	synonymous variant	Likely benign	May 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1774A>G (p.Ser592Gly)	TSC2	S592G, S543G, S392G, S603G, S555G	not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406019	16	2120514	16	2070513	406019	400793	rs910068556	NC_000016.10:2070512:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1775G>C (p.Ser592Thr)	TSC2	S144T, S555T, S58T, S592T, S392T, S438T, S543T, S573T, S588T, S603T, S622T	Tuberous sclerosis 2	VCV002150095	16	2120515	16	2070514	2150095	1881561	rs374371998	NC_000016.10:2070513:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1775G>A (p.Ser592Asn)	TSC2	S592N, S543N, S555N, S603N, S392N	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000509382	16	2120515	16	2070514	509382	506149	rs374371998	NC_000016.10:2070513:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1776C>G (p.Ser592Arg)	TSC2	S438R, S573R, S58R, S592R, S392R, S603R, S144R, S543R, S555R, S588R, S622R	Tuberous sclerosis 2	VCV002720886	16	2120516	16	2070515	2720886	2891287	rs1555505122	NC_000016.10:2070514:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1776C>T (p.Ser592=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536012	16	2120516	16	2070515	536012	529919	rs1555505122	NC_000016.10:2070514:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1777C>T (p.His593Tyr)	TSC2	H593Y, H556Y, H604Y, H544Y, H393Y	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535889	16	2120517	16	2070516	535889	530129	rs1555505123	NC_000016.10:2070515:C:T	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1778A>G (p.His593Arg)	TSC2	H593R, H544R, H604R, H393R, H556R	not provided|Tuberous sclerosis 2	VCV000049173	16	2120518	16	2070517	49173	58335	rs45517198	NC_000016.10:2070516:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 8, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1779C>T (p.His593=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001156938	16	2120519	16	2070518	1156938	1145923	rs771078126	NC_000016.10:2070517:C:T	single nucleotide variant	synonymous variant	Likely benign	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1780A>G (p.Ile594Val)	TSC2	I594V, I557V, I394V, I545V, I605V	Tuberous sclerosis 2	VCV000467895	16	2120520	16	2070519	467895	465893	rs1555505128	NC_000016.10:2070518:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1782T>C (p.Ile594=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000763220	16	2120522	16	2070521	763220	770694	rs1596336548	NC_000016.10:2070520:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1783C>G (p.Gln595Glu)	TSC2	Q595E, Q395E, Q546E, Q558E, Q606E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000406007	16	2120523	16	2070522	406007	401212	rs45517199	NC_000016.10:2070521:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1783C>T (p.Gln595Ter)	TSC2	Q595*, Q606*, Q395*, Q558*, Q546*	not provided|Tuberous sclerosis 2	VCV000049174	16	2120523	16	2070522	49174	58336	rs45517199	NC_000016.10:2070521:C:T	single nucleotide variant	nonsense	Pathogenic	Jun 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1784A>C (p.Gln595Pro)	TSC2	Q595P, Q606P, Q395P, Q546P, Q558P	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001492794	16	2120524	16	2070523	1492794	1515630	rs781087045	NC_000016.10:2070522:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1785G>A (p.Gln595=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000178809	16	2120525	16	2070524	178809	175773	rs150352976	NC_000016.10:2070523:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1786C>T (p.Leu596Phe)	TSC2	L592F, L596F, L626F, L577F, L148F, L396F, L442F, L547F, L559F, L607F, L62F	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV002061296	16	2120526	16	2070525	2061296	2123988	rs2088136491	NC_000016.10:2070524:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1786C>A (p.Leu596Ile)	TSC2	L396I, L547I, L559I, L596I, L607I	Tuberous sclerosis 2	VCV000999077	16	2120526	16	2070525	999077	996710	rs2088136491	NC_000016.10:2070524:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1787T>A (p.Leu596His)	TSC2	L559H, L396H, L596H, L547H, L607H	Tuberous sclerosis 2	VCV000838714	16	2120527	16	2070526	838714	843386	rs45517200	NC_000016.10:2070525:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1787T>C (p.Leu596Pro)	TSC2	L596P, L547P, L607P, L396P, L559P	not provided	VCV000049628	16	2120527	16	2070526	49628	58790	rs45517200	NC_000016.10:2070525:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1788C>G (p.Leu596=)	TSC2		Tuberous sclerosis 2	VCV001549573	16	2120528	16	2070527	1549573	1637040	rs2151280431	NC_000016.10:2070526:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1789C>T (p.His597Tyr)	TSC2	H597Y, H548Y, H560Y, H608Y, H397Y	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000065334	16	2120529	16	2070528	65334	76267	rs397515246	NC_000016.10:2070527:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1790A>T (p.His597Leu)	TSC2	H397L, H548L, H560L, H608L, H597L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000945750	16	2120530	16	2070529	945750	927644	rs137854322	NC_000016.10:2070528:A:T	single nucleotide variant	missense variant	Uncertain significance	May 27, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1790A>G (p.His597Arg)	TSC2	H597R, H548R, H608R, H397R, H560R	Tuberous sclerosis 2	VCV000049629	16	2120530	16	2070529	49629	58791	rs137854322	NC_000016.10:2070528:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1791C>T (p.His597=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413751	16	2120531	16	2070530	413751	400798	rs886038350	NC_000016.10:2070529:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1791C>G (p.His597Gln)	TSC2	H597Q, H560Q, H608Q, H397Q, H548Q	Tuberous sclerosis 2|not specified	VCV000256621	16	2120531	16	2070530	256621	255492	rs886038350	NC_000016.10:2070529:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 23, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1792T>C (p.Tyr598His)	TSC2	Y598H, Y609H, Y549H, Y398H, Y561H	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049175	16	2120532	16	2070531	49175	58337	rs45517201	NC_000016.10:2070530:T:C	single nucleotide variant	missense variant	Likely pathogenic	Apr 23, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1793A>T (p.Tyr598Phe)	TSC2	Y598F, Y398F, Y549F, Y561F, Y609F	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000646479	16	2120533	16	2070532	646479	644208	rs45509791	NC_000016.10:2070531:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1793A>G (p.Tyr598Cys)	TSC2	Y598C, Y549C, Y609C, Y561C, Y398C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000050162	16	2120533	16	2070532	50162	59324	rs45509791	NC_000016.10:2070531:A:G	single nucleotide variant	missense variant	Pathogenic	Sep 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1794C>G (p.Tyr598Ter)	TSC2	Y598*, Y561*, Y549*, Y398*, Y609*	not provided|Tuberous sclerosis 2	VCV000050163	16	2120534	16	2070533	50163	59325	rs45509094	NC_000016.10:2070532:C:G	single nucleotide variant	nonsense	Pathogenic	Jan 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1794C>T (p.Tyr598=)	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049789	16	2120534	16	2070533	49789	58951	rs45509094	NC_000016.10:2070532:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1795A>G (p.Lys599Glu)	TSC2	K399E, K550E, K562E, K599E, K610E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001006361	16	2120535	16	2070534	1006361	996711	rs2088139595	NC_000016.10:2070533:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1796A>G (p.Lys599Arg)	TSC2	K599R, K550R, K562R, K610R, K399R	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000207722	16	2120536	16	2070535	207722	203126	rs45517202	NC_000016.10:2070534:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1797G>A (p.Lys599=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536018	16	2120537	16	2070536	536018	529603	rs1168827262	NC_000016.10:2070535:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1798C>G (p.His600Asp)	TSC2	H400D, H563D, H551D, H600D, H611D	Tuberous sclerosis 2	VCV001468117	16	2120538	16	2070537	1468117	1362362	rs775390128	NC_000016.10:2070536:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1798C>T (p.His600Tyr)	TSC2	H600Y, H551Y, H563Y, H400Y, H611Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467896	16	2120538	16	2070537	467896	465247	rs775390128	NC_000016.10:2070536:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1799A>C (p.His600Pro)	TSC2	H446P, H551P, H596P, H600P, H581P, H611P, H630P, H152P, H400P, H563P, H66P	Hereditary cancer-predisposing syndrome	VCV003462681	16	2120539	16	2070538	3462681	3621700		NC_000016.10:2070537:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1799A>G (p.His600Arg)	TSC2	H66R, H400R, H551R, H600R, H446R, H581R, H596R, H152R, H563R, H611R, H630R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002173343	16	2120539	16	2070538	2173343	1900774	rs1413259742	NC_000016.10:2070537:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1800C>A (p.His600Gln)	TSC2	H400Q, H551Q, H563Q, H600Q, H611Q	Tuberous sclerosis 2	VCV001053151	16	2120540	16	2070539	1053151	1049433	rs762782913	NC_000016.10:2070538:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1800C>T (p.His600=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000387908	16	2120540	16	2070539	387908	375160	rs762782913	NC_000016.10:2070538:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1801A>G (p.Ser601Gly)	TSC2	S597G, S447G, S552G, S582G, S67G, S153G, S401G, S564G, S601G, S612G, S631G	Tuberous sclerosis 2	VCV002202102	16	2120541	16	2070540	2202102	1931225	rs2151280969	NC_000016.10:2070539:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1802G>C (p.Ser601Thr)	TSC2	S153T, S447T, S601T, S401T, S564T, S631T, S67T, S552T, S597T, S582T, S612T	Hereditary cancer-predisposing syndrome	VCV001780429	16	2120542	16	2070541	1780429	1831725	rs2151281011	NC_000016.10:2070540:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1802G>A (p.Ser601Asn)	TSC2	S552N, S601N, S564N, S401N, S612N	Tuberous sclerosis 2	VCV001495032	16	2120542	16	2070541	1495032	1368818	rs2151281011	NC_000016.10:2070540:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1803C>G (p.Ser601Arg)	TSC2	S401R, S552R, S631R, S601R, S67R, S153R, S582R, S447R, S564R, S597R, S612R	Tuberous sclerosis 2	VCV002744117	16	2120543	16	2070542	2744117	2903594	rs1044401463	NC_000016.10:2070541:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	May 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1803C>T (p.Ser601=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001627704	16	2120543	16	2070542	1627704	1530922	rs1044401463	NC_000016.10:2070541:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1803C>A (p.Ser601Arg)	TSC2	S564R, S601R, S401R, S552R, S612R	Tuberous sclerosis 2	VCV000949495	16	2120543	16	2070542	949495	927645	rs1044401463	NC_000016.10:2070541:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1804T>C (p.Tyr602His)	TSC2	Y68H, Y154H, Y583H, Y598H, Y632H, Y402H, Y553H, Y565H, Y613H, Y448H, Y602H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002959228	16	2120544	16	2070543	2959228	3123029	rs2543630281	NC_000016.10:2070542:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1805A>C (p.Tyr602Ser)	TSC2	Y583S, Y598S, Y565S, Y632S, Y448S, Y553S, Y602S, Y154S, Y402S, Y613S, Y68S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002455348	16	2120545	16	2070544	2455348	2427424	rs1596336738	NC_000016.10:2070543:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1805A>G (p.Tyr602Cys)	TSC2	Y402C, Y553C, Y565C, Y602C, Y613C	Tuberous sclerosis 2	VCV000645588	16	2120545	16	2070544	645588	644209	rs1596336738	NC_000016.10:2070543:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1806C>T (p.Tyr602=)	TSC2		Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome	VCV000486610	16	2120546	16	2070545	486610	477335	rs367553206	NC_000016.10:2070544:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1806C>G (p.Tyr602Ter)	TSC2	Y602*, Y553*, Y565*, Y613*, Y402*	not provided	VCV000424291	16	2120546	16	2070545	424291	409481	rs367553206	NC_000016.10:2070544:C:G	single nucleotide variant	nonsense	Pathogenic	Mar 14, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1807A>G (p.Thr603Ala)	TSC2	T603A, T403A, T614A, T554A, T566A	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467897	16	2120547	16	2070546	467897	466095	rs876660140	NC_000016.10:2070545:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 25, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1807A>T (p.Thr603Ser)	TSC2	T603S, T403S, T554S, T566S, T614S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000233025	16	2120547	16	2070546	233025	235099	rs876660140	NC_000016.10:2070545:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1808C>T (p.Thr603Ile)	TSC2	T614I, T603I, T554I, T566I, T403I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001417670	16	2120548	16	2070547	1417670	1374157	rs1318655892	NC_000016.10:2070546:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 22, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1808C>G (p.Thr603Ser)	TSC2	T403S, T554S, T614S, T566S, T603S	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001362039	16	2120548	16	2070547	1362039	1376665	rs1318655892	NC_000016.10:2070546:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1809C>G (p.Thr603=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000795618	16	2120549	16	2070548	795618	785189	rs1016247433	NC_000016.10:2070547:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1809C>T (p.Thr603=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467898	16	2120549	16	2070548	467898	465898	rs1016247433	NC_000016.10:2070547:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1810C>T (p.Leu604=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002028070	16	2120550	16	2070549	2028070	2088545	rs774082654	NC_000016.10:2070548:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1812G>A (p.Leu604=)	TSC2		Tuberous sclerosis 2	VCV001544628	16	2120552	16	2070551	1544628	1524905	rs2151281344	NC_000016.10:2070550:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1813C>T (p.Pro605Ser)	TSC2	P405S, P556S, P568S, P616S, P605S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000841204	16	2120553	16	2070552	841204	843387	rs1295352648	NC_000016.10:2070551:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1813C>A (p.Pro605Thr)	TSC2	P605T, P568T, P616T, P556T, P405T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000820127	16	2120553	16	2070552	820127	812530	rs1295352648	NC_000016.10:2070551:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1813C>G (p.Pro605Ala)	TSC2	P605A, P556A, P568A, P616A, P405A	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535955	16	2120553	16	2070552	535955	529604	rs1295352648	NC_000016.10:2070551:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1814C>T (p.Pro605Leu)	TSC2	P605L, P405L, P616L, P556L, P568L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000535880	16	2120554	16	2070553	535880	530142	rs1555505178	NC_000016.10:2070552:C:T	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1815A>T (p.Pro605=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467899	16	2120555	16	2070554	467899	466102	rs961687056	NC_000016.10:2070553:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1815A>G (p.Pro605=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000382665	16	2120555	16	2070554	382665	377183	rs961687056	NC_000016.10:2070553:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1816A>T (p.Ile606Phe)	TSC2	I158F, I406F, I452F, I557F, I569F, I587F, I602F, I606F, I617F, I636F, I72F	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002578063	16	2120556	16	2070555	2578063	2742954	rs371074761	NC_000016.10:2070554:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1816A>C (p.Ile606Leu)	TSC2	I587L, I602L, I617L, I72L, I569L, I606L, I636L, I452L, I557L, I158L, I406L	Hereditary cancer-predisposing syndrome	VCV002564674	16	2120556	16	2070555	2564674	2733830	rs371074761	NC_000016.10:2070554:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1816A>G (p.Ile606Val)	TSC2	I606V, I406V, I569V, I557V, I617V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified|not provided	VCV000318315	16	2120556	16	2070555	318315	334162	rs371074761	NC_000016.10:2070554:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1817T>A (p.Ile606Asn)	TSC2	I452N, I606N, I587N, I602N, I636N, I158N, I557N, I569N, I72N, I406N, I617N	Hereditary cancer-predisposing syndrome	VCV003811358	16	2120557	16	2070556	3811358	3928599		NC_000016.10:2070555:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1817T>C (p.Ile606Thr)	TSC2	I557T, I606T, I636T, I158T, I569T, I617T, I72T, I406T, I452T, I587T, I602T	Tuberous sclerosis 2	VCV002845415	16	2120557	16	2070556	2845415	3011614	rs2151281523	NC_000016.10:2070555:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1818C>G (p.Ile606Met)	TSC2	I569M, I606M, I406M, I557M, I617M	not provided|Tuberous sclerosis 2	VCV001460814	16	2120558	16	2070557	1460814	1419623	rs547389841	NC_000016.10:2070556:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1818C>T (p.Ile606=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000286970	16	2120558	16	2070557	286970	271207	rs547389841	NC_000016.10:2070556:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1819G>T (p.Ala607Ser)	TSC2	A607S, A558S, A570S, A407S, A618S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000065184	16	2120559	16	2070558	65184	76116	rs45517203	NC_000016.10:2070557:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 22, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1819G>A (p.Ala607Thr)	TSC2	A607T, A618T, A407T, A558T, A570T	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000041730	16	2120559	16	2070558	41730	50169	rs45517203	NC_000016.10:2070557:G:A	single nucleotide variant	missense variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1820C>G (p.Ala607Gly)	TSC2	A407G, A558G, A607G, A570G, A618G	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001386739	16	2120560	16	2070559	1386739	1357866	rs397515296	NC_000016.10:2070558:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1820C>T (p.Ala607Val)	TSC2	A607V, A570V, A407V, A618V, A558V	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000135372	16	2120560	16	2070559	135372	139111	rs397515296	NC_000016.10:2070558:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1820C>A (p.Ala607Glu)	TSC2	A607E, A407E, A558E, A618E, A570E	Tuberous sclerosis 2	VCV000064879	16	2120560	16	2070559	64879	75808	rs397515296	NC_000016.10:2070558:C:A	single nucleotide variant	missense variant	Uncertain significance	May 23, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1821G>C (p.Ala607=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000886713	16	2120561	16	2070560	886713	874845	rs149543046	NC_000016.10:2070559:G:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1821G>A (p.Ala607=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065382	16	2120561	16	2070560	65382	76316	rs149543046	NC_000016.10:2070559:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1823G>A (p.Ser608Asn)	TSC2	S559N, S608N, S571N, S619N, S408N	not provided|Tuberous sclerosis 2	VCV001421086	16	2120563	16	2070562	1421086	1399813	rs753235037	NC_000016.10:2070561:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1823G>C (p.Ser608Thr)	TSC2	S608T, S559T, S571T, S619T, S408T	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535861	16	2120563	16	2070562	535861	529543	rs753235037	NC_000016.10:2070561:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1824C>T (p.Ser608=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000256622	16	2120564	16	2070563	256622	255493	rs886038351	NC_000016.10:2070562:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1825A>G (p.Ser609Gly)	TSC2	S560G, S620G, S409G, S572G, S609G	not provided	VCV001344941	16	2120565	16	2070564	1344941	1336761	rs2151281861	NC_000016.10:2070563:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1826G>A (p.Ser609Asn)	TSC2	S409N, S572N, S590N, S639N, S455N, S161N, S560N, S605N, S609N, S620N, S75N	Hereditary cancer-predisposing syndrome	VCV003811345	16	2120566	16	2070565	3811345	3928586		NC_000016.10:2070564:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1826G>T (p.Ser609Ile)	TSC2	S609I, S620I, S75I, S161I, S455I, S409I, S639I, S560I, S572I, S590I, S605I	Hereditary cancer-predisposing syndrome|not provided	VCV002564740	16	2120566	16	2070565	2564740	2733896	rs2151281883	NC_000016.10:2070564:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1827C>T (p.Ser609=)	TSC2		Tuberous sclerosis 2	VCV002008804	16	2120567	16	2070566	2008804	2062878	rs2151281915	NC_000016.10:2070565:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1828A>C (p.Ile610Leu)	TSC2	I162L, I591L, I606L, I610L, I76L, I410L, I456L, I561L, I640L, I573L, I621L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001780872	16	2120568	16	2070567	1780872	1839141	rs1285778253	NC_000016.10:2070566:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1828A>G (p.Ile610Val)	TSC2	I610V, I621V, I410V, I573V, I561V	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486600	16	2120568	16	2070567	486600	477913	rs1285778253	NC_000016.10:2070566:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1829T>C (p.Ile610Thr)	TSC2	I162T, I573T, I610T, I456T, I561T, I621T, I640T, I76T, I410T, I591T, I606T	Hereditary cancer-predisposing syndrome	VCV001780906	16	2120569	16	2070568	1780906	1839175	rs2151282006	NC_000016.10:2070567:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1831C>A (p.Arg611=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000762053	16	2120571	16	2070570	762053	770695	rs45469298	NC_000016.10:2070569:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1831C>T (p.Arg611Trp)	TSC2	R611W, R622W, R562W, R411W, R574W	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000049643	16	2120571	16	2070570	49643	58805	rs45469298	NC_000016.10:2070569:C:T	single nucleotide variant	missense variant	Pathogenic	Jul 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1831C>G (p.Arg611Gly)	TSC2	R611G, R574G, R622G, R562G, R411G	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049177	16	2120571	16	2070570	49177	58339	rs45469298	NC_000016.10:2070569:C:G	single nucleotide variant	missense variant	Pathogenic	Feb 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1832G>C (p.Arg611Pro)	TSC2	R163P, R562P, R611P, R411P, R457P, R574P, R622P, R592P, R607P, R641P, R77P	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578789	16	2120572	16	2070571	3578789	3708211		NC_000016.10:2070570:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Apr 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1832G>A (p.Arg611Gln)	TSC2	R611Q, R411Q, R622Q, R574Q, R562Q	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000012397	16	2120572	16	2070571	12397	27436	rs28934872	NC_000016.10:2070570:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1833G>C (p.Arg611=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811375	16	2120573	16	2070572	3811375	3928616		NC_000016.10:2070571:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1833G>A (p.Arg611=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001153181	16	2120573	16	2070572	1153181	1145924	rs1270155533	NC_000016.10:2070571:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1834C>T (p.Leu612=)	TSC2		Tuberous sclerosis 2	VCV001895852	16	2120574	16	2070573	1895852	1952649	rs1192397083	NC_000016.10:2070572:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1834C>G (p.Leu612Val)	TSC2	L563V, L412V, L575V, L623V, L612V	Tuberous sclerosis 2	VCV000942508	16	2120574	16	2070573	942508	937293	rs1192397083	NC_000016.10:2070572:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1835T>C (p.Leu612Pro)	TSC2	L612P, L623P, L563P, L412P, L575P	Tuberous sclerosis 2	VCV000623238	16	2120575	16	2070574	623238	612160	rs1567458244	NC_000016.10:2070573:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1836G>T (p.Leu612=)	TSC2		Tuberous sclerosis 2	VCV000793898	16	2120576	16	2070575	793898	785190	rs758839898	NC_000016.10:2070574:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1836G>A (p.Leu612=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000318316	16	2120576	16	2070575	318316	340855	rs758839898	NC_000016.10:2070574:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1837C>T (p.Gln613Ter)	TSC2	Q613*, Q576*, Q624*, Q413*, Q564*	not provided	VCV000049684	16	2120577	16	2070576	49684	58846	rs45480292	NC_000016.10:2070575:C:T	single nucleotide variant	nonsense	Pathogenic	Feb 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1838A>G (p.Gln613Arg)	TSC2	Q413R, Q613R, Q624R, Q564R, Q576R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV001404023	16	2120578	16	2070577	1404023	1467389	rs2151282389	NC_000016.10:2070576:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839G>A (p.Gln613=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001475831	16	2120579	16	2070578	1475831	1400862	rs1555505208	NC_000016.10:2070577:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839G>C (p.Gln613His)	TSC2	Q613H, Q576H, Q624H, Q413H, Q564H	Tuberous sclerosis 2	VCV000467902	16	2120579	16	2070578	467902	466108	rs1555505208	NC_000016.10:2070577:G:C	single nucleotide variant	missense variant	Pathogenic	May 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+1G>T	TSC2		Tuberous sclerosis 2|not provided	VCV000050178	16	2120580	16	2070579	50178	59340	rs45438400	NC_000016.10:2070578:G:T	single nucleotide variant	splice donor variant	Pathogenic	Nov 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839+2T>C	TSC2		Tuberous sclerosis 2	VCV000467900	16	2120581	16	2070580	467900	465902	rs1555505211	NC_000016.10:2070579:T:C	single nucleotide variant	splice donor variant	Pathogenic	Jan 26, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+3A>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000950589	16	2120582	16	2070581	950589	941123	rs1596336981	NC_000016.10:2070580:A:T	single nucleotide variant	intron variant	Uncertain significance	Apr 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839+3A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000640397	16	2120582	16	2070581	640397	652707	rs1596336981	NC_000016.10:2070580:A:G	single nucleotide variant	intron variant	Uncertain significance	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839+4T>C	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467901	16	2120583	16	2070582	467901	465909	rs1246472342	NC_000016.10:2070581:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1839+5G>A	TSC2		Tuberous sclerosis 2	VCV003659214	16	2120584	16	2070583	3659214	3790154		NC_000016.10:2070582:G:A	single nucleotide variant	intron variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+5G>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000576438	16	2120584	16	2070583	576438	573788	rs200568460	NC_000016.10:2070582:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1839+6G>C	TSC2		Tuberous sclerosis syndrome	VCV003071641	16	2120585	16	2070584	3071641	3233907	rs45517204	NC_000016.10:2070583:G:C	single nucleotide variant	intron variant	Uncertain significance	Jun 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+6G>A	TSC2		not specified|Intellectual disability|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000049658	16	2120585	16	2070584	49658	58820	rs45517204	NC_000016.10:2070583:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1839+7T>C	TSC2		Tuberous sclerosis 2	VCV002901373	16	2120586	16	2070585	2901373	3068164	rs2088153162	NC_000016.10:2070584:T:C	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839+8G>A	TSC2		Tuberous sclerosis 2	VCV000751968	16	2120587	16	2070586	751968	776489	rs778061556	NC_000016.10:2070585:G:A	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839+9G>T	TSC2		Tuberous sclerosis 2	VCV001674560	16	2120588	16	2070587	1674560	1532566	rs751834233	NC_000016.10:2070586:G:T	single nucleotide variant	intron variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+9G>C	TSC2		Tuberous sclerosis 2	VCV000799249	16	2120588	16	2070587	799249	788036	rs751834233	NC_000016.10:2070586:G:C	single nucleotide variant	intron variant	Likely benign	Dec 20, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+9G>A	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not provided|Tuberous sclerosis 2	VCV000413684	16	2120588	16	2070587	413684	400804	rs751834233	NC_000016.10:2070586:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1839+10C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000507711	16	2120589	16	2070588	507711	505686	rs868388786	NC_000016.10:2070587:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839+11T>G	TSC2		Tuberous sclerosis 2	VCV001659897	16	2120590	16	2070589	1659897	1606268	rs1156870913	NC_000016.10:2070588:T:G	single nucleotide variant	intron variant	Likely benign	May 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+11T>C	TSC2		Tuberous sclerosis 2	VCV001597643	16	2120590	16	2070589	1597643	1570782	rs1156870913	NC_000016.10:2070588:T:C	single nucleotide variant	intron variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+12G>A	TSC2		Tuberous sclerosis 2	VCV002738796	16	2120591	16	2070590	2738796	2902161	rs2151282769	NC_000016.10:2070589:G:A	single nucleotide variant	intron variant	Likely benign	Jan 26, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+13G>C	TSC2		Tuberous sclerosis 2	VCV002080004	16	2120592	16	2070591	2080004	2139224	rs556485459	NC_000016.10:2070590:G:C	single nucleotide variant	intron variant	Likely benign	Oct 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+13G>A	TSC2		Tuberous sclerosis 2	VCV001654925	16	2120592	16	2070591	1654925	1549498	rs556485459	NC_000016.10:2070590:G:A	single nucleotide variant	intron variant	Likely benign	Oct 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+14G>A	TSC2		Tuberous sclerosis 2	VCV001576924	16	2120593	16	2070592	1576924	1639781	rs1258455812	NC_000016.10:2070591:G:A	single nucleotide variant	intron variant	Likely benign	Nov 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+15G>C	TSC2		Tuberous sclerosis 2	VCV002117266	16	2120594	16	2070593	2117266	2182907	rs2151282851	NC_000016.10:2070592:G:C	single nucleotide variant	intron variant	Likely benign	Mar 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+15G>A	TSC2		Tuberous sclerosis 2	VCV001631329	16	2120594	16	2070593	1631329	1543740	rs2151282851	NC_000016.10:2070592:G:A	single nucleotide variant	intron variant	Likely benign	Dec 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+15G>T	TSC2		Tuberous sclerosis 2	VCV001559717	16	2120594	16	2070593	1559717	1542307	rs2151282851	NC_000016.10:2070592:G:T	single nucleotide variant	intron variant	Likely benign	May 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+17T>G	TSC2		Tuberous sclerosis 2	VCV001629493	16	2120596	16	2070595	1629493	1532276	rs1401501199	NC_000016.10:2070594:T:G	single nucleotide variant	intron variant	Likely benign	Nov 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+18G>A	TSC2		Tuberous sclerosis 2	VCV002965100	16	2120597	16	2070596	2965100	3117667	rs2151282939	NC_000016.10:2070595:G:A	single nucleotide variant	intron variant	Likely benign	Jan 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+18G>C	TSC2		Tuberous sclerosis 2	VCV001561903	16	2120597	16	2070596	1561903	1608442	rs2151282939	NC_000016.10:2070595:G:C	single nucleotide variant	intron variant	Likely benign	May 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+19C>T	TSC2		Tuberous sclerosis 2	VCV001453004	16	2120598	16	2070597	1453004	1432144	rs746001352	NC_000016.10:2070596:C:T	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+20G>T	TSC2		Tuberous sclerosis 2	VCV001543490	16	2120599	16	2070598	1543490	1632947	rs569912958	NC_000016.10:2070597:G:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+20G>C	TSC2		Tuberous sclerosis 2|not specified	VCV000207664	16	2120599	16	2070598	207664	203127	rs569912958	NC_000016.10:2070597:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839+20G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000137739	16	2120599	16	2070598	137739	141442	rs569912958	NC_000016.10:2070597:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1839+248C>T	TSC2		not provided	VCV000677608	16	2120827	16	2070826	677608	668193	rs142694430	NC_000016.10:2070825:C:T	single nucleotide variant	intron variant	Likely benign	Jun 19, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1839+269G>A	TSC2		not provided	VCV000672862	16	2120848	16	2070847	672862	667393	rs116085243	NC_000016.10:2070846:G:A	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-20C>T	TSC2		Tuberous sclerosis 2	VCV001558299	16	2121491	16	2071490	1558299	1594888	rs370980659	NC_000016.10:2071489:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-19A>G	TSC2		Tuberous sclerosis 2	VCV003724763	16	2121492	16	2071491	3724763	3854543		NC_000016.10:2071490:A:G	single nucleotide variant	intron variant	Likely benign	Nov 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-18C>G	TSC2		Tuberous sclerosis 2	VCV002146264	16	2121493	16	2071492	2146264	1876869	rs2151295417	NC_000016.10:2071491:C:G	single nucleotide variant	intron variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-18C>T	TSC2		Tuberous sclerosis 2	VCV001641074	16	2121493	16	2071492	1641074	1520009	rs2151295417	NC_000016.10:2071491:C:T	single nucleotide variant	intron variant	Likely benign	Apr 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-17C>A	TSC2		Tuberous sclerosis 2	VCV003705280	16	2121494	16	2071493	3705280	3846059		NC_000016.10:2071492:C:A	single nucleotide variant	intron variant	Likely benign	Nov 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-17C>T	TSC2		Tuberous sclerosis 2	VCV001615443	16	2121494	16	2071493	1615443	1547385	rs1246308547	NC_000016.10:2071492:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-16A>G	TSC2		Tuberous sclerosis 2	VCV001586684	16	2121495	16	2071494	1586684	1562841	rs200933920	NC_000016.10:2071493:A:G	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-14C>A	TSC2		Tuberous sclerosis 2	VCV001631362	16	2121497	16	2071496	1631362	1543773	rs539450042	NC_000016.10:2071495:C:A	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-14C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001575907	16	2121497	16	2071496	1575907	1551935	rs539450042	NC_000016.10:2071495:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-13C>T	TSC2		not provided|Tuberous sclerosis 2	VCV001239891	16	2121498	16	2071497	1239891	1229013	rs1186556063	NC_000016.10:2071496:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-13C>G	TSC2		Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2	VCV000512088	16	2121498	16	2071497	512088	505463	rs1186556063	NC_000016.10:2071496:C:G	single nucleotide variant	intron variant	Likely benign	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-12T>A	TSC2		Tuberous sclerosis 2	VCV003000722	16	2121499	16	2071498	3000722	3157193	rs2088378931	NC_000016.10:2071497:T:A	single nucleotide variant	intron variant	Likely benign	Dec 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-12T>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002731298	16	2121499	16	2071498	2731298	2893919	rs2088378931	NC_000016.10:2071497:T:C	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-11C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001986447	16	2121500	16	2071499	1986447	2036596	rs754804519	NC_000016.10:2071498:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-11C>G	TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000516777	16	2121500	16	2071499	516777	506159	rs754804519	NC_000016.10:2071498:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-10T>C	TSC2		Tuberous sclerosis 2	VCV001161194	16	2121501	16	2071500	1161194	1145925	rs2151295657	NC_000016.10:2071499:T:C	single nucleotide variant	intron variant	Likely benign	Nov 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-9T>C	TSC2		Tuberous sclerosis 2	VCV004071100	16	2121502	16	2071501	4071100	4184948		NC_000016.10:2071500:T:C	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-8C>G	TSC2		Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV001421452	16	2121503	16	2071502	1421452	1422868	rs778905320	NC_000016.10:2071501:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1840-8C>T	TSC2		Tuberous sclerosis 2	VCV000536095	16	2121503	16	2071502	536095	530144	rs778905320	NC_000016.10:2071501:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-7C>A	TSC2		Tuberous sclerosis 2	VCV002748664	16	2121504	16	2071503	2748664	2915024	rs1567461653	NC_000016.10:2071502:C:A	single nucleotide variant	intron variant	Likely benign	Jul 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-7C>T	TSC2		Tuberous sclerosis 2	VCV001104687	16	2121504	16	2071503	1104687	1103628	rs1567461653	NC_000016.10:2071502:C:T	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-7C>G	TSC2		Tuberous sclerosis 2	VCV000565649	16	2121504	16	2071503	565649	570078	rs1567461653	NC_000016.10:2071502:C:G	single nucleotide variant	intron variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-6T>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000861714	16	2121505	16	2071504	861714	852643	rs747952317	NC_000016.10:2071503:T:A	single nucleotide variant	intron variant	Uncertain significance	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-6T>G	TSC2		Tuberous sclerosis 2	VCV000572612	16	2121505	16	2071504	572612	570080	rs747952317	NC_000016.10:2071503:T:G	single nucleotide variant	intron variant	Likely benign	May 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-5G>C	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001559398	16	2121506	16	2071505	1559398	1629849	rs2151295776	NC_000016.10:2071504:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1840-4A>C	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413742	16	2121507	16	2071506	413742	401461	rs1057523736	NC_000016.10:2071505:A:C	single nucleotide variant	intron variant	Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-4A>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not specified	VCV000390347	16	2121507	16	2071506	390347	374063	rs1057523736	NC_000016.10:2071505:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1840-3C>A	TSC2		Tuberous sclerosis 2	VCV002767028	16	2121508	16	2071507	2767028	2926472	rs397515154	NC_000016.10:2071506:C:A	single nucleotide variant	intron variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-3C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406109	16	2121508	16	2071507	406109	400805	rs397515154	NC_000016.10:2071506:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 17, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1840-3C>G	TSC2		Tuberous sclerosis 2	VCV000065210	16	2121508	16	2071507	65210	76142	rs397515154	NC_000016.10:2071506:C:G	single nucleotide variant	intron variant	Likely pathogenic	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-2A>C	TSC2		not provided	VCV000995052	16	2121509	16	2071508	995052	982941	rs45517205	NC_000016.10:2071507:A:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Mar 9, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840-2A>G	TSC2		Lymphangiomyomatosis|Tuberous sclerosis 2|not provided	VCV000064895	16	2121509	16	2071508	64895	75825	rs45517205	NC_000016.10:2071507:A:G	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Oct 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1840-1G>A	TSC2		Tuberous sclerosis 2	VCV000064936	16	2121510	16	2071509	64936	75866	rs397514953	NC_000016.10:2071508:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840G>A (p.Ala614Thr)	TSC2	A565T, A625T, A577T, A414T, A614T	Hereditary cancer-predisposing syndrome	VCV000820169	16	2121511	16	2071510	820169	812531	rs397515199	NC_000016.10:2071509:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1840G>C (p.Ala614Pro)	TSC2	A614P, A625P, A577P, A414P, A565P	Tuberous sclerosis 2	VCV000237972	16	2121511	16	2071510	237972	242238	rs397515199	NC_000016.10:2071509:G:C	single nucleotide variant	missense variant	Pathogenic	Jan 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1841C>G (p.Ala614Gly)	TSC2	A166G, A414G, A460G, A565G, A577G, A595G, A610G, A614G, A625G, A644G, A80G	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003073790	16	2121512	16	2071511	3073790	3232660	rs45454398	NC_000016.10:2071510:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1841C>A (p.Ala614Asp)	TSC2	A614D, A414D, A577D, A565D, A625D	not provided|Tuberous sclerosis 2	VCV000049721	16	2121512	16	2071511	49721	58883	rs45454398	NC_000016.10:2071510:C:A	single nucleotide variant	missense variant	Pathogenic	Feb 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1842C>G (p.Ala614=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000719947	16	2121513	16	2071512	719947	726488	rs201575136	NC_000016.10:2071511:C:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1843T>A (p.Phe615Ile)	TSC2	F167I, F415I, F461I, F578I, F596I, F615I, F81I, F566I, F611I, F626I, F645I	Hereditary cancer-predisposing syndrome	VCV003462579	16	2121514	16	2071513	3462579	3621598		NC_000016.10:2071512:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1843T>G (p.Phe615Val)	TSC2	F415V, F615V, F566V, F578V, F626V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000887969	16	2121514	16	2071513	887969	874846	rs1446136662	NC_000016.10:2071512:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1845T>C (p.Phe615=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536090	16	2121516	16	2071515	536090	529544	rs1281870505	NC_000016.10:2071514:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1846G>A (p.Asp616Asn)	TSC2	D597N, D82N, D168N, D627N, D567N, D416N, D462N, D579N, D612N, D616N, D646N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001950258	16	2121517	16	2071516	1950258	2000085	rs2151296118	NC_000016.10:2071515:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1847A>G (p.Asp616Gly)	TSC2	D416G, D462G, D82G, D612G, D627G, D168G, D567G, D597G, D616G, D579G, D646G	Tuberous sclerosis 2	VCV001993761	16	2121518	16	2071517	1993761	2059423	rs2151296149	NC_000016.10:2071516:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1847A>C (p.Asp616Ala)	TSC2	D567A, D579A, D616A, D416A, D627A	Tuberous sclerosis 2	VCV001388746	16	2121518	16	2071517	1388746	1383977	rs2151296149	NC_000016.10:2071516:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1848C>T (p.Asp616=)	TSC2		Tuberous sclerosis syndrome	VCV003386163	16	2121519	16	2071518	3386163	3545304		NC_000016.10:2071517:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1848C>G (p.Asp616Glu)	TSC2	D616E, D416E, D567E, D579E, D627E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000646010	16	2121519	16	2071518	646010	644210	rs1383525805	NC_000016.10:2071517:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1849T>C (p.Phe617Leu)	TSC2	F568L, F417L, F647L, F169L, F598L, F628L, F463L, F580L, F613L, F617L, F83L	Hereditary cancer-predisposing syndrome	VCV001781294	16	2121520	16	2071519	1781294	1838641	rs2543672891	NC_000016.10:2071518:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1850T>C (p.Phe617Ser)	TSC2	F417S, F463S, F598S, F613S, F628S, F647S, F580S, F617S, F83S, F169S, F568S	Hereditary cancer-predisposing syndrome|not provided	VCV001781324	16	2121521	16	2071520	1781324	1838671	rs2543672929	NC_000016.10:2071519:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1850T>A (p.Phe617Tyr)	TSC2	F568Y, F580Y, F617Y, F628Y, F598Y, F613Y, F647Y, F463Y, F83Y, F169Y, F417Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001781321	16	2121521	16	2071520	1781321	1838668	rs2543672929	NC_000016.10:2071519:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1851C>A (p.Phe617Leu)	TSC2	F417L, F580L, F598L, F613L, F628L, F83L, F617L, F647L, F169L, F463L, F568L	Tuberous sclerosis 2	VCV003637195	16	2121522	16	2071521	3637195	3771349		NC_000016.10:2071520:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1851C>T (p.Phe617=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001153616	16	2121522	16	2071521	1153616	1145926	rs1446662814	NC_000016.10:2071520:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1851C>G (p.Phe617Leu)	TSC2	F568L, F617L, F628L, F417L, F580L	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000850081	16	2121522	16	2071521	850081	843388	rs1446662814	NC_000016.10:2071520:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1852C>T (p.Leu618=)	TSC2		Tuberous sclerosis 2	VCV000536084	16	2121523	16	2071522	536084	529547	rs1164507294	NC_000016.10:2071521:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1854G>C (p.Leu618=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000413638	16	2121525	16	2071524	413638	400821	rs1060504088	NC_000016.10:2071523:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1855T>C (p.Leu619=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462658	16	2121526	16	2071525	3462658	3621677		NC_000016.10:2071524:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1856T>A (p.Leu619Ter)	TSC2	L171*, L419*, L465*, L570*, L582*, L600*, L615*, L619*, L630*, L649*, L85*	Tuberous sclerosis syndrome	VCV003236707	16	2121527	16	2071526	3236707	3395827	rs2543673284	NC_000016.10:2071525:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1857G>A (p.Leu619=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449983	16	2121528	16	2071527	2449983	2425940	rs1131826	NC_000016.10:2071526:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1858C>T (p.Leu620=)	TSC2		Tuberous sclerosis 2	VCV001139086	16	2121529	16	2071528	1139086	1125046	rs1212638240	NC_000016.10:2071527:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1858C>G (p.Leu620Val)	TSC2	L420V, L571V, L583V, L620V, L631V	Tuberous sclerosis 2	VCV001054184	16	2121529	16	2071528	1054184	1049434	rs1212638240	NC_000016.10:2071527:C:G	single nucleotide variant	missense variant	Benign	Jan 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1859T>C (p.Leu620Pro)	TSC2	L620P, L420P, L583P, L571P, L631P	Tuberous sclerosis 2	VCV000583168	16	2121530	16	2071529	583168	569651	rs1567461912	NC_000016.10:2071528:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1860G>A (p.Leu620=)	TSC2		Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000049180	16	2121531	16	2071530	49180	58342	rs45492397	NC_000016.10:2071529:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1862T>G (p.Leu621Arg)	TSC2	L173R, L421R, L467R, L572R, L584R, L602R, L617R, L621R, L632R, L651R, L87R	Tuberous sclerosis 2	VCV001720083	16	2121533	16	2071532	1720083	1779122	rs397514927	NC_000016.10:2071531:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1862T>C (p.Leu621Pro)	TSC2	L621P, L584P, L632P, L421P, L572P	not provided	VCV000064906	16	2121533	16	2071532	64906	75836	rs397514927	NC_000016.10:2071531:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1863G>T (p.Leu621=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001119195	16	2121534	16	2071533	1119195	1103629	rs1485599658	NC_000016.10:2071532:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1863G>A (p.Leu621=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000486646	16	2121534	16	2071533	486646	477915	rs1485599658	NC_000016.10:2071532:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1864C>G (p.Arg622Gly)	TSC2	R174G, R422G, R468G, R573G, R585G, R603G, R618G, R622G, R633G, R652G, R88G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003232093	16	2121535	16	2071534	3232093	3385633	rs397514914	NC_000016.10:2071533:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1864C>T (p.Arg622Trp)	TSC2	R622W, R422W, R573W, R633W, R585W	TSC2-related disorder|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000064889	16	2121535	16	2071534	64889	75819	rs397514914	NC_000016.10:2071533:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1865G>C (p.Arg622Pro)	TSC2	R622P, R573P, R633P, R422P, R585P	not provided|Tuberous sclerosis 2	VCV000049775	16	2121536	16	2071535	49775	58937	rs45517206	NC_000016.10:2071534:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 7, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1865G>A (p.Arg622Gln)	TSC2	R622Q, R633Q, R573Q, R585Q, R422Q	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049774	16	2121536	16	2071535	49774	58936	rs45517206	NC_000016.10:2071534:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1866G>C (p.Arg622=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001988452	16	2121537	16	2071536	1988452	2047600	rs1397060903	NC_000016.10:2071535:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1866G>A (p.Arg622=)	TSC2		not provided|Tuberous sclerosis 2	VCV001366900	16	2121537	16	2071536	1366900	1338065	rs1397060903	NC_000016.10:2071535:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1866G>T (p.Arg622=)	TSC2		Tuberous sclerosis 2	VCV001114386	16	2121537	16	2071536	1114386	1103630	rs1397060903	NC_000016.10:2071535:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1867G>A (p.Ala623Thr)	TSC2	A175T, A423T, A574T, A623T, A634T, A469T, A604T, A586T, A619T, A653T, A89T	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV002449960	16	2121538	16	2071537	2449960	2429585	rs1596342269	NC_000016.10:2071536:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1867G>C (p.Ala623Pro)	TSC2	A623P, A634P, A619P, A653P, A89P, A574P, A586P, A175P, A423P, A469P, A604P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001966966	16	2121538	16	2071537	1966966	2028263	rs1596342269	NC_000016.10:2071536:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1867G>T (p.Ala623Ser)	TSC2	A574S, A586S, A623S, A634S, A423S	Tuberous sclerosis 2	VCV000659135	16	2121538	16	2071537	659135	644211	rs1596342269	NC_000016.10:2071536:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1868C>T (p.Ala623Val)	TSC2	A623V, A574V, A634V, A423V, A586V	Tuberous sclerosis 2|not specified	VCV000385710	16	2121539	16	2071538	385710	377184	rs1057522306	NC_000016.10:2071537:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1869C>A (p.Ala623=)	TSC2		Tuberous sclerosis 2	VCV002020390	16	2121540	16	2071539	2020390	2079575	rs111244727	NC_000016.10:2071538:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1869C>G (p.Ala623=)	TSC2		Tuberous sclerosis syndrome|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000378779	16	2121540	16	2071539	378779	374066	rs111244727	NC_000016.10:2071538:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1869C>T (p.Ala623=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000137740	16	2121540	16	2071539	137740	141443	rs111244727	NC_000016.10:2071538:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1870G>C (p.Asp624His)	TSC2	D654H, D176H, D424H, D575H, D624H, D635H, D90H, D605H, D470H, D587H, D620H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462566	16	2121541	16	2071540	3462566	3621585		NC_000016.10:2071539:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1870G>T (p.Asp624Tyr)	TSC2	D176Y, D424Y, D470Y, D575Y, D587Y, D605Y, D620Y, D624Y, D635Y, D654Y, D90Y	Tuberous sclerosis 2|not provided	VCV001714452	16	2121541	16	2071540	1714452	1771069	rs1334081822	NC_000016.10:2071539:G:T	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1870G>A (p.Asp624Asn)	TSC2	D624N, D587N, D424N, D575N, D635N	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000577843	16	2121541	16	2071540	577843	569681	rs1334081822	NC_000016.10:2071539:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1871A>C (p.Asp624Ala)	TSC2	D424A, D575A, D587A, D624A, D635A	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001308131	16	2121542	16	2071541	1308131	1296752	rs2151296839	NC_000016.10:2071540:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 21, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1872C>G (p.Asp624Glu)	TSC2	D624E, D587E, D635E, D424E, D575E	Tuberous sclerosis 2	VCV001490184	16	2121543	16	2071542	1490184	1433253	rs1596342301	NC_000016.10:2071541:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1872C>T (p.Asp624=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000762194	16	2121543	16	2071542	762194	770696	rs1596342301	NC_000016.10:2071541:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1874C>T (p.Ser625Leu)	TSC2	S625L, S576L, S425L, S636L, S588L	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000406127	16	2121545	16	2071544	406127	400707	rs368285556	NC_000016.10:2071543:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1875A>G (p.Ser625=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002049603	16	2121546	16	2071545	2049603	2107490	rs1555505786	NC_000016.10:2071544:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1875A>C (p.Ser625=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000467903	16	2121546	16	2071545	467903	465913	rs1555505786	NC_000016.10:2071544:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1876C>T (p.Leu626=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002454258	16	2121547	16	2071546	2454258	2424147	rs903369062	NC_000016.10:2071545:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1876C>G (p.Leu626Val)	TSC2	L426V, L589V, L637V, L626V, L577V	Tuberous sclerosis 2	VCV000651939	16	2121547	16	2071546	651939	644212	rs903369062	NC_000016.10:2071545:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1877T>C (p.Leu626Pro)	TSC2	L577P, L622P, L607P, L178P, L472P, L589P, L626P, L426P, L637P, L656P, L92P	Tuberous sclerosis 2	VCV002884615	16	2121548	16	2071547	2884615	3053626	rs2151297043	NC_000016.10:2071546:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1878G>A (p.Leu626=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001781822	16	2121549	16	2071548	1781822	1835218	rs2151297078	NC_000016.10:2071547:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1878G>C (p.Leu626=)	TSC2		Tuberous sclerosis 2	VCV001137437	16	2121549	16	2071548	1137437	1125047	rs2151297078	NC_000016.10:2071547:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1879C>A (p.His627Asn)	TSC2	H590N, H608N, H623N, H657N, H578N, H627N, H179N, H473N, H427N, H638N, H93N	Tuberous sclerosis 2	VCV002844239	16	2121550	16	2071549	2844239	3007880	rs2151297114	NC_000016.10:2071548:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1879C>T (p.His627Tyr)	TSC2	H578Y, H590Y, H623Y, H657Y, H427Y, H93Y, H608Y, H627Y, H179Y, H473Y, H638Y	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002088429	16	2121550	16	2071549	2088429	2151503	rs2151297114	NC_000016.10:2071548:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1880A>G (p.His627Arg)	TSC2	H638R, H427R, H590R, H627R, H578R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001038821	16	2121551	16	2071550	1038821	1032443	rs2088392295	NC_000016.10:2071549:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1881C>T (p.His627=)	TSC2		Tuberous sclerosis 2	VCV002898149	16	2121552	16	2071551	2898149	3063442	rs967430707	NC_000016.10:2071550:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1881C>A (p.His627Gln)	TSC2	H578Q, H638Q, H590Q, H627Q, H427Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001436796	16	2121552	16	2071551	1436796	1341186	rs967430707	NC_000016.10:2071550:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1882C>T (p.Arg628Cys)	TSC2	R628C, R579C, R639C, R428C, R591C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000406129	16	2121553	16	2071552	406129	400825	rs45437797	NC_000016.10:2071551:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1882C>G (p.Arg628Gly)	TSC2	R628G, R579G, R428G, R591G, R639G	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|not specified	VCV000049603	16	2121553	16	2071552	49603	58765	rs45437797	NC_000016.10:2071551:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1883G>T (p.Arg628Leu)	TSC2	R428L, R591L, R624L, R180L, R474L, R628L, R658L, R94L, R579L, R639L, R609L	Tuberous sclerosis 2	VCV002902653	16	2121554	16	2071553	2902653	3058249	rs774895427	NC_000016.10:2071552:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1883G>C (p.Arg628Pro)	TSC2	R428P, R628P, R639P, R591P, R579P	not provided	VCV000805695	16	2121554	16	2071553	805695	793572	rs774895427	NC_000016.10:2071552:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1883G>A (p.Arg628His)	TSC2	R628H, R591H, R639H, R579H, R428H	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000186281	16	2121554	16	2071553	186281	184126	rs774895427	NC_000016.10:2071552:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1884C>T (p.Arg628=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001134322	16	2121555	16	2071554	1134322	1125048	rs1225653495	NC_000016.10:2071553:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1885C>G (p.Leu629Val)	TSC2	L429V, L640V, L629V, L580V, L592V	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000645127	16	2121556	16	2071555	645127	644213	rs570409651	NC_000016.10:2071554:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1885C>T (p.Leu629=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000378780	16	2121556	16	2071555	378780	374751	rs570409651	NC_000016.10:2071554:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1888G>A (p.Gly630Ser)	TSC2	G581S, G593S, G630S, G430S, G641S	not provided|Tuberous sclerosis 2	VCV000967334	16	2121559	16	2071558	967334	957674	rs2088394240	NC_000016.10:2071557:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1889G>T (p.Gly630Val)	TSC2	G626V, G641V, G96V, G182V, G581V, G476V, G593V, G611V, G660V, G430V, G630V	Hereditary cancer-predisposing syndrome	VCV003462674	16	2121560	16	2071559	3462674	3621693		NC_000016.10:2071558:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1889G>A (p.Gly630Asp)	TSC2	G630D, G581D, G641D, G430D, G593D	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|not provided|not specified|Tuberous sclerosis 2	VCV000379559	16	2121560	16	2071559	379559	374067	rs1057520642	NC_000016.10:2071558:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1890C>T (p.Gly630=)	TSC2		Tuberous sclerosis 2	VCV001133037	16	2121561	16	2071560	1133037	1125049	rs2151297477	NC_000016.10:2071559:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 24, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1891C>T (p.Leu631=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001115946	16	2121562	16	2071561	1115946	1103631	rs575892718	NC_000016.10:2071560:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1893G>A (p.Leu631=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002727591	16	2121564	16	2071563	2727591	2892797	rs1200431267	NC_000016.10:2071562:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1893G>T (p.Leu631=)	TSC2		Tuberous sclerosis 2	VCV001155388	16	2121564	16	2071563	1155388	1145927	rs1200431267	NC_000016.10:2071562:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 23, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1893G>C (p.Leu631=)	TSC2		Tuberous sclerosis 2	VCV000799834	16	2121564	16	2071563	799834	785191	rs1200431267	NC_000016.10:2071562:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1894C>T (p.Pro632Ser)	TSC2	P478S, P662S, P632S, P432S, P583S, P595S, P643S, P98S, P184S, P613S, P628S	Tuberous sclerosis 2	VCV003679240	16	2121565	16	2071564	3679240	3818144		NC_000016.10:2071563:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1895C>G (p.Pro632Arg)	TSC2	P632R, P432R, P583R, P595R, P643R	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000938158	16	2121566	16	2071565	938158	937294	rs750663771	NC_000016.10:2071564:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1895C>T (p.Pro632Leu)	TSC2	P583L, P595L, P632L, P432L, P643L	Tuberous sclerosis 2	VCV000854365	16	2121566	16	2071565	854365	843389	rs750663771	NC_000016.10:2071564:C:T	single nucleotide variant	missense variant	Benign	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1897A>G (p.Asn633Asp)	TSC2	N614D, N629D, N633D, N99D, N479D, N644D, N433D, N584D, N185D, N596D, N663D	Hereditary cancer-predisposing syndrome	VCV003811372	16	2121568	16	2071567	3811372	3928613		NC_000016.10:2071566:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1897A>C (p.Asn633His)	TSC2	N433H, N584H, N644H, N596H, N633H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000846504	16	2121568	16	2071567	846504	843390	rs1462660984	NC_000016.10:2071566:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1898A>G (p.Asn633Ser)	TSC2	N584S, N633S, N596S, N644S, N433S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000861019	16	2121569	16	2071568	861019	843391	rs1184287685	NC_000016.10:2071567:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1899C>T (p.Asn633=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001130160	16	2121570	16	2071569	1130160	1125050	rs2088398113	NC_000016.10:2071568:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1899C>G (p.Asn633Lys)	TSC2	N633K, N584K, N433K, N596K, N644K	Tuberous sclerosis 2	VCV000958829	16	2121570	16	2071569	958829	949236	rs2088398113	NC_000016.10:2071568:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1901A>G (p.Lys634Arg)	TSC2	K100R, K434R, K186R, K645R, K480R, K630R, K634R, K585R, K597R, K615R, K664R	Tuberous sclerosis 2	VCV001998621	16	2121572	16	2071571	1998621	2050542	rs2088398498	NC_000016.10:2071570:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1902G>A (p.Lys634=)	TSC2		Tuberous sclerosis 2	VCV001020447	16	2121573	16	2071572	1020447	1011953	rs2088398778	NC_000016.10:2071571:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1903G>A (p.Asp635Asn)	TSC2	D635N, D435N, D586N, D646N, D598N	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000406001	16	2121574	16	2071573	406001	401468	rs1060500932	NC_000016.10:2071572:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 10, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1904A>G (p.Asp635Gly)	TSC2	D435G, D586G, D598G, D635G, D646G	Tuberous sclerosis 2	VCV001007427	16	2121575	16	2071574	1007427	996712	rs2088399323	NC_000016.10:2071573:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1905T>C (p.Asp635=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000820281	16	2121576	16	2071575	820281	812532	rs1596342515	NC_000016.10:2071574:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Oct 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1905T>G (p.Asp635Glu)	TSC2	D435E, D635E, D586E, D598E, D646E	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000640367	16	2121576	16	2071575	640367	644214	rs1596342515	NC_000016.10:2071574:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1906G>A (p.Gly636Arg)	TSC2	G102R, G188R, G482R, G647R, G587R, G617R, G636R, G599R, G632R, G436R, G666R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002010913	16	2121577	16	2071576	2010913	2073987	rs2151298009	NC_000016.10:2071575:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1908A>T (p.Gly636=)	TSC2		Tuberous sclerosis 2	VCV003641053	16	2121579	16	2071578	3641053	3768771		NC_000016.10:2071577:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1908A>G (p.Gly636=)	TSC2		Tuberous sclerosis 2	VCV001098112	16	2121579	16	2071578	1098112	1081804	rs2151298080	NC_000016.10:2071577:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1909G>A (p.Val637Ile)	TSC2	V483I, V600I, V618I, V648I, V437I, V633I, V637I, V667I, V103I, V189I, V588I	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV002450003	16	2121580	16	2071579	2450003	2425960	rs2088399918	NC_000016.10:2071578:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1909G>C (p.Val637Leu)	TSC2	V637L, V437L, V588L, V648L, V600L	Tuberous sclerosis 2	VCV000971336	16	2121580	16	2071579	971336	957675	rs2088399918	NC_000016.10:2071578:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1911C>G (p.Val637=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002561945	16	2121582	16	2071581	2561945	2724316	rs543584836	NC_000016.10:2071580:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1911C>A (p.Val637=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001124425	16	2121582	16	2071581	1124425	1125051	rs543584836	NC_000016.10:2071580:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1911C>T (p.Val637=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome	VCV000536024	16	2121582	16	2071581	536024	529551	rs543584836	NC_000016.10:2071580:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1912G>T (p.Val638Leu)	TSC2	V589L, V601L, V638L, V649L, V438L	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000807947	16	2121583	16	2071582	807947	797273	rs587778730	NC_000016.10:2071581:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1912G>C (p.Val638Leu)	TSC2	V638L, V438L, V649L, V589L, V601L	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000571151	16	2121583	16	2071582	571151	573794	rs587778730	NC_000016.10:2071581:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1912G>A (p.Val638Met)	TSC2	V638M, V438M, V589M, V649M, V601M	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135373	16	2121583	16	2071582	135373	139112	rs587778730	NC_000016.10:2071581:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1914G>T (p.Val638=)	TSC2		Tuberous sclerosis 2	VCV002124475	16	2121585	16	2071584	2124475	2184936	rs933464584	NC_000016.10:2071583:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1914G>A (p.Val638=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536061	16	2121585	16	2071584	536061	530145	rs933464584	NC_000016.10:2071583:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1915C>A (p.Arg639=)	TSC2		Tuberous sclerosis 2	VCV001117514	16	2121586	16	2071585	1117514	1103632	rs766451267	NC_000016.10:2071584:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1915C>T (p.Arg639Trp)	TSC2	R639W, R602W, R439W, R590W, R650W	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207723	16	2121586	16	2071585	207723	203128	rs766451267	NC_000016.10:2071584:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1916G>T (p.Arg639Leu)	TSC2	R590L, R602L, R650L, R639L, R439L	Tuberous sclerosis 2	VCV001039976	16	2121587	16	2071586	1039976	1032444	rs753932484	NC_000016.10:2071585:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1916G>A (p.Arg639Gln)	TSC2	R639Q, R590Q, R602Q, R439Q, R650Q	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000207724	16	2121587	16	2071586	207724	203129	rs753932484	NC_000016.10:2071585:G:A	single nucleotide variant	missense variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1917G>A (p.Arg639=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001544018	16	2121588	16	2071587	1544018	1611556	rs2151298410	NC_000016.10:2071586:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1918T>A (p.Phe640Ile)	TSC2	F106I, F440I, F591I, F603I, F621I, F636I, F651I, F192I, F670I, F486I, F640I	Hereditary cancer-predisposing syndrome	VCV003974652	16	2121589	16	2071588	3974652	4086475		NC_000016.10:2071587:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1918T>C (p.Phe640Leu)	TSC2	F636L, F603L, F621L, F192L, F440L, F591L, F640L, F670L, F106L, F486L, F651L	Tuberous sclerosis 2	VCV002713810	16	2121589	16	2071588	2713810	2872233	rs2151298434	NC_000016.10:2071587:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1919T>G (p.Phe640Cys)	TSC2	F106C, F192C, F440C, F486C, F591C, F603C, F621C, F636C, F640C, F651C, F670C	Hereditary cancer-predisposing syndrome	VCV003232094	16	2121590	16	2071589	3232094	3385634	rs2151298478	NC_000016.10:2071588:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1920C>T (p.Phe640=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002816163	16	2121591	16	2071590	2816163	2976833	rs2151298515	NC_000016.10:2071589:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1921A>G (p.Ser641Gly)	TSC2	S441G, S487G, S592G, S637G, S652G, S107G, S622G, S671G, S193G, S604G, S641G	Tuberous sclerosis 2	VCV002991530	16	2121592	16	2071591	2991530	3147963	rs2151298557	NC_000016.10:2071590:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1922G>A (p.Ser641Asn)	TSC2	S441N, S652N, S604N, S641N, S592N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000837446	16	2121593	16	2071592	837446	843392	rs397514964	NC_000016.10:2071591:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1922G>T (p.Ser641Ile)	TSC2	S641I, S441I, S604I, S592I, S652I	Tuberous sclerosis 2	VCV000064952	16	2121593	16	2071592	64952	75882	rs397514964	NC_000016.10:2071591:G:T	single nucleotide variant	missense variant	Benign	Mar 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1923C>A (p.Ser641Arg)	TSC2	S107R, S193R, S441R, S487R, S592R, S604R, S622R, S637R, S641R, S652R, S671R	Tuberous sclerosis 2	VCV003065511	16	2121594	16	2071593	3065511	3225532	rs1555505825	NC_000016.10:2071592:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1923C>T (p.Ser641=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified	VCV000467904	16	2121594	16	2071593	467904	465800	rs1555505825	NC_000016.10:2071592:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1924C>T (p.Pro642Ser)	TSC2	P623S, P653S, P108S, P593S, P672S, P488S, P605S, P638S, P194S, P442S, P642S	Tuberous sclerosis 2	VCV002803227	16	2121595	16	2071594	2803227	2966908	rs889366862	NC_000016.10:2071593:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1924C>A (p.Pro642Thr)	TSC2	P642T, P442T, P605T, P593T, P653T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000566547	16	2121595	16	2071594	566547	569687	rs889366862	NC_000016.10:2071593:C:A	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1925C>A (p.Pro642His)	TSC2	P642H, P442H, P653H, P593H, P605H	Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000836936	16	2121596	16	2071595	836936	843393	rs1408228669	NC_000016.10:2071594:C:A	single nucleotide variant	missense variant	Uncertain significance	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1925C>G (p.Pro642Arg)	TSC2	P642R, P605R, P593R, P653R, P442R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000571889	16	2121596	16	2071595	571889	567792	rs1408228669	NC_000016.10:2071594:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1926C>T (p.Pro642=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV001668837	16	2121597	16	2071596	1668837	1602723	rs778765636	NC_000016.10:2071595:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1926C>G (p.Pro642=)	TSC2		Tuberous sclerosis 2	VCV000744358	16	2121597	16	2071596	744358	754988	rs778765636	NC_000016.10:2071595:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1927T>A (p.Tyr643Asn)	TSC2	Y109N, Y195N, Y624N, Y643N, Y654N, Y639N, Y673N, Y594N, Y443N, Y489N, Y606N	Hereditary cancer-predisposing syndrome	VCV002564675	16	2121598	16	2071597	2564675	2733831	rs2151298743	NC_000016.10:2071596:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1928A>T (p.Tyr643Phe)	TSC2	Y443F, Y624F, Y643F, Y109F, Y639F, Y195F, Y489F, Y594F, Y606F, Y654F, Y673F	Tuberous sclerosis 2	VCV002842027	16	2121599	16	2071598	2842027	3000564	rs1319342312	NC_000016.10:2071597:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1928A>G (p.Tyr643Cys)	TSC2	Y443C, Y594C, Y654C, Y606C, Y643C	not provided|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|TSC2-related disorder|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000648631	16	2121599	16	2071598	648631	644215	rs1319342312	NC_000016.10:2071597:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1929C>T (p.Tyr643=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001454502	16	2121600	16	2071599	1454502	1444842	rs368710573	NC_000016.10:2071598:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1929C>A (p.Tyr643Ter)	TSC2	Y443*, Y594*, Y654*, Y606*, Y643*	Tuberous sclerosis 2	VCV001452046	16	2121600	16	2071599	1452046	1438804	rs368710573	NC_000016.10:2071598:C:A	single nucleotide variant	nonsense	Pathogenic	May 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1929C>G (p.Tyr643Ter)	TSC2	Y643*, Y606*, Y443*, Y594*, Y654*	Tuberous sclerosis 2|not provided	VCV000280365	16	2121600	16	2071599	280365	264929	rs368710573	NC_000016.10:2071598:C:G	single nucleotide variant	nonsense	Pathogenic	Oct 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1930T>C (p.Cys644Arg)	TSC2	C110R, C196R, C444R, C490R, C595R, C607R, C625R, C640R, C644R, C655R, C674R	Hereditary cancer-predisposing syndrome|not provided	VCV003232095	16	2121601	16	2071600	3232095	3385635	rs1567462577	NC_000016.10:2071599:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1930T>G (p.Cys644Gly)	TSC2	C644G, C444G, C655G, C595G, C607G	Tuberous sclerosis 2|not provided	VCV000571007	16	2121601	16	2071600	571007	569698	rs1567462577	NC_000016.10:2071599:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1931G>A (p.Cys644Tyr)	TSC2	C444Y, C644Y, C607Y, C595Y, C655Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000748540	16	2121602	16	2071601	748540	754989	rs758301934	NC_000016.10:2071600:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 10, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1932C>A (p.Cys644Ter)	TSC2	C444*, C196*, C595*, C607*, C640*, C644*, C674*, C490*, C625*, C655*, C110*	Tuberous sclerosis 2	VCV002816262	16	2121603	16	2071602	2816262	2976932	rs777665839	NC_000016.10:2071601:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1932C>T (p.Cys644=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000378781	16	2121603	16	2071602	378781	375163	rs777665839	NC_000016.10:2071601:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1933G>T (p.Val645Phe)	TSC2	V608F, V645F, V656F, V445F, V596F	Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000838446	16	2121604	16	2071603	838446	843394	rs746677177	NC_000016.10:2071602:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1933G>C (p.Val645Leu)	TSC2	V645L, V656L, V445L, V608L, V596L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000655290	16	2121604	16	2071603	655290	644216	rs746677177	NC_000016.10:2071602:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1933G>A (p.Val645Ile)	TSC2	V645I, V608I, V596I, V445I, V656I	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000406009	16	2121604	16	2071603	406009	400830	rs746677177	NC_000016.10:2071602:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1935C>G (p.Val645=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000820375	16	2121606	16	2071605	820375	812533	rs1596342693	NC_000016.10:2071604:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1935C>T (p.Val645=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000767340	16	2121606	16	2071605	767340	703549	rs1596342693	NC_000016.10:2071604:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1937G>A (p.Cys646Tyr)	TSC2	C646Y, C597Y, C609Y, C657Y, C446Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486627	16	2121608	16	2071607	486627	477299	rs1555505863	NC_000016.10:2071606:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1938C>G (p.Cys646Trp)	TSC2	C609W, C676W, C446W, C627W, C642W, C646W, C657W, C492W, C112W, C198W, C597W	Hereditary cancer-predisposing syndrome	VCV003329494	16	2121609	16	2071608	3329494	3489086		NC_000016.10:2071607:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1938C>A (p.Cys646Ter)	TSC2	C646*, C446*, C657*, C597*, C609*	not provided	VCV000620215	16	2121609	16	2071608	620215	611817	rs745414854	NC_000016.10:2071607:C:A	single nucleotide variant	nonsense	Pathogenic	May 29, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1938C>T (p.Cys646=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467905	16	2121609	16	2071608	467905	465801	rs745414854	NC_000016.10:2071607:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1939G>T (p.Asp647Tyr)	TSC2	D113Y, D598Y, D643Y, D677Y, D628Y, D647Y, D658Y, D493Y, D199Y, D447Y, D610Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001960039	16	2121610	16	2071609	1960039	2016295	rs45509392	NC_000016.10:2071608:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1939G>C (p.Asp647His)	TSC2	D610H, D658H, D447H, D598H, D647H	Tuberous sclerosis 2	VCV001426217	16	2121610	16	2071609	1426217	1450824	rs45509392	NC_000016.10:2071608:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1939G>A (p.Asp647Asn)	TSC2	D647N, D447N, D610N, D598N, D658N	Tuberous sclerosis 2|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000041731	16	2121610	16	2071609	41731	50170	rs45509392	NC_000016.10:2071608:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1940A>G (p.Asp647Gly)	TSC2	D199G, D447G, D677G, D598G, D643G, D628G, D647G, D113G, D493G, D610G, D658G	Tuberous sclerosis 2	VCV002108392	16	2121611	16	2071610	2108392	2159806	rs2151299187	NC_000016.10:2071609:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1940A>C (p.Asp647Ala)	TSC2	D647A, D658A, D610A, D447A, D598A	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001373080	16	2121611	16	2071610	1373080	1452798	rs2151299187	NC_000016.10:2071609:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1941C>G (p.Asp647Glu)	TSC2	D658E, D610E, D647E, D447E, D598E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001042911	16	2121612	16	2071611	1042911	1032445	rs1326318078	NC_000016.10:2071610:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1942T>C (p.Tyr648His)	TSC2	Y200H, Y448H, Y494H, Y644H, Y648H, Y659H, Y599H, Y629H, Y114H, Y611H, Y678H	Tuberous sclerosis 2	VCV002711441	16	2121613	16	2071612	2711441	2875044	rs2543680976	NC_000016.10:2071611:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1943A>G (p.Tyr648Cys)	TSC2	Y448C, Y611C, Y629C, Y114C, Y494C, Y599C, Y648C, Y200C, Y644C, Y659C, Y678C	Hereditary cancer-predisposing syndrome	VCV002561943	16	2121614	16	2071613	2561943	2724314	rs1204327898	NC_000016.10:2071612:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1943A>C (p.Tyr648Ser)	TSC2	Y114S, Y494S, Y200S, Y599S, Y678S, Y611S, Y644S, Y648S, Y659S, Y448S, Y629S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002003703	16	2121614	16	2071613	2003703	2051760	rs1204327898	NC_000016.10:2071612:A:C	single nucleotide variant	missense variant	Uncertain significance	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1944C>T (p.Tyr648=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000467906	16	2121615	16	2071614	467906	465253	rs878925198	NC_000016.10:2071613:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1945A>T (p.Met649Leu)	TSC2	M600L, M449L, M612L, M649L, M660L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000855784	16	2121616	16	2071615	855784	843395	rs762331610	NC_000016.10:2071614:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1945A>G (p.Met649Val)	TSC2	M649V, M449V, M660V, M600V, M612V	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000467907	16	2121616	16	2071615	467907	465254	rs762331610	NC_000016.10:2071614:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1946T>C (p.Met649Thr)	TSC2	M649T, M612T, M449T, M600T, M660T	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000050189	16	2121617	16	2071616	50189	59351	rs45490792	NC_000016.10:2071615:T:C	single nucleotide variant	missense variant	Benign/Likely benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1946+1G>T	TSC2		not provided	VCV000546435	16	2121618	16	2071617	546435	536898	rs397514994	NC_000016.10:2071616:G:T	single nucleotide variant	splice donor variant	Pathogenic	May 21, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+1G>A	TSC2		Tuberous sclerosis 2|not provided	VCV000448722	16	2121618	16	2071617	448722	441782	rs397514994	NC_000016.10:2071616:G:A	single nucleotide variant	splice donor variant	Pathogenic	Oct 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1946+2T>A	TSC2		not provided	VCV000207779	16	2121619	16	2071618	207779	203130	rs397515247	NC_000016.10:2071617:T:A	single nucleotide variant	splice donor variant	Pathogenic	Oct 8, 2014	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+3A>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002143518	16	2121620	16	2071619	2143518	1869755	rs1596342841	NC_000016.10:2071618:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1946+3A>C	TSC2		Rhabdomyoma|Tuberous sclerosis 2	VCV000661062	16	2121620	16	2071619	661062	652947	rs1596342841	NC_000016.10:2071618:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1946+4C>A	TSC2		Tuberous sclerosis 2	VCV004071117	16	2121621	16	2071620	4071117	4184965		NC_000016.10:2071619:C:A	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+4C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000405982	16	2121621	16	2071620	405982	400832	rs752017577	NC_000016.10:2071619:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1946+5G>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000406022	16	2121622	16	2071621	406022	401469	rs766646261	NC_000016.10:2071620:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1946+5G>A	TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000405996	16	2121622	16	2071621	405996	401213	rs766646261	NC_000016.10:2071620:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1946+6C>G	TSC2		Tuberous sclerosis 2	VCV000581313	16	2121623	16	2071622	581313	573798	rs754069880	NC_000016.10:2071621:C:G	single nucleotide variant	intron variant	Uncertain significance	Oct 3, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+6C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000467909	16	2121623	16	2071622	467909	465266	rs754069880	NC_000016.10:2071621:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1946+6C>A	TSC2		Tuberous sclerosis 2	VCV000467908	16	2121623	16	2071622	467908	465264	rs754069880	NC_000016.10:2071621:C:A	single nucleotide variant	intron variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+7G>T	TSC2		Tuberous sclerosis 2	VCV001598541	16	2121624	16	2071623	1598541	1630540	rs759576009	NC_000016.10:2071622:G:T	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1946+7G>C	TSC2		Tuberous sclerosis 2	VCV000703783	16	2121624	16	2071623	703783	695684	rs759576009	NC_000016.10:2071622:G:C	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1946+7G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000379713	16	2121624	16	2071623	379713	374072	rs759576009	NC_000016.10:2071622:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1946+8G>A	TSC2		Tuberous sclerosis 2	VCV002920343	16	2121625	16	2071624	2920343	3077783	rs2151299675	NC_000016.10:2071623:G:A	single nucleotide variant	intron variant	Likely benign	Aug 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+9G>C	TSC2		Tuberous sclerosis 2	VCV004071237	16	2121626	16	2071625	4071237	4185085		NC_000016.10:2071624:G:C	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+9G>A	TSC2		Tuberous sclerosis 2	VCV003605375	16	2121626	16	2071625	3605375	3736790		NC_000016.10:2071624:G:A	single nucleotide variant	intron variant	Likely benign	Jun 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+9G>T	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000535911	16	2121626	16	2071625	535911	530151	rs1470276886	NC_000016.10:2071624:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1946+11C>T	TSC2		Tuberous sclerosis 2	VCV003708148	16	2121628	16	2071627	3708148	3836425		NC_000016.10:2071626:C:T	single nucleotide variant	intron variant	Likely benign	Sep 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+11C>G	TSC2		Tuberous sclerosis 2	VCV003641645	16	2121628	16	2071627	3641645	3775802		NC_000016.10:2071626:C:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+14C>G	TSC2		Tuberous sclerosis 2	VCV003660916	16	2121631	16	2071630	3660916	3794631		NC_000016.10:2071629:C:G	single nucleotide variant	intron variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+14C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000378782	16	2121631	16	2071630	378782	375166	rs765322549	NC_000016.10:2071629:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1946+15G>T	TSC2		Tuberous sclerosis 2	VCV002872755	16	2121632	16	2071631	2872755	3037834	rs752601710	NC_000016.10:2071630:G:T	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+15G>A	TSC2		Tuberous sclerosis syndrome|not specified|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000378783	16	2121632	16	2071631	378783	377188	rs752601710	NC_000016.10:2071630:G:A	single nucleotide variant	intron variant	Likely benign	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1946+16C>G	TSC2		Tuberous sclerosis 2	VCV003722729	16	2121633	16	2071632	3722729	3857241		NC_000016.10:2071631:C:G	single nucleotide variant	intron variant	Likely benign	Oct 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+16C>T	TSC2		Tuberous sclerosis 2	VCV001581973	16	2121633	16	2071632	1581973	1653934	rs2151299899	NC_000016.10:2071631:C:T	single nucleotide variant	intron variant	Likely benign	Apr 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+17C>T	TSC2		Tuberous sclerosis 2	VCV002197942	16	2121634	16	2071633	2197942	1924103	rs758357102	NC_000016.10:2071632:C:T	single nucleotide variant	intron variant	Likely benign	Apr 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+18C>T	TSC2		Tuberous sclerosis 2	VCV001580461	16	2121635	16	2071634	1580461	1653283	rs1351856624	NC_000016.10:2071633:C:T	single nucleotide variant	intron variant	Likely benign	Jan 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+19A>G	TSC2		Tuberous sclerosis 2	VCV001590166	16	2121636	16	2071635	1590166	1576711	rs1442266522	NC_000016.10:2071634:A:G	single nucleotide variant	intron variant	Likely benign	May 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1946+20C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000378784	16	2121637	16	2071636	378784	377190	rs372149311	NC_000016.10:2071635:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1947-83G>T	TSC2		Tuberous sclerosis 2	VCV001687239	16	2121702	16	2071701	1687239	1679532	rs2151301458	NC_000016.10:2071700:G:T	single nucleotide variant	intron variant	Uncertain significance	May 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-20T>C	TSC2		Tuberous sclerosis 2	VCV002908263	16	2121765	16	2071764	2908263	3069861	rs2088440938	NC_000016.10:2071763:T:C	single nucleotide variant	intron variant	Likely benign	Dec 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-19G>T	TSC2		Tuberous sclerosis 2	VCV002089609	16	2121766	16	2071765	2089609	2144939	rs748855035	NC_000016.10:2071764:G:T	single nucleotide variant	intron variant	Likely benign	Apr 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-19G>C	TSC2		Tuberous sclerosis 2	VCV001590689	16	2121766	16	2071765	1590689	1555168	rs748855035	NC_000016.10:2071764:G:C	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1947-18C>T	TSC2		Tuberous sclerosis 2	VCV001954754	16	2121767	16	2071766	1954754	2014896	rs1225503186	NC_000016.10:2071765:C:T	single nucleotide variant	intron variant	Likely benign	Jul 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-17T>G	TSC2		Tuberous sclerosis 2	VCV002003299	16	2121768	16	2071767	2003299	2055218	rs2151303084	NC_000016.10:2071766:T:G	single nucleotide variant	intron variant	Likely benign	Jun 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-16T>C	TSC2		Tuberous sclerosis 2	VCV004071301	16	2121769	16	2071768	4071301	4185149		NC_000016.10:2071767:T:C	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-15C>T	TSC2		Tuberous sclerosis 2	VCV003637682	16	2121770	16	2071769	3637682	3767966		NC_000016.10:2071768:C:T	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1947-15C>G	TSC2		Tuberous sclerosis 2	VCV002715433	16	2121770	16	2071769	2715433	2872558	rs768132665	NC_000016.10:2071768:C:G	single nucleotide variant	intron variant	Likely benign	May 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-13C>G	TSC2		Tuberous sclerosis 2	VCV001619644	16	2121772	16	2071771	1619644	1615190	rs2151303173	NC_000016.10:2071770:C:G	single nucleotide variant	intron variant	Likely benign	Nov 29, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-13C>T	TSC2		Tuberous sclerosis 2	VCV001617594	16	2121772	16	2071771	1617594	1614447	rs2151303173	NC_000016.10:2071770:C:T	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1947-10G>T	TSC2		Tuberous sclerosis 2	VCV004071084	16	2121775	16	2071774	4071084	4184932		NC_000016.10:2071773:G:T	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-10G>A	TSC2		Tuberous sclerosis 2	VCV000467910	16	2121775	16	2071774	467910	465805	rs778293037	NC_000016.10:2071773:G:A	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1947-9C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000413655	16	2121776	16	2071775	413655	400841	rs747475590	NC_000016.10:2071774:C:T	single nucleotide variant	intron variant	Benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1947-8T>G	TSC2		Tuberous sclerosis 2	VCV002126882	16	2121777	16	2071776	2126882	2178195	rs2151303337	NC_000016.10:2071775:T:G	single nucleotide variant	intron variant	Likely benign	Jul 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-7T>G	TSC2		Tuberous sclerosis 2	VCV001011987	16	2121778	16	2071777	1011987	996713	rs45450193	NC_000016.10:2071776:T:G	single nucleotide variant	intron variant	Likely benign	May 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-6C>G	TSC2		Tuberous sclerosis 2	VCV002032791	16	2121779	16	2071778	2032791	2079153	rs2088443606	NC_000016.10:2071777:C:G	single nucleotide variant	intron variant	Likely benign	Sep 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-6C>T	TSC2		Tuberous sclerosis 2	VCV001582043	16	2121779	16	2071778	1582043	1654004	rs2088443606	NC_000016.10:2071777:C:T	single nucleotide variant	intron variant	Likely benign	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-4G>T	TSC2		Tuberous sclerosis 2	VCV004071454	16	2121781	16	2071780	4071454	4185301		NC_000016.10:2071779:G:T	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-4G>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000774307	16	2121781	16	2071780	774307	778239	rs201633455	NC_000016.10:2071779:G:C	single nucleotide variant	intron variant	Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1947-4G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000318317	16	2121781	16	2071780	318317	340856	rs201633455	NC_000016.10:2071779:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1947-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided	VCV000406118	16	2121782	16	2071781	406118	401472	rs201106259	NC_000016.10:2071780:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1947-2A>C	TSC2		Tuberous sclerosis 2	VCV000835464	16	2121783	16	2071782	835464	851661	rs45517207	NC_000016.10:2071781:A:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Dec 3, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-2A>G	TSC2		Hereditary cancer-predisposing syndrome	VCV000050190	16	2121783	16	2071782	50190	59352	rs45517207	NC_000016.10:2071781:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947-1G>T	TSC2		Tuberous sclerosis 2	VCV001484599	16	2121784	16	2071783	1484599	1478138	rs397515310	NC_000016.10:2071782:G:T	single nucleotide variant	splice acceptor variant	Likely pathogenic	Oct 27, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1947G>A (p.Met649Ile)	TSC2	M649I, M612I, M449I, M600I, M660I	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486628	16	2121785	16	2071784	486628	477306	rs775845436	NC_000016.10:2071783:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1948G>T (p.Glu650Ter)	TSC2	E450*, E601*, E613*, E650*, E661*	Tuberous sclerosis 2	VCV001076299	16	2121786	16	2071785	1076299	1063527	rs2151303613	NC_000016.10:2071784:G:T	single nucleotide variant	nonsense	Pathogenic	Mar 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1949A>C (p.Glu650Ala)	TSC2	E116A, E202A, E450A, E496A, E601A, E613A, E631A, E646A, E650A, E661A, E680A	Tuberous sclerosis 2	VCV001715424	16	2121787	16	2071786	1715424	1775569	rs2151303649	NC_000016.10:2071785:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1950G>A (p.Glu650=)	TSC2		Tuberous sclerosis 2	VCV001088192	16	2121788	16	2071787	1088192	1081805	rs2151303677	NC_000016.10:2071786:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1951C>G (p.Pro651Ala)	TSC2	P117A, P203A, P451A, P497A, P602A, P614A, P632A, P647A, P651A, P662A, P681A	Hereditary cancer-predisposing syndrome	VCV003232096	16	2121789	16	2071788	3232096	3385636	rs763160835	NC_000016.10:2071787:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1951C>T (p.Pro651Ser)	TSC2	P614S, P451S, P602S, P651S, P662S	Tuberous sclerosis 2	VCV001499250	16	2121789	16	2071788	1499250	1488995	rs763160835	NC_000016.10:2071787:C:T	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1952C>T (p.Pro651Leu)	TSC2	P614L, P451L, P602L, P651L, P662L	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000659700	16	2121790	16	2071789	659700	644218	rs1300730043	NC_000016.10:2071788:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1953A>C (p.Pro651=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000820401	16	2121791	16	2071790	820401	812534	rs1051935578	NC_000016.10:2071789:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Sep 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1954G>C (p.Glu652Gln)	TSC2	E118Q, E204Q, E452Q, E498Q, E603Q, E615Q, E633Q, E648Q, E652Q, E663Q, E682Q	Hereditary cancer-predisposing syndrome	VCV003232097	16	2121792	16	2071791	3232097	3385637	rs1555505954	NC_000016.10:2071790:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1954G>A (p.Glu652Lys)	TSC2	E452K, E603K, E615K, E652K, E663K	Tuberous sclerosis 2	VCV001014916	16	2121792	16	2071791	1014916	1011955	rs1555505954	NC_000016.10:2071790:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1954G>T (p.Glu652Ter)	TSC2	E652*, E452*, E663*, E603*, E615*	not provided	VCV000431929	16	2121792	16	2071791	431929	426151	rs1555505954	NC_000016.10:2071790:G:T	single nucleotide variant	nonsense	Pathogenic	Oct 23, 2015	criteria provided, single submitter							
NM_000548.5(TSC2):c.1955A>T (p.Glu652Val)	TSC2	E118V, E204V, E452V, E498V, E603V, E615V, E633V, E648V, E652V, E663V, E682V	Isolated focal cortical dysplasia type II	VCV002679325	16	2121793	16	2071792	2679325	2836902	rs2151303846	NC_000016.10:2071791:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1955A>G (p.Glu652Gly)	TSC2	E648G, E652G, E118G, E615G, E452G, E498G, E603G, E663G, E204G, E633G, E682G	Tuberous sclerosis 2	VCV002089377	16	2121793	16	2071792	2089377	2144707	rs2151303846	NC_000016.10:2071791:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1957A>G (p.Arg653Gly)	TSC2	R453G, R604G, R616G, R653G, R664G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001026938	16	2121795	16	2071794	1026938	1011956	rs764225717	NC_000016.10:2071793:A:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1957A>T (p.Arg653Ter)	TSC2	R653*, R453*, R616*, R604*, R664*	not provided	VCV000280891	16	2121795	16	2071794	280891	264752	rs764225717	NC_000016.10:2071793:A:T	single nucleotide variant	nonsense	Pathogenic	Jul 18, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.1958G>C (p.Arg653Thr)	TSC2	R604T, R664T, R453T, R653T, R616T	Tuberous sclerosis 2	VCV000956143	16	2121796	16	2071795	956143	949237	rs876658202	NC_000016.10:2071794:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1958G>A (p.Arg653Lys)	TSC2	R653K, R604K, R453K, R616K, R664K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000229799	16	2121796	16	2071795	229799	235100	rs876658202	NC_000016.10:2071794:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1959A>C (p.Arg653Ser)	TSC2	R205S, R453S, R616S, R664S, R119S, R499S, R649S, R653S, R634S, R604S, R683S	Tuberous sclerosis 2	VCV003637196	16	2121797	16	2071796	3637196	3771350		NC_000016.10:2071795:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1959A>G (p.Arg653=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001783362	16	2121797	16	2071796	1783362	1843307	rs2151303954	NC_000016.10:2071795:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 7, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1960G>C (p.Gly654Arg)	TSC2	G454R, G605R, G617R, G654R, G665R	Tuberous sclerosis 2	VCV001406765	16	2121798	16	2071797	1406765	1486823	rs397515114	NC_000016.10:2071796:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1960G>A (p.Gly654Ser)	TSC2	G654S, G454S, G617S, G665S, G605S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486638	16	2121798	16	2071797	486638	477309	rs397515114	NC_000016.10:2071796:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1961G>T (p.Gly654Val)	TSC2	G206V, G635V, G650V, G120V, G454V, G500V, G665V, G605V, G617V, G654V, G684V	Hereditary cancer-predisposing syndrome	VCV003329530	16	2121799	16	2071798	3329530	3489122		NC_000016.10:2071797:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1961G>A (p.Gly654Asp)	TSC2	G617D, G120D, G654D, G605D, G635D, G665D, G454D, G500D, G650D, G684D, G206D	Hereditary cancer-predisposing syndrome	VCV003329517	16	2121799	16	2071798	3329517	3489109		NC_000016.10:2071797:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1962C>T (p.Gly654=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000820430	16	2121800	16	2071799	820430	812535	rs1596344030	NC_000016.10:2071798:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1964C>T (p.Ser655Phe)	TSC2	S655F, S606F, S618F, S666F, S455F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536000	16	2121802	16	2071801	536000	529615	rs1442388532	NC_000016.10:2071800:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 25, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1965T>C (p.Ser655=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564716	16	2121803	16	2071802	2564716	2733872	rs2151304159	NC_000016.10:2071801:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1967A>C (p.Glu656Ala)	TSC2	E122A, E208A, E619A, E502A, E637A, E656A, E686A, E456A, E607A, E652A, E667A	Tuberous sclerosis 2	VCV001920574	16	2121805	16	2071804	1920574	1971717	rs2088449468	NC_000016.10:2071803:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1967A>G (p.Glu656Gly)	TSC2	E619G, E607G, E456G, E656G, E667G	Tuberous sclerosis 2	VCV000936033	16	2121805	16	2071804	936033	937295	rs2088449468	NC_000016.10:2071803:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.1968G>A (p.Glu656=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001102740	16	2121806	16	2071805	1102740	1103633	rs761781650	NC_000016.10:2071804:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1969A>G (p.Lys657Glu)	TSC2	K620E, K657E, K668E, K457E, K608E	Tuberous sclerosis 2	VCV001357642	16	2121807	16	2071806	1357642	1367539	rs45488199	NC_000016.10:2071805:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1969A>C (p.Lys657Gln)	TSC2	K657Q, K457Q, K620Q, K668Q, K608Q	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000405983	16	2121807	16	2071806	405983	401473	rs45488199	NC_000016.10:2071805:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1970A>G (p.Lys657Arg)	TSC2	K620R, K638R, K653R, K687R, K209R, K503R, K668R, K123R, K457R, K657R, K608R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002626451	16	2121808	16	2071807	2626451	2794217	rs2151304339	NC_000016.10:2071806:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1971G>T (p.Lys657Asn)	TSC2	K457N, K608N, K620N, K657N, K668N	Tuberous sclerosis 2	VCV001010411	16	2121809	16	2071808	1010411	996714	rs1596344117	NC_000016.10:2071807:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1971G>C (p.Lys657Asn)	TSC2	K668N, K608N, K457N, K620N, K657N	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000957721	16	2121809	16	2071808	957721	949238	rs1596344117	NC_000016.10:2071807:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1971G>A (p.Lys657=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000752868	16	2121809	16	2071808	752868	770697	rs1596344117	NC_000016.10:2071807:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1972A>G (p.Lys658Glu)	TSC2	K658E, K609E, K458E, K621E, K669E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000820445	16	2121810	16	2071809	820445	812536	rs1596344129	NC_000016.10:2071808:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1973A>C (p.Lys658Thr)	TSC2	K658T, K458T, K609T, K669T, K621T	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065307	16	2121811	16	2071810	65307	76239	rs397515223	NC_000016.10:2071809:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1974G>T (p.Lys658Asn)	TSC2	K458N, K609N, K639N, K124N, K688N, K658N, K669N, K210N, K504N, K621N, K654N	Hereditary cancer-predisposing syndrome	VCV002564678	16	2121812	16	2071811	2564678	2733834	rs1353218608	NC_000016.10:2071810:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1974G>A (p.Lys658=)	TSC2		Tuberous sclerosis 2	VCV001115415	16	2121812	16	2071811	1115415	1103634	rs1353218608	NC_000016.10:2071810:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 11, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1975A>T (p.Thr659Ser)	TSC2	T640S, T670S, T125S, T459S, T610S, T655S, T211S, T505S, T622S, T659S, T689S	Tuberous sclerosis 2	VCV002089170	16	2121813	16	2071812	2089170	2148270	rs1398495219	NC_000016.10:2071811:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1975A>C (p.Thr659Pro)	TSC2	T125P, T211P, T459P, T505P, T610P, T622P, T640P, T655P, T659P, T670P, T689P	Tuberous sclerosis 2	VCV001718992	16	2121813	16	2071812	1718992	1776496	rs1398495219	NC_000016.10:2071811:A:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1975A>G (p.Thr659Ala)	TSC2	T459A, T659A, T622A, T670A, T610A	Tuberous sclerosis 2	VCV001039176	16	2121813	16	2071812	1039176	1032446	rs1398495219	NC_000016.10:2071811:A:G	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1976C>T (p.Thr659Ile)	TSC2	T125I, T459I, T505I, T670I, T689I, T655I, T659I, T211I, T610I, T622I, T640I	Tuberous sclerosis 2	VCV002816068	16	2121814	16	2071813	2816068	2976738	rs755847664	NC_000016.10:2071812:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1976C>A (p.Thr659Asn)	TSC2	T459N, T610N, T622N, T659N, T670N	Tuberous sclerosis 2	VCV000661926	16	2121814	16	2071813	661926	644219	rs755847664	NC_000016.10:2071812:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.1976C>G (p.Thr659Ser)	TSC2	T659S, T459S, T670S, T610S, T622S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000649349	16	2121814	16	2071813	649349	644220	rs755847664	NC_000016.10:2071812:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1977C>T (p.Thr659=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000387482	16	2121815	16	2071814	387482	374078	rs369065703	NC_000016.10:2071813:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1978A>T (p.Ser660Cys)	TSC2	S212C, S623C, S641C, S611C, S660C, S460C, S506C, S656C, S671C, S126C, S690C	Tuberous sclerosis 2	VCV003637197	16	2121816	16	2071815	3637197	3771351		NC_000016.10:2071814:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1978A>C (p.Ser660Arg)	TSC2	S460R, S623R, S641R, S656R, S660R, S506R, S690R, S212R, S671R, S126R, S611R	Hereditary cancer-predisposing syndrome	VCV002564679	16	2121816	16	2071815	2564679	2733835	rs200923172	NC_000016.10:2071814:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1978A>G (p.Ser660Gly)	TSC2	S690G, S212G, S460G, S641G, S506G, S611G, S623G, S656G, S126G, S660G, S671G	Tuberous sclerosis 2	VCV002179574	16	2121816	16	2071815	2179574	1916095	rs200923172	NC_000016.10:2071814:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1979G>T (p.Ser660Ile)	TSC2	S671I, S460I, S611I, S623I, S660I	Tuberous sclerosis 2	VCV001488061	16	2121817	16	2071816	1488061	1504770	rs754504918	NC_000016.10:2071815:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1979G>C (p.Ser660Thr)	TSC2	S623T, S671T, S660T, S460T, S611T	Tuberous sclerosis 2	VCV000858037	16	2121817	16	2071816	858037	843396	rs754504918	NC_000016.10:2071815:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1979G>A (p.Ser660Asn)	TSC2	S660N, S611N, S460N, S671N, S623N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000237973	16	2121817	16	2071816	237973	242239	rs754504918	NC_000016.10:2071815:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1980C>G (p.Ser660Arg)	TSC2	S506R, S623R, S656R, S690R, S212R, S660R, S126R, S611R, S671R, S460R, S641R	Tuberous sclerosis 2	VCV002893449	16	2121818	16	2071817	2893449	3048835	rs959705365	NC_000016.10:2071816:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1980C>A (p.Ser660Arg)	TSC2	S460R, S671R, S611R, S623R, S660R	Tuberous sclerosis 2	VCV001447549	16	2121818	16	2071817	1447549	1503603	rs959705365	NC_000016.10:2071816:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1980C>T (p.Ser660=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000751170	16	2121818	16	2071817	751170	770698	rs959705365	NC_000016.10:2071816:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1981G>T (p.Gly661Cys)	TSC2	G213C, G642C, G672C, G691C, G127C, G661C, G461C, G624C, G657C, G507C, G612C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002897020	16	2121819	16	2071818	2897020	3059948	rs137854168	NC_000016.10:2071817:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1981G>A (p.Gly661Ser)	TSC2	G661S, G612S, G624S, G461S, G672S	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000237974	16	2121819	16	2071818	237974	242240	rs137854168	NC_000016.10:2071817:G:A	single nucleotide variant	missense variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1981G>C (p.Gly661Arg)	TSC2	G661R, G461R, G612R, G672R, G624R	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049697	16	2121819	16	2071818	49697	58859	rs137854168	NC_000016.10:2071817:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1982G>T (p.Gly661Val)	TSC2	G461V, G624V, G657V, G661V, G691V, G612V, G642V, G127V, G507V, G213V, G672V	Tuberous sclerosis 2	VCV002978997	16	2121820	16	2071819	2978997	3141526	rs1213719461	NC_000016.10:2071818:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1982G>A (p.Gly661Asp)	TSC2	G661D, G624D, G612D, G461D, G672D	Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000953480	16	2121820	16	2071819	953480	949239	rs1213719461	NC_000016.10:2071818:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1983C>T (p.Gly661=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000467911	16	2121821	16	2071820	467911	465271	rs1270679683	NC_000016.10:2071819:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1984C>A (p.Pro662Thr)	TSC2	P128T, P214T, P462T, P508T, P613T, P625T, P643T, P658T, P662T, P673T, P692T	Hereditary cancer-predisposing syndrome	VCV003232098	16	2121822	16	2071821	3232098	3385638	rs1309151152	NC_000016.10:2071820:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1984C>T (p.Pro662Ser)	TSC2	P625S, P662S, P673S, P613S, P462S	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000842221	16	2121822	16	2071821	842221	843397	rs1309151152	NC_000016.10:2071820:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1984C>G (p.Pro662Ala)	TSC2	P662A, P625A, P462A, P673A, P613A	Tuberous sclerosis 2	VCV000576412	16	2121822	16	2071821	576412	573802	rs1309151152	NC_000016.10:2071820:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1985C>G (p.Pro662Arg)	TSC2	P462R, P643R, P128R, P508R, P625R, P692R, P613R, P658R, P214R, P662R, P673R	Tuberous sclerosis 2	VCV003707570	16	2121823	16	2071822	3707570	3843176		NC_000016.10:2071821:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1985C>A (p.Pro662His)	TSC2	P462H, P613H, P625H, P662H, P673H	Tuberous sclerosis 2	VCV001001562	16	2121823	16	2071822	1001562	996715	rs2088455520	NC_000016.10:2071821:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.1985C>T (p.Pro662Leu)	TSC2	P462L, P613L, P625L, P662L, P673L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000983049	16	2121823	16	2071822	983049	971040	rs2088455520	NC_000016.10:2071821:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1986C>A (p.Pro662=)	TSC2		Tuberous sclerosis 2	VCV004071339	16	2121824	16	2071823	4071339	4185187		NC_000016.10:2071822:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.1986C>T (p.Pro662=)	TSC2		Tuberous sclerosis 2	VCV002704681	16	2121824	16	2071823	2704681	2863093	rs2151305006	NC_000016.10:2071822:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.1986C>G (p.Pro662=)	TSC2		Tuberous sclerosis 2	VCV001562678	16	2121824	16	2071823	1562678	1643089	rs2151305006	NC_000016.10:2071822:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.1987C>G (p.Leu663Val)	TSC2	L463V, L614V, L626V, L663V, L674V	not provided	VCV001694777	16	2121825	16	2071824	1694777	1687209	rs747516623	NC_000016.10:2071823:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1987C>T (p.Leu663Phe)	TSC2	L663F, L674F, L463F, L626F, L614F	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000467912	16	2121825	16	2071824	467912	465809	rs747516623	NC_000016.10:2071823:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1988T>C (p.Leu663Pro)	TSC2	L614P, L626P, L663P, L463P, L674P	Tuberous sclerosis 2	VCV000940828	16	2121826	16	2071825	940828	937296	rs1555506026	NC_000016.10:2071824:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.1988T>G (p.Leu663Arg)	TSC2	L663R, L626R, L674R, L463R, L614R	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000535908	16	2121826	16	2071825	535908	529552	rs1555506026	NC_000016.10:2071824:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1990T>G (p.Ser664Ala)	TSC2	S664A, S675A, S627A, S615A, S464A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486707	16	2121828	16	2071827	486707	477310	rs1555506028	NC_000016.10:2071826:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1991C>T (p.Ser664Phe)	TSC2	S615F, S664F, S627F, S675F, S464F	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000647861	16	2121829	16	2071828	647861	644221	rs991714565	NC_000016.10:2071827:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1991C>A (p.Ser664Tyr)	TSC2	S664Y, S615Y, S464Y, S675Y, S627Y	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535897	16	2121829	16	2071828	535897	529925	rs991714565	NC_000016.10:2071827:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1991C>G (p.Ser664Cys)	TSC2	S664C, S464C, S627C, S675C, S615C	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467913	16	2121829	16	2071828	467913	466110	rs991714565	NC_000016.10:2071827:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1992T>C (p.Ser664=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000702268	16	2121830	16	2071829	702268	693808	rs1459545137	NC_000016.10:2071828:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1993C>T (p.Pro665Ser)	TSC2	P131S, P465S, P511S, P628S, P676S, P646S, P665S, P695S, P217S, P616S, P661S	Hereditary cancer-predisposing syndrome	VCV003329525	16	2121831	16	2071830	3329525	3489117		NC_000016.10:2071829:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.1993C>G (p.Pro665Ala)	TSC2	P665A, P465A, P616A, P676A, P628A	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536057	16	2121831	16	2071830	536057	530152	rs1184908674	NC_000016.10:2071829:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.1994C>T (p.Pro665Leu)	TSC2	P465L, P616L, P646L, P676L, P217L, P511L, P665L, P661L, P131L, P628L, P695L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001784028	16	2121832	16	2071831	1784028	1849587	rs2088458769	NC_000016.10:2071830:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1996C>G (p.Pro666Ala)	TSC2	P218A, P466A, P617A, P647A, P512A, P662A, P696A, P666A, P132A, P629A, P677A	Tuberous sclerosis 2|not specified	VCV002102988	16	2121834	16	2071833	2102988	2162048	rs2151305388	NC_000016.10:2071832:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1996C>T (p.Pro666Ser)	TSC2	P677S, P617S, P666S, P466S, P629S	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001425749	16	2121834	16	2071833	1425749	1428123	rs2151305388	NC_000016.10:2071832:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1998C>T (p.Pro666=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467914	16	2121836	16	2071835	467914	465914	rs1474891284	NC_000016.10:2071834:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.1999A>G (p.Thr667Ala)	TSC2	T467A, T618A, T630A, T667A, T678A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001025457	16	2121837	16	2071836	1025457	1011957	rs757722513	NC_000016.10:2071835:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2000C>G (p.Thr667Arg)	TSC2	T133R, T219R, T630R, T697R, T467R, T618R, T667R, T678R, T663R, T513R, T648R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002743653	16	2121838	16	2071837	2743653	2907006	rs781533796	NC_000016.10:2071836:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2000C>T (p.Thr667Ile)	TSC2	T467I, T618I, T630I, T667I, T678I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001395830	16	2121838	16	2071837	1395830	1425229	rs781533796	NC_000016.10:2071836:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2001A>C (p.Thr667=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564680	16	2121839	16	2071838	2564680	2733836	rs1412129753	NC_000016.10:2071837:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2001A>T (p.Thr667=)	TSC2		Tuberous sclerosis 2	VCV001093446	16	2121839	16	2071838	1093446	1081806	rs1412129753	NC_000016.10:2071837:A:T	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2001A>G (p.Thr667=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000467915	16	2121839	16	2071838	467915	465922	rs1412129753	NC_000016.10:2071837:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2003G>A (p.Gly668Glu)	TSC2	G631E, G468E, G619E, G679E, G668E	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000820511	16	2121841	16	2071840	820511	812537	rs1406015247	NC_000016.10:2071839:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2004G>A (p.Gly668=)	TSC2		Tuberous sclerosis 2	VCV002838254	16	2121842	16	2071841	2838254	3002754	rs746307631	NC_000016.10:2071840:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2004G>T (p.Gly668=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000729835	16	2121842	16	2071841	729835	740019	rs746307631	NC_000016.10:2071840:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2005C>G (p.Pro669Ala)	TSC2	P135A, P665A, P221A, P469A, P515A, P680A, P669A, P699A, P620A, P632A, P650A	Hereditary cancer-predisposing syndrome	VCV003462641	16	2121843	16	2071842	3462641	3621660		NC_000016.10:2071841:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2005C>A (p.Pro669Thr)	TSC2	P135T, P665T, P669T, P680T, P650T, P221T, P469T, P620T, P699T, P515T, P632T	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002825177	16	2121843	16	2071842	2825177	2986262	rs2151305683	NC_000016.10:2071841:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2005C>T (p.Pro669Ser)	TSC2	P135S, P665S, P469S, P515S, P620S, P632S, P650S, P680S, P221S, P669S, P699S	Hereditary cancer-predisposing syndrome	VCV002564616	16	2121843	16	2071842	2564616	2733772	rs2151305683	NC_000016.10:2071841:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2006C>A (p.Pro669His)	TSC2	P221H, P515H, P620H, P632H, P669H, P135H, P665H, P469H, P650H, P680H, P699H	Tuberous sclerosis 2	VCV002767368	16	2121844	16	2071843	2767368	2922942	rs794727221	NC_000016.10:2071842:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2006C>G (p.Pro669Arg)	TSC2	P135R, P221R, P620R, P469R, P515R, P632R, P669R, P680R, P699R, P650R, P665R	Tuberous sclerosis 2	VCV002712879	16	2121844	16	2071843	2712879	2879026	rs794727221	NC_000016.10:2071842:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2006C>T (p.Pro669Leu)	TSC2	P669L, P680L, P620L, P469L, P632L	not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000194924	16	2121844	16	2071843	194924	192086	rs794727221	NC_000016.10:2071842:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2007T>C (p.Pro669=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001604467	16	2121845	16	2071844	1604467	1558981	rs2151305733	NC_000016.10:2071843:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2008C>T (p.Pro670Ser)	TSC2	P222S, P470S, P666S, P670S, P681S, P516S, P633S, P621S, P700S, P136S, P651S	Hereditary cancer-predisposing syndrome|not provided	VCV001784358	16	2121846	16	2071845	1784358	1846420	rs1338802781	NC_000016.10:2071844:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2008C>G (p.Pro670Ala)	TSC2	P470A, P633A, P670A, P621A, P681A	Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000649915	16	2121846	16	2071845	649915	644222	rs1338802781	NC_000016.10:2071844:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2009C>A (p.Pro670His)	TSC2	P651H, P666H, P700H, P516H, P621H, P670H, P136H, P222H, P681H, P470H, P633H	Hereditary cancer-predisposing syndrome	VCV003462675	16	2121847	16	2071846	3462675	3621694		NC_000016.10:2071845:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2009C>T (p.Pro670Leu)	TSC2	P670L, P621L, P633L, P681L, P470L	Hereditary cancer-predisposing syndrome|not specified|Epilepsy|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065383	16	2121847	16	2071846	65383	76317	rs397515288	NC_000016.10:2071845:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2010T>A (p.Pro670=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002626454	16	2121848	16	2071847	2626454	2794220	rs2088462482	NC_000016.10:2071846:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2010T>G (p.Pro670=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564681	16	2121848	16	2071847	2564681	2733837	rs2088462482	NC_000016.10:2071846:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2011G>A (p.Gly671Ser)	TSC2	G682S, G471S, G622S, G671S, G634S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001399324	16	2121849	16	2071848	1399324	1450618	rs1268191908	NC_000016.10:2071847:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2012G>A (p.Gly671Asp)	TSC2	G671D, G471D, G622D, G634D, G682D	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000535899	16	2121850	16	2071849	535899	529618	rs775881847	NC_000016.10:2071848:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2013C>A (p.Gly671=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536047	16	2121851	16	2071850	536047	529622	rs566848799	NC_000016.10:2071849:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2013C>T (p.Gly671=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467916	16	2121851	16	2071850	467916	465925	rs566848799	NC_000016.10:2071849:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2014C>T (p.Pro672Ser)	TSC2	P635S, P472S, P623S, P672S, P683S	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000820528	16	2121852	16	2071851	820528	812538	rs1262368552	NC_000016.10:2071850:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2014C>G (p.Pro672Ala)	TSC2	P672A, P472A, P623A, P683A, P635A	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000535909	16	2121852	16	2071851	535909	530154	rs1262368552	NC_000016.10:2071850:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2015C>G (p.Pro672Arg)	TSC2	P635R, P653R, P702R, P224R, P472R, P672R, P668R, P683R, P138R, P518R, P623R	Tuberous sclerosis 2	VCV002064894	16	2121853	16	2071852	2064894	2125006	rs768864353	NC_000016.10:2071851:C:G	single nucleotide variant	missense variant	Benign	Apr 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2015C>T (p.Pro672Leu)	TSC2	P672L, P623L, P635L, P472L, P683L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000406039	16	2121853	16	2071852	406039	401474	rs768864353	NC_000016.10:2071851:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2016G>C (p.Pro672=)	TSC2		Tuberous sclerosis 2	VCV000536099	16	2121854	16	2071853	536099	529554	rs774517903	NC_000016.10:2071852:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2016G>A (p.Pro672=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405969	16	2121854	16	2071853	405969	400710	rs774517903	NC_000016.10:2071852:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2017G>T (p.Ala673Ser)	TSC2	A139S, A673S, A684S, A473S, A519S, A669S, A636S, A225S, A624S, A654S, A703S	Tuberous sclerosis 2	VCV002869772	16	2121855	16	2071854	2869772	3024653	rs2151306062	NC_000016.10:2071853:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2017G>C (p.Ala673Pro)	TSC2	A624P, A636P, A703P, A669P, A673P, A139P, A225P, A684P, A473P, A519P, A654P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001784483	16	2121855	16	2071854	1784483	1846543	rs2151306062	NC_000016.10:2071853:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2018C>T (p.Ala673Val)	TSC2	A673V, A473V, A636V, A684V, A624V	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Renal cyst	VCV000207665	16	2121856	16	2071855	207665	203131	rs745897413	NC_000016.10:2071854:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2019G>C (p.Ala673=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001899626	16	2121857	16	2071856	1899626	1960302	rs772993105	NC_000016.10:2071855:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2019G>T (p.Ala673=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001142108	16	2121857	16	2071856	1142108	1145928	rs772993105	NC_000016.10:2071855:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2019G>A (p.Ala673=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000388343	16	2121857	16	2071856	388343	374082	rs772993105	NC_000016.10:2071855:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2020C>T (p.Pro674Ser)	TSC2	P674S, P637S, P474S, P625S, P685S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535965	16	2121858	16	2071857	535965	529558	rs760566516	NC_000016.10:2071856:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2021C>A (p.Pro674His)	TSC2	P140H, P226H, P670H, P655H, P674H, P520H, P625H, P637H, P685H, P704H, P474H	Hereditary cancer-predisposing syndrome	VCV003462695	16	2121859	16	2071858	3462695	3621714		NC_000016.10:2071857:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2021C>T (p.Pro674Leu)	TSC2	P625L, P674L, P704L, P637L, P226L, P520L, P670L, P685L, P140L, P474L, P655L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002724275	16	2121859	16	2071858	2724275	2892077	rs2151306195	NC_000016.10:2071857:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2022T>C (p.Pro674=)	TSC2		Tuberous sclerosis 2	VCV004071029	16	2121860	16	2071859	4071029	4184877		NC_000016.10:2071858:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2023G>C (p.Ala675Pro)	TSC2	A638P, A656P, A705P, A475P, A626P, A675P, A141P, A227P, A521P, A671P, A686P	Tuberous sclerosis 2	VCV002709520	16	2121861	16	2071860	2709520	2878266	rs764840082	NC_000016.10:2071859:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2023G>T (p.Ala675Ser)	TSC2	A675S, A475S, A626S, A638S, A686S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis	VCV000535866	16	2121861	16	2071860	535866	529560	rs764840082	NC_000016.10:2071859:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2023G>A (p.Ala675Thr)	TSC2	A675T, A475T, A638T, A626T, A686T	Ovarian cancer|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000237975	16	2121861	16	2071860	237975	242241	rs764840082	NC_000016.10:2071859:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2024C>A (p.Ala675Glu)	TSC2	A141E, A227E, A475E, A521E, A626E, A638E, A656E, A671E, A675E, A686E, A705E	Tuberous sclerosis 2	VCV002691867	16	2121862	16	2071861	2691867	2852870	rs1261337087	NC_000016.10:2071860:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2024C>T (p.Ala675Val)	TSC2	A638V, A705V, A475V, A521V, A656V, A671V, A675V, A626V, A686V, A141V, A227V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001784627	16	2121862	16	2071861	1784627	1846687	rs1261337087	NC_000016.10:2071860:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2025A>C (p.Ala675=)	TSC2		not provided	VCV001200347	16	2121863	16	2071862	1200347	1191768	rs766113544	NC_000016.10:2071861:A:C	single nucleotide variant	synonymous variant	Likely benign	Jan 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2025A>G (p.Ala675=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001091343	16	2121863	16	2071862	1091343	1081807	rs766113544	NC_000016.10:2071861:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2027G>C (p.Gly676Ala)	TSC2	G676A, G639A, G476A, G687A, G627A	Tuberous sclerosis 2	VCV000803149	16	2121865	16	2071864	803149	791533	rs754556513	NC_000016.10:2071863:G:C	single nucleotide variant	missense variant	Likely benign	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2027G>T (p.Gly676Val)	TSC2	G676V, G687V, G476V, G627V, G639V	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486625	16	2121865	16	2071864	486625	477922	rs754556513	NC_000016.10:2071863:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2028C>G (p.Gly676=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003232100	16	2121866	16	2071865	3232100	3385640	rs1057520807	NC_000016.10:2071864:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2028C>T (p.Gly676=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000380251	16	2121866	16	2071865	380251	377210	rs1057520807	NC_000016.10:2071864:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2029C>T (p.Pro677Ser)	TSC2	P229S, P523S, P628S, P658S, P143S, P677S, P688S, P640S, P477S, P673S, P707S	Tuberous sclerosis 2	VCV002169263	16	2121867	16	2071866	2169263	1903210	rs1178654694	NC_000016.10:2071865:C:T	single nucleotide variant	missense variant	Benign	Apr 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2029C>G (p.Pro677Ala)	TSC2	P477A, P628A, P640A, P677A, P688A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001000492	16	2121867	16	2071866	1000492	996716	rs1178654694	NC_000016.10:2071865:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2030C>T (p.Pro677Leu)	TSC2	P677L, P628L, P640L, P477L, P688L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome	VCV000384076	16	2121868	16	2071867	384076	374753	rs376974525	NC_000016.10:2071866:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2031C>G (p.Pro677=)	TSC2		Tuberous sclerosis 2	VCV001089275	16	2121869	16	2071868	1089275	1081808	rs45517208	NC_000016.10:2071867:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2031C>T (p.Pro677=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lung lymphangioleiomyomatosis|not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049616	16	2121869	16	2071868	49616	58778	rs45517208	NC_000016.10:2071867:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2032G>A (p.Ala678Thr)	TSC2	A678T, A478T, A641T, A689T, A629T	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184135	16	2121870	16	2071869	184135	184127	rs200494044	NC_000016.10:2071868:G:A	single nucleotide variant	missense variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2033C>A (p.Ala678Asp)	TSC2	A629D, A689D, A641D, A478D, A678D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000938414	16	2121871	16	2071870	938414	937297	rs1567464805	NC_000016.10:2071869:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2033C>G (p.Ala678Gly)	TSC2	A678G, A629G, A641G, A689G, A478G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000575588	16	2121871	16	2071870	575588	570081	rs1567464805	NC_000016.10:2071869:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2034C>A (p.Ala678=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002414764	16	2121872	16	2071871	2414764	1947268	rs781740263	NC_000016.10:2071870:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2034C>G (p.Ala678=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000939442	16	2121872	16	2071871	939442	937298	rs781740263	NC_000016.10:2071870:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2034C>T (p.Ala678=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000185220	16	2121872	16	2071871	185220	184128	rs781740263	NC_000016.10:2071870:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2035G>T (p.Val679Leu)	TSC2	V479L, V630L, V642L, V679L, V690L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001052187	16	2121873	16	2071872	1052187	1049435	rs746315218	NC_000016.10:2071871:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2035G>C (p.Val679Leu)	TSC2	V479L, V630L, V690L, V642L, V679L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000937500	16	2121873	16	2071872	937500	937299	rs746315218	NC_000016.10:2071871:G:C	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2035G>A (p.Val679Met)	TSC2	V679M, V479M, V630M, V690M, V642M	Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|TSC2-related disorder|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000237976	16	2121873	16	2071872	237976	242242	rs746315218	NC_000016.10:2071871:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2036T>C (p.Val679Ala)	TSC2	V630A, V642A, V675A, V679A, V231A, V479A, V525A, V690A, V145A, V660A, V709A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002178101	16	2121874	16	2071873	2178101	1915911	rs2151306774	NC_000016.10:2071872:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2037G>T (p.Val679=)	TSC2		Tuberous sclerosis 2	VCV002054295	16	2121875	16	2071874	2054295	2112177	rs2088471235	NC_000016.10:2071873:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2037G>A (p.Val679=)	TSC2		Tuberous sclerosis 2	VCV002022376	16	2121875	16	2071874	2022376	2080284	rs2088471235	NC_000016.10:2071873:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2038C>G (p.Arg680Gly)	TSC2	R680G, R691G, R643G, R480G, R631G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000589454	16	2121876	16	2071875	589454	579974	rs876658578	NC_000016.10:2071874:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2038C>T (p.Arg680Trp)	TSC2	R680W, R631W, R643W, R480W, R691W	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000230458	16	2121876	16	2071875	230458	235101	rs876658578	NC_000016.10:2071874:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2039G>T (p.Arg680Leu)	TSC2	R680L, R691L, R480L, R631L, R643L	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000535981	16	2121877	16	2071876	535981	530158	rs756536921	NC_000016.10:2071875:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2039G>C (p.Arg680Pro)	TSC2	R680P, R480P, R631P, R691P, R643P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467918	16	2121877	16	2071876	467918	465818	rs756536921	NC_000016.10:2071875:G:C	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2039G>A (p.Arg680Gln)	TSC2	R680Q, R480Q, R691Q, R631Q, R643Q	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000406003	16	2121877	16	2071876	406003	400716	rs756536921	NC_000016.10:2071875:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2040G>C (p.Arg680=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974708	16	2121878	16	2071877	3974708	4086531		NC_000016.10:2071876:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2040G>A (p.Arg680=)	TSC2		Tuberous sclerosis 2	VCV002997975	16	2121878	16	2071877	2997975	3163393	rs1596344740	NC_000016.10:2071876:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2040G>T (p.Arg680=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000759268	16	2121878	16	2071877	759268	770699	rs1596344740	NC_000016.10:2071876:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2041C>T (p.Leu681=)	TSC2		Tuberous sclerosis 2	VCV001966733	16	2121879	16	2071878	1966733	2028030	rs780502079	NC_000016.10:2071877:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2042T>G (p.Leu681Arg)	TSC2	L233R, L677R, L681R, L692R, L527R, L632R, L662R, L147R, L481R, L644R, L711R	Hereditary cancer-predisposing syndrome	VCV002449967	16	2121880	16	2071879	2449967	2429592	rs878854079	NC_000016.10:2071878:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2042T>C (p.Leu681Pro)	TSC2	L481P, L644P, L681P, L692P, L632P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000664430	16	2121880	16	2071879	664430	644223	rs878854079	NC_000016.10:2071878:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2042T>A (p.Leu681Gln)	TSC2	L681Q, L481Q, L692Q, L632Q, L644Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000237977	16	2121880	16	2071879	237977	242243	rs878854079	NC_000016.10:2071878:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2043G>A (p.Leu681=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001501283	16	2121881	16	2071880	1501283	1402031	rs1296448095	NC_000016.10:2071879:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2044G>T (p.Gly682Trp)	TSC2	G682W, G645W, G633W, G693W, G482W	Tuberous sclerosis 2	VCV000567157	16	2121882	16	2071881	567157	569699	rs1432565227	NC_000016.10:2071880:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2045G>T (p.Gly682Val)	TSC2	G148V, G234V, G482V, G528V, G633V, G645V, G663V, G678V, G682V, G693V, G712V	Tuberous sclerosis syndrome|not provided	VCV003386165	16	2121883	16	2071882	3386165	3545306		NC_000016.10:2071881:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2045G>C (p.Gly682Ala)	TSC2	G633A, G482A, G645A, G682A, G693A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001506748	16	2121883	16	2071882	1506748	1426808	rs1567465004	NC_000016.10:2071881:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2045G>A (p.Gly682Glu)	TSC2	G682E, G633E, G645E, G693E, G482E	Tuberous sclerosis 2	VCV000566246	16	2121883	16	2071882	566246	570083	rs1567465004	NC_000016.10:2071881:G:A	single nucleotide variant	missense variant	Uncertain significance	May 2, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2046G>T (p.Gly682=)	TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001555142	16	2121884	16	2071883	1555142	1564886	rs749536123	NC_000016.10:2071882:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2046G>A (p.Gly682=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not specified	VCV000237978	16	2121884	16	2071883	237978	242244	rs749536123	NC_000016.10:2071882:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2047T>G (p.Ser683Ala)	TSC2	S683A, S483A, S634A, S694A, S646A	Tuberous sclerosis syndrome	VCV000318318	16	2121885	16	2071884	318318	334167	rs878854080	NC_000016.10:2071883:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.2047T>C (p.Ser683Pro)	TSC2	S683P, S634P, S646P, S483P, S694P	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000237979	16	2121885	16	2071884	237979	242245	rs878854080	NC_000016.10:2071883:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2048C>G (p.Ser683Cys)	TSC2	S483C, S694C, S634C, S646C, S683C	Tuberous sclerosis 2	VCV001476583	16	2121886	16	2071885	1476583	1339356	rs919334398	NC_000016.10:2071884:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2048C>A (p.Ser683Tyr)	TSC2	S646Y, S694Y, S634Y, S483Y, S683Y	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000858920	16	2121886	16	2071885	858920	843398	rs919334398	NC_000016.10:2071884:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2048C>T (p.Ser683Phe)	TSC2	S634F, S646F, S483F, S683F, S694F	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000654307	16	2121886	16	2071885	654307	644224	rs919334398	NC_000016.10:2071884:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2049C>G (p.Ser683=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001632029	16	2121887	16	2071886	1632029	1650362	rs569518378	NC_000016.10:2071885:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 8, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2049C>A (p.Ser683=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000648929	16	2121887	16	2071886	648929	644225	rs569518378	NC_000016.10:2071885:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2049C>T (p.Ser683=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207666	16	2121887	16	2071886	207666	203132	rs569518378	NC_000016.10:2071885:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2050G>C (p.Val684Leu)	TSC2	V150L, V236L, V484L, V530L, V635L, V647L, V665L, V680L, V684L, V695L, V714L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001717813	16	2121888	16	2071887	1717813	1771789	rs779275341	NC_000016.10:2071886:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 1, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2050G>T (p.Val684Leu)	TSC2	V484L, V635L, V684L, V647L, V695L	Tuberous sclerosis 2	VCV000961871	16	2121888	16	2071887	961871	949240	rs779275341	NC_000016.10:2071886:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2050G>A (p.Val684Met)	TSC2	V684M, V695M, V484M, V635M, V647M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000231348	16	2121888	16	2071887	231348	235102	rs779275341	NC_000016.10:2071886:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2052G>A (p.Val684=)	TSC2		Tuberous sclerosis syndrome	VCV003072977	16	2121890	16	2071889	3072977	3229248	rs2543704731	NC_000016.10:2071888:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2053C>T (p.Pro685Ser)	TSC2	P648S, P485S, P636S, P696S, P685S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000955151	16	2121891	16	2071890	955151	949241	rs748300709	NC_000016.10:2071889:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2054C>T (p.Pro685Leu)	TSC2	P485L, P636L, P648L, P685L, P696L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001016081	16	2121892	16	2071891	1016081	1011958	rs959165669	NC_000016.10:2071890:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2054C>G (p.Pro685Arg)	TSC2	P685R, P485R, P636R, P696R, P648R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000382914	16	2121892	16	2071891	382914	374087	rs959165669	NC_000016.10:2071890:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2055C>T (p.Pro685=)	TSC2		Tuberous sclerosis 2	VCV002884557	16	2121893	16	2071892	2884557	3053568	rs200450119	NC_000016.10:2071891:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2056T>A (p.Tyr686Asn)	TSC2	Y486N, Y637N, Y649N, Y686N, Y697N	Tuberous sclerosis 2	VCV001466717	16	2121894	16	2071893	1466717	1348075	rs2151307522	NC_000016.10:2071892:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2057A>G (p.Tyr686Cys)	TSC2	Y238C, Y532C, Y637C, Y486C, Y667C, Y716C, Y152C, Y649C, Y682C, Y697C, Y686C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002080527	16	2121895	16	2071894	2080527	2135760	rs2151307563	NC_000016.10:2071893:A:G	single nucleotide variant	missense variant	Uncertain significance	May 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2057A>C (p.Tyr686Ser)	TSC2	Y637S, Y697S, Y532S, Y649S, Y667S, Y152S, Y238S, Y486S, Y682S, Y686S, Y716S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002041925	16	2121895	16	2071894	2041925	2102397	rs2151307563	NC_000016.10:2071893:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2058C>A (p.Tyr686Ter)	TSC2	Y486*, Y697*, Y637*, Y649*, Y686*	Tuberous sclerosis 2	VCV001440861	16	2121896	16	2071895	1440861	1362008	rs1186913814	NC_000016.10:2071894:C:A	single nucleotide variant	nonsense	Pathogenic	Nov 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2058C>T (p.Tyr686=)	TSC2		not specified|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000514750	16	2121896	16	2071895	514750	505688	rs1186913814	NC_000016.10:2071894:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2060C>A (p.Ser687Tyr)	TSC2	S638Y, S698Y, S650Y, S687Y, S487Y	Tuberous sclerosis 2	VCV000937512	16	2121898	16	2071897	937512	937300	rs1455799897	NC_000016.10:2071896:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2060C>T (p.Ser687Phe)	TSC2	S487F, S638F, S650F, S687F, S698F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000664491	16	2121898	16	2071897	664491	644226	rs1455799897	NC_000016.10:2071896:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2061C>T (p.Ser687=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811338	16	2121899	16	2071898	3811338	3928579		NC_000016.10:2071897:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2061C>G (p.Ser687=)	TSC2		Tuberous sclerosis 2	VCV002819819	16	2121899	16	2071898	2819819	2984750	rs1596344926	NC_000016.10:2071897:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2061C>A (p.Ser687=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000698035	16	2121899	16	2071898	698035	688538	rs1596344926	NC_000016.10:2071897:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2062C>G (p.Leu688Val)	TSC2	L154V, L240V, L488V, L534V, L639V, L651V, L669V, L684V, L688V, L699V, L718V	not provided|Hereditary cancer-predisposing syndrome	VCV001801091	16	2121900	16	2071899	1801091	1858378	rs1479736808	NC_000016.10:2071898:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2062C>T (p.Leu688=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001153468	16	2121900	16	2071899	1153468	1145929	rs1479736808	NC_000016.10:2071898:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2064G>T (p.Leu688=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974689	16	2121902	16	2071901	3974689	4086512		NC_000016.10:2071900:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2064G>C (p.Leu688=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536050	16	2121902	16	2071901	536050	529561	rs1202311439	NC_000016.10:2071900:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 2, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2065C>G (p.Leu689Val)	TSC2	L489V, L640V, L652V, L689V, L700V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001007297	16	2121903	16	2071902	1007297	996717	rs1567465268	NC_000016.10:2071901:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2065C>T (p.Leu689Phe)	TSC2	L689F, L489F, L640F, L700F, L652F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000580881	16	2121903	16	2071902	580881	569703	rs1567465268	NC_000016.10:2071901:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2066T>C (p.Leu689Pro)	TSC2	L155P, L241P, L489P, L535P, L640P, L652P, L670P, L685P, L689P, L700P, L719P	not provided	VCV003342698	16	2121904	16	2071903	3342698	3501930		NC_000016.10:2071902:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2066T>A (p.Leu689His)	TSC2	L489H, L640H, L689H, L652H, L700H	Tuberous sclerosis 2	VCV001036631	16	2121904	16	2071903	1036631	1032447	rs2088480123	NC_000016.10:2071902:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2067C>G (p.Leu689=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002729757	16	2121905	16	2071904	2729757	2889799	rs1060504107	NC_000016.10:2071903:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2067C>T (p.Leu689=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413711	16	2121905	16	2071904	413711	401224	rs1060504107	NC_000016.10:2071903:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2068T>G (p.Phe690Val)	TSC2	F156V, F242V, F490V, F536V, F641V, F653V, F671V, F686V, F690V, F701V, F720V	Tuberous sclerosis 2	VCV001716576	16	2121906	16	2071905	1716576	1778257	rs2151307978	NC_000016.10:2071904:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2070C>T (p.Phe690=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001785391	16	2121908	16	2071907	1785391	1840188	rs558292668	NC_000016.10:2071906:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2070C>G (p.Phe690Leu)	TSC2	F641L, F653L, F490L, F690L, F701L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000944325	16	2121908	16	2071907	944325	927647	rs558292668	NC_000016.10:2071906:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2070C>A (p.Phe690Leu)	TSC2	F690L, F641L, F653L, F490L, F701L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535884	16	2121908	16	2071907	535884	529572	rs558292668	NC_000016.10:2071906:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2071C>G (p.Arg691Gly)	TSC2	R691G, R642G, R491G, R702G, R654G	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000467920	16	2121909	16	2071908	467920	465821	rs760489473	NC_000016.10:2071907:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2071C>T (p.Arg691Cys)	TSC2	R691C, R642C, R654C, R702C, R491C	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184386	16	2121909	16	2071908	184386	184129	rs760489473	NC_000016.10:2071907:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2072G>A (p.Arg691His)	TSC2	R691H, R654H, R642H, R702H, R491H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000580725	16	2121910	16	2071909	580725	570088	rs370553131	NC_000016.10:2071908:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2072G>T (p.Arg691Leu)	TSC2	R691L, R491L, R702L, R642L, R654L	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207725	16	2121910	16	2071909	207725	203133	rs370553131	NC_000016.10:2071908:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2073C>A (p.Arg691=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000702694	16	2121911	16	2071910	702694	693809	rs45512398	NC_000016.10:2071909:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2073C>T (p.Arg691=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000049716	16	2121911	16	2071910	49716	58878	rs45512398	NC_000016.10:2071909:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2074G>C (p.Val692Leu)	TSC2	V492L, V643L, V688L, V703L, V722L, V158L, V538L, V655L, V244L, V673L, V692L	Tuberous sclerosis 2	VCV002996594	16	2121912	16	2071911	2996594	3159479	rs201769220	NC_000016.10:2071910:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2074G>T (p.Val692Phe)	TSC2	V692F, V703F, V643F, V655F, V492F	Tuberous sclerosis 2	VCV000406002	16	2121912	16	2071911	406002	400842	rs201769220	NC_000016.10:2071910:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2074G>A (p.Val692Ile)	TSC2	V692I, V492I, V655I, V643I, V703I	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000226045	16	2121912	16	2071911	226045	227853	rs201769220	NC_000016.10:2071910:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2075T>C (p.Val692Ala)	TSC2	V244A, V492A, V703A, V158A, V538A, V643A, V655A, V673A, V692A, V722A, V688A	Tuberous sclerosis 2	VCV002812913	16	2121913	16	2071912	2812913	2976145	rs2151308291	NC_000016.10:2071911:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2076C>T (p.Val692=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001635107	16	2121914	16	2071913	1635107	1610833	rs2151308324	NC_000016.10:2071912:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2077C>G (p.Leu693Val)	TSC2	L493V, L644V, L656V, L693V, L704V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001051118	16	2121915	16	2071914	1051118	1049436	rs1167258871	NC_000016.10:2071913:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2077C>T (p.Leu693=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000467921	16	2121915	16	2071914	467921	465275	rs1167258871	NC_000016.10:2071913:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2079G>A (p.Leu693=)	TSC2		Tuberous sclerosis 2	VCV001532372	16	2121917	16	2071916	1532372	1635983	rs764932531	NC_000016.10:2071915:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2079G>C (p.Leu693=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000237980	16	2121917	16	2071916	237980	242246	rs764932531	NC_000016.10:2071915:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2080C>G (p.Leu694Val)	TSC2	L160V, L246V, L494V, L540V, L645V, L657V, L675V, L690V, L694V, L705V, L724V	not provided	VCV003360430	16	2121918	16	2071917	3360430	3519641		NC_000016.10:2071916:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2082G>A (p.Leu694=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001672265	16	2121920	16	2071919	1672265	1647574	rs45458592	NC_000016.10:2071918:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2083C>T (p.Gln695Ter)	TSC2	Q695*, Q706*, Q495*, Q646*, Q658*	not provided|Tuberous sclerosis 2	VCV000049632	16	2121921	16	2071920	49632	58794	rs45517209	NC_000016.10:2071919:C:T	single nucleotide variant	nonsense	Pathogenic	Dec 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2084A>G (p.Gln695Arg)	TSC2	Q646R, Q658R, Q695R, Q495R, Q706R	Hereditary cancer-predisposing syndrome	VCV000820681	16	2121922	16	2071921	820681	812539	rs1596345118	NC_000016.10:2071920:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2085G>C (p.Gln695His)	TSC2	Q161H, Q247H, Q495H, Q541H, Q646H, Q658H, Q676H, Q691H, Q695H, Q706H, Q725H	Tuberous sclerosis 2	VCV004071445	16	2121923	16	2071922	4071445	4185292		NC_000016.10:2071921:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jun 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2086T>C (p.Cys696Arg)	TSC2	C696R, C659R, C496R, C647R, C707R	Tuberous sclerosis 2	VCV000050105	16	2121924	16	2071923	50105	59267	rs45483301	NC_000016.10:2071922:T:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2087G>T (p.Cys696Phe)	TSC2	C496F, C647F, C659F, C696F, C707F	not provided	VCV000993650	16	2121925	16	2071924	993650	981952	rs45486196	NC_000016.10:2071923:G:T	single nucleotide variant	missense variant	Likely pathogenic	Mar 9, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2087G>A (p.Cys696Tyr)	TSC2	C696Y, C496Y, C707Y, C647Y, C659Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000050106	16	2121925	16	2071924	50106	59268	rs45486196	NC_000016.10:2071923:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2088C>T (p.Cys696=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002414628	16	2121926	16	2071925	2414628	1947127	rs137854217	NC_000016.10:2071924:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2089T>C (p.Leu697=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000764063	16	2121927	16	2071926	764063	770700	rs1596345177	NC_000016.10:2071925:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2090T>C (p.Leu697Ser)	TSC2	L497S, L648S, L660S, L697S, L708S	not provided|Tuberous sclerosis 2	VCV000976011	16	2121928	16	2071927	976011	964444	rs2088487335	NC_000016.10:2071926:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2091G>T (p.Leu697Phe)	TSC2	L497F, L648F, L660F, L697F, L708F	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001218153	16	2121929	16	2071928	1218153	1208135	rs2151308956	NC_000016.10:2071927:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2092A>G (p.Lys698Glu)	TSC2	K698E, K649E, K498E, K661E, K709E	not provided|Tuberous sclerosis 2	VCV000207781	16	2121930	16	2071929	207781	203134	rs796053510	NC_000016.10:2071928:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2093A>T (p.Lys698Met)	TSC2	K164M, K250M, K498M, K544M, K649M, K661M, K679M, K694M, K698M, K709M, K728M	Hereditary cancer-predisposing syndrome	VCV003232102	16	2121931	16	2071930	3232102	3385642	rs2151309008	NC_000016.10:2071929:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2094G>A (p.Lys698=)	TSC2		Tuberous sclerosis 2	VCV003729347	16	2121932	16	2071931	3729347	3858676		NC_000016.10:2071930:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2094G>C (p.Lys698Asn)	TSC2	K498N, K649N, K661N, K698N, K709N	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV001059538	16	2121932	16	2071931	1059538	1049437	rs752256613	NC_000016.10:2071930:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2095C>T (p.Gln699Ter)	TSC2	Q699*, Q499*, Q710*, Q662*, Q650*	not provided|Tuberous sclerosis 2	VCV000049191	16	2121933	16	2071932	49191	58353	rs45517210	NC_000016.10:2071931:C:T	single nucleotide variant	nonsense	Pathogenic	May 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2096A>G (p.Gln699Arg)	TSC2	Q662R, Q699R, Q710R, Q499R, Q650R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000820704	16	2121934	16	2071933	820704	812540	rs1596345229	NC_000016.10:2071932:A:G	single nucleotide variant	missense variant	Uncertain significance	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2097G>C (p.Gln699His)	TSC2	Q499H, Q650H, Q662H, Q699H, Q710H	not provided	VCV001302339	16	2121935	16	2071934	1302339	1292621	rs2151309145	NC_000016.10:2071933:G:C	single nucleotide variant	missense variant	Uncertain significance	May 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+1G>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003232103	16	2121936	16	2071935	3232103	3385643	rs2543709038	NC_000016.10:2071934:G:T	single nucleotide variant	splice donor variant	Likely pathogenic	Nov 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+4A>G	TSC2		Tuberous sclerosis 2	VCV000577192	16	2121939	16	2071938	577192	567801	rs1567465686	NC_000016.10:2071937:A:G	single nucleotide variant	intron variant	Uncertain significance	Jun 6, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+5G>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003462672	16	2121940	16	2071939	3462672	3621691		NC_000016.10:2071938:G:T	single nucleotide variant	intron variant	Uncertain significance	Nov 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+5G>A	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000848502	16	2121940	16	2071939	848502	851663	rs977777731	NC_000016.10:2071938:G:A	single nucleotide variant	intron variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2097+5G>C	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis	VCV000535862	16	2121940	16	2071939	535862	529633	rs977777731	NC_000016.10:2071938:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2097+6T>G	TSC2		Tuberous sclerosis 2	VCV003657382	16	2121941	16	2071940	3657382	3793661		NC_000016.10:2071939:T:G	single nucleotide variant	intron variant	Uncertain significance	Jun 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+6T>A	TSC2		Tuberous sclerosis 2	VCV002711146	16	2121941	16	2071940	2711146	2878598	rs762550686	NC_000016.10:2071939:T:A	single nucleotide variant	intron variant	Uncertain significance	Jan 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+6T>C	TSC2		Tuberous sclerosis 2	VCV001367256	16	2121941	16	2071940	1367256	1404977	rs762550686	NC_000016.10:2071939:T:C	single nucleotide variant	intron variant	Likely benign	Dec 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+7G>A	TSC2		Tuberous sclerosis 2	VCV001142327	16	2121942	16	2071941	1142327	1145930	rs1280828990	NC_000016.10:2071940:G:A	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2097+7G>C	TSC2		Tuberous sclerosis 2	VCV001085977	16	2121942	16	2071941	1085977	1081809	rs1280828990	NC_000016.10:2071940:G:C	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2097+9G>A	TSC2		Tuberous sclerosis 2	VCV001098124	16	2121944	16	2071943	1098124	1081810	rs1350920103	NC_000016.10:2071942:G:A	single nucleotide variant	intron variant	Likely benign	Jul 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+10G>A	TSC2		Tuberous sclerosis 2	VCV000770064	16	2121945	16	2071944	770064	778396	rs1596345324	NC_000016.10:2071943:G:A	single nucleotide variant	intron variant	Likely benign	Jan 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+12C>T	TSC2		Tuberous sclerosis 2	VCV000049192	16	2121947	16	2071946	49192	58354	rs137854029	NC_000016.10:2071945:C:T	single nucleotide variant	intron variant	Likely benign	Nov 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+13G>T	TSC2		Tuberous sclerosis 2	VCV001553739	16	2121948	16	2071947	1553739	1521919	rs367915255	NC_000016.10:2071946:G:T	single nucleotide variant	intron variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+13G>A	TSC2		not specified|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207667	16	2121948	16	2071947	207667	203135	rs367915255	NC_000016.10:2071946:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2097+14G>A	TSC2		Tuberous sclerosis 2	VCV003729479	16	2121949	16	2071948	3729479	3858808		NC_000016.10:2071947:G:A	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+14G>C	TSC2		Tuberous sclerosis 2	VCV001947540	16	2121949	16	2071948	1947540	2006396	rs2151309575	NC_000016.10:2071947:G:C	single nucleotide variant	intron variant	Likely benign	Mar 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+15G>T	TSC2		Tuberous sclerosis 2	VCV003612338	16	2121950	16	2071949	3612338	3738569		NC_000016.10:2071948:G:T	single nucleotide variant	intron variant	Likely benign	Feb 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+15G>A	TSC2		Tuberous sclerosis 2	VCV002730264	16	2121950	16	2071949	2730264	2886865	rs2151309600	NC_000016.10:2071948:G:A	single nucleotide variant	intron variant	Likely benign	Nov 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+16C>T	TSC2		Tuberous sclerosis 2	VCV001430051	16	2121951	16	2071950	1430051	1392973	rs2151309631	NC_000016.10:2071949:C:T	single nucleotide variant	intron variant	Likely benign	Apr 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+17A>G	TSC2		Tuberous sclerosis 2	VCV002051626	16	2121952	16	2071951	2051626	2108216	rs2151309671	NC_000016.10:2071950:A:G	single nucleotide variant	intron variant	Likely benign	May 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+18G>C	TSC2		Tuberous sclerosis 2	VCV003660147	16	2121953	16	2071952	3660147	3797288		NC_000016.10:2071951:G:C	single nucleotide variant	intron variant	Likely benign	Jul 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+18G>A	TSC2		Tuberous sclerosis 2	VCV001569745	16	2121953	16	2071952	1569745	1559715	rs2151309700	NC_000016.10:2071951:G:A	single nucleotide variant	intron variant	Likely benign	Apr 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+19G>A	TSC2		Tuberous sclerosis 2	VCV002039051	16	2121954	16	2071953	2039051	2098244	rs1489943176	NC_000016.10:2071952:G:A	single nucleotide variant	intron variant	Likely benign	Nov 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+20G>C	TSC2		Tuberous sclerosis 2	VCV003650688	16	2121955	16	2071954	3650688	3781418		NC_000016.10:2071953:G:C	single nucleotide variant	intron variant	Likely benign	Apr 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+20G>T	TSC2		Tuberous sclerosis 2	VCV001390028	16	2121955	16	2071954	1390028	1373627	rs750948161	NC_000016.10:2071953:G:T	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2097+43A>G	TSC2		not provided|not specified	VCV000064899	16	2121978	16	2071977	64899	75829	rs186681035	NC_000016.10:2071976:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Jun 19, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2097+48G>T	TSC2		not provided	VCV000670876	16	2121983	16	2071982	670876	668673	rs190309164	NC_000016.10:2071981:G:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-114A>G	TSC2		not provided	VCV000675965	16	2122128	16	2072127	675965	668376	rs6600185	NC_000016.10:2072126:A:G	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-20G>C	TSC2		Tuberous sclerosis 2	VCV004071209	16	2122222	16	2072221	4071209	4185057		NC_000016.10:2072220:G:C	single nucleotide variant	non-coding transcript variant|intron variant	Likely benign	May 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-20G>T	TSC2		Tuberous sclerosis 2	VCV004071074	16	2122222	16	2072221	4071074	4184922		NC_000016.10:2072220:G:T	single nucleotide variant	non-coding transcript variant|intron variant	Likely benign	May 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-18C>T	TSC2		not provided|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000681091	16	2122224	16	2072223	681091	667396	rs1246072517	NC_000016.10:2072222:C:T	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-17G>T	TSC2		Tuberous sclerosis 2	VCV002042758	16	2122225	16	2072224	2042758	2095483	rs759006353	NC_000016.10:2072223:G:T	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-17G>A	TSC2		Tuberous sclerosis 2	VCV001594668	16	2122225	16	2072224	1594668	1621792	rs759006353	NC_000016.10:2072223:G:A	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-16C>T	TSC2		Tuberous sclerosis 2	VCV001626730	16	2122226	16	2072225	1626730	1636423	rs764694797	NC_000016.10:2072224:C:T	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-16C>A	TSC2		Tuberous sclerosis 2	VCV001611819	16	2122226	16	2072225	1611819	1552335	rs764694797	NC_000016.10:2072224:C:A	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-15C>T	TSC2		Tuberous sclerosis 2	VCV002416163	16	2122227	16	2072226	2416163	1937521	rs775111741	NC_000016.10:2072225:C:T	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-15C>G	TSC2		Tuberous sclerosis 2	VCV002064479	16	2122227	16	2072226	2064479	2128463	rs775111741	NC_000016.10:2072225:C:G	single nucleotide variant	intron variant	Likely benign	Jul 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-15C>A	TSC2		Tuberous sclerosis 2|not specified	VCV001672468	16	2122227	16	2072226	1672468	1616723	rs775111741	NC_000016.10:2072225:C:A	single nucleotide variant	intron variant	Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-14T>C	TSC2		Tuberous sclerosis syndrome	VCV003073360	16	2122228	16	2072227	3073360	3234316	rs551711987	NC_000016.10:2072226:T:C	single nucleotide variant	non-coding transcript variant|intron variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-14T>G	TSC2		Tuberous sclerosis 2	VCV002077143	16	2122228	16	2072227	2077143	2131202	rs551711987	NC_000016.10:2072226:T:G	single nucleotide variant	intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-13C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV001203780	16	2122229	16	2072228	1203780	1195030	rs375903453	NC_000016.10:2072227:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-12C>T	TSC2		Tuberous sclerosis 2	VCV001532954	16	2122230	16	2072229	1532954	1605508	rs1460403520	NC_000016.10:2072228:C:T	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-12C>G	TSC2		Tuberous sclerosis 2|not provided	VCV000681144	16	2122230	16	2072229	681144	668678	rs1460403520	NC_000016.10:2072228:C:G	single nucleotide variant	intron variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-10C>G	TSC2		Tuberous sclerosis 2	VCV001616251	16	2122232	16	2072231	1616251	1526441	rs754375630	NC_000016.10:2072230:C:G	single nucleotide variant	intron variant	Likely benign	Dec 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-10C>T	TSC2		Tuberous sclerosis 2	VCV001124163	16	2122232	16	2072231	1124163	1125052	rs754375630	NC_000016.10:2072230:C:T	single nucleotide variant	intron variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-9T>C	TSC2		Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome	VCV000772220	16	2122233	16	2072232	772220	778192	rs755416873	NC_000016.10:2072231:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-8C>G	TSC2		Tuberous sclerosis 2	VCV001151427	16	2122234	16	2072233	1151427	1145931	rs1468788322	NC_000016.10:2072232:C:G	single nucleotide variant	intron variant	Likely benign	Mar 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-8C>T	TSC2		Tuberous sclerosis 2	VCV001130115	16	2122234	16	2072233	1130115	1125053	rs1468788322	NC_000016.10:2072232:C:T	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-7C>T	TSC2		Tuberous sclerosis 2	VCV003624678	16	2122235	16	2072234	3624678	3757816		NC_000016.10:2072233:C:T	single nucleotide variant	non-coding transcript variant|intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-6T>C	TSC2		not specified|Tuberous sclerosis 2	VCV000388859	16	2122236	16	2072235	388859	377211	rs1057523252	NC_000016.10:2072234:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-5C>T	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000237981	16	2122237	16	2072236	237981	242247	rs369072310	NC_000016.10:2072235:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2098-5C>G	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000232992	16	2122237	16	2072236	232992	235103	rs369072310	NC_000016.10:2072235:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2098-4G>C	TSC2		Tuberous sclerosis 2	VCV003643362	16	2122238	16	2072237	3643362	3776233		NC_000016.10:2072236:G:C	single nucleotide variant	non-coding transcript variant|intron variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-4G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000701207	16	2122238	16	2072237	701207	690135	rs1306044216	NC_000016.10:2072236:G:A	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-4G>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000467923	16	2122238	16	2072237	467923	465929	rs1306044216	NC_000016.10:2072236:G:T	single nucleotide variant	intron variant	Likely benign	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-3C>G	TSC2		Tuberous sclerosis 2	VCV002861943	16	2122239	16	2072238	2861943	3029305	rs876660489	NC_000016.10:2072237:C:G	single nucleotide variant	non-coding transcript variant|intron variant	Uncertain significance	Feb 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-3C>A	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000828014	16	2122239	16	2072238	828014	816332	rs876660489	NC_000016.10:2072237:C:A	single nucleotide variant	intron variant	Uncertain significance		criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000233558	16	2122239	16	2072238	233558	235104	rs876660489	NC_000016.10:2072237:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2098-2A>T	TSC2		Tuberous sclerosis 2	VCV000974584	16	2122240	16	2072239	974584	962885	rs45501596	NC_000016.10:2072238:A:T	single nucleotide variant	non-coding transcript variant|splice acceptor variant	Pathogenic	Jul 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098-2A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049731	16	2122240	16	2072239	49731	58893	rs45501596	NC_000016.10:2072238:A:G	single nucleotide variant	non-coding transcript variant|splice acceptor variant	Pathogenic	Jun 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098-1G>A	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000049730	16	2122241	16	2072240	49730	58892	rs45517212	NC_000016.10:2072239:G:A	single nucleotide variant	non-coding transcript variant|splice acceptor variant	Pathogenic	Feb 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2098G>T (p.Glu700Ter)	TSC2	E166*, E500*, E681*, E711*, E730*, E651*, E663*, E700*, E546*, E696*, E252*	Tuberous sclerosis 2	VCV002029164	16	2122242	16	2072241	2029164	2081956	rs45496402	NC_000016.10:2072240:G:T	single nucleotide variant	nonsense	Pathogenic	Sep 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2098G>A (p.Glu700Lys)	TSC2	E700K, E663K, E500K, E651K, E711K	Tuberous sclerosis 2	VCV000049732	16	2122242	16	2072241	49732	58894	rs45496402	NC_000016.10:2072240:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2099A>G (p.Glu700Gly)	TSC2	E166G, E252G, E500G, E546G, E651G, E663G, E681G, E696G, E700G, E711G, E730G	not provided	VCV002684083	16	2122243	16	2072242	2684083	2845118	rs2151315397	NC_000016.10:2072241:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2100G>A (p.Glu700=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001785911	16	2122244	16	2072243	1785911	1850168	rs571792874	NC_000016.10:2072242:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2100G>T (p.Glu700Asp)	TSC2	E700D, E711D, E651D, E500D, E663D	Tuberous sclerosis 2	VCV000836888	16	2122244	16	2072243	836888	843400	rs571792874	NC_000016.10:2072242:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2101T>G (p.Ser701Ala)	TSC2	S664A, S682A, S712A, S652A, S697A, S701A, S253A, S547A, S167A, S501A, S731A	Tuberous sclerosis 2	VCV002708469	16	2122245	16	2072244	2708469	2870760	rs1596346996	NC_000016.10:2072243:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2101T>C (p.Ser701Pro)	TSC2	S701P, S501P, S652P, S664P, S712P	Hereditary cancer-predisposing syndrome	VCV000820720	16	2122245	16	2072244	820720	812541	rs1596346996	NC_000016.10:2072243:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2102C>G (p.Ser701Cys)	TSC2	S664C, S501C, S701C, S652C, S712C	Tuberous sclerosis 2	VCV001373176	16	2122246	16	2072245	1373176	1463176	rs1044030046	NC_000016.10:2072244:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2102C>T (p.Ser701Phe)	TSC2	S501F, S652F, S664F, S701F, S712F	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001025687	16	2122246	16	2072245	1025687	1011959	rs1044030046	NC_000016.10:2072244:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2104G>A (p.Asp702Asn)	TSC2	D168N, D254N, D502N, D548N, D653N, D665N, D683N, D698N, D702N, D713N, D732N	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003071552	16	2122248	16	2072247	3071552	3233818	rs2151315707	NC_000016.10:2072246:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2104G>T (p.Asp702Tyr)	TSC2	D548Y, D502Y, D653Y, D665Y, D254Y, D683Y, D698Y, D702Y, D168Y, D713Y, D732Y	Tuberous sclerosis 2	VCV002713812	16	2122248	16	2072247	2713812	2872235	rs2151315707	NC_000016.10:2072246:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2105A>G (p.Asp702Gly)	TSC2	D254G, D548G, D665G, D702G, D732G, D168G, D713G, D502G, D653G, D683G, D698G	Hereditary cancer-predisposing syndrome	VCV003974693	16	2122249	16	2072248	3974693	4086516		NC_000016.10:2072247:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 25, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2105A>T (p.Asp702Val)	TSC2	D665V, D713V, D502V, D702V, D653V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000942046	16	2122249	16	2072248	942046	937301	rs898836681	NC_000016.10:2072247:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2106C>A (p.Asp702Glu)	TSC2	D254E, D698E, D702E, D168E, D548E, D665E, D683E, D713E, D502E, D653E, D732E	Tuberous sclerosis 2	VCV002079208	16	2122250	16	2072249	2079208	2131973	rs1396298404	NC_000016.10:2072248:C:A	single nucleotide variant	missense variant	Uncertain significance	May 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2106C>G (p.Asp702Glu)	TSC2	D502E, D653E, D665E, D702E, D713E	Tuberous sclerosis 2	VCV001015938	16	2122250	16	2072249	1015938	1011960	rs1396298404	NC_000016.10:2072248:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2106C>T (p.Asp702=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000748124	16	2122250	16	2072249	748124	754990	rs1396298404	NC_000016.10:2072248:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2108G>A (p.Trp703Ter)	TSC2	W703*, W654*, W503*, W714*, W666*	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|not provided	VCV000049736	16	2122252	16	2072251	49736	58898	rs45517213	NC_000016.10:2072250:G:A	single nucleotide variant	nonsense	Pathogenic	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2109G>A (p.Trp703Ter)	TSC2	W703*, W654*, W666*, W503*, W714*	Tuberous sclerosis 2	VCV000049737	16	2122253	16	2072252	49737	58899	rs45462192	NC_000016.10:2072251:G:A	single nucleotide variant	nonsense	Pathogenic	Sep 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2112G>C (p.Lys704Asn)	TSC2	K704N, K715N, K504N, K667N, K655N	Tuberous sclerosis 2	VCV000536001	16	2122256	16	2072255	536001	529926	rs1555506423	NC_000016.10:2072254:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.2112G>T (p.Lys704Asn)	TSC2	K704N, K715N, K504N, K655N, K667N	Tuberous sclerosis 2	VCV000467925	16	2122256	16	2072255	467925	466133	rs1555506423	NC_000016.10:2072254:G:T	single nucleotide variant	missense variant	Uncertain significance	May 14, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2112G>A (p.Lys704=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467924	16	2122256	16	2072255	467924	465278	rs1555506423	NC_000016.10:2072254:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2113G>T (p.Val705Leu)	TSC2	V257L, V505L, V551L, V171L, V656L, V716L, V735L, V668L, V686L, V701L, V705L	Tuberous sclerosis 2	VCV002756035	16	2122257	16	2072256	2756035	2914180	rs397515241	NC_000016.10:2072255:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2113G>C (p.Val705Leu)	TSC2	V505L, V656L, V716L, V668L, V705L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000838204	16	2122257	16	2072256	838204	843401	rs397515241	NC_000016.10:2072255:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2113G>A (p.Val705Met)	TSC2	V705M, V505M, V656M, V668M, V716M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000065328	16	2122257	16	2072256	65328	76261	rs397515241	NC_000016.10:2072255:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2114T>C (p.Val705Ala)	TSC2	V505A, V656A, V668A, V716A, V705A	Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000967989	16	2122258	16	2072257	967989	957676	rs397515068	NC_000016.10:2072256:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2115G>A (p.Val705=)	TSC2		Tuberous sclerosis 2	VCV002095670	16	2122259	16	2072258	2095670	2149587	rs1263670341	NC_000016.10:2072257:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jul 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2116C>A (p.Leu706Met)	TSC2	L669M, L717M, L736M, L172M, L506M, L687M, L258M, L552M, L657M, L702M, L706M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564726	16	2122260	16	2072259	2564726	2733882	rs2151316135	NC_000016.10:2072258:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2117T>C (p.Leu706Pro)	TSC2	L172P, L258P, L506P, L552P, L657P, L669P, L687P, L702P, L706P, L717P, L736P	Tuberous sclerosis 2|not provided	VCV001709718	16	2122261	16	2072260	1709718	1708072	rs2151316174	NC_000016.10:2072259:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2118G>A (p.Leu706=)	TSC2		Tuberous sclerosis 2	VCV000761593	16	2122262	16	2072261	761593	770701	rs1596347135	NC_000016.10:2072260:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2119A>G (p.Lys707Glu)	TSC2	K507E, K658E, K707E, K718E, K670E	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000654904	16	2122263	16	2072262	654904	644227	rs1596347145	NC_000016.10:2072261:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2120A>T (p.Lys707Met)	TSC2	K173M, K259M, K507M, K553M, K658M, K670M, K688M, K703M, K707M, K718M, K737M	Hereditary cancer-predisposing syndrome	VCV003232104	16	2122264	16	2072263	3232104	3385644	rs2151316282	NC_000016.10:2072262:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2120A>G (p.Lys707Arg)	TSC2	K173R, K658R, K670R, K507R, K553R, K688R, K703R, K707R, K737R, K259R, K718R	Hereditary cancer-predisposing syndrome	VCV002626455	16	2122264	16	2072263	2626455	2794221	rs2151316282	NC_000016.10:2072262:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2121G>A (p.Lys707=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001134103	16	2122265	16	2072264	1134103	1125054	rs2151316314	NC_000016.10:2072263:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2122C>A (p.Leu708Met)	TSC2	L708M, L671M, L719M, L508M, L659M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|not provided	VCV000572497	16	2122266	16	2072265	572497	569707	rs778040604	NC_000016.10:2072264:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2122C>T (p.Leu708=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000231927	16	2122266	16	2072265	231927	235105	rs778040604	NC_000016.10:2072264:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2123T>C (p.Leu708Pro)	TSC2	L708P, L659P, L671P, L719P, L508P	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000232311	16	2122267	16	2072266	232311	235106	rs876659689	NC_000016.10:2072265:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2124G>C (p.Leu708=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000820764	16	2122268	16	2072267	820764	812542	rs1596347174	NC_000016.10:2072266:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 6, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2125G>T (p.Val709Phe)	TSC2	V709F, V672F, V509F, V660F, V720F	Tuberous sclerosis 2	VCV000579442	16	2122269	16	2072268	579442	573803	rs1567467135	NC_000016.10:2072267:G:T	single nucleotide variant	missense variant	Likely pathogenic	Mar 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2126T>G (p.Val709Gly)	TSC2	V175G, V261G, V509G, V555G, V660G, V672G, V690G, V705G, V709G, V720G, V739G	Tuberous sclerosis 2	VCV002504642	16	2122270	16	2072269	2504642	2669608	rs1326276839	NC_000016.10:2072268:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2126T>C (p.Val709Ala)	TSC2	V509A, V672A, V660A, V709A, V720A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000944139	16	2122270	16	2072269	944139	927648	rs1326276839	NC_000016.10:2072268:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2128C>T (p.Leu710=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000467926	16	2122272	16	2072271	467926	465823	rs1225700612	NC_000016.10:2072270:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2130G>A (p.Leu710=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000731967	16	2122274	16	2072273	731967	740020	rs747122485	NC_000016.10:2072272:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2132G>C (p.Gly711Ala)	TSC2	G177A, G263A, G511A, G557A, G662A, G674A, G692A, G707A, G711A, G722A, G741A	Tuberous sclerosis syndrome	VCV003386166	16	2122276	16	2072275	3386166	3545307		NC_000016.10:2072274:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2132G>A (p.Gly711Asp)	TSC2	G177D, G674D, G692D, G707D, G741D, G662D, G557D, G263D, G511D, G711D, G722D	Hereditary cancer-predisposing syndrome	VCV002624601	16	2122276	16	2072275	2624601	2793690	rs2088567807	NC_000016.10:2072274:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2133C>T (p.Gly711=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000405957	16	2122277	16	2072276	405957	400719	rs1060500915	NC_000016.10:2072275:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Mar 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2134A>G (p.Arg712Gly)	TSC2	R178G, R264G, R512G, R558G, R663G, R675G, R693G, R708G, R712G, R723G, R742G	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003072288	16	2122278	16	2072277	3072288	3230732	rs2151316730	NC_000016.10:2072276:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2136G>A (p.Arg712=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000710560	16	2122280	16	2072279	710560	726489	rs995073369	NC_000016.10:2072278:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2137C>G (p.Leu713Val)	TSC2	L694V, L709V, L743V, L513V, L713V, L179V, L265V, L559V, L676V, L664V, L724V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001786493	16	2122281	16	2072280	1786493	1843863	rs1555506453	NC_000016.10:2072279:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2137C>T (p.Leu713=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536015	16	2122281	16	2072280	536015	529635	rs1555506453	NC_000016.10:2072279:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2138T>C (p.Leu713Pro)	TSC2	L713P, L664P, L724P, L513P, L676P	Tuberous sclerosis 2	VCV000406033	16	2122282	16	2072281	406033	401478	rs1060500942	NC_000016.10:2072280:T:C	single nucleotide variant	missense variant	Uncertain significance	May 13, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.2139G>A (p.Leu713=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001786519	16	2122283	16	2072282	1786519	1843889	rs757293747	NC_000016.10:2072281:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Dec 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2139G>T (p.Leu713=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001540005	16	2122283	16	2072282	1540005	1630322	rs757293747	NC_000016.10:2072281:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2139G>C (p.Leu713=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001157593	16	2122283	16	2072282	1157593	1145932	rs757293747	NC_000016.10:2072281:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2140C>G (p.Pro714Ala)	TSC2	P514A, P714A, P665A, P725A, P677A	Tuberous sclerosis 2	VCV001038493	16	2122284	16	2072283	1038493	1032448	rs1596347240	NC_000016.10:2072282:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2140C>T (p.Pro714Ser)	TSC2	P677S, P725S, P514S, P665S, P714S	Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000847324	16	2122284	16	2072283	847324	843402	rs1596347240	NC_000016.10:2072282:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2141C>T (p.Pro714Leu)	TSC2	P180L, P266L, P514L, P560L, P665L, P677L, P695L, P710L, P714L, P725L, P744L	Hereditary cancer-predisposing syndrome	VCV003232105	16	2122285	16	2072284	3232105	3385645	rs2151316994	NC_000016.10:2072283:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2142T>G (p.Pro714=)	TSC2		Tuberous sclerosis 2	VCV002912310	16	2122286	16	2072285	2912310	3073467	rs2151317023	NC_000016.10:2072284:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2142T>C (p.Pro714=)	TSC2		Tuberous sclerosis 2	VCV002851800	16	2122286	16	2072285	2851800	3006477	rs2151317023	NC_000016.10:2072284:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2143G>A (p.Glu715Lys)	TSC2	E515K, E678K, E726K, E666K, E715K	Tuberous sclerosis 2	VCV001498734	16	2122287	16	2072286	1498734	1395635	rs1292305111	NC_000016.10:2072285:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2144A>G (p.Glu715Gly)	TSC2	E515G, E666G, E678G, E715G, E726G	Tuberous sclerosis 2	VCV001518718	16	2122288	16	2072287	1518718	1509111	rs763351805	NC_000016.10:2072286:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2144A>C (p.Glu715Ala)	TSC2	E726A, E515A, E678A, E666A, E715A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000863196	16	2122288	16	2072287	863196	843403	rs763351805	NC_000016.10:2072286:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2145G>T (p.Glu715Asp)	TSC2	E181D, E267D, E678D, E696D, E711D, E715D, E515D, E666D, E561D, E726D, E745D	Tuberous sclerosis 2	VCV002037041	16	2122289	16	2072288	2037041	2097534	rs1596347274	NC_000016.10:2072287:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2145G>A (p.Glu715=)	TSC2		Tuberous sclerosis 2	VCV000779038	16	2122289	16	2072288	779038	703550	rs1596347274	NC_000016.10:2072287:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2146T>G (p.Ser716Ala)	TSC2	S182A, S268A, S516A, S562A, S667A, S679A, S697A, S712A, S716A, S727A, S746A	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV001809594	16	2122290	16	2072289	1809594	1866598	rs1203066126	NC_000016.10:2072288:T:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2147C>A (p.Ser716Tyr)	TSC2	S182Y, S268Y, S516Y, S562Y, S667Y, S679Y, S697Y, S712Y, S716Y, S727Y, S746Y	Hereditary cancer-predisposing syndrome	VCV003232106	16	2122291	16	2072290	3232106	3385646	rs781153452	NC_000016.10:2072289:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2147C>T (p.Ser716Phe)	TSC2	S716F, S679F, S667F, S727F, S516F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified	VCV000380717	16	2122291	16	2072290	380717	374760	rs781153452	NC_000016.10:2072289:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2148C>T (p.Ser716=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003386167	16	2122292	16	2072291	3386167	3545308		NC_000016.10:2072290:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2149C>T (p.Leu717=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002887874	16	2122293	16	2072292	2887874	3054287	rs745752883	NC_000016.10:2072291:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2150T>A (p.Leu717Gln)	TSC2	L717Q, L728Q, L517Q, L668Q, L680Q	not specified	VCV000448724	16	2122294	16	2072293	448724	441784	rs45517214	NC_000016.10:2072292:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.2151G>A (p.Leu717=)	TSC2		Tuberous sclerosis 2	VCV002849067	16	2122295	16	2072294	2849067	3012711	rs2151317395	NC_000016.10:2072293:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2152C>A (p.Arg718Ser)	TSC2	R718S, R681S, R729S, R518S, R669S	not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000586850	16	2122296	16	2072295	586850	577453	rs182538665	NC_000016.10:2072294:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2152C>T (p.Arg718Cys)	TSC2	R718C, R518C, R729C, R669C, R681C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Ovarian cancer|not provided	VCV000406077	16	2122296	16	2072295	406077	401234	rs182538665	NC_000016.10:2072294:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2153G>T (p.Arg718Leu)	TSC2	R564L, R699L, R184L, R270L, R518L, R681L, R669L, R714L, R718L, R729L, R748L	Tuberous sclerosis 2	VCV003680129	16	2122297	16	2072296	3680129	3807570		NC_000016.10:2072295:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2153G>A (p.Arg718His)	TSC2	R718H, R669H, R518H, R729H, R681H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000186667	16	2122297	16	2072296	186667	184130	rs45517215	NC_000016.10:2072295:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2153G>C (p.Arg718Pro)	TSC2	R718P, R681P, R729P, R518P, R669P	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not specified|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000049597	16	2122297	16	2072296	49597	58759	rs45517215	NC_000016.10:2072295:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2154C>G (p.Arg718=)	TSC2		Tuberous sclerosis 2	VCV001493911	16	2122298	16	2072297	1493911	1449413	rs878854081	NC_000016.10:2072296:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2154C>T (p.Arg718=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001452764	16	2122298	16	2072297	1452764	1431908	rs878854081	NC_000016.10:2072296:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2154C>A (p.Arg718=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000237982	16	2122298	16	2072297	237982	242248	rs878854081	NC_000016.10:2072296:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2155T>A (p.Tyr719Asn)	TSC2	Y719N, Y519N, Y670N, Y682N, Y730N	Tuberous sclerosis 2	VCV000934974	16	2122299	16	2072298	934974	937302	rs2088573694	NC_000016.10:2072297:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2155T>C (p.Tyr719His)	TSC2	Y682H, Y730H, Y519H, Y670H, Y719H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000847463	16	2122299	16	2072298	847463	843404	rs2088573694	NC_000016.10:2072297:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2156A>C (p.Tyr719Ser)	TSC2	Y185S, Y565S, Y715S, Y271S, Y670S, Y682S, Y700S, Y730S, Y749S, Y519S, Y719S	Tuberous sclerosis 2	VCV002008800	16	2122300	16	2072299	2008800	2062874	rs2088573975	NC_000016.10:2072298:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2156A>G (p.Tyr719Cys)	TSC2	Y670C, Y719C, Y519C, Y730C, Y682C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000843399	16	2122300	16	2072299	843399	843405	rs2088573975	NC_000016.10:2072298:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2157T>G (p.Tyr719Ter)	TSC2	Y519*, Y670*, Y682*, Y719*, Y730*	not provided	VCV001701269	16	2122301	16	2072300	1701269	1693661	rs902456479	NC_000016.10:2072299:T:G	single nucleotide variant	nonsense	Pathogenic	Jul 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2157T>C (p.Tyr719=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001118182	16	2122301	16	2072300	1118182	1103635	rs902456479	NC_000016.10:2072299:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2158A>C (p.Lys720Gln)	TSC2	K671Q, K520Q, K683Q, K720Q, K731Q	Tuberous sclerosis 2	VCV001475238	16	2122302	16	2072301	1475238	1404147	rs1195091149	NC_000016.10:2072300:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2158A>T (p.Lys720Ter)	TSC2	K520*, K683*, K671*, K731*, K720*	Tuberous sclerosis 2	VCV001458946	16	2122302	16	2072301	1458946	1491293	rs1195091149	NC_000016.10:2072300:A:T	single nucleotide variant	nonsense	Pathogenic	Feb 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2158A>G (p.Lys720Glu)	TSC2	K520E, K671E, K683E, K720E, K731E	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000659239	16	2122302	16	2072301	659239	644228	rs1195091149	NC_000016.10:2072300:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2161G>C (p.Val721Leu)	TSC2	V273L, V717L, V187L, V672L, V702L, V721L, V684L, V732L, V751L, V521L, V567L	Tuberous sclerosis 2	VCV002765151	16	2122305	16	2072304	2765151	2925898	rs768261185	NC_000016.10:2072303:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2161G>A (p.Val721Met)	TSC2	V732M, V684M, V521M, V672M, V721M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV001041864	16	2122305	16	2072304	1041864	1032449	rs768261185	NC_000016.10:2072303:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2162T>G (p.Val721Gly)	TSC2	V567G, V672G, V684G, V717G, V732G, V187G, V721G, V273G, V521G, V751G, V702G	Tuberous sclerosis 2	VCV003720983	16	2122306	16	2072305	3720983	3856784		NC_000016.10:2072304:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2162T>C (p.Val721Ala)	TSC2	V273A, V521A, V567A, V672A, V684A, V721A, V751A, V187A, V702A, V717A, V732A	Tuberous sclerosis 2	VCV002817670	16	2122306	16	2072305	2817670	2987311	rs2151317813	NC_000016.10:2072304:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2163G>C (p.Val721=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232107	16	2122307	16	2072306	3232107	3385647	rs552644975	NC_000016.10:2072305:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2163G>A (p.Val721=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000388224	16	2122307	16	2072306	388224	374094	rs552644975	NC_000016.10:2072305:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2164C>G (p.Leu722Val)	TSC2	L722V, L703V, L733V, L274V, L522V, L568V, L685V, L718V, L188V, L673V, L752V	Tuberous sclerosis 2	VCV002701758	16	2122308	16	2072307	2701758	2859341	rs1029969953	NC_000016.10:2072306:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2164C>T (p.Leu722Phe)	TSC2	L722F, L733F, L685F, L522F, L673F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535867	16	2122308	16	2072307	535867	529575	rs1029969953	NC_000016.10:2072306:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2166C>A (p.Leu722=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV002645968	16	2122310	16	2072309	2645968	2810849	rs1009050362	NC_000016.10:2072308:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2166C>T (p.Leu722=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001093381	16	2122310	16	2072309	1093381	1081811	rs1009050362	NC_000016.10:2072308:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2167A>C (p.Ile723Leu)	TSC2	I189L, I523L, I704L, I719L, I569L, I734L, I753L, I275L, I674L, I686L, I723L	Hereditary cancer-predisposing syndrome	VCV001786998	16	2122311	16	2072310	1786998	1840519	rs764725850	NC_000016.10:2072309:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2167A>T (p.Ile723Phe)	TSC2	I723F, I523F, I686F, I734F, I674F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000237984	16	2122311	16	2072310	237984	242250	rs764725850	NC_000016.10:2072309:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2167A>G (p.Ile723Val)	TSC2	I723V, I674V, I523V, I686V, I734V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000237983	16	2122311	16	2072310	237983	242249	rs764725850	NC_000016.10:2072309:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2169C>T (p.Ile723=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001787027	16	2122313	16	2072312	1787027	1840548	rs1287857429	NC_000016.10:2072311:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Apr 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2169C>A (p.Ile723=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001787024	16	2122313	16	2072312	1787024	1840545	rs1287857429	NC_000016.10:2072311:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2170T>G (p.Phe724Val)	TSC2	F724V, F524V, F687V, F735V, F675V	Tuberous sclerosis 2	VCV001490933	16	2122314	16	2072313	1490933	1512040	rs2088577923	NC_000016.10:2072312:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2170T>C (p.Phe724Leu)	TSC2	F524L, F675L, F687L, F724L, F735L	Tuberous sclerosis 2	VCV000853498	16	2122314	16	2072313	853498	843406	rs2088577923	NC_000016.10:2072312:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2171T>C (p.Phe724Ser)	TSC2	F276S, F524S, F570S, F687S, F705S, F754S, F190S, F735S, F720S, F724S, F675S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001787114	16	2122315	16	2072314	1787114	1840635	rs761458933	NC_000016.10:2072313:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2172T>C (p.Phe724=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001589162	16	2122316	16	2072315	1589162	1554070	rs2151318241	NC_000016.10:2072314:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2173A>T (p.Thr725Ser)	TSC2	T525S, T706S, T191S, T736S, T725S, T755S, T277S, T571S, T676S, T688S, T721S	Hereditary cancer-predisposing syndrome	VCV003462564	16	2122317	16	2072316	3462564	3621584		NC_000016.10:2072315:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2174C>T (p.Thr725Ile)	TSC2	T525I, T676I, T688I, T725I, T736I	not provided|Tuberous sclerosis 2	VCV001298645	16	2122318	16	2072317	1298645	1288507	rs1567467623	NC_000016.10:2072316:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2174C>A (p.Thr725Asn)	TSC2	T725N, T525N, T676N, T688N, T736N	Tuberous sclerosis 2	VCV000580443	16	2122318	16	2072317	580443	573808	rs1567467623	NC_000016.10:2072316:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2175T>G (p.Thr725=)	TSC2		Tuberous sclerosis 2	VCV002080081	16	2122319	16	2072318	2080081	2139301	rs2151318294	NC_000016.10:2072317:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2177C>A (p.Ser726Tyr)	TSC2	S192Y, S278Y, S526Y, S722Y, S677Y, S572Y, S707Y, S689Y, S726Y, S737Y, S756Y	Tuberous sclerosis 2	VCV002704101	16	2122321	16	2072320	2704101	2856527	rs2088578578	NC_000016.10:2072319:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2177C>G (p.Ser726Cys)	TSC2	S526C, S726C, S737C, S756C, S192C, S572C, S677C, S689C, S278C, S707C, S722C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001787197	16	2122321	16	2072320	1787197	1840717	rs2088578578	NC_000016.10:2072319:C:G	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2177C>T (p.Ser726Phe)	TSC2	S689F, S526F, S726F, S737F, S677F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001037381	16	2122321	16	2072320	1037381	1032450	rs2088578578	NC_000016.10:2072319:C:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2178C>T (p.Ser726=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001635020	16	2122322	16	2072321	1635020	1610746	rs1380835459	NC_000016.10:2072320:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2178C>G (p.Ser726=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000588486	16	2122322	16	2072321	588486	580053	rs1380835459	NC_000016.10:2072320:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 21, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2179C>A (p.Pro727Thr)	TSC2	P193T, P527T, P690T, P738T, P279T, P708T, P727T, P678T, P723T, P573T, P757T	Hereditary cancer-predisposing syndrome	VCV003462543	16	2122323	16	2072322	3462543	3621563		NC_000016.10:2072321:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2179C>G (p.Pro727Ala)	TSC2	P193A, P279A, P527A, P573A, P678A, P690A, P708A, P723A, P727A, P738A, P757A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001721229	16	2122323	16	2072322	1721229	1772563	rs2151318416	NC_000016.10:2072321:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2179C>T (p.Pro727Ser)	TSC2	P727S, P678S, P690S, P738S, P527S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001418592	16	2122323	16	2072322	1418592	1490188	rs2151318416	NC_000016.10:2072321:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2180C>T (p.Pro727Leu)	TSC2	P727L, P678L, P527L, P738L, P690L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000231749	16	2122324	16	2072323	231749	235107	rs767086409	NC_000016.10:2072322:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2183G>T (p.Cys728Phe)	TSC2	C728F, C679F, C528F, C691F, C739F	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000064882	16	2122327	16	2072326	64882	75812	rs397514908	NC_000016.10:2072325:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2184C>A (p.Cys728Ter)	TSC2	C528*, C679*, C691*, C728*, C739*	not provided	VCV001330746	16	2122328	16	2072327	1330746	1321424	rs1555506557	NC_000016.10:2072326:C:A	single nucleotide variant	nonsense	Pathogenic	Jun 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2184C>T (p.Cys728=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467928	16	2122328	16	2072327	467928	465825	rs1555506557	NC_000016.10:2072326:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2185A>T (p.Ser729Cys)	TSC2	S710C, S725C, S759C, S195C, S575C, S692C, S281C, S529C, S680C, S729C, S740C	Hereditary cancer-predisposing syndrome	VCV002560703	16	2122329	16	2072328	2560703	2716863	rs2088581010	NC_000016.10:2072327:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2185A>C (p.Ser729Arg)	TSC2	S740R, S529R, S680R, S692R, S729R	Tuberous sclerosis 2	VCV000863799	16	2122329	16	2072328	863799	843407	rs2088581010	NC_000016.10:2072327:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2186G>T (p.Ser729Ile)	TSC2	S729I, S740I, S759I, S281I, S529I, S710I, S725I, S680I, S195I, S575I, S692I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002450007	16	2122330	16	2072329	2450007	2425964	rs2088581254	NC_000016.10:2072328:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2186G>A (p.Ser729Asn)	TSC2	S529N, S680N, S692N, S729N, S740N	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001007199	16	2122330	16	2072329	1007199	996719	rs2088581254	NC_000016.10:2072328:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2187T>C (p.Ser729=)	TSC2		Tuberous sclerosis 2	VCV002022212	16	2122331	16	2072330	2022212	2080120	rs2151318732	NC_000016.10:2072329:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2188G>T (p.Val730Leu)	TSC2	V693L, V681L, V741L, V530L, V730L	Tuberous sclerosis 2	VCV001514691	16	2122332	16	2072331	1514691	1485734	rs1555506559	NC_000016.10:2072330:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2188G>A (p.Val730Met)	TSC2	V730M, V741M, V530M, V681M, V693M	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000467929	16	2122332	16	2072331	467929	465284	rs1555506559	NC_000016.10:2072330:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2189T>C (p.Val730Ala)	TSC2	V196A, V730A, V760A, V741A, V282A, V576A, V681A, V693A, V711A, V726A, V530A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002087204	16	2122333	16	2072332	2087204	2137265	rs2543734450	NC_000016.10:2072331:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2190G>T (p.Val730=)	TSC2		Tuberous sclerosis 2	VCV004071287	16	2122334	16	2072333	4071287	4185135		NC_000016.10:2072332:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2190G>C (p.Val730=)	TSC2		Tuberous sclerosis 2	VCV001908472	16	2122334	16	2072333	1908472	1958774	rs2151318803	NC_000016.10:2072332:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2191G>T (p.Asp731Tyr)	TSC2	D197Y, D283Y, D531Y, D577Y, D682Y, D694Y, D712Y, D727Y, D731Y, D742Y, D761Y	not provided	VCV002572799	16	2122335	16	2072334	2572799	2737741	rs777308285	NC_000016.10:2072333:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2191G>A (p.Asp731Asn)	TSC2	D682N, D731N, D742N, D531N, D694N	Tuberous sclerosis 2	VCV000965799	16	2122335	16	2072334	965799	957677	rs777308285	NC_000016.10:2072333:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2192A>G (p.Asp731Gly)	TSC2	D197G, D531G, D727G, D283G, D731G, D682G, D712G, D742G, D761G, D577G, D694G	Hereditary cancer-predisposing syndrome	VCV003462549	16	2122336	16	2072335	3462549	3621569		NC_000016.10:2072334:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2192A>C (p.Asp731Ala)	TSC2	D694A, D742A, D682A, D731A, D531A	Tuberous sclerosis 2	VCV001394019	16	2122336	16	2072335	1394019	1422557	rs2151318889	NC_000016.10:2072334:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2193C>G (p.Asp731Glu)	TSC2	D283E, D577E, D694E, D742E, D727E, D731E, D197E, D682E, D712E, D531E, D761E	Tuberous sclerosis 2	VCV002133500	16	2122337	16	2072336	2133500	2190189	rs760053529	NC_000016.10:2072335:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2193C>T (p.Asp731=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000413687	16	2122337	16	2072336	413687	400724	rs760053529	NC_000016.10:2072335:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2194C>A (p.Gln732Lys)	TSC2	Q683K, Q732K, Q532K, Q695K, Q743K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000943047	16	2122338	16	2072337	943047	937303	rs45517216	NC_000016.10:2072336:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2194C>T (p.Gln732Ter)	TSC2	Q732*, Q532*, Q683*, Q695*, Q743*	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000050118	16	2122338	16	2072337	50118	59280	rs45517216	NC_000016.10:2072336:C:T	single nucleotide variant	nonsense	Pathogenic	Mar 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2196G>T (p.Gln732His)	TSC2	Q683H, Q743H, Q732H, Q532H, Q695H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001434449	16	2122340	16	2072339	1434449	1494265	rs765646245	NC_000016.10:2072338:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2196G>C (p.Gln732His)	TSC2	Q732H, Q683H, Q695H, Q532H, Q743H	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000841759	16	2122340	16	2072339	841759	843408	rs765646245	NC_000016.10:2072338:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2197C>A (p.Leu733Met)	TSC2	L199M, L285M, L533M, L579M, L684M, L696M, L714M, L729M, L733M, L744M, L763M	Tuberous sclerosis 2	VCV001722061	16	2122341	16	2072340	1722061	1779779	rs397515163	NC_000016.10:2072339:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2197C>T (p.Leu733=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000699914	16	2122341	16	2072340	699914	688539	rs397515163	NC_000016.10:2072339:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2197C>G (p.Leu733Val)	TSC2	L733V, L696V, L744V, L684V, L533V	Tuberous sclerosis 2	VCV000065222	16	2122341	16	2072340	65222	76154	rs397515163	NC_000016.10:2072339:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2198T>C (p.Leu733Pro)	TSC2	L733P, L684P, L533P, L696P, L744P	Tuberous sclerosis 2	VCV000050119	16	2122342	16	2072341	50119	59281	rs45517217	NC_000016.10:2072340:T:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2199G>T (p.Leu733=)	TSC2		Tuberous sclerosis 2	VCV004071238	16	2122343	16	2072342	4071238	4185086		NC_000016.10:2072341:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2199G>A (p.Leu733=)	TSC2		Tuberous sclerosis 2	VCV003607792	16	2122343	16	2072342	3607792	3743953		NC_000016.10:2072341:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2199G>C (p.Leu733=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001787534	16	2122343	16	2072342	1787534	1850515	rs2543735318	NC_000016.10:2072341:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 29, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2200T>A (p.Cys734Ser)	TSC2	C200S, C286S, C534S, C580S, C685S, C697S, C715S, C730S, C734S, C745S, C764S	Hereditary cancer-predisposing syndrome	VCV003232109	16	2122344	16	2072343	3232109	3385649	rs1596347570	NC_000016.10:2072342:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2201G>A (p.Cys734Tyr)	TSC2	C697Y, C734Y, C200Y, C730Y, C764Y, C534Y, C580Y, C286Y, C685Y, C715Y, C745Y	Hereditary cancer-predisposing syndrome	VCV002564724	16	2122345	16	2072344	2564724	2733880	rs2151319207	NC_000016.10:2072343:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2202C>T (p.Cys734=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003074470	16	2122346	16	2072345	3074470	3229437	rs2151319241	NC_000016.10:2072344:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2203T>C (p.Ser735Pro)	TSC2	S698P, S535P, S686P, S735P, S746P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001367368	16	2122347	16	2072346	1367368	1405088	rs753059579	NC_000016.10:2072345:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2203T>G (p.Ser735Ala)	TSC2	S535A, S735A, S746A, S698A, S686A	Tuberous sclerosis syndrome	VCV000884831	16	2122347	16	2072346	884831	874847	rs753059579	NC_000016.10:2072345:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.2204C>G (p.Ser735Cys)	TSC2	S535C, S735C, S686C, S698C, S746C	Tuberous sclerosis 2	VCV001461015	16	2122348	16	2072347	1461015	1419824	rs1596347589	NC_000016.10:2072346:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2204C>T (p.Ser735Phe)	TSC2	S535F, S735F, S686F, S698F, S746F	Tuberous sclerosis 2	VCV000642152	16	2122348	16	2072347	642152	644229	rs1596347589	NC_000016.10:2072346:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2205T>A (p.Ser735=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000793781	16	2122349	16	2072348	793781	785192	rs758782629	NC_000016.10:2072347:T:A	single nucleotide variant	synonymous variant	Likely benign	Apr 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2206G>A (p.Ala736Thr)	TSC2	A536T, A747T, A687T, A699T, A736T	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000639404	16	2122350	16	2072349	639404	644230	rs1252599854	NC_000016.10:2072348:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2207C>T (p.Ala736Val)	TSC2	A747V, A699V, A736V, A536V, A687V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000703051	16	2122351	16	2072350	703051	693810	rs764259520	NC_000016.10:2072349:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2208T>C (p.Ala736=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003329506	16	2122352	16	2072351	3329506	3489098		NC_000016.10:2072350:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2209C>G (p.Leu737Val)	TSC2	L748V, L537V, L688V, L737V, L700V	Tuberous sclerosis 2	VCV001507695	16	2122353	16	2072352	1507695	1352154	rs1485034650	NC_000016.10:2072351:C:G	single nucleotide variant	missense variant	Likely benign	May 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2209C>T (p.Leu737Phe)	TSC2	L737F, L537F, L688F, L700F, L748F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000581016	16	2122353	16	2072352	581016	569708	rs1485034650	NC_000016.10:2072351:C:T	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2210T>C (p.Leu737Pro)	TSC2	L737P, L688P, L748P, L537P, L700P	not provided	VCV000049601	16	2122354	16	2072353	49601	58763	rs45464093	NC_000016.10:2072352:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2211C>A (p.Leu737=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001622226	16	2122355	16	2072354	1622226	1593429	rs369851248	NC_000016.10:2072353:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2211C>T (p.Leu737=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000237985	16	2122355	16	2072354	237985	242251	rs369851248	NC_000016.10:2072353:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2213G>C (p.Cys738Ser)	TSC2	C204S, C538S, C768S, C290S, C701S, C734S, C749S, C584S, C689S, C719S, C738S	Hereditary cancer-predisposing syndrome	VCV001787802	16	2122357	16	2072356	1787802	1847245	rs2151319643	NC_000016.10:2072355:G:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2213G>A (p.Cys738Tyr)	TSC2	C538Y, C738Y, C689Y, C701Y, C749Y	Tuberous sclerosis 2	VCV001499028	16	2122357	16	2072356	1499028	1488773	rs2151319643	NC_000016.10:2072355:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2216C>T (p.Ser739Phe)	TSC2	S585F, S702F, S750F, S205F, S690F, S735F, S539F, S739F, S769F, S291F, S720F	Hereditary cancer-predisposing syndrome	VCV002450004	16	2122360	16	2072359	2450004	2425961	rs2151319715	NC_000016.10:2072358:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2216C>G (p.Ser739Cys)	TSC2	S205C, S750C, S291C, S585C, S739C, S539C, S690C, S735C, S769C, S702C, S720C	Tuberous sclerosis 2	VCV002016189	16	2122360	16	2072359	2016189	2075395	rs2151319715	NC_000016.10:2072358:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2216C>A (p.Ser739Tyr)	TSC2	S205Y, S585Y, S735Y, S750Y, S690Y, S720Y, S739Y, S769Y, S291Y, S539Y, S702Y	Hereditary cancer-predisposing syndrome	VCV001787841	16	2122360	16	2072359	1787841	1847284	rs2151319715	NC_000016.10:2072358:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2217C>T (p.Ser739=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000757323	16	2122361	16	2072360	757323	770702	rs1596347651	NC_000016.10:2072359:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2218A>T (p.Met740Leu)	TSC2	M691L, M740L, M540L, M751L, M703L	Tuberous sclerosis 2	VCV001044058	16	2122362	16	2072361	1044058	1032451	rs757345150	NC_000016.10:2072360:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2218A>G (p.Met740Val)	TSC2	M740V, M540V, M703V, M691V, M751V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000570811	16	2122362	16	2072361	570811	569711	rs757345150	NC_000016.10:2072360:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2219T>C (p.Met740Thr)	TSC2	M740T, M540T, M703T, M691T, M751T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000578982	16	2122363	16	2072362	578982	570089	rs757347786	NC_000016.10:2072361:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2220G>C (p.Met740Ile)	TSC2	M292I, M540I, M721I, M751I, M691I, M586I, M703I, M770I, M206I, M736I, M740I	Tuberous sclerosis 2	VCV001998088	16	2122364	16	2072363	1998088	2053869	rs2151319848	NC_000016.10:2072362:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220G>A (p.Met740Ile)	TSC2	M540I, M691I, M703I, M740I, M751I	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001686682	16	2122364	16	2072363	1686682	1678799	rs2151319848	NC_000016.10:2072362:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2220+1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000065259	16	2122365	16	2072364	65259	76191	rs137854361	NC_000016.10:2072363:G:A	single nucleotide variant	splice donor variant	Pathogenic	Aug 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2220+2T>C	TSC2		Tuberous sclerosis 2	VCV001696846	16	2122366	16	2072365	1696846	1689243	rs397515121	NC_000016.10:2072364:T:C	single nucleotide variant	splice donor variant	Pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+4C>A	TSC2		Hereditary cancer-predisposing syndrome	VCV001787917	16	2122368	16	2072367	1787917	1847360	rs781186613	NC_000016.10:2072366:C:A	single nucleotide variant	intron variant	Uncertain significance	Jul 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+4C>T	TSC2		Tuberous sclerosis 2	VCV000952721	16	2122368	16	2072367	952721	941124	rs781186613	NC_000016.10:2072366:C:T	single nucleotide variant	intron variant	Uncertain significance	Apr 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+4C>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000381732	16	2122368	16	2072367	381732	377213	rs781186613	NC_000016.10:2072366:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2220+5C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000820917	16	2122369	16	2072368	820917	815613	rs1164941572	NC_000016.10:2072367:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2220+6A>C	TSC2		Tuberous sclerosis 2	VCV002853122	16	2122370	16	2072369	2853122	3016594	rs745822483	NC_000016.10:2072368:A:C	single nucleotide variant	intron variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+6A>G	TSC2		Tuberous sclerosis 2	VCV000859463	16	2122370	16	2072369	859463	852095	rs745822483	NC_000016.10:2072368:A:G	single nucleotide variant	intron variant	Likely benign	Oct 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+7T>C	TSC2		Tuberous sclerosis 2	VCV000756835	16	2122371	16	2072370	756835	776287	rs1431356866	NC_000016.10:2072369:T:C	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2220+8G>T	TSC2		Tuberous sclerosis 2	VCV002810465	16	2122372	16	2072371	2810465	2965139	rs2543737824	NC_000016.10:2072370:G:T	single nucleotide variant	intron variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+9G>A	TSC2		Tuberous sclerosis 2	VCV001953266	16	2122373	16	2072372	1953266	2014700	rs1433200235	NC_000016.10:2072371:G:A	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2220+10C>T	TSC2		Tuberous sclerosis 2	VCV002418714	16	2122374	16	2072373	2418714	1944609	rs2543737981	NC_000016.10:2072372:C:T	single nucleotide variant	intron variant	Likely benign	Apr 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+11C>T	TSC2		not specified|not provided|Tuberous sclerosis 2	VCV000207668	16	2122375	16	2072374	207668	203136	rs372555496	NC_000016.10:2072373:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2220+12G>C	TSC2		Tuberous sclerosis 2	VCV001655455	16	2122376	16	2072375	1655455	1615805	rs780039835	NC_000016.10:2072374:G:C	single nucleotide variant	intron variant	Likely benign	Feb 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+12G>T	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV001541476	16	2122376	16	2072375	1541476	1631359	rs780039835	NC_000016.10:2072374:G:T	single nucleotide variant	intron variant	Likely benign	Nov 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2220+12G>A	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not specified|Tuberous sclerosis 2	VCV000392360	16	2122376	16	2072375	392360	375173	rs780039835	NC_000016.10:2072374:G:A	single nucleotide variant	intron variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2220+14C>A	TSC2		Tuberous sclerosis 2	VCV002828294	16	2122378	16	2072377	2828294	2990232	rs2151320226	NC_000016.10:2072376:C:A	single nucleotide variant	intron variant	Likely benign	Jan 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+14C>T	TSC2		Tuberous sclerosis 2	VCV002139172	16	2122378	16	2072377	2139172	1874967	rs2151320226	NC_000016.10:2072376:C:T	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+15C>T	TSC2		Tuberous sclerosis 2	VCV001583849	16	2122379	16	2072378	1583849	1528295	rs1455057080	NC_000016.10:2072377:C:T	single nucleotide variant	intron variant	Likely benign	Dec 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+16T>C	TSC2		Tuberous sclerosis 2	VCV001529908	16	2122380	16	2072379	1529908	1665264	rs749079366	NC_000016.10:2072378:T:C	single nucleotide variant	intron variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+17G>T	TSC2		Tuberous sclerosis 2	VCV001983325	16	2122381	16	2072380	1983325	2046385	rs768477166	NC_000016.10:2072379:G:T	single nucleotide variant	intron variant	Likely benign	Mar 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+17G>C	TSC2		Tuberous sclerosis 2	VCV001620796	16	2122381	16	2072380	1620796	1549268	rs768477166	NC_000016.10:2072379:G:C	single nucleotide variant	intron variant	Likely benign	Jul 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+18G>C	TSC2		Tuberous sclerosis 2	VCV002132468	16	2122382	16	2072381	2132468	2186469	rs2151320378	NC_000016.10:2072380:G:C	single nucleotide variant	intron variant	Likely benign	May 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+19G>C	TSC2		Tuberous sclerosis 2	VCV003724498	16	2122383	16	2072382	3724498	3857695		NC_000016.10:2072381:G:C	single nucleotide variant	intron variant	Likely benign	Nov 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+19G>T	TSC2		Tuberous sclerosis 2	VCV003675014	16	2122383	16	2072382	3675014	3806342		NC_000016.10:2072381:G:T	single nucleotide variant	intron variant	Likely benign	Jul 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+19G>A	TSC2		Tuberous sclerosis 2	VCV003636870	16	2122383	16	2072382	3636870	3774454		NC_000016.10:2072381:G:A	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+20G>T	TSC2		Tuberous sclerosis 2	VCV001563406	16	2122384	16	2072383	1563406	1619910	rs747764105	NC_000016.10:2072382:G:T	single nucleotide variant	intron variant	Likely benign	Sep 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+25G>C	TSC2		not provided	VCV000065282	16	2122389	16	2072388	65282	76214	rs149860839	NC_000016.10:2072387:G:C	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2220+182C>T	TSC2		not provided	VCV000677251	16	2122546	16	2072545	677251	667401	rs12325450	NC_000016.10:2072544:C:T	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221-169C>T	TSC2		Tuberous sclerosis 2	VCV002108085	16	2122681	16	2072680	2108085	2163258	rs2543752790	NC_000016.10:2072679:C:T	single nucleotide variant	intron variant	Uncertain significance	Apr 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-28A>G	TSC2		not provided|not specified	VCV000049604	16	2122822	16	2072821	49604	58766	rs7196184	NC_000016.10:2072820:A:G	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221-20T>A	TSC2		Tuberous sclerosis 2	VCV002820964	16	2122830	16	2072829	2820964	2978209	rs2088678037	NC_000016.10:2072828:T:A	single nucleotide variant	intron variant	Likely benign	Dec 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-20T>G	TSC2		Tuberous sclerosis 2	VCV002110423	16	2122830	16	2072829	2110423	2170887	rs2088678037	NC_000016.10:2072828:T:G	single nucleotide variant	intron variant	Likely benign	Mar 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-20T>C	TSC2		Tuberous sclerosis 2	VCV001562729	16	2122830	16	2072829	1562729	1643140	rs2088678037	NC_000016.10:2072828:T:C	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221-19G>T	TSC2		Tuberous sclerosis 2	VCV002096257	16	2122831	16	2072830	2096257	2146408	rs775879508	NC_000016.10:2072829:G:T	single nucleotide variant	intron variant	Likely benign	Feb 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-19G>A	TSC2		Tuberous sclerosis 2	VCV001528686	16	2122831	16	2072830	1528686	1581768	rs775879508	NC_000016.10:2072829:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221-18C>G	TSC2		Tuberous sclerosis 2	VCV003630178	16	2122832	16	2072831	3630178	3769520		NC_000016.10:2072830:C:G	single nucleotide variant	intron variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-16T>C	TSC2		Tuberous sclerosis 2	VCV001621126	16	2122834	16	2072833	1621126	1615373	rs956986385	NC_000016.10:2072832:T:C	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221-15G>A	TSC2		Tuberous sclerosis 2	VCV002865135	16	2122835	16	2072834	2865135	3029916	rs2151325785	NC_000016.10:2072833:G:A	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-14G>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002747158	16	2122836	16	2072835	2747158	2907918	rs763473889	NC_000016.10:2072834:G:T	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221-13A>G	TSC2		Tuberous sclerosis 2	VCV001530872	16	2122837	16	2072836	1530872	1635344	rs2151325840	NC_000016.10:2072835:A:G	single nucleotide variant	intron variant	Likely benign	Oct 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-12T>G	TSC2		Tuberous sclerosis 2	VCV002090489	16	2122838	16	2072837	2090489	2148293	rs2543760138	NC_000016.10:2072836:T:G	single nucleotide variant	intron variant	Uncertain significance	Mar 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-10T>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692483	16	2122840	16	2072839	1692483	1684923	rs2151325875	NC_000016.10:2072838:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2221-9G>T	TSC2		Tuberous sclerosis 2	VCV002007356	16	2122841	16	2072840	2007356	2062716	rs2543760225	NC_000016.10:2072839:G:T	single nucleotide variant	intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-8G>A	TSC2		not provided|Tuberous sclerosis 2	VCV001153712	16	2122842	16	2072841	1153712	1145933	rs768919244	NC_000016.10:2072840:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 4, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2221-8G>C	TSC2		Tuberous sclerosis 2	VCV001106644	16	2122842	16	2072841	1106644	1103636	rs768919244	NC_000016.10:2072840:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221-6C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536019	16	2122844	16	2072843	536019	529637	rs1555506823	NC_000016.10:2072842:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2221-5A>C	TSC2		Tuberous sclerosis 2	VCV003721614	16	2122845	16	2072844	3721614	3850115		NC_000016.10:2072843:A:C	single nucleotide variant	intron variant	Likely benign	Sep 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-5A>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000480828	16	2122845	16	2072844	480828	477342	rs1555506829	NC_000016.10:2072843:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2221-3C>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003232110	16	2122847	16	2072846	3232110	3385650	rs1555506834	NC_000016.10:2072845:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-3C>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467930	16	2122847	16	2072846	467930	466134	rs1555506834	NC_000016.10:2072845:C:G	single nucleotide variant	intron variant	Uncertain significance	Nov 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221-2A>G	TSC2		Tuberous sclerosis 2	VCV000049815	16	2122848	16	2072847	49815	58977	rs45502196	NC_000016.10:2072846:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Jan 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2221-1G>A	TSC2		Tuberous sclerosis 2|not provided	VCV000419433	16	2122849	16	2072848	419433	409484	rs45517218	NC_000016.10:2072847:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221-1G>C	TSC2		Tuberous sclerosis 1|Tuberous sclerosis 2	VCV000049197	16	2122849	16	2072848	49197	58359	rs45517218	NC_000016.10:2072847:G:C	single nucleotide variant	splice acceptor variant	Pathogenic	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2221C>T (p.Leu741Phe)	TSC2	L741F, L541F, L704F, L752F, L692F	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000318319	16	2122850	16	2072849	318319	340858	rs886051789	NC_000016.10:2072848:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2222T>G (p.Leu741Arg)	TSC2	L541R, L692R, L704R, L741R, L752R	Tuberous sclerosis 2	VCV001028341	16	2122851	16	2072850	1028341	1018043	rs2088681390	NC_000016.10:2072849:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2222T>C (p.Leu741Pro)	TSC2	L541P, L692P, L704P, L741P, L752P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000967653	16	2122851	16	2072850	967653	957678	rs2088681390	NC_000016.10:2072849:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2223T>G (p.Leu741=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003642671	16	2122852	16	2072851	3642671	3765442		NC_000016.10:2072850:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2225C>T (p.Ser742Leu)	TSC2	S742L, S753L, S693L, S542L, S705L	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000406093	16	2122854	16	2072853	406093	401482	rs45517220	NC_000016.10:2072852:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2225C>G (p.Ser742Ter)	TSC2	S742*, S705*, S753*, S542*, S693*	not provided	VCV000049199	16	2122854	16	2072853	49199	58361	rs45517220	NC_000016.10:2072852:C:G	single nucleotide variant	nonsense	Pathogenic	Feb 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2226A>G (p.Ser742=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413665	16	2122855	16	2072854	413665	401484	rs1060504097	NC_000016.10:2072853:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2227G>A (p.Gly743Ser)	TSC2	G743S, G543S, G694S, G706S, G754S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467931	16	2122856	16	2072855	467931	465933	rs1555506852	NC_000016.10:2072854:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2228G>A (p.Gly743Asp)	TSC2	G209D, G694D, G724D, G739D, G543D, G589D, G743D, G295D, G773D, G706D, G754D	Tuberous sclerosis 2	VCV002991338	16	2122857	16	2072856	2991338	3147771	rs2151326174	NC_000016.10:2072855:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2228G>T (p.Gly743Val)	TSC2	G543V, G694V, G706V, G743V, G754V	Hereditary cancer-predisposing syndrome	VCV001692484	16	2122857	16	2072856	1692484	1684924	rs2151326174	NC_000016.10:2072855:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2229C>T (p.Gly743=)	TSC2		Tuberous sclerosis 2	VCV000798099	16	2122858	16	2072857	798099	785193	rs1322227597	NC_000016.10:2072856:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2230C>T (p.Pro744Ser)	TSC2	P210S, P296S, P544S, P590S, P695S, P707S, P725S, P740S, P744S, P755S, P774S	Tuberous sclerosis 2	VCV001717008	16	2122859	16	2072858	1717008	1775833	rs1596350020	NC_000016.10:2072857:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2230C>G (p.Pro744Ala)	TSC2	P695A, P744A, P755A, P544A, P707A	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000664186	16	2122859	16	2072858	664186	644231	rs1596350020	NC_000016.10:2072857:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2231C>T (p.Pro744Leu)	TSC2	P210L, P590L, P740L, P725L, P755L, P774L, P544L, P695L, P707L, P744L, P296L	Tuberous sclerosis 2	VCV003718653	16	2122860	16	2072859	3718653	3859355		NC_000016.10:2072858:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Sep 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2231C>G (p.Pro744Arg)	TSC2	P744R, P755R, P695R, P544R, P707R	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535876	16	2122860	16	2072859	535876	529638	rs774759789	NC_000016.10:2072858:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2232A>G (p.Pro744=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002587828	16	2122861	16	2072860	2587828	2764166	rs1259596608	NC_000016.10:2072859:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2232A>C (p.Pro744=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001551626	16	2122861	16	2072860	1551626	1551405	rs1259596608	NC_000016.10:2072859:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2235G>A (p.Lys745=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000509319	16	2122864	16	2072863	509319	505698	rs762162898	NC_000016.10:2072862:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Sep 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2236A>G (p.Thr746Ala)	TSC2	T212A, T546A, T697A, T709A, T757A, T298A, T727A, T746A, T776A, T592A, T742A	Hereditary cancer-predisposing syndrome	VCV001788190	16	2122865	16	2072864	1788190	1847632	rs2543761693	NC_000016.10:2072863:A:G	single nucleotide variant	missense variant	Uncertain significance	May 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2237C>A (p.Thr746Lys)	TSC2	T592K, T727K, T546K, T697K, T742K, T746K, T298K, T757K, T776K, T212K, T709K	Hereditary cancer-predisposing syndrome	VCV003974636	16	2122866	16	2072865	3974636	4086459		NC_000016.10:2072864:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2237C>T (p.Thr746Ile)	TSC2	T746I, T546I, T697I, T709I, T757I	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207726	16	2122866	16	2072865	207726	203137	rs767770242	NC_000016.10:2072864:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2238A>C (p.Thr746=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001612568	16	2122867	16	2072866	1612568	1601651	rs1060504115	NC_000016.10:2072865:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2238A>G (p.Thr746=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000413729	16	2122867	16	2072866	413729	401485	rs1060504115	NC_000016.10:2072865:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2239C>A (p.Leu747Met)	TSC2	L747M, L710M, L547M, L698M, L758M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000233802	16	2122868	16	2072867	233802	235108	rs45517221	NC_000016.10:2072866:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2239C>T (p.Leu747=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049611	16	2122868	16	2072867	49611	58773	rs45517221	NC_000016.10:2072866:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2240T>A (p.Leu747Gln)	TSC2	L213Q, L547Q, L710Q, L743Q, L593Q, L299Q, L758Q, L698Q, L728Q, L747Q, L777Q	Hereditary cancer-predisposing syndrome	VCV002560715	16	2122869	16	2072868	2560715	2716875	rs2543762052	NC_000016.10:2072867:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2242G>C (p.Glu748Gln)	TSC2	E300Q, E594Q, E214Q, E711Q, E744Q, E548Q, E729Q, E778Q, E699Q, E748Q, E759Q	Tuberous sclerosis 2	VCV003637198	16	2122871	16	2072870	3637198	3771352		NC_000016.10:2072869:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2242G>A (p.Glu748Lys)	TSC2	E748K, E548K, E759K, E699K, E711K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis	VCV000569849	16	2122871	16	2072870	569849	569712	rs1442440961	NC_000016.10:2072869:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2243A>G (p.Glu748Gly)	TSC2	E214G, E729G, E778G, E548G, E594G, E300G, E744G, E748G, E759G, E699G, E711G	Tuberous sclerosis 2	VCV002043481	16	2122872	16	2072871	2043481	2092342	rs2543762277	NC_000016.10:2072870:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2244G>T (p.Glu748Asp)	TSC2	E548D, E711D, E748D, E759D, E699D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001346059	16	2122873	16	2072872	1346059	1378348	rs2151326551	NC_000016.10:2072871:G:T	single nucleotide variant	missense variant	Uncertain significance	May 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2245C>T (p.Arg749Trp)	TSC2	R749W, R700W, R712W, R760W, R549W	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536065	16	2122874	16	2072873	536065	529642	rs377397369	NC_000016.10:2072872:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2246G>A (p.Arg749Gln)	TSC2	R749Q, R760Q, R700Q, R549Q, R712Q	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207727	16	2122875	16	2072874	207727	203138	rs766442736	NC_000016.10:2072873:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2247G>A (p.Arg749=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329471	16	2122876	16	2072875	3329471	3489063		NC_000016.10:2072874:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2247G>C (p.Arg749=)	TSC2		Tuberous sclerosis 2	VCV001994309	16	2122876	16	2072875	1994309	2056109	rs753723736	NC_000016.10:2072874:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2247G>T (p.Arg749=)	TSC2		Tuberous sclerosis 2	VCV001106826	16	2122876	16	2072875	1106826	1103637	rs753723736	NC_000016.10:2072874:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2248C>T (p.Leu750Phe)	TSC2	L550F, L701F, L713F, L750F, L761F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV001022694	16	2122877	16	2072876	1022694	1011961	rs754885213	NC_000016.10:2072875:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2249T>C (p.Leu750Pro)	TSC2	L596P, L731P, L780P, L750P, L701P, L746P, L761P, L216P, L302P, L550P, L713P	Tuberous sclerosis 2	VCV003637199	16	2122878	16	2072877	3637199	3771353		NC_000016.10:2072876:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2250C>T (p.Leu750=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000820966	16	2122879	16	2072878	820966	812543	rs1387127083	NC_000016.10:2072877:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2251C>T (p.Arg751Ter)	TSC2	R751*, R702*, R551*, R762*, R714*	not provided|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000050131	16	2122880	16	2072879	50131	59293	rs45517222	NC_000016.10:2072878:C:T	single nucleotide variant	nonsense	Pathogenic	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2252G>T (p.Arg751Leu)	TSC2	R714L, R751L, R702L, R762L, R551L	Tuberous sclerosis 2	VCV001477467	16	2122881	16	2072880	1477467	1413651	rs749593050	NC_000016.10:2072879:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2252G>A (p.Arg751Gln)	TSC2	R751Q, R551Q, R714Q, R702Q, R762Q	Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000535887	16	2122881	16	2072880	535887	529578	rs749593050	NC_000016.10:2072879:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2254G>T (p.Gly752Cys)	TSC2	G218C, G304C, G552C, G598C, G703C, G715C, G733C, G748C, G752C, G763C, G782C	Tuberous sclerosis syndrome	VCV003074469	16	2122883	16	2072882	3074469	3229436	rs2151326864	NC_000016.10:2072881:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2254G>A (p.Gly752Ser)	TSC2	G715S, G703S, G552S, G752S, G763S	Tuberous sclerosis 2	VCV001403817	16	2122883	16	2072882	1403817	1467183	rs2151326864	NC_000016.10:2072881:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2255G>A (p.Gly752Asp)	TSC2	G752D, G703D, G715D, G552D, G763D	Hereditary cancer-predisposing syndrome	VCV000233659	16	2122884	16	2072883	233659	235109	rs876660553	NC_000016.10:2072882:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2015	criteria provided, single submitter							
NM_000548.5(TSC2):c.2256C>A (p.Gly752=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001672918	16	2122885	16	2072884	1672918	1531364	rs778981034	NC_000016.10:2072883:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2256C>T (p.Gly752=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000467932	16	2122885	16	2072884	467932	465934	rs778981034	NC_000016.10:2072883:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2257G>C (p.Ala753Pro)	TSC2	A704P, A734P, A305P, A749P, A553P, A219P, A599P, A716P, A753P, A764P, A783P	Hereditary cancer-predisposing syndrome	VCV002564672	16	2122886	16	2072885	2564672	2733828	rs574205203	NC_000016.10:2072884:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2257G>A (p.Ala753Thr)	TSC2	A753T, A553T, A704T, A716T, A764T	Tuberous sclerosis 2|TSC2-related disorder|Hereditary cancer-predisposing syndrome	VCV000141526	16	2122886	16	2072885	141526	151240	rs574205203	NC_000016.10:2072884:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2258C>G (p.Ala753Gly)	TSC2	A219G, A305G, A553G, A599G, A704G, A716G, A734G, A749G, A753G, A764G, A783G	not provided	VCV003903144	16	2122887	16	2072886	3903144	4019018		NC_000016.10:2072885:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2258C>T (p.Ala753Val)	TSC2	A305V, A553V, A599V, A764V, A734V, A753V, A704V, A749V, A219V, A716V, A783V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002082975	16	2122887	16	2072886	2082975	2143487	rs2543763492	NC_000016.10:2072885:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2259C>G (p.Ala753=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003050259	16	2122888	16	2072887	3050259	3216418	rs1382268457	NC_000016.10:2072886:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2259C>T (p.Ala753=)	TSC2		Tuberous sclerosis 2	VCV001963862	16	2122888	16	2072887	1963862	2013658	rs1382268457	NC_000016.10:2072886:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2260C>G (p.Pro754Ala)	TSC2	P220A, P717A, P754A, P306A, P554A, P750A, P765A, P600A, P705A, P735A, P784A	Tuberous sclerosis 2	VCV002820529	16	2122889	16	2072888	2820529	2981615	rs752603642	NC_000016.10:2072887:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2260C>T (p.Pro754Ser)	TSC2	P554S, P717S, P765S, P754S, P705S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001501972	16	2122889	16	2072888	1501972	1411190	rs752603642	NC_000016.10:2072887:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2261C>T (p.Pro754Leu)	TSC2	P554L, P705L, P717L, P754L, P765L	not provided|Tuberous sclerosis 2	VCV001700568	16	2122890	16	2072889	1700568	1692961	rs2088690950	NC_000016.10:2072888:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 14, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2261C>G (p.Pro754Arg)	TSC2	P754R, P765R, P554R, P705R, P717R	Tuberous sclerosis 2	VCV000940398	16	2122890	16	2072889	940398	937304	rs2088690950	NC_000016.10:2072888:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2262A>C (p.Pro754=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564682	16	2122891	16	2072890	2564682	2733838	rs2088691180	NC_000016.10:2072889:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2262A>G (p.Pro754=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001539195	16	2122891	16	2072890	1539195	1598076	rs2088691180	NC_000016.10:2072889:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2263G>C (p.Glu755Gln)	TSC2	E555Q, E706Q, E718Q, E755Q, E766Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001008986	16	2122892	16	2072891	1008986	996720	rs2088691487	NC_000016.10:2072890:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2266G>A (p.Gly756Ser)	TSC2	G308S, G719S, G556S, G756S, G786S, G222S, G602S, G707S, G737S, G767S, G752S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001915155	16	2122895	16	2072894	1915155	1974078	rs1285714005	NC_000016.10:2072893:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2267G>T (p.Gly756Val)	TSC2	G222V, G308V, G556V, G602V, G707V, G719V, G737V, G752V, G756V, G767V, G786V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003232111	16	2122896	16	2072895	3232111	3385651	rs2543764468	NC_000016.10:2072894:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2267G>C (p.Gly756Ala)	TSC2	G556A, G767A, G719A, G756A, G786A, G707A, G737A, G222A, G308A, G602A, G752A	Tuberous sclerosis 2	VCV002708494	16	2122896	16	2072895	2708494	2870785	rs2543764468	NC_000016.10:2072894:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2268C>A (p.Gly756=)	TSC2		Tuberous sclerosis 2	VCV001093266	16	2122897	16	2072896	1093266	1081812	rs2151327216	NC_000016.10:2072895:C:A	single nucleotide variant	synonymous variant	Likely benign	May 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2269T>C (p.Phe757Leu)	TSC2	F738L, F768L, F787L, F223L, F557L, F708L, F309L, F603L, F720L, F753L, F757L	Hereditary cancer-predisposing syndrome	VCV003811317	16	2122898	16	2072897	3811317	3928558		NC_000016.10:2072896:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2269T>A (p.Phe757Ile)	TSC2	F708I, F557I, F753I, F223I, F768I, F787I, F309I, F603I, F720I, F738I, F757I	Hereditary cancer-predisposing syndrome	VCV002449968	16	2122898	16	2072897	2449968	2429593	rs2543764591	NC_000016.10:2072896:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2270T>C (p.Phe757Ser)	TSC2	F309S, F753S, F557S, F603S, F738S, F768S, F223S, F708S, F720S, F757S, F787S	Hereditary cancer-predisposing syndrome	VCV003974635	16	2122899	16	2072898	3974635	4086458		NC_000016.10:2072897:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2270T>A (p.Phe757Tyr)	TSC2	F223Y, F309Y, F753Y, F757Y, F708Y, F720Y, F557Y, F603Y, F768Y, F787Y, F738Y	Hereditary cancer-predisposing syndrome	VCV003811318	16	2122899	16	2072898	3811318	3928559		NC_000016.10:2072897:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2271C>A (p.Phe757Leu)	TSC2	F223L, F309L, F557L, F603L, F708L, F720L, F738L, F753L, F757L, F768L, F787L	not specified	VCV003769064	16	2122900	16	2072899	3769064	3885218		NC_000016.10:2072898:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 13, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2271C>T (p.Phe757=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000536030	16	2122900	16	2072899	536030	529580	rs1555506918	NC_000016.10:2072898:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2272T>A (p.Ser758Thr)	TSC2	S224T, S310T, S558T, S604T, S709T, S721T, S739T, S754T, S758T, S769T, S788T	Hereditary cancer-predisposing syndrome	VCV003232112	16	2122901	16	2072900	3232112	3385652	rs2151327279	NC_000016.10:2072899:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2272T>C (p.Ser758Pro)	TSC2	S721P, S709P, S558P, S758P, S769P	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001438202	16	2122901	16	2072900	1438202	1355055	rs2151327279	NC_000016.10:2072899:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2273C>G (p.Ser758Cys)	TSC2	S758C, S558C, S709C, S721C, S769C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000237986	16	2122902	16	2072901	237986	242252	rs45517223	NC_000016.10:2072900:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2273C>T (p.Ser758Phe)	TSC2	S758F, S558F, S709F, S769F, S721F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049710	16	2122902	16	2072901	49710	58872	rs45517223	NC_000016.10:2072900:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2274C>T (p.Ser758=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001119487	16	2122903	16	2072902	1119487	1103638	rs2151327344	NC_000016.10:2072901:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2275A>C (p.Arg759=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003329520	16	2122904	16	2072903	3329520	3489112		NC_000016.10:2072902:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2276G>A (p.Arg759Lys)	TSC2	R605K, R722K, R770K, R225K, R740K, R311K, R559K, R710K, R755K, R759K, R789K	Tuberous sclerosis 2	VCV002095098	16	2122905	16	2072904	2095098	2156882	rs2543765012	NC_000016.10:2072903:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2276G>C (p.Arg759Thr)	TSC2	R710T, R722T, R740T, R755T, R770T, R559T, R759T, R225T, R605T, R311T, R789T	Tuberous sclerosis 2	VCV001977737	16	2122905	16	2072904	1977737	2024097	rs2543765012	NC_000016.10:2072903:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2278A>G (p.Thr760Ala)	TSC2	T560A, T711A, T723A, T760A, T771A	Tuberous sclerosis 2	VCV000933685	16	2122907	16	2072906	933685	937305	rs1213793365	NC_000016.10:2072905:A:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2279C>G (p.Thr760Ser)	TSC2	T226S, T560S, T711S, T741S, T723S, T756S, T760S, T312S, T606S, T771S, T790S	Tuberous sclerosis 2	VCV002817264	16	2122908	16	2072907	2817264	2977075	rs1060500920	NC_000016.10:2072906:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2279C>T (p.Thr760Ile)	TSC2	T760I, T723I, T560I, T771I, T711I	Tuberous sclerosis 2	VCV000405974	16	2122908	16	2072907	405974	401486	rs1060500920	NC_000016.10:2072906:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2280T>C (p.Thr760=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001118456	16	2122909	16	2072908	1118456	1103639	rs2088693411	NC_000016.10:2072907:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2283C>T (p.Asp761=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001619632	16	2122912	16	2072911	1619632	1615178	rs2088693660	NC_000016.10:2072910:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 29, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2284T>C (p.Leu762=)	TSC2		Tuberous sclerosis 2	VCV001146318	16	2122913	16	2072912	1146318	1145934	rs1249640615	NC_000016.10:2072911:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2285T>G (p.Leu762Trp)	TSC2	L562W, L713W, L725W, L762W, L773W	Hereditary cancer-predisposing syndrome	VCV001692485	16	2122914	16	2072913	1692485	1684925	rs2151327516	NC_000016.10:2072912:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2285T>A (p.Leu762Ter)	TSC2	L562*, L713*, L725*, L762*, L773*	Tuberous sclerosis 2	VCV001072814	16	2122914	16	2072913	1072814	1063531	rs2151327516	NC_000016.10:2072912:T:A	single nucleotide variant	nonsense	Pathogenic	Oct 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2286G>C (p.Leu762Phe)	TSC2	L562F, L725F, L773F, L713F, L743F, L792F, L314F, L608F, L762F, L228F, L758F	Tuberous sclerosis 2	VCV002786476	16	2122915	16	2072914	2786476	2938981	rs2543765401	NC_000016.10:2072913:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2286G>A (p.Leu762=)	TSC2		Tuberous sclerosis 2	VCV002092190	16	2122915	16	2072914	2092190	2152688	rs2543765401	NC_000016.10:2072913:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2287C>G (p.His763Asp)	TSC2	H229D, H315D, H563D, H609D, H714D, H726D, H744D, H759D, H763D, H774D, H793D	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003070887	16	2122916	16	2072915	3070887	3230643	rs758234726	NC_000016.10:2072914:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2287C>A (p.His763Asn)	TSC2	H774N, H229N, H714N, H744N, H315N, H563N, H609N, H763N, H726N, H759N, H793N	Tuberous sclerosis 2	VCV002121739	16	2122916	16	2072915	2121739	2176933	rs758234726	NC_000016.10:2072914:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2287C>T (p.His763Tyr)	TSC2	H763Y, H563Y, H726Y, H774Y, H714Y	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000207669	16	2122916	16	2072915	207669	203139	rs758234726	NC_000016.10:2072914:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2288A>C (p.His763Pro)	TSC2	H229P, H315P, H563P, H609P, H714P, H726P, H744P, H759P, H763P, H774P, H793P	Isolated focal cortical dysplasia type II	VCV002679344	16	2122917	16	2072916	2679344	2836921	rs1464357699	NC_000016.10:2072915:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2288A>T (p.His763Leu)	TSC2	H315L, H563L, H744L, H759L, H763L, H726L, H714L, H774L, H229L, H609L, H793L	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001789039	16	2122917	16	2072916	1789039	1841252	rs1464357699	NC_000016.10:2072915:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2289C>T (p.His763=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692486	16	2122918	16	2072917	1692486	1684926	rs1319959937	NC_000016.10:2072916:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jan 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2289C>G (p.His763Gln)	TSC2	H563Q, H714Q, H763Q, H726Q, H774Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000846564	16	2122918	16	2072917	846564	843410	rs1319959937	NC_000016.10:2072916:C:G	single nucleotide variant	missense variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2290C>G (p.Leu764Val)	TSC2	L764V, L715V, L727V, L775V, L564V	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486641	16	2122919	16	2072918	486641	477315	rs777614710	NC_000016.10:2072917:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2290C>T (p.Leu764=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413709	16	2122919	16	2072918	413709	401243	rs777614710	NC_000016.10:2072917:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2290C>A (p.Leu764Met)	TSC2	L764M, L727M, L564M, L775M, L715M	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000406028	16	2122919	16	2072918	406028	401493	rs777614710	NC_000016.10:2072917:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2291T>C (p.Leu764Pro)	TSC2	L564P, L610P, L775P, L316P, L794P, L715P, L727P, L230P, L745P, L760P, L764P	Hereditary cancer-predisposing syndrome	VCV002564623	16	2122920	16	2072919	2564623	2733779	rs2543765855	NC_000016.10:2072918:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2292G>A (p.Leu764=)	TSC2		Tuberous sclerosis 2	VCV004071134	16	2122921	16	2072920	4071134	4184982		NC_000016.10:2072919:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2292G>C (p.Leu764=)	TSC2		Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV002853541	16	2122921	16	2072920	2853541	3013340	rs2543765925	NC_000016.10:2072919:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2293G>T (p.Ala765Ser)	TSC2	A795S, A231S, A716S, A761S, A565S, A611S, A776S, A317S, A728S, A746S, A765S	Tuberous sclerosis 2	VCV002848376	16	2122922	16	2072921	2848376	3005618	rs2151327662	NC_000016.10:2072920:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2294C>A (p.Ala765Asp)	TSC2	A565D, A716D, A728D, A765D, A776D	Hereditary cancer-predisposing syndrome	VCV001692487	16	2122923	16	2072922	1692487	1684927	rs886042145	NC_000016.10:2072921:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2294C>T (p.Ala765Val)	TSC2	A765V, A565V, A776V, A728V, A716V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000281384	16	2122923	16	2072922	281384	265621	rs886042145	NC_000016.10:2072921:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2295C>G (p.Ala765=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000626038	16	2122924	16	2072923	626038	614416	rs45509500	NC_000016.10:2072922:C:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2295C>T (p.Ala765=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000049677	16	2122924	16	2072923	49677	58839	rs45509500	NC_000016.10:2072922:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2296G>T (p.Val766Leu)	TSC2	V232L, V318L, V566L, V612L, V766L, V729L, V762L, V796L, V717L, V777L, V747L	Hereditary cancer-predisposing syndrome	VCV002626446	16	2122925	16	2072924	2626446	2794212	rs150672640	NC_000016.10:2072923:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2296G>C (p.Val766Leu)	TSC2	V766L, V566L, V612L, V717L, V796L, V747L, V762L, V777L, V232L, V318L, V729L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001789178	16	2122925	16	2072924	1789178	1850849	rs150672640	NC_000016.10:2072923:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2296G>A (p.Val766Met)	TSC2	V766M, V717M, V566M, V729M, V777M	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000237987	16	2122925	16	2072924	237987	242253	rs150672640	NC_000016.10:2072923:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2297T>C (p.Val766Ala)	TSC2	V766A, V729A, V777A, V566A, V717A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000535969	16	2122926	16	2072925	535969	530160	rs780682938	NC_000016.10:2072924:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2298G>A (p.Val766=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462607	16	2122927	16	2072926	3462607	3621626		NC_000016.10:2072925:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2298G>C (p.Val766=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000701082	16	2122927	16	2072926	701082	688540	rs1157138703	NC_000016.10:2072925:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2299G>T (p.Val767Phe)	TSC2	V567F, V718F, V778F, V319F, V613F, V730F, V233F, V748F, V763F, V767F, V797F	Tuberous sclerosis 2	VCV002756911	16	2122928	16	2072927	2756911	2920682	rs745359720	NC_000016.10:2072926:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Aug 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2301T>C (p.Val767=)	TSC2		Tuberous sclerosis 2	VCV002030883	16	2122930	16	2072929	2030883	2082386	rs531724951	NC_000016.10:2072928:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2301T>A (p.Val767=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486685	16	2122930	16	2072929	486685	477923	rs531724951	NC_000016.10:2072928:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2301T>G (p.Val767=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413740	16	2122930	16	2072929	413740	401250	rs531724951	NC_000016.10:2072928:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2302C>T (p.Pro768Ser)	TSC2	P234S, P320S, P568S, P614S, P719S, P731S, P749S, P764S, P768S, P779S, P798S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003232113	16	2122931	16	2072930	3232113	3385653	rs1422055326	NC_000016.10:2072929:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2303C>G (p.Pro768Arg)	TSC2	P320R, P614R, P749R, P779R, P798R, P719R, P731R, P234R, P568R, P768R, P764R	Hereditary cancer-predisposing syndrome	VCV001789321	16	2122932	16	2072931	1789321	1850991	rs1555506977	NC_000016.10:2072930:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2303C>T (p.Pro768Leu)	TSC2	P768L, P719L, P568L, P731L, P779L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000467933	16	2122932	16	2072931	467933	466136	rs1555506977	NC_000016.10:2072930:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2304A>G (p.Pro768=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002021536	16	2122933	16	2072932	2021536	2087139	rs2543767045	NC_000016.10:2072931:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2305G>A (p.Val769Met)	TSC2	V321M, V615M, V235M, V720M, V765M, V799M, V732M, V769M, V569M, V750M, V780M	Tuberous sclerosis 2	VCV003672714	16	2122934	16	2072933	3672714	3804851		NC_000016.10:2072932:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2307G>A (p.Val769=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001789370	16	2122936	16	2072935	1789370	1851040	rs1479110270	NC_000016.10:2072934:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2308C>A (p.Leu770Met)	TSC2	L770M, L721M, L733M, L781M, L570M	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535910	16	2122937	16	2072936	535910	530164	rs762215859	NC_000016.10:2072935:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2308C>T (p.Leu770=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467934	16	2122937	16	2072936	467934	465831	rs762215859	NC_000016.10:2072935:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2310G>A (p.Leu770=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449955	16	2122939	16	2072938	2449955	2429581	rs772380298	NC_000016.10:2072937:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2310G>C (p.Leu770=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000821074	16	2122939	16	2072938	821074	812544	rs772380298	NC_000016.10:2072937:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2311A>G (p.Thr771Ala)	TSC2	T617A, T801A, T571A, T752A, T782A, T237A, T722A, T734A, T767A, T323A, T771A	Tuberous sclerosis 2	VCV003637200	16	2122940	16	2072939	3637200	3771354		NC_000016.10:2072938:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2311A>T (p.Thr771Ser)	TSC2	T771S, T571S, T722S, T782S, T734S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467935	16	2122940	16	2072939	467935	466140	rs1555506986	NC_000016.10:2072938:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2312C>G (p.Thr771Arg)	TSC2	T771R, T734R, T722R, T571R, T782R	Tuberous sclerosis 2	VCV000568874	16	2122941	16	2072940	568874	567802	rs886051790	NC_000016.10:2072939:C:G	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2312C>T (p.Thr771Ile)	TSC2	T771I, T722I, T571I, T734I, T782I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000318320	16	2122941	16	2072940	318320	324618	rs886051790	NC_000016.10:2072939:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2313A>T (p.Thr771=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000762040	16	2122942	16	2072941	762040	770703	rs876658215	NC_000016.10:2072940:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2313A>G (p.Thr771=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000229817	16	2122942	16	2072941	229817	235110	rs876658215	NC_000016.10:2072940:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2314G>A (p.Ala772Thr)	TSC2	A572T, A723T, A735T, A753T, A772T, A783T, A618T, A768T, A238T, A324T, A802T	Hereditary cancer-predisposing syndrome	VCV003811333	16	2122943	16	2072942	3811333	3928574		NC_000016.10:2072941:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2315C>T (p.Ala772Val)	TSC2	A772V, A572V, A723V, A735V, A783V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000467936	16	2122944	16	2072943	467936	465832	rs397514984	NC_000016.10:2072942:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2315C>A (p.Ala772Glu)	TSC2	A772E, A735E, A572E, A783E, A723E	Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000064979	16	2122944	16	2072943	64979	75909	rs397514984	NC_000016.10:2072942:C:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2316A>G (p.Ala772=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001789490	16	2122945	16	2072944	1789490	1851160	rs2088700038	NC_000016.10:2072943:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2316A>C (p.Ala772=)	TSC2		Tuberous sclerosis 2	VCV001094516	16	2122945	16	2072944	1094516	1081813	rs2088700038	NC_000016.10:2072943:A:C	single nucleotide variant	synonymous variant	Likely benign	Sep 14, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2319A>G (p.Leu773=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000821088	16	2122948	16	2072947	821088	812545	rs1359991984	NC_000016.10:2072946:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2319A>C (p.Leu773Phe)	TSC2	L773F, L724F, L736F, L784F, L573F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000582709	16	2122948	16	2072947	582709	569716	rs1359991984	NC_000016.10:2072946:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2322C>A (p.Ile774=)	TSC2		Tuberous sclerosis 2	VCV003646653	16	2122951	16	2072950	3646653	3787206		NC_000016.10:2072949:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2322C>G (p.Ile774Met)	TSC2	I737M, I574M, I774M, I725M, I785M	Hereditary cancer-predisposing syndrome	VCV000821098	16	2122951	16	2072950	821098	812546	rs760885994	NC_000016.10:2072949:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2322C>T (p.Ile774=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000185059	16	2122951	16	2072950	185059	184131	rs760885994	NC_000016.10:2072949:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2324C>T (p.Ser775Phe)	TSC2	S575F, S726F, S738F, S775F, S786F	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001002262	16	2122953	16	2072952	1002262	996721	rs2088701360	NC_000016.10:2072951:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2324C>G (p.Ser775Cys)	TSC2	S726C, S775C, S738C, S575C, S786C	Tuberous sclerosis 2	VCV000859973	16	2122953	16	2072952	859973	843411	rs2088701360	NC_000016.10:2072951:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2325T>C (p.Ser775=)	TSC2		Tuberous sclerosis 2	VCV002812568	16	2122954	16	2072953	2812568	2975800	rs2543768376	NC_000016.10:2072952:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2325T>G (p.Ser775=)	TSC2		not provided|Hereditary cancer-predisposing syndrome	VCV002645969	16	2122954	16	2072953	2645969	2810850	rs2543768376	NC_000016.10:2072952:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2326T>C (p.Tyr776His)	TSC2	Y242H, Y576H, Y622H, Y757H, Y787H, Y727H, Y776H, Y806H, Y772H, Y328H, Y739H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002713813	16	2122955	16	2072954	2713813	2872236	rs2543768462	NC_000016.10:2072953:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2326T>A (p.Tyr776Asn)	TSC2	Y787N, Y576N, Y622N, Y772N, Y776N, Y739N, Y757N, Y806N, Y242N, Y328N, Y727N	Tuberous sclerosis 2	VCV002115081	16	2122955	16	2072954	2115081	2165084	rs2543768462	NC_000016.10:2072953:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2327A>G (p.Tyr776Cys)	TSC2	Y576C, Y776C, Y727C, Y739C, Y787C	Tuberous sclerosis 2	VCV000848136	16	2122956	16	2072955	848136	843412	rs766382381	NC_000016.10:2072954:A:G	single nucleotide variant	missense variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2328C>T (p.Tyr776=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001093106	16	2122957	16	2072956	1093106	1081814	rs45517225	NC_000016.10:2072955:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2328C>A (p.Tyr776Ter)	TSC2	Y776*, Y739*, Y576*, Y787*, Y727*	not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000049679	16	2122957	16	2072956	49679	58841	rs45517225	NC_000016.10:2072955:C:A	single nucleotide variant	nonsense	Pathogenic	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2329C>T (p.His777Tyr)	TSC2	H577Y, H728Y, H740Y, H777Y, H788Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000844104	16	2122958	16	2072957	844104	843413	rs1349953143	NC_000016.10:2072956:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2330A>C (p.His777Pro)	TSC2	H773P, H243P, H623P, H740P, H577P, H758P, H777P, H807P, H329P, H728P, H788P	Tuberous sclerosis 2	VCV002767023	16	2122959	16	2072958	2767023	2926467	rs759528809	NC_000016.10:2072957:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2330A>G (p.His777Arg)	TSC2	H577R, H740R, H788R, H728R, H777R	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000844308	16	2122959	16	2072958	844308	843414	rs759528809	NC_000016.10:2072957:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2331T>A (p.His777Gln)	TSC2	H623Q, H777Q, H807Q, H728Q, H243Q, H740Q, H773Q, H788Q, H329Q, H577Q, H758Q	Tuberous sclerosis 2	VCV002831789	16	2122960	16	2072959	2831789	2998003	rs139963953	NC_000016.10:2072958:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2331T>C (p.His777=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000130643	16	2122960	16	2072959	130643	136089	rs139963953	NC_000016.10:2072958:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2332A>G (p.Asn778Asp)	TSC2	N778D, N729D, N741D, N789D, N578D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406045	16	2122961	16	2072960	406045	401251	rs1060500946	NC_000016.10:2072959:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2334C>T (p.Asn778=)	TSC2		Tuberous sclerosis syndrome	VCV003074684	16	2122963	16	2072962	3074684	3229651	rs1320712673	NC_000016.10:2072961:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2334C>G (p.Asn778Lys)	TSC2	N578K, N729K, N741K, N778K, N789K	Tuberous sclerosis 2	VCV001060841	16	2122963	16	2072962	1060841	1049438	rs1320712673	NC_000016.10:2072961:C:G	single nucleotide variant	missense variant	Benign	May 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2336A>G (p.Tyr779Cys)	TSC2	Y579C, Y779C, Y730C, Y742C, Y790C	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV001510913	16	2122965	16	2072964	1510913	1465590	rs752656474	NC_000016.10:2072963:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2336A>T (p.Tyr779Phe)	TSC2	Y779F, Y730F, Y742F, Y790F, Y579F	Tuberous sclerosis 2	VCV000577818	16	2122965	16	2072964	577818	573812	rs752656474	NC_000016.10:2072963:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2337C>T (p.Tyr779=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000413737	16	2122966	16	2072965	413737	401256	rs1060504118	NC_000016.10:2072964:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2338C>A (p.Leu780Met)	TSC2	L776M, L780M, L791M, L246M, L332M, L580M, L626M, L761M, L810M, L731M, L743M	Tuberous sclerosis 2	VCV003637201	16	2122967	16	2072966	3637201	3771355		NC_000016.10:2072965:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2338C>T (p.Leu780=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536067	16	2122967	16	2072966	536067	529645	rs1555507017	NC_000016.10:2072965:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2339T>C (p.Leu780Pro)	TSC2	L580P, L731P, L743P, L780P, L791P	Tuberous sclerosis 2	VCV001700569	16	2122968	16	2072967	1700569	1692962	rs2151328709	NC_000016.10:2072966:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 18, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2339T>G (p.Leu780Arg)	TSC2	L580R, L780R, L731R, L743R, L791R	Tuberous sclerosis 2	VCV001449704	16	2122968	16	2072967	1449704	1416760	rs2151328709	NC_000016.10:2072966:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2340G>A (p.Leu780=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001789860	16	2122969	16	2072968	1789860	1847991	rs2151328730	NC_000016.10:2072967:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2341G>C (p.Asp781His)	TSC2	D732H, D781H, D247H, D333H, D744H, D762H, D811H, D581H, D627H, D777H, D792H	Tuberous sclerosis 2	VCV002832396	16	2122970	16	2072969	2832396	2994780	rs1278830553	NC_000016.10:2072968:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2341G>A (p.Asp781Asn)	TSC2	D781N, D732N, D581N, D744N, D792N	Tuberous sclerosis 2	VCV000952221	16	2122970	16	2072969	952221	927649	rs1278830553	NC_000016.10:2072968:G:A	single nucleotide variant	missense variant	Benign	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2342A>T (p.Asp781Val)	TSC2	D247V, D581V, D627V, D781V, D333V, D744V, D811V, D732V, D777V, D792V, D762V	Tuberous sclerosis 2	VCV003637202	16	2122971	16	2072970	3637202	3771356		NC_000016.10:2072969:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2342A>G (p.Asp781Gly)	TSC2	D581G, D732G, D744G, D781G, D792G	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001409009	16	2122971	16	2072970	1409009	1496798	rs2088705306	NC_000016.10:2072969:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2343C>A (p.Asp781Glu)	TSC2	D581E, D627E, D732E, D247E, D744E, D777E, D792E, D811E, D333E, D781E, D762E	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578792	16	2122972	16	2072971	3578792	3708214		NC_000016.10:2072970:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2343C>G (p.Asp781Glu)	TSC2	D744E, D732E, D792E, D581E, D781E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000848792	16	2122972	16	2072971	848792	843415	rs1446097378	NC_000016.10:2072970:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2344A>G (p.Lys782Glu)	TSC2	K793E, K334E, K582E, K745E, K763E, K778E, K812E, K628E, K248E, K733E, K782E	Tuberous sclerosis 2	VCV002833405	16	2122973	16	2072972	2833405	3001732	rs2543769778	NC_000016.10:2072971:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2345A>G (p.Lys782Arg)	TSC2	K782R, K582R, K793R, K733R, K745R	Tuberous sclerosis 2	VCV001472793	16	2122974	16	2072973	1472793	1398174	rs2151328864	NC_000016.10:2072972:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2346A>T (p.Lys782Asn)	TSC2	K733N, K334N, K812N, K582N, K248N, K628N, K745N, K763N, K778N, K782N, K793N	Tuberous sclerosis 2	VCV002854256	16	2122975	16	2072974	2854256	3010622	rs2543769864	NC_000016.10:2072973:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2347A>G (p.Thr783Ala)	TSC2	T629A, T779A, T783A, T813A, T583A, T794A, T335A, T764A, T249A, T734A, T746A	Hereditary cancer-predisposing syndrome	VCV001789933	16	2122976	16	2072975	1789933	1848063	rs2543769935	NC_000016.10:2072974:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2348C>G (p.Thr783Ser)	TSC2	T783S, T583S, T734S, T746S, T794S	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207728	16	2122977	16	2072976	207728	203140	rs562945619	NC_000016.10:2072975:C:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2348C>T (p.Thr783Ile)	TSC2	T783I, T734I, T746I, T794I, T583I	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000135374	16	2122977	16	2072976	135374	139113	rs562945619	NC_000016.10:2072975:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2349C>A (p.Thr783=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811351	16	2122978	16	2072977	3811351	3928592		NC_000016.10:2072976:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2349C>T (p.Thr783=)	TSC2		Tuberous sclerosis 2	VCV000755284	16	2122978	16	2072977	755284	770704	rs1003048370	NC_000016.10:2072976:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 3, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2350A>G (p.Lys784Glu)	TSC2	K630E, K747E, K784E, K814E, K336E, K795E, K250E, K584E, K735E, K765E, K780E	Tuberous sclerosis 2	VCV002110695	16	2122979	16	2072978	2110695	2171159	rs751172150	NC_000016.10:2072977:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 16, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2350A>T (p.Lys784Ter)	TSC2	K584*, K747*, K784*, K735*, K795*	Tuberous sclerosis 2	VCV000803150	16	2122979	16	2072978	803150	791534	rs751172150	NC_000016.10:2072977:A:T	single nucleotide variant	nonsense	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2351A>G (p.Lys784Arg)	TSC2	K784R, K795R, K735R, K584R, K747R	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000849308	16	2122980	16	2072979	849308	843416	rs1489548085	NC_000016.10:2072978:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2351A>C (p.Lys784Thr)	TSC2	K784T, K584T, K735T, K747T, K795T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000467937	16	2122980	16	2072979	467937	465935	rs1489548085	NC_000016.10:2072978:A:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2352A>G (p.Lys784=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000757940	16	2122981	16	2072980	757940	770705	rs1596350666	NC_000016.10:2072979:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2353C>T (p.Gln785Ter)	TSC2	Q785*, Q748*, Q796*, Q585*, Q736*	not provided|Tuberous sclerosis 2	VCV000050143	16	2122982	16	2072981	50143	59305	rs45517226	NC_000016.10:2072980:C:T	single nucleotide variant	nonsense	Pathogenic	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2354A>G (p.Gln785Arg)	TSC2	Q736R, Q815R, Q631R, Q748R, Q337R, Q781R, Q796R, Q251R, Q585R, Q766R, Q785R	Hereditary cancer-predisposing syndrome	VCV003462608	16	2122983	16	2072982	3462608	3621627		NC_000016.10:2072981:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355G>A (p.Gln785=)	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000835435	16	2122984	16	2072983	835435	843417	rs2088708544	NC_000016.10:2072982:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2355+1G>C	TSC2		not provided	VCV004075470	16	2122985	16	2072984	4075470	4188173		NC_000016.10:2072983:G:C	single nucleotide variant	splice donor variant	Pathogenic	Feb 18, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+1G>T	TSC2		Tuberous sclerosis 2	VCV003721958	16	2122985	16	2072984	3721958	3860062		NC_000016.10:2072983:G:T	single nucleotide variant	splice donor variant	Pathogenic	Jun 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+1G>A	TSC2		Tuberous sclerosis 2	VCV000049711	16	2122985	16	2072984	49711	58873	rs45517227	NC_000016.10:2072983:G:A	single nucleotide variant	splice donor variant	Pathogenic	Aug 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+2T>C	TSC2		Tuberous sclerosis 2	VCV000049713	16	2122986	16	2072985	49713	58875	rs45517228	NC_000016.10:2072984:T:C	single nucleotide variant	splice donor variant	Pathogenic	Sep 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+3A>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001790060	16	2122987	16	2072986	1790060	1844807	rs2151329166	NC_000016.10:2072985:A:G	single nucleotide variant	intron variant	Uncertain significance	Apr 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2355+3A>C	TSC2		Tuberous sclerosis 2	VCV001349060	16	2122987	16	2072986	1349060	1479071	rs2151329166	NC_000016.10:2072985:A:C	single nucleotide variant	intron variant	Uncertain significance	Apr 26, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+4G>A	TSC2		Tuberous sclerosis 2	VCV002022805	16	2122988	16	2072987	2022805	2076868	rs375935312	NC_000016.10:2072986:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+5G>C	TSC2		Hereditary cancer-predisposing syndrome	VCV000821067	16	2122989	16	2072988	821067	815614	rs756995937	NC_000016.10:2072987:G:C	single nucleotide variant	intron variant	Uncertain significance	Jun 25, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+5G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000514055	16	2122989	16	2072988	514055	505177	rs756995937	NC_000016.10:2072987:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2355+6A>G	TSC2		Tuberous sclerosis 2	VCV002165235	16	2122990	16	2072989	2165235	1895375	rs904030973	NC_000016.10:2072988:A:G	single nucleotide variant	intron variant	Uncertain significance	Jan 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+6A>T	TSC2		Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome	VCV000509160	16	2122990	16	2072989	509160	505465	rs904030973	NC_000016.10:2072988:A:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2355+7G>T	TSC2		Tuberous sclerosis 2	VCV003656218	16	2122991	16	2072990	3656218	3783085		NC_000016.10:2072989:G:T	single nucleotide variant	intron variant	Likely benign	Jun 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+7G>A	TSC2		Tuberous sclerosis 2	VCV000536100	16	2122991	16	2072990	536100	529654	rs999583473	NC_000016.10:2072989:G:A	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2355+8G>A	TSC2		Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome	VCV000318321	16	2122992	16	2072991	318321	342266	rs199558375	NC_000016.10:2072990:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2355+12G>A	TSC2		Tuberous sclerosis 2	VCV002900524	16	2122996	16	2072995	2900524	3060867	rs745425504	NC_000016.10:2072994:G:A	single nucleotide variant	intron variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+12G>C	TSC2		Tuberous sclerosis 2	VCV001538827	16	2122996	16	2072995	1538827	1597708	rs745425504	NC_000016.10:2072994:G:C	single nucleotide variant	intron variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+14G>T	TSC2		Tuberous sclerosis 2	VCV002819161	16	2122998	16	2072997	2819161	2977687	rs2151329389	NC_000016.10:2072996:G:T	single nucleotide variant	intron variant	Likely benign	Dec 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+15C>G	TSC2		Tuberous sclerosis 2	VCV002961076	16	2122999	16	2072998	2961076	3119694	rs1246183175	NC_000016.10:2072997:C:G	single nucleotide variant	intron variant	Likely benign	May 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+15C>T	TSC2		Tuberous sclerosis 2	VCV002044443	16	2122999	16	2072998	2044443	2095868	rs1246183175	NC_000016.10:2072997:C:T	single nucleotide variant	intron variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+16A>C	TSC2		Tuberous sclerosis 2	VCV002061638	16	2123000	16	2072999	2061638	2120786	rs2543771500	NC_000016.10:2072998:A:C	single nucleotide variant	intron variant	Likely benign	Dec 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+17G>A	TSC2		Tuberous sclerosis 2	VCV001568655	16	2123001	16	2073000	1568655	1634256	rs896658517	NC_000016.10:2072999:G:A	single nucleotide variant	intron variant	Likely benign	Dec 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+19A>T	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV002763729	16	2123003	16	2073002	2763729	2925768	rs535037838	NC_000016.10:2073001:A:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2355+19A>G	TSC2		Tuberous sclerosis 2	VCV002070805	16	2123003	16	2073002	2070805	2130029	rs535037838	NC_000016.10:2073001:A:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+20C>G	TSC2		Tuberous sclerosis 2	VCV002131910	16	2123004	16	2073003	2131910	2187751	rs1031112467	NC_000016.10:2073002:C:G	single nucleotide variant	intron variant	Likely benign	Apr 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+20C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000507690	16	2123004	16	2073003	507690	505189	rs1031112467	NC_000016.10:2073002:C:T	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2355+153A>G	TSC2		not provided	VCV000678377	16	2123137	16	2073136	678377	668378	rs114648999	NC_000016.10:2073135:A:G	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+166C>T	TSC2		not provided	VCV001219853	16	2123150	16	2073149	1219853	1209831	rs116671341	NC_000016.10:2073148:C:T	single nucleotide variant	intron variant	Likely benign	Jun 21, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2355+214G>T	TSC2		not provided	VCV000677147	16	2123198	16	2073197	677147	668679	rs117996133	NC_000016.10:2073196:G:T	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-176G>T	TSC2		not provided	VCV000677528	16	2124025	16	2074024	677528	667402	rs116444190	NC_000016.10:2074023:G:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-20A>G	TSC2		Tuberous sclerosis 2	VCV002817502	16	2124181	16	2074180	2817502	2977313	rs2151345796	NC_000016.10:2074179:A:G	single nucleotide variant	intron variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-19G>T	TSC2		Tuberous sclerosis 2	VCV002128769	16	2124182	16	2074181	2128769	2178792	rs1009319783	NC_000016.10:2074180:G:T	single nucleotide variant	intron variant	Likely benign	Apr 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-17T>G	TSC2		Tuberous sclerosis 2	VCV002857453	16	2124184	16	2074183	2857453	3021350	rs1596355928	NC_000016.10:2074182:T:G	single nucleotide variant	intron variant	Likely benign	Oct 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-17T>C	TSC2		Tuberous sclerosis 2	VCV002138905	16	2124184	16	2074183	2138905	1878576	rs1596355928	NC_000016.10:2074182:T:C	single nucleotide variant	intron variant	Likely benign	Oct 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-16G>T	TSC2		Tuberous sclerosis 2	VCV002781445	16	2124185	16	2074184	2781445	2937843	rs1362962816	NC_000016.10:2074183:G:T	single nucleotide variant	intron variant	Likely benign	May 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-16G>A	TSC2		Tuberous sclerosis 2	VCV002165050	16	2124185	16	2074184	2165050	1895189	rs1362962816	NC_000016.10:2074183:G:A	single nucleotide variant	intron variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-15T>A	TSC2		not specified|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000207670	16	2124186	16	2074185	207670	203141	rs189674303	NC_000016.10:2074184:T:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2356-14C>G	TSC2		Tuberous sclerosis 2	VCV002766355	16	2124187	16	2074186	2766355	2932260	rs2088906710	NC_000016.10:2074185:C:G	single nucleotide variant	intron variant	Likely benign	Nov 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-14C>T	TSC2		Tuberous sclerosis 2	VCV002151710	16	2124187	16	2074186	2151710	1881877	rs2088906710	NC_000016.10:2074185:C:T	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2356-13C>T	TSC2		Tuberous sclerosis 2	VCV001616398	16	2124188	16	2074187	1616398	1526588	rs1388447580	NC_000016.10:2074186:C:T	single nucleotide variant	intron variant	Likely benign	Nov 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-12T>G	TSC2		Tuberous sclerosis 2	VCV002033297	16	2124189	16	2074188	2033297	2100229	rs1388493955	NC_000016.10:2074187:T:G	single nucleotide variant	intron variant	Uncertain significance	Sep 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-12T>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001570846	16	2124189	16	2074188	1570846	1646074	rs1388493955	NC_000016.10:2074187:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2356-11G>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002840166	16	2124190	16	2074189	2840166	3003387	rs756976305	NC_000016.10:2074188:G:C	single nucleotide variant	intron variant	Likely benign	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2356-11G>T	TSC2		Tuberous sclerosis 2	VCV002016649	16	2124190	16	2074189	2016649	2072009	rs756976305	NC_000016.10:2074188:G:T	single nucleotide variant	intron variant	Likely benign	Jul 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-9C>T	TSC2		Tuberous sclerosis 2	VCV003647120	16	2124192	16	2074191	3647120	3784253		NC_000016.10:2074190:C:T	single nucleotide variant	intron variant	Likely benign	Mar 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-9C>G	TSC2		Tuberous sclerosis 2	VCV001112606	16	2124192	16	2074191	1112606	1103640	rs1334725181	NC_000016.10:2074190:C:G	single nucleotide variant	intron variant	Likely benign	Oct 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-7C>A	TSC2		Tuberous sclerosis 2	VCV002769791	16	2124194	16	2074193	2769791	2933106	rs2151346130	NC_000016.10:2074192:C:A	single nucleotide variant	intron variant	Likely benign	Nov 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-7C>T	TSC2		Tuberous sclerosis 2	VCV001623764	16	2124194	16	2074193	1623764	1594531	rs2151346130	NC_000016.10:2074192:C:T	single nucleotide variant	intron variant	Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2356-6C>G	TSC2		Tuberous sclerosis 2	VCV001530428	16	2124195	16	2074194	1530428	1582213	rs2151346147	NC_000016.10:2074193:C:G	single nucleotide variant	intron variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-6C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001151658	16	2124195	16	2074194	1151658	1145936	rs2151346147	NC_000016.10:2074193:C:T	single nucleotide variant	intron variant	Likely benign	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2356-5T>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000207729	16	2124196	16	2074195	207729	203142	rs796053488	NC_000016.10:2074194:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2356-4G>A	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000427996	16	2124197	16	2074196	427996	419869	rs201156748	NC_000016.10:2074195:G:A	single nucleotide variant	intron variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2356-3C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000664599	16	2124198	16	2074197	664599	652708	rs1310938905	NC_000016.10:2074196:C:T	single nucleotide variant	intron variant	Uncertain significance	Jul 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2356-2A>C	TSC2		Tuberous sclerosis 2	VCV000049205	16	2124199	16	2074198	49205	58367	rs45517229	NC_000016.10:2074197:A:C	single nucleotide variant	splice acceptor variant	Pathogenic	Sep 24, 2014	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-1G>T	TSC2		not provided|Tuberous sclerosis 2	VCV000805696	16	2124200	16	2074199	805696	794051	rs45481704	NC_000016.10:2074198:G:T	single nucleotide variant	splice acceptor variant	Pathogenic	Jan 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2356-1G>C	TSC2		Tuberous sclerosis 2	VCV000658503	16	2124200	16	2074199	658503	653236	rs45481704	NC_000016.10:2074198:G:C	single nucleotide variant	splice acceptor variant	Pathogenic	Jan 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2356-1G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000049204	16	2124200	16	2074199	49204	58366	rs45481704	NC_000016.10:2074198:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2356C>A (p.Arg786Ser)	TSC2	R586S, R737S, R749S, R786S, R797S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001007453	16	2124201	16	2074200	1007453	996722	rs767252128	NC_000016.10:2074199:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2356C>T (p.Arg786Cys)	TSC2	R786C, R586C, R737C, R749C, R797C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000374680	16	2124201	16	2074200	374680	361566	rs767252128	NC_000016.10:2074199:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2357G>T (p.Arg786Leu)	TSC2	R749L, R786L, R797L, R737L, R586L	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001476003	16	2124202	16	2074201	1476003	1423722	rs796053511	NC_000016.10:2074200:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2357G>A (p.Arg786His)	TSC2	R786H, R749H, R586H, R797H, R737H	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000207782	16	2124202	16	2074201	207782	203143	rs796053511	NC_000016.10:2074200:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2358C>G (p.Arg786=)	TSC2		Tuberous sclerosis 2	VCV000748088	16	2124203	16	2074202	748088	754991	rs372834284	NC_000016.10:2074201:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2358C>A (p.Arg786=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467938	16	2124203	16	2074202	467938	465834	rs372834284	NC_000016.10:2074201:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2358C>T (p.Arg786=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000237988	16	2124203	16	2074202	237988	242254	rs372834284	NC_000016.10:2074201:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2359G>C (p.Glu787Gln)	TSC2	E633Q, E750Q, E817Q, E587Q, E798Q, E253Q, E339Q, E738Q, E768Q, E787Q, E783Q	Tuberous sclerosis 2	VCV003700103	16	2124204	16	2074203	3700103	3826221		NC_000016.10:2074202:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2359G>A (p.Glu787Lys)	TSC2	E587K, E738K, E750K, E798K, E787K	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000648606	16	2124204	16	2074203	648606	644233	rs45517231	NC_000016.10:2074202:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2360A>C (p.Glu787Ala)	TSC2	E339A, E798A, E253A, E587A, E633A, E738A, E768A, E817A, E783A, E750A, E787A	Tuberous sclerosis 2	VCV001992196	16	2124205	16	2074204	1992196	2048945	rs2151346551	NC_000016.10:2074203:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2361G>C (p.Glu787Asp)	TSC2	E633D, E787D, E253D, E738D, E750D, E768D, E587D, E783D, E817D, E339D, E798D	Hereditary cancer-predisposing syndrome	VCV001790173	16	2124206	16	2074205	1790173	1844919	rs2151346581	NC_000016.10:2074204:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.2362A>G (p.Met788Val)	TSC2	M254V, M340V, M588V, M634V, M739V, M751V, M769V, M784V, M788V, M799V, M818V	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003386168	16	2124207	16	2074206	3386168	3545309		NC_000016.10:2074205:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2363T>C (p.Met788Thr)	TSC2	M588T, M784T, M634T, M751T, M769T, M739T, M799T, M254T, M340T, M788T, M818T	Tuberous sclerosis 2	VCV002699388	16	2124208	16	2074207	2699388	2865511	rs45485599	NC_000016.10:2074206:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2364G>T (p.Met788Ile)	TSC2	M340I, M634I, M799I, M818I, M739I, M784I, M788I, M254I, M588I, M751I, M769I	Tuberous sclerosis 2	VCV003637203	16	2124209	16	2074208	3637203	3771357		NC_000016.10:2074207:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2364G>C (p.Met788Ile)	TSC2	M254I, M340I, M818I, M588I, M799I, M634I, M739I, M769I, M784I, M751I, M788I	not provided	VCV003572145	16	2124209	16	2074208	3572145	3731046		NC_000016.10:2074207:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2364G>A (p.Met788Ile)	TSC2	M788I, M751I, M588I, M739I, M799I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000406123	16	2124209	16	2074208	406123	401494	rs773786955	NC_000016.10:2074207:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2365G>C (p.Val789Leu)	TSC2	V341L, V635L, V752L, V789L, V255L, V740L, V770L, V800L, V819L, V589L, V785L	Hereditary cancer-predisposing syndrome	VCV003974673	16	2124210	16	2074209	3974673	4086496		NC_000016.10:2074208:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2365G>A (p.Val789Ile)	TSC2	V789I, V740I, V752I, V589I, V800I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000230946	16	2124210	16	2074209	230946	235111	rs779472379	NC_000016.10:2074208:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2366T>C (p.Val789Ala)	TSC2	V789A, V752A, V589A, V740A, V800A	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000569171	16	2124211	16	2074210	569171	573813	rs748669016	NC_000016.10:2074209:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2367C>T (p.Val789=)	TSC2		Tuberous sclerosis 2	VCV001159115	16	2124212	16	2074211	1159115	1145937	rs1596356163	NC_000016.10:2074210:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2367C>G (p.Val789=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000758611	16	2124212	16	2074211	758611	770706	rs1596356163	NC_000016.10:2074210:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2369A>G (p.Tyr790Cys)	TSC2	Y790C, Y801C, Y741C, Y590C, Y753C	not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000467939	16	2124214	16	2074213	467939	465285	rs1555507478	NC_000016.10:2074212:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2370C>T (p.Tyr790=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000231110	16	2124215	16	2074214	231110	235112	rs45517232	NC_000016.10:2074213:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2370C>A (p.Tyr790Ter)	TSC2	Y790*, Y590*, Y741*, Y753*, Y801*	Tuberous sclerosis 2	VCV000064995	16	2124215	16	2074214	64995	75925	rs45517232	NC_000016.10:2074213:C:A	single nucleotide variant	nonsense	Pathogenic	Oct 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2370C>G (p.Tyr790Ter)	TSC2	Y790*, Y590*, Y801*, Y753*, Y741*	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000050156	16	2124215	16	2074214	50156	59318	rs45517232	NC_000016.10:2074213:C:G	single nucleotide variant	nonsense	Pathogenic	Dec 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2371T>A (p.Cys791Ser)	TSC2	C257S, C343S, C591S, C637S, C742S, C754S, C772S, C787S, C791S, C802S, C821S	Hereditary cancer-predisposing syndrome	VCV003232114	16	2124216	16	2074215	3232114	3385654	rs2543812230	NC_000016.10:2074214:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2371T>C (p.Cys791Arg)	TSC2	C257R, C742R, C637R, C802R, C821R, C343R, C591R, C754R, C772R, C787R, C791R	Hereditary cancer-predisposing syndrome	VCV002449992	16	2124216	16	2074215	2449992	2425949	rs2543812230	NC_000016.10:2074214:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2372G>A (p.Cys791Tyr)	TSC2	C754Y, C772Y, C257Y, C343Y, C742Y, C591Y, C637Y, C791Y, C821Y, C787Y, C802Y	Tuberous sclerosis 2	VCV002012047	16	2124217	16	2074216	2012047	2067424	rs758961134	NC_000016.10:2074215:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2372G>C (p.Cys791Ser)	TSC2	C591S, C742S, C754S, C791S, C802S	Tuberous sclerosis 2	VCV001007359	16	2124217	16	2074216	1007359	996723	rs758961134	NC_000016.10:2074215:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2372G>T (p.Cys791Phe)	TSC2	C791F, C742F, C802F, C591F, C754F	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000318322	16	2124217	16	2074216	318322	340859	rs758961134	NC_000016.10:2074215:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2373C>T (p.Cys791=)	TSC2		Tuberous sclerosis syndrome	VCV003074987	16	2124218	16	2074217	3074987	3234639	rs2088913508	NC_000016.10:2074216:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2374C>T (p.Leu792=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001790338	16	2124219	16	2074218	1790338	1845083	rs2543812488	NC_000016.10:2074217:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2375T>C (p.Leu792Pro)	TSC2	L792P, L743P, L803P, L592P, L755P	not provided	VCV000050157	16	2124220	16	2074219	50157	59319	rs137854241	NC_000016.10:2074218:T:C	single nucleotide variant	missense variant	Uncertain significance	May 29, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2376G>A (p.Leu792=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000643807	16	2124221	16	2074220	643807	644234	rs1596356233	NC_000016.10:2074219:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2377G>C (p.Glu793Gln)	TSC2	E345Q, E756Q, E823Q, E259Q, E593Q, E793Q, E639Q, E789Q, E744Q, E774Q, E804Q	Tuberous sclerosis 2	VCV002723921	16	2124222	16	2074221	2723921	2881833	rs1596356248	NC_000016.10:2074220:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2377G>A (p.Glu793Lys)	TSC2	E639K, E744K, E774K, E593K, E789K, E793K, E804K, E259K, E345K, E756K, E823K	Hereditary cancer-predisposing syndrome	VCV001790380	16	2124222	16	2074221	1790380	1845125	rs1596356248	NC_000016.10:2074220:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2377G>T (p.Glu793Ter)	TSC2	E593*, E793*, E756*, E804*, E744*	Tuberous sclerosis 2|not provided	VCV000817536	16	2124222	16	2074221	817536	805865	rs1596356248	NC_000016.10:2074220:G:T	single nucleotide variant	nonsense	Pathogenic	Aug 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2379G>T (p.Glu793Asp)	TSC2	E259D, E345D, E593D, E639D, E744D, E756D, E774D, E789D, E793D, E804D, E823D	Tuberous sclerosis syndrome	VCV003072573	16	2124224	16	2074223	3072573	3231014	rs2151347499	NC_000016.10:2074222:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2380C>A (p.Gln794Lys)	TSC2	Q346K, Q757K, Q790K, Q640K, Q775K, Q794K, Q805K, Q824K, Q260K, Q594K, Q745K	Hereditary cancer-predisposing syndrome	VCV001790436	16	2124225	16	2074224	1790436	1841337	rs45517233	NC_000016.10:2074223:C:A	single nucleotide variant	missense variant	Uncertain significance	May 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2380C>T (p.Gln794Ter)	TSC2	Q794*, Q594*, Q757*, Q805*, Q745*	not provided	VCV000049583	16	2124225	16	2074224	49583	58745	rs45517233	NC_000016.10:2074223:C:T	single nucleotide variant	nonsense	Pathogenic	Apr 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2381A>G (p.Gln794Arg)	TSC2	Q757R, Q594R, Q794R, Q805R, Q745R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001450989	16	2124226	16	2074225	1450989	1351510	rs2151347628	NC_000016.10:2074224:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2382G>A (p.Gln794=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000807948	16	2124227	16	2074226	807948	797274	rs778138047	NC_000016.10:2074225:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2383G>T (p.Gly795Cys)	TSC2	G758C, G795C, G347C, G595C, G641C, G776C, G261C, G746C, G791C, G806C, G825C	Hereditary cancer-predisposing syndrome	VCV003974653	16	2124228	16	2074227	3974653	4086476		NC_000016.10:2074226:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2384G>A (p.Gly795Asp)	TSC2	G795D, G746D, G806D, G595D, G758D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000535855	16	2124229	16	2074228	535855	529656	rs1555507503	NC_000016.10:2074227:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2385C>T (p.Gly795=)	TSC2		Tuberous sclerosis 2	VCV002839753	16	2124230	16	2074229	2839753	2993190	rs2151347924	NC_000016.10:2074228:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2386C>G (p.Leu796Val)	TSC2	L759V, L596V, L796V, L747V, L807V	Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000650089	16	2124231	16	2074230	650089	644235	rs1596356291	NC_000016.10:2074229:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2387T>G (p.Leu796Arg)	TSC2	L826R, L348R, L596R, L747R, L777R, L796R, L759R, L792R, L262R, L642R, L807R	not provided|Tuberous sclerosis 2	VCV002006441	16	2124232	16	2074231	2006441	2069535	rs2151348106	NC_000016.10:2074230:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2388C>T (p.Leu796=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002034174	16	2124233	16	2074232	2034174	2093380	rs2151348171	NC_000016.10:2074231:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2388C>A (p.Leu796=)	TSC2		Tuberous sclerosis 2	VCV001573833	16	2124233	16	2074232	1573833	1539037	rs2151348171	NC_000016.10:2074231:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2389A>C (p.Ile797Leu)	TSC2	I793L, I797L, I597L, I643L, I263L, I760L, I778L, I349L, I748L, I808L, I827L	Tuberous sclerosis 2	VCV002766356	16	2124234	16	2074233	2766356	2928819	rs1240217406	NC_000016.10:2074232:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2389A>T (p.Ile797Phe)	TSC2	I597F, I748F, I760F, I797F, I808F	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001004676	16	2124234	16	2074233	1004676	996724	rs1240217406	NC_000016.10:2074232:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2389A>G (p.Ile797Val)	TSC2	I597V, I760V, I808V, I748V, I797V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000942158	16	2124234	16	2074233	942158	937306	rs1240217406	NC_000016.10:2074232:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2390T>A (p.Ile797Asn)	TSC2	I748N, I760N, I349N, I597N, I778N, I808N, I827N, I263N, I643N, I793N, I797N	Tuberous sclerosis 2	VCV002820937	16	2124235	16	2074234	2820937	2978182	rs2088916279	NC_000016.10:2074233:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2390T>C (p.Ile797Thr)	TSC2	I597T, I748T, I808T, I760T, I797T	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000856887	16	2124235	16	2074234	856887	843418	rs2088916279	NC_000016.10:2074233:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2391C>T (p.Ile797=)	TSC2		Tuberous sclerosis 2	VCV002036667	16	2124236	16	2074235	2036667	2101034	rs2543814041	NC_000016.10:2074234:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2392C>T (p.His798Tyr)	TSC2	H798Y, H598Y, H749Y, H761Y, H809Y	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405980	16	2124237	16	2074236	405980	400844	rs375809212	NC_000016.10:2074235:C:T	single nucleotide variant	missense variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2393A>G (p.His798Arg)	TSC2	H598R, H761R, H794R, H350R, H749R, H264R, H644R, H779R, H798R, H809R, H828R	Hereditary cancer-predisposing syndrome	VCV003974634	16	2124238	16	2074237	3974634	4086457		NC_000016.10:2074236:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2394C>T (p.His798=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000779500	16	2124239	16	2074238	779500	714797	rs547019464	NC_000016.10:2074237:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2395C>T (p.Arg799Cys)	TSC2	R799C, R599C, R810C, R750C, R762C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000467940	16	2124240	16	2074239	467940	466141	rs1366556255	NC_000016.10:2074238:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2396G>T (p.Arg799Leu)	TSC2	R645L, R762L, R799L, R265L, R351L, R599L, R829L, R750L, R780L, R795L, R810L	Hereditary cancer-predisposing syndrome	VCV003811370	16	2124241	16	2074240	3811370	3928611		NC_000016.10:2074239:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2396G>A (p.Arg799His)	TSC2	R799H, R599H, R762H, R810H, R750H	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000576227	16	2124241	16	2074240	576227	569718	rs1567474646	NC_000016.10:2074239:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2397C>G (p.Arg799=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002454984	16	2124242	16	2074241	2454984	2430733	rs2151348621	NC_000016.10:2074240:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2397C>T (p.Arg799=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001085400	16	2124242	16	2074241	1085400	1081815	rs2151348621	NC_000016.10:2074240:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2398T>C (p.Cys800Arg)	TSC2	C600R, C751R, C763R, C800R, C811R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001010133	16	2124243	16	2074242	1010133	996725	rs776930735	NC_000016.10:2074241:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2399G>C (p.Cys800Ser)	TSC2	C600S, C751S, C800S, C763S, C811S	Tuberous sclerosis 2	VCV000652438	16	2124244	16	2074243	652438	644236	rs746044783	NC_000016.10:2074242:G:C	single nucleotide variant	missense variant	Benign	Aug 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2399G>A (p.Cys800Tyr)	TSC2	C800Y, C763Y, C811Y, C600Y, C751Y	Tuberous sclerosis 2	VCV000406043	16	2124244	16	2074243	406043	401497	rs746044783	NC_000016.10:2074242:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2401G>A (p.Ala801Thr)	TSC2	A353T, A764T, A831T, A812T, A752T, A801T, A267T, A601T, A647T, A782T, A797T	Tuberous sclerosis 2	VCV002135181	16	2124246	16	2074245	2135181	2190589	rs2543815021	NC_000016.10:2074244:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2403C>T (p.Ala801=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001790762	16	2124248	16	2074247	1790762	1841663	rs2151348876	NC_000016.10:2074246:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2404A>G (p.Ser802Gly)	TSC2	S802G, S602G, S753G, S765G, S813G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome	VCV000406060	16	2124249	16	2074248	406060	400727	rs200929621	NC_000016.10:2074247:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2405G>C (p.Ser802Thr)	TSC2	S602T, S753T, S765T, S802T, S813T	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000995666	16	2124250	16	2074249	995666	981953	rs1015629239	NC_000016.10:2074248:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2405G>A (p.Ser802Asn)	TSC2	S802N, S765N, S753N, S813N, S602N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000567273	16	2124250	16	2074249	567273	573819	rs1015629239	NC_000016.10:2074248:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2406C>T (p.Ser802=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001790799	16	2124251	16	2074250	1790799	1841700	rs1051621	NC_000016.10:2074249:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2407C>T (p.Gln803Ter)	TSC2	Q803*, Q603*, Q754*, Q766*, Q814*	Tuberous sclerosis 2	VCV000049207	16	2124252	16	2074251	49207	58369	rs45517234	NC_000016.10:2074250:C:T	single nucleotide variant	nonsense	Pathogenic	Feb 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2408A>C (p.Gln803Pro)	TSC2	Q269P, Q355P, Q603P, Q649P, Q754P, Q766P, Q784P, Q799P, Q803P, Q814P, Q833P	Hereditary cancer-predisposing syndrome	VCV003232115	16	2124253	16	2074252	3232115	3385655	rs2151349126	NC_000016.10:2074251:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2408A>G (p.Gln803Arg)	TSC2	Q269R, Q803R, Q833R, Q355R, Q603R, Q754R, Q784R, Q814R, Q799R, Q649R, Q766R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001790824	16	2124253	16	2074252	1790824	1851185	rs2151349126	NC_000016.10:2074251:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2409G>A (p.Gln803=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002793589	16	2124254	16	2074253	2793589	2950836	rs1400548727	NC_000016.10:2074252:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2409G>C (p.Gln803His)	TSC2	Q603H, Q754H, Q766H, Q803H, Q814H	Tuberous sclerosis 2	VCV001002838	16	2124254	16	2074253	1002838	996726	rs1400548727	NC_000016.10:2074252:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2409G>T (p.Gln803His)	TSC2	Q803H, Q754H, Q766H, Q603H, Q814H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000581380	16	2124254	16	2074253	581380	569728	rs1400548727	NC_000016.10:2074252:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2410T>C (p.Cys804Arg)	TSC2	C804R, C767R, C815R, C604R, C755R	not provided|Tuberous sclerosis 2	VCV000049725	16	2124255	16	2074254	49725	58887	rs137853995	NC_000016.10:2074253:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2412C>A (p.Cys804Ter)	TSC2	C815*, C604*, C755*, C767*, C804*	Tuberous sclerosis 2	VCV001452824	16	2124257	16	2074256	1452824	1431967	rs763123951	NC_000016.10:2074255:C:A	single nucleotide variant	nonsense	Pathogenic	Feb 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2412C>T (p.Cys804=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000467941	16	2124257	16	2074256	467941	465838	rs763123951	NC_000016.10:2074255:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2413G>A (p.Val805Ile)	TSC2	V805I, V605I, V756I, V768I, V816I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000570600	16	2124258	16	2074257	570600	570091	rs768683470	NC_000016.10:2074256:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2415C>A (p.Val805=)	TSC2		Tuberous sclerosis 2	VCV002702781	16	2124260	16	2074259	2702781	2866332	rs45517235	NC_000016.10:2074258:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2415C>T (p.Val805=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000049726	16	2124260	16	2074259	49726	58888	rs45517235	NC_000016.10:2074258:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2416G>T (p.Val806Leu)	TSC2	V769L, V806L, V836L, V272L, V606L, V652L, V358L, V787L, V817L, V757L, V802L	Tuberous sclerosis 2	VCV002141691	16	2124261	16	2074260	2141691	1869226	rs796053473	NC_000016.10:2074259:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2416G>A (p.Val806Met)	TSC2	V806M, V817M, V769M, V757M, V606M	not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome	VCV000207671	16	2124261	16	2074260	207671	203144	rs796053473	NC_000016.10:2074259:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2417T>C (p.Val806Ala)	TSC2	V606A, V806A, V817A, V757A, V769A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000655026	16	2124262	16	2074261	655026	644237	rs1285249923	NC_000016.10:2074260:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2418G>A (p.Val806=)	TSC2		Tuberous sclerosis 2	VCV001533554	16	2124263	16	2074262	1533554	1530694	rs2151349705	NC_000016.10:2074261:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2419G>A (p.Ala807Thr)	TSC2	A758T, A818T, A837T, A273T, A770T, A788T, A803T, A359T, A607T, A653T, A807T	Hereditary cancer-predisposing syndrome	VCV003811380	16	2124264	16	2074263	3811380	3928621		NC_000016.10:2074262:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2420C>T (p.Ala807Val)	TSC2	A273V, A607V, A788V, A807V, A818V, A837V, A359V, A758V, A803V, A653V, A770V	Tuberous sclerosis 2	VCV002710052	16	2124265	16	2074264	2710052	2874950	rs2151349821	NC_000016.10:2074263:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2421C>A (p.Ala807=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002497448	16	2124266	16	2074265	2497448	2472531	rs1060504089	NC_000016.10:2074264:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2421C>T (p.Ala807=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413640	16	2124266	16	2074265	413640	401258	rs1060504089	NC_000016.10:2074264:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2422T>A (p.Leu808Met)	TSC2	L360M, L759M, L804M, L808M, L789M, L819M, L274M, L608M, L654M, L771M, L838M	Hereditary cancer-predisposing syndrome	VCV003462667	16	2124267	16	2074266	3462667	3621686		NC_000016.10:2074265:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2422T>C (p.Leu808=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001791042	16	2124267	16	2074266	1791042	1851403	rs2088922499	NC_000016.10:2074265:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2423T>C (p.Leu808Ser)	TSC2	L808S, L759S, L608S, L771S, L819S	Tuberous sclerosis 2	VCV000049587	16	2124268	16	2074267	49587	58749	rs45489791	NC_000016.10:2074266:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2424G>C (p.Leu808Phe)	TSC2	L360F, L819F, L838F, L771F, L789F, L804F, L274F, L759F, L808F, L608F, L654F	Hereditary cancer-predisposing syndrome	VCV001791064	16	2124269	16	2074268	1791064	1851425	rs796053489	NC_000016.10:2074267:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2424G>T (p.Leu808Phe)	TSC2	L808F, L759F, L608F, L771F, L819F	not provided|Hereditary cancer-predisposing syndrome	VCV000207730	16	2124269	16	2074268	207730	203145	rs796053489	NC_000016.10:2074267:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2425T>G (p.Ser809Ala)	TSC2	S760A, S772A, S820A, S609A, S839A, S275A, S655A, S805A, S809A, S361A, S790A	Hereditary cancer-predisposing syndrome	VCV002449996	16	2124270	16	2074269	2449996	2425953	rs2151350123	NC_000016.10:2074268:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2426C>A (p.Ser809Tyr)	TSC2	S809Y, S820Y, S760Y, S772Y, S609Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001395264	16	2124271	16	2074270	1395264	1412278	rs2151350205	NC_000016.10:2074269:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2427C>T (p.Ser809=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000064860	16	2124272	16	2074271	64860	75789	rs182849638	NC_000016.10:2074270:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2428A>G (p.Ile810Val)	TSC2	I610V, I761V, I773V, I810V, I821V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001019581	16	2124273	16	2074272	1019581	1011962	rs1196792438	NC_000016.10:2074271:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2430C>T (p.Ile810=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974632	16	2124275	16	2074274	3974632	4086455		NC_000016.10:2074273:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Apr 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2431T>G (p.Cys811Gly)	TSC2	C774G, C822G, C611G, C657G, C762G, C811G, C841G, C363G, C792G, C277G, C807G	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV002893681	16	2124276	16	2074275	2893681	3049067	rs2151350705	NC_000016.10:2074274:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2432G>A (p.Cys811Tyr)	TSC2	C611Y, C774Y, C792Y, C277Y, C363Y, C657Y, C807Y, C822Y, C841Y, C762Y, C811Y	Tuberous sclerosis 2	VCV003697559	16	2124277	16	2074276	3697559	3833044		NC_000016.10:2074275:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2433C>T (p.Cys811=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000766731	16	2124278	16	2074277	766731	770707	rs1596356520	NC_000016.10:2074276:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2434A>G (p.Ser812Gly)	TSC2	S278G, S364G, S775G, S808G, S842G, S823G, S658G, S763G, S612G, S793G, S812G	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002191484	16	2124279	16	2074278	2191484	1931927	rs2151350854	NC_000016.10:2074277:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2436C>T (p.Ser812=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000237990	16	2124281	16	2074280	237990	242256	rs767178958	NC_000016.10:2074279:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2437G>T (p.Val813Leu)	TSC2	V613L, V764L, V776L, V813L, V824L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692488	16	2124282	16	2074281	1692488	1684928	rs375030314	NC_000016.10:2074280:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2437G>A (p.Val813Met)	TSC2	V813M, V764M, V776M, V613M, V824M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000467942	16	2124282	16	2074281	467942	465936	rs375030314	NC_000016.10:2074280:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2439G>A (p.Val813=)	TSC2		Tuberous sclerosis 2	VCV001471823	16	2124284	16	2074283	1471823	1388850	rs2151351167	NC_000016.10:2074282:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2440G>C (p.Glu814Gln)	TSC2	E280Q, E614Q, E777Q, E366Q, E765Q, E795Q, E825Q, E810Q, E844Q, E660Q, E814Q	Tuberous sclerosis 2	VCV002735318	16	2124285	16	2074284	2735318	2901343	rs45485395	NC_000016.10:2074283:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2440G>T (p.Glu814Ter)	TSC2	E765*, E777*, E825*, E614*, E814*	Tuberous sclerosis 2	VCV000645592	16	2124285	16	2074284	645592	644238	rs45485395	NC_000016.10:2074283:G:T	single nucleotide variant	nonsense	Pathogenic	Nov 6, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2441A>C (p.Glu814Ala)	TSC2	E280A, E366A, E795A, E810A, E660A, E825A, E777A, E844A, E614A, E765A, E814A	Tuberous sclerosis 2	VCV002184533	16	2124286	16	2074285	2184533	1921041	rs2151351285	NC_000016.10:2074284:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2443A>G (p.Met815Val)	TSC2	M367V, M661V, M796V, M815V, M281V, M766V, M826V, M845V, M615V, M778V, M811V	Tuberous sclerosis 2	VCV002756916	16	2124288	16	2074287	2756916	2920687	rs2151351428	NC_000016.10:2074286:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2443A>T (p.Met815Leu)	TSC2	M281L, M367L, M615L, M661L, M766L, M778L, M796L, M811L, M815L, M826L, M845L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV002429581	16	2124288	16	2074287	2429581	2403079	rs2151351428	NC_000016.10:2074286:A:T	single nucleotide variant	missense variant	Uncertain significance	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2444T>A (p.Met815Lys)	TSC2	M281K, M367K, M615K, M661K, M766K, M778K, M796K, M811K, M815K, M826K, M845K	Tuberous sclerosis 2	VCV001716679	16	2124289	16	2074288	1716679	1778360	rs2543819692	NC_000016.10:2074287:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2445G>C (p.Met815Ile)	TSC2	M281I, M615I, M661I, M796I, M826I, M367I, M766I, M778I, M815I, M811I, M845I	Hereditary cancer-predisposing syndrome	VCV001791384	16	2124290	16	2074289	1791384	1848204	rs1203344843	NC_000016.10:2074288:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2445G>T (p.Met815Ile)	TSC2	M815I, M615I, M826I, M778I, M766I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000834126	16	2124290	16	2074289	834126	843419	rs1203344843	NC_000016.10:2074288:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2446C>A (p.Pro816Thr)	TSC2	P827T, P767T, P816T, P616T, P779T	Tuberous sclerosis 2	VCV001517242	16	2124291	16	2074290	1517242	1515402	rs760265207	NC_000016.10:2074289:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2446C>T (p.Pro816Ser)	TSC2	P616S, P767S, P779S, P816S, P827S	Tuberous sclerosis 2	VCV001063987	16	2124291	16	2074290	1063987	1049439	rs760265207	NC_000016.10:2074289:C:T	single nucleotide variant	missense variant	Benign	Aug 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2446C>G (p.Pro816Ala)	TSC2	P816A, P827A, P616A, P779A, P767A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467943	16	2124291	16	2074290	467943	466143	rs760265207	NC_000016.10:2074289:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2447C>T (p.Pro816Leu)	TSC2	P816L, P827L, P616L, P767L, P779L	not provided|Tuberous sclerosis 2	VCV000050182	16	2124292	16	2074291	50182	59344	rs45517236	NC_000016.10:2074290:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2449G>A (p.Asp817Asn)	TSC2	D369N, D817N, D828N, D847N, D283N, D617N, D663N, D798N, D768N, D780N, D813N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001943093	16	2124294	16	2074293	1943093	1998081	rs2151351717	NC_000016.10:2074292:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2450A>C (p.Asp817Ala)	TSC2	D283A, D369A, D768A, D813A, D847A, D617A, D663A, D817A, D828A, D780A, D798A	Tuberous sclerosis 2	VCV002844529	16	2124295	16	2074294	2844529	3008170	rs2543820164	NC_000016.10:2074293:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2451C>T (p.Asp817=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000064991	16	2124296	16	2074295	64991	75921	rs201442542	NC_000016.10:2074294:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2452A>G (p.Ile818Val)	TSC2	I818V, I618V, I769V, I781V, I829V	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000661721	16	2124297	16	2074296	661721	644239	rs1596356585	NC_000016.10:2074295:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2453T>C (p.Ile818Thr)	TSC2	I781T, I618T, I818T, I769T, I829T	Tuberous sclerosis 2	VCV001461347	16	2124298	16	2074297	1461347	1498178	rs2151352015	NC_000016.10:2074296:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2453T>A (p.Ile818Asn)	TSC2	I618N, I769N, I781N, I818N, I829N	Tuberous sclerosis 2	VCV001051177	16	2124298	16	2074297	1051177	1049440	rs2151352015	NC_000016.10:2074296:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2454C>G (p.Ile818Met)	TSC2	I769M, I814M, I618M, I664M, I829M, I370M, I781M, I799M, I284M, I818M, I848M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002982502	16	2124299	16	2074298	2982502	3149223	rs786201599	NC_000016.10:2074297:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2454C>T (p.Ile818=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184659	16	2124299	16	2074298	184659	184132	rs786201599	NC_000016.10:2074297:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2455A>G (p.Ile819Val)	TSC2	I619V, I782V, I819V, I830V, I770V	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001525824	16	2124300	16	2074299	1525824	1395880	rs1426302691	NC_000016.10:2074298:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2456T>G (p.Ile819Ser)	TSC2	I285S, I665S, I770S, I815S, I849S, I782S, I800S, I371S, I619S, I819S, I830S	Hereditary cancer-predisposing syndrome	VCV003974659	16	2124301	16	2074300	3974659	4086482		NC_000016.10:2074299:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2457C>T (p.Ile819=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000467944	16	2124302	16	2074301	467944	465937	rs753410949	NC_000016.10:2074300:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2458A>C (p.Ile820Leu)	TSC2	I620L, I771L, I783L, I820L, I831L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001039652	16	2124303	16	2074302	1039652	1032452	rs754451657	NC_000016.10:2074301:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 10, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2458A>G (p.Ile820Val)	TSC2	I620V, I783V, I831V, I820V, I771V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000949937	16	2124303	16	2074302	949937	927650	rs754451657	NC_000016.10:2074301:A:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2460C>T (p.Ile820=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001699790	16	2124305	16	2074304	1699790	1692162	rs2151352359	NC_000016.10:2074303:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2461A>G (p.Lys821Glu)	TSC2	K287E, K373E, K802E, K817E, K821E, K772E, K851E, K621E, K667E, K784E, K832E	Tuberous sclerosis 2	VCV003675960	16	2124306	16	2074305	3675960	3813576		NC_000016.10:2074304:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2464G>A (p.Ala822Thr)	TSC2	A622T, A773T, A822T, A833T, A785T	Tuberous sclerosis 2	VCV001475118	16	2124309	16	2074308	1475118	1404028	rs2151352584	NC_000016.10:2074307:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2465C>A (p.Ala822Glu)	TSC2	A288E, A773E, A803E, A852E, A818E, A833E, A622E, A668E, A374E, A785E, A822E	Hereditary cancer-predisposing syndrome	VCV003462631	16	2124310	16	2074309	3462631	3621650		NC_000016.10:2074308:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2465C>T (p.Ala822Val)	TSC2	A822V, A785V, A773V, A833V, A622V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406081	16	2124310	16	2074309	406081	400848	rs936484229	NC_000016.10:2074308:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2466G>T (p.Ala822=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564734	16	2124311	16	2074310	2564734	2733890	rs141728350	NC_000016.10:2074309:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2466G>C (p.Ala822=)	TSC2		Tuberous sclerosis 2	VCV002032792	16	2124311	16	2074310	2032792	2079154	rs141728350	NC_000016.10:2074309:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2466G>A (p.Ala822=)	TSC2		Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000467945	16	2124311	16	2074310	467945	465290	rs141728350	NC_000016.10:2074309:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2467C>G (p.Leu823Val)	TSC2	L669V, L774V, L786V, L804V, L819V, L823V, L375V, L289V, L623V, L834V, L853V	Hereditary cancer-predisposing syndrome	VCV001791703	16	2124312	16	2074311	1791703	1845136	rs554509064	NC_000016.10:2074310:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2467C>T (p.Leu823=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000467946	16	2124312	16	2074311	467946	466148	rs554509064	NC_000016.10:2074310:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2468T>A (p.Leu823Gln)	TSC2	L289Q, L375Q, L623Q, L669Q, L774Q, L786Q, L804Q, L819Q, L823Q, L834Q, L853Q	TSC2-related disorder	VCV002635392	16	2124313	16	2074312	2635392	2799397	rs2151352777	NC_000016.10:2074311:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2469G>T (p.Leu823=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232116	16	2124314	16	2074313	3232116	3385656	rs2151352856	NC_000016.10:2074312:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2469G>C (p.Leu823=)	TSC2		Tuberous sclerosis 2	VCV002954719	16	2124314	16	2074313	2954719	3115073	rs2151352856	NC_000016.10:2074312:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2469G>A (p.Leu823=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001634304	16	2124314	16	2074313	1634304	1632391	rs2151352856	NC_000016.10:2074312:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2470C>T (p.Pro824Ser)	TSC2	P824S, P835S, P775S, P624S, P787S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000646188	16	2124315	16	2074314	646188	644240	rs1596356675	NC_000016.10:2074313:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2471C>T (p.Pro824Leu)	TSC2	P624L, P775L, P820L, P835L, P854L, P787L, P824L, P290L, P376L, P670L, P805L	Tuberous sclerosis 2	VCV001962961	16	2124316	16	2074315	1962961	2020512	rs940077353	NC_000016.10:2074314:C:T	single nucleotide variant	missense variant	Uncertain significance	May 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2471C>G (p.Pro824Arg)	TSC2	P624R, P787R, P824R, P376R, P670R, P820R, P854R, P805R, P290R, P775R, P835R	Hereditary cancer-predisposing syndrome	VCV001791787	16	2124316	16	2074315	1791787	1845220	rs940077353	NC_000016.10:2074314:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2471C>A (p.Pro824His)	TSC2	P290H, P624H, P670H, P824H, P854H, P376H, P805H, P787H, P835H, P775H, P820H	Hereditary cancer-predisposing syndrome|not provided	VCV001791785	16	2124316	16	2074315	1791785	1845218	rs940077353	NC_000016.10:2074314:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2472T>C (p.Pro824=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000821346	16	2124317	16	2074316	821346	812547	rs1596356689	NC_000016.10:2074315:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2473G>T (p.Val825Phe)	TSC2	V625F, V788F, V836F, V776F, V825F	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001479007	16	2124318	16	2074317	1479007	1426378	rs149860212	NC_000016.10:2074316:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2473G>A (p.Val825Ile)	TSC2	V825I, V776I, V836I, V788I, V625I	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000572501	16	2124318	16	2074317	572501	573820	rs149860212	NC_000016.10:2074316:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2473G>C (p.Val825Leu)	TSC2	V825L, V625L, V836L, V776L, V788L	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000405987	16	2124318	16	2074317	405987	400733	rs149860212	NC_000016.10:2074316:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2475T>G (p.Val825=)	TSC2		Tuberous sclerosis 2	VCV002851951	16	2124320	16	2074319	2851951	3016279	rs2088932822	NC_000016.10:2074318:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2475T>C (p.Val825=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001791835	16	2124320	16	2074319	1791835	1845268	rs2088932822	NC_000016.10:2074318:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2476C>T (p.Leu826=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000772965	16	2124321	16	2074320	772965	703551	rs45517238	NC_000016.10:2074319:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2476C>G (p.Leu826Val)	TSC2	L626V, L777V, L789V, L826V, L837V	Tuberous sclerosis 2	VCV000640596	16	2124321	16	2074320	640596	644241	rs45517238	NC_000016.10:2074319:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2476C>A (p.Leu826Met)	TSC2	L826M, L837M, L626M, L777M, L789M	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome	VCV000041732	16	2124321	16	2074320	41732	50171	rs45517238	NC_000016.10:2074319:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2477T>C (p.Leu826Pro)	TSC2	L826P, L626P, L777P, L789P, L837P	Tuberous sclerosis 2	VCV000049751	16	2124322	16	2074321	49751	58913	rs45517239	NC_000016.10:2074320:T:C	single nucleotide variant	missense variant	Likely pathogenic	Oct 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2478G>A (p.Leu826=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001791862	16	2124323	16	2074322	1791862	1845295	rs1398112464	NC_000016.10:2074321:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 13, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2478G>C (p.Leu826=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001557898	16	2124323	16	2074322	1557898	1540917	rs1398112464	NC_000016.10:2074321:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2479G>A (p.Val827Met)	TSC2	V827M, V627M, V778M, V790M, V838M	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000626040	16	2124324	16	2074323	626040	614418	rs543738044	NC_000016.10:2074322:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2480T>C (p.Val827Ala)	TSC2	V827A, V673A, V838A, V293A, V790A, V808A, V823A, V857A, V379A, V627A, V778A	Tuberous sclerosis 2	VCV003669443	16	2124325	16	2074324	3669443	3796719		NC_000016.10:2074323:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2481G>C (p.Val827=)	TSC2		Tuberous sclerosis 2	VCV003681505	16	2124326	16	2074325	3681505	3811526		NC_000016.10:2074324:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2481G>A (p.Val827=)	TSC2		Tuberous sclerosis 2	VCV000641728	16	2124326	16	2074325	641728	644242	rs1046589212	NC_000016.10:2074324:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2482G>A (p.Val828Met)	TSC2	V828M, V791M, V839M, V779M, V628M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000581316	16	2124327	16	2074326	581316	569736	rs150178524	NC_000016.10:2074325:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2484G>A (p.Val828=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000467947	16	2124329	16	2074328	467947	465842	rs780395534	NC_000016.10:2074327:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2486A>C (p.Lys829Thr)	TSC2	K829T, K780T, K629T, K840T, K792T	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000432979	16	2124331	16	2074330	432979	426152	rs1555507617	NC_000016.10:2074329:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2487G>T (p.Lys829Asn)	TSC2	K629N, K792N, K829N, K780N, K295N, K381N, K825N, K840N, K675N, K810N, K859N	Tuberous sclerosis 2	VCV003637204	16	2124332	16	2074331	3637204	3771358		NC_000016.10:2074330:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2487G>C (p.Lys829Asn)	TSC2	K629N, K780N, K792N, K829N, K840N	not provided	VCV001186986	16	2124332	16	2074331	1186986	1177965	rs749431392	NC_000016.10:2074330:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2488C>T (p.Leu830Phe)	TSC2	L793F, L781F, L830F, L841F, L630F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000651466	16	2124333	16	2074332	651466	644243	rs1596356808	NC_000016.10:2074331:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2490C>G (p.Leu830=)	TSC2		Hereditary cancer-predisposing syndrome|not provided	VCV001186068	16	2124335	16	2074334	1186068	1177966	rs768573698	NC_000016.10:2074333:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2490C>T (p.Leu830=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000231902	16	2124335	16	2074334	231902	235113	rs768573698	NC_000016.10:2074333:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2491A>C (p.Thr831Pro)	TSC2	T677P, T297P, T631P, T794P, T861P, T782P, T812P, T827P, T831P, T842P, T383P	Tuberous sclerosis 2	VCV002834590	16	2124336	16	2074335	2834590	2991857	rs2151353949	NC_000016.10:2074334:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2492C>T (p.Thr831Met)	TSC2	T631M, T782M, T794M, T831M, T842M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001015115	16	2124337	16	2074336	1015115	1011963	rs774380711	NC_000016.10:2074335:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2492C>A (p.Thr831Lys)	TSC2	T842K, T631K, T794K, T782K, T831K	Tuberous sclerosis 2	VCV000947574	16	2124337	16	2074336	947574	927651	rs774380711	NC_000016.10:2074335:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2493G>T (p.Thr831=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001535457	16	2124338	16	2074337	1535457	1595912	rs773645613	NC_000016.10:2074336:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2493G>A (p.Thr831=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000821359	16	2124338	16	2074337	821359	812548	rs773645613	NC_000016.10:2074336:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2494C>T (p.His832Tyr)	TSC2	H632Y, H795Y, H843Y, H783Y, H832Y	Tuberous sclerosis 2	VCV000953745	16	2124339	16	2074338	953745	949243	rs2088939242	NC_000016.10:2074337:C:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2495A>T (p.His832Leu)	TSC2	H832L, H384L, H862L, H298L, H632L, H813L, H828L, H843L, H678L, H783L, H795L	Tuberous sclerosis 2	VCV002066190	16	2124340	16	2074339	2066190	2128875	rs2151354325	NC_000016.10:2074338:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2496C>T (p.His832=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000760177	16	2124341	16	2074340	760177	770708	rs1225070343	NC_000016.10:2074339:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2497A>T (p.Ile833Phe)	TSC2	I784F, I299F, I385F, I844F, I796F, I829F, I833F, I633F, I679F, I814F, I863F	Tuberous sclerosis 2	VCV002861492	16	2124342	16	2074341	2861492	3018967	rs2151354485	NC_000016.10:2074340:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2497A>G (p.Ile833Val)	TSC2	I633V, I833V, I784V, I796V, I844V	Tuberous sclerosis 2	VCV001448335	16	2124342	16	2074341	1448335	1400346	rs2151354485	NC_000016.10:2074340:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2499C>T (p.Ile833=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002755850	16	2124344	16	2074343	2755850	2917022	rs2151354582	NC_000016.10:2074342:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2499C>G (p.Ile833Met)	TSC2	I299M, I385M, I679M, I833M, I784M, I796M, I844M, I633M, I814M, I829M, I863M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002449975	16	2124344	16	2074343	2449975	2429600	rs2151354582	NC_000016.10:2074342:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2500T>A (p.Ser834Thr)	TSC2	S680T, S785T, S815T, S300T, S386T, S634T, S834T, S864T, S797T, S830T, S845T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002140762	16	2124345	16	2074344	2140762	1875260	rs2543825208	NC_000016.10:2074343:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2501C>G (p.Ser834Ter)	TSC2	S834*, S634*, S785*, S797*, S845*	Tuberous sclerosis 2	VCV000803151	16	2124346	16	2074345	803151	791535	rs1596356898	NC_000016.10:2074344:C:G	single nucleotide variant	nonsense	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2502A>T (p.Ser834=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002156321	16	2124347	16	2074346	2156321	1885993	rs2151354707	NC_000016.10:2074345:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2502A>G (p.Ser834=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001612719	16	2124347	16	2074346	1612719	1601802	rs2151354707	NC_000016.10:2074345:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2503G>T (p.Ala835Ser)	TSC2	A835S, A635S, A786S, A798S, A846S	Tuberous sclerosis 2	VCV001359040	16	2124348	16	2074347	1359040	1357317	rs2151354761	NC_000016.10:2074346:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2504C>A (p.Ala835Asp)	TSC2	A786D, A865D, A301D, A387D, A635D, A681D, A798D, A816D, A835D, A831D, A846D	Tuberous sclerosis 2	VCV003637205	16	2124349	16	2074348	3637205	3771359		NC_000016.10:2074347:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2504C>T (p.Ala835Val)	TSC2	A846V, A635V, A798V, A831V, A865V, A387V, A786V, A816V, A301V, A681V, A835V	Hereditary cancer-predisposing syndrome	VCV001792292	16	2124349	16	2074348	1792292	1841880	rs761588986	NC_000016.10:2074347:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2505C>T (p.Ala835=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001111798	16	2124350	16	2074349	1111798	1103641	rs1200802987	NC_000016.10:2074348:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2507C>T (p.Thr836Ile)	TSC2	T636I, T799I, T836I, T388I, T787I, T847I, T302I, T682I, T832I, T866I, T817I	not provided|Hereditary cancer-predisposing syndrome	VCV001792326	16	2124352	16	2074351	1792326	1841914	rs2088941589	NC_000016.10:2074350:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2508A>C (p.Thr836=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001692489	16	2124353	16	2074352	1692489	1684929	rs137854242	NC_000016.10:2074351:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2508A>T (p.Thr836=)	TSC2		Tuberous sclerosis 2	VCV000743664	16	2124353	16	2074352	743664	754992	rs137854242	NC_000016.10:2074351:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2510C>T (p.Ala837Val)	TSC2	A637V, A800V, A788V, A837V, A848V	Tuberous sclerosis 2	VCV001423393	16	2124355	16	2074354	1423393	1425672	rs139919040	NC_000016.10:2074353:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2510C>G (p.Ala837Gly)	TSC2	A837G, A800G, A788G, A848G, A637G	Tuberous sclerosis 2|TSC2-related disorder|Hereditary cancer-predisposing syndrome	VCV000467948	16	2124355	16	2074354	467948	465944	rs139919040	NC_000016.10:2074353:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2511C>G (p.Ala837=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000386564	16	2124356	16	2074355	386564	377215	rs145351030	NC_000016.10:2074354:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2512A>G (p.Ser838Gly)	TSC2	S304G, S390G, S638G, S684G, S789G, S801G, S819G, S834G, S838G, S849G, S868G	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV002679346	16	2124357	16	2074356	2679346	2836923	rs2151355156	NC_000016.10:2074355:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2515A>C (p.Met839Leu)	TSC2	M839L, M790L, M639L, M802L, M850L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000821387	16	2124360	16	2074359	821387	812549	rs876660457	NC_000016.10:2074358:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2515A>G (p.Met839Val)	TSC2	M839V, M850V, M639V, M790V, M802V	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000233517	16	2124360	16	2074359	233517	235114	rs876660457	NC_000016.10:2074358:A:G	single nucleotide variant	missense variant	Uncertain significance	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2518G>A (p.Ala840Thr)	TSC2	A640T, A791T, A803T, A840T, A851T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001055992	16	2124363	16	2074362	1055992	1049441	rs2151355372	NC_000016.10:2074361:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2520C>T (p.Ala840=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000237993	16	2124365	16	2074364	237993	242258	rs147683438	NC_000016.10:2074363:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2520C>G (p.Ala840=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000237992	16	2124365	16	2074364	237992	242257	rs147683438	NC_000016.10:2074363:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2521G>C (p.Val841Leu)	TSC2	V307L, V804L, V393L, V687L, V792L, V822L, V837L, V852L, V641L, V841L, V871L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001792553	16	2124366	16	2074365	1792553	1842140	rs549612492	NC_000016.10:2074364:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2521G>A (p.Val841Ile)	TSC2	V841I, V792I, V852I, V641I, V804I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|TSC2-related disorder|Tuberous sclerosis 2	VCV000237994	16	2124366	16	2074365	237994	242259	rs549612492	NC_000016.10:2074364:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2523C>A (p.Val841=)	TSC2		Tuberous sclerosis 2	VCV001660306	16	2124368	16	2074367	1660306	1575629	rs1364740785	NC_000016.10:2074366:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2523C>G (p.Val841=)	TSC2		Tuberous sclerosis 2	VCV001121496	16	2124368	16	2074367	1121496	1125055	rs1364740785	NC_000016.10:2074366:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 29, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2524C>G (p.Pro842Ala)	TSC2	P308A, P394A, P642A, P688A, P793A, P805A, P823A, P838A, P842A, P853A, P872A	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV003232117	16	2124369	16	2074368	3232117	3391918	rs1271366576	NC_000016.10:2074367:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2524C>T (p.Pro842Ser)	TSC2	P793S, P838S, P688S, P842S, P308S, P394S, P642S, P823S, P805S, P853S, P872S	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis	VCV002896860	16	2124369	16	2074368	2896860	3059788	rs1271366576	NC_000016.10:2074367:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2525C>G (p.Pro842Arg)	TSC2	P688R, P853R, P308R, P805R, P823R, P394R, P842R, P872R, P642R, P793R, P838R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002762234	16	2124370	16	2074369	2762234	2930730	rs2151355682	NC_000016.10:2074368:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2525C>T (p.Pro842Leu)	TSC2	P642L, P805L, P793L, P853L, P842L	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001398712	16	2124370	16	2074369	1398712	1427778	rs2151355682	NC_000016.10:2074368:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2526A>G (p.Pro842=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486621	16	2124371	16	2074370	486621	477346	rs753466189	NC_000016.10:2074369:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2527C>T (p.Leu843=)	TSC2		Tuberous sclerosis 2	VCV001114160	16	2124372	16	2074371	1114160	1103642	rs2151355813	NC_000016.10:2074370:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2528T>C (p.Leu843Pro)	TSC2	L843P, L794P, L806P, L854P, L643P	not provided|Tuberous sclerosis 2	VCV000387803	16	2124373	16	2074372	387803	374095	rs1057522911	NC_000016.10:2074371:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 27, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2529G>C (p.Leu843=)	TSC2		Tuberous sclerosis 2	VCV001149319	16	2124374	16	2074373	1149319	1145938	rs759108698	NC_000016.10:2074372:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 31, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2529G>T (p.Leu843=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000762683	16	2124374	16	2074373	762683	770709	rs759108698	NC_000016.10:2074372:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2530C>T (p.Leu844=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001611317	16	2124375	16	2074374	1611317	1650780	rs1596357053	NC_000016.10:2074373:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2530C>G (p.Leu844Val)	TSC2	L807V, L855V, L644V, L795V, L844V	Tuberous sclerosis 2	VCV000665930	16	2124375	16	2074374	665930	644244	rs1596357053	NC_000016.10:2074373:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2531T>A (p.Leu844Gln)	TSC2	L844Q, L855Q, L795Q, L644Q, L807Q	Tuberous sclerosis 2	VCV001043402	16	2124376	16	2074375	1043402	1032453	rs397515303	NC_000016.10:2074374:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2531T>C (p.Leu844Pro)	TSC2	L844P, L644P, L795P, L855P, L807P	Tuberous sclerosis 2	VCV000064921	16	2124376	16	2074375	64921	75851	rs397515303	NC_000016.10:2074374:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2532G>A (p.Leu844=)	TSC2		not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001694778	16	2124377	16	2074376	1694778	1687210	rs2151356150	NC_000016.10:2074375:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2533G>C (p.Glu845Gln)	TSC2	E311Q, E397Q, E645Q, E691Q, E796Q, E808Q, E826Q, E841Q, E845Q, E856Q, E875Q	Hereditary cancer-predisposing syndrome	VCV003232118	16	2124378	16	2074377	3232118	3391919	rs1466275499	NC_000016.10:2074376:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2534A>G (p.Glu845Gly)	TSC2	E845G, E645G, E796G, E808G, E856G	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not provided	VCV000406086	16	2124379	16	2074378	406086	400854	rs764608837	NC_000016.10:2074377:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2535G>A (p.Glu845=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001120291	16	2124380	16	2074379	1120291	1125056	rs2088947794	NC_000016.10:2074378:G:A	single nucleotide variant	synonymous variant	Likely benign	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2538C>G (p.Phe846Leu)	TSC2	F312L, F398L, F646L, F692L, F797L, F809L, F827L, F842L, F846L, F857L, F876L	not provided	VCV003908051	16	2124383	16	2074382	3908051	4023959		NC_000016.10:2074381:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2538C>A (p.Phe846Leu)	TSC2	F312L, F797L, F827L, F846L, F857L, F842L, F876L, F398L, F646L, F692L, F809L	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578793	16	2124383	16	2074382	3578793	3708215		NC_000016.10:2074381:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2538C>T (p.Phe846=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000795648	16	2124383	16	2074382	795648	785194	rs1360361868	NC_000016.10:2074381:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2539C>T (p.Leu847=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207672	16	2124384	16	2074383	207672	203147	rs377300009	NC_000016.10:2074382:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2541G>T (p.Leu847=)	TSC2		Tuberous sclerosis 2	VCV004071153	16	2124386	16	2074385	4071153	4185001		NC_000016.10:2074384:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2542T>A (p.Ser848Thr)	TSC2	S314T, S648T, S799T, S848T, S400T, S694T, S811T, S859T, S829T, S844T, S878T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002704809	16	2124387	16	2074386	2704809	2863221	rs2543829026	NC_000016.10:2074385:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2542T>C (p.Ser848Pro)	TSC2	S314P, S400P, S648P, S694P, S799P, S811P, S829P, S844P, S848P, S859P, S878P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001715781	16	2124387	16	2074386	1715781	1773726	rs2543829026	NC_000016.10:2074385:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2543C>G (p.Ser848Cys)	TSC2	S848C, S859C, S648C, S811C, S799C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000405977	16	2124388	16	2074387	405977	401503	rs1060500922	NC_000016.10:2074386:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2544C>T (p.Ser848=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329502	16	2124389	16	2074388	3329502	3489094		NC_000016.10:2074387:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2544C>A (p.Ser848=)	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001508906	16	2124389	16	2074388	1508906	1452023	rs2151356741	NC_000016.10:2074387:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Sep 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2545A>T (p.Thr849Ser)	TSC2	T800S, T812S, T845S, T860S, T695S, T830S, T849S, T879S, T315S, T401S, T649S	Tuberous sclerosis 2	VCV002837249	16	2124390	16	2074389	2837249	2999628	rs781713438	NC_000016.10:2074388:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545A>C (p.Thr849Pro)	TSC2	T401P, T845P, T315P, T649P, T800P, T849P, T695P, T812P, T830P, T860P, T879P	Tuberous sclerosis 2	VCV002068302	16	2124390	16	2074389	2068302	2125826	rs781713438	NC_000016.10:2074388:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545A>G (p.Thr849Ala)	TSC2	T849A, T800A, T812A, T860A, T649A	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000391969	16	2124390	16	2074389	391969	375175	rs781713438	NC_000016.10:2074388:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2545+1G>A	TSC2		Tuberous sclerosis 2|not provided	VCV002780314	16	2124391	16	2074390	2780314	2944054	rs2151356819	NC_000016.10:2074389:G:A	single nucleotide variant	splice donor variant	Pathogenic	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+2T>C	TSC2		Tuberous sclerosis 2	VCV000065351	16	2124392	16	2074391	65351	76285	rs397515262	NC_000016.10:2074390:T:C	single nucleotide variant	splice donor variant	Pathogenic	Mar 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+3G>C	TSC2		not specified	VCV003385299	16	2124393	16	2074392	3385299	3544441		NC_000016.10:2074391:G:C	single nucleotide variant	intron variant	Uncertain significance	Jan 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+3G>A	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000888041	16	2124393	16	2074392	888041	876635	rs2088950824	NC_000016.10:2074391:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2545+4A>G	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000975896	16	2124394	16	2074393	975896	964685	rs2088951100	NC_000016.10:2074392:A:G	single nucleotide variant	intron variant	Uncertain significance	Apr 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+5G>A	TSC2		Hereditary cancer-predisposing syndrome	VCV003811356	16	2124395	16	2074394	3811356	3928597		NC_000016.10:2074393:G:A	single nucleotide variant	intron variant	Uncertain significance	Mar 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+5G>C	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided	VCV000430442	16	2124395	16	2074394	430442	422079	rs1131691965	NC_000016.10:2074393:G:C	single nucleotide variant	intron variant	Likely pathogenic	Oct 31, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+6T>G	TSC2		Tuberous sclerosis 2	VCV000050073	16	2124396	16	2074395	50073	59235	rs45517245	NC_000016.10:2074394:T:G	single nucleotide variant	intron variant	Uncertain significance	Jul 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+7C>T	TSC2		Tuberous sclerosis 2	VCV001082472	16	2124397	16	2074396	1082472	1081816	rs1193769778	NC_000016.10:2074395:C:T	single nucleotide variant	intron variant	Likely benign	Jul 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+8C>T	TSC2		Tuberous sclerosis 2	VCV002833853	16	2124398	16	2074397	2833853	2998793	rs2151357001	NC_000016.10:2074396:C:T	single nucleotide variant	intron variant	Likely benign	Feb 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+9C>T	TSC2		Tuberous sclerosis 2	VCV000467949	16	2124399	16	2074398	467949	465850	rs369385105	NC_000016.10:2074397:C:T	single nucleotide variant	intron variant	Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+9C>G	TSC2		Tuberous sclerosis 2|not specified	VCV000256625	16	2124399	16	2074398	256625	255494	rs369385105	NC_000016.10:2074397:C:G	single nucleotide variant	intron variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+10C>G	TSC2		Tuberous sclerosis 2	VCV002728483	16	2124400	16	2074399	2728483	2886380	rs45517241	NC_000016.10:2074398:C:G	single nucleotide variant	intron variant	Likely benign	Dec 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+10C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000049625	16	2124400	16	2074399	49625	58787	rs45517241	NC_000016.10:2074398:C:T	single nucleotide variant	intron variant	Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+11G>T	TSC2		Tuberous sclerosis 2	VCV003711747	16	2124401	16	2074400	3711747	3837429		NC_000016.10:2074399:G:T	single nucleotide variant	intron variant	Likely benign	Jul 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+11G>A	TSC2		Tuberous sclerosis 2	VCV001632642	16	2124401	16	2074400	1632642	1631168	rs768787639	NC_000016.10:2074399:G:A	single nucleotide variant	intron variant	Likely benign	Sep 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+12C>T	TSC2		Tuberous sclerosis 2	VCV002413341	16	2124402	16	2074401	2413341	1946674	rs1168509664	NC_000016.10:2074400:C:T	single nucleotide variant	intron variant	Likely benign	Mar 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+13C>T	TSC2		Tuberous sclerosis 2	VCV001549150	16	2124403	16	2074402	1549150	1573265	rs905699423	NC_000016.10:2074401:C:T	single nucleotide variant	intron variant	Likely benign	Oct 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+14C>T	TSC2		Tuberous sclerosis 2	VCV002887778	16	2124404	16	2074403	2887778	3054191	rs2151357168	NC_000016.10:2074402:C:T	single nucleotide variant	intron variant	Likely benign	Jun 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+14C>G	TSC2		Tuberous sclerosis 2	VCV002705245	16	2124404	16	2074403	2705245	2860253	rs2151357168	NC_000016.10:2074402:C:G	single nucleotide variant	intron variant	Likely benign	Dec 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+16G>A	TSC2		Tuberous sclerosis 2	VCV002057483	16	2124406	16	2074405	2057483	2116640	rs778800480	NC_000016.10:2074404:G:A	single nucleotide variant	intron variant	Likely benign	Oct 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+16G>C	TSC2		Tuberous sclerosis 2	VCV002035919	16	2124406	16	2074405	2035919	2093836	rs778800480	NC_000016.10:2074404:G:C	single nucleotide variant	intron variant	Likely benign	Jul 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+17C>A	TSC2		Tuberous sclerosis 2	VCV001602814	16	2124407	16	2074406	1602814	1611153	rs748247724	NC_000016.10:2074405:C:A	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+18C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000513682	16	2124408	16	2074407	513682	505198	rs771970930	NC_000016.10:2074406:C:T	single nucleotide variant	intron variant	Likely benign	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+19T>C	TSC2		Tuberous sclerosis 2	VCV001585287	16	2124409	16	2074408	1585287	1627222	rs773100764	NC_000016.10:2074407:T:C	single nucleotide variant	intron variant	Likely benign	Nov 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+20G>C	TSC2		Tuberous sclerosis 2	VCV001644672	16	2124410	16	2074409	1644672	1522719	rs1490177129	NC_000016.10:2074408:G:C	single nucleotide variant	intron variant	Likely benign	Nov 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+26G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000049626	16	2124416	16	2074415	49626	58788	rs45517242	NC_000016.10:2074414:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+31C>T	TSC2		not provided	VCV000049727	16	2124421	16	2074420	49727	58889	rs45517243	NC_000016.10:2074419:C:T	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+135C>T	TSC2		not provided	VCV001178871	16	2124525	16	2074524	1178871	1168349	rs139579913	NC_000016.10:2074523:C:T	single nucleotide variant	intron variant	Likely benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+157G>C	TSC2		not provided	VCV000677252	16	2124547	16	2074546	677252	668194	rs9941195	NC_000016.10:2074545:G:C	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+194A>G	TSC2		not provided	VCV001292795	16	2124584	16	2074583	1292795	1282601	rs7185909	NC_000016.10:2074582:A:G	single nucleotide variant	intron variant	Benign	Jun 21, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+240C>T	TSC2		not provided	VCV001233259	16	2124630	16	2074629	1233259	1222381	rs9921591	NC_000016.10:2074628:C:T	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2545+244C>A	TSC2		not provided	VCV001213081	16	2124634	16	2074633	1213081	1203075	rs143553665	NC_000016.10:2074632:C:A	single nucleotide variant	intron variant	Likely benign	Jul 6, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2545+244C>G	TSC2		not provided	VCV001198990	16	2124634	16	2074633	1198990	1188330	rs143553665	NC_000016.10:2074632:C:G	single nucleotide variant	intron variant	Likely benign	Jul 9, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-31G>A	TSC2		not specified|not provided|Tuberous sclerosis 2	VCV000065156	16	2125769	16	2075768	65156	76087	rs145738496	NC_000016.10:2075767:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2546-20C>G	TSC2		Tuberous sclerosis 2	VCV001553202	16	2125780	16	2075779	1553202	1552986	rs1293594428	NC_000016.10:2075778:C:G	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-19A>G	TSC2		Tuberous sclerosis 2	VCV002054862	16	2125781	16	2075780	2054862	2108863	rs1596364643	NC_000016.10:2075779:A:G	single nucleotide variant	intron variant	Likely benign	Nov 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-17C>T	TSC2		Tuberous sclerosis 2	VCV002189348	16	2125783	16	2075782	2189348	1911691	rs1216321428	NC_000016.10:2075781:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2546-17C>A	TSC2		Tuberous sclerosis 2	VCV001559643	16	2125783	16	2075782	1559643	1542234	rs1216321428	NC_000016.10:2075781:C:A	single nucleotide variant	intron variant	Likely benign	May 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-16C>T	TSC2		Tuberous sclerosis 2	VCV002157967	16	2125784	16	2075783	2157967	1886344	rs773863945	NC_000016.10:2075782:C:T	single nucleotide variant	intron variant	Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2546-15T>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002138813	16	2125785	16	2075784	2138813	1878486	rs371256839	NC_000016.10:2075783:T:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 8, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2546-15T>G	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001576060	16	2125785	16	2075784	1576060	1520922	rs371256839	NC_000016.10:2075783:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2546-15T>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001552570	16	2125785	16	2075784	1552570	1586649	rs371256839	NC_000016.10:2075783:T:C	single nucleotide variant	intron variant	Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2546-14C>T	TSC2		Tuberous sclerosis 2	VCV002026260	16	2125786	16	2075785	2026260	2077751	rs2151379427	NC_000016.10:2075784:C:T	single nucleotide variant	intron variant	Likely benign	Jun 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-14C>G	TSC2		Tuberous sclerosis 2	VCV001406662	16	2125786	16	2075785	1406662	1419018	rs2151379427	NC_000016.10:2075784:C:G	single nucleotide variant	intron variant	Likely benign	Aug 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-13T>G	TSC2		Tuberous sclerosis 2	VCV003009628	16	2125787	16	2075786	3009628	3180319	rs2151379439	NC_000016.10:2075785:T:G	single nucleotide variant	intron variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-12C>G	TSC2		Tuberous sclerosis 2	VCV002859995	16	2125788	16	2075787	2859995	3028632	rs13331451	NC_000016.10:2075786:C:G	single nucleotide variant	intron variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-12C>T	TSC2		not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049214	16	2125788	16	2075787	49214	58376	rs13331451	NC_000016.10:2075786:C:T	single nucleotide variant	intron variant	Benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2546-11C>T	TSC2		Tuberous sclerosis 2	VCV002831603	16	2125789	16	2075788	2831603	3001203	rs397515157	NC_000016.10:2075787:C:T	single nucleotide variant	intron variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-10A>T	TSC2		Tuberous sclerosis 2	VCV002137944	16	2125790	16	2075789	2137944	1871553	rs551894111	NC_000016.10:2075788:A:T	single nucleotide variant	intron variant	Uncertain significance	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-10A>G	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000237995	16	2125790	16	2075789	237995	242260	rs551894111	NC_000016.10:2075788:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2546-6C>G	TSC2		Isolated focal cortical dysplasia type II	VCV002679329	16	2125794	16	2075793	2679329	2836906	rs372088609	NC_000016.10:2075792:C:G	single nucleotide variant	intron variant	Uncertain significance	Oct 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-6C>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001400032	16	2125794	16	2075793	1400032	1444121	rs372088609	NC_000016.10:2075792:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2546-6C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000413637	16	2125794	16	2075793	413637	400741	rs372088609	NC_000016.10:2075792:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2546-5C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000836129	16	2125795	16	2075794	836129	852097	rs45517247	NC_000016.10:2075793:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2546-5C>T	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000049216	16	2125795	16	2075794	49216	58378	rs45517247	NC_000016.10:2075793:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2546-4G>T	TSC2		Tuberous sclerosis 2	VCV004071057	16	2125796	16	2075795	4071057	4184905		NC_000016.10:2075794:G:T	single nucleotide variant	intron variant	Likely benign	May 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-4G>A	TSC2		not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000221070	16	2125796	16	2075795	221070	222450	rs746958032	NC_000016.10:2075794:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2546-2A>G	TSC2		not provided|Tuberous sclerosis 2	VCV000049780	16	2125798	16	2075797	49780	58942	rs45517246	NC_000016.10:2075796:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2546-1G>C	TSC2		Tuberous sclerosis 2	VCV000049570	16	2125799	16	2075798	49570	58732	rs45468292	NC_000016.10:2075797:G:C	single nucleotide variant	splice acceptor variant	Pathogenic	Oct 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546-1G>A	TSC2		not provided	VCV000049569	16	2125799	16	2075798	49569	58731	rs45468292	NC_000016.10:2075797:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Mar 25, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2546C>T (p.Thr849Ile)	TSC2	T695I, T812I, T315I, T649I, T401I, T800I, T830I, T845I, T849I, T860I, T879I	Tuberous sclerosis 2	VCV001991003	16	2125800	16	2075799	1991003	2041045	rs2151379681	NC_000016.10:2075798:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2547T>A (p.Thr849=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002449972	16	2125801	16	2075800	2449972	2429597	rs1596364841	NC_000016.10:2075799:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2547T>C (p.Thr849=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000821469	16	2125801	16	2075800	821469	812550	rs1596364841	NC_000016.10:2075799:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2548C>G (p.Leu850Val)	TSC2	L650V, L801V, L813V, L850V, L861V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001012032	16	2125802	16	2075801	1012032	996727	rs2089256658	NC_000016.10:2075800:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2549T>C (p.Leu850Pro)	TSC2	L850P, L650P, L861P, L813P, L801P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000050077	16	2125803	16	2075802	50077	59239	rs45517248	NC_000016.10:2075801:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2550G>A (p.Leu850=)	TSC2		Tuberous sclerosis 2	VCV001669866	16	2125804	16	2075803	1669866	1582544	rs781100484	NC_000016.10:2075802:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2551G>T (p.Ala851Ser)	TSC2	A317S, A403S, A651S, A697S, A802S, A814S, A832S, A847S, A851S, A862S, A881S	Tuberous sclerosis 2	VCV004082330	16	2125805	16	2075804	4082330	4195019		NC_000016.10:2075803:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2551G>A (p.Ala851Thr)	TSC2	A317T, A403T, A651T, A697T, A802T, A814T, A832T, A847T, A851T, A862T, A881T	Tuberous sclerosis 2	VCV003064751	16	2125805	16	2075804	3064751	3224952	rs1459561397	NC_000016.10:2075803:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2552C>G (p.Ala851Gly)	TSC2	A317G, A403G, A651G, A697G, A802G, A814G, A832G, A847G, A851G, A862G, A881G	Tuberous sclerosis 2	VCV001713806	16	2125806	16	2075805	1713806	1773077	rs1596364874	NC_000016.10:2075804:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2552C>T (p.Ala851Val)	TSC2	A651V, A814V, A851V, A862V, A802V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000644945	16	2125806	16	2075805	644945	644245	rs1596364874	NC_000016.10:2075804:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2553C>T (p.Ala851=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000703685	16	2125807	16	2075806	703685	693811	rs745687916	NC_000016.10:2075805:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2554A>C (p.Arg852=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536083	16	2125808	16	2075807	536083	529927	rs769586763	NC_000016.10:2075806:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2555G>C (p.Arg852Thr)	TSC2	R652T, R803T, R882T, R318T, R404T, R815T, R852T, R833T, R863T, R698T, R848T	Tuberous sclerosis 2	VCV003671122	16	2125809	16	2075808	3671122	3804558		NC_000016.10:2075807:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2555G>A (p.Arg852Lys)	TSC2	R803K, R815K, R652K, R863K, R852K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001430377	16	2125809	16	2075808	1430377	1470912	rs2151379894	NC_000016.10:2075807:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2556G>A (p.Arg852=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002987453	16	2125810	16	2075809	2987453	3150298	rs1596364897	NC_000016.10:2075808:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2556G>T (p.Arg852Ser)	TSC2	R652S, R803S, R815S, R852S, R863S	Tuberous sclerosis 2	VCV001051297	16	2125810	16	2075809	1051297	1049442	rs1596364897	NC_000016.10:2075808:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2557C>T (p.Leu853=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002068311	16	2125811	16	2075810	2068311	2125835	rs2151379936	NC_000016.10:2075809:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2558T>C (p.Leu853Pro)	TSC2	L816P, L653P, L834P, L849P, L883P, L804P, L864P, L319P, L405P, L699P, L853P	not provided	VCV002920866	16	2125812	16	2075811	2920866	3081329	rs2151379959	NC_000016.10:2075810:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2559G>C (p.Leu853=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000717997	16	2125813	16	2075812	717997	726490	rs149169643	NC_000016.10:2075811:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2559G>T (p.Leu853=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413746	16	2125813	16	2075812	413746	400745	rs149169643	NC_000016.10:2075811:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2560C>T (p.Pro854Ser)	TSC2	P854S, P805S, P817S, P865S, P654S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000467950	16	2125814	16	2075813	467950	465945	rs1060500959	NC_000016.10:2075812:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2560C>G (p.Pro854Ala)	TSC2	P854A, P805A, P865A, P654A, P817A	Tuberous sclerosis 2	VCV000406087	16	2125814	16	2075813	406087	400752	rs1060500959	NC_000016.10:2075812:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2561C>A (p.Pro854Gln)	TSC2	P817Q, P854Q, P865Q, P406Q, P805Q, P320Q, P654Q, P700Q, P835Q, P850Q, P884Q	Hereditary cancer-predisposing syndrome	VCV003974663	16	2125815	16	2075814	3974663	4086486		NC_000016.10:2075813:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2561C>G (p.Pro854Arg)	TSC2	P854R, P805R, P865R, P654R, P817R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001041273	16	2125815	16	2075814	1041273	1032454	rs1180511535	NC_000016.10:2075813:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2561C>T (p.Pro854Leu)	TSC2	P854L, P817L, P805L, P654L, P865L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000467951	16	2125815	16	2075814	467951	465291	rs1180511535	NC_000016.10:2075813:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2562G>T (p.Pro854=)	TSC2		Tuberous sclerosis 2	VCV003679089	16	2125816	16	2075815	3679089	3817993		NC_000016.10:2075814:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2562G>C (p.Pro854=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001128615	16	2125816	16	2075815	1128615	1125057	rs779606786	NC_000016.10:2075814:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2562G>A (p.Pro854=)	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000391161	16	2125816	16	2075815	391161	374096	rs779606786	NC_000016.10:2075814:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2563C>T (p.His855Tyr)	TSC2	H655Y, H806Y, H818Y, H855Y, H866Y	Tuberous sclerosis 2	VCV001059528	16	2125817	16	2075816	1059528	1049443	rs2089259816	NC_000016.10:2075815:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2564A>C (p.His855Pro)	TSC2	H655P, H806P, H866P, H818P, H855P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001467154	16	2125818	16	2075817	1467154	1346781	rs1424946987	NC_000016.10:2075816:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2564A>G (p.His855Arg)	TSC2	H855R, H806R, H866R, H655R, H818R	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000834303	16	2125818	16	2075817	834303	843422	rs1424946987	NC_000016.10:2075816:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 21, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2565C>A (p.His855Gln)	TSC2	H818Q, H655Q, H866Q, H806Q, H855Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000663457	16	2125819	16	2075818	663457	644246	rs143537386	NC_000016.10:2075817:C:A	single nucleotide variant	missense variant	Benign/Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2565C>T (p.His855=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000137741	16	2125819	16	2075818	137741	141444	rs143537386	NC_000016.10:2075817:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2566C>T (p.Leu856Phe)	TSC2	L819F, L856F, L867F, L656F, L807F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000821495	16	2125820	16	2075819	821495	812551	rs1596364980	NC_000016.10:2075818:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2567T>G (p.Leu856Arg)	TSC2	L656R, L807R, L856R, L408R, L837R, L852R, L886R, L322R, L702R, L819R, L867R	Hereditary cancer-predisposing syndrome	VCV003974664	16	2125821	16	2075820	3974664	4086487		NC_000016.10:2075819:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2567T>A (p.Leu856His)	TSC2	L656H, L807H, L819H, L856H, L867H	Hereditary cancer-predisposing syndrome|not provided	VCV001700886	16	2125821	16	2075820	1700886	1693279	rs2151380235	NC_000016.10:2075819:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2568C>T (p.Leu856=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001793182	16	2125822	16	2075821	1793182	1848695	rs886038354	NC_000016.10:2075820:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2568C>G (p.Leu856=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000256626	16	2125822	16	2075821	256626	255495	rs886038354	NC_000016.10:2075820:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2569T>G (p.Tyr857Asp)	TSC2	Y409D, Y853D, Y857D, Y703D, Y808D, Y887D, Y820D, Y323D, Y657D, Y838D, Y868D	Hereditary cancer-predisposing syndrome	VCV002564683	16	2125823	16	2075822	2564683	2733839	rs2151380293	NC_000016.10:2075821:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2570A>G (p.Tyr857Cys)	TSC2	Y857C, Y657C, Y820C, Y868C, Y808C	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000237996	16	2125824	16	2075823	237996	242261	rs878854084	NC_000016.10:2075822:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2571C>T (p.Tyr857=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000536026	16	2125825	16	2075824	536026	529591	rs774063865	NC_000016.10:2075823:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2572A>G (p.Arg858Gly)	TSC2	R658G, R869G, R809G, R821G, R858G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000845919	16	2125826	16	2075825	845919	843424	rs2089261730	NC_000016.10:2075824:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2574G>A (p.Arg858=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462533	16	2125828	16	2075827	3462533	3621553		NC_000016.10:2075826:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2574G>T (p.Arg858Ser)	TSC2	R869S, R821S, R858S, R658S, R809S	Tuberous sclerosis 2	VCV000654014	16	2125828	16	2075827	654014	644247	rs1596365022	NC_000016.10:2075826:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2575A>G (p.Asn859Asp)	TSC2	N325D, N822D, N705D, N810D, N870D, N840D, N855D, N859D, N411D, N659D, N889D	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578794	16	2125829	16	2075828	3578794	3708216		NC_000016.10:2075827:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2575A>T (p.Asn859Tyr)	TSC2	N810Y, N822Y, N870Y, N659Y, N859Y	Tuberous sclerosis 2	VCV001519368	16	2125829	16	2075828	1519368	1433864	rs2151380450	NC_000016.10:2075827:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2576A>G (p.Asn859Ser)	TSC2	N659S, N810S, N822S, N859S, N870S	Hereditary cancer-predisposing syndrome	VCV001692490	16	2125830	16	2075829	1692490	1684930	rs878854085	NC_000016.10:2075828:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2576A>C (p.Asn859Thr)	TSC2	N859T, N810T, N659T, N870T, N822T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000237997	16	2125830	16	2075829	237997	242262	rs878854085	NC_000016.10:2075828:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2577C>G (p.Asn859Lys)	TSC2	N659K, N810K, N840K, N870K, N855K, N889K, N325K, N705K, N859K, N411K, N822K	Tuberous sclerosis 2	VCV002708598	16	2125831	16	2075830	2708598	2870889	rs1555508337	NC_000016.10:2075829:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2577C>T (p.Asn859=)	TSC2		Tuberous sclerosis 2|not specified	VCV000517978	16	2125831	16	2075830	517978	505468	rs1555508337	NC_000016.10:2075829:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2580T>C (p.Phe860=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049573	16	2125834	16	2075833	49573	58735	rs13337626	NC_000016.10:2075832:T:C	single nucleotide variant	synonymous variant	Benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2583C>G (p.Ala861=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003462649	16	2125837	16	2075836	3462649	3621668		NC_000016.10:2075835:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2583C>T (p.Ala861=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000390535	16	2125837	16	2075836	390535	377219	rs144924053	NC_000016.10:2075835:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2584G>T (p.Ala862Ser)	TSC2	A328S, A662S, A813S, A873S, A892S, A825S, A843S, A858S, A862S, A414S, A708S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001793417	16	2125838	16	2075837	1793417	1848930	rs759837836	NC_000016.10:2075836:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2584G>A (p.Ala862Thr)	TSC2	A862T, A662T, A813T, A825T, A873T	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000185434	16	2125838	16	2075837	185434	184133	rs759837836	NC_000016.10:2075836:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2585C>G (p.Ala862Gly)	TSC2	A813G, A862G, A662G, A825G, A873G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001467118	16	2125839	16	2075838	1467118	1346745	rs45517249	NC_000016.10:2075837:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2585C>T (p.Ala862Val)	TSC2	A862V, A662V, A825V, A813V, A873V	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050078	16	2125839	16	2075838	50078	59240	rs45517249	NC_000016.10:2075837:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2586G>C (p.Ala862=)	TSC2		Tuberous sclerosis 2	VCV002813050	16	2125840	16	2075839	2813050	2972852	rs752865665	NC_000016.10:2075838:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2586G>A (p.Ala862=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000467952	16	2125840	16	2075839	467952	465852	rs752865665	NC_000016.10:2075838:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2587G>C (p.Glu863Gln)	TSC2	E329Q, E415Q, E663Q, E709Q, E814Q, E826Q, E844Q, E859Q, E863Q, E874Q, E893Q	Hereditary cancer-predisposing syndrome	VCV003232119	16	2125841	16	2075840	3232119	3391920	rs2151380836	NC_000016.10:2075839:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2587G>T (p.Glu863Ter)	TSC2	E329*, E415*, E663*, E709*, E814*, E826*, E844*, E859*, E863*, E874*, E893*	TSC2-related disorder	VCV002633779	16	2125841	16	2075840	2633779	2799106	rs2151380836	NC_000016.10:2075839:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Mar 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2587G>A (p.Glu863Lys)	TSC2	E415K, E863K, E874K, E709K, E859K, E329K, E663K, E814K, E826K, E844K, E893K	Hereditary cancer-predisposing syndrome	VCV002564733	16	2125841	16	2075840	2564733	2733889	rs2151380836	NC_000016.10:2075839:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2589G>T (p.Glu863Asp)	TSC2	E415D, E893D, E329D, E663D, E826D, E874D, E709D, E859D, E814D, E844D, E863D	Tuberous sclerosis 2	VCV002757668	16	2125843	16	2075842	2757668	2917540	rs1596365136	NC_000016.10:2075841:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2589G>A (p.Glu863=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000745445	16	2125843	16	2075842	745445	754993	rs1596365136	NC_000016.10:2075841:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2590C>A (p.Gln864Lys)	TSC2	Q815K, Q875K, Q664K, Q864K, Q827K	Tuberous sclerosis 2	VCV001042045	16	2125844	16	2075843	1042045	1032455	rs45517250	NC_000016.10:2075842:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2590C>T (p.Gln864Ter)	TSC2	Q864*, Q815*, Q827*, Q875*, Q664*	not provided|Tuberous sclerosis 2	VCV000050080	16	2125844	16	2075843	50080	59242	rs45517250	NC_000016.10:2075842:C:T	single nucleotide variant	nonsense	Pathogenic	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2591A>T (p.Gln864Leu)	TSC2	Q330L, Q827L, Q860L, Q664L, Q845L, Q864L, Q710L, Q815L, Q875L, Q416L, Q894L	Tuberous sclerosis 2	VCV002045184	16	2125845	16	2075844	2045184	2092756	rs2151380945	NC_000016.10:2075843:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2591A>G (p.Gln864Arg)	TSC2	Q815R, Q827R, Q864R, Q875R, Q664R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001434239	16	2125845	16	2075844	1434239	1494055	rs2151380945	NC_000016.10:2075843:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2591A>C (p.Gln864Pro)	TSC2	Q875P, Q664P, Q864P, Q815P, Q827P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001417178	16	2125845	16	2075844	1417178	1377545	rs2151380945	NC_000016.10:2075843:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2592G>T (p.Gln864His)	TSC2	Q330H, Q845H, Q860H, Q710H, Q827H, Q864H, Q894H, Q416H, Q875H, Q664H, Q815H	Hereditary cancer-predisposing syndrome	VCV003462574	16	2125846	16	2075845	3462574	3621593		NC_000016.10:2075844:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2592G>A (p.Gln864=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692491	16	2125846	16	2075845	1692491	1684931	rs763099064	NC_000016.10:2075844:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2592G>C (p.Gln864His)	TSC2	Q664H, Q815H, Q827H, Q864H, Q875H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000644522	16	2125846	16	2075845	644522	644248	rs763099064	NC_000016.10:2075844:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2595T>C (p.Tyr865=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000779757	16	2125849	16	2075848	779757	714798	rs1277430773	NC_000016.10:2075847:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2596G>T (p.Ala866Ser)	TSC2	A866S, A666S, A877S, A817S, A829S	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001405479	16	2125850	16	2075849	1405479	203148	rs1555508378	NC_000016.10:2075848:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2596G>A (p.Ala866Thr)	TSC2	A666T, A817T, A829T, A866T, A877T	Tuberous sclerosis 2	VCV000962572	16	2125850	16	2075849	962572	949244	rs1555508378	NC_000016.10:2075848:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2597C>T (p.Ala866Val)	TSC2	A332V, A418V, A666V, A712V, A817V, A829V, A847V, A862V, A866V, A877V, A896V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002437382	16	2125851	16	2075850	2437382	2411313	rs1261601321	NC_000016.10:2075849:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2598C>T (p.Ala866=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001139167	16	2125852	16	2075851	1139167	1125058	rs1395372159	NC_000016.10:2075850:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2598C>A (p.Ala866=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001119034	16	2125852	16	2075851	1119034	1103643	rs1395372159	NC_000016.10:2075850:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2599A>G (p.Ser867Gly)	TSC2	S667G, S830G, S818G, S867G, S878G	Tuberous sclerosis 2	VCV000659244	16	2125853	16	2075852	659244	644249	rs1596365202	NC_000016.10:2075851:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2600G>T (p.Ser867Ile)	TSC2	S818I, S878I, S667I, S830I, S867I	Tuberous sclerosis 2	VCV001356108	16	2125854	16	2075853	1356108	1354403	rs751702841	NC_000016.10:2075852:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2600G>A (p.Ser867Asn)	TSC2	S667N, S818N, S830N, S867N, S878N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000843081	16	2125854	16	2075853	843081	843425	rs751702841	NC_000016.10:2075852:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 20, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2601T>C (p.Ser867=)	TSC2		Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome	VCV000237998	16	2125855	16	2075854	237998	242263	rs878854086	NC_000016.10:2075853:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2602G>A (p.Val868Met)	TSC2	V668M, V879M, V819M, V831M, V868M	Tuberous sclerosis 2	VCV000934024	16	2125856	16	2075855	934024	937308	rs2089267679	NC_000016.10:2075854:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2603T>C (p.Val868Ala)	TSC2	V831A, V879A, V819A, V668A, V868A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001037821	16	2125857	16	2075856	1037821	1032456	rs2089267892	NC_000016.10:2075855:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2604G>A (p.Val868=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462639	16	2125858	16	2075857	3462639	3621658		NC_000016.10:2075856:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2604G>T (p.Val868=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232121	16	2125858	16	2075857	3232121	3391922	rs757293684	NC_000016.10:2075856:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2606T>G (p.Phe869Cys)	TSC2	F880C, F669C, F820C, F832C, F869C	Tuberous sclerosis 2	VCV001438304	16	2125860	16	2075859	1438304	1355157	rs2151381329	NC_000016.10:2075858:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2606T>A (p.Phe869Tyr)	TSC2	F669Y, F820Y, F832Y, F869Y, F880Y	Tuberous sclerosis 2	VCV001052040	16	2125860	16	2075859	1052040	1049444	rs2151381329	NC_000016.10:2075858:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2607C>A (p.Phe869Leu)	TSC2	F869L, F820L, F880L, F669L, F832L	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV001416223	16	2125861	16	2075860	1416223	203149	rs750336814	NC_000016.10:2075859:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2607C>T (p.Phe869=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000486626	16	2125861	16	2075860	486626	477466	rs750336814	NC_000016.10:2075859:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2608G>C (p.Ala870Pro)	TSC2	A670P, A821P, A833P, A870P, A881P	Tuberous sclerosis 2	VCV000947280	16	2125862	16	2075861	947280	927653	rs1060500975	NC_000016.10:2075860:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2608G>A (p.Ala870Thr)	TSC2	A821T, A833T, A670T, A881T, A870T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000821541	16	2125862	16	2075861	821541	812552	rs1060500975	NC_000016.10:2075860:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2608G>T (p.Ala870Ser)	TSC2	A870S, A833S, A670S, A821S, A881S	Tuberous sclerosis 2	VCV000406130	16	2125862	16	2075861	406130	401268	rs1060500975	NC_000016.10:2075860:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2609C>A (p.Ala870Asp)	TSC2	A422D, A833D, A866D, A851D, A881D, A900D, A336D, A670D, A716D, A821D, A870D	Hereditary cancer-predisposing syndrome	VCV003974682	16	2125863	16	2075862	3974682	4086505		NC_000016.10:2075861:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2610C>T (p.Ala870=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000387194	16	2125864	16	2075863	387194	377224	rs755870234	NC_000016.10:2075862:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2611A>G (p.Ile871Val)	TSC2	I337V, I423V, I671V, I717V, I822V, I834V, I852V, I867V, I871V, I882V, I901V	Tuberous sclerosis 2	VCV001720647	16	2125865	16	2075864	1720647	1776829	rs2151381494	NC_000016.10:2075863:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2612T>C (p.Ile871Thr)	TSC2	I671T, I822T, I834T, I871T, I882T	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001025382	16	2125866	16	2075865	1025382	1011964	rs2089269466	NC_000016.10:2075864:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2613C>T (p.Ile871=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000536017	16	2125867	16	2075866	536017	530166	rs1555508408	NC_000016.10:2075865:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2614T>A (p.Ser872Thr)	TSC2	S672T, S718T, S823T, S872T, S902T, S338T, S424T, S868T, S835T, S883T, S853T	Tuberous sclerosis 2	VCV003637206	16	2125868	16	2075867	3637206	3771360		NC_000016.10:2075866:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2616C>A (p.Ser872=)	TSC2		Tuberous sclerosis 2	VCV002105162	16	2125870	16	2075869	2105162	2159168	rs779843919	NC_000016.10:2075868:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2616C>T (p.Ser872=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000413664	16	2125870	16	2075869	413664	400859	rs779843919	NC_000016.10:2075868:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2617C>G (p.Leu873Val)	TSC2	L673V, L824V, L836V, L873V, L884V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001055364	16	2125871	16	2075870	1055364	1049445	rs1555508418	NC_000016.10:2075869:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2617C>T (p.Leu873=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536028	16	2125871	16	2075870	536028	530173	rs1555508418	NC_000016.10:2075869:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2618T>C (p.Leu873Pro)	TSC2	L673P, L824P, L836P, L873P, L884P	not provided	VCV001344943	16	2125872	16	2075871	1344943	1336763	rs2151381717	NC_000016.10:2075870:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2619G>A (p.Leu873=)	TSC2		Tuberous sclerosis 2	VCV002765298	16	2125873	16	2075872	2765298	2926045	rs137854054	NC_000016.10:2075871:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2619G>C (p.Leu873=)	TSC2		Tuberous sclerosis 2	VCV002066663	16	2125873	16	2075872	2066663	2125476	rs137854054	NC_000016.10:2075871:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2621C>G (p.Pro874Arg)	TSC2	P837R, P885R, P874R, P825R, P674R	Tuberous sclerosis 2	VCV001362010	16	2125875	16	2075874	1362010	1376636	rs138527121	NC_000016.10:2075873:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2621C>T (p.Pro874Leu)	TSC2	P874L, P837L, P885L, P825L, P674L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486642	16	2125875	16	2075874	486642	477349	rs138527121	NC_000016.10:2075873:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2622G>T (p.Pro874=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000467953	16	2125876	16	2075875	467953	465854	rs141486629	NC_000016.10:2075874:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2622G>A (p.Pro874=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000413642	16	2125876	16	2075875	413642	400861	rs141486629	NC_000016.10:2075874:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2623T>C (p.Tyr875His)	TSC2	Y856H, Y875H, Y886H, Y341H, Y826H, Y838H, Y905H, Y675H, Y871H, Y427H, Y721H	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002786165	16	2125877	16	2075876	2786165	2942127	rs2089272680	NC_000016.10:2075875:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2623T>G (p.Tyr875Asp)	TSC2	Y826D, Y675D, Y875D, Y838D, Y886D	Tuberous sclerosis 2	VCV000846778	16	2125877	16	2075876	846778	843426	rs2089272680	NC_000016.10:2075875:T:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2624A>G (p.Tyr875Cys)	TSC2	Y826C, Y905C, Y856C, Y871C, Y341C, Y675C, Y838C, Y427C, Y721C, Y875C, Y886C	Hereditary cancer-predisposing syndrome	VCV003811331	16	2125878	16	2075877	3811331	3928572		NC_000016.10:2075876:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2625C>A (p.Tyr875Ter)	TSC2	Y675*, Y856*, Y905*, Y871*, Y341*, Y721*, Y826*, Y838*, Y427*, Y875*, Y886*	Tuberous sclerosis 2	VCV003642439	16	2125879	16	2075878	3642439	3769295		NC_000016.10:2075877:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Feb 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2625C>T (p.Tyr875=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000758364	16	2125879	16	2075878	758364	770710	rs1475326651	NC_000016.10:2075877:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2627C>T (p.Thr876Ile)	TSC2	T722I, T827I, T839I, T872I, T857I, T876I, T428I, T676I, T887I, T342I, T906I	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV003578796	16	2125881	16	2075880	3578796	3708217		NC_000016.10:2075879:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2627C>G (p.Thr876Ser)	TSC2	T676S, T827S, T839S, T876S, T887S	Tuberous sclerosis 2	VCV001010935	16	2125881	16	2075880	1010935	996728	rs768490850	NC_000016.10:2075879:C:G	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2628C>A (p.Thr876=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001958938	16	2125882	16	2075881	1958938	2009173	rs778678783	NC_000016.10:2075880:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2628C>T (p.Thr876=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000517799	16	2125882	16	2075881	517799	506160	rs778678783	NC_000016.10:2075880:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2629A>G (p.Asn877Asp)	TSC2	N343D, N840D, N858D, N907D, N677D, N723D, N828D, N873D, N429D, N877D, N888D	Hereditary cancer-predisposing syndrome	VCV003974684	16	2125883	16	2075882	3974684	4086507		NC_000016.10:2075881:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2630A>G (p.Asn877Ser)	TSC2	N877S, N840S, N677S, N888S, N828S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000572415	16	2125884	16	2075883	572415	569741	rs1567482364	NC_000016.10:2075882:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2631C>G (p.Asn877Lys)	TSC2	N888K, N828K, N840K, N677K, N877K	Tuberous sclerosis 2	VCV000964437	16	2125885	16	2075884	964437	949245	rs45517251	NC_000016.10:2075883:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2631C>T (p.Asn877=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000049218	16	2125885	16	2075884	49218	58380	rs45517251	NC_000016.10:2075883:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2632C>G (p.Pro878Ala)	TSC2	P889A, P678A, P829A, P841A, P878A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000864733	16	2125886	16	2075885	864733	843427	rs397515077	NC_000016.10:2075884:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2632C>T (p.Pro878Ser)	TSC2	P878S, P678S, P829S, P889S, P841S	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000065104	16	2125886	16	2075885	65104	76035	rs397515077	NC_000016.10:2075884:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2633C>T (p.Pro878Leu)	TSC2	P430L, P678L, P724L, P829L, P841L, P859L, P889L, P908L, P878L, P344L, P874L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV002741875	16	2125887	16	2075886	2741875	2906521	rs1060500925	NC_000016.10:2075885:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2633C>A (p.Pro878His)	TSC2	P878H, P829H, P889H, P841H, P678H	Tuberous sclerosis 2	VCV000405988	16	2125887	16	2075886	405988	401507	rs1060500925	NC_000016.10:2075885:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2634C>T (p.Pro878=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001794099	16	2125888	16	2075887	1794099	1842379	rs963726383	NC_000016.10:2075886:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2635T>A (p.Ser879Thr)	TSC2	S345T, S830T, S860T, S879T, S909T, S679T, S725T, S431T, S842T, S875T, S890T	Hereditary cancer-predisposing syndrome	VCV002564684	16	2125889	16	2075888	2564684	2733840	rs2151382181	NC_000016.10:2075887:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2635T>C (p.Ser879Pro)	TSC2	S679P, S830P, S842P, S879P, S890P	Tuberous sclerosis 2|not provided	VCV001057006	16	2125889	16	2075888	1057006	1049446	rs2151382181	NC_000016.10:2075887:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2636C>T (p.Ser879Phe)	TSC2	S879F, S679F, S830F, S842F, S890F	Tuberous sclerosis 2	VCV000467954	16	2125890	16	2075889	467954	465294	rs1555508444	NC_000016.10:2075888:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2637C>A (p.Ser879=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232122	16	2125891	16	2075890	3232122	3391923	rs1596365444	NC_000016.10:2075889:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2637C>T (p.Ser879=)	TSC2		Tuberous sclerosis 2	VCV000758287	16	2125891	16	2075890	758287	770711	rs1596365444	NC_000016.10:2075889:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2638A>G (p.Lys880Glu)	TSC2	K680E, K831E, K843E, K880E, K891E	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV001050883	16	2125892	16	2075891	1050883	1049447	rs2151382293	NC_000016.10:2075890:A:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2639A>C (p.Lys880Thr)	TSC2	K346T, K843T, K861T, K876T, K910T, K432T, K891T, K680T, K726T, K831T, K880T	Tuberous sclerosis 2	VCV002906572	16	2125893	16	2075892	2906572	3069469	rs2089276233	NC_000016.10:2075891:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639A>G (p.Lys880Arg)	TSC2	K680R, K831R, K891R, K843R, K880R	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000947641	16	2125893	16	2075892	947641	927654	rs2089276233	NC_000016.10:2075891:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2639+1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000207733	16	2125894	16	2075893	207733	203150	rs45517252	NC_000016.10:2075892:G:A	single nucleotide variant	splice donor variant	Pathogenic	Aug 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2639+1G>C	TSC2		Tuberous sclerosis 2	VCV000049845	16	2125894	16	2075893	49845	59007	rs45517252	NC_000016.10:2075892:G:C	single nucleotide variant	splice donor variant	Pathogenic	Aug 8, 2012	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+3G>A	TSC2		Hereditary cancer-predisposing syndrome	VCV003811329	16	2125896	16	2075895	3811329	3928570		NC_000016.10:2075894:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 18, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+5G>C	TSC2		TSC2-related disorder	VCV002636544	16	2125898	16	2075897	2636544	2804747	rs397515171	NC_000016.10:2075896:G:C	single nucleotide variant	intron variant	Likely pathogenic	Nov 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+5G>A	TSC2		Tuberous sclerosis 2	VCV000065235	16	2125898	16	2075897	65235	76167	rs397515171	NC_000016.10:2075896:G:A	single nucleotide variant	intron variant	Uncertain significance	May 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+6T>C	TSC2		not provided|Tuberous sclerosis 2	VCV001060156	16	2125899	16	2075898	1060156	1049448	rs2151382514	NC_000016.10:2075897:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 19, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2639+7G>A	TSC2		Tuberous sclerosis 2	VCV002959344	16	2125900	16	2075899	2959344	3119258	rs2151382537	NC_000016.10:2075898:G:A	single nucleotide variant	intron variant	Likely benign	Jun 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+8G>A	TSC2		Tuberous sclerosis 2	VCV001627435	16	2125901	16	2075900	1627435	1616460	rs777033931	NC_000016.10:2075899:G:A	single nucleotide variant	intron variant	Likely benign	Sep 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+8G>C	TSC2		Tuberous sclerosis 2	VCV001126418	16	2125901	16	2075900	1126418	1125059	rs777033931	NC_000016.10:2075899:G:C	single nucleotide variant	intron variant	Likely benign	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2639+10C>A	TSC2		Tuberous sclerosis 2	VCV000754890	16	2125903	16	2075902	754890	776493	rs137854378	NC_000016.10:2075901:C:A	single nucleotide variant	intron variant	Likely benign	Nov 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+10C>T	TSC2		not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049844	16	2125903	16	2075902	49844	59006	rs137854378	NC_000016.10:2075901:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2639+11G>C	TSC2		Tuberous sclerosis 2	VCV002035388	16	2125904	16	2075903	2035388	2097172	rs1057520919	NC_000016.10:2075902:G:C	single nucleotide variant	intron variant	Likely benign	Nov 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+11G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000380977	16	2125904	16	2075903	380977	374761	rs1057520919	NC_000016.10:2075902:G:A	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2639+12C>T	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001626636	16	2125905	16	2075904	1626636	1583639	rs1400051232	NC_000016.10:2075903:C:T	single nucleotide variant	intron variant	Likely benign	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2639+14C>T	TSC2		Tuberous sclerosis 2	VCV001569430	16	2125907	16	2075906	1569430	1603975	rs1057520927	NC_000016.10:2075905:C:T	single nucleotide variant	intron variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+14C>G	TSC2		Tuberous sclerosis 2|not specified	VCV000381013	16	2125907	16	2075906	381013	374764	rs1057520927	NC_000016.10:2075905:C:G	single nucleotide variant	intron variant	Likely benign	Jul 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2639+15C>G	TSC2		Tuberous sclerosis 2	VCV001588787	16	2125908	16	2075907	1588787	1641113	rs397515299	NC_000016.10:2075906:C:G	single nucleotide variant	intron variant	Likely benign	Nov 20, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+15C>T	TSC2		Tuberous sclerosis 2	VCV000064894	16	2125908	16	2075907	64894	75824	rs397515299	NC_000016.10:2075906:C:T	single nucleotide variant	intron variant	Likely benign	Jan 11, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+16A>C	TSC2		Tuberous sclerosis 2	VCV002761030	16	2125909	16	2075908	2761030	2918324	rs1342417901	NC_000016.10:2075907:A:C	single nucleotide variant	intron variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+16A>G	TSC2		Tuberous sclerosis 2	VCV002046476	16	2125909	16	2075908	2046476	2096610	rs1342417901	NC_000016.10:2075907:A:G	single nucleotide variant	intron variant	Likely benign	Jul 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+17G>C	TSC2		Tuberous sclerosis 2	VCV003649797	16	2125910	16	2075909	3649797	3787793		NC_000016.10:2075908:G:C	single nucleotide variant	intron variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+18G>A	TSC2		Tuberous sclerosis 2	VCV002068339	16	2125911	16	2075910	2068339	2125863	rs763296043	NC_000016.10:2075909:G:A	single nucleotide variant	intron variant	Likely benign	Jan 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+19C>G	TSC2		Tuberous sclerosis 2	VCV002419547	16	2125912	16	2075911	2419547	1938368	rs2151382809	NC_000016.10:2075910:C:G	single nucleotide variant	intron variant	Likely benign	Jul 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+19C>T	TSC2		Tuberous sclerosis 2	VCV001429910	16	2125912	16	2075911	1429910	1477643	rs2151382809	NC_000016.10:2075910:C:T	single nucleotide variant	intron variant	Likely benign	May 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+20C>G	TSC2		Tuberous sclerosis 2	VCV002111253	16	2125913	16	2075912	2111253	2163828	rs764337376	NC_000016.10:2075911:C:G	single nucleotide variant	intron variant	Likely benign	Mar 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+20C>A	TSC2		Tuberous sclerosis 2	VCV001644938	16	2125913	16	2075912	1644938	1598836	rs764337376	NC_000016.10:2075911:C:A	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2639+44C>G	TSC2		not specified|not provided|Tuberous sclerosis 2	VCV000050084	16	2125937	16	2075936	50084	59246	rs1800715	NC_000016.10:2075935:C:G	single nucleotide variant	intron variant	Benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-74G>A	TSC2		not provided	VCV000673262	16	2125995	16	2075994	673262	667406	rs143128054	NC_000016.10:2075993:G:A	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-65C>T	TSC2		not provided	VCV000673263	16	2126004	16	2076003	673263	668701	rs138967036	NC_000016.10:2076002:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-26G>T	TSC2		not provided	VCV000050085	16	2126043	16	2076042	50085	59247	rs45483797	NC_000016.10:2076041:G:T	single nucleotide variant	intron variant	Likely benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-17C>T	TSC2		Tuberous sclerosis 2	VCV002188317	16	2126052	16	2076051	2188317	1918361	rs2151385497	NC_000016.10:2076050:C:T	single nucleotide variant	intron variant	Likely benign	Feb 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-16C>T	TSC2		Tuberous sclerosis 2	VCV003683899	16	2126053	16	2076052	3683899	3808748		NC_000016.10:2076051:C:T	single nucleotide variant	intron variant	Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-16C>A	TSC2		Tuberous sclerosis 2	VCV002912353	16	2126053	16	2076052	2912353	3073510	rs773409154	NC_000016.10:2076051:C:A	single nucleotide variant	intron variant	Likely benign	Nov 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-15C>T	TSC2		Tuberous sclerosis 2	VCV004071195	16	2126054	16	2076053	4071195	4185043		NC_000016.10:2076052:C:T	single nucleotide variant	intron variant	Likely benign	May 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-15C>G	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001586196	16	2126054	16	2076053	1586196	1593841	rs1011282445	NC_000016.10:2076052:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2640-14C>T	TSC2		Tuberous sclerosis 2	VCV001668774	16	2126055	16	2076054	1668774	1634148	rs2089304828	NC_000016.10:2076053:C:T	single nucleotide variant	intron variant	Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-14C>G	TSC2		Tuberous sclerosis 2	VCV001667437	16	2126055	16	2076054	1667437	1591375	rs2089304828	NC_000016.10:2076053:C:G	single nucleotide variant	intron variant	Likely benign	Feb 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-13C>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003070137	16	2126056	16	2076055	3070137	3231626	rs201184637	NC_000016.10:2076054:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2640-13C>T	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000137742	16	2126056	16	2076055	137742	141445	rs201184637	NC_000016.10:2076054:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-12T>G	TSC2		Tuberous sclerosis 2	VCV002761184	16	2126057	16	2076056	2761184	2924950	rs2543902958	NC_000016.10:2076055:T:G	single nucleotide variant	intron variant	Likely benign	Sep 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-10C>T	TSC2		Tuberous sclerosis 2	VCV004071059	16	2126059	16	2076058	4071059	4184907		NC_000016.10:2076057:C:T	single nucleotide variant	intron variant	Likely benign	May 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-10C>G	TSC2		not provided|Tuberous sclerosis 2	VCV000384424	16	2126059	16	2076058	384424	377225	rs964883731	NC_000016.10:2076057:C:G	single nucleotide variant	intron variant	Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-8C>T	TSC2		Tuberous sclerosis 2	VCV001610667	16	2126061	16	2076060	1610667	1585485	rs766389789	NC_000016.10:2076059:C:T	single nucleotide variant	intron variant	Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-7A>T	TSC2		Tuberous sclerosis 2	VCV001144931	16	2126062	16	2076061	1144931	1145939	rs1555508569	NC_000016.10:2076060:A:T	single nucleotide variant	intron variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-7A>C	TSC2		Tuberous sclerosis 2	VCV001086977	16	2126062	16	2076061	1086977	1081817	rs1555508569	NC_000016.10:2076060:A:C	single nucleotide variant	intron variant	Likely benign	Jan 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-7A>G	TSC2		Tuberous sclerosis 2	VCV000467955	16	2126062	16	2076061	467955	465953	rs1555508569	NC_000016.10:2076060:A:G	single nucleotide variant	intron variant	Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-5C>G	TSC2		Tuberous sclerosis 2	VCV001143617	16	2126064	16	2076063	1143617	1145940	rs753781434	NC_000016.10:2076062:C:G	single nucleotide variant	intron variant	Likely benign	Jul 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-5C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000232719	16	2126064	16	2076063	232719	235115	rs753781434	NC_000016.10:2076062:C:T	single nucleotide variant	intron variant	Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-4T>C	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000757048	16	2126065	16	2076064	757048	776292	rs1596366489	NC_000016.10:2076063:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2640-3C>T	TSC2		Tuberous sclerosis 2	VCV000850834	16	2126066	16	2076065	850834	852644	rs2089308821	NC_000016.10:2076064:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2640-2A>G	TSC2		Tuberous sclerosis 2|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000280185	16	2126067	16	2076066	280185	264678	rs137854380	NC_000016.10:2076065:A:G	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2640-1G>A	TSC2		Tuberous sclerosis 2|not provided	VCV000065277	16	2126068	16	2076067	65277	76209	rs397515203	NC_000016.10:2076066:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Oct 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2646T>C (p.Asn882=)	TSC2		Tuberous sclerosis 2	VCV003657601	16	2126075	16	2076074	3657601	3779556		NC_000016.10:2076073:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2646T>G (p.Asn882Lys)	TSC2	N893K, N682K, N845K, N833K, N882K	Tuberous sclerosis 2	VCV001488823	16	2126075	16	2076074	1488823	1420293	rs2151386177	NC_000016.10:2076073:T:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2647C>G (p.Gln883Glu)	TSC2	Q883E, Q846E, Q683E, Q834E, Q894E	Tuberous sclerosis 2	VCV000237999	16	2126076	16	2076075	237999	242264	rs45476100	NC_000016.10:2076074:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2647C>T (p.Gln883Ter)	TSC2	Q883*, Q834*, Q846*, Q683*, Q894*	not provided|Tuberous sclerosis 2	VCV000049580	16	2126076	16	2076075	49580	58742	rs45476100	NC_000016.10:2076074:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jun 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2649G>A (p.Gln883=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV001897428	16	2126078	16	2076077	1897428	1962856	rs2151386276	NC_000016.10:2076076:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2651A>G (p.Tyr884Cys)	TSC2	Y835C, Y847C, Y684C, Y884C, Y895C	Tuberous sclerosis 2	VCV001520231	16	2126080	16	2076079	1520231	1516225	rs754849580	NC_000016.10:2076078:A:G	single nucleotide variant	missense variant	Likely benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2652C>T (p.Tyr884=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049220	16	2126081	16	2076080	49220	58382	rs45489200	NC_000016.10:2076079:C:T	single nucleotide variant	synonymous variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2653A>C (p.Ile885Leu)	TSC2	I866L, I885L, I881L, I915L, I351L, I731L, I836L, I848L, I437L, I685L, I896L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002626423	16	2126082	16	2076081	2626423	2794189	rs1555508581	NC_000016.10:2076080:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2653A>G (p.Ile885Val)	TSC2	I885V, I836V, I848V, I685V, I896V	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535859	16	2126082	16	2076081	535859	529596	rs1555508581	NC_000016.10:2076080:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2655C>A (p.Ile885=)	TSC2		Tuberous sclerosis 2	VCV001559224	16	2126084	16	2076083	1559224	1629675	rs1060504116	NC_000016.10:2076082:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2655C>G (p.Ile885Met)	TSC2	I848M, I685M, I836M, I885M, I896M	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000959178	16	2126084	16	2076083	959178	949246	rs1060504116	NC_000016.10:2076082:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2655C>T (p.Ile885=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413734	16	2126084	16	2076083	413734	400864	rs1060504116	NC_000016.10:2076082:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2656G>A (p.Val886Met)	TSC2	V686M, V837M, V849M, V886M, V897M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Congenital anomaly of kidney and urinary tract|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000843014	16	2126085	16	2076084	843014	843428	rs999523698	NC_000016.10:2076083:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2656G>T (p.Val886Leu)	TSC2	V886L, V849L, V837L, V897L, V686L	Tuberous sclerosis 2	VCV000535905	16	2126085	16	2076084	535905	529657	rs999523698	NC_000016.10:2076083:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.2656G>C (p.Val886Leu)	TSC2	V886L, V837L, V897L, V686L, V849L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000422850	16	2126085	16	2076084	422850	409485	rs999523698	NC_000016.10:2076083:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2658G>A (p.Val886=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000516012	16	2126087	16	2076086	516012	505204	rs1035837417	NC_000016.10:2076085:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2660G>T (p.Cys887Phe)	TSC2	C687F, C838F, C887F, C353F, C439F, C883F, C898F, C733F, C850F, C868F, C917F	Tuberous sclerosis 2	VCV003631824	16	2126089	16	2076088	3631824	3769866		NC_000016.10:2076087:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2661T>A (p.Cys887Ter)	TSC2	C887*, C687*, C898*, C838*, C850*	not provided	VCV000049222	16	2126090	16	2076089	49222	58384	rs45475594	NC_000016.10:2076088:T:A	single nucleotide variant	nonsense	Pathogenic	Aug 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2662C>A (p.Leu888Met)	TSC2	L354M, L851M, L884M, L839M, L869M, L888M, L899M, L688M, L918M, L440M, L734M	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV002450000	16	2126091	16	2076090	2450000	2425957	rs765057258	NC_000016.10:2076089:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2662C>G (p.Leu888Val)	TSC2	L688V, L839V, L851V, L899V, L918V, L354V, L440V, L869V, L888V, L734V, L884V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001794460	16	2126091	16	2076090	1794460	1852206	rs765057258	NC_000016.10:2076089:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2662C>T (p.Leu888=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001082044	16	2126091	16	2076090	1082044	1081818	rs765057258	NC_000016.10:2076089:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2663T>G (p.Leu888Arg)	TSC2	L354R, L440R, L688R, L734R, L839R, L851R, L869R, L884R, L888R, L899R, L918R	Tuberous sclerosis 2	VCV003346142	16	2126092	16	2076091	3346142	3505811		NC_000016.10:2076090:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2664G>C (p.Leu888=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462583	16	2126093	16	2076092	3462583	3621602		NC_000016.10:2076091:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2664G>T (p.Leu888=)	TSC2		Tuberous sclerosis 2	VCV002701980	16	2126093	16	2076092	2701980	2859563	rs1326043043	NC_000016.10:2076091:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Dec 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2665G>A (p.Ala889Thr)	TSC2	A889T, A689T, A900T, A840T, A852T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467956	16	2126094	16	2076093	467956	465955	rs397515054	NC_000016.10:2076092:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2665G>C (p.Ala889Pro)	TSC2	A889P, A840P, A900P, A852P, A689P	Tuberous sclerosis 2	VCV000065074	16	2126094	16	2076093	65074	76005	rs397515054	NC_000016.10:2076092:G:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2666C>T (p.Ala889Val)	TSC2	A889V, A689V, A840V, A852V, A900V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049586	16	2126095	16	2076094	49586	58748	rs137854155	NC_000016.10:2076093:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2667C>G (p.Ala889=)	TSC2		Tuberous sclerosis 2	VCV004071335	16	2126096	16	2076095	4071335	4185183		NC_000016.10:2076094:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2667C>T (p.Ala889=)	TSC2		Tuberous sclerosis 2	VCV000807949	16	2126096	16	2076095	807949	797275	rs774740459	NC_000016.10:2076094:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2668C>T (p.His890Tyr)	TSC2	H890Y, H690Y, H853Y, H901Y, H841Y	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000536006	16	2126097	16	2076096	536006	529929	rs145258407	NC_000016.10:2076095:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2671C>T (p.His891Tyr)	TSC2	H691Y, H891Y, H842Y, H854Y, H902Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000843516	16	2126100	16	2076099	843516	843429	rs2089316693	NC_000016.10:2076098:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2673C>T (p.His891=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000413699	16	2126102	16	2076101	413699	400866	rs373866604	NC_000016.10:2076100:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2674G>T (p.Val892Phe)	TSC2	V692F, V855F, V444F, V843F, V873F, V903F, V738F, V358F, V888F, V892F, V922F	Hereditary cancer-predisposing syndrome	VCV003329521	16	2126103	16	2076102	3329521	3489113		NC_000016.10:2076101:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2674G>A (p.Val892Ile)	TSC2	V892I, V692I, V843I, V855I, V903I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535858	16	2126103	16	2076102	535858	529938	rs376801256	NC_000016.10:2076101:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2676C>T (p.Val892=)	TSC2		Tuberous sclerosis 2	VCV004071252	16	2126105	16	2076104	4071252	4185100		NC_000016.10:2076103:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2676C>G (p.Val892=)	TSC2		Tuberous sclerosis 2	VCV004071244	16	2126105	16	2076104	4071244	4185092		NC_000016.10:2076103:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2676C>A (p.Val892=)	TSC2		Tuberous sclerosis 2	VCV002825188	16	2126105	16	2076104	2825188	2986273	rs2089318045	NC_000016.10:2076103:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Oct 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2677A>G (p.Ile893Val)	TSC2	I359V, I445V, I693V, I739V, I844V, I856V, I874V, I889V, I893V, I904V, I923V	Tuberous sclerosis syndrome|not provided	VCV003074464	16	2126106	16	2076105	3074464	3229431	rs2151387209	NC_000016.10:2076104:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2677A>T (p.Ile893Leu)	TSC2	I844L, I856L, I893L, I693L, I904L	Tuberous sclerosis 2	VCV001444363	16	2126106	16	2076105	1444363	1388328	rs2151387209	NC_000016.10:2076104:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2678T>A (p.Ile893Lys)	TSC2	I856K, I889K, I904K, I445K, I693K, I739K, I844K, I923K, I359K, I874K, I893K	Tuberous sclerosis 2	VCV002160821	16	2126107	16	2076106	2160821	1894414	rs796053491	NC_000016.10:2076105:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2678T>C (p.Ile893Thr)	TSC2	I893T, I693T, I844T, I904T, I856T	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000207734	16	2126107	16	2076106	207734	203151	rs796053491	NC_000016.10:2076105:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2679A>G (p.Ile893Met)	TSC2	I874M, I889M, I904M, I923M, I693M, I739M, I893M, I359M, I445M, I844M, I856M	Tuberous sclerosis 2	VCV002694660	16	2126108	16	2076107	2694660	2860799	rs2151387290	NC_000016.10:2076106:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2680G>A (p.Ala894Thr)	TSC2	A446T, A845T, A875T, A894T, A905T, A740T, A857T, A924T, A360T, A694T, A890T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001794682	16	2126109	16	2076108	1794682	1852427	rs1379507306	NC_000016.10:2076107:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2680G>C (p.Ala894Pro)	TSC2	A694P, A845P, A857P, A894P, A905P	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001335195	16	2126109	16	2076108	1335195	1326168	rs1379507306	NC_000016.10:2076107:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2681C>T (p.Ala894Val)	TSC2	A894V, A905V, A694V, A845V, A857V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000467957	16	2126110	16	2076109	467957	465856	rs777282955	NC_000016.10:2076108:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2682C>T (p.Ala894=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000753460	16	2126111	16	2076110	753460	770712	rs45517253	NC_000016.10:2076109:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2683A>T (p.Met895Leu)	TSC2	M695L, M846L, M895L, M906L, M858L	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001418379	16	2126112	16	2076111	1418379	1489975	rs45470695	NC_000016.10:2076110:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2683A>G (p.Met895Val)	TSC2	M895V, M695V, M846V, M858V, M906V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000050091	16	2126112	16	2076111	50091	59253	rs45470695	NC_000016.10:2076110:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2684T>C (p.Met895Thr)	TSC2	M695T, M846T, M858T, M895T, M906T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001016121	16	2126113	16	2076112	1016121	1011965	rs1284083563	NC_000016.10:2076111:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2686T>C (p.Trp896Arg)	TSC2	W896R, W847R, W696R, W859R, W907R	Tuberous sclerosis 2	VCV000579975	16	2126115	16	2076114	579975	567805	rs1567483855	NC_000016.10:2076113:T:C	single nucleotide variant	missense variant	Uncertain significance	May 2, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2688G>A (p.Trp896Ter)	TSC2	W896*, W847*, W859*, W696*, W907*	Tuberous sclerosis 2	VCV000064888	16	2126117	16	2076116	64888	75818	rs397514913	NC_000016.10:2076115:G:A	single nucleotide variant	nonsense	Pathogenic	Jun 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2690T>A (p.Phe897Tyr)	TSC2	F908Y, F697Y, F860Y, F897Y, F848Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001497306	16	2126119	16	2076118	1497306	1475927	rs45517255	NC_000016.10:2076117:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2690T>C (p.Phe897Ser)	TSC2	F897S, F697S, F848S, F860S, F908S	not provided	VCV000049595	16	2126119	16	2076118	49595	58757	rs45517255	NC_000016.10:2076117:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 17, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.2691C>T (p.Phe897=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001794810	16	2126120	16	2076119	1794810	1849019	rs2151387700	NC_000016.10:2076118:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2694C>A (p.Ile898=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001794827	16	2126123	16	2076122	1794827	1849036	rs200360213	NC_000016.10:2076121:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2694C>T (p.Ile898=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000536036	16	2126123	16	2076122	536036	529941	rs200360213	NC_000016.10:2076121:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2695A>C (p.Arg899=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001134108	16	2126124	16	2076123	1134108	1125060	rs2089322279	NC_000016.10:2076122:A:C	single nucleotide variant	synonymous variant	Likely benign	Sep 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2695A>G (p.Arg899Gly)	TSC2	R699G, R862G, R899G, R910G, R850G	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000836706	16	2126124	16	2076123	836706	843430	rs2089322279	NC_000016.10:2076122:A:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2696G>C (p.Arg899Thr)	TSC2	R451T, R745T, R880T, R929T, R862T, R895T, R899T, R910T, R365T, R699T, R850T	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578797	16	2126125	16	2076124	3578797	3708218		NC_000016.10:2076123:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2696G>A (p.Arg899Lys)	TSC2	R929K, R451K, R699K, R850K, R880K, R899K, R745K, R895K, R365K, R862K, R910K	Tuberous sclerosis 2	VCV002188336	16	2126125	16	2076124	2188336	1918380	rs2151387855	NC_000016.10:2076123:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2698T>A (p.Cys900Ser)	TSC2	C851S, C863S, C900S, C452S, C700S, C746S, C881S, C896S, C930S, C366S, C911S	Hereditary cancer-predisposing syndrome	VCV003462611	16	2126127	16	2076126	3462611	3621630		NC_000016.10:2076125:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2698T>G (p.Cys900Gly)	TSC2	C366G, C700G, C746G, C863G, C900G, C930G, C851G, C881G, C896G, C452G, C911G	Tuberous sclerosis 2	VCV002115144	16	2126127	16	2076126	2115144	2161380	rs1354917235	NC_000016.10:2076125:T:G	single nucleotide variant	missense variant	Likely pathogenic	Apr 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2698T>C (p.Cys900Arg)	TSC2	C452R, C900R, C930R, C896R, C700R, C851R, C863R, C911R, C366R, C746R, C881R	Tuberous sclerosis 2	VCV002037148	16	2126127	16	2076126	2037148	2097640	rs1354917235	NC_000016.10:2076125:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2699G>A (p.Cys900Tyr)	TSC2	C863Y, C900Y, C700Y, C911Y, C851Y	Tuberous sclerosis 2	VCV001455380	16	2126128	16	2076127	1455380	1464497	rs2089323124	NC_000016.10:2076126:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2700C>T (p.Cys900=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001794927	16	2126129	16	2076128	1794927	1849136	rs45517257	NC_000016.10:2076127:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2700C>A (p.Cys900Ter)	TSC2	C900*, C700*, C851*, C863*, C911*	Tuberous sclerosis 2	VCV000050093	16	2126129	16	2076128	50093	59255	rs45517257	NC_000016.10:2076127:C:A	single nucleotide variant	nonsense	Pathogenic	Feb 24, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2701C>T (p.Arg901Cys)	TSC2	R901C, R864C, R912C, R701C, R852C	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000207783	16	2126130	16	2076129	207783	203152	rs796053512	NC_000016.10:2076128:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2702G>T (p.Arg901Leu)	TSC2	R701L, R852L, R864L, R901L, R912L	Tuberous sclerosis 2	VCV001016670	16	2126131	16	2076130	1016670	1011967	rs1273957629	NC_000016.10:2076129:G:T	single nucleotide variant	missense variant	Likely benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2702G>A (p.Arg901His)	TSC2	R701H, R852H, R864H, R901H, R912H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001015778	16	2126131	16	2076130	1015778	1011966	rs1273957629	NC_000016.10:2076129:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2703C>A (p.Arg901=)	TSC2		Tuberous sclerosis syndrome	VCV003071975	16	2126132	16	2076131	3071975	3232152	rs2151388104	NC_000016.10:2076130:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2703C>T (p.Arg901=)	TSC2		Tuberous sclerosis 2	VCV001896198	16	2126132	16	2076131	1896198	1959470	rs2151388104	NC_000016.10:2076130:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2704C>T (p.Leu902=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001583162	16	2126133	16	2076132	1583162	1535400	rs756696525	NC_000016.10:2076131:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2706G>A (p.Leu902=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001094247	16	2126135	16	2076134	1094247	1081819	rs2151388216	NC_000016.10:2076133:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2707C>A (p.Pro903Thr)	TSC2	P854T, P703T, P914T, P866T, P903T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001516394	16	2126136	16	2076135	1516394	1499048	rs2089324682	NC_000016.10:2076134:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2707C>T (p.Pro903Ser)	TSC2	P866S, P903S, P703S, P854S, P914S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000852624	16	2126136	16	2076135	852624	843431	rs2089324682	NC_000016.10:2076134:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2708C>T (p.Pro903Leu)	TSC2	P455L, P884L, P914L, P866L, P899L, P933L, P369L, P903L, P703L, P749L, P854L	Tuberous sclerosis 2	VCV002762661	16	2126137	16	2076136	2762661	2931155	rs2151388289	NC_000016.10:2076135:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2709C>A (p.Pro903=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001557997	16	2126138	16	2076137	1557997	1541016	rs780558633	NC_000016.10:2076136:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2709C>T (p.Pro903=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001148869	16	2126138	16	2076137	1148869	1145941	rs780558633	NC_000016.10:2076136:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2710T>C (p.Phe904Leu)	TSC2	F370L, F456L, F704L, F750L, F855L, F867L, F885L, F900L, F904L, F915L, F934L	Tuberous sclerosis 2	VCV004071225	16	2126139	16	2076138	4071225	4185073		NC_000016.10:2076137:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2710T>G (p.Phe904Val)	TSC2	F855V, F704V, F867V, F904V, F915V	Tuberous sclerosis 2	VCV001512406	16	2126139	16	2076138	1512406	1478656	rs2151388349	NC_000016.10:2076137:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2711T>G (p.Phe904Cys)	TSC2	F370C, F885C, F900C, F915C, F904C, F704C, F855C, F934C, F456C, F750C, F867C	Hereditary cancer-predisposing syndrome	VCV001795083	16	2126140	16	2076139	1795083	1849292	rs2089325564	NC_000016.10:2076138:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2711T>C (p.Phe904Ser)	TSC2	F904S, F704S, F915S, F855S, F867S	Tuberous sclerosis 2	VCV000943498	16	2126140	16	2076139	943498	937310	rs2089325564	NC_000016.10:2076138:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2712C>T (p.Phe904=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001638638	16	2126141	16	2076140	1638638	1624324	rs137920189	NC_000016.10:2076139:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2712C>A (p.Phe904Leu)	TSC2	F704L, F855L, F867L, F904L, F915L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001007392	16	2126141	16	2076140	1007392	996730	rs137920189	NC_000016.10:2076139:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2712C>G (p.Phe904Leu)	TSC2	F904L, F915L, F855L, F867L, F704L	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207673	16	2126141	16	2076140	207673	203153	rs137920189	NC_000016.10:2076139:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2713C>G (p.Arg905Gly)	TSC2	R905G, R868G, R916G, R856G, R705G	not provided	VCV000012405	16	2126142	16	2076141	12405	27444	rs45517258	NC_000016.10:2076140:C:G	single nucleotide variant	missense variant	Pathogenic	Apr 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2713C>T (p.Arg905Trp)	TSC2	R905W, R868W, R916W, R856W, R705W	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000012404	16	2126142	16	2076141	12404	27443	rs45517258	NC_000016.10:2076140:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2714G>A (p.Arg905Gln)	TSC2	R905Q, R705Q, R868Q, R856Q, R916Q	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|TSC2-related disorder|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000012403	16	2126143	16	2076142	12403	27442	rs45517259	NC_000016.10:2076141:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2716A>G (p.Lys906Glu)	TSC2	K372E, K752E, K902E, K936E, K458E, K706E, K869E, K887E, K906E, K917E, K857E	Tuberous sclerosis 2	VCV002092647	16	2126145	16	2076144	2092647	2145390	rs397515243	NC_000016.10:2076143:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2717A>C (p.Lys906Thr)	TSC2	K458T, K917T, K936T, K752T, K887T, K906T, K372T, K706T, K857T, K869T, K902T	Hereditary cancer-predisposing syndrome	VCV002564685	16	2126146	16	2076145	2564685	2733841	rs2089327881	NC_000016.10:2076144:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2718G>T (p.Lys906Asn)	TSC2	K372N, K458N, K706N, K752N, K857N, K869N, K887N, K902N, K906N, K917N, K936N	not provided	VCV003369743	16	2126147	16	2076146	3369743	3528934		NC_000016.10:2076145:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2719G>A (p.Asp907Asn)	TSC2	D707N, D918N, D858N, D870N, D907N	Hereditary cancer-predisposing syndrome	VCV000821708	16	2126148	16	2076147	821708	812553	rs1287273870	NC_000016.10:2076146:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2719G>T (p.Asp907Tyr)	TSC2	D907Y, D707Y, D918Y, D870Y, D858Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000467959	16	2126148	16	2076147	467959	465961	rs1287273870	NC_000016.10:2076146:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2720A>G (p.Asp907Gly)	TSC2	D707G, D858G, D870G, D907G, D918G	not provided|Tuberous sclerosis 2	VCV001193421	16	2126149	16	2076148	1193421	1185072	rs2151388705	NC_000016.10:2076147:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2721T>A (p.Asp907Glu)	TSC2	D707E, D858E, D870E, D907E, D918E	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001010039	16	2126150	16	2076149	1010039	996731	rs2089328474	NC_000016.10:2076148:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2722T>C (p.Phe908Leu)	TSC2	F754L, F904L, F871L, F460L, F708L, F889L, F908L, F374L, F859L, F919L, F938L	Tuberous sclerosis 2	VCV002100443	16	2126151	16	2076150	2100443	2154459	rs2151388791	NC_000016.10:2076149:T:C	single nucleotide variant	missense variant	Uncertain significance	May 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2725G>A (p.Val909Ile)	TSC2	V461I, V890I, V905I, V375I, V709I, V920I, V909I, V939I, V755I, V860I, V872I	Tuberous sclerosis 2	VCV002131864	16	2126154	16	2076153	2131864	2189852	rs2151388847	NC_000016.10:2076152:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2726T>A (p.Val909Asp)	TSC2	V890D, V709D, V755D, V872D, V909D, V939D, V375D, V860D, V920D, V461D, V905D	Tuberous sclerosis 2|not provided	VCV002736292	16	2126155	16	2076154	2736292	2894984	rs2151388871	NC_000016.10:2076153:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2727C>G (p.Val909=)	TSC2		Tuberous sclerosis 2	VCV001156769	16	2126156	16	2076155	1156769	1145942	rs2151388902	NC_000016.10:2076154:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2727C>T (p.Val909=)	TSC2		Tuberous sclerosis 2	VCV001097883	16	2126156	16	2076155	1097883	1081820	rs2151388902	NC_000016.10:2076154:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2728C>A (p.Pro910Thr)	TSC2	P861T, P921T, P940T, P710T, P891T, P462T, P756T, P906T, P376T, P873T, P910T	Hereditary cancer-predisposing syndrome	VCV003811379	16	2126157	16	2076156	3811379	3928620		NC_000016.10:2076155:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2728C>T (p.Pro910Ser)	TSC2	P710S, P921S, P873S, P861S, P910S	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000953559	16	2126157	16	2076156	953559	949247	rs1319146226	NC_000016.10:2076155:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2729C>A (p.Pro910His)	TSC2	P910H, P376H, P710H, P861H, P891H, P921H, P906H, P462H, P756H, P873H, P940H	Tuberous sclerosis 2	VCV003637207	16	2126158	16	2076157	3637207	3771361		NC_000016.10:2076156:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2729C>T (p.Pro910Leu)	TSC2	P376L, P873L, P906L, P462L, P891L, P756L, P940L, P710L, P861L, P910L, P921L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002098452	16	2126158	16	2076157	2098452	2157648	rs2089329428	NC_000016.10:2076156:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2729C>G (p.Pro910Arg)	TSC2	P376R, P906R, P861R, P462R, P756R, P873R, P710R, P891R, P910R, P921R, P940R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001795258	16	2126158	16	2076157	1795258	1853920	rs2089329428	NC_000016.10:2076156:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2732T>C (p.Phe911Ser)	TSC2	F862S, F911S, F922S, F711S, F874S	Tuberous sclerosis 2	VCV000940202	16	2126161	16	2076160	940202	937311	rs774758044	NC_000016.10:2076159:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2732T>G (p.Phe911Cys)	TSC2	F874C, F711C, F911C, F922C, F862C	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II	VCV000663652	16	2126161	16	2076160	663652	644251	rs774758044	NC_000016.10:2076159:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2733C>T (p.Phe911=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000821732	16	2126162	16	2076161	821732	812554	rs1596367012	NC_000016.10:2076160:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2734A>C (p.Ile912Leu)	TSC2	I912L, I923L, I942L, I378L, I464L, I712L, I758L, I863L, I875L, I893L, I908L	Isolated focal cortical dysplasia type II	VCV002679330	16	2126163	16	2076162	2679330	2836907	rs748461293	NC_000016.10:2076161:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2734A>G (p.Ile912Val)	TSC2	I712V, I863V, I875V, I912V, I923V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001057525	16	2126163	16	2076162	1057525	1049449	rs748461293	NC_000016.10:2076161:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2735T>C (p.Ile912Thr)	TSC2	I942T, I863T, I875T, I893T, I378T, I712T, I912T, I464T, I758T, I908T, I923T	Tuberous sclerosis 2	VCV002910388	16	2126164	16	2076163	2910388	3072860	rs2151389141	NC_000016.10:2076162:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2736C>T (p.Ile912=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000759227	16	2126165	16	2076164	759227	770713	rs1366613803	NC_000016.10:2076163:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2737A>G (p.Thr913Ala)	TSC2	T379A, T913A, T924A, T465A, T713A, T876A, T943A, T759A, T864A, T894A, T909A	Hereditary cancer-predisposing syndrome	VCV001795357	16	2126166	16	2076165	1795357	1854018	rs772378578	NC_000016.10:2076164:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2737A>C (p.Thr913Pro)	TSC2	T713P, T924P, T379P, T894P, T943P, T465P, T759P, T864P, T876P, T909P, T913P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001795355	16	2126166	16	2076165	1795355	1854016	rs772378578	NC_000016.10:2076164:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2737A>T (p.Thr913Ser)	TSC2	T913S, T924S, T713S, T864S, T876S	Tuberous sclerosis 2	VCV001466640	16	2126166	16	2076165	1466640	1347998	rs772378578	NC_000016.10:2076164:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2738C>T (p.Thr913Ile)	TSC2	T465I, T759I, T864I, T894I, T909I, T379I, T713I, T876I, T943I, T913I, T924I	Tuberous sclerosis 2	VCV002699303	16	2126167	16	2076166	2699303	2865426	rs2151389251	NC_000016.10:2076165:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2738C>G (p.Thr913Ser)	TSC2	T713S, T876S, T913S, T924S, T864S	Tuberous sclerosis 2	VCV001470920	16	2126167	16	2076166	1470920	1395147	rs2151389251	NC_000016.10:2076165:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2739T>C (p.Thr913=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467961	16	2126168	16	2076167	467961	465972	rs773285889	NC_000016.10:2076166:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2740A>C (p.Lys914Gln)	TSC2	K914Q, K865Q, K714Q, K925Q, K877Q	not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535953	16	2126169	16	2076168	535953	529660	rs1422374195	NC_000016.10:2076167:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2741A>C (p.Lys914Thr)	TSC2	K865T, K877T, K714T, K914T, K925T	Tuberous sclerosis 2	VCV000941108	16	2126170	16	2076169	941108	937312	rs1405342761	NC_000016.10:2076168:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742G>A (p.Lys914=)	TSC2		not provided|Tuberous sclerosis 2	VCV000050103	16	2126171	16	2076170	50103	59265	rs137854877	NC_000016.10:2076169:G:A	single nucleotide variant	synonymous variant	Pathogenic/Likely pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+1G>A	TSC2		Tuberous sclerosis 2	VCV000049746	16	2126172	16	2076171	49746	58908	rs45517262	NC_000016.10:2076170:G:A	single nucleotide variant	splice donor variant	Pathogenic	Jan 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742+3G>C	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001461416	16	2126174	16	2076173	1461416	1498247	rs373935836	NC_000016.10:2076172:G:C	single nucleotide variant	intron variant	Uncertain significance	Mar 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+3G>A	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535860	16	2126174	16	2076173	535860	529944	rs373935836	NC_000016.10:2076172:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2742+4G>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000943293	16	2126175	16	2076174	943293	940349	rs587781683	NC_000016.10:2076173:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2742+4G>A	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000141356	16	2126175	16	2076174	141356	151070	rs587781683	NC_000016.10:2076173:G:A	single nucleotide variant	intron variant	Benign/Likely benign	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+5G>C	TSC2		Tuberous sclerosis 2	VCV001801724	16	2126176	16	2076175	1801724	1858916	rs397515076	NC_000016.10:2076174:G:C	single nucleotide variant	intron variant	Pathogenic	Nov 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742+5G>A	TSC2		Tuberous sclerosis 2	VCV000065101	16	2126176	16	2076175	65101	76032	rs397515076	NC_000016.10:2076174:G:A	single nucleotide variant	intron variant	Pathogenic	Feb 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742+6C>T	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000406063	16	2126177	16	2076176	406063	400874	rs377568673	NC_000016.10:2076175:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2742+6C>G	TSC2		not provided|Tuberous sclerosis 2	VCV000384425	16	2126177	16	2076176	384425	375182	rs377568673	NC_000016.10:2076175:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2742+7T>C	TSC2		Tuberous sclerosis 2	VCV001117253	16	2126178	16	2076177	1117253	1103644	rs2151389494	NC_000016.10:2076176:T:C	single nucleotide variant	intron variant	Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+8C>G	TSC2		Tuberous sclerosis 2	VCV001617340	16	2126179	16	2076178	1617340	1548417	rs1596367157	NC_000016.10:2076177:C:G	single nucleotide variant	intron variant	Likely benign	Aug 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742+8C>T	TSC2		Tuberous sclerosis 2	VCV000760032	16	2126179	16	2076178	760032	776128	rs1596367157	NC_000016.10:2076177:C:T	single nucleotide variant	intron variant	Likely benign	Jul 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742+10G>A	TSC2		Tuberous sclerosis 2	VCV001652760	16	2126181	16	2076180	1652760	1579260	rs2151389563	NC_000016.10:2076179:G:A	single nucleotide variant	intron variant	Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+11G>A	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001657974	16	2126182	16	2076181	1657974	1593975	rs1256570311	NC_000016.10:2076180:G:A	single nucleotide variant	intron variant	Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+12G>A	TSC2		Tuberous sclerosis 2	VCV001583988	16	2126183	16	2076182	1583988	1528434	rs2089335458	NC_000016.10:2076181:G:A	single nucleotide variant	intron variant	Likely benign	Apr 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742+13C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome	VCV000049557	16	2126184	16	2076183	49557	58719	rs45517260	NC_000016.10:2076182:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+14C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000384426	16	2126185	16	2076184	384426	374768	rs765251896	NC_000016.10:2076183:C:T	single nucleotide variant	intron variant	Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+15G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000049558	16	2126186	16	2076185	49558	58720	rs45517261	NC_000016.10:2076184:G:A	single nucleotide variant	intron variant	Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+16G>T	TSC2		Tuberous sclerosis 2	VCV002989873	16	2126187	16	2076186	2989873	3147602	rs2151389690	NC_000016.10:2076185:G:T	single nucleotide variant	intron variant	Likely benign	Aug 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742+16G>A	TSC2		Tuberous sclerosis 2	VCV002913263	16	2126187	16	2076186	2913263	3079303	rs2151389690	NC_000016.10:2076185:G:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742+20A>G	TSC2		Tuberous sclerosis 2	VCV001376810	16	2126191	16	2076190	1376810	1479674	rs1057521395	NC_000016.10:2076189:A:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2742+20A>C	TSC2		not specified|Tuberous sclerosis 2	VCV000382592	16	2126191	16	2076190	382592	374097	rs1057521395	NC_000016.10:2076189:A:C	single nucleotide variant	intron variant	Likely benign	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2742+33C>T	TSC2		not specified	VCV003911128	16	2126204	16	2076203	3911128	4025104		NC_000016.10:2076202:C:T	single nucleotide variant	intron variant	Benign	Feb 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-40A>G	TSC2		not specified|not provided	VCV000049756	16	2126452	16	2076451	49756	58918	rs45517265	NC_000016.10:2076450:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Jun 21, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-20G>A	TSC2		Tuberous sclerosis 2	VCV001393197	16	2126472	16	2076471	1393197	1402924	rs2089393160	NC_000016.10:2076470:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-19G>T	TSC2		Tuberous sclerosis 2	VCV002105916	16	2126473	16	2076472	2105916	2166377	rs539121865	NC_000016.10:2076471:G:T	single nucleotide variant	intron variant	Likely benign	Nov 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-19G>C	TSC2		Tuberous sclerosis 2	VCV001556870	16	2126473	16	2076472	1556870	1593014	rs539121865	NC_000016.10:2076471:G:C	single nucleotide variant	intron variant	Likely benign	Nov 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-19G>A	TSC2		not specified|Tuberous sclerosis 2	VCV000378785	16	2126473	16	2076472	378785	374100	rs539121865	NC_000016.10:2076471:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-18G>T	TSC2		Tuberous sclerosis 2	VCV001624207	16	2126474	16	2076473	1624207	1563046	rs199539512	NC_000016.10:2076472:G:T	single nucleotide variant	intron variant	Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-18G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000512449	16	2126474	16	2076473	512449	505208	rs199539512	NC_000016.10:2076472:G:A	single nucleotide variant	intron variant	Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-17T>G	TSC2		Tuberous sclerosis 2	VCV001612627	16	2126475	16	2076474	1612627	1601710	rs1057375876	NC_000016.10:2076473:T:G	single nucleotide variant	intron variant	Likely benign	Nov 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-16G>T	TSC2		Tuberous sclerosis 2	VCV004071183	16	2126476	16	2076475	4071183	4185031		NC_000016.10:2076474:G:T	single nucleotide variant	intron variant	Likely benign	May 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-16G>A	TSC2		not specified|Tuberous sclerosis 2	VCV000507120	16	2126476	16	2076475	507120	506167	rs896016432	NC_000016.10:2076474:G:A	single nucleotide variant	intron variant	Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-15T>C	TSC2		Tuberous sclerosis 2	VCV001547763	16	2126477	16	2076476	1547763	1624837	rs2089396082	NC_000016.10:2076475:T:C	single nucleotide variant	intron variant	Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-13C>T	TSC2		Tuberous sclerosis 2	VCV002877027	16	2126479	16	2076478	2877027	3033132	rs2089396453	NC_000016.10:2076477:C:T	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-13C>G	TSC2		Tuberous sclerosis 2	VCV001550623	16	2126479	16	2076478	1550623	1574312	rs2089396453	NC_000016.10:2076477:C:G	single nucleotide variant	intron variant	Likely benign	Nov 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-11C>A	TSC2		Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002843173	16	2126481	16	2076480	2843173	2994045	rs137854426	NC_000016.10:2076479:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2743-11C>G	TSC2		Tuberous sclerosis 2	VCV001582586	16	2126481	16	2076480	1582586	1566856	rs137854426	NC_000016.10:2076479:C:G	single nucleotide variant	intron variant	Likely benign	Oct 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-11C>T	TSC2		Tuberous sclerosis 2	VCV000049559	16	2126481	16	2076480	49559	58721	rs137854426	NC_000016.10:2076479:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-10A>C	TSC2		Tuberous sclerosis 2	VCV002057145	16	2126482	16	2076481	2057145	2105967	rs1060504094	NC_000016.10:2076480:A:C	single nucleotide variant	intron variant	Likely benign	Mar 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-10A>G	TSC2		Tuberous sclerosis 2|not provided	VCV000413659	16	2126482	16	2076481	413659	400754	rs1060504094	NC_000016.10:2076480:A:G	single nucleotide variant	intron variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-9C>T	TSC2		Tuberous sclerosis 2|not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000389808	16	2126483	16	2076482	389808	377231	rs397515319	NC_000016.10:2076481:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-9C>G	TSC2		Tuberous sclerosis 2|not provided	VCV000065300	16	2126483	16	2076482	65300	76232	rs397515319	NC_000016.10:2076481:C:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Jul 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-8T>C	TSC2		Tuberous sclerosis 2	VCV002007473	16	2126484	16	2076483	2007473	2073134	rs2543927839	NC_000016.10:2076482:T:C	single nucleotide variant	intron variant	Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-7C>A	TSC2		Tuberous sclerosis 2	VCV002025570	16	2126485	16	2076484	2025570	2080918	rs566118686	NC_000016.10:2076483:C:A	single nucleotide variant	intron variant	Likely benign	May 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-7C>T	TSC2		Tuberous sclerosis 2	VCV000756257	16	2126485	16	2076484	756257	776158	rs566118686	NC_000016.10:2076483:C:T	single nucleotide variant	intron variant	Likely benign	Sep 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-7C>G	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207674	16	2126485	16	2076484	207674	203154	rs566118686	NC_000016.10:2076483:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-5G>C	TSC2		Hereditary cancer-predisposing syndrome	VCV003232123	16	2126487	16	2076486	3232123	3391924	rs2089398808	NC_000016.10:2076485:G:C	single nucleotide variant	intron variant	Uncertain significance	Dec 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-5G>T	TSC2		Hereditary cancer-predisposing syndrome	VCV001795461	16	2126487	16	2076486	1795461	1854120	rs2089398808	NC_000016.10:2076485:G:T	single nucleotide variant	intron variant	Likely benign	May 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-4C>A	TSC2		Tuberous sclerosis 2	VCV001101263	16	2126488	16	2076487	1101263	1103645	rs1258692002	NC_000016.10:2076486:C:A	single nucleotide variant	intron variant	Likely benign	Jul 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-4C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000467962	16	2126488	16	2076487	467962	466151	rs1258692002	NC_000016.10:2076486:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2743-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002165662	16	2126489	16	2076488	2165662	1906079	rs45517264	NC_000016.10:2076487:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2743-3C>A	TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not specified	VCV000049229	16	2126489	16	2076488	49229	58391	rs45517264	NC_000016.10:2076487:C:A	single nucleotide variant	intron variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-1G>T	TSC2		Tuberous sclerosis 2	VCV001372985	16	2126491	16	2076490	1372985	1440363	rs45517263	NC_000016.10:2076489:G:T	single nucleotide variant	splice acceptor variant	Pathogenic	Aug 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2743-1G>C	TSC2		not provided|Tuberous sclerosis 2	VCV000049561	16	2126491	16	2076490	49561	58723	rs45517263	NC_000016.10:2076489:G:C	single nucleotide variant	splice acceptor variant	Pathogenic	Aug 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743-1G>A	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049560	16	2126491	16	2076490	49560	58722	rs45517263	NC_000016.10:2076489:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2743G>A (p.Gly915Ser)	TSC2	G381S, G896S, G911S, G915S, G926S, G878S, G467S, G761S, G866S, G945S, G715S	Tuberous sclerosis 2	VCV002825896	16	2126492	16	2076491	2825896	2979289	rs2543928232	NC_000016.10:2076490:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2744G>A (p.Gly915Asp)	TSC2	G381D, G467D, G715D, G761D, G866D, G878D, G896D, G911D, G915D, G926D, G945D	Hereditary cancer-predisposing syndrome	VCV003345618	16	2126493	16	2076492	3345618	3506592		NC_000016.10:2076491:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2744G>T (p.Gly915Val)	TSC2	G381V, G467V, G715V, G761V, G866V, G878V, G896V, G911V, G915V, G926V, G945V	Tuberous sclerosis 2	VCV001718263	16	2126493	16	2076492	1718263	1778623	rs2089400486	NC_000016.10:2076491:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2745C>T (p.Gly915=)	TSC2		Tuberous sclerosis 2	VCV001500878	16	2126494	16	2076493	1500878	1501800	rs2151393775	NC_000016.10:2076492:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2746C>A (p.Leu916Met)	TSC2	L716M, L867M, L879M, L916M, L927M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001062050	16	2126495	16	2076494	1062050	1049450	rs137854274	NC_000016.10:2076493:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2746C>T (p.Leu916=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049230	16	2126495	16	2076494	49230	58392	rs137854274	NC_000016.10:2076493:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2747T>C (p.Leu916Pro)	TSC2	L916P, L867P, L927P, L716P, L879P	not provided	VCV000448726	16	2126496	16	2076495	448726	441786	rs137854405	NC_000016.10:2076494:T:C	single nucleotide variant	missense variant	Pathogenic	Sep 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2748G>A (p.Leu916=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000467963	16	2126497	16	2076496	467963	466152	rs757674443	NC_000016.10:2076495:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2749C>T (p.Arg917Trp)	TSC2	R917W, R880W, R717W, R868W, R928W	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000467964	16	2126498	16	2076497	467964	465865	rs781587135	NC_000016.10:2076496:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2750G>C (p.Arg917Pro)	TSC2	R917P, R928P, R717P, R868P, R880P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406098	16	2126499	16	2076498	406098	400756	rs397515046	NC_000016.10:2076497:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2750G>A (p.Arg917Gln)	TSC2	R917Q, R717Q, R880Q, R868Q, R928Q	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000065065	16	2126499	16	2076498	65065	75995	rs397515046	NC_000016.10:2076497:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2751G>T (p.Arg917=)	TSC2		Tuberous sclerosis 2	VCV001996574	16	2126500	16	2076499	1996574	2053649	rs1555508897	NC_000016.10:2076498:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2751G>A (p.Arg917=)	TSC2		Tuberous sclerosis 2|not specified	VCV000507242	16	2126500	16	2076499	507242	505706	rs1555508897	NC_000016.10:2076498:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2754C>T (p.Ser918=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002842370	16	2126503	16	2076502	2842370	3000907	rs756264848	NC_000016.10:2076501:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2755A>G (p.Asn919Asp)	TSC2	N765D, N882D, N915D, N930D, N719D, N919D, N949D, N900D, N385D, N471D, N870D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV002624599	16	2126504	16	2076503	2624599	2793688	rs2089403036	NC_000016.10:2076502:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2756A>T (p.Asn919Ile)	TSC2	N870I, N919I, N719I, N882I, N930I	Tuberous sclerosis 2	VCV000940315	16	2126505	16	2076504	940315	937313	rs780057014	NC_000016.10:2076503:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2756A>G (p.Asn919Ser)	TSC2	N919S, N882S, N930S, N719S, N870S	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000207735	16	2126505	16	2076504	207735	203155	rs780057014	NC_000016.10:2076503:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2758G>T (p.Val920Phe)	TSC2	V386F, V883F, V916F, V920F, V472F, V720F, V766F, V931F, V871F, V901F, V950F	Hereditary cancer-predisposing syndrome	VCV002449954	16	2126507	16	2076506	2449954	2429580	rs2151394156	NC_000016.10:2076505:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2758G>A (p.Val920Ile)	TSC2	V883I, V920I, V720I, V871I, V931I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001364357	16	2126507	16	2076506	1364357	1386296	rs2151394156	NC_000016.10:2076505:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2759T>C (p.Val920Ala)	TSC2	V920A, V931A, V871A, V720A, V883A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000467965	16	2126508	16	2076507	467965	465974	rs749383639	NC_000016.10:2076506:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2760C>A (p.Val920=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000467966	16	2126509	16	2076508	467966	466161	rs149490538	NC_000016.10:2076507:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2760C>T (p.Val920=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184267	16	2126509	16	2076508	184267	184134	rs149490538	NC_000016.10:2076507:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2761C>A (p.Leu921Ile)	TSC2	L387I, L473I, L721I, L767I, L872I, L884I, L902I, L917I, L921I, L932I, L951I	not provided	VCV003365131	16	2126510	16	2076509	3365131	3524338		NC_000016.10:2076508:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2761C>T (p.Leu921Phe)	TSC2	L721F, L872F, L884F, L921F, L932F	Tuberous sclerosis 2	VCV001056742	16	2126510	16	2076509	1056742	1049451	rs201835391	NC_000016.10:2076508:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2761C>G (p.Leu921Val)	TSC2	L921V, L884V, L721V, L932V, L872V	not specified|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000135375	16	2126510	16	2076509	135375	139114	rs201835391	NC_000016.10:2076508:C:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2763C>A (p.Leu921=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002960257	16	2126512	16	2076511	2960257	3126265	rs771817176	NC_000016.10:2076510:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2763C>G (p.Leu921=)	TSC2		Tuberous sclerosis 2	VCV001132203	16	2126512	16	2076511	1132203	1125061	rs771817176	NC_000016.10:2076510:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2763C>T (p.Leu921=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486647	16	2126512	16	2076511	486647	477333	rs771817176	NC_000016.10:2076510:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2764T>C (p.Leu922=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462683	16	2126513	16	2076512	3462683	3621702		NC_000016.10:2076511:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2764T>G (p.Leu922Val)	TSC2	L722V, L873V, L885V, L933V, L922V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000957427	16	2126513	16	2076512	957427	949248	rs2089404994	NC_000016.10:2076511:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2765T>G (p.Leu922Trp)	TSC2	L388W, L768W, L885W, L918W, L952W, L903W, L933W, L474W, L722W, L873W, L922W	Tuberous sclerosis 2	VCV003637208	16	2126514	16	2076513	3637208	3771362		NC_000016.10:2076512:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2765T>A (p.Leu922Ter)	TSC2	L873*, L922*, L933*, L918*, L952*, L388*, L474*, L722*, L768*, L903*, L885*	Tuberous sclerosis 2	VCV002697524	16	2126514	16	2076513	2697524	2864921	rs2543929566	NC_000016.10:2076512:T:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Nov 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2766G>C (p.Leu922Phe)	TSC2	L388F, L474F, L722F, L918F, L922F, L768F, L933F, L873F, L885F, L903F, L952F	Hereditary cancer-predisposing syndrome	VCV001795744	16	2126515	16	2076514	1795744	1853103	rs772858520	NC_000016.10:2076513:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2766G>A (p.Leu922=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000702472	16	2126515	16	2076514	702472	693812	rs772858520	NC_000016.10:2076513:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2768C>T (p.Ser923Phe)	TSC2	S874F, S934F, S886F, S723F, S923F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|not provided	VCV000643215	16	2126517	16	2076516	643215	644252	rs587778731	NC_000016.10:2076515:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2768C>G (p.Ser923Cys)	TSC2	S923C, S874C, S934C, S723C, S886C	Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135376	16	2126517	16	2076516	135376	139115	rs587778731	NC_000016.10:2076515:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2771T>C (p.Phe924Ser)	TSC2	F887S, F476S, F875S, F954S, F770S, F905S, F390S, F724S, F920S, F924S, F935S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001795818	16	2126520	16	2076519	1795818	1853177	rs2543929873	NC_000016.10:2076518:T:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2772T>G (p.Phe924Leu)	TSC2	F390L, F476L, F724L, F770L, F875L, F887L, F905L, F920L, F924L, F935L, F954L	Tuberous sclerosis syndrome	VCV003072544	16	2126521	16	2076520	3072544	3230985	rs2089406887	NC_000016.10:2076519:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2772T>C (p.Phe924=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001944998	16	2126521	16	2076520	1944998	1998697	rs2089406887	NC_000016.10:2076519:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2774A>G (p.Asp925Gly)	TSC2	D925G, D725G, D888G, D876G, D936G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467967	16	2126523	16	2076522	467967	466166	rs1555508942	NC_000016.10:2076521:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2775T>A (p.Asp925Glu)	TSC2	D771E, D888E, D921E, D391E, D876E, D906E, D936E, D955E, D477E, D725E, D925E	Tuberous sclerosis 2	VCV002767426	16	2126524	16	2076523	2767426	2923000	rs1596369419	NC_000016.10:2076522:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2775T>C (p.Asp925=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000746267	16	2126524	16	2076523	746267	754994	rs1596369419	NC_000016.10:2076522:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2776G>T (p.Asp926Tyr)	TSC2	D726Y, D877Y, D926Y, D937Y, D889Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000821786	16	2126525	16	2076524	821786	812555	rs766039435	NC_000016.10:2076523:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2778C>T (p.Asp926=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000389861	16	2126527	16	2076526	389861	374101	rs776069297	NC_000016.10:2076525:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2779A>T (p.Thr927Ser)	TSC2	T393S, T479S, T727S, T773S, T878S, T890S, T908S, T923S, T927S, T938S, T957S	Hereditary cancer-predisposing syndrome	VCV003232124	16	2126528	16	2076527	3232124	3391925	rs1420034406	NC_000016.10:2076526:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2779A>G (p.Thr927Ala)	TSC2	T393A, T727A, T878A, T908A, T923A, T938A, T890A, T479A, T927A, T957A, T773A	Hereditary cancer-predisposing syndrome	VCV002454129	16	2126528	16	2076527	2454129	2424018	rs1420034406	NC_000016.10:2076526:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2779A>C (p.Thr927Pro)	TSC2	T727P, T878P, T927P, T938P, T890P	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000934044	16	2126528	16	2076527	934044	937314	rs1420034406	NC_000016.10:2076526:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2780C>G (p.Thr927Ser)	TSC2	T773S, T957S, T393S, T727S, T878S, T479S, T890S, T923S, T927S, T908S, T938S	Tuberous sclerosis 2	VCV003020528	16	2126529	16	2076528	3020528	3179436	rs144329595	NC_000016.10:2076527:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2780C>A (p.Thr927Asn)	TSC2	T938N, T878N, T890N, T727N, T927N	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000952008	16	2126529	16	2076528	952008	927655	rs144329595	NC_000016.10:2076527:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2780C>T (p.Thr927Ile)	TSC2	T927I, T727I, T878I, T938I, T890I	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486602	16	2126529	16	2076528	486602	477351	rs144329595	NC_000016.10:2076527:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2781C>A (p.Thr927=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001083556	16	2126530	16	2076529	1083556	1081821	rs376275903	NC_000016.10:2076528:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2781C>T (p.Thr927=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000137743	16	2126530	16	2076529	137743	141446	rs376275903	NC_000016.10:2076528:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2782C>T (p.Pro928Ser)	TSC2	P394S, P728S, P924S, P939S, P909S, P958S, P480S, P774S, P891S, P879S, P928S	Tuberous sclerosis 2	VCV003637209	16	2126531	16	2076530	3637209	3771363		NC_000016.10:2076529:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2782C>G (p.Pro928Ala)	TSC2	P480A, P728A, P909A, P924A, P928A, P939A, P394A, P774A, P879A, P891A, P958A	Tuberous sclerosis 2	VCV002076121	16	2126531	16	2076530	2076121	2141793	rs2543930637	NC_000016.10:2076529:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2783C>G (p.Pro928Arg)	TSC2	P728R, P879R, P891R, P928R, P939R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001052659	16	2126532	16	2076531	1052659	1049452	rs2151394997	NC_000016.10:2076530:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2784C>T (p.Pro928=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000137744	16	2126533	16	2076532	137744	141447	rs45517267	NC_000016.10:2076531:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2784C>G (p.Pro928=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049231	16	2126533	16	2076532	49231	58393	rs45517267	NC_000016.10:2076531:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2785G>A (p.Glu929Lys)	TSC2	E929K, E880K, E729K, E892K, E940K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000480854	16	2126534	16	2076533	480854	477352	rs45517268	NC_000016.10:2076532:G:A	single nucleotide variant	missense variant	Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2785G>T (p.Glu929Ter)	TSC2	E929*, E892*, E729*, E880*, E940*	not provided	VCV000049782	16	2126534	16	2076533	49782	58944	rs45517268	NC_000016.10:2076532:G:T	single nucleotide variant	nonsense	Pathogenic	Feb 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2786A>G (p.Glu929Gly)	TSC2	E892G, E929G, E729G, E880G, E940G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001364822	16	2126535	16	2076534	1364822	1409303	rs2151395129	NC_000016.10:2076533:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2787G>A (p.Glu929=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001637445	16	2126536	16	2076535	1637445	1525473	rs968144525	NC_000016.10:2076534:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2787G>T (p.Glu929Asp)	TSC2	E929D, E892D, E729D, E880D, E940D	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000574701	16	2126536	16	2076535	574701	569744	rs968144525	NC_000016.10:2076534:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2788A>G (p.Lys930Glu)	TSC2	K893E, K930E, K941E, K730E, K881E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000703797	16	2126537	16	2076536	703797	465300	rs1596369527	NC_000016.10:2076535:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2790G>A (p.Lys930=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001641572	16	2126539	16	2076538	1641572	1585970	rs2151395271	NC_000016.10:2076537:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2792A>G (p.Asp931Gly)	TSC2	D731G, D882G, D894G, D931G, D942G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001011599	16	2126541	16	2076540	1011599	996732	rs2089411255	NC_000016.10:2076539:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2793C>A (p.Asp931Glu)	TSC2	D894E, D942E, D912E, D931E, D397E, D882E, D927E, D961E, D483E, D731E, D777E	Hereditary cancer-predisposing syndrome	VCV003811291	16	2126542	16	2076541	3811291	3928532		NC_000016.10:2076540:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2793C>T (p.Asp931=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001653013	16	2126542	16	2076541	1653013	1579513	rs2151395350	NC_000016.10:2076540:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2794A>G (p.Ser932Gly)	TSC2	S962G, S398G, S883G, S484G, S778G, S932G, S943G, S732G, S895G, S913G, S928G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002832741	16	2126543	16	2076542	2832741	2991285	rs2543931328	NC_000016.10:2076541:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2795G>C (p.Ser932Thr)	TSC2	S732T, S895T, S398T, S778T, S913T, S928T, S943T, S962T, S484T, S883T, S932T	Hereditary cancer-predisposing syndrome	VCV003462570	16	2126544	16	2076543	3462570	3621589		NC_000016.10:2076542:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2795G>T (p.Ser932Ile)	TSC2	S398I, S484I, S732I, S778I, S883I, S895I, S913I, S928I, S932I, S943I, S962I	Hereditary cancer-predisposing syndrome	VCV003232125	16	2126544	16	2076543	3232125	3391926	rs397515138	NC_000016.10:2076542:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2796C>T (p.Ser932=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001529389	16	2126545	16	2076544	1529389	1604104	rs2151395410	NC_000016.10:2076543:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2798T>G (p.Phe933Cys)	TSC2	F933C, F733C, F884C, F896C, F944C	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000049233	16	2126547	16	2076546	49233	58395	rs45517269	NC_000016.10:2076545:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2802G>A (p.Arg934=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001153637	16	2126551	16	2076550	1153637	1145943	rs2151395548	NC_000016.10:2076549:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2803G>T (p.Ala935Ser)	TSC2	A735S, A886S, A898S, A935S, A946S	Tuberous sclerosis 2	VCV001019623	16	2126552	16	2076551	1019623	1011968	rs979456797	NC_000016.10:2076550:G:T	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2803G>A (p.Ala935Thr)	TSC2	A946T, A735T, A898T, A935T, A886T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000843209	16	2126552	16	2076551	843209	843432	rs979456797	NC_000016.10:2076550:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2804C>A (p.Ala935Asp)	TSC2	A946D, A735D, A898D, A935D, A886D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000640310	16	2126553	16	2076552	640310	644253	rs1555508975	NC_000016.10:2076551:C:A	single nucleotide variant	missense variant	Uncertain significance	May 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2804C>T (p.Ala935Val)	TSC2	A935V, A735V, A946V, A886V, A898V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535886	16	2126553	16	2076552	535886	530178	rs1555508975	NC_000016.10:2076551:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2805C>T (p.Ala935=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001796258	16	2126554	16	2076553	1796258	1852693	rs2151395702	NC_000016.10:2076552:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2805C>G (p.Ala935=)	TSC2		Tuberous sclerosis 2	VCV001157392	16	2126554	16	2076553	1157392	1145944	rs2151395702	NC_000016.10:2076552:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2806C>G (p.Arg936Gly)	TSC2	R488G, R917G, R932G, R899G, R936G, R402G, R736G, R782G, R887G, R947G, R966G	Tuberous sclerosis 2	VCV003637210	16	2126555	16	2076554	3637210	3771364		NC_000016.10:2076553:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2806C>T (p.Arg936Trp)	TSC2	R936W, R899W, R947W, R887W, R736W	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001364631	16	2126555	16	2076554	1364631	1409112	rs2151395746	NC_000016.10:2076553:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2808G>A (p.Arg936=)	TSC2		Tuberous sclerosis 2	VCV004071112	16	2126557	16	2076556	4071112	4184960		NC_000016.10:2076555:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2808G>C (p.Arg936=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001923125	16	2126557	16	2076556	1923125	1979871	rs147003028	NC_000016.10:2076555:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2811T>C (p.Ser937=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449970	16	2126560	16	2076559	2449970	2429595	rs2543932236	NC_000016.10:2076558:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2811T>A (p.Ser937Arg)	TSC2	S783R, S937R, S489R, S967R, S737R, S888R, S403R, S900R, S918R, S933R, S948R	Hereditary cancer-predisposing syndrome	VCV001796342	16	2126560	16	2076559	1796342	1852777	rs2543932236	NC_000016.10:2076558:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2812A>C (p.Thr938Pro)	TSC2	T938P, T738P, T949P, T889P, T901P	Tuberous sclerosis 2	VCV000582208	16	2126561	16	2076560	582208	573821	rs1567486660	NC_000016.10:2076559:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2813C>T (p.Thr938Ile)	TSC2	T490I, T784I, T738I, T901I, T919I, T938I, T889I, T934I, T949I, T968I, T404I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001796352	16	2126562	16	2076561	1796352	1852787	rs2089413903	NC_000016.10:2076560:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2814T>C (p.Thr938=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001100182	16	2126563	16	2076562	1100182	1103646	rs950740348	NC_000016.10:2076561:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2817T>A (p.Ser939Arg)	TSC2	S939R, S890R, S950R, S739R, S902R	Tuberous sclerosis 2	VCV001510709	16	2126566	16	2076565	1510709	1465386	rs2151396025	NC_000016.10:2076564:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2818C>A (p.Leu940Ile)	TSC2	L891I, L921I, L940I, L786I, L936I, L406I, L740I, L970I, L492I, L903I, L951I	Hereditary cancer-predisposing syndrome	VCV001796392	16	2126567	16	2076566	1796392	1852827	rs1378325757	NC_000016.10:2076565:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2818C>G (p.Leu940Val)	TSC2	L406V, L492V, L740V, L786V, L891V, L903V, L921V, L936V, L940V, L951V, L970V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001718803	16	2126567	16	2076566	1718803	1776307	rs1378325757	NC_000016.10:2076565:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2818C>T (p.Leu940Phe)	TSC2	L903F, L940F, L891F, L740F, L951F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000665968	16	2126567	16	2076566	665968	644254	rs1378325757	NC_000016.10:2076565:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2820C>T (p.Leu940=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000821856	16	2126569	16	2076568	821856	812556	rs876659493	NC_000016.10:2076567:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2820C>G (p.Leu940=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000232013	16	2126569	16	2076568	232013	235116	rs876659493	NC_000016.10:2076567:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2821A>G (p.Asn941Asp)	TSC2	N941D, N741D, N892D, N904D, N952D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000238000	16	2126570	16	2076569	238000	242265	rs878854087	NC_000016.10:2076568:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2822A>G (p.Asn941Ser)	TSC2	N407S, N493S, N787S, N922S, N937S, N741S, N892S, N904S, N952S, N971S, N941S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002871534	16	2126571	16	2076570	2871534	3034712	rs2089415203	NC_000016.10:2076569:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2822A>C (p.Asn941Thr)	TSC2	N741T, N892T, N904T, N941T, N952T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001021603	16	2126571	16	2076570	1021603	1011969	rs2089415203	NC_000016.10:2076569:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2823C>G (p.Asn941Lys)	TSC2	N407K, N787K, N941K, N952K, N971K, N904K, N922K, N493K, N741K, N892K, N937K	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001946059	16	2126572	16	2076571	1946059	2002337	rs750806272	NC_000016.10:2076570:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2823C>T (p.Asn941=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000467972	16	2126572	16	2076571	467972	465869	rs750806272	NC_000016.10:2076570:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2824G>A (p.Glu942Lys)	TSC2	E408K, E494K, E742K, E788K, E893K, E905K, E923K, E938K, E942K, E953K, E972K	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003073008	16	2126573	16	2076572	3073008	3229279	rs45517270	NC_000016.10:2076571:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2824G>T (p.Glu942Ter)	TSC2	E942*, E742*, E905*, E953*, E893*	not specified|not provided|Tuberous sclerosis 2	VCV000049843	16	2126573	16	2076572	49843	59005	rs45517270	NC_000016.10:2076571:G:T	single nucleotide variant	nonsense	Pathogenic	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2825A>G (p.Glu942Gly)	TSC2	E942G, E742G, E905G, E893G, E953G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535970	16	2126574	16	2076573	535970	529664	rs1018951391	NC_000016.10:2076572:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2827A>C (p.Arg943=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462514	16	2126576	16	2076575	3462514	3621534		NC_000016.10:2076574:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2827A>T (p.Arg943Ter)	TSC2	R743*, R894*, R906*, R943*, R954*	Tuberous sclerosis 2	VCV000654223	16	2126576	16	2076575	654223	644255	rs1596369682	NC_000016.10:2076574:A:T	single nucleotide variant	nonsense	Pathogenic	Mar 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2828G>C (p.Arg943Thr)	TSC2	R906T, R954T, R409T, R894T, R973T, R743T, R924T, R495T, R789T, R939T, R943T	Tuberous sclerosis 2	VCV003637211	16	2126577	16	2076576	3637211	3771365		NC_000016.10:2076575:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2828G>A (p.Arg943Lys)	TSC2	R954K, R743K, R906K, R943K, R894K	not provided|Tuberous sclerosis 2	VCV001492417	16	2126577	16	2076576	1492417	1516555	rs1447031509	NC_000016.10:2076575:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2829A>T (p.Arg943Ser)	TSC2	R906S, R924S, R939S, R973S, R743S, R789S, R894S, R943S, R409S, R495S, R954S	Tuberous sclerosis 2	VCV003637212	16	2126578	16	2076577	3637212	3771366		NC_000016.10:2076576:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2832C>T (p.Pro944=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001674143	16	2126581	16	2076580	1674143	1617956	rs2151396371	NC_000016.10:2076579:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2832C>A (p.Pro944=)	TSC2		Tuberous sclerosis 2	VCV001671371	16	2126581	16	2076580	1671371	1530261	rs2151396371	NC_000016.10:2076579:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2832C>G (p.Pro944=)	TSC2		Tuberous sclerosis 2	VCV001154436	16	2126581	16	2076580	1154436	1145945	rs2151396371	NC_000016.10:2076579:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 12, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2834A>C (p.Lys945Thr)	TSC2	K896T, K926T, K497T, K745T, K941T, K945T, K908T, K975T, K411T, K791T, K956T	Hereditary cancer-predisposing syndrome	VCV001796620	16	2126583	16	2076582	1796620	1855195	rs886051791	NC_000016.10:2076581:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2834A>G (p.Lys945Arg)	TSC2	K945R, K956R, K896R, K745R, K908R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000318323	16	2126583	16	2076582	318323	342269	rs886051791	NC_000016.10:2076581:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2835G>A (p.Lys945=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001639581	16	2126584	16	2076583	1639581	1647169	rs780292534	NC_000016.10:2076582:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2836A>G (p.Ser946Gly)	TSC2	S946G, R957G, R946G, S909G, R746G, S897G	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV001398510	16	2126585	16	2076584	1398510	1427577	rs2151396480	NC_000016.10:2076583:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837G>A (p.Ser946Asn)	TSC2	S792N, S942N, S976N, R746K, R897K, R946K, S498N, S909N, R412K, R909K, R976K, S897N, R498K, R927K, R942K, R957K, S746N, S946N	Hereditary cancer-predisposing syndrome	VCV003811330	16	2126586	16	2076585	3811330	3928571		NC_000016.10:2076584:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+1G>A	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV001067682	16	2126587	16	2076586	1067682	1056295	rs45517271	NC_000016.10:2076585:G:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+3A>G	TSC2		Hereditary cancer-predisposing syndrome	VCV001796652	16	2126589	16	2076588	1796652	1855227	rs2543933870	NC_000016.10:2076587:A:G	single nucleotide variant	intron variant	Likely benign	Oct 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+4C>G	TSC2		Tuberous sclerosis 2	VCV001505751	16	2126590	16	2076589	1505751	1339482	rs544409858	NC_000016.10:2076588:C:G	single nucleotide variant	intron variant	Uncertain significance	Nov 26, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+4C>T	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406125	16	2126590	16	2076589	406125	401279	rs544409858	NC_000016.10:2076588:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2837+5G>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003010577	16	2126591	16	2076590	3010577	3173467	rs786203791	NC_000016.10:2076589:G:T	single nucleotide variant	intron variant	Uncertain significance	Mar 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+5G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000187511	16	2126591	16	2076590	187511	184135	rs786203791	NC_000016.10:2076589:G:A	single nucleotide variant	intron variant	Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+7C>T	TSC2		Tuberous sclerosis 2	VCV004071154	16	2126593	16	2076592	4071154	4185002		NC_000016.10:2076591:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+7C>G	TSC2		Tuberous sclerosis 2	VCV001153056	16	2126593	16	2076592	1153056	1145946	rs2089418654	NC_000016.10:2076591:C:G	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+8C>G	TSC2		Tuberous sclerosis 2	VCV002106198	16	2126594	16	2076593	2106198	2162665	rs1596369779	NC_000016.10:2076592:C:G	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+8C>T	TSC2		Tuberous sclerosis 2	VCV000793199	16	2126594	16	2076593	793199	788038	rs1596369779	NC_000016.10:2076592:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+9T>G	TSC2		Tuberous sclerosis 2	VCV001552603	16	2126595	16	2076594	1552603	1586682	rs912479360	NC_000016.10:2076593:T:G	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+9T>C	TSC2		Tuberous sclerosis 2	VCV000467973	16	2126595	16	2076594	467973	465875	rs912479360	NC_000016.10:2076593:T:C	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+10G>A	TSC2		not specified|Tuberous sclerosis 2	VCV001122967	16	2126596	16	2076595	1122967	1125062	rs1232454175	NC_000016.10:2076594:G:A	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+10G>T	TSC2		not provided|Tuberous sclerosis 2	VCV000995054	16	2126596	16	2076595	995054	982943	rs1232454175	NC_000016.10:2076594:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2837+11C>T	TSC2		Tuberous sclerosis 2	VCV001543836	16	2126597	16	2076596	1543836	1557991	rs754592874	NC_000016.10:2076595:C:T	single nucleotide variant	intron variant	Likely benign	Oct 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+12G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000380978	16	2126598	16	2076597	380978	374771	rs755041349	NC_000016.10:2076596:G:A	single nucleotide variant	intron variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2837+13G>C	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001610829	16	2126599	16	2076598	1610829	1585647	rs2089421033	NC_000016.10:2076597:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2837+14G>A	TSC2		Tuberous sclerosis 2	VCV002785038	16	2126600	16	2076599	2785038	2948340	rs975343086	NC_000016.10:2076598:G:A	single nucleotide variant	intron variant	Likely benign	Aug 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+14G>T	TSC2		Tuberous sclerosis 2	VCV001592644	16	2126600	16	2076599	1592644	1556690	rs975343086	NC_000016.10:2076598:G:T	single nucleotide variant	intron variant	Likely benign	Dec 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+14G>C	TSC2		Tuberous sclerosis 2	VCV001562413	16	2126600	16	2076599	1562413	1577477	rs975343086	NC_000016.10:2076598:G:C	single nucleotide variant	intron variant	Likely benign	Jan 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+15G>T	TSC2		Tuberous sclerosis 2	VCV003730750	16	2126601	16	2076600	3730750	3863085		NC_000016.10:2076599:G:T	single nucleotide variant	intron variant	Likely benign	May 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+15G>A	TSC2		Tuberous sclerosis 2	VCV002817217	16	2126601	16	2076600	2817217	2980875	rs2543934743	NC_000016.10:2076599:G:A	single nucleotide variant	intron variant	Likely benign	Nov 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+15G>C	TSC2		Tuberous sclerosis 2	VCV002019826	16	2126601	16	2076600	2019826	2086713	rs2543934743	NC_000016.10:2076599:G:C	single nucleotide variant	intron variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+16G>C	TSC2		Tuberous sclerosis 2	VCV002163015	16	2126602	16	2076601	2163015	1891432	rs397515095	NC_000016.10:2076600:G:C	single nucleotide variant	intron variant	Likely benign	Mar 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+16G>T	TSC2		Tuberous sclerosis 2	VCV001624683	16	2126602	16	2076601	1624683	1629302	rs397515095	NC_000016.10:2076600:G:T	single nucleotide variant	intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+16G>A	TSC2		Tuberous sclerosis 2	VCV000065128	16	2126602	16	2076601	65128	76059	rs397515095	NC_000016.10:2076600:G:A	single nucleotide variant	intron variant	Likely benign	Jul 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+17T>C	TSC2		Tuberous sclerosis 2	VCV002843329	16	2126603	16	2076602	2843329	3003984	rs1596369892	NC_000016.10:2076601:T:C	single nucleotide variant	intron variant	Likely benign	Aug 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+18G>A	TSC2		Tuberous sclerosis 2	VCV002698629	16	2126604	16	2076603	2698629	2854920	rs2543934987	NC_000016.10:2076602:G:A	single nucleotide variant	intron variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+20G>A	TSC2		Tuberous sclerosis 2	VCV002787470	16	2126606	16	2076605	2787470	2946019	rs2089421979	NC_000016.10:2076604:G:A	single nucleotide variant	intron variant	Likely benign	Sep 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+20G>T	TSC2		Tuberous sclerosis 2	VCV001961136	16	2126606	16	2076605	1961136	2019982	rs2089421979	NC_000016.10:2076604:G:T	single nucleotide variant	intron variant	Likely benign	Jul 31, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+220C>T	TSC2		not provided	VCV001241336	16	2126806	16	2076805	1241336	1233393	rs74002770	NC_000016.10:2076804:C:T	single nucleotide variant	intron variant	Benign	Jun 21, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+251G>A	TSC2		not provided	VCV001187606	16	2126837	16	2076836	1187606	1177967	rs185041572	NC_000016.10:2076835:G:A	single nucleotide variant	intron variant	Likely benign	Jul 2, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2837+286T>G	TSC2		not provided	VCV000671853	16	2126872	16	2076871	671853	668705	rs189502160	NC_000016.10:2076870:T:G	single nucleotide variant	intron variant	Likely benign	Jun 19, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-372C>T	TSC2		not provided	VCV000669913	16	2127227	16	2077226	669913	668708	rs61260040	NC_000016.10:2077225:C:T	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-282A>C	TSC2		not provided	VCV000680986	16	2127317	16	2077316	680986	668197	rs13339195	NC_000016.10:2077315:A:C	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-125C>A	TSC2		Tuberous sclerosis 2	VCV003778713	16	2127474	16	2077473	3778713	3894715		NC_000016.10:2077472:C:A	single nucleotide variant	intron variant	Uncertain significance	Mar 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-123C>T	TSC2		Tuberous sclerosis syndrome	VCV003070573	16	2127476	16	2077475	3070573	3230330	rs922114187	NC_000016.10:2077474:C:T	single nucleotide variant	intron variant	Likely benign	Sep 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-122G>A	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000570837	16	2127477	16	2077476	570837	567807	rs1567489890	NC_000016.10:2077475:G:A	single nucleotide variant	intron variant	Pathogenic	Jul 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-47G>A	TSC2		Hereditary cancer-predisposing syndrome	VCV002449999	16	2127552	16	2077551	2449999	2425956	rs2543969428	NC_000016.10:2077550:G:A	single nucleotide variant	intron variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-20G>A	TSC2		Tuberous sclerosis 2	VCV001975819	16	2127579	16	2077578	1975819	2023467	rs2151412600	NC_000016.10:2077577:G:A	single nucleotide variant	intron variant	Likely benign	May 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-20G>T	TSC2		Tuberous sclerosis 2	VCV001668416	16	2127579	16	2077578	1668416	1633790	rs2151412600	NC_000016.10:2077577:G:T	single nucleotide variant	intron variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-19C>T	TSC2		Tuberous sclerosis 2	VCV002116941	16	2127580	16	2077579	2116941	2172248	rs2543970850	NC_000016.10:2077578:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-18T>C	TSC2		Tuberous sclerosis 2	VCV003666704	16	2127581	16	2077580	3666704	3802530		NC_000016.10:2077579:T:C	single nucleotide variant	intron variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-17C>G	TSC2		Tuberous sclerosis 2	VCV002844928	16	2127582	16	2077581	2844928	3004729	rs1431191501	NC_000016.10:2077580:C:G	single nucleotide variant	intron variant	Likely benign	Mar 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-17C>T	TSC2		Tuberous sclerosis 2	VCV002729336	16	2127582	16	2077581	2729336	2893249	rs1431191501	NC_000016.10:2077580:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-16C>G	TSC2		Tuberous sclerosis 2	VCV002742733	16	2127583	16	2077582	2742733	2900496	rs778996893	NC_000016.10:2077581:C:G	single nucleotide variant	intron variant	Likely benign	Jul 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-16C>T	TSC2		not provided|Tuberous sclerosis 2	VCV000668449	16	2127583	16	2077582	668449	668202	rs778996893	NC_000016.10:2077581:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-14T>C	TSC2		Tuberous sclerosis 2	VCV003658401	16	2127585	16	2077584	3658401	3796822		NC_000016.10:2077583:T:C	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-14T>G	TSC2		Tuberous sclerosis 2	VCV002036929	16	2127585	16	2077584	2036929	2101296	rs1375979558	NC_000016.10:2077583:T:G	single nucleotide variant	intron variant	Likely benign	Oct 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-13C>T	TSC2		Tuberous sclerosis 2	VCV002723038	16	2127586	16	2077585	2723038	2888264	rs1419094468	NC_000016.10:2077584:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-12C>T	TSC2		Tuberous sclerosis 2	VCV002153210	16	2127587	16	2077586	2153210	1882072	rs1296273540	NC_000016.10:2077585:C:T	single nucleotide variant	intron variant	Likely benign	Mar 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-11T>C	TSC2		Tuberous sclerosis 2	VCV001567276	16	2127588	16	2077587	1567276	1622918	rs2151412800	NC_000016.10:2077586:T:C	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-10C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000767092	16	2127589	16	2077588	767092	778194	rs1596374422	NC_000016.10:2077587:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2838-9A>T	TSC2		Tuberous sclerosis 2	VCV002818092	16	2127590	16	2077589	2818092	2987733	rs1596374434	NC_000016.10:2077588:A:T	single nucleotide variant	intron variant	Likely benign	Dec 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-8C>A	TSC2		Tuberous sclerosis 2	VCV001503731	16	2127591	16	2077590	1503731	1424135	rs1567490339	NC_000016.10:2077589:C:A	single nucleotide variant	intron variant	Likely benign	Mar 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-8C>T	TSC2		Tuberous sclerosis 2	VCV001118144	16	2127591	16	2077590	1118144	1103647	rs1567490339	NC_000016.10:2077589:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-7C>G	TSC2		Tuberous sclerosis 2	VCV003020440	16	2127592	16	2077591	3020440	3179348	rs752762518	NC_000016.10:2077590:C:G	single nucleotide variant	intron variant	Likely benign	Sep 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-7C>A	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535854	16	2127592	16	2077591	535854	529948	rs752762518	NC_000016.10:2077590:C:A	single nucleotide variant	intron variant	Likely benign	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-6C>G	TSC2		Tuberous sclerosis 2	VCV002030106	16	2127593	16	2077592	2030106	2089298	rs528706539	NC_000016.10:2077591:C:G	single nucleotide variant	intron variant	Likely benign	Sep 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-6C>A	TSC2		Tuberous sclerosis 2	VCV001999157	16	2127593	16	2077592	1999157	2060950	rs528706539	NC_000016.10:2077591:C:A	single nucleotide variant	intron variant	Uncertain significance	May 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-6C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000221121	16	2127593	16	2077592	221121	222451	rs528706539	NC_000016.10:2077591:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2838-5G>C	TSC2		Tuberous sclerosis 2	VCV001587001	16	2127594	16	2077593	1587001	1628941	rs876660419	NC_000016.10:2077592:G:C	single nucleotide variant	intron variant	Likely benign	Apr 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-5G>A	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000233454	16	2127594	16	2077593	233454	235117	rs876660419	NC_000016.10:2077592:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2838-4A>G	TSC2		not provided|not specified|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049718	16	2127595	16	2077594	49718	58880	rs45517272	NC_000016.10:2077593:A:G	single nucleotide variant	intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-3T>C	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000536062	16	2127596	16	2077595	536062	530186	rs553942147	NC_000016.10:2077594:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2838-3T>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000424000	16	2127596	16	2077595	424000	409487	rs553942147	NC_000016.10:2077594:T:G	single nucleotide variant	intron variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838-2A>G	TSC2		Tuberous sclerosis 2	VCV002844726	16	2127597	16	2077596	2844726	3004527	rs2543971791	NC_000016.10:2077595:A:G	single nucleotide variant	intron variant|splice acceptor variant	Uncertain significance	Mar 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2838-2A>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002014252	16	2127597	16	2077596	2014252	2064465	rs2543971791	NC_000016.10:2077595:A:C	single nucleotide variant	intron variant|splice acceptor variant	Uncertain significance	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2838T>C (p.Ser946=)	TSC2		Tuberous sclerosis 2	VCV001019059	16	2127599	16	2077598	1019059	1011970	rs2089574542	NC_000016.10:2077597:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2839C>T (p.Leu947=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001132806	16	2127600	16	2077599	1132806	1125063	rs2089574802	NC_000016.10:2077598:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2840T>C (p.Leu947Pro)	TSC2	L947P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000467974	16	2127601	16	2077600	467974	466167	rs1555509447	NC_000016.10:2077599:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2841G>C (p.Leu947=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232126	16	2127602	16	2077601	3232126	3391927	rs2543971997	NC_000016.10:2077600:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2842A>G (p.Arg948Gly)	TSC2	R748G, R948G, R500G, R899G, R911G	Hereditary cancer-predisposing syndrome	VCV003974582	16	2127603	16	2077602	3974582	4086405		NC_000016.10:2077601:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2842A>C (p.Arg948=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000710308	16	2127603	16	2077602	710308	726491	rs770710202	NC_000016.10:2077601:A:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2843G>C (p.Arg948Thr)	TSC2	R948T, R748T, R899T, R500T, R911T	Hereditary cancer-predisposing syndrome	VCV001796744	16	2127604	16	2077603	1796744	1855319	rs1555509449	NC_000016.10:2077602:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2843G>T (p.Arg948Met)	TSC2	R948M	Tuberous sclerosis 2	VCV000467975	16	2127604	16	2077603	467975	465887	rs1555509449	NC_000016.10:2077602:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 21, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.2844G>A (p.Arg948=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000413724	16	2127605	16	2077604	413724	401518	rs1060504114	NC_000016.10:2077603:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2845A>C (p.Ile949Leu)	TSC2	I501L, I749L, I900L, I912L, I949L	Tuberous sclerosis 2	VCV003609043	16	2127606	16	2077605	3609043	3747631		NC_000016.10:2077604:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2845A>G (p.Ile949Val)	TSC2	I501V, I900V, I949V, I912V, I749V	Tuberous sclerosis 2	VCV002122941	16	2127606	16	2077605	2122941	2180835	rs2543972192	NC_000016.10:2077604:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2846T>C (p.Ile949Thr)	TSC2	I949T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001014357	16	2127607	16	2077606	1014357	1011971	rs2089576147	NC_000016.10:2077605:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2847A>T (p.Ile949=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811306	16	2127608	16	2077607	3811306	3928547		NC_000016.10:2077606:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2847A>G (p.Ile949Met)	TSC2	I949M	Tuberous sclerosis 2	VCV000963378	16	2127608	16	2077607	963378	949249	rs1596374592	NC_000016.10:2077606:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2848G>A (p.Ala950Thr)	TSC2	A750T, A901T, A913T, A950T, A502T	Hereditary cancer-predisposing syndrome	VCV001796793	16	2127609	16	2077608	1796793	1855368	rs886051792	NC_000016.10:2077607:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2848G>C (p.Ala950Pro)	TSC2	A950P	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000318324	16	2127609	16	2077608	318324	342270	rs886051792	NC_000016.10:2077607:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2849C>T (p.Ala950Val)	TSC2	A950V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000821899	16	2127610	16	2077609	821899	812557	rs780737734	NC_000016.10:2077608:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2850C>T (p.Ala950=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974688	16	2127611	16	2077610	3974688	4086511		NC_000016.10:2077609:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2850C>G (p.Ala950=)	TSC2		Tuberous sclerosis 2	VCV001096527	16	2127611	16	2077610	1096527	1081822	rs2151413318	NC_000016.10:2077609:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 12, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2852G>A (p.Arg951Lys)	TSC2	R503K, R751K, R902K, R914K, R951K	Tuberous sclerosis 2	VCV001719172	16	2127613	16	2077612	1719172	1774476	rs1216438701	NC_000016.10:2077611:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2852G>T (p.Arg951Ile)	TSC2	R951I	Tuberous sclerosis 2	VCV001409401	16	2127613	16	2077612	1409401	1340472	rs1216438701	NC_000016.10:2077611:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 1, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2852G>C (p.Arg951Thr)	TSC2	R951T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000963710	16	2127613	16	2077612	963710	949250	rs1216438701	NC_000016.10:2077611:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2853A>G (p.Arg951=)	TSC2		Tuberous sclerosis 2|not provided	VCV001615027	16	2127614	16	2077613	1615027	1578894	rs45517273	NC_000016.10:2077612:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2853A>C (p.Arg951Ser)	TSC2	R951S	Tuberous sclerosis 2	VCV001472621	16	2127614	16	2077613	1472621	1398003	rs45517273	NC_000016.10:2077612:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2853A>T (p.Arg951Ser)	TSC2	R951S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049719	16	2127614	16	2077613	49719	58881	rs45517273	NC_000016.10:2077612:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2854C>G (p.Pro952Ala)	TSC2	P952A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001488624	16	2127615	16	2077614	1488624	1420095	rs745456980	NC_000016.10:2077613:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2854C>T (p.Pro952Ser)	TSC2	P952S	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535961	16	2127615	16	2077614	535961	529598	rs745456980	NC_000016.10:2077613:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2854C>A (p.Pro952Thr)	TSC2	P952T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486683	16	2127615	16	2077614	486683	477363	rs745456980	NC_000016.10:2077613:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2855C>T (p.Pro952Leu)	TSC2	P915L, P903L, P504L, P752L, P952L	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV003462552	16	2127616	16	2077615	3462552	3621572		NC_000016.10:2077614:C:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2855C>A (p.Pro952His)	TSC2	P504H, P752H, P903H, P915H, P952H	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV002503256	16	2127616	16	2077615	2503256	2668437	rs2089578491	NC_000016.10:2077614:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2855C>G (p.Pro952Arg)	TSC2	P952R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000842593	16	2127616	16	2077615	842593	843433	rs2089578491	NC_000016.10:2077614:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2856C>G (p.Pro952=)	TSC2		Tuberous sclerosis 2	VCV004071262	16	2127617	16	2077616	4071262	4185110		NC_000016.10:2077615:C:G	single nucleotide variant	synonymous variant|intron variant	Benign	May 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2856C>T (p.Pro952=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811267	16	2127617	16	2077616	3811267	3928509		NC_000016.10:2077615:C:T	single nucleotide variant	intron variant|synonymous variant	Likely benign	Feb 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2856C>A (p.Pro952=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000233428	16	2127617	16	2077616	233428	235118	rs876660401	NC_000016.10:2077615:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2857C>A (p.Pro953Thr)	TSC2	P505T, P753T, P953T, P916T, P904T	Hereditary cancer-predisposing syndrome	VCV002564744	16	2127618	16	2077617	2564744	2733900	rs2151413577	NC_000016.10:2077616:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2857C>G (p.Pro953Ala)	TSC2	P953A	Tuberous sclerosis 2	VCV001514016	16	2127618	16	2077617	1514016	1491831	rs2151413577	NC_000016.10:2077616:C:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Apr 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2857C>T (p.Pro953Ser)	TSC2	P953S	Tuberous sclerosis 2	VCV001347028	16	2127618	16	2077617	1347028	1453141	rs2151413577	NC_000016.10:2077616:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2858C>T (p.Pro953Leu)	TSC2	P953L	Tuberous sclerosis 2	VCV001460704	16	2127619	16	2077618	1460704	1419513	rs1303011979	NC_000016.10:2077617:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2858C>A (p.Pro953His)	TSC2	P953H	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001374865	16	2127619	16	2077618	1374865	1466152	rs1303011979	NC_000016.10:2077617:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2858C>G (p.Pro953Arg)	TSC2	P953R	Tuberous sclerosis 2	VCV000650376	16	2127619	16	2077618	650376	644256	rs1303011979	NC_000016.10:2077617:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2859C>G (p.Pro953=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV002626448	16	2127620	16	2077619	2626448	2794214	rs397514968	NC_000016.10:2077618:C:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2859C>A (p.Pro953=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001612642	16	2127620	16	2077619	1612642	1601725	rs397514968	NC_000016.10:2077618:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2859C>T (p.Pro953=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000064958	16	2127620	16	2077619	64958	75888	rs397514968	NC_000016.10:2077618:C:T	single nucleotide variant	intron variant|synonymous variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2861A>T (p.Lys954Ile)	TSC2	K954I, K754I, K917I, K506I, K905I	Tuberous sclerosis 2	VCV003637213	16	2127622	16	2077621	3637213	3771367		NC_000016.10:2077620:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2861A>G (p.Lys954Arg)	TSC2	K954R	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000065263	16	2127622	16	2077621	65263	76195	rs397515191	NC_000016.10:2077620:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2863C>G (p.Gln955Glu)	TSC2	Q955E	Tuberous sclerosis 2	VCV000948731	16	2127624	16	2077623	948731	927656	rs1596374761	NC_000016.10:2077622:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2863C>T (p.Gln955Ter)	TSC2	Q955*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000821922	16	2127624	16	2077623	821922	812558	rs1596374761	NC_000016.10:2077622:C:T	single nucleotide variant	nonsense|intron variant	Uncertain significance	Jul 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2864A>G (p.Gln955Arg)	TSC2	Q906R, Q955R, Q755R, Q918R, Q507R	Hereditary cancer-predisposing syndrome	VCV003462606	16	2127625	16	2077624	3462606	3621625		NC_000016.10:2077623:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2866G>T (p.Gly956Cys)	TSC2	G956C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001431030	16	2127627	16	2077626	1431030	1467706	rs769199118	NC_000016.10:2077625:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2866G>A (p.Gly956Ser)	TSC2	G956S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486687	16	2127627	16	2077626	486687	477368	rs769199118	NC_000016.10:2077625:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2867G>C (p.Gly956Ala)	TSC2	G508A, G756A, G907A, G919A, G956A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003232127	16	2127628	16	2077627	3232127	3391928	rs2151413781	NC_000016.10:2077626:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2867G>T (p.Gly956Val)	TSC2	G956V	Tuberous sclerosis 2	VCV001477349	16	2127628	16	2077627	1477349	1413533	rs2151413781	NC_000016.10:2077626:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2867G>A (p.Gly956Asp)	TSC2	G956D	Tuberous sclerosis 2	VCV001061716	16	2127628	16	2077627	1061716	1049454	rs2151413781	NC_000016.10:2077626:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2868C>A (p.Gly956=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564686	16	2127629	16	2077628	2564686	2733842	rs141573736	NC_000016.10:2077627:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2868C>G (p.Gly956=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001086831	16	2127629	16	2077628	1086831	1081823	rs141573736	NC_000016.10:2077627:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2868C>T (p.Gly956=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000567230	16	2127629	16	2077628	567230	569746	rs141573736	NC_000016.10:2077627:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2869T>C (p.Leu957=)	TSC2		Tuberous sclerosis 2	VCV001560183	16	2127630	16	2077629	1560183	1606717	rs2151413863	NC_000016.10:2077628:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2870T>C (p.Leu957Ser)	TSC2	L920S, L509S, L757S, L908S, L957S	Tuberous sclerosis 2	VCV002752856	16	2127631	16	2077630	2752856	2913597	rs200030367	NC_000016.10:2077629:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2870T>G (p.Leu957Trp)	TSC2	L957W	Tuberous sclerosis 2	VCV000966695	16	2127631	16	2077630	966695	957681	rs200030367	NC_000016.10:2077629:T:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2871G>A (p.Leu957=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002038460	16	2127632	16	2077631	2038460	2101528	rs772755332	NC_000016.10:2077630:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Sep 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2871G>C (p.Leu957Phe)	TSC2	L957F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000839036	16	2127632	16	2077631	839036	843434	rs772755332	NC_000016.10:2077630:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2872A>G (p.Asn958Asp)	TSC2	N958D	Tuberous sclerosis 2	VCV000568241	16	2127633	16	2077632	568241	569749	rs1567490706	NC_000016.10:2077631:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2873A>G (p.Asn958Ser)	TSC2	N958S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000065137	16	2127634	16	2077633	65137	76068	rs397515104	NC_000016.10:2077632:A:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2877C>T (p.Asn959=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000723731	16	2127638	16	2077637	723731	740021	rs147523833	NC_000016.10:2077636:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2877C>G (p.Asn959Lys)	TSC2	N959K	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000566565	16	2127638	16	2077637	566565	573827	rs147523833	NC_000016.10:2077636:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2878T>C (p.Ser960Pro)	TSC2	S512P, S760P, S911P, S960P, S923P	Hereditary cancer-predisposing syndrome	VCV002564618	16	2127639	16	2077638	2564618	2733774	rs1005027685	NC_000016.10:2077637:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2878T>G (p.Ser960Ala)	TSC2	S960A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467976	16	2127639	16	2077638	467976	465980	rs1005027685	NC_000016.10:2077637:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2879C>G (p.Ser960Cys)	TSC2	S960C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000660343	16	2127640	16	2077639	660343	644257	rs397514898	NC_000016.10:2077638:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2879C>T (p.Ser960Phe)	TSC2	S960F	Tuberous sclerosis 2	VCV000064872	16	2127640	16	2077639	64872	75801	rs397514898	NC_000016.10:2077638:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2880T>C (p.Ser960=)	TSC2		not provided	VCV004085769	16	2127641	16	2077640	4085769	4198454		NC_000016.10:2077639:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2880T>G (p.Ser960=)	TSC2		Tuberous sclerosis 2	VCV002022419	16	2127641	16	2077640	2022419	2080327	rs2543974499	NC_000016.10:2077639:T:G	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Aug 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2881C>G (p.Pro961Ala)	TSC2	P513A, P912A, P761A, P924A, P961A	Tuberous sclerosis 2	VCV002816373	16	2127642	16	2077641	2816373	2977043	rs2089584361	NC_000016.10:2077640:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2881C>T (p.Pro961Ser)	TSC2	P961S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001036741	16	2127642	16	2077641	1036741	1032457	rs2089584361	NC_000016.10:2077640:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2881C>A (p.Pro961Thr)	TSC2	P961T	Tuberous sclerosis 2	VCV000966750	16	2127642	16	2077641	966750	957682	rs2089584361	NC_000016.10:2077640:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2882C>T (p.Pro961Leu)	TSC2	P961L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000645028	16	2127643	16	2077642	645028	644258	rs370415754	NC_000016.10:2077641:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2883A>C (p.Pro961=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974624	16	2127644	16	2077643	3974624	4086447		NC_000016.10:2077642:A:C	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Mar 24, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2883A>T (p.Pro961=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001546703	16	2127644	16	2077643	1546703	1645679	rs1596374943	NC_000016.10:2077642:A:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2884C>T (p.Pro962Ser)	TSC2	P962S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001356621	16	2127645	16	2077644	1356621	1447370	rs1477697117	NC_000016.10:2077643:C:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2884C>G (p.Pro962Ala)	TSC2	P962A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000821933	16	2127645	16	2077644	821933	812559	rs1477697117	NC_000016.10:2077643:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 23, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2885C>A (p.Pro962His)	TSC2	P514H, P762H, P913H, P925H, P962H	not provided|Hereditary cancer-predisposing syndrome	VCV003232128	16	2127646	16	2077645	3232128	3391929	rs367640434	NC_000016.10:2077644:C:A	single nucleotide variant	intron variant|missense variant	Uncertain significance	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2885C>T (p.Pro962Leu)	TSC2	P962L	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001504566	16	2127646	16	2077645	1504566	1417317	rs367640434	NC_000016.10:2077644:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2886C>T (p.Pro962=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000233537	16	2127647	16	2077646	233537	235119	rs140202176	NC_000016.10:2077645:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2887G>A (p.Val963Met)	TSC2	V963M	Tuberous sclerosis 2|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000049235	16	2127648	16	2077647	49235	58397	rs45517275	NC_000016.10:2077646:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2890A>G (p.Lys964Glu)	TSC2	K964E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000646700	16	2127651	16	2077650	646700	644259	rs1596375009	NC_000016.10:2077649:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2891A>T (p.Lys964Ile)	TSC2	K915I, K964I, K516I, K764I, K927I	Hereditary cancer-predisposing syndrome	VCV003462622	16	2127652	16	2077651	3462622	3621641		NC_000016.10:2077650:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2892A>T (p.Lys964Asn)	TSC2	K964N, K764N, K516N, K915N, K927N	Tuberous sclerosis 2	VCV002130045	16	2127653	16	2077652	2130045	2189322	rs1326171191	NC_000016.10:2077651:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2892A>G (p.Lys964=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000821952	16	2127653	16	2077652	821952	812560	rs1326171191	NC_000016.10:2077651:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2893G>T (p.Glu965Ter)	TSC2	E928*, E765*, E916*, E965*, E517*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002564628	16	2127654	16	2077653	2564628	2733784	rs1372107115	NC_000016.10:2077652:G:T	single nucleotide variant	nonsense|intron variant	Conflicting classifications of pathogenicity	Apr 4, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2894A>C (p.Glu965Ala)	TSC2	E928A, E916A, E517A, E765A, E965A	Hereditary cancer-predisposing syndrome	VCV001797330	16	2127655	16	2077654	1797330	1855904	rs2543975417	NC_000016.10:2077653:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 26, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2895A>C (p.Glu965Asp)	TSC2	E928D, E916D, E517D, E765D, E965D	Tuberous sclerosis 2	VCV001990636	16	2127656	16	2077655	1990636	2044575	rs961472582	NC_000016.10:2077654:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2896T>G (p.Phe966Val)	TSC2	F917V, F518V, F766V, F966V, F929V	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV002449950	16	2127657	16	2077656	2449950	2429576	rs1567490884	NC_000016.10:2077655:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2896T>C (p.Phe966Leu)	TSC2	F966L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000575148	16	2127657	16	2077656	575148	570095	rs1567490884	NC_000016.10:2077655:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2897T>C (p.Phe966Ser)	TSC2	F966S	Tuberous sclerosis 2	VCV001465667	16	2127658	16	2077657	1465667	1353899	rs2151414797	NC_000016.10:2077656:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2898C>G (p.Phe966Leu)	TSC2	F966L	Tuberous sclerosis 2	VCV001361808	16	2127659	16	2077658	1361808	1476532	rs2151414830	NC_000016.10:2077657:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2899A>G (p.Lys967Glu)	TSC2	K930E, K918E, K967E, K519E, K767E	Tuberous sclerosis 2	VCV002141886	16	2127660	16	2077659	2141886	1869421	rs2151414911	NC_000016.10:2077658:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2900A>T (p.Lys967Met)	TSC2	K967M	Tuberous sclerosis 2	VCV000835353	16	2127661	16	2077660	835353	843435	rs2089588117	NC_000016.10:2077659:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2901G>A (p.Lys967=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001797464	16	2127662	16	2077661	1797464	1854382	rs1168031047	NC_000016.10:2077660:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 7, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2901G>T (p.Lys967Asn)	TSC2	K967N	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000821969	16	2127662	16	2077661	821969	812561	rs1168031047	NC_000016.10:2077660:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2902G>T (p.Glu968Ter)	TSC2	E919*, E520*, E931*, E768*, E968*	Tuberous sclerosis 2	VCV002759564	16	2127663	16	2077662	2759564	2924617	rs2543975960	NC_000016.10:2077661:G:T	single nucleotide variant	nonsense|intron variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2904G>C (p.Glu968Asp)	TSC2	E968D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000652818	16	2127665	16	2077664	652818	644260	rs765438249	NC_000016.10:2077663:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 1, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2907C>G (p.Ser969Arg)	TSC2	S521R, S969R, S769R, S920R, S932R	Hereditary cancer-predisposing syndrome	VCV002587758	16	2127668	16	2077667	2587758	2764096	rs1596375110	NC_000016.10:2077666:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2907C>T (p.Ser969=)	TSC2		Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000821960	16	2127668	16	2077667	821960	812562	rs1596375110	NC_000016.10:2077666:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2908T>C (p.Ser970Pro)	TSC2	S522P, S970P, S770P, S921P, S933P	Hereditary cancer-predisposing syndrome	VCV003462626	16	2127669	16	2077668	3462626	3621645		NC_000016.10:2077667:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2909C>T (p.Ser970Phe)	TSC2	S970F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001425523	16	2127670	16	2077669	1425523	1431762	rs758447107	NC_000016.10:2077668:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2909C>G (p.Ser970Cys)	TSC2	S970C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001053789	16	2127670	16	2077669	1053789	1049455	rs758447107	NC_000016.10:2077668:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2910T>C (p.Ser970=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001115659	16	2127671	16	2077670	1115659	1103648	rs777705428	NC_000016.10:2077669:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2912C>T (p.Ala971Val)	TSC2	A971V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000639391	16	2127673	16	2077672	639391	644261	rs1596375143	NC_000016.10:2077671:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2913A>C (p.Ala971=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329465	16	2127674	16	2077673	3329465	3489057		NC_000016.10:2077672:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2914G>A (p.Ala972Thr)	TSC2	A972T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000582874	16	2127675	16	2077674	582874	569750	rs1567490981	NC_000016.10:2077673:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2915C>T (p.Ala972Val)	TSC2	A972V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000854147	16	2127676	16	2077675	854147	843436	rs2089590552	NC_000016.10:2077674:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2916C>G (p.Ala972=)	TSC2		Tuberous sclerosis 2	VCV001613015	16	2127677	16	2077676	1613015	1663166	rs751474097	NC_000016.10:2077675:C:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2916C>A (p.Ala972=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000413688	16	2127677	16	2077676	413688	401280	rs751474097	NC_000016.10:2077675:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2916C>T (p.Ala972=)	TSC2		not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000238002	16	2127677	16	2077676	238002	242266	rs751474097	NC_000016.10:2077675:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2917G>T (p.Glu973Ter)	TSC2	E973*	Tuberous sclerosis 2	VCV001520782	16	2127678	16	2077677	1520782	1356141	rs780981335	NC_000016.10:2077676:G:T	single nucleotide variant	nonsense|intron variant	Uncertain significance	Sep 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2917G>A (p.Glu973Lys)	TSC2	E973K	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000654833	16	2127678	16	2077677	654833	644262	rs780981335	NC_000016.10:2077676:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2917G>C (p.Glu973Gln)	TSC2	E973Q	Tuberous sclerosis 2	VCV000572645	16	2127678	16	2077677	572645	567810	rs780981335	NC_000016.10:2077676:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2919G>T (p.Glu973Asp)	TSC2	E525D, E773D, E924D, E936D, E973D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002624602	16	2127680	16	2077679	2624602	2793691	rs2543976914	NC_000016.10:2077678:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2919G>A (p.Glu973=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001797657	16	2127680	16	2077679	1797657	1854575	rs2543976914	NC_000016.10:2077678:G:A	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	May 7, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2920G>T (p.Ala974Ser)	TSC2	A526S, A974S, A774S, A925S, A937S	Hereditary cancer-predisposing syndrome	VCV003462651	16	2127681	16	2077680	3462651	3621670		NC_000016.10:2077679:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2920G>A (p.Ala974Thr)	TSC2	A974T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000849909	16	2127681	16	2077680	849909	843437	rs556778889	NC_000016.10:2077679:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2921C>A (p.Ala974Asp)	TSC2	A774D, A526D, A937D, A925D, A974D	Hereditary cancer-predisposing syndrome	VCV002626421	16	2127682	16	2077681	2626421	2794187	rs1289330733	NC_000016.10:2077680:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2921C>T (p.Ala974Val)	TSC2	A937V, A774V, A526V, A974V, A925V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001797718	16	2127682	16	2077681	1797718	1854635	rs1289330733	NC_000016.10:2077680:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 21, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2922C>G (p.Ala974=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001614597	16	2127683	16	2077682	1614597	1663871	rs1555509505	NC_000016.10:2077681:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2922C>T (p.Ala974=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536091	16	2127683	16	2077682	536091	530189	rs1555509505	NC_000016.10:2077681:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2924T>C (p.Phe975Ser)	TSC2	F975S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001511333	16	2127685	16	2077684	1511333	1378148	rs2151415659	NC_000016.10:2077683:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2925C>T (p.Phe975=)	TSC2		Tuberous sclerosis 2	VCV004071247	16	2127686	16	2077685	4071247	4185095		NC_000016.10:2077684:C:T	single nucleotide variant	synonymous variant|intron variant	Benign	May 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2926C>A (p.Arg976=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486667	16	2127687	16	2077686	486667	477374	rs769527912	NC_000016.10:2077685:C:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Nov 8, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2926C>T (p.Arg976Trp)	TSC2	R976W	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000405954	16	2127687	16	2077686	405954	400878	rs769527912	NC_000016.10:2077685:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2927G>A (p.Arg976Gln)	TSC2	R976Q	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001036378	16	2127688	16	2077687	1036378	1032458	rs779832805	NC_000016.10:2077686:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2927G>C (p.Arg976Pro)	TSC2	R976P	not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000957657	16	2127688	16	2077687	957657	949251	rs779832805	NC_000016.10:2077686:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Apr 10, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2928G>A (p.Arg976=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001113878	16	2127689	16	2077688	1113878	1103649	rs2151415832	NC_000016.10:2077687:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2930G>T (p.Cys977Phe)	TSC2	C777F, C529F, C977F, C928F, C940F	Hereditary cancer-predisposing syndrome	VCV001797814	16	2127691	16	2077690	1797814	1853433	rs2089593473	NC_000016.10:2077689:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2930G>A (p.Cys977Tyr)	TSC2	C977Y	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001001389	16	2127691	16	2077690	1001389	996733	rs2089593473	NC_000016.10:2077689:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2931C>A (p.Cys977Ter)	TSC2	C977*	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001362820	16	2127692	16	2077691	1362820	1396140	rs2089593888	NC_000016.10:2077690:C:A	single nucleotide variant	nonsense|intron variant	Uncertain significance	Dec 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2931C>T (p.Cys977=)	TSC2		Tuberous sclerosis 2	VCV001099164	16	2127692	16	2077691	1099164	1103650	rs2089593888	NC_000016.10:2077690:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2932C>G (p.Arg978Gly)	TSC2	R978G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000649777	16	2127693	16	2077692	649777	644263	rs768241596	NC_000016.10:2077691:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2932C>T (p.Arg978Cys)	TSC2	R978C	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000423627	16	2127693	16	2077692	423627	409488	rs768241596	NC_000016.10:2077691:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2933G>T (p.Arg978Leu)	TSC2	R978L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000655346	16	2127694	16	2077693	655346	644264	rs876660733	NC_000016.10:2077692:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 11, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2933G>A (p.Arg978His)	TSC2	R978H	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000233921	16	2127694	16	2077693	233921	235120	rs876660733	NC_000016.10:2077692:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2934C>T (p.Arg978=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001149452	16	2127695	16	2077694	1149452	1145947	rs2089594737	NC_000016.10:2077693:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2935A>G (p.Ser979Gly)	TSC2	S779G, S930G, S942G, S979G, S531G	Tuberous sclerosis 2	VCV002102875	16	2127696	16	2077695	2102875	2161935	rs2543977903	NC_000016.10:2077694:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2936G>C (p.Ser979Thr)	TSC2	S979T	Tuberous sclerosis 2	VCV001424671	16	2127697	16	2077696	1424671	1438547	rs2151416062	NC_000016.10:2077695:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2938A>G (p.Ile980Val)	TSC2	I943V, I980V, I931V, I532V, I780V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001797876	16	2127699	16	2077698	1797876	1853495	rs2089594947	NC_000016.10:2077697:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2940C>T (p.Ile980=)	TSC2		Tuberous sclerosis 2	VCV001097509	16	2127701	16	2077700	1097509	1081824	rs2151416105	NC_000016.10:2077699:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2941A>G (p.Ser981Gly)	TSC2	S981G	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000999644	16	2127702	16	2077701	999644	996735	rs2089595149	NC_000016.10:2077700:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2942G>T (p.Ser981Ile)	TSC2	S533I, S781I, S932I, S944I, S981I	Tuberous sclerosis syndrome	VCV003386170	16	2127703	16	2077702	3386170	3545311		NC_000016.10:2077701:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2942G>A (p.Ser981Asn)	TSC2	S932N, S781N, S533N, S944N, S981N	Tuberous sclerosis 2	VCV002842783	16	2127703	16	2077702	2842783	2997489	rs1596375336	NC_000016.10:2077701:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2942G>C (p.Ser981Thr)	TSC2	S981T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000654322	16	2127703	16	2077702	654322	644265	rs1596375336	NC_000016.10:2077701:G:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2943T>C (p.Ser981=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001610967	16	2127704	16	2077703	1610967	1585785	rs1596375342	NC_000016.10:2077702:T:C	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jul 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2943T>G (p.Ser981Arg)	TSC2	S981R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001043006	16	2127704	16	2077703	1043006	1032459	rs1596375342	NC_000016.10:2077702:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2944G>A (p.Val982Met)	TSC2	V534M, V782M, V945M, V982M, V933M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002561948	16	2127705	16	2077704	2561948	2724319	rs773864188	NC_000016.10:2077703:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2944G>T (p.Val982Leu)	TSC2	V982L	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000845950	16	2127705	16	2077704	845950	843438	rs773864188	NC_000016.10:2077703:G:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2946G>C (p.Val982=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000256627	16	2127707	16	2077706	256627	255496	rs771332931	NC_000016.10:2077705:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2948C>G (p.Ser983Cys)	TSC2	S983C	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000582899	16	2127709	16	2077708	582899	573830	rs759786102	NC_000016.10:2077707:C:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2949T>C (p.Ser983=)	TSC2		Tuberous sclerosis 2	VCV001588153	16	2127710	16	2077709	1588153	1574696	rs2151416372	NC_000016.10:2077708:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2950G>A (p.Glu984Lys)	TSC2	E935K, E784K, E947K, E536K, E984K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002747225	16	2127711	16	2077710	2747225	2907985	rs397515156	NC_000016.10:2077709:G:A	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2950G>C (p.Glu984Gln)	TSC2	E984Q	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065212	16	2127711	16	2077710	65212	76144	rs397515156	NC_000016.10:2077709:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2953C>T (p.His985Tyr)	TSC2	H785Y, H936Y, H948Y, H537Y, H985Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462581	16	2127714	16	2077713	3462581	3621600		NC_000016.10:2077712:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2954A>G (p.His985Arg)	TSC2	H985R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000574929	16	2127715	16	2077714	574929	567812	rs1330306605	NC_000016.10:2077713:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2955T>C (p.His985=)	TSC2		Tuberous sclerosis 2	VCV001100951	16	2127716	16	2077715	1100951	1103651	rs2151416490	NC_000016.10:2077714:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2956G>A (p.Val986Met)	TSC2	V986M	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000643957	16	2127717	16	2077716	643957	644266	rs765489754	NC_000016.10:2077715:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2957T>G (p.Val986Gly)	TSC2	V986G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000822364	16	2127718	16	2077717	822364	812563	rs1596375441	NC_000016.10:2077716:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2958G>T (p.Val986=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001154729	16	2127719	16	2077718	1154729	1145948	rs1114167464	NC_000016.10:2077717:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2958G>A (p.Val986=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000427993	16	2127719	16	2077718	427993	419871	rs1114167464	NC_000016.10:2077717:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jun 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2959G>A (p.Val987Ile)	TSC2	V987I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001042438	16	2127720	16	2077719	1042438	1032460	rs2089598568	NC_000016.10:2077718:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2960T>C (p.Val987Ala)	TSC2	V950A, V938A, V987A, V539A, V787A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002846314	16	2127721	16	2077720	2846314	3004840	rs1391148381	NC_000016.10:2077719:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 26, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2960T>G (p.Val987Gly)	TSC2	V987G	Tuberous sclerosis 2	VCV000574713	16	2127721	16	2077720	574713	570099	rs1391148381	NC_000016.10:2077719:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 22, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2961C>T (p.Val987=)	TSC2		Tuberous sclerosis 2	VCV001133614	16	2127722	16	2077721	1133614	1125064	rs775637322	NC_000016.10:2077720:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2961C>A (p.Val987=)	TSC2		Tuberous sclerosis 2	VCV000536014	16	2127722	16	2077721	536014	529601	rs775637322	NC_000016.10:2077720:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2961C>G (p.Val987=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000467978	16	2127722	16	2077721	467978	465302	rs775637322	NC_000016.10:2077720:C:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2962C>T (p.Arg988Cys)	TSC2	R988C	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000467979	16	2127723	16	2077722	467979	465986	rs763047420	NC_000016.10:2077721:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 21, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2963G>A (p.Arg988His)	TSC2	R988H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467980	16	2127724	16	2077723	467980	465890	rs397515306	NC_000016.10:2077722:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2963G>C (p.Arg988Pro)	TSC2	R988P	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000064997	16	2127724	16	2077723	64997	75927	rs397515306	NC_000016.10:2077722:G:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2964C>T (p.Arg988=)	TSC2		Hereditary cancer-predisposing syndrome|Acute myeloid leukemia|Tuberous sclerosis 2	VCV000836767	16	2127725	16	2077724	836767	843439	rs757274577	NC_000016.10:2077723:C:T	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Jul 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2964C>A (p.Arg988=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486664	16	2127725	16	2077724	486664	477334	rs757274577	NC_000016.10:2077723:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2965A>G (p.Ser989Gly)	TSC2	S989G	Tuberous sclerosis 2	VCV000580483	16	2127726	16	2077725	580483	573831	rs1567491278	NC_000016.10:2077724:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966G>C (p.Ser989Thr)	TSC2	S989T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535978	16	2127727	16	2077726	535978	529953	rs1555509538	NC_000016.10:2077725:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2966+1G>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001422070	16	2127728	16	2077727	1422070	1337684	rs2089600815	NC_000016.10:2077726:G:A	single nucleotide variant	intron variant|splice donor variant	Uncertain significance	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2966+1G>C	TSC2		Tuberous sclerosis 2	VCV000944050	16	2127728	16	2077727	944050	941125	rs2089600815	NC_000016.10:2077726:G:C	single nucleotide variant	intron variant|splice donor variant	Uncertain significance	Mar 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+3A>C	TSC2		Tuberous sclerosis 2	VCV001486962	16	2127730	16	2077729	1486962	1406819	rs1332708335	NC_000016.10:2077728:A:C	single nucleotide variant	intron variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+4G>C	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001518992	16	2127731	16	2077730	1518992	1343185	rs1235253082	NC_000016.10:2077729:G:C	single nucleotide variant	intron variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2966+4G>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467981	16	2127731	16	2077730	467981	465896	rs1235253082	NC_000016.10:2077729:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2966+5C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486609	16	2127732	16	2077731	486609	477337	rs767328300	NC_000016.10:2077730:C:T	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2966+6G>A	TSC2		Tuberous sclerosis 2	VCV000238004	16	2127733	16	2077732	238004	242267	rs878854088	NC_000016.10:2077731:G:A	single nucleotide variant	intron variant	Likely benign	Apr 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+7G>A	TSC2		Tuberous sclerosis 2	VCV003728599	16	2127734	16	2077733	3728599	3851930		NC_000016.10:2077732:G:A	single nucleotide variant	intron variant	Likely benign	Jan 7, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+8G>C	TSC2		Tuberous sclerosis 2	VCV001620329	16	2127735	16	2077734	1620329	1581155	rs750283532	NC_000016.10:2077733:G:C	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2966+9A>G	TSC2		Tuberous sclerosis 2	VCV001928583	16	2127736	16	2077735	1928583	1991350	rs2543980443	NC_000016.10:2077734:A:G	single nucleotide variant	intron variant	Likely benign	Jun 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+10C>T	TSC2		Tuberous sclerosis 2	VCV001552040	16	2127737	16	2077736	1552040	1520651	rs1596375636	NC_000016.10:2077735:C:T	single nucleotide variant	intron variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+10C>G	TSC2		Tuberous sclerosis 2	VCV001131539	16	2127737	16	2077736	1131539	1125065	rs1596375636	NC_000016.10:2077735:C:G	single nucleotide variant	intron variant	Likely benign	Apr 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+10C>A	TSC2		Tuberous sclerosis 2	VCV000795018	16	2127737	16	2077736	795018	787999	rs1596375636	NC_000016.10:2077735:C:A	single nucleotide variant	intron variant	Likely benign	Nov 11, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+11T>C	TSC2		Tuberous sclerosis 2	VCV002094426	16	2127738	16	2077737	2094426	2145874	rs980464907	NC_000016.10:2077736:T:C	single nucleotide variant	intron variant	Likely benign	Feb 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+14C>T	TSC2		Tuberous sclerosis 2	VCV001577077	16	2127741	16	2077740	1577077	1639934	rs377238278	NC_000016.10:2077739:C:T	single nucleotide variant	intron variant	Likely benign	Nov 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+14C>G	TSC2		Tuberous sclerosis 2	VCV001571117	16	2127741	16	2077740	1571117	1646345	rs377238278	NC_000016.10:2077739:C:G	single nucleotide variant	intron variant	Likely benign	Jul 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+14C>A	TSC2		Tuberous sclerosis 2	VCV001549093	16	2127741	16	2077740	1549093	1573208	rs377238278	NC_000016.10:2077739:C:A	single nucleotide variant	intron variant	Likely benign	Oct 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+15G>T	TSC2		Tuberous sclerosis 2	VCV001614527	16	2127742	16	2077741	1614527	1663801	rs779884344	NC_000016.10:2077740:G:T	single nucleotide variant	intron variant	Likely benign	Dec 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+15G>A	TSC2		Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis 2	VCV000453030	16	2127742	16	2077741	453030	445518	rs779884344	NC_000016.10:2077740:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2966+16G>A	TSC2		Tuberous sclerosis 2	VCV003653966	16	2127743	16	2077742	3653966	3785969		NC_000016.10:2077741:G:A	single nucleotide variant	intron variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+17G>C	TSC2		Tuberous sclerosis 2	VCV002056145	16	2127744	16	2077743	2056145	2112728	rs748886866	NC_000016.10:2077742:G:C	single nucleotide variant	intron variant	Likely benign	Dec 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+17G>A	TSC2		Tuberous sclerosis 2	VCV001555083	16	2127744	16	2077743	1555083	1564827	rs748886866	NC_000016.10:2077742:G:A	single nucleotide variant	intron variant	Likely benign	Oct 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+18T>G	TSC2		Tuberous sclerosis 2	VCV002738994	16	2127745	16	2077744	2738994	2902358	rs2543981034	NC_000016.10:2077743:T:G	single nucleotide variant	intron variant	Likely benign	Jul 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+19G>A	TSC2		Tuberous sclerosis 2	VCV001594918	16	2127746	16	2077745	1594918	1622041	rs377514748	NC_000016.10:2077744:G:A	single nucleotide variant	intron variant	Likely benign	Jan 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+19G>C	TSC2		Tuberous sclerosis 2	VCV001542460	16	2127746	16	2077745	1542460	1609997	rs377514748	NC_000016.10:2077744:G:C	single nucleotide variant	intron variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+19G>T	TSC2		Tuberous sclerosis 2|not specified	VCV000517731	16	2127746	16	2077745	517731	505213	rs377514748	NC_000016.10:2077744:G:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2966+20G>C	TSC2		Tuberous sclerosis 2	VCV001655920	16	2127747	16	2077746	1655920	1529167	rs778545519	NC_000016.10:2077745:G:C	single nucleotide variant	intron variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+20G>A	TSC2		Tuberous sclerosis 2	VCV001624826	16	2127747	16	2077746	1624826	1629445	rs778545519	NC_000016.10:2077745:G:A	single nucleotide variant	intron variant	Likely benign	Mar 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+20G>T	TSC2		Tuberous sclerosis 2|not provided	VCV001275670	16	2127747	16	2077746	1275670	1263848	rs778545519	NC_000016.10:2077745:G:T	single nucleotide variant	intron variant	Benign/Likely benign	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2966+121C>G	TSC2		not provided	VCV000677253	16	2127848	16	2077847	677253	668383	rs74002771	NC_000016.10:2077846:C:G	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+217G>T	TSC2		not provided	VCV000677554	16	2127944	16	2077943	677554	667409	rs118124428	NC_000016.10:2077942:G:T	single nucleotide variant	intron variant	Likely benign	Jun 18, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2966+247G>A	TSC2		not provided	VCV001194882	16	2127974	16	2077973	1194882	1185073	rs531503301	NC_000016.10:2077972:G:A	single nucleotide variant	intron variant	Likely benign	Aug 17, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-304G>A	TSC2		not provided	VCV001208416	16	2128729	16	2078728	1208416	1198739	rs77620349	NC_000016.10:2078727:G:A	single nucleotide variant	intron variant	Likely benign	Jul 7, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-185C>T	TSC2		not provided	VCV000678378	16	2128848	16	2078847	678378	668388	rs114526593	NC_000016.10:2078846:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-165T>A	TSC2		not provided	VCV001195782	16	2128868	16	2078867	1195782	1185074	rs77735328	NC_000016.10:2078866:T:A	single nucleotide variant	intron variant	Likely benign	Jun 28, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-118T>C	TSC2		not provided	VCV000675966	16	2128915	16	2078914	675966	667411	rs9925571	NC_000016.10:2078913:T:C	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2967-18C>A	TSC2		Tuberous sclerosis 2	VCV001553956	16	2129015	16	2079014	1553956	1588040	rs2151429604	NC_000016.10:2079013:C:A	single nucleotide variant	intron variant	Likely benign	Aug 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-16C>T	TSC2		Tuberous sclerosis 2	VCV001609646	16	2129017	16	2079016	1609646	1639159	rs774389795	NC_000016.10:2079015:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2967-15G>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003069347	16	2129018	16	2079017	3069347	3229973	rs375423568	NC_000016.10:2079016:G:C	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2967-15G>A	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001365079	16	2129018	16	2079017	1365079	1502123	rs375423568	NC_000016.10:2079016:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2967-14G>C	TSC2		Tuberous sclerosis 2	VCV002821248	16	2129019	16	2079018	2821248	2988324	rs2151429681	NC_000016.10:2079017:G:C	single nucleotide variant	intron variant	Likely benign	Dec 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-13C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV001237644	16	2129020	16	2079019	1237644	1229264	rs536150612	NC_000016.10:2079018:C:T	single nucleotide variant	intron variant	Benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2967-12C>T	TSC2		Tuberous sclerosis 2	VCV001558289	16	2129021	16	2079020	1558289	1594878	rs2151429722	NC_000016.10:2079019:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2967-11T>A	TSC2		Tuberous sclerosis 2	VCV003648648	16	2129022	16	2079021	3648648	3784505		NC_000016.10:2079020:T:A	single nucleotide variant	intron variant	Likely benign	Apr 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-10C>G	TSC2		Tuberous sclerosis 2	VCV001129991	16	2129023	16	2079022	1129991	1125066	rs1322718501	NC_000016.10:2079021:C:G	single nucleotide variant	intron variant	Likely benign	Mar 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-10C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001101193	16	2129023	16	2079022	1101193	1103652	rs1322718501	NC_000016.10:2079021:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2967-8C>G	TSC2		Tuberous sclerosis 2	VCV002917097	16	2129025	16	2079024	2917097	3077159	rs1060504085	NC_000016.10:2079023:C:G	single nucleotide variant	intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-8C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000413634	16	2129025	16	2079024	413634	400882	rs1060504085	NC_000016.10:2079023:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2967-7C>T	TSC2		Tuberous sclerosis 2	VCV002810938	16	2129026	16	2079025	2810938	2975451	rs2544023060	NC_000016.10:2079024:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2967-6C>T	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000238005	16	2129027	16	2079026	238005	242268	rs200746335	NC_000016.10:2079025:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2967-4C>G	TSC2		Tuberous sclerosis 2	VCV002860250	16	2129029	16	2079028	2860250	3028887	rs781646681	NC_000016.10:2079027:C:G	single nucleotide variant	intron variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-4C>T	TSC2		Tuberous sclerosis 2	VCV002771981	16	2129029	16	2079028	2771981	2924091	rs781646681	NC_000016.10:2079027:C:T	single nucleotide variant	intron variant	Likely benign	Oct 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-3C>T	TSC2		Tuberous sclerosis 2	VCV002859413	16	2129030	16	2079029	2859413	3022026	rs2151429873	NC_000016.10:2079028:C:T	single nucleotide variant	intron variant	Likely benign	Sep 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-2A>C	TSC2		Hereditary cancer-predisposing syndrome	VCV002626419	16	2129031	16	2079030	2626419	2794185	rs2151429895	NC_000016.10:2079029:A:C	single nucleotide variant	splice acceptor variant|intron variant	Likely benign	Jul 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2967-1G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001937007	16	2129032	16	2079031	1937007	2003628	rs1596382055	NC_000016.10:2079030:G:A	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Mar 31, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2967-1G>T	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000639030	16	2129032	16	2079031	639030	653240	rs1596382055	NC_000016.10:2079030:G:T	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Mar 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2967C>T (p.Ser989=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001516402	16	2129033	16	2079032	1516402	1499056	rs766417784	NC_000016.10:2079031:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jul 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2968A>T (p.Arg990Trp)	TSC2	R910W, R947W, R990W, R898W, R499W, R542W, R747W, R790W, R793W, R941W, R943W, R953W, R977W	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV001474281	16	2129034	16	2079033	1474281	1410812	rs753730009	NC_000016.10:2079032:A:T	single nucleotide variant	splice acceptor variant|missense variant|non-coding transcript variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2968A>G (p.Arg990Gly)	TSC2	R990G, R898G, R947G, R910G, R499G, R542G, R747G, R790G, R793G, R941G, R943G, R953G, R977G	not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000207675	16	2129034	16	2079033	207675	203157	rs753730009	NC_000016.10:2079032:A:G	single nucleotide variant	missense variant|non-coding transcript variant|splice acceptor variant	Conflicting classifications of pathogenicity	Dec 31, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2969G>T (p.Arg990Met)	TSC2	R499M, R542M, R747M, R790M, R793M, R898M, R910M, R941M, R943M, R947M, R953M, R977M, R990M	Cystic fibrosis	VCV003390948	16	2129035	16	2079034	3390948	3550034		NC_000016.10:2079033:G:T	single nucleotide variant	missense variant|non-coding transcript variant|splice acceptor variant	Uncertain significance	Dec 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2970G>T (p.Arg990Ser)	TSC2	R910S, R947S, R746S, R898S, R957S, R990S, R946S	TSC2-related disorder|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001476559	16	2129036	16	2079035	1476559	1339332	rs1317631053	NC_000016.10:2079034:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2971A>G (p.Ile991Val)	TSC2	I991V, I747V, I899V, I911V, I948V, I958V, I947V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000207737	16	2129037	16	2079036	207737	203158	rs369524855	NC_000016.10:2079035:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2972T>C (p.Ile991Thr)	TSC2	I748T, I790T, I943T, I958T, I978T, I413T, I500T, I794T, I898T, I944T, I954T, I977T, I991T, I499T, I747T, I910T, I928T, I947T, I990T, I543T, I791T, I899T, I911T, I941T, I942T, I948T	Hereditary cancer-predisposing syndrome	VCV001798302	16	2129038	16	2079037	1798302	1856444	rs2151430075	NC_000016.10:2079036:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.2973A>G (p.Ile991Met)	TSC2	I748M, I790M, I791M, I794M, I911M, I941M, I942M, I958M, I413M, I500M, I543M, I898M, I910M, I944M, I947M, I978M, I948M, I990M, I499M, I747M, I899M, I928M, I943M, I954M, I977M, I991M	Tuberous sclerosis 2	VCV001978932	16	2129039	16	2079038	1978932	2038109	rs750003833	NC_000016.10:2079037:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2973A>C (p.Ile991=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467982	16	2129039	16	2079038	467982	465304	rs750003833	NC_000016.10:2079037:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2974C>T (p.Gln992Ter)	TSC2	Q992*, Q912*, Q949*, Q959*, Q748*, Q900*, Q948*	Hereditary cancer-predisposing syndrome	VCV000049236	16	2129040	16	2079039	49236	58398	rs45438592	NC_000016.10:2079038:C:T	single nucleotide variant	nonsense	Pathogenic	Jan 16, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2975A>G (p.Gln992Arg)	TSC2	Q501R, Q943R, Q978R, Q544R, Q748R, Q792R, Q900R, Q912R, Q942R, Q949R, Q955R, Q979R, Q992R, Q414R, Q500R, Q749R, Q795R, Q899R, Q929R, Q944R, Q948R, Q991R, Q791R, Q911R, Q945R, Q959R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001908418	16	2129041	16	2079040	1908418	1962602	rs2089787414	NC_000016.10:2079039:A:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2976G>A (p.Gln992=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001798333	16	2129042	16	2079041	1798333	1856474	rs2151430182	NC_000016.10:2079040:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 14, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.2978C>T (p.Thr993Met)	TSC2	T993M, T749M, T901M, T913M, T949M, T960M, T950M	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000049772	16	2129044	16	2079043	49772	58934	rs137854410	NC_000016.10:2079042:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2979G>C (p.Thr993=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001798365	16	2129045	16	2079044	1798365	1856505	rs45517277	NC_000016.10:2079043:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2979G>T (p.Thr993=)	TSC2		Tuberous sclerosis 2	VCV001081300	16	2129045	16	2079044	1081300	1081825	rs45517277	NC_000016.10:2079043:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2979G>A (p.Thr993=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000049773	16	2129045	16	2079044	49773	58935	rs45517277	NC_000016.10:2079043:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2981C>A (p.Ser994Tyr)	TSC2	S750Y, S961Y, S994Y, S902Y, S914Y, S951Y, S950Y	Tuberous sclerosis 2	VCV001502665	16	2129047	16	2079046	1502665	1514769	rs2151430416	NC_000016.10:2079045:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.2981C>T (p.Ser994Phe)	TSC2	S902F, S914F, S950F, S750F, S951F, S961F, S994F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001373001	16	2129047	16	2079046	1373001	1440379	rs2151430416	NC_000016.10:2079045:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2982C>T (p.Ser994=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002878379	16	2129048	16	2079047	2878379	3036347	rs1555510188	NC_000016.10:2079046:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2982C>G (p.Ser994=)	TSC2		Tuberous sclerosis 2	VCV001632465	16	2129048	16	2079047	1632465	1630991	rs1555510188	NC_000016.10:2079046:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2982C>A (p.Ser994=)	TSC2		Tuberous sclerosis 2|not specified	VCV000515662	16	2129048	16	2079047	515662	505474	rs1555510188	NC_000016.10:2079046:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2983C>T (p.Leu995Phe)	TSC2	L417F, L504F, L752F, L795F, L914F, L952F, L981F, L982F, L751F, L794F, L902F, L947F, L962F, L995F, L798F, L903F, L915F, L945F, L951F, L958F, L994F, L503F, L547F, L932F, L946F, L948F	Tuberous sclerosis 2	VCV003002112	16	2129049	16	2079048	3002112	3157289	rs752248140	NC_000016.10:2079047:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2983C>A (p.Leu995Ile)	TSC2	L915I, L995I, L962I, L903I, L951I, L751I, L952I	Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome	VCV000930390	16	2129049	16	2079048	930390	919617	rs752248140	NC_000016.10:2079047:C:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2985C>T (p.Leu995=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000186919	16	2129051	16	2079050	186919	184136	rs786203324	NC_000016.10:2079049:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2986A>T (p.Thr996Ser)	TSC2	T504S, T505S, T752S, T753S, T796S, T933S, T959S, T995S, T996S, T915S, T916S, T947S, T952S, T983S, T418S, T903S, T904S, T946S, T949S, T982S, T548S, T795S, T799S, T948S, T953S, T963S	Hereditary cancer-predisposing syndrome	VCV003462689	16	2129052	16	2079051	3462689	3621708		NC_000016.10:2079050:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2986A>G (p.Thr996Ala)	TSC2	T996A, T752A, T916A, T952A, T963A, T904A, T953A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000207738	16	2129052	16	2079051	207738	203159	rs139753238	NC_000016.10:2079050:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2987C>A (p.Thr996Asn)	TSC2	T418N, T504N, T505N, T548N, T752N, T753N, T795N, T796N, T799N, T903N, T904N, T915N, T916N, T933N, T946N, T947N, T948N, T949N, T952N, T953N, T959N, T963N, T982N, T983N, T995N, T996N	Tuberous sclerosis 2	VCV001720168	16	2129053	16	2079052	1720168	1779207	rs1596382185	NC_000016.10:2079051:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2987C>T (p.Thr996Ile)	TSC2	T904I, T996I, T953I, T916I, T952I, T752I, T963I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000663317	16	2129053	16	2079052	663317	644267	rs1596382185	NC_000016.10:2079051:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2988C>T (p.Thr996=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002138809	16	2129054	16	2079053	2138809	1878482	rs2089789414	NC_000016.10:2079052:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2989A>C (p.Ser997Arg)	TSC2	S917R, S948R, S949R, S950R, S964R, S984R, S549R, S754R, S796R, S797R, S954R, S997R, S419R, S505R, S506R, S904R, S905R, S916R, S953R, S960R, S753R, S800R, S934R, S947R, S983R, S996R	Tuberous sclerosis 2	VCV002130967	16	2129055	16	2079054	2130967	2186262	rs1555510209	NC_000016.10:2079053:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.2989A>G (p.Ser997Gly)	TSC2	S997G, S753G, S954G, S964G, S953G, S905G, S917G	Tuberous sclerosis 2	VCV000535971	16	2129055	16	2079054	535971	529666	rs1555510209	NC_000016.10:2079053:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2990G>C (p.Ser997Thr)	TSC2	S506T, S796T, S934T, S949T, S950T, S954T, S960T, S419T, S549T, S800T, S947T, S953T, S996T, S917T, S997T, S505T, S753T, S754T, S797T, S904T, S905T, S916T, S948T, S964T, S983T, S984T	Hereditary cancer-predisposing syndrome	VCV003462688	16	2129056	16	2079055	3462688	3621707		NC_000016.10:2079054:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2990G>A (p.Ser997Asn)	TSC2	S917N, S753N, S905N, S954N, S953N, S964N, S997N	Tuberous sclerosis 2	VCV000945828	16	2129056	16	2079055	945828	927657	rs1596382214	NC_000016.10:2079054:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2990G>T (p.Ser997Ile)	TSC2	S917I, S753I, S905I, S953I, S954I, S964I, S997I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000641667	16	2129056	16	2079055	641667	644268	rs1596382214	NC_000016.10:2079054:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2992G>A (p.Ala998Thr)	TSC2	A998T, A955T, A754T, A906T, A954T, A918T, A965T	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001462357	16	2129058	16	2079057	1462357	1507684	rs1440361406	NC_000016.10:2079056:G:A	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2992G>C (p.Ala998Pro)	TSC2	A754P, A906P, A918P, A954P, A955P, A965P, A998P	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001003894	16	2129058	16	2079057	1003894	996736	rs1440361406	NC_000016.10:2079056:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2992G>T (p.Ala998Ser)	TSC2	A754S, A954S, A906S, A955S, A998S, A918S, A965S	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000822458	16	2129058	16	2079057	822458	812564	rs1440361406	NC_000016.10:2079056:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2993C>T (p.Ala998Val)	TSC2	A955V, A998V, A918V, A954V, A965V, A754V, A906V	Tuberous sclerosis 2|not provided	VCV000862238	16	2129059	16	2079058	862238	843441	rs2089790275	NC_000016.10:2079057:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2994C>T (p.Ala998=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002140767	16	2129060	16	2079059	2140767	1875265	rs2151430926	NC_000016.10:2079058:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2994C>A (p.Ala998=)	TSC2		Tuberous sclerosis 2	VCV001147694	16	2129060	16	2079059	1147694	1145949	rs2151430926	NC_000016.10:2079058:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.2995A>C (p.Ser999Arg)	TSC2	S421R, S508R, S756R, S906R, S936R, S956R, S962R, S986R, S551R, S755R, S799R, S918R, S919R, S950R, S985R, S998R, S507R, S907R, S952R, S966R, S798R, S802R, S949R, S951R, S955R, S999R	Hereditary cancer-predisposing syndrome	VCV003462618	16	2129061	16	2079060	3462618	3621637		NC_000016.10:2079059:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.2995A>T (p.Ser999Cys)	TSC2	S955C, S755C, S907C, S919C, S956C, S966C, S999C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000652670	16	2129061	16	2079060	652670	644269	rs777089012	NC_000016.10:2079059:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2996G>T (p.Ser999Ile)	TSC2	S907I, S955I, S966I, S755I, S919I, S956I, S999I	Tuberous sclerosis 2	VCV000940756	16	2129062	16	2079061	940756	937316	rs149808366	NC_000016.10:2079060:G:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.2996G>A (p.Ser999Asn)	TSC2	S955N, S907N, S919N, S956N, S966N, S999N, S755N	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000664836	16	2129062	16	2079061	664836	644270	rs149808366	NC_000016.10:2079060:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.2996G>C (p.Ser999Thr)	TSC2	S907T, S955T, S755T, S919T, S956T, S966T, S999T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000649255	16	2129062	16	2079061	649255	644271	rs149808366	NC_000016.10:2079060:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2997C>T (p.Ser999=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000536038	16	2129063	16	2079062	536038	530192	rs893757571	NC_000016.10:2079061:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2998T>A (p.Leu1000Met)	TSC2	L1000M, L422M, L508M, L509M, L552M, L756M, L757M, L799M, L800M, L803M, L907M, L908M, L919M, L920M, L937M, L950M, L951M, L952M, L953M, L956M, L957M, L963M, L967M, L986M, L987M, L999M	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001717908	16	2129064	16	2079063	1717908	1771884	rs756679047	NC_000016.10:2079062:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2998T>C (p.Leu1000=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000385050	16	2129064	16	2079063	385050	375186	rs756679047	NC_000016.10:2079062:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.2999T>C (p.Leu1000Ser)	TSC2	L552S, L756S, L757S, L800S, L803S, L907S, L919S, L957S, L986S, L509S, L799S, L908S, L937S, L953S, L508S, L950S, L963S, L967S, L987S, L1000S, L422S, L920S, L951S, L952S, L956S, L999S	Hereditary cancer-predisposing syndrome|not provided	VCV002564721	16	2129065	16	2079064	2564721	2733877	rs2544026723	NC_000016.10:2079063:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3000G>A (p.Leu1000=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001124125	16	2129066	16	2079065	1124125	1125067	rs2151431126	NC_000016.10:2079064:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3001G>A (p.Gly1001Arg)	TSC2	G1000R, G1001R, G423R, G509R, G510R, G553R, G757R, G758R, G800R, G801R, G804R, G908R, G909R, G920R, G921R, G938R, G951R, G952R, G953R, G954R, G957R, G958R, G964R, G968R, G987R, G988R	not provided	VCV003364713	16	2129067	16	2079066	3364713	3523920		NC_000016.10:2079065:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3002G>T (p.Gly1001Val)	TSC2	G1001V, G909V, G957V, G968V, G757V, G921V, G958V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000839746	16	2129068	16	2079067	839746	843442	rs368878445	NC_000016.10:2079066:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3002G>A (p.Gly1001Glu)	TSC2	G1001E, G909E, G957E, G958E, G757E, G921E, G968E	not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000229369	16	2129068	16	2079067	229369	230612	rs368878445	NC_000016.10:2079066:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3003G>C (p.Gly1001=)	TSC2		Tuberous sclerosis 2	VCV001121797	16	2129069	16	2079068	1121797	1125068	rs768864105	NC_000016.10:2079067:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3003G>A (p.Gly1001=)	TSC2		Tuberous sclerosis 2	VCV001112947	16	2129069	16	2079068	1112947	1103653	rs768864105	NC_000016.10:2079067:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3003G>T (p.Gly1001=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001087340	16	2129069	16	2079068	1087340	1081826	rs768864105	NC_000016.10:2079067:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3005C>A (p.Ser1002Tyr)	TSC2	S910Y, S922Y, S758Y, S958Y, S959Y, S969Y, S1002Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001475211	16	2129071	16	2079070	1475211	1404120	rs748261129	NC_000016.10:2079069:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3005C>T (p.Ser1002Phe)	TSC2	S1002F, S910F, S969F, S922F, S958F, S959F, S758F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000570889	16	2129071	16	2079070	570889	570103	rs748261129	NC_000016.10:2079069:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3006T>C (p.Ser1002=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232129	16	2129072	16	2079071	3232129	3391930	rs2151431356	NC_000016.10:2079070:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3007G>T (p.Ala1003Ser)	TSC2	A923S, A959S, A960S, A1003S, A759S, A911S, A970S	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001412338	16	2129073	16	2079072	1412338	1344319	rs1555510234	NC_000016.10:2079071:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3007G>A (p.Ala1003Thr)	TSC2	A1003T, A759T, A960T, A923T, A970T, A911T, A959T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000467985	16	2129073	16	2079072	467985	466171	rs1555510234	NC_000016.10:2079071:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3010G>T (p.Asp1004Tyr)	TSC2	D1003Y, D1004Y, D426Y, D512Y, D513Y, D556Y, D760Y, D761Y, D803Y, D804Y, D807Y, D911Y, D912Y, D923Y, D924Y, D941Y, D954Y, D955Y, D956Y, D957Y, D960Y, D961Y, D967Y, D971Y, D990Y, D991Y	Isolated focal cortical dysplasia type II	VCV003240654	16	2129076	16	2079075	3240654	3399640	rs2151431461	NC_000016.10:2079074:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3010G>A (p.Asp1004Asn)	TSC2	D1003N, D1004N, D426N, D512N, D513N, D556N, D760N, D761N, D803N, D804N, D807N, D911N, D912N, D923N, D924N, D941N, D954N, D955N, D956N, D957N, D960N, D961N, D967N, D971N, D990N, D991N	Hereditary cancer-predisposing syndrome	VCV003232130	16	2129076	16	2079075	3232130	3391931	rs2151431461	NC_000016.10:2079074:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3011A>C (p.Asp1004Ala)	TSC2	D760A, D924A, D961A, D912A, D960A, D971A, D1004A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001394453	16	2129077	16	2079076	1394453	1338476	rs2151431476	NC_000016.10:2079075:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3012T>A (p.Asp1004Glu)	TSC2	D761E, D803E, D911E, D954E, D956E, D1003E, D512E, D941E, D955E, D990E, D991E, D426E, D556E, D760E, D804E, D912E, D957E, D967E, D971E, D1004E, D513E, D807E, D923E, D924E, D960E, D961E	Hereditary cancer-predisposing syndrome	VCV003462582	16	2129078	16	2079077	3462582	3621601		NC_000016.10:2079076:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3012T>G (p.Asp1004Glu)	TSC2	D1004E, D760E, D912E, D924E, D960E, D961E, D971E	Tuberous sclerosis 2	VCV001027007	16	2129078	16	2079077	1027007	1011972	rs772328985	NC_000016.10:2079076:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3015G>C (p.Glu1005Asp)	TSC2	E427D, E804D, E805D, E913D, E958D, E972D, E991D, E513D, E514D, E557D, E761D, E808D, E924D, E925D, E942D, E956D, E1004D, E1005D, E957D, E961D, E962D, E968D, E762D, E912D, E955D, E992D	Hereditary cancer-predisposing syndrome	VCV003811340	16	2129081	16	2079080	3811340	3928581		NC_000016.10:2079079:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3015G>A (p.Glu1005=)	TSC2		Tuberous sclerosis 2	VCV001157938	16	2129081	16	2079080	1157938	1145950	rs2151431602	NC_000016.10:2079079:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3017A>C (p.Asn1006Thr)	TSC2	N1006T, N926T, N914T, N962T, N963T, N762T, N973T	Tuberous sclerosis 2	VCV001374262	16	2129083	16	2079082	1374262	1457079	rs2151431671	NC_000016.10:2079081:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3018C>T (p.Asn1006=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049543	16	2129084	16	2079083	49543	58705	rs45471697	NC_000016.10:2079082:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3020C>T (p.Ser1007Phe)	TSC2	S1007F, S516F, S559F, S806F, S927F, S944F, S958F, S960F, S993F, S429F, S763F, S764F, S915F, S926F, S957F, S959F, S994F, S810F, S914F, S963F, S964F, S1006F, S515F, S807F, S970F, S974F	Hereditary cancer-predisposing syndrome	VCV003462677	16	2129086	16	2079085	3462677	3621696		NC_000016.10:2079084:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3020C>G (p.Ser1007Cys)	TSC2	S1007C, S763C, S915C, S927C, S963C, S964C, S974C	not provided	VCV001311893	16	2129086	16	2079085	1311893	1302424	rs2151431750	NC_000016.10:2079084:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3021C>G (p.Ser1007=)	TSC2		Tuberous sclerosis 2	VCV002114687	16	2129087	16	2079086	2114687	2164690	rs201516931	NC_000016.10:2079085:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3021C>T (p.Ser1007=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000536076	16	2129087	16	2079086	536076	529961	rs201516931	NC_000016.10:2079085:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3022G>A (p.Val1008Met)	TSC2	V1008M, V916M, V964M, V975M, V764M, V928M, V965M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000064980	16	2129088	16	2079087	64980	75910	rs397514985	NC_000016.10:2079086:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3023T>A (p.Val1008Glu)	TSC2	V1008E, V928E, V965E, V764E, V964E, V916E, V975E	Tuberous sclerosis 2	VCV001497361	16	2129089	16	2079088	1497361	1475982	rs2151431875	NC_000016.10:2079087:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3024G>A (p.Val1008=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001995105	16	2129090	16	2079089	1995105	2049605	rs2151431887	NC_000016.10:2079088:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3025G>A (p.Ala1009Thr)	TSC2	A1008T, A1009T, A431T, A809T, A917T, A960T, A965T, A995T, A561T, A765T, A812T, A946T, A972T, A976T, A517T, A766T, A916T, A928T, A962T, A996T, A518T, A808T, A929T, A959T, A961T, A966T	Hereditary cancer-predisposing syndrome	VCV002624603	16	2129091	16	2079090	2624603	2793692	rs45517278	NC_000016.10:2079089:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3025G>T (p.Ala1009Ser)	TSC2	A1009S, A917S, A966S, A976S, A965S, A765S, A929S	Tuberous sclerosis syndrome	VCV000049544	16	2129091	16	2079090	49544	58706	rs45517278	NC_000016.10:2079089:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3026C>G (p.Ala1009Gly)	TSC2	A1008G, A1009G, A431G, A517G, A518G, A561G, A765G, A766G, A808G, A809G, A812G, A916G, A917G, A928G, A929G, A946G, A959G, A960G, A961G, A962G, A965G, A966G, A972G, A976G, A995G, A996G	Tuberous sclerosis 2	VCV001719481	16	2129092	16	2079091	1719481	1772137	rs1567496227	NC_000016.10:2079090:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3026C>T (p.Ala1009Val)	TSC2	A1009V, A917V, A965V, A976V, A929V, A765V, A966V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000579110	16	2129092	16	2079091	579110	567816	rs1567496227	NC_000016.10:2079090:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3027C>T (p.Ala1009=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001798977	16	2129093	16	2079092	1798977	1856246	rs1320888448	NC_000016.10:2079091:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3027C>A (p.Ala1009=)	TSC2		Tuberous sclerosis 2	VCV001552029	16	2129093	16	2079092	1552029	1520640	rs1320888448	NC_000016.10:2079091:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3027C>G (p.Ala1009=)	TSC2		Tuberous sclerosis 2	VCV001116293	16	2129093	16	2079092	1116293	1103654	rs1320888448	NC_000016.10:2079091:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3028C>A (p.Gln1010Lys)	TSC2	Q518K, Q766K, Q961K, Q962K, Q963K, Q967K, Q977K, Q562K, Q813K, Q917K, Q918K, Q960K, Q966K, Q997K, Q1009K, Q432K, Q519K, Q947K, Q1010K, Q767K, Q809K, Q810K, Q929K, Q930K, Q973K, Q996K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002450002	16	2129094	16	2079093	2450002	2425959	rs45514100	NC_000016.10:2079092:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3028C>G (p.Gln1010Glu)	TSC2	Q1010E, Q930E, Q966E, Q967E, Q766E, Q918E, Q977E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000238007	16	2129094	16	2079093	238007	242269	rs45514100	NC_000016.10:2079092:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3029A>G (p.Gln1010Arg)	TSC2	Q766R, Q917R, Q929R, Q966R, Q973R, Q977R, Q1009R, Q1010R, Q518R, Q918R, Q930R, Q947R, Q963R, Q967R, Q996R, Q432R, Q519R, Q562R, Q809R, Q810R, Q813R, Q962R, Q767R, Q960R, Q961R, Q997R	Hereditary cancer-predisposing syndrome	VCV001798988	16	2129095	16	2079094	1798988	1856257	rs1194695685	NC_000016.10:2079093:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3030G>A (p.Gln1010=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000747051	16	2129096	16	2079095	747051	754995	rs776658284	NC_000016.10:2079094:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3030G>C (p.Gln1010His)	TSC2	Q1010H, Q918H, Q967H, Q977H, Q930H, Q766H, Q966H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000467986	16	2129096	16	2079095	467986	466175	rs776658284	NC_000016.10:2079094:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3031G>T (p.Ala1011Ser)	TSC2	A811S, A930S, A931S, A563S, A918S, A1010S, A519S, A520S, A768S, A948S, A961S, A962S, A963S, A967S, A968S, A974S, A997S, A998S, A1011S, A433S, A767S, A810S, A814S, A919S, A964S, A978S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001799053	16	2129097	16	2079096	1799053	1856321	rs1430119276	NC_000016.10:2079095:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3032C>A (p.Ala1011Asp)	TSC2	A767D, A768D, A961D, A962D, A963D, A968D, A974D, A998D, A1011D, A433D, A520D, A814D, A918D, A948D, A978D, A519D, A811D, A930D, A931D, A967D, A997D, A1010D, A563D, A810D, A919D, A964D	Hereditary cancer-predisposing syndrome	VCV003462673	16	2129098	16	2079097	3462673	3621692		NC_000016.10:2079096:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3033T>G (p.Ala1011=)	TSC2		Tuberous sclerosis 2	VCV002061698	16	2129099	16	2079098	2061698	2120846	rs878854090	NC_000016.10:2079097:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3033T>C (p.Ala1011=)	TSC2		Tuberous sclerosis 2	VCV000238008	16	2129099	16	2079098	238008	242270	rs878854090	NC_000016.10:2079097:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 27, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3034G>C (p.Asp1012His)	TSC2	D1011H, D1012H, D434H, D520H, D521H, D564H, D768H, D769H, D811H, D812H, D815H, D919H, D920H, D931H, D932H, D949H, D962H, D963H, D964H, D965H, D968H, D969H, D975H, D979H, D998H, D999H	Hereditary cancer-predisposing syndrome	VCV003232131	16	2129100	16	2079099	3232131	3391932	rs2151432182	NC_000016.10:2079098:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3036C>G (p.Asp1012Glu)	TSC2	D968E, D1012E, D768E, D920E, D932E, D969E, D979E	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000952012	16	2129102	16	2079101	952012	927658	rs144997264	NC_000016.10:2079100:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3036C>T (p.Asp1012=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065303	16	2129102	16	2079101	65303	76235	rs144997264	NC_000016.10:2079100:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3037G>C (p.Asp1013His)	TSC2	D921H, D970H, D969H, D769H, D933H, D980H, D1013H	Tuberous sclerosis 2	VCV001377887	16	2129103	16	2079102	1377887	1469692	rs45517279	NC_000016.10:2079101:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3037G>A (p.Asp1013Asn)	TSC2	D1013N, D921N, D969N, D970N, D980N, D933N, D769N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000050171	16	2129103	16	2079102	50171	59333	rs45517279	NC_000016.10:2079101:G:A	single nucleotide variant	missense variant	Likely benign	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3038A>G (p.Asp1013Gly)	TSC2	D1013G, D933G, D969G, D970G, D769G, D921G, D980G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000406089	16	2129104	16	2079103	406089	401519	rs1060500961	NC_000016.10:2079102:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3039T>C (p.Asp1013=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000467987	16	2129105	16	2079104	467987	465988	rs149098424	NC_000016.10:2079103:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3040A>G (p.Ser1014Gly)	TSC2	S1014G, S770G, S922G, S934G, S970G, S971G, S981G	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001335196	16	2129106	16	2079105	1335196	1326169	rs1163007321	NC_000016.10:2079104:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3041G>A (p.Ser1014Asn)	TSC2	S1013N, S566N, S770N, S814N, S934N, S967N, S970N, S1001N, S436N, S522N, S771N, S817N, S921N, S933N, S951N, S966N, S971N, S1000N, S1014N, S523N, S813N, S922N, S964N, S965N, S977N, S981N	Tuberous sclerosis 2	VCV003689032	16	2129107	16	2079106	3689032	3831002		NC_000016.10:2079105:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3042C>T (p.Ser1014=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002001838	16	2129108	16	2079107	2001838	2055039	rs2151432422	NC_000016.10:2079106:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3043C>G (p.Leu1015Val)	TSC2	L1015V, L771V, L923V, L935V, L971V, L972V, L982V	not provided	VCV001313358	16	2129109	16	2079108	1313358	1303619	rs2151432458	NC_000016.10:2079107:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3045G>A (p.Leu1015=)	TSC2		Tuberous sclerosis 2	VCV004071343	16	2129111	16	2079110	4071343	4185191		NC_000016.10:2079109:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3046A>G (p.Lys1016Glu)	TSC2	K1002E, K773E, K973E, K983E, K438E, K525E, K816E, K924E, K968E, K969E, K1016E, K524E, K772E, K819E, K967E, K979E, K1003E, K1015E, K568E, K815E, K923E, K935E, K936E, K953E, K966E, K972E	Tuberous sclerosis 2	VCV003678493	16	2129112	16	2079111	3678493	3807229		NC_000016.10:2079110:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3048A>G (p.Lys1016=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000467988	16	2129114	16	2079113	467988	466180	rs1555510299	NC_000016.10:2079112:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 6, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3049A>G (p.Asn1017Asp)	TSC2	N1017D, N439D, N817D, N925D, N967D, N969D, N1016D, N773D, N924D, N974D, N984D, N1004D, N569D, N774D, N937D, N968D, N970D, N980D, N1003D, N525D, N526D, N816D, N820D, N936D, N954D, N973D	Tuberous sclerosis 2	VCV002006356	16	2129115	16	2079114	2006356	2069451	rs2151432618	NC_000016.10:2079113:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3050A>G (p.Asn1017Ser)	TSC2	N1017S, N773S, N925S, N937S, N973S, N974S, N984S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001051341	16	2129116	16	2079115	1051341	1049456	rs2151432652	NC_000016.10:2079114:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3051C>T (p.Asn1017=)	TSC2		Tuberous sclerosis 2	VCV001577221	16	2129117	16	2079116	1577221	1553257	rs752404221	NC_000016.10:2079115:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3052C>G (p.Leu1018Val)	TSC2	L1004V, L1005V, L1017V, L1018V, L440V, L526V, L527V, L570V, L774V, L775V, L817V, L818V, L821V, L925V, L926V, L937V, L938V, L955V, L968V, L969V, L970V, L971V, L974V, L975V, L981V, L985V	Tuberous sclerosis 2	VCV003627089	16	2129118	16	2079117	3627089	3752269		NC_000016.10:2079116:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3052C>T (p.Leu1018Phe)	TSC2	L1018F, L774F, L926F, L938F, L974F, L975F, L985F	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001056128	16	2129118	16	2079117	1056128	1049457	rs1034696882	NC_000016.10:2079116:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3052C>A (p.Leu1018Ile)	TSC2	L1018I, L774I, L926I, L938I, L974I, L975I, L985I	Tuberous sclerosis 2	VCV001021193	16	2129118	16	2079117	1021193	1011973	rs1034696882	NC_000016.10:2079116:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3053T>C (p.Leu1018Pro)	TSC2	L774P, L926P, L975P, L1018P, L938P, L985P, L974P	Tuberous sclerosis 2	VCV001373992	16	2129119	16	2079118	1373992	1456810	rs2151432741	NC_000016.10:2079117:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3054C>G (p.Leu1018=)	TSC2		Tuberous sclerosis 2|not provided	VCV001616205	16	2129120	16	2079119	1616205	1613925	rs762570079	NC_000016.10:2079118:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3054C>T (p.Leu1018=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238009	16	2129120	16	2079119	238009	242271	rs762570079	NC_000016.10:2079118:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3055C>T (p.His1019Tyr)	TSC2	H986Y, H1019Y, H775Y, H927Y, H976Y, H975Y, H939Y	Tuberous sclerosis 2	VCV000934028	16	2129121	16	2079120	934028	937317	rs2089797662	NC_000016.10:2079119:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3056A>T (p.His1019Leu)	TSC2	H1019L, H527L, H571L, H822L, H926L, H927L, H938L, H971L, H975L, H986L, H441L, H775L, H818L, H819L, H939L, H982L, H1005L, H776L, H956L, H969L, H976L, H1006L, H1018L, H528L, H970L, H972L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002839222	16	2129122	16	2079121	2839222	2996493	rs1555510317	NC_000016.10:2079120:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3056A>G (p.His1019Arg)	TSC2	H1019R, H775R, H927R, H976R, H986R, H939R, H975R	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000822741	16	2129122	16	2079121	822741	812565	rs1555510317	NC_000016.10:2079120:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3056A>C (p.His1019Pro)	TSC2	H1019P, H975P, H976P, H927P, H939P, H775P, H986P	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000486706	16	2129122	16	2079121	486706	477472	rs1555510317	NC_000016.10:2079120:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3057C>T (p.His1019=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413689	16	2129123	16	2079122	413689	400888	rs1060504102	NC_000016.10:2079121:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3058C>A (p.Leu1020Met)	TSC2	L1006M, L1007M, L1019M, L1020M, L442M, L528M, L529M, L572M, L776M, L777M, L819M, L820M, L823M, L927M, L928M, L939M, L940M, L957M, L970M, L971M, L972M, L973M, L976M, L977M, L983M, L987M	Tuberous sclerosis 2	VCV003620328	16	2129124	16	2079123	3620328	3750712		NC_000016.10:2079122:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3058C>T (p.Leu1020=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001158568	16	2129124	16	2079123	1158568	1145951	rs574318440	NC_000016.10:2079122:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3059T>C (p.Leu1020Pro)	TSC2	L776P, L976P, L928P, L940P, L977P, L1020P, L987P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001043264	16	2129125	16	2079124	1043264	1032461	rs2089798643	NC_000016.10:2079123:T:C	single nucleotide variant	missense variant	Uncertain significance	May 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3060G>A (p.Leu1020=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002750962	16	2129126	16	2079125	2750962	2913000	rs2151432959	NC_000016.10:2079124:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3062A>T (p.Glu1021Val)	TSC2	E1008V, E1020V, E443V, E530V, E972V, E984V, E1021V, E529V, E928V, E940V, E941V, E974V, E977V, E988V, E778V, E824V, E929V, E971V, E1007V, E573V, E777V, E820V, E821V, E958V, E973V, E978V	Hereditary cancer-predisposing syndrome	VCV003462687	16	2129128	16	2079127	3462687	3621706		NC_000016.10:2079126:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3063G>A (p.Glu1021=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811352	16	2129129	16	2079128	3811352	3928593		NC_000016.10:2079127:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 31, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3063G>T (p.Glu1021Asp)	TSC2	E1020D, E573D, E928D, E958D, E988D, E777D, E820D, E940D, E984D, E1007D, E1021D, E529D, E530D, E778D, E824D, E929D, E971D, E972D, E973D, E978D, E1008D, E443D, E821D, E941D, E974D, E977D	Hereditary cancer-predisposing syndrome	VCV003462577	16	2129129	16	2079128	3462577	3621596		NC_000016.10:2079127:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3064C>G (p.Leu1022Val)	TSC2	L1009V, L530V, L531V, L778V, L822V, L825V, L941V, L989V, L1021V, L972V, L975V, L985V, L1008V, L444V, L574V, L930V, L942V, L974V, L979V, L1022V, L779V, L821V, L929V, L959V, L973V, L978V	Tuberous sclerosis 2	VCV002853591	16	2129130	16	2079129	2853591	3013390	rs2151433071	NC_000016.10:2079128:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3065T>C (p.Leu1022Pro)	TSC2	L530P, L531P, L778P, L825P, L929P, L930P, L941P, L972P, L974P, L975P, L985P, L989P, L1022P, L444P, L779P, L979P, L1008P, L1021P, L574P, L821P, L973P, L978P, L1009P, L822P, L942P, L959P	Tuberous sclerosis 2	VCV003637214	16	2129131	16	2079130	3637214	3771368		NC_000016.10:2079129:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 26, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3067A>G (p.Thr1023Ala)	TSC2	T1023A, T779A, T931A, T943A, T979A, T980A, T990A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000845867	16	2129133	16	2079132	845867	843443	rs2089798819	NC_000016.10:2079131:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3068C>T (p.Thr1023Met)	TSC2	T1023M, T931M, T943M, T979M, T980M, T779M, T990M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535959	16	2129134	16	2079133	535959	530195	rs1555510327	NC_000016.10:2079132:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3069G>C (p.Thr1023=)	TSC2		Tuberous sclerosis 2	VCV002919661	16	2129135	16	2079134	2919661	3072542	rs373950550	NC_000016.10:2079133:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3069G>T (p.Thr1023=)	TSC2		Tuberous sclerosis 2	VCV002894079	16	2129135	16	2079134	2894079	3046011	rs373950550	NC_000016.10:2079133:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3069G>A (p.Thr1023=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238010	16	2129135	16	2079134	238010	242272	rs373950550	NC_000016.10:2079133:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3070G>C (p.Glu1024Gln)	TSC2	E446Q, E532Q, E781Q, E932Q, E961Q, E974Q, E987Q, E991Q, E1011Q, E533Q, E931Q, E943Q, E977Q, E1010Q, E1023Q, E576Q, E824Q, E827Q, E944Q, E975Q, E976Q, E980Q, E1024Q, E780Q, E823Q, E981Q	Hereditary cancer-predisposing syndrome	VCV003329500	16	2129136	16	2079135	3329500	3489092		NC_000016.10:2079134:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3070G>A (p.Glu1024Lys)	TSC2	E1024K, E780K, E932K, E991K, E944K, E980K, E981K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406088	16	2129136	16	2079135	406088	401283	rs1060500960	NC_000016.10:2079134:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3072A>T (p.Glu1024Asp)	TSC2	E1010D, E1011D, E1023D, E1024D, E446D, E532D, E533D, E576D, E780D, E781D, E823D, E824D, E827D, E931D, E932D, E943D, E944D, E961D, E974D, E975D, E976D, E977D, E980D, E981D, E987D, E991D	Hereditary cancer-predisposing syndrome	VCV003232132	16	2129138	16	2079137	3232132	3391933	rs2089799620	NC_000016.10:2079136:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3074C>T (p.Thr1025Ile)	TSC2	T447I, T577I, T978I, T988I, T781I, T828I, T945I, T976I, T977I, T981I, T1012I, T1025I, T533I, T534I, T782I, T825I, T932I, T933I, T975I, T992I, T1011I, T1024I, T824I, T944I, T962I, T982I	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578798	16	2129140	16	2079139	3578798	3708219		NC_000016.10:2079138:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3074C>G (p.Thr1025Ser)	TSC2	T1011S, T1012S, T1024S, T1025S, T447S, T533S, T534S, T577S, T781S, T782S, T824S, T825S, T828S, T932S, T933S, T944S, T945S, T962S, T975S, T976S, T977S, T978S, T981S, T982S, T988S, T992S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003070183	16	2129140	16	2079139	3070183	3231671	rs1371092393	NC_000016.10:2079138:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3075C>G (p.Thr1025=)	TSC2		Tuberous sclerosis 2	VCV002125371	16	2129141	16	2079140	2125371	2177972	rs1596382606	NC_000016.10:2079139:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3075C>T (p.Thr1025=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000706000	16	2129141	16	2079140	706000	693813	rs1596382606	NC_000016.10:2079139:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3076T>A (p.Cys1026Ser)	TSC2	C1025S, C535S, C825S, C826S, C829S, C979S, C982S, C989S, C993S, C1012S, C534S, C977S, C1013S, C578S, C782S, C783S, C933S, C934S, C946S, C976S, C983S, C1026S, C448S, C945S, C963S, C978S	Hereditary cancer-predisposing syndrome	VCV003329487	16	2129142	16	2079141	3329487	3489079		NC_000016.10:2079140:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3077G>T (p.Cys1026Phe)	TSC2	C1013F, C535F, C829F, C963F, C979F, C982F, C993F, C1012F, C534F, C578F, C934F, C945F, C1025F, C783F, C825F, C933F, C946F, C977F, C978F, C989F, C1026F, C448F, C782F, C826F, C976F, C983F	Hereditary cancer-predisposing syndrome	VCV001727322	16	2129143	16	2079142	1727322	1784802	rs2151433476	NC_000016.10:2079141:G:T	single nucleotide variant	missense variant	Uncertain significance	May 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3079C>T (p.Leu1027=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000795587	16	2129145	16	2079144	795587	785195	rs1596382637	NC_000016.10:2079143:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3080T>C (p.Leu1027Pro)	TSC2	L1027P, L783P, L935P, L983P, L984P, L994P, L947P	Tuberous sclerosis 2	VCV000049874	16	2129146	16	2079145	49874	59036	rs45438192	NC_000016.10:2079144:T:C	single nucleotide variant	missense variant	Likely pathogenic	Apr 8, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3081G>A (p.Leu1027=)	TSC2		Tuberous sclerosis 2	VCV003632644	16	2129147	16	2079146	3632644	3763157		NC_000016.10:2079145:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3081G>C (p.Leu1027=)	TSC2		Tuberous sclerosis 2	VCV002845522	16	2129147	16	2079146	2845522	3011721	rs2151433575	NC_000016.10:2079145:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3082G>A (p.Asp1028Asn)	TSC2	D1028N, D984N, D995N, D936N, D784N, D948N, D985N	Tuberous sclerosis 2	VCV000049547	16	2129148	16	2079147	49547	58709	rs45517280	NC_000016.10:2079146:G:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3083A>T (p.Asp1028Val)	TSC2	D1015V, D450V, D537V, D580V, D831V, D978V, D1014V, D1028V, D785V, D979V, D991V, D536V, D827V, D947V, D948V, D965V, D981V, D995V, D1027V, D784V, D828V, D935V, D936V, D980V, D984V, D985V	Tuberous sclerosis 2	VCV002033708	16	2129149	16	2079148	2033708	2096768	rs397515255	NC_000016.10:2079147:A:T	single nucleotide variant	missense variant	Likely pathogenic	Oct 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3084C>A (p.Asp1028Glu)	TSC2	D984E, D1028E, D978E, D979E, D1014E, D450E, D536E, D537E, D828E, D935E, D980E, D991E, D995E, D1027E, D785E, D827E, D831E, D936E, D948E, D1015E, D580E, D784E, D947E, D965E, D981E, D985E	Hereditary cancer-predisposing syndrome	VCV001727389	16	2129150	16	2079149	1727389	1784869	rs1555510350	NC_000016.10:2079148:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3084C>T (p.Asp1028=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536010	16	2129150	16	2079149	536010	529668	rs1555510350	NC_000016.10:2079148:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3085A>G (p.Met1029Val)	TSC2	M1028V, M786V, M937V, M948V, M966V, M980V, M986V, M992V, M1015V, M1016V, M537V, M949V, M979V, M982V, M996V, M1029V, M581V, M451V, M538V, M785V, M828V, M829V, M981V, M985V, M832V, M936V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001727397	16	2129151	16	2079150	1727397	1784877	rs780572757	NC_000016.10:2079149:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3085A>C (p.Met1029Leu)	TSC2	M1028L, M581L, M451L, M832L, M936L, M948L, M966L, M985L, M1015L, M1016L, M537L, M538L, M829L, M949L, M979L, M981L, M982L, M992L, M1029L, M785L, M786L, M828L, M937L, M980L, M986L, M996L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001727396	16	2129151	16	2079150	1727396	1784876	rs780572757	NC_000016.10:2079149:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3086T>G (p.Met1029Arg)	TSC2	M832R, M966R, M992R, M1015R, M1029R, M786R, M936R, M937R, M948R, M979R, M982R, M985R, M828R, M829R, M949R, M1016R, M1028R, M451R, M537R, M538R, M581R, M785R, M980R, M981R, M986R, M996R	Tuberous sclerosis 2	VCV002754808	16	2129152	16	2079151	2754808	2909507	rs1057522974	NC_000016.10:2079150:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Sep 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3086T>C (p.Met1029Thr)	TSC2	M1029T, M985T, M785T, M996T, M937T, M949T, M986T	not provided	VCV000387996	16	2129152	16	2079151	387996	374775	rs1057522974	NC_000016.10:2079150:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3088A>G (p.Met1030Val)	TSC2	M1030V, M986V, M987V, M950V, M997V, M786V, M938V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified|not provided	VCV000386865	16	2129154	16	2079153	386865	375187	rs754276150	NC_000016.10:2079152:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3089T>G (p.Met1030Arg)	TSC2	M1030R, M786R, M987R, M997R, M938R, M986R, M950R	Tuberous sclerosis 2|not provided	VCV000586852	16	2129155	16	2079154	586852	577455	rs1567496821	NC_000016.10:2079153:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3089T>C (p.Met1030Thr)	TSC2	M1030T, M987T, M986T, M786T, M938T, M950T, M997T	Tuberous sclerosis 2	VCV000574830	16	2129155	16	2079154	574830	573835	rs1567496821	NC_000016.10:2079153:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3090G>C (p.Met1030Ile)	TSC2	M987I, M938I, M950I, M986I, M1030I, M786I, M997I	Tuberous sclerosis 2	VCV001365142	16	2129156	16	2079155	1365142	1502186	rs2151433890	NC_000016.10:2079154:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3091G>C (p.Ala1031Pro)	TSC2	A1017P, A834P, A950P, A982P, A998P, A1030P, A1031P, A938P, A939P, A987P, A1018P, A453P, A539P, A787P, A968P, A983P, A984P, A540P, A583P, A788P, A830P, A831P, A951P, A981P, A988P, A994P	Tuberous sclerosis 2	VCV002835323	16	2129157	16	2079156	2835323	2998981	rs2151433921	NC_000016.10:2079155:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3091G>T (p.Ala1031Ser)	TSC2	A1031S, A951S, A998S, A787S, A939S, A987S, A988S	Tuberous sclerosis 2	VCV001436066	16	2129157	16	2079156	1436066	1497182	rs2151433921	NC_000016.10:2079155:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3092C>T (p.Ala1031Val)	TSC2	A951V, A988V, A1031V, A939V, A987V, A998V, A787V	Tuberous sclerosis 2	VCV001475917	16	2129158	16	2079157	1475917	1423637	rs2151433942	NC_000016.10:2079156:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3094C>A (p.Arg1032=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001727491	16	2129160	16	2079159	1727491	1784971	rs45465195	NC_000016.10:2079158:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 22, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3094C>G (p.Arg1032Gly)	TSC2	R788G, R952G, R988G, R989G, R1032G, R940G, R999G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000822853	16	2129160	16	2079159	822853	812566	rs45465195	NC_000016.10:2079158:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3094C>T (p.Arg1032Ter)	TSC2	R1032*, R788*, R989*, R952*, R999*, R988*, R940*	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000049240	16	2129160	16	2079159	49240	58402	rs45465195	NC_000016.10:2079158:C:T	single nucleotide variant	nonsense	Pathogenic	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3095G>A (p.Arg1032Gln)	TSC2	R1032Q, R988Q, R999Q, R788Q, R940Q, R952Q, R989Q	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535975	16	2129161	16	2079160	535975	529606	rs45491698	NC_000016.10:2079159:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3095G>C (p.Arg1032Pro)	TSC2	R1032P, R952P, R988P, R940P, R788P, R989P, R999P	not provided|Tuberous sclerosis 2	VCV000049241	16	2129161	16	2079160	49241	58403	rs45491698	NC_000016.10:2079159:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3096A>G (p.Arg1032=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000851678	16	2129162	16	2079161	851678	843444	rs2089803859	NC_000016.10:2079160:A:G	single nucleotide variant	synonymous variant	Likely pathogenic	Sep 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3097T>C (p.Tyr1033His)	TSC2	Y1033H, Y789H, Y953H, Y941H, Y990H, Y989H, Y1000H	Tuberous sclerosis 2	VCV000050040	16	2129163	16	2079162	50040	59202	rs137854404	NC_000016.10:2079161:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3099C>T (p.Tyr1033=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000379842	16	2129165	16	2079164	379842	374116	rs45464800	NC_000016.10:2079163:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3099C>G (p.Tyr1033Ter)	TSC2	Y1033*, Y953*, Y789*, Y941*, Y990*, Y1000*, Y989*	Tuberous sclerosis 2|not provided	VCV000049735	16	2129165	16	2079164	49735	58897	rs45464800	NC_000016.10:2079163:C:G	single nucleotide variant	nonsense	Pathogenic	Jul 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3099C>A (p.Tyr1033Ter)	TSC2	Y1033*, Y1000*, Y941*, Y989*, Y789*, Y990*, Y953*	not provided|Tuberous sclerosis 2	VCV000049734	16	2129165	16	2079164	49734	58896	rs45464800	NC_000016.10:2079163:C:A	single nucleotide variant	nonsense	Pathogenic	Jun 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3100G>T (p.Val1034Phe)	TSC2	V942F, V1034F, V1001F, V790F, V954F, V990F, V991F	Tuberous sclerosis 2	VCV000854649	16	2129166	16	2079165	854649	843445	rs146745242	NC_000016.10:2079164:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3100G>A (p.Val1034Ile)	TSC2	V1034I, V1001I, V942I, V790I, V990I, V991I, V954I	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000389789	16	2129166	16	2079165	389789	374117	rs146745242	NC_000016.10:2079164:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3101T>C (p.Val1034Ala)	TSC2	V1034A, V790A, V791A, V971A, V985A, V456A, V542A, V586A, V997A, V1020A, V1021A, V543A, V837A, V941A, V953A, V986A, V990A, V991A, V1001A, V1033A, V833A, V834A, V942A, V954A, V984A, V987A	Tuberous sclerosis 2	VCV002810881	16	2129167	16	2079166	2810881	2975395	rs2151434288	NC_000016.10:2079165:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 31, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3102C>T (p.Val1034=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238012	16	2129168	16	2079167	238012	242274	rs562998574	NC_000016.10:2079166:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3102C>G (p.Val1034=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000238011	16	2129168	16	2079167	238011	242273	rs562998574	NC_000016.10:2079166:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3103T>C (p.Phe1035Leu)	TSC2	F1002L, F1035L, F791L, F943L, F955L, F991L, F992L	not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis	VCV001698206	16	2129169	16	2079168	1698206	1690585	rs2151434349	NC_000016.10:2079167:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3103T>G (p.Phe1035Val)	TSC2	F955V, F1035V, F791V, F991V, F1002V, F943V, F992V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001465948	16	2129169	16	2079168	1465948	1448773	rs2151434349	NC_000016.10:2079167:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3105C>G (p.Phe1035Leu)	TSC2	F544L, F791L, F942L, F955L, F992L, F1002L, F1034L, F835L, F838L, F972L, F1021L, F1035L, F543L, F587L, F792L, F985L, F987L, F988L, F1022L, F457L, F834L, F943L, F954L, F986L, F991L, F998L	Hereditary cancer-predisposing syndrome	VCV003462590	16	2129171	16	2079170	3462590	3621609		NC_000016.10:2079169:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3105C>A (p.Phe1035Leu)	TSC2	F1035L, F834L, F838L, F985L, F986L, F991L, F992L, F1021L, F1022L, F457L, F942L, F972L, F1002L, F543L, F544L, F954L, F955L, F988L, F1034L, F587L, F791L, F792L, F835L, F943L, F987L, F998L	Hereditary cancer-predisposing syndrome	VCV001727681	16	2129171	16	2079170	1727681	1785161	rs2151434410	NC_000016.10:2079169:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3105C>T (p.Phe1035=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001124209	16	2129171	16	2079170	1124209	1125069	rs2151434410	NC_000016.10:2079169:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3106T>G (p.Ser1036Ala)	TSC2	S1036A, S944A, S992A, S792A, S956A, S1003A, S993A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000207739	16	2129172	16	2079171	207739	203160	rs45517281	NC_000016.10:2079170:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3106T>C (p.Ser1036Pro)	TSC2	S1036P, S944P, S993P, S792P, S1003P, S956P, S992P	Tuberous sclerosis 2	VCV000050043	16	2129172	16	2079171	50043	59205	rs45517281	NC_000016.10:2079170:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3108C>G (p.Ser1036=)	TSC2		Tuberous sclerosis 2	VCV003647916	16	2129174	16	2079173	3647916	3777162		NC_000016.10:2079172:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3108C>T (p.Ser1036=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000742076	16	2129174	16	2079173	742076	754996	rs377575867	NC_000016.10:2079172:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3110A>G (p.Asn1037Ser)	TSC2	N1037S, N546S, N793S, N794S, N956S, N1023S, N545S, N589S, N836S, N837S, N987S, N990S, N993S, N994S, N1004S, N944S, N957S, N974S, N988S, N1000S, N1024S, N1036S, N459S, N840S, N945S, N989S	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002964482	16	2129176	16	2079175	2964482	3124385	rs2089806008	NC_000016.10:2079174:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3110A>C (p.Asn1037Thr)	TSC2	N793T, N945T, N994T, N1004T, N1037T, N957T, N993T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000933296	16	2129176	16	2079175	933296	937318	rs2089806008	NC_000016.10:2079174:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3111C>G (p.Asn1037Lys)	TSC2	N988K, N989K, N994K, N1023K, N1024K, N794K, N945K, N956K, N1036K, N459K, N545K, N793K, N836K, N837K, N840K, N987K, N993K, N1000K, N1037K, N546K, N589K, N944K, N957K, N974K, N1004K, N990K	Hereditary cancer-predisposing syndrome	VCV003462595	16	2129177	16	2079176	3462595	3621614		NC_000016.10:2079175:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3111C>T (p.Asn1037=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001086843	16	2129177	16	2079176	1086843	1081827	rs1222753588	NC_000016.10:2079175:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3114C>T (p.Phe1038=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001151424	16	2129180	16	2079179	1151424	1145952	rs1567497089	NC_000016.10:2079178:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3114C>A (p.Phe1038Leu)	TSC2	F1038L, F946L, F958L, F994L, F794L, F1005L, F995L	Tuberous sclerosis 2	VCV000568978	16	2129180	16	2079179	568978	573838	rs1567497089	NC_000016.10:2079178:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3115A>G (p.Thr1039Ala)	TSC2	T995A, T1039A, T795A, T996A, T1006A, T947A, T959A	Tuberous sclerosis 2	VCV001378239	16	2129181	16	2079180	1378239	1492669	rs2151434691	NC_000016.10:2079179:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3116C>T (p.Thr1039Met)	TSC2	T1039M, T947M, T995M, T1006M, T959M, T795M, T996M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000650591	16	2129182	16	2079181	650591	644273	rs1596382895	NC_000016.10:2079180:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3117G>T (p.Thr1039=)	TSC2		Tuberous sclerosis 2	VCV002760030	16	2129183	16	2079182	2760030	2910842	rs747104674	NC_000016.10:2079181:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3117G>C (p.Thr1039=)	TSC2		Tuberous sclerosis 2	VCV001115366	16	2129183	16	2079182	1115366	1103655	rs747104674	NC_000016.10:2079181:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3117G>A (p.Thr1039=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000452788	16	2129183	16	2079182	452788	445519	rs747104674	NC_000016.10:2079181:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3118G>A (p.Ala1040Thr)	TSC2	A1003T, A1007T, A1026T, A1027T, A1039T, A1040T, A462T, A548T, A549T, A592T, A796T, A797T, A839T, A840T, A843T, A947T, A948T, A959T, A960T, A977T, A990T, A991T, A992T, A993T, A996T, A997T	Tuberous sclerosis 2	VCV003603917	16	2129184	16	2079183	3603917	3746391		NC_000016.10:2079182:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3118G>T (p.Ala1040Ser)	TSC2	A1027S, A1039S, A549S, A948S, A959S, A990S, A996S, A1003S, A1007S, A462S, A592S, A840S, A977S, A993S, A548S, A797S, A839S, A843S, A960S, A992S, A997S, A1026S, A1040S, A796S, A947S, A991S	Tuberous sclerosis 2	VCV002749959	16	2129184	16	2079183	2749959	2918917	rs2151434791	NC_000016.10:2079182:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3119C>G (p.Ala1040Gly)	TSC2	A1026G, A1040G, A796G, A839G, A840G, A1039G, A548G, A549G, A843G, A990G, A993G, A462G, A592G, A797G, A959G, A977G, A991G, A996G, A997G, A1003G, A1007G, A1027G, A947G, A948G, A960G, A992G	Tuberous sclerosis 2	VCV003637215	16	2129185	16	2079184	3637215	3771369		NC_000016.10:2079183:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3119C>T (p.Ala1040Val)	TSC2	A1007V, A1040V, A796V, A948V, A960V, A996V, A997V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV001331726	16	2129185	16	2079184	1331726	1322446	rs2089807202	NC_000016.10:2079183:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3120T>C (p.Ala1040=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002449964	16	2129186	16	2079185	2449964	2429589	rs2151434865	NC_000016.10:2079184:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3121G>A (p.Val1041Ile)	TSC2	V1008I, V1040I, V949I, V960I, V961I, V991I, V998I, V1027I, V1028I, V593I, V840I, V948I, V993I, V1041I, V463I, V797I, V798I, V978I, V1004I, V549I, V550I, V841I, V844I, V992I, V997I, V994I	Hereditary cancer-predisposing syndrome	VCV003974633	16	2129187	16	2079186	3974633	4086456		NC_000016.10:2079185:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3122T>C (p.Val1041Ala)	TSC2	V1004A, V1008A, V1027A, V1028A, V1040A, V1041A, V463A, V549A, V550A, V593A, V797A, V798A, V840A, V841A, V844A, V948A, V949A, V960A, V961A, V978A, V991A, V992A, V993A, V994A, V997A, V998A	Tuberous sclerosis 2	VCV001720749	16	2129188	16	2079187	1720749	1776931	rs771092741	NC_000016.10:2079186:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3123C>G (p.Val1041=)	TSC2		Tuberous sclerosis 2	VCV004071272	16	2129189	16	2079188	4071272	4185120		NC_000016.10:2079187:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 27, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3123C>T (p.Val1041=)	TSC2		Tuberous sclerosis 2	VCV001582923	16	2129189	16	2079188	1582923	1535161	rs776710692	NC_000016.10:2079187:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3124C>T (p.Pro1042Ser)	TSC2	P1028S, P551S, P594S, P799S, P841S, P842S, P950S, P962S, P999S, P1005S, P845S, P961S, P1009S, P1041S, P1042S, P979S, P994S, P995S, P1029S, P464S, P550S, P798S, P949S, P992S, P993S, P998S	Hereditary cancer-predisposing syndrome	VCV002564626	16	2129190	16	2079189	2564626	2733782	rs2151434980	NC_000016.10:2079188:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3124C>A (p.Pro1042Thr)	TSC2	P1005T, P1009T, P1028T, P1029T, P1041T, P1042T, P464T, P550T, P551T, P594T, P798T, P799T, P841T, P842T, P845T, P949T, P950T, P961T, P962T, P979T, P992T, P993T, P994T, P995T, P998T, P999T	not provided	VCV001809738	16	2129190	16	2079189	1809738	1866742	rs2151434980	NC_000016.10:2079188:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3125C>A (p.Pro1042Gln)	TSC2	P1005Q, P1009Q, P841Q, P842Q, P845Q, P1041Q, P594Q, P949Q, P962Q, P992Q, P995Q, P1029Q, P464Q, P550Q, P551Q, P950Q, P961Q, P993Q, P994Q, P999Q, P1028Q, P1042Q, P798Q, P799Q, P979Q, P998Q	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002199354	16	2129191	16	2079190	2199354	1927621	rs745731000	NC_000016.10:2079189:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3125C>T (p.Pro1042Leu)	TSC2	P950L, P1009L, P1042L, P962L, P998L, P798L, P999L	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000962287	16	2129191	16	2079190	962287	949252	rs745731000	NC_000016.10:2079189:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3125C>G (p.Pro1042Arg)	TSC2	P1042R, P999R, P962R, P998R, P1009R, P798R, P950R	Tuberous sclerosis 2	VCV000577842	16	2129191	16	2079190	577842	569758	rs745731000	NC_000016.10:2079189:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3126G>A (p.Pro1042=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000378786	16	2129192	16	2079191	378786	374782	rs36078782	NC_000016.10:2079190:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3126G>T (p.Pro1042=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000049740	16	2129192	16	2079191	49740	58902	rs36078782	NC_000016.10:2079190:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3126G>C (p.Pro1042=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049739	16	2129192	16	2079191	49739	58901	rs36078782	NC_000016.10:2079190:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3127A>T (p.Lys1043Ter)	TSC2	K1000*, K1006*, K1010*, K1029*, K1030*, K1042*, K1043*, K465*, K551*, K552*, K595*, K799*, K800*, K842*, K843*, K846*, K950*, K951*, K962*, K963*, K980*, K993*, K994*, K995*, K996*, K999*	Tuberous sclerosis 2	VCV002434292	16	2129193	16	2079192	2434292	2408229	rs2151435107	NC_000016.10:2079191:A:T	single nucleotide variant	nonsense	Likely pathogenic	Mar 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3130A>G (p.Arg1044Gly)	TSC2	R1011G, R1031G, R1043G, R552G, R800G, R844G, R952G, R964G, R1044G, R801G, R963G, R994G, R997G, R1007G, R553G, R596G, R847G, R981G, R995G, R1000G, R1001G, R1030G, R466G, R843G, R951G, R996G	Tuberous sclerosis 2	VCV002762086	16	2129196	16	2079195	2762086	2930582	rs2151435222	NC_000016.10:2079194:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131G>C (p.Arg1044Thr)	TSC2	R1000T, R1001T, R964T, R1011T, R1044T, R952T, R800T	Tuberous sclerosis 2	VCV001458097	16	2129197	16	2079196	1458097	1471662	rs397515302	NC_000016.10:2079195:G:C	single nucleotide variant	missense variant	Pathogenic	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131G>A (p.Arg1044Lys)	TSC2	R1044K, R1011K, R952K, R1001K, R800K, R964K, R1000K	Tuberous sclerosis 2	VCV000065309	16	2129197	16	2079196	65309	76241	rs397515302	NC_000016.10:2079195:G:A	single nucleotide variant	missense variant	Pathogenic	Jun 2, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+1G>A	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis 2	VCV000049244	16	2129198	16	2079197	49244	58406	rs45506401	NC_000016.10:2079196:G:A	single nucleotide variant	splice donor variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3131+2T>A	TSC2		not provided	VCV000379256	16	2129199	16	2079198	379256	377241	rs397515036	NC_000016.10:2079197:T:A	single nucleotide variant	splice donor variant	Pathogenic	Mar 10, 2015	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+3C>G	TSC2		Tuberous sclerosis 2	VCV002021717	16	2129200	16	2079199	2021717	2083478	rs1420280878	NC_000016.10:2079198:C:G	single nucleotide variant	intron variant	Uncertain significance	Sep 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+3C>A	TSC2		not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535894	16	2129200	16	2079199	535894	530197	rs1420280878	NC_000016.10:2079198:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3131+4C>T	TSC2		Tuberous sclerosis 2	VCV001045473	16	2129201	16	2079200	1045473	1032462	rs559015964	NC_000016.10:2079199:C:T	single nucleotide variant	intron variant	Likely benign	Feb 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+4C>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000955317	16	2129201	16	2079200	955317	960146	rs559015964	NC_000016.10:2079199:C:G	single nucleotide variant	intron variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3131+5A>C	TSC2		Tuberous sclerosis 2	VCV001378627	16	2129202	16	2079201	1378627	1493057	rs1843069967	NC_000016.10:2079200:A:C	single nucleotide variant	intron variant	Uncertain significance	Oct 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+7G>A	TSC2		Tuberous sclerosis 2	VCV000757437	16	2129204	16	2079203	757437	776160	rs1596383060	NC_000016.10:2079202:G:A	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3131+8C>A	TSC2		Tuberous sclerosis 2	VCV000467990	16	2129205	16	2079204	467990	465990	rs763702215	NC_000016.10:2079203:C:A	single nucleotide variant	intron variant	Likely benign	Oct 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+8C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000384390	16	2129205	16	2079204	384390	374785	rs763702215	NC_000016.10:2079203:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3131+9G>A	TSC2		Tuberous sclerosis 2	VCV000467991	16	2129206	16	2079205	467991	466182	rs1352481690	NC_000016.10:2079204:G:A	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3131+10G>A	TSC2		Tuberous sclerosis 2	VCV003708422	16	2129207	16	2079206	3708422	3836699		NC_000016.10:2079205:G:A	single nucleotide variant	intron variant	Likely benign	May 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+12A>C	TSC2		Tuberous sclerosis 2	VCV002755695	16	2129209	16	2079208	2755695	2916867	rs1463350025	NC_000016.10:2079207:A:C	single nucleotide variant	intron variant	Likely benign	Aug 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+14T>A	TSC2		Tuberous sclerosis 2	VCV002750205	16	2129211	16	2079210	2750205	2919163	rs2151435632	NC_000016.10:2079209:T:A	single nucleotide variant	intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+16C>T	TSC2		Tuberous sclerosis 2	VCV001584953	16	2129213	16	2079212	1584953	1561104	rs1298637729	NC_000016.10:2079211:C:T	single nucleotide variant	intron variant	Likely benign	Aug 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+17A>G	TSC2		Tuberous sclerosis 2	VCV002022595	16	2129214	16	2079213	2022595	2076659	rs1354784865	NC_000016.10:2079212:A:G	single nucleotide variant	intron variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+18G>C	TSC2		Tuberous sclerosis 2	VCV001660091	16	2129215	16	2079214	1660091	1606462	rs2151435723	NC_000016.10:2079213:G:C	single nucleotide variant	intron variant	Likely benign	Nov 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+19G>A	TSC2		Tuberous sclerosis 2	VCV002915607	16	2129216	16	2079215	2915607	3074157	rs754157205	NC_000016.10:2079214:G:A	single nucleotide variant	intron variant	Uncertain significance	Sep 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+19G>C	TSC2		Tuberous sclerosis 2	VCV001619000	16	2129216	16	2079215	1619000	1548775	rs754157205	NC_000016.10:2079214:G:C	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3131+34C>T	TSC2		not provided	VCV000049747	16	2129231	16	2079230	49747	58909	rs45487103	NC_000016.10:2079229:C:T	single nucleotide variant	intron variant	Likely benign	Sep 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-31C>T	TSC2		Hereditary cancer-predisposing syndrome	VCV002626408	16	2129246	16	2079245	2626408	2794174	rs2089816432	NC_000016.10:2079244:C:T	single nucleotide variant	intron variant	Uncertain significance	Jun 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-30A>G	TSC2		not provided	VCV000050049	16	2129247	16	2079246	50049	59211	rs45517283	NC_000016.10:2079245:A:G	single nucleotide variant	intron variant	Likely benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132-20T>C	TSC2		Tuberous sclerosis 2	VCV002820906	16	2129257	16	2079256	2820906	2978151	rs2544042406	NC_000016.10:2079255:T:C	single nucleotide variant	intron variant	Likely benign	Sep 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-19C>T	TSC2		Tuberous sclerosis 2	VCV004071318	16	2129258	16	2079257	4071318	4185166		NC_000016.10:2079256:C:T	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-18A>C	TSC2		Tuberous sclerosis 2	VCV002019874	16	2129259	16	2079258	2019874	2086761	rs137854120	NC_000016.10:2079257:A:C	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132-17C>T	TSC2		Tuberous sclerosis 2	VCV001560492	16	2129260	16	2079259	1560492	1575983	rs781476832	NC_000016.10:2079258:C:T	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132-16G>T	TSC2		Tuberous sclerosis 2	VCV002986954	16	2129261	16	2079260	2986954	3143445	rs199572528	NC_000016.10:2079259:G:T	single nucleotide variant	intron variant	Likely benign	Mar 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-16G>A	TSC2		Tuberous sclerosis 2	VCV000065317	16	2129261	16	2079260	65317	76249	rs199572528	NC_000016.10:2079259:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132-15C>T	TSC2		Tuberous sclerosis 2	VCV002081992	16	2129262	16	2079261	2081992	2135946	rs769659537	NC_000016.10:2079260:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132-15C>G	TSC2		Tuberous sclerosis 2	VCV001530706	16	2129262	16	2079261	1530706	1635178	rs769659537	NC_000016.10:2079260:C:G	single nucleotide variant	intron variant	Likely benign	Feb 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-14T>A	TSC2		Tuberous sclerosis 2	VCV001575097	16	2129263	16	2079262	1575097	1638382	rs2151436540	NC_000016.10:2079261:T:A	single nucleotide variant	intron variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-13C>G	TSC2		Tuberous sclerosis 2	VCV001605164	16	2129264	16	2079263	1605164	1537492	rs371948435	NC_000016.10:2079262:C:G	single nucleotide variant	intron variant	Likely benign	Oct 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-13C>T	TSC2		Lymphangiomyomatosis|Tuberous sclerosis 2|not provided	VCV000930490	16	2129264	16	2079263	930490	920354	rs371948435	NC_000016.10:2079262:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3132-12C>T	TSC2		Tuberous sclerosis 2	VCV002996244	16	2129265	16	2079264	2996244	3162952	rs112484256	NC_000016.10:2079263:C:T	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132-12C>G	TSC2		Tuberous sclerosis 2	VCV001985900	16	2129265	16	2079264	1985900	2039851	rs112484256	NC_000016.10:2079263:C:G	single nucleotide variant	intron variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-11C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001607097	16	2129266	16	2079265	1607097	1572407	rs2089819486	NC_000016.10:2079264:C:T	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132-11C>G	TSC2		Tuberous sclerosis 2	VCV001582489	16	2129266	16	2079265	1582489	1566759	rs2089819486	NC_000016.10:2079264:C:G	single nucleotide variant	intron variant	Likely benign	Apr 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-9G>T	TSC2		Tuberous sclerosis 2	VCV002005917	16	2129268	16	2079267	2005917	2072863	rs1367489214	NC_000016.10:2079266:G:T	single nucleotide variant	intron variant	Likely benign	May 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-9G>A	TSC2		Tuberous sclerosis 2	VCV001547663	16	2129268	16	2079267	1547663	1624737	rs1367489214	NC_000016.10:2079266:G:A	single nucleotide variant	intron variant	Likely benign	Apr 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-8T>A	TSC2		Tuberous sclerosis 2	VCV003648772	16	2129269	16	2079268	3648772	3784629		NC_000016.10:2079267:T:A	single nucleotide variant	intron variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-7C>T	TSC2		Tuberous sclerosis 2	VCV001562976	16	2129270	16	2079269	1562976	1555974	rs2089820591	NC_000016.10:2079268:C:T	single nucleotide variant	intron variant	Likely benign	Sep 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-4C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001945453	16	2129273	16	2079272	1945453	1995709	rs1228693719	NC_000016.10:2079271:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 12, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3132-4C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000695869	16	2129273	16	2079272	695869	685415	rs1228693719	NC_000016.10:2079271:C:T	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132-3T>C	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome	VCV000931337	16	2129274	16	2079273	931337	920355	rs2089821106	NC_000016.10:2079272:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3132-2A>G	TSC2		Hereditary cancer-predisposing syndrome|not provided	VCV001727977	16	2129275	16	2079274	1727977	1794845	rs45517282	NC_000016.10:2079273:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Jan 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132-2A>C	TSC2		Tuberous sclerosis 2	VCV000050048	16	2129275	16	2079274	50048	59210	rs45517282	NC_000016.10:2079273:A:C	single nucleotide variant	splice acceptor variant	Pathogenic	Mar 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-1G>T	TSC2		Tuberous sclerosis 2	VCV000406021	16	2129276	16	2079275	406021	401289	rs45443096	NC_000016.10:2079274:G:T	single nucleotide variant	splice acceptor variant	Pathogenic	Mar 31, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-1G>A	TSC2		Tuberous sclerosis 2	VCV000049749	16	2129276	16	2079275	49749	58911	rs45443096	NC_000016.10:2079274:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Oct 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3132-1G>C	TSC2		Tuberous sclerosis syndrome	VCV000049245	16	2129276	16	2079275	49245	58407	rs45443096	NC_000016.10:2079274:G:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Jul 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3132G>A (p.Arg1044=)	TSC2		Tuberous sclerosis 2	VCV002008779	16	2129277	16	2079276	2008779	2062853	rs2151436847	NC_000016.10:2079275:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Jun 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3133T>A (p.Ser1045Thr)	TSC2	S801T, S1012T, S1045T, S1001T, S1002T, S953T, S965T	Tuberous sclerosis 2	VCV000665844	16	2129278	16	2079277	665844	644274	rs1596383557	NC_000016.10:2079276:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3134C>T (p.Ser1045Phe)	TSC2	S1001F, S1002F, S1008F, S1012F, S1031F, S1032F, S1044F, S1045F, S467F, S553F, S554F, S597F, S801F, S802F, S844F, S845F, S848F, S952F, S953F, S964F, S965F, S982F, S995F, S996F, S997F, S998F	not provided	VCV001711398	16	2129279	16	2079278	1711398	1709814	rs1567497647	NC_000016.10:2079277:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3134C>G (p.Ser1045Cys)	TSC2	S1045C, S1001C, S1012C, S801C, S953C, S1002C, S965C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000571585	16	2129279	16	2079278	571585	570106	rs1567497647	NC_000016.10:2079277:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3136C>T (p.Pro1046Ser)	TSC2	P1046S, P1003S, P954S, P1013S, P802S, P1002S, P966S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467992	16	2129281	16	2079280	467992	466193	rs774008119	NC_000016.10:2079279:C:T	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3137C>T (p.Pro1046Leu)	TSC2	P1046L, P1002L, P802L, P1003L, P1013L, P954L, P966L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000591058	16	2129282	16	2079281	591058	582052	rs1567497682	NC_000016.10:2079280:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3139G>A (p.Val1047Met)	TSC2	V1004M, V1014M, V955M, V967M, V1003M, V1047M, V803M	Tuberous sclerosis 2	VCV000956212	16	2129284	16	2079283	956212	949253	rs761513970	NC_000016.10:2079282:G:A	single nucleotide variant	missense variant	Benign	Dec 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3140T>C (p.Val1047Ala)	TSC2	V1047A, V1004A, V1003A, V803A, V1014A, V955A, V967A	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049565	16	2129285	16	2079284	49565	58727	rs45517284	NC_000016.10:2079283:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3141G>A (p.Val1047=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000850193	16	2129286	16	2079285	850193	843446	rs1596383623	NC_000016.10:2079284:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3141G>T (p.Val1047=)	TSC2		Tuberous sclerosis 2	VCV000761583	16	2129286	16	2079285	761583	770714	rs1596383623	NC_000016.10:2079284:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3143G>A (p.Gly1048Asp)	TSC2	G1000D, G1005D, G470D, G848D, G999D, G1011D, G1015D, G1034D, G847D, G967D, G1004D, G1035D, G1047D, G557D, G600D, G955D, G956D, G985D, G998D, G1001D, G1048D, G556D, G804D, G805D, G851D, G968D	Hereditary cancer-predisposing syndrome	VCV002564646	16	2129288	16	2079287	2564646	2733802	rs2151437111	NC_000016.10:2079286:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3144C>T (p.Gly1048=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000822990	16	2129289	16	2079288	822990	812567	rs772640324	NC_000016.10:2079287:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3145G>C (p.Glu1049Gln)	TSC2	E1006Q, E1005Q, E1049Q, E1016Q, E805Q, E969Q, E957Q	Tuberous sclerosis 2	VCV000936312	16	2129290	16	2079289	936312	937319	rs796053492	NC_000016.10:2079288:G:C	single nucleotide variant	missense variant	Uncertain significance	May 12, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3145G>T (p.Glu1049Ter)	TSC2	E1016*, E805*, E957*, E1049*, E1005*, E1006*, E969*	Tuberous sclerosis 2	VCV000663337	16	2129290	16	2079289	663337	644275	rs796053492	NC_000016.10:2079288:G:T	single nucleotide variant	nonsense	Pathogenic	Jul 2, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3145G>A (p.Glu1049Lys)	TSC2	E1049K, E1005K, E1006K, E805K, E1016K, E969K, E957K	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000207741	16	2129290	16	2079289	207741	203161	rs796053492	NC_000016.10:2079288:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3150C>T (p.Phe1050=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413702	16	2129295	16	2079294	413702	400889	rs1060504105	NC_000016.10:2079293:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3152T>G (p.Leu1051Arg)	TSC2	L1007R, L1014R, L1037R, L473R, L603R, L850R, L854R, L971R, L1001R, L1004R, L1038R, L559R, L807R, L959R, L1002R, L1003R, L1008R, L1018R, L1050R, L808R, L970R, L1051R, L560R, L851R, L958R, L988R	Hereditary cancer-predisposing syndrome	VCV001728211	16	2129297	16	2079296	1728211	1791611	rs2151437364	NC_000016.10:2079295:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3153C>T (p.Leu1051=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002449982	16	2129298	16	2079297	2449982	2425939	rs1298892692	NC_000016.10:2079296:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3153C>G (p.Leu1051=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001119890	16	2129298	16	2079297	1119890	1103656	rs1298892692	NC_000016.10:2079296:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3153C>A (p.Leu1051=)	TSC2		Tuberous sclerosis 2	VCV000759302	16	2129298	16	2079297	759302	770715	rs1298892692	NC_000016.10:2079296:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3154C>T (p.Leu1052=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232133	16	2129299	16	2079298	3232133	3391934	rs2151437416	NC_000016.10:2079297:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3155T>C (p.Leu1052Pro)	TSC2	L1052P, L1019P, L1008P, L960P, L972P, L1009P, L808P	not provided|Tuberous sclerosis 2	VCV000238013	16	2129300	16	2079299	238013	242275	rs878854091	NC_000016.10:2079298:T:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3156A>T (p.Leu1052=)	TSC2		Tuberous sclerosis 2	VCV003727836	16	2129301	16	2079300	3727836	3858459		NC_000016.10:2079299:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3156A>C (p.Leu1052=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564688	16	2129301	16	2079300	2564688	2733844	rs1347619346	NC_000016.10:2079299:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3156A>G (p.Leu1052=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001134232	16	2129301	16	2079300	1134232	1125070	rs1347619346	NC_000016.10:2079299:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3157G>A (p.Ala1053Thr)	TSC2	A1020T, A973T, A1009T, A1010T, A961T, A1053T, A809T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001480011	16	2129302	16	2079301	1480011	1364681	rs2151437502	NC_000016.10:2079300:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3158C>T (p.Ala1053Val)	TSC2	A1053V, A973V, A1009V, A1010V, A961V, A1020V, A809V	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406074	16	2129303	16	2079302	406074	400770	rs760214724	NC_000016.10:2079301:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3159G>T (p.Ala1053=)	TSC2		Tuberous sclerosis 2	VCV001911832	16	2129304	16	2079303	1911832	1973344	rs765689518	NC_000016.10:2079302:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3159G>A (p.Ala1053=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000467993	16	2129304	16	2079303	467993	465899	rs765689518	NC_000016.10:2079302:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3160G>A (p.Gly1054Ser)	TSC2	G1004S, G1041S, G1053S, G562S, G811S, G854S, G974S, G1010S, G1021S, G563S, G810S, G853S, G961S, G1006S, G1040S, G476S, G857S, G973S, G991S, G1005S, G1007S, G1011S, G1017S, G1054S, G606S, G962S	Tuberous sclerosis 2	VCV002765036	16	2129305	16	2079304	2765036	2928802	rs2151437597	NC_000016.10:2079303:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3161G>T (p.Gly1054Val)	TSC2	G1004V, G1054V, G810V, G811V, G857V, G991V, G1006V, G1007V, G1011V, G1021V, G1040V, G1053V, G563V, G853V, G854V, G1010V, G1017V, G476V, G562V, G961V, G973V, G974V, G1005V, G1041V, G606V, G962V	Tuberous sclerosis 2	VCV002860338	16	2129306	16	2079305	2860338	3028975	rs2151437621	NC_000016.10:2079304:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3161G>A (p.Gly1054Asp)	TSC2	G1007D, G1010D, G1021D, G476D, G854D, G857D, G1006D, G1041D, G562D, G563D, G853D, G961D, G1004D, G1011D, G1040D, G1054D, G810D, G811D, G962D, G973D, G974D, G991D, G1005D, G1017D, G1053D, G606D	Tuberous sclerosis 2	VCV002816713	16	2129306	16	2079305	2816713	2984215	rs2151437621	NC_000016.10:2079304:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3162T>C (p.Gly1054=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001728332	16	2129307	16	2079306	1728332	1791732	rs2544045758	NC_000016.10:2079305:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Sep 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3163G>A (p.Gly1055Ser)	TSC2	G1012S, G1018S, G1042S, G1054S, G563S, G811S, G855S, G962S, G1007S, G1008S, G1022S, G1055S, G477S, G607S, G854S, G974S, G975S, G1005S, G1006S, G1041S, G992S, G1011S, G564S, G812S, G858S, G963S	Tuberous sclerosis 2	VCV003637217	16	2129308	16	2079307	3637217	3771371		NC_000016.10:2079306:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3163G>T (p.Gly1055Cys)	TSC2	G1007C, G1018C, G1042C, G1055C, G477C, G563C, G1005C, G1006C, G1008C, G1011C, G1022C, G564C, G858C, G963C, G1041C, G854C, G974C, G992C, G607C, G811C, G812C, G1012C, G1054C, G855C, G962C, G975C	Tuberous sclerosis 2	VCV003637216	16	2129308	16	2079307	3637216	3771370		NC_000016.10:2079306:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3164G>A (p.Gly1055Asp)	TSC2	G1011D, G963D, G1012D, G811D, G1022D, G1055D, G975D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001407119	16	2129309	16	2079308	1407119	1483329	rs1443030830	NC_000016.10:2079307:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3165C>G (p.Gly1055=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002497451	16	2129310	16	2079309	2497451	2472534	rs1215210783	NC_000016.10:2079308:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Jan 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3165C>T (p.Gly1055=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001053402	16	2129310	16	2079309	1053402	1049458	rs1215210783	NC_000016.10:2079308:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3166A>G (p.Arg1056Gly)	TSC2	R1056G, R964G, R1013G, R812G, R976G, R1012G, R1023G	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001468271	16	2129311	16	2079310	1468271	1362515	rs2151437774	NC_000016.10:2079309:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3167G>A (p.Arg1056Lys)	TSC2	R1006K, R1007K, R1008K, R1009K, R1012K, R1013K, R1019K, R1023K, R1042K, R1043K, R1055K, R1056K, R478K, R564K, R565K, R608K, R812K, R813K, R855K, R856K, R859K, R963K, R964K, R975K, R976K, R993K	Isolated focal cortical dysplasia type II	VCV002679338	16	2129312	16	2079311	2679338	2836915	rs2151437796	NC_000016.10:2079310:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3168G>A (p.Arg1056=)	TSC2		Tuberous sclerosis 2	VCV000754119	16	2129313	16	2079312	754119	770716	rs1240555646	NC_000016.10:2079311:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3169A>G (p.Thr1057Ala)	TSC2	T1008A, T1013A, T1014A, T1024A, T1043A, T1044A, T1057A, T965A, T1009A, T1010A, T565A, T814A, T856A, T857A, T977A, T1056A, T813A, T964A, T976A, T1007A, T1020A, T479A, T566A, T609A, T860A, T994A	Hereditary cancer-predisposing syndrome	VCV002564615	16	2129314	16	2079313	2564615	2733771	rs2544046385	NC_000016.10:2079312:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3170C>A (p.Thr1057Asn)	TSC2	T1009N, T1014N, T479N, T565N, T860N, T965N, T994N, T1010N, T1056N, T813N, T856N, T976N, T1008N, T1024N, T1043N, T1057N, T566N, T814N, T857N, T977N, T1007N, T1013N, T1020N, T1044N, T609N, T964N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449956	16	2129315	16	2079314	2449956	2429582	rs1596383758	NC_000016.10:2079313:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3170C>T (p.Thr1057Ile)	TSC2	T977I, T1013I, T1014I, T965I, T1024I, T1057I, T813I	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000823063	16	2129315	16	2079314	823063	812568	rs1596383758	NC_000016.10:2079313:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3171C>T (p.Thr1057=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002449980	16	2129316	16	2079315	2449980	2425937	rs1487006409	NC_000016.10:2079314:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3171C>G (p.Thr1057=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000706824	16	2129316	16	2079315	706824	693814	rs1487006409	NC_000016.10:2079314:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3172A>G (p.Lys1058Glu)	TSC2	K1008E, K1009E, K1010E, K1011E, K1014E, K1015E, K1021E, K1025E, K1044E, K1045E, K1057E, K1058E, K480E, K566E, K567E, K610E, K814E, K815E, K857E, K858E, K861E, K965E, K966E, K977E, K978E, K995E	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003073716	16	2129317	16	2079316	3073716	3232586	rs2089826724	NC_000016.10:2079315:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3174A>G (p.Lys1058=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974677	16	2129319	16	2079318	3974677	4086500		NC_000016.10:2079317:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 11, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3176C>T (p.Thr1059Ile)	TSC2	T1026I, T1059I, T967I, T979I, T1015I, T1016I, T815I	Tuberous sclerosis 2	VCV000946370	16	2129321	16	2079320	946370	927659	rs753205147	NC_000016.10:2079319:C:T	single nucleotide variant	missense variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3176C>G (p.Thr1059Ser)	TSC2	T1059S, T1016S, T815S, T1015S, T979S, T1026S, T967S	not provided	VCV000452351	16	2129321	16	2079320	452351	445520	rs753205147	NC_000016.10:2079319:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3177C>A (p.Thr1059=)	TSC2		Tuberous sclerosis 2	VCV004071359	16	2129322	16	2079321	4071359	4185207		NC_000016.10:2079320:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3177C>G (p.Thr1059=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001536267	16	2129322	16	2079321	1536267	1618356	rs1031918517	NC_000016.10:2079320:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3177C>T (p.Thr1059=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486693	16	2129322	16	2079321	486693	477382	rs1031918517	NC_000016.10:2079320:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3179G>C (p.Trp1060Ser)	TSC2	W1017S, W816S, W1060S, W968S, W980S, W1016S, W1027S	Tuberous sclerosis 2	VCV001042872	16	2129324	16	2079323	1042872	1032463	rs2089827541	NC_000016.10:2079322:G:C	single nucleotide variant	missense variant	Pathogenic	Aug 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3180G>A (p.Trp1060Ter)	TSC2	W1060*, W1016*, W1027*, W816*, W968*, W980*, W1017*	not provided|Tuberous sclerosis 2	VCV000207780	16	2129325	16	2079324	207780	203162	rs796053509	NC_000016.10:2079323:G:A	single nucleotide variant	nonsense	Pathogenic	Jun 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3181C>A (p.Leu1061Met)	TSC2	L1013M, L1048M, L1061M, L861M, L969M, L1014M, L1047M, L1060M, L483M, L569M, L613M, L817M, L818M, L998M, L1024M, L570M, L864M, L981M, L1011M, L1012M, L1017M, L1018M, L1028M, L860M, L968M, L980M	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002747514	16	2129326	16	2079325	2747514	2904407	rs946673791	NC_000016.10:2079324:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3181C>G (p.Leu1061Val)	TSC2	L1061V, L817V, L981V, L1018V, L969V, L1028V, L1017V	Tuberous sclerosis 2	VCV000535942	16	2129326	16	2079325	535942	529669	rs946673791	NC_000016.10:2079324:C:G	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3181C>T (p.Leu1061=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406010	16	2129326	16	2079325	406010	401290	rs946673791	NC_000016.10:2079324:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3182T>G (p.Leu1061Arg)	TSC2	L1061R, L1028R, L817R, L969R, L981R, L1017R, L1018R	Tuberous sclerosis 2	VCV000406056	16	2129327	16	2079326	406056	400892	rs397514919	NC_000016.10:2079325:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3182T>C (p.Leu1061Pro)	TSC2	L1061P, L1017P, L817P, L1018P, L969P, L981P, L1028P	Hereditary cancer-predisposing syndrome	VCV000064897	16	2129327	16	2079326	64897	75827	rs397514919	NC_000016.10:2079325:T:C	single nucleotide variant	missense variant	Likely pathogenic	Nov 18, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.3183G>T (p.Leu1061=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564725	16	2129328	16	2079327	2564725	2733881	rs2151438241	NC_000016.10:2079326:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3184G>A (p.Val1062Ile)	TSC2	V1014I, V1018I, V1019I, V1029I, V1049I, V1061I, V819I, V865I, V999I, V1062I, V570I, V818I, V861I, V969I, V970I, V981I, V1012I, V1025I, V484I, V571I, V862I, V1013I, V1015I, V1048I, V614I, V982I	Tuberous sclerosis 2	VCV003637218	16	2129329	16	2079328	3637218	3771372		NC_000016.10:2079327:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3184G>T (p.Val1062Phe)	TSC2	V1015F, V1019F, V1049F, V484F, V570F, V571F, V614F, V865F, V982F, V999F, V1012F, V1025F, V1048F, V1062F, V819F, V1013F, V818F, V861F, V969F, V970F, V981F, V1014F, V1018F, V1029F, V1061F, V862F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001728572	16	2129329	16	2079328	1728572	1788207	rs2151438280	NC_000016.10:2079327:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3185T>G (p.Val1062Gly)	TSC2	V1014G, V1018G, V1062G, V571G, V862G, V1012G, V1025G, V1029G, V484G, V614G, V819G, V865G, V970G, V1013G, V1015G, V1049G, V818G, V861G, V969G, V981G, V982G, V1019G, V1048G, V1061G, V570G, V999G	Hereditary cancer-predisposing syndrome	VCV002564689	16	2129330	16	2079329	2564689	2733845	rs2151438305	NC_000016.10:2079328:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3185T>C (p.Val1062Ala)	TSC2	V1012A, V1013A, V1014A, V1015A, V1018A, V1019A, V1025A, V1029A, V1048A, V1049A, V1061A, V1062A, V484A, V570A, V571A, V614A, V818A, V819A, V861A, V862A, V865A, V969A, V970A, V981A, V982A, V999A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001713547	16	2129330	16	2079329	1713547	1777442	rs2151438305	NC_000016.10:2079328:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3187G>T (p.Gly1063Trp)	TSC2	G1016W, G970W, G982W, G1013W, G1014W, G1020W, G1063W, G485W, G572W, G819W, G862W, G983W, G1015W, G1026W, G1030W, G1049W, G571W, G820W, G863W, G1000W, G1019W, G1050W, G1062W, G615W, G866W, G971W	Hereditary cancer-predisposing syndrome	VCV003811307	16	2129332	16	2079331	3811307	3928548		NC_000016.10:2079330:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3188G>A (p.Gly1063Glu)	TSC2	G819E, G983E, G1020E, G971E, G1019E, G1030E, G1063E	Tuberous sclerosis 2	VCV000839912	16	2129333	16	2079332	839912	843447	rs2089828784	NC_000016.10:2079331:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3190A>G (p.Asn1064Asp)	TSC2	N1020D, N1031D, N984D, N972D, N1021D, N1064D, N820D	Tuberous sclerosis 2	VCV001405846	16	2129335	16	2079334	1405846	1493108	rs2151438419	NC_000016.10:2079333:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3191A>T (p.Asn1064Ile)	TSC2	N1017I, N1020I, N1027I, N1051I, N572I, N864I, N971I, N1021I, N1063I, N616I, N820I, N821I, N984I, N1014I, N1016I, N1050I, N1064I, N573I, N867I, N1001I, N1015I, N1031I, N486I, N863I, N972I, N983I	Hereditary cancer-predisposing syndrome	VCV001728675	16	2129336	16	2079335	1728675	1788310	rs758690821	NC_000016.10:2079334:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3191A>G (p.Asn1064Ser)	TSC2	N1020S, N1021S, N1031S, N1064S, N820S, N972S, N984S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV001017751	16	2129336	16	2079335	1017751	1011974	rs758690821	NC_000016.10:2079334:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3192C>G (p.Asn1064Lys)	TSC2	N1021K, N820K, N972K, N984K, N1020K, N1031K, N1064K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000823131	16	2129337	16	2079336	823131	812569	rs201670791	NC_000016.10:2079335:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3192C>A (p.Asn1064Lys)	TSC2	N1064K, N1031K, N1021K, N1020K, N820K, N972K, N984K	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000238014	16	2129337	16	2079336	238014	242276	rs201670791	NC_000016.10:2079335:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3193A>G (p.Lys1065Glu)	TSC2	K1032E, K1022E, K1065E, K985E, K1021E, K821E, K973E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001398994	16	2129338	16	2079337	1398994	1450290	rs751955670	NC_000016.10:2079336:A:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3193A>C (p.Lys1065Gln)	TSC2	K973Q, K1021Q, K1022Q, K1032Q, K1065Q, K985Q, K821Q	Tuberous sclerosis 2	VCV000854748	16	2129338	16	2079337	854748	843448	rs751955670	NC_000016.10:2079336:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3195G>A (p.Lys1065=)	TSC2		Tuberous sclerosis 2	VCV000792210	16	2129340	16	2079339	792210	785196	rs1596383887	NC_000016.10:2079338:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3196C>G (p.Leu1066Val)	TSC2	L822V, L1023V, L986V, L1022V, L1033V, L1066V, L974V	Tuberous sclerosis 2	VCV000854265	16	2129341	16	2079340	854265	843449	rs886051793	NC_000016.10:2079339:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3196C>T (p.Leu1066Phe)	TSC2	L1066F, L1022F, L1023F, L1033F, L986F, L822F, L974F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000318325	16	2129341	16	2079340	318325	342271	rs886051793	NC_000016.10:2079339:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3197T>C (p.Leu1066Pro)	TSC2	L1066P, L1022P, L974P, L1023P, L986P, L1033P, L822P	Tuberous sclerosis 2|not provided	VCV000065283	16	2129342	16	2079341	65283	76215	rs397515207	NC_000016.10:2079340:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3199G>C (p.Val1067Leu)	TSC2	V1067L, V1023L, V1034L, V987L, V1024L, V823L, V975L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000467994	16	2129344	16	2079343	467994	465907	rs200681169	NC_000016.10:2079342:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3201C>T (p.Val1067=)	TSC2		Tuberous sclerosis 2	VCV002909793	16	2129346	16	2079345	2909793	3078460	rs781532053	NC_000016.10:2079344:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3201C>G (p.Val1067=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000779502	16	2129346	16	2079345	779502	714799	rs781532053	NC_000016.10:2079344:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3202A>G (p.Thr1068Ala)	TSC2	T1005A, T1024A, T1068A, T824A, T871A, T1019A, T1020A, T1025A, T1054A, T576A, T867A, T987A, T1067A, T825A, T976A, T988A, T1018A, T1021A, T1031A, T1035A, T1055A, T490A, T577A, T620A, T868A, T975A	Tuberous sclerosis 2	VCV003010117	16	2129347	16	2079346	3010117	3176854	rs1060500947	NC_000016.10:2079345:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3202A>C (p.Thr1068Pro)	TSC2	T1068P, T976P, T988P, T1035P, T1024P, T1025P, T824P	Tuberous sclerosis 2	VCV000406049	16	2129347	16	2079346	406049	401522	rs1060500947	NC_000016.10:2079345:A:C	single nucleotide variant	missense variant	Likely pathogenic	May 22, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3203C>A (p.Thr1068Asn)	TSC2	T1024N, T1025N, T1035N, T1068N, T824N, T976N, T988N	Tuberous sclerosis 2	VCV001010404	16	2129348	16	2079347	1010404	996737	rs397515284	NC_000016.10:2079346:C:A	single nucleotide variant	missense variant	Uncertain significance	May 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3203C>T (p.Thr1068Ile)	TSC2	T1068I, T824I, T976I, T1024I, T988I, T1025I, T1035I	Tuberous sclerosis 2	VCV000065377	16	2129348	16	2079347	65377	76311	rs397515284	NC_000016.10:2079346:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3204T>C (p.Thr1068=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413683	16	2129349	16	2079348	413683	400893	rs1060504101	NC_000016.10:2079347:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3205G>C (p.Val1069Leu)	TSC2	V1025L, V1026L, V1036L, V1069L, V825L, V977L, V989L	Tuberous sclerosis 2|not provided	VCV001319398	16	2129350	16	2079349	1319398	1309651	rs2151438862	NC_000016.10:2079348:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3205G>A (p.Val1069Met)	TSC2	V1025M, V1026M, V1036M, V1069M, V825M, V977M, V989M	Tuberous sclerosis 2	VCV001062343	16	2129350	16	2079349	1062343	1049459	rs2151438862	NC_000016.10:2079348:G:A	single nucleotide variant	missense variant	Uncertain significance	May 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3209C>G (p.Thr1070Arg)	TSC2	T1020R, T1027R, T1033R, T1037R, T492R, T826R, T1023R, T1069R, T1070R, T622R, T827R, T870R, T873R, T977R, T1021R, T1057R, T578R, T579R, T869R, T978R, T989R, T1007R, T1022R, T1026R, T1056R, T990R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002626459	16	2129354	16	2079353	2626459	2794225	rs147989574	NC_000016.10:2079352:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3209C>T (p.Thr1070Met)	TSC2	T1070M, T826M, T1026M, T1037M, T990M, T978M, T1027M	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000428000	16	2129354	16	2079353	428000	419873	rs147989574	NC_000016.10:2079352:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3210G>T (p.Thr1070=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001102334	16	2129355	16	2079354	1102334	1103657	rs539927192	NC_000016.10:2079353:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3210G>C (p.Thr1070=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000467995	16	2129355	16	2079354	467995	465911	rs539927192	NC_000016.10:2079353:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3210G>A (p.Thr1070=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000318326	16	2129355	16	2079354	318326	340862	rs539927192	NC_000016.10:2079353:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3211A>G (p.Thr1071Ala)	TSC2	T1008A, T1022A, T1023A, T1027A, T1038A, T623A, T978A, T979A, T1034A, T1057A, T493A, T579A, T580A, T828A, T871A, T874A, T1024A, T1028A, T827A, T870A, T990A, T1021A, T1058A, T1070A, T1071A, T991A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001728941	16	2129356	16	2079355	1728941	1785231	rs2151439062	NC_000016.10:2079354:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3212C>T (p.Thr1071Ile)	TSC2	T1071I, T1027I, T1028I, T991I, T1038I, T979I, T827I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000406076	16	2129357	16	2079356	406076	401523	rs45498892	NC_000016.10:2079355:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3212C>G (p.Thr1071Arg)	TSC2	T1071R, T827R, T1028R, T1027R, T979R, T991R, T1038R	Tuberous sclerosis 2	VCV000049247	16	2129357	16	2079356	49247	58409	rs45498892	NC_000016.10:2079355:C:G	single nucleotide variant	missense variant	Pathogenic	Feb 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3213A>G (p.Thr1071=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232134	16	2129358	16	2079357	3232134	3391935	rs553534593	NC_000016.10:2079356:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3214A>C (p.Ser1072Arg)	TSC2	S1009R, S1022R, S1023R, S1024R, S1025R, S1028R, S1029R, S1035R, S1039R, S1058R, S1059R, S1071R, S1072R, S494R, S580R, S581R, S624R, S828R, S829R, S871R, S872R, S875R, S979R, S980R, S991R, S992R	Hereditary cancer-predisposing syndrome	VCV003232135	16	2129359	16	2079358	3232135	3391936	rs2151439176	NC_000016.10:2079357:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3214A>G (p.Ser1072Gly)	TSC2	S1022G, S1023G, S1028G, S1059G, S1071G, S1072G, S581G, S872G, S980G, S992G, S1009G, S1058G, S580G, S991G, S1024G, S1039G, S494G, S828G, S829G, S871G, S979G, S1025G, S1029G, S1035G, S624G, S875G	Tuberous sclerosis 2	VCV002101785	16	2129359	16	2079358	2101785	2168725	rs2151439176	NC_000016.10:2079357:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3215G>A (p.Ser1072Asn)	TSC2	S1025N, S1035N, S1072N, S580N, S581N, S979N, S991N, S1023N, S1024N, S1071N, S494N, S624N, S829N, S875N, S1009N, S1022N, S1028N, S1029N, S1039N, S1058N, S1059N, S828N, S872N, S980N, S992N, S871N	Hereditary cancer-predisposing syndrome	VCV001728983	16	2129360	16	2079359	1728983	1785273	rs2151439187	NC_000016.10:2079358:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3216C>T (p.Ser1072=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001045802	16	2129361	16	2079360	1045802	1032464	rs1306234469	NC_000016.10:2079359:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3217G>T (p.Val1073Leu)	TSC2	V1026L, V1029L, V1059L, V625L, V830L, V872L, V876L, V993L, V1023L, V1024L, V1025L, V1060L, V1072L, V581L, V582L, V873L, V981L, V1010L, V1040L, V1073L, V992L, V1030L, V1036L, V495L, V829L, V980L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001729008	16	2129362	16	2079361	1729008	1785298	rs749192298	NC_000016.10:2079360:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3217G>A (p.Val1073Met)	TSC2	V1073M, V829M, V1029M, V1030M, V981M, V993M, V1040M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000238015	16	2129362	16	2079361	238015	242277	rs749192298	NC_000016.10:2079360:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3221G>T (p.Gly1074Val)	TSC2	G1031V, G830V, G982V, G1041V, G1074V, G1030V, G994V	Tuberous sclerosis 2	VCV000943349	16	2129366	16	2079365	943349	937320	rs2089833187	NC_000016.10:2079364:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3222A>T (p.Gly1074=)	TSC2		Tuberous sclerosis 2	VCV001041604	16	2129367	16	2079366	1041604	1032465	rs1223282413	NC_000016.10:2079365:A:T	single nucleotide variant	synonymous variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3223A>C (p.Thr1075Pro)	TSC2	T1012P, T1025P, T1026P, T1027P, T1028P, T1031P, T1032P, T1038P, T1042P, T1061P, T1062P, T1074P, T1075P, T497P, T583P, T584P, T627P, T831P, T832P, T874P, T875P, T878P, T982P, T983P, T994P, T995P	Tuberous sclerosis syndrome	VCV003073959	16	2129368	16	2079367	3073959	3232829	rs768568810	NC_000016.10:2079366:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3223A>G (p.Thr1075Ala)	TSC2	T1031A, T983A, T995A, T1042A, T1075A, T1032A, T831A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000665443	16	2129368	16	2079367	665443	644276	rs768568810	NC_000016.10:2079366:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3224C>A (p.Thr1075Asn)	TSC2	T1032N, T1042N, T995N, T831N, T983N, T1031N, T1075N	Tuberous sclerosis 2	VCV000954021	16	2129369	16	2079368	954021	949254	rs397515024	NC_000016.10:2079367:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3224C>T (p.Thr1075Ile)	TSC2	T1075I, T1031I, T1032I, T831I, T983I, T1042I, T995I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000065039	16	2129369	16	2079368	65039	75969	rs397515024	NC_000016.10:2079367:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3225C>A (p.Thr1075=)	TSC2		Tuberous sclerosis 2	VCV002838593	16	2129370	16	2079369	2838593	2999695	rs374145104	NC_000016.10:2079368:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3225C>T (p.Thr1075=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065148	16	2129370	16	2079369	65148	76079	rs374145104	NC_000016.10:2079368:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3226G>C (p.Gly1076Arg)	TSC2	G1013R, G1026R, G1027R, G1028R, G1029R, G1032R, G1033R, G1039R, G1043R, G1062R, G1063R, G1075R, G1076R, G498R, G584R, G585R, G628R, G832R, G833R, G875R, G876R, G879R, G983R, G984R, G995R, G996R	Hereditary cancer-predisposing syndrome	VCV003232136	16	2129371	16	2079370	3232136	3391937	rs747910305	NC_000016.10:2079369:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3226G>A (p.Gly1076Arg)	TSC2	G1076R, G1033R, G1043R, G984R, G1032R, G832R, G996R	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000207742	16	2129371	16	2079370	207742	203163	rs747910305	NC_000016.10:2079369:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3227G>C (p.Gly1076Ala)	TSC2	G1013A, G1026A, G1027A, G1028A, G1029A, G1032A, G1033A, G1039A, G1043A, G1062A, G1063A, G1075A, G1076A, G498A, G584A, G585A, G628A, G832A, G833A, G875A, G876A, G879A, G983A, G984A, G995A, G996A	Isolated focal cortical dysplasia type II	VCV002679335	16	2129372	16	2079371	2679335	2836912	rs2151439605	NC_000016.10:2079370:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3228G>C (p.Gly1076=)	TSC2		Tuberous sclerosis 2	VCV000759448	16	2129373	16	2079372	759448	770717	rs771763773	NC_000016.10:2079371:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3229A>T (p.Thr1077Ser)	TSC2	T1014S, T1027S, T1028S, T1029S, T1030S, T1033S, T1034S, T1040S, T1044S, T1063S, T1064S, T1076S, T1077S, T499S, T585S, T586S, T629S, T833S, T834S, T876S, T877S, T880S, T984S, T985S, T996S, T997S	not provided	VCV003252542	16	2129374	16	2079373	3252542	3411337	rs2151439654	NC_000016.10:2079372:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3230C>A (p.Thr1077Asn)	TSC2	T1033N, T1076N, T834N, T984N, T1027N, T1044N, T586N, T833N, T876N, T877N, T1014N, T1028N, T1040N, T1063N, T499N, T585N, T880N, T985N, T996N, T1029N, T1030N, T1034N, T1064N, T1077N, T629N, T997N	Hereditary cancer-predisposing syndrome	VCV003462633	16	2129375	16	2079374	3462633	3621652		NC_000016.10:2079373:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3231C>T (p.Thr1077=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000744171	16	2129376	16	2079375	744171	754997	rs772876273	NC_000016.10:2079374:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3232C>A (p.Arg1078=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413619	16	2129377	16	2079376	413619	401528	rs78956195	NC_000016.10:2079375:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3232C>T (p.Arg1078Trp)	TSC2	R1078W, R1034W, R834W, R986W, R998W, R1035W, R1045W	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405964	16	2129377	16	2079376	405964	401292	rs78956195	NC_000016.10:2079375:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3233G>A (p.Arg1078Gln)	TSC2	R1078Q, R1034Q, R834Q, R1045Q, R1035Q, R986Q, R998Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000406055	16	2129378	16	2079377	406055	400900	rs368095502	NC_000016.10:2079376:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3234G>A (p.Arg1078=)	TSC2		Tuberous sclerosis 2	VCV001091905	16	2129379	16	2079378	1091905	1081828	rs1256666302	NC_000016.10:2079377:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3235T>G (p.Ser1079Ala)	TSC2	S1079A, S1036A, S999A, S1035A, S987A, S1046A, S835A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535952	16	2129380	16	2079379	535952	529609	rs1555510643	NC_000016.10:2079378:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3236C>T (p.Ser1079Leu)	TSC2	S1035L, S1046L, S1036L, S1079L, S987L, S999L, S835L	Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001408372	16	2129381	16	2079380	1408372	1422019	rs397515087	NC_000016.10:2079379:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3236C>A (p.Ser1079Ter)	TSC2	S1079*, S1035*, S1046*, S987*, S1036*, S835*, S999*	Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided	VCV000065117	16	2129381	16	2079380	65117	76048	rs397515087	NC_000016.10:2079379:C:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Mar 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3237G>C (p.Ser1079=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462609	16	2129382	16	2079381	3462609	3621628		NC_000016.10:2079380:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3237G>T (p.Ser1079=)	TSC2		Tuberous sclerosis 2	VCV002835877	16	2129382	16	2079381	2835877	2995709	rs572243694	NC_000016.10:2079380:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3237G>A (p.Ser1079=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000700986	16	2129382	16	2079381	700986	688541	rs572243694	NC_000016.10:2079380:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3238T>C (p.Leu1080=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000752733	16	2129383	16	2079382	752733	770718	rs1596384213	NC_000016.10:2079381:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3239T>G (p.Leu1080Ter)	TSC2	L1000*, L1017*, L1030*, L1031*, L1032*, L1033*, L1036*, L1037*, L1043*, L1047*, L1066*, L1067*, L1079*, L1080*, L502*, L588*, L589*, L632*, L836*, L837*, L879*, L880*, L883*, L987*, L988*, L999*	Tuberous sclerosis 2	VCV003775960	16	2129384	16	2079383	3775960	3892106		NC_000016.10:2079382:T:G	single nucleotide variant	nonsense|non-coding transcript variant	Likely pathogenic	Nov 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3239T>A (p.Leu1080Ter)	TSC2	L1037*, L1080*, L836*, L988*, L1000*, L1036*, L1047*	Tuberous sclerosis 2	VCV000951399	16	2129384	16	2079383	951399	927660	rs2089838149	NC_000016.10:2079382:T:A	single nucleotide variant	nonsense	Pathogenic	Aug 26, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3240A>T (p.Leu1080Phe)	TSC2	L1036F, L1043F, L1079F, L502F, L837F, L883F, L1032F, L1033F, L589F, L632F, L879F, L987F, L1031F, L1000F, L1047F, L1067F, L1080F, L588F, L988F, L999F, L1017F, L1030F, L1037F, L1066F, L836F, L880F	Hereditary cancer-predisposing syndrome	VCV001729298	16	2129385	16	2079384	1729298	1785586	rs371514669	NC_000016.10:2079383:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3240A>C (p.Leu1080Phe)	TSC2	L1080F, L1036F, L1047F, L1000F, L1037F, L836F, L988F	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535907	16	2129385	16	2079384	535907	529970	rs371514669	NC_000016.10:2079383:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3240A>G (p.Leu1080=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413621	16	2129385	16	2079384	413621	401294	rs371514669	NC_000016.10:2079383:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3241C>T (p.Leu1081=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486670	16	2129386	16	2079385	486670	477479	rs1555510658	NC_000016.10:2079384:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3242T>A (p.Leu1081Gln)	TSC2	L1018Q, L1031Q, L1038Q, L1067Q, L589Q, L837Q, L988Q, L1001Q, L1037Q, L1044Q, L1080Q, L503Q, L590Q, L989Q, L1032Q, L1033Q, L1034Q, L1081Q, L633Q, L881Q, L884Q, L1000Q, L1048Q, L1068Q, L838Q, L880Q	Hereditary cancer-predisposing syndrome	VCV003329493	16	2129387	16	2079386	3329493	3489085		NC_000016.10:2079385:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3243A>G (p.Leu1081=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000706602	16	2129388	16	2079387	706602	693815	rs1156745816	NC_000016.10:2079386:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3244G>T (p.Gly1082Cys)	TSC2	G1001C, G1002C, G1019C, G1032C, G1033C, G1034C, G1035C, G1038C, G1039C, G1045C, G1049C, G1068C, G1069C, G1081C, G1082C, G504C, G590C, G591C, G634C, G838C, G839C, G881C, G882C, G885C, G989C, G990C	Hereditary cancer-predisposing syndrome	VCV003232137	16	2129389	16	2079388	3232137	3391938	rs2151440072	NC_000016.10:2079387:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3244G>A (p.Gly1082Ser)	TSC2	G1019S, G1035S, G1045S, G1068S, G1069S, G504S, G838S, G839S, G1049S, G634S, G990S, G1001S, G1032S, G1034S, G1081S, G591S, G885S, G989S, G1002S, G1033S, G1038S, G1039S, G1082S, G590S, G881S, G882S	Hereditary cancer-predisposing syndrome	VCV001729334	16	2129389	16	2079388	1729334	1795010	rs2151440072	NC_000016.10:2079387:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3245G>T (p.Gly1082Val)	TSC2	G1039V, G990V, G1002V, G1038V, G838V, G1082V, G1049V	Tuberous sclerosis 2	VCV001444509	16	2129390	16	2079389	1444509	1388473	rs2151440096	NC_000016.10:2079388:G:T	single nucleotide variant	missense variant	Uncertain significance	May 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3246C>T (p.Gly1082=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002994069	16	2129391	16	2079390	2994069	3155666	rs764691385	NC_000016.10:2079389:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3247C>T (p.Leu1083=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001729356	16	2129392	16	2079391	1729356	1795032	rs752010244	NC_000016.10:2079390:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3248T>A (p.Leu1083Gln)	TSC2	L1002Q, L1003Q, L1020Q, L1033Q, L1034Q, L1035Q, L1036Q, L1039Q, L1040Q, L1046Q, L1050Q, L1069Q, L1070Q, L1082Q, L1083Q, L505Q, L591Q, L592Q, L635Q, L839Q, L840Q, L882Q, L883Q, L886Q, L990Q, L991Q	Hereditary cancer-predisposing syndrome	VCV003232138	16	2129393	16	2079392	3232138	3391939	rs2089839896	NC_000016.10:2079391:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3248T>G (p.Leu1083Arg)	TSC2	L1034R, L591R, L635R, L883R, L886R, L1002R, L1003R, L1036R, L1046R, L1083R, L592R, L840R, L882R, L991R, L1033R, L1040R, L1050R, L1069R, L1070R, L839R, L1020R, L1035R, L1039R, L1082R, L505R, L990R	Hereditary cancer-predisposing syndrome	VCV001729364	16	2129393	16	2079392	1729364	1795040	rs2089839896	NC_000016.10:2079391:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3248T>C (p.Leu1083Pro)	TSC2	L1083P, L1003P, L1039P, L839P, L1040P, L1050P, L991P	Tuberous sclerosis 2	VCV000962016	16	2129393	16	2079392	962016	949255	rs2089839896	NC_000016.10:2079391:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3249G>C (p.Leu1083=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811328	16	2129394	16	2079393	3811328	3928569		NC_000016.10:2079392:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3249G>A (p.Leu1083=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000708092	16	2129394	16	2079393	708092	726492	rs762243606	NC_000016.10:2079392:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3250G>A (p.Asp1084Asn)	TSC2	D1004N, D1041N, D1051N, D1084N, D840N, D992N, D1040N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001520434	16	2129395	16	2079394	1520434	1516428	rs2151440238	NC_000016.10:2079393:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3251A>G (p.Asp1084Gly)	TSC2	D1004G, D1034G, D1035G, D1036G, D1051G, D1071G, D636G, D1021G, D1040G, D1070G, D1084G, D506G, D840G, D887G, D991G, D1037G, D1041G, D592G, D593G, D883G, D1003G, D1047G, D1083G, D841G, D884G, D992G	Tuberous sclerosis 2	VCV002841671	16	2129396	16	2079395	2841671	3003608	rs2151440273	NC_000016.10:2079394:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3251A>T (p.Asp1084Val)	TSC2	D1040V, D1047V, D593V, D884V, D992V, D1004V, D1034V, D1041V, D1083V, D592V, D1021V, D1051V, D1070V, D1071V, D636V, D840V, D841V, D883V, D991V, D1003V, D1035V, D1036V, D1037V, D1084V, D506V, D887V	Tuberous sclerosis 2	VCV002757631	16	2129396	16	2079395	2757631	2917503	rs2151440273	NC_000016.10:2079394:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3252C>T (p.Asp1084=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001978743	16	2129397	16	2079396	1978743	2037920	rs45517286	NC_000016.10:2079395:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3252C>A (p.Asp1084Glu)	TSC2	D1051E, D1041E, D1084E, D840E, D992E, D1004E, D1040E	Tuberous sclerosis 2	VCV001348312	16	2129397	16	2079396	1348312	1459542	rs45517286	NC_000016.10:2079395:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3252C>G (p.Asp1084Glu)	TSC2	D1084E, D1041E, D992E, D1040E, D1051E, D840E, D1004E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000049248	16	2129397	16	2079396	49248	58410	rs45517286	NC_000016.10:2079395:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3253T>G (p.Ser1085Ala)	TSC2	S1005A, S1042A, S1085A, S993A, S1041A, S1052A, S841A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001483522	16	2129398	16	2079397	1483522	1380639	rs767655384	NC_000016.10:2079396:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3253T>C (p.Ser1085Pro)	TSC2	S1005P, S1041P, S1042P, S1052P, S1085P, S841P, S993P	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001059023	16	2129398	16	2079397	1059023	1049460	rs767655384	NC_000016.10:2079396:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3254C>G (p.Ser1085Trp)	TSC2	S1004W, S1005W, S1036W, S1038W, S1048W, S594W, S884W, S1037W, S1071W, S1084W, S637W, S992W, S1022W, S1041W, S1042W, S1085W, S507W, S993W, S1035W, S1052W, S1072W, S593W, S841W, S842W, S885W, S888W	Hereditary cancer-predisposing syndrome	VCV001729447	16	2129399	16	2079398	1729447	1795123	rs45517287	NC_000016.10:2079397:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3254C>T (p.Ser1085Leu)	TSC2	S1085L, S1005L, S1041L, S841L, S1042L, S993L, S1052L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406094	16	2129399	16	2079398	406094	400774	rs45517287	NC_000016.10:2079397:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3254C>A (p.Ser1085Ter)	TSC2	S1085*, S1005*, S841*, S1041*, S1052*, S993*, S1042*	Tuberous sclerosis 2	VCV000050055	16	2129399	16	2079398	50055	59217	rs45517287	NC_000016.10:2079397:C:A	single nucleotide variant	nonsense	Pathogenic	Mar 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3255G>C (p.Ser1085=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001158864	16	2129400	16	2079399	1158864	1145953	rs750617693	NC_000016.10:2079398:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3255G>T (p.Ser1085=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000754405	16	2129400	16	2079399	754405	770719	rs750617693	NC_000016.10:2079398:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3255G>A (p.Ser1085=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000186584	16	2129400	16	2079399	186584	184137	rs750617693	NC_000016.10:2079398:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3256G>A (p.Gly1086Arg)	TSC2	G1036R, G1037R, G1039R, G1042R, G1043R, G1085R, G843R, G993R, G994R, G1005R, G1006R, G1038R, G594R, G842R, G889R, G1023R, G1086R, G595R, G638R, G885R, G1049R, G1053R, G1072R, G1073R, G508R, G886R	Hereditary cancer-predisposing syndrome	VCV001729465	16	2129401	16	2079400	1729465	1795141	rs2151440506	NC_000016.10:2079399:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3258G>A (p.Gly1086=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001079105	16	2129403	16	2079402	1079105	1081829	rs2151440552	NC_000016.10:2079401:G:A	single nucleotide variant	synonymous variant	Likely benign	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3259G>A (p.Glu1087Lys)	TSC2	E1087K, E1007K, E995K, E1044K, E1043K, E843K, E1054K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000578801	16	2129404	16	2079403	578801	570111	rs1085307762	NC_000016.10:2079402:G:A	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3259G>T (p.Glu1087Ter)	TSC2	E1087*, E995*, E1044*, E1007*, E1043*, E1054*, E843*	not provided	VCV000426725	16	2129404	16	2079403	426725	415476	rs1085307762	NC_000016.10:2079402:G:T	single nucleotide variant	nonsense	Pathogenic	Apr 6, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3260A>G (p.Glu1087Gly)	TSC2	E1037G, E1038G, E1040G, E1050G, E1086G, E887G, E995G, E1039G, E1044G, E509G, E595G, E596G, E844G, E1054G, E843G, E890G, E994G, E1006G, E1007G, E1024G, E1043G, E1073G, E1074G, E1087G, E639G, E886G	Hereditary cancer-predisposing syndrome	VCV003811273	16	2129405	16	2079404	3811273	3928515		NC_000016.10:2079403:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3261G>A (p.Glu1087=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000467997	16	2129406	16	2079405	467997	465307	rs45438093	NC_000016.10:2079404:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3261G>C (p.Glu1087Asp)	TSC2	E1087D, E1044D, E1043D, E843D, E1054D, E1007D, E995D	Tuberous sclerosis 2	VCV000049588	16	2129406	16	2079405	49588	58750	rs45438093	NC_000016.10:2079404:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3262C>T (p.Leu1088=)	TSC2		Tuberous sclerosis 2	VCV002416851	16	2129407	16	2079406	2416851	1944014	rs375934693	NC_000016.10:2079405:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3262C>G (p.Leu1088Val)	TSC2	L1025V, L1040V, L1044V, L1045V, L1075V, L510V, L888V, L1038V, L1051V, L1055V, L1074V, L1087V, L845V, L1041V, L597V, L640V, L844V, L995V, L1007V, L1008V, L1039V, L1088V, L596V, L887V, L891V, L996V	Hereditary cancer-predisposing syndrome	VCV001729546	16	2129407	16	2079406	1729546	1795222	rs375934693	NC_000016.10:2079405:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3263T>C (p.Leu1088Pro)	TSC2	L1007P, L1008P, L1025P, L1038P, L1039P, L1040P, L1041P, L1044P, L1045P, L1051P, L1055P, L1074P, L1075P, L1087P, L1088P, L510P, L596P, L597P, L640P, L844P, L845P, L887P, L888P, L891P, L995P, L996P	Isolated focal cortical dysplasia type II	VCV002679350	16	2129408	16	2079407	2679350	2836927	rs753860755	NC_000016.10:2079406:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3264G>A (p.Leu1088=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413653	16	2129409	16	2079408	413653	400908	rs920434484	NC_000016.10:2079407:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3265C>T (p.Gln1089Ter)	TSC2	Q1089*, Q1056*, Q845*, Q1009*, Q1045*, Q1046*, Q997*	not provided|Tuberous sclerosis 2	VCV000049589	16	2129410	16	2079409	49589	58751	rs45517288	NC_000016.10:2079408:C:T	single nucleotide variant	nonsense	Pathogenic	Oct 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3266A>G (p.Gln1089Arg)	TSC2	Q1046R, Q1056R, Q1089R, Q997R, Q1045R, Q845R, Q1009R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001037054	16	2129411	16	2079410	1037054	1032466	rs2089843844	NC_000016.10:2079409:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3267G>T (p.Gln1089His)	TSC2	Q1039H, Q1046H, Q1088H, Q641H, Q846H, Q888H, Q892H, Q1008H, Q1009H, Q1026H, Q1056H, Q597H, Q598H, Q845H, Q1040H, Q1041H, Q1045H, Q1052H, Q1075H, Q1076H, Q511H, Q997H, Q1042H, Q1089H, Q889H, Q996H	Tuberous sclerosis 2	VCV002989626	16	2129412	16	2079411	2989626	3147355	rs1555510717	NC_000016.10:2079410:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3267G>A (p.Gln1089=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome	VCV000514906	16	2129412	16	2079411	514906	506170	rs1555510717	NC_000016.10:2079410:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3268T>C (p.Ser1090Pro)	TSC2	S1090P, S1046P, S998P, S1010P, S1047P, S1057P, S846P	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000406015	16	2129413	16	2079412	406015	401531	rs1060500936	NC_000016.10:2079411:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3269C>G (p.Ser1090Cys)	TSC2	S1010C, S1046C, S1047C, S1057C, S1090C, S846C, S998C	Tuberous sclerosis 2	VCV001021483	16	2129414	16	2079413	1021483	1011975	rs1596384471	NC_000016.10:2079412:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3269C>A (p.Ser1090Tyr)	TSC2	S1046Y, S1047Y, S1057Y, S846Y, S1010Y, S998Y, S1090Y	Tuberous sclerosis 2	VCV000661825	16	2129414	16	2079413	661825	644277	rs1596384471	NC_000016.10:2079412:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3270C>T (p.Ser1090=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000413750	16	2129415	16	2079414	413750	401301	rs754951889	NC_000016.10:2079413:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3271G>T (p.Gly1091Cys)	TSC2	G1010C, G1028C, G1043C, G1044C, G1054C, G1090C, G1091C, G643C, G848C, G999C, G1011C, G1041C, G1042C, G1058C, G1077C, G599C, G600C, G890C, G891C, G1047C, G1048C, G1078C, G513C, G847C, G894C, G998C	Tuberous sclerosis 2	VCV003678352	16	2129416	16	2079415	3678352	3810950		NC_000016.10:2079414:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3271G>C (p.Gly1091Arg)	TSC2	G1047R, G1048R, G1054R, G1091R, G513R, G848R, G1010R, G1028R, G1042R, G1058R, G1077R, G847R, G890R, G891R, G999R, G1044R, G1090R, G600R, G643R, G894R, G998R, G1011R, G1041R, G1043R, G1078R, G599R	Hereditary cancer-predisposing syndrome	VCV003329495	16	2129416	16	2079415	3329495	3489087		NC_000016.10:2079414:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3271G>A (p.Gly1091Ser)	TSC2	G1091S, G1047S, G1058S, G1048S, G847S, G999S, G1011S	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|TSC2-related disorder	VCV000207743	16	2129416	16	2079415	207743	203164	rs796053493	NC_000016.10:2079414:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3272G>T (p.Gly1091Val)	TSC2	G1028V, G1091V, G847V, G890V, G894V, G1041V, G1077V, G1078V, G1010V, G1011V, G1043V, G1047V, G1048V, G1090V, G599V, G891V, G998V, G999V, G1042V, G1044V, G1054V, G1058V, G513V, G600V, G643V, G848V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564632	16	2129417	16	2079416	2564632	2733788	rs2089845275	NC_000016.10:2079415:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3272G>C (p.Gly1091Ala)	TSC2	G1054A, G1077A, G1090A, G513A, G847A, G998A, G1010A, G1011A, G1028A, G1044A, G1058A, G600A, G999A, G1041A, G1047A, G1078A, G599A, G643A, G891A, G1042A, G1043A, G1048A, G1091A, G848A, G890A, G894A	Tuberous sclerosis 2	VCV002087421	16	2129417	16	2079416	2087421	2137482	rs2089845275	NC_000016.10:2079415:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3272G>A (p.Gly1091Asp)	TSC2	G1011D, G1047D, G1048D, G1058D, G1091D, G847D, G999D	Tuberous sclerosis 2	VCV001005289	16	2129417	16	2079416	1005289	996738	rs2089845275	NC_000016.10:2079415:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3273C>G (p.Gly1091=)	TSC2		Tuberous sclerosis 2	VCV004071048	16	2129418	16	2079417	4071048	4184896		NC_000016.10:2079416:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3273C>T (p.Gly1091=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406117	16	2129418	16	2079417	406117	400910	rs1060500971	NC_000016.10:2079416:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3274C>T (p.Pro1092Ser)	TSC2	P1049S, P1092S, P1000S, P1059S, P848S, P1048S, P1012S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001045275	16	2129419	16	2079418	1045275	1032467	rs2089845906	NC_000016.10:2079417:C:T	single nucleotide variant	missense variant	Uncertain significance	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3275C>G (p.Pro1092Arg)	TSC2	P1000R, P1011R, P1012R, P1091R, P600R, P895R, P1029R, P1044R, P1049R, P1055R, P1079R, P601R, P848R, P1042R, P1043R, P1045R, P1059R, P1078R, P1092R, P514R, P644R, P1048R, P849R, P891R, P892R, P999R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002626443	16	2129420	16	2079419	2626443	2794209	rs587781774	NC_000016.10:2079418:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3275C>A (p.Pro1092Gln)	TSC2	P1011Q, P1045Q, P1048Q, P514Q, P600Q, P1000Q, P1012Q, P1029Q, P1055Q, P1092Q, P848Q, P849Q, P895Q, P999Q, P1042Q, P1043Q, P1044Q, P1078Q, P1091Q, P644Q, P891Q, P892Q, P1049Q, P1059Q, P1079Q, P601Q	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001729663	16	2129420	16	2079419	1729663	1795338	rs587781774	NC_000016.10:2079418:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3275C>T (p.Pro1092Leu)	TSC2	P1092L, P1000L, P1048L, P1049L, P1059L, P1012L, P848L	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000141472	16	2129420	16	2079419	141472	151186	rs587781774	NC_000016.10:2079418:C:T	single nucleotide variant	missense variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3276G>C (p.Pro1092=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000536013	16	2129421	16	2079420	536013	529971	rs368923127	NC_000016.10:2079419:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3276G>A (p.Pro1092=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000238016	16	2129421	16	2079420	238016	242278	rs368923127	NC_000016.10:2079419:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3277G>C (p.Glu1093Gln)	TSC2	E1043Q, E1060Q, E601Q, E892Q, E1013Q, E1046Q, E1080Q, E1092Q, E515Q, E602Q, E849Q, E1000Q, E1001Q, E1045Q, E1050Q, E1093Q, E645Q, E850Q, E1012Q, E1030Q, E1044Q, E1049Q, E1056Q, E1079Q, E893Q, E896Q	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV002449949	16	2129422	16	2079421	2449949	2429575	rs1182829976	NC_000016.10:2079420:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3277G>A (p.Glu1093Lys)	TSC2	E849K, E1013K, E1050K, E1001K, E1060K, E1093K, E1049K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000847132	16	2129422	16	2079421	847132	843450	rs1182829976	NC_000016.10:2079420:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3278A>G (p.Glu1093Gly)	TSC2	E1093G, E1060G, E849G, E1013G, E1049G, E1001G, E1050G	not provided|Tuberous sclerosis 2	VCV000207744	16	2129423	16	2079422	207744	203165	rs796053494	NC_000016.10:2079421:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3279G>A (p.Glu1093=)	TSC2		Tuberous sclerosis 2	VCV002907842	16	2129424	16	2079423	2907842	3059541	rs2151441188	NC_000016.10:2079422:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3280T>G (p.Ser1094Ala)	TSC2	S1093A, S516A, S603A, S897A, S1014A, S1044A, S1047A, S1050A, S646A, S1045A, S1057A, S1061A, S1094A, S602A, S893A, S1002A, S1046A, S1001A, S1013A, S1031A, S1051A, S1080A, S1081A, S850A, S851A, S894A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002450005	16	2129425	16	2079424	2450005	2425962	rs2151441205	NC_000016.10:2079423:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3281C>A (p.Ser1094Ter)	TSC2	S1002*, S1051*, S1014*, S850*, S1050*, S1061*, S1094*	Tuberous sclerosis 2	VCV000951721	16	2129426	16	2079425	951721	927661	rs397514887	NC_000016.10:2079424:C:A	single nucleotide variant	nonsense	Pathogenic	Jul 8, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3281C>G (p.Ser1094Trp)	TSC2	S1094W, S1002W, S1014W, S1050W, S850W, S1051W, S1061W	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000233995	16	2129426	16	2079425	233995	235122	rs397514887	NC_000016.10:2079424:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3281C>T (p.Ser1094Leu)	TSC2	S1094L, S1014L, S1050L, S1061L, S1002L, S1051L, S850L	Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome	VCV000064856	16	2129426	16	2079425	64856	75785	rs397514887	NC_000016.10:2079424:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3282G>A (p.Ser1094=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000413660	16	2129427	16	2079426	413660	401534	rs1060504095	NC_000016.10:2079425:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3283A>T (p.Ser1095Cys)	TSC2	S1002C, S1003C, S1015C, S1032C, S1058C, S1082C, S603C, S1046C, S1047C, S1052C, S517C, S851C, S852C, S1014C, S1048C, S1051C, S1094C, S1095C, S604C, S647C, S898C, S1045C, S1062C, S1081C, S894C, S895C	Hereditary cancer-predisposing syndrome	VCV002626430	16	2129428	16	2079427	2626430	2794196	rs2089847209	NC_000016.10:2079426:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3283A>G (p.Ser1095Gly)	TSC2	S1003G, S851G, S1015G, S1062G, S1095G, S1052G, S1051G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001039804	16	2129428	16	2079427	1039804	1032468	rs2089847209	NC_000016.10:2079426:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284G>T (p.Ser1095Ile)	TSC2	S1095I, S1003I, S1051I, S1015I, S1052I, S851I, S1062I	not provided	VCV000586853	16	2129429	16	2079428	586853	577456	rs1555510754	NC_000016.10:2079427:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284G>A (p.Ser1095Asn)	TSC2	S1095N, S1003N, S1015N, S851N, S1062N, S1051N, S1052N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000050058	16	2129429	16	2079428	50058	59220	rs1555510754	NC_000016.10:2079427:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+1G>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000065245	16	2129430	16	2079429	65245	76177	rs45517289	NC_000016.10:2079428:G:C	single nucleotide variant	splice donor variant	Pathogenic	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000050057	16	2129430	16	2079429	50057	59219	rs45517289	NC_000016.10:2079428:G:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+3G>C	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002076505	16	2129432	16	2079431	2076505	2138308	rs2089847916	NC_000016.10:2079430:G:C	single nucleotide variant	intron variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+3G>T	TSC2		Tuberous sclerosis 2	VCV002031584	16	2129432	16	2079431	2031584	2089489	rs2089847916	NC_000016.10:2079430:G:T	single nucleotide variant	intron variant	Uncertain significance	Sep 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+3G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000860987	16	2129432	16	2079431	860987	852807	rs2089847916	NC_000016.10:2079430:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 19, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3284+4A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462525	16	2129433	16	2079432	3462525	3621545		NC_000016.10:2079431:A:G	single nucleotide variant	intron variant	Uncertain significance	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+5C>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003462629	16	2129434	16	2079433	3462629	3621648		NC_000016.10:2079432:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+5C>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000663538	16	2129434	16	2079433	663538	653245	rs1596384620	NC_000016.10:2079432:C:G	single nucleotide variant	intron variant	Uncertain significance	Apr 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+6T>G	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis	VCV000406126	16	2129435	16	2079434	406126	401549	rs375837026	NC_000016.10:2079433:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3284+7G>A	TSC2		Tuberous sclerosis 2	VCV002006030	16	2129436	16	2079435	2006030	2072976	rs1179505582	NC_000016.10:2079434:G:A	single nucleotide variant	intron variant	Likely benign	Jun 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+7G>T	TSC2		not specified|Tuberous sclerosis 2	VCV000755373	16	2129436	16	2079435	755373	776131	rs1179505582	NC_000016.10:2079434:G:T	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+8C>T	TSC2		Tuberous sclerosis 2	VCV000837089	16	2129437	16	2079436	837089	852645	rs2089849102	NC_000016.10:2079435:C:T	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+10C>G	TSC2		Tuberous sclerosis 2	VCV001538840	16	2129439	16	2079438	1538840	1597721	rs776269274	NC_000016.10:2079437:C:G	single nucleotide variant	intron variant	Likely benign	Aug 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+10C>T	TSC2		Tuberous sclerosis 2	VCV000536063	16	2129439	16	2079438	536063	529616	rs776269274	NC_000016.10:2079437:C:T	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+11C>T	TSC2		Tuberous sclerosis 2	VCV002971993	16	2129440	16	2079439	2971993	3139708	rs769334480	NC_000016.10:2079438:C:T	single nucleotide variant	intron variant	Likely benign	Feb 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+11C>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV001565995	16	2129440	16	2079439	1565995	1655933	rs769334480	NC_000016.10:2079438:C:A	single nucleotide variant	intron variant	Likely benign	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+13T>A	TSC2		Tuberous sclerosis 2	VCV001961159	16	2129442	16	2079441	1961159	2020005	rs774949592	NC_000016.10:2079440:T:A	single nucleotide variant	intron variant	Likely benign	Sep 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+14C>G	TSC2		Tuberous sclerosis 2	VCV001652305	16	2129443	16	2079442	1652305	1664218	rs762298669	NC_000016.10:2079441:C:G	single nucleotide variant	intron variant	Likely benign	Aug 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+15C>T	TSC2		Tuberous sclerosis 2	VCV001622138	16	2129444	16	2079443	1622138	1593341	rs939235755	NC_000016.10:2079442:C:T	single nucleotide variant	intron variant	Likely benign	Feb 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+16T>C	TSC2		Tuberous sclerosis 2	VCV002120310	16	2129445	16	2079444	2120310	2173030	rs2151441728	NC_000016.10:2079443:T:C	single nucleotide variant	intron variant	Likely benign	Apr 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+18T>A	TSC2		Tuberous sclerosis 2	VCV003640967	16	2129447	16	2079446	3640967	3768685		NC_000016.10:2079445:T:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+18T>G	TSC2		Tuberous sclerosis 2	VCV001664514	16	2129447	16	2079446	1664514	1556877	rs1280873987	NC_000016.10:2079445:T:G	single nucleotide variant	intron variant	Likely benign	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+19C>T	TSC2		Tuberous sclerosis 2	VCV001586019	16	2129448	16	2079447	1586019	1593664	rs1391837432	NC_000016.10:2079446:C:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3284+20C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000382882	16	2129449	16	2079448	382882	377245	rs1057521477	NC_000016.10:2079447:C:T	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3284+25C>T	TSC2		Tuberous sclerosis 2	VCV000803153	16	2129454	16	2079453	803153	791537	rs370495938	NC_000016.10:2079452:C:T	single nucleotide variant	intron variant	Benign	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-19C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000049785	16	2129539	16	2079538	49785	58947	rs45517291	NC_000016.10:2079537:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3285-18G>C	TSC2		Tuberous sclerosis 2	VCV001938349	16	2129540	16	2079539	1938349	1993779	rs752756174	NC_000016.10:2079538:G:C	single nucleotide variant	intron variant	Likely benign	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-18G>A	TSC2		Tuberous sclerosis 2	VCV001638388	16	2129540	16	2079539	1638388	1624074	rs752756174	NC_000016.10:2079538:G:A	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3285-15G>A	TSC2		Tuberous sclerosis 2	VCV001547940	16	2129543	16	2079542	1547940	1537758	rs1342617015	NC_000016.10:2079541:G:A	single nucleotide variant	intron variant	Likely benign	Oct 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-14G>A	TSC2		Tuberous sclerosis 2	VCV002091271	16	2129544	16	2079543	2091271	2145310	rs2544063606	NC_000016.10:2079542:G:A	single nucleotide variant	intron variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-13A>G	TSC2		Tuberous sclerosis 2	VCV003647411	16	2129545	16	2079544	3647411	3780704		NC_000016.10:2079543:A:G	single nucleotide variant	intron variant	Likely benign	Mar 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-13A>T	TSC2		Tuberous sclerosis 2	VCV002195207	16	2129545	16	2079544	2195207	1929574	rs2544063648	NC_000016.10:2079543:A:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3285-12T>G	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002193663	16	2129546	16	2079545	2193663	1929339	rs1233401491	NC_000016.10:2079544:T:G	single nucleotide variant	intron variant	Uncertain significance	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3285-10C>G	TSC2		Tuberous sclerosis 2	VCV001025869	16	2129548	16	2079547	1025869	1011976	rs763903351	NC_000016.10:2079546:C:G	single nucleotide variant	intron variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-8C>G	TSC2		Tuberous sclerosis 2	VCV001094548	16	2129550	16	2079549	1094548	1081830	rs751418785	NC_000016.10:2079548:C:G	single nucleotide variant	intron variant	Likely benign	Nov 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-8C>T	TSC2		Tuberous sclerosis 2	VCV000752386	16	2129550	16	2079549	752386	776499	rs751418785	NC_000016.10:2079548:C:T	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3285-7T>C	TSC2		Tuberous sclerosis 2	VCV004071109	16	2129551	16	2079550	4071109	4184957		NC_000016.10:2079549:T:C	single nucleotide variant	intron variant	Likely benign	May 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-7T>A	TSC2		Tuberous sclerosis 2	VCV003632100	16	2129551	16	2079550	3632100	3770141		NC_000016.10:2079549:T:A	single nucleotide variant	intron variant	Uncertain significance	Sep 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-7T>G	TSC2		Tuberous sclerosis 2	VCV001373077	16	2129551	16	2079550	1373077	1452795	rs1260593322	NC_000016.10:2079549:T:G	single nucleotide variant	intron variant	Uncertain significance	Oct 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-5C>G	TSC2		Tuberous sclerosis 2	VCV001559149	16	2129553	16	2079552	1559149	1629600	rs1444989940	NC_000016.10:2079551:C:G	single nucleotide variant	intron variant	Likely benign	May 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-5C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000536011	16	2129553	16	2079552	536011	529677	rs1444989940	NC_000016.10:2079551:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3285-4T>C	TSC2		Tuberous sclerosis 2	VCV001105230	16	2129554	16	2079553	1105230	1103658	rs756951926	NC_000016.10:2079552:T:C	single nucleotide variant	intron variant	Likely benign	Oct 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-4T>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001082590	16	2129554	16	2079553	1082590	1081831	rs756951926	NC_000016.10:2079552:T:G	single nucleotide variant	intron variant	Likely benign	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3285-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001064160	16	2129555	16	2079554	1064160	1049461	rs781023043	NC_000016.10:2079553:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3285-3C>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000823429	16	2129555	16	2079554	823429	815615	rs781023043	NC_000016.10:2079553:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3285-1G>A	TSC2		Hereditary cancer-predisposing syndrome	VCV003811302	16	2129557	16	2079556	3811302	3928543		NC_000016.10:2079555:G:A	single nucleotide variant	splice acceptor variant	Uncertain significance	Dec 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285-1G>C	TSC2		Hereditary cancer-predisposing syndrome	VCV003329478	16	2129557	16	2079556	3329478	3489070		NC_000016.10:2079555:G:C	single nucleotide variant	splice acceptor variant	Uncertain significance	Jun 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3285C>T (p.Ser1095=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000467998	16	2129558	16	2079557	467998	465927	rs745446277	NC_000016.10:2079556:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3286T>A (p.Ser1096Thr)	TSC2	S1003T, S1004T, S1046T, S1049T, S1063T, S1095T, S605T, S853T, S896T, S1015T, S1048T, S518T, S648T, S852T, S1016T, S1033T, S1052T, S1053T, S1059T, S1096T, S604T, S895T, S1047T, S1082T, S1083T, S899T	Tuberous sclerosis 2	VCV002744895	16	2129559	16	2079558	2744895	2897058	rs755815612	NC_000016.10:2079557:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3286T>C (p.Ser1096Pro)	TSC2	S1096P, S1053P, S1004P, S1016P, S852P, S1052P, S1063P	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535856	16	2129559	16	2079558	535856	530199	rs755815612	NC_000016.10:2079557:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3287C>G (p.Ser1096Cys)	TSC2	S1004C, S1016C, S1063C, S1096C, S1052C, S1053C, S852C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000957650	16	2129560	16	2079559	957650	949256	rs140772300	NC_000016.10:2079558:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3287C>T (p.Ser1096Phe)	TSC2	S1096F, S1004F, S1063F, S1016F, S852F, S1052F, S1053F	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|TSC2-related disorder|not provided|Tuberous sclerosis 2	VCV000405973	16	2129560	16	2079559	405973	400777	rs140772300	NC_000016.10:2079558:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3288C>T (p.Ser1096=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000794555	16	2129561	16	2079560	794555	785197	rs1596385627	NC_000016.10:2079559:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3290G>A (p.Ser1097Asn)	TSC2	S1097N, S1054N, S1053N, S1017N, S853N, S1005N, S1064N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000405946	16	2129563	16	2079562	405946	400782	rs1060500912	NC_000016.10:2079561:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3291C>G (p.Ser1097Arg)	TSC2	S1005R, S1017R, S1064R, S853R, S1054R, S1097R, S1053R	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000958501	16	2129564	16	2079563	958501	949257	rs1173297358	NC_000016.10:2079562:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3291C>T (p.Ser1097=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000733129	16	2129564	16	2079563	733129	740022	rs1173297358	NC_000016.10:2079562:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3292C>G (p.Pro1098Ala)	TSC2	P1006A, P854A, P1018A, P1054A, P1098A, P1055A, P1065A	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001421282	16	2129565	16	2079564	1421282	1400009	rs772686090	NC_000016.10:2079563:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3292C>T (p.Pro1098Ser)	TSC2	P1018S, P1065S, P854S, P1055S, P1054S, P1098S, P1006S	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000823456	16	2129565	16	2079564	823456	812570	rs772686090	NC_000016.10:2079563:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3293C>G (p.Pro1098Arg)	TSC2	P1098R, P1065R, P854R, P1055R, P1006R, P1018R, P1054R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000467999	16	2129566	16	2079565	467999	466201	rs773545852	NC_000016.10:2079564:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3293C>T (p.Pro1098Leu)	TSC2	P1098L, P1055L, P1065L, P1006L, P1018L, P1054L, P854L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000405953	16	2129566	16	2079565	405953	400790	rs773545852	NC_000016.10:2079564:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3294C>T (p.Pro1098=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468000	16	2129567	16	2079566	468000	466207	rs150126331	NC_000016.10:2079565:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3295G>C (p.Gly1099Arg)	TSC2	G1006R, G1007R, G1018R, G1019R, G1036R, G1049R, G1050R, G1051R, G1052R, G1055R, G1056R, G1062R, G1066R, G1085R, G1086R, G1098R, G1099R, G521R, G607R, G608R, G651R, G855R, G856R, G898R, G899R, G902R	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003074916	16	2129568	16	2079567	3074916	3234569	rs776855601	NC_000016.10:2079566:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3295G>T (p.Gly1099Trp)	TSC2	G1007W, G1066W, G1099W, G1055W, G855W, G1019W, G1056W	Tuberous sclerosis 2	VCV001411876	16	2129568	16	2079567	1411876	1349016	rs776855601	NC_000016.10:2079566:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3295G>A (p.Gly1099Arg)	TSC2	G1099R, G1055R, G1056R, G855R, G1007R, G1019R, G1066R	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000405978	16	2129568	16	2079567	405978	401308	rs776855601	NC_000016.10:2079566:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3296G>T (p.Gly1099Val)	TSC2	G1055V, G1056V, G1099V, G1007V, G1019V, G855V, G1066V	Tuberous sclerosis 2	VCV001520827	16	2129569	16	2079568	1520827	1356186	rs2151444560	NC_000016.10:2079567:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3297G>T (p.Gly1099=)	TSC2		Tuberous sclerosis 2	VCV004071307	16	2129570	16	2079569	4071307	4185155		NC_000016.10:2079568:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3297G>A (p.Gly1099=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002626439	16	2129570	16	2079569	2626439	2794205	rs138459325	NC_000016.10:2079568:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3297G>C (p.Gly1099=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000766896	16	2129570	16	2079569	766896	703552	rs138459325	NC_000016.10:2079568:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3298G>A (p.Val1100Met)	TSC2	V1008M, V1020M, V1056M, V1057M, V1067M, V1100M, V856M	Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000847784	16	2129571	16	2079570	847784	843451	rs1596385749	NC_000016.10:2079569:G:A	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3298G>T (p.Val1100Leu)	TSC2	V1056L, V1057L, V1067L, V1008L, V1020L, V1100L, V856L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000844676	16	2129571	16	2079570	844676	843452	rs1596385749	NC_000016.10:2079569:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3298G>C (p.Val1100Leu)	TSC2	V1008L, V1057L, V1100L, V1056L, V1020L, V1067L, V856L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000823488	16	2129571	16	2079570	823488	812571	rs1596385749	NC_000016.10:2079569:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3299T>G (p.Val1100Gly)	TSC2	V1007G, V1037G, V1053G, V1100G, V1020G, V1050G, V1067G, V1086G, V522G, V608G, V857G, V1019G, V1051G, V1056G, V1057G, V856G, V903G, V1008G, V1052G, V1063G, V1087G, V1099G, V609G, V652G, V899G, V900G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001729913	16	2129572	16	2079571	1729913	1792120	rs2089868343	NC_000016.10:2079570:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3300G>A (p.Val1100=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692492	16	2129573	16	2079572	1692492	1684932	rs765436350	NC_000016.10:2079571:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 4, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3301C>T (p.His1101Tyr)	TSC2	H1101Y, H1057Y, H1058Y, H1068Y, H1009Y, H857Y, H1021Y	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406005	16	2129574	16	2079573	406005	401555	rs1060500933	NC_000016.10:2079572:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3302A>G (p.His1101Arg)	TSC2	H1008R, H1009R, H1020R, H1021R, H1038R, H1051R, H1052R, H1053R, H1054R, H1057R, H1058R, H1064R, H1068R, H1087R, H1088R, H1100R, H1101R, H523R, H609R, H610R, H653R, H857R, H858R, H900R, H901R, H904R	Hereditary cancer-predisposing syndrome	VCV003232139	16	2129575	16	2079574	3232139	3391940	rs2544065765	NC_000016.10:2079573:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3303T>C (p.His1101=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468001	16	2129576	16	2079575	468001	465309	rs1233334406	NC_000016.10:2079574:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3304G>A (p.Val1102Met)	TSC2	V1102M, V1010M, V1059M, V858M, V1022M, V1058M, V1069M	not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535906	16	2129577	16	2079576	535906	530207	rs775584262	NC_000016.10:2079575:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3305T>G (p.Val1102Gly)	TSC2	V1010G, V1021G, V1058G, V1088G, V654G, V858G, V859G, V901G, V905G, V1009G, V1022G, V1039G, V1052G, V1102G, V524G, V1055G, V1065G, V1089G, V1101G, V611G, V902G, V1053G, V1054G, V1059G, V1069G, V610G	Tuberous sclerosis 2	VCV002710801	16	2129578	16	2079577	2710801	2867942	rs2544066004	NC_000016.10:2079576:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3306G>C (p.Val1102=)	TSC2		Tuberous sclerosis 2	VCV001086509	16	2129579	16	2079578	1086509	1081833	rs762917290	NC_000016.10:2079577:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3306G>A (p.Val1102=)	TSC2		Tuberous sclerosis 2	VCV001077621	16	2129579	16	2079578	1077621	1081832	rs762917290	NC_000016.10:2079577:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3307A>T (p.Arg1103Ter)	TSC2	R1010*, R1011*, R1022*, R1059*, R1102*, R525*, R612*, R906*, R1066*, R1089*, R902*, R1023*, R1040*, R1053*, R1054*, R1055*, R1060*, R1090*, R1103*, R611*, R860*, R903*, R1056*, R1070*, R655*, R859*	Tuberous sclerosis 2	VCV002834245	16	2129580	16	2079579	2834245	2995354	rs2544066099	NC_000016.10:2079578:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jun 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3309A>G (p.Arg1103=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001730039	16	2129582	16	2079581	1730039	1792245	rs2544066235	NC_000016.10:2079580:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3310C>A (p.Gln1104Lys)	TSC2	Q1012K, Q1024K, Q1071K, Q860K, Q1060K, Q1061K, Q1104K	Tuberous sclerosis 2	VCV000847013	16	2129583	16	2079582	847013	843453	rs397514978	NC_000016.10:2079581:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3310C>T (p.Gln1104Ter)	TSC2	Q1104*, Q1024*, Q1061*, Q1012*, Q1060*, Q860*, Q1071*	Tuberous sclerosis 2	VCV000064972	16	2129583	16	2079582	64972	75902	rs397514978	NC_000016.10:2079581:C:T	single nucleotide variant	nonsense	Pathogenic	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3311A>C (p.Gln1104Pro)	TSC2	Q1012P, Q1024P, Q1060P, Q1061P, Q1071P, Q1104P, Q860P	not provided	VCV001307148	16	2129584	16	2079583	1307148	1296097	rs869144637	NC_000016.10:2079582:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3313A>G (p.Thr1105Ala)	TSC2	T1105A, T1013A, T1025A, T1061A, T861A, T1062A, T1072A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000840705	16	2129586	16	2079585	840705	843454	rs2089870323	NC_000016.10:2079584:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3314C>T (p.Thr1105Ile)	TSC2	T1105I, T1072I, T1025I, T1013I, T1061I, T1062I, T861I	Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome	VCV000570726	16	2129587	16	2079586	570726	567817	rs946381749	NC_000016.10:2079585:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3315C>G (p.Thr1105=)	TSC2		Tuberous sclerosis 2	VCV001673468	16	2129588	16	2079587	1673468	1595655	rs1206474156	NC_000016.10:2079586:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3316A>T (p.Lys1106Ter)	TSC2	K1014*, K1026*, K1062*, K1063*, K1073*, K1106*, K862*	Tuberous sclerosis 2	VCV001072867	16	2129589	16	2079588	1072867	1063537	rs2151445155	NC_000016.10:2079587:A:T	single nucleotide variant	nonsense	Pathogenic	May 13, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3317A>C (p.Lys1106Thr)	TSC2	K1014T, K1062T, K1063T, K1106T, K1026T, K1073T, K862T	Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001474481	16	2129590	16	2079589	1474481	1411012	rs764113584	NC_000016.10:2079588:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3317A>G (p.Lys1106Arg)	TSC2	K1062R, K1106R, K862R, K1014R, K1026R, K1063R, K1073R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001401403	16	2129590	16	2079589	1401403	1379390	rs764113584	NC_000016.10:2079588:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3317A>T (p.Lys1106Met)	TSC2	K1106M, K1062M, K1063M, K862M, K1014M, K1026M, K1073M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486673	16	2129590	16	2079589	486673	477343	rs764113584	NC_000016.10:2079588:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3318G>A (p.Lys1106=)	TSC2		not provided|not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000413738	16	2129591	16	2079590	413738	401566	rs1060504119	NC_000016.10:2079589:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3320A>G (p.Glu1107Gly)	TSC2	E1015G, E1044G, E1060G, E616G, E1026G, E1058G, E1059G, E1064G, E1070G, E1093G, E1094G, E1107G, E529G, E615G, E864G, E910G, E1057G, E1074G, E863G, E906G, E907G, E1014G, E1027G, E1063G, E1106G, E659G	Tuberous sclerosis 2	VCV002818674	16	2129593	16	2079592	2818674	2981046	rs2544067010	NC_000016.10:2079591:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3321G>A (p.Glu1107=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000792645	16	2129594	16	2079593	792645	785198	rs1596385920	NC_000016.10:2079592:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3323C>T (p.Ala1108Val)	TSC2	A1108V, A1016V, A1064V, A864V, A1065V, A1028V, A1075V	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000141482	16	2129596	16	2079595	141482	151196	rs587781782	NC_000016.10:2079594:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3324G>T (p.Ala1108=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000702692	16	2129597	16	2079596	702692	693816	rs786203392	NC_000016.10:2079595:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3324G>A (p.Ala1108=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000187001	16	2129597	16	2079596	187001	184138	rs786203392	NC_000016.10:2079595:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3325C>T (p.Pro1109Ser)	TSC2	P1016S, P1017S, P1028S, P1029S, P1046S, P1059S, P1060S, P1061S, P1062S, P1065S, P1066S, P1072S, P1076S, P1095S, P1096S, P1108S, P1109S, P531S, P617S, P618S, P661S, P865S, P866S, P908S, P909S, P912S	not provided	VCV002580677	16	2129598	16	2079597	2580677	2748263	rs1555510880	NC_000016.10:2079596:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3325C>G (p.Pro1109Ala)	TSC2	P1109A, P1017A, P1076A, P1029A, P1065A, P865A, P1066A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468002	16	2129598	16	2079597	468002	466209	rs1555510880	NC_000016.10:2079596:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3326C>G (p.Pro1109Arg)	TSC2	P1059R, P1066R, P1108R, P617R, P661R, P865R, P1016R, P1028R, P1029R, P1046R, P1065R, P1076R, P912R, P866R, P909R, P1017R, P1062R, P1095R, P1096R, P1109R, P531R, P1060R, P1061R, P1072R, P618R, P908R	Hereditary cancer-predisposing syndrome	VCV003811354	16	2129599	16	2079598	3811354	3928595		NC_000016.10:2079597:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3326C>A (p.Pro1109Gln)	TSC2	P1029Q, P1065Q, P617Q, P866Q, P908Q, P909Q, P1016Q, P1059Q, P1062Q, P1066Q, P661Q, P865Q, P912Q, P1017Q, P1028Q, P1046Q, P1060Q, P1072Q, P1095Q, P618Q, P1061Q, P1076Q, P1096Q, P1108Q, P1109Q, P531Q	Hereditary cancer-predisposing syndrome	VCV001730247	16	2129599	16	2079598	1730247	1788582	rs796053474	NC_000016.10:2079597:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3326C>T (p.Pro1109Leu)	TSC2	P1109L, P1017L, P1065L, P1029L, P1066L, P1076L, P865L	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000207676	16	2129599	16	2079598	207676	203166	rs796053474	NC_000016.10:2079597:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3327G>C (p.Pro1109=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974627	16	2129600	16	2079599	3974627	4086450		NC_000016.10:2079598:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3327G>T (p.Pro1109=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486608	16	2129600	16	2079599	486608	477386	rs45478393	NC_000016.10:2079598:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3327G>A (p.Pro1109=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049251	16	2129600	16	2079599	49251	58413	rs45478393	NC_000016.10:2079598:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3328G>C (p.Ala1110Pro)	TSC2	A1018P, A1110P, A866P, A1066P, A1030P, A1067P, A1077P	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000959189	16	2129601	16	2079600	959189	949258	rs1260370117	NC_000016.10:2079599:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3328G>A (p.Ala1110Thr)	TSC2	A1110T, A1018T, A1077T, A866T, A1030T, A1066T, A1067T	Tuberous sclerosis 2	VCV000579257	16	2129601	16	2079600	579257	573839	rs1260370117	NC_000016.10:2079599:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3329C>T (p.Ala1110Val)	TSC2	A1029V, A1060V, A1062V, A1066V, A1077V, A1096V, A1097V, A1110V, A662V, A867V, A909V, A910V, A1047V, A1063V, A1067V, A1073V, A1109V, A532V, A866V, A913V, A1017V, A618V, A1018V, A1030V, A1061V, A619V	Tuberous sclerosis 2	VCV002817261	16	2129602	16	2079601	2817261	2977072	rs1060500923	NC_000016.10:2079600:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3329C>G (p.Ala1110Gly)	TSC2	A1110G, A1018G, A866G, A1030G, A1077G, A1066G, A1067G	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000405981	16	2129602	16	2079601	405981	401316	rs1060500923	NC_000016.10:2079600:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3330C>T (p.Ala1110=)	TSC2		Tuberous sclerosis 2	VCV001158887	16	2129603	16	2079602	1158887	1145954	rs1555510912	NC_000016.10:2079601:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3330C>G (p.Ala1110=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486605	16	2129603	16	2079602	486605	477480	rs1555510912	NC_000016.10:2079601:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3331A>G (p.Lys1111Glu)	TSC2	K1067E, K1068E, K867E, K1031E, K1078E, K1111E, K1019E	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV001449304	16	2129604	16	2079603	1449304	1416360	rs2151445646	NC_000016.10:2079602:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3333G>C (p.Lys1111Asn)	TSC2	K1019N, K1062N, K1064N, K1068N, K1078N, K1097N, K1110N, K533N, K663N, K1063N, K1098N, K868N, K1018N, K1031N, K1074N, K619N, K867N, K910N, K911N, K914N, K1030N, K1048N, K1061N, K1067N, K1111N, K620N	Hereditary cancer-predisposing syndrome	VCV003462644	16	2129606	16	2079605	3462644	3621663		NC_000016.10:2079604:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3333G>A (p.Lys1111=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000137745	16	2129606	16	2079605	137745	141448	rs557648435	NC_000016.10:2079604:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3334C>G (p.Leu1112Val)	TSC2	L1079V, L1020V, L1068V, L1069V, L1112V, L868V, L1032V	Tuberous sclerosis 2	VCV001355612	16	2129607	16	2079606	1355612	1509363	rs531172613	NC_000016.10:2079605:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3334C>T (p.Leu1112=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468003	16	2129607	16	2079606	468003	465996	rs531172613	NC_000016.10:2079605:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3336G>A (p.Leu1112=)	TSC2		Tuberous sclerosis 2	VCV004071211	16	2129609	16	2079608	4071211	4185059		NC_000016.10:2079607:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 28, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3336G>T (p.Leu1112=)	TSC2		Tuberous sclerosis 2	VCV000536105	16	2129609	16	2079608	536105	529624	rs1389714633	NC_000016.10:2079607:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3337G>C (p.Glu1113Gln)	TSC2	E1033Q, E869Q, E1021Q, E1069Q, E1070Q, E1080Q, E1113Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001383611	16	2129610	16	2079609	1383611	1354751	rs1567500491	NC_000016.10:2079608:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3337G>A (p.Glu1113Lys)	TSC2	E1113K, E1069K, E1070K, E869K, E1021K, E1033K, E1080K	Tuberous sclerosis 2	VCV000569792	16	2129610	16	2079609	569792	567823	rs1567500491	NC_000016.10:2079608:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3338A>T (p.Glu1113Val)	TSC2	E1020V, E1021V, E1032V, E1033V, E1050V, E1063V, E1064V, E1065V, E1066V, E1069V, E1070V, E1076V, E1080V, E1099V, E1100V, E1112V, E1113V, E535V, E621V, E622V, E665V, E869V, E870V, E912V, E913V, E916V	Hereditary cancer-predisposing syndrome	VCV003232140	16	2129611	16	2079610	3232140	3391941	rs2151445909	NC_000016.10:2079609:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3338A>G (p.Glu1113Gly)	TSC2	E1069G, E1021G, E1080G, E1113G, E1070G, E1033G, E869G	Tuberous sclerosis 2	VCV001492659	16	2129611	16	2079610	1492659	1516797	rs2151445909	NC_000016.10:2079609:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3339G>A (p.Glu1113=)	TSC2		Tuberous sclerosis 2	VCV000413656	16	2129612	16	2079611	413656	401568	rs1060504092	NC_000016.10:2079610:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3340T>G (p.Ser1114Ala)	TSC2	S1021A, S1022A, S1033A, S1034A, S1051A, S1064A, S1065A, S1066A, S1067A, S1070A, S1071A, S1077A, S1081A, S1100A, S1101A, S1113A, S1114A, S536A, S622A, S623A, S666A, S870A, S871A, S913A, S914A, S917A	Tuberous sclerosis 2	VCV001721458	16	2129613	16	2079612	1721458	1772792	rs2151446011	NC_000016.10:2079611:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3341C>T (p.Ser1114Phe)	TSC2	S1021F, S1022F, S1033F, S1034F, S1051F, S1064F, S1065F, S1066F, S1067F, S1070F, S1071F, S1077F, S1081F, S1100F, S1101F, S1113F, S1114F, S536F, S622F, S623F, S666F, S870F, S871F, S913F, S914F, S917F	Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Intellectual disability	VCV003071287	16	2129614	16	2079613	3071287	3228868	rs2151446048	NC_000016.10:2079612:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3341C>A (p.Ser1114Tyr)	TSC2	S1034Y, S1051Y, S1066Y, S1070Y, S1101Y, S1113Y, S622Y, S623Y, S1022Y, S1065Y, S1071Y, S536Y, S870Y, S913Y, S914Y, S1021Y, S1033Y, S1064Y, S1067Y, S871Y, S917Y, S1077Y, S1081Y, S1100Y, S1114Y, S666Y	Tuberous sclerosis 2	VCV002004215	16	2129614	16	2079613	2004215	2062150	rs2151446048	NC_000016.10:2079612:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3342C>A (p.Ser1114=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001530292	16	2129615	16	2079614	1530292	1582077	rs755871381	NC_000016.10:2079613:C:A	single nucleotide variant	synonymous variant	Likely benign	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3342C>T (p.Ser1114=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000763008	16	2129615	16	2079614	763008	770720	rs755871381	NC_000016.10:2079613:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3343C>T (p.Gln1115Ter)	TSC2	Q1115*, Q1023*, Q1082*, Q1071*, Q871*, Q1035*, Q1072*	Tuberous sclerosis 2	VCV000049252	16	2129616	16	2079615	49252	58414	rs137854253	NC_000016.10:2079614:C:T	single nucleotide variant	nonsense	Pathogenic	Mar 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3345G>A (p.Gln1115=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564636	16	2129618	16	2079617	2564636	2733792	rs1323724570	NC_000016.10:2079616:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3345G>T (p.Gln1115His)	TSC2	Q1023H, Q1071H, Q1072H, Q1082H, Q1115H, Q871H, Q1035H	Tuberous sclerosis 2	VCV000943644	16	2129618	16	2079617	943644	937322	rs1323724570	NC_000016.10:2079616:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3346G>A (p.Ala1116Thr)	TSC2	A1024T, A872T, A1083T, A1036T, A1072T, A1073T, A1116T	Tuberous sclerosis 2	VCV000658246	16	2129619	16	2079618	658246	644279	rs1369469515	NC_000016.10:2079617:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3347C>T (p.Ala1116Val)	TSC2	A1116V, A1024V, A1083V, A1036V, A1072V, A1073V, A872V	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000282965	16	2129620	16	2079619	282965	267202	rs878854092	NC_000016.10:2079618:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3347C>G (p.Ala1116Gly)	TSC2	A1116G, A1024G, A1083G, A1073G, A872G, A1036G, A1072G	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238017	16	2129620	16	2079619	238017	242279	rs878854092	NC_000016.10:2079618:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3348T>C (p.Ala1116=)	TSC2		Tuberous sclerosis 2	VCV002125823	16	2129621	16	2079620	2125823	2174654	rs1219033645	NC_000016.10:2079619:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3351G>A (p.Gly1117=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000805697	16	2129624	16	2079623	805697	793573	rs1596386166	NC_000016.10:2079622:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3352C>T (p.Gln1118Ter)	TSC2	Q1118*, Q1038*, Q1074*, Q1075*, Q1085*, Q874*, Q1026*	not provided	VCV000049797	16	2129625	16	2079624	49797	58959	rs45496291	NC_000016.10:2079623:C:T	single nucleotide variant	nonsense	Pathogenic	Feb 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3353A>T (p.Gln1118Leu)	TSC2	Q1026L, Q1038L, Q1074L, Q1075L, Q1085L, Q1118L, Q874L	Tuberous sclerosis 2	VCV001020115	16	2129626	16	2079625	1020115	1011977	rs2089877003	NC_000016.10:2079624:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3355C>T (p.Gln1119Ter)	TSC2	Q1119*, Q1075*, Q1027*, Q1039*, Q875*, Q1076*, Q1086*	Tuberous sclerosis 2	VCV000050063	16	2129628	16	2079627	50063	59225	rs45517292	NC_000016.10:2079626:C:T	single nucleotide variant	nonsense	Pathogenic	Sep 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3356A>G (p.Gln1119Arg)	TSC2	Q1119R, Q1075R, Q1076R, Q1027R, Q1039R, Q1086R, Q875R	not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000580272	16	2129629	16	2079628	580272	569761	rs1567500641	NC_000016.10:2079627:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3357G>A (p.Gln1119=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001086546	16	2129630	16	2079629	1086546	1081834	rs1309073649	NC_000016.10:2079628:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3357G>T (p.Gln1119His)	TSC2	Q1075H, Q1039H, Q1076H, Q1119H, Q875H, Q1027H, Q1086H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001040813	16	2129630	16	2079629	1040813	1032469	rs1309073649	NC_000016.10:2079628:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3358G>T (p.Val1120Leu)	TSC2	V1120L, V1028L, V1040L, V1076L, V1077L, V876L, V1087L	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000578164	16	2129631	16	2079630	578164	573840	rs1053311636	NC_000016.10:2079629:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3358G>C (p.Val1120Leu)	TSC2	V1120L, V1077L, V1087L, V876L, V1028L, V1076L, V1040L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|TSC2-related disorder|not provided	VCV000468005	16	2129631	16	2079630	468005	465931	rs1053311636	NC_000016.10:2079629:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3359T>C (p.Val1120Ala)	TSC2	V1057A, V1070A, V1072A, V1106A, V1119A, V542A, V629A, V1039A, V1040A, V1071A, V1077A, V1087A, V877A, V919A, V920A, V1027A, V1028A, V1076A, V672A, V923A, V1073A, V1083A, V1107A, V1120A, V628A, V876A	Hereditary cancer-predisposing syndrome	VCV002564738	16	2129632	16	2079631	2564738	2733894	rs397514895	NC_000016.10:2079630:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3359T>A (p.Val1120Glu)	TSC2	V1120E, V1077E, V876E, V1040E, V1087E, V1028E, V1076E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000064869	16	2129632	16	2079631	64869	75798	rs397514895	NC_000016.10:2079630:T:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3360G>T (p.Val1120=)	TSC2		Tuberous sclerosis 2	VCV000766711	16	2129633	16	2079632	766711	770721	rs1596386237	NC_000016.10:2079631:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 29, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3361T>C (p.Ser1121Pro)	TSC2	S1041P, S1058P, S1088P, S1108P, S1120P, S924P, S1040P, S1071P, S1072P, S1073P, S1084P, S543P, S630P, S673P, S1029P, S1077P, S1078P, S1107P, S1121P, S877P, S878P, S921P, S1028P, S1074P, S629P, S920P	Tuberous sclerosis 2	VCV002165194	16	2129634	16	2079633	2165194	1895334	rs779833011	NC_000016.10:2079632:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3362C>A (p.Ser1121Tyr)	TSC2	S1077Y, S1088Y, S1029Y, S877Y, S1041Y, S1078Y, S1121Y	Tuberous sclerosis 2	VCV001522638	16	2129635	16	2079634	1522638	1459833	rs1596386254	NC_000016.10:2079633:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3362C>T (p.Ser1121Phe)	TSC2	S1078F, S1088F, S1077F, S1121F, S1029F, S1041F, S877F	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000823667	16	2129635	16	2079634	823667	812572	rs1596386254	NC_000016.10:2079633:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3363C>T (p.Ser1121=)	TSC2		Tuberous sclerosis 2	VCV004071258	16	2129636	16	2079635	4071258	4185106		NC_000016.10:2079634:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3363C>A (p.Ser1121=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232141	16	2129636	16	2079635	3232141	3391942	rs1555510946	NC_000016.10:2079634:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3363C>G (p.Ser1121=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468006	16	2129636	16	2079635	468006	465932	rs1555510946	NC_000016.10:2079634:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3364C>T (p.Arg1122Cys)	TSC2	R1122C, R1042C, R1030C, R878C, R1079C, R1089C, R1078C	not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000064919	16	2129637	16	2079636	64919	75849	rs397514938	NC_000016.10:2079635:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3365G>T (p.Arg1122Leu)	TSC2	R1079L, R1089L, R1042L, R1078L, R1030L, R1122L, R878L	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001429885	16	2129638	16	2079637	1429885	1477618	rs369536711	NC_000016.10:2079636:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3365G>A (p.Arg1122His)	TSC2	R1122H, R1089H, R1030H, R1078H, R1042H, R878H, R1079H	not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468007	16	2129638	16	2079637	468007	465311	rs369536711	NC_000016.10:2079636:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3365G>C (p.Arg1122Pro)	TSC2	R1122P, R1030P, R878P, R1089P, R1078P, R1079P, R1042P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000451736	16	2129638	16	2079637	451736	445522	rs369536711	NC_000016.10:2079636:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3366T>C (p.Arg1122=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000281341	16	2129639	16	2079638	281341	265578	rs778352969	NC_000016.10:2079637:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3367G>A (p.Gly1123Arg)	TSC2	G1060R, G1073R, G1074R, G1079R, G1086R, G1122R, G632R, G1076R, G1080R, G1109R, G545R, G880R, G1030R, G1090R, G1110R, G631R, G879R, G922R, G926R, G1031R, G1042R, G1043R, G1075R, G1123R, G675R, G923R	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV003578799	16	2129640	16	2079639	3578799	3708220		NC_000016.10:2079638:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3367G>T (p.Gly1123Trp)	TSC2	G1042W, G1075W, G1080W, G1122W, G1030W, G1031W, G1076W, G1086W, G1123W, G631W, G922W, G1060W, G1074W, G1079W, G1109W, G632W, G675W, G926W, G1043W, G1073W, G1090W, G1110W, G545W, G879W, G880W, G923W	Tuberous sclerosis 2	VCV002825143	16	2129640	16	2079639	2825143	2986228	rs2544070094	NC_000016.10:2079638:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3368G>T (p.Gly1123Val)	TSC2	G1031V, G1075V, G1076V, G1109V, G545V, G632V, G675V, G923V, G926V, G1074V, G1079V, G879V, G1030V, G1060V, G1080V, G1086V, G1122V, G1042V, G1043V, G1073V, G1090V, G1110V, G1123V, G631V, G880V, G922V	Hereditary cancer-predisposing syndrome	VCV003811313	16	2129641	16	2079640	3811313	3928554		NC_000016.10:2079639:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3368G>A (p.Gly1123Glu)	TSC2	G1123E, G1079E, G1043E, G1031E, G1090E, G1080E, G879E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406114	16	2129641	16	2079640	406114	400917	rs1060500968	NC_000016.10:2079639:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3369G>T (p.Gly1123=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001730689	16	2129642	16	2079641	1730689	1785678	rs1555510958	NC_000016.10:2079640:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3369G>A (p.Gly1123=)	TSC2		Tuberous sclerosis 2	VCV000468008	16	2129642	16	2079641	468008	466212	rs1555510958	NC_000016.10:2079640:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3370G>A (p.Ala1124Thr)	TSC2	A1044T, A1061T, A1074T, A1076T, A1091T, A1123T, A632T, A633T, A1043T, A1087T, A1124T, A676T, A881T, A923T, A927T, A1032T, A1077T, A1080T, A1081T, A1111T, A924T, A1031T, A1075T, A1110T, A546T, A880T	Tuberous sclerosis 2	VCV003637219	16	2129643	16	2079642	3637219	3771373		NC_000016.10:2079641:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3372C>G (p.Ala1124=)	TSC2		Tuberous sclerosis 2	VCV001541286	16	2129645	16	2079644	1541286	1661780	rs1555510963	NC_000016.10:2079643:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3372C>T (p.Ala1124=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000536064	16	2129645	16	2079644	536064	530209	rs1555510963	NC_000016.10:2079643:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3373C>A (p.Arg1125=)	TSC2		Tuberous sclerosis 2	VCV002057348	16	2129646	16	2079645	2057348	2116505	rs747420910	NC_000016.10:2079644:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3373C>T (p.Arg1125Trp)	TSC2	R1045W, R1081W, R1125W, R881W, R1033W, R1082W, R1092W	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000659094	16	2129646	16	2079645	659094	644280	rs747420910	NC_000016.10:2079644:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3374G>A (p.Arg1125Gln)	TSC2	R1125Q, R1033Q, R1045Q, R881Q, R1081Q, R1082Q, R1092Q	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000207677	16	2129647	16	2079646	207677	203167	rs796053475	NC_000016.10:2079645:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3375G>A (p.Arg1125=)	TSC2		Tuberous sclerosis 2	VCV000238018	16	2129648	16	2079647	238018	242280	rs878854093	NC_000016.10:2079646:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 5, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.3376G>A (p.Asp1126Asn)	TSC2	D1034N, D1046N, D1082N, D1083N, D1093N, D1126N, D882N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001053564	16	2129649	16	2079648	1053564	1049462	rs2151447156	NC_000016.10:2079647:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3377A>G (p.Asp1126Gly)	TSC2	D1034G, D1126G, D1046G, D1082G, D1083G, D1093G, D882G	Tuberous sclerosis 2	VCV001364282	16	2129650	16	2079649	1364282	1386221	rs397514945	NC_000016.10:2079648:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3377A>T (p.Asp1126Val)	TSC2	D1126V, D1082V, D1083V, D1093V, D1034V, D1046V, D882V	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000064927	16	2129650	16	2079649	64927	75857	rs397514945	NC_000016.10:2079648:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3378T>C (p.Asp1126=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564736	16	2129651	16	2079650	2564736	2733892	rs2151447231	NC_000016.10:2079649:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3379C>A (p.Arg1127=)	TSC2		Tuberous sclerosis 2	VCV004071094	16	2129652	16	2079651	4071094	4184942		NC_000016.10:2079650:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3379C>T (p.Arg1127Trp)	TSC2	R1127W, R1035W, R1084W, R1083W, R1094W, R883W, R1047W	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2|TSC2-related disorder|Tuberous sclerosis syndrome	VCV000406072	16	2129652	16	2079651	406072	400792	rs373939435	NC_000016.10:2079650:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3380G>A (p.Arg1127Gln)	TSC2	R1127Q, R1083Q, R1094Q, R1035Q, R883Q, R1047Q, R1084Q	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000536003	16	2129653	16	2079652	536003	529973	rs746197874	NC_000016.10:2079651:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3381G>A (p.Arg1127=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000823695	16	2129654	16	2079653	823695	812573	rs1596386421	NC_000016.10:2079652:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3381G>C (p.Arg1127=)	TSC2		Tuberous sclerosis 2	VCV000800083	16	2129654	16	2079653	800083	785199	rs1596386421	NC_000016.10:2079652:G:C	single nucleotide variant	synonymous variant	Likely benign	May 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3382G>A (p.Val1128Ile)	TSC2	V1036I, V1048I, V1084I, V1085I, V1095I, V1128I, V884I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001002022	16	2129655	16	2079654	1002022	996739	rs1417366523	NC_000016.10:2079653:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3384C>G (p.Val1128=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232142	16	2129657	16	2079656	3232142	3391943	rs1567500984	NC_000016.10:2079655:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Dec 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3385C>A (p.Arg1129Ser)	TSC2	R1036S, R1048S, R1082S, R1096S, R1128S, R1129S, R681S, R886S, R928S, R929S, R1037S, R1066S, R1085S, R1092S, R1116S, R551S, R638S, R1049S, R1079S, R1081S, R637S, R885S, R1080S, R1086S, R1115S, R932S	Hereditary cancer-predisposing syndrome	VCV002449969	16	2129658	16	2079657	2449969	2429594	rs1028039505	NC_000016.10:2079656:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3385C>T (p.Arg1129Cys)	TSC2	R1129C, R1085C, R1086C, R1096C, R1037C, R1049C, R885C	Hereditary cancer-predisposing syndrome|TSC2-related disorder|Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome	VCV000406032	16	2129658	16	2079657	406032	401573	rs1028039505	NC_000016.10:2079656:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3386G>A (p.Arg1129His)	TSC2	R1129H, R1096H, R1049H, R1085H, R1086H, R1037H, R885H	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000535973	16	2129659	16	2079658	535973	530210	rs1412967226	NC_000016.10:2079657:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3387T>C (p.Arg1129=)	TSC2		Tuberous sclerosis 2	VCV002109919	16	2129660	16	2079659	2109919	2163794	rs2544071369	NC_000016.10:2079658:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3388T>G (p.Ser1130Ala)	TSC2	S1086A, S1087A, S1097A, S1038A, S1050A, S1130A, S886A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000641149	16	2129661	16	2079660	641149	644282	rs770048768	NC_000016.10:2079659:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3389C>T (p.Ser1130Phe)	TSC2	S1038F, S1050F, S1086F, S1087F, S1097F, S1130F, S886F	not provided	VCV001312547	16	2129662	16	2079661	1312547	1302808	rs1163066622	NC_000016.10:2079660:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3389C>G (p.Ser1130Cys)	TSC2	S1097C, S886C, S1086C, S1087C, S1038C, S1050C, S1130C	Tuberous sclerosis 2	VCV000861466	16	2129662	16	2079661	861466	843456	rs1163066622	NC_000016.10:2079660:C:G	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3390C>A (p.Ser1130=)	TSC2		Tuberous sclerosis 2	VCV003649740	16	2129663	16	2079662	3649740	3777702		NC_000016.10:2079661:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3390C>T (p.Ser1130=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486697	16	2129663	16	2079662	486697	477939	rs867238767	NC_000016.10:2079661:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3391A>T (p.Met1131Leu)	TSC2	M1039L, M1098L, M1051L, M887L, M1087L, M1088L, M1131L	Tuberous sclerosis 2	VCV001407097	16	2129664	16	2079663	1407097	1487155	rs775639244	NC_000016.10:2079662:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3391A>G (p.Met1131Val)	TSC2	M1131V, M1039V, M1098V, M1051V, M1088V, M1087V, M887V	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000406099	16	2129664	16	2079663	406099	400923	rs775639244	NC_000016.10:2079662:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3392T>C (p.Met1131Thr)	TSC2	M1039T, M887T, M1088T, M1051T, M1087T, M1098T, M1131T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000653459	16	2129665	16	2079664	653459	644283	rs763122999	NC_000016.10:2079663:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3393G>C (p.Met1131Ile)	TSC2	M1038I, M1039I, M1050I, M1051I, M1068I, M1081I, M1082I, M1083I, M1084I, M1087I, M1088I, M1094I, M1098I, M1117I, M1118I, M1130I, M1131I, M553I, M639I, M640I, M683I, M887I, M888I, M930I, M931I, M934I	Tuberous sclerosis 2	VCV003777068	16	2129666	16	2079665	3777068	3893208		NC_000016.10:2079664:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic		criteria provided, single submitter							
NM_000548.5(TSC2):c.3393G>A (p.Met1131Ile)	TSC2	M1038I, M1039I, M1068I, M1083I, M1094I, M1130I, M640I, M887I, M888I, M1051I, M1082I, M1084I, M1087I, M1118I, M930I, M931I, M1050I, M639I, M1081I, M1088I, M1098I, M1117I, M1131I, M553I, M683I, M934I	Hereditary cancer-predisposing syndrome	VCV002497441	16	2129666	16	2079665	2497441	2472524	rs1297504532	NC_000016.10:2079664:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3393G>T (p.Met1131Ile)	TSC2	M1039I, M1051I, M1087I, M1088I, M1098I, M1131I, M887I	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV001015445	16	2129666	16	2079665	1015445	1011978	rs1297504532	NC_000016.10:2079664:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3395C>G (p.Ser1132Trp)	TSC2	S1039W, S1040W, S1051W, S1052W, S1069W, S1082W, S1083W, S1084W, S1085W, S1088W, S1089W, S1095W, S1099W, S1118W, S1119W, S1131W, S1132W, S554W, S640W, S641W, S684W, S888W, S889W, S931W, S932W, S935W	Hereditary cancer-predisposing syndrome	VCV003232143	16	2129668	16	2079667	3232143	3391944	rs137854074	NC_000016.10:2079666:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3395C>T (p.Ser1132Leu)	TSC2	S1132L, S1089L, S1040L, S1088L, S1052L, S1099L, S888L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000406107	16	2129668	16	2079667	406107	400800	rs137854074	NC_000016.10:2079666:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3395C>A (p.Ser1132Ter)	TSC2	S1132*, S1052*, S888*, S1089*, S1099*, S1040*, S1088*	not provided	VCV000049828	16	2129668	16	2079667	49828	58990	rs137854074	NC_000016.10:2079666:C:A	single nucleotide variant	nonsense	Pathogenic	Nov 21, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.3396G>A (p.Ser1132=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000405995	16	2129669	16	2079668	405995	401574	rs373004429	NC_000016.10:2079667:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3396G>T (p.Ser1132=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000232786	16	2129669	16	2079668	232786	235123	rs373004429	NC_000016.10:2079667:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 7, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3397G>T (p.Gly1133Trp)	TSC2	G1041W, G1053W, G1089W, G1090W, G1100W, G1133W, G889W	Tuberous sclerosis 2	VCV001055788	16	2129670	16	2079669	1055788	1049463	rs1555511031	NC_000016.10:2079668:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397G>A (p.Gly1133Arg)	TSC2	G1133R, G1090R, G1100R, G1041R, G889R, G1053R, G1089R	Tuberous sclerosis 2	VCV000535989	16	2129670	16	2079669	535989	529978	rs1555511031	NC_000016.10:2079668:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+1G>T	TSC2		Tuberous sclerosis 2	VCV001068835	16	2129671	16	2079670	1068835	1063539	rs137854208	NC_000016.10:2079669:G:T	single nucleotide variant	splice donor variant	Pathogenic	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+1G>A	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2	VCV000049256	16	2129671	16	2079670	49256	58418	rs137854208	NC_000016.10:2079669:G:A	single nucleotide variant	splice donor variant	Pathogenic	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3397+3G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001428196	16	2129673	16	2079672	1428196	1379488	rs1481437660	NC_000016.10:2079671:G:A	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3397+4A>G	TSC2		Tuberous sclerosis 2	VCV001805434	16	2129674	16	2079673	1805434	1862446	rs2544072093	NC_000016.10:2079672:A:G	single nucleotide variant	intron variant	Pathogenic	Mar 31, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+5G>A	TSC2		Tuberous sclerosis 2|not provided	VCV000050075	16	2129675	16	2079674	50075	59237	rs45501492	NC_000016.10:2079673:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 19, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3397+6C>T	TSC2		Tuberous sclerosis 2	VCV004071145	16	2129676	16	2079675	4071145	4184993		NC_000016.10:2079674:C:T	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+6C>A	TSC2		Tuberous sclerosis 2	VCV001044817	16	2129676	16	2079675	1044817	1032470	rs955636757	NC_000016.10:2079674:C:A	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+6C>G	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000951344	16	2129676	16	2079675	951344	941126	rs955636757	NC_000016.10:2079674:C:G	single nucleotide variant	intron variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3397+7C>G	TSC2		Tuberous sclerosis 2	VCV004071146	16	2129677	16	2079676	4071146	4184994		NC_000016.10:2079675:C:G	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+7C>T	TSC2		not provided|Tuberous sclerosis 2	VCV000468010	16	2129677	16	2079676	468010	465997	rs767531844	NC_000016.10:2079675:C:T	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3397+8T>G	TSC2		Tuberous sclerosis 2	VCV004071319	16	2129678	16	2079677	4071319	4185167		NC_000016.10:2079676:T:G	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+8T>C	TSC2		Tuberous sclerosis 2	VCV002014253	16	2129678	16	2079677	2014253	2064466	rs1231016004	NC_000016.10:2079676:T:C	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3397+9T>G	TSC2		Tuberous sclerosis 2	VCV002134634	16	2129679	16	2079678	2134634	2192192	rs2544072408	NC_000016.10:2079677:T:G	single nucleotide variant	intron variant	Likely benign	Nov 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+11G>A	TSC2		Tuberous sclerosis 2	VCV001631487	16	2129681	16	2079680	1631487	1597291	rs1596386676	NC_000016.10:2079679:G:A	single nucleotide variant	intron variant	Likely benign	May 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+15C>T	TSC2		not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000445392	16	2129685	16	2079684	445392	438664	rs202246408	NC_000016.10:2079683:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3397+16A>C	TSC2		Tuberous sclerosis 2	VCV001650532	16	2129686	16	2079685	1650532	1602244	rs1456373944	NC_000016.10:2079684:A:C	single nucleotide variant	intron variant	Likely benign	Jun 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+17G>A	TSC2		Tuberous sclerosis 2	VCV003010840	16	2129687	16	2079686	3010840	3169875	rs2151448229	NC_000016.10:2079685:G:A	single nucleotide variant	intron variant	Likely benign	Oct 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+17G>C	TSC2		Tuberous sclerosis 2	VCV002763847	16	2129687	16	2079686	2763847	2922016	rs2151448229	NC_000016.10:2079685:G:C	single nucleotide variant	intron variant	Likely benign	Sep 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+18C>T	TSC2		Tuberous sclerosis 2	VCV002920374	16	2129688	16	2079687	2920374	3077813	rs2544072993	NC_000016.10:2079686:C:T	single nucleotide variant	intron variant	Likely benign	Jan 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+19C>G	TSC2		Tuberous sclerosis 2	VCV003645413	16	2129689	16	2079688	3645413	3783828		NC_000016.10:2079687:C:G	single nucleotide variant	intron variant	Likely benign	Mar 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+19C>T	TSC2		Tuberous sclerosis 2	VCV002906687	16	2129689	16	2079688	2906687	3069584	rs1596386724	NC_000016.10:2079687:C:T	single nucleotide variant	intron variant	Likely benign	May 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+19C>A	TSC2		Tuberous sclerosis 2	VCV002181222	16	2129689	16	2079688	2181222	1920323	rs1596386724	NC_000016.10:2079687:C:A	single nucleotide variant	intron variant	Likely benign	Jan 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+20A>G	TSC2		Tuberous sclerosis 2	VCV001615270	16	2129690	16	2079689	1615270	1579137	rs376079104	NC_000016.10:2079688:A:G	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+20A>C	TSC2		Tuberous sclerosis 2	VCV001578114	16	2129690	16	2079689	1578114	1587582	rs376079104	NC_000016.10:2079688:A:C	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+56C>T	TSC2		not provided	VCV001204613	16	2129726	16	2079725	1204613	1195031	rs533389245	NC_000016.10:2079724:C:T	single nucleotide variant	intron variant	Likely benign	Jul 8, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+126C>T	TSC2		not provided	VCV000677254	16	2129796	16	2079795	677254	667413	rs115243225	NC_000016.10:2079794:C:T	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3397+161G>A	TSC2		not provided	VCV001189351	16	2129831	16	2079830	1189351	1181347	rs191264187	NC_000016.10:2079829:G:A	single nucleotide variant	intron variant	Likely benign	Jun 26, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-140C>T	TSC2		not provided	VCV000674435	16	2130026	16	2080025	674435	668710	rs56725934	NC_000016.10:2080024:C:T	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-19C>T	TSC2		Tuberous sclerosis 2	VCV001541462	16	2130147	16	2080146	1541462	1631345	rs969734217	NC_000016.10:2080145:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-18C>G	TSC2		Tuberous sclerosis 2	VCV001674660	16	2130148	16	2080147	1674660	1532666	rs772159760	NC_000016.10:2080146:C:G	single nucleotide variant	intron variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-18C>T	TSC2		Tuberous sclerosis 2	VCV001564708	16	2130148	16	2080147	1564708	1567662	rs772159760	NC_000016.10:2080146:C:T	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-17T>C	TSC2		Tuberous sclerosis 2	VCV002831219	16	2130149	16	2080148	2831219	2991020	rs2544089999	NC_000016.10:2080147:T:C	single nucleotide variant	intron variant	Likely benign	Jan 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-16C>T	TSC2		Tuberous sclerosis 2	VCV002082153	16	2130150	16	2080149	2082153	2136107	rs1231192960	NC_000016.10:2080148:C:T	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-14G>C	TSC2		Tuberous sclerosis 2	VCV003727520	16	2130152	16	2080151	3727520	3861745		NC_000016.10:2080150:G:C	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-14G>A	TSC2		Tuberous sclerosis 2	VCV001994988	16	2130152	16	2080151	1994988	2053354	rs773246388	NC_000016.10:2080150:G:A	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-13C>T	TSC2		Tuberous sclerosis 2	VCV003624884	16	2130153	16	2080152	3624884	3758022		NC_000016.10:2080151:C:T	single nucleotide variant	intron variant	Likely benign	May 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-12C>A	TSC2		Tuberous sclerosis 2	VCV002743651	16	2130154	16	2080153	2743651	2907004	rs2151455240	NC_000016.10:2080152:C:A	single nucleotide variant	intron variant	Likely benign	Jul 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-12C>T	TSC2		Tuberous sclerosis 2	VCV001459646	16	2130154	16	2080153	1459646	1484834	rs2151455240	NC_000016.10:2080152:C:T	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-11C>T	TSC2		Tuberous sclerosis 2	VCV001596517	16	2130155	16	2080154	1596517	1633600	rs1567503013	NC_000016.10:2080153:C:T	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-10T>G	TSC2		Tuberous sclerosis 2	VCV001152441	16	2130156	16	2080155	1152441	1145955	rs137854369	NC_000016.10:2080154:T:G	single nucleotide variant	intron variant	Likely benign	Mar 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-9C>G	TSC2		Tuberous sclerosis 2	VCV002034751	16	2130157	16	2080156	2034751	2090099	rs555194713	NC_000016.10:2080155:C:G	single nucleotide variant	intron variant	Likely benign	Oct 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-9C>T	TSC2		Tuberous sclerosis 2	VCV000468011	16	2130157	16	2080156	468011	465315	rs555194713	NC_000016.10:2080155:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-8T>G	TSC2		Tuberous sclerosis 2	VCV001953172	16	2130158	16	2080157	1953172	2014606	rs2089951021	NC_000016.10:2080156:T:G	single nucleotide variant	intron variant	Likely benign	Jun 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-6C>G	TSC2		Tuberous sclerosis 2	VCV001097245	16	2130160	16	2080159	1097245	1081835	rs1555511284	NC_000016.10:2080158:C:G	single nucleotide variant	intron variant	Likely benign	Sep 8, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-6C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000536029	16	2130160	16	2080159	536029	530212	rs1555511284	NC_000016.10:2080158:C:T	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-3C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000863048	16	2130163	16	2080162	863048	852099	rs2089951550	NC_000016.10:2080161:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3398-2A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001066677	16	2130164	16	2080163	1066677	1056296	rs2151455445	NC_000016.10:2080162:A:G	single nucleotide variant	splice acceptor variant	Conflicting classifications of pathogenicity	Feb 2, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3398-1G>C	TSC2		Tuberous sclerosis 2	VCV002114065	16	2130165	16	2080164	2114065	2171960	rs45517293	NC_000016.10:2080163:G:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Mar 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398-1G>A	TSC2		Hereditary cancer-predisposing syndrome	VCV000049871	16	2130165	16	2080164	49871	59033	rs45517293	NC_000016.10:2080163:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Nov 1, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3398G>A (p.Gly1133Glu)	TSC2	G1133E, G1100E, G1090E, G1053E, G889E, G1041E, G1089E	Tuberous sclerosis 2	VCV000535902	16	2130166	16	2080165	535902	529626	rs1208166840	NC_000016.10:2080164:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3399G>A (p.Gly1133=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001537204	16	2130167	16	2080166	1537204	1596797	rs2151455530	NC_000016.10:2080165:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3400G>A (p.Gly1134Ser)	TSC2	G1042S, G1054S, G1090S, G1091S, G1101S, G1134S, G890S	not provided|Tuberous sclerosis 2	VCV001679486	16	2130168	16	2080167	1679486	1671406	rs2089952201	NC_000016.10:2080166:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3400G>T (p.Gly1134Cys)	TSC2	G1054C, G1042C, G1090C, G1091C, G1101C, G1134C, G890C	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001415828	16	2130168	16	2080167	1415828	1371456	rs2089952201	NC_000016.10:2080166:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3401G>C (p.Gly1134Ala)	TSC2	G1042A, G1054A, G1090A, G1091A, G1101A, G1134A, G890A	Tuberous sclerosis 2	VCV001022888	16	2130169	16	2080168	1022888	1011979	rs766223343	NC_000016.10:2080167:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3401G>A (p.Gly1134Asp)	TSC2	G1134D, G890D, G1042D, G1091D, G1054D, G1101D, G1090D	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000572797	16	2130169	16	2080168	572797	569769	rs766223343	NC_000016.10:2080167:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3402C>T (p.Gly1134=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001634047	16	2130170	16	2080169	1634047	1632135	rs973994676	NC_000016.10:2080168:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3403C>A (p.His1135Asn)	TSC2	H1072N, H1091N, H1121N, H1122N, H1134N, H1135N, H644N, H687N, H1055N, H1098N, H1102N, H643N, H892N, H1087N, H1092N, H557N, H891N, H1042N, H1043N, H1054N, H1085N, H1086N, H1088N, H934N, H935N, H938N	Tuberous sclerosis 2	VCV002832596	16	2130171	16	2080170	2832596	2994980	rs2151455693	NC_000016.10:2080169:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3403C>G (p.His1135Asp)	TSC2	H1043D, H1054D, H1087D, H1102D, H1135D, H643D, H644D, H934D, H935D, H1042D, H1088D, H1092D, H1098D, H1121D, H557D, H938D, H1055D, H1072D, H1085D, H1086D, H1122D, H687D, H1091D, H1134D, H891D, H892D	Hereditary cancer-predisposing syndrome	VCV001731096	16	2130171	16	2080170	1731096	1795470	rs2151455693	NC_000016.10:2080169:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3403C>T (p.His1135Tyr)	TSC2	H1135Y, H1043Y, H1055Y, H1102Y, H891Y, H1091Y, H1092Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001442116	16	2130171	16	2080170	1442116	1474981	rs2151455693	NC_000016.10:2080169:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3404A>G (p.His1135Arg)	TSC2	H1135R, H1102R, H1043R, H1055R, H1091R, H891R, H1092R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535851	16	2130172	16	2080171	535851	530215	rs1309968292	NC_000016.10:2080170:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3405T>A (p.His1135Gln)	TSC2	H1091Q, H687Q, H1087Q, H1102Q, H1134Q, H644Q, H1043Q, H1055Q, H1072Q, H1085Q, H1086Q, H1042Q, H1054Q, H1122Q, H557Q, H891Q, H934Q, H935Q, H1088Q, H1092Q, H1098Q, H1121Q, H1135Q, H643Q, H892Q, H938Q	Tuberous sclerosis 2	VCV002820225	16	2130173	16	2080172	2820225	2985156	rs2544091262	NC_000016.10:2080171:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3406G>C (p.Gly1136Arg)	TSC2	G1092R, G1093R, G1103R, G644R, G936R, G939R, G1056R, G1073R, G1087R, G1122R, G1136R, G935R, G1043R, G1088R, G1135R, G645R, G893R, G1044R, G1055R, G1086R, G1089R, G1099R, G1123R, G558R, G688R, G892R	Tuberous sclerosis 2	VCV002119164	16	2130174	16	2080173	2119164	2183511	rs2089953185	NC_000016.10:2080172:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3406G>A (p.Gly1136Ser)	TSC2	G1044S, G1056S, G1092S, G1093S, G1103S, G1136S, G892S	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001019343	16	2130174	16	2080173	1019343	1011980	rs2089953185	NC_000016.10:2080172:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3409C>G (p.Leu1137Val)	TSC2	L1045V, L1088V, L1094V, L1104V, L559V, L646V, L689V, L940V, L1044V, L1057V, L1100V, L1123V, L1124V, L1056V, L1089V, L1093V, L1137V, L893V, L894V, L1074V, L1087V, L1090V, L1136V, L645V, L936V, L937V	Tuberous sclerosis 2	VCV002808554	16	2130177	16	2080176	2808554	2968356	rs2544091396	NC_000016.10:2080175:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3411T>G (p.Leu1137=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000233971	16	2130179	16	2080178	233971	235124	rs876660766	NC_000016.10:2080177:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3412C>T (p.Arg1138Ter)	TSC2	R1138*, R1094*, R1095*, R894*, R1105*, R1046*, R1058*	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000049257	16	2130180	16	2080179	49257	58419	rs45451497	NC_000016.10:2080178:C:T	single nucleotide variant	nonsense	Pathogenic	Mar 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3413G>C (p.Arg1138Pro)	TSC2	R1138P, R894P, R1058P, R1046P, R1094P, R1095P, R1105P	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486643	16	2130181	16	2080180	486643	477391	rs143168379	NC_000016.10:2080179:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3413G>T (p.Arg1138Leu)	TSC2	R1138L, R1058L, R894L, R1046L, R1094L, R1095L, R1105L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468012	16	2130181	16	2080180	468012	466214	rs143168379	NC_000016.10:2080179:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3413G>A (p.Arg1138Gln)	TSC2	R1138Q, R1046Q, R1094Q, R1105Q, R894Q, R1058Q, R1095Q	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135381	16	2130181	16	2080180	135381	139120	rs143168379	NC_000016.10:2080179:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3414A>T (p.Arg1138=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462668	16	2130182	16	2080181	3462668	3621687		NC_000016.10:2080180:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3415G>T (p.Val1139Phe)	TSC2	V1046F, V1047F, V1058F, V1059F, V1076F, V1089F, V1090F, V1091F, V1092F, V1095F, V1096F, V1102F, V1106F, V1125F, V1126F, V1138F, V1139F, V561F, V647F, V648F, V691F, V895F, V896F, V938F, V939F, V942F	Hereditary cancer-predisposing syndrome	VCV003232144	16	2130183	16	2080182	3232144	3391945	rs759174655	NC_000016.10:2080181:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3415G>C (p.Val1139Leu)	TSC2	V1047L, V1106L, V1059L, V1095L, V1139L, V1096L, V895L	Tuberous sclerosis 2	VCV000861515	16	2130183	16	2080182	861515	843457	rs759174655	NC_000016.10:2080181:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3415G>A (p.Val1139Ile)	TSC2	V1139I, V1095I, V1106I, V1047I, V1059I, V1096I, V895I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000468013	16	2130183	16	2080182	468013	466002	rs759174655	NC_000016.10:2080181:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 21, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3416T>C (p.Val1139Ala)	TSC2	V1047A, V1059A, V1096A, V1095A, V1139A, V895A, V1106A	Tuberous sclerosis 2	VCV000847293	16	2130184	16	2080183	847293	843458	rs2089954332	NC_000016.10:2080182:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3417T>C (p.Val1139=)	TSC2		Tuberous sclerosis 2	VCV002831814	16	2130185	16	2080184	2831814	2998028	rs2544091914	NC_000016.10:2080183:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3419G>T (p.Gly1140Val)	TSC2	G1107V, G1140V, G896V, G1048V, G1097V, G1060V, G1096V	Tuberous sclerosis 2	VCV001346702	16	2130187	16	2080186	1346702	1456664	rs2089954788	NC_000016.10:2080185:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3419G>A (p.Gly1140Asp)	TSC2	G1048D, G1060D, G1096D, G1097D, G1107D, G1140D, G896D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001001529	16	2130187	16	2080186	1001529	996740	rs2089954788	NC_000016.10:2080185:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3420C>G (p.Gly1140=)	TSC2		Tuberous sclerosis 2	VCV003009147	16	2130188	16	2080187	3009147	3159153	rs373968155	NC_000016.10:2080186:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3420C>T (p.Gly1140=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000380719	16	2130188	16	2080187	380719	374118	rs373968155	NC_000016.10:2080186:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3421G>A (p.Ala1141Thr)	TSC2	A1141T, A1097T, A1098T, A1108T, A897T, A1049T, A1061T	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000049258	16	2130189	16	2080188	49258	58420	rs45505895	NC_000016.10:2080187:G:A	single nucleotide variant	missense variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3422C>G (p.Ala1141Gly)	TSC2	A1078G, A1091G, A1092G, A1098G, A1127G, A1141G, A650G, A941G, A1049G, A1094G, A649G, A940G, A944G, A1060G, A1104G, A1140G, A898G, A1048G, A1061G, A1093G, A1097G, A1108G, A1128G, A563G, A693G, A897G	Tuberous sclerosis 2	VCV002792741	16	2130190	16	2080189	2792741	2953873	rs34870424	NC_000016.10:2080188:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3422C>T (p.Ala1141Val)	TSC2	A1141V, A1049V, A1061V, A1108V, A1097V, A1098V, A897V	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000049551	16	2130190	16	2080189	49551	58713	rs34870424	NC_000016.10:2080188:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3423C>T (p.Ala1141=)	TSC2		Tuberous sclerosis 2	VCV004071120	16	2130191	16	2080190	4071120	4184968		NC_000016.10:2080189:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3423C>A (p.Ala1141=)	TSC2		Tuberous sclerosis 2	VCV003647317	16	2130191	16	2080190	3647317	3780610		NC_000016.10:2080189:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3424C>G (p.Leu1142Val)	TSC2	L1050V, L1062V, L1098V, L1099V, L1109V, L1142V, L898V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001003261	16	2130192	16	2080191	1003261	996741	rs1060504111	NC_000016.10:2080190:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3424C>T (p.Leu1142=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413720	16	2130192	16	2080191	413720	401575	rs1060504111	NC_000016.10:2080190:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3425T>C (p.Leu1142Pro)	TSC2	L1142P, L1050P, L1062P, L1098P, L1099P, L1109P, L898P	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000207784	16	2130193	16	2080192	207784	203168	rs796053513	NC_000016.10:2080191:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3426G>A (p.Leu1142=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974686	16	2130194	16	2080193	3974686	4086509		NC_000016.10:2080192:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3428A>G (p.Asp1143Gly)	TSC2	D1063G, D1099G, D1110G, D1143G, D899G, D1100G, D1051G	Tuberous sclerosis 2	VCV001477412	16	2130196	16	2080195	1477412	1413596	rs796053495	NC_000016.10:2080194:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3428A>T (p.Asp1143Val)	TSC2	D1143V, D1099V, D1051V, D1100V, D1110V, D1063V, D899V	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000207745	16	2130196	16	2080195	207745	203169	rs796053495	NC_000016.10:2080194:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3429C>G (p.Asp1143Glu)	TSC2	D1051E, D1095E, D1096E, D565E, D946E, D1050E, D1063E, D1094E, D1129E, D1142E, D652E, D943E, D1062E, D1080E, D1093E, D1100E, D1106E, D1130E, D1143E, D695E, D1099E, D1110E, D651E, D899E, D900E, D942E	Tuberous sclerosis 2	VCV002013872	16	2130197	16	2080196	2013872	2067955	rs45487691	NC_000016.10:2080195:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3429C>T (p.Asp1143=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049553	16	2130197	16	2080196	49553	58715	rs45487691	NC_000016.10:2080195:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3430G>C (p.Val1144Leu)	TSC2	V1063L, V1100L, V1111L, V1144L, V566L, V653L, V1052L, V1081L, V1107L, V1051L, V1064L, V1094L, V1095L, V1097L, V1101L, V1143L, V696L, V944L, V947L, V1096L, V1130L, V1131L, V652L, V900L, V901L, V943L	Tuberous sclerosis 2	VCV002095096	16	2130198	16	2080197	2095096	2156880	rs45517294	NC_000016.10:2080196:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3430G>T (p.Val1144Leu)	TSC2	V1144L, V1111L, V1100L, V900L, V1052L, V1064L, V1101L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049259	16	2130198	16	2080197	49259	58421	rs45517294	NC_000016.10:2080196:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3430G>A (p.Val1144Met)	TSC2	V1144M, V1064M, V1101M, V1100M, V1052M, V1111M, V900M	not provided|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000041733	16	2130198	16	2080197	41733	50172	rs45517294	NC_000016.10:2080196:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3431T>C (p.Val1144Ala)	TSC2	V1051A, V1095A, V1100A, V1130A, V653A, V696A, V900A, V943A, V1063A, V1064A, V1101A, V1107A, V1111A, V1143A, V566A, V1052A, V1081A, V1096A, V1131A, V652A, V1094A, V1097A, V1144A, V901A, V944A, V947A	Tuberous sclerosis 2	VCV002076000	16	2130199	16	2080198	2076000	2141672	rs2151456551	NC_000016.10:2080197:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3432G>A (p.Val1144=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001731393	16	2130200	16	2080199	1731393	1795766	rs564724053	NC_000016.10:2080198:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3432G>T (p.Val1144=)	TSC2		Tuberous sclerosis 2	VCV001137228	16	2130200	16	2080199	1137228	1125071	rs564724053	NC_000016.10:2080198:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3433C>G (p.Pro1145Ala)	TSC2	P1065A, P1102A, P654A, P697A, P1064A, P1095A, P1096A, P1098A, P1108A, P1132A, P653A, P1131A, P1145A, P567A, P901A, P902A, P945A, P1052A, P1053A, P1082A, P1097A, P1101A, P1112A, P1144A, P944A, P948A	Tuberous sclerosis 2	VCV003637220	16	2130201	16	2080200	3637220	3771374		NC_000016.10:2080199:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3434C>T (p.Pro1145Leu)	TSC2	P1145L, P1065L, P1053L, P1102L, P1101L, P1112L, P901L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|not specified	VCV000065221	16	2130202	16	2080201	65221	76153	rs397515162	NC_000016.10:2080200:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3435G>T (p.Pro1145=)	TSC2		Tuberous sclerosis 2	VCV000795361	16	2130203	16	2080202	795361	785200	rs749633483	NC_000016.10:2080201:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3435G>A (p.Pro1145=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided	VCV000468015	16	2130203	16	2080202	468015	466003	rs749633483	NC_000016.10:2080201:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3437C>T (p.Ala1146Val)	TSC2	A1066V, A1103V, A1146V, A1113V, A1054V, A1102V, A902V	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001429990	16	2130205	16	2080204	1429990	1392912	rs2089957253	NC_000016.10:2080203:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3438C>T (p.Ala1146=)	TSC2		Tuberous sclerosis 2	VCV001572232	16	2130206	16	2080205	1572232	1538301	rs755204133	NC_000016.10:2080204:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3440C>A (p.Ser1147Tyr)	TSC2	S1103Y, S1104Y, S903Y, S1055Y, S1067Y, S1114Y, S1147Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000836752	16	2130208	16	2080207	836752	843459	rs779149155	NC_000016.10:2080206:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3440C>T (p.Ser1147Phe)	TSC2	S1147F, S1067F, S1055F, S1103F, S1114F, S1104F, S903F	Tuberous sclerosis 2	VCV000577449	16	2130208	16	2080207	577449	567826	rs779149155	NC_000016.10:2080206:C:T	single nucleotide variant	missense variant	Benign	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3441C>T (p.Ser1147=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002129174	16	2130209	16	2080208	2129174	2175423	rs2544093501	NC_000016.10:2080207:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3442C>G (p.Gln1148Glu)	TSC2	Q1101E, Q1104E, Q1135E, Q656E, Q947E, Q951E, Q1056E, Q1067E, Q1068E, Q1111E, Q1115E, Q1148E, Q570E, Q1055E, Q1085E, Q1099E, Q1105E, Q1134E, Q1147E, Q657E, Q700E, Q904E, Q905E, Q1098E, Q1100E, Q948E	Tuberous sclerosis 2|not provided	VCV001969171	16	2130210	16	2080209	1969171	2025309	rs45477491	NC_000016.10:2080208:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3442C>A (p.Gln1148Lys)	TSC2	Q1056K, Q1068K, Q1104K, Q1105K, Q1115K, Q1148K, Q904K	Tuberous sclerosis 2	VCV001019197	16	2130210	16	2080209	1019197	1011981	rs45477491	NC_000016.10:2080208:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3442C>T (p.Gln1148Ter)	TSC2	Q1148*, Q1056*, Q1068*, Q1105*, Q1104*, Q1115*, Q904*	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided	VCV000050087	16	2130210	16	2080209	50087	59249	rs45477491	NC_000016.10:2080208:C:T	single nucleotide variant	nonsense	Pathogenic	Jun 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3443A>T (p.Gln1148Leu)	TSC2	Q1068L, Q1098L, Q1104L, Q1111L, Q570L, Q657L, Q948L, Q1099L, Q1134L, Q904L, Q905L, Q947L, Q1055L, Q1101L, Q1115L, Q1135L, Q1148L, Q700L, Q1056L, Q1067L, Q1085L, Q1100L, Q1105L, Q1147L, Q656L, Q951L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003022288	16	2130211	16	2080210	3022288	3179889	rs1217539900	NC_000016.10:2080209:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3443A>G (p.Gln1148Arg)	TSC2	Q1055R, Q1056R, Q1104R, Q1115R, Q1147R, Q1148R, Q904R, Q905R, Q948R, Q1099R, Q1134R, Q656R, Q1067R, Q1068R, Q1098R, Q1100R, Q1135R, Q570R, Q1085R, Q1101R, Q1105R, Q1111R, Q657R, Q700R, Q947R, Q951R	Tuberous sclerosis 2	VCV002072370	16	2130211	16	2080210	2072370	2120310	rs1217539900	NC_000016.10:2080209:A:G	single nucleotide variant	missense variant	Benign	Jul 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3443A>C (p.Gln1148Pro)	TSC2	Q1148P, Q1056P, Q1068P, Q1115P, Q1104P, Q1105P, Q904P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000589043	16	2130211	16	2080210	589043	580270	rs1217539900	NC_000016.10:2080209:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3447C>G (p.Phe1149Leu)	TSC2	F1069L, F1105L, F905L, F1057L, F1106L, F1116L, F1149L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001417090	16	2130215	16	2080214	1417090	1377458	rs1265832990	NC_000016.10:2080213:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3447C>T (p.Phe1149=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000739795	16	2130215	16	2080214	739795	754998	rs1265832990	NC_000016.10:2080213:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3447C>A (p.Phe1149Leu)	TSC2	F1149L, F1057L, F1069L, F1116L, F1105L, F1106L, F905L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486703	16	2130215	16	2080214	486703	477483	rs1265832990	NC_000016.10:2080213:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3448C>G (p.Leu1150Val)	TSC2	L1058V, L1070V, L1106V, L1107V, L1117V, L1150V, L906V	Tuberous sclerosis 2	VCV001000464	16	2130216	16	2080215	1000464	996742	rs1060504121	NC_000016.10:2080214:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3448C>T (p.Leu1150=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413747	16	2130216	16	2080215	413747	401576	rs1060504121	NC_000016.10:2080214:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3449T>A (p.Leu1150Gln)	TSC2	L1058Q, L1070Q, L1100Q, L1102Q, L1113Q, L572Q, L658Q, L906Q, L949Q, L953Q, L1057Q, L1101Q, L1150Q, L702Q, L1087Q, L1106Q, L1107Q, L1136Q, L659Q, L1069Q, L1103Q, L1117Q, L1137Q, L1149Q, L907Q, L950Q	Hereditary cancer-predisposing syndrome	VCV001731529	16	2130217	16	2080216	1731529	1792434	rs2544094229	NC_000016.10:2080215:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3450G>T (p.Leu1150=)	TSC2		Tuberous sclerosis 2	VCV003634916	16	2130218	16	2080217	3634916	3773802		NC_000016.10:2080216:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3450G>A (p.Leu1150=)	TSC2		Tuberous sclerosis 2	VCV002858118	16	2130218	16	2080217	2858118	3018164	rs2151457176	NC_000016.10:2080216:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3450G>C (p.Leu1150=)	TSC2		Tuberous sclerosis 2	VCV001091261	16	2130218	16	2080217	1091261	1081836	rs2151457176	NC_000016.10:2080216:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3453C>A (p.Gly1151=)	TSC2		Tuberous sclerosis 2	VCV001149040	16	2130221	16	2080220	1149040	1145956	rs1596389809	NC_000016.10:2080219:C:A	single nucleotide variant	synonymous variant	Likely benign	May 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3453C>T (p.Gly1151=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000708995	16	2130221	16	2080220	708995	726493	rs1596389809	NC_000016.10:2080219:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3454A>G (p.Ser1152Gly)	TSC2	S1060G, S1072G, S1108G, S1109G, S1119G, S1152G, S908G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV001305393	16	2130222	16	2080221	1305393	1295668	rs772215032	NC_000016.10:2080220:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3454A>C (p.Ser1152Arg)	TSC2	S1152R, S1060R, S1108R, S1109R, S1119R, S908R, S1072R	not specified|Tuberous sclerosis 2	VCV000373567	16	2130222	16	2080221	373567	360245	rs772215032	NC_000016.10:2080220:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3455G>T (p.Ser1152Ile)	TSC2	S1071I, S1089I, S1102I, S1104I, S1138I, S1139I, S660I, S909I, S952I, S1072I, S1109I, S1115I, S1152I, S951I, S955I, S1103I, S1105I, S1108I, S1151I, S574I, S704I, S908I, S1059I, S1060I, S1119I, S661I	Tuberous sclerosis 2	VCV001975290	16	2130223	16	2080222	1975290	2026697	rs2089960768	NC_000016.10:2080221:G:T	single nucleotide variant	missense variant	Uncertain significance	May 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3455G>A (p.Ser1152Asn)	TSC2	S1152N, S1109N, S908N, S1108N, S1060N, S1072N, S1119N	Tuberous sclerosis 2	VCV001046268	16	2130223	16	2080222	1046268	1032471	rs2089960768	NC_000016.10:2080221:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3456T>C (p.Ser1152=)	TSC2		Tuberous sclerosis 2	VCV002120985	16	2130224	16	2080223	2120985	2184037	rs2151457466	NC_000016.10:2080222:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3457G>A (p.Ala1153Thr)	TSC2	A1073T, A1109T, A1153T, A1061T, A1110T, A1120T, A909T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000947319	16	2130225	16	2080224	947319	927662	rs1352230225	NC_000016.10:2080223:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3458C>T (p.Ala1153Val)	TSC2	A1073V, A1103V, A1104V, A1106V, A1116V, A1120V, A661V, A662V, A705V, A953V, A956V, A1061V, A1090V, A1105V, A1139V, A1152V, A1109V, A1140V, A1153V, A952V, A1060V, A1072V, A1110V, A575V, A909V, A910V	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002723932	16	2130226	16	2080225	2723932	2881844	rs2151457521	NC_000016.10:2080224:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3459C>T (p.Ala1153=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV002955087	16	2130227	16	2080226	2955087	3124991	rs1596389837	NC_000016.10:2080225:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3459C>G (p.Ala1153=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000797172	16	2130227	16	2080226	797172	785201	rs1596389837	NC_000016.10:2080225:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3460A>G (p.Thr1154Ala)	TSC2	T1062A, T1074A, T1110A, T1111A, T1121A, T1154A, T910A	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001052160	16	2130228	16	2080227	1052160	1049464	rs1266509754	NC_000016.10:2080226:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3460A>T (p.Thr1154Ser)	TSC2	T1074S, T1110S, T1154S, T910S, T1062S, T1111S, T1121S	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001044555	16	2130228	16	2080227	1044555	1032472	rs1266509754	NC_000016.10:2080226:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3460A>C (p.Thr1154Pro)	TSC2	T1062P, T1074P, T1110P, T1111P, T1121P, T1154P, T910P	Tuberous sclerosis 2	VCV001022153	16	2130228	16	2080227	1022153	1011982	rs1266509754	NC_000016.10:2080226:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3461C>T (p.Thr1154Ile)	TSC2	T1062I, T1074I, T1110I, T1111I, T1121I, T1154I, T910I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001051428	16	2130229	16	2080228	1051428	1049465	rs377137483	NC_000016.10:2080227:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3461C>G (p.Thr1154Ser)	TSC2	T1062S, T1110S, T1074S, T1121S, T910S, T1111S, T1154S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000642808	16	2130229	16	2080228	642808	644284	rs377137483	NC_000016.10:2080227:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3464C>T (p.Ser1155Phe)	TSC2	S1155F, S1112F, S1122F, S1111F, S1063F, S911F, S1075F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000406051	16	2130232	16	2080231	406051	400927	rs1060500948	NC_000016.10:2080230:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3465T>A (p.Ser1155=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002902141	16	2130233	16	2080232	2902141	3061188	rs747004487	NC_000016.10:2080231:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3466C>T (p.Pro1156Ser)	TSC2	P1106S, P1112S, P1113S, P1123S, P1156S, P708S, P912S, P956S, P959S, P1109S, P1155S, P578S, P664S, P1075S, P1093S, P1107S, P1119S, P913S, P955S, P1063S, P1064S, P1076S, P1108S, P1142S, P1143S, P665S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002102756	16	2130234	16	2080233	2102756	2161816	rs2151457816	NC_000016.10:2080232:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3467C>T (p.Pro1156Leu)	TSC2	P1156L, P1113L, P1076L, P912L, P1123L, P1064L, P1112L	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535917	16	2130235	16	2080234	535917	529630	rs144126969	NC_000016.10:2080233:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3468A>G (p.Pro1156=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000380698	16	2130236	16	2080235	380698	374120	rs147242130	NC_000016.10:2080234:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3469G>A (p.Gly1157Arg)	TSC2	G1157R, G913R, G1065R, G1113R, G1077R, G1124R, G1114R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486665	16	2130237	16	2080236	486665	477486	rs1555511390	NC_000016.10:2080235:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3470G>A (p.Gly1157Glu)	TSC2	G1077E, G1107E, G1109E, G1114E, G1157E, G579E, G914E, G960E, G1064E, G1108E, G1113E, G1143E, G957E, G1124E, G1144E, G709E, G956E, G1065E, G1076E, G1094E, G1110E, G1120E, G1156E, G665E, G666E, G913E	Tuberous sclerosis 2	VCV002876793	16	2130238	16	2080237	2876793	3032898	rs1477039147	NC_000016.10:2080236:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3470G>C (p.Gly1157Ala)	TSC2	G1065A, G1157A, G913A, G1077A, G1114A, G1124A, G1113A	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000648676	16	2130238	16	2080237	648676	644285	rs1477039147	NC_000016.10:2080236:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3471A>G (p.Gly1157=)	TSC2		Tuberous sclerosis 2	VCV001643219	16	2130239	16	2080238	1643219	1587177	rs1192862238	NC_000016.10:2080237:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3472C>A (p.Pro1158Thr)	TSC2	P1114T, P1115T, P1125T, P1158T, P914T, P1066T, P1078T	Tuberous sclerosis 2	VCV000643697	16	2130240	16	2080239	643697	644286	rs759350468	NC_000016.10:2080238:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3472C>T (p.Pro1158Ser)	TSC2	P1158S, P1078S, P1114S, P914S, P1115S, P1066S, P1125S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535966	16	2130240	16	2080239	535966	530218	rs759350468	NC_000016.10:2080238:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3472C>G (p.Pro1158Ala)	TSC2	P1158A, P1125A, P1066A, P1114A, P914A, P1078A, P1115A	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000390104	16	2130240	16	2080239	390104	374788	rs759350468	NC_000016.10:2080238:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3473C>T (p.Pro1158Leu)	TSC2	P1065L, P1115L, P1145L, P1078L, P1108L, P1109L, P1111L, P1121L, P1157L, P580L, P667L, P915L, P957L, P1095L, P1110L, P1125L, P1158L, P958L, P1066L, P1077L, P1114L, P1144L, P666L, P710L, P914L, P961L	Tuberous sclerosis 2	VCV002100663	16	2130241	16	2080240	2100663	2154679	rs992338076	NC_000016.10:2080239:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3473C>A (p.Pro1158Gln)	TSC2	P1110Q, P1115Q, P710Q, P914Q, P961Q, P1078Q, P1108Q, P1109Q, P1111Q, P1121Q, P1145Q, P1157Q, P666Q, P915Q, P958Q, P1077Q, P1114Q, P1144Q, P1158Q, P580Q, P667Q, P957Q, P1065Q, P1066Q, P1095Q, P1125Q	Hereditary cancer-predisposing syndrome	VCV001731757	16	2130241	16	2080240	1731757	1792661	rs992338076	NC_000016.10:2080239:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3473C>G (p.Pro1158Arg)	TSC2	P1066R, P1115R, P1125R, P1078R, P1114R, P1158R, P914R	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000658181	16	2130241	16	2080240	658181	644287	rs992338076	NC_000016.10:2080239:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3474A>G (p.Pro1158=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003000408	16	2130242	16	2080241	3000408	3156879	rs764816862	NC_000016.10:2080240:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3475C>T (p.Arg1159Trp)	TSC2	R1159W, R1079W, R915W, R1126W, R1067W, R1115W, R1116W	not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049754	16	2130243	16	2080242	49754	58916	rs45517295	NC_000016.10:2080241:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3476G>T (p.Arg1159Leu)	TSC2	R1159L, R1126L, R915L, R1067L, R1079L, R1115L, R1116L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000050089	16	2130244	16	2080243	50089	59251	rs45473098	NC_000016.10:2080242:G:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3476G>A (p.Arg1159Gln)	TSC2	R1159Q, R1079Q, R1126Q, R1115Q, R1116Q, R915Q, R1067Q	Hereditary cancer-predisposing syndrome|not specified|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis 2	VCV000049755	16	2130244	16	2080243	49755	58917	rs45473098	NC_000016.10:2080242:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3479C>G (p.Thr1160Ser)	TSC2	T1068S, T1080S, T1116S, T1117S, T1127S, T1160S, T916S	Hereditary cancer-predisposing syndrome	VCV001692494	16	2130247	16	2080246	1692494	1684934	rs2151458293	NC_000016.10:2080245:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3480T>C (p.Thr1160=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000795344	16	2130248	16	2080247	795344	785202	rs766888262	NC_000016.10:2080246:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3480T>G (p.Thr1160=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536069	16	2130248	16	2080247	536069	529636	rs766888262	NC_000016.10:2080246:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3481G>A (p.Ala1161Thr)	TSC2	A1117T, A1161T, A1069T, A1118T, A1081T, A1128T, A917T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000823823	16	2130249	16	2080248	823823	812574	rs754177014	NC_000016.10:2080247:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3482C>T (p.Ala1161Val)	TSC2	A1161V, A1069V, A1117V, A1128V, A917V, A1118V, A1081V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000064875	16	2130250	16	2080249	64875	75804	rs397514901	NC_000016.10:2080248:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3483A>T (p.Ala1161=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002126970	16	2130251	16	2080250	2126970	2178283	rs748326601	NC_000016.10:2080249:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3483A>G (p.Ala1161=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001731860	16	2130251	16	2080250	1731860	1792763	rs748326601	NC_000016.10:2080249:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3484C>G (p.Pro1162Ala)	TSC2	P1162A, P1118A, P1119A, P918A, P1082A, P1070A, P1129A	Tuberous sclerosis 2	VCV000566466	16	2130252	16	2080251	566466	569773	rs895935495	NC_000016.10:2080250:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3484C>T (p.Pro1162Ser)	TSC2	P1162S, P1070S, P1119S, P1082S, P1118S, P1129S, P918S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000406071	16	2130252	16	2080251	406071	400933	rs895935495	NC_000016.10:2080250:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3485C>G (p.Pro1162Arg)	TSC2	P1069R, P1081R, P1112R, P1115R, P1119R, P1162R, P962R, P1114R, P1118R, P1148R, P1149R, P584R, P671R, P919R, P961R, P1099R, P1113R, P1125R, P670R, P714R, P1070R, P1082R, P1129R, P1161R, P918R, P965R	Tuberous sclerosis 2	VCV003013557	16	2130253	16	2080252	3013557	3177694	rs778069675	NC_000016.10:2080251:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3485C>T (p.Pro1162Leu)	TSC2	P1162L, P1082L, P1070L, P1118L, P1119L, P1129L, P918L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000450949	16	2130253	16	2080252	450949	445523	rs778069675	NC_000016.10:2080251:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3486A>G (p.Pro1162=)	TSC2		Tuberous sclerosis 2	VCV001611550	16	2130254	16	2080253	1611550	1552066	rs1277144134	NC_000016.10:2080252:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3486A>T (p.Pro1162=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000701348	16	2130254	16	2080253	701348	688542	rs1277144134	NC_000016.10:2080252:A:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3487G>C (p.Ala1163Pro)	TSC2	A1083P, A1119P, A1120P, A1071P, A1163P, A919P, A1130P	Tuberous sclerosis 2	VCV001384645	16	2130255	16	2080254	1384645	1348920	rs560522093	NC_000016.10:2080253:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3487G>T (p.Ala1163Ser)	TSC2	A1163S, A1119S, A1130S, A919S, A1071S, A1083S, A1120S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000565488	16	2130255	16	2080254	565488	570112	rs560522093	NC_000016.10:2080253:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3488C>G (p.Ala1163Gly)	TSC2	A1119G, A1071G, A1130G, A1163G, A919G, A1083G, A1120G	Tuberous sclerosis 2	VCV000943033	16	2130256	16	2080255	943033	937323	rs1596390123	NC_000016.10:2080254:C:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3488C>T (p.Ala1163Val)	TSC2	A1130V, A1163V, A1119V, A919V, A1071V, A1120V, A1083V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000942665	16	2130256	16	2080255	942665	937324	rs1596390123	NC_000016.10:2080254:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3488C>A (p.Ala1163Asp)	TSC2	A1119D, A1163D, A919D, A1083D, A1120D, A1071D, A1130D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000663690	16	2130256	16	2080255	663690	644288	rs1596390123	NC_000016.10:2080254:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3489C>T (p.Ala1163=)	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000381380	16	2130257	16	2080256	381380	374126	rs200346578	NC_000016.10:2080255:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3490G>T (p.Ala1164Ser)	TSC2	A1084S, A1120S, A1131S, A1164S, A1072S, A1121S, A920S	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000772079	16	2130258	16	2080257	772079	703553	rs776579875	NC_000016.10:2080256:G:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3490G>A (p.Ala1164Thr)	TSC2	A1164T, A1072T, A1131T, A1120T, A1121T, A1084T, A920T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000567746	16	2130258	16	2080257	567746	567830	rs776579875	NC_000016.10:2080256:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3491C>T (p.Ala1164Val)	TSC2	A1164V, A1072V, A1120V, A1121V, A1084V, A920V, A1131V	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000050090	16	2130259	16	2080258	50090	59252	rs45448801	NC_000016.10:2080257:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3492G>A (p.Ala1164=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome	VCV000318327	16	2130260	16	2080259	318327	324619	rs769562717	NC_000016.10:2080258:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3493A>C (p.Lys1165Gln)	TSC2	K1102Q, K1121Q, K1128Q, K1165Q, K964Q, K1085Q, K1122Q, K1151Q, K1152Q, K717Q, K965Q, K968Q, K1073Q, K1115Q, K1116Q, K1117Q, K1132Q, K1164Q, K587Q, K922Q, K1072Q, K1084Q, K1118Q, K673Q, K674Q, K921Q	Hereditary cancer-predisposing syndrome	VCV002626420	16	2130261	16	2080260	2626420	2794186	rs375444767	NC_000016.10:2080259:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3493A>G (p.Lys1165Glu)	TSC2	K1085E, K1121E, K1165E, K1073E, K1122E, K1132E, K921E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000823839	16	2130261	16	2080260	823839	812575	rs375444767	NC_000016.10:2080259:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3495A>G (p.Lys1165=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000707785	16	2130263	16	2080262	707785	693817	rs1555511443	NC_000016.10:2080261:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3495A>T (p.Lys1165Asn)	TSC2	K1165N, K1073N, K921N, K1085N, K1121N, K1122N, K1132N	Tuberous sclerosis 2	VCV000468018	16	2130263	16	2080262	468018	466220	rs1555511443	NC_000016.10:2080261:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3496C>G (p.Pro1166Ala)	TSC2	P1073A, P1123A, P1129A, P1153A, P674A, P922A, P969A, P1074A, P1119A, P588A, P675A, P923A, P1085A, P1103A, P1116A, P1117A, P1133A, P1152A, P965A, P1086A, P1118A, P1122A, P1165A, P1166A, P718A, P966A	Hereditary cancer-predisposing syndrome	VCV003811376	16	2130264	16	2080263	3811376	3928617		NC_000016.10:2080262:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3496C>T (p.Pro1166Ser)	TSC2	P1073S, P1103S, P1153S, P1085S, P1118S, P1119S, P1129S, P1165S, P1166S, P674S, P675S, P965S, P1122S, P1123S, P1152S, P588S, P966S, P1074S, P1086S, P1116S, P1117S, P1133S, P718S, P922S, P923S, P969S	Hereditary cancer-predisposing syndrome	VCV001731986	16	2130264	16	2080263	1731986	1789018	rs1265032446	NC_000016.10:2080262:C:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3496C>A (p.Pro1166Thr)	TSC2	P1116T, P1117T, P1123T, P1133T, P1153T, P966T, P1085T, P1119T, P965T, P1073T, P1086T, P1103T, P1118T, P1122T, P1152T, P1166T, P675T, P923T, P969T, P1074T, P1129T, P1165T, P588T, P674T, P718T, P922T	Hereditary cancer-predisposing syndrome	VCV001731984	16	2130264	16	2080263	1731984	1789016	rs1265032446	NC_000016.10:2080262:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3497C>G (p.Pro1166Arg)	TSC2	P1074R, P1086R, P1122R, P1123R, P1133R, P1166R, P922R	Tuberous sclerosis 2	VCV001062740	16	2130265	16	2080264	1062740	1049466	rs762650392	NC_000016.10:2080263:C:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3497C>T (p.Pro1166Leu)	TSC2	P1074L, P1122L, P1123L, P1166L, P922L, P1086L, P1133L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001042399	16	2130265	16	2080264	1042399	1032473	rs762650392	NC_000016.10:2080263:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3498T>C (p.Pro1166=)	TSC2		Tuberous sclerosis 2	VCV001132069	16	2130266	16	2080265	1132069	1125072	rs2151458951	NC_000016.10:2080264:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3501G>C (p.Glu1167Asp)	TSC2	E1087D, E1124D, E1123D, E1134D, E1167D, E923D, E1075D	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001370815	16	2130269	16	2080268	1370815	1430882	rs2151459095	NC_000016.10:2080267:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3502A>G (p.Lys1168Glu)	TSC2	K1088E, K1120E, K1125E, K1167E, K1168E, K971E, K1087E, K1105E, K1121E, K1131E, K1155E, K590E, K676E, K677E, K720E, K925E, K1075E, K1076E, K1118E, K1135E, K967E, K968E, K1119E, K1124E, K1154E, K924E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001732080	16	2130270	16	2080269	1732080	1789111	rs2544098276	NC_000016.10:2080268:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3503A>G (p.Lys1168Arg)	TSC2	K1076R, K1088R, K1105R, K1125R, K1131R, K1135R, K1154R, K720R, K924R, K968R, K1075R, K1087R, K1118R, K1124R, K590R, K925R, K1120R, K1121R, K1155R, K1167R, K676R, K677R, K967R, K1119R, K1168R, K971R	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002995300	16	2130271	16	2080270	2995300	3145322	rs2151459132	NC_000016.10:2080269:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3503A>C (p.Lys1168Thr)	TSC2	K1118T, K1120T, K1131T, K1155T, K1088T, K1119T, K1121T, K1168T, K924T, K971T, K1076T, K1087T, K1135T, K1154T, K1167T, K676T, K720T, K925T, K967T, K1075T, K1105T, K1124T, K1125T, K590T, K677T, K968T	Hereditary cancer-predisposing syndrome	VCV001732087	16	2130271	16	2080270	1732087	1789118	rs2151459132	NC_000016.10:2080269:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3504G>A (p.Lys1168=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001732103	16	2130272	16	2080271	1732103	1789134	rs1247259128	NC_000016.10:2080270:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3505G>A (p.Ala1169Thr)	TSC2	A1077T, A1125T, A1136T, A1089T, A1169T, A1126T, A925T	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000823861	16	2130273	16	2080272	823861	812576	rs773900333	NC_000016.10:2080271:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3505G>T (p.Ala1169Ser)	TSC2	A1126S, A925S, A1077S, A1089S, A1125S, A1136S, A1169S	not provided|Tuberous sclerosis 2	VCV000647710	16	2130273	16	2080272	647710	644289	rs773900333	NC_000016.10:2080271:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3506C>T (p.Ala1169Val)	TSC2	A1136V, A1155V, A1156V, A721V, A925V, A926V, A1088V, A1119V, A1120V, A1126V, A591V, A968V, A1076V, A1077V, A1106V, A1121V, A1168V, A1169V, A1089V, A1122V, A1125V, A1132V, A677V, A678V, A969V, A972V	Tuberous sclerosis 2|not provided	VCV002692461	16	2130274	16	2080273	2692461	2853459	rs1171383859	NC_000016.10:2080272:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3507C>G (p.Ala1169=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003664419	16	2130275	16	2080274	3664419	3791516		NC_000016.10:2080273:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3507C>T (p.Ala1169=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001593709	16	2130275	16	2080274	1593709	1655128	rs2089968510	NC_000016.10:2080273:C:T	single nucleotide variant	synonymous variant	Likely benign	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3508T>C (p.Ser1170Pro)	TSC2	S1089P, S1090P, S1127P, S1137P, S678P, S679P, S969P, S973P, S1107P, S1169P, S1077P, S1078P, S1121P, S1122P, S1123P, S1133P, S1157P, S722P, S970P, S1120P, S1126P, S1156P, S1170P, S592P, S926P, S927P	Tuberous sclerosis 2	VCV002045006	16	2130276	16	2080275	2045006	2092579	rs761264878	NC_000016.10:2080274:T:C	single nucleotide variant	missense variant	Benign	Sep 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3509C>T (p.Ser1170Leu)	TSC2	S1170L, S1137L, S926L, S1078L, S1090L, S1127L, S1126L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535949	16	2130277	16	2080276	535949	530222	rs45517296	NC_000016.10:2080275:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3509C>G (p.Ser1170Ter)	TSC2	S1170*, S1127*, S1090*, S1126*, S1137*, S1078*, S926*	Tuberous sclerosis syndrome	VCV000049578	16	2130277	16	2080276	49578	58740	rs45517296	NC_000016.10:2080275:C:G	single nucleotide variant	nonsense	Pathogenic	Aug 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3510A>T (p.Ser1170=)	TSC2		Tuberous sclerosis syndrome	VCV003386171	16	2130278	16	2080277	3386171	3545312		NC_000016.10:2080276:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3512C>T (p.Ala1171Val)	TSC2	A1078V, A1079V, A1090V, A1091V, A1108V, A1121V, A1122V, A1123V, A1124V, A1127V, A1128V, A1134V, A1138V, A1157V, A1158V, A1170V, A1171V, A593V, A679V, A680V, A723V, A927V, A928V, A970V, A971V, A974V	not provided|Tuberous sclerosis 2	VCV002672603	16	2130280	16	2080279	2672603	2840123	rs2151459473	NC_000016.10:2080278:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3512C>G (p.Ala1171Gly)	TSC2	A1128G, A1079G, A1091G, A1138G, A1171G, A927G, A1127G	Tuberous sclerosis 2	VCV001392461	16	2130280	16	2080279	1392461	1502364	rs2151459473	NC_000016.10:2080278:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3515G>A (p.Gly1172Asp)	TSC2	G1172D, G1080D, G1092D, G1139D, G928D, G1128D, G1129D	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000573126	16	2130283	16	2080282	573126	569787	rs1567504268	NC_000016.10:2080281:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 2, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3516C>A (p.Gly1172=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001671755	16	2130284	16	2080283	1671755	1583992	rs1555511474	NC_000016.10:2080282:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3516C>T (p.Gly1172=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486662	16	2130284	16	2080283	486662	477487	rs1555511474	NC_000016.10:2080282:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3517A>C (p.Thr1173Pro)	TSC2	T1080P, T1081P, T1092P, T1093P, T1110P, T1123P, T1124P, T1125P, T1126P, T1129P, T1130P, T1136P, T1140P, T1159P, T1160P, T1172P, T1173P, T595P, T681P, T682P, T725P, T929P, T930P, T972P, T973P, T976P	Hereditary cancer-predisposing syndrome	VCV003232146	16	2130285	16	2080284	3232146	3391947	rs766827673	NC_000016.10:2080283:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3517A>G (p.Thr1173Ala)	TSC2	T1081A, T1092A, T1124A, T1126A, T1136A, T1140A, T1173A, T929A, T973A, T1093A, T1110A, T1125A, T1159A, T681A, T930A, T1080A, T1129A, T1172A, T972A, T1123A, T1130A, T1160A, T595A, T682A, T725A, T976A	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV002982287	16	2130285	16	2080284	2982287	3149011	rs766827673	NC_000016.10:2080283:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3517A>T (p.Thr1173Ser)	TSC2	T1081S, T1093S, T929S, T1130S, T1173S, T1129S, T1140S	Tuberous sclerosis 2	VCV000968589	16	2130285	16	2080284	968589	957685	rs766827673	NC_000016.10:2080283:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3518C>G (p.Thr1173Ser)	TSC2	T1124S, T1172S, T681S, T973S, T976S, T1081S, T1126S, T1140S, T1159S, T1160S, T1173S, T725S, T1093S, T1110S, T1123S, T1125S, T1130S, T1136S, T595S, T930S, T972S, T1080S, T1092S, T1129S, T682S, T929S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002560705	16	2130286	16	2080285	2560705	2716865	rs2089969949	NC_000016.10:2080284:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3518C>T (p.Thr1173Ile)	TSC2	T1093I, T1129I, T1130I, T1140I, T1081I, T1173I, T929I	Tuberous sclerosis 2	VCV000938968	16	2130286	16	2080285	938968	937325	rs2089969949	NC_000016.10:2080284:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3519C>G (p.Thr1173=)	TSC2		Tuberous sclerosis 2	VCV002813192	16	2130287	16	2080286	2813192	2972994	rs754306983	NC_000016.10:2080285:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3519C>A (p.Thr1173=)	TSC2		Tuberous sclerosis 2	VCV002705796	16	2130287	16	2080286	2705796	2856933	rs754306983	NC_000016.10:2080285:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3519C>T (p.Thr1173=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000468019	16	2130287	16	2080286	468019	466222	rs754306983	NC_000016.10:2080285:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3520C>A (p.Arg1174=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001732271	16	2130288	16	2080287	1732271	1789302	rs529298825	NC_000016.10:2080286:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3520C>T (p.Arg1174Trp)	TSC2	R1174W, R1082W, R1094W, R1130W, R1131W, R1141W, R930W	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000406059	16	2130288	16	2080287	406059	401581	rs529298825	NC_000016.10:2080286:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3521G>T (p.Arg1174Leu)	TSC2	R1130L, R930L, R1174L, R1082L, R1141L, R1094L, R1131L	Tuberous sclerosis 2	VCV000647606	16	2130289	16	2080288	647606	644290	rs368666554	NC_000016.10:2080287:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3521G>A (p.Arg1174Gln)	TSC2	R1174Q, R1094Q, R1131Q, R1141Q, R1082Q, R930Q, R1130Q	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486630	16	2130289	16	2080288	486630	477347	rs368666554	NC_000016.10:2080287:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3522G>A (p.Arg1174=)	TSC2		Tuberous sclerosis 2	VCV004071078	16	2130290	16	2080289	4071078	4184926		NC_000016.10:2080288:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3522G>C (p.Arg1174=)	TSC2		Tuberous sclerosis 2	VCV001603622	16	2130290	16	2080289	1603622	1644691	rs2151459876	NC_000016.10:2080288:G:C	single nucleotide variant	synonymous variant	Likely benign	May 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3524T>C (p.Val1175Ala)	TSC2	V1125A, V1127A, V1138A, V1142A, V975A, V978A, V1126A, V1128A, V1131A, V1161A, V1175A, V684A, V1083A, V1132A, V597A, V727A, V932A, V974A, V1082A, V1094A, V1095A, V1112A, V1162A, V1174A, V683A, V931A	Tuberous sclerosis 2	VCV002984087	16	2130292	16	2080291	2984087	3149520	rs1403988261	NC_000016.10:2080290:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jul 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3526C>T (p.Pro1176Ser)	TSC2	P1176S, P1084S, P1096S, P1132S, P1133S, P1143S, P932S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000468020	16	2130294	16	2080293	468020	466006	rs1326077397	NC_000016.10:2080292:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3527C>T (p.Pro1176Leu)	TSC2	P1176L, P1132L, P1084L, P1133L, P1096L, P1143L, P932L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000486701	16	2130295	16	2080294	486701	477942	rs753110463	NC_000016.10:2080293:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3528T>G (p.Pro1176=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232148	16	2130296	16	2080295	3232148	3391949	rs1157894225	NC_000016.10:2080294:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3528T>C (p.Pro1176=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001125294	16	2130296	16	2080295	1125294	1125073	rs1157894225	NC_000016.10:2080294:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3529G>A (p.Val1177Met)	TSC2	V1085M, V1097M, V1133M, V1134M, V1144M, V1177M, V933M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001059964	16	2130297	16	2080296	1059964	1049467	rs1417220666	NC_000016.10:2080295:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3530T>G (p.Val1177Gly)	TSC2	V1085G, V1097G, V1144G, V1133G, V1134G, V933G, V1177G	Tuberous sclerosis 2	VCV000937451	16	2130298	16	2080297	937451	937326	rs1567504468	NC_000016.10:2080296:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3530T>A (p.Val1177Glu)	TSC2	V1177E, V1133E, V1144E, V1085E, V1097E, V1134E, V933E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000569638	16	2130298	16	2080297	569638	567832	rs1567504468	NC_000016.10:2080296:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3532C>G (p.Gln1178Glu)	TSC2	Q1178E, Q1098E, Q1086E, Q1134E, Q1135E, Q1145E, Q934E	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207746	16	2130300	16	2080299	207746	203170	rs45517297	NC_000016.10:2080298:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3532C>T (p.Gln1178Ter)	TSC2	Q1178*, Q1098*, Q1145*, Q1134*, Q1135*, Q934*, Q1086*	not provided|Tuberous sclerosis 2	VCV000049263	16	2130300	16	2080299	49263	58425	rs45517297	NC_000016.10:2080298:C:T	single nucleotide variant	nonsense	Pathogenic	Nov 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3533A>G (p.Gln1178Arg)	TSC2	Q1145R, Q1178R, Q934R, Q1098R, Q1134R, Q1086R, Q1135R	Tuberous sclerosis 2	VCV001357946	16	2130301	16	2080300	1357946	1367841	rs2151460233	NC_000016.10:2080299:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3534G>A (p.Gln1178=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000238020	16	2130302	16	2080301	238020	242281	rs201305783	NC_000016.10:2080300:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3535G>A (p.Glu1179Lys)	TSC2	E1179K, E1099K, E1135K, E1136K, E1146K, E935K, E1087K	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000184243	16	2130303	16	2080302	184243	184139	rs45483391	NC_000016.10:2080301:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3536A>G (p.Glu1179Gly)	TSC2	E1116G, E1130G, E1165G, E1178G, E1179G, E1086G, E1099G, E1135G, E688G, E731G, E978G, E1087G, E1132G, E1146G, E979G, E1098G, E1129G, E1131G, E1136G, E1142G, E1166G, E601G, E687G, E935G, E936G, E982G	Tuberous sclerosis 2	VCV003637221	16	2130304	16	2080303	3637221	3771375		NC_000016.10:2080302:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3538A>G (p.Lys1180Glu)	TSC2	K1180E, K1088E, K1100E, K936E, K1136E, K1137E, K1147E	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000577421	16	2130306	16	2080305	577421	567833	rs751708490	NC_000016.10:2080304:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3539A>G (p.Lys1180Arg)	TSC2	K1087R, K1130R, K1136R, K1137R, K1143R, K1167R, K732R, K979R, K980R, K983R, K1088R, K1100R, K1131R, K1132R, K1180R, K602R, K688R, K937R, K1099R, K1117R, K1166R, K1179R, K689R, K936R, K1133R, K1147R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002561950	16	2130307	16	2080306	2561950	2724321	rs2151460453	NC_000016.10:2080305:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3539A>C (p.Lys1180Thr)	TSC2	K1087T, K1088T, K1136T, K1137T, K1166T, K1180T, K1099T, K1167T, K688T, K732T, K936T, K1117T, K1130T, K1147T, K602T, K937T, K979T, K980T, K983T, K1100T, K1131T, K1132T, K1133T, K1143T, K1179T, K689T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449962	16	2130307	16	2080306	2449962	2429587	rs2151460453	NC_000016.10:2080305:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3540G>A (p.Lys1180=)	TSC2		Tuberous sclerosis 2	VCV004071236	16	2130308	16	2080307	4071236	4185084		NC_000016.10:2080306:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3540G>T (p.Lys1180Asn)	TSC2	K1180N, K936N, K1088N, K1100N, K1136N, K1137N, K1147N	Hereditary cancer-predisposing syndrome	VCV000480833	16	2130308	16	2080307	480833	477348	rs1555511520	NC_000016.10:2080306:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.3541A>G (p.Thr1181Ala)	TSC2	T1138A, T937A, T1101A, T1137A, T1089A, T1148A, T1181A	Tuberous sclerosis 2	VCV001365110	16	2130309	16	2080308	1365110	1502154	rs2151460498	NC_000016.10:2080307:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3542C>A (p.Thr1181Lys)	TSC2	T1089K, T1101K, T1137K, T1138K, T1148K, T1181K, T937K	Tuberous sclerosis 2	VCV000997565	16	2130310	16	2080309	997565	985336	rs373481458	NC_000016.10:2080308:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3542C>G (p.Thr1181Arg)	TSC2	T1148R, T1101R, T1089R, T1137R, T1138R, T1181R, T937R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000938957	16	2130310	16	2080309	938957	937327	rs373481458	NC_000016.10:2080308:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3542C>T (p.Thr1181Met)	TSC2	T1181M, T1089M, T1137M, T1148M, T1101M, T1138M, T937M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135380	16	2130310	16	2080309	135380	139119	rs373481458	NC_000016.10:2080308:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3543G>C (p.Thr1181=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001153004	16	2130311	16	2080310	1153004	1145957	rs139313964	NC_000016.10:2080309:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3543G>A (p.Thr1181=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000413686	16	2130311	16	2080310	413686	401589	rs139313964	NC_000016.10:2080309:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3544A>T (p.Asn1182Tyr)	TSC2	N1090Y, N1101Y, N1119Y, N1133Y, N1149Y, N1168Y, N604Y, N690Y, N985Y, N1102Y, N1134Y, N1169Y, N1181Y, N1182Y, N691Y, N981Y, N982Y, N1135Y, N1138Y, N938Y, N1089Y, N1132Y, N1139Y, N1145Y, N734Y, N939Y	Tuberous sclerosis 2	VCV002870345	16	2130312	16	2080311	2870345	3031229	rs2089974047	NC_000016.10:2080310:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3544A>G (p.Asn1182Asp)	TSC2	N1139D, N1149D, N1090D, N1102D, N1138D, N938D, N1182D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001034787	16	2130312	16	2080311	1034787	1032474	rs2089974047	NC_000016.10:2080310:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3545A>C (p.Asn1182Thr)	TSC2	N1101T, N1119T, N1149T, N1168T, N1169T, N939T, N985T, N1089T, N1090T, N1102T, N1138T, N1182T, N604T, N691T, N938T, N981T, N982T, N1133T, N1134T, N1145T, N690T, N734T, N1132T, N1135T, N1139T, N1181T	Tuberous sclerosis 2	VCV002192442	16	2130313	16	2080312	2192442	1925941	rs2089974168	NC_000016.10:2080311:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3545A>G (p.Asn1182Ser)	TSC2	N1090S, N1182S, N1149S, N1102S, N1139S, N938S, N1138S	Tuberous sclerosis 2	VCV000951556	16	2130313	16	2080312	951556	927663	rs2089974168	NC_000016.10:2080311:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3546C>T (p.Asn1182=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002091281	16	2130314	16	2080313	2091281	2145320	rs2151460683	NC_000016.10:2080312:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3549G>T (p.Leu1183=)	TSC2		Tuberous sclerosis 2	VCV002829213	16	2130317	16	2080316	2829213	2983879	rs1596390611	NC_000016.10:2080315:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3549G>C (p.Leu1183=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001084285	16	2130317	16	2080316	1084285	1081837	rs1596390611	NC_000016.10:2080315:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3549G>A (p.Leu1183=)	TSC2		Tuberous sclerosis 2	VCV000754406	16	2130317	16	2080316	754406	770722	rs1596390611	NC_000016.10:2080315:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3551C>T (p.Ala1184Val)	TSC2	A1184V, A1104V, A1140V, A940V, A1092V, A1141V, A1151V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided	VCV000468021	16	2130319	16	2080318	468021	465939	rs1060500939	NC_000016.10:2080317:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3551C>A (p.Ala1184Glu)	TSC2	A1184E, A1141E, A1140E, A1092E, A1104E, A1151E, A940E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406024	16	2130319	16	2080318	406024	401604	rs1060500939	NC_000016.10:2080317:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 24, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3552G>T (p.Ala1184=)	TSC2		Tuberous sclerosis 2	VCV002820642	16	2130320	16	2080319	2820642	2981728	rs549427685	NC_000016.10:2080318:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3552G>A (p.Ala1184=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238021	16	2130320	16	2080319	238021	242282	rs549427685	NC_000016.10:2080318:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3553G>A (p.Ala1185Thr)	TSC2	A1142T, A1152T, A1093T, A1141T, A1185T, A1105T, A941T	Tuberous sclerosis 2	VCV001361145	16	2130321	16	2080320	1361145	1383517	rs2151460899	NC_000016.10:2080319:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3554C>T (p.Ala1185Val)	TSC2	A1185V, A1152V, A1105V, A1141V, A1093V, A941V, A1142V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000384002	16	2130322	16	2080321	384002	374796	rs1057521812	NC_000016.10:2080320:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3555C>A (p.Ala1185=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468022	16	2130323	16	2080322	468022	465321	rs745762286	NC_000016.10:2080321:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3555C>T (p.Ala1185=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000413708	16	2130323	16	2080322	413708	401320	rs745762286	NC_000016.10:2080321:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3557A>C (p.Tyr1186Ser)	TSC2	Y1106S, Y1143S, Y1094S, Y1142S, Y1186S, Y942S, Y1153S	Tuberous sclerosis syndrome|not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001381607	16	2130325	16	2080324	1381607	1496569	rs137854421	NC_000016.10:2080323:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3557A>T (p.Tyr1186Phe)	TSC2	Y1143F, Y942F, Y1094F, Y1186F, Y1106F, Y1142F, Y1153F	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000663289	16	2130325	16	2080324	663289	644291	rs137854421	NC_000016.10:2080323:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3557A>G (p.Tyr1186Cys)	TSC2	Y1186C, Y1094C, Y942C, Y1106C, Y1142C, Y1143C, Y1153C	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000049764	16	2130325	16	2080324	49764	58926	rs137854421	NC_000016.10:2080323:A:G	single nucleotide variant	missense variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3558T>C (p.Tyr1186=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001671986	16	2130326	16	2080325	1671986	1647295	rs1202939879	NC_000016.10:2080324:T:C	single nucleotide variant	synonymous variant	Likely benign	May 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3558T>G (p.Tyr1186Ter)	TSC2	Y1186*, Y1142*, Y1153*, Y942*, Y1094*, Y1106*, Y1143*	Tuberous sclerosis 2	VCV000565758	16	2130326	16	2080325	565758	573841	rs1202939879	NC_000016.10:2080324:T:G	single nucleotide variant	nonsense	Pathogenic	Jun 4, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3559G>A (p.Val1187Met)	TSC2	V1095M, V1144M, V1143M, V1187M, V1107M, V943M, V1154M	Tuberous sclerosis 2	VCV001447523	16	2130327	16	2080326	1447523	1503577	rs2151461121	NC_000016.10:2080325:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3561G>A (p.Val1187=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001571584	16	2130329	16	2080328	1571584	1572377	rs2151461210	NC_000016.10:2080327:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3562C>T (p.Pro1188Ser)	TSC2	P1107S, P1140S, P696S, P740S, P944S, P1125S, P1175S, P697S, P987S, P991S, P1096S, P1108S, P1138S, P1139S, P1141S, P1151S, P1155S, P1174S, P1187S, P1188S, P945S, P1095S, P1144S, P1145S, P610S, P988S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002891225	16	2130330	16	2080329	2891225	3055036	rs2151461242	NC_000016.10:2080328:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3562C>G (p.Pro1188Ala)	TSC2	P1095A, P1140A, P1144A, P1145A, P1155A, P1187A, P991A, P697A, P740A, P1096A, P1108A, P1138A, P1151A, P1175A, P696A, P944A, P988A, P1107A, P1125A, P1139A, P1141A, P1174A, P1188A, P610A, P945A, P987A	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV001732719	16	2130330	16	2080329	1732719	1786406	rs2151461242	NC_000016.10:2080328:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3562C>A (p.Pro1188Thr)	TSC2	P1145T, P944T, P1108T, P1155T, P1096T, P1144T, P1188T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001387039	16	2130330	16	2080329	1387039	1381404	rs2151461242	NC_000016.10:2080328:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3563C>T (p.Pro1188Leu)	TSC2	P1107L, P1125L, P1138L, P1139L, P1141L, P1187L, P740L, P944L, P991L, P1108L, P1096L, P1140L, P1151L, P1174L, P1188L, P1145L, P696L, P697L, P945L, P987L, P988L, P1095L, P1144L, P1155L, P1175L, P610L	Tuberous sclerosis 2	VCV002857032	16	2130331	16	2080330	2857032	3014252	rs2151461327	NC_000016.10:2080329:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3564C>T (p.Pro1188=)	TSC2		Tuberous sclerosis 2	VCV001989263	16	2130332	16	2080331	1989263	2040607	rs1253270588	NC_000016.10:2080330:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3564C>G (p.Pro1188=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001119689	16	2130332	16	2080331	1119689	1103659	rs1253270588	NC_000016.10:2080330:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3565C>T (p.Leu1189=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001096254	16	2130333	16	2080332	1096254	1081838	rs796053476	NC_000016.10:2080331:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3565C>G (p.Leu1189Val)	TSC2	L1189V, L1146V, L945V, L1097V, L1145V, L1109V, L1156V	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207678	16	2130333	16	2080332	207678	203171	rs796053476	NC_000016.10:2080331:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3567G>A (p.Leu1189=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000468023	16	2130335	16	2080334	468023	465322	rs146734084	NC_000016.10:2080333:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3568C>A (p.Leu1190Met)	TSC2	L1097M, L1142M, L1143M, L1146M, L1147M, L612M, L699M, L742M, L993M, L698M, L946M, L947M, L989M, L1140M, L1153M, L1157M, L990M, L1098M, L1109M, L1110M, L1127M, L1141M, L1176M, L1177M, L1189M, L1190M	Hereditary cancer-predisposing syndrome	VCV002449966	16	2130336	16	2080335	2449966	2429591	rs2151461483	NC_000016.10:2080334:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3568C>T (p.Leu1190=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001106779	16	2130336	16	2080335	1106779	1103660	rs2151461483	NC_000016.10:2080334:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3568C>G (p.Leu1190Val)	TSC2	L1098V, L1110V, L1146V, L1147V, L1157V, L1190V, L946V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001059828	16	2130336	16	2080335	1059828	1049468	rs2151461483	NC_000016.10:2080334:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3570G>A (p.Leu1190=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001113495	16	2130338	16	2080337	1113495	1103661	rs1366398727	NC_000016.10:2080336:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3572C>T (p.Thr1191Ile)	TSC2	T1111I, T1128I, T1154I, T1177I, T743I, T991I, T1110I, T1148I, T1158I, T1190I, T1098I, T1099I, T1142I, T1178I, T613I, T699I, T700I, T990I, T1141I, T1143I, T1144I, T1147I, T1191I, T947I, T948I, T994I	Hereditary cancer-predisposing syndrome	VCV003811304	16	2130340	16	2080339	3811304	3928545		NC_000016.10:2080338:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3573C>G (p.Thr1191=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001581950	16	2130341	16	2080340	1581950	1600509	rs768318835	NC_000016.10:2080339:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3573C>T (p.Thr1191=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001105598	16	2130341	16	2080340	1105598	1103662	rs768318835	NC_000016.10:2080339:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3574C>T (p.Gln1192Ter)	TSC2	Q1192*, Q1159*, Q1149*, Q1100*, Q1148*, Q948*, Q1112*	Tuberous sclerosis 2	VCV000050109	16	2130342	16	2080341	50109	59271	rs45517298	NC_000016.10:2080340:C:T	single nucleotide variant	nonsense	Pathogenic	May 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3575A>C (p.Gln1192Pro)	TSC2	Q1099P, Q1112P, Q1143P, Q1148P, Q1155P, Q1192P, Q949P, Q1100P, Q1129P, Q1142P, Q1145P, Q700P, Q948P, Q1111P, Q1144P, Q1149P, Q1178P, Q1191P, Q701P, Q991P, Q995P, Q1159P, Q1179P, Q614P, Q744P, Q992P	Tuberous sclerosis 2	VCV002847006	16	2130343	16	2080342	2847006	3015181	rs755559677	NC_000016.10:2080341:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3575A>G (p.Gln1192Arg)	TSC2	Q1192R, Q1149R, Q1159R, Q1148R, Q1100R, Q1112R, Q948R	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000642107	16	2130343	16	2080342	642107	644292	rs755559677	NC_000016.10:2080341:A:G	single nucleotide variant	missense variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3576G>A (p.Gln1192=)	TSC2		Tuberous sclerosis 2	VCV002014246	16	2130344	16	2080343	2014246	2064459	rs2151461822	NC_000016.10:2080342:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3576G>C (p.Gln1192His)	TSC2	Q1112H, Q948H, Q1149H, Q1192H, Q1100H, Q1148H, Q1159H	Tuberous sclerosis 2	VCV001525200	16	2130344	16	2080343	1525200	1363539	rs2151461822	NC_000016.10:2080342:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3578G>T (p.Gly1193Val)	TSC2	G1149V, G1160V, G1113V, G1150V, G1193V, G1101V, G949V	Tuberous sclerosis 2	VCV000944105	16	2130346	16	2080345	944105	927664	rs2089978360	NC_000016.10:2080344:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3580T>C (p.Trp1194Arg)	TSC2	W1113R, W1114R, W616R, W994R, W1101R, W1131R, W1150R, W1157R, W1180R, W1181R, W746R, W951R, W1145R, W1193R, W703R, W993R, W997R, W1102R, W1144R, W1146R, W1147R, W1151R, W1161R, W1194R, W702R, W950R	Tuberous sclerosis 2	VCV003637222	16	2130348	16	2080347	3637222	3771376		NC_000016.10:2080346:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3581G>A (p.Trp1194Ter)	TSC2	W1194*, W1102*, W950*, W1114*, W1150*, W1151*, W1161*	Tuberous sclerosis 2	VCV000065230	16	2130349	16	2080348	65230	76162	rs397515168	NC_000016.10:2080347:G:A	single nucleotide variant	nonsense	Pathogenic	Dec 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3582G>A (p.Trp1194Ter)	TSC2	W1102*, W1114*, W1150*, W1151*, W1161*, W1194*, W950*	Tuberous sclerosis 2	VCV001072663	16	2130350	16	2080349	1072663	1063544	rs2151462008	NC_000016.10:2080348:G:A	single nucleotide variant	nonsense	Pathogenic	Jun 28, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3583G>A (p.Ala1195Thr)	TSC2	A1132T, A1152T, A1162T, A1182T, A1195T, A747T, A1145T, A617T, A951T, A995T, A1115T, A1146T, A1148T, A1181T, A703T, A998T, A1102T, A1103T, A1114T, A1147T, A1151T, A1158T, A1194T, A704T, A952T, A994T	Tuberous sclerosis 2	VCV002812777	16	2130351	16	2080350	2812777	2976009	rs2089978833	NC_000016.10:2080349:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3583G>C (p.Ala1195Pro)	TSC2	A1103P, A1115P, A1151P, A1152P, A1162P, A1195P, A951P	Tuberous sclerosis 2	VCV001014624	16	2130351	16	2080350	1014624	1011983	rs2089978833	NC_000016.10:2080349:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3584C>G (p.Ala1195Gly)	TSC2	A1151G, A1152G, A1162G, A1195G, A1103G, A1115G, A951G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000823957	16	2130352	16	2080351	823957	812577	rs773951533	NC_000016.10:2080350:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3584C>T (p.Ala1195Val)	TSC2	A1195V, A1103V, A1152V, A1115V, A1162V, A951V, A1151V	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000406069	16	2130352	16	2080351	406069	401605	rs773951533	NC_000016.10:2080350:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3585G>A (p.Ala1195=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000468025	16	2130353	16	2080352	468025	465951	rs761232933	NC_000016.10:2080351:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3586G>T (p.Glu1196Ter)	TSC2	E1196*, E1153*, E952*, E1152*, E1163*, E1104*, E1116*	Tuberous sclerosis 2	VCV000535875	16	2130354	16	2080353	535875	530228	rs1555511585	NC_000016.10:2080352:G:T	single nucleotide variant	nonsense	Pathogenic	Nov 19, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3587A>G (p.Glu1196Gly)	TSC2	E1116G, E1152G, E1163G, E1104G, E1153G, E952G, E1196G	Tuberous sclerosis 2	VCV001393717	16	2130355	16	2080354	1393717	1399569	rs2151462165	NC_000016.10:2080353:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3588G>A (p.Glu1196=)	TSC2		Tuberous sclerosis 2	VCV004071346	16	2130356	16	2080355	4071346	4185194		NC_000016.10:2080354:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3589A>C (p.Ile1197Leu)	TSC2	I1105L, I953L, I1153L, I1154L, I1197L, I1117L, I1164L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000956166	16	2130357	16	2080356	956166	949259	rs2089979590	NC_000016.10:2080355:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3589A>G (p.Ile1197Val)	TSC2	I1117V, I1197V, I1105V, I1164V, I1153V, I1154V, I953V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000841276	16	2130357	16	2080356	841276	843460	rs2089979590	NC_000016.10:2080355:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3590T>A (p.Ile1197Asn)	TSC2	I1117N, I1153N, I1164N, I1183N, I1197N, I1104N, I1116N, I1147N, I1149N, I1150N, I619N, I953N, I1000N, I1105N, I1134N, I1148N, I1160N, I1196N, I954N, I1154N, I1184N, I705N, I706N, I749N, I996N, I997N	Tuberous sclerosis 2	VCV002842710	16	2130358	16	2080357	2842710	2997416	rs2151462263	NC_000016.10:2080356:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3591C>G (p.Ile1197Met)	TSC2	I1000M, I1104M, I1150M, I1184M, I619M, I705M, I1134M, I1148M, I1149M, I1154M, I1197M, I954M, I1105M, I1116M, I1117M, I1147M, I1160M, I1164M, I1183M, I1196M, I706M, I749M, I996M, I1153M, I953M, I997M	Tuberous sclerosis 2	VCV002762271	16	2130359	16	2080358	2762271	2930767	rs765503216	NC_000016.10:2080357:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3591C>T (p.Ile1197=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000699930	16	2130359	16	2080358	699930	688543	rs765503216	NC_000016.10:2080357:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3592C>T (p.Leu1198=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001551021	16	2130360	16	2080359	1551021	1638058	rs2151462335	NC_000016.10:2080358:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3594G>C (p.Leu1198=)	TSC2		Tuberous sclerosis 2	VCV002793083	16	2130362	16	2080361	2793083	2954215	rs202114637	NC_000016.10:2080360:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3594G>A (p.Leu1198=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000698450	16	2130362	16	2080361	698450	688544	rs202114637	NC_000016.10:2080360:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3595G>T (p.Val1199Phe)	TSC2	V1107F, V1199F, V1155F, V1156F, V1166F, V1119F, V955F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000944512	16	2130363	16	2080362	944512	927665	rs1596390891	NC_000016.10:2080361:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3595G>A (p.Val1199Ile)	TSC2	V1107I, V1119I, V1166I, V1155I, V1156I, V1199I, V955I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000653547	16	2130363	16	2080362	653547	644293	rs1596390891	NC_000016.10:2080361:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3596T>G (p.Val1199Gly)	TSC2	V1199G, V1156G, V1155G, V1107G, V1166G, V1119G, V955G	Tuberous sclerosis 2	VCV000065119	16	2130364	16	2080363	65119	76050	rs397515088	NC_000016.10:2080362:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3597C>G (p.Val1199=)	TSC2		Tuberous sclerosis 2	VCV001634996	16	2130365	16	2080364	1634996	1610722	rs2151462541	NC_000016.10:2080363:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3598C>G (p.Arg1200Gly)	TSC2	R1000G, R1003G, R1119G, R1153G, R1156G, R1200G, R956G, R999G, R1108G, R1150G, R1151G, R1157G, R1187G, R622G, R709G, R1137G, R1167G, R1186G, R1199G, R752G, R957G, R1107G, R1120G, R1152G, R1163G, R708G	Tuberous sclerosis 2	VCV002049812	16	2130366	16	2080365	2049812	2107699	rs45438205	NC_000016.10:2080364:C:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 20, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3598C>T (p.Arg1200Trp)	TSC2	R1200W, R1156W, R1167W, R956W, R1108W, R1120W, R1157W	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000049770	16	2130366	16	2080365	49770	58932	rs45438205	NC_000016.10:2080364:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3599G>A (p.Arg1200Gln)	TSC2	R1200Q, R1108Q, R1120Q, R1156Q, R1157Q, R956Q, R1167Q	not provided|Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome	VCV000388628	16	2130367	16	2080366	388628	374131	rs397515225	NC_000016.10:2080365:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3600G>T (p.Arg1200=)	TSC2		Tuberous sclerosis 2	VCV002710812	16	2130368	16	2080367	2710812	2867953	rs1410559096	NC_000016.10:2080366:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3600G>A (p.Arg1200=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536055	16	2130368	16	2080367	536055	530229	rs1410559096	NC_000016.10:2080366:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3602G>A (p.Arg1201Lys)	TSC2	R1201K, R1157K, R1158K, R1168K, R1109K, R1121K, R957K	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000653824	16	2130370	16	2080369	653824	644294	rs1596390955	NC_000016.10:2080368:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3604C>T (p.Pro1202Ser)	TSC2	P1005S, P1109S, P1121S, P1152S, P1154S, P1169S, P1202S, P754S, P1139S, P1155S, P1159S, P1001S, P1153S, P1165S, P1189S, P710S, P958S, P959S, P1002S, P1110S, P1122S, P1158S, P1188S, P1201S, P624S, P711S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003004908	16	2130372	16	2080371	3004908	3165150	rs2151462708	NC_000016.10:2080370:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3606C>T (p.Pro1202=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000468026	16	2130374	16	2080373	468026	465325	rs772580979	NC_000016.10:2080372:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3607A>C (p.Thr1203Pro)	TSC2	T1203P, T1160P, T1159P, T959P, T1111P, T1170P, T1123P	Tuberous sclerosis 2	VCV000065354	16	2130375	16	2080374	65354	76288	rs397515265	NC_000016.10:2080373:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3608C>T (p.Thr1203Ile)	TSC2	T1006I, T1123I, T1153I, T625I, T711I, T959I, T960I, T712I, T755I, T1111I, T1159I, T1166I, T1170I, T1189I, T1203I, T1002I, T1154I, T1202I, T1003I, T1110I, T1122I, T1140I, T1155I, T1156I, T1160I, T1190I	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001733175	16	2130376	16	2080375	1733175	1796249	rs397515030	NC_000016.10:2080374:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3608C>G (p.Thr1203Arg)	TSC2	T1123R, T1159R, T1111R, T1203R, T1160R, T1170R, T959R	Tuberous sclerosis 2	VCV000943892	16	2130376	16	2080375	943892	937328	rs397515030	NC_000016.10:2080374:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3609A>C (p.Thr1203=)	TSC2		Tuberous sclerosis 2	VCV002580966	16	2130377	16	2080376	2580966	2748551	rs1567505082	NC_000016.10:2080375:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	May 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3609A>G (p.Thr1203=)	TSC2		Tuberous sclerosis 2	VCV000566975	16	2130377	16	2080376	566975	569789	rs1567505082	NC_000016.10:2080375:A:G	single nucleotide variant	synonymous variant	Uncertain significance	Oct 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610G>A (p.Gly1204Arg)	TSC2	G1204R, G1171R, G1160R, G960R, G1112R, G1124R, G1161R	not provided|Tuberous sclerosis 2	VCV000049527	16	2130378	16	2080377	49527	58689	rs1555511663	NC_000016.10:2080376:G:A	single nucleotide variant	missense variant	Likely pathogenic	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3610+1G>T	TSC2		Tuberous sclerosis 2|not provided	VCV001072488	16	2130379	16	2080378	1072488	1063545	rs45517299	NC_000016.10:2080377:G:T	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Mar 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3610+1G>C	TSC2		Tuberous sclerosis 2	VCV000468027	16	2130379	16	2080378	468027	466019	rs45517299	NC_000016.10:2080377:G:C	single nucleotide variant	splice donor variant	Pathogenic	Mar 8, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000049264	16	2130379	16	2080378	49264	58426	rs45517299	NC_000016.10:2080377:G:A	single nucleotide variant	splice donor variant	Pathogenic	Nov 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3610+2T>C	TSC2		Tuberous sclerosis 2	VCV002822858	16	2130380	16	2080379	2822858	2988646	rs2151462990	NC_000016.10:2080378:T:C	single nucleotide variant	splice donor variant	Pathogenic	Aug 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+3A>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003232149	16	2130381	16	2080380	3232149	3391950	rs760153227	NC_000016.10:2080379:A:T	single nucleotide variant	intron variant	Uncertain significance	Apr 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+3A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000659172	16	2130381	16	2080380	659172	652953	rs760153227	NC_000016.10:2080379:A:G	single nucleotide variant	intron variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3610+4C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001382458	16	2130382	16	2080381	1382458	1434887	rs201978396	NC_000016.10:2080380:C:G	single nucleotide variant	intron variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3610+4C>T	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not specified	VCV000405961	16	2130382	16	2080381	405961	400941	rs201978396	NC_000016.10:2080380:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3610+5T>C	TSC2		Tuberous sclerosis 2	VCV001053928	16	2130383	16	2080382	1053928	1049469	rs2151463070	NC_000016.10:2080381:T:C	single nucleotide variant	intron variant	Uncertain significance	Feb 19, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+6G>A	TSC2		Hereditary cancer-predisposing syndrome|Intellectual disability|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000049266	16	2130384	16	2080383	49266	58428	rs45517301	NC_000016.10:2080382:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3610+8G>T	TSC2		Tuberous sclerosis 2	VCV004071271	16	2130386	16	2080385	4071271	4185119		NC_000016.10:2080384:G:T	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+8G>C	TSC2		Tuberous sclerosis 2	VCV004071102	16	2130386	16	2080385	4071102	4184950		NC_000016.10:2080384:G:C	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+8G>A	TSC2		Tuberous sclerosis 2	VCV001094764	16	2130386	16	2080385	1094764	1081839	rs1338516319	NC_000016.10:2080384:G:A	single nucleotide variant	intron variant	Likely benign	Feb 19, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+9C>A	TSC2		Tuberous sclerosis 2	VCV001109036	16	2130387	16	2080386	1109036	1103663	rs45467194	NC_000016.10:2080385:C:A	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3610+9C>T	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000049526	16	2130387	16	2080386	49526	58688	rs45467194	NC_000016.10:2080385:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3610+10G>A	TSC2		Tuberous sclerosis 2	VCV000238022	16	2130388	16	2080387	238022	242283	rs764446159	NC_000016.10:2080386:G:A	single nucleotide variant	intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3610+11G>T	TSC2		Tuberous sclerosis 2	VCV001651785	16	2130389	16	2080388	1651785	1547234	rs751767873	NC_000016.10:2080387:G:T	single nucleotide variant	intron variant	Likely benign	Apr 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+11G>A	TSC2		Tuberous sclerosis 2	VCV001607156	16	2130389	16	2080388	1607156	1572466	rs751767873	NC_000016.10:2080387:G:A	single nucleotide variant	intron variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+16G>A	TSC2		Tuberous sclerosis 2	VCV002021090	16	2130394	16	2080393	2021090	2076435	rs2151463342	NC_000016.10:2080392:G:A	single nucleotide variant	intron variant	Likely benign	Sep 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+18C>T	TSC2		Tuberous sclerosis 2	VCV001384500	16	2130396	16	2080395	1384500	1348777	rs1253628641	NC_000016.10:2080394:C:T	single nucleotide variant	intron variant	Likely benign	May 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+19C>G	TSC2		Tuberous sclerosis 2	VCV001379184	16	2130397	16	2080396	1379184	1486413	rs2151463426	NC_000016.10:2080395:C:G	single nucleotide variant	intron variant	Likely benign	Mar 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+20T>A	TSC2		Tuberous sclerosis 2	VCV001589359	16	2130398	16	2080397	1589359	1607381	rs2151463450	NC_000016.10:2080396:T:A	single nucleotide variant	intron variant	Likely benign	Oct 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+168G>A	TSC2		not provided	VCV000674436	16	2130546	16	2080545	674436	667414	rs9922898	NC_000016.10:2080544:G:A	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+170A>C	TSC2		not provided	VCV000674437	16	2130548	16	2080547	674437	668206	rs9933952	NC_000016.10:2080546:A:C	single nucleotide variant	intron variant	Benign	Jun 19, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+171A>G	TSC2		not provided	VCV001198168	16	2130549	16	2080548	1198168	1188332	rs138163125	NC_000016.10:2080547:A:G	single nucleotide variant	intron variant	Likely benign	Jun 21, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+214C>T	TSC2		not provided	VCV000678379	16	2130592	16	2080591	678379	668389	rs189844584	NC_000016.10:2080590:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+226C>T	TSC2		not provided	VCV000672295	16	2130604	16	2080603	672295	668209	rs182662506	NC_000016.10:2080602:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+262A>G	TSC2		not provided	VCV001174182	16	2130640	16	2080639	1174182	1163616	rs60906239	NC_000016.10:2080638:A:G	single nucleotide variant	intron variant	Benign	Jul 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+264G>A	TSC2		not provided	VCV001215744	16	2130642	16	2080641	1215744	1205725	rs143022087	NC_000016.10:2080640:G:A	single nucleotide variant	intron variant	Likely benign	Jun 29, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+266C>T	TSC2		not provided	VCV000671569	16	2130644	16	2080643	671569	668717	rs184695141	NC_000016.10:2080642:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3610+419C>G	TSC2		Tuberous sclerosis 2	VCV002844238	16	2130797	16	2080796	2844238	3007879	rs1195418667	NC_000016.10:2080795:C:G	single nucleotide variant	intron variant	Pathogenic	Oct 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-59G>A	TSC2		not provided	VCV001190032	16	2131537	16	2081536	1190032	1181348	rs189285826	NC_000016.10:2081535:G:A	single nucleotide variant	intron variant	Likely benign	Jul 8, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-20A>G	TSC2		Tuberous sclerosis 2	VCV002800032	16	2131576	16	2081575	2800032	2955970	rs1450559639	NC_000016.10:2081574:A:G	single nucleotide variant	intron variant	Likely benign	Nov 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-19G>C	TSC2		Tuberous sclerosis 2	VCV004071234	16	2131577	16	2081576	4071234	4185082		NC_000016.10:2081575:G:C	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-18G>T	TSC2		Tuberous sclerosis 2	VCV002064868	16	2131578	16	2081577	2064868	2124980	rs2090146019	NC_000016.10:2081576:G:T	single nucleotide variant	intron variant	Likely benign	Dec 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-17T>C	TSC2		Tuberous sclerosis 2	VCV001637591	16	2131579	16	2081578	1637591	1645184	rs2090146202	NC_000016.10:2081577:T:C	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-16G>A	TSC2		Tuberous sclerosis 2	VCV001615945	16	2131580	16	2081579	1615945	1613665	rs2151480236	NC_000016.10:2081578:G:A	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-15C>G	TSC2		Tuberous sclerosis 2	VCV003647316	16	2131581	16	2081580	3647316	3780609		NC_000016.10:2081579:C:G	single nucleotide variant	intron variant	Likely benign	Mar 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-15C>T	TSC2		Tuberous sclerosis 2	VCV002752698	16	2131581	16	2081580	2752698	2913439	rs1017279918	NC_000016.10:2081579:C:T	single nucleotide variant	intron variant	Likely benign	May 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-14T>C	TSC2		Tuberous sclerosis 2	VCV002036727	16	2131582	16	2081581	2036727	2101094	rs2544151141	NC_000016.10:2081580:T:C	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-13G>A	TSC2		Tuberous sclerosis 2	VCV001641393	16	2131583	16	2081582	1641393	1520327	rs2151480264	NC_000016.10:2081581:G:A	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-12C>T	TSC2		Tuberous sclerosis 2	VCV003661078	16	2131584	16	2081583	3661078	3790737		NC_000016.10:2081582:C:T	single nucleotide variant	intron variant	Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-12C>A	TSC2		Tuberous sclerosis 2	VCV001550311	16	2131584	16	2081583	1550311	1659247	rs2151480298	NC_000016.10:2081582:C:A	single nucleotide variant	intron variant	Likely benign	Jul 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-11C>G	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001313166	16	2131585	16	2081584	1313166	1303427	rs375617364	NC_000016.10:2081583:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3611-11C>A	TSC2		not provided	VCV001203927	16	2131585	16	2081584	1203927	1195032	rs375617364	NC_000016.10:2081583:C:A	single nucleotide variant	intron variant	Uncertain significance	Apr 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-11C>T	TSC2		not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000381987	16	2131585	16	2081584	381987	375192	rs375617364	NC_000016.10:2081583:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-10G>C	TSC2		Tuberous sclerosis 2	VCV001107780	16	2131586	16	2081585	1107780	1103664	rs372045362	NC_000016.10:2081584:G:C	single nucleotide variant	intron variant	Likely benign	Apr 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-10G>A	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065244	16	2131586	16	2081585	65244	76176	rs372045362	NC_000016.10:2081584:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-9C>A	TSC2		Tuberous sclerosis 2	VCV002864315	16	2131587	16	2081586	2864315	3023080	rs45517304	NC_000016.10:2081585:C:A	single nucleotide variant	intron variant	Likely benign	May 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-9C>T	TSC2		not provided|Tuberous sclerosis 2	VCV000049267	16	2131587	16	2081586	49267	58429	rs45517304	NC_000016.10:2081585:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3611-8C>T	TSC2		Tuberous sclerosis 2	VCV000753280	16	2131588	16	2081587	753280	776163	rs1596399469	NC_000016.10:2081586:C:T	single nucleotide variant	intron variant	Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-7T>C	TSC2		Tuberous sclerosis 2	VCV003669843	16	2131589	16	2081588	3669843	3793050		NC_000016.10:2081587:T:C	single nucleotide variant	intron variant	Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-6C>T	TSC2		Tuberous sclerosis 2	VCV000468029	16	2131590	16	2081589	468029	465329	rs989103352	NC_000016.10:2081588:C:T	single nucleotide variant	intron variant	Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-5C>A	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000657785	16	2131591	16	2081590	657785	652530	rs200194551	NC_000016.10:2081589:C:A	single nucleotide variant	intron variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-5C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000385399	16	2131591	16	2081590	385399	374799	rs200194551	NC_000016.10:2081589:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-4G>C	TSC2		Hereditary cancer-predisposing syndrome	VCV003974595	16	2131592	16	2081591	3974595	4086418		NC_000016.10:2081590:G:C	single nucleotide variant	intron variant	Likely benign	May 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-4G>A	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000468028	16	2131592	16	2081591	468028	465336	rs368926908	NC_000016.10:2081590:G:A	single nucleotide variant	intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-4G>T	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000386821	16	2131592	16	2081591	386821	375194	rs368926908	NC_000016.10:2081590:G:T	single nucleotide variant	intron variant	Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001471957	16	2131593	16	2081592	1471957	1385105	rs753716627	NC_000016.10:2081591:C:T	single nucleotide variant	intron variant	Uncertain significance	Apr 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3611-2A>G	TSC2		Tuberous sclerosis 2	VCV000238023	16	2131594	16	2081593	238023	242284	rs397515169	NC_000016.10:2081592:A:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Feb 25, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-2A>T	TSC2		not provided	VCV000065232	16	2131594	16	2081593	65232	76164	rs397515169	NC_000016.10:2081592:A:T	single nucleotide variant	splice acceptor variant	Likely pathogenic	Feb 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-1G>A	TSC2		Tuberous sclerosis syndrome	VCV003572422	16	2131595	16	2081594	3572422	3731322		NC_000016.10:2081593:G:A	single nucleotide variant	splice acceptor variant	Likely pathogenic	Jan 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611-1G>C	TSC2		Tuberous sclerosis 2	VCV001068074	16	2131595	16	2081594	1068074	1056297	rs45517302	NC_000016.10:2081593:G:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Jul 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611G>C (p.Gly1204Ala)	TSC2	G1112A, G1160A, G1161A, G1124A, G1171A, G1204A, G960A	Tuberous sclerosis 2	VCV000945142	16	2131596	16	2081595	945142	927666	rs45462194	NC_000016.10:2081594:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3611G>A (p.Gly1204Glu)	TSC2	G1204E, G1171E, G960E, G1124E, G1112E, G1160E, G1161E	not provided|Tuberous sclerosis 2	VCV000050148	16	2131596	16	2081595	50148	59310	rs45462194	NC_000016.10:2081594:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3612G>C (p.Gly1204=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000757361	16	2131597	16	2081596	757361	770723	rs1555512292	NC_000016.10:2081595:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3612G>A (p.Gly1204=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486704	16	2131597	16	2081596	486704	477409	rs1555512292	NC_000016.10:2081595:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3614A>C (p.Asn1205Thr)	TSC2	N1005T, N1112T, N1124T, N1156T, N1158T, N1162T, N1192T, N757T, N1004T, N1125T, N1168T, N1172T, N627T, N961T, N962T, N1142T, N1155T, N1157T, N1161T, N714T, N1008T, N1113T, N1191T, N1204T, N1205T, N713T	Hereditary cancer-predisposing syndrome	VCV002564690	16	2131599	16	2081598	2564690	2733846	rs2544152198	NC_000016.10:2081597:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3614A>G (p.Asn1205Ser)	TSC2	N1112S, N1125S, N1155S, N1157S, N1161S, N1162S, N1191S, N627S, N757S, N1005S, N1008S, N1113S, N1156S, N1192S, N1205S, N714S, N1004S, N1142S, N1158S, N713S, N962S, N1124S, N1168S, N1172S, N1204S, N961S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001733259	16	2131599	16	2081598	1733259	1792881	rs2544152198	NC_000016.10:2081597:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3615C>G (p.Asn1205Lys)	TSC2	N1113K, N1161K, N1205K, N961K, N1125K, N1162K, N1172K	Tuberous sclerosis 2	VCV000648981	16	2131600	16	2081599	648981	644295	rs924403519	NC_000016.10:2081598:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3615C>T (p.Asn1205=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413726	16	2131600	16	2081599	413726	401321	rs924403519	NC_000016.10:2081598:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3616A>C (p.Thr1206Pro)	TSC2	T1114P, T1125P, T1157P, T1163P, T628P, T1126P, T1143P, T714P, T715P, T962P, T1006P, T1009P, T1158P, T1159P, T1162P, T1169P, T1205P, T963P, T1005P, T1113P, T1156P, T1173P, T1192P, T1193P, T1206P, T758P	Tuberous sclerosis 2	VCV002767430	16	2131601	16	2081600	2767430	2923004	rs1348376140	NC_000016.10:2081599:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Nov 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3617C>G (p.Thr1206Ser)	TSC2	T1173S, T1206S, T962S, T1114S, T1126S, T1162S, T1163S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001042441	16	2131602	16	2081601	1042441	1032475	rs2090150662	NC_000016.10:2081600:C:G	single nucleotide variant	missense variant	Uncertain significance	May 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3618C>A (p.Thr1206=)	TSC2		Tuberous sclerosis 2	VCV001115814	16	2131603	16	2081602	1115814	1103665	rs1057522260	NC_000016.10:2081601:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3618C>T (p.Thr1206=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001079843	16	2131603	16	2081602	1079843	1081840	rs1057522260	NC_000016.10:2081601:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 16, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3618C>G (p.Thr1206=)	TSC2		Tuberous sclerosis 2|not specified	VCV000385558	16	2131603	16	2081602	385558	375196	rs1057522260	NC_000016.10:2081601:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3620G>A (p.Ser1207Asn)	TSC2	S1006N, S1007N, S1010N, S1114N, S1115N, S1126N, S1127N, S1144N, S1157N, S1158N, S1159N, S1160N, S1163N, S1164N, S1170N, S1174N, S1193N, S1194N, S1206N, S1207N, S629N, S715N, S716N, S759N, S963N, S964N	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003071941	16	2131605	16	2081604	3071941	3232118	rs397515313	NC_000016.10:2081603:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3620G>C (p.Ser1207Thr)	TSC2	S1126T, S1007T, S1115T, S1144T, S1158T, S1163T, S1164T, S1194T, S963T, S964T, S1114T, S1127T, S1157T, S1159T, S1160T, S1174T, S1206T, S1207T, S759T, S629T, S716T, S1006T, S1010T, S1170T, S1193T, S715T	Tuberous sclerosis 2	VCV002828988	16	2131605	16	2081604	2828988	2983654	rs397515313	NC_000016.10:2081603:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3621C>T (p.Ser1207=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001145794	16	2131606	16	2081605	1145794	1145958	rs2151480833	NC_000016.10:2081604:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3622T>G (p.Trp1208Gly)	TSC2	W1208G, W1128G, W1165G, W964G, W1116G, W1164G, W1175G	Tuberous sclerosis 2|not specified	VCV000049529	16	2131607	16	2081606	49529	58691	rs45482795	NC_000016.10:2081605:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3622T>C (p.Trp1208Arg)	TSC2	W1208R, W1116R, W1164R, W1165R, W964R, W1128R, W1175R	not provided	VCV000049528	16	2131607	16	2081606	49528	58690	rs45482795	NC_000016.10:2081605:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.3623G>A (p.Trp1208Ter)	TSC2	W1208*, W1165*, W964*, W1116*, W1164*, W1175*, W1128*	Tuberous sclerosis 2	VCV000064973	16	2131608	16	2081607	64973	75903	rs397514979	NC_000016.10:2081606:G:A	single nucleotide variant	nonsense	Pathogenic	May 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3624G>T (p.Trp1208Cys)	TSC2	W1007C, W1008C, W1011C, W1115C, W1116C, W1127C, W1128C, W1145C, W1158C, W1159C, W1160C, W1161C, W1164C, W1165C, W1171C, W1175C, W1194C, W1195C, W1207C, W1208C, W630C, W716C, W717C, W760C, W964C, W965C	Tuberous sclerosis syndrome	VCV003074520	16	2131609	16	2081608	3074520	3229487	rs796053496	NC_000016.10:2081607:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3624G>A (p.Trp1208Ter)	TSC2	W1208*, W1164*, W1116*, W1128*, W1165*, W1175*, W964*	Tuberous sclerosis 2|not provided	VCV000207747	16	2131609	16	2081608	207747	203172	rs796053496	NC_000016.10:2081607:G:A	single nucleotide variant	nonsense	Pathogenic	May 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3625C>T (p.Leu1209=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001591733	16	2131610	16	2081609	1591733	1577849	rs1466425189	NC_000016.10:2081608:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3627G>C (p.Leu1209=)	TSC2		Tuberous sclerosis 2	VCV004071019	16	2131612	16	2081611	4071019	4184867		NC_000016.10:2081610:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3627G>A (p.Leu1209=)	TSC2		Tuberous sclerosis 2	VCV001085490	16	2131612	16	2081611	1085490	1081841	rs2151480958	NC_000016.10:2081610:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 3, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3630G>A (p.Met1210Ile)	TSC2	M1117I, M1129I, M1160I, M1210I, M1161I, M1162I, M1163I, M1166I, M1167I, M1209I, M632I, M762I, M966I, M967I, M1130I, M1147I, M1173I, M1177I, M1196I, M1009I, M1010I, M1013I, M1118I, M1197I, M718I, M719I	Hereditary cancer-predisposing syndrome	VCV003811348	16	2131615	16	2081614	3811348	3928589		NC_000016.10:2081613:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 25, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3632G>A (p.Ser1211Asn)	TSC2	S1148N, S1161N, S1167N, S1168N, S1197N, S720N, S1010N, S1014N, S1119N, S1130N, S763N, S968N, S1118N, S1131N, S1163N, S1164N, S1178N, S1198N, S1211N, S633N, S1011N, S1162N, S1174N, S1210N, S719N, S967N	Tuberous sclerosis 2	VCV001909851	16	2131617	16	2081616	1909851	1972662	rs2544153125	NC_000016.10:2081615:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3633C>T (p.Ser1211=)	TSC2		Tuberous sclerosis 2	VCV001132385	16	2131618	16	2081617	1132385	1125074	rs2090152012	NC_000016.10:2081616:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3634C>A (p.Leu1212Met)	TSC2	L1179M, L1212M, L1120M, L1132M, L1169M, L968M, L1168M	Tuberous sclerosis 2	VCV001483061	16	2131619	16	2081618	1483061	1465044	rs1358537146	NC_000016.10:2081617:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3634C>G (p.Leu1212Val)	TSC2	L1120V, L1132V, L1168V, L1169V, L1179V, L1212V, L968V	Tuberous sclerosis 2	VCV001008888	16	2131619	16	2081618	1008888	996743	rs1358537146	NC_000016.10:2081617:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3634C>T (p.Leu1212=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000468030	16	2131619	16	2081618	468030	465952	rs1358537146	NC_000016.10:2081617:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3636G>C (p.Leu1212=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232150	16	2131621	16	2081620	3232150	3391951	rs778744545	NC_000016.10:2081619:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3636G>A (p.Leu1212=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001551931	16	2131621	16	2081620	1551931	1520542	rs778744545	NC_000016.10:2081619:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3637G>A (p.Glu1213Lys)	TSC2	E1012K, E1120K, E1132K, E1133K, E1150K, E1165K, E1180K, E1200K, E1213K, E1013K, E1016K, E1163K, E1166K, E1170K, E1199K, E1212K, E721K, E969K, E1121K, E1169K, E635K, E1164K, E1176K, E722K, E765K, E970K	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002990275	16	2131622	16	2081621	2990275	3144180	rs2544153409	NC_000016.10:2081620:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3638A>T (p.Glu1213Val)	TSC2	E1213V, E1121V, E1170V, E969V, E1169V, E1133V, E1180V	Tuberous sclerosis 2	VCV000535985	16	2131623	16	2081622	535985	529679	rs1555512322	NC_000016.10:2081621:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3639G>A (p.Glu1213=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000507428	16	2131624	16	2081623	507428	505476	rs747862818	NC_000016.10:2081622:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3642C>A (p.Asn1214Lys)	TSC2	N1014K, N1017K, N1164K, N1166K, N1167K, N1181K, N971K, N1121K, N1134K, N1177K, N1200K, N970K, N1151K, N1171K, N1201K, N1214K, N723K, N1013K, N1122K, N1133K, N1165K, N1170K, N1213K, N636K, N722K, N766K	Tuberous sclerosis 2	VCV002708855	16	2131627	16	2081626	2708855	2871146	rs2151481160	NC_000016.10:2081625:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3642C>T (p.Asn1214=)	TSC2		Tuberous sclerosis 2	VCV001114568	16	2131627	16	2081626	1114568	1103666	rs2151481160	NC_000016.10:2081625:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3643C>T (p.Pro1215Ser)	TSC2	P1172S, P1182S, P1123S, P1171S, P1135S, P1215S, P971S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000666186	16	2131628	16	2081627	666186	644296	rs1555512332	NC_000016.10:2081626:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3643C>G (p.Pro1215Ala)	TSC2	P1215A, P1123A, P1135A, P971A, P1171A, P1172A, P1182A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468031	16	2131628	16	2081627	468031	466232	rs1555512332	NC_000016.10:2081626:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3644C>A (p.Pro1215Gln)	TSC2	P1182Q, P971Q, P1171Q, P1172Q, P1123Q, P1135Q, P1215Q	Tuberous sclerosis 2	VCV001423023	16	2131629	16	2081628	1423023	1425302	rs933257311	NC_000016.10:2081627:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3644C>T (p.Pro1215Leu)	TSC2	P1215L, P1123L, P1172L, P971L, P1135L, P1171L, P1182L	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000535872	16	2131629	16	2081628	535872	530241	rs933257311	NC_000016.10:2081627:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3645G>C (p.Pro1215=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001140439	16	2131630	16	2081629	1140439	1125075	rs758114962	NC_000016.10:2081628:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3645G>A (p.Pro1215=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000413676	16	2131630	16	2081629	413676	400803	rs758114962	NC_000016.10:2081628:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3645G>T (p.Pro1215=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238024	16	2131630	16	2081629	238024	242285	rs758114962	NC_000016.10:2081628:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3646C>T (p.Leu1216Phe)	TSC2	L1167F, L1168F, L1169F, L1172F, L1173F, L1179F, L1183F, L1202F, L1203F, L1215F, L1216F, L638F, L724F, L725F, L768F, L972F, L973F, L1015F, L1016F, L1019F, L1123F, L1124F, L1135F, L1136F, L1153F, L1166F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001715087	16	2131631	16	2081630	1715087	1775232	rs2544153972	NC_000016.10:2081629:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3648C>A (p.Leu1216=)	TSC2		Tuberous sclerosis 2	VCV004071141	16	2131633	16	2081632	4071141	4184989		NC_000016.10:2081631:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3648C>G (p.Leu1216=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001106968	16	2131633	16	2081632	1106968	1103667	rs777246414	NC_000016.10:2081631:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3648C>T (p.Leu1216=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000413622	16	2131633	16	2081632	413622	400806	rs777246414	NC_000016.10:2081631:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3649A>C (p.Ser1217Arg)	TSC2	S1016R, S1017R, S1020R, S1124R, S1125R, S1136R, S1137R, S1154R, S1167R, S1168R, S1169R, S1170R, S1173R, S1174R, S1180R, S1184R, S1203R, S1204R, S1216R, S1217R, S639R, S725R, S726R, S769R, S973R, S974R	Tuberous sclerosis 2	VCV001718047	16	2131634	16	2081633	1718047	1772023	rs2544154181	NC_000016.10:2081632:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3650G>A (p.Ser1217Asn)	TSC2	S1173N, S1174N, S1217N, S1184N, S973N, S1125N, S1137N	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001443610	16	2131635	16	2081634	1443610	1384555	rs2151481330	NC_000016.10:2081633:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3652C>T (p.Pro1218Ser)	TSC2	P1138S, P1185S, P1204S, P1021S, P1155S, P1171S, P1174S, P1217S, P1218S, P727S, P974S, P1018S, P1126S, P1168S, P1169S, P1170S, P1175S, P640S, P726S, P770S, P975S, P1017S, P1125S, P1137S, P1181S, P1205S	Hereditary cancer-predisposing syndrome	VCV003811308	16	2131637	16	2081636	3811308	3928549		NC_000016.10:2081635:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3652C>A (p.Pro1218Thr)	TSC2	P1017T, P1021T, P1155T, P1169T, P1170T, P1175T, P1205T, P727T, P770T, P1018T, P1126T, P1138T, P1174T, P1217T, P640T, P726T, P974T, P1168T, P1171T, P1181T, P1204T, P1218T, P1125T, P1137T, P1185T, P975T	Tuberous sclerosis 2	VCV003637223	16	2131637	16	2081636	3637223	3771377		NC_000016.10:2081635:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3653C>T (p.Pro1218Leu)	TSC2	P1126L, P1137L, P1218L, P974L, P1125L, P1181L, P1185L, P1204L, P1217L, P726L, P770L, P1017L, P1018L, P1169L, P1171L, P1174L, P1205L, P975L, P1021L, P1138L, P1155L, P1168L, P1170L, P1175L, P640L, P727L	Hereditary cancer-predisposing syndrome	VCV003811364	16	2131638	16	2081637	3811364	3928605		NC_000016.10:2081636:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3653C>G (p.Pro1218Arg)	TSC2	P1018R, P1138R, P1174R, P1185R, P1218R, P974R, P975R, P1017R, P1021R, P1170R, P1175R, P1217R, P726R, P1125R, P1168R, P1171R, P1204R, P1205R, P640R, P727R, P1126R, P1137R, P1155R, P1169R, P1181R, P770R	Hereditary cancer-predisposing syndrome	VCV003462602	16	2131638	16	2081637	3462602	3621621		NC_000016.10:2081636:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3653C>A (p.Pro1218His)	TSC2	P1018H, P1021H, P1125H, P1174H, P1175H, P1217H, P1138H, P1204H, P1218H, P640H, P726H, P770H, P1017H, P1126H, P1137H, P1168H, P1169H, P1170H, P1205H, P1155H, P1171H, P1181H, P1185H, P727H, P974H, P975H	Hereditary cancer-predisposing syndrome	VCV001733615	16	2131638	16	2081637	1733615	1793236	rs2090154693	NC_000016.10:2081636:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3654T>C (p.Pro1218=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001733621	16	2131639	16	2081638	1733621	1793242	rs746563588	NC_000016.10:2081637:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3656T>C (p.Phe1219Ser)	TSC2	F1127S, F1169S, F1170S, F1176S, F1182S, F1218S, F728S, F771S, F976S, F1018S, F1022S, F1156S, F1175S, F1019S, F1138S, F1172S, F1219S, F727S, F975S, F1126S, F1139S, F1171S, F1186S, F1205S, F1206S, F641S	Hereditary cancer-predisposing syndrome	VCV001733630	16	2131641	16	2081640	1733630	1789380	rs2544154488	NC_000016.10:2081639:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3657C>T (p.Phe1219=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000762811	16	2131642	16	2081641	762811	770724	rs1596399888	NC_000016.10:2081640:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3659C>T (p.Ser1220Phe)	TSC2	S1177F, S976F, S1187F, S1128F, S1140F, S1176F, S1220F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001392807	16	2131644	16	2081643	1392807	1502709	rs2090155420	NC_000016.10:2081642:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3659C>G (p.Ser1220Cys)	TSC2	S1128C, S1140C, S1176C, S1177C, S1187C, S1220C, S976C	Tuberous sclerosis 2	VCV001003068	16	2131644	16	2081643	1003068	996744	rs2090155420	NC_000016.10:2081642:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3660C>T (p.Ser1220=)	TSC2		Tuberous sclerosis 2	VCV004071105	16	2131645	16	2081644	4071105	4184953		NC_000016.10:2081643:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3661T>A (p.Ser1221Thr)	TSC2	S1141T, S1188T, S977T, S1129T, S1177T, S1178T, S1221T	Tuberous sclerosis 2	VCV001374125	16	2131646	16	2081645	1374125	1456942	rs2151481521	NC_000016.10:2081644:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3662C>T (p.Ser1221Leu)	TSC2	S1129L, S1178L, S1141L, S1177L, S977L, S1188L, S1221L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000943389	16	2131647	16	2081646	943389	937329	rs45517305	NC_000016.10:2081645:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3662C>A (p.Ser1221Ter)	TSC2	S1221*, S1129*, S977*, S1178*, S1177*, S1141*, S1188*	Tuberous sclerosis 2	VCV000049269	16	2131647	16	2081646	49269	58431	rs45517305	NC_000016.10:2081645:C:A	single nucleotide variant	nonsense	Pathogenic	Sep 3, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3663G>C (p.Ser1221=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001150212	16	2131648	16	2081647	1150212	1145959	rs137854268	NC_000016.10:2081646:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3663G>A (p.Ser1221=)	TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000049533	16	2131648	16	2081647	49533	58695	rs137854268	NC_000016.10:2081646:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3664G>A (p.Asp1222Asn)	TSC2	D1179N, D1208N, D1221N, D1025N, D1141N, D1142N, D1172N, D1185N, D644N, D978N, D1159N, D1173N, D1209N, D730N, D731N, D774N, D979N, D1021N, D1022N, D1129N, D1130N, D1174N, D1175N, D1178N, D1189N, D1222N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002193619	16	2131649	16	2081648	2193619	1929295	rs776157698	NC_000016.10:2081647:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3664G>T (p.Asp1222Tyr)	TSC2	D1141Y, D1142Y, D1159Y, D1175Y, D1178Y, D1221Y, D978Y, D1022Y, D1172Y, D1174Y, D1179Y, D1189Y, D1209Y, D1222Y, D731Y, D1025Y, D1130Y, D1185Y, D1208Y, D644Y, D730Y, D774Y, D979Y, D1021Y, D1129Y, D1173Y	Hereditary cancer-predisposing syndrome	VCV001733712	16	2131649	16	2081648	1733712	1789462	rs776157698	NC_000016.10:2081647:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3666C>G (p.Asp1222Glu)	TSC2	D1022E, D1025E, D1130E, D1141E, D1159E, D1179E, D1209E, D1221E, D644E, D1021E, D1129E, D1172E, D1175E, D730E, D774E, D979E, D1142E, D1173E, D1174E, D1185E, D1189E, D731E, D1178E, D1208E, D1222E, D978E	Hereditary cancer-predisposing syndrome	VCV002626434	16	2131651	16	2081650	2626434	2794200	rs749870079	NC_000016.10:2081649:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3666C>T (p.Asp1222=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome	VCV000513890	16	2131651	16	2081650	513890	505479	rs749870079	NC_000016.10:2081649:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3667A>G (p.Ile1223Val)	TSC2	I1022V, I1023V, I1026V, I1130V, I1131V, I1142V, I1143V, I1160V, I1173V, I1174V, I1175V, I1176V, I1179V, I1180V, I1186V, I1190V, I1209V, I1210V, I1222V, I1223V, I645V, I731V, I732V, I775V, I979V, I980V	Tuberous sclerosis 2	VCV003626374	16	2131652	16	2081651	3626374	3758205		NC_000016.10:2081650:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3669C>T (p.Ile1223=)	TSC2		Tuberous sclerosis 2	VCV001551365	16	2131654	16	2081653	1551365	1551144	rs2151481655	NC_000016.10:2081652:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3670A>G (p.Asn1224Asp)	TSC2	N1023D, N1024D, N1131D, N1143D, N1174D, N1180D, N1187D, N1191D, N1027D, N1177D, N732D, N733D, N980D, N1144D, N1210D, N1223D, N776D, N1132D, N1161D, N1175D, N1176D, N1181D, N1211D, N1224D, N646D, N981D	Tuberous sclerosis 2	VCV003697937	16	2131655	16	2081654	3697937	3829532		NC_000016.10:2081653:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3670A>T (p.Asn1224Tyr)	TSC2	N1023Y, N1024Y, N1027Y, N1131Y, N1132Y, N1143Y, N1144Y, N1161Y, N1174Y, N1175Y, N1176Y, N1177Y, N1180Y, N1181Y, N1187Y, N1191Y, N1210Y, N1211Y, N1223Y, N1224Y, N646Y, N732Y, N733Y, N776Y, N980Y, N981Y	Hereditary cancer-predisposing syndrome	VCV003232151	16	2131655	16	2081654	3232151	3391952	rs2544155221	NC_000016.10:2081653:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3670A>C (p.Asn1224His)	TSC2	N1144H, N1161H, N1175H, N1210H, N1223H, N1224H, N733H, N981H, N1024H, N1027H, N1174H, N1132H, N1176H, N1187H, N1191H, N646H, N980H, N1023H, N1131H, N1143H, N1177H, N1180H, N1181H, N1211H, N732H, N776H	Tuberous sclerosis 2	VCV002759180	16	2131655	16	2081654	2759180	2917762	rs2544155221	NC_000016.10:2081653:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3671A>T (p.Asn1224Ile)	TSC2	N1180I, N1144I, N1191I, N1224I, N1132I, N1181I, N980I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001417865	16	2131656	16	2081655	1417865	1396920	rs1434962054	NC_000016.10:2081654:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3671A>G (p.Asn1224Ser)	TSC2	N1181S, N1224S, N980S, N1132S, N1144S, N1180S, N1191S	Tuberous sclerosis 2	VCV001375790	16	2131656	16	2081655	1375790	1470177	rs1434962054	NC_000016.10:2081654:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3672C>T (p.Asn1224=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001127665	16	2131657	16	2081656	1127665	1125076	rs2151481746	NC_000016.10:2081655:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3673A>G (p.Asn1225Asp)	TSC2	N1028D, N1132D, N1162D, N1192D, N1211D, N1225D, N647D, N1024D, N1144D, N1176D, N1178D, N733D, N1133D, N1177D, N1212D, N734D, N777D, N1025D, N1145D, N1175D, N1181D, N1182D, N1188D, N1224D, N981D, N982D	Hereditary cancer-predisposing syndrome	VCV003329524	16	2131658	16	2081657	3329524	3489116		NC_000016.10:2081656:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3673A>T (p.Asn1225Tyr)	TSC2	N1024Y, N1025Y, N1028Y, N1132Y, N1133Y, N1144Y, N1145Y, N1162Y, N1175Y, N1176Y, N1177Y, N1178Y, N1181Y, N1182Y, N1188Y, N1192Y, N1211Y, N1212Y, N1224Y, N1225Y, N647Y, N733Y, N734Y, N777Y, N981Y, N982Y	Hereditary cancer-predisposing syndrome	VCV003232152	16	2131658	16	2081657	3232152	3391953	rs2544155419	NC_000016.10:2081656:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 23, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3674A>G (p.Asn1225Ser)	TSC2	N1133S, N1145S, N1181S, N1182S, N1192S, N1225S, N981S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001018012	16	2131659	16	2081658	1018012	1011984	rs1037743572	NC_000016.10:2081657:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3675C>T (p.Asn1225=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000468033	16	2131660	16	2081659	468033	465957	rs1483188996	NC_000016.10:2081658:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3676A>G (p.Met1226Val)	TSC2	M1226V, M1134V, M1146V, M1193V, M1182V, M1183V, M982V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405975	16	2131661	16	2081660	405975	401331	rs769283410	NC_000016.10:2081659:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3677T>C (p.Met1226Thr)	TSC2	M1146T, M1183T, M982T, M1193T, M1226T, M1134T, M1182T	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000843852	16	2131662	16	2081661	843852	843461	rs2090157003	NC_000016.10:2081660:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3678G>A (p.Met1226Ile)	TSC2	M1193I, M982I, M1226I, M1183I, M1134I, M1146I, M1182I	Tuberous sclerosis 2	VCV001403189	16	2131663	16	2081662	1403189	1392801	rs2151481846	NC_000016.10:2081661:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3679C>T (p.Pro1227Ser)	TSC2	P1227S, P983S, P1135S, P1147S, P1184S, P1183S, P1194S	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486656	16	2131664	16	2081663	486656	477353	rs1555512392	NC_000016.10:2081662:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3680C>A (p.Pro1227His)	TSC2	P1027H, P1177H, P1226H, P735H, P736H, P1026H, P1178H, P1190H, P1213H, P984H, P1135H, P1147H, P1194H, P1227H, P779H, P1030H, P1134H, P1146H, P1164H, P1179H, P1180H, P1183H, P1184H, P1214H, P649H, P983H	Hereditary cancer-predisposing syndrome	VCV003462686	16	2131665	16	2081664	3462686	3621705		NC_000016.10:2081663:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3680C>T (p.Pro1227Leu)	TSC2	P983L, P1147L, P1183L, P1184L, P1227L, P1135L, P1194L	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV001417629	16	2131665	16	2081664	1417629	1374116	rs2090157247	NC_000016.10:2081663:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3681C>G (p.Pro1227=)	TSC2		Tuberous sclerosis 2	VCV004071186	16	2131666	16	2081665	4071186	4185034		NC_000016.10:2081664:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3681C>T (p.Pro1227=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413629	16	2131666	16	2081665	413629	400943	rs181279399	NC_000016.10:2081664:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3681C>A (p.Pro1227=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000379631	16	2131666	16	2081665	379631	375198	rs181279399	NC_000016.10:2081664:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3682C>G (p.Leu1228Val)	TSC2	L1027V, L1028V, L1031V, L1135V, L1136V, L1147V, L1148V, L1165V, L1178V, L1179V, L1180V, L1181V, L1184V, L1185V, L1191V, L1195V, L1214V, L1215V, L1227V, L1228V, L650V, L736V, L737V, L780V, L984V, L985V	Tuberous sclerosis syndrome	VCV003386172	16	2131667	16	2081666	3386172	3545313		NC_000016.10:2081665:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3682C>T (p.Leu1228=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001598535	16	2131667	16	2081666	1598535	1630534	rs938124834	NC_000016.10:2081665:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3682C>A (p.Leu1228Met)	TSC2	L1136M, L1148M, L1184M, L1185M, L1195M, L1228M, L984M	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001050887	16	2131667	16	2081666	1050887	1049470	rs938124834	NC_000016.10:2081665:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3684G>A (p.Leu1228=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001149890	16	2131669	16	2081668	1149890	1145960	rs185457522	NC_000016.10:2081667:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3685C>T (p.Gln1229Ter)	TSC2	Q1229*, Q1186*, Q1137*, Q1185*, Q1196*, Q985*, Q1149*	Tuberous sclerosis 2|not provided	VCV000049270	16	2131670	16	2081669	49270	58432	rs45517306	NC_000016.10:2081668:C:T	single nucleotide variant	nonsense	Pathogenic	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3686A>G (p.Gln1229Arg)	TSC2	Q1229R, Q1185R, Q985R, Q1137R, Q1186R, Q1149R, Q1196R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406092	16	2131671	16	2081670	406092	400814	rs1060500962	NC_000016.10:2081669:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3687G>T (p.Gln1229His)	TSC2	Q1028H, Q1029H, Q1148H, Q1181H, Q1196H, Q1228H, Q1229H, Q738H, Q985H, Q1032H, Q1136H, Q1166H, Q1182H, Q651H, Q737H, Q1149H, Q1179H, Q1185H, Q1192H, Q1215H, Q1137H, Q1180H, Q1186H, Q1216H, Q781H, Q986H	Tuberous sclerosis 2	VCV002016405	16	2131672	16	2081671	2016405	2075611	rs140384709	NC_000016.10:2081670:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3687G>A (p.Gln1229=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468032	16	2131672	16	2081671	468032	465958	rs140384709	NC_000016.10:2081670:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3688G>A (p.Glu1230Lys)	TSC2	E1150K, E1183K, E1186K, E1197K, E1230K, E738K, E1029K, E1030K, E1137K, E1167K, E1181K, E1229K, E739K, E1138K, E1149K, E1182K, E1187K, E1193K, E1216K, E986K, E1033K, E1180K, E1217K, E652K, E782K, E987K	Tuberous sclerosis 2	VCV002090283	16	2131673	16	2081672	2090283	2152066	rs2151482097	NC_000016.10:2081671:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3688G>C (p.Glu1230Gln)	TSC2	E1187Q, E986Q, E1138Q, E1197Q, E1150Q, E1230Q, E1186Q	Tuberous sclerosis 2	VCV001389361	16	2131673	16	2081672	1389361	1487213	rs2151482097	NC_000016.10:2081671:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3690G>A (p.Glu1230=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000231525	16	2131675	16	2081674	231525	235125	rs876659207	NC_000016.10:2081673:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3691C>T (p.Leu1231=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002624598	16	2131676	16	2081675	2624598	2793687	rs2544156361	NC_000016.10:2081674:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3692T>C (p.Leu1231Pro)	TSC2	L1139P, L987P, L1151P, L1187P, L1188P, L1198P, L1231P	Tuberous sclerosis 2	VCV001040960	16	2131677	16	2081676	1040960	1032476	rs1055582947	NC_000016.10:2081675:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3694T>G (p.Ser1232Ala)	TSC2	S1152A, S1169A, S1184A, S1219A, S1031A, S1032A, S1140A, S1183A, S1188A, S1199A, S1218A, S740A, S784A, S989A, S1035A, S1151A, S1185A, S1195A, S1232A, S654A, S741A, S988A, S1139A, S1182A, S1189A, S1231A	Hereditary cancer-predisposing syndrome	VCV002626409	16	2131679	16	2081678	2626409	2794175	rs2544156569	NC_000016.10:2081677:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3695C>G (p.Ser1232Cys)	TSC2	S1031C, S1032C, S1035C, S1139C, S1140C, S1151C, S1152C, S1169C, S1182C, S1183C, S1184C, S1185C, S1188C, S1189C, S1195C, S1199C, S1218C, S1219C, S1231C, S1232C, S654C, S740C, S741C, S784C, S988C, S989C	Tuberous sclerosis syndrome	VCV003071108	16	2131680	16	2081679	3071108	3228689	rs886039876	NC_000016.10:2081678:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3695C>T (p.Ser1232Phe)	TSC2	S1232F, S988F, S1140F, S1152F, S1199F, S1188F, S1189F	Isolated focal cortical dysplasia type II	VCV000265989	16	2131680	16	2081679	265989	260800	rs886039876	NC_000016.10:2081678:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3696T>G (p.Ser1232=)	TSC2		Tuberous sclerosis 2	VCV001160519	16	2131681	16	2081680	1160519	1145961	rs767812115	NC_000016.10:2081679:T:G	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3696T>C (p.Ser1232=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000536009	16	2131681	16	2081680	536009	530244	rs767812115	NC_000016.10:2081679:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3698A>T (p.Asn1233Ile)	TSC2	N1153I, N1189I, N1141I, N1190I, N1200I, N989I, N1233I	Tuberous sclerosis 2	VCV001481562	16	2131683	16	2081682	1481562	1367080	rs1412376534	NC_000016.10:2081681:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3698A>G (p.Asn1233Ser)	TSC2	N1233S, N989S, N1141S, N1153S, N1200S, N1189S, N1190S	Hereditary cancer-predisposing syndrome	VCV000486663	16	2131683	16	2081682	486663	477958	rs1412376534	NC_000016.10:2081681:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.3699C>A (p.Asn1233Lys)	TSC2	N1033K, N1036K, N1140K, N1141K, N1186K, N1183K, N1184K, N1196K, N1232K, N741K, N785K, N1152K, N1153K, N1190K, N1200K, N655K, N990K, N1032K, N1170K, N1185K, N1189K, N1219K, N1220K, N1233K, N742K, N989K	Hereditary cancer-predisposing syndrome	VCV002449976	16	2131684	16	2081683	2449976	2429601	rs773240506	NC_000016.10:2081682:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3699C>T (p.Asn1233=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000468034	16	2131684	16	2081683	468034	465337	rs773240506	NC_000016.10:2081682:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3700G>A (p.Ala1234Thr)	TSC2	A1191T, A1234T, A990T, A1142T, A1190T, A1201T, A1154T	Tuberous sclerosis 2	VCV000860461	16	2131685	16	2081684	860461	843462	rs2090160412	NC_000016.10:2081683:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3701C>T (p.Ala1234Val)	TSC2	A1141V, A1142V, A1184V, A1185V, A1190V, A1197V, A1221V, A1233V, A743V, A786V, A1153V, A1171V, A1187V, A1220V, A1234V, A742V, A990V, A1154V, A991V, A1033V, A1034V, A1037V, A1186V, A1191V, A1201V, A656V	Tuberous sclerosis 2	VCV002704890	16	2131686	16	2081685	2704890	2863302	rs1596400191	NC_000016.10:2081684:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3702C>T (p.Ala1234=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001091199	16	2131687	16	2081686	1091199	1081842	rs760755935	NC_000016.10:2081685:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3703C>G (p.Leu1235Val)	TSC2	L1143V, L1155V, L1234V, L657V, L744V, L787V, L1172V, L1192V, L743V, L991V, L992V, L1034V, L1035V, L1154V, L1185V, L1186V, L1187V, L1221V, L1222V, L1038V, L1142V, L1188V, L1191V, L1198V, L1202V, L1235V	Tuberous sclerosis 2	VCV002114686	16	2131688	16	2081687	2114686	2164689	rs137854303	NC_000016.10:2081686:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3703C>T (p.Leu1235Phe)	TSC2	L1235F, L1191F, L1155F, L1192F, L1202F, L1143F, L991F	Tuberous sclerosis 2	VCV000049540	16	2131688	16	2081687	49540	58702	rs137854303	NC_000016.10:2081686:C:T	single nucleotide variant	missense variant	Benign	Mar 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3705C>T (p.Leu1235=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000536096	16	2131690	16	2081689	536096	529686	rs1386839308	NC_000016.10:2081688:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3706A>T (p.Met1236Leu)	TSC2	M1192L, M1144L, M1203L, M1156L, M1193L, M1236L, M992L	Tuberous sclerosis 2	VCV001352599	16	2131691	16	2081690	1352599	1505808	rs766501228	NC_000016.10:2081689:A:T	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3707T>C (p.Met1236Thr)	TSC2	M1236T, M1193T, M1144T, M1203T, M992T, M1156T, M1192T	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000571503	16	2131692	16	2081691	571503	569793	rs1567510644	NC_000016.10:2081690:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3708G>A (p.Met1236Ile)	TSC2	M1156I, M1173I, M1186I, M1235I, M1236I, M745I, M788I, M993I, M1035I, M1036I, M1039I, M1155I, M1187I, M1188I, M1193I, M1203I, M744I, M992I, M1143I, M1189I, M1192I, M1223I, M658I, M1144I, M1199I, M1222I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002075111	16	2131693	16	2081692	2075111	2134226	rs2544157414	NC_000016.10:2081691:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3710C>T (p.Ala1237Val)	TSC2	A1237V, A1204V, A1193V, A1194V, A1145V, A1157V, A993V	not provided|Tuberous sclerosis 2|TSC2-related disorder|Hereditary cancer-predisposing syndrome|not specified	VCV000383442	16	2131695	16	2081694	383442	374135	rs753907159	NC_000016.10:2081693:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3711G>T (p.Ala1237=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462527	16	2131696	16	2081695	3462527	3621547		NC_000016.10:2081694:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3711G>A (p.Ala1237=)	TSC2		Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not specified|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000405971	16	2131696	16	2081695	405971	400816	rs754945653	NC_000016.10:2081694:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3712G>T (p.Ala1238Ser)	TSC2	A1037S, A1038S, A1157S, A1175S, A1189S, A1195S, A747S, A790S, A1145S, A1188S, A1190S, A1201S, A1205S, A660S, A1158S, A1224S, A1225S, A1237S, A1238S, A994S, A995S, A1041S, A1146S, A1191S, A1194S, A746S	Hereditary cancer-predisposing syndrome	VCV002449991	16	2131697	16	2081696	2449991	2425948	rs2090161746	NC_000016.10:2081695:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3712G>A (p.Ala1238Thr)	TSC2	A1188T, A1191T, A1194T, A1205T, A746T, A994T, A1145T, A1158T, A1189T, A1190T, A1238T, A660T, A1037T, A1041T, A1157T, A1175T, A1225T, A1237T, A995T, A1038T, A1146T, A1195T, A1201T, A1224T, A747T, A790T	Tuberous sclerosis 2	VCV002009194	16	2131697	16	2081696	2009194	2073558	rs2090161746	NC_000016.10:2081695:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3713C>T (p.Ala1238Val)	TSC2	A1037V, A1038V, A1041V, A1145V, A1146V, A1157V, A1158V, A1175V, A1188V, A1189V, A1190V, A1191V, A1194V, A1195V, A1201V, A1205V, A1224V, A1225V, A1237V, A1238V, A660V, A746V, A747V, A790V, A994V, A995V	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003074648	16	2131698	16	2081697	3074648	3229615	rs2151482691	NC_000016.10:2081696:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3717G>A (p.Glu1239=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000752091	16	2131702	16	2081701	752091	770725	rs765060368	NC_000016.10:2081700:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3718C>T (p.Arg1240Cys)	TSC2	R1240C, R1197C, R1207C, R996C, R1148C, R1160C, R1196C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000050015	16	2131703	16	2081702	50015	59177	rs137854353	NC_000016.10:2081701:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3719G>T (p.Arg1240Leu)	TSC2	R1196L, R1207L, R1197L, R1240L, R996L, R1148L, R1160L	Tuberous sclerosis 2	VCV001044744	16	2131704	16	2081703	1044744	1032477	rs1567510707	NC_000016.10:2081702:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3719G>A (p.Arg1240His)	TSC2	R1148H, R1207H, R1160H, R1196H, R1197H, R996H, R1240H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000862069	16	2131704	16	2081703	862069	843463	rs1567510707	NC_000016.10:2081702:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3720C>A (p.Arg1240=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564691	16	2131705	16	2081704	2564691	2733847	rs2151482826	NC_000016.10:2081703:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3720C>G (p.Arg1240=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001142351	16	2131705	16	2081704	1142351	1145962	rs2151482826	NC_000016.10:2081703:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3720C>T (p.Arg1240=)	TSC2		Tuberous sclerosis 2	VCV001093154	16	2131705	16	2081704	1093154	1081843	rs2151482826	NC_000016.10:2081703:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3721T>C (p.Phe1241Leu)	TSC2	F1149L, F1161L, F1197L, F1198L, F1208L, F1241L, F997L	Tuberous sclerosis 2	VCV001025872	16	2131706	16	2081705	1025872	1011985	rs2090162360	NC_000016.10:2081704:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3723C>A (p.Phe1241Leu)	TSC2	F1149L, F1161L, F1197L, F1198L, F1208L, F1241L, F997L	Tuberous sclerosis 2	VCV001026077	16	2131708	16	2081707	1026077	1011986	rs45486193	NC_000016.10:2081706:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3723C>T (p.Phe1241=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000049271	16	2131708	16	2081707	49271	58433	rs45486193	NC_000016.10:2081706:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3725A>T (p.Lys1242Met)	TSC2	K1041M, K1045M, K1194M, K1199M, K794M, K999M, K1193M, K1228M, K750M, K751M, K998M, K1042M, K1150M, K1161M, K1162M, K1195M, K1205M, K1229M, K664M, K1198M, K1209M, K1241M, K1242M, K1149M, K1179M, K1192M	Hereditary cancer-predisposing syndrome	VCV002602462	16	2131710	16	2081709	2602462	2771028	rs1567510728	NC_000016.10:2081708:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3725A>G (p.Lys1242Arg)	TSC2	K998R, K1162R, K1198R, K1209R, K1242R, K1199R, K1150R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000864437	16	2131710	16	2081709	864437	843464	rs1567510728	NC_000016.10:2081708:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3726G>C (p.Lys1242Asn)	TSC2	K1150N, K1162N, K1199N, K998N, K1198N, K1209N, K1242N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001429392	16	2131711	16	2081710	1429392	1454508	rs1596400322	NC_000016.10:2081709:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3726G>A (p.Lys1242=)	TSC2		Tuberous sclerosis 2	VCV000759743	16	2131711	16	2081710	759743	770726	rs1596400322	NC_000016.10:2081709:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3727G>T (p.Glu1243Ter)	TSC2	E1243*, E1163*, E1151*, E1199*, E1200*, E1210*, E999*	not provided	VCV000379853	16	2131712	16	2081711	379853	374802	rs1057520759	NC_000016.10:2081710:G:T	single nucleotide variant	nonsense	Pathogenic	Jun 15, 2015	criteria provided, single submitter							
NM_000548.5(TSC2):c.3728A>G (p.Glu1243Gly)	TSC2	E1162G, E1194G, E1196G, E1199G, E1206G, E1229G, E1043G, E1151G, E1193G, E1242G, E665G, E751G, E795G, E1000G, E1042G, E1150G, E1163G, E1195G, E1210G, E1230G, E752G, E999G, E1046G, E1180G, E1200G, E1243G	Tuberous sclerosis 2	VCV002701402	16	2131713	16	2081712	2701402	2862396	rs2151482988	NC_000016.10:2081711:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3729G>A (p.Glu1243=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002089198	16	2131714	16	2081713	2089198	2144528	rs2151483009	NC_000016.10:2081712:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3729G>C (p.Glu1243Asp)	TSC2	E1151D, E1163D, E1199D, E1200D, E1210D, E1243D, E999D	not provided	VCV001305565	16	2131714	16	2081713	1305565	1298159	rs2151483009	NC_000016.10:2081712:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3730C>A (p.His1244Asn)	TSC2	H1164N, H1000N, H1200N, H1211N, H1152N, H1201N, H1244N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000862789	16	2131715	16	2081714	862789	843465	rs993614997	NC_000016.10:2081713:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3730C>T (p.His1244Tyr)	TSC2	H1244Y, H1164Y, H1200Y, H1201Y, H1152Y, H1000Y, H1211Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided	VCV000406079	16	2131715	16	2081714	406079	401336	rs993614997	NC_000016.10:2081713:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3731A>G (p.His1244Arg)	TSC2	H1000R, H1163R, H1194R, H1195R, H1207R, H1230R, H1243R, H1043R, H1047R, H1164R, H1181R, H1197R, H752R, H1151R, H1152R, H1196R, H1001R, H1044R, H1200R, H1201R, H1211R, H1244R, H753R, H1231R, H666R, H796R	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV002813557	16	2131716	16	2081715	2813557	2969507	rs2151483079	NC_000016.10:2081714:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3731A>T (p.His1244Leu)	TSC2	H1043L, H1164L, H1201L, H1231L, H1044L, H1047L, H1152L, H1163L, H1194L, H1197L, H1207L, H1243L, H753L, H796L, H1195L, H1196L, H1211L, H1244L, H752L, H1181L, H1200L, H1230L, H666L, H1000L, H1001L, H1151L	Hereditary cancer-predisposing syndrome	VCV001734397	16	2131716	16	2081715	1734397	1786816	rs2151483079	NC_000016.10:2081714:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3731A>C (p.His1244Pro)	TSC2	H1244P, H1200P, H1211P, H1000P, H1152P, H1164P, H1201P	Tuberous sclerosis 2	VCV001464568	16	2131716	16	2081715	1464568	1446113	rs2151483079	NC_000016.10:2081714:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3732C>T (p.His1244=)	TSC2		Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000468035	16	2131717	16	2081716	468035	465959	rs1264194267	NC_000016.10:2081715:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3733C>G (p.Arg1245Gly)	TSC2	R1001G, R1153G, R1165G, R1201G, R1202G, R1212G, R1245G	not provided	VCV001309551	16	2131718	16	2081717	1309551	1300250	rs777489742	NC_000016.10:2081716:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3733C>A (p.Arg1245=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis	VCV000413691	16	2131718	16	2081717	413691	401344	rs777489742	NC_000016.10:2081716:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3733C>T (p.Arg1245Trp)	TSC2	R1245W, R1153W, R1165W, R1001W, R1202W, R1212W, R1201W	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000318328	16	2131718	16	2081717	318328	324621	rs777489742	NC_000016.10:2081716:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3734G>C (p.Arg1245Pro)	TSC2	R1001P, R1153P, R1165P, R1201P, R1202P, R1212P, R1245P	Tuberous sclerosis 2	VCV001003157	16	2131719	16	2081718	1003157	996745	rs746588726	NC_000016.10:2081717:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3734G>A (p.Arg1245Gln)	TSC2	R1212Q, R1165Q, R1201Q, R1245Q, R1001Q, R1153Q, R1202Q	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000954608	16	2131719	16	2081718	954608	949260	rs746588726	NC_000016.10:2081717:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3735G>A (p.Arg1245=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000766314	16	2131720	16	2081719	766314	770727	rs756959674	NC_000016.10:2081718:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3736G>A (p.Asp1246Asn)	TSC2	D1002N, D1166N, D1202N, D1246N, D1154N, D1203N, D1213N	Tuberous sclerosis 2	VCV001364789	16	2131721	16	2081720	1364789	1409270	rs1596400382	NC_000016.10:2081719:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3736G>C (p.Asp1246His)	TSC2	D1154H, D1166H, D1213H, D1246H, D1002H, D1202H, D1203H	Tuberous sclerosis 2|not provided	VCV000663826	16	2131721	16	2081720	663826	644298	rs1596400382	NC_000016.10:2081719:G:C	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3738C>T (p.Asp1246=)	TSC2		not provided	VCV002645970	16	2131723	16	2081722	2645970	2810851	rs2544159212	NC_000016.10:2081721:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jun 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3739A>G (p.Thr1247Ala)	TSC2	T1247A, T1214A, T1204A, T1203A, T1003A, T1155A, T1167A	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000406101	16	2131724	16	2081723	406101	400824	rs369961807	NC_000016.10:2081722:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3740C>T (p.Thr1247Ile)	TSC2	T1046I, T1198I, T1204I, T669I, T756I, T799I, T1050I, T1155I, T1166I, T1210I, T1234I, T755I, T1004I, T1167I, T1184I, T1197I, T1199I, T1203I, T1247I, T1003I, T1047I, T1154I, T1200I, T1214I, T1233I, T1246I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002031652	16	2131725	16	2081724	2031652	2089556	rs2151483328	NC_000016.10:2081723:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3740C>G (p.Thr1247Arg)	TSC2	T1003R, T1155R, T1167R, T1203R, T1204R, T1214R, T1247R	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001052906	16	2131725	16	2081724	1052906	1049471	rs2151483328	NC_000016.10:2081723:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3741A>G (p.Thr1247=)	TSC2		Tuberous sclerosis 2	VCV003627338	16	2131726	16	2081725	3627338	3752518		NC_000016.10:2081724:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3743C>T (p.Ala1248Val)	TSC2	A1248V, A1004V, A1168V, A1204V, A1205V, A1156V, A1215V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535958	16	2131728	16	2081727	535958	529639	rs745342041	NC_000016.10:2081726:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3744C>A (p.Ala1248=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003232153	16	2131729	16	2081728	3232153	3391954	rs45517307	NC_000016.10:2081727:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3744C>G (p.Ala1248=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000757176	16	2131729	16	2081728	757176	770728	rs45517307	NC_000016.10:2081727:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3744C>T (p.Ala1248=)	TSC2		Tuberous sclerosis 2|not specified|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049548	16	2131729	16	2081728	49548	58710	rs45517307	NC_000016.10:2081727:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3745C>G (p.Leu1249Val)	TSC2	L1157V, L1249V, L1205V, L1005V, L1169V, L1206V, L1216V	Tuberous sclerosis 2	VCV001512638	16	2131730	16	2081729	1512638	1478888	rs1596400436	NC_000016.10:2081728:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3745C>A (p.Leu1249Met)	TSC2	L1005M, L1157M, L1206M, L1205M, L1169M, L1216M, L1249M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000863642	16	2131730	16	2081729	863642	843466	rs1596400436	NC_000016.10:2081728:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3745C>T (p.Leu1249=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824152	16	2131730	16	2081729	824152	812578	rs1596400436	NC_000016.10:2081728:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3746T>C (p.Leu1249Pro)	TSC2	L1005P, L1199P, L1201P, L1202P, L1248P, L1249P, L1048P, L1049P, L1156P, L1157P, L1168P, L1205P, L757P, L758P, L1052P, L1186P, L1236P, L801P, L1006P, L1169P, L1200P, L1206P, L1212P, L1216P, L1235P, L671P	Tuberous sclerosis 2	VCV002820930	16	2131731	16	2081730	2820930	2978175	rs2151483563	NC_000016.10:2081729:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3747G>A (p.Leu1249=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000468036	16	2131732	16	2081731	468036	465962	rs199593904	NC_000016.10:2081730:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3749A>G (p.Tyr1250Cys)	TSC2	Y1207C, Y1006C, Y1158C, Y1170C, Y1250C, Y1217C, Y1206C	Tuberous sclerosis 2	VCV000645453	16	2131734	16	2081733	645453	644299	rs1596400479	NC_000016.10:2081732:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3750C>T (p.Tyr1250=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413685	16	2131735	16	2081734	413685	400827	rs45517308	NC_000016.10:2081733:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3750C>G (p.Tyr1250Ter)	TSC2	Y1250*, Y1207*, Y1158*, Y1170*, Y1206*, Y1217*, Y1006*	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049550	16	2131735	16	2081734	49550	58712	rs45517308	NC_000016.10:2081733:C:G	single nucleotide variant	nonsense	Pathogenic	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3750C>A (p.Tyr1250Ter)	TSC2	Y1250*, Y1158*, Y1006*, Y1170*, Y1206*, Y1207*, Y1217*	Tuberous sclerosis 2	VCV000049549	16	2131735	16	2081734	49549	58711	rs45517308	NC_000016.10:2081733:C:A	single nucleotide variant	nonsense	Pathogenic	Sep 26, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3751A>G (p.Lys1251Glu)	TSC2	K1007E, K1159E, K1171E, K1207E, K1208E, K1218E, K1251E	Tuberous sclerosis 2	VCV001008518	16	2131736	16	2081735	1008518	996746	rs2090165820	NC_000016.10:2081734:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3753G>A (p.Lys1251=)	TSC2		Tuberous sclerosis 2	VCV002201294	16	2131738	16	2081737	2201294	1924831	rs1567511020	NC_000016.10:2081736:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3753G>T (p.Lys1251Asn)	TSC2	K1251N, K1218N, K1007N, K1159N, K1171N, K1207N, K1208N	Tuberous sclerosis 2	VCV000576147	16	2131738	16	2081737	576147	573843	rs1567511020	NC_000016.10:2081736:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3756A>C (p.Ser1252=)	TSC2		Tuberous sclerosis 2	VCV002115342	16	2131741	16	2081740	2115342	2161578	rs1228112359	NC_000016.10:2081739:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3756A>G (p.Ser1252=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000758285	16	2131741	16	2081740	758285	770729	rs1228112359	NC_000016.10:2081739:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3757C>T (p.Leu1253=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824166	16	2131742	16	2081741	824166	812579	rs1596400529	NC_000016.10:2081740:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3759G>A (p.Leu1253=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001097070	16	2131744	16	2081743	1097070	1081844	rs878854095	NC_000016.10:2081742:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3759G>C (p.Leu1253=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000238025	16	2131744	16	2081743	238025	242286	rs878854095	NC_000016.10:2081742:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3760T>C (p.Ser1254Pro)	TSC2	S1010P, S1011P, S1053P, S1054P, S1057P, S1161P, S1162P, S1173P, S1174P, S1191P, S1204P, S1205P, S1206P, S1207P, S1210P, S1211P, S1217P, S1221P, S1240P, S1241P, S1253P, S1254P, S676P, S762P, S763P, S806P	Tuberous sclerosis syndrome	VCV003072401	16	2131745	16	2081744	3072401	3230842	rs2544160694	NC_000016.10:2081743:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3761C>A (p.Ser1254Ter)	TSC2	S1010*, S1054*, S1162*, S1191*, S1217*, S1253*, S1210*, S1211*, S1254*, S763*, S806*, S1161*, S1174*, S1205*, S1207*, S1240*, S762*, S1011*, S1053*, S1057*, S1173*, S1204*, S1206*, S1221*, S1241*, S676*	Tuberous sclerosis 2|not provided	VCV002098888	16	2131746	16	2081745	2098888	2154203	rs1596400563	NC_000016.10:2081744:C:A	single nucleotide variant	nonsense	Pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3761C>G (p.Ser1254Trp)	TSC2	S1010W, S1162W, S1174W, S1210W, S1211W, S1221W, S1254W	Tuberous sclerosis 2	VCV001020019	16	2131746	16	2081745	1020019	1011987	rs1596400563	NC_000016.10:2081744:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3761C>T (p.Ser1254Leu)	TSC2	S1010L, S1221L, S1254L, S1162L, S1174L, S1210L, S1211L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000640728	16	2131746	16	2081745	640728	644300	rs1596400563	NC_000016.10:2081744:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3762G>T (p.Ser1254=)	TSC2		Tuberous sclerosis 2	VCV002005052	16	2131747	16	2081746	2005052	2055680	rs144891432	NC_000016.10:2081745:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3762G>A (p.Ser1254=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000238026	16	2131747	16	2081746	238026	242287	rs144891432	NC_000016.10:2081745:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3763G>C (p.Val1255Leu)	TSC2	V1163L, V1175L, V1222L, V1255L, V1211L, V1212L, V1011L	Hereditary cancer-predisposing syndrome	VCV000824177	16	2131748	16	2081747	824177	812580	rs1596400585	NC_000016.10:2081746:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3765G>T (p.Val1255=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003232154	16	2131750	16	2081749	3232154	3391955	rs2151483991	NC_000016.10:2081748:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3767C>T (p.Pro1256Leu)	TSC2	P1012L, P1223L, P1176L, P1212L, P1164L, P1213L, P1256L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000652658	16	2131752	16	2081751	652658	644301	rs1596400594	NC_000016.10:2081750:C:T	single nucleotide variant	missense variant	Uncertain significance	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3768G>T (p.Pro1256=)	TSC2		Tuberous sclerosis 2	VCV004071338	16	2131753	16	2081752	4071338	4185186		NC_000016.10:2081751:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3768G>A (p.Pro1256=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000281623	16	2131753	16	2081752	281623	265860	rs201599540	NC_000016.10:2081751:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3770C>T (p.Ala1257Val)	TSC2	A1257V, A1214V, A1165V, A1224V, A1013V, A1213V, A1177V	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided|Hereditary cancer-predisposing syndrome	VCV000041734	16	2131755	16	2081754	41734	50173	rs45466493	NC_000016.10:2081753:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3772G>C (p.Ala1258Pro)	TSC2	A1178P, A1215P, A1225P, A1258P, A1166P, A1014P, A1214P	Tuberous sclerosis 2|not provided	VCV000937246	16	2131757	16	2081756	937246	937330	rs2090168528	NC_000016.10:2081755:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3773C>T (p.Ala1258Val)	TSC2	A1014V, A1015V, A1057V, A1058V, A1061V, A1165V, A1166V, A1177V, A1178V, A1195V, A1208V, A1209V, A1210V, A1211V, A1214V, A1215V, A1221V, A1225V, A1244V, A1245V, A1257V, A1258V, A680V, A766V, A767V, A810V	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003071028	16	2131758	16	2081757	3071028	3228611	rs1060500958	NC_000016.10:2081756:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3773C>A (p.Ala1258Asp)	TSC2	A1215D, A1225D, A1014D, A1166D, A1214D, A1178D, A1258D	Tuberous sclerosis 2	VCV001350854	16	2131758	16	2081757	1350854	1492442	rs1060500958	NC_000016.10:2081756:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3773C>G (p.Ala1258Gly)	TSC2	A1258G, A1225G, A1166G, A1178G, A1014G, A1214G, A1215G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406085	16	2131758	16	2081757	406085	401346	rs1060500958	NC_000016.10:2081756:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3774C>T (p.Ala1258=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000232170	16	2131759	16	2081758	232170	235126	rs876659596	NC_000016.10:2081757:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3775A>G (p.Ser1259Gly)	TSC2	S1016G, S1058G, S1216G, S1222G, S1226G, S681G, S1062G, S1166G, S1167G, S1196G, S1209G, S1211G, S1215G, S1245G, S1246G, S1258G, S1259G, S1015G, S1179G, S1059G, S1178G, S1210G, S1212G, S767G, S768G, S811G	Hereditary cancer-predisposing syndrome	VCV001734789	16	2131760	16	2081759	1734789	1796581	rs2544161638	NC_000016.10:2081758:A:G	single nucleotide variant	missense variant	Likely benign	Jul 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3776G>A (p.Ser1259Asn)	TSC2	S1167N, S1215N, S1226N, S1015N, S1179N, S1259N, S1216N	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000650007	16	2131761	16	2081760	650007	644302	rs1596400661	NC_000016.10:2081759:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3777C>T (p.Ser1259=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000185446	16	2131762	16	2081761	185446	184140	rs786202178	NC_000016.10:2081760:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3778A>G (p.Thr1260Ala)	TSC2	T1168A, T1180A, T1216A, T1217A, T1260A, T1016A, T1227A	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000836095	16	2131763	16	2081762	836095	843467	rs1310948800	NC_000016.10:2081761:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 15, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3779C>G (p.Thr1260Arg)	TSC2	T1168R, T1216R, T1227R, T1260R, T1016R, T1180R, T1217R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001426525	16	2131764	16	2081763	1426525	1366198	rs776738338	NC_000016.10:2081762:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3779C>T (p.Thr1260Met)	TSC2	T1260M, T1227M, T1016M, T1168M, T1216M, T1217M, T1180M	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000381049	16	2131764	16	2081763	381049	374140	rs776738338	NC_000016.10:2081762:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3780G>C (p.Thr1260=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002626456	16	2131765	16	2081764	2626456	2794222	rs199742312	NC_000016.10:2081763:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3780G>T (p.Thr1260=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001734849	16	2131765	16	2081764	1734849	1796641	rs199742312	NC_000016.10:2081763:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3780G>A (p.Thr1260=)	TSC2		not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000378787	16	2131765	16	2081764	378787	375199	rs199742312	NC_000016.10:2081763:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3781G>A (p.Ala1261Thr)	TSC2	A1169T, A1217T, A1218T, A1228T, A1261T, A1181T, A1017T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000945522	16	2131766	16	2081765	945522	927667	rs2090170043	NC_000016.10:2081764:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3782C>T (p.Ala1261Val)	TSC2	A1181V, A1217V, A1228V, A1261V, A1169V, A1017V, A1218V	Tuberous sclerosis 2	VCV001410149	16	2131767	16	2081766	1410149	1513457	rs45517310	NC_000016.10:2081765:C:T	single nucleotide variant	missense variant	Benign	May 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3782C>A (p.Ala1261Asp)	TSC2	A1261D, A1218D, A1228D, A1017D, A1169D, A1217D, A1181D	not provided	VCV000049567	16	2131767	16	2081766	49567	58729	rs45517310	NC_000016.10:2081765:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3783C>T (p.Ala1261=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001097513	16	2131768	16	2081767	1097513	1081845	rs2090170500	NC_000016.10:2081766:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3785A>T (p.Lys1262Ile)	TSC2	K1169I, K1170I, K1182I, K1229I, K1249I, K1261I, K814I, K1214I, K1218I, K684I, K770I, K1062I, K1065I, K1181I, K1215I, K1225I, K1262I, K771I, K1018I, K1019I, K1061I, K1199I, K1212I, K1213I, K1219I, K1248I	Tuberous sclerosis 2	VCV002081896	16	2131770	16	2081769	2081896	2135850	rs765255206	NC_000016.10:2081768:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3785A>G (p.Lys1262Arg)	TSC2	K1262R, K1218R, K1219R, K1229R, K1170R, K1018R, K1182R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468039	16	2131770	16	2081769	468039	465339	rs765255206	NC_000016.10:2081768:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3786A>C (p.Lys1262Asn)	TSC2	K1018N, K1019N, K1061N, K1062N, K1065N, K1169N, K1170N, K1181N, K1182N, K1199N, K1212N, K1213N, K1214N, K1215N, K1218N, K1219N, K1225N, K1229N, K1248N, K1249N, K1261N, K1262N, K684N, K770N, K771N, K814N	Tuberous sclerosis syndrome	VCV003386173	16	2131771	16	2081770	3386173	3545314		NC_000016.10:2081769:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3786A>G (p.Lys1262=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001586247	16	2131771	16	2081770	1586247	1593892	rs752513898	NC_000016.10:2081769:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3787C>G (p.Pro1263Ala)	TSC2	P1019A, P1170A, P1250A, P771A, P1062A, P1063A, P1066A, P1183A, P1200A, P1216A, P1220A, P1226A, P1230A, P772A, P815A, P1213A, P1215A, P1249A, P1263A, P1020A, P1171A, P1182A, P1214A, P1219A, P1262A, P685A	Tuberous sclerosis 2	VCV003637224	16	2131772	16	2081771	3637224	3771378		NC_000016.10:2081770:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3787C>A (p.Pro1263Thr)	TSC2	P1019T, P1020T, P1062T, P1063T, P1066T, P1170T, P1171T, P1182T, P1183T, P1200T, P1213T, P1214T, P1215T, P1216T, P1219T, P1220T, P1226T, P1230T, P1249T, P1250T, P1262T, P1263T, P685T, P771T, P772T, P815T	Tuberous sclerosis syndrome	VCV003072477	16	2131772	16	2081771	3072477	3230918	rs1233661099	NC_000016.10:2081770:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3787C>T (p.Pro1263Ser)	TSC2	P1183S, P1219S, P1263S, P1171S, P1220S, P1019S, P1230S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided	VCV000641062	16	2131772	16	2081771	641062	644303	rs1233661099	NC_000016.10:2081770:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3788C>A (p.Pro1263His)	TSC2	P1020H, P1063H, P1171H, P1214H, P1249H, P685H, P1062H, P1170H, P1182H, P1213H, P1216H, P1219H, P1220H, P772H, P1066H, P1215H, P1226H, P1250H, P1262H, P771H, P1019H, P1183H, P1200H, P1230H, P1263H, P815H	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV002145463	16	2131773	16	2081772	2145463	1879949	rs1057523452	NC_000016.10:2081771:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3788C>T (p.Pro1263Leu)	TSC2	P1263L, P1183L, P1219L, P1019L, P1171L, P1220L, P1230L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000389507	16	2131773	16	2081772	389507	374804	rs1057523452	NC_000016.10:2081771:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3789C>G (p.Pro1263=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564617	16	2131774	16	2081773	2564617	2733773	rs2151484598	NC_000016.10:2081772:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3789C>T (p.Pro1263=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001094631	16	2131774	16	2081773	1094631	1081846	rs2151484598	NC_000016.10:2081772:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3790C>A (p.Pro1264Thr)	TSC2	P1021T, P1171T, P1216T, P1217T, P1220T, P1227T, P1263T, P1020T, P1063T, P1172T, P1214T, P1221T, P1250T, P1251T, P686T, P816T, P1064T, P1067T, P1231T, P1264T, P772T, P1183T, P1184T, P1201T, P1215T, P773T	Tuberous sclerosis 2	VCV002899997	16	2131775	16	2081774	2899997	3063996	rs2090171531	NC_000016.10:2081773:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3790C>T (p.Pro1264Ser)	TSC2	P1020S, P1172S, P1184S, P1220S, P1221S, P1231S, P1264S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001018920	16	2131775	16	2081774	1018920	1011988	rs2090171531	NC_000016.10:2081773:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3792T>G (p.Pro1264=)	TSC2		Tuberous sclerosis 2	VCV004071056	16	2131777	16	2081776	4071056	4184904		NC_000016.10:2081775:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3792T>C (p.Pro1264=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413626	16	2131777	16	2081776	413626	401351	rs763855971	NC_000016.10:2081775:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3793C>G (p.Pro1265Ala)	TSC2	P1021A, P1173A, P1185A, P1221A, P1222A, P1232A, P1265A	not provided|Tuberous sclerosis 2	VCV001310402	16	2131778	16	2081777	1310402	1302252	rs45517311	NC_000016.10:2081776:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3793C>T (p.Pro1265Ser)	TSC2	P1265S, P1221S, P1222S, P1021S, P1173S, P1232S, P1185S	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000050020	16	2131778	16	2081777	50020	59182	rs45517311	NC_000016.10:2081776:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3794C>T (p.Pro1265Leu)	TSC2	P1021L, P1221L, P1222L, P1185L, P1265L, P1232L, P1173L	Tuberous sclerosis 2	VCV001509577	16	2131779	16	2081778	1509577	1365197	rs1424206593	NC_000016.10:2081777:C:T	single nucleotide variant	missense variant	Benign	Jan 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3795T>C (p.Pro1265=)	TSC2		Tuberous sclerosis 2	VCV004071045	16	2131780	16	2081779	4071045	4184893		NC_000016.10:2081778:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	May 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3795T>A (p.Pro1265=)	TSC2		Tuberous sclerosis 2	VCV002013149	16	2131780	16	2081779	2013149	2071086	rs2544163223	NC_000016.10:2081778:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3796C>G (p.Leu1266Val)	TSC2	L1023V, L1216V, L1219V, L1222V, L1233V, L1253V, L818V, L1022V, L1174V, L1223V, L1252V, L688V, L774V, L1065V, L1066V, L1185V, L1217V, L1218V, L1229V, L1265V, L1069V, L1173V, L1186V, L1203V, L1266V, L775V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001734981	16	2131781	16	2081780	1734981	1793320	rs2090172721	NC_000016.10:2081779:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3796C>T (p.Leu1266=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001089015	16	2131781	16	2081780	1089015	1081847	rs2090172721	NC_000016.10:2081779:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3798G>T (p.Leu1266=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462669	16	2131783	16	2081782	3462669	3621688		NC_000016.10:2081781:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3798G>C (p.Leu1266=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001735000	16	2131783	16	2081782	1735000	1793339	rs1187813837	NC_000016.10:2081781:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3798G>A (p.Leu1266=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000748006	16	2131783	16	2081782	748006	754999	rs1187813837	NC_000016.10:2081781:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3799C>T (p.Pro1267Ser)	TSC2	P1267S, P1023S, P1187S, P1234S, P1223S, P1224S, P1175S	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000452681	16	2131784	16	2081783	452681	445524	rs757010959	NC_000016.10:2081782:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3800C>T (p.Pro1267Leu)	TSC2	P1023L, P1175L, P1234L, P1224L, P1187L, P1223L, P1267L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001441976	16	2131785	16	2081784	1441976	1382050	rs1245115663	NC_000016.10:2081783:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3801T>C (p.Pro1267=)	TSC2		Tuberous sclerosis 2	VCV002846184	16	2131786	16	2081785	2846184	3008544	rs2544163507	NC_000016.10:2081784:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3802C>G (p.Arg1268Gly)	TSC2	R1025G, R1187G, R1219G, R1220G, R1255G, R1267G, R690G, R1068G, R1071G, R1188G, R1218G, R1224G, R1254G, R1268G, R1231G, R1235G, R776G, R777G, R820G, R1024G, R1067G, R1175G, R1176G, R1205G, R1221G, R1225G	Tuberous sclerosis 2	VCV003637225	16	2131787	16	2081786	3637225	3771379		NC_000016.10:2081785:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3802C>T (p.Arg1268Cys)	TSC2	R1268C, R1176C, R1225C, R1235C, R1188C, R1024C, R1224C	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000486637	16	2131787	16	2081786	486637	477357	rs1020561347	NC_000016.10:2081785:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3803G>C (p.Arg1268Pro)	TSC2	R1024P, R1067P, R1188P, R1255P, R776P, R777P, R1175P, R1187P, R1220P, R1221P, R1224P, R1231P, R1235P, R1254P, R1268P, R1068P, R1071P, R1205P, R1219P, R1225P, R820P, R1025P, R1176P, R1218P, R1267P, R690P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002835546	16	2131788	16	2081787	2835546	2999204	rs200577441	NC_000016.10:2081786:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3803G>T (p.Arg1268Leu)	TSC2	R1176L, R1188L, R1224L, R1024L, R1235L, R1225L, R1268L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000951136	16	2131788	16	2081787	951136	927668	rs200577441	NC_000016.10:2081786:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3803G>A (p.Arg1268His)	TSC2	R1268H, R1176H, R1024H, R1188H, R1235H, R1224H, R1225H	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000065034	16	2131788	16	2081787	65034	75964	rs200577441	NC_000016.10:2081786:G:A	single nucleotide variant	missense variant	Benign/Likely benign	May 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3804C>T (p.Arg1268=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001628001	16	2131789	16	2081788	1628001	1584569	rs1358080651	NC_000016.10:2081787:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3805T>C (p.Ser1269Pro)	TSC2	S1189P, S1225P, S1269P, S1177P, S1236P, S1025P, S1226P	Tuberous sclerosis 2	VCV000942998	16	2131790	16	2081789	942998	937331	rs991523072	NC_000016.10:2081788:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3806C>T (p.Ser1269Phe)	TSC2	S1025F, S1026F, S1068F, S1069F, S1072F, S1176F, S1177F, S1188F, S1189F, S1206F, S1219F, S1220F, S1221F, S1222F, S1225F, S1226F, S1232F, S1236F, S1255F, S1256F, S1268F, S1269F, S691F, S777F, S778F, S821F	not provided	VCV003389675	16	2131791	16	2081790	3389675	3548798		NC_000016.10:2081789:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3806C>G (p.Ser1269Cys)	TSC2	S1025C, S1026C, S1068C, S1069C, S1072C, S1176C, S1177C, S1188C, S1189C, S1206C, S1219C, S1220C, S1221C, S1222C, S1225C, S1226C, S1232C, S1236C, S1255C, S1256C, S1268C, S1269C, S691C, S777C, S778C, S821C	Tuberous sclerosis 2	VCV003064495	16	2131791	16	2081790	3064495	3224699	rs1464179701	NC_000016.10:2081789:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3807C>T (p.Ser1269=)	TSC2		Tuberous sclerosis 2	VCV000702885	16	2131792	16	2081791	702885	693818	rs1596400911	NC_000016.10:2081790:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3808A>C (p.Asn1270His)	TSC2	N1069H, N1177H, N1222H, N1223H, N1257H, N1026H, N1027H, N1178H, N1190H, N1207H, N1220H, N778H, N779H, N1221H, N1226H, N1227H, N1237H, N1256H, N1269H, N1270H, N1070H, N1073H, N1189H, N1233H, N692H, N822H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV001735113	16	2131793	16	2081792	1735113	1793452	rs2544163886	NC_000016.10:2081791:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3809A>G (p.Asn1270Ser)	TSC2	N1270S, N1026S, N1226S, N1227S, N1237S, N1178S, N1190S	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535915	16	2131794	16	2081793	535915	529979	rs1304251276	NC_000016.10:2081792:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3810C>A (p.Asn1270Lys)	TSC2	N1177K, N1207K, N1226K, N1257K, N1270K, N779K, N1073K, N1178K, N1227K, N1233K, N1256K, N1026K, N1027K, N1189K, N1220K, N1223K, N1237K, N692K, N1069K, N1070K, N1190K, N1221K, N1222K, N1269K, N778K, N822K	Hereditary cancer-predisposing syndrome	VCV003462621	16	2131795	16	2081794	3462621	3621640		NC_000016.10:2081793:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3810C>T (p.Asn1270=)	TSC2		Tuberous sclerosis 2	VCV002814449	16	2131795	16	2081794	2814449	2976402	rs2544163997	NC_000016.10:2081793:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3811A>G (p.Thr1271Ala)	TSC2	T1027A, T1028A, T1071A, T1178A, T1190A, T1208A, T1222A, T780A, T1224A, T1228A, T1271A, T693A, T779A, T1070A, T1179A, T1227A, T1257A, T1074A, T1191A, T1221A, T1223A, T1234A, T1238A, T1258A, T1270A, T823A	Tuberous sclerosis 2	VCV003637226	16	2131796	16	2081795	3637226	3771380		NC_000016.10:2081794:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3812C>G (p.Thr1271Arg)	TSC2	T1179R, T1238R, T1271R, T1027R, T1227R, T1191R, T1228R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001465472	16	2131797	16	2081796	1465472	1353705	rs1567511623	NC_000016.10:2081795:C:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3812C>T (p.Thr1271Ile)	TSC2	T1271I, T1227I, T1027I, T1179I, T1191I, T1228I, T1238I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000567402	16	2131797	16	2081796	567402	573844	rs1567511623	NC_000016.10:2081795:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3813A>G (p.Thr1271=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468040	16	2131798	16	2081797	468040	465965	rs1555512577	NC_000016.10:2081796:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3814G>C (p.Val1272Leu)	TSC2	D1180H, D1192H, D1228H, D1229H, D1239H, D1272H, V1028L, V1228L, V1229L, V1272L	Tuberous sclerosis 2	VCV000999086	16	2131799	16	2081798	999086	996747	rs2090175224	NC_000016.10:2081797:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+1G>C	TSC2		not provided	VCV000065032	16	2131800	16	2081799	65032	75962	rs397514902	NC_000016.10:2081798:G:C	single nucleotide variant	splice donor variant	Likely pathogenic	Jul 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+1G>A	TSC2		Tuberous sclerosis 2	VCV000064876	16	2131800	16	2081799	64876	75805	rs397514902	NC_000016.10:2081798:G:A	single nucleotide variant	splice donor variant	Pathogenic	Mar 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+2T>G	TSC2		Hereditary cancer-predisposing syndrome	VCV001735184	16	2131801	16	2081800	1735184	1793523	rs2544164322	NC_000016.10:2081799:T:G	single nucleotide variant	splice donor variant	Likely pathogenic	Aug 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+5G>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003974592	16	2131804	16	2081803	3974592	4086415		NC_000016.10:2081802:G:T	single nucleotide variant	intron variant	Uncertain significance	May 7, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+5G>A	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535869	16	2131804	16	2081803	535869	529644	rs1555512582	NC_000016.10:2081802:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3814+6T>C	TSC2		Tuberous sclerosis 2	VCV003692899	16	2131805	16	2081804	3692899	3828397		NC_000016.10:2081803:T:C	single nucleotide variant	intron variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+7G>A	TSC2		Tuberous sclerosis 2	VCV001088077	16	2131806	16	2081805	1088077	1081848	rs372189946	NC_000016.10:2081804:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3814+8G>T	TSC2		Tuberous sclerosis 2	VCV002093032	16	2131807	16	2081806	2093032	2145773	rs1297489453	NC_000016.10:2081805:G:T	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+8G>A	TSC2		Tuberous sclerosis 2	VCV001970618	16	2131807	16	2081806	1970618	2025461	rs1297489453	NC_000016.10:2081805:G:A	single nucleotide variant	intron variant	Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3814+8G>C	TSC2		Tuberous sclerosis 2	VCV000536023	16	2131807	16	2081806	536023	529987	rs1297489453	NC_000016.10:2081805:G:C	single nucleotide variant	intron variant	Likely benign	Oct 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+9C>T	TSC2		Tuberous sclerosis 2	VCV001046743	16	2131808	16	2081807	1046743	1032478	rs371944932	NC_000016.10:2081806:C:T	single nucleotide variant	intron variant	Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3814+9C>A	TSC2		Tuberous sclerosis 2	VCV000761813	16	2131808	16	2081807	761813	776168	rs371944932	NC_000016.10:2081806:C:A	single nucleotide variant	intron variant	Benign/Likely benign	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3814+10A>G	TSC2		not specified|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000514041	16	2131809	16	2081808	514041	505217	rs200309006	NC_000016.10:2081807:A:G	single nucleotide variant	intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3814+13G>A	TSC2		Tuberous sclerosis 2	VCV002828566	16	2131812	16	2081811	2828566	2987085	rs2544164770	NC_000016.10:2081810:G:A	single nucleotide variant	intron variant	Likely benign	Jan 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+14C>A	TSC2		Tuberous sclerosis 2	VCV002756038	16	2131813	16	2081812	2756038	2914183	rs374139943	NC_000016.10:2081811:C:A	single nucleotide variant	intron variant	Likely benign	Jun 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+14C>T	TSC2		not specified|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001471639	16	2131813	16	2081812	1471639	1388667	rs374139943	NC_000016.10:2081811:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3814+15G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000387000	16	2131814	16	2081813	387000	374812	rs201225719	NC_000016.10:2081812:G:A	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3814+17G>T	TSC2		Tuberous sclerosis 2	VCV002149061	16	2131816	16	2081815	2149061	1877509	rs1567511733	NC_000016.10:2081814:G:T	single nucleotide variant	intron variant	Likely benign	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+18C>T	TSC2		Tuberous sclerosis 2	VCV001567444	16	2131817	16	2081816	1567444	1591604	rs2090177503	NC_000016.10:2081815:C:T	single nucleotide variant	intron variant	Likely benign	Aug 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+19C>G	TSC2		Tuberous sclerosis 2	VCV001996440	16	2131818	16	2081817	1996440	2053515	rs778036099	NC_000016.10:2081816:C:G	single nucleotide variant	intron variant	Likely benign	Jan 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+20T>C	TSC2		Tuberous sclerosis 2	VCV002982073	16	2131819	16	2081818	2982073	3152728	rs2544164987	NC_000016.10:2081817:T:C	single nucleotide variant	intron variant	Likely benign	Sep 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3814+141C>T	TSC2		not provided	VCV000677552	16	2131940	16	2081939	677552	668401	rs7196774	NC_000016.10:2081938:C:T	single nucleotide variant	intron variant	Benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-308T>C	TSC2		not provided	VCV000672863	16	2132129	16	2082128	672863	668404	rs186379642	NC_000016.10:2082127:T:C	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-155A>G	TSC2		not provided	VCV000677818	16	2132282	16	2082281	677818	668213	rs187607083	NC_000016.10:2082280:A:G	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3815-58C>T	TSC2		not provided	VCV001219806	16	2132379	16	2082378	1219806	1209784	rs145101905	NC_000016.10:2082377:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-21G>A	TSC2		Tuberous sclerosis 2	VCV002130134	16	2132416	16	2082415	2130134	2189411	rs778201014	NC_000016.10:2082414:G:A	single nucleotide variant	intron variant	Benign	Nov 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-20C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000137746	16	2132417	16	2082416	137746	141449	rs201878712	NC_000016.10:2082415:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3815-18C>T	TSC2		Tuberous sclerosis 2	VCV001951246	16	2132419	16	2082418	1951246	2013975	rs947736117	NC_000016.10:2082417:C:T	single nucleotide variant	intron variant	Likely benign	Nov 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-18C>G	TSC2		Tuberous sclerosis 2	VCV001525781	16	2132419	16	2082418	1525781	1395837	rs947736117	NC_000016.10:2082417:C:G	single nucleotide variant	intron variant	Uncertain significance	Apr 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-18C>A	TSC2		not specified|Tuberous sclerosis 2	VCV000388948	16	2132419	16	2082418	388948	377255	rs947736117	NC_000016.10:2082417:C:A	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3815-16C>A	TSC2		Tuberous sclerosis 2	VCV002144850	16	2132421	16	2082420	2144850	1873252	rs546810161	NC_000016.10:2082419:C:A	single nucleotide variant	intron variant	Uncertain significance	Sep 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-16C>T	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|not specified	VCV000378788	16	2132421	16	2082420	378788	374143	rs546810161	NC_000016.10:2082419:C:T	single nucleotide variant	intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3815-15G>T	TSC2		Tuberous sclerosis 2	VCV002713119	16	2132422	16	2082421	2713119	2879265	rs45480591	NC_000016.10:2082420:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3815-15G>A	TSC2		not provided|Tuberous sclerosis syndrome|Lung lymphangioleiomyomatosis|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050023	16	2132422	16	2082421	50023	59185	rs45480591	NC_000016.10:2082420:G:A	single nucleotide variant	intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3815-14G>A	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002057224	16	2132423	16	2082422	2057224	2106046	rs2151492084	NC_000016.10:2082421:G:A	single nucleotide variant	intron variant	Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3815-9C>G	TSC2		Tuberous sclerosis 2	VCV001044299	16	2132428	16	2082427	1044299	1032479	rs1060504091	NC_000016.10:2082426:C:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-9C>T	TSC2		Tuberous sclerosis 2	VCV000413647	16	2132428	16	2082427	413647	401616	rs1060504091	NC_000016.10:2082426:C:T	single nucleotide variant	intron variant	Likely benign	May 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-8C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001130375	16	2132429	16	2082428	1130375	1125077	rs1596404187	NC_000016.10:2082427:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3815-8C>G	TSC2		not provided|Tuberous sclerosis 2	VCV000652339	16	2132429	16	2082428	652339	652714	rs1596404187	NC_000016.10:2082427:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3815-7C>T	TSC2		Tuberous sclerosis 2	VCV002814985	16	2132430	16	2082429	2814985	2973515	rs1441898498	NC_000016.10:2082428:C:T	single nucleotide variant	intron variant	Likely benign	Oct 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-7C>G	TSC2		Tuberous sclerosis 2	VCV000963987	16	2132430	16	2082429	963987	960147	rs1441898498	NC_000016.10:2082428:C:G	single nucleotide variant	intron variant	Likely benign	Nov 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-5T>C	TSC2		Tuberous sclerosis 2	VCV003684856	16	2132432	16	2082431	3684856	3808843		NC_000016.10:2082430:T:C	single nucleotide variant	intron variant	Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3815-5T>A	TSC2		Tuberous sclerosis 2	VCV002820780	16	2132432	16	2082431	2820780	2978025	rs2544188528	NC_000016.10:2082430:T:A	single nucleotide variant	intron variant	Uncertain significance	Dec 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-4G>T	TSC2		not provided|Tuberous sclerosis 2	VCV000753155	16	2132433	16	2082432	753155	776132	rs1410163756	NC_000016.10:2082431:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3815-4G>A	TSC2		Tuberous sclerosis 2	VCV000745250	16	2132433	16	2082432	745250	760415	rs1410163756	NC_000016.10:2082431:G:A	single nucleotide variant	intron variant	Likely benign	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-3C>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468041	16	2132434	16	2082433	468041	466235	rs770054036	NC_000016.10:2082432:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3815-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000406073	16	2132434	16	2082433	406073	400837	rs770054036	NC_000016.10:2082432:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3815-2A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002153828	16	2132435	16	2082434	2153828	1892603	rs1567513626	NC_000016.10:2082433:A:G	single nucleotide variant	intron variant|splice acceptor variant	Uncertain significance	Jan 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3815-2A>T	TSC2		Tuberous sclerosis 2	VCV000569645	16	2132435	16	2082434	569645	569796	rs1567513626	NC_000016.10:2082433:A:T	single nucleotide variant	intron variant|splice acceptor variant	Uncertain significance	May 17, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3815-1G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000979125	16	2132436	16	2082435	979125	967160	rs2090256621	NC_000016.10:2082434:G:A	single nucleotide variant	intron variant|splice acceptor variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3815T>C (p.Val1272Ala)	TSC2	V1271A, V780A, V1072A, V1272A, V1228A, V1229A, V1028A, V781A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001735196	16	2132437	16	2082436	1735196	1793535	rs1319528505	NC_000016.10:2082435:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3815T>G (p.Val1272Gly)	TSC2	V1228G, V1028G, V1229G, V1272G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000663001	16	2132437	16	2082436	663001	644304	rs1319528505	NC_000016.10:2082435:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3816G>A (p.Val1272=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000049835	16	2132438	16	2082437	49835	58997	rs45517314	NC_000016.10:2082436:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3817G>T (p.Ala1273Ser)	TSC2	A1029S, A1073S, A1229S, A1230S, A1272S, A1273S, A781S, A782S	Hereditary cancer-predisposing syndrome	VCV003232155	16	2132439	16	2082438	3232155	3391956	rs1596404280	NC_000016.10:2082437:G:T	single nucleotide variant	intron variant|missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3817G>A (p.Ala1273Thr)	TSC2	A1029T, A1229T, A1273T, A1230T	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000824256	16	2132439	16	2082438	824256	812581	rs1596404280	NC_000016.10:2082437:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3818C>T (p.Ala1273Val)	TSC2	A1273V, A1230V, A1029V, A1229V	not provided|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000380401	16	2132440	16	2082439	380401	377260	rs749367382	NC_000016.10:2082438:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3819C>T (p.Ala1273=)	TSC2		Tuberous sclerosis 2	VCV002741819	16	2132441	16	2082440	2741819	2906465	rs1248167345	NC_000016.10:2082439:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3819C>G (p.Ala1273=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001156785	16	2132441	16	2082440	1156785	1145963	rs1248167345	NC_000016.10:2082439:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3819C>A (p.Ala1273=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536007	16	2132441	16	2082440	536007	529989	rs1248167345	NC_000016.10:2082439:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3820T>C (p.Ser1274Pro)	TSC2	S1030P, S1274P, S1230P, S1231P	Tuberous sclerosis 2	VCV000959327	16	2132442	16	2082441	959327	949261	rs534533805	NC_000016.10:2082440:T:C	single nucleotide variant	missense variant|intron variant	Benign	Aug 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3821C>T (p.Ser1274Phe)	TSC2	S1030F, S1230F, S1273F, S1274F, S782F, S1074F, S1231F, S783F	Hereditary cancer-predisposing syndrome	VCV003811278	16	2132443	16	2082442	3811278	3928520		NC_000016.10:2082441:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3821C>G (p.Ser1274Cys)	TSC2	S1230C, S1273C, S1274C, S782C, S783C, S1030C, S1074C, S1231C	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV003578801	16	2132443	16	2082442	3578801	3708222		NC_000016.10:2082441:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 21, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3823T>C (p.Phe1275Leu)	TSC2	F1031L, F1231L, F1232L, F1275L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001015836	16	2132445	16	2082444	1015836	1011990	rs2090258908	NC_000016.10:2082443:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3825C>T (p.Phe1275=)	TSC2		Tuberous sclerosis 2	VCV004071212	16	2132447	16	2082446	4071212	4185060		NC_000016.10:2082445:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	May 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3825C>G (p.Phe1275Leu)	TSC2	F1031L, F1075L, F1231L, F1232L, F1274L, F1275L, F783L, F784L	not provided	VCV002571769	16	2132447	16	2082446	2571769	2736716	rs761713908	NC_000016.10:2082445:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3825C>A (p.Phe1275Leu)	TSC2	F1275L, F1031L, F1231L, F1232L	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000565415	16	2132447	16	2082446	565415	573845	rs761713908	NC_000016.10:2082445:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3826T>G (p.Ser1276Ala)	TSC2	S1232A, S1276A, S1032A, S1233A	Tuberous sclerosis 2	VCV001512339	16	2132448	16	2082447	1512339	1478589	rs2151492520	NC_000016.10:2082446:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3827C>T (p.Ser1276Phe)	TSC2	S1276F, S1233F, S1032F, S1232F	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000041735	16	2132449	16	2082448	41735	50174	rs45478595	NC_000016.10:2082447:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3828C>T (p.Ser1276=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002192318	16	2132450	16	2082449	2192318	1925817	rs773135685	NC_000016.10:2082448:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3829T>G (p.Ser1277Ala)	TSC2	S1277A, S1033A, S1234A, S1233A	Tuberous sclerosis 2	VCV000934723	16	2132451	16	2082450	934723	937332	rs2090259818	NC_000016.10:2082449:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 5, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3830C>G (p.Ser1277Cys)	TSC2	S1077C, S1277C, S1234C, S786C, S1276C, S785C, S1033C, S1233C	Hereditary cancer-predisposing syndrome	VCV003811303	16	2132452	16	2082451	3811303	3928544		NC_000016.10:2082450:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3830C>T (p.Ser1277Phe)	TSC2	S1033F, S1277F, S1233F, S1234F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000854083	16	2132452	16	2082451	854083	843470	rs1330915229	NC_000016.10:2082450:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3831C>T (p.Ser1277=)	TSC2		Tuberous sclerosis 2	VCV003651083	16	2132453	16	2082452	3651083	3777761		NC_000016.10:2082451:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	May 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3832C>G (p.Leu1278Val)	TSC2	L1034V, L1234V, L1235V, L1278V	Tuberous sclerosis syndrome	VCV001172744	16	2132454	16	2082453	1172744	1161935	rs374146919	NC_000016.10:2082452:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3832C>T (p.Leu1278=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000468042	16	2132454	16	2082453	468042	465967	rs374146919	NC_000016.10:2082452:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3833T>C (p.Leu1278Pro)	TSC2	L1235P, L1278P, L1034P, L1234P	Tuberous sclerosis 2	VCV001463413	16	2132455	16	2082454	1463413	1507976	rs568015523	NC_000016.10:2082453:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3834G>A (p.Leu1278=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000735798	16	2132456	16	2082455	735798	755000	rs766029525	NC_000016.10:2082454:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Oct 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3834G>C (p.Leu1278=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238027	16	2132456	16	2082455	238027	242288	rs766029525	NC_000016.10:2082454:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3835T>C (p.Tyr1279His)	TSC2	Y1279H, Y1035H, Y1235H, Y1236H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000824276	16	2132457	16	2082456	824276	812582	rs1449727037	NC_000016.10:2082455:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3836A>T (p.Tyr1279Phe)	TSC2	Y1278F, Y787F, Y788F, Y1079F, Y1235F, Y1236F, Y1279F, Y1035F	Hereditary cancer-predisposing syndrome	VCV003811294	16	2132458	16	2082457	3811294	3928535		NC_000016.10:2082456:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3837C>T (p.Tyr1279=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000743610	16	2132459	16	2082458	743610	755001	rs1555512861	NC_000016.10:2082457:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3837C>G (p.Tyr1279Ter)	TSC2	Y1279*, Y1035*, Y1236*, Y1235*	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535896	16	2132459	16	2082458	535896	529687	rs1555512861	NC_000016.10:2082457:C:G	single nucleotide variant	nonsense|intron variant	Uncertain significance	Apr 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3838C>T (p.Gln1280Ter)	TSC2	Q1036*, Q1080*, Q1236*, Q1237*, Q1279*, Q1280*, Q788*, Q789*	not provided	VCV003772024	16	2132460	16	2082459	3772024	3888173		NC_000016.10:2082458:C:T	single nucleotide variant	intron variant|nonsense|non-coding transcript variant	Pathogenic	Dec 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3838C>G (p.Gln1280Glu)	TSC2	Q1237E, Q1279E, Q1280E, Q788E, Q789E, Q1080E, Q1036E, Q1236E	Hereditary cancer-predisposing syndrome	VCV003329473	16	2132460	16	2082459	3329473	3489065		NC_000016.10:2082458:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3839A>G (p.Gln1280Arg)	TSC2	Q1237R, Q788R, Q1036R, Q1279R, Q1280R, Q789R, Q1080R, Q1236R	Tuberous sclerosis 2	VCV002037535	16	2132461	16	2082460	2037535	2094157	rs1596404506	NC_000016.10:2082459:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 8, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3839A>T (p.Gln1280Leu)	TSC2	Q1236L, Q1280L, Q1036L, Q1237L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000824279	16	2132461	16	2082460	824279	812583	rs1596404506	NC_000016.10:2082459:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3840G>A (p.Gln1280=)	TSC2		Tuberous sclerosis 2	VCV004071303	16	2132462	16	2082461	4071303	4185151		NC_000016.10:2082460:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	May 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3840G>C (p.Gln1280His)	TSC2	Q1280H, Q1237H, Q1036H, Q1236H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406030	16	2132462	16	2082461	406030	401361	rs1060500941	NC_000016.10:2082460:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3841T>G (p.Ser1281Ala)	TSC2	S1281A, S1037A, S1237A, S1238A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000583139	16	2132463	16	2082462	583139	567844	rs1358527360	NC_000016.10:2082461:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3842C>T (p.Ser1281Phe)	TSC2	S1081F, S1237F, S1280F, S1281F, S789F, S790F, S1037F, S1238F	Hereditary cancer-predisposing syndrome	VCV003974680	16	2132464	16	2082463	3974680	4086503		NC_000016.10:2082462:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3843C>T (p.Ser1281=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000766864	16	2132465	16	2082464	766864	703554	rs1223688571	NC_000016.10:2082463:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3844A>C (p.Ser1282Arg)	TSC2	S1038R, S1238R, S1239R, S1282R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001052995	16	2132466	16	2082465	1052995	1049472	rs45446700	NC_000016.10:2082464:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3845G>T (p.Ser1282Ile)	TSC2	S1282I, S1239I, S1038I, S1238I	Tuberous sclerosis 2	VCV000644205	16	2132467	16	2082466	644205	644305	rs1596404603	NC_000016.10:2082465:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 19, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3846C>T (p.Ser1282=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001082958	16	2132468	16	2082467	1082958	1081849	rs1596404651	NC_000016.10:2082466:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3846C>G (p.Ser1282Arg)	TSC2	S1239R, S1282R, S1038R, S1238R	Tuberous sclerosis 2	VCV000798155	16	2132468	16	2082467	798155	785203	rs1596404651	NC_000016.10:2082466:C:G	single nucleotide variant	missense variant|intron variant	Benign	Apr 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3847T>C (p.Cys1283Arg)	TSC2	C1240R, C1282R, C791R, C1039R, C1083R, C1283R, C1239R, C792R	Hereditary cancer-predisposing syndrome	VCV002564642	16	2132469	16	2082468	2564642	2733798	rs2544190835	NC_000016.10:2082467:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3850C>G (p.Gln1284Glu)	TSC2	Q1040E, Q1084E, Q793E, Q1240E, Q1283E, Q792E, Q1241E, Q1284E	Tuberous sclerosis 2	VCV002908184	16	2132472	16	2082471	2908184	3069782	rs753308966	NC_000016.10:2082470:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3850C>T (p.Gln1284Ter)	TSC2	Q1284*, Q1241*, Q1240*, Q1040*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000238028	16	2132472	16	2082471	238028	242289	rs753308966	NC_000016.10:2082470:C:T	single nucleotide variant	nonsense|intron variant	Benign/Likely benign	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3851A>G (p.Gln1284Arg)	TSC2	Q1284R, Q1040R, Q1240R, Q1241R	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535957	16	2132473	16	2082472	535957	529646	rs944693159	NC_000016.10:2082471:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3853G>A (p.Gly1285Arg)	TSC2	G1242R, G1285R, G1041R, G1241R	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000859070	16	2132475	16	2082474	859070	843471	rs2090264891	NC_000016.10:2082473:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3854G>A (p.Gly1285Glu)	TSC2	G1041E, G1241E, G1242E, G1285E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000961557	16	2132476	16	2082475	961557	949262	rs2090265081	NC_000016.10:2082474:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3855A>G (p.Gly1285=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000413672	16	2132477	16	2082476	413672	401618	rs891262541	NC_000016.10:2082475:A:G	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	May 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3856C>T (p.Gln1286Ter)	TSC2	Q1042*, Q1242*, Q1243*, Q1286*	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001062612	16	2132478	16	2082477	1062612	1049473	rs2151493215	NC_000016.10:2082476:C:T	single nucleotide variant	nonsense|intron variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3857A>G (p.Gln1286Arg)	TSC2	Q1242R, Q1285R, Q1042R, Q1086R, Q1286R, Q794R, Q1243R, Q795R	Hereditary cancer-predisposing syndrome	VCV003811335	16	2132479	16	2082478	3811335	3928576		NC_000016.10:2082477:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3858G>A (p.Gln1286=)	TSC2		not provided	VCV003371428	16	2132480	16	2082479	3371428	3530618		NC_000016.10:2082478:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3859C>T (p.Leu1287=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002102811	16	2132481	16	2082480	2102811	2161871	rs1425321534	NC_000016.10:2082479:C:T	single nucleotide variant	intron variant|synonymous variant|non-coding transcript variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3860T>C (p.Leu1287Pro)	TSC2	L1043P, L1087P, L1243P, L1244P, L1286P, L1287P, L795P, L796P	not provided	VCV001810136	16	2132482	16	2082481	1810136	1867140	rs2544191550	NC_000016.10:2082480:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3861G>A (p.Leu1287=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001735615	16	2132483	16	2082482	1735615	1790109	rs2151493248	NC_000016.10:2082481:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 8, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3861G>C (p.Leu1287=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001546728	16	2132483	16	2082482	1546728	1645704	rs2151493248	NC_000016.10:2082481:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3863A>C (p.His1288Pro)	TSC2	H1288P, H1044P, H1244P, H1245P	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000581187	16	2132485	16	2082484	581187	573847	rs1567514069	NC_000016.10:2082483:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3864C>T (p.His1288=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001563886	16	2132486	16	2082485	1563886	1588907	rs2151493292	NC_000016.10:2082484:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3865A>G (p.Arg1289Gly)	TSC2	R1245G, R1289G, R1045G, R1246G	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000855361	16	2132487	16	2082486	855361	843472	rs2090265922	NC_000016.10:2082485:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3866G>A (p.Arg1289Lys)	TSC2	R1289K, R1245K, R1246K, R1045K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000572483	16	2132488	16	2082487	572483	573853	rs900604900	NC_000016.10:2082486:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3867G>A (p.Arg1289=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001548285	16	2132489	16	2082488	1548285	1538103	rs1008733639	NC_000016.10:2082487:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3867G>C (p.Arg1289Ser)	TSC2	R1245S, R1289S, R1246S, R1045S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824319	16	2132489	16	2082488	824319	812584	rs1008733639	NC_000016.10:2082487:G:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 3, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3867G>T (p.Arg1289Ser)	TSC2	R1245S, R1289S, R1246S, R1045S	not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000642278	16	2132489	16	2082488	642278	644306	rs1008733639	NC_000016.10:2082487:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3869G>C (p.Ser1290Thr)	TSC2	S1246T, S1247T, S1090T, S1290T, S1046T, S799T, S1289T, S798T	Hereditary cancer-predisposing syndrome	VCV002626438	16	2132491	16	2082490	2626438	2794204	rs2090266691	NC_000016.10:2082489:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3870C>T (p.Ser1290=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468043	16	2132492	16	2082491	468043	466237	rs754466663	NC_000016.10:2082490:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3870C>G (p.Ser1290Arg)	TSC2	S1290R, S1046R, S1246R, S1247R	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406113	16	2132492	16	2082491	406113	400949	rs754466663	NC_000016.10:2082490:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3871G>T (p.Val1291Phe)	TSC2	V1291F, V1047F, V1247F, V1248F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000567147	16	2132493	16	2082492	567147	573854	rs201135184	NC_000016.10:2082491:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3871G>A (p.Val1291Ile)	TSC2	V1291I, V1248I, V1047I, V1247I	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000064847	16	2132493	16	2082492	64847	75776	rs201135184	NC_000016.10:2082491:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3874T>G (p.Ser1292Ala)	TSC2	S1248A, S1292A, S801A, S1291A, S1048A, S1092A, S1249A, S800A	Hereditary cancer-predisposing syndrome	VCV001735741	16	2132496	16	2082495	1735741	1786902	rs1166042912	NC_000016.10:2082494:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3874T>C (p.Ser1292Pro)	TSC2	S1249P, S1048P, S1248P, S1292P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000807950	16	2132496	16	2082495	807950	797276	rs1166042912	NC_000016.10:2082494:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Sep 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3875C>T (p.Ser1292Phe)	TSC2	S1292F, S1048F, S1248F, S1249F	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468044	16	2132497	16	2082496	468044	466029	rs796053497	NC_000016.10:2082495:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3875C>G (p.Ser1292Cys)	TSC2	S1292C, S1048C, S1248C, S1249C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000207748	16	2132497	16	2082496	207748	203178	rs796053497	NC_000016.10:2082495:C:G	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3876C>G (p.Ser1292=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003072431	16	2132498	16	2082497	3072431	3230872	rs1173548095	NC_000016.10:2082496:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3876C>T (p.Ser1292=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV002893855	16	2132498	16	2082497	2893855	3045787	rs1173548095	NC_000016.10:2082496:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3876C>A (p.Ser1292=)	TSC2		Tuberous sclerosis 2	VCV001095128	16	2132498	16	2082497	1095128	1081852	rs1173548095	NC_000016.10:2082496:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3877T>G (p.Trp1293Gly)	TSC2	W1049G, W1093G, W1249G, W1293G, W1250G, W1292G, W801G, W802G	Hereditary cancer-predisposing syndrome	VCV002564692	16	2132499	16	2082498	2564692	2733848	rs1596404879	NC_000016.10:2082497:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3877T>C (p.Trp1293Arg)	TSC2	W1250R, W1093R, W1249R, W1292R, W802R, W801R, W1049R, W1293R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001966080	16	2132499	16	2082498	1966080	2021471	rs1596404879	NC_000016.10:2082497:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3878G>A (p.Trp1293Ter)	TSC2	W1049*, W1293*, W1250*, W1249*	Tuberous sclerosis 2	VCV000856912	16	2132500	16	2082499	856912	843473	rs2090268487	NC_000016.10:2082498:G:A	single nucleotide variant	nonsense|intron variant	Uncertain significance	Mar 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3879G>A (p.Trp1293Ter)	TSC2	W1049*, W1093*, W1249*, W1250*, W1292*, W1293*, W801*, W802*	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003386174	16	2132501	16	2082500	3386174	3545315		NC_000016.10:2082499:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Uncertain significance	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3879G>T (p.Trp1293Cys)	TSC2	W1049C, W1249C, W1093C, W1250C, W1292C, W801C, W1293C, W802C	Hereditary cancer-predisposing syndrome	VCV002564719	16	2132501	16	2082500	2564719	2733875	rs2544192629	NC_000016.10:2082499:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3880G>A (p.Ala1294Thr)	TSC2	A1251T, A802T, A1050T, A1094T, A1250T, A1293T, A1294T, A803T	Tuberous sclerosis 2	VCV002716861	16	2132502	16	2082501	2716861	2876559	rs2544192673	NC_000016.10:2082500:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3881C>T (p.Ala1294Val)	TSC2	A1050V, A1250V, A802V, A1251V, A1294V, A803V, A1094V, A1293V	Hereditary cancer-predisposing syndrome	VCV002626441	16	2132503	16	2082502	2626441	2794207	rs2544192725	NC_000016.10:2082501:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883G>A (p.Asp1295Asn)	TSC2	D1051N, D1251N, D1252N, D1295N	Hereditary cancer-predisposing syndrome	VCV001692496	16	2132505	16	2082504	1692496	1684936	rs2090268813	NC_000016.10:2082503:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+1G>C	TSC2	G1251A	Tuberous sclerosis syndrome	VCV003073489	16	2132506	16	2082505	3073489	3234445	rs2090268989	NC_000016.10:2082504:G:C	single nucleotide variant	missense variant|intron variant|splice donor variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+1G>T	TSC2	G1251V	Tuberous sclerosis 2|not provided	VCV001931755	16	2132506	16	2082505	1931755	1982018	rs2090268989	NC_000016.10:2082504:G:T	single nucleotide variant	missense variant|intron variant|splice donor variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3883+1G>A	TSC2	G1251D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001021490	16	2132506	16	2082505	1021490	1011991	rs2090268989	NC_000016.10:2082504:G:A	single nucleotide variant	missense variant|intron variant|splice donor variant	Uncertain significance	Mar 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3883+2T>C	TSC2		Tuberous sclerosis 2	VCV002751437	16	2132507	16	2082506	2751437	2908733	rs2090269194	NC_000016.10:2082505:T:C	single nucleotide variant	synonymous variant|intron variant|splice donor variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+2T>G	TSC2		not provided	VCV001314110	16	2132507	16	2082506	1314110	1304371	rs2090269194	NC_000016.10:2082505:T:G	single nucleotide variant	synonymous variant|intron variant|splice donor variant	Uncertain significance	Feb 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+3A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000824334	16	2132508	16	2082507	824334	815616	rs1366233650	NC_000016.10:2082506:A:G	single nucleotide variant	intron variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3883+4T>G	TSC2	I1252S	Tuberous sclerosis 2	VCV003611381	16	2132509	16	2082508	3611381	3744947		NC_000016.10:2082507:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+4T>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001504408	16	2132509	16	2082508	1504408	1337283	rs2090269579	NC_000016.10:2082507:T:C	single nucleotide variant	intron variant	Uncertain significance	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3883+5C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049855	16	2132510	16	2082509	49855	59017	rs45448994	NC_000016.10:2082508:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 21, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3883+6G>A	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000406112	16	2132511	16	2082510	406112	400954	rs757751865	NC_000016.10:2082509:G:A	single nucleotide variant	intron variant	Benign/Likely benign	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3883+7C>A	TSC2		Tuberous sclerosis 2	VCV001642166	16	2132512	16	2082511	1642166	1651209	rs2151493855	NC_000016.10:2082510:C:A	single nucleotide variant	intron variant	Likely benign	Mar 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+8C>T	TSC2		Tuberous sclerosis 2	VCV001088861	16	2132513	16	2082512	1088861	1081853	rs45517316	NC_000016.10:2082511:C:T	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3883+8C>G	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050027	16	2132513	16	2082512	50027	59189	rs45517316	NC_000016.10:2082511:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3883+9T>C	TSC2	S1254P	Tuberous sclerosis 2	VCV004071061	16	2132514	16	2082513	4071061	4184909		NC_000016.10:2082512:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+10C>T	TSC2	S1254F	Tuberous sclerosis 2	VCV002809068	16	2132515	16	2082514	2809068	2965019	rs2544193272	NC_000016.10:2082513:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Feb 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+10C>G	TSC2	S1254C	Tuberous sclerosis 2	VCV002020429	16	2132515	16	2082514	2020429	2079613	rs2544193272	NC_000016.10:2082513:C:G	single nucleotide variant	missense variant|intron variant	Likely benign	Nov 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+12C>T	TSC2	Q1255*	Tuberous sclerosis 2	VCV003611340	16	2132517	16	2082516	3611340	3744906		NC_000016.10:2082515:C:T	single nucleotide variant	nonsense|intron variant	Likely benign	Dec 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+14G>C	TSC2	Q1255H	Tuberous sclerosis 2	VCV002852548	16	2132519	16	2082518	2852548	3010192	rs2544193412	NC_000016.10:2082517:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+15A>T	TSC2	R1256W	Tuberous sclerosis 2	VCV002762649	16	2132520	16	2082519	2762649	2931143	rs112925751	NC_000016.10:2082518:A:T	single nucleotide variant	missense variant|intron variant	Likely benign	Sep 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+15A>G	TSC2		Tuberous sclerosis 2	VCV001611880	16	2132520	16	2082519	1611880	1535508	rs112925751	NC_000016.10:2082518:A:G	single nucleotide variant	intron variant	Likely benign	Oct 20, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+15A>C	TSC2		Tuberous sclerosis 2	VCV001586768	16	2132520	16	2082519	1586768	1628708	rs112925751	NC_000016.10:2082518:A:C	single nucleotide variant	intron variant	Likely benign	Jun 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+16G>A	TSC2	R1256K	Tuberous sclerosis 2	VCV002038372	16	2132521	16	2082520	2038372	2101441	rs746215819	NC_000016.10:2082519:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+17G>A	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001583456	16	2132522	16	2082521	1583456	1601152	rs1207142968	NC_000016.10:2082520:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3883+20A>G	TSC2		Tuberous sclerosis 2	VCV003662404	16	2132525	16	2082524	3662404	3794838		NC_000016.10:2082523:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+37C>T	TSC2		not provided	VCV000049512	16	2132542	16	2082541	49512	58674	rs45517315	NC_000016.10:2082540:C:T	single nucleotide variant	intron variant	Benign	Mar 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+38G>A	TSC2		not provided	VCV004084647	16	2132543	16	2082542	4084647	4197332		NC_000016.10:2082541:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+66G>A	TSC2		not provided	VCV000670878	16	2132571	16	2082570	670878	667417	rs74002774	NC_000016.10:2082569:G:A	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+68C>T	TSC2		not provided	VCV003771538	16	2132573	16	2082572	3771538	3887687		NC_000016.10:2082571:C:T	single nucleotide variant	intron variant	Likely benign	Feb 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+69G>A	TSC2		not provided	VCV003771460	16	2132574	16	2082573	3771460	3887610		NC_000016.10:2082572:G:A	single nucleotide variant	intron variant	Likely benign	Dec 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+78G>A	TSC2		not provided	VCV000049278	16	2132583	16	2082582	49278	58440	rs1800705	NC_000016.10:2082581:G:A	single nucleotide variant	intron variant	Likely benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3883+94C>T	TSC2		not provided	VCV003905616	16	2132599	16	2082598	3905616	4021488		NC_000016.10:2082597:C:T	single nucleotide variant	intron variant	Likely benign	Jun 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3883+226G>A	TSC2		not provided	VCV001248085	16	2132731	16	2082730	1248085	1238039	rs9928737	NC_000016.10:2082729:G:A	single nucleotide variant	intron variant	Benign	Jun 21, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-68C>T	TSC2		not provided	VCV000673264	16	2133628	16	2083627	673264	668406	rs114209035	NC_000016.10:2083626:C:T	single nucleotide variant	intron variant	Likely benign	Jun 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-56C>G	TSC2		not provided	VCV000049900	16	2133640	16	2083639	49900	59062	rs1800724	NC_000016.10:2083638:C:G	single nucleotide variant	intron variant	Benign	Jun 22, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-37A>T	TSC2		not specified	VCV000256630	16	2133659	16	2083658	256630	255497	rs886038356	NC_000016.10:2083657:A:T	single nucleotide variant	intron variant	Benign		criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-32C>T	TSC2		not specified	VCV000256629	16	2133664	16	2083663	256629	255498	rs886038355	NC_000016.10:2083662:C:T	single nucleotide variant	intron variant	Likely benign		criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-20C>T	TSC2		Tuberous sclerosis 2	VCV004071139	16	2133676	16	2083675	4071139	4184987		NC_000016.10:2083674:C:T	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-19C>T	TSC2		Tuberous sclerosis 2	VCV002785441	16	2133677	16	2083676	2785441	2945288	rs2151509370	NC_000016.10:2083675:C:T	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-19C>G	TSC2		Tuberous sclerosis 2	VCV001572186	16	2133677	16	2083676	1572186	1538255	rs2151509370	NC_000016.10:2083675:C:G	single nucleotide variant	intron variant	Likely benign	Apr 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-18C>T	TSC2		Tuberous sclerosis 2	VCV002768288	16	2133678	16	2083677	2768288	2929456	rs879594483	NC_000016.10:2083676:C:T	single nucleotide variant	intron variant	Likely benign	Oct 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-18C>G	TSC2		Tuberous sclerosis 2	VCV001558648	16	2133678	16	2083677	1558648	1595237	rs879594483	NC_000016.10:2083676:C:G	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-17C>T	TSC2		Tuberous sclerosis 2	VCV001654453	16	2133679	16	2083678	1654453	1527271	rs45517317	NC_000016.10:2083677:C:T	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-17C>A	TSC2		Tuberous sclerosis 2	VCV001597408	16	2133679	16	2083678	1597408	1664942	rs45517317	NC_000016.10:2083677:C:A	single nucleotide variant	intron variant	Likely benign	Nov 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-17C>G	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000049513	16	2133679	16	2083678	49513	58675	rs45517317	NC_000016.10:2083677:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3884-16G>C	TSC2		Tuberous sclerosis 2	VCV002710232	16	2133680	16	2083679	2710232	2871256	rs544004178	NC_000016.10:2083678:G:C	single nucleotide variant	intron variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-16G>A	TSC2		not specified|Tuberous sclerosis 2	VCV000516148	16	2133680	16	2083679	516148	505218	rs544004178	NC_000016.10:2083678:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-15T>A	TSC2		Tuberous sclerosis 2	VCV001542270	16	2133681	16	2083680	1542270	1609807	rs2090412969	NC_000016.10:2083679:T:A	single nucleotide variant	intron variant	Likely benign	Nov 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-14C>T	TSC2		Tuberous sclerosis 2	VCV004071098	16	2133682	16	2083681	4071098	4184946		NC_000016.10:2083680:C:T	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-12G>A	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001585461	16	2133684	16	2083683	1585461	1539977	rs1282062597	NC_000016.10:2083682:G:A	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-10G>A	TSC2		Tuberous sclerosis 2	VCV002916980	16	2133686	16	2083685	2916980	3077042	rs1318587547	NC_000016.10:2083684:G:A	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-8C>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000468045	16	2133688	16	2083687	468045	465342	rs397515219	NC_000016.10:2083686:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3884-8C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065299	16	2133688	16	2083687	65299	76231	rs397515219	NC_000016.10:2083686:C:T	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-7C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000792589	16	2133689	16	2083688	792589	788000	rs1277989059	NC_000016.10:2083687:C:T	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-5C>A	TSC2		Hereditary cancer-predisposing syndrome	VCV002564741	16	2133691	16	2083690	2564741	2733897	rs980261526	NC_000016.10:2083689:C:A	single nucleotide variant	intron variant	Uncertain significance	Jun 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-5C>T	TSC2		Tuberous sclerosis 2	VCV001120649	16	2133691	16	2083690	1120649	1125078	rs980261526	NC_000016.10:2083689:C:T	single nucleotide variant	intron variant	Likely benign	Oct 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-5C>G	TSC2		Tuberous sclerosis 2	VCV000760084	16	2133691	16	2083690	760084	776309	rs980261526	NC_000016.10:2083689:C:G	single nucleotide variant	intron variant	Likely benign	May 15, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-4C>T	TSC2		Tuberous sclerosis 2	VCV002050085	16	2133692	16	2083691	2050085	2104089	rs2151509808	NC_000016.10:2083690:C:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-4C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001617491	16	2133692	16	2083691	1617491	1548568	rs2151509808	NC_000016.10:2083690:C:G	single nucleotide variant	intron variant	Likely benign	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884-3C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000940837	16	2133693	16	2083692	940837	940350	rs2090415795	NC_000016.10:2083691:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3884-2A>T	TSC2		Tuberous sclerosis 2	VCV000049515	16	2133694	16	2083693	49515	58677	rs137854053	NC_000016.10:2083692:A:T	single nucleotide variant	splice acceptor variant	Pathogenic	Apr 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-1G>T	TSC2		Tuberous sclerosis 2	VCV001339106	16	2133695	16	2083694	1339106	1330149	rs137854079	NC_000016.10:2083693:G:T	single nucleotide variant	splice acceptor variant	Likely pathogenic		criteria provided, single submitter							
NM_000548.5(TSC2):c.3884-1G>C	TSC2		not provided|Tuberous sclerosis 2	VCV000065005	16	2133695	16	2083694	65005	75935	rs137854079	NC_000016.10:2083693:G:C	single nucleotide variant	splice acceptor variant	Pathogenic	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3884A>G (p.Asp1295Gly)	TSC2	D1051G, D1228G, D1251G, D1192G, D1180G, D1229G, D1239G, D1252G, D1272G, D1295G	Tuberous sclerosis 2	VCV001041467	16	2133696	16	2083695	1041467	1032480	rs2090416468	NC_000016.10:2083694:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3885C>T (p.Asp1295=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000282972	16	2133697	16	2083696	282972	267209	rs766771526	NC_000016.10:2083695:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3886T>G (p.Ser1296Ala)	TSC2	S1052A, S1073A, S1240A, S1252A, S1273A, S1030A, S1076A, S1192A, S1224A, S1229A, S825A, S1029A, S1181A, S1193A, S1223A, S1225A, S1226A, S1230A, S1236A, S1270A, S1296A, S695A, S781A, S1072A, S1096A, S1180A, S1210A, S1253A, S1259A, S1260A, S1272A, S1295A, S782A, S804A, S805A	Tuberous sclerosis 2	VCV002835676	16	2133698	16	2083697	2835676	2995508	rs2544229122	NC_000016.10:2083696:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3887C>T (p.Ser1296Phe)	TSC2	S1181F, S1193F, S1273F, S1229F, S1252F, S1296F, S1253F, S1052F, S1230F, S1240F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000646426	16	2133699	16	2083698	646426	644307	rs1027773484	NC_000016.10:2083697:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3887C>A (p.Ser1296Tyr)	TSC2	S1296Y, S1052Y, S1230Y, S1253Y, S1193Y, S1181Y, S1229Y, S1240Y, S1252Y, S1273Y	Tuberous sclerosis 2	VCV000572914	16	2133699	16	2083698	572914	567849	rs1027773484	NC_000016.10:2083697:C:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3888C>A (p.Ser1296=)	TSC2		Tuberous sclerosis 2	VCV004071233	16	2133700	16	2083699	4071233	4185081		NC_000016.10:2083698:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3888C>G (p.Ser1296=)	TSC2		Tuberous sclerosis 2	VCV001670656	16	2133700	16	2083699	1670656	1604963	rs141252704	NC_000016.10:2083698:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3888C>T (p.Ser1296=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000238030	16	2133700	16	2083699	238030	242291	rs141252704	NC_000016.10:2083698:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3889G>T (p.Ala1297Ser)	TSC2	A1077S, A1182S, A1211S, A1224S, A1226S, A1254S, A1274S, A783S, A826S, A1030S, A1053S, A1073S, A1097S, A1194S, A1241S, A1260S, A1271S, A1273S, A1296S, A1297S, A696S, A782S, A1074S, A1230S, A1231S, A1261S, A805S, A1031S, A1181S, A1193S, A1225S, A1227S, A1237S, A1253S, A806S	Tuberous sclerosis 2	VCV003691332	16	2133701	16	2083700	3691332	3823955		NC_000016.10:2083699:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3889G>A (p.Ala1297Thr)	TSC2	A1297T, A1182T, A1194T, A1231T, A1253T, A1230T, A1254T, A1053T, A1241T, A1274T	not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000041736	16	2133701	16	2083700	41736	50175	rs45517319	NC_000016.10:2083699:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3890C>T (p.Ala1297Val)	TSC2	A1297V, A1182V, A1230V, A1241V, A1274V, A1231V, A1254V, A1053V, A1194V, A1253V	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II	VCV000468046	16	2133702	16	2083701	468046	465973	rs371239156	NC_000016.10:2083700:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3891C>G (p.Ala1297=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000468047	16	2133703	16	2083702	468047	466031	rs373508609	NC_000016.10:2083701:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3891C>T (p.Ala1297=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000413730	16	2133703	16	2083702	413730	400956	rs373508609	NC_000016.10:2083701:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3892G>A (p.Val1298Met)	TSC2	V1298M, V1195M, V1275M, V1054M, V1231M, V1242M, V1183M, V1232M, V1254M, V1255M	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000380462	16	2133704	16	2083703	380462	374819	rs147284943	NC_000016.10:2083702:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3893T>C (p.Val1298Ala)	TSC2	V1298A, V1054A, V1183A, V1195A, V1254A, V1255A, V1231A, V1232A, V1242A, V1275A	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000577294	16	2133705	16	2083704	577294	570114	rs758677443	NC_000016.10:2083703:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3894G>T (p.Val1298=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974642	16	2133706	16	2083705	3974642	4086465		NC_000016.10:2083704:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3895G>C (p.Val1299Leu)	TSC2	V1055L, V1075L, V1079L, V1196L, V1229L, V1239L, V698L, V784L, V828L, V1033L, V1183L, V1195L, V1232L, V1233L, V1263L, V807L, V1032L, V1099L, V1227L, V1243L, V1255L, V1256L, V1273L, V1276L, V1299L, V808L, V1076L, V1184L, V1213L, V1226L, V1228L, V1262L, V1275L, V1298L, V785L	Hereditary cancer-predisposing syndrome	VCV003811357	16	2133707	16	2083706	3811357	3928598		NC_000016.10:2083705:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3897C>T (p.Val1299=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002000312	16	2133709	16	2083708	2000312	2050946	rs2151510391	NC_000016.10:2083707:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3898A>G (p.Met1300Val)	TSC2	M1056V, M1197V, M1257V, M1300V, M1185V, M1234V, M1256V, M1233V, M1244V, M1277V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000824348	16	2133710	16	2083709	824348	812585	rs1596411880	NC_000016.10:2083708:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3899T>G (p.Met1300Arg)	TSC2	M1100R, M1230R, M1233R, M1234R, M1240R, M1264R, M1299R, M785R, M829R, M1033R, M1034R, M1076R, M1214R, M1227R, M1228R, M1274R, M1276R, M786R, M1056R, M1077R, M1080R, M1229R, M1263R, M808R, M1184R, M1185R, M1196R, M1197R, M1244R, M1256R, M1257R, M1277R, M1300R, M699R, M809R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564693	16	2133711	16	2083710	2564693	2733849	rs1349341137	NC_000016.10:2083709:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3899T>A (p.Met1300Lys)	TSC2	M1185K, M1233K, M1197K, M1234K, M1256K, M1244K, M1277K, M1056K, M1257K, M1300K	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000951522	16	2133711	16	2083710	951522	927669	rs1349341137	NC_000016.10:2083709:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3899T>C (p.Met1300Thr)	TSC2	M1300T, M1185T, M1233T, M1256T, M1277T, M1056T, M1197T, M1234T, M1257T, M1244T	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000468048	16	2133711	16	2083710	468048	465345	rs1349341137	NC_000016.10:2083709:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3900G>A (p.Met1300Ile)	TSC2	M1197I, M1244I, M1185I, M1233I, M1256I, M1277I, M1056I, M1300I, M1234I, M1257I	Hereditary cancer-predisposing syndrome	VCV000824363	16	2133712	16	2083711	824363	812586	rs1596411903	NC_000016.10:2083710:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3901G>A (p.Glu1301Lys)	TSC2	E1245K, E1057K, E1278K, E1301K, E1186K, E1198K, E1235K, E1234K, E1257K, E1258K	Tuberous sclerosis 2	VCV001045226	16	2133713	16	2083712	1045226	1032481	rs2090419072	NC_000016.10:2083711:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3902A>G (p.Glu1301Gly)	TSC2	E1057G, E1198G, E1234G, E1245G, E1257G, E1301G, E1278G, E1186G, E1235G, E1258G	Tuberous sclerosis 2	VCV001396339	16	2133714	16	2083713	1396339	1418090	rs2090419224	NC_000016.10:2083712:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3903G>A (p.Glu1301=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001126866	16	2133715	16	2083714	1126866	1125079	rs1429956058	NC_000016.10:2083713:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3903G>T (p.Glu1301Asp)	TSC2	E1301D, E1057D, E1235D, E1258D, E1186D, E1198D, E1257D, E1278D, E1234D, E1245D	Tuberous sclerosis 2	VCV000576160	16	2133715	16	2083714	576160	570115	rs1429956058	NC_000016.10:2083713:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3904G>A (p.Glu1302Lys)	TSC2	E1102K, E1216K, E1242K, E1265K, E1278K, E1302K, E788K, E1079K, E1082K, E1186K, E1198K, E1229K, E1235K, E1246K, E1258K, E1276K, E1279K, E787K, E1035K, E1036K, E1078K, E1187K, E1230K, E1232K, E1236K, E1266K, E1301K, E701K, E831K, E1058K, E1199K, E1231K, E1259K, E810K, E811K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001736050	16	2133716	16	2083715	1736050	1787209	rs886039680	NC_000016.10:2083714:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3904G>T (p.Glu1302Ter)	TSC2	E1302*, E1236*, E1279*, E1246*, E1258*, E1199*, E1235*, E1259*, E1058*, E1187*	not provided	VCV000265629	16	2133716	16	2083715	265629	260090	rs886039680	NC_000016.10:2083714:G:T	single nucleotide variant	nonsense	Pathogenic	Jun 24, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.3906G>C (p.Glu1302Asp)	TSC2	E1036D, E1079D, E1082D, E1199D, E1232D, E1242D, E1266D, E1279D, E788D, E1058D, E1078D, E1102D, E1216D, E1229D, E1230D, E1235D, E1246D, E1276D, E1278D, E810D, E1231D, E1265D, E701D, E811D, E831D, E1187D, E1236D, E1258D, E1259D, E1301D, E1302D, E787D, E1035D, E1186D, E1198D	Hereditary cancer-predisposing syndrome	VCV003811314	16	2133718	16	2083717	3811314	3928555		NC_000016.10:2083716:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3906G>A (p.Glu1302=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001091678	16	2133718	16	2083717	1091678	1081854	rs2151510679	NC_000016.10:2083716:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3907G>A (p.Gly1303Arg)	TSC2	G1200R, G1247R, G1260R, G1059R, G1280R, G1188R, G1237R, G1259R, G1236R, G1303R	Tuberous sclerosis 2	VCV001479865	16	2133719	16	2083718	1479865	1364535	rs1422874936	NC_000016.10:2083717:G:A	single nucleotide variant	missense variant	Benign	Aug 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3908G>A (p.Gly1303Glu)	TSC2	G1036E, G1059E, G1103E, G1231E, G1233E, G1247E, G1260E, G1277E, G1302E, G812E, G1188E, G1200E, G1217E, G1237E, G788E, G789E, G1079E, G1232E, G1243E, G1279E, G1280E, G702E, G811E, G1037E, G1080E, G1083E, G1187E, G1199E, G1230E, G1236E, G1259E, G1266E, G1267E, G1303E, G832E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002903047	16	2133720	16	2083719	2903047	3068541	rs2151510757	NC_000016.10:2083718:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3910A>C (p.Ser1304Arg)	TSC2	S1037R, S1218R, S1232R, S1233R, S1238R, S1244R, S1281R, S833R, S1081R, S1188R, S1189R, S1201R, S1231R, S1261R, S1268R, S703R, S812R, S1038R, S1104R, S1200R, S1237R, S1248R, S1260R, S1267R, S1278R, S790R, S1060R, S1080R, S1084R, S1234R, S1280R, S1303R, S1304R, S789R, S813R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002564694	16	2133722	16	2083721	2564694	2733850	rs1305173000	NC_000016.10:2083720:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3910A>T (p.Ser1304Cys)	TSC2	S1304C, S1201C, S1248C, S1060C, S1238C, S1261C, S1281C, S1189C, S1260C, S1237C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000573648	16	2133722	16	2083721	573648	569811	rs1305173000	NC_000016.10:2083720:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3911G>T (p.Ser1304Ile)	TSC2	S1189I, S1201I, S1248I, S1237I, S1304I, S1060I, S1238I, S1260I, S1261I, S1281I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000939713	16	2133723	16	2083722	939713	937333	rs751564566	NC_000016.10:2083721:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3912T>G (p.Ser1304Arg)	TSC2	S1038R, S1080R, S1189R, S1232R, S1233R, S1234R, S1237R, S789R, S1188R, S1260R, S1278R, S790R, S812R, S1037R, S1081R, S1084R, S1104R, S1231R, S1238R, S1244R, S1248R, S1261R, S1268R, S703R, S813R, S1060R, S1200R, S1201R, S1218R, S1267R, S1280R, S1281R, S1303R, S1304R, S833R	Tuberous sclerosis 2	VCV003004157	16	2133724	16	2083723	3004157	3158040	rs2151510895	NC_000016.10:2083722:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3913C>A (p.Pro1305Thr)	TSC2	P1038T, P1039T, P1061T, P1081T, P1082T, P1085T, P1105T, P1189T, P1190T, P1201T, P1202T, P1219T, P1232T, P1233T, P1234T, P1235T, P1238T, P1239T, P1245T, P1249T, P1261T, P1262T, P1268T, P1269T, P1279T, P1281T, P1282T, P1304T, P1305T, P704T, P790T, P791T, P813T, P814T, P834T	Tuberous sclerosis syndrome	VCV003070502	16	2133725	16	2083724	3070502	3231990	rs45452994	NC_000016.10:2083723:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3914C>A (p.Pro1305Gln)	TSC2	P1061Q, P1190Q, P1202Q, P1238Q, P1239Q, P1249Q, P1261Q, P1262Q, P1282Q, P1305Q	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001055991	16	2133726	16	2083725	1055991	1049474	rs45517320	NC_000016.10:2083724:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3914C>G (p.Pro1305Arg)	TSC2	P1061R, P1190R, P1261R, P1238R, P1249R, P1202R, P1239R, P1262R, P1305R, P1282R	Tuberous sclerosis 2	VCV000653658	16	2133726	16	2083725	653658	644308	rs45517320	NC_000016.10:2083724:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3914C>T (p.Pro1305Leu)	TSC2	P1305L, P1061L, P1202L, P1261L, P1238L, P1249L, P1190L, P1262L, P1282L, P1239L	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000041737	16	2133726	16	2083725	41737	50176	rs45517320	NC_000016.10:2083724:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3915G>C (p.Pro1305=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001529611	16	2133727	16	2083726	1529611	1604325	rs11551373	NC_000016.10:2083725:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3915G>A (p.Pro1305=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049280	16	2133727	16	2083726	49280	58442	rs11551373	NC_000016.10:2083725:G:A	single nucleotide variant	synonymous variant	Benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3916G>A (p.Gly1306Ser)	TSC2	G1040S, G1235S, G1236S, G1246S, G1262S, G1283S, G1305S, G705S, G792S, G1082S, G1083S, G1106S, G1233S, G1239S, G1240S, G1263S, G1280S, G791S, G814S, G815S, G1039S, G1062S, G1191S, G1203S, G1282S, G1306S, G835S, G1086S, G1190S, G1202S, G1220S, G1234S, G1250S, G1269S, G1270S	Hereditary cancer-predisposing syndrome	VCV002626415	16	2133728	16	2083727	2626415	2794181	rs2151511096	NC_000016.10:2083726:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3917G>A (p.Gly1306Asp)	TSC2	G1203D, G1239D, G1062D, G1191D, G1262D, G1263D, G1306D, G1240D, G1250D, G1283D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000953348	16	2133729	16	2083728	953348	949263	rs1567518028	NC_000016.10:2083727:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3918C>A (p.Gly1306=)	TSC2		Tuberous sclerosis 2	VCV001130855	16	2133730	16	2083729	1130855	1125080	rs368712041	NC_000016.10:2083728:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3918C>T (p.Gly1306=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000389429	16	2133730	16	2083729	389429	374151	rs368712041	NC_000016.10:2083728:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3919G>A (p.Glu1307Lys)	TSC2	E1307K, E1204K, E1264K, E1284K, E1063K, E1241K, E1263K, E1192K, E1240K, E1251K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000238031	16	2133731	16	2083730	238031	242292	rs62642481	NC_000016.10:2083729:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3920A>T (p.Glu1307Val)	TSC2	E1063V, E1087V, E1234V, E1236V, E1237V, E1240V, E1247V, E1251V, E1281V, E706V, E1040V, E1041V, E1107V, E1203V, E1204V, E1235V, E1241V, E1271V, E1283V, E1306V, E815V, E816V, E1192V, E1221V, E1270V, E792V, E836V, E1083V, E1084V, E1191V, E1263V, E1264V, E1284V, E1307V, E793V	Hereditary cancer-predisposing syndrome	VCV002626453	16	2133732	16	2083731	2626453	2794219	rs2151511236	NC_000016.10:2083730:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3921G>A (p.Glu1307=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003232156	16	2133733	16	2083732	3232156	3391957	rs2090421407	NC_000016.10:2083731:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3921G>C (p.Glu1307Asp)	TSC2	E1041D, E1087D, E1107D, E1204D, E1237D, E1251D, E1270D, E1040D, E1083D, E1191D, E1234D, E1235D, E1264D, E1307D, E793D, E1063D, E1084D, E1192D, E1236D, E1240D, E1247D, E1284D, E816D, E836D, E1203D, E1221D, E1241D, E1263D, E1271D, E1281D, E1283D, E1306D, E706D, E792D, E815D	Hereditary cancer-predisposing syndrome	VCV002449957	16	2133733	16	2083732	2449957	2429583	rs2090421407	NC_000016.10:2083731:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3922G>A (p.Val1308Ile)	TSC2	V1064I, V1088I, V1108I, V1222I, V1241I, V1248I, V1284I, V816I, V1042I, V1084I, V1192I, V1193I, V1238I, V1242I, V1265I, V1272I, V1285I, V1308I, V794I, V817I, V1235I, V1236I, V1237I, V1264I, V1271I, V1282I, V1307I, V837I, V1041I, V1085I, V1204I, V1205I, V1252I, V707I, V793I	Hereditary cancer-predisposing syndrome	VCV003462573	16	2133734	16	2083733	3462573	3621592		NC_000016.10:2083732:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3922G>C (p.Val1308Leu)	TSC2	V1085L, V1088L, V1192L, V1205L, V1236L, V1242L, V1248L, V1272L, V1308L, V794L, V817L, V837L, V1041L, V1108L, V1237L, V1241L, V1271L, V1285L, V793L, V816L, V1042L, V1204L, V1252L, V1265L, V1282L, V707L, V1064L, V1084L, V1193L, V1222L, V1235L, V1238L, V1264L, V1284L, V1307L	Hereditary cancer-predisposing syndrome	VCV003462529	16	2133734	16	2083733	3462529	3621549		NC_000016.10:2083732:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3924T>A (p.Val1308=)	TSC2		Tuberous sclerosis 2	VCV002749458	16	2133736	16	2083735	2749458	2912799	rs878854097	NC_000016.10:2083734:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3924T>C (p.Val1308=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468049	16	2133736	16	2083735	468049	465977	rs878854097	NC_000016.10:2083734:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3924T>G (p.Val1308=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000238033	16	2133736	16	2083735	238033	242293	rs878854097	NC_000016.10:2083734:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3925C>G (p.Pro1309Ala)	TSC2	P1109A, P1223A, P1242A, P1285A, P708A, P817A, P1085A, P1193A, P1205A, P1239A, P1273A, P1283A, P1286A, P794A, P795A, P1042A, P1043A, P1065A, P1089A, P1236A, P1243A, P1249A, P1272A, P1308A, P1309A, P818A, P1086A, P1194A, P1206A, P1237A, P1238A, P1253A, P1265A, P1266A, P838A	Tuberous sclerosis 2	VCV003690631	16	2133737	16	2083736	3690631	3831307		NC_000016.10:2083735:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3925C>T (p.Pro1309Ser)	TSC2	P1065S, P1243S, P1265S, P1206S, P1253S, P1194S, P1286S, P1309S, P1242S, P1266S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000665077	16	2133737	16	2083736	665077	644309	rs1049538280	NC_000016.10:2083735:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3926C>T (p.Pro1309Leu)	TSC2	P1194L, P1243L, P1286L, P1206L, P1309L, P1265L, P1065L, P1242L, P1253L, P1266L	Tuberous sclerosis 2	VCV001366186	16	2133738	16	2083737	1366186	1411528	rs1356621621	NC_000016.10:2083736:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3927T>A (p.Pro1309=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002821553	16	2133739	16	2083738	2821553	2985206	rs1488161104	NC_000016.10:2083737:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3927T>C (p.Pro1309=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001120472	16	2133739	16	2083738	1120472	1125081	rs1488161104	NC_000016.10:2083737:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3928G>T (p.Val1310Leu)	TSC2	V1043L, V1044L, V1066L, V1086L, V1087L, V1090L, V1110L, V1194L, V1195L, V1206L, V1207L, V1224L, V1237L, V1238L, V1239L, V1240L, V1243L, V1244L, V1250L, V1254L, V1266L, V1267L, V1273L, V1274L, V1284L, V1286L, V1287L, V1309L, V1310L, V709L, V795L, V796L, V818L, V819L, V839L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003232157	16	2133740	16	2083739	3232157	3391958	rs1046522975	NC_000016.10:2083738:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3928G>A (p.Val1310Met)	TSC2	V1266M, V1244M, V1267M, V1066M, V1195M, V1207M, V1243M, V1254M, V1287M, V1310M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824392	16	2133740	16	2083739	824392	812587	rs1046522975	NC_000016.10:2083738:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 7, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3930G>A (p.Val1310=)	TSC2		Tuberous sclerosis 2	VCV004071038	16	2133742	16	2083741	4071038	4184886		NC_000016.10:2083740:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3931C>T (p.Leu1311=)	TSC2		Tuberous sclerosis 2	VCV002719396	16	2133743	16	2083742	2719396	2870032	rs2151511633	NC_000016.10:2083741:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3931C>G (p.Leu1311Val)	TSC2	L1088V, L1225V, L1239V, L1244V, L1268V, L1287V, L796V, L797V, L820V, L1251V, L1267V, L1285V, L1067V, L1195V, L1208V, L1238V, L1240V, L1241V, L1275V, L1288V, L1311V, L710V, L819V, L840V, L1045V, L1091V, L1044V, L1087V, L1111V, L1196V, L1207V, L1245V, L1255V, L1274V, L1310V	Tuberous sclerosis 2	VCV001960606	16	2133743	16	2083742	1960606	2012990	rs2151511633	NC_000016.10:2083741:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3932T>G (p.Leu1311Arg)	TSC2	L1255R, L1311R, L1244R, L1267R, L1268R, L1067R, L1196R, L1208R, L1245R, L1288R	Tuberous sclerosis 2	VCV001046293	16	2133744	16	2083743	1046293	1032482	rs2090422516	NC_000016.10:2083742:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3933G>C (p.Leu1311=)	TSC2		Tuberous sclerosis 2	VCV004071322	16	2133745	16	2083744	4071322	4185170		NC_000016.10:2083743:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3933G>A (p.Leu1311=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001516919	16	2133745	16	2083744	1516919	1495692	rs768160843	NC_000016.10:2083743:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3933G>T (p.Leu1311=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000701085	16	2133745	16	2083744	701085	688545	rs768160843	NC_000016.10:2083743:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3934G>T (p.Val1312Leu)	TSC2	V1068L, V1197L, V1209L, V1245L, V1246L, V1256L, V1268L, V1269L, V1289L, V1312L	Tuberous sclerosis 2	VCV001003951	16	2133746	16	2083745	1003951	996748	rs201584397	NC_000016.10:2083744:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3934G>C (p.Val1312Leu)	TSC2	V1209L, V1068L, V1197L, V1256L, V1269L, V1245L, V1246L, V1268L, V1289L, V1312L	Tuberous sclerosis 2	VCV000840490	16	2133746	16	2083745	840490	843474	rs201584397	NC_000016.10:2083744:G:C	single nucleotide variant	missense variant	Benign	Jun 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3934G>A (p.Val1312Met)	TSC2	V1068M, V1197M, V1209M, V1246M, V1268M, V1289M, V1312M, V1245M, V1256M, V1269M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000659015	16	2133746	16	2083745	659015	644310	rs201584397	NC_000016.10:2083744:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3935T>C (p.Val1312Ala)	TSC2	V1045A, V1046A, V1068A, V1088A, V1089A, V1092A, V1112A, V1196A, V1197A, V1208A, V1209A, V1226A, V1239A, V1240A, V1241A, V1242A, V1245A, V1246A, V1252A, V1256A, V1268A, V1269A, V1275A, V1276A, V1286A, V1288A, V1289A, V1311A, V1312A, V711A, V797A, V798A, V820A, V821A, V841A	not provided	VCV003776731	16	2133747	16	2083746	3776731	3892877		NC_000016.10:2083745:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3935T>G (p.Val1312Gly)	TSC2	V1209G, V1242G, V1268G, V1269G, V1311G, V711G, V1045G, V1112G, V1208G, V1226G, V1241G, V1286G, V1288G, V1289G, V798G, V1089G, V1196G, V1197G, V1239G, V1245G, V1252G, V1256G, V1276G, V1312G, V821G, V841G, V1046G, V1068G, V1088G, V1092G, V1240G, V1246G, V1275G, V797G, V820G	Hereditary cancer-predisposing syndrome	VCV001736296	16	2133747	16	2083746	1736296	1796829	rs2544232954	NC_000016.10:2083745:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3936G>A (p.Val1312=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000232698	16	2133748	16	2083747	232698	235128	rs876659932	NC_000016.10:2083746:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3937G>C (p.Glu1313Gln)	TSC2	E1246Q, E1257Q, E1069Q, E1269Q, E1290Q, E1313Q, E1210Q, E1247Q, E1198Q, E1270Q	Tuberous sclerosis 2	VCV001524729	16	2133749	16	2083748	1524729	1473493	rs45517321	NC_000016.10:2083747:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3937G>A (p.Glu1313Lys)	TSC2	E1069K, E1198K, E1247K, E1257K, E1290K, E1313K, E1210K, E1270K, E1246K, E1269K	Tuberous sclerosis 2	VCV001421322	16	2133749	16	2083748	1421322	1422738	rs45517321	NC_000016.10:2083747:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3939G>A (p.Glu1313=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000747719	16	2133751	16	2083750	747719	755002	rs149340262	NC_000016.10:2083749:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3939G>T (p.Glu1313Asp)	TSC2	E1313D, E1246D, E1069D, E1198D, E1247D, E1269D, E1210D, E1257D, E1270D, E1290D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000207749	16	2133751	16	2083750	207749	203179	rs149340262	NC_000016.10:2083749:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3940C>A (p.Pro1314Thr)	TSC2	P1048T, P1090T, P1091T, P1210T, P1241T, P1247T, P1271T, P1288T, P800T, P1114T, P1244T, P1290T, P1047T, P1198T, P1228T, P1248T, P1258T, P1270T, P1291T, P1313T, P1314T, P799T, P1070T, P1094T, P1199T, P1211T, P1242T, P1243T, P1254T, P1277T, P1278T, P713T, P822T, P823T, P843T	Hereditary cancer-predisposing syndrome	VCV001736352	16	2133752	16	2083751	1736352	1796885	rs771499212	NC_000016.10:2083750:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3940C>G (p.Pro1314Ala)	TSC2	P1199A, P1314A, P1248A, P1270A, P1070A, P1247A, P1271A, P1211A, P1258A, P1291A	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001449828	16	2133752	16	2083751	1449828	1413011	rs771499212	NC_000016.10:2083750:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3940C>T (p.Pro1314Ser)	TSC2	P1314S, P1070S, P1199S, P1211S, P1247S, P1248S, P1270S, P1271S, P1291S, P1258S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000566430	16	2133752	16	2083751	566430	569819	rs771499212	NC_000016.10:2083750:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3941C>T (p.Pro1314Leu)	TSC2	P1211L, P1270L, P1070L, P1247L, P1199L, P1248L, P1258L, P1271L, P1291L, P1314L	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000851103	16	2133753	16	2083752	851103	843476	rs1217156011	NC_000016.10:2083751:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3942C>G (p.Pro1314=)	TSC2		Tuberous sclerosis 2	VCV001564524	16	2133754	16	2083753	1564524	1654893	rs759988275	NC_000016.10:2083752:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3942C>A (p.Pro1314=)	TSC2		Tuberous sclerosis 2	VCV000536077	16	2133754	16	2083753	536077	529995	rs759988275	NC_000016.10:2083752:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3942C>T (p.Pro1314=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000413666	16	2133754	16	2083753	413666	401621	rs759988275	NC_000016.10:2083752:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3943C>A (p.Pro1315Thr)	TSC2	P1249T, P1271T, P1272T, P1212T, P1071T, P1248T, P1259T, P1292T, P1315T, P1200T	Hereditary cancer-predisposing syndrome	VCV000824405	16	2133755	16	2083754	824405	812588	rs397514916	NC_000016.10:2083753:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3943C>T (p.Pro1315Ser)	TSC2	P1315S, P1200S, P1212S, P1248S, P1259S, P1071S, P1249S, P1272S, P1271S, P1292S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000064947	16	2133755	16	2083754	64947	75877	rs397514916	NC_000016.10:2083753:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 24, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3943C>G (p.Pro1315Ala)	TSC2	P1315A, P1200A, P1272A, P1071A, P1259A, P1212A, P1248A, P1249A, P1271A, P1292A	Tuberous sclerosis 2	VCV000064892	16	2133755	16	2083754	64892	75822	rs397514916	NC_000016.10:2083753:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3944C>T (p.Pro1315Leu)	TSC2	P1315L, P1292L, P1212L, P1248L, P1271L, P1272L, P1071L, P1200L, P1249L, P1259L	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000583261	16	2133756	16	2083755	583261	573856	rs775990159	NC_000016.10:2083754:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3945A>T (p.Pro1315=)	TSC2		Tuberous sclerosis 2	VCV001936340	16	2133757	16	2083756	1936340	1986171	rs1811018177	NC_000016.10:2083755:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3945A>G (p.Pro1315=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000884981	16	2133757	16	2083756	884981	874848	rs1811018177	NC_000016.10:2083755:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3946G>A (p.Gly1316Arg)	TSC2	G1316R, G1072R, G1273R, G1250R, G1293R, G1213R, G1249R, G1201R, G1260R, G1272R	Tuberous sclerosis 2	VCV000536002	16	2133758	16	2083757	536002	530007	rs1555513510	NC_000016.10:2083756:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.3947G>A (p.Gly1316Glu)	TSC2	G1072E, G1272E, G1273E, G1316E, G1249E, G1293E, G1201E, G1213E, G1250E, G1260E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001383306	16	2133759	16	2083758	1383306	1509902	rs1555513513	NC_000016.10:2083757:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 11, 2020	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3947G>C (p.Gly1316Ala)	TSC2	G1316A, G1249A, G1213A, G1260A, G1272A, G1201A, G1293A, G1072A, G1250A, G1273A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468050	16	2133759	16	2083758	468050	466033	rs1555513513	NC_000016.10:2083757:G:C	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3948G>T (p.Gly1316=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001736398	16	2133760	16	2083759	1736398	1796931	rs763278787	NC_000016.10:2083758:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3948G>A (p.Gly1316=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001117412	16	2133760	16	2083759	1117412	1103668	rs763278787	NC_000016.10:2083758:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3949T>C (p.Leu1317=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001736404	16	2133761	16	2083760	1736404	1796937	rs2151512409	NC_000016.10:2083759:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3950T>C (p.Leu1317Ser)	TSC2	L1261S, L1273S, L1202S, L1251S, L1073S, L1214S, L1317S, L1250S, L1274S, L1294S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000839038	16	2133762	16	2083761	839038	843477	rs2090425460	NC_000016.10:2083760:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3951G>C (p.Leu1317Phe)	TSC2	L1202F, L1261F, L1317F, L1214F, L1250F, L1274F, L1073F, L1251F, L1273F, L1294F	Tuberous sclerosis 2	VCV001381600	16	2133763	16	2083762	1381600	1496562	rs2090425580	NC_000016.10:2083761:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3952G>A (p.Glu1318Lys)	TSC2	E1318K, E1203K, E1215K, E1262K, E1275K, E1074K, E1252K, E1251K, E1274K, E1295K	Tuberous sclerosis 2	VCV000468051	16	2133764	16	2083763	468051	466238	rs1064793797	NC_000016.10:2083762:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3952G>T (p.Glu1318Ter)	TSC2	E1318*, E1275*, E1295*, E1203*, E1252*, E1274*, E1074*, E1215*, E1251*, E1262*	not provided	VCV000419329	16	2133764	16	2083763	419329	409492	rs1064793797	NC_000016.10:2083762:G:T	single nucleotide variant	nonsense	Pathogenic	Jun 25, 2015	criteria provided, single submitter							
NM_000548.5(TSC2):c.3954G>A (p.Glu1318=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001158156	16	2133766	16	2083765	1158156	1145964	rs1165479631	NC_000016.10:2083764:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3955G>C (p.Asp1319His)	TSC2	D1053H, D1204H, D1215H, D1216H, D1283H, D1293H, D1318H, D804H, D827H, D1246H, D1247H, D1252H, D1253H, D1259H, D1276H, D1295H, D1296H, D1075H, D1095H, D1096H, D1099H, D1203H, D1248H, D1263H, D1282H, D1319H, D718H, D1052H, D1119H, D1233H, D1249H, D1275H, D805H, D828H, D848H	Tuberous sclerosis 2	VCV002013165	16	2133767	16	2083766	2013165	2071102	rs375883030	NC_000016.10:2083765:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3955G>A (p.Asp1319Asn)	TSC2	D1319N, D1204N, D1216N, D1275N, D1075N, D1252N, D1253N, D1263N, D1276N, D1296N	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406066	16	2133767	16	2083766	406066	400838	rs375883030	NC_000016.10:2083765:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3956A>G (p.Asp1319Gly)	TSC2	D1075G, D1204G, D1216G, D1252G, D1253G, D1263G, D1275G, D1276G, D1296G, D1319G	Tuberous sclerosis 2	VCV001026328	16	2133768	16	2083767	1026328	1011992	rs45517322	NC_000016.10:2083766:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3956A>T (p.Asp1319Val)	TSC2	D1319V, D1204V, D1216V, D1275V, D1075V, D1252V, D1253V, D1263V, D1276V, D1296V	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049522	16	2133768	16	2083767	49522	58684	rs45517322	NC_000016.10:2083766:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3957C>G (p.Asp1319Glu)	TSC2	D1075E, D1203E, D1204E, D1263E, D718E, D804E, D828E, D1052E, D1095E, D1096E, D1119E, D1249E, D1253E, D1275E, D1293E, D1318E, D1319E, D848E, D1053E, D1215E, D1233E, D1247E, D1248E, D1259E, D1283E, D1296E, D1099E, D1216E, D1246E, D1252E, D1276E, D1282E, D1295E, D805E, D827E	Hereditary cancer-predisposing syndrome	VCV001736476	16	2133769	16	2083768	1736476	1797009	rs757244510	NC_000016.10:2083767:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3957C>T (p.Asp1319=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413679	16	2133769	16	2083768	413679	401369	rs757244510	NC_000016.10:2083767:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3958G>T (p.Val1320Phe)	TSC2	V1216F, V1217F, V1264F, V1296F, V1053F, V1054F, V1076F, V1096F, V1120F, V1249F, V1277F, V719F, V828F, V829F, V1100F, V1204F, V1205F, V1234F, V1248F, V1253F, V1260F, V1284F, V1294F, V1297F, V805F, V806F, V849F, V1097F, V1247F, V1250F, V1254F, V1276F, V1283F, V1319F, V1320F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002168342	16	2133770	16	2083769	2168342	1895890	rs767495365	NC_000016.10:2083768:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3958G>A (p.Val1320Ile)	TSC2	V1320I, V1253I, V1254I, V1277I, V1076I, V1276I, V1297I, V1205I, V1217I, V1264I	not specified|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Ovarian cancer	VCV000486629	16	2133770	16	2083769	486629	477495	rs767495365	NC_000016.10:2083768:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3959T>C (p.Val1320Ala)	TSC2	V1054A, V1097A, V1234A, V1248A, V1250A, V1253A, V1264A, V1284A, V1297A, V805A, V828A, V1096A, V1205A, V1216A, V1249A, V1260A, V1296A, V1076A, V1217A, V1247A, V1254A, V1277A, V1283A, V1319A, V806A, V829A, V849A, V1053A, V1100A, V1120A, V1204A, V1276A, V1294A, V1320A, V719A	Hereditary cancer-predisposing syndrome	VCV003974698	16	2133771	16	2083770	3974698	4086521		NC_000016.10:2083769:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 31, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3962A>C (p.Glu1321Ala)	TSC2	E1054A, E1055A, E1077A, E1097A, E1098A, E1101A, E1121A, E1205A, E1206A, E1217A, E1218A, E1235A, E1248A, E1249A, E1250A, E1251A, E1254A, E1255A, E1261A, E1265A, E1277A, E1278A, E1284A, E1285A, E1295A, E1297A, E1298A, E1320A, E1321A, E720A, E806A, E807A, E829A, E830A, E850A	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003072101	16	2133774	16	2083773	3072101	3232278	rs587778736	NC_000016.10:2083772:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3962A>G (p.Glu1321Gly)	TSC2	E1077G, E1206G, E1218G, E1254G, E1255G, E1265G, E1277G, E1278G, E1298G, E1321G	Tuberous sclerosis 2	VCV001021902	16	2133774	16	2083773	1021902	1011993	rs587778736	NC_000016.10:2083772:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3962A>T (p.Glu1321Val)	TSC2	E1321V, E1077V, E1278V, E1206V, E1254V, E1265V, E1218V, E1255V, E1277V, E1298V	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000135383	16	2133774	16	2083773	135383	139122	rs587778736	NC_000016.10:2083772:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3963G>T (p.Glu1321Asp)	TSC2	E1054D, E1077D, E1097D, E1101D, E1205D, E1235D, E1248D, E1250D, E1255D, E1261D, E1321D, E720D, E807D, E830D, E1098D, E1121D, E1218D, E1249D, E1277D, E1278D, E1284D, E1297D, E1298D, E1055D, E1251D, E1254D, E1320D, E806D, E850D, E1206D, E1217D, E1265D, E1285D, E1295D, E829D	Tuberous sclerosis 2	VCV002837265	16	2133775	16	2083774	2837265	2999644	rs587778737	NC_000016.10:2083773:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3963G>A (p.Glu1321=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000536046	16	2133775	16	2083774	536046	530262	rs587778737	NC_000016.10:2083773:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3963G>C (p.Glu1321Asp)	TSC2	E1321D, E1254D, E1255D, E1265D, E1278D, E1077D, E1206D, E1218D, E1277D, E1298D	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135384	16	2133775	16	2083774	135384	139123	rs587778737	NC_000016.10:2083773:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3964G>A (p.Ala1322Thr)	TSC2	A1322T, A1255T, A1219T, A1256T, A1266T, A1278T, A1299T, A1078T, A1207T, A1279T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000568497	16	2133776	16	2083775	568497	573857	rs759790981	NC_000016.10:2083774:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3965C>T (p.Ala1322Val)	TSC2	A1322V, A1078V, A1207V, A1255V, A1279V, A1219V, A1299V, A1256V, A1266V, A1278V	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000535995	16	2133777	16	2083776	535995	530265	rs1380402492	NC_000016.10:2083775:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3966A>G (p.Ala1322=)	TSC2		Tuberous sclerosis 2	VCV002039769	16	2133778	16	2083777	2039769	2091231	rs2151513012	NC_000016.10:2083776:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3967G>T (p.Ala1323Ser)	TSC2	A1056S, A1079S, A1208S, A1219S, A1251S, A1279S, A1297S, A1300S, A809S, A852S, A1057S, A1123S, A1250S, A1253S, A1256S, A1263S, A1267S, A1287S, A1322S, A1323S, A722S, A831S, A1100S, A1207S, A1220S, A1237S, A1257S, A1286S, A808S, A1099S, A1103S, A1252S, A1280S, A1299S, A832S	Tuberous sclerosis 2	VCV002855026	16	2133779	16	2083778	2855026	3017206	rs1248093496	NC_000016.10:2083777:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3967G>C (p.Ala1323Pro)	TSC2	A1057P, A1099P, A1207P, A1219P, A1220P, A1251P, A1257P, A1267P, A1287P, A1297P, A722P, A1079P, A1100P, A1208P, A1252P, A1263P, A1279P, A1323P, A1056P, A1253P, A1256P, A1286P, A1299P, A1322P, A832P, A1103P, A1123P, A1237P, A1250P, A1280P, A1300P, A808P, A809P, A831P, A852P	Tuberous sclerosis 2	VCV002742263	16	2133779	16	2083778	2742263	2903034	rs1248093496	NC_000016.10:2083777:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Oct 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3967G>A (p.Ala1323Thr)	TSC2	A1208T, A1220T, A1300T, A1323T, A1280T, A1079T, A1267T, A1279T, A1256T, A1257T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001388488	16	2133779	16	2083778	1388488	1371229	rs1248093496	NC_000016.10:2083777:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3968C>G (p.Ala1323Gly)	TSC2	A1056G, A1103G, A1207G, A1219G, A1220G, A1253G, A1279G, A1280G, A1299G, A808G, A1057G, A1100G, A1123G, A1251G, A1256G, A1267G, A1287G, A1300G, A1322G, A809G, A1099G, A1237G, A1250G, A1263G, A1286G, A1297G, A1323G, A831G, A1079G, A1208G, A1252G, A1257G, A722G, A832G, A852G	Tuberous sclerosis 2	VCV003695120	16	2133780	16	2083779	3695120	3825158		NC_000016.10:2083778:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3968C>A (p.Ala1323Glu)	TSC2	A1079E, A1208E, A1220E, A1257E, A1267E, A1280E, A1300E, A1256E, A1323E, A1279E	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000643999	16	2133780	16	2083779	643999	644311	rs397515062	NC_000016.10:2083778:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3968C>T (p.Ala1323Val)	TSC2	A1323V, A1257V, A1279V, A1208V, A1220V, A1256V, A1267V, A1280V, A1079V, A1300V	Hereditary cancer-predisposing syndrome|Ovarian cancer|not specified|not provided|Tuberous sclerosis 2	VCV000065083	16	2133780	16	2083779	65083	76014	rs397515062	NC_000016.10:2083778:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3969G>C (p.Ala1323=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001736583	16	2133781	16	2083780	1736583	1797116	rs749057825	NC_000016.10:2083779:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 22, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3969G>T (p.Ala1323=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824440	16	2133781	16	2083780	824440	812589	rs749057825	NC_000016.10:2083779:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3969G>A (p.Ala1323=)	TSC2		not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238034	16	2133781	16	2083780	238034	242294	rs749057825	NC_000016.10:2083779:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3970C>T (p.Leu1324=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824445	16	2133782	16	2083781	824445	812591	rs549060036	NC_000016.10:2083780:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3970C>G (p.Leu1324Val)	TSC2	L1209V, L1221V, L1268V, L1281V, L1301V, L1257V, L1280V, L1324V, L1080V, L1258V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000824444	16	2133782	16	2083781	824444	812590	rs549060036	NC_000016.10:2083780:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3971T>A (p.Leu1324Gln)	TSC2	L1281Q, L1301Q, L1209Q, L1257Q, L1268Q, L1324Q, L1280Q, L1080Q, L1221Q, L1258Q	Tuberous sclerosis 2	VCV000959895	16	2133783	16	2083782	959895	949264	rs878854098	NC_000016.10:2083781:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3971T>C (p.Leu1324Pro)	TSC2	L1324P, L1209P, L1221P, L1268P, L1280P, L1281P, L1258P, L1301P, L1080P, L1257P	Tuberous sclerosis 2	VCV000238035	16	2133783	16	2083782	238035	242295	rs878854098	NC_000016.10:2083781:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3972A>G (p.Leu1324=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003011591	16	2133784	16	2083783	3011591	3177023	rs2151513217	NC_000016.10:2083782:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3972A>T (p.Leu1324=)	TSC2		Tuberous sclerosis 2	VCV002032513	16	2133784	16	2083783	2032513	2082731	rs2151513217	NC_000016.10:2083782:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3973G>A (p.Gly1325Ser)	TSC2	G1259S, G1282S, G1325S, G1258S, G1302S, G1081S, G1210S, G1281S, G1222S, G1269S	Tuberous sclerosis 2	VCV001400908	16	2133785	16	2083784	1400908	1463760	rs2151513235	NC_000016.10:2083783:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3974G>T (p.Gly1325Val)	TSC2	G1258V, G1259V, G1269V, G1281V, G1081V, G1222V, G1282V, G1302V, G1210V, G1325V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000849558	16	2133786	16	2083785	849558	843478	rs754680848	NC_000016.10:2083784:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3974G>A (p.Gly1325Asp)	TSC2	G1325D, G1259D, G1269D, G1081D, G1210D, G1281D, G1302D, G1222D, G1258D, G1282D	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000448730	16	2133786	16	2083785	448730	441790	rs754680848	NC_000016.10:2083784:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3975C>T (p.Gly1325=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002860216	16	2133787	16	2083786	2860216	3028853	rs2151513295	NC_000016.10:2083785:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3976A>T (p.Met1326Leu)	TSC2	M1059L, M1082L, M1210L, M1254L, M1260L, M725L, M855L, M1102L, M1106L, M1253L, M1266L, M1270L, M1302L, M1325L, M1326L, M834L, M1060L, M1211L, M1222L, M1223L, M1259L, M811L, M812L, M835L, M1103L, M1126L, M1240L, M1255L, M1256L, M1282L, M1283L, M1289L, M1290L, M1300L, M1303L	Tuberous sclerosis 2	VCV002759763	16	2133788	16	2083787	2759763	2924816	rs2151513326	NC_000016.10:2083786:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3976A>G (p.Met1326Val)	TSC2	M1060V, M1082V, M1106V, M1126V, M1210V, M1222V, M1259V, M1260V, M1266V, M1290V, M1300V, M1303V, M1059V, M1102V, M1211V, M1255V, M1283V, M1325V, M811V, M1103V, M1223V, M1240V, M1253V, M1289V, M1302V, M1326V, M812V, M835V, M725V, M834V, M1254V, M1256V, M1270V, M1282V, M855V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001736649	16	2133788	16	2083787	1736649	1793692	rs2151513326	NC_000016.10:2083786:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 4, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3977T>C (p.Met1326Thr)	TSC2	M1270T, M1326T, M1082T, M1223T, M1259T, M1282T, M1283T, M1211T, M1260T, M1303T	Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000848112	16	2133789	16	2083788	848112	843479	rs2090429801	NC_000016.10:2083787:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3979G>C (p.Asp1327His)	TSC2	D1103H, D1211H, D1256H, D1284H, D1290H, D1060H, D1061H, D1223H, D1257H, D1260H, D1267H, D1271H, D1327H, D1291H, D1303H, D812H, D1107H, D1127H, D1224H, D1254H, D1261H, D1301H, D1304H, D1326H, D835H, D1083H, D1104H, D1212H, D1241H, D1255H, D1283H, D726H, D813H, D836H, D856H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001736674	16	2133791	16	2083790	1736674	1793717	rs2090430035	NC_000016.10:2083789:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3980A>G (p.Asp1327Gly)	TSC2	D1327G, D1261G, D1284G, D1224G, D1260G, D1283G, D1304G, D1212G, D1083G, D1271G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486671	16	2133792	16	2083791	486671	477416	rs1555513553	NC_000016.10:2083790:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3981C>T (p.Asp1327=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000238036	16	2133793	16	2083792	238036	242296	rs876659087	NC_000016.10:2083791:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3981C>G (p.Asp1327Glu)	TSC2	D1327E, D1083E, D1212E, D1261E, D1271E, D1284E, D1224E, D1283E, D1260E, D1304E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000231318	16	2133793	16	2083792	231318	235129	rs876659087	NC_000016.10:2083791:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3982A>C (p.Arg1328=)	TSC2		Tuberous sclerosis 2	VCV003641022	16	2133794	16	2083793	3641022	3768740		NC_000016.10:2083792:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3982A>G (p.Arg1328Gly)	TSC2	R1061G, R1108G, R1213G, R1225G, R1255G, R1256G, R1292G, R1328G, R857G, R1104G, R1128G, R1258G, R1262G, R1272G, R1284G, R1302G, R727G, R813G, R814G, R1212G, R1242G, R1268G, R1291G, R1304G, R1305G, R1062G, R1084G, R1105G, R1224G, R1257G, R1261G, R1285G, R1327G, R836G, R837G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001954946	16	2133794	16	2083793	1954946	2015088	rs778389399	NC_000016.10:2083792:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3983G>T (p.Arg1328Met)	TSC2	R1262M, R1272M, R1305M, R1328M, R1225M, R1261M, R1284M, R1285M, R1084M, R1213M	Tuberous sclerosis 2	VCV001366794	16	2133795	16	2083794	1366794	1337959	rs112885324	NC_000016.10:2083793:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.3983G>A (p.Arg1328Lys)	TSC2	R1084K, R1213K, R1225K, R1261K, R1262K, R1272K, R1284K, R1285K, R1305K, R1328K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001027195	16	2133795	16	2083794	1027195	1011994	rs112885324	NC_000016.10:2083793:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3984G>A (p.Arg1328=)	TSC2		Tuberous sclerosis 2	VCV001142629	16	2133796	16	2083795	1142629	1145965	rs2151513555	NC_000016.10:2083794:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 4, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.3985C>T (p.Arg1329Cys)	TSC2	R1329C, R1273C, R1085C, R1262C, R1263C, R1285C, R1286C, R1214C, R1226C, R1306C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535925	16	2133797	16	2083796	535925	529648	rs747695245	NC_000016.10:2083795:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3986G>C (p.Arg1329Pro)	TSC2	R1305P, R814P, R815P, R837P, R838P, R1106P, R1273P, R1062P, R1105P, R1129P, R1258P, R1263P, R1285P, R1286P, R1306P, R1329P, R1085P, R1109P, R1213P, R1225P, R1226P, R1256P, R1257P, R1262P, R1269P, R1293P, R1328P, R1063P, R1214P, R1243P, R1259P, R1292P, R1303P, R728P, R858P	Hereditary cancer-predisposing syndrome	VCV001736731	16	2133798	16	2083797	1736731	1793773	rs45517323	NC_000016.10:2083796:G:C	single nucleotide variant	missense variant	Uncertain significance	May 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.3986G>A (p.Arg1329His)	TSC2	R1329H, R1085H, R1273H, R1263H, R1306H, R1214H, R1226H, R1285H, R1262H, R1286H	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Ovarian cancer|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000041738	16	2133798	16	2083797	41738	50177	rs45517323	NC_000016.10:2083796:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3987C>T (p.Arg1329=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564739	16	2133799	16	2083798	2564739	2733895	rs2151513672	NC_000016.10:2083797:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3988A>G (p.Thr1330Ala)	TSC2	T1330A, T1227A, T1263A, T1286A, T1287A, T1086A, T1264A, T1307A, T1215A, T1274A	Tuberous sclerosis 2	VCV000468052	16	2133800	16	2083799	468052	466040	rs1555513561	NC_000016.10:2083798:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3989C>A (p.Thr1330Lys)	TSC2	T1214K, T1257K, T1274K, T1286K, T1293K, T1294K, T1107K, T1110K, T1227K, T1258K, T1270K, T1287K, T1306K, T1330K, T839K, T1106K, T1215K, T1244K, T1259K, T1263K, T1307K, T838K, T859K, T1063K, T1064K, T1086K, T1130K, T1226K, T1260K, T1264K, T1304K, T1329K, T729K, T815K, T816K	Tuberous sclerosis 2	VCV002742840	16	2133801	16	2083800	2742840	2900603	rs397515209	NC_000016.10:2083799:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3989C>G (p.Thr1330Arg)	TSC2	T1215R, T1086R, T1330R, T1263R, T1264R, T1286R, T1287R, T1307R, T1227R, T1274R	Tuberous sclerosis 2	VCV000853272	16	2133801	16	2083800	853272	843480	rs397515209	NC_000016.10:2083799:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.3989C>T (p.Thr1330Met)	TSC2	T1330M, T1086M, T1227M, T1287M, T1263M, T1215M, T1274M, T1307M, T1264M, T1286M	Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000065285	16	2133801	16	2083800	65285	76217	rs397515209	NC_000016.10:2083799:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3990G>C (p.Thr1330=)	TSC2		Tuberous sclerosis 2	VCV003639813	16	2133802	16	2083801	3639813	3765156		NC_000016.10:2083800:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.3990G>T (p.Thr1330=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001155967	16	2133802	16	2083801	1155967	1145966	rs369943684	NC_000016.10:2083800:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3990G>A (p.Thr1330=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000238037	16	2133802	16	2083801	238037	242297	rs369943684	NC_000016.10:2083800:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3991G>A (p.Asp1331Asn)	TSC2	D1087N, D1216N, D1228N, D1264N, D1265N, D1275N, D1287N, D1288N, D1308N, D1331N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001692499	16	2133803	16	2083802	1692499	1684939	rs770396146	NC_000016.10:2083801:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3991G>C (p.Asp1331His)	TSC2	D1264H, D1308H, D1087H, D1216H, D1287H, D1275H, D1288H, D1331H, D1228H, D1265H	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000651961	16	2133803	16	2083802	651961	644312	rs770396146	NC_000016.10:2083801:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 31, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3992A>C (p.Asp1331Ala)	TSC2	D1111A, D1228A, D1245A, D1259A, D1260A, D1271A, D1287A, D1294A, D1295A, D816A, D817A, D840A, D860A, D1064A, D1065A, D1107A, D1108A, D1131A, D1227A, D1288A, D1305A, D730A, D839A, D1215A, D1216A, D1258A, D1261A, D1264A, D1265A, D1308A, D1330A, D1087A, D1275A, D1307A, D1331A	Tuberous sclerosis 2	VCV002830521	16	2133804	16	2083803	2830521	2994166	rs2090433367	NC_000016.10:2083802:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3992A>G (p.Asp1331Gly)	TSC2	D1265G, D1331G, D1087G, D1216G, D1287G, D1288G, D1308G, D1228G, D1264G, D1275G	Tuberous sclerosis 2	VCV000952443	16	2133804	16	2083803	952443	927670	rs2090433367	NC_000016.10:2083802:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.3993T>A (p.Asp1331Glu)	TSC2	D1331E, D1287E, D1288E, D1264E, D1087E, D1216E, D1228E, D1265E, D1275E, D1308E	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000406131	16	2133805	16	2083804	406131	400839	rs776049462	NC_000016.10:2083803:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3994G>C (p.Ala1332Pro)	TSC2	A1332P, A1229P, A1266P, A1288P, A1088P, A1217P, A1276P, A1289P, A1309P, A1265P	not provided|Tuberous sclerosis 2	VCV000451438	16	2133806	16	2083805	451438	445525	rs1555513574	NC_000016.10:2083804:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3995C>T (p.Ala1332Val)	TSC2	A1088V, A1109V, A1217V, A1228V, A1260V, A1288V, A1289V, A1295V, A1308V, A1309V, A1332V, A731V, A840V, A841V, A861V, A1065V, A1066V, A1112V, A1132V, A1216V, A1266V, A1272V, A1276V, A1296V, A1229V, A1259V, A817V, A818V, A1108V, A1246V, A1261V, A1262V, A1265V, A1306V, A1331V	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002157737	16	2133807	16	2083806	2157737	1890043	rs1166352281	NC_000016.10:2083805:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.3996C>G (p.Ala1332=)	TSC2		Tuberous sclerosis 2	VCV004071138	16	2133808	16	2083807	4071138	4184986		NC_000016.10:2083806:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.3996C>T (p.Ala1332=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000700813	16	2133808	16	2083807	700813	688546	rs1421997373	NC_000016.10:2083806:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3996C>A (p.Ala1332=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000535980	16	2133808	16	2083807	535980	529649	rs1421997373	NC_000016.10:2083806:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3997T>G (p.Tyr1333Asp)	TSC2	Y1089D, Y1230D, Y1266D, Y1218D, Y1290D, Y1310D, Y1267D, Y1277D, Y1289D, Y1333D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000953511	16	2133809	16	2083808	953511	949265	rs901222751	NC_000016.10:2083807:T:G	single nucleotide variant	missense variant	Benign/Likely benign	Oct 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3998A>G (p.Tyr1333Cys)	TSC2	Y1333C, Y1277C, Y1218C, Y1266C, Y1310C, Y1290C, Y1089C, Y1230C, Y1267C, Y1289C	Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238038	16	2133810	16	2083809	238038	242298	rs878854099	NC_000016.10:2083808:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.3999C>A (p.Tyr1333Ter)	TSC2	Y1333*, Y1218*, Y1310*, Y1266*, Y1289*, Y1230*, Y1290*, Y1089*, Y1267*, Y1277*	Tuberous sclerosis 2	VCV000575698	16	2133811	16	2083810	575698	573859	rs775604492	NC_000016.10:2083809:C:A	single nucleotide variant	nonsense	Pathogenic	Jan 10, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.3999C>T (p.Tyr1333=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000468053	16	2133811	16	2083810	468053	466244	rs775604492	NC_000016.10:2083809:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4001G>T (p.Ser1334Ile)	TSC2	S1134I, S1230I, S1297I, S1298I, S1308I, S1334I, S820I, S1110I, S1111I, S1114I, S1248I, S1264I, S1267I, S1274I, S1278I, S1291I, S1311I, S733I, S842I, S843I, S863I, S1090I, S1218I, S1231I, S1262I, S1268I, S819I, S1067I, S1068I, S1219I, S1261I, S1263I, S1290I, S1310I, S1333I	Tuberous sclerosis 2	VCV002807583	16	2133813	16	2083812	2807583	2974655	rs1060500964	NC_000016.10:2083811:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4001G>C (p.Ser1334Thr)	TSC2	S1067T, S1218T, S1219T, S1263T, S1267T, S1274T, S1278T, S1311T, S863T, S1111T, S1231T, S1248T, S1261T, S1262T, S1298T, S1308T, S1310T, S820T, S843T, S1291T, S1333T, S819T, S1068T, S1090T, S1110T, S1114T, S1134T, S1230T, S1264T, S1268T, S1290T, S1297T, S1334T, S733T, S842T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002564629	16	2133813	16	2083812	2564629	2733785	rs1060500964	NC_000016.10:2083811:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4001G>A (p.Ser1334Asn)	TSC2	S1334N, S1231N, S1278N, S1290N, S1090N, S1311N, S1267N, S1268N, S1219N, S1291N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000406097	16	2133813	16	2083812	406097	401371	rs1060500964	NC_000016.10:2083811:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4002C>G (p.Ser1334Arg)	TSC2	S1278R, S1291R, S1334R, S1090R, S1267R, S1268R, S1290R, S1311R, S1231R, S1219R	Tuberous sclerosis 2	VCV000664472	16	2133814	16	2083813	664472	644313	rs1060500911	NC_000016.10:2083812:C:G	single nucleotide variant	missense variant	Benign	Oct 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4002C>T (p.Ser1334=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000405945	16	2133814	16	2083813	405945	401377	rs1060500911	NC_000016.10:2083812:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4003A>C (p.Arg1335=)	TSC2		Tuberous sclerosis 2	VCV004071220	16	2133815	16	2083814	4071220	4185068		NC_000016.10:2083813:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4003A>T (p.Arg1335Trp)	TSC2	R1091W, R1111W, R1112W, R1219W, R1231W, R1262W, R1264W, R1299W, R1309W, R1311W, R844W, R1115W, R1135W, R1249W, R1268W, R1292W, R1298W, R821W, R864W, R1069W, R1232W, R1265W, R1279W, R1312W, R843W, R1068W, R1220W, R1263W, R1269W, R1275W, R1291W, R1334W, R1335W, R734W, R820W	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564630	16	2133815	16	2083814	2564630	2733786	rs1335768928	NC_000016.10:2083813:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4003A>G (p.Arg1335Gly)	TSC2	R1091G, R1111G, R1115G, R1135G, R1249G, R1263G, R1298G, R820G, R843G, R844G, R1232G, R1279G, R1292G, R1299G, R1309G, R1335G, R864G, R1068G, R1112G, R1262G, R1265G, R1275G, R1311G, R1312G, R1334G, R734G, R1069G, R1219G, R1220G, R1231G, R1264G, R1268G, R1269G, R1291G, R821G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001926526	16	2133815	16	2083814	1926526	1980674	rs1335768928	NC_000016.10:2083813:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4004G>T (p.Arg1335Met)	TSC2	R1068M, R1069M, R1091M, R1111M, R1112M, R1115M, R1135M, R1219M, R1220M, R1231M, R1232M, R1249M, R1262M, R1263M, R1264M, R1265M, R1268M, R1269M, R1275M, R1279M, R1291M, R1292M, R1298M, R1299M, R1309M, R1311M, R1312M, R1334M, R1335M, R734M, R820M, R821M, R843M, R844M, R864M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV002570923	16	2133816	16	2083815	2570923	2735881	rs1403658994	NC_000016.10:2083814:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4004G>A (p.Arg1335Lys)	TSC2	R1220K, R1268K, R1279K, R1269K, R1291K, R1232K, R1335K, R1091K, R1292K, R1312K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001517467	16	2133816	16	2083815	1517467	1420370	rs1403658994	NC_000016.10:2083814:G:A	single nucleotide variant	missense variant	Uncertain significance	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4004G>C (p.Arg1335Thr)	TSC2	R1335T, R1269T, R1232T, R1291T, R1292T, R1091T, R1220T, R1268T, R1279T, R1312T	Tuberous sclerosis 2	VCV000468054	16	2133816	16	2083815	468054	466050	rs1403658994	NC_000016.10:2083814:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005G>A (p.Arg1335=)	TSC2		Tuberous sclerosis 2	VCV002762085	16	2133817	16	2083816	2762085	2930581	rs2090436302	NC_000016.10:2083815:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Oct 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005G>C (p.Arg1335Ser)	TSC2	R1232S, R1268S, R1335S, R1091S, R1220S, R1291S, R1292S, R1312S, R1269S, R1279S	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV001037131	16	2133817	16	2083816	1037131	1032483	rs2090436302	NC_000016.10:2083815:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4005+1G>C	TSC2		not provided	VCV000995055	16	2133818	16	2083817	995055	982944	rs45517324	NC_000016.10:2083816:G:C	single nucleotide variant	splice donor variant	Pathogenic	Jan 15, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+1G>A	TSC2		Tuberous sclerosis 2|not provided	VCV000803154	16	2133818	16	2083817	803154	791538	rs45517324	NC_000016.10:2083816:G:A	single nucleotide variant	splice donor variant	Pathogenic	Mar 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4005+1G>T	TSC2		not provided|Tuberous sclerosis 2	VCV000049778	16	2133818	16	2083817	49778	58940	rs45517324	NC_000016.10:2083816:G:T	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Oct 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4005+2T>C	TSC2		Tuberous sclerosis 2	VCV000803155	16	2133819	16	2083818	803155	791539	rs137854254	NC_000016.10:2083817:T:C	single nucleotide variant	splice donor variant	Likely pathogenic	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+3G>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003462625	16	2133820	16	2083819	3462625	3621644		NC_000016.10:2083818:G:T	single nucleotide variant	intron variant	Uncertain significance	Sep 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+3G>A	TSC2		Hereditary cancer-predisposing syndrome	VCV003462591	16	2133820	16	2083819	3462591	3621610		NC_000016.10:2083818:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+3G>C	TSC2		Tuberous sclerosis 2	VCV002756041	16	2133820	16	2083819	2756041	2914186	rs2151514353	NC_000016.10:2083818:G:C	single nucleotide variant	intron variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+4A>T	TSC2		not provided	VCV002645971	16	2133821	16	2083820	2645971	2810852	rs1454470740	NC_000016.10:2083819:A:T	single nucleotide variant	intron variant	Uncertain significance	Jul 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+5G>T	TSC2		Tuberous sclerosis 2	VCV003692709	16	2133822	16	2083821	3692709	3828207		NC_000016.10:2083820:G:T	single nucleotide variant	intron variant	Uncertain significance	Sep 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+5G>C	TSC2		Tuberous sclerosis 2	VCV003237378	16	2133822	16	2083821	3237378	3396499	rs2151514405	NC_000016.10:2083820:G:C	single nucleotide variant	intron variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+5G>A	TSC2		Tuberous sclerosis 2	VCV002721176	16	2133822	16	2083821	2721176	2887702	rs2151514405	NC_000016.10:2083820:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+6T>C	TSC2		Tuberous sclerosis 2	VCV001483793	16	2133823	16	2083822	1483793	1458577	rs2151514450	NC_000016.10:2083821:T:C	single nucleotide variant	intron variant	Uncertain significance	Apr 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+7G>A	TSC2		Tuberous sclerosis 2	VCV001625387	16	2133824	16	2083823	1625387	1606948	rs2151514474	NC_000016.10:2083822:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4005+8T>C	TSC2		Tuberous sclerosis 2	VCV003727169	16	2133825	16	2083824	3727169	3861394		NC_000016.10:2083823:T:C	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+9G>A	TSC2		Tuberous sclerosis 2	VCV003684927	16	2133826	16	2083825	3684927	3808914		NC_000016.10:2083824:G:A	single nucleotide variant	intron variant	Likely benign	Aug 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+10G>A	TSC2		Tuberous sclerosis 2	VCV004071177	16	2133827	16	2083826	4071177	4185025		NC_000016.10:2083825:G:A	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+10G>T	TSC2		Tuberous sclerosis 2	VCV001114449	16	2133827	16	2083826	1114449	1103669	rs2090437677	NC_000016.10:2083825:G:T	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4005+11C>G	TSC2		Tuberous sclerosis 2	VCV002000315	16	2133828	16	2083827	2000315	2050949	rs768957548	NC_000016.10:2083826:C:G	single nucleotide variant	intron variant	Likely benign	May 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+11C>T	TSC2		Tuberous sclerosis 2	VCV001558388	16	2133828	16	2083827	1558388	1594977	rs768957548	NC_000016.10:2083826:C:T	single nucleotide variant	intron variant	Likely benign	Nov 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+12T>C	TSC2		Tuberous sclerosis 2	VCV002988230	16	2133829	16	2083828	2988230	3147253	rs2151514578	NC_000016.10:2083827:T:C	single nucleotide variant	intron variant	Likely benign	Dec 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+13C>T	TSC2		Tuberous sclerosis 2	VCV001962882	16	2133830	16	2083829	1962882	2020433	rs2544239672	NC_000016.10:2083828:C:T	single nucleotide variant	intron variant	Likely benign	Apr 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+14A>G	TSC2		Tuberous sclerosis 2	VCV001550873	16	2133831	16	2083830	1550873	1574562	rs774371313	NC_000016.10:2083829:A:G	single nucleotide variant	intron variant	Likely benign	Dec 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+16A>T	TSC2		Tuberous sclerosis 2	VCV003638547	16	2133833	16	2083832	3638547	3774842		NC_000016.10:2083831:A:T	single nucleotide variant	intron variant	Likely benign	Dec 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+16A>C	TSC2		Tuberous sclerosis 2	VCV002061806	16	2133833	16	2083832	2061806	2120954	rs998429192	NC_000016.10:2083831:A:C	single nucleotide variant	intron variant	Likely benign	Sep 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+16A>G	TSC2		Tuberous sclerosis 2	VCV001642438	16	2133833	16	2083832	1642438	1552536	rs998429192	NC_000016.10:2083831:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+17G>C	TSC2		Tuberous sclerosis 2	VCV003655421	16	2133834	16	2083833	3655421	3786137		NC_000016.10:2083832:G:C	single nucleotide variant	intron variant	Likely benign	Dec 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+17G>A	TSC2		Tuberous sclerosis 2	VCV001586306	16	2133834	16	2083833	1586306	1562465	rs1346482272	NC_000016.10:2083832:G:A	single nucleotide variant	intron variant	Likely benign	Oct 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+18C>T	TSC2		Tuberous sclerosis 2	VCV001530769	16	2133835	16	2083834	1530769	1635241	rs1339579825	NC_000016.10:2083833:C:T	single nucleotide variant	intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+19C>G	TSC2		Tuberous sclerosis 2	VCV001616735	16	2133836	16	2083835	1616735	1579738	rs558058715	NC_000016.10:2083834:C:G	single nucleotide variant	intron variant	Likely benign	Nov 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4005+84C>T	TSC2		not provided	VCV001266887	16	2133901	16	2083900	1266887	1255922	rs30259	NC_000016.10:2083899:C:T	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4005+153T>A	TSC2		not provided	VCV001204311	16	2133970	16	2083969	1204311	1195033	rs28535326	NC_000016.10:2083968:T:A	single nucleotide variant	intron variant	Likely benign	Jul 2, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-94G>A	TSC2		not provided	VCV001214757	16	2134135	16	2084134	1214757	1204740	rs145263137	NC_000016.10:2084133:G:A	single nucleotide variant	intron variant	Likely benign	Jun 26, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-19T>G	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not specified	VCV000516794	16	2134210	16	2084209	516794	505219	rs200900825	NC_000016.10:2084208:T:G	single nucleotide variant	intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4006-17G>C	TSC2		Tuberous sclerosis 2	VCV002844609	16	2134212	16	2084211	2844609	3004410	rs1264142922	NC_000016.10:2084210:G:C	single nucleotide variant	intron variant	Likely benign	May 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-17G>A	TSC2		Tuberous sclerosis 2	VCV002027153	16	2134212	16	2084211	2027153	2081226	rs1264142922	NC_000016.10:2084210:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-15G>C	TSC2		Tuberous sclerosis 2	VCV001605747	16	2134214	16	2084213	1605747	1646799	rs2090477452	NC_000016.10:2084212:G:C	single nucleotide variant	intron variant	Likely benign	Sep 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-14A>C	TSC2		Tuberous sclerosis 2	VCV001579113	16	2134215	16	2084214	1579113	1565103	rs1350511311	NC_000016.10:2084213:A:C	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4006-14A>G	TSC2		Tuberous sclerosis 2	VCV001559946	16	2134215	16	2084214	1559946	1606480	rs1350511311	NC_000016.10:2084213:A:G	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4006-12G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000392438	16	2134217	16	2084216	392438	374155	rs1057524490	NC_000016.10:2084215:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 31, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4006-11G>A	TSC2		Tuberous sclerosis 2	VCV002079668	16	2134218	16	2084217	2079668	2142755	rs2151520129	NC_000016.10:2084216:G:A	single nucleotide variant	intron variant	Likely benign	Mar 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-10T>G	TSC2		Tuberous sclerosis 2	VCV001002918	16	2134219	16	2084218	1002918	996749	rs2090477960	NC_000016.10:2084217:T:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-9C>T	TSC2		Tuberous sclerosis 2	VCV000468056	16	2134220	16	2084219	468056	466248	rs1555513765	NC_000016.10:2084218:C:T	single nucleotide variant	intron variant	Likely benign	Dec 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-8C>T	TSC2		not provided|not specified|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049281	16	2134221	16	2084220	49281	58443	rs45517325	NC_000016.10:2084219:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Sep 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4006-7T>G	TSC2		not provided|Tuberous sclerosis 2	VCV001131911	16	2134222	16	2084221	1131911	1125082	rs2151520224	NC_000016.10:2084220:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 7, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4006-7T>C	TSC2		Tuberous sclerosis 2	VCV001087147	16	2134222	16	2084221	1087147	1081856	rs2151520224	NC_000016.10:2084220:T:C	single nucleotide variant	intron variant	Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4006-6T>C	TSC2		Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000406058	16	2134223	16	2084222	406058	401622	rs1060500953	NC_000016.10:2084221:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4006-5T>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000824495	16	2134224	16	2084223	824495	815617	rs1596415173	NC_000016.10:2084222:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4006-4C>T	TSC2		Tuberous sclerosis 2	VCV001123812	16	2134225	16	2084224	1123812	1125083	rs772258522	NC_000016.10:2084223:C:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-4C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468055	16	2134225	16	2084224	468055	466255	rs772258522	NC_000016.10:2084223:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4006-2A>T	TSC2		Tuberous sclerosis 2	VCV000974588	16	2134227	16	2084226	974588	962886	rs397514941	NC_000016.10:2084225:A:T	single nucleotide variant	splice acceptor variant	Pathogenic	Jul 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4006-2A>G	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis	VCV000064922	16	2134227	16	2084226	64922	75852	rs397514941	NC_000016.10:2084225:A:G	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4006-1G>C	TSC2		not provided|Tuberous sclerosis 2	VCV000805698	16	2134228	16	2084227	805698	794052	rs1085307853	NC_000016.10:2084226:G:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4006-1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000426923	16	2134228	16	2084227	426923	415477	rs1085307853	NC_000016.10:2084226:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Oct 18, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4007C>A (p.Ser1336Ter)	TSC2	S1092*, S1136*, S1220*, S1263*, S1276*, S1293*, S1299*, S1310*, S1312*, S1335*, S845*, S1070*, S1113*, S1232*, S1250*, S1264*, S1265*, S1292*, S1300*, S1069*, S1269*, S1270*, S1280*, S1336*, S822*, S1313*, S844*, S1112*, S1116*, S1221*, S1233*, S1266*, S735*, S821*, S865*	Tuberous sclerosis 2	VCV003689912	16	2134230	16	2084229	3689912	3823827		NC_000016.10:2084228:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Mar 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4007C>G (p.Ser1336Trp)	TSC2	S1270W, S1280W, S1313W, S1336W, S1292W, S1293W, S1092W, S1221W, S1233W, S1269W	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000938643	16	2134230	16	2084229	938643	937334	rs148527903	NC_000016.10:2084228:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4007C>T (p.Ser1336Leu)	TSC2	S1336L, S1269L, S1221L, S1293L, S1233L, S1270L, S1313L, S1092L, S1280L, S1292L	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135385	16	2134230	16	2084229	135385	139124	rs148527903	NC_000016.10:2084228:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4008G>T (p.Ser1336=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486689	16	2134231	16	2084230	486689	477360	rs760704956	NC_000016.10:2084229:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4008G>A (p.Ser1336=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000468057	16	2134231	16	2084230	468057	466051	rs760704956	NC_000016.10:2084229:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4009T>A (p.Ser1337Thr)	TSC2	S1071T, S1093T, S1222T, S1234T, S1267T, S1294T, S1301T, S1314T, S736T, S1114T, S1265T, S1277T, S1293T, S1300T, S1336T, S866T, S1113T, S1117T, S1221T, S1270T, S1271T, S1281T, S1311T, S1313T, S1337T, S822T, S845T, S846T, S1070T, S1137T, S1233T, S1251T, S1264T, S1266T, S823T	Hereditary cancer-predisposing syndrome	VCV002626461	16	2134232	16	2084231	2626461	2794227	rs2544253877	NC_000016.10:2084230:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4010C>T (p.Ser1337Phe)	TSC2	S1271F, S1093F, S1270F, S1281F, S1293F, S1222F, S1314F, S1234F, S1294F, S1337F	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000681136	16	2134233	16	2084232	681136	656346	rs200411484	NC_000016.10:2084231:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4010C>A (p.Ser1337Tyr)	TSC2	S1337Y, S1222Y, S1270Y, S1271Y, S1281Y, S1294Y, S1093Y, S1234Y, S1293Y, S1314Y	Tuberous sclerosis 2	VCV000566913	16	2134233	16	2084232	566913	569820	rs200411484	NC_000016.10:2084231:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4011C>T (p.Ser1337=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001737020	16	2134234	16	2084233	1737020	1794062	rs2544254073	NC_000016.10:2084232:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4012T>C (p.Ser1338Pro)	TSC2	S1222P, S1235P, S1302P, S867P, S1223P, S1266P, S1267P, S1278P, S1294P, S1314P, S737P, S823P, S824P, S846P, S1071P, S1094P, S1114P, S1115P, S1138P, S1234P, S1252P, S1282P, S1295P, S1312P, S1337P, S1338P, S847P, S1072P, S1118P, S1265P, S1268P, S1271P, S1272P, S1301P, S1315P	Tuberous sclerosis 2	VCV003637227	16	2134235	16	2084234	3637227	3771381		NC_000016.10:2084233:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4013C>T (p.Ser1338Leu)	TSC2	S1235L, S1294L, S1223L, S1271L, S1094L, S1282L, S1315L, S1338L, S1272L, S1295L	not provided|Tuberous sclerosis 2	VCV001426342	16	2134236	16	2084235	1426342	1450949	rs2151520475	NC_000016.10:2084234:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4014A>C (p.Ser1338=)	TSC2		Tuberous sclerosis 2	VCV001612927	16	2134237	16	2084236	1612927	1663078	rs1481292684	NC_000016.10:2084235:A:C	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4014A>G (p.Ser1338=)	TSC2		Tuberous sclerosis 2	VCV001091886	16	2134237	16	2084236	1091886	1081857	rs1481292684	NC_000016.10:2084235:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4016T>A (p.Val1339Asp)	TSC2	V1072D, V1119D, V1139D, V1224D, V1266D, V1267D, V1272D, V1273D, V1315D, V825D, V847D, V868D, V1115D, V1116D, V1235D, V1269D, V1279D, V1302D, V1338D, V1339D, V1073D, V1095D, V1253D, V1295D, V1296D, V738D, V824D, V1223D, V1236D, V1268D, V1283D, V1303D, V1313D, V1316D, V848D	Hereditary cancer-predisposing syndrome|not provided	VCV002564641	16	2134239	16	2084238	2564641	2733797	rs2544254233	NC_000016.10:2084237:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4017C>G (p.Val1339=)	TSC2		Tuberous sclerosis 2	VCV001656667	16	2134240	16	2084239	1656667	1562052	rs876658217	NC_000016.10:2084238:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4017C>T (p.Val1339=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000229821	16	2134240	16	2084239	229821	235130	rs876658217	NC_000016.10:2084238:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4019C>G (p.Ser1340Cys)	TSC2	S1096C, S1273C, S1225C, S1237C, S1274C, S1317C, S1284C, S1297C, S1340C, S1296C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001403409	16	2134242	16	2084241	1403409	1470632	rs753656246	NC_000016.10:2084240:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4019C>T (p.Ser1340Phe)	TSC2	S1340F, S1274F, S1225F, S1296F, S1096F, S1237F, S1317F, S1273F, S1284F, S1297F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000468059	16	2134242	16	2084241	468059	465981	rs753656246	NC_000016.10:2084240:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4020C>T (p.Ser1340=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000763107	16	2134243	16	2084242	763107	770730	rs1596415292	NC_000016.10:2084241:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4021A>G (p.Ser1341Gly)	TSC2	S1285G, S1341G, S1274G, S1318G, S1097G, S1226G, S1238G, S1275G, S1297G, S1298G	Tuberous sclerosis 2	VCV000962390	16	2134244	16	2084243	962390	949266	rs2090480803	NC_000016.10:2084242:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4022G>C (p.Ser1341Thr)	TSC2	S1075T, S1141T, S1281T, S1305T, S1340T, S740T, S826T, S1097T, S1118T, S1226T, S1237T, S1238T, S1255T, S1275T, S827T, S850T, S870T, S1117T, S1121T, S1268T, S1269T, S1271T, S1274T, S1304T, S1315T, S1317T, S1341T, S849T, S1074T, S1225T, S1270T, S1285T, S1297T, S1298T, S1318T	Tuberous sclerosis 2	VCV002075934	16	2134245	16	2084244	2075934	2141607	rs1451479803	NC_000016.10:2084243:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4022G>A (p.Ser1341Asn)	TSC2	S1097N, S1226N, S1238N, S1274N, S1275N, S1285N, S1297N, S1298N, S1318N, S1341N	Tuberous sclerosis 2	VCV001064083	16	2134245	16	2084244	1064083	1049475	rs1451479803	NC_000016.10:2084243:G:A	single nucleotide variant	missense variant	Benign	Feb 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4023C>A (p.Ser1341Arg)	TSC2	S1341R, S1226R, S1297R, S1274R, S1275R, S1318R, S1285R, S1298R, S1097R, S1238R	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049282	16	2134246	16	2084245	49282	58444	rs45462593	NC_000016.10:2084244:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4024C>A (p.Gln1342Lys)	TSC2	Q1299K, Q1319K, Q741K, Q828K, Q1098K, Q1119K, Q1122K, Q1269K, Q1270K, Q1275K, Q1305K, Q1306K, Q1316K, Q1341K, Q1076K, Q1238K, Q1272K, Q1282K, Q1286K, Q1318K, Q827K, Q850K, Q851K, Q1075K, Q1118K, Q1142K, Q1227K, Q1298K, Q1226K, Q1239K, Q1256K, Q1271K, Q1276K, Q1342K, Q871K	Hereditary cancer-predisposing syndrome	VCV003974696	16	2134247	16	2084246	3974696	4086519		NC_000016.10:2084245:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 31, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4024C>T (p.Gln1342Ter)	TSC2	Q1342*, Q1227*, Q1275*, Q1286*, Q1299*, Q1319*, Q1098*, Q1239*, Q1276*, Q1298*	Tuberous sclerosis 2|not provided	VCV000065012	16	2134247	16	2084246	65012	75942	rs397515003	NC_000016.10:2084245:C:T	single nucleotide variant	nonsense	Pathogenic	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4025A>T (p.Gln1342Leu)	TSC2	Q1238L, Q1239L, Q1271L, Q1286L, Q1298L, Q1299L, Q828L, Q850L, Q1118L, Q1256L, Q1269L, Q1282L, Q1318L, Q1341L, Q827L, Q851L, Q871L, Q1075L, Q1076L, Q1098L, Q1122L, Q1226L, Q1270L, Q1275L, Q1276L, Q1316L, Q741L, Q1119L, Q1142L, Q1227L, Q1272L, Q1305L, Q1306L, Q1319L, Q1342L	Hereditary cancer-predisposing syndrome	VCV001737138	16	2134248	16	2084247	1737138	1790337	rs1060500951	NC_000016.10:2084246:A:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4025A>G (p.Gln1342Arg)	TSC2	Q1342R, Q1239R, Q1298R, Q1098R, Q1227R, Q1319R, Q1275R, Q1286R, Q1299R, Q1276R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406054	16	2134248	16	2084247	406054	401623	rs1060500951	NC_000016.10:2084246:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4026G>A (p.Gln1342=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001096045	16	2134249	16	2084248	1096045	1081858	rs765005488	NC_000016.10:2084247:G:A	single nucleotide variant	synonymous variant	Likely benign	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4028A>G (p.Glu1343Gly)	TSC2	E1099G, E1228G, E1240G, E1276G, E1277G, E1287G, E1299G, E1300G, E1320G, E1343G	Tuberous sclerosis 2	VCV001009958	16	2134251	16	2084250	1009958	996750	rs2090481775	NC_000016.10:2084249:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4029G>A (p.Glu1343=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413703	16	2134252	16	2084251	413703	400840	rs752502287	NC_000016.10:2084250:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4029G>C (p.Glu1343Asp)	TSC2	E1343D, E1228D, E1240D, E1276D, E1320D, E1299D, E1099D, E1277D, E1287D, E1300D	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207679	16	2134252	16	2084251	207679	203181	rs752502287	NC_000016.10:2084250:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4030G>A (p.Glu1344Lys)	TSC2	E1344K, E1278K, E1321K, E1241K, E1301K, E1100K, E1288K, E1229K, E1277K, E1300K	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000207750	16	2134253	16	2084252	207750	203182	rs397515035	NC_000016.10:2084251:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4031A>G (p.Glu1344Gly)	TSC2	E1229G, E1277G, E1241G, E1278G, E1288G, E1344G, E1100G, E1300G, E1301G, E1321G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000954178	16	2134254	16	2084253	954178	949267	rs2090482288	NC_000016.10:2084252:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4032G>A (p.Glu1344=)	TSC2		Tuberous sclerosis 2	VCV001968179	16	2134255	16	2084254	1968179	2032054	rs777520842	NC_000016.10:2084253:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Oct 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4033A>G (p.Lys1345Glu)	TSC2	K1078E, K1101E, K1122E, K1241E, K1272E, K1274E, K1275E, K1278E, K1285E, K1321E, K1344E, K854E, K1229E, K1242E, K1259E, K1273E, K1279E, K1301E, K1302E, K1319E, K1322E, K831E, K874E, K1121E, K1145E, K1308E, K744E, K1079E, K1125E, K1230E, K1289E, K1309E, K1345E, K830E, K853E	Tuberous sclerosis 2	VCV002064694	16	2134256	16	2084255	2064694	2124807	rs2151521044	NC_000016.10:2084254:A:G	single nucleotide variant	missense variant	Uncertain significance	May 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4033A>T (p.Lys1345Ter)	TSC2	K1101*, K1230*, K1242*, K1278*, K1279*, K1289*, K1301*, K1302*, K1322*, K1345*	Tuberous sclerosis 2	VCV001696845	16	2134256	16	2084255	1696845	1689242	rs2151521044	NC_000016.10:2084254:A:T	single nucleotide variant	nonsense	Pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4034A>G (p.Lys1345Arg)	TSC2	K1078R, K1079R, K1101R, K1121R, K1122R, K1125R, K1145R, K1229R, K1230R, K1241R, K1242R, K1259R, K1272R, K1273R, K1274R, K1275R, K1278R, K1279R, K1285R, K1289R, K1301R, K1302R, K1308R, K1309R, K1319R, K1321R, K1322R, K1344R, K1345R, K744R, K830R, K831R, K853R, K854R, K874R	Tuberous sclerosis syndrome	VCV003386175	16	2134257	16	2084256	3386175	3545316		NC_000016.10:2084255:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4034A>T (p.Lys1345Met)	TSC2	K1345M, K1230M, K1242M, K1278M, K1279M, K1322M, K1301M, K1302M, K1101M, K1289M	Tuberous sclerosis 2	VCV000468060	16	2134257	16	2084256	468060	466058	rs1302353294	NC_000016.10:2084255:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4035G>A (p.Lys1345=)	TSC2		Tuberous sclerosis 2	VCV000797411	16	2134258	16	2084257	797411	785204	rs1335576471	NC_000016.10:2084256:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4035G>C (p.Lys1345Asn)	TSC2	K1242N, K1101N, K1230N, K1289N, K1278N, K1345N, K1279N, K1301N, K1302N, K1322N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000647403	16	2134258	16	2084257	647403	644315	rs1335576471	NC_000016.10:2084256:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4037C>G (p.Ser1346Trp)	TSC2	S1260W, S1273W, S1280W, S1323W, S1345W, S831W, S832W, S875W, S1286W, S745W, S854W, S1102W, S1122W, S1230W, S1243W, S1275W, S1276W, S1303W, S1310W, S1320W, S855W, S1079W, S1274W, S1290W, S1302W, S1309W, S1322W, S1346W, S1080W, S1123W, S1126W, S1146W, S1231W, S1242W, S1279W	Hereditary cancer-predisposing syndrome	VCV001737247	16	2134260	16	2084259	1737247	1790446	rs45517326	NC_000016.10:2084258:C:G	single nucleotide variant	missense variant	Uncertain significance	May 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4037C>T (p.Ser1346Leu)	TSC2	S1346L, S1302L, S1303L, S1243L, S1280L, S1290L, S1323L, S1279L, S1102L, S1231L	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486606	16	2134260	16	2084259	486606	477421	rs45517326	NC_000016.10:2084258:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4038G>A (p.Ser1346=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000480815	16	2134261	16	2084260	480815	477370	rs756763596	NC_000016.10:2084259:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4038G>T (p.Ser1346=)	TSC2		Tuberous sclerosis 2	VCV000413739	16	2134261	16	2084260	413739	400847	rs756763596	NC_000016.10:2084259:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4039C>G (p.Leu1347Val)	TSC2	L1103V, L1232V, L1244V, L1280V, L1281V, L1291V, L1303V, L1304V, L1324V, L1347V	Tuberous sclerosis 2	VCV000992916	16	2134262	16	2084261	992916	980847	rs377050648	NC_000016.10:2084260:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4039C>T (p.Leu1347Phe)	TSC2	L1280F, L1281F, L1291F, L1324F, L1103F, L1304F, L1232F, L1244F, L1303F, L1347F	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000935558	16	2134262	16	2084261	935558	937335	rs377050648	NC_000016.10:2084260:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4040T>A (p.Leu1347His)	TSC2	L1231H, L1080H, L1147H, L1243H, L1274H, L1276H, L1291H, L1303H, L1311H, L1323H, L1324H, L855H, L1081H, L1123H, L1124H, L1127H, L1277H, L1281H, L1347H, L833H, L1103H, L1232H, L1244H, L1261H, L1275H, L1280H, L1287H, L1304H, L1310H, L1321H, L1346H, L746H, L832H, L856H, L876H	Hereditary cancer-predisposing syndrome	VCV001737286	16	2134263	16	2084262	1737286	1790485	rs1221929408	NC_000016.10:2084261:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4040T>C (p.Leu1347Pro)	TSC2	L1347P, L1103P, L1280P, L1281P, L1291P, L1232P, L1303P, L1244P, L1324P, L1304P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000535968	16	2134263	16	2084262	535968	529651	rs1221929408	NC_000016.10:2084261:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4041C>T (p.Leu1347=)	TSC2		Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000413714	16	2134264	16	2084263	413714	401379	rs1060504109	NC_000016.10:2084262:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4042C>T (p.His1348Tyr)	TSC2	H1233Y, H1305Y, H1325Y, H1348Y, H1282Y, H1304Y, H1104Y, H1245Y, H1281Y, H1292Y	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001388142	16	2134265	16	2084264	1388142	1370883	rs2151521367	NC_000016.10:2084263:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4043A>G (p.His1348Arg)	TSC2	H1081R, H1276R, H1311R, H1347R, H834R, H856R, H1082R, H1125R, H1128R, H1244R, H1277R, H1278R, H1282R, H1292R, H1305R, H1312R, H1322R, H1124R, H1262R, H1275R, H857R, H1104R, H1148R, H1232R, H1233R, H1245R, H1288R, H1304R, H747R, H833R, H1281R, H1324R, H1325R, H1348R, H877R	Tuberous sclerosis 2	VCV003637228	16	2134266	16	2084265	3637228	3771382		NC_000016.10:2084264:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4044C>G (p.His1348Gln)	TSC2	H1124Q, H1277Q, H1312Q, H1322Q, H1324Q, H1125Q, H1148Q, H1233Q, H1292Q, H1311Q, H1325Q, H1348Q, H877Q, H1081Q, H1128Q, H1245Q, H1262Q, H1275Q, H1276Q, H1278Q, H1282Q, H1288Q, H1305Q, H1347Q, H747Q, H856Q, H857Q, H1082Q, H1104Q, H1232Q, H1244Q, H1281Q, H1304Q, H833Q, H834Q	Hereditary cancer-predisposing syndrome	VCV003974631	16	2134267	16	2084266	3974631	4086454		NC_000016.10:2084265:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4044C>T (p.His1348=)	TSC2		not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049537	16	2134267	16	2084266	49537	58699	rs137854084	NC_000016.10:2084265:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4045G>T (p.Ala1349Ser)	TSC2	A1105S, A1233S, A1278S, A1306S, A1312S, A1313S, A878S, A1082S, A1149S, A1279S, A1323S, A1348S, A1349S, A748S, A834S, A1083S, A1234S, A1245S, A1276S, A1277S, A1289S, A1293S, A1305S, A1325S, A1326S, A857S, A1125S, A1126S, A1129S, A1246S, A1263S, A1282S, A1283S, A835S, A858S	Tuberous sclerosis 2	VCV003637229	16	2134268	16	2084267	3637229	3771383		NC_000016.10:2084266:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4045G>A (p.Ala1349Thr)	TSC2	A1349T, A1305T, A1306T, A1105T, A1234T, A1293T, A1326T, A1246T, A1283T, A1282T	Hereditary cancer-predisposing syndrome|not provided|not specified|Tuberous sclerosis 2	VCV000207751	16	2134268	16	2084267	207751	203183	rs146239734	NC_000016.10:2084266:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4046C>A (p.Ala1349Glu)	TSC2	A1234E, A1282E, A1305E, A1306E, A1105E, A1283E, A1246E, A1293E, A1326E, A1349E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000645415	16	2134269	16	2084268	645415	644316	rs201979616	NC_000016.10:2084267:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4046C>T (p.Ala1349Val)	TSC2	A1349V, A1305V, A1326V, A1105V, A1246V, A1283V, A1293V, A1306V, A1234V, A1282V	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000041739	16	2134269	16	2084268	41739	50178	rs201979616	NC_000016.10:2084267:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4047G>A (p.Ala1349=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050045	16	2134270	16	2084269	50045	59207	rs45468491	NC_000016.10:2084268:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4048G>A (p.Glu1350Lys)	TSC2	E1106K, E1126K, E1130K, E1278K, E1283K, E1314K, E1324K, E1349K, E1350K, E858K, E879K, E1235K, E1246K, E1264K, E1277K, E1290K, E859K, E1084K, E1127K, E1150K, E1234K, E1247K, E1279K, E1284K, E1306K, E1307K, E1313K, E1327K, E749K, E835K, E1083K, E1280K, E1294K, E1326K, E836K	Tuberous sclerosis 2	VCV002107466	16	2134271	16	2084270	2107466	2166630	rs2544256415	NC_000016.10:2084269:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4049A>T (p.Glu1350Val)	TSC2	E1235V, E1283V, E1294V, E1350V, E1106V, E1306V, E1307V, E1247V, E1327V, E1284V	Tuberous sclerosis 2|TSC2-related disorder|Hereditary cancer-predisposing syndrome|not provided	VCV000950089	16	2134272	16	2084271	950089	927671	rs1378842608	NC_000016.10:2084270:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4050G>A (p.Glu1350=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001088534	16	2134273	16	2084272	1088534	1081859	rs2090485089	NC_000016.10:2084271:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4051G>T (p.Glu1351Ter)	TSC2	E1107*, E1284*, E1285*, E1351*, E1295*, E1307*, E1236*, E1248*, E1308*, E1328*	Tuberous sclerosis 2	VCV000862394	16	2134274	16	2084273	862394	843481	rs878854101	NC_000016.10:2084272:G:T	single nucleotide variant	nonsense	Pathogenic	Feb 18, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4051G>A (p.Glu1351Lys)	TSC2	E1351K, E1284K, E1107K, E1308K, E1328K, E1248K, E1295K, E1236K, E1285K, E1307K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000238040	16	2134274	16	2084273	238040	242300	rs878854101	NC_000016.10:2084272:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 31, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4053G>A (p.Glu1351=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001737390	16	2134276	16	2084275	1737390	1790589	rs2544256680	NC_000016.10:2084274:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4054C>G (p.Leu1352Val)	TSC2	L1108V, L1237V, L1249V, L1285V, L1286V, L1296V, L1308V, L1309V, L1329V, L1352V	Tuberous sclerosis 2	VCV001016045	16	2134277	16	2084276	1016045	1011995	rs2090485397	NC_000016.10:2084275:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4055T>A (p.Leu1352Gln)	TSC2	L1248Q, L1266Q, L1308Q, L1329Q, L751Q, L861Q, L1108Q, L1286Q, L1292Q, L1296Q, L1351Q, L1352Q, L837Q, L1086Q, L1132Q, L1236Q, L1237Q, L1249Q, L1279Q, L1281Q, L1285Q, L1309Q, L860Q, L1085Q, L1128Q, L1129Q, L1152Q, L1280Q, L1282Q, L1315Q, L1316Q, L1326Q, L1328Q, L838Q, L881Q	Hereditary cancer-predisposing syndrome	VCV002626447	16	2134278	16	2084277	2626447	2794213	rs2544256801	NC_000016.10:2084276:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4056G>T (p.Leu1352=)	TSC2		Tuberous sclerosis 2	VCV001137135	16	2134279	16	2084278	1137135	1125084	rs772309833	NC_000016.10:2084277:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4056G>A (p.Leu1352=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413648	16	2134279	16	2084278	413648	400849	rs772309833	NC_000016.10:2084277:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4056G>C (p.Leu1352=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000386117	16	2134279	16	2084278	386117	375200	rs772309833	NC_000016.10:2084277:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4057G>T (p.Val1353Phe)	TSC2	V1250F, V1287F, V1297F, V1309F, V1310F, V1353F, V1109F, V1238F, V1330F, V1286F	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000645686	16	2134280	16	2084279	645686	644317	rs373982157	NC_000016.10:2084278:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4057G>A (p.Val1353Ile)	TSC2	V1353I, V1109I, V1250I, V1286I, V1287I, V1310I, V1238I, V1297I, V1309I, V1330I	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000486660	16	2134280	16	2084279	486660	477501	rs373982157	NC_000016.10:2084278:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4058T>C (p.Val1353Ala)	TSC2	V1238A, V1297A, V1309A, V1310A, V1330A, V1353A, V1109A, V1250A, V1286A, V1287A	Tuberous sclerosis 2	VCV001412982	16	2134281	16	2084280	1412982	1356579	rs2151521778	NC_000016.10:2084279:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4060G>A (p.Gly1354Ser)	TSC2	G1110S, G1131S, G1134S, G1154S, G1251S, G1288S, G1328S, G839S, G863S, G1088S, G1281S, G1284S, G1353S, G840S, G862S, G1087S, G1239S, G1250S, G1268S, G1282S, G1283S, G1294S, G1298S, G1311S, G1318S, G1330S, G1354S, G753S, G1130S, G1238S, G1287S, G1310S, G1317S, G1331S, G883S	Tuberous sclerosis 2	VCV002712891	16	2134283	16	2084282	2712891	2879038	rs1567520803	NC_000016.10:2084281:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4061G>T (p.Gly1354Val)	TSC2	G1088V, G1110V, G1239V, G1250V, G1281V, G1282V, G1298V, G1311V, G1318V, G1354V, G840V, G1287V, G1288V, G1294V, G1330V, G1331V, G1353V, G839V, G863V, G883V, G1131V, G1154V, G1238V, G1283V, G1328V, G1087V, G1130V, G1134V, G1251V, G1268V, G1284V, G1310V, G1317V, G753V, G862V	Tuberous sclerosis 2	VCV003637230	16	2134284	16	2084283	3637230	3771384		NC_000016.10:2084282:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4061G>A (p.Gly1354Asp)	TSC2	G1354D, G1331D, G1239D, G1287D, G1298D, G1310D, G1251D, G1311D, G1110D, G1288D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000238041	16	2134284	16	2084283	238041	242301	rs878854102	NC_000016.10:2084282:G:A	single nucleotide variant	missense variant	Uncertain significance	May 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4062C>T (p.Gly1354=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001737482	16	2134285	16	2084284	1737482	1787346	rs2151521887	NC_000016.10:2084283:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4063A>C (p.Arg1355=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002030376	16	2134286	16	2084285	2030376	2085723	rs1555513911	NC_000016.10:2084284:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4063A>G (p.Arg1355Gly)	TSC2	R1355G, R1111G, R1252G, R1332G, R1288G, R1299G, R1311G, R1240G, R1289G, R1312G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|not provided	VCV000468061	16	2134286	16	2084285	468061	465350	rs1555513911	NC_000016.10:2084284:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4065G>A (p.Arg1355=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001610243	16	2134288	16	2084287	1610243	1519597	rs2151521953	NC_000016.10:2084286:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4066G>A (p.Gly1356Ser)	TSC2	G1089S, G1112S, G1156S, G1253S, G1284S, G1285S, G1286S, G1313S, G1333S, G1136S, G1252S, G1283S, G1300S, G1319S, G1320S, G1330S, G1355S, G1356S, G841S, G842S, G1090S, G1132S, G1133S, G1241S, G1289S, G1312S, G1332S, G865S, G1240S, G1270S, G1290S, G1296S, G755S, G864S, G885S	Hereditary cancer-predisposing syndrome	VCV002561947	16	2134289	16	2084288	2561947	2724318	rs2544257595	NC_000016.10:2084287:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4067G>T (p.Gly1356Val)	TSC2	G1356V, G1289V, G1300V, G1313V, G1290V, G1112V, G1241V, G1253V, G1312V, G1333V	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000432576	16	2134290	16	2084289	432576	426153	rs747104864	NC_000016.10:2084288:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4067G>A (p.Gly1356Asp)	TSC2	G1356D, G1289D, G1300D, G1312D, G1313D, G1333D, G1290D, G1112D, G1241D, G1253D	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207752	16	2134290	16	2084289	207752	203184	rs747104864	NC_000016.10:2084288:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4068C>T (p.Gly1356=)	TSC2		Tuberous sclerosis 2	VCV000999850	16	2134291	16	2084290	999850	996751	rs2090486866	NC_000016.10:2084289:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4069A>C (p.Ile1357Leu)	TSC2	I1357L, I1113L, I1301L, I1313L, I1242L, I1290L, I1254L, I1291L, I1314L, I1334L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000535992	16	2134292	16	2084291	535992	529695	rs1555513920	NC_000016.10:2084290:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4070T>C (p.Ile1357Thr)	TSC2	I1357T, I1242T, I1290T, I1291T, I1334T, I1113T, I1301T, I1313T, I1314T, I1254T	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis syndrome	VCV000468062	16	2134293	16	2084292	468062	465353	rs878854103	NC_000016.10:2084291:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4070T>A (p.Ile1357Asn)	TSC2	I1357N, I1254N, I1242N, I1301N, I1314N, I1334N, I1113N, I1290N, I1291N, I1313N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000238042	16	2134293	16	2084292	238042	242302	rs878854103	NC_000016.10:2084291:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4071C>T (p.Ile1357=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001737559	16	2134294	16	2084293	1737559	1787423	rs771052700	NC_000016.10:2084292:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4072C>G (p.Pro1358Ala)	TSC2	P1358A, P1255A, P1291A, P1314A, P1114A, P1243A, P1302A, P1315A, P1292A, P1335A	Seizure|Neurodevelopmental delay|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000238043	16	2134295	16	2084294	238043	242303	rs878854104	NC_000016.10:2084293:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4074C>T (p.Pro1358=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468063	16	2134297	16	2084296	468063	465992	rs144098854	NC_000016.10:2084295:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4075A>T (p.Ile1359Phe)	TSC2	I1256F, I1292F, I1303F, I1244F, I1293F, I1315F, I1316F, I1359F, I1115F, I1336F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001475915	16	2134298	16	2084297	1475915	1423635	rs2151522243	NC_000016.10:2084296:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4077C>A (p.Ile1359=)	TSC2		Tuberous sclerosis 2	VCV004071115	16	2134300	16	2084299	4071115	4184963		NC_000016.10:2084298:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4077C>G (p.Ile1359Met)	TSC2	I1244M, I1256M, I1292M, I1316M, I1293M, I1336M, I1359M, I1115M, I1303M, I1315M	Tuberous sclerosis 2	VCV000941992	16	2134300	16	2084299	941992	937336	rs150999168	NC_000016.10:2084298:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4077C>T (p.Ile1359=)	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000196885	16	2134300	16	2084299	196885	194046	rs150999168	NC_000016.10:2084298:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4078G>C (p.Glu1360Gln)	TSC2	E1245Q, E1316Q, E1337Q, E1360Q, E1116Q, E1257Q, E1294Q, E1293Q, E1304Q, E1317Q	Tuberous sclerosis 2	VCV000640346	16	2134301	16	2084300	640346	644318	rs397514997	NC_000016.10:2084299:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4078G>A (p.Glu1360Lys)	TSC2	E1360K, E1293K, E1304K, E1337K, E1294K, E1316K, E1116K, E1257K, E1317K, E1245K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535922	16	2134301	16	2084300	535922	529696	rs397514997	NC_000016.10:2084299:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4078G>T (p.Glu1360Ter)	TSC2	E1360*, E1304*, E1317*, E1257*, E1293*, E1245*, E1294*, E1316*, E1116*, E1337*	Tuberous sclerosis 2	VCV000065003	16	2134301	16	2084300	65003	75933	rs397514997	NC_000016.10:2084299:G:T	single nucleotide variant	nonsense	Pathogenic	Apr 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4080G>A (p.Glu1360=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000187524	16	2134303	16	2084302	187524	184141	rs786203798	NC_000016.10:2084301:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4081C>G (p.Arg1361Gly)	TSC2	R1117G, R1246G, R1258G, R1294G, R1295G, R1305G, R1317G, R1318G, R1338G, R1361G	not provided	VCV001197355	16	2134304	16	2084303	1197355	1188333	rs560831385	NC_000016.10:2084302:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4081C>T (p.Arg1361Ter)	TSC2	R1361*, R1294*, R1258*, R1317*, R1338*, R1117*, R1246*, R1295*, R1305*, R1318*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000571122	16	2134304	16	2084303	571122	573861	rs560831385	NC_000016.10:2084302:C:T	single nucleotide variant	nonsense	Uncertain significance	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4082G>C (p.Arg1361Pro)	TSC2	R1317P, R1258P, R1338P, R1246P, R1294P, R1305P, R1117P, R1295P, R1318P, R1361P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000824575	16	2134305	16	2084304	824575	812592	rs762798984	NC_000016.10:2084303:G:C	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4082G>A (p.Arg1361Gln)	TSC2	R1361Q, R1258Q, R1305Q, R1318Q, R1117Q, R1246Q, R1294Q, R1295Q, R1338Q, R1317Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000577577	16	2134305	16	2084304	577577	573862	rs762798984	NC_000016.10:2084303:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4084G>T (p.Val1362Phe)	TSC2	V1118F, V1296F, V1259F, V1295F, V1318F, V1339F, V1362F, V1247F, V1306F, V1319F	Tuberous sclerosis 2	VCV001039778	16	2134307	16	2084306	1039778	1032484	rs2090489392	NC_000016.10:2084305:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4085T>G (p.Val1362Gly)	TSC2	V1095G, V1096G, V1118G, V1138G, V1139G, V1142G, V1162G, V1246G, V1247G, V1258G, V1259G, V1276G, V1289G, V1290G, V1291G, V1292G, V1295G, V1296G, V1302G, V1306G, V1318G, V1319G, V1325G, V1326G, V1336G, V1338G, V1339G, V1361G, V1362G, V761G, V847G, V848G, V870G, V871G, V891G	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003386176	16	2134308	16	2084307	3386176	3545317		NC_000016.10:2084306:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4086C>G (p.Val1362=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002878812	16	2134309	16	2084308	2878812	3033611	rs763847509	NC_000016.10:2084307:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4086C>T (p.Val1362=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000413692	16	2134309	16	2084308	413692	401383	rs763847509	NC_000016.10:2084307:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4087G>T (p.Val1363Phe)	TSC2	V1319F, V1320F, V1119F, V1297F, V1307F, V1260F, V1296F, V1340F, V1248F, V1363F	not provided|Tuberous sclerosis 2	VCV001039558	16	2134310	16	2084309	1039558	1032485	rs751203255	NC_000016.10:2084308:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4087G>A (p.Val1363Ile)	TSC2	V1363I, V1319I, V1119I, V1297I, V1320I, V1307I, V1248I, V1260I, V1296I, V1340I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000405949	16	2134310	16	2084309	405949	401388	rs751203255	NC_000016.10:2084308:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4089C>T (p.Val1363=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486674	16	2134312	16	2084311	486674	477968	rs1036544111	NC_000016.10:2084310:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4090T>G (p.Ser1364Ala)	TSC2	S1261A, S1298A, S1341A, S1120A, S1249A, S1308A, S1320A, S1321A, S1364A, S1297A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000849814	16	2134313	16	2084312	849814	843482	rs756957699	NC_000016.10:2084311:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4091C>A (p.Ser1364Tyr)	TSC2	S1120Y, S1141Y, S1144Y, S1249Y, S1260Y, S1261Y, S1293Y, S1304Y, S1308Y, S1321Y, S1338Y, S850Y, S872Y, S893Y, S1098Y, S1140Y, S1164Y, S1248Y, S1291Y, S1292Y, S1320Y, S1340Y, S763Y, S1097Y, S1294Y, S1328Y, S873Y, S1278Y, S1297Y, S1298Y, S1327Y, S1341Y, S1363Y, S1364Y, S849Y	Tuberous sclerosis 2	VCV002768978	16	2134314	16	2084313	2768978	2923253	rs1245757559	NC_000016.10:2084312:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Oct 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4091C>T (p.Ser1364Phe)	TSC2	S1097F, S1098F, S1249F, S1291F, S1293F, S1304F, S1363F, S849F, S850F, S872F, S1140F, S1141F, S1261F, S1278F, S1292F, S1320F, S1328F, S1340F, S1341F, S893F, S1120F, S1298F, S1308F, S1327F, S1364F, S873F, S1144F, S1164F, S1248F, S1260F, S1294F, S1297F, S1321F, S1338F, S763F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002454061	16	2134314	16	2084313	2454061	2423950	rs1245757559	NC_000016.10:2084312:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4091C>G (p.Ser1364Cys)	TSC2	S1120C, S1140C, S1291C, S1320C, S1327C, S1364C, S893C, S1141C, S1144C, S1164C, S1249C, S1260C, S1293C, S1297C, S1304C, S1341C, S850C, S873C, S1098C, S1292C, S1298C, S1308C, S1321C, S1328C, S1340C, S763C, S849C, S1097C, S1248C, S1261C, S1278C, S1294C, S1338C, S1363C, S872C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001737749	16	2134314	16	2084313	1737749	1787612	rs1245757559	NC_000016.10:2084312:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4092C>A (p.Ser1364=)	TSC2		Tuberous sclerosis 2	VCV002751179	16	2134315	16	2084314	2751179	2913217	rs1251019267	NC_000016.10:2084313:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4092C>T (p.Ser1364=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536040	16	2134315	16	2084314	536040	530274	rs1251019267	NC_000016.10:2084313:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4093T>A (p.Ser1365Thr)	TSC2	S1099T, S1141T, S1145T, S1249T, S1262T, S1322T, S1365T, S874T, S894T, S1098T, S1142T, S1165T, S1261T, S1279T, S1295T, S1309T, S1329T, S1339T, S850T, S1121T, S1250T, S1292T, S1298T, S1328T, S1342T, S1364T, S1293T, S1294T, S1299T, S1305T, S1321T, S1341T, S764T, S851T, S873T	Hereditary cancer-predisposing syndrome	VCV002564695	16	2134316	16	2084315	2564695	2733851	rs2544259594	NC_000016.10:2084314:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4094C>T (p.Ser1365Leu)	TSC2	S1365L, S1262L, S1250L, S1298L, S1322L, S1342L, S1121L, S1299L, S1309L, S1321L	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000207680	16	2134317	16	2084316	207680	203185	rs377123510	NC_000016.10:2084315:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4095G>C (p.Ser1365=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001737775	16	2134318	16	2084317	1737775	1787638	rs139630605	NC_000016.10:2084316:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4095G>A (p.Ser1365=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065044	16	2134318	16	2084317	65044	75974	rs139630605	NC_000016.10:2084316:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4096G>T (p.Glu1366Ter)	TSC2	E1366*, E1299*, E1310*, E1343*, E1323*, E1322*, E1122*, E1251*, E1263*, E1300*	not provided|Tuberous sclerosis 2	VCV000049555	16	2134319	16	2084318	49555	58717	rs45517327	NC_000016.10:2084317:G:T	single nucleotide variant	nonsense	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4097A>C (p.Glu1366Ala)	TSC2	E1366A, E1122A, E1263A, E1300A, E1322A, E1323A, E1299A, E1343A, E1251A, E1310A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000230453	16	2134320	16	2084319	230453	235131	rs755461310	NC_000016.10:2084318:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4098G>C (p.Glu1366Asp)	TSC2	E1100D, E1166D, E1300D, E1322D, E1323D, E1330D, E1342D, E851D, E874D, E1251D, E1262D, E1306D, E1310D, E1340D, E1365D, E765D, E852D, E875D, E895D, E1142D, E1146D, E1263D, E1293D, E1294D, E1329D, E1099D, E1122D, E1143D, E1250D, E1280D, E1295D, E1296D, E1299D, E1343D, E1366D	Hereditary cancer-predisposing syndrome	VCV003974701	16	2134321	16	2084320	3974701	4086524		NC_000016.10:2084319:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4098G>A (p.Glu1366=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001737786	16	2134321	16	2084320	1737786	1787649	rs2544259800	NC_000016.10:2084319:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4100G>A (p.Gly1367Asp)	TSC2	G1123D, G1311D, G1344D, G1252D, G1367D, G1264D, G1300D, G1301D, G1323D, G1324D	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000656711	16	2134323	16	2084322	656711	644319	rs1460776110	NC_000016.10:2084321:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4101T>A (p.Gly1367=)	TSC2		Tuberous sclerosis 2	VCV004071140	16	2134324	16	2084323	4071140	4184988		NC_000016.10:2084322:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4102G>C (p.Gly1368Arg)	TSC2	G1124R, G1253R, G1265R, G1301R, G1302R, G1312R, G1324R, G1325R, G1345R, G1368R	Tuberous sclerosis 2	VCV001010921	16	2134325	16	2084324	1010921	996752	rs1596415966	NC_000016.10:2084323:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4102G>A (p.Gly1368Ser)	TSC2	G1124S, G1253S, G1265S, G1302S, G1301S, G1312S, G1324S, G1325S, G1345S, G1368S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000664684	16	2134325	16	2084324	664684	644320	rs1596415966	NC_000016.10:2084323:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4103G>T (p.Gly1368Val)	TSC2	G1124V, G1265V, G1325V, G1253V, G1345V, G1301V, G1302V, G1312V, G1324V, G1368V	Tuberous sclerosis 2	VCV001365139	16	2134326	16	2084325	1365139	1502183	rs1596415974	NC_000016.10:2084324:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4103G>A (p.Gly1368Asp)	TSC2	G1124D, G1368D, G1265D, G1301D, G1302D, G1324D, G1253D, G1312D, G1325D, G1345D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000824596	16	2134326	16	2084325	824596	812593	rs1596415974	NC_000016.10:2084324:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4104C>T (p.Gly1368=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811298	16	2134327	16	2084326	3811298	3928539		NC_000016.10:2084325:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4105C>A (p.Arg1369=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000824599	16	2134328	16	2084327	824599	812594	rs45517328	NC_000016.10:2084326:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4105C>T (p.Arg1369Trp)	TSC2	R1369W, R1125W, R1326W, R1325W, R1254W, R1266W, R1302W, R1346W, R1303W, R1313W	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified	VCV000049556	16	2134328	16	2084327	49556	58718	rs45517328	NC_000016.10:2084326:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4106G>C (p.Arg1369Pro)	TSC2	R1102P, R1125P, R1254P, R1283P, R1296P, R1299P, R1326P, R1333P, R898P, R1145P, R1146P, R1169P, R1266P, R1332P, R1343P, R1346P, R1368P, R877P, R878P, R1149P, R1265P, R1297P, R1302P, R1309P, R1313P, R1369P, R768P, R854P, R855P, R1103P, R1253P, R1298P, R1303P, R1325P, R1345P	Tuberous sclerosis 2	VCV003637231	16	2134329	16	2084328	3637231	3771385		NC_000016.10:2084327:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4106G>A (p.Arg1369Gln)	TSC2	R1369Q, R1254Q, R1326Q, R1125Q, R1303Q, R1313Q, R1266Q, R1302Q, R1325Q, R1346Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135386	16	2134329	16	2084328	135386	139125	rs587778738	NC_000016.10:2084327:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4107G>C (p.Arg1369=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not provided|not specified	VCV000413698	16	2134330	16	2084329	413698	400862	rs201688447	NC_000016.10:2084328:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4107G>A (p.Arg1369=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207681	16	2134330	16	2084329	207681	203186	rs201688447	NC_000016.10:2084328:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4108C>T (p.Pro1370Ser)	TSC2	P1370S, P1126S, P1255S, P1267S, P1327S, P1303S, P1304S, P1326S, P1347S, P1314S	Tuberous sclerosis 2|not specified|Hereditary cancer-predisposing syndrome	VCV000514571	16	2134331	16	2084330	514571	506177	rs747293303	NC_000016.10:2084329:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4109C>T (p.Pro1370Leu)	TSC2	P1103L, P1104L, P1126L, P1146L, P1147L, P1150L, P1170L, P1254L, P1255L, P1266L, P1267L, P1284L, P1297L, P1298L, P1299L, P1300L, P1303L, P1304L, P1310L, P1314L, P1326L, P1327L, P1333L, P1334L, P1344L, P1346L, P1347L, P1369L, P1370L, P769L, P855L, P856L, P878L, P879L, P899L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV003343153	16	2134332	16	2084331	3343153	3502385		NC_000016.10:2084330:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4110C>A (p.Pro1370=)	TSC2		Tuberous sclerosis 2	VCV002843553	16	2134333	16	2084332	2843553	3004208	rs771107874	NC_000016.10:2084331:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4110C>G (p.Pro1370=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001129767	16	2134333	16	2084332	1129767	1125085	rs771107874	NC_000016.10:2084331:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4110C>T (p.Pro1370=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000468065	16	2134333	16	2084332	468065	466001	rs771107874	NC_000016.10:2084331:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4111T>A (p.Ser1371Thr)	TSC2	S1147T, S1267T, S1327T, S1328T, S857T, S879T, S900T, S1105T, S1127T, S1151T, S1298T, S1299T, S1301T, S1304T, S1345T, S1347T, S1370T, S856T, S1268T, S1300T, S1335T, S770T, S880T, S1104T, S1148T, S1171T, S1255T, S1256T, S1285T, S1305T, S1311T, S1315T, S1334T, S1348T, S1371T	Hereditary cancer-predisposing syndrome	VCV002449995	16	2134334	16	2084333	2449995	2425952	rs1463203351	NC_000016.10:2084332:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4112C>G (p.Ser1371Cys)	TSC2	S1371C, S1268C, S1305C, S1256C, S1327C, S1348C, S1127C, S1304C, S1315C, S1328C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000405994	16	2134335	16	2084334	405994	401624	rs1060500929	NC_000016.10:2084333:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4113T>G (p.Ser1371=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462685	16	2134336	16	2084335	3462685	3621704		NC_000016.10:2084334:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4114G>T (p.Val1372Leu)	TSC2	V1256L, V1299L, V1302L, V1316L, V1346L, V1348L, V857L, V1268L, V1286L, V1306L, V1328L, V1349L, V1372L, V771L, V880L, V881L, V901L, V1149L, V1269L, V1301L, V1305L, V1329L, V1336L, V1105L, V1106L, V1128L, V1148L, V1152L, V1172L, V1257L, V1300L, V1312L, V1335L, V1371L, V858L	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002130128	16	2134337	16	2084336	2130128	2189405	rs2090494113	NC_000016.10:2084335:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4114G>C (p.Val1372Leu)	TSC2	V1257L, V1305L, V1328L, V1349L, V1329L, V1306L, V1316L, V1372L, V1128L, V1269L	Tuberous sclerosis 2	VCV001462943	16	2134337	16	2084336	1462943	1511380	rs2090494113	NC_000016.10:2084335:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4114G>A (p.Val1372Met)	TSC2	V1128M, V1305M, V1306M, V1372M, V1316M, V1329M, V1257M, V1269M, V1328M, V1349M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000945393	16	2134337	16	2084336	945393	927673	rs2090494113	NC_000016.10:2084335:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4115T>C (p.Val1372Ala)	TSC2	V1257A, V1269A, V1305A, V1316A, V1128A, V1306A, V1372A, V1328A, V1329A, V1349A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000660549	16	2134338	16	2084337	660549	644321	rs1300203299	NC_000016.10:2084336:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4116G>C (p.Val1372=)	TSC2		Tuberous sclerosis 2	VCV004071165	16	2134339	16	2084338	4071165	4185013		NC_000016.10:2084337:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4116G>A (p.Val1372=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462571	16	2134339	16	2084338	3462571	3621590		NC_000016.10:2084337:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4118A>G (p.Asp1373Gly)	TSC2	D1258G, D1307G, D1329G, D1350G, D1270G, D1306G, D1317G, D1330G, D1129G, D1373G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000835912	16	2134341	16	2084340	835912	843483	rs1596416094	NC_000016.10:2084339:A:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4119C>T (p.Asp1373=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001654735	16	2134342	16	2084341	1654735	1580364	rs2090494735	NC_000016.10:2084340:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4119C>G (p.Asp1373Glu)	TSC2	D1129E, D1258E, D1270E, D1306E, D1317E, D1329E, D1350E, D1373E, D1307E, D1330E	Tuberous sclerosis 2	VCV000961402	16	2134342	16	2084341	961402	949268	rs2090494735	NC_000016.10:2084340:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4120C>G (p.Leu1374Val)	TSC2	L1107V, L1108V, L1130V, L1150V, L1151V, L1154V, L1174V, L1258V, L1259V, L1270V, L1271V, L1288V, L1301V, L1302V, L1303V, L1304V, L1307V, L1308V, L1314V, L1318V, L1330V, L1331V, L1337V, L1338V, L1348V, L1350V, L1351V, L1373V, L1374V, L773V, L859V, L860V, L882V, L883V, L903V	Hereditary cancer-predisposing syndrome	VCV003232160	16	2134343	16	2084342	3232160	3391961	rs2544261169	NC_000016.10:2084341:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4120C>T (p.Leu1374Phe)	TSC2	L1108F, L1259F, L1270F, L1288F, L1302F, L1314F, L1318F, L1337F, L1373F, L1130F, L1151F, L1303F, L1338F, L1374F, L773F, L860F, L1107F, L1154F, L1271F, L1304F, L1307F, L1348F, L1350F, L883F, L1150F, L1174F, L1258F, L1301F, L1308F, L1330F, L1331F, L1351F, L859F, L882F, L903F	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002991778	16	2134343	16	2084342	2991778	3144388	rs2544261169	NC_000016.10:2084341:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4121T>G (p.Leu1374Arg)	TSC2	L1271R, L1330R, L1130R, L1308R, L1331R, L1259R, L1351R, L1374R, L1307R, L1318R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001419494	16	2134344	16	2084343	1419494	1387173	rs2151523920	NC_000016.10:2084342:T:G	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4122C>G (p.Leu1374=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002879013	16	2134345	16	2084344	2879013	3041916	rs2544261338	NC_000016.10:2084343:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4124C>G (p.Ser1375Cys)	TSC2	S1260C, S1319C, S1131C, S1309C, S1331C, S1332C, S1352C, S1375C, S1272C, S1308C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824610	16	2134347	16	2084346	824610	812595	rs145476528	NC_000016.10:2084345:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4124C>T (p.Ser1375Phe)	TSC2	S1375F, S1332F, S1260F, S1308F, S1309F, S1319F, S1331F, S1272F, S1131F, S1352F	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not provided|TSC2-related disorder|Hereditary cancer-predisposing syndrome	VCV000577422	16	2134347	16	2084346	577422	573866	rs145476528	NC_000016.10:2084345:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4125C>G (p.Ser1375=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000754896	16	2134348	16	2084347	754896	770731	rs1050512482	NC_000016.10:2084346:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4127T>A (p.Phe1376Tyr)	TSC2	F1110Y, F1176Y, F1290Y, F1305Y, F1310Y, F1339Y, F1353Y, F862Y, F884Y, F905Y, F1153Y, F1156Y, F1260Y, F1304Y, F1306Y, F1316Y, F1352Y, F1376Y, F1132Y, F1152Y, F1261Y, F1272Y, F1309Y, F1332Y, F1350Y, F775Y, F885Y, F1109Y, F1273Y, F1303Y, F1320Y, F1333Y, F1340Y, F1375Y, F861Y	Hereditary cancer-predisposing syndrome	VCV001738051	16	2134350	16	2084349	1738051	1797287	rs2544261534	NC_000016.10:2084348:T:A	single nucleotide variant	missense variant	Uncertain significance	May 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4128C>G (p.Phe1376Leu)	TSC2	F1156L, F1176L, F1290L, F1306L, F1309L, F1340L, F1109L, F1152L, F1261L, F1273L, F1316L, F1332L, F1339L, F775L, F861L, F862L, F1110L, F1153L, F1260L, F1272L, F1305L, F1320L, F1352L, F1353L, F1376L, F884L, F1132L, F1303L, F1304L, F1310L, F1333L, F1350L, F1375L, F885L, F905L	Hereditary cancer-predisposing syndrome	VCV002626452	16	2134351	16	2084350	2626452	2794218	rs1060504086	NC_000016.10:2084349:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4128C>T (p.Phe1376=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413635	16	2134351	16	2084350	413635	400872	rs1060504086	NC_000016.10:2084349:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4129C>T (p.Gln1377Ter)	TSC2	Q1377*, Q1133*, Q1311*, Q1310*, Q1321*, Q1333*, Q1334*, Q1354*, Q1262*, Q1274*	not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000049800	16	2134352	16	2084351	49800	58962	rs45517329	NC_000016.10:2084350:C:T	single nucleotide variant	nonsense	Pathogenic	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4130A>C (p.Gln1377Pro)	TSC2	Q1307P, Q1310P, Q1311P, Q1317P, Q1321P, Q1333P, Q1334P, Q1340P, Q1341P, Q1351P, Q1353P, Q1354P, Q1376P, Q1377P, Q776P, Q862P, Q863P, Q885P, Q886P, Q906P, Q1110P, Q1111P, Q1133P, Q1153P, Q1154P, Q1157P, Q1177P, Q1261P, Q1262P, Q1273P, Q1274P, Q1291P, Q1304P, Q1305P, Q1306P	Hereditary cancer-predisposing syndrome	VCV003232161	16	2134353	16	2084352	3232161	3391962	rs2151524153	NC_000016.10:2084351:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4130A>G (p.Gln1377Arg)	TSC2	Q1110R, Q1111R, Q1133R, Q1153R, Q1154R, Q1157R, Q1177R, Q1261R, Q1262R, Q1273R, Q1274R, Q1291R, Q1304R, Q1305R, Q1306R, Q1307R, Q1310R, Q1311R, Q1317R, Q1321R, Q1333R, Q1334R, Q1340R, Q1341R, Q1351R, Q1353R, Q1354R, Q1376R, Q1377R, Q776R, Q862R, Q863R, Q885R, Q886R, Q906R	Tuberous sclerosis syndrome	VCV003073920	16	2134353	16	2084352	3073920	3232790	rs2151524153	NC_000016.10:2084351:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4131G>C (p.Gln1377His)	TSC2	Q1110H, Q1154H, Q1157H, Q1262H, Q1291H, Q1306H, Q1321H, Q1333H, Q776H, Q885H, Q1177H, Q1261H, Q1273H, Q1274H, Q1305H, Q1317H, Q1341H, Q1351H, Q1354H, Q1304H, Q1310H, Q1334H, Q1377H, Q862H, Q1111H, Q1133H, Q1153H, Q1307H, Q1311H, Q1340H, Q1353H, Q1376H, Q863H, Q886H, Q906H	Hereditary cancer-predisposing syndrome	VCV002626417	16	2134354	16	2084353	2626417	2794183	rs2544261790	NC_000016.10:2084352:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4132C>A (p.Pro1378Thr)	TSC2	P1263T, P1312T, P1334T, P1355T, P1275T, P1134T, P1311T, P1322T, P1335T, P1378T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001372965	16	2134355	16	2084354	1372965	1440343	rs1060500921	NC_000016.10:2084353:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4132C>T (p.Pro1378Ser)	TSC2	P1263S, P1312S, P1322S, P1355S, P1378S, P1134S, P1311S, P1335S, P1275S, P1334S	Tuberous sclerosis 2	VCV000840263	16	2134355	16	2084354	840263	843484	rs1060500921	NC_000016.10:2084353:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4132C>G (p.Pro1378Ala)	TSC2	P1378A, P1263A, P1322A, P1311A, P1335A, P1355A, P1275A, P1312A, P1134A, P1334A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405976	16	2134355	16	2084354	405976	400957	rs1060500921	NC_000016.10:2084353:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4133C>T (p.Pro1378Leu)	TSC2	P1111L, P1134L, P1158L, P1262L, P1292L, P1311L, P1312L, P1334L, P1341L, P1355L, P864L, P886L, P1178L, P1305L, P1322L, P1342L, P1378L, P777L, P1155L, P1263L, P1318L, P1354L, P1377L, P863L, P907L, P1112L, P1154L, P1274L, P1275L, P1306L, P1307L, P1308L, P1335L, P1352L, P887L	Hereditary cancer-predisposing syndrome	VCV001738098	16	2134356	16	2084355	1738098	1797334	rs1596416159	NC_000016.10:2084354:C:T	single nucleotide variant	missense variant	Uncertain significance	May 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4133C>G (p.Pro1378Arg)	TSC2	P1134R, P1312R, P1355R, P1378R, P1263R, P1275R, P1311R, P1322R, P1334R, P1335R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000954023	16	2134356	16	2084355	954023	949269	rs1596416159	NC_000016.10:2084354:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4134C>G (p.Pro1378=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000760973	16	2134357	16	2084356	760973	770732	rs1060504081	NC_000016.10:2084355:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4134C>T (p.Pro1378=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413618	16	2134357	16	2084356	413618	401626	rs1060504081	NC_000016.10:2084355:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4136C>T (p.Ser1379Leu)	TSC2	S1379L, S1276L, S1313L, S1356L, S1135L, S1335L, S1264L, S1312L, S1323L, S1336L	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000065358	16	2134359	16	2084358	65358	76292	rs137854065	NC_000016.10:2084357:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4137G>T (p.Ser1379=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000231256	16	2134360	16	2084359	231256	235133	rs769653533	NC_000016.10:2084358:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4137G>A (p.Ser1379=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000230390	16	2134360	16	2084359	230390	235132	rs769653533	NC_000016.10:2084358:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4138C>A (p.Gln1380Lys)	TSC2	Q1277K, Q1136K, Q1265K, Q1313K, Q1314K, Q1324K, Q1380K, Q1337K, Q1336K, Q1357K	Tuberous sclerosis 2|not provided	VCV001039315	16	2134361	16	2084360	1039315	1032486	rs137854045	NC_000016.10:2084359:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 27, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4138C>T (p.Gln1380Ter)	TSC2	Q1380*, Q1136*, Q1357*, Q1324*, Q1277*, Q1313*, Q1314*, Q1336*, Q1265*, Q1337*	Tuberous sclerosis 2	VCV000049497	16	2134361	16	2084360	49497	58659	rs137854045	NC_000016.10:2084359:C:T	single nucleotide variant	nonsense	Pathogenic	Aug 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4139A>G (p.Gln1380Arg)	TSC2	Q1357R, Q865R, Q1157R, Q1180R, Q1294R, Q1308R, Q1309R, Q1314R, Q1354R, Q1356R, Q888R, Q889R, Q1160R, Q1313R, Q1343R, Q1344R, Q1379R, Q1380R, Q1113R, Q1114R, Q1136R, Q1156R, Q1265R, Q1310R, Q1320R, Q1324R, Q779R, Q866R, Q909R, Q1264R, Q1276R, Q1277R, Q1307R, Q1336R, Q1337R	Hereditary cancer-predisposing syndrome	VCV001738128	16	2134362	16	2084361	1738128	1797364	rs2151524503	NC_000016.10:2084360:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4140G>A (p.Gln1380=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000761488	16	2134363	16	2084362	761488	770733	rs1596416227	NC_000016.10:2084361:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4141C>A (p.Pro1381Thr)	TSC2	P1115T, P1266T, P1308T, P1310T, P1325T, P1357T, P1381T, P866T, P889T, P890T, P1114T, P1137T, P1181T, P1295T, P1314T, P1380T, P910T, P1157T, P1158T, P1265T, P1277T, P1278T, P1311T, P1321T, P1337T, P1344T, P1345T, P1161T, P1309T, P1315T, P1338T, P1355T, P1358T, P780T, P867T	Tuberous sclerosis 2	VCV002760486	16	2134364	16	2084363	2760486	2921666	rs2090497403	NC_000016.10:2084362:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4141C>T (p.Pro1381Ser)	TSC2	P1137S, P1278S, P1338S, P1314S, P1315S, P1325S, P1337S, P1358S, P1266S, P1381S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000841409	16	2134364	16	2084363	841409	843485	rs2090497403	NC_000016.10:2084362:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4142C>A (p.Pro1381His)	TSC2	P1381H, P1278H, P1137H, P1314H, P1325H, P1358H, P1266H, P1338H, P1315H, P1337H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000577826	16	2134365	16	2084364	577826	567850	rs397515264	NC_000016.10:2084363:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4142C>T (p.Pro1381Leu)	TSC2	P1381L, P1266L, P1278L, P1137L, P1315L, P1337L, P1338L, P1314L, P1325L, P1358L	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000065353	16	2134365	16	2084364	65353	76287	rs397515264	NC_000016.10:2084363:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4143C>T (p.Pro1381=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000512582	16	2134366	16	2084365	512582	505223	rs1555514056	NC_000016.10:2084364:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4144C>T (p.Leu1382=)	TSC2		Tuberous sclerosis 2	VCV004071160	16	2134367	16	2084366	4071160	4185008		NC_000016.10:2084365:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4145T>A (p.Leu1382Gln)	TSC2	L1266Q, L1279Q, L1311Q, L1312Q, L1315Q, L1316Q, L1338Q, L1339Q, L1356Q, L867Q, L868Q, L1138Q, L1159Q, L1162Q, L1267Q, L1296Q, L1309Q, L1322Q, L1158Q, L1278Q, L1310Q, L1326Q, L1346Q, L1358Q, L781Q, L890Q, L891Q, L1115Q, L1116Q, L1182Q, L1345Q, L1359Q, L1381Q, L1382Q, L911Q	Hereditary cancer-predisposing syndrome	VCV002564696	16	2134368	16	2084367	2564696	2733852	rs2151524776	NC_000016.10:2084366:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4146G>C (p.Leu1382=)	TSC2		Tuberous sclerosis 2	VCV002968117	16	2134369	16	2084368	2968117	3128506	rs1162436739	NC_000016.10:2084367:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4146G>A (p.Leu1382=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468067	16	2134369	16	2084368	468067	466264	rs1162436739	NC_000016.10:2084367:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4148G>C (p.Ser1383Thr)	TSC2	S1339T, S1316T, S1317T, S1327T, S1139T, S1383T, S1268T, S1280T, S1340T, S1360T	Tuberous sclerosis 2	VCV000664412	16	2134371	16	2084370	664412	644322	rs1596416285	NC_000016.10:2084369:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4149C>A (p.Ser1383Arg)	TSC2	S1116R, S1117R, S1139R, S1159R, S1160R, S1163R, S1183R, S1267R, S1268R, S1279R, S1280R, S1297R, S1310R, S1311R, S1312R, S1313R, S1316R, S1317R, S1323R, S1327R, S1339R, S1340R, S1346R, S1347R, S1357R, S1359R, S1360R, S1382R, S1383R, S782R, S868R, S869R, S891R, S892R, S912R	Hereditary cancer-predisposing syndrome	VCV003232162	16	2134372	16	2084371	3232162	3391963	rs2151524944	NC_000016.10:2084370:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4149C>T (p.Ser1383=)	TSC2		Tuberous sclerosis 2	VCV002736296	16	2134372	16	2084371	2736296	2894988	rs2151524944	NC_000016.10:2084370:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Pathogenic	Jun 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4149C>G (p.Ser1383Arg)	TSC2	S1139R, S1279R, S1280R, S1313R, S1323R, S1346R, S1382R, S912R, S1160R, S1163R, S1267R, S1311R, S1312R, S1317R, S1340R, S1347R, S1383R, S869R, S1116R, S1183R, S1297R, S1310R, S1316R, S1327R, S1339R, S782R, S892R, S1117R, S1159R, S1268R, S1357R, S1359R, S1360R, S868R, S891R	Hereditary cancer-predisposing syndrome	VCV001738218	16	2134372	16	2084371	1738218	1797454	rs2151524944	NC_000016.10:2084370:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4152G>A (p.Lys1384=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001110239	16	2134375	16	2084374	1110239	1103670	rs2151525029	NC_000016.10:2084373:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4153T>G (p.Ser1385Ala)	TSC2	S1118A, S1119A, S1318A, S1342A, S1361A, S1384A, S870A, S894A, S1141A, S1161A, S1185A, S1281A, S1299A, S1315A, S1348A, S784A, S1269A, S1270A, S1312A, S1313A, S1314A, S1325A, S1329A, S1341A, S1359A, S914A, S1162A, S1165A, S1282A, S1319A, S1349A, S1362A, S1385A, S871A, S893A	Tuberous sclerosis 2	VCV003637232	16	2134376	16	2084375	3637232	3771386		NC_000016.10:2084374:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4154C>G (p.Ser1385Cys)	TSC2	S1161C, S1270C, S1281C, S1325C, S1348C, S1349C, S1384C, S784C, S1162C, S1269C, S1361C, S870C, S871C, S894C, S914C, S1118C, S1119C, S1141C, S1185C, S1282C, S1299C, S1313C, S1319C, S1329C, S1341C, S1342C, S1362C, S893C, S1165C, S1312C, S1314C, S1315C, S1318C, S1359C, S1385C	Hereditary cancer-predisposing syndrome	VCV001738285	16	2134377	16	2084376	1738285	1797519	rs762859177	NC_000016.10:2084375:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4155C>T (p.Ser1385=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000536081	16	2134378	16	2084377	536081	529725	rs1057521540	NC_000016.10:2084376:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4155C>G (p.Ser1385=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000383173	16	2134378	16	2084377	383173	374825	rs1057521540	NC_000016.10:2084376:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4157G>T (p.Ser1386Ile)	TSC2	S1120I, S1162I, S1315I, S1385I, S871I, S895I, S1163I, S1166I, S1271I, S1314I, S1316I, S1342I, S1343I, S1349I, S1360I, S1363I, S894I, S1119I, S1186I, S1282I, S1300I, S1313I, S1330I, S785I, S1142I, S1270I, S1283I, S1319I, S1320I, S1326I, S1350I, S1362I, S1386I, S872I, S915I	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001738304	16	2134380	16	2084379	1738304	1797538	rs1555514071	NC_000016.10:2084378:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4157G>C (p.Ser1386Thr)	TSC2	S1319T, S1330T, S1386T, S1342T, S1343T, S1363T, S1142T, S1271T, S1283T, S1320T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000836569	16	2134380	16	2084379	836569	843486	rs1555514071	NC_000016.10:2084378:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4157G>A (p.Ser1386Asn)	TSC2	S1386N, S1142N, S1271N, S1319N, S1320N, S1342N, S1363N, S1283N, S1330N, S1343N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468068	16	2134380	16	2084379	468068	465359	rs1555514071	NC_000016.10:2084378:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4158C>G (p.Ser1386Arg)	TSC2	S1119R, S1142R, S1283R, S1313R, S1319R, S1326R, S1330R, S1349R, S1363R, S1386R, S871R, S872R, S1163R, S1271R, S1316R, S1342R, S1362R, S1385R, S785R, S894R, S1120R, S1162R, S1166R, S1314R, S1320R, S1360R, S1186R, S1270R, S1282R, S1300R, S1315R, S1343R, S1350R, S895R, S915R	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578802	16	2134381	16	2084380	3578802	3708223		NC_000016.10:2084379:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4158C>T (p.Ser1386=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462596	16	2134381	16	2084380	3462596	3621615		NC_000016.10:2084379:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4161C>T (p.Ser1387=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003386177	16	2134384	16	2084383	3386177	3545318		NC_000016.10:2084382:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4161C>A (p.Ser1387=)	TSC2		not provided|Tuberous sclerosis 2	VCV002184477	16	2134384	16	2084383	2184477	1920985	rs985829355	NC_000016.10:2084382:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4162T>G (p.Ser1388Ala)	TSC2	S1168A, S1284A, S1317A, S1318A, S1364A, S787A, S874A, S896A, S917A, S1122A, S1164A, S1188A, S1272A, S1285A, S1322A, S1332A, S1345A, S1387A, S897A, S1144A, S1273A, S1302A, S1315A, S1344A, S1351A, S1352A, S1388A, S1121A, S1165A, S1316A, S1321A, S1328A, S1362A, S1365A, S873A	Hereditary cancer-predisposing syndrome	VCV002449986	16	2134385	16	2084384	2449986	2425943	rs2151525463	NC_000016.10:2084383:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4163C>G (p.Ser1388Cys)	TSC2	S1121C, S1168C, S1284C, S1344C, S1364C, S1387C, S1388C, S1144C, S1164C, S1272C, S1273C, S1315C, S1316C, S1322C, S1345C, S1362C, S1365C, S897C, S917C, S1122C, S1188C, S1285C, S1302C, S1317C, S1318C, S1321C, S1328C, S1332C, S1351C, S787C, S873C, S874C, S896C, S1165C, S1352C	Hereditary cancer-predisposing syndrome	VCV003974658	16	2134386	16	2084385	3974658	4086481		NC_000016.10:2084384:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4163C>A (p.Ser1388Tyr)	TSC2	S1188Y, S1273Y, S1316Y, S1344Y, S1352Y, S873Y, S1122Y, S1164Y, S1318Y, S1321Y, S1351Y, S1364Y, S1365Y, S1387Y, S874Y, S897Y, S1285Y, S1322Y, S1362Y, S1388Y, S1121Y, S1144Y, S1165Y, S1168Y, S1272Y, S1284Y, S1302Y, S1315Y, S1317Y, S1328Y, S1332Y, S1345Y, S787Y, S896Y, S917Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001738357	16	2134386	16	2084385	1738357	1790690	rs764039393	NC_000016.10:2084384:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4163C>T (p.Ser1388Phe)	TSC2	S1144F, S1273F, S1285F, S1321F, S1322F, S1332F, S1344F, S1345F, S1365F, S1388F	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001056540	16	2134386	16	2084385	1056540	1049477	rs764039393	NC_000016.10:2084384:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4164T>C (p.Ser1388=)	TSC2		Tuberous sclerosis 2	VCV001575960	16	2134387	16	2084386	1575960	1520822	rs2151525515	NC_000016.10:2084385:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4164T>A (p.Ser1388=)	TSC2		Tuberous sclerosis 2	VCV001146675	16	2134387	16	2084386	1146675	1145967	rs2151525515	NC_000016.10:2084385:T:A	single nucleotide variant	synonymous variant	Likely benign	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4165C>T (p.Pro1389Ser)	TSC2	P1389S, P1145S, P1274S, P1322S, P1323S, P1286S, P1333S, P1345S, P1346S, P1366S	not specified|Tuberous sclerosis 2	VCV000380381	16	2134388	16	2084387	380381	374827	rs1057520843	NC_000016.10:2084386:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 19, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4166C>T (p.Pro1389Leu)	TSC2	P1286L, P1323L, P1389L, P1145L, P1345L, P1274L, P1346L, P1322L, P1333L, P1366L	Tuberous sclerosis 2	VCV000653494	16	2134389	16	2084388	653494	644323	rs1596416369	NC_000016.10:2084387:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4167C>A (p.Pro1389=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000846354	16	2134390	16	2084389	846354	843487	rs45508504	NC_000016.10:2084388:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4167C>G (p.Pro1389=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000386872	16	2134390	16	2084389	386872	377268	rs45508504	NC_000016.10:2084388:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4167C>T (p.Pro1389=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000050060	16	2134390	16	2084389	50060	59222	rs45508504	NC_000016.10:2084388:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4168G>C (p.Glu1390Gln)	TSC2	E1146Q, E1166Q, E1274Q, E1304Q, E1317Q, E1323Q, E1390Q, E789Q, E875Q, E876Q, E1190Q, E1286Q, E1318Q, E1319Q, E1324Q, E1366Q, E899Q, E1123Q, E1124Q, E1167Q, E1170Q, E1320Q, E1330Q, E1346Q, E1347Q, E898Q, E919Q, E1275Q, E1287Q, E1334Q, E1353Q, E1354Q, E1364Q, E1367Q, E1389Q	Tuberous sclerosis 2	VCV002093353	16	2134391	16	2084390	2093353	2156434	rs397515033	NC_000016.10:2084389:G:C	single nucleotide variant	missense variant	Benign	Jun 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4168G>A (p.Glu1390Lys)	TSC2	E1390K, E1146K, E1287K, E1347K, E1367K, E1334K, E1323K, E1324K, E1346K, E1275K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238044	16	2134391	16	2084390	238044	242304	rs397515033	NC_000016.10:2084389:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4168G>T (p.Glu1390Ter)	TSC2	E1390*, E1324*, E1347*, E1323*, E1334*, E1146*, E1275*, E1287*, E1346*, E1367*	not provided	VCV000065050	16	2134391	16	2084390	65050	75980	rs397515033	NC_000016.10:2084389:G:T	single nucleotide variant	nonsense	Pathogenic	Nov 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4170G>A (p.Glu1390=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486652	16	2134393	16	2084392	486652	477377	rs1244952951	NC_000016.10:2084391:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4171C>T (p.Leu1391=)	TSC2		Tuberous sclerosis 2	VCV001092414	16	2134394	16	2084393	1092414	1081860	rs1483287924	NC_000016.10:2084392:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4173G>A (p.Leu1391=)	TSC2		Tuberous sclerosis 2	VCV002060966	16	2134396	16	2084395	2060966	2127533	rs2151525915	NC_000016.10:2084394:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4174C>T (p.Gln1392Ter)	TSC2	Q1392*, Q1289*, Q1277*, Q1336*, Q1148*, Q1325*, Q1369*, Q1349*, Q1326*, Q1348*	See cases|not provided|Tuberous sclerosis 2	VCV000049806	16	2134397	16	2084396	49806	58968	rs45517330	NC_000016.10:2084395:C:T	single nucleotide variant	nonsense	Pathogenic	Jan 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4176G>T (p.Gln1392His)	TSC2	Q1326H, Q1348H, Q1325H, Q1336H, Q1349H, Q1392H, Q1148H, Q1277H, Q1369H, Q1289H	Tuberous sclerosis 2	VCV001485482	16	2134399	16	2084398	1485482	1471829	rs749930791	NC_000016.10:2084397:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 23, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4176G>C (p.Gln1392His)	TSC2	Q1392H, Q1325H, Q1277H, Q1348H, Q1349H, Q1148H, Q1326H, Q1369H, Q1289H, Q1336H	Tuberous sclerosis 2	VCV000535977	16	2134399	16	2084398	535977	529729	rs749930791	NC_000016.10:2084397:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4176G>A (p.Gln1392=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468069	16	2134399	16	2084398	468069	466060	rs749930791	NC_000016.10:2084397:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4177A>T (p.Thr1393Ser)	TSC2	T1126S, T1127S, T1149S, T1169S, T1170S, T1173S, T1193S, T1277S, T1278S, T1289S, T1290S, T1307S, T1320S, T1321S, T1322S, T1323S, T1326S, T1327S, T1333S, T1337S, T1349S, T1350S, T1356S, T1357S, T1367S, T1369S, T1370S, T1392S, T1393S, T792S, T878S, T879S, T901S, T902S, T922S	Hereditary cancer-predisposing syndrome	VCV003232163	16	2134400	16	2084399	3232163	3391964	rs2151526138	NC_000016.10:2084398:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4177A>G (p.Thr1393Ala)	TSC2	T1149A, T1170A, T1193A, T1277A, T1278A, T1289A, T1322A, T1326A, T1349A, T1367A, T1392A, T1393A, T879A, T902A, T1169A, T1307A, T1323A, T1327A, T1337A, T1350A, T1370A, T1126A, T1127A, T1173A, T1321A, T1333A, T922A, T1290A, T1320A, T1356A, T1357A, T1369A, T792A, T878A, T901A	Tuberous sclerosis 2	VCV002705489	16	2134400	16	2084399	2705489	2856627	rs2151526138	NC_000016.10:2084398:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4178C>T (p.Thr1393Ile)	TSC2	T1290I, T1321I, T1333I, T1356I, T1367I, T1369I, T1393I, T901I, T1169I, T1193I, T1277I, T1289I, T1327I, T1337I, T1349I, T1357I, T1370I, T1392I, T878I, T902I, T922I, T1126I, T1170I, T1173I, T1278I, T1307I, T1322I, T1323I, T1350I, T879I, T1127I, T1149I, T1320I, T1326I, T792I	Tuberous sclerosis 2	VCV002201783	16	2134401	16	2084400	2201783	1934385	rs755583869	NC_000016.10:2084399:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4178C>G (p.Thr1393Ser)	TSC2	T1326S, T1149S, T1278S, T1327S, T1370S, T1350S, T1290S, T1337S, T1349S, T1393S	Tuberous sclerosis 2	VCV001036982	16	2134401	16	2084400	1036982	1032487	rs755583869	NC_000016.10:2084399:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4179T>G (p.Thr1393=)	TSC2		Tuberous sclerosis 2	VCV000536071	16	2134402	16	2084401	536071	529741	rs1555514101	NC_000016.10:2084400:T:G	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4180C>G (p.Leu1394Val)	TSC2	L1127V, L1128V, L1150V, L1170V, L1171V, L1174V, L1194V, L1278V, L1279V, L1290V, L1291V, L1308V, L1321V, L1322V, L1323V, L1324V, L1327V, L1328V, L1334V, L1338V, L1350V, L1351V, L1357V, L1358V, L1368V, L1370V, L1371V, L1393V, L1394V, L793V, L879V, L880V, L902V, L903V, L923V	Tuberous sclerosis syndrome	VCV003073468	16	2134403	16	2084402	3073468	3234424	rs911307922	NC_000016.10:2084401:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4180C>T (p.Leu1394=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000382628	16	2134403	16	2084402	382628	374839	rs911307922	NC_000016.10:2084401:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4181T>C (p.Leu1394Pro)	TSC2	L1127P, L1128P, L1150P, L1170P, L1171P, L1174P, L1194P, L1278P, L1279P, L1290P, L1291P, L1308P, L1321P, L1322P, L1323P, L1324P, L1327P, L1328P, L1334P, L1338P, L1350P, L1351P, L1357P, L1358P, L1368P, L1370P, L1371P, L1393P, L1394P, L793P, L879P, L880P, L902P, L903P, L923P	Ovarian cancer	VCV002445326	16	2134404	16	2084403	2445326	2419052	rs2151526348	NC_000016.10:2084402:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4182G>A (p.Leu1394=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000756721	16	2134405	16	2084404	756721	770734	rs1191824850	NC_000016.10:2084403:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4183C>T (p.Gln1395Ter)	TSC2	Q1395*, Q1280*, Q1372*, Q1151*, Q1339*, Q1292*, Q1351*, Q1352*, Q1328*, Q1329*	not provided|Tuberous sclerosis 2|Tuberous sclerosis 1	VCV000280596	16	2134406	16	2084405	280596	264758	rs886041772	NC_000016.10:2084404:C:T	single nucleotide variant	nonsense	Pathogenic	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4184A>G (p.Gln1395Arg)	TSC2	Q1323R, Q1324R, Q1335R, Q1358R, Q1372R, Q1172R, Q1175R, Q1195R, Q1309R, Q1322R, Q1328R, Q1329R, Q1351R, Q1352R, Q794R, Q880R, Q1129R, Q1151R, Q1279R, Q1292R, Q1325R, Q1339R, Q1394R, Q881R, Q904R, Q924R, Q1128R, Q1171R, Q1280R, Q1291R, Q1359R, Q1369R, Q1371R, Q1395R, Q903R	Tuberous sclerosis 2	VCV002865764	16	2134407	16	2084406	2865764	3026837	rs2151526513	NC_000016.10:2084405:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4185G>A (p.Gln1395=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811324	16	2134408	16	2084407	3811324	3928565		NC_000016.10:2084406:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Dec 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4185G>T (p.Gln1395His)	TSC2	Q1280H, Q1292H, Q1339H, Q1351H, Q1328H, Q1329H, Q1395H, Q1151H, Q1352H, Q1372H	Tuberous sclerosis 2	VCV001500760	16	2134408	16	2084407	1500760	1501683	rs2151526541	NC_000016.10:2084406:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4185G>C (p.Gln1395His)	TSC2	Q1328H, Q1339H, Q1351H, Q1372H, Q1292H, Q1329H, Q1280H, Q1352H, Q1151H, Q1395H	Tuberous sclerosis 2	VCV001447424	16	2134408	16	2084407	1447424	1503478	rs2151526541	NC_000016.10:2084406:G:C	single nucleotide variant	missense variant	Uncertain significance	May 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4186G>A (p.Asp1396Asn)	TSC2	D1129N, D1130N, D1152N, D1172N, D1173N, D1176N, D1196N, D1280N, D1281N, D1292N, D1293N, D1310N, D1323N, D1324N, D1325N, D1326N, D1329N, D1330N, D1336N, D1340N, D1352N, D1353N, D1359N, D1360N, D1370N, D1372N, D1373N, D1395N, D1396N, D795N, D881N, D882N, D904N, D905N, D925N	Hereditary cancer-predisposing syndrome	VCV003232164	16	2134409	16	2084408	3232164	3391965	rs2151526594	NC_000016.10:2084407:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4187A>G (p.Asp1396Gly)	TSC2	D1173G, D1176G, D1281G, D1292G, D1359G, D1360G, D1372G, D795G, D881G, D905G, D1172G, D1196G, D1293G, D1310G, D1324G, D1329G, D1330G, D1336G, D1352G, D1353G, D1373G, D882G, D1129G, D1325G, D1340G, D904G, D1130G, D1152G, D1280G, D1323G, D1326G, D1370G, D1395G, D1396G, D925G	Tuberous sclerosis 2	VCV003637233	16	2134410	16	2084409	3637233	3771387		NC_000016.10:2084408:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4188C>T (p.Asp1396=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002862999	16	2134411	16	2084410	2862999	3019187	rs765675223	NC_000016.10:2084409:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4189A>G (p.Ile1397Val)	TSC2	I1153V, I1331V, I1341V, I1353V, I1374V, I1354V, I1397V, I1282V, I1294V, I1330V	Tuberous sclerosis 2	VCV000652624	16	2134412	16	2084411	652624	644324	rs1596416534	NC_000016.10:2084410:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4190T>C (p.Ile1397Thr)	TSC2	I1331T, I1374T, I1353T, I1153T, I1282T, I1341T, I1354T, I1294T, I1330T, I1397T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001361105	16	2134413	16	2084412	1361105	1383477	rs2090503435	NC_000016.10:2084411:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4190T>A (p.Ile1397Asn)	TSC2	I1282N, I1330N, I1331N, I1354N, I1294N, I1341N, I1353N, I1374N, I1153N, I1397N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000856603	16	2134413	16	2084412	856603	843488	rs2090503435	NC_000016.10:2084411:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4191C>T (p.Ile1397=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000719797	16	2134414	16	2084413	719797	726494	rs1170748581	NC_000016.10:2084412:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4192C>T (p.Leu1398Phe)	TSC2	L1283F, L1375F, L1355F, L1398F, L1154F, L1295F, L1331F, L1332F, L1342F, L1354F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001367435	16	2134415	16	2084414	1367435	1405154	rs1060500928	NC_000016.10:2084413:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4192C>G (p.Leu1398Val)	TSC2	L1398V, L1283V, L1342V, L1354V, L1295V, L1375V, L1154V, L1331V, L1332V, L1355V	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000405993	16	2134415	16	2084414	405993	400873	rs1060500928	NC_000016.10:2084413:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4194C>G (p.Leu1398=)	TSC2		Tuberous sclerosis 2	VCV002134363	16	2134417	16	2084416	2134363	2187082	rs1060504106	NC_000016.10:2084415:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4194C>T (p.Leu1398=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000413710	16	2134417	16	2084416	413710	400958	rs1060504106	NC_000016.10:2084415:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4195G>C (p.Gly1399Arg)	TSC2	G1132R, G1283R, G1295R, G1296R, G1332R, G1375R, G884R, G907R, G1175R, G1199R, G1327R, G1329R, G1343R, G1356R, G1362R, G1373R, G1376R, G1398R, G928R, G1179R, G1284R, G1326R, G1328R, G1339R, G1355R, G908R, G1133R, G1155R, G1176R, G1313R, G1333R, G1363R, G1399R, G798R, G885R	Tuberous sclerosis 2	VCV003672275	16	2134418	16	2084417	3672275	3805332		NC_000016.10:2084416:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4195G>A (p.Gly1399Arg)	TSC2	G1399R, G1284R, G1356R, G1296R, G1376R, G1332R, G1343R, G1355R, G1155R, G1333R	Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	VCV000050062	16	2134418	16	2084417	50062	59224	rs45466399	NC_000016.10:2084416:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4196G>T (p.Gly1399Val)	TSC2	G1132V, G1155V, G1176V, G1313V, G1339V, G1398V, G1399V, G908V, G1326V, G1327V, G1332V, G1356V, G1373V, G1375V, G907V, G1328V, G1333V, G1343V, G1355V, G1362V, G1363V, G798V, G885V, G1133V, G1175V, G1179V, G1199V, G1283V, G1284V, G1295V, G1296V, G1329V, G1376V, G884V, G928V	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|not provided	VCV001738594	16	2134419	16	2084418	1738594	1790927	rs2090504166	NC_000016.10:2084417:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4196G>A (p.Gly1399Glu)	TSC2	G1155E, G1332E, G1376E, G1284E, G1333E, G1355E, G1399E, G1343E, G1356E, G1296E	Tuberous sclerosis 2	VCV001364815	16	2134419	16	2084418	1364815	1409296	rs2090504166	NC_000016.10:2084417:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4197G>A (p.Gly1399=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001642742	16	2134420	16	2084419	1642742	1521234	rs2151527039	NC_000016.10:2084418:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4198G>A (p.Asp1400Asn)	TSC2	D1400N, D1285N, D1297N, D1334N, D1156N, D1357N, D1333N, D1356N, D1377N, D1344N	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207682	16	2134421	16	2084420	207682	203187	rs762368225	NC_000016.10:2084419:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4200C>A (p.Asp1400Glu)	TSC2	D1133E, D1134E, D1156E, D1176E, D1177E, D1180E, D1200E, D1284E, D1285E, D1296E, D1297E, D1314E, D1327E, D1328E, D1329E, D1330E, D1333E, D1334E, D1340E, D1344E, D1356E, D1357E, D1363E, D1364E, D1374E, D1376E, D1377E, D1399E, D1400E, D799E, D885E, D886E, D908E, D909E, D929E	Hereditary cancer-predisposing syndrome	VCV003232165	16	2134423	16	2084422	3232165	3391966	rs758897944	NC_000016.10:2084421:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4200C>T (p.Asp1400=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001147248	16	2134423	16	2084422	1147248	1145968	rs758897944	NC_000016.10:2084421:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4201C>A (p.Pro1401Thr)	TSC2	P1378T, P1401T, P1298T, P1334T, P1345T, P1357T, P1358T, P1157T, P1286T, P1335T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001373647	16	2134424	16	2084423	1373647	1378787	rs778147657	NC_000016.10:2084422:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4201C>T (p.Pro1401Ser)	TSC2	P1335S, P1286S, P1357S, P1358S, P1378S, P1401S, P1157S, P1298S, P1334S, P1345S	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000664373	16	2134424	16	2084423	664373	644325	rs778147657	NC_000016.10:2084422:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4201C>G (p.Pro1401Ala)	TSC2	P1401A, P1286A, P1334A, P1357A, P1358A, P1378A, P1157A, P1298A, P1335A, P1345A	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000406078	16	2134424	16	2084423	406078	401390	rs778147657	NC_000016.10:2084422:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 31, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4202C>T (p.Pro1401Leu)	TSC2	P1157L, P1357L, P1401L, P1358L, P1286L, P1334L, P1335L, P1378L, P1298L, P1345L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000835322	16	2134425	16	2084424	835322	843489	rs1596416623	NC_000016.10:2084423:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4202C>G (p.Pro1401Arg)	TSC2	P1298R, P1357R, P1358R, P1157R, P1286R, P1345R, P1378R, P1401R, P1334R, P1335R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824673	16	2134425	16	2084424	824673	812596	rs1596416623	NC_000016.10:2084423:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4203T>C (p.Pro1401=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001127724	16	2134426	16	2084425	1127724	1125086	rs893072428	NC_000016.10:2084424:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4204G>A (p.Gly1402Arg)	TSC2	G1287R, G1335R, G1336R, G1346R, G1402R, G1359R, G1158R, G1299R, G1358R, G1379R	Tuberous sclerosis 2	VCV001507356	16	2134427	16	2084426	1507356	1449646	rs2151527362	NC_000016.10:2084425:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4206G>C (p.Gly1402=)	TSC2		Tuberous sclerosis 2	VCV004071355	16	2134429	16	2084428	4071355	4185203		NC_000016.10:2084427:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4206G>A (p.Gly1402=)	TSC2		Tuberous sclerosis 2	VCV002178206	16	2134429	16	2084428	2178206	1916016	rs2090505727	NC_000016.10:2084427:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4206G>T (p.Gly1402=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000957574	16	2134429	16	2084428	957574	949270	rs2090505727	NC_000016.10:2084427:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4207G>A (p.Asp1403Asn)	TSC2	D1159N, D1203N, D1299N, D1331N, D1337N, D1367N, D1377N, D1403N, D932N, D1179N, D1300N, D1317N, D1333N, D1359N, D1380N, D802N, D889N, D1137N, D1183N, D1287N, D1288N, D1332N, D1366N, D912N, D1136N, D1180N, D1330N, D1336N, D1343N, D1347N, D1360N, D1379N, D1402N, D888N, D911N	Tuberous sclerosis 2	VCV002834775	16	2134430	16	2084429	2834775	3001827	rs1288307487	NC_000016.10:2084428:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4207G>T (p.Asp1403Tyr)	TSC2	D1288Y, D1336Y, D1380Y, D1403Y, D1159Y, D1337Y, D1360Y, D1300Y, D1347Y, D1359Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000862701	16	2134430	16	2084429	862701	843490	rs1288307487	NC_000016.10:2084428:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4208A>C (p.Asp1403Ala)	TSC2	D1159A, D1288A, D1300A, D1336A, D1337A, D1347A, D1359A, D1360A, D1380A, D1403A	Hereditary cancer-predisposing syndrome	VCV001692501	16	2134431	16	2084430	1692501	1684941	rs1359988294	NC_000016.10:2084429:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4209C>T (p.Asp1403=)	TSC2		Tuberous sclerosis 2	VCV001561803	16	2134432	16	2084431	1561803	1608342	rs1257841799	NC_000016.10:2084430:C:T	single nucleotide variant	synonymous variant	Likely benign	May 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4209C>G (p.Asp1403Glu)	TSC2	D1159E, D1360E, D1380E, D1337E, D1359E, D1403E, D1288E, D1300E, D1336E, D1347E	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001372319	16	2134432	16	2084431	1372319	1443564	rs1257841799	NC_000016.10:2084430:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4210A>C (p.Lys1404Gln)	TSC2	K1137Q, K1138Q, K1160Q, K1180Q, K1181Q, K1184Q, K1204Q, K1288Q, K1289Q, K1300Q, K1301Q, K1318Q, K1331Q, K1332Q, K1333Q, K1334Q, K1337Q, K1338Q, K1344Q, K1348Q, K1360Q, K1361Q, K1367Q, K1368Q, K1378Q, K1380Q, K1381Q, K1403Q, K1404Q, K803Q, K889Q, K890Q, K912Q, K913Q, K933Q	Tuberous sclerosis 2	VCV001720649	16	2134433	16	2084432	1720649	1776831	rs1384101814	NC_000016.10:2084431:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4210A>G (p.Lys1404Glu)	TSC2	K1381E, K1337E, K1160E, K1289E, K1338E, K1301E, K1348E, K1360E, K1361E, K1404E	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV001417934	16	2134433	16	2084432	1417934	1396988	rs1384101814	NC_000016.10:2084431:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4211A>G (p.Lys1404Arg)	TSC2	K1137R, K1138R, K1160R, K1180R, K1181R, K1184R, K1204R, K1288R, K1289R, K1300R, K1301R, K1318R, K1331R, K1332R, K1333R, K1334R, K1337R, K1338R, K1344R, K1348R, K1360R, K1361R, K1367R, K1368R, K1378R, K1380R, K1381R, K1403R, K1404R, K803R, K889R, K890R, K912R, K913R, K933R	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003072085	16	2134434	16	2084433	3072085	3232262	rs2090506505	NC_000016.10:2084432:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4212G>A (p.Lys1404=)	TSC2		Tuberous sclerosis 2	VCV001159465	16	2134435	16	2084434	1159465	1145969	rs2090506660	NC_000016.10:2084433:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4212G>C (p.Lys1404Asn)	TSC2	K1160N, K1289N, K1301N, K1337N, K1338N, K1348N, K1360N, K1361N, K1381N, K1404N	Tuberous sclerosis 2	VCV001026982	16	2134435	16	2084434	1026982	1011996	rs2090506660	NC_000016.10:2084433:G:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4214C>T (p.Ala1405Val)	TSC2	A1138V, A1139V, A1161V, A1369V, A1382V, A1404V, A1405V, A890V, A913V, A1185V, A1302V, A1332V, A1338V, A1339V, A1349V, A1368V, A1379V, A914V, A1182V, A1289V, A1301V, A1319V, A1361V, A1362V, A804V, A934V, A1181V, A1205V, A1290V, A1333V, A1334V, A1335V, A1345V, A1381V, A891V	Tuberous sclerosis 2	VCV003637234	16	2134437	16	2084436	3637234	3771388		NC_000016.10:2084435:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4214C>A (p.Ala1405Asp)	TSC2	A1139D, A1205D, A1289D, A1335D, A1338D, A1349D, A1368D, A1381D, A804D, A1182D, A1290D, A1332D, A1339D, A1345D, A1361D, A890D, A1161D, A1181D, A1302D, A1334D, A1362D, A1369D, A1379D, A1382D, A891D, A913D, A934D, A1138D, A1185D, A1301D, A1319D, A1333D, A1404D, A1405D, A914D	Tuberous sclerosis 2	VCV002883833	16	2134437	16	2084436	2883833	3046587	rs1279133289	NC_000016.10:2084435:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4215C>T (p.Ala1405=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049503	16	2134438	16	2084437	49503	58665	rs45517331	NC_000016.10:2084436:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4216G>T (p.Asp1406Tyr)	TSC2	D1406Y, D1162Y, D1363Y, D1340Y, D1383Y, D1303Y, D1350Y, D1291Y, D1339Y, D1362Y	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406008	16	2134439	16	2084438	406008	400959	rs147719291	NC_000016.10:2084437:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4216G>A (p.Asp1406Asn)	TSC2	D1406N, D1162N, D1303N, D1291N, D1383N, D1339N, D1340N, D1362N, D1350N, D1363N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000405984	16	2134439	16	2084438	405984	400875	rs147719291	NC_000016.10:2084437:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4218C>G (p.Asp1406Glu)	TSC2	D1182E, D1333E, D1335E, D805E, D935E, D1139E, D1140E, D1186E, D1302E, D1303E, D1346E, D1370E, D1406E, D915E, D1206E, D1334E, D1340E, D1369E, D1380E, D1382E, D1383E, D1405E, D1162E, D1183E, D1290E, D1291E, D1320E, D1336E, D1339E, D1350E, D1362E, D1363E, D891E, D892E, D914E	Tuberous sclerosis 2	VCV003637235	16	2134441	16	2084440	3637235	3771389		NC_000016.10:2084439:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4218C>T (p.Asp1406=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000318329	16	2134441	16	2084440	318329	340863	rs886051794	NC_000016.10:2084439:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4219G>A (p.Val1407Met)	TSC2	V1407M, V1340M, V1351M, V1364M, V1384M, V1304M, V1341M, V1163M, V1292M, V1363M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000406016	16	2134442	16	2084441	406016	401631	rs45517332	NC_000016.10:2084440:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4219G>C (p.Val1407Leu)	TSC2	V1407L, V1163L, V1304L, V1341L, V1351L, V1364L, V1292L, V1340L, V1363L, V1384L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049812	16	2134442	16	2084441	49812	58974	rs45517332	NC_000016.10:2084440:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4220T>G (p.Val1407Gly)	TSC2	V1407G, V1340G, V1341G, V1363G, V1163G, V1292G, V1304G, V1384G, V1351G, V1364G	Tuberous sclerosis 2	VCV000535898	16	2134443	16	2084442	535898	529662	rs1555514182	NC_000016.10:2084441:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4222G>C (p.Gly1408Arg)	TSC2	G1141R, G1164R, G1188R, G1292R, G1293R, G1342R, G1348R, G1372R, G893R, G1185R, G1335R, G1352R, G1364R, G1371R, G1385R, G1407R, G807R, G1142R, G1184R, G1305R, G1322R, G1337R, G1338R, G1341R, G1365R, G1408R, G916R, G917R, G1208R, G1304R, G1336R, G1382R, G1384R, G894R, G937R	Hereditary cancer-predisposing syndrome	VCV003462663	16	2134445	16	2084444	3462663	3621682		NC_000016.10:2084443:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4222G>T (p.Gly1408Cys)	TSC2	G1185C, G1322C, G1341C, G1382C, G1384C, G893C, G1141C, G1293C, G1335C, G1336C, G1337C, G1364C, G1372C, G1385C, G1408C, G894C, G916C, G937C, G1184C, G1188C, G1208C, G1348C, G1352C, G1371C, G1142C, G1164C, G1292C, G1304C, G1305C, G1338C, G1342C, G1365C, G1407C, G807C, G917C	Hereditary cancer-predisposing syndrome	VCV003462537	16	2134445	16	2084444	3462537	3621557		NC_000016.10:2084443:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4223G>A (p.Gly1408Asp)	TSC2	G1141D, G1142D, G1164D, G1184D, G1185D, G1188D, G1208D, G1292D, G1293D, G1304D, G1305D, G1322D, G1335D, G1336D, G1337D, G1338D, G1341D, G1342D, G1348D, G1352D, G1364D, G1365D, G1371D, G1372D, G1382D, G1384D, G1385D, G1407D, G1408D, G807D, G893D, G894D, G916D, G917D, G937D	Tuberous sclerosis 2	VCV002506402	16	2134446	16	2084445	2506402	2671356	rs202068995	NC_000016.10:2084444:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4223G>C (p.Gly1408Ala)	TSC2	G1164A, G1305A, G1341A, G1342A, G1365A, G1352A, G1293A, G1364A, G1385A, G1408A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001366198	16	2134446	16	2084445	1366198	1411540	rs202068995	NC_000016.10:2084444:G:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4223G>T (p.Gly1408Val)	TSC2	G1408V, G1164V, G1305V, G1341V, G1342V, G1352V, G1365V, G1293V, G1364V, G1385V	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207753	16	2134446	16	2084445	207753	203188	rs202068995	NC_000016.10:2084444:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4224C>A (p.Gly1408=)	TSC2		Tuberous sclerosis 2	VCV002024221	16	2134447	16	2084446	2024221	2076998	rs1596416816	NC_000016.10:2084445:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4224C>T (p.Gly1408=)	TSC2		Tuberous sclerosis 2	VCV000738624	16	2134447	16	2084446	738624	755003	rs1596416816	NC_000016.10:2084445:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4225C>G (p.Arg1409Gly)	TSC2	R1409G, R1306G, R1365G, R1165G, R1294G, R1386G, R1366G, R1342G, R1343G, R1353G	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000468071	16	2134448	16	2084447	468071	466067	rs45517333	NC_000016.10:2084446:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4225C>T (p.Arg1409Trp)	TSC2	R1409W, R1294W, R1342W, R1306W, R1343W, R1353W, R1365W, R1386W, R1165W, R1366W	not provided|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not specified	VCV000041740	16	2134448	16	2084447	41740	50179	rs45517333	NC_000016.10:2084446:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4226G>C (p.Arg1409Pro)	TSC2	R1142P, R1189P, R1293P, R1306P, R1339P, R1349P, R1373P, R1305P, R1323P, R1338P, R1342P, R1343P, R1353P, R1365P, R1385P, R1409P, R808P, R1143P, R1165P, R1185P, R1337P, R1366P, R1386P, R1408P, R938P, R1186P, R1209P, R1294P, R1336P, R1372P, R1383P, R894P, R895P, R917P, R918P	Tuberous sclerosis 2	VCV003667048	16	2134449	16	2084448	3667048	3799060		NC_000016.10:2084447:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4226G>A (p.Arg1409Gln)	TSC2	R1409Q, R1165Q, R1366Q, R1353Q, R1365Q, R1386Q, R1294Q, R1306Q, R1342Q, R1343Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000207683	16	2134449	16	2084448	207683	203189	rs768684515	NC_000016.10:2084447:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4227G>C (p.Arg1409=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003232166	16	2134450	16	2084449	3232166	3391967	rs1555514188	NC_000016.10:2084448:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4227G>T (p.Arg1409=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468072	16	2134450	16	2084449	468072	466265	rs1555514188	NC_000016.10:2084448:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4228C>T (p.Leu1410=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001078504	16	2134451	16	2084450	1078504	1081861	rs2151528481	NC_000016.10:2084449:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4229T>C (p.Leu1410Pro)	TSC2	L1187P, L1190P, L1306P, L1340P, L1344P, L1350P, L1166P, L1186P, L1210P, L1295P, L1324P, L1354P, L1384P, L1386P, L1410P, L918P, L1294P, L1307P, L1337P, L1366P, L1374P, L1387P, L895P, L919P, L939P, L1143P, L1144P, L1338P, L1339P, L1343P, L1367P, L1373P, L1409P, L809P, L896P	Tuberous sclerosis 2	VCV003637236	16	2134452	16	2084451	3637236	3771390		NC_000016.10:2084450:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4230G>C (p.Leu1410=)	TSC2		Tuberous sclerosis 2	VCV000536093	16	2134453	16	2084452	536093	530276	rs1193907816	NC_000016.10:2084451:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4232G>A (p.Ser1411Asn)	TSC2	S1411N, S1308N, S1355N, S1388N, S1167N, S1296N, S1344N, S1345N, S1367N, S1368N	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000579558	16	2134455	16	2084454	579558	573867	rs1267811475	NC_000016.10:2084453:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4233C>A (p.Ser1411Arg)	TSC2	S1167R, S1188R, S1211R, S1295R, S1340R, S1341R, S1374R, S1388R, S896R, S897R, S940R, S1191R, S1296R, S1339R, S1351R, S1375R, S810R, S919R, S1145R, S1307R, S1338R, S1345R, S1367R, S1368R, S1385R, S1387R, S1410R, S920R, S1144R, S1187R, S1308R, S1325R, S1344R, S1355R, S1411R	Tuberous sclerosis 2	VCV002827102	16	2134456	16	2084455	2827102	2983054	rs1060504090	NC_000016.10:2084454:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4233C>T (p.Ser1411=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413641	16	2134456	16	2084455	413641	400880	rs1060504090	NC_000016.10:2084454:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4234C>T (p.Pro1412Ser)	TSC2	P1345S, P1346S, P1368S, P1309S, P1356S, P1369S, P1389S, P1168S, P1297S, P1412S	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000824705	16	2134457	16	2084456	824705	812597	rs1480313663	NC_000016.10:2084455:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4235C>T (p.Pro1412Leu)	TSC2	P1145L, P1146L, P1168L, P1188L, P1189L, P1192L, P1212L, P1296L, P1297L, P1308L, P1309L, P1326L, P1339L, P1340L, P1341L, P1342L, P1345L, P1346L, P1352L, P1356L, P1368L, P1369L, P1375L, P1376L, P1386L, P1388L, P1389L, P1411L, P1412L, P811L, P897L, P898L, P920L, P921L, P941L	Isolated focal cortical dysplasia type II	VCV003240660	16	2134458	16	2084457	3240660	3399646	rs1197792694	NC_000016.10:2084456:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4235C>G (p.Pro1412Arg)	TSC2	P1297R, P1389R, P1346R, P1369R, P1412R, P1168R, P1309R, P1356R, P1368R, P1345R	Tuberous sclerosis 2	VCV000943888	16	2134458	16	2084457	943888	937338	rs1197792694	NC_000016.10:2084456:C:G	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4236T>G (p.Pro1412=)	TSC2		Tuberous sclerosis 2	VCV004071223	16	2134459	16	2084458	4071223	4185071		NC_000016.10:2084457:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4237G>A (p.Glu1413Lys)	TSC2	E1147K, E1310K, E1340K, E1347K, E1353K, E1357K, E1387K, E812K, E898K, E942K, E1189K, E1298K, E1327K, E1342K, E1346K, E1369K, E1376K, E899K, E922K, E1193K, E1341K, E1343K, E1370K, E1377K, E1390K, E1412K, E921K, E1146K, E1169K, E1190K, E1213K, E1297K, E1309K, E1389K, E1413K	Tuberous sclerosis 2	VCV002714249	16	2134460	16	2084459	2714249	2868786	rs2151528836	NC_000016.10:2084458:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4239G>A (p.Glu1413=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000702378	16	2134462	16	2084461	702378	693819	rs907082165	NC_000016.10:2084460:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4240G>A (p.Val1414Ile)	TSC2	V1170I, V1191I, V1298I, V1344I, V1391I, V813I, V1147I, V1328I, V1341I, V1354I, V1371I, V1377I, V1414I, V923I, V1358I, V1378I, V1388I, V899I, V900I, V922I, V943I, V1214I, V1299I, V1343I, V1348I, V1148I, V1190I, V1194I, V1310I, V1311I, V1342I, V1347I, V1370I, V1390I, V1413I	Hereditary cancer-predisposing syndrome	VCV003462548	16	2134463	16	2084462	3462548	3621568		NC_000016.10:2084461:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4241T>C (p.Val1414Ala)	TSC2	V1147A, V1170A, V1194A, V1298A, V1311A, V1341A, V1358A, V1371A, V1377A, V1391A, V1413A, V1414A, V899A, V900A, V922A, V943A, V1190A, V1344A, V1347A, V1370A, V1388A, V813A, V1191A, V1214A, V1299A, V1348A, V1148A, V1310A, V1328A, V1342A, V1343A, V1354A, V1378A, V1390A, V923A	Tuberous sclerosis 2	VCV002164386	16	2134464	16	2084463	2164386	1902217	rs2151528990	NC_000016.10:2084462:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4245G>A (p.Lys1415=)	TSC2		Tuberous sclerosis 2	VCV004071290	16	2134468	16	2084467	4071290	4185138		NC_000016.10:2084466:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4245G>C (p.Lys1415Asn)	TSC2	K1148N, K1149N, K1171N, K1191N, K1192N, K1195N, K1215N, K1299N, K1300N, K1311N, K1312N, K1329N, K1342N, K1343N, K1344N, K1345N, K1348N, K1349N, K1355N, K1359N, K1371N, K1372N, K1378N, K1379N, K1389N, K1391N, K1392N, K1414N, K1415N, K814N, K900N, K901N, K923N, K924N, K944N	Tuberous sclerosis syndrome	VCV003075053	16	2134468	16	2084467	3075053	3234705	rs1431882138	NC_000016.10:2084466:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4245G>T (p.Lys1415Asn)	TSC2	K1171N, K1300N, K1312N, K1348N, K1349N, K1359N, K1371N, K1372N, K1392N, K1415N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001056301	16	2134468	16	2084467	1056301	1049478	rs1431882138	NC_000016.10:2084466:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4246G>T (p.Ala1416Ser)	TSC2	A1372S, A1416S, A1301S, A1313S, A1172S, A1350S, A1349S, A1360S, A1373S, A1393S	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000853078	16	2134469	16	2084468	853078	843492	rs1001211672	NC_000016.10:2084467:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4247C>G (p.Ala1416Gly)	TSC2	A1149G, A1150G, A1172G, A1192G, A1193G, A1196G, A1216G, A1300G, A1301G, A1312G, A1313G, A1330G, A1343G, A1344G, A1345G, A1346G, A1349G, A1350G, A1356G, A1360G, A1372G, A1373G, A1379G, A1380G, A1390G, A1392G, A1393G, A1415G, A1416G, A815G, A901G, A902G, A924G, A925G, A945G	Tuberous sclerosis 2	VCV001717781	16	2134470	16	2084469	1717781	1771757	rs2090510754	NC_000016.10:2084468:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4247C>T (p.Ala1416Val)	TSC2	A1301V, A1373V, A1416V, A1349V, A1360V, A1350V, A1372V, A1172V, A1313V, A1393V	Tuberous sclerosis 2	VCV000953679	16	2134470	16	2084469	953679	949271	rs2090510754	NC_000016.10:2084468:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4248C>A (p.Ala1416=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001545907	16	2134471	16	2084470	1545907	1612579	rs1393358018	NC_000016.10:2084469:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4248C>G (p.Ala1416=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001133753	16	2134471	16	2084470	1133753	1125087	rs1393358018	NC_000016.10:2084469:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4249C>A (p.Arg1417=)	TSC2		Tuberous sclerosis 2	VCV001614347	16	2134472	16	2084471	1614347	1612934	rs774338461	NC_000016.10:2084470:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 31, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4249C>G (p.Arg1417Gly)	TSC2	R1173G, R1302G, R1314G, R1350G, R1351G, R1394G, R1361G, R1417G, R1373G, R1374G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001475954	16	2134472	16	2084471	1475954	1423673	rs774338461	NC_000016.10:2084470:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4249C>T (p.Arg1417Trp)	TSC2	R1417W, R1173W, R1302W, R1350W, R1351W, R1314W, R1361W, R1373W, R1374W, R1394W	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis	VCV000535982	16	2134472	16	2084471	535982	530012	rs774338461	NC_000016.10:2084470:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4250G>A (p.Arg1417Gln)	TSC2	R1417Q, R1314Q, R1351Q, R1374Q, R1394Q, R1302Q, R1361Q, R1373Q, R1173Q, R1350Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468073	16	2134473	16	2084472	468073	466069	rs1343536158	NC_000016.10:2084471:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4251G>A (p.Arg1417=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001115703	16	2134474	16	2084473	1115703	1103671	rs1455362130	NC_000016.10:2084472:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4253C>T (p.Ser1418Leu)	TSC2	S1174L, S1303L, S1315L, S1351L, S1352L, S1362L, S1374L, S1375L, S1395L, S1418L	not provided|Tuberous sclerosis 2	VCV001310879	16	2134476	16	2084475	1310879	1301583	rs369164761	NC_000016.10:2084474:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4254A>G (p.Ser1418=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001739109	16	2134477	16	2084476	1739109	1788106	rs2151529613	NC_000016.10:2084475:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 6, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4255C>A (p.Gln1419Lys)	TSC2	Q1352K, Q1353K, Q1376K, Q1153K, Q1219K, Q1303K, Q1333K, Q1346K, Q1199K, Q1315K, Q1316K, Q1348K, Q1363K, Q1383K, Q1393K, Q928K, Q1195K, Q1304K, Q1347K, Q1349K, Q1396K, Q1419K, Q818K, Q1152K, Q1175K, Q1196K, Q1359K, Q1375K, Q1382K, Q1395K, Q1418K, Q904K, Q905K, Q927K, Q948K	Hereditary cancer-predisposing syndrome	VCV003974679	16	2134478	16	2084477	3974679	4086502		NC_000016.10:2084476:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4255C>G (p.Gln1419Glu)	TSC2	Q1175E, Q1304E, Q1316E, Q1352E, Q1353E, Q1363E, Q1375E, Q1376E, Q1396E, Q1419E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692502	16	2134478	16	2084477	1692502	1684942	rs45437193	NC_000016.10:2084476:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4255C>T (p.Gln1419Ter)	TSC2	Q1419*, Q1376*, Q1396*, Q1375*, Q1316*, Q1352*, Q1353*, Q1175*, Q1304*, Q1363*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000049821	16	2134478	16	2084477	49821	58983	rs45437193	NC_000016.10:2084476:C:T	single nucleotide variant	nonsense	Pathogenic	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4256A>G (p.Gln1419Arg)	TSC2	Q1419R, Q1304R, Q1316R, Q1352R, Q1375R, Q1376R, Q1353R, Q1363R, Q1396R, Q1175R	not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486632	16	2134479	16	2084478	486632	477425	rs562443546	NC_000016.10:2084477:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 10, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4257G>A (p.Gln1419=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001140823	16	2134480	16	2084479	1140823	1125088	rs1403321543	NC_000016.10:2084478:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4257G>C (p.Gln1419His)	TSC2	Q1419H, Q1316H, Q1396H, Q1304H, Q1375H, Q1175H, Q1352H, Q1353H, Q1363H, Q1376H	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000535918	16	2134480	16	2084479	535918	529673	rs1403321543	NC_000016.10:2084478:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4260A>C (p.Ser1420=)	TSC2		Tuberous sclerosis 2	VCV003006801	16	2134483	16	2084482	3006801	3161922	rs1285012780	NC_000016.10:2084481:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4260A>G (p.Ser1420=)	TSC2		Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000546764	16	2134483	16	2084482	546764	537253	rs1285012780	NC_000016.10:2084481:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4262G>C (p.Gly1421Ala)	TSC2	G1177A, G1318A, G1355A, G1398A, G1421A, G1306A, G1354A, G1365A, G1377A, G1378A	Lymphangiomyomatosis	VCV000931762	16	2134485	16	2084484	931762	919618	rs1368001965	NC_000016.10:2084483:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4262G>A (p.Gly1421Glu)	TSC2	G1421E, G1306E, G1354E, G1365E, G1377E, G1378E, G1398E, G1177E, G1318E, G1355E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000571772	16	2134485	16	2084484	571772	570124	rs1368001965	NC_000016.10:2084483:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4263G>T (p.Gly1421=)	TSC2		Tuberous sclerosis 2	VCV000468074	16	2134486	16	2084485	468074	466276	rs772862165	NC_000016.10:2084484:G:T	single nucleotide variant	synonymous variant	Benign	Nov 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4265C>A (p.Thr1422Asn)	TSC2	T1178N, T1355N, T1379N, T1307N, T1378N, T1319N, T1356N, T1366N, T1399N, T1422N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001501629	16	2134488	16	2084487	1501629	1398497	rs760230300	NC_000016.10:2084486:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4265C>T (p.Thr1422Ile)	TSC2	T1422I, T1178I, T1307I, T1355I, T1356I, T1378I, T1399I, T1319I, T1366I, T1379I	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535904	16	2134488	16	2084487	535904	530279	rs760230300	NC_000016.10:2084486:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4266C>T (p.Thr1422=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002806325	16	2134489	16	2084488	2806325	2971257	rs2090513817	NC_000016.10:2084487:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4267C>G (p.Leu1423Val)	TSC2	L1157V, L1203V, L1319V, L1351V, L1353V, L1386V, L1397V, L1422V, L1156V, L1337V, L1352V, L1356V, L1357V, L1387V, L822V, L909V, L1200V, L1223V, L1307V, L1308V, L1320V, L1350V, L1367V, L1379V, L1399V, L932V, L952V, L1179V, L1199V, L1363V, L1380V, L1400V, L1423V, L908V, L931V	Tuberous sclerosis 2	VCV003000186	16	2134490	16	2084489	3000186	3160481	rs1484475537	NC_000016.10:2084488:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4267C>T (p.Leu1423=)	TSC2		not provided|Tuberous sclerosis 2	VCV001611115	16	2134490	16	2084489	1611115	1640191	rs1484475537	NC_000016.10:2084488:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4268T>C (p.Leu1423Pro)	TSC2	L1423P, L1380P, L1400P, L1179P, L1308P, L1320P, L1356P, L1367P, L1379P, L1357P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000573907	16	2134491	16	2084490	573907	573873	rs1567523138	NC_000016.10:2084489:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4269G>C (p.Leu1423=)	TSC2		Tuberous sclerosis 2	VCV003727457	16	2134492	16	2084491	3727457	3861682		NC_000016.10:2084490:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4269G>A (p.Leu1423=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049289	16	2134492	16	2084491	49289	58451	rs45438898	NC_000016.10:2084490:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4270G>C (p.Asp1424His)	TSC2	D1321H, D1358H, D1380H, D1381H, D1424H, D1309H, D1368H, D1401H, D1180H, D1357H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000944752	16	2134493	16	2084492	944752	927674	rs1216613310	NC_000016.10:2084491:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4271A>G (p.Asp1424Gly)	TSC2	D1424G, D1309G, D1380G, D1401G, D1357G, D1381G, D1321G, D1358G, D1368G, D1180G	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000232699	16	2134494	16	2084493	232699	235134	rs876659933	NC_000016.10:2084492:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4272C>A (p.Asp1424Glu)	TSC2	D1351E, D1358E, D1380E, D1387E, D1398E, D1424E, D823E, D932E, D1180E, D1357E, D1400E, D1401E, D1423E, D909E, D910E, D953E, D1200E, D1204E, D1224E, D1308E, D1321E, D1352E, D1353E, D1354E, D1364E, D1157E, D1158E, D1201E, D1309E, D1320E, D1338E, D1368E, D1381E, D1388E, D933E	Tuberous sclerosis 2	VCV002917256	16	2134495	16	2084494	2917256	3074498	rs371541319	NC_000016.10:2084493:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4272C>G (p.Asp1424Glu)	TSC2	D1180E, D1357E, D1358E, D1309E, D1321E, D1368E, D1424E, D1380E, D1381E, D1401E	Tuberous sclerosis 2	VCV001403917	16	2134495	16	2084494	1403917	1467283	rs371541319	NC_000016.10:2084493:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4272C>T (p.Asp1424=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000137747	16	2134495	16	2084494	137747	141450	rs371541319	NC_000016.10:2084493:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4273G>C (p.Gly1425Arg)	TSC2	G1425R, G1181R, G1358R, G1369R, G1381R, G1382R, G1402R, G1310R, G1322R, G1359R	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000468076	16	2134496	16	2084495	468076	466078	rs763497329	NC_000016.10:2084494:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4273G>A (p.Gly1425Arg)	TSC2	G1425R, G1322R, G1359R, G1310R, G1358R, G1181R, G1381R, G1402R, G1369R, G1382R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468075	16	2134496	16	2084495	468075	466073	rs763497329	NC_000016.10:2084494:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4274G>C (p.Gly1425Ala)	TSC2	G1201A, G1225A, G1322A, G1352A, G1382A, G1399A, G954A, G1181A, G1202A, G1309A, G1353A, G1358A, G1401A, G1424A, G824A, G910A, G1159A, G1310A, G1339A, G1359A, G1365A, G1369A, G933A, G1158A, G1205A, G1321A, G1354A, G1355A, G1381A, G1388A, G1389A, G1402A, G1425A, G911A, G934A	Hereditary cancer-predisposing syndrome	VCV003329514	16	2134497	16	2084496	3329514	3489106		NC_000016.10:2084495:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4274G>T (p.Gly1425Val)	TSC2	G1201V, G1352V, G1355V, G1369V, G1388V, G1402V, G1425V, G1181V, G1202V, G1205V, G1321V, G1322V, G1339V, G1354V, G1365V, G1382V, G1399V, G1424V, G954V, G1309V, G1310V, G1353V, G1381V, G824V, G911V, G933V, G1158V, G1159V, G1225V, G1358V, G1359V, G1389V, G1401V, G910V, G934V	Hereditary cancer-predisposing syndrome	VCV002626444	16	2134497	16	2084496	2626444	2794210	rs2151530560	NC_000016.10:2084495:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4275G>A (p.Gly1425=)	TSC2		not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000385484	16	2134498	16	2084497	385484	374840	rs1057522238	NC_000016.10:2084496:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4276G>A (p.Glu1426Lys)	TSC2	E1160K, E1206K, E1310K, E1323K, E1340K, E1353K, E1356K, E1370K, E1382K, E1390K, E1400K, E1403K, E825K, E1182K, E1202K, E1426K, E911K, E1159K, E1203K, E1311K, E1354K, E1360K, E1389K, E1425K, E1226K, E1322K, E1355K, E1359K, E1366K, E1383K, E1402K, E912K, E934K, E935K, E955K	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002848721	16	2134499	16	2084498	2848721	3015618	rs45449094	NC_000016.10:2084497:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4277A>C (p.Glu1426Ala)	TSC2	E1203A, E1323A, E1353A, E1354A, E1355A, E912A, E934A, E1160A, E1359A, E1370A, E1389A, E1402A, E1425A, E1426A, E1159A, E1310A, E1322A, E1356A, E1360A, E1382A, E1383A, E1390A, E911A, E935A, E955A, E1182A, E1202A, E1206A, E1226A, E1311A, E1340A, E1366A, E1400A, E1403A, E825A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002802419	16	2134500	16	2084499	2802419	2963104	rs2090515740	NC_000016.10:2084498:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4277A>G (p.Glu1426Gly)	TSC2	E1323G, E1359G, E1370G, E1182G, E1311G, E1360G, E1382G, E1403G, E1383G, E1426G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000955988	16	2134500	16	2084499	955988	949272	rs2090515740	NC_000016.10:2084498:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4278A>C (p.Glu1426Asp)	TSC2	E1311D, E1322D, E1354D, E1360D, E1383D, E1390D, E1402D, E1426D, E825D, E911D, E935D, E955D, E1206D, E1226D, E1323D, E1366D, E1382D, E934D, E1159D, E1160D, E1202D, E1203D, E1355D, E1359D, E1389D, E1425D, E912D, E1182D, E1310D, E1340D, E1353D, E1356D, E1370D, E1400D, E1403D	Hereditary cancer-predisposing syndrome	VCV001739306	16	2134501	16	2084500	1739306	1797676	rs2151530709	NC_000016.10:2084499:A:C	single nucleotide variant	missense variant	Likely benign	Sep 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4279A>G (p.Ser1427Gly)	TSC2	S1360G, S1383G, S1361G, S1183G, S1384G, S1312G, S1324G, S1371G, S1404G, S1427G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000837127	16	2134502	16	2084501	837127	843493	rs1248855623	NC_000016.10:2084500:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4280G>A (p.Ser1427Asn)	TSC2	S1183N, S1160N, S1355N, S1357N, S1371N, S1383N, S1426N, S1312N, S1361N, S1390N, S1391N, S1404N, S913N, S956N, S1161N, S1204N, S1227N, S1311N, S1323N, S1341N, S1356N, S1367N, S1384N, S1401N, S1427N, S935N, S936N, S1203N, S1207N, S1324N, S1354N, S1360N, S1403N, S826N, S912N	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV001739347	16	2134503	16	2084502	1739347	1797717	rs397515250	NC_000016.10:2084501:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4280G>T (p.Ser1427Ile)	TSC2	S1183I, S1312I, S1324I, S1427I, S1361I, S1371I, S1404I, S1360I, S1383I, S1384I	Tuberous sclerosis 2	VCV001472671	16	2134503	16	2084502	1472671	1398053	rs397515250	NC_000016.10:2084501:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4280G>C (p.Ser1427Thr)	TSC2	S1427T, S1371T, S1312T, S1360T, S1361T, S1383T, S1384T, S1183T, S1324T, S1404T	Tuberous sclerosis 2	VCV000065338	16	2134503	16	2084502	65338	76271	rs397515250	NC_000016.10:2084501:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4281T>C (p.Ser1427=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811339	16	2134504	16	2084503	3811339	3928580		NC_000016.10:2084502:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4282G>A (p.Ala1428Thr)	TSC2	A1184T, A1325T, A1428T, A1361T, A1372T, A1405T, A1384T, A1313T, A1362T, A1385T	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000943580	16	2134505	16	2084504	943580	937339	rs764533757	NC_000016.10:2084503:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4283C>T (p.Ala1428Val)	TSC2	A1362V, A1372V, A1384V, A1405V, A1313V, A1361V, A1428V, A1184V, A1385V, A1325V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001487082	16	2134506	16	2084505	1487082	1406939	rs2151530908	NC_000016.10:2084504:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4284T>C (p.Ala1428=)	TSC2		Tuberous sclerosis 2	VCV001577632	16	2134507	16	2084506	1577632	1553668	rs2151530962	NC_000016.10:2084505:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4285G>A (p.Ala1429Thr)	TSC2	A1162T, A1206T, A1326T, A1358T, A1362T, A1373T, A1385T, A914T, A915T, A938T, A1163T, A1209T, A1357T, A1363T, A1386T, A1393T, A1405T, A1428T, A828T, A937T, A958T, A1185T, A1205T, A1229T, A1313T, A1343T, A1356T, A1359T, A1403T, A1429T, A1314T, A1325T, A1369T, A1392T, A1406T	Tuberous sclerosis 2	VCV002733689	16	2134508	16	2084507	2733689	2898024	rs45474795	NC_000016.10:2084506:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4285G>T (p.Ala1429Ser)	TSC2	A1429S, A1185S, A1326S, A1386S, A1406S, A1363S, A1314S, A1385S, A1362S, A1373S	Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|not specified|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000041741	16	2134508	16	2084507	41741	50180	rs45474795	NC_000016.10:2084506:G:T	single nucleotide variant	missense variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4286C>G (p.Ala1429Gly)	TSC2	A1362G, A1363G, A1406G, A1429G, A1185G, A1314G, A1385G, A1386G, A1326G, A1373G	Tuberous sclerosis 2	VCV001427263	16	2134509	16	2084508	1427263	1444665	rs757579310	NC_000016.10:2084507:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4286C>T (p.Ala1429Val)	TSC2	A1429V, A1314V, A1326V, A1362V, A1386V, A1363V, A1385V, A1373V, A1185V, A1406V	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000318330	16	2134509	16	2084508	318330	334173	rs757579310	NC_000016.10:2084507:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4287C>T (p.Ala1429=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001120825	16	2134510	16	2084509	1120825	1125089	rs2151531120	NC_000016.10:2084508:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4288T>C (p.Trp1430Arg)	TSC2	W1186R, W1315R, W1387R, W1430R, W1327R, W1363R, W1374R, W1364R, W1386R, W1407R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824756	16	2134511	16	2084510	824756	812598	rs1596417336	NC_000016.10:2084509:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4289G>C (p.Trp1430Ser)	TSC2	W1210S, W1315S, W1326S, W1358S, W1360S, W1363S, W1370S, W829S, W959S, W1186S, W1206S, W1359S, W1394S, W1404S, W1430S, W916S, W1164S, W1207S, W1327S, W1344S, W1386S, W1387S, W1393S, W1406S, W1407S, W1429S, W938S, W939S, W1163S, W1230S, W1314S, W1357S, W1364S, W1374S, W915S	Tuberous sclerosis 2	VCV002694689	16	2134512	16	2084511	2694689	2860828	rs45507198	NC_000016.10:2084510:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4289G>T (p.Trp1430Leu)	TSC2	W1163L, W1164L, W1186L, W1207L, W1344L, W1364L, W1404L, W1430L, W939L, W1230L, W1357L, W1358L, W1370L, W1387L, W1394L, W1429L, W915L, W959L, W1315L, W1326L, W1359L, W1363L, W1374L, W916L, W938L, W1206L, W1210L, W1314L, W1327L, W1360L, W1386L, W1393L, W1406L, W1407L, W829L	Hereditary cancer-predisposing syndrome	VCV001739402	16	2134512	16	2084511	1739402	1797771	rs45507198	NC_000016.10:2084510:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4290G>T (p.Trp1430Cys)	TSC2	W1315C, W1386C, W1387C, W1186C, W1374C, W1407C, W1430C, W1327C, W1363C, W1364C	Tuberous sclerosis 2	VCV000944353	16	2134513	16	2084512	944353	927675	rs45517334	NC_000016.10:2084511:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4290G>A (p.Trp1430Ter)	TSC2	W1430*, W1327*, W1364*, W1363*, W1374*, W1407*, W1387*, W1186*, W1315*, W1386*	Tuberous sclerosis 2	VCV000049291	16	2134513	16	2084512	49291	58453	rs45517334	NC_000016.10:2084511:G:A	single nucleotide variant	nonsense	Pathogenic	Mar 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4292C>G (p.Ser1431Trp)	TSC2	S1364W, S1408W, S1187W, S1316W, S1328W, S1365W, S1431W, S1375W, S1388W, S1387W	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000663810	16	2134515	16	2084514	663810	644326	rs375785710	NC_000016.10:2084513:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4292C>T (p.Ser1431Leu)	TSC2	S1431L, S1187L, S1408L, S1316L, S1364L, S1328L, S1365L, S1375L, S1387L, S1388L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468077	16	2134515	16	2084514	468077	465362	rs375785710	NC_000016.10:2084513:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4293G>A (p.Ser1431=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified	VCV000049292	16	2134516	16	2084515	49292	58454	rs45487992	NC_000016.10:2084514:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4294G>T (p.Ala1432Ser)	TSC2	A1232S, A1359S, A1361S, A1362S, A1366S, A1372S, A1396S, A1431S, A1432S, A1188S, A1208S, A1389S, A1408S, A917S, A940S, A961S, A1209S, A1212S, A1317S, A1329S, A1376S, A1406S, A918S, A941S, A1165S, A1166S, A1316S, A1328S, A1346S, A1360S, A1365S, A1388S, A1395S, A1409S, A831S	Hereditary cancer-predisposing syndrome	VCV003462652	16	2134517	16	2084516	3462652	3621671		NC_000016.10:2084515:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4294G>A (p.Ala1432Thr)	TSC2	A1316T, A1329T, A1359T, A1365T, A1389T, A940T, A1212T, A1232T, A1317T, A1328T, A1346T, A1366T, A1388T, A1431T, A917T, A1166T, A1209T, A1360T, A1362T, A1372T, A1395T, A1396T, A1406T, A1409T, A941T, A961T, A1165T, A1188T, A1208T, A1361T, A1376T, A1408T, A1432T, A831T, A918T	Tuberous sclerosis 2	VCV002035491	16	2134517	16	2084516	2035491	2097275	rs756286233	NC_000016.10:2084515:G:A	single nucleotide variant	missense variant	Benign	Oct 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4295C>T (p.Ala1432Val)	TSC2	A1409V, A1329V, A1366V, A1376V, A1432V, A1317V, A1365V, A1388V, A1389V, A1188V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001435761	16	2134518	16	2084517	1435761	1500757	rs2151531391	NC_000016.10:2084516:C:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4296C>T (p.Ala1432=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329526	16	2134519	16	2084518	3329526	3489118		NC_000016.10:2084517:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4296C>G (p.Ala1432=)	TSC2		Tuberous sclerosis 2	VCV000468078	16	2134519	16	2084518	468078	465364	rs1555514284	NC_000016.10:2084517:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 28, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4298C>G (p.Ser1433Trp)	TSC2	S1189W, S1318W, S1330W, S1366W, S1367W, S1377W, S1389W, S1390W, S1410W, S1433W	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001302975	16	2134521	16	2084520	1302975	1293254	rs45517335	NC_000016.10:2084519:C:G	single nucleotide variant	missense variant	Uncertain significance	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4298C>T (p.Ser1433Leu)	TSC2	S1433L, S1366L, S1367L, S1189L, S1318L, S1330L, S1390L, S1410L, S1377L, S1389L	not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000065193	16	2134521	16	2084520	65193	76125	rs45517335	NC_000016.10:2084519:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4298C>A (p.Ser1433Ter)	TSC2	S1433*, S1189*, S1318*, S1330*, S1366*, S1377*, S1367*, S1389*, S1410*, S1390*	Tuberous sclerosis 2	VCV000049516	16	2134521	16	2084520	49516	58678	rs45517335	NC_000016.10:2084519:C:A	single nucleotide variant	nonsense	Pathogenic	Oct 9, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4299G>T (p.Ser1433=)	TSC2		Tuberous sclerosis 2	VCV004071169	16	2134522	16	2084521	4071169	4185017		NC_000016.10:2084520:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4299G>A (p.Ser1433=)	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468079	16	2134522	16	2084521	468079	466278	rs749358180	NC_000016.10:2084520:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4300G>T (p.Gly1434Cys)	TSC2	G1434C, G1190C, G1319C, G1331C, G1378C, G1390C, G1368C, G1391C, G1367C, G1411C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535936	16	2134523	16	2084522	535936	529675	rs1555514295	NC_000016.10:2084521:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4302C>G (p.Gly1434=)	TSC2		Tuberous sclerosis 2	VCV002762907	16	2134525	16	2084524	2762907	2927968	rs137854000	NC_000016.10:2084523:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4302C>T (p.Gly1434=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Tuberous sclerosis 2	VCV000049899	16	2134525	16	2084524	49899	59061	rs137854000	NC_000016.10:2084523:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4303G>T (p.Glu1435Ter)	TSC2	E1391*, E1368*, E1191*, E1332*, E1392*, E1412*, E1320*, E1369*, E1379*, E1435*	Tuberous sclerosis 2	VCV000941899	16	2134526	16	2084525	941899	937340	rs1441136255	NC_000016.10:2084524:G:T	single nucleotide variant	nonsense	Pathogenic	Jun 17, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4303G>A (p.Glu1435Lys)	TSC2	E1435K, E1391K, E1191K, E1332K, E1392K, E1412K, E1320K, E1368K, E1369K, E1379K	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000574570	16	2134526	16	2084525	574570	570127	rs1441136255	NC_000016.10:2084524:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4304A>T (p.Glu1435Val)	TSC2	E1168V, E1191V, E1319V, E1349V, E1362V, E1435V, E920V, E1211V, E1364V, E1365V, E1368V, E1375V, E1399V, E921V, E943V, E944V, E1169V, E1212V, E1235V, E1332V, E1369V, E1379V, E1391V, E1398V, E1411V, E1434V, E964V, E1215V, E1320V, E1331V, E1363V, E1392V, E1409V, E1412V, E834V	Tuberous sclerosis 2	VCV002854081	16	2134527	16	2084526	2854081	3010447	rs2151531797	NC_000016.10:2084525:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 9, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4305A>G (p.Glu1435=)	TSC2		Tuberous sclerosis 2	VCV003606986	16	2134528	16	2084527	3606986	3737107		NC_000016.10:2084526:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4305A>T (p.Glu1435Asp)	TSC2	E1168D, E1169D, E1191D, E1211D, E1212D, E1215D, E1235D, E1319D, E1320D, E1331D, E1332D, E1349D, E1362D, E1363D, E1364D, E1365D, E1368D, E1369D, E1375D, E1379D, E1391D, E1392D, E1398D, E1399D, E1409D, E1411D, E1412D, E1434D, E1435D, E834D, E920D, E921D, E943D, E944D, E964D	not provided	VCV003252752	16	2134528	16	2084527	3252752	3411546	rs2544276521	NC_000016.10:2084526:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4306G>A (p.Asp1436Asn)	TSC2	D1320N, D1333N, D1364N, D1365N, D1370N, D1380N, D1435N, D921N, D945N, D1169N, D1216N, D1236N, D1332N, D1363N, D1366N, D1376N, D1393N, D1410N, D1413N, D835N, D922N, D944N, D1170N, D1192N, D1212N, D1369N, D1399N, D1400N, D1436N, D965N, D1213N, D1321N, D1350N, D1392N, D1412N	Tuberous sclerosis 2	VCV002771163	16	2134529	16	2084528	2771163	2933179	rs2090518816	NC_000016.10:2084527:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4308C>T (p.Asp1436=)	TSC2		Tuberous sclerosis 2	VCV000050122	16	2134531	16	2084530	50122	59284	rs45517336	NC_000016.10:2084529:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4309A>T (p.Ser1437Cys)	TSC2	S1170C, S1171C, S1193C, S1213C, S1214C, S1217C, S1237C, S1321C, S1322C, S1333C, S1334C, S1351C, S1364C, S1365C, S1366C, S1367C, S1370C, S1371C, S1377C, S1381C, S1393C, S1394C, S1400C, S1401C, S1411C, S1413C, S1414C, S1436C, S1437C, S836C, S922C, S923C, S945C, S946C, S966C	Tuberous sclerosis syndrome	VCV003070855	16	2134532	16	2084531	3070855	3230611	rs1440449585	NC_000016.10:2084530:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4310G>T (p.Ser1437Ile)	TSC2	S1171I, S1237I, S1322I, S1351I, S1371I, S1377I, S1400I, S1414I, S1437I, S945I, S966I, S1170I, S1193I, S1214I, S1321I, S1367I, S1370I, S1381I, S1436I, S946I, S1213I, S1217I, S1365I, S1394I, S1411I, S1413I, S836I, S923I, S1333I, S1334I, S1364I, S1366I, S1393I, S1401I, S922I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002112675	16	2134533	16	2084532	2112675	2167957	rs2151531998	NC_000016.10:2084531:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4311T>C (p.Ser1437=)	TSC2		Tuberous sclerosis 2	VCV002817545	16	2134534	16	2084533	2817545	2977356	rs2151532036	NC_000016.10:2084532:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Nov 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4312C>T (p.Arg1438Trp)	TSC2	R1438W, R1372W, R1415W, R1323W, R1382W, R1395W, R1194W, R1371W, R1394W, R1335W	Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000207785	16	2134535	16	2084534	207785	203190	rs778925833	NC_000016.10:2084533:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4313G>C (p.Arg1438Pro)	TSC2	R1171P, R1214P, R1352P, R1371P, R1401P, R1412P, R1437P, R837P, R924P, R1218P, R1238P, R1335P, R1366P, R1368P, R1382P, R1395P, R1438P, R923P, R1172P, R1323P, R1367P, R1372P, R1378P, R1402P, R1414P, R1415P, R1194P, R1215P, R1322P, R1334P, R1365P, R1394P, R946P, R947P, R967P	Tuberous sclerosis 2	VCV003638025	16	2134536	16	2084535	3638025	3764654		NC_000016.10:2084534:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Sep 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4313G>A (p.Arg1438Gln)	TSC2	R1438Q, R1371Q, R1394Q, R1372Q, R1415Q, R1194Q, R1323Q, R1335Q, R1382Q, R1395Q	Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000050124	16	2134536	16	2084535	50124	59286	rs45448791	NC_000016.10:2084534:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4314G>A (p.Arg1438=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002125887	16	2134537	16	2084536	2125887	2185056	rs1240764768	NC_000016.10:2084535:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4314G>T (p.Arg1438=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001739655	16	2134537	16	2084536	1739655	1794101	rs1240764768	NC_000016.10:2084535:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4315G>A (p.Gly1439Ser)	TSC2	G1336S, G1373S, G1372S, G1395S, G1416S, G1324S, G1396S, G1195S, G1383S, G1439S	Tuberous sclerosis 2	VCV001372706	16	2134538	16	2084537	1372706	1440084	rs1313797378	NC_000016.10:2084536:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4316G>C (p.Gly1439Ala)	TSC2	G1172A, G1173A, G1215A, G1239A, G1366A, G1369A, G1396A, G1413A, G1415A, G1439A, G838A, G968A, G1335A, G1395A, G924A, G1323A, G1324A, G1336A, G1353A, G1372A, G1379A, G1383A, G1402A, G1403A, G1416A, G1195A, G1216A, G1219A, G1367A, G1368A, G1373A, G1438A, G925A, G947A, G948A	Hereditary cancer-predisposing syndrome	VCV001739662	16	2134539	16	2084538	1739662	1794108	rs150397923	NC_000016.10:2084537:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4316G>A (p.Gly1439Asp)	TSC2	G1439D, G1383D, G1416D, G1195D, G1395D, G1396D, G1324D, G1336D, G1372D, G1373D	not specified|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000065126	16	2134539	16	2084538	65126	76057	rs150397923	NC_000016.10:2084537:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4317C>T (p.Gly1439=)	TSC2		Tuberous sclerosis 2	VCV004071279	16	2134540	16	2084539	4071279	4185127		NC_000016.10:2084538:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4318C>A (p.Gln1440Lys)	TSC2	Q1173K, Q1174K, Q1196K, Q1216K, Q1217K, Q1220K, Q1240K, Q1324K, Q1325K, Q1336K, Q1337K, Q1354K, Q1367K, Q1368K, Q1369K, Q1370K, Q1373K, Q1374K, Q1380K, Q1384K, Q1396K, Q1397K, Q1403K, Q1404K, Q1414K, Q1416K, Q1417K, Q1439K, Q1440K, Q839K, Q925K, Q926K, Q948K, Q949K, Q969K	Hereditary cancer-predisposing syndrome	VCV003232167	16	2134541	16	2084540	3232167	3391968	rs45517337	NC_000016.10:2084539:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4318C>T (p.Gln1440Ter)	TSC2	Q1440*, Q1373*, Q1417*, Q1374*, Q1384*, Q1196*, Q1325*, Q1337*, Q1396*, Q1397*	not provided|Tuberous sclerosis 2	VCV000049524	16	2134541	16	2084540	49524	58686	rs45517337	NC_000016.10:2084539:C:T	single nucleotide variant	nonsense	Pathogenic	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4319A>G (p.Gln1440Arg)	TSC2	Q1173R, Q1324R, Q1368R, Q1370R, Q1373R, Q1396R, Q1397R, Q1440R, Q926R, Q1174R, Q1337R, Q1369R, Q1403R, Q1404R, Q948R, Q1196R, Q1220R, Q1325R, Q1367R, Q1414R, Q1416R, Q1417R, Q949R, Q1216R, Q1217R, Q1240R, Q1336R, Q1354R, Q1374R, Q1380R, Q1384R, Q1439R, Q839R, Q925R, Q969R	Hereditary cancer-predisposing syndrome	VCV003811310	16	2134542	16	2084541	3811310	3928551		NC_000016.10:2084540:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4320G>T (p.Gln1440His)	TSC2	Q1216H, Q1336H, Q1337H, Q1367H, Q1373H, Q1374H, Q1384H, Q1416H, Q1417H, Q1440H, Q948H, Q949H, Q1196H, Q1354H, Q1370H, Q1380H, Q1404H, Q1439H, Q1220H, Q1325H, Q1368H, Q1369H, Q1397H, Q1403H, Q926H, Q1173H, Q1174H, Q1217H, Q1240H, Q1324H, Q1396H, Q1414H, Q839H, Q925H, Q969H	Tuberous sclerosis 2	VCV002829816	16	2134543	16	2084542	2829816	2990478	rs2151532377	NC_000016.10:2084541:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4320G>A (p.Gln1440=)	TSC2		Tuberous sclerosis 2	VCV001145542	16	2134543	16	2084542	1145542	1145970	rs2151532377	NC_000016.10:2084541:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4321C>T (p.Pro1441Ser)	TSC2	P1441S, P1374S, P1197S, P1326S, P1338S, P1398S, P1385S, P1397S, P1375S, P1418S	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000388436	16	2134544	16	2084543	388436	374841	rs201710642	NC_000016.10:2084542:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4322C>G (p.Pro1441Arg)	TSC2	P1197R, P1217R, P1338R, P1355R, P1371R, P1385R, P1398R, P1404R, P1415R, P1441R, P927R, P1221R, P1368R, P1369R, P1397R, P1417R, P1418R, P840R, P950R, P970R, P1174R, P1175R, P1218R, P1241R, P1325R, P1374R, P1381R, P1405R, P926R, P949R, P1326R, P1337R, P1370R, P1375R, P1440R	Tuberous sclerosis 2	VCV003637237	16	2134545	16	2084544	3637237	3771391		NC_000016.10:2084543:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4322C>T (p.Pro1441Leu)	TSC2	P1374L, P1397L, P1441L, P1197L, P1338L, P1398L, P1418L, P1326L, P1375L, P1385L	Tuberous sclerosis 2	VCV000968906	16	2134545	16	2084544	968906	957687	rs2090520912	NC_000016.10:2084543:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4323C>G (p.Pro1441=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000427989	16	2134546	16	2084545	427989	419876	rs536527623	NC_000016.10:2084544:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4323C>T (p.Pro1441=)	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000413743	16	2134546	16	2084545	413743	401404	rs536527623	NC_000016.10:2084544:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4324G>C (p.Glu1442Gln)	TSC2	E1219Q, E1371Q, E1372Q, E1382Q, E1398Q, E1418Q, E1442Q, E1327Q, E1369Q, E1375Q, E1376Q, E1406Q, E950Q, E971Q, E1175Q, E1176Q, E1198Q, E1222Q, E1326Q, E1338Q, E1356Q, E1370Q, E1405Q, E841Q, E928Q, E951Q, E1218Q, E1242Q, E1339Q, E1386Q, E1399Q, E1416Q, E1419Q, E1441Q, E927Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001963872	16	2134547	16	2084546	1963872	2013668	rs45469392	NC_000016.10:2084545:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4324G>T (p.Glu1442Ter)	TSC2	E1442*, E1386*, E1198*, E1398*, E1399*, E1327*, E1339*, E1419*, E1375*, E1376*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000427995	16	2134547	16	2084546	427995	419877	rs45469392	NC_000016.10:2084545:G:T	single nucleotide variant	nonsense	Pathogenic	Aug 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4324G>A (p.Glu1442Lys)	TSC2	E1442K, E1198K, E1327K, E1339K, E1386K, E1398K, E1419K, E1375K, E1376K, E1399K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000050125	16	2134547	16	2084546	50125	59287	rs45469392	NC_000016.10:2084545:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4325A>G (p.Glu1442Gly)	TSC2	E1175G, E1198G, E1338G, E1372G, E1382G, E1418G, E1419G, E1441G, E1222G, E1242G, E1370G, E1375G, E1398G, E1406G, E1416G, E927G, E928G, E951G, E1218G, E1219G, E1326G, E1327G, E1356G, E1369G, E1371G, E1376G, E1386G, E1405G, E841G, E950G, E971G, E1176G, E1339G, E1399G, E1442G	Tuberous sclerosis 2	VCV003637238	16	2134548	16	2084547	3637238	3771392		NC_000016.10:2084546:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4325A>C (p.Glu1442Ala)	TSC2	E1175A, E1242A, E1339A, E1369A, E1375A, E1398A, E1399A, E1416A, E841A, E971A, E1218A, E1326A, E1376A, E1406A, E1418A, E950A, E951A, E1176A, E1219A, E1222A, E1327A, E1370A, E1372A, E1441A, E1442A, E927A, E928A, E1198A, E1338A, E1356A, E1371A, E1382A, E1386A, E1405A, E1419A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001739726	16	2134548	16	2084547	1739726	1794172	rs1204349917	NC_000016.10:2084546:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4325A>T (p.Glu1442Val)	TSC2	E1442V, E1375V, E1376V, E1386V, E1198V, E1339V, E1398V, E1399V, E1419V, E1327V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome	VCV000468080	16	2134548	16	2084547	468080	466005	rs1204349917	NC_000016.10:2084546:A:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4327G>A (p.Gly1443Ser)	TSC2	G1387S, G1400S, G1443S, G1199S, G1376S, G1377S, G1328S, G1340S, G1399S, G1420S	not provided|Tuberous sclerosis 2	VCV001365523	16	2134550	16	2084549	1365523	1402393	rs1231519628	NC_000016.10:2084548:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4328G>T (p.Gly1443Val)	TSC2	G1199V, G1328V, G1340V, G1376V, G1377V, G1387V, G1399V, G1400V, G1420V, G1443V	Tuberous sclerosis 2	VCV001058594	16	2134551	16	2084550	1058594	1049479	rs2090521873	NC_000016.10:2084549:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4330C>T (p.Pro1444Ser)	TSC2	P1421S, P1200S, P1329S, P1444S, P1377S, P1378S, P1388S, P1400S, P1341S, P1401S	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000863806	16	2134553	16	2084552	863806	843494	rs1459518095	NC_000016.10:2084551:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4330C>G (p.Pro1444Ala)	TSC2	P1444A, P1421A, P1329A, P1341A, P1377A, P1388A, P1378A, P1400A, P1401A, P1200A	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486613	16	2134553	16	2084552	486613	477378	rs1459518095	NC_000016.10:2084551:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4331C>T (p.Pro1444Leu)	TSC2	P1444L, P1400L, P1329L, P1341L, P1401L, P1378L, P1200L, P1377L, P1388L, P1421L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000567263	16	2134554	16	2084553	567263	573874	rs550084361	NC_000016.10:2084552:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4332C>G (p.Pro1444=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468081	16	2134555	16	2084554	468081	466082	rs373973956	NC_000016.10:2084553:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4332C>T (p.Pro1444=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000380426	16	2134555	16	2084554	380426	374159	rs373973956	NC_000016.10:2084553:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4334T>C (p.Leu1445Ser)	TSC2	L1178S, L1201S, L1221S, L1409S, L1421S, L1444S, L1179S, L1225S, L1342S, L1372S, L1378S, L1379S, L1385S, L1389S, L974S, L1222S, L1329S, L1341S, L1359S, L1375S, L1401S, L1402S, L1408S, L1419S, L1445S, L844S, L930S, L931S, L953S, L1245S, L1330S, L1373S, L1374S, L1422S, L954S	Tuberous sclerosis 2	VCV001992981	16	2134557	16	2084556	1992981	2052634	rs2544279067	NC_000016.10:2084555:T:C	single nucleotide variant	missense variant	Uncertain significance	May 11, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4335G>C (p.Leu1445Phe)	TSC2	L1179F, L1222F, L1329F, L1359F, L1372F, L1379F, L1409F, L1444F, L930F, L931F, L1201F, L1221F, L1225F, L1245F, L1375F, L1419F, L1422F, L1178F, L1342F, L1378F, L1385F, L1401F, L1445F, L953F, L954F, L974F, L1330F, L1341F, L1373F, L1374F, L1389F, L1402F, L1408F, L1421F, L844F	Tuberous sclerosis 2	VCV002856494	16	2134558	16	2084557	2856494	3007746	rs587778739	NC_000016.10:2084556:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4335G>A (p.Leu1445=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002089335	16	2134558	16	2084557	2089335	2144665	rs587778739	NC_000016.10:2084556:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4335G>T (p.Leu1445Phe)	TSC2	L1445F, L1378F, L1379F, L1389F, L1330F, L1401F, L1342F, L1422F, L1201F, L1402F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135387	16	2134558	16	2084557	135387	139126	rs587778739	NC_000016.10:2084556:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4336C>T (p.Pro1446Ser)	TSC2	P1226S, P1331S, P1379S, P1420S, P975S, P1179S, P1246S, P1330S, P1360S, P1373S, P1380S, P1403S, P1410S, P845S, P931S, P1223S, P1343S, P1375S, P1376S, P1390S, P1402S, P1422S, P1423S, P1445S, P1446S, P954S, P955S, P1180S, P1202S, P1222S, P1342S, P1374S, P1386S, P1409S, P932S	Tuberous sclerosis 2	VCV003630369	16	2134559	16	2084558	3630369	3769709		NC_000016.10:2084557:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4336C>A (p.Pro1446Thr)	TSC2	P1179T, P1180T, P1202T, P1222T, P1223T, P1226T, P1246T, P1330T, P1331T, P1342T, P1343T, P1360T, P1373T, P1374T, P1375T, P1376T, P1379T, P1380T, P1386T, P1390T, P1402T, P1403T, P1409T, P1410T, P1420T, P1422T, P1423T, P1445T, P1446T, P845T, P931T, P932T, P954T, P955T, P975T	Hereditary cancer-predisposing syndrome	VCV003232168	16	2134559	16	2084558	3232168	3391969	rs2151533149	NC_000016.10:2084557:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4337C>T (p.Pro1446Leu)	TSC2	P1331L, P1379L, P1402L, P1403L, P1423L, P1343L, P1446L, P1390L, P1202L, P1380L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000945452	16	2134560	16	2084559	945452	927676	rs2090523005	NC_000016.10:2084558:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4338T>C (p.Pro1446=)	TSC2		Tuberous sclerosis 2	VCV002857656	16	2134561	16	2084560	2857656	3021553	rs2544279401	NC_000016.10:2084559:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4339T>C (p.Ser1447Pro)	TSC2	S1203P, S1223P, S1344P, S1376P, S1403P, S1411P, S1423P, S932P, S933P, S1247P, S1377P, S1380P, S1404P, S1447P, S1332P, S1343P, S1374P, S1375P, S1381P, S1387P, S1391P, S1421P, S1424P, S1446P, S846P, S955P, S976P, S1180P, S1181P, S1224P, S1227P, S1331P, S1361P, S1410P, S956P	Hereditary cancer-predisposing syndrome	VCV003462587	16	2134562	16	2084561	3462587	3621606		NC_000016.10:2084560:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4340C>T (p.Ser1447Phe)	TSC2	S1203F, S1344F, S1380F, S1404F, S1391F, S1424F, S1332F, S1381F, S1403F, S1447F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001374047	16	2134563	16	2084562	1374047	1456865	rs1218154295	NC_000016.10:2084561:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4341C>T (p.Ser1447=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000413735	16	2134564	16	2084563	413735	400881	rs1060504117	NC_000016.10:2084562:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4342A>G (p.Ser1448Gly)	TSC2	S1345G, S1381G, S1204G, S1382G, S1392G, S1405G, S1333G, S1404G, S1425G, S1448G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000859891	16	2134565	16	2084564	859891	843495	rs2090523420	NC_000016.10:2084563:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4343G>A (p.Ser1448Asn)	TSC2	S1204N, S1381N, S1392N, S1448N, S1333N, S1382N, S1405N, S1425N, S1345N, S1404N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001432142	16	2134566	16	2084565	1432142	1484253	rs776137955	NC_000016.10:2084564:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4344C>T (p.Ser1448=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003054966	16	2134567	16	2084566	3054966	3219626	rs2090523818	NC_000016.10:2084565:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4345T>A (p.Ser1449Thr)	TSC2	S1334T, S1346T, S1405T, S1423T, S1448T, S958T, S1205T, S1249T, S1363T, S1377T, S1389T, S1406T, S1413T, S1449T, S848T, S934T, S957T, S978T, S1182T, S1225T, S1333T, S1345T, S1378T, S1382T, S1383T, S1426T, S1183T, S1226T, S1229T, S1376T, S1379T, S1393T, S1412T, S1425T, S935T	Hereditary cancer-predisposing syndrome	VCV003329534	16	2134568	16	2084567	3329534	3489126		NC_000016.10:2084566:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4346C>G (p.Ser1449Cys)	TSC2	S1225C, S1229C, S1334C, S1377C, S1378C, S1389C, S1406C, S1413C, S1448C, S1449C, S1182C, S1183C, S1205C, S1333C, S1345C, S1363C, S1383C, S1412C, S1425C, S1426C, S957C, S958C, S1379C, S1382C, S1405C, S1423C, S934C, S935C, S1226C, S1249C, S1346C, S1376C, S1393C, S848C, S978C	Hereditary cancer-predisposing syndrome	VCV001739889	16	2134569	16	2084568	1739889	1794335	rs759004251	NC_000016.10:2084567:C:G	single nucleotide variant	missense variant	Likely benign	Feb 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4346C>A (p.Ser1449Tyr)	TSC2	S1182Y, S1226Y, S1249Y, S1345Y, S1376Y, S1378Y, S1382Y, S1389Y, S1393Y, S1425Y, S935Y, S958Y, S978Y, S1333Y, S1346Y, S1363Y, S1379Y, S1383Y, S1413Y, S1423Y, S1449Y, S848Y, S957Y, S1205Y, S1229Y, S1405Y, S1426Y, S1448Y, S1183Y, S1225Y, S1334Y, S1377Y, S1406Y, S1412Y, S934Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001739887	16	2134569	16	2084568	1739887	1794333	rs759004251	NC_000016.10:2084567:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4346C>T (p.Ser1449Phe)	TSC2	S1449F, S1334F, S1405F, S1406F, S1426F, S1205F, S1346F, S1382F, S1383F, S1393F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|TSC2-related disorder|not specified|Tuberous sclerosis 2	VCV000238045	16	2134569	16	2084568	238045	242305	rs759004251	NC_000016.10:2084567:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4347C>T (p.Ser1449=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001155673	16	2134570	16	2084569	1155673	1145971	rs2151533587	NC_000016.10:2084568:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4348C>T (p.Pro1450Ser)	TSC2	P1424S, P1184S, P1206S, P1230S, P1346S, P1377S, P1379S, P1383S, P1407S, P1413S, P1449S, P1450S, P936S, P958S, P959S, P1227S, P1250S, P1335S, P1364S, P1390S, P1394S, P1414S, P849S, P935S, P1183S, P1226S, P1334S, P1347S, P1378S, P1380S, P1384S, P1406S, P1426S, P1427S, P979S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002797101	16	2134571	16	2084570	2797101	2961677	rs376381196	NC_000016.10:2084569:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4348C>G (p.Pro1450Ala)	TSC2	P1450A, P1206A, P1347A, P1335A, P1406A, P1427A, P1383A, P1384A, P1394A, P1407A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468083	16	2134571	16	2084570	468083	466007	rs376381196	NC_000016.10:2084569:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4349C>A (p.Pro1450His)	TSC2	P1335H, P1206H, P1407H, P1384H, P1394H, P1406H, P1427H, P1450H, P1347H, P1383H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000849515	16	2134572	16	2084571	849515	843497	rs45517338	NC_000016.10:2084570:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4349C>G (p.Pro1450Arg)	TSC2	P1450R, P1206R, P1406R, P1407R, P1347R, P1383R, P1394R, P1427R, P1335R, P1384R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000049293	16	2134572	16	2084571	49293	58455	rs45517338	NC_000016.10:2084570:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4350C>G (p.Pro1450=)	TSC2		Tuberous sclerosis syndrome	VCV003071177	16	2134573	16	2084572	3071177	3228758	rs767996683	NC_000016.10:2084571:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4350C>A (p.Pro1450=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001591868	16	2134573	16	2084572	1591868	1577984	rs767996683	NC_000016.10:2084571:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4350C>T (p.Pro1450=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536031	16	2134573	16	2084572	536031	530015	rs767996683	NC_000016.10:2084571:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4351C>G (p.Arg1451Gly)	TSC2	R1451G, R1336G, R1407G, R1348G, R1385G, R1428G, R1207G, R1384G, R1395G, R1408G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468085	16	2134574	16	2084573	468085	466281	rs369553241	NC_000016.10:2084572:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4351C>A (p.Arg1451Ser)	TSC2	R1451S, R1407S, R1336S, R1385S, R1428S, R1207S, R1348S, R1384S, R1395S, R1408S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified|TSC2-related disorder	VCV000468084	16	2134574	16	2084573	468084	466084	rs369553241	NC_000016.10:2084572:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4351C>T (p.Arg1451Cys)	TSC2	R1451C, R1207C, R1348C, R1384C, R1428C, R1408C, R1385C, R1407C, R1336C, R1395C	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000406124	16	2134574	16	2084573	406124	400884	rs369553241	NC_000016.10:2084572:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4352G>C (p.Arg1451Pro)	TSC2	R1348P, R1384P, R1428P, R1385P, R1395P, R1408P, R1451P, R1336P, R1207P, R1407P	Tuberous sclerosis 2	VCV001407494	16	2134575	16	2084574	1407494	1483703	rs142848358	NC_000016.10:2084573:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4352G>A (p.Arg1451His)	TSC2	R1451H, R1336H, R1348H, R1428H, R1207H, R1384H, R1385H, R1395H, R1407H, R1408H	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000238046	16	2134575	16	2084574	238046	242306	rs142848358	NC_000016.10:2084573:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4353C>T (p.Arg1451=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811374	16	2134576	16	2084575	3811374	3928615		NC_000016.10:2084574:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4355C>T (p.Ser1452Leu)	TSC2	S1452L, S1349L, S1429L, S1208L, S1385L, S1386L, S1396L, S1408L, S1337L, S1409L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000049829	16	2134578	16	2084577	49829	58991	rs45517339	NC_000016.10:2084576:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4355C>A (p.Ser1452Ter)	TSC2	S1452*, S1208*, S1337*, S1385*, S1396*, S1408*, S1349*, S1386*, S1409*, S1429*	not provided	VCV000049294	16	2134578	16	2084577	49294	58456	rs45517339	NC_000016.10:2084576:C:A	single nucleotide variant	nonsense	Pathogenic	Mar 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4356G>T (p.Ser1452=)	TSC2		Tuberous sclerosis 2	VCV001538286	16	2134579	16	2084578	1538286	1619512	rs779122170	NC_000016.10:2084577:G:T	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4356G>A (p.Ser1452=)	TSC2		Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413727	16	2134579	16	2084578	413727	401407	rs779122170	NC_000016.10:2084577:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4357C>T (p.Pro1453Ser)	TSC2	P1186S, P1338S, P1380S, P1382S, P1393S, P1416S, P1417S, P1427S, P1452S, P938S, P961S, P1209S, P1229S, P1233S, P1349S, P1350S, P1383S, P1429S, P1430S, P1367S, P1387S, P1410S, P1187S, P1230S, P1253S, P1337S, P1381S, P1386S, P1397S, P1409S, P1453S, P852S, P939S, P962S, P982S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002626462	16	2134580	16	2084579	2626462	2794228	rs2544280849	NC_000016.10:2084578:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4358C>G (p.Pro1453Arg)	TSC2	P1367R, P1382R, P1387R, P1393R, P1416R, P1427R, P1430R, P1452R, P1453R, P1186R, P1230R, P1350R, P1386R, P1397R, P1233R, P1253R, P1337R, P1349R, P938R, P962R, P1187R, P1209R, P1229R, P1338R, P1380R, P1381R, P1383R, P1409R, P1410R, P1417R, P1429R, P852R, P939R, P961R, P982R	Tuberous sclerosis 2	VCV002706772	16	2134581	16	2084580	2706772	2870345	rs748182471	NC_000016.10:2084579:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4358C>T (p.Pro1453Leu)	TSC2	P1186L, P1338L, P1367L, P1382L, P1452L, P852L, P939L, P982L, P1229L, P1230L, P1349L, P1350L, P1386L, P1416L, P1417L, P1187L, P1253L, P1337L, P1381L, P1387L, P1393L, P1397L, P1409L, P1410L, P1427L, P1429L, P1430L, P1453L, P938L, P962L, P1209L, P1233L, P1380L, P1383L, P961L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001739974	16	2134581	16	2084580	1739974	1794420	rs748182471	NC_000016.10:2084579:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 11, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4359C>T (p.Pro1453=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000705991	16	2134582	16	2084581	705991	693820	rs1212442267	NC_000016.10:2084580:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4360A>G (p.Ser1454Gly)	TSC2	S1454G, S1339G, S1388G, S1410G, S1411G, S1431G, S1210G, S1387G, S1398G, S1351G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049830	16	2134583	16	2084582	49830	58992	rs137854366	NC_000016.10:2084581:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4361G>T (p.Ser1454Ile)	TSC2	S1210I, S1339I, S1351I, S1387I, S1388I, S1398I, S1410I, S1411I, S1431I, S1454I	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000999023	16	2134584	16	2084583	999023	996753	rs758233186	NC_000016.10:2084582:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4361G>A (p.Ser1454Asn)	TSC2	S1454N, S1339N, S1387N, S1388N, S1398N, S1431N, S1210N, S1410N, S1351N, S1411N	Tuberous sclerosis 2	VCV000579637	16	2134584	16	2084583	579637	569824	rs758233186	NC_000016.10:2084582:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4362T>A (p.Ser1454Arg)	TSC2	S1210R, S1339R, S1351R, S1387R, S1388R, S1398R, S1410R, S1411R, S1431R, S1454R	not specified|Tuberous sclerosis 2	VCV001057663	16	2134585	16	2084584	1057663	1049480	rs1320400029	NC_000016.10:2084583:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4362T>G (p.Ser1454Arg)	TSC2	S1454R, S1351R, S1339R, S1398R, S1410R, S1411R, S1210R, S1387R, S1388R, S1431R	Ovarian cancer|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535857	16	2134585	16	2084584	535857	529745	rs1320400029	NC_000016.10:2084583:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4363G>A (p.Gly1455Ser)	TSC2	G1231S, G1339S, G1384S, G1385S, G1389S, G1419S, G1431S, G1211S, G1235S, G1340S, G1352S, G1395S, G1455S, G854S, G963S, G984S, G1188S, G1399S, G1411S, G1412S, G1429S, G1432S, G1454S, G940S, G941S, G1189S, G1232S, G1255S, G1351S, G1369S, G1382S, G1383S, G1388S, G1418S, G964S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001740031	16	2134586	16	2084585	1740031	1794477	rs2544281315	NC_000016.10:2084584:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4364G>C (p.Gly1455Ala)	TSC2	G1455A, G1389A, G1399A, G1211A, G1388A, G1432A, G1340A, G1352A, G1411A, G1412A	Tuberous sclerosis 2|not provided	VCV000586857	16	2134587	16	2084586	586857	577459	rs1567524174	NC_000016.10:2084585:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4365C>A (p.Gly1455=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974704	16	2134588	16	2084587	3974704	4086527		NC_000016.10:2084586:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4365C>T (p.Gly1455=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001087239	16	2134588	16	2084587	1087239	1081862	rs2090527409	NC_000016.10:2084586:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4366C>G (p.Leu1456Val)	TSC2	L1189V, L1190V, L1212V, L1232V, L1233V, L1236V, L1256V, L1340V, L1341V, L1352V, L1353V, L1370V, L1383V, L1384V, L1385V, L1386V, L1389V, L1390V, L1396V, L1400V, L1412V, L1413V, L1419V, L1420V, L1430V, L1432V, L1433V, L1455V, L1456V, L855V, L941V, L942V, L964V, L965V, L985V	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002679332	16	2134589	16	2084588	2679332	2836909	rs1199848222	NC_000016.10:2084587:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 15, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4366C>T (p.Leu1456Phe)	TSC2	L1400F, L1412F, L1212F, L1353F, L1389F, L1390F, L1413F, L1456F, L1341F, L1433F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000960711	16	2134589	16	2084588	960711	949273	rs1199848222	NC_000016.10:2084587:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4367T>A (p.Leu1456His)	TSC2	L1341H, L1353H, L1389H, L1390H, L1400H, L1412H, L1413H, L1433H, L1456H, L1212H	Tuberous sclerosis 2	VCV001654457	16	2134590	16	2084589	1654457	1527275	rs777669350	NC_000016.10:2084588:T:A	single nucleotide variant	missense variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4368C>G (p.Leu1456=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002805182	16	2134591	16	2084590	2805182	2967565	rs1555514397	NC_000016.10:2084589:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4368C>T (p.Leu1456=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468086	16	2134591	16	2084590	468086	466087	rs1555514397	NC_000016.10:2084589:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4369C>A (p.Arg1457=)	TSC2		Tuberous sclerosis 2	VCV004071450	16	2134592	16	2084591	4071450	4185297		NC_000016.10:2084590:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4369C>T (p.Arg1457Trp)	TSC2	R1457W, R1213W, R1354W, R1390W, R1391W, R1401W, R1342W, R1413W, R1414W, R1434W	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535870	16	2134592	16	2084591	535870	529688	rs746729857	NC_000016.10:2084590:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4370G>A (p.Arg1457Gln)	TSC2	R1457Q, R1401Q, R1342Q, R1390Q, R1391Q, R1213Q, R1413Q, R1414Q, R1354Q, R1434Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406057	16	2134593	16	2084592	406057	400885	rs1060500952	NC_000016.10:2084591:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4371G>A (p.Arg1457=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000762546	16	2134594	16	2084593	762546	770735	rs1596417989	NC_000016.10:2084592:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4372C>T (p.Pro1458Ser)	TSC2	P1214S, P1343S, P1355S, P1391S, P1392S, P1402S, P1414S, P1415S, P1435S, P1458S	not provided	VCV001307306	16	2134595	16	2084594	1307306	1298576	rs1189784704	NC_000016.10:2084593:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4372C>A (p.Pro1458Thr)	TSC2	P1458T, P1214T, P1355T, P1402T, P1414T, P1415T, P1391T, P1392T, P1435T, P1343T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000497137	16	2134595	16	2084594	497137	488561	rs1189784704	NC_000016.10:2084593:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4373C>T (p.Pro1458Leu)	TSC2	P1191L, P1238L, P1258L, P1342L, P1392L, P1415L, P1457L, P944L, P966L, P987L, P1235L, P1192L, P1214L, P1234L, P1422L, P1434L, P857L, P1354L, P1355L, P1372L, P1386L, P1391L, P1402L, P1421L, P1432L, P1435L, P943L, P1343L, P1385L, P1387L, P1388L, P1398L, P1414L, P1458L, P967L	Hereditary cancer-predisposing syndrome	VCV001740105	16	2134596	16	2084595	1740105	1791138	rs2544282164	NC_000016.10:2084594:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4375C>A (p.Arg1459=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001061646	16	2134598	16	2084597	1061646	1049481	rs45517340	NC_000016.10:2084596:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4375C>T (p.Arg1459Ter)	PKD1|TSC2	R1459*, R1344*, R1393*, R1392*, R1403*, R1415*, R1215*, R1356*, R1416*, R1436*	not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049986	16	2134598	16	2084597	49986	59148	rs45517340	NC_000016.10:2084596:C:T	single nucleotide variant	nonsense	Pathogenic	May 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4376G>C (p.Arg1459Pro)	TSC2	R1436P, R1459P, R1392P, R1415P, R1215P, R1344P, R1356P, R1393P, R1403P, R1416P	Tuberous sclerosis 2	VCV000962135	16	2134599	16	2084598	962135	949274	rs1555514409	NC_000016.10:2084597:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4376G>A (p.Arg1459Gln)	TSC2	R1459Q, R1403Q, R1356Q, R1436Q, R1215Q, R1344Q, R1415Q, R1416Q, R1392Q, R1393Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486601	16	2134599	16	2084598	486601	477970	rs1555514409	NC_000016.10:2084597:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4377A>T (p.Arg1459=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003329489	16	2134600	16	2084599	3329489	3489081		NC_000016.10:2084598:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4377A>G (p.Arg1459=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003232169	16	2134600	16	2084599	3232169	3391970	rs2544282598	NC_000016.10:2084598:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4378G>T (p.Gly1460Cys)	TSC2	G1193C, G1194C, G1237C, G1344C, G1374C, G1390C, G1393C, G1423C, G989C, G1260C, G1345C, G1424C, G1437C, G1459C, G1460C, G968C, G1216C, G1240C, G1388C, G1389C, G1394C, G1416C, G1417C, G946C, G969C, G1236C, G1356C, G1357C, G1387C, G1400C, G1404C, G1434C, G1436C, G859C, G945C	Hereditary cancer-predisposing syndrome	VCV003329522	16	2134601	16	2084600	3329522	3489114		NC_000016.10:2084599:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4378G>A (p.Gly1460Ser)	TSC2	G1193S, G1236S, G1260S, G1344S, G1356S, G1400S, G1416S, G1194S, G1216S, G1357S, G1389S, G1393S, G1460S, G859S, G945S, G946S, G969S, G1237S, G1374S, G1388S, G1417S, G1423S, G968S, G1240S, G1345S, G1387S, G1390S, G1394S, G1404S, G1424S, G1434S, G1436S, G1437S, G1459S, G989S	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001740126	16	2134601	16	2084600	1740126	1791159	rs1238109196	NC_000016.10:2084599:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4379G>T (p.Gly1460Val)	TSC2	G1194V, G1216V, G1374V, G1387V, G1394V, G945V, G969V, G989V, G1193V, G1237V, G1345V, G1356V, G1357V, G1388V, G1390V, G1404V, G1416V, G1437V, G968V, G1240V, G1260V, G1344V, G1393V, G1400V, G1417V, G1434V, G1460V, G946V, G1236V, G1389V, G1423V, G1424V, G1436V, G1459V, G859V	Tuberous sclerosis 2	VCV002865251	16	2134602	16	2084601	2865251	3030032	rs2544282753	NC_000016.10:2084600:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4380T>G (p.Gly1460=)	TSC2		Tuberous sclerosis 2	VCV001057368	16	2134603	16	2084602	1057368	1049482	rs2151534821	NC_000016.10:2084601:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4381T>C (p.Tyr1461His)	TSC2	Y1388H, Y1391H, Y1401H, Y1425H, Y1438H, Y990H, Y1241H, Y1345H, Y1405H, Y1424H, Y1435H, Y1460H, Y1461H, Y969H, Y1194H, Y1237H, Y1238H, Y1261H, Y1346H, Y1358H, Y1389H, Y1394H, Y1417H, Y1418H, Y860H, Y946H, Y947H, Y1195H, Y1217H, Y1357H, Y1375H, Y1390H, Y1395H, Y1437H, Y970H	Hereditary cancer-predisposing syndrome	VCV003462627	16	2134604	16	2084603	3462627	3621646		NC_000016.10:2084602:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4381T>A (p.Tyr1461Asn)	TSC2	Y1195N, Y1238N, Y1261N, Y1357N, Y1375N, Y1391N, Y860N, Y946N, Y947N, Y1194N, Y1358N, Y1395N, Y1401N, Y1217N, Y1237N, Y1390N, Y1418N, Y1435N, Y970N, Y990N, Y1405N, Y1425N, Y1437N, Y1460N, Y1461N, Y1241N, Y1345N, Y1346N, Y1388N, Y1389N, Y1394N, Y1417N, Y1424N, Y1438N, Y969N	Hereditary cancer-predisposing syndrome	VCV002564643	16	2134604	16	2084603	2564643	2733799	rs2544282826	NC_000016.10:2084602:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4383C>T (p.Tyr1461=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468087	16	2134606	16	2084605	468087	466013	rs397514977	NC_000016.10:2084604:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4384A>C (p.Thr1462Pro)	TSC2	T1218P, T1242P, T1389P, T1395P, T1396P, T1425P, T1426P, T1438P, T948P, T1262P, T1347P, T1358P, T1391P, T1462P, T970P, T991P, T1195P, T1238P, T1390P, T1418P, T1419P, T1436P, T1439P, T1461P, T861P, T1196P, T1239P, T1346P, T1359P, T1376P, T1392P, T1402P, T1406P, T947P, T971P	Tuberous sclerosis 2	VCV001913198	16	2134607	16	2084606	1913198	1973414	rs2544283052	NC_000016.10:2084605:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4385C>G (p.Thr1462Ser)	TSC2	T1462S, T1218S, T1406S, T1347S, T1419S, T1395S, T1396S, T1439S, T1359S, T1418S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000207684	16	2134608	16	2084607	207684	203191	rs373018205	NC_000016.10:2084606:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4386C>T (p.Thr1462=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002104609	16	2134609	16	2084608	2104609	2162372	rs2151534904	NC_000016.10:2084607:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4386C>A (p.Thr1462=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001536555	16	2134609	16	2084608	1536555	1618644	rs2151534904	NC_000016.10:2084607:C:A	single nucleotide variant	synonymous variant	Likely benign	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4387A>G (p.Ile1463Val)	TSC2	I1403V, I1420V, I862V, I949V, I1196V, I1197V, I1219V, I1239V, I1263V, I1359V, I1377V, I1393V, I1397V, I1426V, I1439V, I1440V, I971V, I972V, I1243V, I1347V, I1360V, I1390V, I1391V, I1396V, I1407V, I1419V, I1427V, I1463V, I948V, I1240V, I1348V, I1392V, I1437V, I1462V, I992V	Tuberous sclerosis 2	VCV002199537	16	2134610	16	2084609	2199537	1924383	rs2544283195	NC_000016.10:2084608:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4388T>A (p.Ile1463Asn)	TSC2	I1197N, I1240N, I1348N, I1392N, I1397N, I1463N, I862N, I948N, I1196N, I1239N, I1347N, I1390N, I1420N, I1440N, I971N, I1219N, I1243N, I1360N, I1377N, I1419N, I972N, I992N, I1263N, I1359N, I1391N, I1393N, I1396N, I1403N, I1407N, I1426N, I1427N, I1437N, I1439N, I1462N, I949N	Hereditary cancer-predisposing syndrome	VCV002564697	16	2134611	16	2084610	2564697	2733853	rs2151534940	NC_000016.10:2084609:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4389C>T (p.Ile1463=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000536033	16	2134612	16	2084611	536033	530017	rs1555514425	NC_000016.10:2084610:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4390T>A (p.Ser1464Thr)	TSC2	S1349T, S1361T, S1393T, S1404T, S1408T, S1464T, S949T, S973T, S993T, S1197T, S1240T, S1241T, S1360T, S1392T, S1398T, S1421T, S1428T, S1438T, S1441T, S1463T, S1391T, S1394T, S1397T, S1427T, S863T, S950T, S1198T, S1220T, S1244T, S1264T, S1348T, S1378T, S1420T, S1440T, S972T	Tuberous sclerosis 2	VCV002697553	16	2134613	16	2084612	2697553	2864950	rs2544283370	NC_000016.10:2084611:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4390T>G (p.Ser1464Ala)	TSC2	S1241A, S1378A, S1393A, S1394A, S1397A, S1428A, S1438A, S1440A, S1441A, S1198A, S1220A, S1360A, S1361A, S1391A, S1398A, S1404A, S1408A, S1427A, S1464A, S950A, S973A, S1197A, S1348A, S1420A, S1421A, S863A, S949A, S972A, S993A, S1240A, S1244A, S1264A, S1349A, S1392A, S1463A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002086681	16	2134613	16	2084612	2086681	2140722	rs2544283370	NC_000016.10:2084611:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4391C>G (p.Ser1464Cys)	TSC2	S1349C, S1361C, S1220C, S1398C, S1408C, S1421C, S1441C, S1397C, S1420C, S1464C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824859	16	2134614	16	2084613	824859	812600	rs1596418078	NC_000016.10:2084612:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4392C>G (p.Ser1464=)	TSC2		Hereditary cancer-predisposing syndrome	VCV000480836	16	2134615	16	2084614	480836	477383	rs528080018	NC_000016.10:2084613:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 13, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.4392C>T (p.Ser1464=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis syndrome	VCV000378789	16	2134615	16	2084614	378789	374160	rs528080018	NC_000016.10:2084613:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4393G>T (p.Asp1465Tyr)	TSC2	D1198Y, D1199Y, D1221Y, D1241Y, D1242Y, D1245Y, D1265Y, D1349Y, D1350Y, D1361Y, D1362Y, D1379Y, D1392Y, D1393Y, D1394Y, D1395Y, D1398Y, D1399Y, D1405Y, D1409Y, D1421Y, D1422Y, D1428Y, D1429Y, D1439Y, D1441Y, D1442Y, D1464Y, D1465Y, D864Y, D950Y, D951Y, D973Y, D974Y, D994Y	Tuberous sclerosis 2	VCV001713439	16	2134616	16	2084615	1713439	1777334	rs1425542648	NC_000016.10:2084614:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4393G>C (p.Asp1465His)	TSC2	D1221H, D1350H, D1362H, D1398H, D1399H, D1409H, D1421H, D1422H, D1442H, D1465H	Tuberous sclerosis 2	VCV001000624	16	2134616	16	2084615	1000624	996754	rs1425542648	NC_000016.10:2084614:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4393G>A (p.Asp1465Asn)	TSC2	D1221N, D1362N, D1399N, D1421N, D1422N, D1398N, D1409N, D1465N, D1350N, D1442N	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000824860	16	2134616	16	2084615	824860	812601	rs1425542648	NC_000016.10:2084614:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4394A>T (p.Asp1465Val)	TSC2	D1198V, D1199V, D1349V, D1379V, D1392V, D1394V, D1439V, D1442V, D1465V, D973V, D994V, D1350V, D1362V, D1393V, D1405V, D1409V, D1464V, D864V, D1221V, D1241V, D1265V, D1361V, D1395V, D1422V, D1429V, D950V, D1242V, D1245V, D1398V, D1399V, D1421V, D1428V, D1441V, D951V, D974V	Tuberous sclerosis 2	VCV003637240	16	2134617	16	2084616	3637240	3771394		NC_000016.10:2084615:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4394A>C (p.Asp1465Ala)	TSC2	D1221A, D1242A, D1349A, D1379A, D1405A, D1439A, D1442A, D1464A, D974A, D1198A, D1245A, D1392A, D1395A, D1398A, D1399A, D1421A, D864A, D1265A, D1350A, D1394A, D1428A, D1441A, D950A, D951A, D973A, D1199A, D1241A, D1361A, D1362A, D1393A, D1409A, D1422A, D1429A, D1465A, D994A	Tuberous sclerosis 2	VCV003637239	16	2134617	16	2084616	3637239	3771393		NC_000016.10:2084615:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4394A>G (p.Asp1465Gly)	TSC2	D1221G, D1350G, D1362G, D1399G, D1465G, D1398G, D1421G, D1442G, D1409G, D1422G	Tuberous sclerosis 2	VCV001501943	16	2134617	16	2084616	1501943	1411161	rs2151535102	NC_000016.10:2084615:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4395C>G (p.Asp1465Glu)	TSC2	D1199E, D1241E, D1242E, D1265E, D1394E, D1398E, D1428E, D864E, D950E, D974E, D1245E, D1350E, D1362E, D1405E, D1422E, D1221E, D1349E, D1392E, D1399E, D1409E, D1421E, D1439E, D1465E, D951E, D973E, D1429E, D1441E, D1464E, D994E, D1198E, D1361E, D1379E, D1393E, D1395E, D1442E	Tuberous sclerosis 2	VCV002818081	16	2134618	16	2084617	2818081	2987722	rs2151535121	NC_000016.10:2084616:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4395C>T (p.Asp1465=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001103727	16	2134618	16	2084617	1103727	1103672	rs2151535121	NC_000016.10:2084616:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4397C>G (p.Ser1466Trp)	TSC2	S1266W, S1350W, S1363W, S1380W, S1396W, S1406W, S974W, S1200W, S1222W, S1242W, S1351W, S1393W, S1422W, S1465W, S1466W, S865W, S1199W, S1243W, S1246W, S1400W, S1410W, S1430W, S1443W, S975W, S995W, S1362W, S1394W, S1395W, S1399W, S1423W, S1429W, S1440W, S1442W, S951W, S952W	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001740260	16	2134620	16	2084619	1740260	1791293	rs45517341	NC_000016.10:2084618:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4397C>T (p.Ser1466Leu)	TSC2	S1466L, S1222L, S1423L, S1399L, S1410L, S1443L, S1363L, S1351L, S1400L, S1422L	Hereditary cancer-predisposing syndrome|not provided|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238048	16	2134620	16	2084619	238048	242307	rs45517341	NC_000016.10:2084618:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4397C>A (p.Ser1466Ter)	TSC2	S1466*, S1363*, S1399*, S1410*, S1222*, S1351*, S1400*, S1422*, S1423*, S1443*	Tuberous sclerosis 2	VCV000049987	16	2134620	16	2084619	49987	59149	rs45517341	NC_000016.10:2084618:C:A	single nucleotide variant	nonsense	Pathogenic	Apr 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4398G>T (p.Ser1466=)	TSC2		Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000486681	16	2134621	16	2084620	486681	477973	rs376086638	NC_000016.10:2084619:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4398G>A (p.Ser1466=)	TSC2		not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000381384	16	2134621	16	2084620	381384	374161	rs376086638	NC_000016.10:2084619:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4399G>A (p.Ala1467Thr)	TSC2	A1467T, A1223T, A1400T, A1401T, A1411T, A1444T, A1352T, A1364T, A1423T, A1424T	Tuberous sclerosis 2	VCV001369812	16	2134622	16	2084621	1369812	1437518	rs774980656	NC_000016.10:2084620:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4399G>T (p.Ala1467Ser)	TSC2	A1364S, A1411S, A1467S, A1400S, A1401S, A1444S, A1223S, A1424S, A1352S, A1423S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000957101	16	2134622	16	2084621	957101	949275	rs774980656	NC_000016.10:2084620:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4400C>T (p.Ala1467Val)	TSC2	A1400V, A1467V, A1401V, A1411V, A1423V, A1424V, A1223V, A1352V, A1364V, A1444V	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000966044	16	2134623	16	2084622	966044	957688	rs2090531407	NC_000016.10:2084621:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4401C>G (p.Ala1467=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001107834	16	2134624	16	2084623	1107834	1103673	rs370735624	NC_000016.10:2084622:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4401C>T (p.Ala1467=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000799765	16	2134624	16	2084623	799765	785205	rs370735624	NC_000016.10:2084622:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4401C>A (p.Ala1467=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000755482	16	2134624	16	2084623	755482	770736	rs370735624	NC_000016.10:2084622:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4402C>G (p.Pro1468Ala)	TSC2	P1224A, P1401A, P1402A, P1424A, P1425A, P1445A, P1468A, P1365A, P1412A, P1353A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000864002	16	2134625	16	2084624	864002	843498	rs1217359412	NC_000016.10:2084623:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4403C>T (p.Pro1468Leu)	TSC2	P1468L, P1224L, P1401L, P1353L, P1365L, P1424L, P1402L, P1412L, P1425L, P1445L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535938	16	2134626	16	2084625	535938	529746	rs762423563	NC_000016.10:2084624:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 10, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4404A>C (p.Pro1468=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564699	16	2134627	16	2084626	2564699	2733855	rs2544284619	NC_000016.10:2084625:A:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4404A>G (p.Pro1468=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002135822	16	2134627	16	2084626	2135822	2187250	rs2544284619	NC_000016.10:2084625:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4405T>A (p.Ser1469Thr)	TSC2	S1245T, S1246T, S1269T, S1354T, S1383T, S1403T, S868T, S998T, S1202T, S1225T, S1249T, S1353T, S1365T, S1397T, S1398T, S1399T, S1402T, S1425T, S1426T, S1433T, S1445T, S1446T, S955T, S977T, S1203T, S1366T, S1409T, S1413T, S978T, S1396T, S1432T, S1443T, S1468T, S1469T, S954T	Hereditary cancer-predisposing syndrome	VCV002564700	16	2134628	16	2084627	2564700	2733856	rs907136617	NC_000016.10:2084626:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4405T>G (p.Ser1469Ala)	TSC2	S1413A, S1225A, S1354A, S1366A, S1402A, S1403A, S1425A, S1426A, S1469A, S1446A	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000843357	16	2134628	16	2084627	843357	843499	rs907136617	NC_000016.10:2084626:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4407A>G (p.Ser1469=)	TSC2		Tuberous sclerosis 2	VCV001545189	16	2134630	16	2084629	1545189	1644595	rs1596418218	NC_000016.10:2084628:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4408C>T (p.Arg1470Cys)	TSC2	R1470C, R1355C, R1403C, R1404C, R1367C, R1414C, R1426C, R1226C, R1427C, R1447C	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406108	16	2134631	16	2084630	406108	400887	rs767889030	NC_000016.10:2084629:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4409G>T (p.Arg1470Leu)	TSC2	R1203L, R1226L, R1354L, R1384L, R1398L, R1426L, R1427L, R1433L, R1470L, R1246L, R1410L, R1414L, R1434L, R1444L, R1447L, R1250L, R1270L, R1355L, R1400L, R1403L, R1404L, R1446L, R956L, R979L, R999L, R1204L, R1247L, R1366L, R1367L, R1397L, R1399L, R1469L, R869L, R955L, R978L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002994722	16	2134632	16	2084631	2994722	3148568	rs1060500969	NC_000016.10:2084630:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4409G>A (p.Arg1470His)	TSC2	R1470H, R1367H, R1404H, R1414H, R1447H, R1426H, R1427H, R1226H, R1355H, R1403H	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000406115	16	2134632	16	2084631	406115	400904	rs1060500969	NC_000016.10:2084630:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4410C>G (p.Arg1470=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002449953	16	2134633	16	2084632	2449953	2429579	rs539032553	NC_000016.10:2084631:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4410C>T (p.Arg1470=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000233060	16	2134633	16	2084632	233060	235135	rs539032553	NC_000016.10:2084631:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4411A>T (p.Arg1471Trp)	TSC2	R1205W, R1247W, R1251W, R1367W, R1368W, R1399W, R1400W, R1411W, R1427W, R1428W, R1435W, R1447W, R957W, R979W, R1000W, R1204W, R1248W, R1355W, R1415W, R1470W, R870W, R1271W, R1385W, R1398W, R1471W, R980W, R1227W, R1356W, R1401W, R1404W, R1405W, R1434W, R1445W, R1448W, R956W	Hereditary cancer-predisposing syndrome	VCV002564731	16	2134634	16	2084633	2564731	2733887	rs2544285201	NC_000016.10:2084632:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4411A>C (p.Arg1471=)	TSC2		Tuberous sclerosis 2	VCV002034358	16	2134634	16	2084633	2034358	2093564	rs2544285201	NC_000016.10:2084632:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4412G>C (p.Arg1471Thr)	TSC2	R1367T, R1385T, R1404T, R1411T, R1415T, R1428T, R1434T, R957T, R1204T, R1227T, R1251T, R1368T, R1398T, R1399T, R1427T, R1447T, R1470T, R1471T, R956T, R1000T, R1205T, R1247T, R1248T, R1355T, R1400T, R1405T, R1435T, R1448T, R979T, R1271T, R1356T, R1401T, R1445T, R870T, R980T	Hereditary cancer-predisposing syndrome	VCV001740416	16	2134635	16	2084634	1740416	1791447	rs2544285256	NC_000016.10:2084633:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4412G>A (p.Arg1471Lys)	TSC2	R1448K, R1470K, R956K, R979K, R1205K, R1248K, R1251K, R1367K, R1401K, R1204K, R1368K, R1404K, R1411K, R1415K, R1428K, R1434K, R1447K, R957K, R1227K, R1247K, R1271K, R1355K, R1356K, R1385K, R1398K, R1400K, R1435K, R1000K, R1399K, R1405K, R1427K, R1445K, R1471K, R870K, R980K	Hereditary cancer-predisposing syndrome	VCV001740415	16	2134635	16	2084634	1740415	1791446	rs2544285256	NC_000016.10:2084633:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4413G>A (p.Arg1471=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000752732	16	2134636	16	2084635	752732	770737	rs1596418285	NC_000016.10:2084634:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4414G>C (p.Gly1472Arg)	TSC2	G1206R, G1248R, G1249R, G1369R, G1405R, G1412R, G1416R, G1449R, G1471R, G1472R, G958R, G1001R, G1357R, G1386R, G1399R, G1400R, G1401R, G1406R, G1428R, G1436R, G957R, G1205R, G1228R, G1356R, G1429R, G1435R, G1446R, G1448R, G871R, G981R, G1252R, G1272R, G1368R, G1402R, G980R	Hereditary cancer-predisposing syndrome	VCV001740425	16	2134637	16	2084636	1740425	1791456	rs558737770	NC_000016.10:2084635:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4414G>A (p.Gly1472Ser)	TSC2	G1472S, G1357S, G1369S, G1416S, G1429S, G1449S, G1428S, G1228S, G1405S, G1406S	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000405951	16	2134637	16	2084636	405951	400963	rs558737770	NC_000016.10:2084635:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4415G>A (p.Gly1472Asp)	TSC2	G1001D, G1272D, G1368D, G1386D, G1401D, G1412D, G1416D, G1436D, G1448D, G1449D, G1228D, G1356D, G1399D, G1400D, G1405D, G1406D, G957D, G980D, G981D, G1205D, G1249D, G1252D, G1357D, G1369D, G1428D, G1429D, G1435D, G1446D, G1472D, G1206D, G1248D, G1402D, G1471D, G871D, G958D	Hereditary cancer-predisposing syndrome	VCV003329529	16	2134638	16	2084637	3329529	3489121		NC_000016.10:2084636:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4415G>T (p.Gly1472Val)	TSC2	G1369V, G1405V, G1406V, G1416V, G1429V, G1449V, G1228V, G1428V, G1357V, G1472V	Tuberous sclerosis 2	VCV001038017	16	2134638	16	2084637	1038017	1032488	rs2090534118	NC_000016.10:2084636:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4416C>T (p.Gly1472=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV001036049	16	2134639	16	2084638	1036049	1032489	rs2090534289	NC_000016.10:2084637:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4417A>G (p.Lys1473Glu)	TSC2	K1229E, K1249E, K1250E, K1369E, K1401E, K1403E, K1413E, K1417E, K1430E, K1436E, K1437E, K1447E, K872E, K1207E, K1273E, K1370E, K1387E, K1400E, K1402E, K1406E, K1429E, K1449E, K958E, K959E, K981E, K1002E, K1206E, K1253E, K1407E, K1450E, K982E, K1357E, K1358E, K1472E, K1473E	Tuberous sclerosis 2	VCV002015868	16	2134640	16	2084639	2015868	2064796	rs397515136	NC_000016.10:2084638:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4417A>C (p.Lys1473Gln)	TSC2	K1473Q, K1229Q, K1358Q, K1417Q, K1430Q, K1429Q, K1370Q, K1406Q, K1407Q, K1450Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000065182	16	2134640	16	2084639	65182	76113	rs397515136	NC_000016.10:2084638:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4418A>G (p.Lys1473Arg)	TSC2	K1473R, K1229R, K1417R, K1430R, K1358R, K1370R, K1406R, K1407R, K1429R, K1450R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|not specified|Tuberous sclerosis syndrome	VCV000571006	16	2134641	16	2084640	571006	567853	rs1219556604	NC_000016.10:2084639:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4420A>C (p.Arg1474=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824881	16	2134643	16	2084642	824881	812602	rs766719443	NC_000016.10:2084641:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4420A>G (p.Arg1474Gly)	TSC2	R1474G, R1430G, R1230G, R1371G, R1407G, R1418G, R1431G, R1451G, R1359G, R1408G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000406035	16	2134643	16	2084642	406035	401413	rs766719443	NC_000016.10:2084641:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4421G>A (p.Arg1474Lys)	TSC2	R1230K, R1451K, R1474K, R1430K, R1371K, R1407K, R1418K, R1431K, R1359K, R1408K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000942182	16	2134644	16	2084643	942182	937341	rs2090535225	NC_000016.10:2084642:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4422A>C (p.Arg1474Ser)	TSC2	R1208S, R1254S, R1359S, R1371S, R1402S, R1403S, R1473S, R1003S, R1274S, R1448S, R1474S, R960S, R1207S, R1250S, R1358S, R1388S, R1401S, R1404S, R1407S, R1414S, R1418S, R1430S, R1450S, R982S, R1230S, R1251S, R1370S, R1408S, R1431S, R1437S, R1438S, R1451S, R873S, R959S, R983S	Tuberous sclerosis 2	VCV003693932	16	2134645	16	2084644	3693932	3832034		NC_000016.10:2084643:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4422A>T (p.Arg1474Ser)	TSC2	R1359S, R1431S, R1371S, R1230S, R1418S, R1430S, R1451S, R1407S, R1408S, R1474S	Tuberous sclerosis 2|not provided	VCV001484215	16	2134645	16	2084644	1484215	1455145	rs754169255	NC_000016.10:2084643:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4423G>A (p.Val1475Ile)	TSC2	V1360I, V1431I, V1432I, V1408I, V1409I, V1419I, V1231I, V1372I, V1452I, V1475I	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000944447	16	2134646	16	2084645	944447	927678	rs1202676769	NC_000016.10:2084644:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4425A>G (p.Val1475=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536054	16	2134648	16	2084647	536054	530281	rs878854106	NC_000016.10:2084646:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4425A>C (p.Val1475=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238049	16	2134648	16	2084647	238049	242308	rs878854106	NC_000016.10:2084646:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4426G>C (p.Glu1476Gln)	TSC2	E1476Q, E1432Q, E1361Q, E1409Q, E1453Q, E1373Q, E1420Q, E1232Q, E1410Q, E1433Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000565643	16	2134649	16	2084648	565643	567854	rs376946970	NC_000016.10:2084647:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4426G>A (p.Glu1476Lys)	TSC2	E1476K, E1420K, E1432K, E1433K, E1373K, E1409K, E1410K, E1232K, E1361K, E1453K	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207685	16	2134649	16	2084648	207685	203192	rs376946970	NC_000016.10:2084647:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4427A>C (p.Glu1476Ala)	TSC2	E1210A, E1232A, E1256A, E1361A, E1373A, E1404A, E1405A, E1409A, E1420A, E1439A, E1450A, E1476A, E875A, E961A, E984A, E1209A, E1252A, E1276A, E1360A, E1372A, E1403A, E1452A, E1475A, E985A, E1433A, E1440A, E1453A, E1253A, E1390A, E1410A, E1432A, E962A, E1005A, E1406A, E1416A	Hereditary cancer-predisposing syndrome	VCV002626426	16	2134650	16	2084649	2626426	2794192	rs2544286435	NC_000016.10:2084648:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4428G>C (p.Glu1476Asp)	TSC2	E1232D, E1432D, E1476D, E1410D, E1361D, E1373D, E1409D, E1433D, E1420D, E1453D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001035569	16	2134651	16	2084650	1035569	1032490	rs765447466	NC_000016.10:2084649:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4429A>G (p.Arg1477Gly)	TSC2	R1233G, R1421G, R1454G, R1374G, R1411G, R1433G, R1434G, R1362G, R1410G, R1477G	Tuberous sclerosis 2	VCV001355707	16	2134652	16	2084651	1355707	1509458	rs2090536576	NC_000016.10:2084650:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4430G>C (p.Arg1477Thr)	TSC2	R1410T, R1421T, R1434T, R1454T, R1433T, R1362T, R1374T, R1233T, R1411T, R1477T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001512141	16	2134653	16	2084652	1512141	1455775	rs752693719	NC_000016.10:2084651:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4430G>A (p.Arg1477Lys)	TSC2	R1477K, R1433K, R1434K, R1421K, R1454K, R1362K, R1374K, R1410K, R1233K, R1411K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000578769	16	2134653	16	2084652	578769	570131	rs752693719	NC_000016.10:2084651:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4431G>A (p.Arg1477=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000733206	16	2134654	16	2084653	733206	740023	rs76934857	NC_000016.10:2084652:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4431G>C (p.Arg1477Ser)	TSC2	R1411S, R1434S, R1233S, R1433S, R1374S, R1410S, R1362S, R1421S, R1454S, R1477S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000642802	16	2134654	16	2084653	642802	644328	rs76934857	NC_000016.10:2084652:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4432G>A (p.Asp1478Asn)	TSC2	D1478N, D1411N, D1412N, D1435N, D1234N, D1363N, D1422N, D1434N, D1375N, D1455N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535987	16	2134655	16	2084654	535987	529690	rs45517343	NC_000016.10:2084653:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4432G>C (p.Asp1478His)	TSC2	D1478H, D1435H, D1234H, D1412H, D1363H, D1411H, D1422H, D1434H, D1455H, D1375H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000049925	16	2134655	16	2084654	49925	59087	rs45517343	NC_000016.10:2084653:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4433A>C (p.Asp1478Ala)	TSC2	D1234A, D1363A, D1375A, D1411A, D1412A, D1422A, D1434A, D1435A, D1455A, D1478A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001052237	16	2134656	16	2084655	1052237	1049483	rs1596418447	NC_000016.10:2084654:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4433A>T (p.Asp1478Val)	TSC2	D1411V, D1412V, D1435V, D1375V, D1455V, D1234V, D1363V, D1422V, D1434V, D1478V	Tuberous sclerosis 2	VCV000641928	16	2134656	16	2084655	641928	644329	rs1596418447	NC_000016.10:2084654:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4434C>A (p.Asp1478Glu)	TSC2	D1254E, D1362E, D1363E, D1405E, D1418E, D1478E, D987E, D1212E, D1258E, D1278E, D1374E, D1375E, D1392E, D1407E, D1408E, D1422E, D1441E, D1452E, D1455E, D963E, D1007E, D1234E, D1406E, D1411E, D1434E, D1442E, D1477E, D1211E, D1255E, D1412E, D1435E, D1454E, D877E, D964E, D986E	Tuberous sclerosis 2	VCV002961779	16	2134657	16	2084656	2961779	3116941	rs758374702	NC_000016.10:2084655:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4434C>T (p.Asp1478=)	TSC2		Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000413681	16	2134657	16	2084656	413681	401637	rs758374702	NC_000016.10:2084655:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4435G>C (p.Ala1479Pro)	TSC2	A1008P, A1212P, A1213P, A1235P, A1255P, A1256P, A1259P, A1279P, A1363P, A1364P, A1375P, A1376P, A1393P, A1406P, A1407P, A1408P, A1409P, A1412P, A1413P, A1419P, A1423P, A1435P, A1436P, A1442P, A1443P, A1453P, A1455P, A1456P, A1478P, A1479P, A878P, A964P, A965P, A987P, A988P	Isolated focal cortical dysplasia type II	VCV002679323	16	2134658	16	2084657	2679323	2836900	rs777529733	NC_000016.10:2084656:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4435G>A (p.Ala1479Thr)	TSC2	A1479T, A1235T, A1413T, A1423T, A1456T, A1376T, A1435T, A1364T, A1412T, A1436T	not specified|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000405956	16	2134658	16	2084657	405956	401415	rs777529733	NC_000016.10:2084656:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4436C>A (p.Ala1479Asp)	TSC2	A1364D, A1406D, A1408D, A1409D, A1436D, A1453D, A1456D, A987D, A1363D, A1376D, A1412D, A1419D, A1455D, A1478D, A1479D, A964D, A988D, A1235D, A1256D, A1279D, A1413D, A1423D, A1443D, A878D, A1008D, A1212D, A1213D, A1255D, A1259D, A1375D, A1393D, A1407D, A1435D, A1442D, A965D	Tuberous sclerosis 2	VCV002776375	16	2134659	16	2084658	2776375	2946166	rs397515242	NC_000016.10:2084657:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4436C>T (p.Ala1479Val)	TSC2	A1479V, A1413V, A1435V, A1436V, A1235V, A1376V, A1423V, A1456V, A1364V, A1412V	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000065329	16	2134659	16	2084658	65329	76262	rs397515242	NC_000016.10:2084657:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4437C>G (p.Ala1479=)	TSC2		Tuberous sclerosis 2	VCV004071239	16	2134660	16	2084659	4071239	4185087		NC_000016.10:2084658:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4437C>A (p.Ala1479=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692503	16	2134660	16	2084659	1692503	1684943	rs2151536553	NC_000016.10:2084658:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4437C>T (p.Ala1479=)	TSC2		Tuberous sclerosis 2	VCV001604837	16	2134660	16	2084659	1604837	1623991	rs2151536553	NC_000016.10:2084658:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4439T>A (p.Leu1480Ter)	TSC2	L1480*, L1236*, L1414*, L1436*, L1437*, L1424*, L1365*, L1377*, L1413*, L1457*	Tuberous sclerosis 2|Neoplasm	VCV000049926	16	2134662	16	2084661	49926	59088	rs45446594	NC_000016.10:2084660:T:A	single nucleotide variant	nonsense	Pathogenic	Jul 28, 2021	criteria provided, single submitter				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000548.5(TSC2):c.4440A>C (p.Leu1480Phe)	TSC2	L1214F, L1236F, L1280F, L1377F, L1394F, L1414F, L1437F, L1443F, L1454F, L1479F, L879F, L989F, L1213F, L1376F, L1408F, L1420F, L1457F, L1480F, L966F, L1009F, L1364F, L1365F, L1407F, L1410F, L1413F, L1456F, L965F, L988F, L1256F, L1257F, L1260F, L1409F, L1424F, L1436F, L1444F	Hereditary cancer-predisposing syndrome	VCV001740623	16	2134663	16	2084662	1740623	1798124	rs756991335	NC_000016.10:2084661:A:C	single nucleotide variant	missense variant	Likely benign	Mar 31, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4440A>G (p.Leu1480=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000705748	16	2134663	16	2084662	705748	693821	rs756991335	NC_000016.10:2084661:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4441A>T (p.Lys1481Ter)	TSC2	K1010*, K1214*, K1215*, K1237*, K1257*, K1258*, K1261*, K1281*, K1365*, K1366*, K1377*, K1378*, K1395*, K1408*, K1409*, K1410*, K1411*, K1414*, K1415*, K1421*, K1425*, K1437*, K1438*, K1444*, K1445*, K1455*, K1457*, K1458*, K1480*, K1481*, K880*, K966*, K967*, K989*, K990*	Tuberous sclerosis 2	VCV001708477	16	2134664	16	2084663	1708477	1706775	rs1596418520	NC_000016.10:2084662:A:T	single nucleotide variant	nonsense	Pathogenic	Oct 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4441A>G (p.Lys1481Glu)	TSC2	K1366E, K1237E, K1378E, K1425E, K1438E, K1415E, K1481E, K1414E, K1437E, K1458E	Tuberous sclerosis 2	VCV000654637	16	2134664	16	2084663	654637	644330	rs1596418520	NC_000016.10:2084662:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4442A>T (p.Lys1481Met)	TSC2	K1366M, K1408M, K1410M, K1415M, K1444M, K1457M, K1458M, K1481M, K966M, K1010M, K1257M, K1258M, K1281M, K1365M, K1395M, K1409M, K1421M, K1455M, K989M, K1214M, K1237M, K1261M, K1377M, K1378M, K1480M, K1215M, K1411M, K1414M, K1425M, K1437M, K1438M, K1445M, K880M, K967M, K990M	Hereditary cancer-predisposing syndrome	VCV001740634	16	2134665	16	2084664	1740634	1798135	rs2090538754	NC_000016.10:2084663:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4442A>G (p.Lys1481Arg)	TSC2	K1237R, K1414R, K1481R, K1415R, K1437R, K1438R, K1458R, K1366R, K1378R, K1425R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000941698	16	2134665	16	2084664	941698	937342	rs2090538754	NC_000016.10:2084663:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4443G>C (p.Lys1481Asn)	TSC2	K1237N, K1366N, K1378N, K1414N, K1415N, K1425N, K1437N, K1438N, K1458N, K1481N	Tuberous sclerosis 2	VCV001019590	16	2134666	16	2084665	1019590	1011997	rs2090538903	NC_000016.10:2084664:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4444A>T (p.Ser1482Cys)	TSC2	S1366C, S1415C, S1422C, S1426C, S1458C, S967C, S1215C, S1216C, S1238C, S1259C, S1282C, S1416C, S1438C, S1482C, S991C, S1258C, S1262C, S1367C, S1378C, S1379C, S1396C, S1409C, S1412C, S1439C, S1456C, S1459C, S1481C, S881C, S968C, S1011C, S1410C, S1411C, S1445C, S1446C, S990C	Tuberous sclerosis 2	VCV002758274	16	2134667	16	2084666	2758274	2910373	rs2544287909	NC_000016.10:2084665:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4446C>G (p.Ser1482Arg)	TSC2	S1011R, S1238R, S1258R, S1379R, S1409R, S1415R, S1422R, S1439R, S1481R, S990R, S991R, S1262R, S1366R, S1367R, S1396R, S1411R, S1445R, S1459R, S881R, S1215R, S1216R, S1378R, S1410R, S1412R, S1416R, S1438R, S1456R, S1458R, S1259R, S1282R, S1426R, S1446R, S1482R, S967R, S968R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001919785	16	2134669	16	2084668	1919785	1978698	rs780955293	NC_000016.10:2084667:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4446C>T (p.Ser1482=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000413755	16	2134669	16	2084668	413755	400964	rs780955293	NC_000016.10:2084667:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4447A>G (p.Arg1483Gly)	TSC2	R1483G, R1417G, R1439G, R1460G, R1239G, R1368G, R1416G, R1440G, R1380G, R1427G	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000207754	16	2134670	16	2084669	207754	203193	rs199644840	NC_000016.10:2084668:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4448G>A (p.Arg1483Lys)	TSC2	R1263K, R1283K, R1368K, R1379K, R1380K, R1410K, R1413K, R1416K, R1427K, R1460K, R1239K, R1397K, R1423K, R1447K, R1459K, R1482K, R1483K, R882K, R1217K, R1260K, R1412K, R1446K, R1457K, R968K, R991K, R992K, R1012K, R1216K, R1259K, R1367K, R1411K, R1417K, R1439K, R1440K, R969K	Hereditary cancer-predisposing syndrome	VCV001740660	16	2134671	16	2084670	1740660	1798161	rs370114027	NC_000016.10:2084669:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4448G>C (p.Arg1483Thr)	TSC2	R1483T, R1239T, R1380T, R1427T, R1439T, R1368T, R1416T, R1417T, R1440T, R1460T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000065332	16	2134671	16	2084670	65332	76265	rs370114027	NC_000016.10:2084669:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4449A>G (p.Arg1483=)	TSC2		Tuberous sclerosis 2	VCV001624695	16	2134672	16	2084671	1624695	1629314	rs775115896	NC_000016.10:2084670:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 12, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4450G>C (p.Ala1484Pro)	TSC2	A1260P, A1261P, A1284P, A1369P, A1380P, A1412P, A1414P, A1428P, A1458P, A1483P, A1218P, A1240P, A1264P, A1411P, A1413P, A1460P, A1013P, A1398P, A1418P, A1440P, A1441P, A1448P, A883P, A970P, A993P, A1217P, A1368P, A1381P, A1417P, A1424P, A1447P, A1461P, A1484P, A969P, A992P	Hereditary cancer-predisposing syndrome	VCV003462597	16	2134673	16	2084672	3462597	3621616		NC_000016.10:2084671:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4450G>A (p.Ala1484Thr)	TSC2	A1218T, A1264T, A1398T, A1413T, A1418T, A1440T, A1447T, A1458T, A969T, A992T, A1260T, A1380T, A1411T, A1414T, A1417T, A1428T, A970T, A1240T, A1284T, A1368T, A1424T, A1460T, A1483T, A1484T, A883T, A1013T, A1217T, A1261T, A1369T, A1381T, A1412T, A1441T, A1448T, A1461T, A993T	Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002587783	16	2134673	16	2084672	2587783	2764121	rs748698490	NC_000016.10:2084671:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 15, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4451C>T (p.Ala1484Val)	TSC2	A1284V, A1381V, A1411V, A1412V, A1458V, A1013V, A1240V, A1368V, A1380V, A1424V, A1440V, A1447V, A1460V, A1484V, A969V, A970V, A1260V, A1261V, A1264V, A1413V, A1414V, A1418V, A1448V, A1483V, A993V, A1217V, A1218V, A1369V, A1398V, A1417V, A1428V, A1441V, A1461V, A883V, A992V	Hereditary cancer-predisposing syndrome	VCV003462612	16	2134674	16	2084673	3462612	3621631		NC_000016.10:2084672:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4451C>A (p.Ala1484Asp)	TSC2	A1260D, A1381D, A1398D, A1417D, A1418D, A1440D, A1448D, A1458D, A1483D, A1217D, A1264D, A1284D, A1368D, A1412D, A1414D, A1461D, A969D, A1240D, A1369D, A1411D, A1413D, A1424D, A1441D, A1447D, A1484D, A883D, A970D, A1013D, A1218D, A1261D, A1380D, A1428D, A1460D, A992D, A993D	Hereditary cancer-predisposing syndrome	VCV003329515	16	2134674	16	2084673	3329515	3489107		NC_000016.10:2084672:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4452C>T (p.Ala1484=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486690	16	2134675	16	2084674	486690	477385	rs1555514573	NC_000016.10:2084673:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4453A>G (p.Thr1485Ala)	TSC2	T1219A, T1265A, T1285A, T1399A, T1412A, T1413A, T1415A, T1449A, T1462A, T884A, T1262A, T1414A, T1418A, T1425A, T1441A, T1442A, T1448A, T1461A, T1485A, T993A, T994A, T1218A, T1261A, T1369A, T1381A, T1419A, T1484A, T970A, T971A, T1014A, T1241A, T1370A, T1382A, T1429A, T1459A	Hereditary cancer-predisposing syndrome	VCV003974647	16	2134676	16	2084675	3974647	4086470		NC_000016.10:2084674:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4453A>C (p.Thr1485Pro)	TSC2	T1370P, T1418P, T1429P, T1419P, T1441P, T1241P, T1382P, T1442P, T1462P, T1485P	Tuberous sclerosis 2	VCV000643010	16	2134676	16	2084675	643010	644331	rs1596418612	NC_000016.10:2084674:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4454C>T (p.Thr1485Ile)	TSC2	T1485I, T1370I, T1418I, T1419I, T1441I, T1442I, T1382I, T1241I, T1429I, T1462I	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535928	16	2134677	16	2084676	535928	530286	rs772667717	NC_000016.10:2084675:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 10, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4455A>G (p.Thr1485=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468088	16	2134678	16	2084677	468088	466014	rs1555514579	NC_000016.10:2084676:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4457C>T (p.Ala1486Val)	TSC2	A1486V, A1242V, A1383V, A1430V, A1371V, A1442V, A1443V, A1419V, A1420V, A1463V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not specified|Tuberous sclerosis syndrome	VCV000406105	16	2134680	16	2084679	406105	401418	rs773527337	NC_000016.10:2084678:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4458C>T (p.Ala1486=)	TSC2		not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000318331	16	2134681	16	2084680	318331	324627	rs761248238	NC_000016.10:2084679:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4460C>T (p.Ser1487Phe)	TSC2	S1243F, S1287F, S1371F, S1372F, S1431F, S1451F, S1461F, S1464F, S996F, S1220F, S1263F, S1384F, S1401F, S1414F, S1420F, S1427F, S1444F, S1487F, S1016F, S1383F, S1415F, S1417F, S1443F, S1463F, S886F, S973F, S995F, S1221F, S1264F, S1267F, S1416F, S1421F, S1450F, S1486F, S972F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002843983	16	2134683	16	2084682	2843983	3011456	rs766916450	NC_000016.10:2084681:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4460C>G (p.Ser1487Cys)	TSC2	S1487C, S1372C, S1384C, S1431C, S1464C, S1444C, S1243C, S1420C, S1421C, S1443C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000570942	16	2134683	16	2084682	570942	567856	rs766916450	NC_000016.10:2084681:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4461C>G (p.Ser1487=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468089	16	2134684	16	2084683	468089	466282	rs777104003	NC_000016.10:2084682:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4461C>T (p.Ser1487=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413633	16	2134684	16	2084683	413633	401640	rs777104003	NC_000016.10:2084682:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4462A>G (p.Asn1488Asp)	TSC2	N1432D, N1244D, N1422D, N1488D, N1444D, N1445D, N1465D, N1373D, N1385D, N1421D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000663537	16	2134685	16	2084684	663537	644332	rs1203541600	NC_000016.10:2084683:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4463A>C (p.Asn1488Thr)	TSC2	N1244T, N1373T, N1385T, N1421T, N1422T, N1432T, N1444T, N1445T, N1465T, N1488T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001008784	16	2134686	16	2084685	1008784	996755	rs999699219	NC_000016.10:2084684:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4463A>G (p.Asn1488Ser)	TSC2	N1488S, N1385S, N1421S, N1244S, N1373S, N1445S, N1422S, N1444S, N1432S, N1465S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535914	16	2134686	16	2084685	535914	530288	rs999699219	NC_000016.10:2084684:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4464T>A (p.Asn1488Lys)	TSC2	N1244K, N1421K, N1488K, N1373K, N1422K, N1432K, N1445K, N1385K, N1444K, N1465K	Tuberous sclerosis 2	VCV001042638	16	2134687	16	2084686	1042638	1032491	rs2090541614	NC_000016.10:2084685:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4465G>A (p.Ala1489Thr)	TSC2	A1489T, A1446T, A1466T, A1245T, A1374T, A1386T, A1422T, A1433T, A1445T, A1423T	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000135388	16	2134688	16	2084687	135388	139127	rs587778740	NC_000016.10:2084686:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4466C>G (p.Ala1489Gly)	TSC2	A1018G, A1222G, A1223G, A1245G, A1265G, A1266G, A1269G, A1289G, A1373G, A1374G, A1385G, A1386G, A1403G, A1416G, A1417G, A1418G, A1419G, A1422G, A1423G, A1429G, A1433G, A1445G, A1446G, A1452G, A1453G, A1463G, A1465G, A1466G, A1488G, A1489G, A888G, A974G, A975G, A997G, A998G	not provided	VCV003366185	16	2134689	16	2084688	3366185	3525392		NC_000016.10:2084687:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4466C>A (p.Ala1489Glu)	TSC2	A1223E, A1265E, A1418E, A1423E, A1433E, A1446E, A1488E, A997E, A998E, A1245E, A1403E, A1422E, A1466E, A1489E, A888E, A974E, A1266E, A1269E, A1289E, A1373E, A1416E, A1417E, A1419E, A1429E, A1465E, A1018E, A1222E, A1374E, A1385E, A1386E, A1445E, A1452E, A1453E, A1463E, A975E	Hereditary cancer-predisposing syndrome	VCV001740794	16	2134689	16	2084688	1740794	1798294	rs1596418744	NC_000016.10:2084687:C:A	single nucleotide variant	missense variant	Uncertain significance	May 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4466C>T (p.Ala1489Val)	TSC2	A1245V, A1466V, A1374V, A1386V, A1423V, A1446V, A1489V, A1422V, A1433V, A1445V	Hereditary cancer-predisposing syndrome	VCV000824909	16	2134689	16	2084688	824909	812603	rs1596418744	NC_000016.10:2084687:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4467A>G (p.Ala1489=)	TSC2		Tuberous sclerosis 2	VCV004071205	16	2134690	16	2084689	4071205	4185053		NC_000016.10:2084688:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4467A>C (p.Ala1489=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000233307	16	2134690	16	2084689	233307	235136	rs876660324	NC_000016.10:2084688:A:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4468G>A (p.Glu1490Lys)	TSC2	E1375K, E1423K, E1446K, E1467K, E1490K, E1246K, E1387K, E1424K, E1434K, E1447K	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000860627	16	2134691	16	2084690	860627	843500	rs2090542133	NC_000016.10:2084689:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4469A>G (p.Glu1490Gly)	TSC2	E1490G, E1423G, E1447G, E1467G, E1375G, E1387G, E1446G, E1246G, E1424G, E1434G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238051	16	2134692	16	2084691	238051	242309	rs759882146	NC_000016.10:2084690:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4470G>A (p.Glu1490=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002450001	16	2134693	16	2084692	2450001	2425958	rs1221986548	NC_000016.10:2084691:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4470G>C (p.Glu1490Asp)	TSC2	E1446D, E1490D, E1246D, E1375D, E1387D, E1423D, E1424D, E1467D, E1434D, E1447D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001398873	16	2134693	16	2084692	1398873	1427938	rs1221986548	NC_000016.10:2084691:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4470G>T (p.Glu1490Asp)	TSC2	E1490D, E1467D, E1375D, E1387D, E1423D, E1434D, E1446D, E1447D, E1246D, E1424D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486695	16	2134693	16	2084692	486695	477511	rs1221986548	NC_000016.10:2084691:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4471A>C (p.Lys1491Gln)	TSC2	K1387Q, K1388Q, K1405Q, K1435Q, K977Q, K999Q, K1020Q, K1247Q, K1376Q, K1418Q, K1424Q, K1431Q, K1447Q, K1448Q, K1455Q, K1465Q, K1490Q, K1000Q, K1224Q, K1271Q, K1375Q, K1419Q, K1425Q, K1454Q, K1467Q, K1491Q, K890Q, K1225Q, K1267Q, K1268Q, K1291Q, K1420Q, K1421Q, K1468Q, K976Q	Tuberous sclerosis 2	VCV002010924	16	2134694	16	2084693	2010924	2073998	rs2090542726	NC_000016.10:2084692:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4471A>G (p.Lys1491Glu)	TSC2	K1247E, K1376E, K1388E, K1424E, K1425E, K1435E, K1447E, K1448E, K1468E, K1491E	Tuberous sclerosis 2	VCV001005979	16	2134694	16	2084693	1005979	996756	rs2090542726	NC_000016.10:2084692:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4472A>G (p.Lys1491Arg)	TSC2	K1376R, K1424R, K1448R, K1247R, K1425R, K1468R, K1491R, K1435R, K1447R, K1388R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000839013	16	2134695	16	2084694	839013	843502	rs2090543060	NC_000016.10:2084693:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4473A>T (p.Lys1491Asn)	TSC2	K1424N, K1448N, K1247N, K1376N, K1425N, K1447N, K1491N, K1388N, K1435N, K1468N	Tuberous sclerosis 2	VCV001409218	16	2134696	16	2084695	1409218	1497007	rs1266546987	NC_000016.10:2084694:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4473A>C (p.Lys1491Asn)	TSC2	K1424N, K1425N, K1388N, K1435N, K1448N, K1468N, K1247N, K1376N, K1491N, K1447N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000947184	16	2134696	16	2084695	947184	927679	rs1266546987	NC_000016.10:2084694:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4473A>G (p.Lys1491=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536042	16	2134696	16	2084695	536042	529694	rs1266546987	NC_000016.10:2084694:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4474G>C (p.Val1492Leu)	TSC2	V1226L, V1269L, V1389L, V1419L, V1426L, V1436L, V1456L, V1466L, V1469L, V1491L, V977L, V1000L, V1001L, V1021L, V1377L, V1432L, V1449L, V1455L, V1468L, V1248L, V1272L, V1292L, V1376L, V1406L, V1421L, V1422L, V1425L, V1448L, V1492L, V978L, V1225L, V1268L, V1388L, V1420L, V891L	Tuberous sclerosis 2	VCV003637241	16	2134697	16	2084696	3637241	3771395		NC_000016.10:2084695:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Mar 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4475T>C (p.Val1492Ala)	TSC2	V1000A, V1001A, V1021A, V1225A, V1226A, V1248A, V1268A, V1269A, V1272A, V1292A, V1376A, V1377A, V1388A, V1389A, V1406A, V1419A, V1420A, V1421A, V1422A, V1425A, V1426A, V1432A, V1436A, V1448A, V1449A, V1455A, V1456A, V1466A, V1468A, V1469A, V1491A, V1492A, V891A, V977A, V978A	Isolated focal cortical dysplasia type II	VCV003240657	16	2134698	16	2084697	3240657	3399643	rs2151537873	NC_000016.10:2084696:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4476G>C (p.Val1492=)	TSC2		Tuberous sclerosis 2	VCV003726265	16	2134699	16	2084698	3726265	3854756		NC_000016.10:2084697:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4476G>T (p.Val1492=)	TSC2		Tuberous sclerosis 2	VCV001143358	16	2134699	16	2084698	1143358	1145972	rs1596418854	NC_000016.10:2084697:G:T	single nucleotide variant	synonymous variant	Likely benign	May 1, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4476G>A (p.Val1492=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000700325	16	2134699	16	2084698	700325	688547	rs1596418854	NC_000016.10:2084697:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4477C>T (p.Pro1493Ser)	TSC2	P1249S, P1378S, P1390S, P1426S, P1427S, P1437S, P1449S, P1450S, P1470S, P1493S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001051769	16	2134700	16	2084699	1051769	1049484	rs878854108	NC_000016.10:2084698:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4477C>G (p.Pro1493Ala)	TSC2	P1493A, P1378A, P1437A, P1249A, P1390A, P1426A, P1449A, P1450A, P1427A, P1470A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238052	16	2134700	16	2084699	238052	242311	rs878854108	NC_000016.10:2084698:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4478C>T (p.Pro1493Leu)	TSC2	P1249L, P1378L, P1390L, P1426L, P1427L, P1437L, P1449L, P1450L, P1470L, P1493L	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001056336	16	2134701	16	2084700	1056336	1049485	rs2090543900	NC_000016.10:2084699:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4478C>A (p.Pro1493Gln)	TSC2	P1249Q, P1378Q, P1390Q, P1426Q, P1427Q, P1437Q, P1449Q, P1450Q, P1470Q, P1493Q	Tuberous sclerosis 2	VCV001005703	16	2134701	16	2084700	1005703	996757	rs2090543900	NC_000016.10:2084699:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4481G>C (p.Gly1494Ala)	TSC2	G1003A, G1228A, G1250A, G1274A, G1294A, G1408A, G1422A, G1427A, G1494A, G893A, G980A, G1002A, G1271A, G1391A, G1434A, G1438A, G1450A, G1470A, G1471A, G1023A, G1270A, G1378A, G1423A, G1424A, G1457A, G1458A, G1468A, G979A, G1227A, G1379A, G1390A, G1421A, G1428A, G1451A, G1493A	Tuberous sclerosis 2	VCV002096262	16	2134704	16	2084703	2096262	2146413	rs2544291203	NC_000016.10:2084702:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4481G>A (p.Gly1494Asp)	TSC2	G1003D, G1270D, G1390D, G1423D, G1424D, G1450D, G1451D, G1457D, G1471D, G893D, G1250D, G1271D, G1294D, G1427D, G1458D, G1468D, G1470D, G1023D, G1227D, G1378D, G1379D, G1408D, G1428D, G1434D, G1438D, G1493D, G979D, G980D, G1002D, G1228D, G1274D, G1391D, G1421D, G1422D, G1494D	Hereditary cancer-predisposing syndrome	VCV001740917	16	2134704	16	2084703	1740917	1798417	rs2544291203	NC_000016.10:2084702:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4482C>T (p.Gly1494=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002170428	16	2134705	16	2084704	2170428	1896682	rs1363090464	NC_000016.10:2084703:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4483A>G (p.Ile1495Val)	TSC2	I1379V, I1424V, I1452V, I1458V, I1471V, I981V, I1004V, I1251V, I1275V, I1392V, I1425V, I1429V, I1451V, I1469V, I980V, I1228V, I1271V, I1380V, I1409V, I1422V, I1423V, I1428V, I1495V, I894V, I1003V, I1024V, I1272V, I1391V, I1435V, I1439V, I1459V, I1472V, I1494V, I1229V, I1295V	Tuberous sclerosis 2	VCV003675913	16	2134706	16	2084705	3675913	3813529		NC_000016.10:2084704:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4484T>G (p.Ile1495Ser)	TSC2	I1229S, I1271S, I1391S, I1422S, I1423S, I1459S, I1003S, I1024S, I1275S, I1379S, I1409S, I1435S, I1439S, I1452S, I1472S, I894S, I981S, I1272S, I1380S, I1424S, I1425S, I1428S, I1429S, I1458S, I1471S, I1495S, I980S, I1004S, I1228S, I1251S, I1295S, I1392S, I1451S, I1469S, I1494S	Tuberous sclerosis 2	VCV002813152	16	2134707	16	2084706	2813152	2972954	rs2544291339	NC_000016.10:2084705:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4485C>T (p.Ile1495=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001128339	16	2134708	16	2084707	1128339	1125090	rs1030218603	NC_000016.10:2084706:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4485C>G (p.Ile1495Met)	TSC2	I1251M, I1495M, I1380M, I1451M, I1392M, I1428M, I1429M, I1472M, I1439M, I1452M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000824930	16	2134708	16	2084707	824930	812604	rs1030218603	NC_000016.10:2084706:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4486A>G (p.Asn1496Asp)	TSC2	N1429D, N1393D, N1440D, N1452D, N1496D, N1381D, N1430D, N1453D, N1252D, N1473D	Tuberous sclerosis 2	VCV000844267	16	2134709	16	2084708	844267	843503	rs2090544468	NC_000016.10:2084707:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4487A>T (p.Asn1496Ile)	TSC2	N1230I, N1252I, N1272I, N1273I, N1276I, N1381I, N1425I, N1436I, N1473I, N1496I, N895I, N981I, N1380I, N1393I, N1452I, N1453I, N982I, N1004I, N1025I, N1296I, N1392I, N1423I, N1426I, N1430I, N1440I, N1459I, N1470I, N1472I, N1495I, N1005I, N1229I, N1410I, N1424I, N1429I, N1460I	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002855422	16	2134710	16	2084709	2855422	3013930	rs2151538221	NC_000016.10:2084708:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4488C>T (p.Asn1496=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001557776	16	2134711	16	2084710	1557776	1628218	rs2151538251	NC_000016.10:2084709:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4489C>T (p.Pro1497Ser)	TSC2	P1497S, P1253S, P1453S, P1382S, P1394S, P1430S, P1474S, P1431S, P1441S, P1454S	not provided|Tuberous sclerosis 2	VCV000065206	16	2134712	16	2084711	65206	76138	rs45517344	NC_000016.10:2084710:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4489C>A (p.Pro1497Thr)	TSC2	P1497T, P1253T, P1394T, P1430T, P1431T, P1453T, P1382T, P1441T, P1454T, P1474T	not provided|Tuberous sclerosis 2	VCV000049490	16	2134712	16	2084711	49490	58652	rs45517344	NC_000016.10:2084710:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4490C>T (p.Pro1497Leu)	TSC2	P1253L, P1430L, P1431L, P1454L, P1474L, P1497L, P1382L, P1394L, P1441L, P1453L	Tuberous sclerosis 2	VCV001457373	16	2134713	16	2084712	1457373	1393314	rs45497997	NC_000016.10:2084711:C:T	single nucleotide variant	missense variant	Pathogenic	Oct 28, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4490C>A (p.Pro1497His)	TSC2	P1474H, P1430H, P1431H, P1253H, P1382H, P1453H, P1454H, P1394H, P1441H, P1497H	Tuberous sclerosis 2	VCV001346285	16	2134713	16	2084712	1346285	1378574	rs45497997	NC_000016.10:2084711:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4490C>G (p.Pro1497Arg)	TSC2	P1497R, P1431R, P1441R, P1253R, P1382R, P1394R, P1430R, P1454R, P1453R, P1474R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049491	16	2134713	16	2084712	49491	58653	rs45497997	NC_000016.10:2084711:C:G	single nucleotide variant	missense variant	Pathogenic	Nov 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4491C>T (p.Pro1497=)	TSC2		Tuberous sclerosis 2	VCV001573801	16	2134714	16	2084713	1573801	1539005	rs955680135	NC_000016.10:2084712:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4492A>T (p.Ser1498Cys)	TSC2	S1027C, S1278C, S1425C, S1454C, S1455C, S1497C, S897C, S1006C, S1383C, S1394C, S1427C, S1428C, S1431C, S983C, S1232C, S1254C, S1275C, S1395C, S1412C, S1426C, S1442C, S1472C, S1474C, S984C, S1007C, S1231C, S1274C, S1298C, S1382C, S1432C, S1438C, S1461C, S1462C, S1475C, S1498C	Tuberous sclerosis 2	VCV002091922	16	2134715	16	2084714	2091922	2152420	rs2544291942	NC_000016.10:2084713:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493G>C (p.Ser1498Thr)	TSC2	S1498T, S1395T, S1455T, S1475T, S1383T, S1432T, S1254T, S1431T, S1442T, S1454T	TSC2-related disorder|See cases	VCV000065304	16	2134716	16	2084715	65304	76236	rs137854879	NC_000016.10:2084714:G:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4493+1G>C	TSC2		Tuberous sclerosis 2	VCV002012670	16	2134717	16	2084716	2012670	2074459	rs1057518230	NC_000016.10:2084715:G:C	single nucleotide variant	splice donor variant	Pathogenic	Mar 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+1G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000373118	16	2134717	16	2084716	373118	360250	rs1057518230	NC_000016.10:2084715:G:A	single nucleotide variant	splice donor variant	Pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4493+2T>C	TSC2		Tuberous sclerosis 2	VCV003656086	16	2134718	16	2084717	3656086	3782953		NC_000016.10:2084716:T:C	single nucleotide variant	splice donor variant	Pathogenic	Jan 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+3G>T	TSC2		Hereditary cancer-predisposing syndrome	VCV003329486	16	2134719	16	2084718	3329486	3489078		NC_000016.10:2084717:G:T	single nucleotide variant	intron variant	Uncertain significance	Mar 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+3G>C	TSC2		Tuberous sclerosis 2	VCV002413990	16	2134719	16	2084718	2413990	1940396	rs1259786285	NC_000016.10:2084717:G:C	single nucleotide variant	intron variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+3G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000643015	16	2134719	16	2084718	643015	652957	rs1259786285	NC_000016.10:2084717:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4493+4G>A	TSC2		Tuberous sclerosis 2	VCV003628254	16	2134720	16	2084719	3628254	3758776		NC_000016.10:2084718:G:A	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4493+4G>C	TSC2		Tuberous sclerosis 2	VCV002033881	16	2134720	16	2084719	2033881	2096941	rs2090545964	NC_000016.10:2084718:G:C	single nucleotide variant	intron variant	Uncertain significance	Oct 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+5G>A	TSC2		Tuberous sclerosis 2	VCV001355678	16	2134721	16	2084720	1355678	1509429	rs752851868	NC_000016.10:2084719:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+6C>T	TSC2		Tuberous sclerosis 2	VCV000468091	16	2134722	16	2084721	468091	465367	rs1555514697	NC_000016.10:2084720:C:T	single nucleotide variant	intron variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+7C>T	TSC2		Tuberous sclerosis 2	VCV002133315	16	2134723	16	2084722	2133315	2190004	rs199943270	NC_000016.10:2084721:C:T	single nucleotide variant	intron variant	Likely benign	May 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+7C>A	TSC2		not provided|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238053	16	2134723	16	2084722	238053	242312	rs199943270	NC_000016.10:2084721:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4493+8T>A	TSC2		Tuberous sclerosis 2	VCV001670615	16	2134724	16	2084723	1670615	1604922	rs2090546767	NC_000016.10:2084722:T:A	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4493+10T>A	TSC2		Tuberous sclerosis 2	VCV001131698	16	2134726	16	2084725	1131698	1125091	rs764108528	NC_000016.10:2084724:T:A	single nucleotide variant	intron variant	Likely benign	Dec 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+10T>C	TSC2		Tuberous sclerosis 2	VCV000468090	16	2134726	16	2084725	468090	466088	rs764108528	NC_000016.10:2084724:T:C	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4493+11T>G	TSC2		Tuberous sclerosis 2	VCV002193653	16	2134727	16	2084726	2193653	1929329	rs2544292844	NC_000016.10:2084725:T:G	single nucleotide variant	intron variant	Likely benign	Jul 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+12G>C	TSC2		Tuberous sclerosis 2	VCV002107072	16	2134728	16	2084727	2107072	2170126	rs1423647790	NC_000016.10:2084726:G:C	single nucleotide variant	intron variant	Likely benign	Oct 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+13C>A	TSC2		Tuberous sclerosis 2	VCV001572330	16	2134729	16	2084728	1572330	1538399	rs757183419	NC_000016.10:2084727:C:A	single nucleotide variant	intron variant	Likely benign	Jul 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+13C>T	TSC2		Tuberous sclerosis 2	VCV001555818	16	2134729	16	2084728	1555818	1626692	rs757183419	NC_000016.10:2084727:C:T	single nucleotide variant	intron variant	Likely benign	Nov 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+15T>C	TSC2		Tuberous sclerosis 2	VCV001555628	16	2134731	16	2084730	1555628	1626502	rs2090547818	NC_000016.10:2084729:T:C	single nucleotide variant	intron variant	Likely benign	May 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+15T>G	TSC2		Tuberous sclerosis syndrome	VCV000886888	16	2134731	16	2084730	886888	876636	rs2090547818	NC_000016.10:2084729:T:G	single nucleotide variant	intron variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+16C>T	TSC2		Tuberous sclerosis 2	VCV003654332	16	2134732	16	2084731	3654332	3782483		NC_000016.10:2084730:C:T	single nucleotide variant	intron variant	Likely benign	May 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+16C>G	TSC2		Tuberous sclerosis 2|not specified|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000049791	16	2134732	16	2084731	49791	58953	rs45491597	NC_000016.10:2084730:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4493+17C>A	TSC2		Tuberous sclerosis 2	VCV001507864	16	2134733	16	2084732	1507864	1352323	rs45517345	NC_000016.10:2084731:C:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+17C>T	TSC2		Tuberous sclerosis 2|not specified|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000049995	16	2134733	16	2084732	49995	59157	rs45517345	NC_000016.10:2084731:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4493+18G>A	TSC2		not specified|not provided|Tuberous sclerosis 2	VCV000049996	16	2134734	16	2084733	49996	59158	rs45454201	NC_000016.10:2084732:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4493+19G>A	TSC2		Tuberous sclerosis 2	VCV002043843	16	2134735	16	2084734	2043843	2103016	rs1335749760	NC_000016.10:2084733:G:A	single nucleotide variant	intron variant	Likely benign	Aug 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4493+20G>A	TSC2		Tuberous sclerosis 2	VCV001584986	16	2134736	16	2084735	1584986	1561137	rs2090548880	NC_000016.10:2084734:G:A	single nucleotide variant	intron variant	Likely benign	Dec 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4494-20A>G	TSC2		Tuberous sclerosis 2	VCV002909773	16	2134932	16	2084931	2909773	3078440	rs2151542538	NC_000016.10:2084930:A:G	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-19C>T	TSC2		Tuberous sclerosis 2	VCV001552388	16	2134933	16	2084932	1552388	1586467	rs779772312	NC_000016.10:2084931:C:T	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-18C>T	TSC2		Tuberous sclerosis 2	VCV002044490	16	2134934	16	2084933	2044490	2095915	rs1215206005	NC_000016.10:2084932:C:T	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-17A>G	TSC2		Tuberous sclerosis 2	VCV004071457	16	2134935	16	2084934	4071457	4185304		NC_000016.10:2084933:A:G	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4494-17A>T	TSC2		Tuberous sclerosis 2	VCV002010480	16	2134935	16	2084934	2010480	2063270	rs2151542646	NC_000016.10:2084933:A:T	single nucleotide variant	intron variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4494-15C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001595130	16	2134937	16	2084936	1595130	1590770	rs993595235	NC_000016.10:2084935:C:T	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-15C>G	TSC2		Tuberous sclerosis 2|not specified	VCV000512024	16	2134937	16	2084936	512024	506182	rs993595235	NC_000016.10:2084935:C:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-14C>T	TSC2		Tuberous sclerosis 2	VCV002870187	16	2134938	16	2084937	2870187	3021196	rs2544302695	NC_000016.10:2084936:C:T	single nucleotide variant	intron variant	Likely benign	May 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4494-13C>T	TSC2		Tuberous sclerosis 2	VCV001650138	16	2134939	16	2084938	1650138	1601850	rs981915272	NC_000016.10:2084937:C:T	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-12C>T	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|not provided|Tuberous sclerosis 2	VCV001342083	16	2134940	16	2084939	1342083	1333481	rs780056359	NC_000016.10:2084938:C:T	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-11T>A	TSC2		Tuberous sclerosis 2	VCV003658370	16	2134941	16	2084940	3658370	3796791		NC_000016.10:2084939:T:A	single nucleotide variant	intron variant	Likely benign	Jul 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4494-10C>G	TSC2		Tuberous sclerosis 2	VCV000941209	16	2134942	16	2084941	941209	940351	rs753499012	NC_000016.10:2084940:C:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4494-10C>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000570166	16	2134942	16	2084941	570166	569825	rs753499012	NC_000016.10:2084940:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4494-10C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000536082	16	2134942	16	2084941	536082	529752	rs753499012	NC_000016.10:2084940:C:T	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-9C>T	TSC2		Tuberous sclerosis 2	VCV003641647	16	2134943	16	2084942	3641647	3775804		NC_000016.10:2084941:C:T	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-8C>T	TSC2		Tuberous sclerosis 2	VCV001085790	16	2134944	16	2084943	1085790	1081863	rs2090576761	NC_000016.10:2084942:C:T	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-7T>C	TSC2		Tuberous sclerosis 2	VCV000413671	16	2134945	16	2084944	413671	400913	rs1060504099	NC_000016.10:2084943:T:C	single nucleotide variant	intron variant	Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-4G>A	TSC2		Tuberous sclerosis 2	VCV003631942	16	2134948	16	2084947	3631942	3769984		NC_000016.10:2084946:G:A	single nucleotide variant	intron variant	Likely benign	Jul 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4494-3C>A	TSC2		Hereditary cancer-predisposing syndrome	VCV002626440	16	2134949	16	2084948	2626440	2794206	rs2151542933	NC_000016.10:2084947:C:A	single nucleotide variant	intron variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4494-3C>T	TSC2		Tuberous sclerosis 2	VCV001492761	16	2134949	16	2084948	1492761	1515597	rs2151542933	NC_000016.10:2084947:C:T	single nucleotide variant	intron variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4494-2A>G	TSC2		not provided|Tuberous sclerosis 2	VCV001256579	16	2134950	16	2084949	1256579	1246508	rs397514990	NC_000016.10:2084948:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Sep 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4494-1G>A	TSC2		Tuberous sclerosis 2	VCV000049492	16	2134951	16	2084950	49492	58654	rs45517346	NC_000016.10:2084949:G:A	single nucleotide variant	splice acceptor variant	Likely pathogenic	Nov 1, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.4495T>G (p.Phe1499Val)	TSC2	F1255V, F1384V, F1396V, F1456V, F1476V, F1499V, F1455V, F1432V, F1443V, F1433V	Tuberous sclerosis 2	VCV001512879	16	2134953	16	2084952	1512879	1380972	rs2151543061	NC_000016.10:2084951:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4496T>A (p.Phe1499Tyr)	TSC2	F1255Y, F1395Y, F1427Y, F1428Y, F1429Y, F1433Y, F1439Y, F1007Y, F1028Y, F1233Y, F1275Y, F1279Y, F1413Y, F1463Y, F1008Y, F1383Y, F1384Y, F1432Y, F1443Y, F1462Y, F1476Y, F1499Y, F898Y, F984Y, F1232Y, F1276Y, F1299Y, F1396Y, F1426Y, F1455Y, F1456Y, F1473Y, F1475Y, F1498Y, F985Y	Hereditary cancer-predisposing syndrome	VCV003811337	16	2134954	16	2084953	3811337	3928578		NC_000016.10:2084952:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4496T>C (p.Phe1499Ser)	TSC2	F1255S, F1384S, F1456S, F1396S, F1433S, F1443S, F1476S, F1432S, F1455S, F1499S	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001036527	16	2134954	16	2084953	1036527	1032492	rs1596422033	NC_000016.10:2084952:T:C	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4496T>G (p.Phe1499Cys)	TSC2	F1443C, F1499C, F1456C, F1255C, F1384C, F1396C, F1432C, F1433C, F1455C, F1476C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000824940	16	2134954	16	2084953	824940	812605	rs1596422033	NC_000016.10:2084952:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4497C>G (p.Phe1499Leu)	TSC2	F1499L, F1255L, F1443L, F1476L, F1433L, F1432L, F1455L, F1456L, F1384L, F1396L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000579299	16	2134955	16	2084954	579299	567861	rs372974007	NC_000016.10:2084953:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4497C>T (p.Phe1499=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413677	16	2134955	16	2084954	413677	401656	rs372974007	NC_000016.10:2084953:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4498G>C (p.Val1500Leu)	TSC2	V1009L, V1256L, V1277L, V1384L, V1429L, V1430L, V1434L, V1456L, V1463L, V1500L, V1280L, V1396L, V1427L, V1428L, V1433L, V985L, V986L, V1008L, V1234L, V1276L, V1385L, V1414L, V1440L, V1457L, V899L, V1029L, V1233L, V1300L, V1397L, V1444L, V1464L, V1474L, V1476L, V1477L, V1499L	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002918467	16	2134956	16	2084955	2918467	3080587	rs397515167	NC_000016.10:2084954:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4498G>A (p.Val1500Met)	TSC2	V1500M, V1456M, V1256M, V1385M, V1397M, V1433M, V1444M, V1457M, V1434M, V1477M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified	VCV000065229	16	2134956	16	2084955	65229	76161	rs397515167	NC_000016.10:2084954:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4499T>C (p.Val1500Ala)	TSC2	V1385A, V1397A, V1457A, V1477A, V1256A, V1500A, V1433A, V1434A, V1444A, V1456A	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000656915	16	2134957	16	2084956	656915	644333	rs45517347	NC_000016.10:2084955:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4499T>G (p.Val1500Gly)	TSC2	V1500G, V1433G, V1457G, V1456G, V1385G, V1434G, V1477G, V1256G, V1397G, V1444G	Tuberous sclerosis 2	VCV000049494	16	2134957	16	2084956	49494	58656	rs45517347	NC_000016.10:2084955:T:G	single nucleotide variant	missense variant	Uncertain significance	May 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4500G>C (p.Val1500=)	TSC2		Tuberous sclerosis 2	VCV002013849	16	2134958	16	2084957	2013849	2067932	rs2090578725	NC_000016.10:2084956:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4502T>C (p.Phe1501Ser)	TSC2	F1386S, F1434S, F1435S, F1445S, F1457S, F1501S, F1478S, F1257S, F1398S, F1458S	Tuberous sclerosis 2	VCV000947515	16	2134960	16	2084959	947515	927680	rs2090578878	NC_000016.10:2084958:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4503C>G (p.Phe1501Leu)	TSC2	F1281L, F1385L, F1386L, F1428L, F1458L, F1464L, F1478L, F1009L, F1234L, F1277L, F1301L, F1397L, F1398L, F1434L, F1465L, F900L, F986L, F987L, F1235L, F1257L, F1278L, F1415L, F1435L, F1445L, F1457L, F1500L, F1501L, F1010L, F1030L, F1429L, F1430L, F1431L, F1441L, F1475L, F1477L	Tuberous sclerosis 2	VCV002784848	16	2134961	16	2084960	2784848	2938650	rs778332133	NC_000016.10:2084959:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4503C>T (p.Phe1501=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001147478	16	2134961	16	2084960	1147478	1145973	rs778332133	NC_000016.10:2084959:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4504C>A (p.Leu1502Met)	TSC2	L1258M, L1387M, L1436M, L1458M, L1479M, L1502M, L1399M, L1435M, L1446M, L1459M	Hereditary cancer-predisposing syndrome|TSC2-related disorder|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000655106	16	2134962	16	2084961	655106	644334	rs928525608	NC_000016.10:2084960:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4504C>T (p.Leu1502=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536085	16	2134962	16	2084961	536085	529760	rs928525608	NC_000016.10:2084960:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4506G>T (p.Leu1502=)	TSC2		Tuberous sclerosis 2	VCV001619014	16	2134964	16	2084963	1619014	1548789	rs1555514870	NC_000016.10:2084962:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4506G>C (p.Leu1502=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001084667	16	2134964	16	2084963	1084667	1081864	rs1555514870	NC_000016.10:2084962:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4506G>A (p.Leu1502=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000536088	16	2134964	16	2084963	536088	529698	rs1555514870	NC_000016.10:2084962:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 3, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4507C>A (p.Gln1503Lys)	TSC2	Q1459K, Q1480K, Q1503K, Q1400K, Q1437K, Q1436K, Q1259K, Q1388K, Q1447K, Q1460K	Tuberous sclerosis 2	VCV000838445	16	2134965	16	2084964	838445	843504	rs45517348	NC_000016.10:2084963:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4507C>T (p.Gln1503Ter)	TSC2	Q1503*, Q1259*, Q1447*, Q1459*, Q1460*, Q1388*, Q1400*, Q1480*, Q1436*, Q1437*	not provided|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000049301	16	2134965	16	2084964	49301	58463	rs45517348	NC_000016.10:2084963:C:T	single nucleotide variant	nonsense	Pathogenic	Jun 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4508A>G (p.Gln1503Arg)	TSC2	Q1503R, Q1388R, Q1400R, Q1459R, Q1480R, Q1259R, Q1447R, Q1436R, Q1437R, Q1460R	Tuberous sclerosis 2	VCV000468092	16	2134966	16	2084965	468092	466289	rs45516293	NC_000016.10:2084964:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4508A>C (p.Gln1503Pro)	TSC2	Q1503P, Q1400P, Q1436P, Q1437P, Q1388P, Q1459P, Q1460P, Q1480P, Q1259P, Q1447P	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000012401	16	2134966	16	2084965	12401	27440	rs45516293	NC_000016.10:2084964:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4509G>C (p.Gln1503His)	TSC2	Q1259H, Q1388H, Q1447H, Q1459H, Q1460H, Q1480H, Q1503H, Q1400H, Q1436H, Q1437H	Tuberous sclerosis 2	VCV001390361	16	2134967	16	2084966	1390361	1396534	rs45517349	NC_000016.10:2084965:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4509G>A (p.Gln1503=)	TSC2		Tuberous sclerosis 2|not provided	VCV000468093	16	2134967	16	2084966	468093	465370	rs45517349	NC_000016.10:2084965:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4509G>T (p.Gln1503His)	TSC2	Q1503H, Q1388H, Q1437H, Q1480H, Q1400H, Q1436H, Q1447H, Q1259H, Q1459H, Q1460H	Tuberous sclerosis 2	VCV000049498	16	2134967	16	2084966	49498	58660	rs45517349	NC_000016.10:2084965:G:T	single nucleotide variant	missense variant	Likely pathogenic	May 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4510C>T (p.Leu1504Phe)	TSC2	L1504F, L1438F, L1461F, L1260F, L1401F, L1437F, L1448F, L1481F, L1389F, L1460F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406121	16	2134968	16	2084967	406121	401659	rs747613240	NC_000016.10:2084966:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4511T>C (p.Leu1504Pro)	TSC2	L1012P, L1013P, L1033P, L1237P, L1238P, L1260P, L1280P, L1281P, L1284P, L1304P, L1388P, L1389P, L1400P, L1401P, L1418P, L1431P, L1432P, L1433P, L1434P, L1437P, L1438P, L1444P, L1448P, L1460P, L1461P, L1467P, L1468P, L1478P, L1480P, L1481P, L1503P, L1504P, L903P, L989P, L990P	Xanthinuria type II	VCV003895493	16	2134969	16	2084968	3895493	4011367		NC_000016.10:2084967:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Feb 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4512C>A (p.Leu1504=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468094	16	2134970	16	2084969	468094	466016	rs771595886	NC_000016.10:2084968:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4512C>G (p.Leu1504=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000413670	16	2134970	16	2084969	413670	401419	rs771595886	NC_000016.10:2084968:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4513T>C (p.Tyr1505His)	TSC2	Y1285H, Y1390H, Y1432H, Y1435H, Y1445H, Y1449H, Y1469H, Y991H, Y1013H, Y1034H, Y1438H, Y1439H, Y1462H, Y1468H, Y904H, Y1261H, Y1282H, Y1305H, Y1389H, Y1479H, Y1481H, Y990H, Y1014H, Y1238H, Y1239H, Y1281H, Y1401H, Y1402H, Y1419H, Y1433H, Y1434H, Y1461H, Y1482H, Y1504H, Y1505H	Tuberous sclerosis 2	VCV002866536	16	2134971	16	2084970	2866536	3020144	rs2544304591	NC_000016.10:2084969:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4514A>G (p.Tyr1505Cys)	TSC2	Y1261C, Y1390C, Y1402C, Y1438C, Y1439C, Y1449C, Y1461C, Y1462C, Y1482C, Y1505C	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV001017292	16	2134972	16	2084971	1017292	1011998	rs2090580905	NC_000016.10:2084970:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4515C>T (p.Tyr1505=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413627	16	2134973	16	2084972	413627	401661	rs45471791	NC_000016.10:2084971:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4515C>G (p.Tyr1505Ter)	TSC2	Y1505*, Y1390*, Y1461*, Y1402*, Y1462*, Y1261*, Y1438*, Y1439*, Y1449*, Y1482*	Tuberous sclerosis 2	VCV000065087	16	2134973	16	2084972	65087	76018	rs45471791	NC_000016.10:2084971:C:G	single nucleotide variant	nonsense	Pathogenic	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4516C>G (p.His1506Asp)	TSC2	H1262D, H1450D, H1462D, H1506D, H1439D, H1391D, H1403D, H1440D, H1463D, H1483D	Tuberous sclerosis 2	VCV001367134	16	2134974	16	2084973	1367134	1404856	rs1173459869	NC_000016.10:2084972:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4516C>T (p.His1506Tyr)	TSC2	H1506Y, H1439Y, H1462Y, H1262Y, H1391Y, H1440Y, H1450Y, H1403Y, H1463Y, H1483Y	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468095	16	2134974	16	2084973	468095	465373	rs1173459869	NC_000016.10:2084972:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4517A>G (p.His1506Arg)	TSC2	H1391R, H1439R, H1463R, H1440R, H1450R, H1262R, H1462R, H1483R, H1403R, H1506R	Tuberous sclerosis 2	VCV001355133	16	2134975	16	2084974	1355133	1512761	rs2090581620	NC_000016.10:2084973:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4517A>T (p.His1506Leu)	TSC2	H1262L, H1391L, H1403L, H1439L, H1440L, H1450L, H1462L, H1463L, H1483L, H1506L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001023769	16	2134975	16	2084974	1023769	1011999	rs2090581620	NC_000016.10:2084973:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4517A>C (p.His1506Pro)	TSC2	H1403P, H1391P, H1439P, H1450P, H1462P, H1262P, H1440P, H1463P, H1483P, H1506P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000840836	16	2134975	16	2084974	840836	843505	rs2090581620	NC_000016.10:2084973:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4518T>G (p.His1506Gln)	TSC2	H1015Q, H1282Q, H1403Q, H1420Q, H1435Q, H1436Q, H1470Q, H1506Q, H991Q, H1239Q, H1240Q, H1306Q, H1390Q, H1035Q, H1283Q, H1439Q, H1446Q, H1450Q, H1462Q, H1483Q, H992Q, H1014Q, H1262Q, H1286Q, H1391Q, H1402Q, H1463Q, H1482Q, H1505Q, H905Q, H1433Q, H1434Q, H1440Q, H1469Q, H1480Q	Hereditary cancer-predisposing syndrome	VCV002564701	16	2134976	16	2084975	2564701	2733857	rs2544304981	NC_000016.10:2084974:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4519T>G (p.Ser1507Ala)	TSC2	S1263A, S1440A, S1451A, S1484A, S1392A, S1441A, S1463A, S1464A, S1507A, S1404A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000934023	16	2134977	16	2084976	934023	937343	rs781736405	NC_000016.10:2084975:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4520C>A (p.Ser1507Tyr)	TSC2	S1507Y, S1440Y, S1263Y, S1392Y, S1404Y, S1441Y, S1463Y, S1464Y, S1451Y, S1484Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000535877	16	2134978	16	2084977	535877	530027	rs746246149	NC_000016.10:2084976:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4520C>G (p.Ser1507Cys)	TSC2	S1507C, S1441C, S1463C, S1263C, S1392C, S1404C, S1440C, S1451C, S1484C, S1464C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II	VCV000468096	16	2134978	16	2084977	468096	466092	rs746246149	NC_000016.10:2084976:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4520C>T (p.Ser1507Phe)	TSC2	S1507F, S1464F, S1263F, S1404F, S1463F, S1392F, S1484F, S1440F, S1441F, S1451F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000432500	16	2134978	16	2084977	432500	426155	rs746246149	NC_000016.10:2084976:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4521C>T (p.Ser1507=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000536111	16	2134979	16	2084978	536111	529700	rs140081676	NC_000016.10:2084977:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4522C>T (p.Pro1508Ser)	TSC2	P1441S, P1465S, P1508S, P1393S, P1442S, P1485S, P1264S, P1405S, P1452S, P1464S	Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV001517946	16	2134980	16	2084979	1517946	1512218	rs2090582590	NC_000016.10:2084978:C:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4523C>G (p.Pro1508Arg)	TSC2	P1016R, P1242R, P1404R, P1422R, P1448R, P1452R, P1465R, P1472R, P1482R, P1508R, P907R, P994R, P1017R, P1264R, P1405R, P1436R, P1438R, P1471R, P1485R, P1037R, P1285R, P1288R, P1435R, P1437R, P1442R, P1464R, P1241R, P1284R, P1308R, P1392R, P1393R, P1441R, P1484R, P1507R, P993R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002000313	16	2134981	16	2084980	2000313	2050947	rs2151543885	NC_000016.10:2084979:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4523C>T (p.Pro1508Leu)	TSC2	P1441L, P1442L, P1485L, P1393L, P1465L, P1264L, P1405L, P1452L, P1464L, P1508L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001410902	16	2134981	16	2084980	1410902	1510339	rs2151543885	NC_000016.10:2084979:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4524C>T (p.Pro1508=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001104068	16	2134982	16	2084981	1104068	1103674	rs1596422510	NC_000016.10:2084980:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4524C>A (p.Pro1508=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000741668	16	2134982	16	2084981	741668	755004	rs1596422510	NC_000016.10:2084980:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4526T>C (p.Phe1509Ser)	TSC2	F1017S, F1018S, F1038S, F1242S, F1243S, F1265S, F1285S, F1286S, F1289S, F1309S, F1393S, F1394S, F1405S, F1406S, F1423S, F1436S, F1437S, F1438S, F1439S, F1442S, F1443S, F1449S, F1453S, F1465S, F1466S, F1472S, F1473S, F1483S, F1485S, F1486S, F1508S, F1509S, F908S, F994S, F995S	Tuberous sclerosis syndrome	VCV003071040	16	2134984	16	2084983	3071040	3228623	rs2544305439	NC_000016.10:2084982:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4527C>T (p.Phe1509=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449981	16	2134985	16	2084984	2449981	2425938	rs775919951	NC_000016.10:2084983:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4527C>G (p.Phe1509Leu)	TSC2	F1509L, F1465L, F1394L, F1406L, F1442L, F1486L, F1265L, F1443L, F1453L, F1466L	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468097	16	2134985	16	2084984	468097	466094	rs775919951	NC_000016.10:2084983:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4527C>A (p.Phe1509Leu)	TSC2	F1509L, F1265L, F1394L, F1442L, F1443L, F1453L, F1486L, F1406L, F1466L, F1465L	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000187598	16	2134985	16	2084984	187598	184142	rs775919951	NC_000016.10:2084983:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4528T>A (p.Phe1510Ile)	TSC2	F1466I, F1487I, F1467I, F1266I, F1510I, F1395I, F1407I, F1443I, F1444I, F1454I	Tuberous sclerosis 2	VCV001040073	16	2134986	16	2084985	1040073	1032493	rs2090583733	NC_000016.10:2084984:T:A	single nucleotide variant	missense variant	Uncertain significance	May 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4529T>C (p.Phe1510Ser)	TSC2	F1243S, F1290S, F1310S, F1394S, F1395S, F1406S, F1439S, F1443S, F1444S, F1473S, F1484S, F909S, F1018S, F1019S, F1039S, F1286S, F1287S, F1424S, F1437S, F1440S, F1450S, F1486S, F1509S, F1407S, F1466S, F1467S, F1474S, F995S, F1244S, F1266S, F1438S, F1454S, F1487S, F1510S, F996S	Hereditary cancer-predisposing syndrome	VCV001741247	16	2134987	16	2084986	1741247	1808624	rs2090583886	NC_000016.10:2084985:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4529T>A (p.Phe1510Tyr)	TSC2	F1266Y, F1395Y, F1407Y, F1443Y, F1444Y, F1454Y, F1466Y, F1467Y, F1487Y, F1510Y	Tuberous sclerosis 2	VCV001026707	16	2134987	16	2084986	1026707	1012000	rs2090583886	NC_000016.10:2084985:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4530T>G (p.Phe1510Leu)	TSC2	F1039L, F1424L, F1440L, F1443L, F1444L, F1474L, F1484L, F1266L, F1286L, F1394L, F1406L, F1407L, F1454L, F1487L, F1018L, F1019L, F1243L, F1310L, F1395L, F1466L, F1467L, F1509L, F1510L, F996L, F1244L, F1287L, F1290L, F1437L, F1438L, F1439L, F1450L, F1473L, F1486L, F909L, F995L	Tuberous sclerosis 2	VCV002846488	16	2134988	16	2084987	2846488	3005014	rs763126313	NC_000016.10:2084986:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4530T>C (p.Phe1510=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002162499	16	2134988	16	2084987	2162499	1894795	rs763126313	NC_000016.10:2084986:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4531G>T (p.Gly1511Cys)	TSC2	G1040C, G1288C, G1291C, G1395C, G1407C, G1444C, G1474C, G1485C, G1311C, G1396C, G1439C, G1468C, G1475C, G1487C, G1488C, G1510C, G996C, G1019C, G1020C, G1267C, G1287C, G1408C, G1438C, G1441C, G1445C, G910C, G1244C, G1245C, G1425C, G1440C, G1451C, G1455C, G1467C, G1511C, G997C	Hereditary cancer-predisposing syndrome	VCV001741286	16	2134989	16	2084988	1741286	1808663	rs2544305929	NC_000016.10:2084987:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4532G>A (p.Gly1511Asp)	TSC2	G1267D, G1408D, G1467D, G1511D, G1445D, G1488D, G1396D, G1455D, G1444D, G1468D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|not specified	VCV001523857	16	2134990	16	2084989	1523857	1347153	rs2151544129	NC_000016.10:2084988:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4532G>T (p.Gly1511Val)	TSC2	G1445V, G1467V, G1267V, G1408V, G1488V, G1511V, G1396V, G1444V, G1455V, G1468V	Tuberous sclerosis 2	VCV001390293	16	2134990	16	2084989	1390293	1396466	rs2151544129	NC_000016.10:2084988:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4533C>A (p.Gly1511=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002587445	16	2134991	16	2084990	2587445	2763783	rs201126835	NC_000016.10:2084989:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4533C>T (p.Gly1511=)	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000378790	16	2134991	16	2084990	378790	374844	rs201126835	NC_000016.10:2084989:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4534G>C (p.Asp1512His)	TSC2	D1268H, D1445H, D1409H, D1468H, D1469H, D1489H, D1397H, D1446H, D1456H, D1512H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000942670	16	2134992	16	2084991	942670	937344	rs774441486	NC_000016.10:2084990:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4534G>A (p.Asp1512Asn)	TSC2	D1512N, D1397N, D1445N, D1446N, D1456N, D1468N, D1469N, D1268N, D1409N, D1489N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000405960	16	2134992	16	2084991	405960	400966	rs774441486	NC_000016.10:2084990:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4535A>G (p.Asp1512Gly)	TSC2	D1268G, D1397G, D1409G, D1445G, D1446G, D1456G, D1468G, D1469G, D1489G, D1512G	Tuberous sclerosis 2|not provided	VCV000998572	16	2134993	16	2084992	998572	996758	rs2090584497	NC_000016.10:2084991:A:G	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4536C>A (p.Asp1512Glu)	TSC2	D1020E, D1289E, D1397E, D1408E, D1441E, D1445E, D1475E, D1489E, D1512E, D911E, D1396E, D1409E, D1439E, D1456E, D1468E, D1488E, D1511E, D1021E, D1041E, D1245E, D1246E, D1288E, D1312E, D1440E, D1452E, D998E, D1268E, D1292E, D1426E, D1442E, D1446E, D1469E, D1476E, D1486E, D997E	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV001741301	16	2134994	16	2084993	1741301	1808678	rs35986575	NC_000016.10:2084992:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4536C>G (p.Asp1512Glu)	TSC2	D1409E, D1456E, D1489E, D1397E, D1446E, D1268E, D1445E, D1469E, D1512E, D1468E	Tuberous sclerosis 2	VCV001392457	16	2134994	16	2084993	1392457	1502360	rs35986575	NC_000016.10:2084992:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4536C>T (p.Asp1512=)	TSC2		Tuberous sclerosis syndrome|Lung lymphangioleiomyomatosis|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2	VCV000049504	16	2134994	16	2084993	49504	58666	rs35986575	NC_000016.10:2084992:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4537G>T (p.Glu1513Ter)	TSC2	E1021*, E1022*, E1042*, E1246*, E1247*, E1269*, E1289*, E1290*, E1293*, E1313*, E1397*, E1398*, E1409*, E1410*, E1427*, E1440*, E1441*, E1442*, E1443*, E1446*, E1447*, E1453*, E1457*, E1469*, E1470*, E1476*, E1477*, E1487*, E1489*, E1490*, E1512*, E1513*, E912*, E998*, E999*	not provided	VCV002428816	16	2134995	16	2084994	2428816	2402258	rs767449740	NC_000016.10:2084993:G:T	single nucleotide variant	nonsense	Pathogenic	Aug 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4537G>A (p.Glu1513Lys)	TSC2	E1513K, E1269K, E1398K, E1446K, E1490K, E1447K, E1469K, E1410K, E1457K, E1470K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000406004	16	2134995	16	2084994	406004	400919	rs767449740	NC_000016.10:2084993:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4538A>G (p.Glu1513Gly)	TSC2	E1457G, E1469G, E1470G, E1513G, E1269G, E1410G, E1447G, E1490G, E1398G, E1446G	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000824985	16	2134996	16	2084995	824985	812606	rs1596422775	NC_000016.10:2084994:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4539G>A (p.Glu1513=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000755003	16	2134997	16	2084996	755003	770738	rs1322800885	NC_000016.10:2084995:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4541C>T (p.Ser1514Leu)	TSC2	S1022L, S1043L, S1247L, S1291L, S1398L, S1428L, S1442L, S1477L, S1490L, S1270L, S1294L, S1410L, S1411L, S1447L, S1458L, S1470L, S1471L, S1248L, S1399L, S1441L, S1444L, S1448L, S1491L, S1513L, S1514L, S1000L, S1023L, S1290L, S1314L, S1443L, S1454L, S1478L, S1488L, S913L, S999L	Hereditary cancer-predisposing syndrome	VCV003974683	16	2134999	16	2084998	3974683	4086506		NC_000016.10:2084997:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4541C>G (p.Ser1514Ter)	TSC2	S1514*, S1270*, S1470*, S1491*, S1447*, S1448*, S1399*, S1411*, S1458*, S1471*	not provided	VCV000620335	16	2134999	16	2084998	620335	611818	rs74363455	NC_000016.10:2084997:C:G	single nucleotide variant	nonsense	Pathogenic	Aug 20, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4542A>C (p.Ser1514=)	TSC2		Tuberous sclerosis 2	VCV004071350	16	2135000	16	2084999	4071350	4185198		NC_000016.10:2084998:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4543A>G (p.Asn1515Asp)	TSC2	N1023D, N1044D, N1248D, N1399D, N1400D, N1442D, N1443D, N1444D, N1455D, N1472D, N1492D, N1001D, N1249D, N1295D, N1449D, N1478D, N1489D, N1514D, N914D, N1292D, N1315D, N1411D, N1429D, N1445D, N1448D, N1471D, N1491D, N1000D, N1024D, N1271D, N1291D, N1412D, N1459D, N1479D, N1515D	Hereditary cancer-predisposing syndrome	VCV001741374	16	2135001	16	2085000	1741374	1794520	rs766124907	NC_000016.10:2084999:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4544A>G (p.Asn1515Ser)	TSC2	N1449S, N1400S, N1412S, N1448S, N1459S, N1471S, N1515S, N1271S, N1472S, N1492S	Tuberous sclerosis 2	VCV000854478	16	2135002	16	2085001	854478	843506	rs2090586394	NC_000016.10:2085000:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4545C>T (p.Asn1515=)	TSC2		Tuberous sclerosis 2	VCV001586974	16	2135003	16	2085002	1586974	1628914	rs753641948	NC_000016.10:2085001:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4546A>G (p.Lys1516Glu)	TSC2	K1413E, K1460E, K1472E, K1473E, K1493E, K1401E, K1450E, K1272E, K1449E, K1516E	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000660837	16	2135004	16	2085003	660837	644335	rs1596422969	NC_000016.10:2085002:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4547A>G (p.Lys1516Arg)	TSC2	K1025R, K1400R, K1401R, K1450R, K1473R, K1515R, K1024R, K1250R, K1293R, K1430R, K1460R, K1480R, K1001R, K1249R, K1292R, K1296R, K1443R, K1445R, K1446R, K1456R, K1472R, K1490R, K1492R, K1516R, K915R, K1479R, K1493R, K1002R, K1045R, K1272R, K1316R, K1412R, K1413R, K1444R, K1449R	Hereditary cancer-predisposing syndrome	VCV003462615	16	2135005	16	2085004	3462615	3621634		NC_000016.10:2085003:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4549C>G (p.Pro1517Ala)	TSC2	P1273A, P1402A, P1414A, P1450A, P1451A, P1461A, P1473A, P1474A, P1494A, P1517A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001021319	16	2135007	16	2085006	1021319	1012001	rs1057522800	NC_000016.10:2085005:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4549C>A (p.Pro1517Thr)	TSC2	P1517T, P1402T, P1414T, P1461T, P1473T, P1494T, P1451T, P1474T, P1273T, P1450T	not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000387484	16	2135007	16	2085006	387484	374163	rs1057522800	NC_000016.10:2085005:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4550C>T (p.Pro1517Leu)	TSC2	P1474L, P1402L, P1414L, P1461L, P1473L, P1494L, P1517L, P1273L, P1450L, P1451L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000950491	16	2135008	16	2085007	950491	927681	rs1279603512	NC_000016.10:2085006:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4550C>G (p.Pro1517Arg)	TSC2	P1450R, P1451R, P1474R, P1494R, P1273R, P1402R, P1473R, P1517R, P1414R, P1461R	not provided|Tuberous sclerosis 2	VCV000803156	16	2135008	16	2085007	803156	791540	rs1279603512	NC_000016.10:2085006:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4552A>C (p.Ile1518Leu)	TSC2	I1003L, I1004L, I1026L, I1027L, I1047L, I1251L, I1252L, I1274L, I1294L, I1295L, I1298L, I1318L, I1402L, I1403L, I1414L, I1415L, I1432L, I1445L, I1446L, I1447L, I1448L, I1451L, I1452L, I1458L, I1462L, I1474L, I1475L, I1481L, I1482L, I1492L, I1494L, I1495L, I1517L, I1518L, I917L	Hereditary cancer-predisposing syndrome	VCV003232170	16	2135010	16	2085009	3232170	3391971	rs764903148	NC_000016.10:2085008:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4552A>T (p.Ile1518Phe)	TSC2	I1027F, I1251F, I1318F, I1402F, I1403F, I1432F, I1445F, I1481F, I1482F, I1517F, I1518F, I1295F, I1414F, I1446F, I1448F, I1451F, I1452F, I1475F, I1495F, I1003F, I1047F, I1274F, I1298F, I1462F, I1492F, I1004F, I1026F, I1252F, I1294F, I1415F, I1447F, I1458F, I1474F, I1494F, I917F	Tuberous sclerosis 2	VCV002861847	16	2135010	16	2085009	2861847	3029209	rs764903148	NC_000016.10:2085008:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4552A>G (p.Ile1518Val)	TSC2	I1518V, I1274V, I1495V, I1403V, I1462V, I1474V, I1475V, I1415V, I1451V, I1452V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000468098	16	2135010	16	2085009	468098	466290	rs764903148	NC_000016.10:2085008:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4554C>G (p.Ile1518Met)	TSC2	I1274M, I1403M, I1415M, I1451M, I1452M, I1462M, I1474M, I1475M, I1495M, I1518M	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV001014334	16	2135012	16	2085011	1014334	1012002	rs1204199739	NC_000016.10:2085010:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4554C>T (p.Ile1518=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468099	16	2135012	16	2085011	468099	466023	rs1204199739	NC_000016.10:2085010:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4555C>T (p.Leu1519=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001088039	16	2135013	16	2085012	1088039	1081865	rs958487832	NC_000016.10:2085011:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4556T>G (p.Leu1519Arg)	TSC2	L1028R, L1295R, L1299R, L1415R, L1446R, L1495R, L1027R, L1253R, L1452R, L1453R, L1475R, L1476R, L918R, L1005R, L1048R, L1252R, L1404R, L1433R, L1448R, L1449R, L1459R, L1463R, L1496R, L1519R, L1004R, L1275R, L1296R, L1319R, L1403R, L1416R, L1447R, L1482R, L1483R, L1493R, L1518R	Hereditary cancer-predisposing syndrome	VCV003974669	16	2135014	16	2085013	3974669	4086492		NC_000016.10:2085012:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4556T>C (p.Leu1519Pro)	TSC2	L1519P, L1404P, L1453P, L1475P, L1476P, L1275P, L1416P, L1496P, L1452P, L1463P	Tuberous sclerosis 2	VCV000468100	16	2135014	16	2085013	468100	466293	rs1555514956	NC_000016.10:2085012:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4557G>A (p.Leu1519=)	TSC2		Tuberous sclerosis 2	VCV003645164	16	2135015	16	2085014	3645164	3783579		NC_000016.10:2085013:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4557G>T (p.Leu1519=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000486682	16	2135015	16	2085014	486682	477387	rs1260508226	NC_000016.10:2085013:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4558C>T (p.Leu1520=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413675	16	2135016	16	2085015	413675	400926	rs374687688	NC_000016.10:2085014:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4560G>C (p.Leu1520=)	TSC2		Tuberous sclerosis 2	VCV002750956	16	2135018	16	2085017	2750956	2912994	rs1596423200	NC_000016.10:2085016:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4560G>A (p.Leu1520=)	TSC2		Tuberous sclerosis 2	VCV002750605	16	2135018	16	2085017	2750605	2915668	rs1596423200	NC_000016.10:2085016:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4560G>T (p.Leu1520=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000746261	16	2135018	16	2085017	746261	755005	rs1596423200	NC_000016.10:2085016:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4561C>T (p.Pro1521Ser)	TSC2	P1277S, P1406S, P1455S, P1477S, P1418S, P1454S, P1465S, P1478S, P1498S, P1521S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000934051	16	2135019	16	2085018	934051	937345	rs1468281970	NC_000016.10:2085017:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4562C>T (p.Pro1521Leu)	TSC2	P1406L, P1478L, P1277L, P1498L, P1521L, P1454L, P1455L, P1477L, P1418L, P1465L	TSC2-related disorder|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001515144	16	2135020	16	2085019	1515144	1482333	rs1060500966	NC_000016.10:2085018:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4562C>G (p.Pro1521Arg)	TSC2	P1521R, P1418R, P1465R, P1498R, P1277R, P1454R, P1455R, P1406R, P1477R, P1478R	Tuberous sclerosis 2	VCV000406104	16	2135020	16	2085019	406104	400973	rs1060500966	NC_000016.10:2085018:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.4563C>A (p.Pro1521=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001100766	16	2135021	16	2085020	1100766	1103675	rs989650743	NC_000016.10:2085019:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4563C>T (p.Pro1521=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825004	16	2135021	16	2085020	825004	812607	rs989650743	NC_000016.10:2085019:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4564A>T (p.Asn1522Tyr)	TSC2	N1256Y, N1298Y, N1302Y, N1419Y, N1436Y, N1449Y, N1452Y, N1456Y, N1466Y, N1499Y, N1031Y, N1299Y, N1406Y, N1462Y, N1479Y, N1485Y, N1496Y, N1498Y, N1522Y, N1007Y, N1008Y, N1051Y, N1255Y, N1322Y, N1418Y, N1451Y, N1478Y, N1486Y, N1030Y, N1278Y, N1407Y, N1450Y, N1455Y, N1521Y, N921Y	Hereditary cancer-predisposing syndrome	VCV003811359	16	2135022	16	2085021	3811359	3928600		NC_000016.10:2085020:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4564A>G (p.Asn1522Asp)	TSC2	N1278D, N1407D, N1419D, N1455D, N1456D, N1466D, N1478D, N1479D, N1499D, N1522D	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001020190	16	2135022	16	2085021	1020190	1012003	rs2090589266	NC_000016.10:2085020:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4565A>C (p.Asn1522Thr)	TSC2	N1278T, N1407T, N1419T, N1455T, N1456T, N1466T, N1478T, N1479T, N1499T, N1522T	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001057393	16	2135023	16	2085022	1057393	1049486	rs144062721	NC_000016.10:2085021:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4565A>T (p.Asn1522Ile)	TSC2	N1522I, N1407I, N1456I, N1466I, N1479I, N1278I, N1419I, N1478I, N1499I, N1455I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000230388	16	2135023	16	2085022	230388	235137	rs144062721	NC_000016.10:2085021:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4565A>G (p.Asn1522Ser)	TSC2	N1522S, N1478S, N1479S, N1455S, N1466S, N1499S, N1278S, N1407S, N1419S, N1456S	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065118	16	2135023	16	2085022	65118	76049	rs144062721	NC_000016.10:2085021:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4566T>G (p.Asn1522Lys)	TSC2	N1008K, N1030K, N1255K, N1298K, N1302K, N1406K, N1418K, N1436K, N1456K, N1478K, N1499K, N921K, N1031K, N1256K, N1407K, N1449K, N1455K, N1466K, N1479K, N1498K, N1007K, N1278K, N1451K, N1452K, N1485K, N1496K, N1521K, N1522K, N1051K, N1299K, N1322K, N1419K, N1450K, N1462K, N1486K	Tuberous sclerosis 2	VCV002719382	16	2135024	16	2085023	2719382	2870018	rs2544308739	NC_000016.10:2085022:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4566T>A (p.Asn1522Lys)	TSC2	N1007K, N1256K, N1302K, N1322K, N1407K, N1486K, N1521K, N1522K, N1008K, N1278K, N1298K, N1419K, N1449K, N1452K, N1455K, N1498K, N1030K, N1299K, N1406K, N1418K, N1436K, N1450K, N1456K, N1462K, N1466K, N1478K, N1496K, N921K, N1031K, N1051K, N1255K, N1451K, N1479K, N1485K, N1499K	Hereditary cancer-predisposing syndrome	VCV002564702	16	2135024	16	2085023	2564702	2733858	rs2544308739	NC_000016.10:2085022:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4567G>A (p.Glu1523Lys)	TSC2	E1479K, E1500K, E1523K, E1279K, E1420K, E1456K, E1408K, E1467K, E1480K, E1457K	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV001037708	16	2135025	16	2085024	1037708	1032494	rs2090589588	NC_000016.10:2085023:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4568A>G (p.Glu1523Gly)	TSC2	E1279G, E1408G, E1420G, E1456G, E1457G, E1467G, E1479G, E1480G, E1500G, E1523G	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001051826	16	2135026	16	2085025	1051826	1049487	rs777406873	NC_000016.10:2085024:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4568A>C (p.Glu1523Ala)	TSC2	E1457A, E1467A, E1523A, E1479A, E1279A, E1408A, E1480A, E1500A, E1420A, E1456A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000962921	16	2135026	16	2085025	962921	949277	rs777406873	NC_000016.10:2085024:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569G>A (p.Glu1523=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001060595	16	2135027	16	2085026	1060595	1049488	rs945456651	NC_000016.10:2085025:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jun 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+1G>A	TSC2		Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis 2	VCV000448732	16	2135028	16	2085027	448732	441792	rs1060500972	NC_000016.10:2085026:G:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+1G>T	TSC2		Tuberous sclerosis 2	VCV000406119	16	2135028	16	2085027	406119	400930	rs1060500972	NC_000016.10:2085026:G:T	single nucleotide variant	splice donor variant	Pathogenic	Jan 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+2T>C	TSC2		Tuberous sclerosis 2	VCV002674428	16	2135029	16	2085028	2674428	2841914	rs1555514984	NC_000016.10:2085027:T:C	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+2T>G	TSC2		Tuberous sclerosis 2	VCV000468102	16	2135029	16	2085028	468102	466096	rs1555514984	NC_000016.10:2085027:T:G	single nucleotide variant	splice donor variant	Pathogenic	Jan 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+2T>A	TSC2		Tuberous sclerosis 2	VCV000468101	16	2135029	16	2085028	468101	466025	rs1555514984	NC_000016.10:2085027:T:A	single nucleotide variant	splice donor variant	Pathogenic	Jan 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+3A>G	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000959355	16	2135030	16	2085029	959355	960148	rs2090590453	NC_000016.10:2085028:A:G	single nucleotide variant	intron variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+4G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406090	16	2135031	16	2085030	406090	400937	rs1051944517	NC_000016.10:2085029:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+5G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000660451	16	2135032	16	2085031	660451	652961	rs746446349	NC_000016.10:2085030:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4569+6C>T	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000238054	16	2135033	16	2085032	238054	242313	rs756614796	NC_000016.10:2085031:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4569+7G>T	TSC2		Tuberous sclerosis 2	VCV003640278	16	2135034	16	2085033	3640278	3775292		NC_000016.10:2085032:G:T	single nucleotide variant	intron variant	Likely benign	Feb 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+7G>A	TSC2		Tuberous sclerosis 2	VCV001086377	16	2135034	16	2085033	1086377	1081866	rs45497598	NC_000016.10:2085032:G:A	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+7G>C	TSC2		Tuberous sclerosis 2	VCV000050007	16	2135034	16	2085033	50007	59169	rs45497598	NC_000016.10:2085032:G:C	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+8T>C	TSC2		Tuberous sclerosis 2	VCV002701404	16	2135035	16	2085034	2701404	2862398	rs2544309454	NC_000016.10:2085033:T:C	single nucleotide variant	intron variant	Likely benign	Dec 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+9G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000763686	16	2135036	16	2085035	763686	776315	rs1596423506	NC_000016.10:2085034:G:A	single nucleotide variant	intron variant	Likely benign	May 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+10G>T	TSC2		Tuberous sclerosis 2	VCV004071147	16	2135037	16	2085036	4071147	4184995		NC_000016.10:2085035:G:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+10G>C	TSC2		Tuberous sclerosis 2	VCV003702091	16	2135037	16	2085036	3702091	3834096		NC_000016.10:2085035:G:C	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+10G>A	TSC2		Tuberous sclerosis 2	VCV001139084	16	2135037	16	2085036	1139084	1125092	rs2151545475	NC_000016.10:2085035:G:A	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+11C>T	TSC2		Tuberous sclerosis 2	VCV001605855	16	2135038	16	2085037	1605855	1560350	rs749616902	NC_000016.10:2085036:C:T	single nucleotide variant	intron variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+12C>G	TSC2		Tuberous sclerosis 2	VCV001577919	16	2135039	16	2085038	1577919	1522347	rs45517350	NC_000016.10:2085037:C:G	single nucleotide variant	intron variant	Likely benign	May 29, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+12C>T	TSC2		Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|not specified	VCV000049856	16	2135039	16	2085038	49856	59018	rs45517350	NC_000016.10:2085037:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4569+14C>T	TSC2		Tuberous sclerosis 2	VCV002077537	16	2135041	16	2085040	2077537	2131595	rs1402060359	NC_000016.10:2085039:C:T	single nucleotide variant	intron variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+14C>A	TSC2		Tuberous sclerosis 2	VCV001933068	16	2135041	16	2085040	1933068	1985486	rs1402060359	NC_000016.10:2085039:C:A	single nucleotide variant	intron variant	Likely benign	Oct 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+15C>G	TSC2		Tuberous sclerosis 2	VCV002054178	16	2135042	16	2085041	2054178	2115928	rs2544309824	NC_000016.10:2085040:C:G	single nucleotide variant	intron variant	Likely benign	May 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+16C>T	TSC2		Tuberous sclerosis 2	VCV003622986	16	2135043	16	2085042	3622986	3757425		NC_000016.10:2085041:C:T	single nucleotide variant	intron variant	Likely benign	Mar 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+16C>A	TSC2		Tuberous sclerosis 2	VCV002134943	16	2135043	16	2085042	2134943	2190351	rs2151545577	NC_000016.10:2085041:C:A	single nucleotide variant	intron variant	Likely benign	May 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+17T>A	TSC2		Tuberous sclerosis 2	VCV002731140	16	2135044	16	2085043	2731140	2893761	rs2544309975	NC_000016.10:2085042:T:A	single nucleotide variant	intron variant	Likely benign	May 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+18C>G	TSC2		Tuberous sclerosis 2	VCV002758503	16	2135045	16	2085044	2758503	2910602	rs1278654590	NC_000016.10:2085043:C:G	single nucleotide variant	intron variant	Likely benign	Sep 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+18C>T	TSC2		Tuberous sclerosis 2	VCV001624661	16	2135045	16	2085044	1624661	1629280	rs1278654590	NC_000016.10:2085043:C:T	single nucleotide variant	intron variant	Likely benign	Nov 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+19T>G	TSC2		Tuberous sclerosis 2	VCV002076891	16	2135046	16	2085045	2076891	2134712	rs2151545612	NC_000016.10:2085044:T:G	single nucleotide variant	intron variant	Likely benign	Dec 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+20C>T	TSC2		Tuberous sclerosis 2	VCV001590520	16	2135047	16	2085046	1590520	1642413	rs774494009	NC_000016.10:2085045:C:T	single nucleotide variant	intron variant	Likely benign	Mar 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+44C>T	TSC2		not provided	VCV000065225	16	2135071	16	2085070	65225	76157	rs142227748	NC_000016.10:2085069:C:T	single nucleotide variant	intron variant	Likely benign	Jun 21, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4569+46C>T	TSC2		not specified|Tuberous sclerosis 2|not provided	VCV000049857	16	2135073	16	2085072	49857	59019	rs45482793	NC_000016.10:2085071:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4569+47G>A	TSC2		not provided|not specified|Tuberous sclerosis 2	VCV000049858	16	2135074	16	2085073	49858	59020	rs45517351	NC_000016.10:2085072:G:A	single nucleotide variant	intron variant	Benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4570-66G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000049783	16	2135165	16	2085164	49783	58945	rs45496499	NC_000016.10:2085163:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 15, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4570-20C>A	TSC2		Tuberous sclerosis 2	VCV002194248	16	2135211	16	2085210	2194248	1923031	rs761324622	NC_000016.10:2085209:C:A	single nucleotide variant	intron variant	Likely benign	Mar 31, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-20C>G	TSC2		Tuberous sclerosis 2	VCV001985435	16	2135211	16	2085210	1985435	2043287	rs761324622	NC_000016.10:2085209:C:G	single nucleotide variant	intron variant	Likely benign	Mar 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-20C>T	TSC2		Tuberous sclerosis 2	VCV001511623	16	2135211	16	2085210	1511623	1459104	rs761324622	NC_000016.10:2085209:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4570-18G>C	TSC2		Tuberous sclerosis 2	VCV004071256	16	2135213	16	2085212	4071256	4185104		NC_000016.10:2085211:G:C	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-17G>A	TSC2		Tuberous sclerosis 2	VCV001583664	16	2135214	16	2085213	1583664	1601359	rs1236463140	NC_000016.10:2085212:G:A	single nucleotide variant	intron variant	Likely benign	Jul 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-16G>T	TSC2		Tuberous sclerosis 2	VCV002762751	16	2135215	16	2085214	2762751	2931245	rs2151549045	NC_000016.10:2085213:G:T	single nucleotide variant	intron variant	Likely benign	Sep 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-15C>T	TSC2		Tuberous sclerosis 2	VCV001672755	16	2135216	16	2085215	1672755	1531202	rs766813076	NC_000016.10:2085214:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4570-15C>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV001576070	16	2135216	16	2085215	1576070	1520932	rs766813076	NC_000016.10:2085214:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4570-14T>C	TSC2		Tuberous sclerosis 2	VCV001464233	16	2135217	16	2085216	1464233	1435904	rs2151549125	NC_000016.10:2085215:T:C	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4570-13C>T	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001559751	16	2135218	16	2085217	1559751	1542341	rs370549253	NC_000016.10:2085216:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4570-13C>G	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001314119	16	2135218	16	2085217	1314119	1304380	rs370549253	NC_000016.10:2085216:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4570-12T>A	TSC2		not provided	VCV000050008	16	2135219	16	2085218	50008	59170	rs137854256	NC_000016.10:2085217:T:A	single nucleotide variant	intron variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-11G>C	TSC2		Tuberous sclerosis 2	VCV001996576	16	2135220	16	2085219	1996576	2053651	rs753007714	NC_000016.10:2085218:G:C	single nucleotide variant	intron variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-10T>G	TSC2		Tuberous sclerosis 2	VCV001061384	16	2135221	16	2085220	1061384	1049489	rs2151549277	NC_000016.10:2085219:T:G	single nucleotide variant	intron variant	Uncertain significance	Mar 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-9G>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002006991	16	2135222	16	2085221	2006991	2066226	rs1323293907	NC_000016.10:2085220:G:A	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4570-6C>T	TSC2		Tuberous sclerosis 2	VCV002779695	16	2135225	16	2085224	2779695	2937392	rs2151549406	NC_000016.10:2085223:C:T	single nucleotide variant	intron variant	Likely benign	Oct 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-6C>A	TSC2		Tuberous sclerosis 2	VCV001402710	16	2135225	16	2085224	1402710	1477136	rs2151549406	NC_000016.10:2085223:C:A	single nucleotide variant	intron variant	Likely benign	Dec 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-5C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001741573	16	2135226	16	2085225	1741573	1805016	rs2151549469	NC_000016.10:2085224:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4570-4A>G	TSC2		Tuberous sclerosis 2	VCV002792330	16	2135227	16	2085226	2792330	2957342	rs758646674	NC_000016.10:2085225:A:G	single nucleotide variant	intron variant	Likely benign	Apr 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4570-3C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000515115	16	2135228	16	2085227	515115	505228	rs1166715944	NC_000016.10:2085226:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4570-2A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV001463353	16	2135229	16	2085228	1463353	1507916	rs2151549641	NC_000016.10:2085227:A:G	single nucleotide variant	splice acceptor variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4570-1G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II	VCV000665991	16	2135230	16	2085229	665991	653247	rs777985056	NC_000016.10:2085228:G:A	single nucleotide variant	splice acceptor variant	Conflicting classifications of pathogenicity	Feb 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4571C>T (p.Ser1524Leu)	TSC2	S1468L, S1501L, S1524L, S1409L, S1421L, S1480L, S1481L, S1280L, S1457L, S1458L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001371331	16	2135232	16	2085231	1371331	1427537	rs1441428144	NC_000016.10:2085230:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4571C>A (p.Ser1524Ter)	TSC2	S1524*, S1481*, S1409*, S1480*, S1501*, S1458*, S1280*, S1421*, S1457*, S1468*	not provided	VCV000620252	16	2135232	16	2085231	620252	611819	rs1441428144	NC_000016.10:2085230:C:A	single nucleotide variant	nonsense	Pathogenic	Feb 18, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4571C>G (p.Ser1524Ter)	TSC2	S1524*, S1409*, S1480*, S1481*, S1280*, S1421*, S1457*, S1468*, S1501*, S1458*	Tuberous sclerosis 2	VCV000468103	16	2135232	16	2085231	468103	466295	rs1441428144	NC_000016.10:2085230:C:G	single nucleotide variant	nonsense	Pathogenic	Feb 28, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4572A>T (p.Ser1524=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003232171	16	2135233	16	2085232	3232171	3391972	rs2151549833	NC_000016.10:2085231:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4572A>G (p.Ser1524=)	TSC2		Tuberous sclerosis 2	VCV002697840	16	2135233	16	2085232	2697840	2861402	rs2151549833	NC_000016.10:2085231:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4573C>A (p.Gln1525Lys)	TSC2	Q1010K, Q1011K, Q1302K, Q1439K, Q1481K, Q1502K, Q1525K, Q924K, Q1033K, Q1421K, Q1452K, Q1458K, Q1459K, Q1258K, Q1305K, Q1325K, Q1409K, Q1422K, Q1453K, Q1455K, Q1465K, Q1469K, Q1489K, Q1501K, Q1524K, Q1034K, Q1054K, Q1259K, Q1281K, Q1301K, Q1410K, Q1454K, Q1482K, Q1488K, Q1499K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449973	16	2135234	16	2085233	2449973	2429598	rs45517352	NC_000016.10:2085232:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4573C>G (p.Gln1525Glu)	TSC2	Q1458E, Q1481E, Q1502E, Q1459E, Q1482E, Q1525E, Q1281E, Q1410E, Q1422E, Q1469E	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000663392	16	2135234	16	2085233	663392	644336	rs45517352	NC_000016.10:2085232:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4573C>T (p.Gln1525Ter)	TSC2	Q1525*, Q1458*, Q1410*, Q1469*, Q1482*, Q1459*, Q1281*, Q1422*, Q1481*, Q1502*	not provided|Tuberous sclerosis 2	VCV000049306	16	2135234	16	2085233	49306	58468	rs45517352	NC_000016.10:2085232:C:T	single nucleotide variant	nonsense	Pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4574A>G (p.Gln1525Arg)	TSC2	Q1410R, Q1525R, Q1281R, Q1458R, Q1459R, Q1469R, Q1481R, Q1482R, Q1502R, Q1422R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000639390	16	2135235	16	2085234	639390	644337	rs1596426462	NC_000016.10:2085233:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4575G>A (p.Gln1525=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000743154	16	2135236	16	2085235	743154	755006	rs1596426497	NC_000016.10:2085234:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4576T>A (p.Ser1526Thr)	TSC2	S1282T, S1411T, S1460T, S1482T, S1503T, S1459T, S1470T, S1483T, S1423T, S1526T	Hereditary cancer-predisposing syndrome	VCV000825015	16	2135237	16	2085236	825015	812608	rs1596426554	NC_000016.10:2085235:T:A	single nucleotide variant	missense variant	Uncertain significance	May 22, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4577C>G (p.Ser1526Cys)	TSC2	S1055C, S1259C, S1303C, S1411C, S1423C, S1466C, S1503C, S1525C, S1260C, S1302C, S1455C, S1460C, S1483C, S1502C, S1526C, S1012C, S1034C, S1410C, S1422C, S1453C, S1456C, S1470C, S1482C, S1490C, S1500C, S925C, S1011C, S1035C, S1282C, S1306C, S1326C, S1440C, S1454C, S1459C, S1489C	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002844410	16	2135238	16	2085237	2844410	3008051	rs796053498	NC_000016.10:2085236:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4577C>A (p.Ser1526Tyr)	TSC2	S1526Y, S1282Y, S1459Y, S1423Y, S1503Y, S1411Y, S1470Y, S1482Y, S1483Y, S1460Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207755	16	2135238	16	2085237	207755	203194	rs796053498	NC_000016.10:2085236:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4578C>A (p.Ser1526=)	TSC2		Tuberous sclerosis syndrome	VCV003072844	16	2135239	16	2085238	3072844	3229116	rs771098638	NC_000016.10:2085237:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4579T>G (p.Phe1527Val)	TSC2	F1412V, F1504V, F1471V, F1483V, F1283V, F1460V, F1527V, F1424V, F1461V, F1484V	Tuberous sclerosis 2	VCV001469764	16	2135240	16	2085239	1469764	1475712	rs45514391	NC_000016.10:2085238:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4579T>C (p.Phe1527Leu)	TSC2	F1527L, F1283L, F1460L, F1412L, F1424L, F1483L, F1504L, F1461L, F1471L, F1484L	TSC2-related disorder|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000049473	16	2135240	16	2085239	49473	58635	rs45514391	NC_000016.10:2085238:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4580T>C (p.Phe1527Ser)	TSC2	F1460S, F1484S, F1504S, F1283S, F1483S, F1527S, F1424S, F1471S, F1412S, F1461S	Tuberous sclerosis 2	VCV001512761	16	2135241	16	2085240	1512761	1380854	rs2151550358	NC_000016.10:2085239:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4581T>G (p.Phe1527Leu)	TSC2	F1036L, F1441L, F1456L, F1457L, F1461L, F1483L, F926L, F1013L, F1056L, F1260L, F1283L, F1303L, F1327L, F1411L, F1412L, F1423L, F1460L, F1490L, F1491L, F1501L, F1503L, F1012L, F1035L, F1455L, F1467L, F1471L, F1527L, F1261L, F1304L, F1307L, F1424L, F1454L, F1484L, F1504L, F1526L	Tuberous sclerosis 2	VCV002705118	16	2135242	16	2085241	2705118	2860129	rs745860116	NC_000016.10:2085240:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4581T>A (p.Phe1527Leu)	TSC2	F1412L, F1424L, F1471L, F1504L, F1483L, F1484L, F1283L, F1461L, F1460L, F1527L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000648504	16	2135242	16	2085241	648504	644338	rs745860116	NC_000016.10:2085240:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4581T>C (p.Phe1527=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468104	16	2135242	16	2085241	468104	465374	rs745860116	NC_000016.10:2085240:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4582G>T (p.Glu1528Ter)	TSC2	E1013*, E1014*, E1036*, E1037*, E1057*, E1261*, E1262*, E1284*, E1304*, E1305*, E1308*, E1328*, E1412*, E1413*, E1424*, E1425*, E1442*, E1455*, E1456*, E1457*, E1458*, E1461*, E1462*, E1468*, E1472*, E1484*, E1485*, E1491*, E1492*, E1502*, E1504*, E1505*, E1527*, E1528*, E927*	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV002500105	16	2135243	16	2085242	2500105	2478086	rs2090622255	NC_000016.10:2085241:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic		criteria provided, single submitter							
NM_000548.5(TSC2):c.4582G>C (p.Glu1528Gln)	TSC2	E1461Q, E1472Q, E1528Q, E1425Q, E1485Q, E1505Q, E1484Q, E1284Q, E1413Q, E1462Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000848503	16	2135243	16	2085242	848503	843508	rs2090622255	NC_000016.10:2085241:G:C	single nucleotide variant	missense variant	Uncertain significance	May 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4584G>A (p.Glu1528=)	TSC2		Tuberous sclerosis 2	VCV001613715	16	2135245	16	2085244	1613715	1536470	rs199848388	NC_000016.10:2085243:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4584G>T (p.Glu1528Asp)	TSC2	E1528D, E1284D, E1425D, E1461D, E1462D, E1472D, E1413D, E1485D, E1484D, E1505D	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000041743	16	2135245	16	2085244	41743	50182	rs199848388	NC_000016.10:2085243:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4585C>G (p.Arg1529Gly)	TSC2	R1306G, R1413G, R1426G, R1456G, R1457G, R1459G, R1485G, R1528G, R1015G, R1038G, R1263G, R1309G, R1414G, R1425G, R1469G, R1486G, R1492G, R1506G, R1037G, R1058G, R1262G, R1285G, R1329G, R1458G, R1462G, R1473G, R1505G, R1529G, R928G, R1014G, R1305G, R1443G, R1463G, R1493G, R1503G	Hereditary cancer-predisposing syndrome	VCV001741666	16	2135246	16	2085245	1741666	1805109	rs1051502900	NC_000016.10:2085244:C:G	single nucleotide variant	missense variant	Uncertain significance	May 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4585C>T (p.Arg1529Trp)	TSC2	R1529W, R1486W, R1506W, R1414W, R1463W, R1473W, R1485W, R1462W, R1285W, R1426W	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536044	16	2135246	16	2085245	536044	529761	rs1051502900	NC_000016.10:2085244:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4586G>T (p.Arg1529Leu)	TSC2	R1426L, R1463L, R1485L, R1486L, R1506L, R1414L, R1462L, R1285L, R1473L, R1529L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001046768	16	2135247	16	2085246	1046768	1032495	rs769834772	NC_000016.10:2085245:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4586G>A (p.Arg1529Gln)	TSC2	R1529Q, R1462Q, R1473Q, R1285Q, R1486Q, R1506Q, R1414Q, R1426Q, R1463Q, R1485Q	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000468105	16	2135247	16	2085246	468105	465377	rs769834772	NC_000016.10:2085245:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4587G>A (p.Arg1529=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001123236	16	2135248	16	2085247	1123236	1125093	rs2151550637	NC_000016.10:2085246:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4589C>A (p.Ser1530Ter)	TSC2	S1015*, S1016*, S1039*, S1059*, S1307*, S1426*, S1427*, S1458*, S1460*, S1463*, S1470*, S1486*, S1529*, S1530*, S1286*, S1444*, S1506*, S1263*, S1414*, S1459*, S1464*, S1487*, S1494*, S1507*, S929*, S1038*, S1264*, S1306*, S1310*, S1330*, S1415*, S1457*, S1474*, S1493*, S1504*	Hereditary cancer-predisposing syndrome	VCV001741685	16	2135250	16	2085249	1741685	1805128	rs1567528487	NC_000016.10:2085248:C:A	single nucleotide variant	nonsense	Pathogenic	May 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4589C>T (p.Ser1530Leu)	TSC2	S1530L, S1415L, S1427L, S1286L, S1464L, S1474L, S1487L, S1463L, S1507L, S1486L	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000573348	16	2135250	16	2085249	573348	569835	rs1567528487	NC_000016.10:2085248:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4590G>T (p.Ser1530=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003183562	16	2135251	16	2085250	3183562	3340635	rs377377367	NC_000016.10:2085249:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Oct 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4590G>C (p.Ser1530=)	TSC2		Tuberous sclerosis 2	VCV001119919	16	2135251	16	2085250	1119919	1103676	rs377377367	NC_000016.10:2085249:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4590G>A (p.Ser1530=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000406096	16	2135251	16	2085250	406096	401664	rs377377367	NC_000016.10:2085249:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4591G>T (p.Val1531Leu)	TSC2	V1040L, V1458L, V1461L, V1465L, V1487L, V1494L, V1508L, V1530L, V1265L, V1307L, V1311L, V1459L, V1464L, V1495L, V1507L, V930L, V1016L, V1039L, V1287L, V1415L, V1427L, V1488L, V1531L, V1017L, V1060L, V1264L, V1308L, V1331L, V1416L, V1428L, V1445L, V1460L, V1471L, V1475L, V1505L	Tuberous sclerosis 2	VCV002810197	16	2135252	16	2085251	2810197	2968725	rs762797016	NC_000016.10:2085250:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4591G>C (p.Val1531Leu)	TSC2	V1016L, V1017L, V1039L, V1040L, V1060L, V1264L, V1265L, V1287L, V1307L, V1308L, V1311L, V1331L, V1415L, V1416L, V1427L, V1428L, V1445L, V1458L, V1459L, V1460L, V1461L, V1464L, V1465L, V1471L, V1475L, V1487L, V1488L, V1494L, V1495L, V1505L, V1507L, V1508L, V1530L, V1531L, V930L	Tuberous sclerosis 2	VCV001718303	16	2135252	16	2085251	1718303	1778663	rs762797016	NC_000016.10:2085250:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4591G>A (p.Val1531Met)	TSC2	V1465M, V1487M, V1531M, V1287M, V1416M, V1475M, V1428M, V1464M, V1488M, V1508M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001398100	16	2135252	16	2085251	1398100	1431029	rs762797016	NC_000016.10:2085250:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4592T>C (p.Val1531Ala)	TSC2	V1287A, V1416A, V1428A, V1464A, V1465A, V1475A, V1487A, V1488A, V1508A, V1531A	Tuberous sclerosis 2	VCV001061534	16	2135253	16	2085252	1061534	1049490	rs2090623543	NC_000016.10:2085251:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4593G>A (p.Val1531=)	TSC2		Tuberous sclerosis 2	VCV004071151	16	2135254	16	2085253	4071151	4184999		NC_000016.10:2085252:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4594C>T (p.Gln1532Ter)	TSC2	Q1532*, Q1417*, Q1429*, Q1488*, Q1489*, Q1509*, Q1288*, Q1476*, Q1466*, Q1465*	Tuberous sclerosis 2|not provided	VCV000280774	16	2135255	16	2085254	280774	264936	rs886041919	NC_000016.10:2085253:C:T	single nucleotide variant	nonsense	Pathogenic	Nov 23, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4596G>A (p.Gln1532=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002045146	16	2135257	16	2085256	2045146	2092718	rs2151551059	NC_000016.10:2085255:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 17, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4597C>T (p.Leu1533Phe)	TSC2	L1533F, L1430F, L1490F, L1510F, L1289F, L1466F, L1477F, L1418F, L1467F, L1489F	Tuberous sclerosis 2	VCV000572768	16	2135258	16	2085257	572768	569843	rs1567528528	NC_000016.10:2085256:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4598T>C (p.Leu1533Pro)	TSC2	L1018P, L1313P, L1430P, L1467P, L1497P, L1266P, L1267P, L1333P, L1418P, L1429P, L1447P, L1463P, L1477P, L1489P, L1496P, L1533P, L932P, L1041P, L1042P, L1062P, L1309P, L1310P, L1417P, L1460P, L1461P, L1462P, L1466P, L1510P, L1019P, L1289P, L1473P, L1490P, L1507P, L1509P, L1532P	Hereditary cancer-predisposing syndrome	VCV003974665	16	2135259	16	2085258	3974665	4086488		NC_000016.10:2085257:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4599C>G (p.Leu1533=)	TSC2		Tuberous sclerosis 2	VCV004071199	16	2135260	16	2085259	4071199	4185047		NC_000016.10:2085258:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4599C>A (p.Leu1533=)	TSC2		Tuberous sclerosis 2	VCV001113326	16	2135260	16	2085259	1113326	1103677	rs768431568	NC_000016.10:2085258:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 4, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4599C>T (p.Leu1533=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000480844	16	2135260	16	2085259	480844	477389	rs768431568	NC_000016.10:2085258:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4600C>G (p.Leu1534Val)	TSC2	L1290V, L1478V, L1534V, L1419V, L1468V, L1431V, L1490V, L1511V, L1467V, L1491V	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000963446	16	2135261	16	2085260	963446	949278	rs375520841	NC_000016.10:2085259:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4602C>G (p.Leu1534=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002909961	16	2135263	16	2085262	2909961	3066602	rs368534883	NC_000016.10:2085261:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4602C>T (p.Leu1534=)	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000378791	16	2135263	16	2085262	378791	377271	rs368534883	NC_000016.10:2085261:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4603G>C (p.Asp1535His)	TSC2	D1291H, D1420H, D1432H, D1468H, D1469H, D1479H, D1491H, D1492H, D1512H, D1535H	Hereditary cancer-predisposing syndrome|not provided	VCV001013089	16	2135264	16	2085263	1013089	1000927	rs45517353	NC_000016.10:2085262:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 26, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4603G>A (p.Asp1535Asn)	TSC2	D1512N, D1491N, D1291N, D1420N, D1432N, D1468N, D1469N, D1492N, D1535N, D1479N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000798176	16	2135264	16	2085263	798176	785206	rs45517353	NC_000016.10:2085262:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4603G>T (p.Asp1535Tyr)	TSC2	D1535Y, D1420Y, D1468Y, D1479Y, D1432Y, D1469Y, D1491Y, D1492Y, D1512Y, D1291Y	Tuberous sclerosis 2	VCV000050016	16	2135264	16	2085263	50016	59178	rs45517353	NC_000016.10:2085262:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4604A>T (p.Asp1535Val)	TSC2	D1535V, D1512V, D1479V, D1491V, D1291V, D1420V, D1432V, D1468V, D1469V, D1492V	Tuberous sclerosis 2	VCV000065305	16	2135265	16	2085264	65305	76237	rs397515160	NC_000016.10:2085263:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4605C>T (p.Asp1535=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825038	16	2135266	16	2085265	825038	812609	rs1555515283	NC_000016.10:2085264:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4605C>A (p.Asp1535Glu)	TSC2	D1535E, D1291E, D1420E, D1469E, D1432E, D1468E, D1512E, D1479E, D1491E, D1492E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486640	16	2135266	16	2085265	486640	477978	rs1555515283	NC_000016.10:2085264:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4606C>T (p.Gln1536Ter)	TSC2	Q1536*, Q1421*, Q1469*, Q1470*, Q1480*, Q1513*, Q1433*, Q1292*, Q1492*, Q1493*	Tuberous sclerosis 2	VCV000049475	16	2135267	16	2085266	49475	58637	rs45495796	NC_000016.10:2085265:C:T	single nucleotide variant	nonsense	Pathogenic	Apr 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4607A>G (p.Gln1536Arg)	TSC2	Q1480R, Q1536R, Q1292R, Q1421R, Q1470R, Q1493R, Q1513R, Q1433R, Q1492R, Q1469R	Tuberous sclerosis 2	VCV001400703	16	2135268	16	2085267	1400703	1463555	rs2151551661	NC_000016.10:2085266:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4608G>C (p.Gln1536His)	TSC2	Q1022H, Q1313H, Q1420H, Q1433H, Q1464H, Q1480H, Q1045H, Q1463H, Q1469H, Q1476H, Q1493H, Q1513H, Q1535H, Q1065H, Q1312H, Q1316H, Q1421H, Q1450H, Q1465H, Q1470H, Q1492H, Q1500H, Q1510H, Q1536H, Q1021H, Q1044H, Q1269H, Q1270H, Q1292H, Q1336H, Q1432H, Q1466H, Q1499H, Q1512H, Q935H	Tuberous sclerosis 2	VCV003730259	16	2135269	16	2085268	3730259	3862326		NC_000016.10:2085267:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4608G>T (p.Gln1536His)	TSC2	Q1292H, Q1470H, Q1480H, Q1433H, Q1421H, Q1493H, Q1469H, Q1492H, Q1513H, Q1536H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001420522	16	2135269	16	2085268	1420522	1403130	rs749875773	NC_000016.10:2085267:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4610T>A (p.Ile1537Asn)	TSC2	I1023N, I1465N, I1536N, I1537N, I936N, I1022N, I1271N, I1293N, I1313N, I1314N, I1421N, I1422N, I1467N, I1477N, I1494N, I1514N, I1046N, I1270N, I1317N, I1434N, I1466N, I1471N, I1481N, I1493N, I1511N, I1513N, I1045N, I1066N, I1337N, I1433N, I1451N, I1464N, I1470N, I1500N, I1501N	Hereditary cancer-predisposing syndrome	VCV001741892	16	2135271	16	2085270	1741892	1801535	rs760056622	NC_000016.10:2085269:T:A	single nucleotide variant	missense variant	Uncertain significance	May 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4610T>G (p.Ile1537Ser)	TSC2	I1293S, I1494S, I1493S, I1537S, I1422S, I1434S, I1471S, I1470S, I1481S, I1514S	Tuberous sclerosis 2	VCV001509011	16	2135271	16	2085270	1509011	1452128	rs760056622	NC_000016.10:2085269:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4610T>C (p.Ile1537Thr)	TSC2	I1537T, I1293T, I1434T, I1494T, I1514T, I1422T, I1481T, I1470T, I1471T, I1493T	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000579053	16	2135271	16	2085270	579053	567873	rs760056622	NC_000016.10:2085269:T:C	single nucleotide variant	missense variant	Benign/Likely benign	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4611C>T (p.Ile1537=)	TSC2		Tuberous sclerosis 2	VCV002849258	16	2135272	16	2085271	2849258	3009049	rs765688277	NC_000016.10:2085270:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Mar 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4612C>G (p.Pro1538Ala)	TSC2	P1294A, P1435A, P1494A, P1471A, P1482A, P1515A, P1423A, P1472A, P1495A, P1538A	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000843912	16	2135273	16	2085272	843912	843509	rs1060500930	NC_000016.10:2085271:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4612C>T (p.Pro1538Ser)	TSC2	P1538S, P1423S, P1435S, P1472S, P1515S, P1482S, P1494S, P1495S, P1294S, P1471S	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405997	16	2135273	16	2085272	405997	401423	rs1060500930	NC_000016.10:2085271:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4613C>T (p.Pro1538Leu)	TSC2	P1423L, P1494L, P1294L, P1435L, P1472L, P1482L, P1495L, P1515L, P1538L, P1471L	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV001038007	16	2135274	16	2085273	1038007	1032496	rs753060862	NC_000016.10:2085272:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4613C>A (p.Pro1538Gln)	TSC2	P1538Q, P1423Q, P1472Q, P1495Q, P1294Q, P1435Q, P1471Q, P1482Q, P1494Q, P1515Q	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II	VCV000579379	16	2135274	16	2085273	579379	569850	rs753060862	NC_000016.10:2085272:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 18, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4614A>T (p.Pro1538=)	TSC2		Tuberous sclerosis 2	VCV004071159	16	2135275	16	2085274	4071159	4185007		NC_000016.10:2085273:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4614A>G (p.Pro1538=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536074	16	2135275	16	2085274	536074	529765	rs1382897280	NC_000016.10:2085273:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4616C>A (p.Ser1539Ter)	TSC2	S1025*, S1273*, S1316*, S1436*, S1466*, S1469*, S1483*, S1496*, S1515*, S938*, S1024*, S1068*, S1295*, S1315*, S1435*, S1467*, S1502*, S1503*, S1516*, S1538*, S1319*, S1472*, S1479*, S1513*, S1539*, S1047*, S1048*, S1272*, S1339*, S1423*, S1424*, S1453*, S1468*, S1473*, S1495*	Tuberous sclerosis 2	VCV002725064	16	2135277	16	2085276	2725064	2885556	rs2151551960	NC_000016.10:2085275:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jun 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4617A>G (p.Ser1539=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000220843	16	2135278	16	2085277	220843	222452	rs201038907	NC_000016.10:2085276:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4619A>G (p.Tyr1540Cys)	TSC2	Y1025C, Y1049C, Y1274C, Y1425C, Y1468C, Y1470C, Y1480C, Y1069C, Y1317C, Y1340C, Y1454C, Y1467C, Y1484C, Y1497C, Y1503C, Y1516C, Y939C, Y1026C, Y1296C, Y1424C, Y1436C, Y1469C, Y1474C, Y1496C, Y1517C, Y1539C, Y1540C, Y1048C, Y1273C, Y1316C, Y1320C, Y1437C, Y1473C, Y1504C, Y1514C	Hereditary cancer-predisposing syndrome	VCV003811284	16	2135280	16	2085279	3811284	3928526		NC_000016.10:2085278:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4620C>T (p.Tyr1540=)	TSC2		not provided|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413749	16	2135281	16	2085280	413749	400976	rs45455897	NC_000016.10:2085279:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4620C>G (p.Tyr1540Ter)	TSC2	Y1540*, Y1474*, Y1497*, Y1425*, Y1437*, Y1484*, Y1296*, Y1496*, Y1473*, Y1517*	Tuberous sclerosis 2	VCV000049849	16	2135281	16	2085280	49849	59011	rs45455897	NC_000016.10:2085279:C:G	single nucleotide variant	nonsense	Pathogenic	Feb 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4620C>A (p.Tyr1540Ter)	TSC2	Y1540*, Y1425*, Y1296*, Y1473*, Y1497*, Y1517*, Y1437*, Y1474*, Y1484*, Y1496*	Tuberous sclerosis 2	VCV000049476	16	2135281	16	2085280	49476	58638	rs45455897	NC_000016.10:2085279:C:A	single nucleotide variant	nonsense	Pathogenic	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4621G>A (p.Asp1541Asn)	TSC2	D1541N, D1498N, D1474N, D1475N, D1426N, D1518N, D1297N, D1438N, D1485N, D1497N	not provided|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535990	16	2135282	16	2085281	535990	530029	rs796872464	NC_000016.10:2085280:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4622A>G (p.Asp1541Gly)	TSC2	D1504G, D1505G, D1515G, D1517G, D1518G, D1540G, D1541G, D940G, D1026G, D1027G, D1049G, D1050G, D1070G, D1274G, D1275G, D1297G, D1317G, D1318G, D1321G, D1341G, D1425G, D1426G, D1437G, D1438G, D1455G, D1468G, D1469G, D1470G, D1471G, D1474G, D1475G, D1481G, D1485G, D1497G, D1498G	TSC2-related disorder|Tuberous sclerosis 2	VCV002633616	16	2135283	16	2085282	2633616	2801833	rs1419056951	NC_000016.10:2085281:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4623C>T (p.Asp1541=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468106	16	2135284	16	2085283	468106	465380	rs1555515315	NC_000016.10:2085282:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4624A>G (p.Thr1542Ala)	TSC2	T1275A, T1298A, T1319A, T1438A, T1469A, T1470A, T1486A, T1499A, T1505A, T1518A, T1542A, T1027A, T1051A, T1276A, T1318A, T1426A, T1427A, T1475A, T1516A, T1541A, T1028A, T1050A, T1071A, T1342A, T1439A, T1471A, T1476A, T1482A, T1498A, T1506A, T1519A, T1322A, T1456A, T1472A, T941A	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV002725000	16	2135285	16	2085284	2725000	2885492	rs2544325339	NC_000016.10:2085283:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4625C>G (p.Thr1542Ser)	TSC2	T1298S, T1427S, T1439S, T1475S, T1476S, T1486S, T1498S, T1499S, T1519S, T1542S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692504	16	2135286	16	2085285	1692504	1684944	rs2090628070	NC_000016.10:2085284:C:G	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4625C>T (p.Thr1542Ile)	TSC2	T1298I, T1427I, T1439I, T1475I, T1476I, T1486I, T1498I, T1499I, T1519I, T1542I	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001051582	16	2135286	16	2085285	1051582	1049491	rs2090628070	NC_000016.10:2085284:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4625C>A (p.Thr1542Asn)	TSC2	T1427N, T1475N, T1476N, T1439N, T1498N, T1499N, T1519N, T1542N, T1298N, T1486N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001047812	16	2135286	16	2085285	1047812	1032497	rs2090628070	NC_000016.10:2085284:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4626C>T (p.Thr1542=)	TSC2		Tuberous sclerosis 2	VCV001106340	16	2135287	16	2085286	1106340	1103678	rs1164781795	NC_000016.10:2085285:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 5, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4626C>A (p.Thr1542=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000755660	16	2135287	16	2085286	755660	770739	rs1164781795	NC_000016.10:2085285:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4627C>T (p.His1543Tyr)	TSC2	H1543Y, H1476Y, H1487Y, H1499Y, H1520Y, H1428Y, H1477Y, H1299Y, H1440Y, H1500Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000570564	16	2135288	16	2085287	570564	569852	rs1567528890	NC_000016.10:2085286:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4628A>G (p.His1543Arg)	TSC2	H1299R, H1428R, H1440R, H1476R, H1477R, H1487R, H1499R, H1500R, H1520R, H1543R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000973206	16	2135289	16	2085288	973206	961581	rs2090628516	NC_000016.10:2085287:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4629C>T (p.His1543=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002861462	16	2135290	16	2085289	2861462	3018937	rs751873212	NC_000016.10:2085288:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4629C>G (p.His1543Gln)	TSC2	H1320Q, H1343Q, H1472Q, H1483Q, H1542Q, H942Q, H1029Q, H1276Q, H1440Q, H1457Q, H1471Q, H1487Q, H1506Q, H1543Q, H1052Q, H1299Q, H1323Q, H1507Q, H1519Q, H1520Q, H1072Q, H1277Q, H1427Q, H1428Q, H1439Q, H1470Q, H1473Q, H1476Q, H1477Q, H1499Q, H1500Q, H1517Q, H1028Q, H1051Q, H1319Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001741992	16	2135290	16	2085289	1741992	1801635	rs751873212	NC_000016.10:2085288:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4630A>G (p.Lys1544Glu)	TSC2	K1320E, K1324E, K1441E, K1484E, K1029E, K1030E, K1073E, K1344E, K1429E, K1458E, K1471E, K1477E, K1478E, K1488E, K1501E, K1521E, K1543E, K1544E, K943E, K1052E, K1277E, K1428E, K1473E, K1500E, K1507E, K1518E, K1520E, K1053E, K1278E, K1300E, K1321E, K1440E, K1472E, K1474E, K1508E	Tuberous sclerosis 2	VCV003706140	16	2135291	16	2085290	3706140	3839593		NC_000016.10:2085289:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4631A>C (p.Lys1544Thr)	TSC2	K1029T, K1052T, K1277T, K1321T, K1472T, K1473T, K1478T, K1484T, K943T, K1300T, K1428T, K1440T, K1471T, K1500T, K1501T, K1507T, K1508T, K1520T, K1521T, K1544T, K1053T, K1073T, K1324T, K1429T, K1458T, K1030T, K1278T, K1320T, K1344T, K1441T, K1474T, K1477T, K1488T, K1518T, K1543T	Tuberous sclerosis 2	VCV002717127	16	2135292	16	2085291	2717127	2872953	rs2090629229	NC_000016.10:2085290:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4631A>G (p.Lys1544Arg)	TSC2	K1429R, K1477R, K1500R, K1478R, K1501R, K1441R, K1521R, K1300R, K1488R, K1544R	Tuberous sclerosis 2	VCV000847208	16	2135292	16	2085291	847208	843510	rs2090629229	NC_000016.10:2085290:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4632G>C (p.Lys1544Asn)	TSC2	K1277N, K1344N, K1428N, K1441N, K1458N, K1484N, K1488N, K1501N, K1507N, K1520N, K1543N, K1030N, K1052N, K1073N, K1429N, K1440N, K1518N, K943N, K1278N, K1300N, K1320N, K1321N, K1324N, K1472N, K1473N, K1478N, K1500N, K1544N, K1029N, K1053N, K1471N, K1474N, K1477N, K1508N, K1521N	Tuberous sclerosis 2	VCV002767300	16	2135293	16	2085292	2767300	2922874	rs2090629438	NC_000016.10:2085291:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4632G>A (p.Lys1544=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564620	16	2135293	16	2085292	2564620	2733776	rs2090629438	NC_000016.10:2085291:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4633A>T (p.Ile1545Phe)	TSC2	I1279F, I1321F, I1322F, I1442F, I1544F, I1030F, I1074F, I1429F, I1473F, I1475F, I1478F, I1489F, I1278F, I1345F, I1430F, I1441F, I1459F, I1472F, I1474F, I1479F, I1502F, I1508F, I1521F, I1545F, I944F, I1031F, I1053F, I1054F, I1301F, I1325F, I1485F, I1501F, I1509F, I1519F, I1522F	Hereditary cancer-predisposing syndrome	VCV002564745	16	2135294	16	2085293	2564745	2733901	rs878854109	NC_000016.10:2085292:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4633A>G (p.Ile1545Val)	TSC2	I1545V, I1442V, I1478V, I1501V, I1479V, I1502V, I1301V, I1430V, I1489V, I1522V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome	VCV000238055	16	2135294	16	2085293	238055	242314	rs878854109	NC_000016.10:2085292:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4634T>C (p.Ile1545Thr)	TSC2	I1030T, I1031T, I1053T, I1054T, I1074T, I1278T, I1279T, I1301T, I1321T, I1322T, I1325T, I1345T, I1429T, I1430T, I1441T, I1442T, I1459T, I1472T, I1473T, I1474T, I1475T, I1478T, I1479T, I1485T, I1489T, I1501T, I1502T, I1508T, I1509T, I1519T, I1521T, I1522T, I1544T, I1545T, I944T	not provided	VCV003342104	16	2135295	16	2085294	3342104	3501336		NC_000016.10:2085293:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Aug 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4635C>A (p.Ile1545=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002074367	16	2135296	16	2085295	2074367	2141329	rs757388437	NC_000016.10:2085294:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4635C>G (p.Ile1545Met)	TSC2	I1301M, I1430M, I1522M, I1442M, I1478M, I1479M, I1489M, I1501M, I1502M, I1545M	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000838523	16	2135296	16	2085295	838523	843511	rs757388437	NC_000016.10:2085294:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4635C>T (p.Ile1545=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000413701	16	2135296	16	2085295	413701	400978	rs757388437	NC_000016.10:2085294:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4636G>C (p.Ala1546Pro)	TSC2	A1032P, A1054P, A1075P, A1323P, A1460P, A1473P, A1479P, A1480P, A1502P, A1520P, A1545P, A1055P, A1430P, A1474P, A1475P, A1476P, A1486P, A1522P, A945P, A1031P, A1302P, A1326P, A1443P, A1490P, A1503P, A1509P, A1523P, A1279P, A1280P, A1322P, A1346P, A1431P, A1442P, A1510P, A1546P	Tuberous sclerosis 2	VCV003637242	16	2135297	16	2085296	3637242	3771396		NC_000016.10:2085295:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4636G>T (p.Ala1546Ser)	TSC2	A1302S, A1431S, A1443S, A1479S, A1480S, A1490S, A1502S, A1503S, A1523S, A1546S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001005935	16	2135297	16	2085296	1005935	996759	rs1332979299	NC_000016.10:2085295:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4636G>A (p.Ala1546Thr)	TSC2	A1480T, A1502T, A1443T, A1523T, A1546T, A1490T, A1302T, A1431T, A1479T, A1503T	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000825059	16	2135297	16	2085296	825059	812610	rs1332979299	NC_000016.10:2085295:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4637C>T (p.Ala1546Val)	TSC2	A1054V, A1302V, A1322V, A1346V, A1431V, A1479V, A1486V, A1503V, A1545V, A1326V, A1443V, A1473V, A1509V, A1510V, A1523V, A1546V, A1031V, A1075V, A1279V, A1280V, A1442V, A1474V, A1475V, A1480V, A1490V, A1502V, A1522V, A945V, A1032V, A1055V, A1323V, A1430V, A1460V, A1476V, A1520V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002626432	16	2135298	16	2085297	2626432	2794198	rs2151552752	NC_000016.10:2085296:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4638C>T (p.Ala1546=)	TSC2		not specified|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050019	16	2135299	16	2085298	50019	59181	rs45517354	NC_000016.10:2085297:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4639G>A (p.Val1547Ile)	TSC2	V1547I, V1480I, V1481I, V1491I, V1524I, V1303I, V1504I, V1432I, V1444I, V1503I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000238056	16	2135300	16	2085299	238056	242315	rs745895675	NC_000016.10:2085298:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4640T>A (p.Val1547Asp)	TSC2	V1547D, V1444D, V1503D, V1432D, V1480D, V1491D, V1524D, V1504D, V1303D, V1481D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000547827	16	2135301	16	2085300	547827	538097	rs397514988	NC_000016.10:2085299:T:A	single nucleotide variant	missense variant	Uncertain significance	May 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4641C>A (p.Val1547=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329490	16	2135302	16	2085301	3329490	3489082		NC_000016.10:2085300:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4641C>G (p.Val1547=)	TSC2		Tuberous sclerosis syndrome	VCV003074298	16	2135302	16	2085301	3074298	3231433	rs1060504087	NC_000016.10:2085300:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4641C>T (p.Val1547=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413636	16	2135302	16	2085301	413636	400986	rs1060504087	NC_000016.10:2085300:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4642C>T (p.Leu1548=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001742119	16	2135303	16	2085302	1742119	1801761	rs769883910	NC_000016.10:2085301:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4643T>G (p.Leu1548Arg)	TSC2	L1033R, L1034R, L1056R, L1057R, L1077R, L1281R, L1282R, L1304R, L1324R, L1325R, L1328R, L1348R, L1432R, L1433R, L1444R, L1445R, L1462R, L1475R, L1476R, L1477R, L1478R, L1481R, L1482R, L1488R, L1492R, L1504R, L1505R, L1511R, L1512R, L1522R, L1524R, L1525R, L1547R, L1548R, L947R	Tuberous sclerosis 2	VCV004080616	16	2135304	16	2085303	4080616	4194039		NC_000016.10:2085302:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4643T>C (p.Leu1548Pro)	TSC2	L1548P, L1445P, L1481P, L1482P, L1504P, L1492P, L1304P, L1433P, L1525P, L1505P	Tuberous sclerosis 2	VCV000065095	16	2135304	16	2085303	65095	76026	rs397515070	NC_000016.10:2085302:T:C	single nucleotide variant	missense variant	Pathogenic	Oct 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4644G>T (p.Leu1548=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001125473	16	2135305	16	2085304	1125473	1125094	rs780071959	NC_000016.10:2085303:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4644G>A (p.Leu1548=)	TSC2		Tuberous sclerosis 2	VCV000752136	16	2135305	16	2085304	752136	770740	rs780071959	NC_000016.10:2085303:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4645T>C (p.Tyr1549His)	TSC2	Y1305H, Y1483H, Y1446H, Y1493H, Y1505H, Y1506H, Y1549H, Y1434H, Y1482H, Y1526H	Tuberous sclerosis 2	VCV001519233	16	2135306	16	2085305	1519233	1433730	rs45488595	NC_000016.10:2085304:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4646A>G (p.Tyr1549Cys)	TSC2	Y1549C, Y1446C, Y1526C, Y1305C, Y1434C, Y1483C, Y1493C, Y1505C, Y1506C, Y1482C	not provided|Tuberous sclerosis 2	VCV000049479	16	2135307	16	2085306	49479	58641	rs45517355	NC_000016.10:2085305:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4647T>C (p.Tyr1549=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000825068	16	2135308	16	2085307	825068	812611	rs397515028	NC_000016.10:2085306:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4648G>A (p.Val1550Ile)	TSC2	V1283I, V1327I, V1330I, V1350I, V1435I, V1446I, V1507I, V1524I, V1526I, V1550I, V949I, V1058I, V1306I, V1434I, V1447I, V1478I, V1479I, V1506I, V1527I, V1035I, V1036I, V1059I, V1326I, V1464I, V1477I, V1480I, V1483I, V1490I, V1494I, V1514I, V1549I, V1079I, V1284I, V1484I, V1513I	Tuberous sclerosis 2	VCV002717103	16	2135309	16	2085308	2717103	2872929	rs2090633103	NC_000016.10:2085307:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4648G>T (p.Val1550Phe)	TSC2	V1306F, V1435F, V1447F, V1483F, V1484F, V1494F, V1506F, V1507F, V1527F, V1550F	Tuberous sclerosis 2	VCV001000977	16	2135309	16	2085308	1000977	996760	rs2090633103	NC_000016.10:2085307:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4649T>A (p.Val1550Asp)	TSC2	V1435D, V1483D, V1507D, V1494D, V1506D, V1550D, V1306D, V1527D, V1447D, V1484D	Tuberous sclerosis 2	VCV001424662	16	2135310	16	2085309	1424662	1438538	rs2151553395	NC_000016.10:2085308:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4650T>C (p.Val1550=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468107	16	2135311	16	2085310	468107	466100	rs1555515367	NC_000016.10:2085309:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4652G>C (p.Gly1551Ala)	TSC2	G1036A, G1037A, G1059A, G1060A, G1080A, G1284A, G1285A, G1307A, G1327A, G1328A, G1331A, G1351A, G1435A, G1436A, G1447A, G1448A, G1465A, G1478A, G1479A, G1480A, G1481A, G1484A, G1485A, G1491A, G1495A, G1507A, G1508A, G1514A, G1515A, G1525A, G1527A, G1528A, G1550A, G1551A, G950A	Hereditary cancer-predisposing syndrome	VCV003232172	16	2135313	16	2085312	3232172	3391973	rs2151553490	NC_000016.10:2085311:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4652G>A (p.Gly1551Glu)	TSC2	G1059E, G1060E, G1331E, G1447E, G1448E, G1485E, G1491E, G1507E, G1508E, G1527E, G1528E, G1550E, G1551E, G1080E, G1284E, G1285E, G1307E, G1328E, G1436E, G1481E, G1515E, G950E, G1435E, G1478E, G1514E, G1036E, G1037E, G1327E, G1351E, G1465E, G1479E, G1480E, G1484E, G1495E, G1525E	Tuberous sclerosis 2	VCV002772414	16	2135313	16	2085312	2772414	2933566	rs2151553490	NC_000016.10:2085311:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4653A>C (p.Gly1551=)	TSC2		Tuberous sclerosis 2	VCV004071304	16	2135314	16	2085313	4071304	4185152		NC_000016.10:2085312:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4653A>G (p.Gly1551=)	TSC2		Tuberous sclerosis 2	VCV001540663	16	2135314	16	2085313	1540663	1598679	rs2151553578	NC_000016.10:2085312:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4654G>A (p.Glu1552Lys)	TSC2	E1037K, E1038K, E1352K, E1437K, E1449K, E1508K, E1516K, E1552K, E951K, E1060K, E1285K, E1286K, E1332K, E1436K, E1466K, E1482K, E1492K, E1509K, E1061K, E1308K, E1329K, E1448K, E1479K, E1480K, E1481K, E1485K, E1515K, E1526K, E1528K, E1081K, E1328K, E1486K, E1496K, E1529K, E1551K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003637243	16	2135315	16	2085314	3637243	3771397		NC_000016.10:2085313:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 31, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4655A>G (p.Glu1552Gly)	TSC2	E1449G, E1509G, E1486G, E1496G, E1552G, E1308G, E1437G, E1508G, E1485G, E1529G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001476653	16	2135316	16	2085315	1476653	1339425	rs2151553694	NC_000016.10:2085314:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4656A>T (p.Glu1552Asp)	TSC2	E1329D, E1436D, E1448D, E1332D, E1352D, E1437D, E1480D, E1482D, E1509D, E1529D, E1552D, E1037D, E1081D, E1286D, E1328D, E1515D, E951D, E1449D, E1466D, E1481D, E1485D, E1486D, E1492D, E1516D, E1526D, E1551D, E1038D, E1060D, E1061D, E1285D, E1308D, E1479D, E1496D, E1508D, E1528D	Tuberous sclerosis 2	VCV003637244	16	2135317	16	2085316	3637244	3771398		NC_000016.10:2085315:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4656A>G (p.Glu1552=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000238057	16	2135317	16	2085316	238057	242316	rs878854110	NC_000016.10:2085315:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4657G>A (p.Gly1553Ser)	TSC2	G1333S, G1437S, G1450S, G1467S, G1481S, G1486S, G1487S, G1516S, G1517S, G952S, G1038S, G1287S, G1330S, G1438S, G1483S, G1497S, G1509S, G1552S, G1553S, G1039S, G1061S, G1286S, G1309S, G1329S, G1353S, G1449S, G1527S, G1529S, G1530S, G1062S, G1082S, G1480S, G1482S, G1493S, G1510S	Tuberous sclerosis 2	VCV002700593	16	2135318	16	2085317	2700593	2855592	rs2151553804	NC_000016.10:2085316:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4657G>T (p.Gly1553Cys)	TSC2	G1038C, G1287C, G1309C, G1450C, G1487C, G1527C, G1530C, G952C, G1330C, G1333C, G1437C, G1438C, G1481C, G1482C, G1509C, G1552C, G1061C, G1082C, G1286C, G1329C, G1353C, G1449C, G1480C, G1486C, G1510C, G1516C, G1517C, G1553C, G1039C, G1062C, G1467C, G1483C, G1493C, G1497C, G1529C	Hereditary cancer-predisposing syndrome	VCV001742213	16	2135318	16	2085317	1742213	1801855	rs2151553804	NC_000016.10:2085316:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4658G>T (p.Gly1553Val)	TSC2	G1082V, G1309V, G1449V, G1467V, G1517V, G1527V, G1553V, G1038V, G1333V, G1353V, G1437V, G1450V, G1481V, G1482V, G1487V, G1510V, G1552V, G1062V, G1286V, G1329V, G1330V, G1480V, G1486V, G1493V, G1497V, G1529V, G1530V, G952V, G1039V, G1061V, G1287V, G1438V, G1483V, G1509V, G1516V	Tuberous sclerosis 2	VCV002058376	16	2135319	16	2085318	2058376	2109783	rs2090634038	NC_000016.10:2085317:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4658G>A (p.Gly1553Asp)	TSC2	G1497D, G1509D, G1530D, G1438D, G1450D, G1486D, G1309D, G1553D, G1487D, G1510D	not provided|Tuberous sclerosis 2	VCV000953372	16	2135319	16	2085318	953372	949280	rs2090634038	NC_000016.10:2085317:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4659C>T (p.Gly1553=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000834532	16	2135320	16	2085319	834532	843512	rs202212109	NC_000016.10:2085318:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4659C>G (p.Gly1553=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000700284	16	2135320	16	2085319	700284	688548	rs202212109	NC_000016.10:2085318:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4660C>A (p.Gln1554Lys)	TSC2	Q1039K, Q1040K, Q1062K, Q1310K, Q1354K, Q1487K, Q1494K, Q1518K, Q1528K, Q953K, Q1063K, Q1288K, Q1331K, Q1334K, Q1439K, Q1450K, Q1481K, Q1482K, Q1483K, Q1484K, Q1511K, Q1083K, Q1287K, Q1330K, Q1488K, Q1517K, Q1438K, Q1451K, Q1468K, Q1498K, Q1510K, Q1530K, Q1531K, Q1553K, Q1554K	Hereditary cancer-predisposing syndrome	VCV002449994	16	2135321	16	2085320	2449994	2425951	rs2090634528	NC_000016.10:2085319:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4660C>T (p.Gln1554Ter)	TSC2	Q1487*, Q1498*, Q1554*, Q1451*, Q1439*, Q1510*, Q1511*, Q1310*, Q1488*, Q1531*	Tuberous sclerosis 2|not provided	VCV000962178	16	2135321	16	2085320	962178	949281	rs2090634528	NC_000016.10:2085319:C:T	single nucleotide variant	nonsense	Pathogenic	Jul 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4661A>C (p.Gln1554Pro)	TSC2	Q1554P, Q1439P, Q1488P, Q1510P, Q1531P, Q1310P, Q1511P, Q1451P, Q1487P, Q1498P	not provided|Tuberous sclerosis 2	VCV000049866	16	2135322	16	2085321	49866	59028	rs45473296	NC_000016.10:2085320:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4662G>T (p.Gln1554His)	TSC2	Q1554H, Q1451H, Q1511H, Q1531H, Q1498H, Q1487H, Q1510H, Q1310H, Q1439H, Q1488H	Tuberous sclerosis 2	VCV000049486	16	2135323	16	2085322	49486	58648	rs137854880	NC_000016.10:2085321:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 31, 2019	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662G>A (p.Gln1554=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049485	16	2135323	16	2085322	49485	58647	rs137854880	NC_000016.10:2085321:G:A	single nucleotide variant	synonymous variant	Pathogenic	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662+1G>T	TSC2		not provided	VCV002580417	16	2135324	16	2085323	2580417	2748005	rs45514095	NC_000016.10:2085322:G:T	single nucleotide variant	splice donor variant	Pathogenic	Mar 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+1G>C	TSC2		Tuberous sclerosis 2	VCV000858998	16	2135324	16	2085323	858998	852103	rs45514095	NC_000016.10:2085322:G:C	single nucleotide variant	splice donor variant	Likely pathogenic	Jan 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+1G>A	TSC2		Lymphangiomyomatosis|Infantile spasms|Intellectual disability, severe|Tuberous sclerosis 2	VCV000050031	16	2135324	16	2085323	50031	59193	rs45514095	NC_000016.10:2085322:G:A	single nucleotide variant	splice donor variant	Pathogenic	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662+2T>C	TSC2		Tuberous sclerosis 2	VCV002747517	16	2135325	16	2085324	2747517	2904410	rs2151554076	NC_000016.10:2085323:T:C	single nucleotide variant	splice donor variant	Pathogenic	Jul 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+4A>C	TSC2		Tuberous sclerosis 2	VCV002024259	16	2135327	16	2085326	2024259	2077036	rs2544329462	NC_000016.10:2085325:A:C	single nucleotide variant	intron variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+5G>A	TSC2		Tuberous sclerosis 2	VCV001006039	16	2135328	16	2085327	1006039	996761	rs2090635893	NC_000016.10:2085326:G:A	single nucleotide variant	intron variant	Uncertain significance	Oct 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+7C>A	TSC2		Tuberous sclerosis 2	VCV001608159	16	2135330	16	2085329	1608159	1539598	rs1555515435	NC_000016.10:2085328:C:A	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662+7C>G	TSC2		Tuberous sclerosis 2	VCV001515360	16	2135330	16	2085329	1515360	1505225	rs1555515435	NC_000016.10:2085328:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4662+7C>T	TSC2		Tuberous sclerosis 2	VCV000536039	16	2135330	16	2085329	536039	529704	rs1555515435	NC_000016.10:2085328:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662+9G>A	TSC2		Tuberous sclerosis 2	VCV001671222	16	2135332	16	2085331	1671222	1530112	rs2151554223	NC_000016.10:2085330:G:A	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662+10C>A	TSC2		Tuberous sclerosis 2	VCV000793716	16	2135333	16	2085332	793716	788002	rs371195832	NC_000016.10:2085331:C:A	single nucleotide variant	intron variant	Likely benign	Mar 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+10C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000207686	16	2135333	16	2085332	207686	203196	rs371195832	NC_000016.10:2085331:C:T	single nucleotide variant	intron variant	Benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662+11G>T	TSC2		Tuberous sclerosis 2	VCV002787548	16	2135334	16	2085333	2787548	2946097	rs761569930	NC_000016.10:2085332:G:T	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+11G>C	TSC2		Tuberous sclerosis 2	VCV001665525	16	2135334	16	2085333	1665525	1589909	rs761569930	NC_000016.10:2085332:G:C	single nucleotide variant	intron variant	Likely benign	Feb 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+11G>A	TSC2		not provided|Tuberous sclerosis 2	VCV001319397	16	2135334	16	2085333	1319397	1309650	rs761569930	NC_000016.10:2085332:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4662+13G>A	TSC2		Tuberous sclerosis 2	VCV002702383	16	2135336	16	2085335	2702383	2856100	rs2151554349	NC_000016.10:2085334:G:A	single nucleotide variant	intron variant	Likely benign	Feb 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+14G>C	TSC2		Tuberous sclerosis 2	VCV003716141	16	2135337	16	2085336	3716141	3852406		NC_000016.10:2085335:G:C	single nucleotide variant	intron variant	Likely benign	Dec 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+14G>T	TSC2		Tuberous sclerosis 2	VCV002725276	16	2135337	16	2085336	2725276	2881895	rs772807006	NC_000016.10:2085335:G:T	single nucleotide variant	intron variant	Likely benign	Apr 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+14G>A	TSC2		Tuberous sclerosis 2	VCV002045265	16	2135337	16	2085336	2045265	2103157	rs772807006	NC_000016.10:2085335:G:A	single nucleotide variant	intron variant	Likely benign	Sep 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+15C>T	TSC2		Tuberous sclerosis 2	VCV002919740	16	2135338	16	2085337	2919740	3072621	rs1567529367	NC_000016.10:2085336:C:T	single nucleotide variant	intron variant	Likely benign	Sep 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+16C>G	TSC2		Tuberous sclerosis 2	VCV001556648	16	2135339	16	2085338	1556648	1592792	rs45517356	NC_000016.10:2085337:C:G	single nucleotide variant	intron variant	Likely benign	Oct 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+16C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000049481	16	2135339	16	2085338	49481	58643	rs45517356	NC_000016.10:2085337:C:T	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662+17G>T	TSC2		Tuberous sclerosis 2	VCV002713904	16	2135340	16	2085339	2713904	2872327	rs45443002	NC_000016.10:2085338:G:T	single nucleotide variant	intron variant	Likely benign	Jan 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+17G>C	TSC2		Tuberous sclerosis 2	VCV001624230	16	2135340	16	2085339	1624230	1563069	rs45443002	NC_000016.10:2085338:G:C	single nucleotide variant	intron variant	Likely benign	Dec 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+17G>A	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|not specified	VCV000049482	16	2135340	16	2085339	49482	58644	rs45443002	NC_000016.10:2085338:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662+18G>A	TSC2		not provided|Tuberous sclerosis 2|not specified	VCV000050030	16	2135341	16	2085340	50030	59192	rs45517357	NC_000016.10:2085339:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jun 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4662+19C>T	TSC2		Tuberous sclerosis 2	VCV003603887	16	2135342	16	2085341	3603887	3746361		NC_000016.10:2085340:C:T	single nucleotide variant	intron variant	Likely benign	Feb 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4662+20C>G	TSC2		Tuberous sclerosis 2	VCV003658256	16	2135343	16	2085342	3658256	3800483		NC_000016.10:2085341:C:G	single nucleotide variant	intron variant	Likely benign	Jun 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-19C>T	TSC2		Tuberous sclerosis 2	VCV001596002	16	2136175	16	2086174	1596002	1569576	rs2090761236	NC_000016.10:2086173:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-19C>G	TSC2		Tuberous sclerosis 2	VCV001590349	16	2136175	16	2086174	1590349	1642242	rs2090761236	NC_000016.10:2086173:C:G	single nucleotide variant	intron variant	Likely benign	May 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-17C>T	TSC2		Tuberous sclerosis 2	VCV002802484	16	2136177	16	2086176	2802484	2963169	rs137854192	NC_000016.10:2086175:C:T	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-15C>T	TSC2		Tuberous sclerosis 2	VCV001605971	16	2136179	16	2086178	1605971	1560466	rs2090761880	NC_000016.10:2086177:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-14C>G	TSC2		Tuberous sclerosis 2	VCV002163634	16	2136180	16	2086179	2163634	1905346	rs397515174	NC_000016.10:2086178:C:G	single nucleotide variant	intron variant	Likely benign	Apr 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-14C>T	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified	VCV000065240	16	2136180	16	2086179	65240	76172	rs397515174	NC_000016.10:2086178:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-13C>T	TSC2		Tuberous sclerosis 2	VCV002139828	16	2136181	16	2086180	2139828	1868661	rs966007423	NC_000016.10:2086179:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-13C>A	TSC2		Tuberous sclerosis 2	VCV001593867	16	2136181	16	2086180	1593867	1655286	rs966007423	NC_000016.10:2086179:C:A	single nucleotide variant	intron variant	Likely benign	Jun 25, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-12C>T	TSC2		Tuberous sclerosis 2	VCV002179400	16	2136182	16	2086181	2179400	1919797	rs750736540	NC_000016.10:2086180:C:T	single nucleotide variant	intron variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-12C>G	TSC2		Tuberous sclerosis 2	VCV002041201	16	2136182	16	2086181	2041201	2095223	rs750736540	NC_000016.10:2086180:C:G	single nucleotide variant	intron variant	Likely benign	Jun 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-11T>C	TSC2		Tuberous sclerosis 2	VCV004071072	16	2136183	16	2086182	4071072	4184920		NC_000016.10:2086181:T:C	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-10C>T	TSC2		Tuberous sclerosis 2	VCV001153304	16	2136184	16	2086183	1153304	1145974	rs766608928	NC_000016.10:2086182:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-10C>G	TSC2		Tuberous sclerosis 2	VCV000750211	16	2136184	16	2086183	750211	760467	rs766608928	NC_000016.10:2086182:C:G	single nucleotide variant	intron variant	Likely benign	Sep 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-9T>C	TSC2		Tuberous sclerosis 2	VCV000755175	16	2136185	16	2086184	755175	776507	rs1596437808	NC_000016.10:2086183:T:C	single nucleotide variant	intron variant	Likely benign	Mar 15, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-8C>A	TSC2		Tuberous sclerosis 2	VCV001122349	16	2136186	16	2086185	1122349	1125095	rs753947985	NC_000016.10:2086184:C:A	single nucleotide variant	intron variant	Likely benign	Aug 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-8C>T	TSC2		Tuberous sclerosis 2	VCV000766464	16	2136186	16	2086185	766464	776512	rs753947985	NC_000016.10:2086184:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-7C>G	TSC2		Tuberous sclerosis 2	VCV003605518	16	2136187	16	2086186	3605518	3746695		NC_000016.10:2086185:C:G	single nucleotide variant	intron variant	Likely benign	Jun 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-7C>T	TSC2		Tuberous sclerosis 2	VCV000413728	16	2136187	16	2086186	413728	400990	rs778646938	NC_000016.10:2086185:C:T	single nucleotide variant	intron variant	Benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-6C>A	TSC2		Tuberous sclerosis 2	VCV003725435	16	2136188	16	2086187	3725435	3860943		NC_000016.10:2086186:C:A	single nucleotide variant	intron variant	Likely benign	Nov 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-6C>G	TSC2		Tuberous sclerosis 2	VCV003641482	16	2136188	16	2086187	3641482	3775639		NC_000016.10:2086186:C:G	single nucleotide variant	intron variant	Likely benign	Apr 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-6C>T	TSC2		Tuberous sclerosis 2	VCV000755005	16	2136188	16	2086187	755005	776319	rs1596437883	NC_000016.10:2086186:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-5C>A	TSC2		not specified	VCV002429162	16	2136189	16	2086188	2429162	2402594	rs1555515976	NC_000016.10:2086187:C:A	single nucleotide variant	intron variant	Uncertain significance	Jan 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-5C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536021	16	2136189	16	2086188	536021	530031	rs1555515976	NC_000016.10:2086187:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-4A>C	TSC2		Hereditary cancer-predisposing syndrome	VCV003974583	16	2136190	16	2086189	3974583	4086406		NC_000016.10:2086188:A:C	single nucleotide variant	intron variant	Likely benign	May 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-4A>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001987457	16	2136190	16	2086189	1987457	2040105	rs1596437939	NC_000016.10:2086188:A:G	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-4A>T	TSC2		Tuberous sclerosis 2	VCV000793734	16	2136190	16	2086189	793734	788188	rs1596437939	NC_000016.10:2086188:A:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-3C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238058	16	2136191	16	2086190	238058	242317	rs397514930	NC_000016.10:2086189:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4663-2A>C	TSC2		Tuberous sclerosis 2	VCV001993912	16	2136192	16	2086191	1993912	2059574	rs2151569037	NC_000016.10:2086190:A:C	single nucleotide variant	splice acceptor variant	Pathogenic	May 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-2A>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001742266	16	2136192	16	2086191	1742266	1798467	rs2151569037	NC_000016.10:2086190:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663-1G>T	TSC2		Tuberous sclerosis 2	VCV000568594	16	2136193	16	2086192	568594	573878	rs45517358	NC_000016.10:2086191:G:T	single nucleotide variant	splice acceptor variant	Pathogenic	Aug 31, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663-1G>A	TSC2		Tuberous sclerosis 2	VCV000049312	16	2136193	16	2086192	49312	58474	rs45517358	NC_000016.10:2086191:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Aug 31, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4663A>G (p.Ser1555Gly)	TSC2	S1311G, S1489G, S1499G, S1511G, S1532G, S1452G, S1488G, S1512G, S1440G, S1555G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001346900	16	2136194	16	2086193	1346900	1453013	rs1555515982	NC_000016.10:2086192:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4663A>T (p.Ser1555Cys)	TSC2	S1555C, S1311C, S1512C, S1499C, S1532C, S1440C, S1488C, S1489C, S1511C, S1452C	Tuberous sclerosis 2	VCV000535871	16	2136194	16	2086193	535871	529706	rs1555515982	NC_000016.10:2086192:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4664G>A (p.Ser1555Asn)	TSC2	S1440N, S1489N, S1499N, S1511N, S1512N, S1311N, S1488N, S1452N, S1532N, S1555N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000851592	16	2136195	16	2086194	851592	843513	rs1354678802	NC_000016.10:2086193:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4665C>A (p.Ser1555Arg)	TSC2	S1064R, S1289R, S1331R, S1355R, S1451R, S1452R, S1483R, S1495R, S1511R, S954R, S1288R, S1335R, S1469R, S1499R, S1512R, S1529R, S1554R, S1555R, S1041R, S1084R, S1332R, S1439R, S1440R, S1482R, S1484R, S1488R, S1489R, S1518R, S1519R, S1531R, S1040R, S1063R, S1311R, S1485R, S1532R	Tuberous sclerosis 2	VCV003661626	16	2136196	16	2086195	3661626	3801305		NC_000016.10:2086194:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4666A>G (p.Asn1556Asp)	TSC2	N1312D, N1441D, N1453D, N1489D, N1490D, N1500D, N1512D, N1513D, N1533D, N1556D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692505	16	2136197	16	2086196	1692505	1684945	rs2151569260	NC_000016.10:2086195:A:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4666A>T (p.Asn1556Tyr)	TSC2	N1441Y, N1513Y, N1489Y, N1556Y, N1312Y, N1500Y, N1512Y, N1533Y, N1453Y, N1490Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001396696	16	2136197	16	2086196	1396696	1418447	rs2151569260	NC_000016.10:2086195:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4667A>G (p.Asn1556Ser)	TSC2	N1556S, N1312S, N1441S, N1500S, N1489S, N1533S, N1453S, N1490S, N1513S, N1512S	Tuberous sclerosis 2	VCV000578149	16	2136198	16	2086197	578149	569853	rs1567532307	NC_000016.10:2086196:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4668C>T (p.Asn1556=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002626424	16	2136199	16	2086198	2626424	2794190	rs2151569345	NC_000016.10:2086197:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4670G>C (p.Ser1557Thr)	TSC2	S1043T, S1066T, S1290T, S1291T, S1484T, S1486T, S1513T, S1520T, S1556T, S1557T, S1313T, S1334T, S1490T, S1501T, S1514T, S1533T, S1534T, S956T, S1042T, S1337T, S1357T, S1441T, S1442T, S1471T, S1485T, S1491T, S1065T, S1086T, S1333T, S1453T, S1454T, S1487T, S1497T, S1521T, S1531T	Hereditary cancer-predisposing syndrome	VCV001742322	16	2136201	16	2086200	1742322	1798523	rs2151569419	NC_000016.10:2086199:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4671C>T (p.Ser1557=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000406044	16	2136202	16	2086201	406044	401667	rs151140709	NC_000016.10:2086200:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4671C>G (p.Ser1557Arg)	TSC2	S1557R, S1501R, S1313R, S1442R, S1513R, S1454R, S1490R, S1514R, S1534R, S1491R	not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000230643	16	2136202	16	2086201	230643	235138	rs151140709	NC_000016.10:2086200:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4672G>T (p.Glu1558Ter)	TSC2	E1314*, E1443*, E1455*, E1491*, E1492*, E1502*, E1514*, E1515*, E1535*, E1558*	TSC2-related disorder	VCV000929512	16	2136203	16	2086202	929512	917833	rs45517360	NC_000016.10:2086201:G:T	single nucleotide variant	nonsense	Pathogenic	Oct 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4672G>A (p.Glu1558Lys)	TSC2	E1558K, E1443K, E1455K, E1502K, E1514K, E1314K, E1491K, E1535K, E1492K, E1515K	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049794	16	2136203	16	2086202	49794	58956	rs45517360	NC_000016.10:2086201:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4674G>A (p.Glu1558=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001119050	16	2136205	16	2086204	1119050	1103679	rs2151569595	NC_000016.10:2086203:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4675C>G (p.Leu1559Val)	TSC2	L1456V, L1492V, L1503V, L1559V, L1315V, L1444V, L1493V, L1515V, L1516V, L1536V	Tuberous sclerosis 2	VCV001422859	16	2136206	16	2086205	1422859	1412752	rs1327797297	NC_000016.10:2086204:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4675C>T (p.Leu1559Phe)	TSC2	L1315F, L1444F, L1456F, L1492F, L1493F, L1503F, L1515F, L1516F, L1536F, L1559F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001017982	16	2136206	16	2086205	1017982	1012004	rs1327797297	NC_000016.10:2086204:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4677C>T (p.Leu1559=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486636	16	2136208	16	2086207	486636	477426	rs45517361	NC_000016.10:2086206:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4677C>G (p.Leu1559=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000050051	16	2136208	16	2086207	50051	59213	rs45517361	NC_000016.10:2086206:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4678G>C (p.Ala1560Pro)	TSC2	A1294P, A1316P, A1337P, A1444P, A1474P, A1500P, A1517P, A1559P, A1045P, A1069P, A1360P, A1445P, A1489P, A1493P, A1494P, A1504P, A1516P, A1524P, A1536P, A1089P, A1336P, A1340P, A1456P, A1487P, A1490P, A1534P, A959P, A1046P, A1068P, A1293P, A1457P, A1488P, A1523P, A1537P, A1560P	Tuberous sclerosis 2	VCV003637245	16	2136209	16	2086208	3637245	3771399		NC_000016.10:2086207:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4678G>T (p.Ala1560Ser)	TSC2	A1445S, A1494S, A1504S, A1537S, A1560S, A1316S, A1457S, A1493S, A1516S, A1517S	Tuberous sclerosis 2	VCV000639107	16	2136209	16	2086208	639107	644339	rs777539610	NC_000016.10:2086207:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4678G>A (p.Ala1560Thr)	TSC2	A1560T, A1445T, A1457T, A1504T, A1316T, A1493T, A1516T, A1517T, A1494T, A1537T	Hereditary cancer-predisposing syndrome|Ovarian cancer|Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000535895	16	2136209	16	2086208	535895	529769	rs777539610	NC_000016.10:2086207:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4679C>T (p.Ala1560Val)	TSC2	A1316V, A1445V, A1457V, A1493V, A1494V, A1504V, A1516V, A1517V, A1537V, A1560V	Tuberous sclerosis 2	VCV001007723	16	2136210	16	2086209	1007723	996762	rs2090766850	NC_000016.10:2086208:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4680C>T (p.Ala1560=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184768	16	2136211	16	2086210	184768	184143	rs139507276	NC_000016.10:2086209:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4681A>G (p.Ile1561Val)	TSC2	I1070V, I1317V, I1338V, I1361V, I1475V, I1517V, I1535V, I1537V, I1047V, I1337V, I1446V, I1490V, I1491V, I1495V, I1518V, I1538V, I1069V, I1090V, I1294V, I1295V, I1341V, I1445V, I1457V, I1488V, I1489V, I1494V, I1501V, I1505V, I1524V, I1561V, I1046V, I1458V, I1525V, I1560V, I960V	Tuberous sclerosis 2	VCV003637246	16	2136212	16	2086211	3637246	3771400		NC_000016.10:2086210:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4681A>T (p.Ile1561Phe)	TSC2	I1317F, I1446F, I1458F, I1494F, I1495F, I1505F, I1517F, I1518F, I1538F, I1561F	Tuberous sclerosis 2	VCV001022708	16	2136212	16	2086211	1022708	1012005	rs2090767182	NC_000016.10:2086210:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4683C>T (p.Ile1561=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065198	16	2136214	16	2086213	65198	76130	rs145033857	NC_000016.10:2086212:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4684C>A (p.Leu1562Met)	TSC2	L1318M, L1447M, L1496M, L1539M, L1562M, L1459M, L1495M, L1518M, L1519M, L1506M	Tuberous sclerosis 2	VCV001492677	16	2136215	16	2086214	1492677	1516815	rs1057523304	NC_000016.10:2086213:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4684C>T (p.Leu1562=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000389020	16	2136215	16	2086214	389020	377272	rs1057523304	NC_000016.10:2086213:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4685T>A (p.Leu1562Gln)	TSC2	L1048Q, L1295Q, L1446Q, L1489Q, L1495Q, L1506Q, L1519Q, L1526Q, L1538Q, L1539Q, L1561Q, L1562Q, L1070Q, L1071Q, L1296Q, L1362Q, L1459Q, L1492Q, L1525Q, L1536Q, L1091Q, L1318Q, L1447Q, L1476Q, L1490Q, L1491Q, L1502Q, L1518Q, L1047Q, L1338Q, L1339Q, L1342Q, L1458Q, L1496Q, L961Q	Tuberous sclerosis 2	VCV002078251	16	2136216	16	2086215	2078251	2138766	rs45517362	NC_000016.10:2086214:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4685T>C (p.Leu1562Pro)	TSC2	L1562P, L1495P, L1506P, L1518P, L1459P, L1519P, L1539P, L1447P, L1318P, L1496P	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000050052	16	2136216	16	2086215	50052	59214	rs45517362	NC_000016.10:2086214:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 20, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4686G>A (p.Leu1562=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001742416	16	2136217	16	2086216	1742416	1798617	rs780703883	NC_000016.10:2086215:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4688C>T (p.Ser1563Phe)	TSC2	S1296F, S1319F, S1343F, S1363F, S1460F, S1477F, S1493F, S1503F, S1537F, S1539F, S1563F, S1049F, S1447F, S1491F, S1496F, S1497F, S1519F, S1048F, S1072F, S1339F, S1448F, S1459F, S1507F, S1527F, S1071F, S1092F, S1297F, S1340F, S1490F, S1492F, S1520F, S1526F, S1540F, S1562F, S962F	Tuberous sclerosis 2	VCV002996725	16	2136219	16	2086218	2996725	3159609	rs533515579	NC_000016.10:2086217:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4688C>G (p.Ser1563Cys)	TSC2	S1048C, S1448C, S1496C, S1503C, S1539C, S1071C, S1092C, S1319C, S1363C, S1520C, S1526C, S1537C, S962C, S1297C, S1339C, S1340C, S1343C, S1447C, S1460C, S1491C, S1492C, S1497C, S1507C, S1519C, S1540C, S1049C, S1072C, S1296C, S1459C, S1477C, S1490C, S1493C, S1527C, S1562C, S1563C	Tuberous sclerosis 2	VCV002054859	16	2136219	16	2086218	2054859	2108860	rs533515579	NC_000016.10:2086217:C:G	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4689C>A (p.Ser1563=)	TSC2		Tuberous sclerosis 2	VCV001924276	16	2136220	16	2086219	1924276	1983176	rs45517363	NC_000016.10:2086218:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4689C>G (p.Ser1563=)	TSC2		Tuberous sclerosis 2	VCV001666129	16	2136220	16	2086219	1666129	1655858	rs45517363	NC_000016.10:2086218:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 27, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4689C>T (p.Ser1563=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000050053	16	2136220	16	2086219	50053	59215	rs45517363	NC_000016.10:2086218:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4691A>C (p.Asn1564Thr)	TSC2	N1320T, N1340T, N1461T, N1478T, N1497T, N1521T, N1540T, N963T, N1049T, N1050T, N1072T, N1297T, N1364T, N1448T, N1492T, N1493T, N1498T, N1508T, N1527T, N1564T, N1344T, N1449T, N1491T, N1504T, N1520T, N1528T, N1073T, N1093T, N1298T, N1341T, N1460T, N1494T, N1563T, N1538T, N1541T	Hereditary cancer-predisposing syndrome	VCV002564703	16	2136222	16	2086221	2564703	2733859	rs876659806	NC_000016.10:2086220:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4691A>G (p.Asn1564Ser)	TSC2	N1564S, N1320S, N1449S, N1461S, N1520S, N1498S, N1508S, N1541S, N1497S, N1521S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000232502	16	2136222	16	2086221	232502	235139	rs876659806	NC_000016.10:2086220:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4692T>G (p.Asn1564Lys)	TSC2	N1050K, N1460K, N1497K, N1504K, N1527K, N1528K, N1564K, N1297K, N1341K, N1364K, N1448K, N1449K, N1520K, N1540K, N963K, N1049K, N1072K, N1073K, N1340K, N1478K, N1492K, N1508K, N1521K, N1538K, N1563K, N1093K, N1298K, N1320K, N1344K, N1461K, N1491K, N1493K, N1494K, N1498K, N1541K	Tuberous sclerosis 2	VCV003637247	16	2136223	16	2086222	3637247	3771401		NC_000016.10:2086221:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4692T>C (p.Asn1564=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000701614	16	2136223	16	2086222	701614	688549	rs774664591	NC_000016.10:2086221:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4694A>T (p.Glu1565Val)	TSC2	E1074V, E1298V, E1345V, E1365V, E1509V, E1541V, E964V, E1050V, E1299V, E1341V, E1449V, E1462V, E1494V, E1522V, E1051V, E1094V, E1492V, E1495V, E1499V, E1521V, E1529V, E1539V, E1542V, E1564V, E1073V, E1321V, E1342V, E1450V, E1461V, E1479V, E1493V, E1498V, E1505V, E1528V, E1565V	Hereditary cancer-predisposing syndrome	VCV003811377	16	2136225	16	2086224	3811377	3928618		NC_000016.10:2086223:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4695G>A (p.Glu1565=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002626442	16	2136226	16	2086225	2626442	2794208	rs762372483	NC_000016.10:2086224:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4695G>T (p.Glu1565Asp)	TSC2	E1509D, E1521D, E1522D, E1450D, E1565D, E1462D, E1498D, E1542D, E1321D, E1499D	Tuberous sclerosis 2	VCV001361035	16	2136226	16	2086225	1361035	1383407	rs762372483	NC_000016.10:2086224:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4695G>C (p.Glu1565Asp)	TSC2	E1450D, E1499D, E1509D, E1521D, E1522D, E1565D, E1321D, E1462D, E1498D, E1542D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000942410	16	2136226	16	2086225	942410	937346	rs762372483	NC_000016.10:2086224:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4696C>G (p.His1566Asp)	TSC2	H1451D, H1510D, H1523D, H1566D, H1499D, H1522D, H1463D, H1500D, H1543D, H1322D	Tuberous sclerosis 2	VCV000845966	16	2136227	16	2086226	845966	843514	rs1596438391	NC_000016.10:2086225:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4696C>T (p.His1566Tyr)	TSC2	H1322Y, H1451Y, H1510Y, H1522Y, H1523Y, H1500Y, H1543Y, H1463Y, H1499Y, H1566Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000646424	16	2136227	16	2086226	646424	644340	rs1596438391	NC_000016.10:2086225:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4697A>G (p.His1566Arg)	TSC2	H1322R, H1451R, H1463R, H1499R, H1500R, H1510R, H1522R, H1523R, H1543R, H1566R	Hereditary cancer-predisposing syndrome|not provided|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV001309870	16	2136228	16	2086227	1309870	1299245	rs1448001502	NC_000016.10:2086226:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4699G>C (p.Gly1567Arg)	TSC2	G1075R, G1096R, G1301R, G1344R, G1347R, G1494R, G1495R, G1500R, G1523R, G1530R, G1531R, G1541R, G1544R, G966R, G1052R, G1323R, G1481R, G1507R, G1543R, G1567R, G1076R, G1343R, G1367R, G1451R, G1452R, G1497R, G1501R, G1511R, G1524R, G1566R, G1053R, G1300R, G1463R, G1464R, G1496R	Tuberous sclerosis 2	VCV002721650	16	2136230	16	2086229	2721650	2884739	rs2151570619	NC_000016.10:2086228:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4700G>C (p.Gly1567Ala)	TSC2	G1075A, G1076A, G1452A, G1494A, G1500A, G1511A, G1524A, G1544A, G1052A, G1323A, G1344A, G1347A, G1367A, G1451A, G1495A, G1507A, G1530A, G1531A, G1541A, G1566A, G1567A, G1053A, G1300A, G1301A, G1463A, G1496A, G1497A, G1543A, G966A, G1096A, G1343A, G1464A, G1481A, G1501A, G1523A	Tuberous sclerosis 2	VCV001947542	16	2136231	16	2086230	1947542	2006398	rs45517364	NC_000016.10:2086229:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4700G>T (p.Gly1567Val)	TSC2	G1567V, G1452V, G1500V, G1544V, G1323V, G1501V, G1523V, G1524V, G1464V, G1511V	not provided	VCV000065318	16	2136231	16	2086230	65318	76250	rs45517364	NC_000016.10:2086229:G:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4700G>A (p.Gly1567Asp)	TSC2	G1567D, G1323D, G1452D, G1501D, G1511D, G1500D, G1544D, G1464D, G1523D, G1524D	Hereditary cancer-predisposing syndrome	VCV000050054	16	2136231	16	2086230	50054	59216	rs45517364	NC_000016.10:2086229:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4701C>T (p.Gly1567=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV001077461	16	2136232	16	2086231	1077461	1081867	rs763804965	NC_000016.10:2086230:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4701C>A (p.Gly1567=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000763767	16	2136232	16	2086231	763767	770741	rs763804965	NC_000016.10:2086230:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4701C>G (p.Gly1567=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000702945	16	2136232	16	2086231	702945	693822	rs763804965	NC_000016.10:2086230:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4702T>C (p.Ser1568Pro)	TSC2	S1345P, S1348P, S1496P, S1508P, S1512P, S967P, S1053P, S1076P, S1301P, S1302P, S1497P, S1524P, S1531P, S1568P, S1097P, S1324P, S1464P, S1482P, S1498P, S1502P, S1567P, S1054P, S1077P, S1344P, S1368P, S1452P, S1453P, S1465P, S1495P, S1501P, S1525P, S1532P, S1542P, S1544P, S1545P	Hereditary cancer-predisposing syndrome	VCV003974637	16	2136233	16	2086232	3974637	4086460		NC_000016.10:2086231:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4703C>T (p.Ser1568Phe)	TSC2	S1054F, S1076F, S1077F, S1302F, S1324F, S1344F, S1348F, S1464F, S1495F, S1497F, S1512F, S1568F, S1097F, S1452F, S1508F, S1525F, S1053F, S1345F, S1453F, S1496F, S1502F, S1524F, S1531F, S1532F, S1542F, S1544F, S1545F, S1301F, S1368F, S1465F, S1482F, S1498F, S1501F, S1567F, S967F	Tuberous sclerosis 2	VCV002972780	16	2136234	16	2086233	2972780	3132727	rs1555516036	NC_000016.10:2086232:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4703C>G (p.Ser1568Cys)	TSC2	S1568C, S1324C, S1512C, S1545C, S1465C, S1502C, S1453C, S1525C, S1501C, S1524C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000468108	16	2136234	16	2086233	468108	466030	rs1555516036	NC_000016.10:2086232:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4704C>A (p.Ser1568=)	TSC2		Tuberous sclerosis 2	VCV004071068	16	2136235	16	2086234	4071068	4184916		NC_000016.10:2086233:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4704C>T (p.Ser1568=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV001124252	16	2136235	16	2086234	1124252	1125096	rs916198158	NC_000016.10:2086233:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4705T>C (p.Tyr1569His)	TSC2	Y1569H, Y1502H, Y1466H, Y1513H, Y1525H, Y1526H, Y1546H, Y1325H, Y1454H, Y1503H	Tuberous sclerosis 2	VCV000568923	16	2136236	16	2086235	568923	570133	rs1567532712	NC_000016.10:2086234:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4706A>G (p.Tyr1569Cys)	TSC2	Y1466C, Y1513C, Y1525C, Y1325C, Y1454C, Y1526C, Y1503C, Y1569C, Y1502C, Y1546C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000956326	16	2136237	16	2086236	956326	949282	rs2090771064	NC_000016.10:2086235:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4707C>T (p.Tyr1569=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000701272	16	2136238	16	2086237	701272	688550	rs397515277	NC_000016.10:2086236:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4707C>G (p.Tyr1569Ter)	TSC2	Y1569*, Y1466*, Y1513*, Y1526*, Y1503*, Y1325*, Y1454*, Y1502*, Y1525*, Y1546*	Tuberous sclerosis 2	VCV000065367	16	2136238	16	2086237	65367	76301	rs397515277	NC_000016.10:2086236:C:G	single nucleotide variant	nonsense	Pathogenic	Jan 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4708A>G (p.Arg1570Gly)	TSC2	R1326G, R1455G, R1467G, R1503G, R1504G, R1514G, R1526G, R1527G, R1547G, R1570G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000998584	16	2136239	16	2086238	998584	996763	rs45517365	NC_000016.10:2086237:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4709G>A (p.Arg1570Lys)	TSC2	R1455K, R1503K, R1504K, R1526K, R1527K, R1570K, R1326K, R1467K, R1547K, R1514K	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000664159	16	2136240	16	2086239	664159	644341	rs397514980	NC_000016.10:2086238:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4710G>C (p.Arg1570Ser)	TSC2	R1056S, R1078S, R1079S, R1099S, R1350S, R1370S, R1466S, R1467S, R1499S, R1503S, R1533S, R1570S, R1055S, R1304S, R1326S, R1346S, R1484S, R1498S, R1510S, R1514S, R1303S, R1347S, R1454S, R1500S, R1527S, R1544S, R1569S, R969S, R1455S, R1497S, R1504S, R1526S, R1534S, R1546S, R1547S	Tuberous sclerosis 2	VCV002109270	16	2136241	16	2086240	2109270	2167135	rs1389060581	NC_000016.10:2086239:G:C	single nucleotide variant	missense variant	Pathogenic	Jun 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4710G>T (p.Arg1570Ser)	TSC2	R1326S, R1455S, R1467S, R1503S, R1504S, R1514S, R1526S, R1527S, R1547S, R1570S	Tuberous sclerosis 2	VCV001056953	16	2136241	16	2086240	1056953	1049492	rs1389060581	NC_000016.10:2086239:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4710G>A (p.Arg1570=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536109	16	2136241	16	2086240	536109	529773	rs1389060581	NC_000016.10:2086239:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4711T>C (p.Tyr1571His)	TSC2	Y1571H, Y1504H, Y1527H, Y1528H, Y1456H, Y1468H, Y1505H, Y1327H, Y1515H, Y1548H	Tuberous sclerosis 2	VCV000535941	16	2136242	16	2086241	535941	530289	rs397514905	NC_000016.10:2086240:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 15, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4712A>G (p.Tyr1571Cys)	TSC2	Y1571C, Y1468C, Y1456C, Y1515C, Y1527C, Y1528C, Y1504C, Y1505C, Y1327C, Y1548C	Tuberous sclerosis 2	VCV000049518	16	2136243	16	2086242	49518	58680	rs45478894	NC_000016.10:2086241:A:G	single nucleotide variant	missense variant	Likely pathogenic	Oct 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4713C>T (p.Tyr1571=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001397933	16	2136244	16	2086243	1397933	1353133	rs45517366	NC_000016.10:2086242:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4714A>C (p.Thr1572Pro)	TSC2	T1058P, T1081P, T1306P, T1348P, T1349P, T1352P, T1468P, T1469P, T1500P, T1506P, T1535P, T1536P, T1572P, T1457P, T1499P, T1502P, T1516P, T1546P, T1571P, T1101P, T1305P, T1328P, T1456P, T1486P, T1501P, T1505P, T1529P, T1548P, T1057P, T1080P, T1372P, T1512P, T1528P, T1549P, T971P	Tuberous sclerosis 2	VCV002813841	16	2136245	16	2086244	2813841	2965955	rs1567532805	NC_000016.10:2086243:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4714A>G (p.Thr1572Ala)	TSC2	T1057A, T1457A, T1486A, T1546A, T1572A, T1080A, T1081A, T1372A, T1456A, T1468A, T1505A, T1506A, T1512A, T1516A, T1529A, T1535A, T1549A, T1058A, T1101A, T1328A, T1348A, T1349A, T1352A, T1469A, T1499A, T1500A, T1501A, T1528A, T1548A, T1571A, T1305A, T1306A, T1502A, T1536A, T971A	Hereditary cancer-predisposing syndrome	VCV001742605	16	2136245	16	2086244	1742605	1798806	rs1567532805	NC_000016.10:2086243:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4715C>T (p.Thr1572Met)	TSC2	T1328M, T1505M, T1529M, T1528M, T1457M, T1516M, T1572M, T1469M, T1506M, T1549M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Ovarian cancer|Tuberous sclerosis syndrome	VCV000948097	16	2136246	16	2086245	948097	927682	rs1327099376	NC_000016.10:2086244:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4716G>T (p.Thr1572=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000486669	16	2136247	16	2086246	486669	477512	rs369346726	NC_000016.10:2086245:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4716G>C (p.Thr1572=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000238059	16	2136247	16	2086246	238059	242318	rs369346726	NC_000016.10:2086245:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4716G>A (p.Thr1572=)	TSC2		Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000220803	16	2136247	16	2086246	220803	222453	rs369346726	NC_000016.10:2086245:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4717G>C (p.Glu1573Gln)	TSC2	E1507Q, E1529Q, E1573Q, E1470Q, E1550Q, E1329Q, E1458Q, E1506Q, E1530Q, E1517Q	Tuberous sclerosis 2	VCV000957358	16	2136248	16	2086247	957358	949283	rs2090773157	NC_000016.10:2086246:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4718A>G (p.Glu1573Gly)	TSC2	E1573G, E1458G, E1506G, E1530G, E1550G, E1517G, E1529G, E1329G, E1470G, E1507G	Tuberous sclerosis 2	VCV000576242	16	2136249	16	2086248	576242	570135	rs1567532847	NC_000016.10:2086247:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4719G>A (p.Glu1573=)	TSC2		not provided|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000536068	16	2136250	16	2086249	536068	530036	rs766665967	NC_000016.10:2086248:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4721T>A (p.Phe1574Tyr)	TSC2	F1059Y, F1060Y, F1082Y, F1083Y, F1103Y, F1307Y, F1308Y, F1330Y, F1350Y, F1351Y, F1354Y, F1374Y, F1458Y, F1459Y, F1470Y, F1471Y, F1488Y, F1501Y, F1502Y, F1503Y, F1504Y, F1507Y, F1508Y, F1514Y, F1518Y, F1530Y, F1531Y, F1537Y, F1538Y, F1548Y, F1550Y, F1551Y, F1573Y, F1574Y, F973Y	Hereditary cancer-predisposing syndrome	VCV004082303	16	2136252	16	2086251	4082303	4194992		NC_000016.10:2086250:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4722C>G (p.Phe1574Leu)	TSC2	F1508L, F1530L, F1330L, F1531L, F1551L, F1574L, F1471L, F1459L, F1507L, F1518L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000858829	16	2136253	16	2086252	858829	843515	rs565576095	NC_000016.10:2086251:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4722C>T (p.Phe1574=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000413756	16	2136253	16	2086252	413756	400939	rs565576095	NC_000016.10:2086251:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4723C>T (p.Leu1575=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001130990	16	2136254	16	2086253	1130990	1125097	rs2151571611	NC_000016.10:2086252:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4725G>C (p.Leu1575=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001668943	16	2136256	16	2086255	1668943	1602829	rs1308764758	NC_000016.10:2086254:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4725G>T (p.Leu1575=)	TSC2		Tuberous sclerosis 2	VCV001119940	16	2136256	16	2086255	1119940	1103680	rs1308764758	NC_000016.10:2086254:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4726A>G (p.Thr1576Ala)	TSC2	T1061A, T1310A, T1332A, T1352A, T1460A, T1461A, T1516A, T1539A, T1550A, T1575A, T1085A, T1105A, T1309A, T1353A, T1472A, T1505A, T1510A, T1520A, T1553A, T1576A, T1062A, T1376A, T1473A, T1503A, T1504A, T1509A, T1540A, T1552A, T1084A, T1356A, T1490A, T1506A, T1532A, T1533A, T975A	Hereditary cancer-predisposing syndrome	VCV002450008	16	2136257	16	2086256	2450008	2425965	rs2151571772	NC_000016.10:2086255:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4727C>G (p.Thr1576Arg)	TSC2	T1352R, T1356R, T1506R, T1509R, T1550R, T1575R, T1062R, T1084R, T1085R, T1460R, T1461R, T1504R, T1505R, T1540R, T1576R, T1061R, T1105R, T1353R, T1376R, T1472R, T1503R, T1539R, T1553R, T1510R, T1516R, T1520R, T1532R, T1533R, T1552R, T975R, T1309R, T1310R, T1332R, T1473R, T1490R	Hereditary cancer-predisposing syndrome	VCV003329532	16	2136258	16	2086257	3329532	3489124		NC_000016.10:2086256:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4727C>A (p.Thr1576Lys)	TSC2	T1332K, T1461K, T1473K, T1509K, T1532K, T1533K, T1553K, T1576K, T1510K, T1520K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000839214	16	2136258	16	2086257	839214	843516	rs45437192	NC_000016.10:2086256:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4727C>T (p.Thr1576Met)	TSC2	T1576M, T1509M, T1532M, T1533M, T1473M, T1510M, T1332M, T1553M, T1461M, T1520M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000049317	16	2136258	16	2086257	49317	58479	rs45437192	NC_000016.10:2086256:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4728G>A (p.Thr1576=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000657021	16	2136259	16	2086258	657021	644342	rs752642825	NC_000016.10:2086257:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4728G>C (p.Thr1576=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238060	16	2136259	16	2086258	238060	242319	rs752642825	NC_000016.10:2086257:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4729G>T (p.Gly1577Cys)	TSC2	G1062C, G1063C, G1085C, G1086C, G1106C, G1310C, G1311C, G1333C, G1353C, G1354C, G1357C, G1377C, G1461C, G1462C, G1473C, G1474C, G1491C, G1504C, G1505C, G1506C, G1507C, G1510C, G1511C, G1517C, G1521C, G1533C, G1534C, G1540C, G1541C, G1551C, G1553C, G1554C, G1576C, G1577C, G976C	not provided	VCV002502721	16	2136260	16	2086259	2502721	2667827	rs796053499	NC_000016.10:2086258:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4729G>A (p.Gly1577Ser)	TSC2	G1577S, G1510S, G1554S, G1333S, G1462S, G1474S, G1511S, G1521S, G1533S, G1534S	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000207756	16	2136260	16	2086259	207756	203199	rs796053499	NC_000016.10:2086258:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4730G>C (p.Gly1577Ala)	TSC2	G1311A, G1333A, G1357A, G1462A, G1504A, G1510A, G1533A, G1553A, G1576A, G1062A, G1353A, G1521A, G1063A, G1086A, G1354A, G1461A, G1507A, G1534A, G1540A, G1541A, G1551A, G1085A, G1106A, G1310A, G1377A, G1473A, G1474A, G1491A, G1505A, G1506A, G1511A, G1517A, G1554A, G1577A, G976A	Tuberous sclerosis 2	VCV003637248	16	2136261	16	2086260	3637248	3771402		NC_000016.10:2086259:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4730G>T (p.Gly1577Val)	TSC2	G1333V, G1462V, G1554V, G1474V, G1510V, G1511V, G1534V, G1521V, G1533V, G1577V	Tuberous sclerosis 2	VCV001396798	16	2136261	16	2086260	1396798	1414673	rs2151571979	NC_000016.10:2086259:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4731C>T (p.Gly1577=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002792524	16	2136262	16	2086261	2792524	2957536	rs920181663	NC_000016.10:2086260:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4732C>G (p.Leu1578Val)	TSC2	L1534V, L1555V, L1463V, L1522V, L1578V, L1334V, L1475V, L1511V, L1512V, L1535V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000940488	16	2136263	16	2086262	940488	937347	rs917807471	NC_000016.10:2086261:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4732C>T (p.Leu1578=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000697555	16	2136263	16	2086262	697555	688551	rs917807471	NC_000016.10:2086261:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4733T>G (p.Leu1578Arg)	TSC2	L1334R, L1463R, L1475R, L1511R, L1512R, L1522R, L1534R, L1535R, L1555R, L1578R	not provided	VCV000995056	16	2136264	16	2086263	995056	982945	rs45517367	NC_000016.10:2086262:T:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4733T>C (p.Leu1578Pro)	TSC2	L1578P, L1511P, L1522P, L1334P, L1475P, L1512P, L1535P, L1463P, L1534P, L1555P	Tuberous sclerosis 2	VCV000050095	16	2136264	16	2086263	50095	59257	rs45517367	NC_000016.10:2086262:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4734G>A (p.Leu1578=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001742739	16	2136265	16	2086264	1742739	1808822	rs1191993288	NC_000016.10:2086263:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4734G>C (p.Leu1578=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001161568	16	2136265	16	2086264	1161568	1145975	rs1191993288	NC_000016.10:2086263:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4735G>A (p.Gly1579Ser)	TSC2	G1579S, G1335S, G1476S, G1513S, G1523S, G1464S, G1512S, G1535S, G1536S, G1556S	Tuberous sclerosis 2	VCV000049956	16	2136266	16	2086265	49956	59118	rs45503995	NC_000016.10:2086264:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4736G>A (p.Gly1579Asp)	TSC2	G1464D, G1476D, G1513D, G1523D, G1536D, G1535D, G1579D, G1335D, G1512D, G1556D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000962194	16	2136267	16	2086266	962194	949284	rs397515222	NC_000016.10:2086265:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4737C>A (p.Gly1579=)	TSC2		Tuberous sclerosis 2	VCV001151913	16	2136268	16	2086267	1151913	1145976	rs2090776434	NC_000016.10:2086266:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4738C>T (p.Arg1580Trp)	TSC2	R1580W, R1524W, R1477W, R1513W, R1537W, R1465W, R1514W, R1536W, R1336W, R1557W	not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000567455	16	2136269	16	2086268	567455	570136	rs777592623	NC_000016.10:2086267:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4739G>A (p.Arg1580Gln)	TSC2	R1336Q, R1465Q, R1524Q, R1536Q, R1477Q, R1513Q, R1557Q, R1514Q, R1537Q, R1580Q	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000836655	16	2136270	16	2086269	836655	843518	rs1371745883	NC_000016.10:2086268:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4740G>A (p.Arg1580=)	TSC2		Tuberous sclerosis 2	VCV004071248	16	2136271	16	2086270	4071248	4185096		NC_000016.10:2086269:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4740G>T (p.Arg1580=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000759185	16	2136271	16	2086270	759185	770742	rs930171871	NC_000016.10:2086269:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4741C>A (p.Leu1581Ile)	TSC2	L1067I, L1090I, L1357I, L1361I, L1465I, L1511I, L1537I, L1555I, L1558I, L980I, L1089I, L1110I, L1314I, L1477I, L1478I, L1525I, L1538I, L1557I, L1581I, L1315I, L1358I, L1381I, L1466I, L1509I, L1515I, L1544I, L1580I, L1066I, L1337I, L1495I, L1508I, L1510I, L1514I, L1521I, L1545I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002104332	16	2136272	16	2086271	2104332	2162095	rs2151572466	NC_000016.10:2086270:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4741C>T (p.Leu1581Phe)	TSC2	L1466F, L1558F, L1581F, L1478F, L1514F, L1515F, L1537F, L1525F, L1538F, L1337F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001499786	16	2136272	16	2086271	1499786	1385606	rs2151572466	NC_000016.10:2086270:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4742T>A (p.Leu1581His)	TSC2	L1066H, L1067H, L1110H, L1314H, L1337H, L1477H, L1495H, L1511H, L1558H, L980H, L1465H, L1478H, L1508H, L1537H, L1545H, L1555H, L1581H, L1315H, L1357H, L1358H, L1361H, L1466H, L1509H, L1515H, L1544H, L1557H, L1089H, L1090H, L1381H, L1510H, L1514H, L1521H, L1525H, L1538H, L1580H	Hereditary cancer-predisposing syndrome	VCV003329511	16	2136273	16	2086272	3329511	3489103		NC_000016.10:2086271:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4742T>G (p.Leu1581Arg)	TSC2	L1337R, L1515R, L1558R, L1478R, L1537R, L1538R, L1466R, L1514R, L1525R, L1581R	Tuberous sclerosis 2	VCV001485200	16	2136273	16	2086272	1485200	1393926	rs2151572499	NC_000016.10:2086271:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4743C>T (p.Leu1581=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001742783	16	2136274	16	2086273	1742783	1808866	rs2544373777	NC_000016.10:2086272:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4744A>G (p.Ile1582Val)	TSC2	I1067V, I1068V, I1090V, I1091V, I1111V, I1315V, I1316V, I1338V, I1358V, I1359V, I1362V, I1382V, I1466V, I1467V, I1478V, I1479V, I1496V, I1509V, I1510V, I1511V, I1512V, I1515V, I1516V, I1522V, I1526V, I1538V, I1539V, I1545V, I1546V, I1556V, I1558V, I1559V, I1581V, I1582V, I981V	Isolated focal cortical dysplasia type II	VCV002679328	16	2136275	16	2086274	2679328	2836905	rs2151572578	NC_000016.10:2086273:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4745T>C (p.Ile1582Thr)	TSC2	I1338T, I1582T, I1526T, I1467T, I1479T, I1538T, I1539T, I1515T, I1516T, I1559T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001350932	16	2136276	16	2086275	1350932	1492520	rs2151572644	NC_000016.10:2086274:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4746C>G (p.Ile1582Met)	TSC2	I1467M, I1538M, I1526M, I1539M, I1582M, I1338M, I1479M, I1515M, I1516M, I1559M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825139	16	2136277	16	2086276	825139	812612	rs751305758	NC_000016.10:2086275:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4746C>T (p.Ile1582=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|not specified	VCV000196994	16	2136277	16	2086276	196994	194155	rs751305758	NC_000016.10:2086275:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4747G>C (p.Glu1583Gln)	TSC2	E1112Q, E1339Q, E1360Q, E1468Q, E1547Q, E1560Q, E1582Q, E1316Q, E1497Q, E1510Q, E1517Q, E1527Q, E1539Q, E1583Q, E982Q, E1068Q, E1069Q, E1091Q, E1092Q, E1363Q, E1383Q, E1511Q, E1512Q, E1546Q, E1559Q, E1317Q, E1359Q, E1467Q, E1479Q, E1480Q, E1513Q, E1516Q, E1523Q, E1540Q, E1557Q	Tuberous sclerosis 2	VCV002859726	16	2136278	16	2086277	2859726	3018486	rs886039446	NC_000016.10:2086276:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4747G>A (p.Glu1583Lys)	TSC2	E1583K, E1527K, E1339K, E1480K, E1516K, E1517K, E1539K, E1468K, E1540K, E1560K	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000265281	16	2136278	16	2086277	265281	260091	rs886039446	NC_000016.10:2086276:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4748A>T (p.Glu1583Val)	TSC2	E1468V, E1480V, E1540V, E1583V, E1339V, E1516V, E1527V, E1539V, E1560V, E1517V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000843698	16	2136279	16	2086278	843698	843519	rs1596439004	NC_000016.10:2086277:A:T	single nucleotide variant	missense variant	Uncertain significance	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4749G>A (p.Glu1583=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001151329	16	2136280	16	2086279	1151329	1145977	rs1257270850	NC_000016.10:2086278:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4750C>A (p.Leu1584Met)	TSC2	L1364M, L1481M, L1512M, L1513M, L1561M, L983M, L1070M, L1092M, L1113M, L1318M, L1511M, L1524M, L1528M, L1560M, L1583M, L1317M, L1340M, L1480M, L1498M, L1514M, L1517M, L1548M, L1069M, L1093M, L1360M, L1361M, L1384M, L1468M, L1469M, L1518M, L1540M, L1541M, L1547M, L1558M, L1584M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001742848	16	2136281	16	2086280	1742848	1808931	rs2151572888	NC_000016.10:2086279:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4750C>T (p.Leu1584=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001668522	16	2136281	16	2086280	1668522	1633896	rs2151572888	NC_000016.10:2086279:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4751T>C (p.Leu1584Pro)	TSC2	L1340P, L1469P, L1481P, L1517P, L1518P, L1528P, L1540P, L1541P, L1561P, L1584P	Tuberous sclerosis 2	VCV001052460	16	2136282	16	2086281	1052460	1049493	rs137854203	NC_000016.10:2086280:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4751T>G (p.Leu1584Arg)	TSC2	L1584R, L1469R, L1518R, L1481R, L1340R, L1517R, L1528R, L1540R, L1541R, L1561R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000050096	16	2136282	16	2086281	50096	59258	rs137854203	NC_000016.10:2086280:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4752G>T (p.Leu1584=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974694	16	2136283	16	2086282	3974694	4086517		NC_000016.10:2086281:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 25, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4752G>C (p.Leu1584=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974594	16	2136283	16	2086282	3974594	4086417		NC_000016.10:2086281:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 21, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4752G>A (p.Leu1584=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468109	16	2136283	16	2086282	468109	466296	rs1555516171	NC_000016.10:2086281:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4753A>G (p.Lys1585Glu)	TSC2	K1385E, K1515E, K1519E, K1542E, K1071E, K1318E, K1361E, K1362E, K1469E, K1470E, K1482E, K1513E, K1518E, K1529E, K1481E, K1499E, K1512E, K1525E, K1541E, K1548E, K1549E, K1561E, K1562E, K984E, K1070E, K1093E, K1094E, K1114E, K1319E, K1341E, K1365E, K1514E, K1559E, K1584E, K1585E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002808923	16	2136284	16	2086283	2808923	2964874	rs2151573030	NC_000016.10:2086282:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4754A>G (p.Lys1585Arg)	TSC2	K1070R, K1093R, K1481R, K1482R, K1499R, K1512R, K1525R, K1529R, K1542R, K984R, K1094R, K1319R, K1385R, K1469R, K1514R, K1515R, K1549R, K1561R, K1114R, K1318R, K1341R, K1361R, K1362R, K1365R, K1518R, K1519R, K1541R, K1584R, K1071R, K1470R, K1513R, K1548R, K1559R, K1562R, K1585R	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV002564627	16	2136285	16	2086284	2564627	2733783	rs780758839	NC_000016.10:2086283:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4755G>C (p.Lys1585Asn)	TSC2	K1070N, K1071N, K1093N, K1094N, K1114N, K1318N, K1319N, K1341N, K1361N, K1362N, K1365N, K1385N, K1469N, K1470N, K1481N, K1482N, K1499N, K1512N, K1513N, K1514N, K1515N, K1518N, K1519N, K1525N, K1529N, K1541N, K1542N, K1548N, K1549N, K1559N, K1561N, K1562N, K1584N, K1585N, K984N	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003072884	16	2136286	16	2086285	3072884	3229155	rs2090778953	NC_000016.10:2086284:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4755G>T (p.Lys1585Asn)	TSC2	K1562N, K1482N, K1519N, K1541N, K1341N, K1518N, K1529N, K1470N, K1542N, K1585N	Tuberous sclerosis 2	VCV001464324	16	2136286	16	2086285	1464324	1435995	rs2090778953	NC_000016.10:2086284:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4756G>A (p.Asp1586Asn)	TSC2	D1071N, D1095N, D1482N, D1514N, D1543N, D1560N, D1562N, D1094N, D1115N, D1386N, D1470N, D1483N, D1515N, D1519N, D1530N, D1550N, D1585N, D1072N, D1320N, D1363N, D1366N, D1500N, D1520N, D1542N, D1549N, D1319N, D1342N, D1362N, D1471N, D1513N, D1516N, D1526N, D1563N, D1586N, D985N	Hereditary cancer-predisposing syndrome	VCV003462646	16	2136287	16	2086286	3462646	3621665		NC_000016.10:2086285:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4758C>T (p.Asp1586=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002747022	16	2136289	16	2086288	2747022	2907782	rs1366814192	NC_000016.10:2086287:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4758C>G (p.Asp1586Glu)	TSC2	D1530E, D1563E, D1471E, D1519E, D1520E, D1542E, D1543E, D1342E, D1483E, D1586E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001519329	16	2136289	16	2086288	1519329	1433826	rs1366814192	NC_000016.10:2086287:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4758C>A (p.Asp1586Glu)	TSC2	D1586E, D1471E, D1520E, D1563E, D1483E, D1542E, D1342E, D1519E, D1530E, D1543E	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000589792	16	2136289	16	2086288	589792	579976	rs1366814192	NC_000016.10:2086287:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4760G>A (p.Cys1587Tyr)	TSC2	C1472Y, C1484Y, C1587Y, C1343Y, C1520Y, C1521Y, C1531Y, C1544Y, C1564Y, C1543Y	Tuberous sclerosis 2	VCV000864512	16	2136291	16	2086290	864512	843520	rs2090779491	NC_000016.10:2086289:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4762C>T (p.Gln1588Ter)	TSC2	Q1588*, Q1485*, Q1521*, Q1544*, Q1344*, Q1545*, Q1522*, Q1565*, Q1473*, Q1532*	not provided|Tuberous sclerosis 2	VCV000050097	16	2136293	16	2086292	50097	59259	rs45479192	NC_000016.10:2086291:C:T	single nucleotide variant	nonsense	Pathogenic	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4763A>G (p.Gln1588Arg)	TSC2	Q1074R, Q1097R, Q1368R, Q1517R, Q1518R, Q1545R, Q1551R, Q1552R, Q1564R, Q987R, Q1073R, Q1365R, Q1484R, Q1485R, Q1502R, Q1522R, Q1528R, Q1544R, Q1587R, Q1096R, Q1117R, Q1321R, Q1344R, Q1473R, Q1515R, Q1516R, Q1532R, Q1565R, Q1588R, Q1322R, Q1364R, Q1388R, Q1472R, Q1521R, Q1562R	Hereditary cancer-predisposing syndrome	VCV002626463	16	2136294	16	2086293	2626463	2794229	rs2151573461	NC_000016.10:2086292:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4764G>A (p.Gln1588=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468110	16	2136295	16	2086294	468110	466103	rs876659800	NC_000016.10:2086293:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4764G>C (p.Gln1588His)	TSC2	Q1588H, Q1473H, Q1485H, Q1521H, Q1522H, Q1545H, Q1344H, Q1544H, Q1532H, Q1565H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000232491	16	2136295	16	2086294	232491	235140	rs876659800	NC_000016.10:2086293:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4766C>T (p.Pro1589Leu)	TSC2	P1533L, P1486L, P1523L, P1546L, P1566L, P1522L, P1589L, P1345L, P1474L, P1545L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000665252	16	2136297	16	2086296	665252	644343	rs373635516	NC_000016.10:2086295:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4767G>A (p.Pro1589=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000413662	16	2136298	16	2086297	413662	400999	rs769246304	NC_000016.10:2086296:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4768G>T (p.Asp1590Tyr)	TSC2	D1346Y, D1487Y, D1523Y, D1524Y, D1534Y, D1547Y, D1475Y, D1546Y, D1567Y, D1590Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000957126	16	2136299	16	2086298	957126	949285	rs2090780462	NC_000016.10:2086297:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4769A>G (p.Asp1590Gly)	TSC2	D1075G, D1076G, D1098G, D1099G, D1119G, D1323G, D1324G, D1346G, D1366G, D1367G, D1370G, D1390G, D1474G, D1475G, D1486G, D1487G, D1504G, D1517G, D1518G, D1519G, D1520G, D1523G, D1524G, D1530G, D1534G, D1546G, D1547G, D1553G, D1554G, D1564G, D1566G, D1567G, D1589G, D1590G, D989G	Hereditary cancer-predisposing syndrome	VCV003232176	16	2136300	16	2086299	3232176	3391977	rs2090780608	NC_000016.10:2086298:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4769A>C (p.Asp1590Ala)	TSC2	D1075A, D1098A, D1486A, D1504A, D1519A, D1523A, D1546A, D1547A, D1554A, D1099A, D1119A, D1324A, D1475A, D1487A, D1517A, D1524A, D1534A, D1553A, D1567A, D989A, D1323A, D1367A, D1390A, D1518A, D1520A, D1530A, D1589A, D1076A, D1346A, D1366A, D1370A, D1474A, D1564A, D1566A, D1590A	Tuberous sclerosis 2	VCV002764505	16	2136300	16	2086299	2764505	2931708	rs2090780608	NC_000016.10:2086298:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 30, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4769A>T (p.Asp1590Val)	TSC2	D1346V, D1475V, D1487V, D1523V, D1524V, D1534V, D1546V, D1547V, D1567V, D1590V	Tuberous sclerosis 2	VCV001001704	16	2136300	16	2086299	1001704	996764	rs2090780608	NC_000016.10:2086298:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4770C>A (p.Asp1590Glu)	TSC2	D1076E, D1323E, D1475E, D1524E, D1534E, D1554E, D1567E, D1099E, D1324E, D1487E, D1530E, D1547E, D1075E, D1098E, D1119E, D1366E, D1367E, D1474E, D1486E, D1519E, D1523E, D1546E, D1564E, D989E, D1346E, D1370E, D1390E, D1504E, D1517E, D1518E, D1520E, D1553E, D1566E, D1589E, D1590E	Tuberous sclerosis 2	VCV002045698	16	2136301	16	2086300	2045698	2099706	rs1596439135	NC_000016.10:2086299:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4770C>G (p.Asp1590Glu)	TSC2	D1366E, D1486E, D1546E, D1075E, D1076E, D1119E, D1346E, D1390E, D1475E, D1520E, D1523E, D1553E, D1554E, D1564E, D1367E, D1370E, D1474E, D1517E, D1524E, D1534E, D1547E, D1566E, D1589E, D989E, D1098E, D1099E, D1323E, D1324E, D1487E, D1504E, D1518E, D1519E, D1530E, D1567E, D1590E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001972758	16	2136301	16	2086300	1972758	2033186	rs1596439135	NC_000016.10:2086299:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4770C>T (p.Asp1590=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000794276	16	2136301	16	2086300	794276	785207	rs1596439135	NC_000016.10:2086299:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4772A>C (p.Lys1591Thr)	TSC2	K1099T, K1100T, K1371T, K1391T, K1487T, K1488T, K1505T, K1521T, K1535T, K1547T, K1567T, K1591T, K990T, K1076T, K1077T, K1324T, K1347T, K1367T, K1476T, K1519T, K1520T, K1531T, K1590T, K1325T, K1368T, K1475T, K1525T, K1548T, K1555T, K1120T, K1518T, K1524T, K1554T, K1565T, K1568T	Hereditary cancer-predisposing syndrome	VCV002564704	16	2136303	16	2086302	2564704	2733860	rs1596439144	NC_000016.10:2086301:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4772A>G (p.Lys1591Arg)	TSC2	K1488R, K1548R, K1591R, K1568R, K1476R, K1524R, K1525R, K1547R, K1347R, K1535R	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825161	16	2136303	16	2086302	825161	812613	rs1596439144	NC_000016.10:2086301:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4773G>C (p.Lys1591Asn)	TSC2	K1077N, K1100N, K1347N, K1488N, K1519N, K1520N, K1547N, K990N, K1099N, K1324N, K1371N, K1391N, K1475N, K1525N, K1535N, K1554N, K1567N, K1568N, K1591N, K1120N, K1325N, K1367N, K1505N, K1518N, K1524N, K1531N, K1548N, K1555N, K1565N, K1076N, K1368N, K1476N, K1487N, K1521N, K1590N	Hereditary cancer-predisposing syndrome	VCV003462620	16	2136304	16	2086303	3462620	3621639		NC_000016.10:2086302:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4774G>A (p.Val1592Met)	TSC2	V1078M, V1100M, V1121M, V1326M, V1368M, V1519M, V1526M, V1536M, V1555M, V1556M, V1566M, V1568M, V1077M, V1369M, V1521M, V1532M, V1569M, V1325M, V1372M, V1477M, V1489M, V1506M, V1522M, V1548M, V1592M, V1101M, V1348M, V1392M, V1476M, V1488M, V1520M, V1525M, V1549M, V1591M, V991M	Tuberous sclerosis 2	VCV002789104	16	2136305	16	2086304	2789104	2956712	rs2151573908	NC_000016.10:2086303:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4775T>C (p.Val1592Ala)	TSC2	V1078A, V1372A, V1488A, V1506A, V1519A, V1555A, V1592A, V991A, V1325A, V1392A, V1525A, V1548A, V1556A, V1326A, V1368A, V1369A, V1476A, V1477A, V1489A, V1521A, V1526A, V1532A, V1568A, V1077A, V1100A, V1101A, V1121A, V1348A, V1520A, V1522A, V1536A, V1549A, V1566A, V1569A, V1591A	Tuberous sclerosis 2	VCV002839101	16	2136306	16	2086305	2839101	2996372	rs2151573942	NC_000016.10:2086304:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4775T>A (p.Val1592Glu)	TSC2	V1348E, V1477E, V1489E, V1525E, V1526E, V1536E, V1548E, V1549E, V1569E, V1592E	Hereditary cancer-predisposing syndrome	VCV001692506	16	2136306	16	2086305	1692506	1684946	rs2151573942	NC_000016.10:2086304:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4776G>A (p.Val1592=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001618098	16	2136307	16	2086306	1618098	1527420	rs2151573973	NC_000016.10:2086305:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4779C>T (p.Tyr1593=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000231786	16	2136310	16	2086309	231786	235141	rs45517368	NC_000016.10:2086308:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4780C>G (p.Leu1594Val)	TSC2	L1102V, L1103V, L1328V, L1479V, L1523V, L1594V, L1080V, L1327V, L1350V, L1371V, L1491V, L1524V, L1538V, L1551V, L1557V, L1558V, L1570V, L1079V, L1370V, L1374V, L1394V, L1478V, L1521V, L1522V, L1534V, L1568V, L1593V, L1123V, L1490V, L1508V, L1527V, L1528V, L1550V, L1571V, L993V	Hereditary cancer-predisposing syndrome	VCV001743048	16	2136311	16	2086310	1743048	1809129	rs45511204	NC_000016.10:2086309:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4780C>T (p.Leu1594=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000618452	16	2136311	16	2086310	618452	609951	rs45511204	NC_000016.10:2086309:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4782G>A (p.Leu1594=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825168	16	2136313	16	2086312	825168	812614	rs1367104092	NC_000016.10:2086311:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4783G>C (p.Gly1595Arg)	TSC2	G1124R, G1329R, G1480R, G1551R, G1552R, G1559R, G1571R, G1594R, G1081R, G1328R, G1395R, G1479R, G1569R, G1572R, G1351R, G1372R, G1375R, G1491R, G1509R, G1522R, G1523R, G1525R, G1529R, G1539R, G1595R, G1080R, G1103R, G1104R, G1371R, G1492R, G1524R, G1528R, G1535R, G1558R, G994R	Tuberous sclerosis 2	VCV002728549	16	2136314	16	2086313	2728549	2886446	rs45517369	NC_000016.10:2086312:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jun 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4783G>A (p.Gly1595Arg)	TSC2	G1595R, G1351R, G1529R, G1572R, G1552R, G1480R, G1492R, G1528R, G1551R, G1539R	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049464	16	2136314	16	2086313	49464	58626	rs45517369	NC_000016.10:2086312:G:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4784G>A (p.Gly1595Glu)	TSC2	G1081E, G1103E, G1104E, G1328E, G1509E, G1522E, G1523E, G1524E, G1525E, G1529E, G1535E, G1551E, G1552E, G1559E, G1569E, G1594E, G1124E, G1371E, G1372E, G1395E, G1491E, G1492E, G1572E, G1595E, G1329E, G1375E, G1528E, G1558E, G1080E, G1351E, G1479E, G1480E, G1539E, G1571E, G994E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002117469	16	2136315	16	2086314	2117469	2183110	rs2090782357	NC_000016.10:2086313:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 28, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4787G>A (p.Gly1596Asp)	TSC2	G1352D, G1481D, G1493D, G1529D, G1530D, G1540D, G1552D, G1553D, G1573D, G1596D	not provided|Tuberous sclerosis 2	VCV001330461	16	2136318	16	2086317	1330461	1321140	rs397515014	NC_000016.10:2086316:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4787G>C (p.Gly1596Ala)	TSC2	G1493A, G1540A, G1481A, G1529A, G1573A, G1530A, G1553A, G1352A, G1552A, G1596A	Tuberous sclerosis 2	VCV001035667	16	2136318	16	2086317	1035667	1032498	rs397515014	NC_000016.10:2086316:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4787G>T (p.Gly1596Val)	TSC2	G1596V, G1530V, G1493V, G1529V, G1573V, G1352V, G1481V, G1552V, G1540V, G1553V	not provided	VCV000065024	16	2136318	16	2086317	65024	75954	rs397515014	NC_000016.10:2086316:G:T	single nucleotide variant	missense variant	Pathogenic	Oct 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4788C>G (p.Gly1596=)	TSC2		Tuberous sclerosis 2	VCV001605649	16	2136319	16	2086318	1605649	1646701	rs1596439233	NC_000016.10:2086317:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4788C>T (p.Gly1596=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000655004	16	2136319	16	2086318	655004	644344	rs1596439233	NC_000016.10:2086317:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4789C>T (p.Leu1597=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002626411	16	2136320	16	2086319	2626411	2794177	rs1459712779	NC_000016.10:2086318:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4790T>C (p.Leu1597Pro)	TSC2	L1597P, L1553P, L1554P, L1353P, L1494P, L1531P, L1574P, L1482P, L1530P, L1541P	Tuberous sclerosis 2	VCV000049320	16	2136321	16	2086320	49320	58482	rs45517370	NC_000016.10:2086319:T:C	single nucleotide variant	missense variant	Pathogenic	Dec 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4791G>A (p.Leu1597=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002822848	16	2136322	16	2086321	2822848	2988636	rs1060504112	NC_000016.10:2086320:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4791G>C (p.Leu1597=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413722	16	2136322	16	2086321	413722	401424	rs1060504112	NC_000016.10:2086320:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4792G>T (p.Asp1598Tyr)	TSC2	D1528Y, D1574Y, D1083Y, D1084Y, D1107Y, D1483Y, D1494Y, D1531Y, D1554Y, D1561Y, D1575Y, D1106Y, D1127Y, D1332Y, D1398Y, D1512Y, D1527Y, D1532Y, D1542Y, D1562Y, D1598Y, D997Y, D1375Y, D1482Y, D1526Y, D1331Y, D1354Y, D1374Y, D1378Y, D1495Y, D1525Y, D1538Y, D1555Y, D1572Y, D1597Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001743116	16	2136323	16	2086322	1743116	1805264	rs2151574648	NC_000016.10:2086321:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4793A>G (p.Asp1598Gly)	TSC2	D1083G, D1084G, D1106G, D1107G, D1127G, D1331G, D1332G, D1354G, D1374G, D1375G, D1378G, D1398G, D1482G, D1483G, D1494G, D1495G, D1512G, D1525G, D1526G, D1527G, D1528G, D1531G, D1532G, D1538G, D1542G, D1554G, D1555G, D1561G, D1562G, D1572G, D1574G, D1575G, D1597G, D1598G, D997G	not provided	VCV003367832	16	2136324	16	2086323	3367832	3527031		NC_000016.10:2086322:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4793A>T (p.Asp1598Val)	TSC2	D1542V, D1483V, D1495V, D1531V, D1532V, D1554V, D1575V, D1598V, D1354V, D1555V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001417842	16	2136324	16	2086323	1417842	1396897	rs2151574689	NC_000016.10:2086322:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4794C>A (p.Asp1598Glu)	TSC2	D1083E, D1084E, D1332E, D1378E, D1512E, D1526E, D1528E, D1532E, D1554E, D1107E, D1331E, D1375E, D1398E, D1527E, D1538E, D1597E, D1598E, D1127E, D1354E, D1531E, D1555E, D1561E, D1572E, D1574E, D1575E, D1106E, D1374E, D1482E, D1483E, D1494E, D1495E, D1525E, D1542E, D1562E, D997E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001743121	16	2136325	16	2086324	1743121	1805268	rs548102930	NC_000016.10:2086323:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4794C>G (p.Asp1598Glu)	TSC2	D1531E, D1542E, D1354E, D1554E, D1575E, D1483E, D1495E, D1555E, D1532E, D1598E	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000825176	16	2136325	16	2086324	825176	812615	rs548102930	NC_000016.10:2086323:C:G	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4794C>T (p.Asp1598=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000468111	16	2136325	16	2086324	468111	466034	rs548102930	NC_000016.10:2086323:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4795G>T (p.Val1599Leu)	TSC2	V1084L, V1128L, V1376L, V1495L, V1513L, V1528L, V1539L, V1543L, V1556L, V1085L, V1355L, V1379L, V1483L, V1526L, V1532L, V1562L, V1573L, V1576L, V1598L, V998L, V1333L, V1496L, V1529L, V1555L, V1575L, V1599L, V1107L, V1108L, V1332L, V1375L, V1399L, V1484L, V1527L, V1533L, V1563L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002564621	16	2136326	16	2086325	2564621	2733777	rs772687631	NC_000016.10:2086324:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4795G>C (p.Val1599Leu)	TSC2	V1543L, V1484L, V1496L, V1533L, V1555L, V1576L, V1599L, V1532L, V1556L, V1355L	not provided|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825177	16	2136326	16	2086325	825177	812616	rs772687631	NC_000016.10:2086324:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4795G>A (p.Val1599Met)	TSC2	V1599M, V1484M, V1355M, V1496M, V1533M, V1532M, V1543M, V1555M, V1556M, V1576M	TSC2-related disorder|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238061	16	2136326	16	2086325	238061	242320	rs772687631	NC_000016.10:2086324:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4796T>C (p.Val1599Ala)	TSC2	V1085A, V1108A, V1355A, V1526A, V1528A, V1563A, V1575A, V998A, V1107A, V1484A, V1495A, V1556A, V1573A, V1599A, V1084A, V1379A, V1513A, V1532A, V1539A, V1543A, V1598A, V1128A, V1332A, V1333A, V1375A, V1376A, V1399A, V1483A, V1496A, V1527A, V1529A, V1533A, V1555A, V1562A, V1576A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002626414	16	2136327	16	2086326	2626414	2794180	rs2544378426	NC_000016.10:2086325:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4799G>T (p.Cys1600Phe)	TSC2	C1356F, C1534F, C1544F, C1556F, C1497F, C1485F, C1533F, C1600F, C1557F, C1577F	Tuberous sclerosis 2	VCV000647426	16	2136330	16	2086329	647426	644345	rs1596439356	NC_000016.10:2086328:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4800T>G (p.Cys1600Trp)	TSC2	C1109W, C1333W, C1334W, C1380W, C1514W, C1544W, C1599W, C999W, C1108W, C1129W, C1377W, C1496W, C1528W, C1533W, C1540W, C1563W, C1574W, C1577W, C1356W, C1376W, C1400W, C1484W, C1497W, C1530W, C1534W, C1557W, C1564W, C1576W, C1085W, C1086W, C1485W, C1527W, C1529W, C1556W, C1600W	Tuberous sclerosis 2	VCV003637249	16	2136331	16	2086330	3637249	3771403		NC_000016.10:2086329:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4802G>C (p.Gly1601Ala)	TSC2	G1335A, G1378A, G1528A, G1541A, G1558A, G1565A, G1000A, G1086A, G1109A, G1401A, G1485A, G1486A, G1530A, G1535A, G1564A, G1601A, G1110A, G1130A, G1334A, G1357A, G1377A, G1497A, G1545A, G1557A, G1578A, G1087A, G1381A, G1498A, G1515A, G1529A, G1531A, G1534A, G1575A, G1577A, G1600A	Tuberous sclerosis 2	VCV003021626	16	2136333	16	2086332	3021626	3183186	rs2151574981	NC_000016.10:2086331:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4802G>A (p.Gly1601Asp)	TSC2	G1110D, G1377D, G1528D, G1529D, G1530D, G1541D, G1545D, G1557D, G1577D, G1378D, G1401D, G1486D, G1564D, G1565D, G1600D, G1601D, G1000D, G1109D, G1130D, G1334D, G1357D, G1381D, G1485D, G1497D, G1515D, G1531D, G1558D, G1578D, G1086D, G1087D, G1335D, G1498D, G1534D, G1535D, G1575D	Hereditary cancer-predisposing syndrome	VCV001743210	16	2136333	16	2086332	1743210	1805357	rs2151574981	NC_000016.10:2086331:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4803T>G (p.Gly1601=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413695	16	2136334	16	2086333	413695	400940	rs377474730	NC_000016.10:2086332:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4804G>T (p.Glu1602Ter)	TSC2	E1087*, E1111*, E1131*, E1378*, E1486*, E1499*, E1530*, E1531*, E1601*, E1382*, E1498*, E1516*, E1529*, E1535*, E1536*, E1602*, E1088*, E1110*, E1335*, E1336*, E1402*, E1542*, E1576*, E1578*, E1001*, E1358*, E1379*, E1487*, E1532*, E1546*, E1558*, E1559*, E1565*, E1566*, E1579*	Tuberous sclerosis 2	VCV002698197	16	2136335	16	2086334	2698197	2858338	rs2151575081	NC_000016.10:2086333:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Nov 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4804G>A (p.Glu1602Lys)	TSC2	E1358K, E1499K, E1559K, E1536K, E1546K, E1558K, E1602K, E1579K, E1487K, E1535K	not provided|Tuberous sclerosis 2	VCV001398866	16	2136335	16	2086334	1398866	1427931	rs2151575081	NC_000016.10:2086333:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4806G>A (p.Glu1602=)	TSC2		Tuberous sclerosis 2	VCV002984179	16	2136337	16	2086336	2984179	3149612	rs1177233720	NC_000016.10:2086335:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4806G>T (p.Glu1602Asp)	TSC2	E1602D, E1358D, E1487D, E1535D, E1536D, E1499D, E1558D, E1579D, E1546D, E1559D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486702	16	2136337	16	2086336	486702	477430	rs1177233720	NC_000016.10:2086335:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4807G>A (p.Asp1603Asn)	TSC2	D1112N, D1336N, D1383N, D1403N, D1517N, D1577N, D1579N, D1580N, D1002N, D1111N, D1359N, D1379N, D1487N, D1536N, D1559N, D1560N, D1603N, D1488N, D1499N, D1500N, D1531N, D1532N, D1533N, D1537N, D1543N, D1602N, D1088N, D1089N, D1132N, D1337N, D1380N, D1530N, D1547N, D1566N, D1567N	Tuberous sclerosis 2	VCV003637250	16	2136338	16	2086337	3637250	3771404		NC_000016.10:2086336:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4809C>T (p.Asp1603=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000238062	16	2136340	16	2086339	238062	242321	rs147578602	NC_000016.10:2086338:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4810G>A (p.Gly1604Ser)	TSC2	G1489S, G1548S, G1560S, G1581S, G1360S, G1561S, G1604S, G1538S, G1501S, G1537S	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001385391	16	2136341	16	2086340	1385391	1368135	rs771289256	NC_000016.10:2086339:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4811G>A (p.Gly1604Asp)	TSC2	G1003D, G1089D, G1090D, G1112D, G1113D, G1133D, G1337D, G1338D, G1360D, G1380D, G1381D, G1384D, G1404D, G1488D, G1489D, G1500D, G1501D, G1518D, G1531D, G1532D, G1533D, G1534D, G1537D, G1538D, G1544D, G1548D, G1560D, G1561D, G1567D, G1568D, G1578D, G1580D, G1581D, G1603D, G1604D	Tuberous sclerosis syndrome	VCV003386179	16	2136342	16	2086341	3386179	3545320		NC_000016.10:2086340:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4812C>T (p.Gly1604=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001743294	16	2136343	16	2086342	1743294	1805440	rs397515103	NC_000016.10:2086341:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4812C>A (p.Gly1604=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065136	16	2136343	16	2086342	65136	76067	rs397515103	NC_000016.10:2086341:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4813C>T (p.Gln1605Ter)	TSC2	Q1605*, Q1361*, Q1502*, Q1538*, Q1549*, Q1562*, Q1582*, Q1561*, Q1490*, Q1539*	Tuberous sclerosis 2	VCV000064857	16	2136344	16	2086343	64857	75786	rs397514888	NC_000016.10:2086342:C:T	single nucleotide variant	nonsense	Pathogenic	Jul 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4814A>C (p.Gln1605Pro)	TSC2	Q1361P, Q1605P, Q1538P, Q1582P, Q1490P, Q1502P, Q1561P, Q1539P, Q1549P, Q1562P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000952108	16	2136345	16	2086344	952108	927683	rs1001010265	NC_000016.10:2086343:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4815G>T (p.Gln1605His)	TSC2	Q1361H, Q1405H, Q1501H, Q1534H, Q1562H, Q1004H, Q1090H, Q1339H, Q1489H, Q1519H, Q1535H, Q1545H, Q1549H, Q1579H, Q1581H, Q1605H, Q1091H, Q1113H, Q1338H, Q1382H, Q1490H, Q1532H, Q1538H, Q1561H, Q1568H, Q1569H, Q1582H, Q1604H, Q1114H, Q1134H, Q1381H, Q1385H, Q1502H, Q1533H, Q1539H	Hereditary cancer-predisposing syndrome	VCV001743312	16	2136346	16	2086345	1743312	1805458	rs2151575480	NC_000016.10:2086344:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4815G>A (p.Gln1605=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001651112	16	2136346	16	2086345	1651112	1578487	rs2151575480	NC_000016.10:2086344:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4816T>G (p.Phe1606Val)	TSC2	F1503V, F1550V, F1563V, F1362V, F1562V, F1491V, F1539V, F1540V, F1583V, F1606V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000954393	16	2136347	16	2086346	954393	949286	rs2090786390	NC_000016.10:2086345:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4817T>C (p.Phe1606Ser)	TSC2	F1135S, F1340S, F1382S, F1534S, F1546S, F1580S, F1005S, F1092S, F1115S, F1339S, F1406S, F1502S, F1535S, F1539S, F1563S, F1582S, F1583S, F1490S, F1491S, F1520S, F1550S, F1562S, F1569S, F1606S, F1091S, F1114S, F1362S, F1383S, F1386S, F1503S, F1533S, F1536S, F1540S, F1570S, F1605S	Hereditary cancer-predisposing syndrome	VCV001743325	16	2136348	16	2086347	1743325	1805471	rs2151575542	NC_000016.10:2086346:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4818C>A (p.Phe1606Leu)	TSC2	F1091L, F1092L, F1135L, F1340L, F1362L, F1503L, F1533L, F1535L, F1546L, F1570L, F1115L, F1383L, F1386L, F1491L, F1536L, F1540L, F1582L, F1583L, F1005L, F1382L, F1534L, F1539L, F1550L, F1562L, F1563L, F1114L, F1339L, F1406L, F1490L, F1502L, F1520L, F1569L, F1580L, F1605L, F1606L	Tuberous sclerosis 2	VCV003695795	16	2136349	16	2086348	3695795	3832586		NC_000016.10:2086347:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4818C>T (p.Phe1606=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003004892	16	2136349	16	2086348	3004892	3165134	rs2151575594	NC_000016.10:2086347:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4820C>T (p.Thr1607Ile)	TSC2	T1006I, T1092I, T1093I, T1115I, T1116I, T1136I, T1340I, T1341I, T1363I, T1383I, T1384I, T1387I, T1407I, T1491I, T1492I, T1503I, T1504I, T1521I, T1534I, T1535I, T1536I, T1537I, T1540I, T1541I, T1547I, T1551I, T1563I, T1564I, T1570I, T1571I, T1581I, T1583I, T1584I, T1606I, T1607I	Tuberous sclerosis syndrome|not provided	VCV003072508	16	2136351	16	2086350	3072508	3230949	rs2151575668	NC_000016.10:2086349:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4821C>T (p.Thr1607=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001635501	16	2136352	16	2086351	1635501	1523963	rs2090786691	NC_000016.10:2086350:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4821C>G (p.Thr1607=)	TSC2		Tuberous sclerosis 2	VCV001043688	16	2136352	16	2086351	1043688	1032499	rs2090786691	NC_000016.10:2086350:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4822T>A (p.Tyr1608Asn)	TSC2	Y1608N, Y1541N, Y1564N, Y1585N, Y1542N, Y1552N, Y1364N, Y1493N, Y1505N, Y1565N	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238064	16	2136353	16	2086352	238064	242322	rs878854111	NC_000016.10:2086351:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4823A>C (p.Tyr1608Ser)	TSC2	Y1608S, Y1364S, Y1552S, Y1564S, Y1585S, Y1541S, Y1542S, Y1565S, Y1493S, Y1505S	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000486679	16	2136354	16	2086353	486679	477393	rs759795928	NC_000016.10:2086352:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4823A>G (p.Tyr1608Cys)	TSC2	Y1608C, Y1493C, Y1505C, Y1542C, Y1364C, Y1552C, Y1564C, Y1565C, Y1585C, Y1541C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468115	16	2136354	16	2086353	468115	466107	rs759795928	NC_000016.10:2086352:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4824C>G (p.Tyr1608Ter)	TSC2	Y1094*, Y1116*, Y1137*, Y1492*, Y1493*, Y1535*, Y1537*, Y1541*, Y1552*, Y1582*, Y1007*, Y1117*, Y1341*, Y1342*, Y1364*, Y1385*, Y1522*, Y1564*, Y1584*, Y1585*, Y1093*, Y1408*, Y1536*, Y1538*, Y1565*, Y1571*, Y1572*, Y1608*, Y1384*, Y1388*, Y1504*, Y1505*, Y1542*, Y1548*, Y1607*	Tuberous sclerosis 2	VCV002073389	16	2136355	16	2086354	2073389	2123477	rs1422829075	NC_000016.10:2086353:C:G	single nucleotide variant	nonsense	Pathogenic	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4824C>T (p.Tyr1608=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001095451	16	2136355	16	2086354	1095451	1081868	rs1422829075	NC_000016.10:2086353:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4826G>A (p.Cys1609Tyr)	TSC2	C1008Y, C1095Y, C1342Y, C1493Y, C1523Y, C1585Y, C1586Y, C1118Y, C1138Y, C1385Y, C1386Y, C1506Y, C1538Y, C1539Y, C1543Y, C1566Y, C1573Y, C1608Y, C1609Y, C1365Y, C1389Y, C1494Y, C1505Y, C1537Y, C1549Y, C1553Y, C1572Y, C1583Y, C1094Y, C1117Y, C1343Y, C1409Y, C1536Y, C1542Y, C1565Y	Hereditary cancer-predisposing syndrome	VCV001743387	16	2136357	16	2086356	1743387	1805533	rs1233744012	NC_000016.10:2086355:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4826G>T (p.Cys1609Phe)	TSC2	C1365F, C1506F, C1565F, C1494F, C1553F, C1566F, C1586F, C1542F, C1543F, C1609F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001461014	16	2136357	16	2086356	1461014	1419823	rs1233744012	NC_000016.10:2086355:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4827C>A (p.Cys1609Ter)	TSC2	C1365*, C1494*, C1506*, C1542*, C1543*, C1553*, C1565*, C1566*, C1586*, C1609*	Tuberous sclerosis 2	VCV001069644	16	2136358	16	2086357	1069644	1063557	rs1179490369	NC_000016.10:2086356:C:A	single nucleotide variant	nonsense	Pathogenic	Aug 27, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4827C>T (p.Cys1609=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536034	16	2136358	16	2086357	536034	530292	rs1179490369	NC_000016.10:2086356:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4828T>G (p.Trp1610Gly)	TSC2	W1610G, W1366G, W1543G, W1554G, W1507G, W1566G, W1587G, W1544G, W1495G, W1567G	Tuberous sclerosis 2	VCV000064955	16	2136359	16	2086358	64955	75885	rs397514966	NC_000016.10:2086357:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4829G>A (p.Trp1610Ter)	TSC2	W1610*, W1543*, W1554*, W1366*, W1495*, W1587*, W1507*, W1567*, W1544*, W1566*	not provided|Tuberous sclerosis 2	VCV000049323	16	2136360	16	2086359	49323	58485	rs45517371	NC_000016.10:2086358:G:A	single nucleotide variant	nonsense	Pathogenic	Apr 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4830G>A (p.Trp1610Ter)	TSC2	W1610*, W1543*, W1554*, W1366*, W1495*, W1587*, W1507*, W1567*, W1544*, W1566*	Tuberous sclerosis 2	VCV000049841	16	2136361	16	2086360	49841	59003	rs45517372	NC_000016.10:2086359:G:A	single nucleotide variant	nonsense	Pathogenic	Oct 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4831C>T (p.His1611Tyr)	TSC2	H1544Y, H1555Y, H1508Y, H1567Y, H1588Y, H1367Y, H1545Y, H1568Y, H1496Y, H1611Y	Tuberous sclerosis 2	VCV000644759	16	2136362	16	2086361	644759	644347	rs1596439600	NC_000016.10:2086360:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4832A>T (p.His1611Leu)	TSC2	H1010L, H1096L, H1140L, H1551L, H1555L, H1568L, H1575L, H1097L, H1119L, H1345L, H1496L, H1567L, H1611L, H1344L, H1367L, H1388L, H1391L, H1508L, H1538L, H1540L, H1544L, H1574L, H1588L, H1610L, H1120L, H1387L, H1411L, H1495L, H1507L, H1525L, H1539L, H1541L, H1545L, H1585L, H1587L	Tuberous sclerosis 2	VCV002862615	16	2136363	16	2086362	2862615	3022664	rs2151576229	NC_000016.10:2086361:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4833C>G (p.His1611Gln)	TSC2	H1574Q, H1611Q, H1140Q, H1345Q, H1367Q, H1387Q, H1496Q, H1539Q, H1540Q, H1541Q, H1545Q, H1551Q, H1567Q, H1568Q, H1575Q, H1587Q, H1096Q, H1119Q, H1411Q, H1508Q, H1525Q, H1610Q, H1010Q, H1120Q, H1344Q, H1391Q, H1507Q, H1538Q, H1544Q, H1555Q, H1097Q, H1388Q, H1495Q, H1585Q, H1588Q	Hereditary cancer-predisposing syndrome	VCV001743447	16	2136364	16	2086363	1743447	1805593	rs765271161	NC_000016.10:2086362:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4833C>T (p.His1611=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000413707	16	2136364	16	2086363	413707	401671	rs765271161	NC_000016.10:2086362:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4834G>T (p.Asp1612Tyr)	TSC2	D1612Y, D1497Y, D1545Y, D1556Y, D1368Y, D1509Y, D1589Y, D1546Y, D1568Y, D1569Y	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000486651	16	2136365	16	2086364	486651	477435	rs886051795	NC_000016.10:2086363:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4834G>A (p.Asp1612Asn)	TSC2	D1612N, D1545N, D1509N, D1556N, D1569N, D1589N, D1368N, D1497N, D1546N, D1568N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000318332	16	2136365	16	2086364	318332	324628	rs886051795	NC_000016.10:2086363:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4836T>C (p.Asp1612=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001136737	16	2136367	16	2086366	1136737	1125098	rs2151576368	NC_000016.10:2086365:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4838A>C (p.Asp1613Ala)	TSC2	D1012A, D1098A, D1099A, D1121A, D1122A, D1142A, D1346A, D1347A, D1369A, D1389A, D1390A, D1393A, D1413A, D1497A, D1498A, D1509A, D1510A, D1527A, D1540A, D1541A, D1542A, D1543A, D1546A, D1547A, D1553A, D1557A, D1569A, D1570A, D1576A, D1577A, D1587A, D1589A, D1590A, D1612A, D1613A	not provided	VCV002579775	16	2136369	16	2086368	2579775	2747285	rs2151576456	NC_000016.10:2086367:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4839C>T (p.Asp1613=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000233815	16	2136370	16	2086369	233815	235142	rs876660657	NC_000016.10:2086368:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4840A>G (p.Ile1614Val)	TSC2	I1099V, I1348V, I1390V, I1394V, I1511V, I1528V, I1542V, I1547V, I1554V, I1614V, I1013V, I1100V, I1122V, I1370V, I1391V, I1498V, I1510V, I1541V, I1543V, I1548V, I1571V, I1577V, I1578V, I1591V, I1143V, I1414V, I1544V, I1558V, I1570V, I1123V, I1347V, I1499V, I1588V, I1590V, I1613V	Tuberous sclerosis 2	VCV002089496	16	2136371	16	2086370	2089496	2144826	rs1555516299	NC_000016.10:2086369:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4840A>C (p.Ile1614Leu)	TSC2	I1614L, I1547L, I1548L, I1570L, I1499L, I1591L, I1370L, I1511L, I1571L, I1558L	Hereditary cancer-predisposing syndrome	VCV000486678	16	2136371	16	2086370	486678	477515	rs1555516299	NC_000016.10:2086369:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.4841T>G (p.Ile1614Ser)	TSC2	I1570S, I1499S, I1558S, I1571S, I1591S, I1614S, I1370S, I1511S, I1547S, I1548S	Tuberous sclerosis 2	VCV000846298	16	2136372	16	2086371	846298	843522	rs2090789775	NC_000016.10:2086370:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4842C>T (p.Ile1614=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974700	16	2136373	16	2086372	3974700	4086523		NC_000016.10:2086371:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4842C>A (p.Ile1614=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329518	16	2136373	16	2086372	3329518	3489110		NC_000016.10:2086371:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4843A>G (p.Met1615Val)	TSC2	M1014V, M1101V, M1349V, M1391V, M1392V, M1500V, M1543V, M1545V, M1548V, M1559V, M1572V, M1579V, M1589V, M1100V, M1395V, M1415V, M1511V, M1512V, M1542V, M1549V, M1592V, M1371V, M1499V, M1544V, M1571V, M1614V, M1615V, M1123V, M1124V, M1144V, M1348V, M1529V, M1555V, M1578V, M1591V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002497447	16	2136374	16	2086373	2497447	2472530	rs752798361	NC_000016.10:2086372:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4844T>G (p.Met1615Arg)	TSC2	M1548R, M1592R, M1512R, M1549R, M1559R, M1571R, M1572R, M1615R, M1371R, M1500R	not provided|Tuberous sclerosis 2	VCV000838362	16	2136375	16	2086374	838362	843523	rs2090790157	NC_000016.10:2086373:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4845G>C (p.Met1615Ile)	TSC2	M1555I, M1578I, M1579I, M1589I, M1591I, M1614I, M1100I, M1123I, M1392I, M1395I, M1511I, M1512I, M1529I, M1542I, M1549I, M1572I, M1615I, M1124I, M1144I, M1543I, M1544I, M1349I, M1371I, M1415I, M1559I, M1592I, M1014I, M1101I, M1348I, M1391I, M1499I, M1500I, M1545I, M1548I, M1571I	Tuberous sclerosis 2	VCV003637251	16	2136376	16	2086375	3637251	3771405		NC_000016.10:2086374:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4845G>T (p.Met1615Ile)	TSC2	M1014I, M1124I, M1348I, M1349I, M1392I, M1571I, M1572I, M1615I, M1100I, M1123I, M1391I, M1500I, M1529I, M1545I, M1144I, M1395I, M1511I, M1512I, M1542I, M1544I, M1549I, M1559I, M1578I, M1579I, M1591I, M1614I, M1101I, M1371I, M1415I, M1499I, M1543I, M1548I, M1555I, M1589I, M1592I	Hereditary cancer-predisposing syndrome	VCV001743528	16	2136376	16	2086375	1743528	1801875	rs2090790316	NC_000016.10:2086374:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4845G>A (p.Met1615Ile)	TSC2	M1371I, M1500I, M1512I, M1548I, M1549I, M1559I, M1571I, M1572I, M1592I, M1615I	not provided|Tuberous sclerosis 2|Intellectual disability	VCV000981444	16	2136376	16	2086375	981444	969536	rs2090790316	NC_000016.10:2086374:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4846C>T (p.Gln1616Ter)	TSC2	Q1616*, Q1501*, Q1513*, Q1549*, Q1573*, Q1593*, Q1560*, Q1372*, Q1550*, Q1572*	Tuberous sclerosis 2|not provided	VCV000049326	16	2136377	16	2086376	49326	58488	rs45455296	NC_000016.10:2086375:C:T	single nucleotide variant	nonsense	Pathogenic	Jan 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4847A>G (p.Gln1616Arg)	TSC2	Q1616R, Q1372R, Q1560R, Q1513R, Q1549R, Q1550R, Q1573R, Q1501R, Q1593R, Q1572R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486604	16	2136378	16	2086377	486604	477980	rs1555516313	NC_000016.10:2086376:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4848A>G (p.Gln1616=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001429204	16	2136379	16	2086378	1429204	1454321	rs762819541	NC_000016.10:2086377:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4848A>C (p.Gln1616His)	TSC2	Q1550H, Q1573H, Q1593H, Q1560H, Q1616H, Q1372H, Q1513H, Q1549H, Q1572H, Q1501H	Tuberous sclerosis 2	VCV001360336	16	2136379	16	2086378	1360336	1363778	rs762819541	NC_000016.10:2086377:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4848A>T (p.Gln1616His)	TSC2	Q1372H, Q1501H, Q1513H, Q1549H, Q1550H, Q1560H, Q1572H, Q1573H, Q1593H, Q1616H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001057471	16	2136379	16	2086378	1057471	1049494	rs762819541	NC_000016.10:2086377:A:T	single nucleotide variant	missense variant	Uncertain significance	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4849G>A (p.Ala1617Thr)	TSC2	A1551T, A1561T, A1550T, A1573T, A1373T, A1502T, A1514T, A1594T, A1574T, A1617T	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000847781	16	2136380	16	2086379	847781	843524	rs2090791005	NC_000016.10:2086378:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4849+1G>C	TSC2		Tuberous sclerosis 2	VCV003382616	16	2136381	16	2086380	3382616	3541793		NC_000016.10:2086379:G:C	single nucleotide variant	splice donor variant	Pathogenic		criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+1G>T	TSC2		Tuberous sclerosis 2	VCV001430667	16	2136381	16	2086380	1430667	1471201	rs45517375	NC_000016.10:2086379:G:T	single nucleotide variant	splice donor variant	Pathogenic	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+1G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049864	16	2136381	16	2086380	49864	59026	rs45517375	NC_000016.10:2086379:G:A	single nucleotide variant	splice donor variant	Pathogenic	Jun 3, 2020	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4849+2T>C	TSC2		Hereditary cancer-predisposing syndrome|not provided	VCV001743539	16	2136382	16	2086381	1743539	1801886	rs397515281	NC_000016.10:2086380:T:C	single nucleotide variant	splice donor variant	Uncertain significance	Oct 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4849+3A>T	TSC2		Tuberous sclerosis 2	VCV000950971	16	2136383	16	2086382	950971	941128	rs1057521378	NC_000016.10:2086381:A:T	single nucleotide variant	intron variant	Uncertain significance	May 10, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+3A>G	TSC2		not specified|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000382536	16	2136383	16	2086382	382536	377280	rs1057521378	NC_000016.10:2086381:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 14, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4849+4C>G	TSC2		Tuberous sclerosis 2	VCV002838343	16	2136384	16	2086383	2838343	3002843	rs370426490	NC_000016.10:2086382:C:G	single nucleotide variant	intron variant	Uncertain significance	Jul 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+4C>A	TSC2		Tuberous sclerosis 2	VCV000406111	16	2136384	16	2086383	406111	401673	rs370426490	NC_000016.10:2086382:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4849+4C>T	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000238065	16	2136384	16	2086383	238065	242323	rs370426490	NC_000016.10:2086382:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4849+5G>C	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003329480	16	2136385	16	2086384	3329480	3489072		NC_000016.10:2086383:G:C	single nucleotide variant	intron variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4849+5G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000579732	16	2136385	16	2086384	579732	569861	rs1198379006	NC_000016.10:2086383:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4849+6G>T	TSC2		Tuberous sclerosis 2	VCV002763347	16	2136386	16	2086385	2763347	2925386	rs2544382798	NC_000016.10:2086384:G:T	single nucleotide variant	intron variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+7C>T	TSC2		Tuberous sclerosis 2	VCV000655860	16	2136387	16	2086386	655860	653250	rs1257925008	NC_000016.10:2086385:C:T	single nucleotide variant	intron variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+8C>T	TSC2		Tuberous sclerosis 2	VCV001637217	16	2136388	16	2086387	1637217	1525245	rs1424021009	NC_000016.10:2086386:C:T	single nucleotide variant	intron variant	Likely benign	Nov 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+9T>C	TSC2		Tuberous sclerosis 2	VCV002035289	16	2136389	16	2086388	2035289	2097073	rs2151577296	NC_000016.10:2086387:T:C	single nucleotide variant	intron variant	Likely benign	Oct 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+11G>C	TSC2		Tuberous sclerosis 2	VCV002059738	16	2136391	16	2086390	2059738	2113727	rs2151577324	NC_000016.10:2086389:G:C	single nucleotide variant	intron variant	Likely benign	Sep 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+12C>T	TSC2		Tuberous sclerosis syndrome|Lung lymphangioleiomyomatosis|Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000049963	16	2136392	16	2086391	49963	59125	rs45517373	NC_000016.10:2086390:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4849+13G>A	TSC2		not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000318333	16	2136393	16	2086392	318333	324633	rs780953278	NC_000016.10:2086391:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4849+14C>T	TSC2		Tuberous sclerosis 2	VCV001664319	16	2136394	16	2086393	1664319	1654488	rs2090793588	NC_000016.10:2086392:C:T	single nucleotide variant	intron variant	Likely benign	Mar 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+15C>A	TSC2		Tuberous sclerosis 2	VCV002032524	16	2136395	16	2086394	2032524	2082742	rs2151577450	NC_000016.10:2086393:C:A	single nucleotide variant	intron variant	Likely benign	Sep 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+15C>T	TSC2		Tuberous sclerosis 2	VCV001984326	16	2136395	16	2086394	1984326	2039579	rs2151577450	NC_000016.10:2086393:C:T	single nucleotide variant	intron variant	Likely benign	Feb 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+18C>G	TSC2		Tuberous sclerosis 2	VCV001567503	16	2136398	16	2086397	1567503	1591663	rs45517374	NC_000016.10:2086396:C:G	single nucleotide variant	intron variant	Likely benign	Jun 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+18C>T	TSC2		not specified|Tuberous sclerosis 2	VCV000049863	16	2136398	16	2086397	49863	59025	rs45517374	NC_000016.10:2086396:C:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4849+19C>A	TSC2		Tuberous sclerosis 2	VCV002824367	16	2136399	16	2086398	2824367	2979041	rs1373729624	NC_000016.10:2086397:C:A	single nucleotide variant	intron variant	Likely benign	Mar 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+20C>G	TSC2		Tuberous sclerosis 2	VCV001616049	16	2136400	16	2086399	1616049	1613769	rs140884776	NC_000016.10:2086398:C:G	single nucleotide variant	intron variant	Benign	Dec 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4849+20C>T	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000384944	16	2136400	16	2086399	384944	374846	rs140884776	NC_000016.10:2086398:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4849+76G>A	TSC2		not provided	VCV000065203	16	2136456	16	2086455	65203	76135	rs144647393	NC_000016.10:2086454:G:A	single nucleotide variant	intron variant	Likely benign	Jul 2, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-109T>C	PKD1|TSC2		not provided|not specified	VCV000065253	16	2136624	16	2086623	65253	76185	rs13335638	NC_000016.10:2086622:T:C	single nucleotide variant	intron variant	Benign	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-20C>T	TSC2		Tuberous sclerosis 2	VCV003704286	16	2136713	16	2086712	3704286	3839036		NC_000016.10:2086711:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-20C>G	TSC2		Tuberous sclerosis 2	VCV002911552	16	2136713	16	2086712	2911552	3078903	rs1269327182	NC_000016.10:2086711:C:G	single nucleotide variant	intron variant	Likely benign	Feb 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-19C>A	TSC2		Tuberous sclerosis 2	VCV001908924	16	2136714	16	2086713	1908924	1965698	rs45517376	NC_000016.10:2086712:C:A	single nucleotide variant	intron variant	Uncertain significance	Jun 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-19C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000388824	16	2136714	16	2086713	388824	374849	rs45517376	NC_000016.10:2086712:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-19C>G	TSC2		Tuberous sclerosis 2	VCV000049964	16	2136714	16	2086713	49964	59126	rs45517376	NC_000016.10:2086712:C:G	single nucleotide variant	intron variant	Likely benign	Aug 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-18G>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV001574367	16	2136715	16	2086714	1574367	1659552	rs902020009	NC_000016.10:2086713:G:A	single nucleotide variant	intron variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-17G>A	TSC2		Tuberous sclerosis 2	VCV002832742	16	2136716	16	2086715	2832742	2991286	rs2151583145	NC_000016.10:2086714:G:A	single nucleotide variant	intron variant	Likely benign	Jan 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-16C>G	TSC2		Tuberous sclerosis 2	VCV003659710	16	2136717	16	2086716	3659710	3800658		NC_000016.10:2086715:C:G	single nucleotide variant	intron variant	Likely benign	Jul 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-16C>A	TSC2		Tuberous sclerosis 2	VCV002713872	16	2136717	16	2086716	2713872	2872295	rs755747804	NC_000016.10:2086715:C:A	single nucleotide variant	intron variant	Likely benign	Jan 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-16C>T	TSC2		Tuberous sclerosis 2	VCV001631856	16	2136717	16	2086716	1631856	1597658	rs755747804	NC_000016.10:2086715:C:T	single nucleotide variant	intron variant	Likely benign	Jul 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-15C>G	TSC2		Tuberous sclerosis 2	VCV001608628	16	2136718	16	2086717	1608628	1660046	rs373982002	NC_000016.10:2086716:C:G	single nucleotide variant	intron variant	Likely benign	Sep 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-15C>T	TSC2		Tuberous sclerosis 2	VCV001389735	16	2136718	16	2086717	1389735	1377215	rs373982002	NC_000016.10:2086716:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-14C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001619957	16	2136719	16	2086718	1619957	1527972	rs397515189	NC_000016.10:2086717:C:T	single nucleotide variant	intron variant	Likely benign	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-12G>A	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV001627691	16	2136721	16	2086720	1627691	1530909	rs371810493	NC_000016.10:2086719:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-11C>T	TSC2		Tuberous sclerosis 2	VCV002006366	16	2136722	16	2086721	2006366	2069461	rs548115101	NC_000016.10:2086720:C:T	single nucleotide variant	intron variant	Uncertain significance	Jun 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-10T>A	TSC2		Tuberous sclerosis 2|not provided	VCV000596499	16	2136723	16	2086722	596499	587560	rs1238997365	NC_000016.10:2086721:T:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4850-9C>A	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003075467	16	2136724	16	2086723	3075467	3233034	rs778560020	NC_000016.10:2086722:C:A	single nucleotide variant	intron variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-9C>T	TSC2		Tuberous sclerosis 2	VCV001559129	16	2136724	16	2086723	1559129	1629580	rs778560020	NC_000016.10:2086722:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-8A>C	TSC2		Tuberous sclerosis 2	VCV001567421	16	2136725	16	2086724	1567421	1591581	rs372258482	NC_000016.10:2086723:A:C	single nucleotide variant	intron variant	Likely benign	Aug 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-8A>G	TSC2		not provided|Tuberous sclerosis 2	VCV000536101	16	2136725	16	2086724	536101	529775	rs372258482	NC_000016.10:2086723:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-7C>T	TSC2		Tuberous sclerosis 2	VCV000536008	16	2136726	16	2086725	536008	529779	rs1188604363	NC_000016.10:2086724:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-6C>T	TSC2		Tuberous sclerosis 2	VCV000413620	16	2136727	16	2086726	413620	401426	rs1060504082	NC_000016.10:2086725:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-5C>G	TSC2		Isolated focal cortical dysplasia type II	VCV002679340	16	2136728	16	2086727	2679340	2836917	rs1596442866	NC_000016.10:2086726:C:G	single nucleotide variant	intron variant	Uncertain significance	Jun 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850-5C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000825230	16	2136728	16	2086727	825230	815618	rs1596442866	NC_000016.10:2086726:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4850-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001939029	16	2136730	16	2086729	1939029	203200	rs397514982	NC_000016.10:2086728:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 16, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4850-2A>G	TSC2		Tuberous sclerosis 2	VCV000065369	16	2136731	16	2086730	65369	76303	rs397515315	NC_000016.10:2086729:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Sep 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850-1G>A	TSC2		Tuberous sclerosis 2	VCV000049965	16	2136732	16	2086731	49965	59127	rs45517377	NC_000016.10:2086730:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Mar 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850C>A (p.Ala1617Asp)	TSC2	A1016D, A1102D, A1103D, A1125D, A1126D, A1146D, A1350D, A1351D, A1373D, A1393D, A1394D, A1397D, A1417D, A1501D, A1502D, A1513D, A1514D, A1531D, A1544D, A1545D, A1546D, A1547D, A1550D, A1551D, A1557D, A1561D, A1573D, A1574D, A1580D, A1581D, A1591D, A1593D, A1594D, A1616D, A1617D	Tuberous sclerosis 2	VCV001721577	16	2136733	16	2086732	1721577	1772911	rs1412545821	NC_000016.10:2086731:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4850C>T (p.Ala1617Val)	TSC2	A1561V, A1573V, A1514V, A1373V, A1551V, A1594V, A1617V, A1502V, A1550V, A1574V	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001519622	16	2136733	16	2086732	1519622	1516911	rs1412545821	NC_000016.10:2086731:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4850C>G (p.Ala1617Gly)	TSC2	A1617G, A1551G, A1594G, A1561G, A1573G, A1574G, A1373G, A1514G, A1550G, A1502G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468116	16	2136733	16	2086732	468116	466299	rs1412545821	NC_000016.10:2086731:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4851C>G (p.Ala1617=)	TSC2		Tuberous sclerosis 2	VCV002830038	16	2136734	16	2086733	2830038	2990700	rs556045045	NC_000016.10:2086732:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4851C>T (p.Ala1617=)	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000388022	16	2136734	16	2086733	388022	374167	rs556045045	NC_000016.10:2086732:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4852G>C (p.Val1618Leu)	TSC2	V1592L, V1594L, V1618L, V1104L, V1127L, V1352L, V1374L, V1395L, V1502L, V1503L, V1532L, V1545L, V1548L, V1103L, V1126L, V1351L, V1394L, V1418L, V1515L, V1546L, V1582L, V1595L, V1147L, V1398L, V1547L, V1552L, V1562L, V1581L, V1017L, V1514L, V1551L, V1558L, V1574L, V1575L, V1617L	Tuberous sclerosis 2	VCV002827016	16	2136735	16	2086734	2827016	2986818	rs377129517	NC_000016.10:2086733:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4852G>A (p.Val1618Ile)	TSC2	V1618I, V1374I, V1515I, V1551I, V1562I, V1575I, V1574I, V1595I, V1503I, V1552I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000238066	16	2136735	16	2086734	238066	242324	rs377129517	NC_000016.10:2086733:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4854C>G (p.Val1618=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468117	16	2136737	16	2086736	468117	465381	rs45517378	NC_000016.10:2086735:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4854C>T (p.Val1618=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000049927	16	2136737	16	2086736	49927	59089	rs45517378	NC_000016.10:2086735:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4857C>G (p.Phe1619Leu)	TSC2	F1105L, F1128L, F1353L, F1395L, F1547L, F1559L, F1563L, F1576L, F1618L, F1504L, F1546L, F1593L, F1104L, F1127L, F1148L, F1375L, F1396L, F1399L, F1419L, F1503L, F1516L, F1533L, F1549L, F1552L, F1583L, F1596L, F1619L, F1018L, F1352L, F1515L, F1548L, F1553L, F1575L, F1582L, F1595L	Tuberous sclerosis 2	VCV003637252	16	2136740	16	2086739	3637252	3771406		NC_000016.10:2086738:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4857C>T (p.Phe1619=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825231	16	2136740	16	2086739	825231	812617	rs1596443022	NC_000016.10:2086738:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4858C>T (p.His1620Tyr)	TSC2	H1620Y, H1376Y, H1517Y, H1553Y, H1564Y, H1576Y, H1505Y, H1554Y, H1577Y, H1597Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049327	16	2136741	16	2086740	49327	58489	rs45446901	NC_000016.10:2086739:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4859A>T (p.His1620Leu)	TSC2	H1620L, H1517L, H1554L, H1564L, H1597L, H1505L, H1553L, H1576L, H1577L, H1376L	not provided	VCV000424510	16	2136742	16	2086741	424510	409495	rs397515177	NC_000016.10:2086740:A:T	single nucleotide variant	missense variant	Likely pathogenic	Dec 29, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4859A>G (p.His1620Arg)	TSC2	H1620R, H1553R, H1505R, H1517R, H1576R, H1577R, H1376R, H1554R, H1564R, H1597R	Tuberous sclerosis 2	VCV000065243	16	2136742	16	2086741	65243	76175	rs397515177	NC_000016.10:2086740:A:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4860C>T (p.His1620=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536060	16	2136743	16	2086742	536060	530039	rs1189943599	NC_000016.10:2086741:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4861A>G (p.Ile1621Val)	TSC2	I1518V, I1578V, I1377V, I1506V, I1555V, I1598V, I1565V, I1577V, I1554V, I1621V	Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000825240	16	2136744	16	2086743	825240	812618	rs1555516628	NC_000016.10:2086742:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4861A>T (p.Ile1621Phe)	TSC2	I1621F, I1518F, I1555F, I1578F, I1565F, I1577F, I1377F, I1506F, I1598F, I1554F	Tuberous sclerosis 2	VCV000535960	16	2136744	16	2086743	535960	530044	rs1555516628	NC_000016.10:2086742:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4863C>A (p.Ile1621=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002626406	16	2136746	16	2086745	2626406	2794172	rs142085017	NC_000016.10:2086744:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Sep 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4863C>T (p.Ile1621=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000238067	16	2136746	16	2086745	238067	242325	rs142085017	NC_000016.10:2086744:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4864G>A (p.Ala1622Thr)	TSC2	A1622T, A1566T, A1579T, A1378T, A1507T, A1556T, A1599T, A1519T, A1555T, A1578T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000536102	16	2136747	16	2086746	536102	529708	rs769913589	NC_000016.10:2086745:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4865C>T (p.Ala1622Val)	TSC2	A1398V, A1399V, A1599V, A1356V, A1378V, A1506V, A1552V, A1562V, A1566V, A1579V, A1586V, A1596V, A1598V, A1621V, A1622V, A1355V, A1402V, A1507V, A1518V, A1549V, A1021V, A1107V, A1422V, A1519V, A1536V, A1550V, A1551V, A1556V, A1108V, A1130V, A1131V, A1151V, A1555V, A1578V, A1585V	Tuberous sclerosis 2	VCV003637253	16	2136748	16	2086747	3637253	3771407		NC_000016.10:2086746:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4865C>G (p.Ala1622Gly)	TSC2	A1107G, A1108G, A1131G, A1378G, A1506G, A1550G, A1555G, A1622G, A1130G, A1519G, A1536G, A1556G, A1578G, A1586G, A1021G, A1151G, A1356G, A1402G, A1422G, A1549G, A1562G, A1566G, A1579G, A1585G, A1598G, A1599G, A1621G, A1355G, A1398G, A1399G, A1507G, A1518G, A1551G, A1552G, A1596G	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578805	16	2136748	16	2086747	3578805	3708225		NC_000016.10:2086746:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4866C>A (p.Ala1622=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329496	16	2136749	16	2086748	3329496	3489088		NC_000016.10:2086747:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4866C>T (p.Ala1622=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001154546	16	2136749	16	2086748	1154546	1145978	rs775723717	NC_000016.10:2086747:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4867A>G (p.Thr1623Ala)	TSC2	T1508A, T1567A, T1580A, T1579A, T1600A, T1520A, T1379A, T1556A, T1557A, T1623A	Tuberous sclerosis 2	VCV000839447	16	2136750	16	2086749	839447	843525	rs749501410	NC_000016.10:2086748:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4867A>T (p.Thr1623Ser)	TSC2	T1623S, T1520S, T1557S, T1580S, T1600S, T1379S, T1508S, T1556S, T1567S, T1579S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000468118	16	2136750	16	2086749	468118	465386	rs749501410	NC_000016.10:2086748:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4868C>G (p.Thr1623Ser)	TSC2	T1379S, T1623S, T1508S, T1557S, T1580S, T1600S, T1520S, T1556S, T1567S, T1579S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|TSC2-related disorder	VCV001415786	16	2136751	16	2086750	1415786	1371414	rs397515220	NC_000016.10:2086749:C:G	single nucleotide variant	missense variant	Uncertain significance	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4868C>T (p.Thr1623Ile)	TSC2	T1623I, T1557I, T1600I, T1567I, T1579I, T1508I, T1520I, T1556I, T1379I, T1580I	Tuberous sclerosis 2|not provided	VCV000065301	16	2136751	16	2086750	65301	76233	rs397515220	NC_000016.10:2086749:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4869C>G (p.Thr1623=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000413706	16	2136752	16	2086751	413706	401428	rs150239180	NC_000016.10:2086750:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4869C>T (p.Thr1623=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000238068	16	2136752	16	2086751	238068	242326	rs150239180	NC_000016.10:2086750:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4870C>G (p.Leu1624Val)	TSC2	L1023V, L1133V, L1401V, L1424V, L1520V, L1552V, L1557V, L1568V, L1581V, L1601V, L1358V, L1521V, L1109V, L1110V, L1357V, L1380V, L1400V, L1404V, L1508V, L1509V, L1538V, L1564V, L1580V, L1588V, L1600V, L1624V, L1554V, L1587V, L1598V, L1132V, L1153V, L1551V, L1553V, L1558V, L1623V	Hereditary cancer-predisposing syndrome	VCV003329533	16	2136753	16	2086752	3329533	3489125		NC_000016.10:2086751:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4870C>T (p.Leu1624=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000186842	16	2136753	16	2086752	186842	184144	rs786203263	NC_000016.10:2086751:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4872G>A (p.Leu1624=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001534614	16	2136755	16	2086754	1534614	1617130	rs2151584763	NC_000016.10:2086753:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4873A>C (p.Met1625Leu)	TSC2	M1134L, M1359L, M1381L, M1402L, M1510L, M1552L, M1554L, M1569L, M1581L, M1599L, M1624L, M1625L, M1024L, M1111L, M1133L, M1425L, M1522L, M1539L, M1553L, M1565L, M1601L, M1602L, M1401L, M1405L, M1509L, M1555L, M1558L, M1588L, M1589L, M1110L, M1154L, M1358L, M1521L, M1559L, M1582L	Hereditary cancer-predisposing syndrome	VCV003329536	16	2136756	16	2086755	3329536	3489128		NC_000016.10:2086754:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4873A>T (p.Met1625Leu)	TSC2	M1381L, M1510L, M1522L, M1558L, M1559L, M1569L, M1581L, M1582L, M1602L, M1625L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001061230	16	2136756	16	2086755	1061230	1049495	rs774386413	NC_000016.10:2086754:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4874T>A (p.Met1625Lys)	TSC2	M1024K, M1110K, M1111K, M1133K, M1134K, M1154K, M1358K, M1359K, M1381K, M1401K, M1402K, M1405K, M1425K, M1509K, M1510K, M1521K, M1522K, M1539K, M1552K, M1553K, M1554K, M1555K, M1558K, M1559K, M1565K, M1569K, M1581K, M1582K, M1588K, M1589K, M1599K, M1601K, M1602K, M1624K, M1625K	Tuberous sclerosis 2	VCV003901192	16	2136757	16	2086756	3901192	4017036		NC_000016.10:2086755:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	May 26, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4875G>A (p.Met1625Ile)	TSC2	M1024I, M1110I, M1111I, M1133I, M1134I, M1154I, M1358I, M1359I, M1381I, M1401I, M1402I, M1405I, M1425I, M1509I, M1510I, M1521I, M1522I, M1539I, M1552I, M1553I, M1554I, M1555I, M1558I, M1559I, M1565I, M1569I, M1581I, M1582I, M1588I, M1589I, M1599I, M1601I, M1602I, M1624I, M1625I	Hereditary cancer-predisposing syndrome	VCV003232178	16	2136758	16	2086757	3232178	3391979	rs1456354354	NC_000016.10:2086756:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4876C>G (p.Pro1626Ala)	TSC2	P1025A, P1111A, P1403A, P1426A, P1540A, P1555A, P1600A, P1603A, P1625A, P1112A, P1155A, P1359A, P1510A, P1511A, P1582A, P1590A, P1402A, P1406A, P1522A, P1553A, P1556A, P1559A, P1566A, P1583A, P1626A, P1134A, P1135A, P1360A, P1382A, P1523A, P1554A, P1560A, P1570A, P1589A, P1602A	Tuberous sclerosis 2	VCV003637254	16	2136759	16	2086758	3637254	3771408		NC_000016.10:2086757:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4876C>A (p.Pro1626Thr)	TSC2	P1382T, P1511T, P1523T, P1559T, P1560T, P1570T, P1582T, P1583T, P1603T, P1626T	Tuberous sclerosis 2|not specified	VCV001685189	16	2136759	16	2086758	1685189	1677211	rs2090852831	NC_000016.10:2086757:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4876C>T (p.Pro1626Ser)	TSC2	P1570S, P1603S, P1559S, P1582S, P1626S, P1382S, P1511S, P1560S, P1523S, P1583S	Tuberous sclerosis 2	VCV001354766	16	2136759	16	2086758	1354766	1434351	rs2090852831	NC_000016.10:2086757:C:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4877C>T (p.Pro1626Leu)	TSC2	P1382L, P1402L, P1511L, P1522L, P1559L, P1566L, P1134L, P1360L, P1426L, P1540L, P1553L, P1555L, P1556L, P1560L, P1589L, P1600L, P1625L, P1111L, P1135L, P1510L, P1554L, P1590L, P1602L, P1626L, P1025L, P1112L, P1155L, P1359L, P1403L, P1406L, P1523L, P1570L, P1582L, P1583L, P1603L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002102808	16	2136760	16	2086759	2102808	2161868	rs2151584994	NC_000016.10:2086758:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4878C>T (p.Pro1626=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002564639	16	2136761	16	2086760	2564639	2733795	rs2151585045	NC_000016.10:2086759:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4879A>G (p.Thr1627Ala)	TSC2	T1113A, T1135A, T1407A, T1511A, T1512A, T1524A, T1557A, T1583A, T1404A, T1541A, T1554A, T1555A, T1560A, T1567A, T1584A, T1591A, T1604A, T1026A, T1112A, T1136A, T1360A, T1383A, T1403A, T1427A, T1523A, T1556A, T1561A, T1590A, T1627A, T1156A, T1361A, T1571A, T1601A, T1603A, T1626A	Hereditary cancer-predisposing syndrome	VCV003974690	16	2136762	16	2086761	3974690	4086513		NC_000016.10:2086760:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4880C>A (p.Thr1627Asn)	TSC2	T1627N, T1524N, T1561N, T1604N, T1512N, T1571N, T1383N, T1560N, T1583N, T1584N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468119	16	2136763	16	2086762	468119	466115	rs1555438434	NC_000016.10:2086761:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4881C>T (p.Thr1627=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811344	16	2136764	16	2086763	3811344	3928585		NC_000016.10:2086762:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 18, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4881C>G (p.Thr1627=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001652073	16	2136764	16	2086763	1652073	1613299	rs2151585189	NC_000016.10:2086762:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4882A>G (p.Lys1628Glu)	TSC2	K1027E, K1113E, K1114E, K1136E, K1137E, K1157E, K1361E, K1362E, K1384E, K1404E, K1405E, K1408E, K1428E, K1512E, K1513E, K1524E, K1525E, K1542E, K1555E, K1556E, K1557E, K1558E, K1561E, K1562E, K1568E, K1572E, K1584E, K1585E, K1591E, K1592E, K1602E, K1604E, K1605E, K1627E, K1628E	not provided|Hereditary cancer-predisposing syndrome	VCV002672604	16	2136765	16	2086764	2672604	2840124	rs2151585228	NC_000016.10:2086763:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4883A>C (p.Lys1628Thr)	TSC2	K1384T, K1404T, K1428T, K1513T, K1542T, K1561T, K1585T, K1592T, K1627T, K1027T, K1113T, K1405T, K1512T, K1524T, K1555T, K1557T, K1584T, K1628T, K1136T, K1137T, K1157T, K1361T, K1362T, K1408T, K1556T, K1558T, K1562T, K1591T, K1604T, K1605T, K1114T, K1525T, K1568T, K1572T, K1602T	Hereditary cancer-predisposing syndrome	VCV002564705	16	2136766	16	2086765	2564705	2733861	rs2544401116	NC_000016.10:2086764:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4884G>A (p.Lys1628=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001010467	16	2136767	16	2086766	1010467	996765	rs2090853639	NC_000016.10:2086765:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4885G>A (p.Asp1629Asn)	TSC2	D1606N, D1385N, D1526N, D1585N, D1629N, D1514N, D1562N, D1573N, D1586N, D1563N	Tuberous sclerosis 2	VCV001477023	16	2136768	16	2086767	1477023	1417088	rs1295162020	NC_000016.10:2086766:G:A	single nucleotide variant	missense variant	Benign	Jun 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4886A>G (p.Asp1629Gly)	TSC2	D1563G, D1573G, D1585G, D1606G, D1514G, D1385G, D1526G, D1562G, D1586G, D1629G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000844440	16	2136769	16	2086768	844440	843527	rs767444397	NC_000016.10:2086767:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4887C>G (p.Asp1629Glu)	TSC2	D1385E, D1514E, D1526E, D1562E, D1563E, D1573E, D1585E, D1586E, D1606E, D1629E	Tuberous sclerosis 2	VCV001024269	16	2136770	16	2086769	1024269	1012007	rs137854152	NC_000016.10:2086768:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4887C>T (p.Asp1629=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049972	16	2136770	16	2086769	49972	59134	rs137854152	NC_000016.10:2086768:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4888G>C (p.Val1630Leu)	TSC2	V1527L, V1607L, V1386L, V1564L, V1587L, V1515L, V1563L, V1574L, V1586L, V1630L	Tuberous sclerosis 2	VCV001045834	16	2136771	16	2086770	1045834	1032500	rs886051796	NC_000016.10:2086769:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4888G>A (p.Val1630Met)	TSC2	V1630M, V1527M, V1515M, V1574M, V1586M, V1386M, V1563M, V1564M, V1587M, V1607M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000318334	16	2136771	16	2086770	318334	342274	rs886051796	NC_000016.10:2086769:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4889T>G (p.Val1630Gly)	TSC2	V1139G, V1410G, V1514G, V1526G, V1563G, V1570G, V1587G, V1606G, V1115G, V1364G, V1430G, V1560G, V1630G, V1029G, V1116G, V1138G, V1159G, V1363G, V1386G, V1406G, V1544G, V1558G, V1574G, V1593G, V1607G, V1629G, V1407G, V1515G, V1527G, V1557G, V1559G, V1564G, V1586G, V1594G, V1604G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001743833	16	2136772	16	2086771	1743833	1802177	rs1281504795	NC_000016.10:2086770:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4890G>C (p.Val1630=)	TSC2		Tuberous sclerosis 2	VCV002197587	16	2136773	16	2086772	2197587	1927168	rs2151585571	NC_000016.10:2086771:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4890G>A (p.Val1630=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001613463	16	2136773	16	2086772	1613463	1578200	rs2151585571	NC_000016.10:2086771:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4891G>A (p.Asp1631Asn)	TSC2	D1116N, D1160N, D1365N, D1515N, D1560N, D1564N, D1571N, D1587N, D1595N, D1630N, D1631N, D1140N, D1364N, D1408N, D1431N, D1545N, D1558N, D1605N, D1607N, D1030N, D1117N, D1407N, D1516N, D1527N, D1528N, D1559N, D1565N, D1594N, D1139N, D1387N, D1411N, D1561N, D1575N, D1588N, D1608N	Hereditary cancer-predisposing syndrome	VCV001743866	16	2136774	16	2086773	1743866	1802210	rs2090855331	NC_000016.10:2086772:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4891G>T (p.Asp1631Tyr)	TSC2	D1564Y, D1587Y, D1565Y, D1575Y, D1588Y, D1387Y, D1516Y, D1528Y, D1608Y, D1631Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000946771	16	2136774	16	2086773	946771	927684	rs2090855331	NC_000016.10:2086772:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4893C>T (p.Asp1631=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000761426	16	2136776	16	2086775	761426	770743	rs772915632	NC_000016.10:2086774:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4894A>G (p.Lys1632Glu)	TSC2	K1529E, K1566E, K1609E, K1632E, K1388E, K1517E, K1589E, K1565E, K1576E, K1588E	Tuberous sclerosis 2	VCV000946823	16	2136777	16	2086776	946823	927685	rs2090855880	NC_000016.10:2086775:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4895A>G (p.Lys1632Arg)	TSC2	K1117R, K1140R, K1432R, K1516R, K1529R, K1561R, K1565R, K1595R, K1141R, K1161R, K1365R, K1388R, K1408R, K1409R, K1546R, K1560R, K1589R, K1596R, K1606R, K1608R, K1609R, K1632R, K1031R, K1517R, K1528R, K1562R, K1588R, K1631R, K1118R, K1366R, K1412R, K1559R, K1566R, K1572R, K1576R	Tuberous sclerosis 2	VCV003637255	16	2136778	16	2086777	3637255	3771409		NC_000016.10:2086776:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4895A>C (p.Lys1632Thr)	TSC2	K1141T, K1546T, K1572T, K1589T, K1606T, K1608T, K1118T, K1562T, K1596T, K1632T, K1117T, K1140T, K1365T, K1366T, K1388T, K1408T, K1432T, K1516T, K1560T, K1565T, K1576T, K1588T, K1595T, K1031T, K1161T, K1409T, K1412T, K1517T, K1528T, K1529T, K1559T, K1561T, K1566T, K1609T, K1631T	Hereditary cancer-predisposing syndrome	VCV002564706	16	2136778	16	2086777	2564706	2733862	rs2151585772	NC_000016.10:2086776:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4896G>A (p.Lys1632=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003462545	16	2136779	16	2086778	3462545	3621565		NC_000016.10:2086777:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4896G>T (p.Lys1632Asn)	TSC2	K1031N, K1117N, K1118N, K1140N, K1141N, K1161N, K1365N, K1366N, K1388N, K1408N, K1409N, K1412N, K1432N, K1516N, K1517N, K1528N, K1529N, K1546N, K1559N, K1560N, K1561N, K1562N, K1565N, K1566N, K1572N, K1576N, K1588N, K1589N, K1595N, K1596N, K1606N, K1608N, K1609N, K1631N, K1632N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001716844	16	2136779	16	2086778	1716844	1775669	rs1555438475	NC_000016.10:2086777:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4896G>C (p.Lys1632Asn)	TSC2	K1632N, K1388N, K1529N, K1566N, K1589N, K1517N, K1565N, K1588N, K1609N, K1576N	Tuberous sclerosis 2	VCV000535923	16	2136779	16	2086778	535923	529711	rs1555438475	NC_000016.10:2086777:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4897C>G (p.His1633Asp)	TSC2	H1367D, H1389D, H1518D, H1597D, H1607D, H1633D, H1162D, H1530D, H1547D, H1590D, H1596D, H1632D, H1118D, H1141D, H1142D, H1410D, H1413D, H1433D, H1517D, H1561D, H1562D, H1563D, H1567D, H1573D, H1589D, H1032D, H1119D, H1366D, H1409D, H1529D, H1560D, H1566D, H1577D, H1609D, H1610D	Hereditary cancer-predisposing syndrome	VCV003974707	16	2136780	16	2086779	3974707	4086530		NC_000016.10:2086778:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 12, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4897C>T (p.His1633Tyr)	TSC2	H1118Y, H1142Y, H1366Y, H1389Y, H1409Y, H1413Y, H1517Y, H1547Y, H1563Y, H1577Y, H1590Y, H1597Y, H1609Y, H1610Y, H1032Y, H1410Y, H1518Y, H1530Y, H1573Y, H1589Y, H1632Y, H1119Y, H1367Y, H1529Y, H1560Y, H1561Y, H1607Y, H1633Y, H1141Y, H1162Y, H1433Y, H1562Y, H1566Y, H1567Y, H1596Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002082235	16	2136780	16	2086779	2082235	2136189	rs2151585854	NC_000016.10:2086778:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4899C>T (p.His1633=)	TSC2		Tuberous sclerosis 2	VCV001558701	16	2136782	16	2086781	1558701	1563366	rs1223963841	NC_000016.10:2086780:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4900C>G (p.Arg1634Gly)	TSC2	R1142G, R1367G, R1518G, R1519G, R1530G, R1531G, R1548G, R1563G, R1564G, R1574G, R1578G, R1591G, R1633G, R1119G, R1120G, R1390G, R1562G, R1597G, R1608G, R1610G, R1033G, R1143G, R1368G, R1410G, R1434G, R1561G, R1568G, R1598G, R1611G, R1163G, R1411G, R1414G, R1567G, R1590G, R1634G	Tuberous sclerosis 2	VCV002997322	16	2136783	16	2086782	2997322	3166667	rs760457821	NC_000016.10:2086781:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4900C>T (p.Arg1634Cys)	TSC2	R1634C, R1519C, R1578C, R1611C, R1531C, R1590C, R1591C, R1390C, R1567C, R1568C	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|not specified	VCV000207757	16	2136783	16	2086782	207757	203201	rs760457821	NC_000016.10:2086781:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4901G>A (p.Arg1634His)	TSC2	R1634H, R1531H, R1590H, R1611H, R1390H, R1567H, R1568H, R1591H, R1519H, R1578H	Hereditary cancer-predisposing syndrome|not provided|not specified|Tuberous sclerosis 2	VCV000135390	16	2136784	16	2086783	135390	139129	rs201694466	NC_000016.10:2086782:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 24, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4902C>A (p.Arg1634=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002449987	16	2136785	16	2086784	2449987	2425944	rs2151586089	NC_000016.10:2086783:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4903T>C (p.Cys1635Arg)	TSC2	C1634R, C1635R, C1034R, C1120R, C1121R, C1143R, C1144R, C1164R, C1368R, C1369R, C1391R, C1411R, C1412R, C1415R, C1435R, C1519R, C1520R, C1531R, C1532R, C1549R, C1562R, C1563R, C1564R, C1565R, C1568R, C1569R, C1575R, C1579R, C1591R, C1592R, C1598R, C1599R, C1609R, C1611R, C1612R	Tuberous sclerosis 2	VCV003605889	16	2136786	16	2086785	3605889	3747065		NC_000016.10:2086784:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4904G>A (p.Cys1635Tyr)	TSC2	C1635Y, C1532Y, C1592Y, C1612Y, C1520Y, C1568Y, C1569Y, C1591Y, C1391Y, C1579Y	Tuberous sclerosis 2	VCV000535983	16	2136787	16	2086786	535983	529717	rs1555438494	NC_000016.10:2086785:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4905C>T (p.Cys1635=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000186947	16	2136788	16	2086787	186947	184145	rs397514999	NC_000016.10:2086786:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4906G>C (p.Asp1636His)	TSC2	D1370H, D1520H, D1521H, D1550H, D1564H, D1565H, D1566H, D1580H, D1035H, D1121H, D1122H, D1165H, D1369H, D1413H, D1569H, D1600H, D1635H, D1145H, D1392H, D1416H, D1533H, D1563H, D1570H, D1576H, D1636H, D1592H, D1593H, D1599H, D1144H, D1412H, D1436H, D1532H, D1610H, D1612H, D1613H	Tuberous sclerosis 2	VCV002763806	16	2136789	16	2086788	2763806	2921975	rs45482398	NC_000016.10:2086787:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4906G>A (p.Asp1636Asn)	TSC2	D1636N, D1569N, D1392N, D1533N, D1593N, D1521N, D1570N, D1580N, D1592N, D1613N	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049880	16	2136789	16	2086788	49880	59042	rs45482398	NC_000016.10:2086787:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4907A>G (p.Asp1636Gly)	TSC2	D1035G, D1121G, D1122G, D1144G, D1145G, D1165G, D1369G, D1370G, D1392G, D1412G, D1413G, D1416G, D1436G, D1520G, D1521G, D1532G, D1533G, D1550G, D1563G, D1564G, D1565G, D1566G, D1569G, D1570G, D1576G, D1580G, D1592G, D1593G, D1599G, D1600G, D1610G, D1612G, D1613G, D1635G, D1636G	not provided|Hereditary cancer-predisposing syndrome	VCV003232179	16	2136790	16	2086789	3232179	3391980	rs764887737	NC_000016.10:2086788:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4908C>A (p.Asp1636Glu)	TSC2	D1144E, D1165E, D1370E, D1520E, D1564E, D1593E, D1612E, D1392E, D1532E, D1563E, D1569E, D1592E, D1635E, D1035E, D1121E, D1369E, D1412E, D1416E, D1436E, D1565E, D1566E, D1570E, D1576E, D1599E, D1600E, D1613E, D1122E, D1145E, D1413E, D1521E, D1533E, D1550E, D1580E, D1610E, D1636E	Tuberous sclerosis 2	VCV002738953	16	2136791	16	2086790	2738953	2902318	rs115200071	NC_000016.10:2086789:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4908C>T (p.Asp1636=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065110	16	2136791	16	2086790	65110	76041	rs115200071	NC_000016.10:2086789:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4909A>G (p.Lys1637Glu)	TSC2	K1581E, K1571E, K1593E, K1637E, K1393E, K1534E, K1570E, K1522E, K1594E, K1614E	Tuberous sclerosis 2	VCV000656150	16	2136792	16	2086791	656150	644348	rs1596443444	NC_000016.10:2086790:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4910A>G (p.Lys1637Arg)	TSC2	K1123R, K1370R, K1521R, K1551R, K1570R, K1581R, K1594R, K1371R, K1566R, K1567R, K1593R, K1611R, K1613R, K1637R, K1036R, K1146R, K1413R, K1437R, K1522R, K1565R, K1600R, K1601R, K1614R, K1122R, K1145R, K1166R, K1393R, K1414R, K1417R, K1533R, K1534R, K1564R, K1571R, K1577R, K1636R	Tuberous sclerosis 2	VCV003666787	16	2136793	16	2086792	3666787	3802613		NC_000016.10:2086791:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4911G>A (p.Lys1637=)	TSC2		not specified|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000049331	16	2136794	16	2086793	49331	58493	rs35282988	NC_000016.10:2086792:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4913A>C (p.Lys1638Thr)	TSC2	K1037T, K1123T, K1167T, K1415T, K1534T, K1535T, K1566T, K1602T, K1615T, K1638T, K1372T, K1414T, K1565T, K1571T, K1578T, K1582T, K1594T, K1595T, K1612T, K1637T, K1146T, K1394T, K1418T, K1438T, K1522T, K1567T, K1568T, K1572T, K1614T, K1124T, K1147T, K1371T, K1523T, K1552T, K1601T	Hereditary cancer-predisposing syndrome	VCV002564707	16	2136796	16	2086795	2564707	2733863	rs2151586573	NC_000016.10:2086794:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4914G>T (p.Lys1638Asn)	TSC2	K1638N, K1572N, K1595N, K1523N, K1571N, K1615N, K1394N, K1535N, K1582N, K1594N	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000569463	16	2136797	16	2086796	569463	573879	rs137854094	NC_000016.10:2086795:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4914G>A (p.Lys1638=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000486598	16	2136797	16	2086796	486598	477398	rs137854094	NC_000016.10:2086795:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4915C>G (p.Arg1639Gly)	TSC2	R1038G, R1124G, R1125G, R1147G, R1148G, R1168G, R1372G, R1373G, R1395G, R1415G, R1416G, R1419G, R1439G, R1523G, R1524G, R1535G, R1536G, R1553G, R1566G, R1567G, R1568G, R1569G, R1572G, R1573G, R1579G, R1583G, R1595G, R1596G, R1602G, R1603G, R1613G, R1615G, R1616G, R1638G, R1639G	Hereditary cancer-predisposing syndrome	VCV003232180	16	2136798	16	2086797	3232180	3391981	rs1555438551	NC_000016.10:2086796:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4915C>T (p.Arg1639Cys)	TSC2	R1639C, R1572C, R1573C, R1524C, R1536C, R1583C, R1596C, R1616C, R1395C, R1595C	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000535976	16	2136798	16	2086797	535976	529718	rs1555438551	NC_000016.10:2086796:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4916G>A (p.Arg1639His)	TSC2	R1395H, R1524H, R1536H, R1572H, R1573H, R1583H, R1595H, R1596H, R1616H, R1639H	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001313626	16	2136799	16	2086798	1313626	1303887	rs137854153	NC_000016.10:2086797:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4917C>T (p.Arg1639=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000391576	16	2136800	16	2086799	391576	377283	rs1057524144	NC_000016.10:2086798:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4918C>T (p.His1640Tyr)	TSC2	H1640Y, H1573Y, H1396Y, H1574Y, H1584Y, H1597Y, H1596Y, H1617Y, H1525Y, H1537Y	Tuberous sclerosis 2	VCV000049333	16	2136801	16	2086800	49333	58495	rs45485092	NC_000016.10:2086799:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4919A>G (p.His1640Arg)	TSC2	H1640R, H1537R, H1573R, H1396R, H1525R, H1574R, H1584R, H1596R, H1597R, H1617R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000547828	16	2136802	16	2086801	547828	538098	rs794727602	NC_000016.10:2086800:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 1, 2017	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4919A>C (p.His1640Pro)	TSC2	H1640P, H1573P, H1596P, H1525P, H1584P, H1617P, H1537P, H1597P, H1396P, H1574P	Tuberous sclerosis 2|not provided	VCV000197025	16	2136802	16	2086801	197025	194186	rs794727602	NC_000016.10:2086800:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 28, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4920C>A (p.His1640Gln)	TSC2	H1573Q, H1617Q, H1640Q, H1525Q, H1537Q, H1396Q, H1574Q, H1597Q, H1584Q, H1596Q	Tuberous sclerosis 2	VCV000843345	16	2136803	16	2086802	843345	843528	rs1555438576	NC_000016.10:2086801:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4920C>T (p.His1640=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536073	16	2136803	16	2086802	536073	530048	rs1555438576	NC_000016.10:2086801:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4921C>G (p.Leu1641Val)	TSC2	L1421V, L1525V, L1569V, L1597V, L1640V, L1126V, L1149V, L1441V, L1526V, L1555V, L1568V, L1574V, L1598V, L1615V, L1617V, L1127V, L1150V, L1170V, L1375V, L1417V, L1418V, L1537V, L1538V, L1571V, L1575V, L1604V, L1618V, L1641V, L1040V, L1374V, L1397V, L1570V, L1581V, L1585V, L1605V	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV002875741	16	2136804	16	2086803	2875741	3041256	rs1343423120	NC_000016.10:2086802:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4921C>T (p.Leu1641=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000765282	16	2136804	16	2086803	765282	770744	rs1343423120	NC_000016.10:2086802:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4923G>C (p.Leu1641=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001744145	16	2136806	16	2086805	1744145	1799041	rs1555438590	NC_000016.10:2086804:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 28, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4923G>A (p.Leu1641=)	TSC2		Hereditary cancer-predisposing syndrome	VCV000486655	16	2136806	16	2086805	486655	477400	rs1555438590	NC_000016.10:2086804:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 19, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.4924G>A (p.Gly1642Ser)	TSC2	G1041S, G1127S, G1128S, G1150S, G1151S, G1171S, G1375S, G1376S, G1398S, G1418S, G1419S, G1422S, G1442S, G1526S, G1527S, G1538S, G1539S, G1556S, G1569S, G1570S, G1571S, G1572S, G1575S, G1576S, G1582S, G1586S, G1598S, G1599S, G1605S, G1606S, G1616S, G1618S, G1619S, G1641S, G1642S	Tuberous sclerosis syndrome	VCV003386180	16	2136807	16	2086806	3386180	3545321		NC_000016.10:2086805:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4925G>C (p.Gly1642Ala)	TSC2	G1539A, G1598A, G1599A, G1642A, G1575A, G1398A, G1527A, G1576A, G1586A, G1619A	Tuberous sclerosis 2	VCV000960046	16	2136808	16	2086807	960046	949287	rs137854343	NC_000016.10:2086806:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4925G>A (p.Gly1642Asp)	TSC2	G1642D, G1599D, G1527D, G1576D, G1586D, G1619D, G1575D, G1598D, G1398D, G1539D	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000049978	16	2136808	16	2086807	49978	59140	rs137854343	NC_000016.10:2086806:G:A	single nucleotide variant	missense variant	Pathogenic	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4926C>T (p.Gly1642=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001521810	16	2136809	16	2086808	1521810	1343825	rs1412821205	NC_000016.10:2086807:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4927A>G (p.Asn1643Asp)	TSC2	N1042D, N1129D, N1152D, N1540D, N1571D, N1572D, N1606D, N1642D, N1128D, N1151D, N1539D, N1557D, N1576D, N1577D, N1599D, N1172D, N1376D, N1528D, N1573D, N1583D, N1587D, N1607D, N1617D, N1619D, N1643D, N1377D, N1399D, N1419D, N1420D, N1423D, N1443D, N1527D, N1570D, N1600D, N1620D	Tuberous sclerosis 2	VCV002007528	16	2136810	16	2086809	2007528	2073189	rs45517379	NC_000016.10:2086808:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4927A>C (p.Asn1643His)	TSC2	N1643H, N1620H, N1399H, N1528H, N1540H, N1576H, N1587H, N1599H, N1577H, N1600H	not provided	VCV000049910	16	2136810	16	2086809	49910	59072	rs45517379	NC_000016.10:2086808:A:C	single nucleotide variant	missense variant	Pathogenic	Mar 22, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4929C>T (p.Asn1643=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis 2	VCV000238069	16	2136812	16	2086811	238069	242327	rs45517381	NC_000016.10:2086810:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4930G>T (p.Asp1644Tyr)	TSC2	D1541Y, D1588Y, D1601Y, D1400Y, D1600Y, D1529Y, D1577Y, D1578Y, D1621Y, D1644Y	Tuberous sclerosis 2	VCV001045993	16	2136813	16	2086812	1045993	1032501	rs137853999	NC_000016.10:2086811:G:T	single nucleotide variant	missense variant	Pathogenic	Nov 18, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4930G>A (p.Asp1644Asn)	TSC2	D1644N, D1621N, D1529N, D1578N, D1601N, D1400N, D1541N, D1577N, D1588N, D1600N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000318335	16	2136813	16	2086812	318335	324634	rs137853999	NC_000016.10:2086811:G:A	single nucleotide variant	missense variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4932C>T (p.Asp1644=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001533030	16	2136815	16	2086814	1533030	1605584	rs1395198412	NC_000016.10:2086813:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4932C>G (p.Asp1644Glu)	TSC2	D1588E, D1601E, D1400E, D1577E, D1600E, D1578E, D1529E, D1541E, D1621E, D1644E	Hereditary cancer-predisposing syndrome	VCV000825304	16	2136815	16	2086814	825304	812619	rs1395198412	NC_000016.10:2086813:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4933T>C (p.Phe1645Leu)	TSC2	F1579L, F1622L, F1645L, F1401L, F1542L, F1578L, F1530L, F1589L, F1601L, F1602L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825308	16	2136816	16	2086815	825308	812620	rs1596443758	NC_000016.10:2086814:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4936G>T (p.Val1646Leu)	TSC2	V1543L, V1623L, V1646L, V1579L, V1580L, V1590L, V1602L, V1402L, V1531L, V1603L	Tuberous sclerosis 2	VCV001490108	16	2136819	16	2086818	1490108	1515101	rs1064796970	NC_000016.10:2086817:G:T	single nucleotide variant	missense variant	Likely pathogenic	Mar 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4936G>C (p.Val1646Leu)	TSC2	V1579L, V1590L, V1543L, V1580L, V1646L, V1402L, V1531L, V1602L, V1603L, V1623L	not specified|Tuberous sclerosis 2	VCV001472268	16	2136819	16	2086818	1472268	1385416	rs1064796970	NC_000016.10:2086817:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 4, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4936G>A (p.Val1646Met)	TSC2	V1646M, V1602M, V1531M, V1623M, V1579M, V1580M, V1603M, V1402M, V1543M, V1590M	not provided|Tuberous sclerosis 2	VCV000424444	16	2136819	16	2086818	424444	409497	rs1064796970	NC_000016.10:2086817:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4938G>T (p.Val1646=)	TSC2		Tuberous sclerosis 2	VCV004071150	16	2136821	16	2086820	4071150	4184998		NC_000016.10:2086819:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4938G>A (p.Val1646=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002824804	16	2136821	16	2086820	2824804	2989306	rs2151587679	NC_000016.10:2086819:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4939T>G (p.Ser1647Ala)	TSC2	S1046A, S1132A, S1133A, S1155A, S1156A, S1176A, S1380A, S1381A, S1403A, S1423A, S1424A, S1427A, S1447A, S1531A, S1532A, S1543A, S1544A, S1561A, S1574A, S1575A, S1576A, S1577A, S1580A, S1581A, S1587A, S1591A, S1603A, S1604A, S1610A, S1611A, S1621A, S1623A, S1624A, S1646A, S1647A	Hereditary cancer-predisposing syndrome	VCV003232181	16	2136822	16	2086821	3232181	3391982	rs2151587714	NC_000016.10:2086820:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4939T>C (p.Ser1647Pro)	TSC2	S1403P, S1532P, S1544P, S1580P, S1581P, S1591P, S1603P, S1604P, S1624P, S1647P	not provided	VCV001163387	16	2136822	16	2086821	1163387	1152670	rs2151587714	NC_000016.10:2086820:T:C	single nucleotide variant	missense variant	Uncertain significance	May 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4940C>T (p.Ser1647Phe)	TSC2	S1403F, S1532F, S1544F, S1580F, S1581F, S1591F, S1603F, S1604F, S1624F, S1647F	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001019089	16	2136823	16	2086822	1019089	1012008	rs2090863579	NC_000016.10:2086821:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4940C>G (p.Ser1647Cys)	TSC2	S1580C, S1581C, S1403C, S1591C, S1603C, S1647C, S1532C, S1544C, S1604C, S1624C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000861907	16	2136823	16	2086822	861907	843529	rs2090863579	NC_000016.10:2086821:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4941C>T (p.Ser1647=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000698016	16	2136824	16	2086823	698016	688552	rs780279747	NC_000016.10:2086822:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4942A>C (p.Ile1648Leu)	TSC2	I1404L, I1545L, I1592L, I1648L, I1605L, I1533L, I1581L, I1582L, I1604L, I1625L	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000958560	16	2136825	16	2086824	958560	949288	rs749554579	NC_000016.10:2086823:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4942A>G (p.Ile1648Val)	TSC2	I1648V, I1604V, I1605V, I1533V, I1581V, I1625V, I1404V, I1545V, I1582V, I1592V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000405966	16	2136825	16	2086824	405966	401683	rs749554579	NC_000016.10:2086823:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4943T>C (p.Ile1648Thr)	TSC2	I1648T, I1545T, I1582T, I1604T, I1605T, I1581T, I1625T, I1404T, I1533T, I1592T	Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided	VCV000049458	16	2136826	16	2086825	49458	58620	rs45471896	NC_000016.10:2086824:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4944T>C (p.Ile1648=)	TSC2		Tuberous sclerosis 2	VCV003691278	16	2136827	16	2086826	3691278	3828065		NC_000016.10:2086825:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4945G>A (p.Val1649Ile)	TSC2	V1605I, V1534I, V1593I, V1606I, V1405I, V1583I, V1546I, V1582I, V1626I, V1649I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000640309	16	2136828	16	2086827	640309	644349	rs768846712	NC_000016.10:2086826:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4947C>T (p.Val1649=)	TSC2		Tuberous sclerosis 2	VCV000799883	16	2136830	16	2086829	799883	785208	rs778989782	NC_000016.10:2086828:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4947C>G (p.Val1649=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000238070	16	2136830	16	2086829	238070	242328	rs778989782	NC_000016.10:2086828:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4948T>C (p.Tyr1650His)	TSC2	Y1135H, Y1406H, Y1450H, Y1534H, Y1547H, Y1577H, Y1584H, Y1594H, Y1624H, Y1650H, Y1383H, Y1426H, Y1564H, Y1578H, Y1579H, Y1607H, Y1626H, Y1049H, Y1158H, Y1159H, Y1384H, Y1427H, Y1430H, Y1583H, Y1590H, Y1606H, Y1613H, Y1627H, Y1649H, Y1136H, Y1179H, Y1535H, Y1546H, Y1580H, Y1614H	Tuberous sclerosis 2	VCV003637256	16	2136831	16	2086830	3637256	3771410		NC_000016.10:2086829:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4949A>C (p.Tyr1650Ser)	TSC2	Y1627S, Y1649S, Y1135S, Y1159S, Y1534S, Y1547S, Y1626S, Y1049S, Y1136S, Y1427S, Y1450S, Y1578S, Y1580S, Y1584S, Y1650S, Y1158S, Y1179S, Y1383S, Y1384S, Y1406S, Y1426S, Y1535S, Y1546S, Y1564S, Y1577S, Y1583S, Y1594S, Y1613S, Y1624S, Y1430S, Y1579S, Y1590S, Y1606S, Y1607S, Y1614S	Tuberous sclerosis 2	VCV002810797	16	2136832	16	2086831	2810797	2965471	rs45501091	NC_000016.10:2086830:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4949A>T (p.Tyr1650Phe)	TSC2	Y1406F, Y1535F, Y1594F, Y1606F, Y1547F, Y1583F, Y1584F, Y1627F, Y1607F, Y1650F	Tuberous sclerosis 2	VCV000851323	16	2136832	16	2086831	851323	843530	rs45501091	NC_000016.10:2086830:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4949A>G (p.Tyr1650Cys)	TSC2	Y1650C, Y1406C, Y1594C, Y1535C, Y1584C, Y1607C, Y1627C, Y1547C, Y1583C, Y1606C	Hereditary cancer-predisposing syndrome	VCV000049334	16	2136832	16	2086831	49334	58496	rs45501091	NC_000016.10:2086830:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.4950C>G (p.Tyr1650Ter)	TSC2	Y1406*, Y1535*, Y1547*, Y1583*, Y1584*, Y1594*, Y1606*, Y1607*, Y1627*, Y1650*	Tuberous sclerosis 2	VCV001076715	16	2136833	16	2086832	1076715	1063558	rs1283177454	NC_000016.10:2086831:C:G	single nucleotide variant	nonsense	Pathogenic	Feb 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4950C>T (p.Tyr1650=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486614	16	2136833	16	2086832	486614	477438	rs1283177454	NC_000016.10:2086831:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4951A>C (p.Asn1651His)	TSC2	N1137H, N1159H, N1427H, N1578H, N1584H, N1607H, N1136H, N1180H, N1431H, N1547H, N1579H, N1580H, N1585H, N1591H, N1625H, N1627H, N1651H, N1050H, N1160H, N1384H, N1385H, N1407H, N1428H, N1548H, N1565H, N1581H, N1595H, N1608H, N1451H, N1535H, N1536H, N1614H, N1615H, N1628H, N1650H	Tuberous sclerosis 2	VCV002032747	16	2136834	16	2086833	2032747	2079110	rs2090865014	NC_000016.10:2086832:A:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4951A>G (p.Asn1651Asp)	TSC2	N1548D, N1584D, N1607D, N1608D, N1628D, N1536D, N1407D, N1651D, N1585D, N1595D	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000965283	16	2136834	16	2086833	965283	957690	rs2090865014	NC_000016.10:2086832:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4952A>G (p.Asn1651Ser)	TSC2	N1651S, N1407S, N1536S, N1608S, N1585S, N1584S, N1628S, N1548S, N1595S, N1607S	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049335	16	2136835	16	2086834	49335	58497	rs45517382	NC_000016.10:2086833:A:G	single nucleotide variant	missense variant	Pathogenic	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4953T>C (p.Asn1651=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001548696	16	2136836	16	2086835	1548696	1658063	rs2151588360	NC_000016.10:2086834:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4956C>G (p.Asp1652Glu)	TSC2	D1138E, D1160E, D1386E, D1408E, D1537E, D1548E, D1549E, D1579E, D1581E, D1585E, D1596E, D1651E, D1385E, D1566E, D1580E, D1608E, D1629E, D1051E, D1137E, D1432E, D1582E, D1586E, D1592E, D1615E, D1628E, D1652E, D1161E, D1181E, D1428E, D1429E, D1452E, D1536E, D1609E, D1616E, D1626E	Tuberous sclerosis 2	VCV003637257	16	2136839	16	2086838	3637257	3771411		NC_000016.10:2086837:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	May 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4956C>T (p.Asp1652=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000468121	16	2136839	16	2086838	468121	466301	rs1376515823	NC_000016.10:2086837:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4957T>C (p.Ser1653Pro)	TSC2	S1653P, S1409P, S1538P, S1610P, S1630P, S1586P, S1597P, S1609P, S1550P, S1587P	Tuberous sclerosis 2	VCV000065215	16	2136840	16	2086839	65215	76147	rs397515159	NC_000016.10:2086838:T:C	single nucleotide variant	missense variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4958C>T (p.Ser1653Phe)	TSC2	S1653F, S1609F, S1550F, S1586F, S1597F, S1630F, S1587F, S1610F, S1409F, S1538F	Tuberous sclerosis 2	VCV000049336	16	2136841	16	2086840	49336	58498	rs45517383	NC_000016.10:2086839:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4959C>G (p.Ser1653=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468122	16	2136842	16	2086841	468122	466304	rs45517384	NC_000016.10:2086840:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4959C>T (p.Ser1653=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000049818	16	2136842	16	2086841	49818	58980	rs45517384	NC_000016.10:2086840:C:T	single nucleotide variant	synonymous variant	Benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4959C>A (p.Ser1653=)	TSC2		not specified|Tuberous sclerosis 2	VCV000049462	16	2136842	16	2086841	49462	58624	rs45517384	NC_000016.10:2086840:C:A	single nucleotide variant	synonymous variant	Uncertain significance	Feb 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4960G>C (p.Gly1654Arg)	TSC2	G1139R, G1162R, G1183R, G1431R, G1550R, G1568R, G1594R, G1618R, G1628R, G1653R, G1551R, G1582R, G1584R, G1631R, G1654R, G1053R, G1140R, G1387R, G1410R, G1538R, G1581R, G1598R, G1610R, G1611R, G1617R, G1163R, G1388R, G1430R, G1434R, G1454R, G1539R, G1583R, G1587R, G1588R, G1630R	Tuberous sclerosis 2	VCV002883066	16	2136843	16	2086842	2883066	3049706	rs771911660	NC_000016.10:2086841:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4960G>T (p.Gly1654Cys)	TSC2	G1539C, G1610C, G1654C, G1410C, G1611C, G1551C, G1587C, G1631C, G1588C, G1598C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000940547	16	2136843	16	2086842	940547	937348	rs771911660	NC_000016.10:2086841:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4960G>A (p.Gly1654Ser)	TSC2	G1654S, G1539S, G1598S, G1610S, G1551S, G1587S, G1588S, G1631S, G1410S, G1611S	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000468123	16	2136843	16	2086842	468123	465387	rs771911660	NC_000016.10:2086841:G:A	single nucleotide variant	missense variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4961G>A (p.Gly1654Asp)	TSC2	G1163D, G1454D, G1551D, G1581D, G1582D, G1588D, G1628D, G1053D, G1162D, G1183D, G1387D, G1410D, G1434D, G1539D, G1550D, G1598D, G1610D, G1618D, G1630D, G1139D, G1388D, G1431D, G1538D, G1583D, G1587D, G1594D, G1611D, G1617D, G1631D, G1140D, G1430D, G1568D, G1584D, G1653D, G1654D	Tuberous sclerosis 2	VCV002184095	16	2136844	16	2086843	2184095	1910326	rs1555438692	NC_000016.10:2086842:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4961G>T (p.Gly1654Val)	TSC2	G1654V, G1410V, G1539V, G1598V, G1611V, G1587V, G1588V, G1631V, G1551V, G1610V	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000468124	16	2136844	16	2086843	468124	465392	rs1555438692	NC_000016.10:2086842:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4962T>C (p.Gly1654=)	TSC2		not provided	VCV004084243	16	2136845	16	2086844	4084243	4196928		NC_000016.10:2086843:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4965G>T (p.Glu1655Asp)	TSC2	E1054D, E1140D, E1141D, E1163D, E1164D, E1184D, E1388D, E1389D, E1411D, E1431D, E1432D, E1435D, E1455D, E1539D, E1540D, E1551D, E1552D, E1569D, E1582D, E1583D, E1584D, E1585D, E1588D, E1589D, E1595D, E1599D, E1611D, E1612D, E1618D, E1619D, E1629D, E1631D, E1632D, E1654D, E1655D	Tuberous sclerosis syndrome	VCV003071138	16	2136848	16	2086847	3071138	3228719	rs1336162242	NC_000016.10:2086846:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4965G>A (p.Glu1655=)	TSC2		Tuberous sclerosis 2	VCV002112885	16	2136848	16	2086847	2112885	2168167	rs1336162242	NC_000016.10:2086846:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4966G>A (p.Asp1656Asn)	TSC2	D1141N, D1164N, D1165N, D1432N, D1570N, D1583N, D1596N, D1620N, D1633N, D1142N, D1185N, D1390N, D1433N, D1553N, D1589N, D1632N, D1055N, D1389N, D1412N, D1436N, D1540N, D1552N, D1584N, D1586N, D1590N, D1612N, D1619N, D1630N, D1655N, D1656N, D1456N, D1541N, D1585N, D1600N, D1613N	Tuberous sclerosis 2	VCV003701779	16	2136849	16	2086848	3701779	3833784		NC_000016.10:2086847:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Mar 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4966G>T (p.Asp1656Tyr)	TSC2	D1164Y, D1552Y, D1570Y, D1585Y, D1613Y, D1632Y, D1142Y, D1185Y, D1412Y, D1436Y, D1456Y, D1541Y, D1583Y, D1584Y, D1619Y, D1620Y, D1633Y, D1655Y, D1656Y, D1141Y, D1165Y, D1433Y, D1553Y, D1586Y, D1589Y, D1596Y, D1600Y, D1055Y, D1389Y, D1390Y, D1432Y, D1540Y, D1590Y, D1612Y, D1630Y	Tuberous sclerosis 2	VCV002152255	16	2136849	16	2086848	2152255	1892327	rs773255614	NC_000016.10:2086847:G:T	single nucleotide variant	missense variant	Pathogenic	Aug 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4967A>C (p.Asp1656Ala)	TSC2	D1141A, D1142A, D1164A, D1412A, D1456A, D1552A, D1584A, D1596A, D1055A, D1389A, D1433A, D1570A, D1583A, D1586A, D1619A, D1620A, D1630A, D1432A, D1436A, D1541A, D1590A, D1600A, D1655A, D1656A, D1165A, D1185A, D1390A, D1540A, D1553A, D1585A, D1589A, D1612A, D1613A, D1632A, D1633A	Hereditary cancer-predisposing syndrome	VCV003462670	16	2136850	16	2086849	3462670	3621689		NC_000016.10:2086848:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4967A>T (p.Asp1656Val)	TSC2	D1055V, D1141V, D1142V, D1164V, D1165V, D1185V, D1389V, D1390V, D1412V, D1432V, D1433V, D1436V, D1456V, D1540V, D1541V, D1552V, D1553V, D1570V, D1583V, D1584V, D1585V, D1586V, D1589V, D1590V, D1596V, D1600V, D1612V, D1613V, D1619V, D1620V, D1630V, D1632V, D1633V, D1655V, D1656V	Tuberous sclerosis 2	VCV001717222	16	2136850	16	2086849	1717222	1776047	rs1567124767	NC_000016.10:2086848:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4967A>G (p.Asp1656Gly)	TSC2	D1656G, D1600G, D1633G, D1553G, D1590G, D1412G, D1589G, D1612G, D1613G, D1541G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000572000	16	2136850	16	2086849	572000	567882	rs1567124767	NC_000016.10:2086848:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4968C>T (p.Asp1656=)	TSC2		not specified|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000256631	16	2136851	16	2086850	256631	255499	rs182327684	NC_000016.10:2086849:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4970T>A (p.Phe1657Tyr)	TSC2	F1657Y, F1614Y, F1542Y, F1554Y, F1590Y, F1613Y, F1413Y, F1591Y, F1601Y, F1634Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238071	16	2136853	16	2086852	238071	242329	rs878854112	NC_000016.10:2086851:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4971C>A (p.Phe1657Leu)	TSC2	F1166L, F1391L, F1413L, F1554L, F1571L, F1585L, F1590L, F1613L, F1631L, F1142L, F1165L, F1587L, F1591L, F1620L, F1621L, F1634L, F1143L, F1390L, F1434L, F1457L, F1586L, F1056L, F1186L, F1433L, F1437L, F1541L, F1542L, F1553L, F1584L, F1597L, F1601L, F1614L, F1633L, F1656L, F1657L	Hereditary cancer-predisposing syndrome	VCV001744468	16	2136854	16	2086853	1744468	1809250	rs1596444029	NC_000016.10:2086852:C:A	single nucleotide variant	missense variant	Uncertain significance	May 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4971C>T (p.Phe1657=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000752512	16	2136854	16	2086853	752512	770745	rs1596444029	NC_000016.10:2086852:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4972A>C (p.Lys1658Gln)	TSC2	K1414Q, K1543Q, K1555Q, K1591Q, K1592Q, K1602Q, K1614Q, K1615Q, K1635Q, K1658Q	Tuberous sclerosis 2	VCV001015693	16	2136855	16	2086854	1015693	1012009	rs2090867792	NC_000016.10:2086853:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4972A>G (p.Lys1658Glu)	TSC2	K1414E, K1543E, K1555E, K1591E, K1592E, K1602E, K1614E, K1615E, K1635E, K1658E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000999616	16	2136855	16	2086854	999616	996766	rs2090867792	NC_000016.10:2086853:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4973A>G (p.Lys1658Arg)	TSC2	K1658R, K1614R, K1414R, K1543R, K1555R, K1615R, K1592R, K1602R, K1635R, K1591R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000406065	16	2136856	16	2086855	406065	401432	rs1050594534	NC_000016.10:2086854:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4974G>C (p.Lys1658Asn)	TSC2	K1555N, K1591N, K1592N, K1635N, K1602N, K1658N, K1414N, K1543N, K1614N, K1615N	Tuberous sclerosis 2	VCV001475462	16	2136857	16	2086856	1475462	1400493	rs45511393	NC_000016.10:2086855:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.4974G>A (p.Lys1658=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049990	16	2136857	16	2086856	49990	59152	rs45511393	NC_000016.10:2086855:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4976T>G (p.Leu1659Arg)	TSC2	L1556R, L1592R, L1615R, L1659R, L1415R, L1544R, L1616R, L1593R, L1603R, L1636R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001472736	16	2136859	16	2086858	1472736	1398117	rs2090868646	NC_000016.10:2086857:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4977T>G (p.Leu1659=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001552930	16	2136860	16	2086859	1552930	1639535	rs2090868794	NC_000016.10:2086858:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4978G>A (p.Gly1660Ser)	TSC2	G1146S, G1393S, G1436S, G1574S, G1590S, G1623S, G1659S, G1189S, G1440S, G1544S, G1557S, G1593S, G1600S, G1634S, G1059S, G1168S, G1416S, G1556S, G1588S, G1589S, G1594S, G1604S, G1617S, G1637S, G1660S, G1145S, G1169S, G1394S, G1437S, G1460S, G1545S, G1587S, G1616S, G1624S, G1636S	Hereditary cancer-predisposing syndrome	VCV002564728	16	2136861	16	2086860	2564728	2733884	rs770797937	NC_000016.10:2086859:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4979G>C (p.Gly1660Ala)	TSC2	G1593A, G1594A, G1616A, G1660A, G1545A, G1557A, G1604A, G1416A, G1617A, G1637A	Tuberous sclerosis 2	VCV001040943	16	2136862	16	2086861	1040943	1032502	rs1189857262	NC_000016.10:2086860:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4979G>A (p.Gly1660Asp)	TSC2	G1416D, G1616D, G1545D, G1557D, G1594D, G1660D, G1593D, G1604D, G1617D, G1637D	Hereditary cancer-predisposing syndrome	VCV000825338	16	2136862	16	2086861	825338	812621	rs1189857262	NC_000016.10:2086860:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4979G>T (p.Gly1660Val)	TSC2	G1660V, G1593V, G1604V, G1637V, G1616V, G1416V, G1594V, G1617V, G1545V, G1557V	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000468125	16	2136862	16	2086861	468125	466037	rs1189857262	NC_000016.10:2086860:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4980C>A (p.Gly1660=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003974676	16	2136863	16	2086862	3974676	4086499		NC_000016.10:2086861:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4980C>T (p.Gly1660=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001161498	16	2136863	16	2086862	1161498	1145979	rs2090869322	NC_000016.10:2086861:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4981A>G (p.Thr1661Ala)	TSC2	T1060A, T1146A, T1147A, T1169A, T1170A, T1190A, T1394A, T1395A, T1417A, T1437A, T1438A, T1441A, T1461A, T1545A, T1546A, T1557A, T1558A, T1575A, T1588A, T1589A, T1590A, T1591A, T1594A, T1595A, T1601A, T1605A, T1617A, T1618A, T1624A, T1625A, T1635A, T1637A, T1638A, T1660A, T1661A	Hereditary cancer-predisposing syndrome	VCV003232182	16	2136864	16	2086863	3232182	3391983	rs2544408808	NC_000016.10:2086862:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4982C>G (p.Thr1661Ser)	TSC2	T1590S, T1624S, T1660S, T1661S, T1190S, T1437S, T1438S, T1545S, T1546S, T1557S, T1558S, T1589S, T1591S, T1594S, T1595S, T1601S, T1605S, T1618S, T1637S, T1638S, T1147S, T1170S, T1394S, T1441S, T1575S, T1617S, T1060S, T1146S, T1169S, T1395S, T1417S, T1461S, T1588S, T1625S, T1635S	Tuberous sclerosis 2	VCV003678464	16	2136865	16	2086864	3678464	3807200		NC_000016.10:2086863:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4982C>T (p.Thr1661Ile)	TSC2	T1661I, T1417I, T1617I, T1618I, T1638I, T1558I, T1594I, T1605I, T1546I, T1595I	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001387739	16	2136865	16	2086864	1387739	1374360	rs776541842	NC_000016.10:2086863:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4982C>A (p.Thr1661Asn)	TSC2	T1661N, T1417N, T1558N, T1605N, T1617N, T1595N, T1618N, T1546N, T1594N, T1638N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468126	16	2136865	16	2086864	468126	466317	rs776541842	NC_000016.10:2086863:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 11, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4983C>T (p.Thr1661=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049467	16	2136866	16	2086865	49467	58629	rs35534817	NC_000016.10:2086864:C:T	single nucleotide variant	synonymous variant	Benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4984A>G (p.Ile1662Val)	TSC2	I1559V, I1619V, I1418V, I1596V, I1606V, I1618V, I1595V, I1547V, I1639V, I1662V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001483779	16	2136867	16	2086866	1483779	1458563	rs2151589566	NC_000016.10:2086865:A:G	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4985T>C (p.Ile1662Thr)	TSC2	I1418T, I1547T, I1559T, I1595T, I1596T, I1606T, I1618T, I1619T, I1639T, I1662T	Tuberous sclerosis 2	VCV001058059	16	2136868	16	2086867	1058059	1049496	rs2151589598	NC_000016.10:2086866:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4988A>C (p.Lys1663Thr)	TSC2	K1148T, K1396T, K1439T, K1463T, K1590T, K1592T, K1603T, K1637T, K1640T, K1662T, K1172T, K1192T, K1440T, K1548T, K1559T, K1577T, K1591T, K1593T, K1062T, K1149T, K1171T, K1547T, K1596T, K1597T, K1607T, K1620T, K1397T, K1419T, K1443T, K1560T, K1619T, K1626T, K1627T, K1639T, K1663T	Tuberous sclerosis 2	VCV002769647	16	2136871	16	2086870	2769647	2932962	rs2544409309	NC_000016.10:2086869:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989G>T (p.Lys1663Asn)	TSC2	K1062N, K1148N, K1149N, K1171N, K1172N, K1192N, K1396N, K1397N, K1419N, K1439N, K1440N, K1443N, K1463N, K1547N, K1548N, K1559N, K1560N, K1577N, K1590N, K1591N, K1592N, K1593N, K1596N, K1597N, K1603N, K1607N, K1619N, K1620N, K1626N, K1627N, K1637N, K1639N, K1640N, K1662N, K1663N	not provided	VCV004070736	16	2136872	16	2086871	4070736	4184576		NC_000016.10:2086870:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 17, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989G>C (p.Lys1663Asn)	TSC2	K1663N, K1640N, K1419N, K1548N, K1596N, K1619N, K1560N, K1597N, K1607N, K1620N	Tuberous sclerosis 2	VCV000954299	16	2136872	16	2086871	954299	949289	rs1567124948	NC_000016.10:2086870:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989G>A (p.Lys1663=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000571995	16	2136872	16	2086871	571995	567891	rs1567124948	NC_000016.10:2086870:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jan 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+1G>T	TSC2		Tuberous sclerosis 2	VCV000049992	16	2136873	16	2086872	49992	59154	rs45517386	NC_000016.10:2086871:G:T	single nucleotide variant	splice donor variant	Pathogenic	May 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+1G>A	TSC2		Tuberous sclerosis 2	VCV000049468	16	2136873	16	2086872	49468	58630	rs45517386	NC_000016.10:2086871:G:A	single nucleotide variant	splice donor variant	Pathogenic	Dec 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+2T>A	TSC2		Tuberous sclerosis 2	VCV001480119	16	2136874	16	2086873	1480119	1364789	rs2090871271	NC_000016.10:2086872:T:A	single nucleotide variant	splice donor variant	Pathogenic	Oct 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+3G>C	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis syndrome	VCV003386181	16	2136875	16	2086874	3386181	3545322		NC_000016.10:2086873:G:C	single nucleotide variant	intron variant	Uncertain significance	Aug 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+5G>C	TSC2		Tuberous sclerosis 2	VCV002076521	16	2136877	16	2086876	2076521	2138324	rs1057522671	NC_000016.10:2086875:G:C	single nucleotide variant	intron variant	Uncertain significance	Jun 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+5G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000387029	16	2136877	16	2086876	387029	374856	rs1057522671	NC_000016.10:2086875:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4989+6T>C	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV002059029	16	2136878	16	2086877	2059029	2116890	rs2151589973	NC_000016.10:2086876:T:C	single nucleotide variant	intron variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+7G>C	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001692507	16	2136879	16	2086878	1692507	1684947	rs1460236999	NC_000016.10:2086877:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4989+7G>T	TSC2		Tuberous sclerosis 2	VCV001556074	16	2136879	16	2086878	1556074	1529458	rs1460236999	NC_000016.10:2086877:G:T	single nucleotide variant	intron variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+7G>A	TSC2		Tuberous sclerosis 2	VCV001129561	16	2136879	16	2086878	1129561	1125099	rs1460236999	NC_000016.10:2086877:G:A	single nucleotide variant	intron variant	Likely benign	Aug 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+9G>A	TSC2		Tuberous sclerosis 2	VCV002824642	16	2136881	16	2086880	2824642	2989144	rs1332919495	NC_000016.10:2086879:G:A	single nucleotide variant	intron variant	Likely benign	Dec 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+9G>C	TSC2		Tuberous sclerosis 2	VCV000771263	16	2136881	16	2086880	771263	778242	rs1332919495	NC_000016.10:2086879:G:C	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+10G>A	TSC2		Tuberous sclerosis 2	VCV002116728	16	2136882	16	2086881	2116728	2175811	rs1357118862	NC_000016.10:2086880:G:A	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+10G>T	TSC2		Tuberous sclerosis 2	VCV001161474	16	2136882	16	2086881	1161474	1145981	rs1357118862	NC_000016.10:2086880:G:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+10G>C	TSC2		Tuberous sclerosis 2	VCV001148968	16	2136882	16	2086881	1148968	1145980	rs1357118862	NC_000016.10:2086880:G:C	single nucleotide variant	intron variant	Likely benign	Sep 12, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+12G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000511972	16	2136884	16	2086883	511972	506183	rs1343916460	NC_000016.10:2086882:G:A	single nucleotide variant	intron variant	Likely benign	Apr 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+13C>T	TSC2		Tuberous sclerosis 2	VCV001902185	16	2136885	16	2086884	1902185	1954225	rs2151590293	NC_000016.10:2086883:C:T	single nucleotide variant	intron variant	Likely benign	Sep 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+14C>T	TSC2		Tuberous sclerosis 2	VCV001580689	16	2136886	16	2086885	1580689	1565816	rs187363476	NC_000016.10:2086884:C:T	single nucleotide variant	intron variant	Likely benign	Jan 29, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+15G>C	TSC2		Tuberous sclerosis 2	VCV002743147	16	2136887	16	2086886	2743147	2896604	rs199610889	NC_000016.10:2086885:G:C	single nucleotide variant	intron variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+15G>A	TSC2		Tuberous sclerosis 2|not specified	VCV000378792	16	2136887	16	2086886	378792	375204	rs199610889	NC_000016.10:2086885:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+17C>T	TSC2		Tuberous sclerosis 2	VCV002767864	16	2136889	16	2086888	2767864	2932476	rs2151590406	NC_000016.10:2086887:C:T	single nucleotide variant	intron variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+18A>G	TSC2		Tuberous sclerosis 2	VCV003653175	16	2136890	16	2086889	3653175	3778564		NC_000016.10:2086888:A:G	single nucleotide variant	intron variant	Likely benign	May 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+19G>T	TSC2		Tuberous sclerosis 2	VCV002957130	16	2136891	16	2086890	2957130	3125734	rs762466695	NC_000016.10:2086889:G:T	single nucleotide variant	intron variant	Likely benign	Aug 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+19G>A	TSC2		Tuberous sclerosis 2	VCV001567466	16	2136891	16	2086890	1567466	1591626	rs762466695	NC_000016.10:2086889:G:A	single nucleotide variant	intron variant	Likely benign	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+20T>C	TSC2		Tuberous sclerosis 2	VCV002853167	16	2136892	16	2086891	2853167	3016639	rs763498977	NC_000016.10:2086890:T:C	single nucleotide variant	intron variant	Likely benign	Apr 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+20T>A	TSC2		Tuberous sclerosis 2	VCV001557540	16	2136892	16	2086891	1557540	1627983	rs763498977	NC_000016.10:2086890:T:A	single nucleotide variant	intron variant	Benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+107A>C	TSC2		not provided	VCV000676007	16	2136979	16	2086978	676007	667422	rs114989209	NC_000016.10:2086977:A:C	single nucleotide variant	intron variant	Benign	Jun 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4989+134G>A	TSC2		not provided	VCV002645972	16	2137006	16	2087005	2645972	2810853	rs538131506	NC_000016.10:2087004:G:A	single nucleotide variant	intron variant	Benign	Apr 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4989+244G>C	TSC2		not provided	VCV001207998	16	2137116	16	2087115	1207998	1198740	rs28721933	NC_000016.10:2087114:G:C	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-58G>A	TSC2		not provided	VCV001223714	16	2137806	16	2087805	1223714	1213987	rs116828573	NC_000016.10:2087804:G:A	single nucleotide variant	intron variant	Likely benign	Jul 2, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-20C>T	TSC2		Tuberous sclerosis 2	VCV003674641	16	2137844	16	2087843	3674641	3809831		NC_000016.10:2087842:C:T	single nucleotide variant	intron variant	Likely benign	Nov 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-20C>G	TSC2		Tuberous sclerosis 2	VCV001583239	16	2137844	16	2087843	1583239	1535477	rs762508695	NC_000016.10:2087842:C:G	single nucleotide variant	intron variant	Likely benign	Mar 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-19C>T	TSC2		Tuberous sclerosis 2	VCV001947682	16	2137845	16	2087844	1947682	2006538	rs1244495150	NC_000016.10:2087843:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-19C>G	TSC2		Tuberous sclerosis 2	VCV001565048	16	2137845	16	2087844	1565048	1568002	rs1244495150	NC_000016.10:2087843:C:G	single nucleotide variant	intron variant	Likely benign	Jan 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-17T>C	TSC2		Tuberous sclerosis 2	VCV001593730	16	2137847	16	2087846	1593730	1655149	rs1455146146	NC_000016.10:2087845:T:C	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-16T>C	TSC2		Tuberous sclerosis 2	VCV002199902	16	2137848	16	2087847	2199902	1933814	rs2151610441	NC_000016.10:2087846:T:C	single nucleotide variant	intron variant	Likely benign	Aug 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-15C>A	TSC2		Tuberous sclerosis 2	VCV002859618	16	2137849	16	2087848	2859618	3018378	rs763702674	NC_000016.10:2087847:C:A	single nucleotide variant	intron variant	Likely benign	Apr 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-15C>G	TSC2		Tuberous sclerosis 2	VCV002717533	16	2137849	16	2087848	2717533	2869470	rs763702674	NC_000016.10:2087847:C:G	single nucleotide variant	intron variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-15C>T	TSC2		Tuberous sclerosis 2	VCV001598049	16	2137849	16	2087848	1598049	1660655	rs763702674	NC_000016.10:2087847:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-14T>C	TSC2		Tuberous sclerosis 2	VCV002011299	16	2137850	16	2087849	2011299	2074373	rs2544459585	NC_000016.10:2087848:T:C	single nucleotide variant	intron variant	Likely benign	Jun 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-13C>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001610187	16	2137851	16	2087850	1610187	1519541	rs1346991628	NC_000016.10:2087849:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-12T>A	TSC2		Tuberous sclerosis 2	VCV001984913	16	2137852	16	2087851	1984913	2046666	rs2151610559	NC_000016.10:2087850:T:A	single nucleotide variant	intron variant	Likely benign	Jun 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-12T>C	TSC2		Tuberous sclerosis 2	VCV001538574	16	2137852	16	2087851	1538574	1544060	rs2151610559	NC_000016.10:2087850:T:C	single nucleotide variant	intron variant	Likely benign	Oct 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-11T>C	TSC2		Tuberous sclerosis 2	VCV001633449	16	2137853	16	2087852	1633449	1598374	rs1006709973	NC_000016.10:2087851:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Sep 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-10G>T	TSC2		Tuberous sclerosis 2	VCV002812603	16	2137854	16	2087853	2812603	2975835	rs751012275	NC_000016.10:2087852:G:T	single nucleotide variant	intron variant	Likely benign	Nov 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-10G>C	TSC2		Tuberous sclerosis 2	VCV001103994	16	2137854	16	2087853	1103994	1103681	rs751012275	NC_000016.10:2087852:G:C	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-10G>A	TSC2		Tuberous sclerosis 2	VCV000762236	16	2137854	16	2087853	762236	776173	rs751012275	NC_000016.10:2087852:G:A	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-9T>A	TSC2		Tuberous sclerosis 2	VCV000941118	16	2137855	16	2087854	941118	940352	rs1596454615	NC_000016.10:2087853:T:A	single nucleotide variant	intron variant	Likely benign	Jul 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-9T>C	TSC2		Tuberous sclerosis 2	VCV000763031	16	2137855	16	2087854	763031	776134	rs1596454615	NC_000016.10:2087853:T:C	single nucleotide variant	intron variant	Likely benign	Jul 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-8C>T	TSC2		Tuberous sclerosis 2	VCV001669492	16	2137856	16	2087855	1669492	1665746	rs766834252	NC_000016.10:2087854:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-7C>A	TSC2		Tuberous sclerosis 2	VCV003728993	16	2137857	16	2087856	3728993	3861928		NC_000016.10:2087855:C:A	single nucleotide variant	intron variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-7C>G	TSC2		Tuberous sclerosis 2	VCV000535940	16	2137857	16	2087856	535940	529719	rs45457095	NC_000016.10:2087855:C:G	single nucleotide variant	intron variant	Benign	Feb 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-7C>T	PKD1|TSC2		not specified|not provided|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type|Tuberous sclerosis 2	VCV000049477	16	2137857	16	2087856	49477	58639	rs45457095	NC_000016.10:2087855:C:T	single nucleotide variant	intron variant	Benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-6G>C	TSC2		Tuberous sclerosis 2	VCV001089804	16	2137858	16	2087857	1089804	1081869	rs137853987	NC_000016.10:2087856:G:C	single nucleotide variant	intron variant	Likely benign	Aug 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-6G>T	TSC2		Tuberous sclerosis 2	VCV000468127	16	2137858	16	2087857	468127	466327	rs137853987	NC_000016.10:2087856:G:T	single nucleotide variant	intron variant	Likely benign	Dec 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990-6G>A	TSC2		not provided|Tuberous sclerosis 2	VCV000049851	16	2137858	16	2087857	49851	59013	rs137853987	NC_000016.10:2087856:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4990-5G>C	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000972091	16	2137859	16	2087858	972091	960841	rs753000765	NC_000016.10:2087857:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4990-5G>T	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000385488	16	2137859	16	2087858	385488	375208	rs753000765	NC_000016.10:2087857:G:T	single nucleotide variant	intron variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-4G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001496586	16	2137860	16	2087859	1496586	1359618	rs1368879013	NC_000016.10:2087858:G:A	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-3C>T	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000231477	16	2137861	16	2087860	231477	235143	rs777928103	NC_000016.10:2087859:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4990-1G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000448734	16	2137863	16	2087862	448734	441794	rs1555439650	NC_000016.10:2087861:G:A	single nucleotide variant	splice acceptor variant	Conflicting classifications of pathogenicity	Nov 1, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4990G>A (p.Gly1664Ser)	TSC2	G1063S, G1149S, G1150S, G1172S, G1173S, G1193S, G1397S, G1398S, G1420S, G1440S, G1441S, G1444S, G1464S, G1548S, G1549S, G1560S, G1561S, G1578S, G1591S, G1592S, G1593S, G1594S, G1597S, G1598S, G1604S, G1608S, G1620S, G1621S, G1627S, G1628S, G1638S, G1640S, G1641S, G1663S, G1664S	not provided	VCV003390453	16	2137864	16	2087863	3390453	3549583		NC_000016.10:2087862:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4990G>T (p.Gly1664Cys)	TSC2	G1398C, G1444C, G1464C, G1549C, G1561C, G1620C, G1638C, G1640C, G1420C, G1440C, G1560C, G1591C, G1592C, G1593C, G1597C, G1628C, G1149C, G1172C, G1173C, G1193C, G1548C, G1608C, G1627C, G1641C, G1663C, G1664C, G1063C, G1150C, G1397C, G1441C, G1578C, G1594C, G1598C, G1604C, G1621C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001744600	16	2137864	16	2087863	1744600	1809380	rs2091044768	NC_000016.10:2087862:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4991G>A (p.Gly1664Asp)	TSC2	G1420D, G1549D, G1561D, G1597D, G1598D, G1608D, G1620D, G1621D, G1641D, G1664D	Tuberous sclerosis 2	VCV001057664	16	2137865	16	2087864	1057664	1049497	rs2091044912	NC_000016.10:2087863:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.4992C>T (p.Gly1664=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000515359	16	2137866	16	2087865	515359	505485	rs145002269	NC_000016.10:2087864:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4993C>G (p.Gln1665Glu)	TSC2	Q1421E, Q1550E, Q1562E, Q1598E, Q1599E, Q1609E, Q1621E, Q1622E, Q1642E, Q1665E	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV001692508	16	2137867	16	2087866	1692508	1684948	rs45448101	NC_000016.10:2087865:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4993C>T (p.Gln1665Ter)	TSC2	Q1665*, Q1421*, Q1550*, Q1562*, Q1598*, Q1622*, Q1599*, Q1609*, Q1621*, Q1642*	not provided|Tuberous sclerosis 2	VCV000049340	16	2137867	16	2087866	49340	58502	rs45448101	NC_000016.10:2087865:C:T	single nucleotide variant	nonsense	Pathogenic	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4994A>T (p.Gln1665Leu)	TSC2	Q1064L, Q1150L, Q1151L, Q1173L, Q1174L, Q1194L, Q1398L, Q1399L, Q1421L, Q1441L, Q1442L, Q1445L, Q1465L, Q1549L, Q1550L, Q1561L, Q1562L, Q1579L, Q1592L, Q1593L, Q1594L, Q1595L, Q1598L, Q1599L, Q1605L, Q1609L, Q1621L, Q1622L, Q1628L, Q1629L, Q1639L, Q1641L, Q1642L, Q1664L, Q1665L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV003071582	16	2137868	16	2087867	3071582	3233848	rs747018176	NC_000016.10:2087866:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4994A>G (p.Gln1665Arg)	TSC2	Q1421R, Q1598R, Q1642R, Q1665R, Q1550R, Q1609R, Q1622R, Q1562R, Q1599R, Q1621R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001512846	16	2137868	16	2087867	1512846	1380939	rs747018176	NC_000016.10:2087866:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 7, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4995G>T (p.Gln1665His)	TSC2	Q1064H, Q1150H, Q1151H, Q1173H, Q1174H, Q1194H, Q1398H, Q1399H, Q1421H, Q1441H, Q1442H, Q1445H, Q1465H, Q1549H, Q1550H, Q1561H, Q1562H, Q1579H, Q1592H, Q1593H, Q1594H, Q1595H, Q1598H, Q1599H, Q1605H, Q1609H, Q1621H, Q1622H, Q1628H, Q1629H, Q1639H, Q1641H, Q1642H, Q1664H, Q1665H	Tuberous sclerosis 2	VCV001721927	16	2137869	16	2087868	1721927	1779645	rs2091045745	NC_000016.10:2087867:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.4995G>C (p.Gln1665His)	TSC2	Q1665H, Q1609H, Q1621H, Q1622H, Q1550H, Q1562H, Q1598H, Q1642H, Q1421H, Q1599H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001487979	16	2137869	16	2087868	1487979	1482011	rs2091045745	NC_000016.10:2087867:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.4996T>G (p.Phe1666Val)	TSC2	F1065V, F1175V, F1399V, F1422V, F1442V, F1466V, F1563V, F1599V, F1400V, F1595V, F1596V, F1600V, F1665V, F1666V, F1151V, F1152V, F1443V, F1550V, F1580V, F1593V, F1606V, F1610V, F1623V, F1630V, F1640V, F1642V, F1174V, F1195V, F1446V, F1551V, F1562V, F1594V, F1622V, F1629V, F1643V	Tuberous sclerosis 2	VCV003698664	16	2137870	16	2087869	3698664	3826091		NC_000016.10:2087868:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.4997T>C (p.Phe1666Ser)	TSC2	F1610S, F1563S, F1622S, F1551S, F1599S, F1666S, F1422S, F1600S, F1623S, F1643S	Tuberous sclerosis 2	VCV000657417	16	2137871	16	2087870	657417	644350	rs1596454907	NC_000016.10:2087869:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.4998C>T (p.Phe1666=)	TSC2		Tuberous sclerosis 2	VCV004071185	16	2137872	16	2087871	4071185	4185033		NC_000016.10:2087870:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.4998C>G (p.Phe1666Leu)	TSC2	F1599L, F1622L, F1551L, F1563L, F1422L, F1643L, F1666L, F1600L, F1610L, F1623L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000952882	16	2137872	16	2087871	952882	927686	rs757221445	NC_000016.10:2087870:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4998C>A (p.Phe1666Leu)	TSC2	F1666L, F1599L, F1622L, F1623L, F1600L, F1422L, F1551L, F1643L, F1563L, F1610L	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000207690	16	2137872	16	2087871	207690	203202	rs757221445	NC_000016.10:2087870:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.4999A>G (p.Asn1667Asp)	TSC2	N1667D, N1601D, N1624D, N1644D, N1423D, N1552D, N1564D, N1600D, N1611D, N1623D	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000566248	16	2137873	16	2087872	566248	573880	rs1182240785	NC_000016.10:2087871:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5000A>G (p.Asn1667Ser)	TSC2	N1667S, N1423S, N1552S, N1624S, N1564S, N1600S, N1601S, N1623S, N1644S, N1611S	Tuberous sclerosis 2	VCV000565948	16	2137874	16	2087873	565948	573884	rs1237105821	NC_000016.10:2087872:A:G	single nucleotide variant	missense variant	Likely benign	Mar 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5001C>G (p.Asn1667Lys)	TSC2	N1423K, N1552K, N1564K, N1600K, N1601K, N1611K, N1623K, N1624K, N1644K, N1667K	Tuberous sclerosis 2	VCV001020058	16	2137875	16	2087874	1020058	1012010	rs551938797	NC_000016.10:2087873:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5001C>T (p.Asn1667=)	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000284593	16	2137875	16	2087874	284593	268830	rs551938797	NC_000016.10:2087873:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5003T>C (p.Phe1668Ser)	TSC2	F1668S, F1424S, F1601S, F1553S, F1602S, F1612S, F1624S, F1645S, F1565S, F1625S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000468129	16	2137877	16	2087876	468129	466330	rs1555439678	NC_000016.10:2087875:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5004T>A (p.Phe1668Leu)	TSC2	F1153L, F1176L, F1197L, F1595L, F1625L, F1667L, F1468L, F1552L, F1553L, F1565L, F1598L, F1612L, F1631L, F1645L, F1668L, F1067L, F1154L, F1424L, F1444L, F1445L, F1448L, F1597L, F1602L, F1632L, F1644L, F1177L, F1401L, F1402L, F1564L, F1582L, F1596L, F1601L, F1608L, F1624L, F1642L	Tuberous sclerosis 2	VCV002009616	16	2137878	16	2087877	2009616	2070138	rs745787082	NC_000016.10:2087876:T:A	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5004T>G (p.Phe1668Leu)	TSC2	F1668L, F1553L, F1565L, F1601L, F1602L, F1624L, F1625L, F1424L, F1645L, F1612L	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000566128	16	2137878	16	2087877	566128	570137	rs745787082	NC_000016.10:2087876:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5004T>C (p.Phe1668=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000413704	16	2137878	16	2087877	413704	400951	rs745787082	NC_000016.10:2087876:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5005G>T (p.Val1669Phe)	TSC2	V1177F, V1403F, V1445F, V1597F, V1609F, V1643F, V1154F, V1178F, V1402F, V1425F, V1449F, V1583F, V1626F, V1068F, V1155F, V1446F, V1553F, V1554F, V1566F, V1599F, V1602F, V1603F, V1613F, V1633F, V1645F, V1646F, V1669F, V1198F, V1469F, V1565F, V1596F, V1598F, V1625F, V1632F, V1668F	Hereditary cancer-predisposing syndrome	VCV002564742	16	2137879	16	2087878	2564742	2733898	rs2091047035	NC_000016.10:2087877:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5005G>A (p.Val1669Ile)	TSC2	V1554I, V1566I, V1602I, V1425I, V1625I, V1626I, V1646I, V1603I, V1669I, V1613I	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001043091	16	2137879	16	2087878	1043091	1032503	rs2091047035	NC_000016.10:2087877:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5007C>G (p.Val1669=)	TSC2		Tuberous sclerosis 2	VCV004071229	16	2137881	16	2087880	4071229	4185077		NC_000016.10:2087879:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5007C>T (p.Val1669=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825365	16	2137881	16	2087880	825365	812622	rs1596454977	NC_000016.10:2087879:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5008C>A (p.His1670Asn)	TSC2	H1567N, H1597N, H1600N, H1604N, H1610N, H1644N, H1670N, H1069N, H1155N, H1404N, H1554N, H1584N, H1598N, H1599N, H1603N, H1626N, H1627N, H1634N, H1646N, H1647N, H1178N, H1179N, H1403N, H1447N, H1470N, H1566N, H1614N, H1633N, H1156N, H1199N, H1426N, H1446N, H1450N, H1555N, H1669N	Tuberous sclerosis 2	VCV002725025	16	2137882	16	2087881	2725025	2885517	rs1596454994	NC_000016.10:2087880:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5008C>T (p.His1670Tyr)	TSC2	H1178Y, H1199Y, H1555Y, H1566Y, H1597Y, H1614Y, H1626Y, H1633Y, H1069Y, H1450Y, H1554Y, H1567Y, H1584Y, H1598Y, H1610Y, H1634Y, H1670Y, H1155Y, H1403Y, H1404Y, H1447Y, H1470Y, H1600Y, H1604Y, H1644Y, H1646Y, H1156Y, H1179Y, H1426Y, H1446Y, H1599Y, H1603Y, H1627Y, H1647Y, H1669Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001744743	16	2137882	16	2087881	1744743	1809523	rs1596454994	NC_000016.10:2087880:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5008C>G (p.His1670Asp)	TSC2	H1604D, H1626D, H1426D, H1603D, H1614D, H1670D, H1627D, H1647D, H1555D, H1567D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000825367	16	2137882	16	2087881	825367	812623	rs1596454994	NC_000016.10:2087880:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5010C>G (p.His1670Gln)	TSC2	H1156Q, H1179Q, H1403Q, H1555Q, H1566Q, H1603Q, H1604Q, H1634Q, H1644Q, H1646Q, H1670Q, H1199Q, H1404Q, H1447Q, H1450Q, H1567Q, H1599Q, H1669Q, H1178Q, H1446Q, H1554Q, H1584Q, H1597Q, H1600Q, H1610Q, H1633Q, H1647Q, H1069Q, H1155Q, H1426Q, H1470Q, H1598Q, H1614Q, H1626Q, H1627Q	Tuberous sclerosis 2	VCV002856491	16	2137884	16	2087883	2856491	3007743	rs376306544	NC_000016.10:2087882:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5010C>A (p.His1670Gln)	TSC2	H1567Q, H1627Q, H1647Q, H1670Q, H1426Q, H1626Q, H1555Q, H1603Q, H1604Q, H1614Q	Tuberous sclerosis 2	VCV000643237	16	2137884	16	2087883	643237	644351	rs376306544	NC_000016.10:2087882:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5010C>T (p.His1670=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000413652	16	2137884	16	2087883	413652	400952	rs376306544	NC_000016.10:2087882:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5011G>T (p.Val1671Leu)	TSC2	V1670L, V1671L, V1070L, V1156L, V1157L, V1179L, V1180L, V1200L, V1404L, V1405L, V1427L, V1447L, V1448L, V1451L, V1471L, V1555L, V1556L, V1567L, V1568L, V1585L, V1598L, V1599L, V1600L, V1601L, V1604L, V1605L, V1611L, V1615L, V1627L, V1628L, V1634L, V1635L, V1645L, V1647L, V1648L	not provided	VCV002661997	16	2137885	16	2087884	2661997	2829448	rs775395648	NC_000016.10:2087883:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5011G>C (p.Val1671Leu)	TSC2	V1605L, V1627L, V1648L, V1671L, V1568L, V1556L, V1604L, V1615L, V1427L, V1628L	Tuberous sclerosis 2	VCV001404720	16	2137885	16	2087884	1404720	1405481	rs775395648	NC_000016.10:2087883:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5011G>A (p.Val1671Met)	TSC2	V1427M, V1556M, V1568M, V1604M, V1605M, V1615M, V1627M, V1628M, V1648M, V1671M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001001876	16	2137885	16	2087884	1001876	996767	rs775395648	NC_000016.10:2087883:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 10, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5012T>A (p.Val1671Glu)	TSC2	V1427E, V1556E, V1568E, V1604E, V1605E, V1615E, V1627E, V1628E, V1648E, V1671E	not provided	VCV001256580	16	2137886	16	2087885	1256580	1246509	rs2151611996	NC_000016.10:2087884:T:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5014A>C (p.Ile1672Leu)	TSC2	I1071L, I1448L, I1452L, I1556L, I1557L, I1569L, I1201L, I1568L, I1599L, I1606L, I1628L, I1635L, I1649L, I1181L, I1405L, I1472L, I1601L, I1612L, I1648L, I1671L, I1157L, I1158L, I1180L, I1406L, I1428L, I1449L, I1586L, I1600L, I1605L, I1616L, I1629L, I1646L, I1602L, I1636L, I1672L	Hereditary cancer-predisposing syndrome	VCV003974703	16	2137888	16	2087887	3974703	4086526		NC_000016.10:2087886:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5014A>G (p.Ile1672Val)	TSC2	I1672V, I1557V, I1605V, I1606V, I1628V, I1428V, I1629V, I1569V, I1616V, I1649V	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406102	16	2137888	16	2087887	406102	401000	rs374066182	NC_000016.10:2087886:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5016C>G (p.Ile1672Met)	TSC2	I1158M, I1181M, I1448M, I1557M, I1605M, I1612M, I1616M, I1646M, I1071M, I1201M, I1428M, I1452M, I1599M, I1600M, I1606M, I1635M, I1636M, I1649M, I1180M, I1406M, I1568M, I1569M, I1601M, I1602M, I1628M, I1629M, I1648M, I1671M, I1672M, I1157M, I1405M, I1449M, I1472M, I1556M, I1586M	Hereditary cancer-predisposing syndrome	VCV003462551	16	2137890	16	2087889	3462551	3621571		NC_000016.10:2087888:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5016C>T (p.Ile1672=)	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413649	16	2137890	16	2087889	413649	401433	rs370770569	NC_000016.10:2087888:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5017G>T (p.Val1673Phe)	TSC2	V1673F, V1606F, V1617F, V1429F, V1607F, V1570F, V1629F, V1630F, V1558F, V1650F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000065153	16	2137891	16	2087890	65153	76084	rs45490993	NC_000016.10:2087889:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2021	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5017G>A (p.Val1673Ile)	PKD1|TSC2	V1673I, V1429I, V1558I, V1570I, V1629I, V1630I, V1606I, V1607I, V1617I, V1650I	Dystonia, early-onset, and/or spastic paraplegia|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type|Tuberous sclerosis 2	VCV000064868	16	2137891	16	2087890	64868	75797	rs45490993	NC_000016.10:2087889:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5017G>C (p.Val1673Leu)	TSC2	V1673L, V1429L, V1617L, V1558L, V1570L, V1607L, V1629L, V1650L, V1606L, V1630L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000049495	16	2137891	16	2087890	49495	58657	rs45490993	NC_000016.10:2087889:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5018T>G (p.Val1673Gly)	TSC2	V1673G, V1630G, V1558G, V1629G, V1429G, V1606G, V1607G, V1617G, V1570G, V1650G	not provided	VCV000448735	16	2137892	16	2087891	448735	441795	rs397515067	NC_000016.10:2087890:T:G	single nucleotide variant	missense variant	Pathogenic	Jan 5, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.5019C>T (p.Val1673=)	TSC2		Tuberous sclerosis 2	VCV001561405	16	2137893	16	2087892	1561405	1554830	rs374149407	NC_000016.10:2087891:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5020A>G (p.Thr1674Ala)	TSC2	T1203A, T1450A, T1570A, T1618A, T1630A, T1648A, T1183A, T1430A, T1571A, T1602A, T1607A, T1637A, T1650A, T1651A, T1159A, T1160A, T1182A, T1474A, T1558A, T1601A, T1604A, T1608A, T1674A, T1073A, T1407A, T1408A, T1451A, T1454A, T1559A, T1588A, T1603A, T1614A, T1631A, T1638A, T1673A	Hereditary cancer-predisposing syndrome	VCV001744837	16	2137894	16	2087893	1744837	1805683	rs45500595	NC_000016.10:2087892:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5021C>A (p.Thr1674Asn)	TSC2	T1073N, T1159N, T1182N, T1454N, T1558N, T1603N, T1608N, T1637N, T1674N, T1183N, T1407N, T1408N, T1430N, T1450N, T1570N, T1638N, T1651N, T1160N, T1203N, T1474N, T1559N, T1601N, T1604N, T1618N, T1673N, T1451N, T1571N, T1588N, T1602N, T1607N, T1614N, T1630N, T1631N, T1648N, T1650N	Hereditary cancer-predisposing syndrome	VCV003462647	16	2137895	16	2087894	3462647	3621666		NC_000016.10:2087893:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5021C>G (p.Thr1674Ser)	TSC2	T1674S, T1618S, T1630S, T1651S, T1430S, T1559S, T1571S, T1607S, T1608S, T1631S	TSC2-related disorder|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535950	16	2137895	16	2087894	535950	529720	rs1555439727	NC_000016.10:2087893:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5021C>T (p.Thr1674Ile)	TSC2	T1674I, T1651I, T1559I, T1571I, T1430I, T1607I, T1608I, T1630I, T1631I, T1618I	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000468131	16	2137895	16	2087894	468131	466117	rs1555439727	NC_000016.10:2087893:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5022C>G (p.Thr1674=)	TSC2		not provided|Tuberous sclerosis 2	VCV000536052	16	2137896	16	2087895	536052	530296	rs777184691	NC_000016.10:2087894:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5022C>T (p.Thr1674=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000486615	16	2137896	16	2087895	486615	477412	rs777184691	NC_000016.10:2087894:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5024C>G (p.Pro1675Arg)	TSC2	P1431R, P1560R, P1572R, P1608R, P1609R, P1619R, P1631R, P1632R, P1652R, P1675R	not provided|Tuberous sclerosis 2	VCV001697094	16	2137898	16	2087897	1697094	1689489	rs45483392	NC_000016.10:2087896:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5024C>A (p.Pro1675Gln)	TSC2	P1675Q, P1431Q, P1608Q, P1609Q, P1619Q, P1632Q, P1560Q, P1572Q, P1631Q, P1652Q	Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000535873	16	2137898	16	2087897	535873	529783	rs45483392	NC_000016.10:2087896:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5024C>T (p.Pro1675Leu)	TSC2	P1675L, P1631L, P1431L, P1572L, P1619L, P1632L, P1560L, P1608L, P1609L, P1652L	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000012393	16	2137898	16	2087897	12393	27432	rs45483392	NC_000016.10:2087896:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5025G>C (p.Pro1675=)	TSC2		Tuberous sclerosis 2	VCV002817492	16	2137899	16	2087898	2817492	2977303	rs35118875	NC_000016.10:2087897:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 29, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5025G>A (p.Pro1675=)	PKD1|TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type|not specified	VCV000050002	16	2137899	16	2087898	50002	59164	rs35118875	NC_000016.10:2087897:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5026C>A (p.Leu1676Met)	TSC2	L1432M, L1633M, L1676M, L1573M, L1609M, L1653M, L1561M, L1610M, L1632M, L1620M	Hereditary cancer-predisposing syndrome	VCV000825382	16	2137900	16	2087899	825382	812624	rs201707249	NC_000016.10:2087898:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5027T>A (p.Leu1676Gln)	TSC2	L1162Q, L1185Q, L1205Q, L1456Q, L1590Q, L1603Q, L1604Q, L1609Q, L1610Q, L1616Q, L1620Q, L1640Q, L1653Q, L1675Q, L1676Q, L1410Q, L1605Q, L1639Q, L1075Q, L1409Q, L1432Q, L1572Q, L1632Q, L1633Q, L1161Q, L1184Q, L1452Q, L1453Q, L1476Q, L1560Q, L1561Q, L1573Q, L1606Q, L1650Q, L1652Q	Hereditary cancer-predisposing syndrome	VCV003462584	16	2137901	16	2087900	3462584	3621603		NC_000016.10:2087899:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5028G>C (p.Leu1676=)	TSC2		Tuberous sclerosis 2	VCV004071294	16	2137902	16	2087901	4071294	4185142		NC_000016.10:2087900:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5028G>A (p.Leu1676=)	PKD1|TSC2		not provided|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type|Tuberous sclerosis 2	VCV000050004	16	2137902	16	2087901	50004	59166	rs45475501	NC_000016.10:2087900:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Sep 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5029G>C (p.Asp1677His)	TSC2	D1454H, D1457H, D1477H, D1561H, D1562H, D1573H, D1574H, D1591H, D1604H, D1605H, D1606H, D1607H, D1610H, D1611H, D1617H, D1621H, D1633H, D1634H, D1640H, D1641H, D1651H, D1653H, D1654H, D1676H, D1677H, D1076H, D1162H, D1163H, D1185H, D1186H, D1206H, D1410H, D1411H, D1433H, D1453H	Hereditary cancer-predisposing syndrome	VCV003232183	16	2137903	16	2087902	3232183	3391984	rs1163037065	NC_000016.10:2087901:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5029G>T (p.Asp1677Tyr)	TSC2	D1185Y, D1433Y, D1453Y, D1573Y, D1574Y, D1611Y, D1617Y, D1634Y, D1654Y, D1076Y, D1186Y, D1411Y, D1477Y, D1591Y, D1653Y, D1163Y, D1454Y, D1561Y, D1605Y, D1607Y, D1621Y, D1676Y, D1162Y, D1206Y, D1410Y, D1457Y, D1562Y, D1604Y, D1606Y, D1610Y, D1633Y, D1640Y, D1641Y, D1651Y, D1677Y	Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV001744873	16	2137903	16	2087902	1744873	1805719	rs1163037065	NC_000016.10:2087901:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5029G>A (p.Asp1677Asn)	TSC2	D1677N, D1562N, D1611N, D1621N, D1574N, D1433N, D1634N, D1654N, D1610N, D1633N	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000576468	16	2137903	16	2087902	576468	567900	rs1163037065	NC_000016.10:2087901:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5030A>C (p.Asp1677Ala)	TSC2	D1610A, D1621A, D1562A, D1633A, D1654A, D1677A, D1433A, D1574A, D1611A, D1634A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000947039	16	2137904	16	2087903	947039	927687	rs1332296997	NC_000016.10:2087902:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 31, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5031C>G (p.Asp1677Glu)	TSC2	D1163E, D1433E, D1454E, D1457E, D1604E, D1611E, D1634E, D1653E, D1411E, D1561E, D1573E, D1591E, D1607E, D1617E, D1651E, D1162E, D1186E, D1206E, D1410E, D1574E, D1605E, D1621E, D1633E, D1641E, D1654E, D1677E, D1076E, D1185E, D1453E, D1477E, D1562E, D1606E, D1610E, D1640E, D1676E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001744901	16	2137905	16	2087904	1744901	1805747	rs878854113	NC_000016.10:2087903:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5031C>T (p.Asp1677=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000238072	16	2137905	16	2087904	238072	242330	rs878854113	NC_000016.10:2087903:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5032T>C (p.Tyr1678His)	TSC2	Y1434H, Y1612H, Y1563H, Y1622H, Y1634H, Y1635H, Y1678H, Y1655H, Y1575H, Y1611H	Tuberous sclerosis 2	VCV001481853	16	2137906	16	2087905	1481853	1367371	rs1463448328	NC_000016.10:2087904:T:C	single nucleotide variant	missense variant	Benign	Jun 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5033A>G (p.Tyr1678Cys)	TSC2	Y1077C, Y1187C, Y1411C, Y1434C, Y1458C, Y1563C, Y1575C, Y1606C, Y1622C, Y1642C, Y1652C, Y1677C, Y1164C, Y1455C, Y1574C, Y1608C, Y1611C, Y1634C, Y1655C, Y1163C, Y1186C, Y1207C, Y1412C, Y1478C, Y1562C, Y1607C, Y1618C, Y1635C, Y1678C, Y1454C, Y1592C, Y1605C, Y1612C, Y1641C, Y1654C	Hereditary cancer-predisposing syndrome	VCV003462628	16	2137907	16	2087906	3462628	3621647		NC_000016.10:2087905:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5034C>T (p.Tyr1678=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000238073	16	2137908	16	2087907	238073	242331	rs45467993	NC_000016.10:2087906:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5034C>G (p.Tyr1678Ter)	TSC2	Y1678*, Y1575*, Y1612*, Y1634*, Y1434*, Y1563*, Y1622*, Y1611*, Y1635*, Y1655*	Tuberous sclerosis 2|not provided	VCV000049852	16	2137908	16	2087907	49852	59014	rs45467993	NC_000016.10:2087906:C:G	single nucleotide variant	nonsense	Pathogenic	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5034C>A (p.Tyr1678Ter)	TSC2	Y1678*, Y1611*, Y1612*, Y1434*, Y1563*, Y1622*, Y1635*, Y1655*, Y1575*, Y1634*	Tuberous sclerosis 2	VCV000049437	16	2137908	16	2087907	49437	58599	rs45467993	NC_000016.10:2087906:C:A	single nucleotide variant	nonsense	Pathogenic	Mar 29, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5035G>T (p.Glu1679Ter)	TSC2	E1078*, E1188*, E1413*, E1455*, E1456*, E1564*, E1609*, E1642*, E1412*, E1575*, E1593*, E1608*, E1612*, E1613*, E1619*, E1623*, E1635*, E1636*, E1655*, E1656*, E1679*, E1165*, E1187*, E1208*, E1459*, E1643*, E1653*, E1164*, E1435*, E1479*, E1563*, E1576*, E1606*, E1607*, E1678*	Tuberous sclerosis 2	VCV003649277	16	2137909	16	2087908	3649277	3781286		NC_000016.10:2087907:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Apr 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5035G>C (p.Glu1679Gln)	TSC2	E1576Q, E1435Q, E1564Q, E1612Q, E1635Q, E1623Q, E1613Q, E1636Q, E1656Q, E1679Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001438216	16	2137909	16	2087908	1438216	1355069	rs370404391	NC_000016.10:2087907:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5035G>A (p.Glu1679Lys)	TSC2	E1679K, E1564K, E1635K, E1435K, E1576K, E1612K, E1613K, E1623K, E1636K, E1656K	Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065289	16	2137909	16	2087908	65289	76221	rs370404391	NC_000016.10:2087907:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5036A>C (p.Glu1679Ala)	TSC2	E1679A, E1435A, E1576A, E1623A, E1635A, E1612A, E1636A, E1564A, E1613A, E1656A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000570371	16	2137910	16	2087909	570371	570139	rs1389903110	NC_000016.10:2087908:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5037G>C (p.Glu1679Asp)	TSC2	E1188D, E1413D, E1479D, E1575D, E1576D, E1606D, E1612D, E1619D, E1635D, E1678D, E1679D, E1164D, E1187D, E1412D, E1455D, E1456D, E1613D, E1623D, E1655D, E1656D, E1078D, E1165D, E1435D, E1564D, E1593D, E1607D, E1636D, E1208D, E1459D, E1563D, E1608D, E1609D, E1642D, E1643D, E1653D	Hereditary cancer-predisposing syndrome	VCV001744925	16	2137911	16	2087910	1744925	1805771	rs876658185	NC_000016.10:2087909:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5037G>A (p.Glu1679=)	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000229772	16	2137911	16	2087910	229772	235144	rs876658185	NC_000016.10:2087909:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5038T>A (p.Cys1680Ser)	TSC2	C1436S, C1565S, C1577S, C1613S, C1614S, C1624S, C1636S, C1637S, C1657S, C1680S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001002935	16	2137912	16	2087911	1002935	996769	rs1555439802	NC_000016.10:2087910:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5038T>G (p.Cys1680Gly)	TSC2	C1680G, C1577G, C1624G, C1636G, C1657G, C1436G, C1565G, C1613G, C1614G, C1637G	Hereditary cancer-predisposing syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000480827	16	2137912	16	2087911	480827	477988	rs1555439802	NC_000016.10:2087910:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5039G>A (p.Cys1680Tyr)	TSC2	C1680Y, C1657Y, C1565Y, C1613Y, C1614Y, C1636Y, C1637Y, C1577Y, C1436Y, C1624Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000207758	16	2137913	16	2087912	207758	203203	rs150558493	NC_000016.10:2087911:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5040C>T (p.Cys1680=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468133	16	2137914	16	2087913	468133	466119	rs139591455	NC_000016.10:2087912:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5041A>C (p.Asn1681His)	TSC2	N1080H, N1166H, N1414H, N1608H, N1609H, N1637H, N1657H, N1658H, N1615H, N1621H, N1680H, N1681H, N1210H, N1437H, N1457H, N1461H, N1577H, N1578H, N1167H, N1189H, N1190H, N1565H, N1566H, N1595H, N1610H, N1415H, N1458H, N1481H, N1611H, N1614H, N1625H, N1638H, N1644H, N1645H, N1655H	not provided	VCV003781139	16	2137915	16	2087914	3781139	3897098		NC_000016.10:2087913:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5041A>G (p.Asn1681Asp)	TSC2	N1681D, N1566D, N1625D, N1658D, N1638D, N1614D, N1437D, N1578D, N1615D, N1637D	Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486644	16	2137915	16	2087914	486644	477413	rs1200837034	NC_000016.10:2087913:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5043C>A (p.Asn1681Lys)	TSC2	N1190K, N1210K, N1611K, N1637K, N1638K, N1080K, N1166K, N1167K, N1458K, N1565K, N1595K, N1609K, N1621K, N1625K, N1657K, N1681K, N1415K, N1578K, N1608K, N1610K, N1615K, N1645K, N1655K, N1680K, N1189K, N1414K, N1437K, N1457K, N1461K, N1481K, N1566K, N1577K, N1614K, N1644K, N1658K	Hereditary cancer-predisposing syndrome	VCV001744965	16	2137917	16	2087916	1744965	1805811	rs45476793	NC_000016.10:2087915:C:A	single nucleotide variant	missense variant	Pathogenic	Sep 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5043C>T (p.Asn1681=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413745	16	2137917	16	2087916	413745	401693	rs45476793	NC_000016.10:2087915:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5043C>G (p.Asn1681Lys)	TSC2	N1681K, N1566K, N1638K, N1578K, N1625K, N1437K, N1614K, N1615K, N1637K, N1658K	Hereditary cancer-predisposing syndrome	VCV000049342	16	2137917	16	2087916	49342	58504	rs45476793	NC_000016.10:2087915:C:G	single nucleotide variant	missense variant	Pathogenic	Apr 12, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5044C>A (p.Leu1682Met)	TSC2	L1081M, L1190M, L1416M, L1482M, L1567M, L1578M, L1596M, L1638M, L1191M, L1415M, L1462M, L1609M, L1610M, L1622M, L1645M, L1658M, L1659M, L1682M, L1167M, L1211M, L1438M, L1612M, L1615M, L1616M, L1639M, L1646M, L1168M, L1458M, L1459M, L1566M, L1579M, L1611M, L1626M, L1656M, L1681M	Tuberous sclerosis 2	VCV001954902	16	2137918	16	2087917	1954902	2015044	rs1336904838	NC_000016.10:2087916:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5044C>T (p.Leu1682=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001629613	16	2137918	16	2087917	1629613	1532396	rs1336904838	NC_000016.10:2087916:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5044C>G (p.Leu1682Val)	TSC2	L1615V, L1616V, L1659V, L1567V, L1682V, L1638V, L1639V, L1438V, L1579V, L1626V	Tuberous sclerosis 2	VCV001398518	16	2137918	16	2087917	1398518	1427585	rs1336904838	NC_000016.10:2087916:C:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5045T>C (p.Leu1682Pro)	TSC2	L1459P, L1578P, L1579P, L1622P, L1638P, L1639P, L1656P, L1438P, L1458P, L1482P, L1566P, L1612P, L1615P, L1616P, L1645P, L1658P, L1659P, L1191P, L1211P, L1415P, L1416P, L1609P, L1626P, L1646P, L1682P, L1081P, L1167P, L1168P, L1190P, L1462P, L1567P, L1596P, L1610P, L1611P, L1681P	Hereditary cancer-predisposing syndrome	VCV001744973	16	2137919	16	2087918	1744973	1805819	rs2091055727	NC_000016.10:2087917:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 5, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.5045T>G (p.Leu1682Arg)	TSC2	L1438R, L1567R, L1579R, L1615R, L1616R, L1626R, L1638R, L1639R, L1659R, L1682R	Tuberous sclerosis 2	VCV001009984	16	2137919	16	2087918	1009984	996770	rs2091055727	NC_000016.10:2087917:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5045T>A (p.Leu1682Gln)	TSC2	L1438Q, L1626Q, L1639Q, L1682Q, L1567Q, L1659Q, L1579Q, L1615Q, L1638Q, L1616Q	Tuberous sclerosis 2	VCV000962536	16	2137919	16	2087918	962536	949290	rs2091055727	NC_000016.10:2087917:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5046G>C (p.Leu1682=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001744976	16	2137920	16	2087919	1744976	1805822	rs781417654	NC_000016.10:2087918:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 1, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5046G>A (p.Leu1682=)	TSC2		Tuberous sclerosis 2	VCV001158701	16	2137920	16	2087919	1158701	1145982	rs781417654	NC_000016.10:2087918:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5047G>A (p.Val1683Met)	TSC2	V1082M, V1168M, V1169M, V1191M, V1192M, V1212M, V1416M, V1417M, V1439M, V1459M, V1460M, V1463M, V1483M, V1567M, V1568M, V1579M, V1580M, V1597M, V1610M, V1611M, V1612M, V1613M, V1616M, V1617M, V1623M, V1627M, V1639M, V1640M, V1646M, V1647M, V1657M, V1659M, V1660M, V1682M, V1683M	not provided	VCV003367669	16	2137921	16	2087920	3367669	3526868		NC_000016.10:2087919:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5047G>T (p.Val1683Leu)	TSC2	V1082L, V1191L, V1439L, V1459L, V1568L, V1610L, V1623L, V1657L, V1683L, V1169L, V1212L, V1416L, V1483L, V1567L, V1611L, V1612L, V1640L, V1646L, V1168L, V1417L, V1460L, V1463L, V1579L, V1580L, V1613L, V1616L, V1660L, V1192L, V1597L, V1617L, V1627L, V1639L, V1647L, V1659L, V1682L	Hereditary cancer-predisposing syndrome	VCV003329482	16	2137921	16	2087920	3329482	3489074		NC_000016.10:2087919:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5047G>C (p.Val1683Leu)	TSC2	V1580L, V1640L, V1568L, V1616L, V1627L, V1639L, V1683L, V1439L, V1617L, V1660L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV001396330	16	2137921	16	2087920	1396330	1418081	rs1596455392	NC_000016.10:2087919:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5048T>C (p.Val1683Ala)	TSC2	V1082A, V1168A, V1169A, V1191A, V1192A, V1212A, V1416A, V1417A, V1439A, V1459A, V1460A, V1463A, V1483A, V1567A, V1568A, V1579A, V1580A, V1597A, V1610A, V1611A, V1612A, V1613A, V1616A, V1617A, V1623A, V1627A, V1639A, V1640A, V1646A, V1647A, V1657A, V1659A, V1660A, V1682A, V1683A	Isolated focal cortical dysplasia type II	VCV003770216	16	2137922	16	2087921	3770216	3886371		NC_000016.10:2087920:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Jan 10, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5048T>G (p.Val1683Gly)	TSC2	V1616G, V1439G, V1568G, V1617G, V1660G, V1683G, V1580G, V1627G, V1639G, V1640G	Tuberous sclerosis 2	VCV001436643	16	2137922	16	2087921	1436643	1341034	rs2151613782	NC_000016.10:2087920:T:G	single nucleotide variant	missense variant	Pathogenic	May 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5049G>C (p.Val1683=)	TSC2		Tuberous sclerosis 2	VCV002736081	16	2137923	16	2087922	2736081	2899073	rs1256890176	NC_000016.10:2087921:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5049G>A (p.Val1683=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000792541	16	2137923	16	2087922	792541	785209	rs1256890176	NC_000016.10:2087921:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5049G>T (p.Val1683=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000566039	16	2137923	16	2087922	566039	567908	rs1256890176	NC_000016.10:2087921:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5050T>A (p.Ser1684Thr)	TSC2	S1083T, S1192T, S1460T, S1461T, S1484T, S1569T, S1580T, S1598T, S1617T, S1640T, S1660T, S1169T, S1213T, S1614T, S1658T, S1170T, S1193T, S1417T, S1418T, S1440T, S1568T, S1581T, S1612T, S1613T, S1624T, S1628T, S1647T, S1661T, S1684T, S1464T, S1611T, S1618T, S1641T, S1648T, S1683T	Tuberous sclerosis 2	VCV002751540	16	2137924	16	2087923	2751540	2908836	rs45517387	NC_000016.10:2087922:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5050T>C (p.Ser1684Pro)	TSC2	S1684P, S1640P, S1661P, S1581P, S1440P, S1617P, S1618P, S1628P, S1641P, S1569P	not provided	VCV000049343	16	2137924	16	2087923	49343	58505	rs45517387	NC_000016.10:2087922:T:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5051C>T (p.Ser1684Phe)	TSC2	S1618F, S1641F, S1661F, S1640F, S1581F, S1617F, S1628F, S1440F, S1569F, S1684F	Tuberous sclerosis 2	VCV001360204	16	2137925	16	2087924	1360204	1363649	rs2151613906	NC_000016.10:2087923:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5052C>A (p.Ser1684=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001126032	16	2137926	16	2087925	1126032	1125100	rs1596455470	NC_000016.10:2087924:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5052C>T (p.Ser1684=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000759487	16	2137926	16	2087925	759487	770746	rs1596455470	NC_000016.10:2087924:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5053C>T (p.Leu1685=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001113334	16	2137927	16	2087926	1113334	1103682	rs2151614096	NC_000016.10:2087925:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5055G>A (p.Leu1685=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001745061	16	2137929	16	2087928	1745061	1805907	rs2091057180	NC_000016.10:2087927:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5056C>G (p.Gln1686Glu)	TSC2	Q1085E, Q1171E, Q1172E, Q1194E, Q1195E, Q1215E, Q1419E, Q1420E, Q1442E, Q1462E, Q1463E, Q1466E, Q1486E, Q1570E, Q1571E, Q1582E, Q1583E, Q1600E, Q1613E, Q1614E, Q1615E, Q1616E, Q1619E, Q1620E, Q1626E, Q1630E, Q1642E, Q1643E, Q1649E, Q1650E, Q1660E, Q1662E, Q1663E, Q1685E, Q1686E	Tuberous sclerosis syndrome	VCV003386184	16	2137930	16	2087929	3386184	3545325		NC_000016.10:2087928:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5056C>A (p.Gln1686Lys)	TSC2	Q1085K, Q1171K, Q1172K, Q1194K, Q1195K, Q1215K, Q1419K, Q1420K, Q1442K, Q1462K, Q1463K, Q1466K, Q1486K, Q1570K, Q1571K, Q1582K, Q1583K, Q1600K, Q1613K, Q1614K, Q1615K, Q1616K, Q1619K, Q1620K, Q1626K, Q1630K, Q1642K, Q1643K, Q1649K, Q1650K, Q1660K, Q1662K, Q1663K, Q1685K, Q1686K	not provided	VCV001802241	16	2137930	16	2087929	1802241	1859427	rs45517388	NC_000016.10:2087928:C:A	single nucleotide variant	missense variant	Likely pathogenic	Aug 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5056C>T (p.Gln1686Ter)	TSC2	Q1686*, Q1571*, Q1642*, Q1643*, Q1663*, Q1442*, Q1619*, Q1620*, Q1630*, Q1583*	not provided|Tuberous sclerosis 2	VCV000049440	16	2137930	16	2087929	49440	58602	rs45517388	NC_000016.10:2087928:C:T	single nucleotide variant	nonsense	Pathogenic	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5057A>G (p.Gln1686Arg)	TSC2	Q1571R, Q1643R, Q1642R, Q1619R, Q1620R, Q1663R, Q1442R, Q1583R, Q1630R, Q1686R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001377096	16	2137931	16	2087930	1377096	1394711	rs397514983	NC_000016.10:2087929:A:G	single nucleotide variant	missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5058G>T (p.Gln1686His)	TSC2	Q1583H, Q1642H, Q1663H, Q1442H, Q1571H, Q1619H, Q1620H, Q1630H, Q1686H, Q1643H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000958792	16	2137932	16	2087931	958792	949291	rs200700923	NC_000016.10:2087930:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5058G>A (p.Gln1686=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486624	16	2137932	16	2087931	486624	477446	rs200700923	NC_000016.10:2087930:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5058G>C (p.Gln1686His)	TSC2	Q1686H, Q1442H, Q1643H, Q1571H, Q1583H, Q1619H, Q1620H, Q1630H, Q1642H, Q1663H	Tuberous sclerosis 2	VCV000468134	16	2137932	16	2087931	468134	466121	rs200700923	NC_000016.10:2087930:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.5059T>C (p.Cys1687Arg)	TSC2	C1661R, C1195R, C1421R, C1463R, C1584R, C1601R, C1620R, C1644R, C1663R, C1196R, C1216R, C1464R, C1467R, C1571R, C1616R, C1617R, C1621R, C1650R, C1686R, C1687R, C1172R, C1173R, C1443R, C1572R, C1583R, C1614R, C1627R, C1631R, C1651R, C1086R, C1420R, C1487R, C1615R, C1643R, C1664R	Hereditary cancer-predisposing syndrome	VCV001745077	16	2137933	16	2087932	1745077	1805923	rs184892282	NC_000016.10:2087931:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5059T>A (p.Cys1687Ser)	TSC2	C1584S, C1643S, C1664S, C1631S, C1443S, C1572S, C1644S, C1687S, C1620S, C1621S	Tuberous sclerosis 2	VCV001357870	16	2137933	16	2087932	1357870	1367765	rs184892282	NC_000016.10:2087931:T:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5060G>A (p.Cys1687Tyr)	TSC2	C1443Y, C1620Y, C1584Y, C1643Y, C1664Y, C1572Y, C1631Y, C1644Y, C1687Y, C1621Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000839292	16	2137934	16	2087933	839292	843532	rs2091058156	NC_000016.10:2087932:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5061C>T (p.Cys1687=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000468135	16	2137935	16	2087934	468135	466122	rs779923426	NC_000016.10:2087933:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5062A>T (p.Arg1688Trp)	TSC2	R1087W, R1421W, R1444W, R1465W, R1616W, R1618W, R1632W, R1644W, R1651W, R1422W, R1585W, R1617W, R1621W, R1622W, R1645W, R1665W, R1688W, R1196W, R1217W, R1488W, R1572W, R1584W, R1615W, R1628W, R1662W, R1664W, R1687W, R1173W, R1174W, R1197W, R1464W, R1468W, R1573W, R1602W, R1652W	Hereditary cancer-predisposing syndrome	VCV003329512	16	2137936	16	2087935	3329512	3489104		NC_000016.10:2087934:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5062A>G (p.Arg1688Gly)	TSC2	R1217G, R1488G, R1573G, R1585G, R1628G, R1632G, R1173G, R1174G, R1196G, R1197G, R1464G, R1468G, R1616G, R1644G, R1651G, R1662G, R1664G, R1665G, R1087G, R1421G, R1465G, R1621G, R1622G, R1652G, R1687G, R1688G, R1422G, R1444G, R1572G, R1584G, R1602G, R1615G, R1617G, R1618G, R1645G	Tuberous sclerosis 2	VCV002704853	16	2137936	16	2087935	2704853	2863265	rs2151614538	NC_000016.10:2087934:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5062A>C (p.Arg1688=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001745112	16	2137936	16	2087935	1745112	1805958	rs2151614538	NC_000016.10:2087934:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5064G>T (p.Arg1688Ser)	TSC2	R1688S, R1444S, R1573S, R1644S, R1645S, R1585S, R1621S, R1665S, R1622S, R1632S	Tuberous sclerosis 2	VCV001434397	16	2137938	16	2087937	1434397	1494213	rs374476631	NC_000016.10:2087936:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5064G>C (p.Arg1688Ser)	TSC2	R1444S, R1573S, R1585S, R1621S, R1622S, R1632S, R1644S, R1645S, R1665S, R1688S	not provided|Tuberous sclerosis 2	VCV001310867	16	2137938	16	2087937	1310867	1301571	rs374476631	NC_000016.10:2087936:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5064G>A (p.Arg1688=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413753	16	2137938	16	2087937	413753	400967	rs374476631	NC_000016.10:2087936:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5065A>G (p.Lys1689Glu)	TSC2	K1689E, K1586E, K1646E, K1574E, K1666E, K1445E, K1623E, K1633E, K1622E, K1645E	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000049441	16	2137939	16	2087938	49441	58603	rs137854315	NC_000016.10:2087937:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5066A>G (p.Lys1689Arg)	TSC2	K1088R, K1174R, K1175R, K1197R, K1198R, K1218R, K1422R, K1423R, K1445R, K1465R, K1466R, K1469R, K1489R, K1573R, K1574R, K1585R, K1586R, K1603R, K1616R, K1617R, K1618R, K1619R, K1622R, K1623R, K1629R, K1633R, K1645R, K1646R, K1652R, K1653R, K1663R, K1665R, K1666R, K1688R, K1689R	Tuberous sclerosis 2	VCV001721908	16	2137940	16	2087939	1721908	1779626	rs2151614767	NC_000016.10:2087938:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5067A>G (p.Lys1689=)	TSC2		Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000863178	16	2137941	16	2087940	863178	843533	rs1018327394	NC_000016.10:2087939:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5068G>A (p.Asp1690Asn)	TSC2	D1690N, D1575N, D1634N, D1646N, D1624N, D1667N, D1587N, D1623N, D1647N, D1446N	Tuberous sclerosis 2	VCV000535944	16	2137942	16	2087941	535944	529731	rs137854882	NC_000016.10:2087940:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 4, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5068G>C (p.Asp1690His)	TSC2	D1690H, D1446H, D1623H, D1634H, D1575H, D1587H, D1647H, D1646H, D1667H, D1624H	Tuberous sclerosis 2	VCV000049443	16	2137942	16	2087941	49443	58605	rs137854882	NC_000016.10:2087940:G:C	single nucleotide variant	missense variant	Pathogenic	Aug 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068G>T (p.Asp1690Tyr)	TSC2	D1690Y, D1446Y, D1623Y, D1647Y, D1667Y, D1634Y, D1646Y, D1575Y, D1587Y, D1624Y	Tuberous sclerosis 2	VCV000049344	16	2137942	16	2087941	49344	58506	rs137854882	NC_000016.10:2087940:G:T	single nucleotide variant	missense variant	Pathogenic	Apr 5, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+1G>T	TSC2		Tuberous sclerosis 2	VCV000648950	16	2137943	16	2087942	648950	652977	rs45445199	NC_000016.10:2087941:G:T	single nucleotide variant	splice donor variant	Pathogenic	Feb 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+1G>A	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000050026	16	2137943	16	2087942	50026	59188	rs45445199	NC_000016.10:2087941:G:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	May 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5068+2T>C	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000449636	16	2137944	16	2087943	449636	445526	rs397515152	NC_000016.10:2087942:T:C	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Jul 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5068+4G>C	TSC2		Tuberous sclerosis 2	VCV000659480	16	2137946	16	2087945	659480	652536	rs1420928521	NC_000016.10:2087944:G:C	single nucleotide variant	intron variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+6G>C	TSC2		Tuberous sclerosis 2	VCV002156082	16	2137948	16	2087947	2156082	1889681	rs2091060639	NC_000016.10:2087946:G:C	single nucleotide variant	intron variant	Uncertain significance	Nov 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+6G>A	TSC2		Tuberous sclerosis 2	VCV000936881	16	2137948	16	2087947	936881	940353	rs2091060639	NC_000016.10:2087946:G:A	single nucleotide variant	intron variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+7C>T	TSC2		Tuberous sclerosis 2	VCV000413625	16	2137949	16	2087948	413625	401437	rs773821477	NC_000016.10:2087947:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5068+8C>G	TSC2		Tuberous sclerosis 2	VCV001151625	16	2137950	16	2087949	1151625	1145983	rs747827911	NC_000016.10:2087948:C:G	single nucleotide variant	intron variant	Likely benign	Jun 13, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+8C>T	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2	VCV000413725	16	2137950	16	2087949	413725	401008	rs747827911	NC_000016.10:2087948:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5068+9G>C	TSC2		Tuberous sclerosis 2	VCV003696340	16	2137951	16	2087950	3696340	3829241		NC_000016.10:2087949:G:C	single nucleotide variant	intron variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+9G>T	TSC2		Tuberous sclerosis 2	VCV001940371	16	2137951	16	2087950	1940371	1994509	rs45445593	NC_000016.10:2087949:G:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+9G>A	TSC2		not provided|not specified|Tuberous sclerosis 2	VCV000049442	16	2137951	16	2087950	49442	58604	rs45445593	NC_000016.10:2087949:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5068+10G>T	TSC2		Tuberous sclerosis 2	VCV004071103	16	2137952	16	2087951	4071103	4184951		NC_000016.10:2087950:G:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+11G>C	TSC2		Tuberous sclerosis 2	VCV002179153	16	2137953	16	2087952	2179153	1919550	rs199999832	NC_000016.10:2087951:G:C	single nucleotide variant	intron variant	Likely benign	Feb 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+11G>A	TSC2		Tuberous sclerosis 2	VCV001643074	16	2137953	16	2087952	1643074	1521565	rs199999832	NC_000016.10:2087951:G:A	single nucleotide variant	intron variant	Likely benign	Jul 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+13G>A	TSC2		Tuberous sclerosis 2	VCV001578632	16	2137955	16	2087954	1578632	1652314	rs1201077508	NC_000016.10:2087953:G:A	single nucleotide variant	intron variant	Likely benign	Sep 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+15G>A	TSC2		Tuberous sclerosis 2	VCV002918405	16	2137957	16	2087956	2918405	3080525	rs1452209083	NC_000016.10:2087955:G:A	single nucleotide variant	intron variant	Likely benign	Jul 31, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+16G>A	TSC2		Tuberous sclerosis 2	VCV001565909	16	2137958	16	2087957	1565909	1590498	rs2151615600	NC_000016.10:2087956:G:A	single nucleotide variant	intron variant	Likely benign	Oct 29, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+17C>A	TSC2		Tuberous sclerosis 2	VCV001538847	16	2137959	16	2087958	1538847	1597728	rs1460592433	NC_000016.10:2087957:C:A	single nucleotide variant	intron variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+18C>G	TSC2		Tuberous sclerosis 2	VCV001545704	16	2137960	16	2087959	1545704	1612376	rs1036320970	NC_000016.10:2087958:C:G	single nucleotide variant	intron variant	Likely benign	Dec 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+18C>T	TSC2		Tuberous sclerosis 2	VCV001537252	16	2137960	16	2087959	1537252	1596845	rs1036320970	NC_000016.10:2087958:C:T	single nucleotide variant	intron variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+19C>T	TSC2		Tuberous sclerosis 2	VCV002887239	16	2137961	16	2087960	2887239	3047397	rs2151615751	NC_000016.10:2087959:C:T	single nucleotide variant	intron variant	Likely benign	Mar 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+19C>G	TSC2		Tuberous sclerosis 2	VCV001624941	16	2137961	16	2087960	1624941	1542561	rs2151615751	NC_000016.10:2087959:C:G	single nucleotide variant	intron variant	Likely benign	Oct 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+20T>C	TSC2		Tuberous sclerosis 2	VCV001643450	16	2137962	16	2087961	1643450	1587407	rs1199000508	NC_000016.10:2087960:T:C	single nucleotide variant	intron variant	Likely benign	Apr 5, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5068+40G>A	TSC2		not provided	VCV000064850	16	2137982	16	2087981	64850	75779	rs185211341	NC_000016.10:2087980:G:A	single nucleotide variant	intron variant	Likely benign	Jun 30, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-21G>A	TSC2		not provided	VCV000049870	16	2138028	16	2088027	49870	59032	rs45517390	NC_000016.10:2088026:G:A	single nucleotide variant	intron variant	Likely benign	Aug 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-20T>C	TSC2		Tuberous sclerosis 2	VCV004071168	16	2138029	16	2088028	4071168	4185016		NC_000016.10:2088027:T:C	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-19G>T	TSC2		Tuberous sclerosis 2	VCV002910627	16	2138030	16	2088029	2910627	3073095	rs775918252	NC_000016.10:2088028:G:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-19G>A	TSC2		Tuberous sclerosis 2	VCV002855446	16	2138030	16	2088029	2855446	3013954	rs775918252	NC_000016.10:2088028:G:A	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-18A>G	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000049345	16	2138031	16	2088030	49345	58507	rs45484794	NC_000016.10:2088029:A:G	single nucleotide variant	intron variant	Pathogenic/Likely pathogenic	Oct 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-17C>T	TSC2		Tuberous sclerosis 2	VCV002727248	16	2138032	16	2088031	2727248	2882566	rs2091081771	NC_000016.10:2088030:C:T	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-16C>T	TSC2		Tuberous sclerosis 2	VCV002920341	16	2138033	16	2088032	2920341	3077781	rs2151618897	NC_000016.10:2088031:C:T	single nucleotide variant	intron variant	Likely benign	Jun 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-15A>G	TSC2		Tuberous sclerosis 2	VCV003706460	16	2138034	16	2088033	3706460	3836032		NC_000016.10:2088032:A:G	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-14C>T	TSC2		Tuberous sclerosis 2	VCV003666997	16	2138035	16	2088034	3666997	3799009		NC_000016.10:2088033:C:T	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-14C>A	TSC2		Tuberous sclerosis 2	VCV001950784	16	2138035	16	2088034	1950784	2017387	rs376712566	NC_000016.10:2088033:C:A	single nucleotide variant	intron variant	Likely benign	Aug 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-14C>G	TSC2		Tuberous sclerosis 2	VCV001495823	16	2138035	16	2088034	1495823	1362738	rs376712566	NC_000016.10:2088033:C:G	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-13C>G	TSC2		Tuberous sclerosis 2	VCV002907874	16	2138036	16	2088035	2907874	3059572	rs542607400	NC_000016.10:2088034:C:G	single nucleotide variant	intron variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-13C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001641966	16	2138036	16	2088035	1641966	1651009	rs542607400	NC_000016.10:2088034:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-12A>G	TSC2		Tuberous sclerosis 2	VCV002828307	16	2138037	16	2088036	2828307	2990245	rs1279354127	NC_000016.10:2088035:A:G	single nucleotide variant	intron variant	Likely benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-11A>C	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002193593	16	2138038	16	2088037	2193593	1929269	rs562381623	NC_000016.10:2088036:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5069-11A>G	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001343068	16	2138038	16	2088037	1343068	1334713	rs562381623	NC_000016.10:2088036:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5069-10G>A	TSC2		Tuberous sclerosis 2	VCV002086594	16	2138039	16	2088038	2086594	2144509	rs1409032179	NC_000016.10:2088037:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5069-10G>C	TSC2		Tuberous sclerosis 2|not provided	VCV000762810	16	2138039	16	2088038	762810	776141	rs1409032179	NC_000016.10:2088037:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5069-9T>C	TSC2		Tuberous sclerosis syndrome	VCV003074976	16	2138040	16	2088039	3074976	3234628	rs1338116109	NC_000016.10:2088038:T:C	single nucleotide variant	intron variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-8C>A	TSC2		Tuberous sclerosis 2	VCV000939227	16	2138041	16	2088040	939227	940354	rs796053478	NC_000016.10:2088039:C:A	single nucleotide variant	intron variant	Likely benign	Mar 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-8C>G	TSC2		Tuberous sclerosis 2	VCV000413630	16	2138041	16	2088040	413630	401016	rs796053478	NC_000016.10:2088039:C:G	single nucleotide variant	intron variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-8C>T	TSC2		Tuberous sclerosis 2|not specified	VCV000207691	16	2138041	16	2088040	207691	203204	rs796053478	NC_000016.10:2088039:C:T	single nucleotide variant	intron variant	Benign	Jun 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-6C>G	TSC2		Tuberous sclerosis 2	VCV000946776	16	2138043	16	2088042	946776	941129	rs1212112210	NC_000016.10:2088041:C:G	single nucleotide variant	intron variant	Uncertain significance	May 5, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-6C>T	TSC2		Tuberous sclerosis 2	VCV000574670	16	2138043	16	2088042	574670	570144	rs1212112210	NC_000016.10:2088041:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-5C>A	TSC2		Hereditary cancer-predisposing syndrome	VCV003974649	16	2138044	16	2088043	3974649	4086472		NC_000016.10:2088042:C:A	single nucleotide variant	intron variant	Uncertain significance	Apr 25, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-5C>G	TSC2		Hereditary cancer-predisposing syndrome	VCV003329504	16	2138044	16	2088043	3329504	3489096		NC_000016.10:2088042:C:G	single nucleotide variant	intron variant	Uncertain significance	May 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-5C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000582732	16	2138044	16	2088043	582732	567911	rs762149472	NC_000016.10:2088042:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5069-4C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468136	16	2138045	16	2088044	468136	466047	rs1555440004	NC_000016.10:2088043:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000853302	16	2138046	16	2088045	853302	851665	rs2091085832	NC_000016.10:2088044:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5069-2A>C	TSC2		not provided	VCV000379819	16	2138047	16	2088046	379819	377292	rs45487291	NC_000016.10:2088045:A:C	single nucleotide variant	splice acceptor variant	Pathogenic	May 18, 2015	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069-2A>G	TSC2		Tuberous sclerosis 2	VCV000050066	16	2138047	16	2088046	50066	59228	rs45487291	NC_000016.10:2088045:A:G	single nucleotide variant	splice acceptor variant	Pathogenic	Mar 14, 2019	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5069-1G>C	TSC2		Tuberous sclerosis 2	VCV000049868	16	2138048	16	2088047	49868	59030	rs45517389	NC_000016.10:2088046:G:C	single nucleotide variant	splice acceptor variant	Pathogenic	Oct 21, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5069A>C (p.Asp1690Ala)	TSC2	D1647A, D1624A, D1634A, D1646A, D1446A, D1575A, D1587A, D1623A, D1667A, D1690A	Tuberous sclerosis 2	VCV001347456	16	2138049	16	2088048	1347456	1465886	rs2091086775	NC_000016.10:2088047:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5070C>G (p.Asp1690Glu)	TSC2	D1176E, D1467E, D1664E, D1089E, D1424E, D1470E, D1490E, D1619E, D1630E, D1634E, D1647E, D1689E, D1198E, D1199E, D1446E, D1575E, D1586E, D1587E, D1604E, D1618E, D1623E, D1654E, D1690E, D1175E, D1219E, D1423E, D1466E, D1574E, D1617E, D1620E, D1624E, D1646E, D1653E, D1666E, D1667E	Tuberous sclerosis 2	VCV002122362	16	2138050	16	2088049	2122362	2173787	rs1596457380	NC_000016.10:2088048:C:G	single nucleotide variant	missense variant	Uncertain significance	May 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5070C>T (p.Asp1690=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001608669	16	2138050	16	2088049	1608669	1660087	rs1596457380	NC_000016.10:2088048:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5070C>A (p.Asp1690Glu)	TSC2	D1587E, D1646E, D1575E, D1624E, D1690E, D1446E, D1623E, D1634E, D1647E, D1667E	Tuberous sclerosis 2	VCV000644167	16	2138050	16	2088049	644167	644353	rs1596457380	NC_000016.10:2088048:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.5071A>G (p.Met1691Val)	TSC2	M1576V, M1588V, M1625V, M1635V, M1447V, M1647V, M1668V, M1624V, M1648V, M1691V	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000837891	16	2138051	16	2088050	837891	843534	rs767809848	NC_000016.10:2088049:A:G	single nucleotide variant	missense variant	Uncertain significance	May 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5072T>C (p.Met1691Thr)	TSC2	M1691T, M1668T, M1576T, M1588T, M1624T, M1635T, M1447T, M1625T, M1647T, M1648T	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000065146	16	2138052	16	2088051	65146	76077	rs397515110	NC_000016.10:2088050:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5073G>A (p.Met1691Ile)	TSC2	M1625I, M1635I, M1647I, M1648I, M1691I, M1447I, M1576I, M1588I, M1624I, M1668I	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000840587	16	2138053	16	2088052	840587	843535	rs2091087331	NC_000016.10:2088051:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5075A>G (p.Glu1692Gly)	TSC2	E1636G, E1669G, E1448G, E1626G, E1648G, E1649G, E1577G, E1589G, E1625G, E1692G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001468762	16	2138055	16	2088054	1468762	1359121	rs984930044	NC_000016.10:2088053:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5076G>A (p.Glu1692=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001566874	16	2138056	16	2088055	1566874	1622517	rs1358186613	NC_000016.10:2088054:G:A	single nucleotide variant	synonymous variant	Likely benign	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5076G>C (p.Glu1692Asp)	TSC2	E1692D, E1625D, E1626D, E1649D, E1669D, E1448D, E1577D, E1589D, E1636D, E1648D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535926	16	2138056	16	2088055	535926	529732	rs1358186613	NC_000016.10:2088054:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5077G>A (p.Gly1693Ser)	TSC2	G1670S, G1590S, G1626S, G1637S, G1627S, G1649S, G1650S, G1693S, G1449S, G1578S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000835921	16	2138057	16	2088056	835921	843536	rs2091088245	NC_000016.10:2088055:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5078G>A (p.Gly1693Asp)	TSC2	G1590D, G1607D, G1622D, G1623D, G1649D, G1692D, G1178D, G1201D, G1426D, G1470D, G1577D, G1626D, G1656D, G1669D, G1670D, G1092D, G1179D, G1202D, G1222D, G1473D, G1493D, G1578D, G1627D, G1633D, G1657D, G1693D, G1427D, G1449D, G1469D, G1589D, G1620D, G1621D, G1637D, G1650D, G1667D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001745188	16	2138058	16	2088057	1745188	1806034	rs2091088393	NC_000016.10:2088056:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5079C>G (p.Gly1693=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002102989	16	2138059	16	2088058	2102989	2162049	rs1173469448	NC_000016.10:2088057:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5079C>T (p.Gly1693=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000706905	16	2138059	16	2088058	706905	693823	rs1173469448	NC_000016.10:2088057:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5080C>G (p.Leu1694Val)	TSC2	L1650V, L1671V, L1450V, L1579V, L1591V, L1638V, L1627V, L1628V, L1651V, L1694V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001390502	16	2138060	16	2088059	1390502	1396675	rs760781650	NC_000016.10:2088058:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 16, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5080C>T (p.Leu1694Phe)	TSC2	L1579F, L1671F, L1694F, L1638F, L1650F, L1450F, L1591F, L1627F, L1628F, L1651F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000951585	16	2138060	16	2088059	951585	927689	rs760781650	NC_000016.10:2088058:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5081T>C (p.Leu1694Pro)	TSC2	L1624P, L1627P, L1638P, L1651P, L1657P, L1668P, L1427P, L1428P, L1470P, L1578P, L1628P, L1634P, L1658P, L1180P, L1471P, L1474P, L1693P, L1694P, L1093P, L1202P, L1203P, L1450P, L1579P, L1590P, L1591P, L1608P, L1622P, L1623P, L1650P, L1670P, L1671P, L1179P, L1223P, L1494P, L1621P	Tuberous sclerosis 2	VCV003637258	16	2138061	16	2088060	3637258	3771412		NC_000016.10:2088059:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Mar 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5082T>C (p.Leu1694=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001157212	16	2138062	16	2088061	1157212	1145984	rs2151620148	NC_000016.10:2088060:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5083G>A (p.Val1695Met)	TSC2	V1094M, V1224M, V1429M, V1579M, V1591M, V1609M, V1624M, V1628M, V1635M, V1639M, V1651M, V1669M, V1695M, V1204M, V1451M, V1471M, V1475M, V1495M, V1625M, V1629M, V1652M, V1658M, V1671M, V1672M, V1180M, V1181M, V1472M, V1592M, V1622M, V1659M, V1203M, V1428M, V1580M, V1623M, V1694M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002910390	16	2138063	16	2088062	2910390	3072862	rs2151620184	NC_000016.10:2088061:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5084T>C (p.Val1695Ala)	TSC2	V1181A, V1428A, V1472A, V1579A, V1591A, V1609A, V1622A, V1623A, V1652A, V1658A, V1695A, V1203A, V1451A, V1475A, V1495A, V1592A, V1628A, V1639A, V1671A, V1672A, V1624A, V1629A, V1635A, V1659A, V1694A, V1094A, V1204A, V1224A, V1429A, V1625A, V1651A, V1669A, V1180A, V1471A, V1580A	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001745238	16	2138064	16	2088063	1745238	1806084	rs1420526276	NC_000016.10:2088062:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5085G>A (p.Val1695=)	TSC2		Tuberous sclerosis 2	VCV001112529	16	2138065	16	2088064	1112529	1103683	rs2151620310	NC_000016.10:2088063:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5086G>C (p.Asp1696His)	TSC2	D1182H, D1205H, D1580H, D1623H, D1626H, D1095H, D1181H, D1204H, D1429H, D1430H, D1473H, D1496H, D1593H, D1629H, D1630H, D1636H, D1672H, D1225H, D1452H, D1581H, D1610H, D1640H, D1652H, D1673H, D1472H, D1476H, D1592H, D1624H, D1625H, D1653H, D1659H, D1660H, D1670H, D1695H, D1696H	Tuberous sclerosis 2	VCV003637259	16	2138066	16	2088065	3637259	3771413		NC_000016.10:2088064:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Nov 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5086G>A (p.Asp1696Asn)	TSC2	D1629N, D1630N, D1653N, D1452N, D1640N, D1581N, D1652N, D1673N, D1696N, D1593N	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000970364	16	2138066	16	2088065	970364	957691	rs1555440048	NC_000016.10:2088064:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5086G>T (p.Asp1696Tyr)	TSC2	D1696Y, D1593Y, D1629Y, D1630Y, D1652Y, D1653Y, D1673Y, D1640Y, D1452Y, D1581Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000468137	16	2138066	16	2088065	468137	465400	rs1555440048	NC_000016.10:2088064:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5088C>T (p.Asp1696=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000698034	16	2138068	16	2088067	698034	688553	rs766472320	NC_000016.10:2088066:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5089A>G (p.Thr1697Ala)	TSC2	T1582A, T1654A, T1674A, T1631A, T1653A, T1697A, T1641A, T1453A, T1594A, T1630A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001388350	16	2138069	16	2088068	1388350	1371091	rs2151620482	NC_000016.10:2088067:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5090C>A (p.Thr1697Asn)	TSC2	T1453N, T1582N, T1594N, T1630N, T1631N, T1641N, T1653N, T1654N, T1674N, T1697N	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001320669	16	2138070	16	2088069	1320669	1310914	rs777223264	NC_000016.10:2088068:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5090C>G (p.Thr1697Ser)	TSC2	T1630S, T1641S, T1654S, T1697S, T1674S, T1582S, T1594S, T1631S, T1453S, T1653S	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001028342	16	2138070	16	2088069	1028342	1018044	rs777223264	NC_000016.10:2088068:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5091C>T (p.Thr1697=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000756905	16	2138071	16	2088070	756905	770747	rs111675922	NC_000016.10:2088069:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5092A>C (p.Ser1698Arg)	TSC2	S1097R, S1183R, S1184R, S1206R, S1207R, S1227R, S1431R, S1432R, S1454R, S1474R, S1475R, S1478R, S1498R, S1582R, S1583R, S1594R, S1595R, S1612R, S1625R, S1626R, S1627R, S1628R, S1631R, S1632R, S1638R, S1642R, S1654R, S1655R, S1661R, S1662R, S1672R, S1674R, S1675R, S1697R, S1698R	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001707603	16	2138072	16	2088071	1707603	1705908	rs1397179937	NC_000016.10:2088070:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5093G>C (p.Ser1698Thr)	TSC2	S1698T, S1631T, S1632T, S1655T, S1454T, S1583T, S1595T, S1642T, S1654T, S1675T	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000578397	16	2138073	16	2088072	578397	569868	rs1267700080	NC_000016.10:2088071:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5094C>T (p.Ser1698=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000137748	16	2138074	16	2088073	137748	141451	rs45514196	NC_000016.10:2088072:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5094C>A (p.Ser1698Arg)	TSC2	S1698R, S1595R, S1631R, S1632R, S1642R, S1654R, S1454R, S1655R, S1675R, S1583R	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	VCV000049451	16	2138074	16	2088073	49451	58613	rs45514196	NC_000016.10:2088072:C:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5095G>A (p.Val1699Met)	TSC2	V1699M, V1633M, V1643M, V1655M, V1584M, V1596M, V1632M, V1676M, V1455M, V1656M	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207692	16	2138075	16	2088074	207692	203205	rs370864445	NC_000016.10:2088073:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5097G>T (p.Val1699=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002786634	16	2138077	16	2088076	2786634	2939139	rs397515314	NC_000016.10:2088075:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5097G>C (p.Val1699=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000065147	16	2138077	16	2088076	65147	76078	rs397515314	NC_000016.10:2088075:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5098G>T (p.Ala1700Ser)	TSC2	A1099S, A1433S, A1456S, A1476S, A1480S, A1500S, A1596S, A1628S, A1644S, A1676S, A1677S, A1185S, A1434S, A1629S, A1630S, A1634S, A1656S, A1209S, A1229S, A1477S, A1597S, A1633S, A1640S, A1664S, A1699S, A1700S, A1186S, A1208S, A1584S, A1585S, A1614S, A1627S, A1657S, A1663S, A1674S	Hereditary cancer-predisposing syndrome	VCV003329513	16	2138078	16	2088077	3329513	3489105		NC_000016.10:2088076:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 9, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5099C>T (p.Ala1700Val)	TSC2	A1456V, A1585V, A1597V, A1633V, A1656V, A1657V, A1700V, A1634V, A1644V, A1677V	Tuberous sclerosis 2	VCV001506911	16	2138079	16	2088078	1506911	1426971	rs2151620769	NC_000016.10:2088077:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5100C>G (p.Ala1700=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001558323	16	2138080	16	2088079	1558323	1594912	rs1172938826	NC_000016.10:2088078:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5100C>T (p.Ala1700=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000738550	16	2138080	16	2088079	738550	755007	rs1172938826	NC_000016.10:2088078:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5101A>C (p.Lys1701Gln)	TSC2	K1186Q, K1434Q, K1435Q, K1478Q, K1597Q, K1615Q, K1631Q, K1641Q, K1657Q, K1658Q, K1678Q, K1700Q, K1100Q, K1209Q, K1501Q, K1630Q, K1664Q, K1665Q, K1701Q, K1187Q, K1230Q, K1585Q, K1586Q, K1635Q, K1675Q, K1210Q, K1457Q, K1477Q, K1481Q, K1598Q, K1628Q, K1629Q, K1634Q, K1645Q, K1677Q	Tuberous sclerosis 2	VCV002756655	16	2138081	16	2088080	2756655	2910056	rs2151620842	NC_000016.10:2088079:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5101A>G (p.Lys1701Glu)	TSC2	K1457E, K1586E, K1598E, K1634E, K1635E, K1645E, K1657E, K1658E, K1678E, K1701E	not provided|Tuberous sclerosis 2	VCV001697184	16	2138081	16	2088080	1697184	1689579	rs2151620842	NC_000016.10:2088079:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5102A>G (p.Lys1701Arg)	TSC2	K1187R, K1210R, K1435R, K1477R, K1481R, K1628R, K1658R, K1664R, K1209R, K1230R, K1434R, K1457R, K1478R, K1501R, K1585R, K1597R, K1629R, K1631R, K1645R, K1665R, K1700R, K1701R, K1598R, K1615R, K1634R, K1641R, K1675R, K1678R, K1586R, K1630R, K1635R, K1657R, K1677R, K1100R, K1186R	Tuberous sclerosis 2	VCV002102448	16	2138082	16	2088081	2102448	2165493	rs2151620879	NC_000016.10:2088080:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5103G>C (p.Lys1701Asn)	TSC2	K1100N, K1186N, K1187N, K1209N, K1210N, K1230N, K1434N, K1435N, K1457N, K1477N, K1478N, K1481N, K1501N, K1585N, K1586N, K1597N, K1598N, K1615N, K1628N, K1629N, K1630N, K1631N, K1634N, K1635N, K1641N, K1645N, K1657N, K1658N, K1664N, K1665N, K1675N, K1677N, K1678N, K1700N, K1701N	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001718416	16	2138083	16	2088082	1718416	1778776	rs768476974	NC_000016.10:2088081:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5103G>A (p.Lys1701=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000751658	16	2138083	16	2088082	751658	770748	rs768476974	NC_000016.10:2088081:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5105T>G (p.Ile1702Ser)	TSC2	I1435S, I1458S, I1478S, I1482S, I1586S, I1616S, I1632S, I1678S, I1701S, I1187S, I1436S, I1598S, I1629S, I1665S, I1679S, I1210S, I1211S, I1231S, I1599S, I1630S, I1631S, I1635S, I1636S, I1659S, I1676S, I1702S, I1101S, I1188S, I1479S, I1502S, I1587S, I1642S, I1646S, I1658S, I1666S	Hereditary cancer-predisposing syndrome	VCV003462604	16	2138085	16	2088084	3462604	3621623		NC_000016.10:2088083:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5106C>G (p.Ile1702Met)	TSC2	I1702M, I1587M, I1658M, I1458M, I1635M, I1646M, I1679M, I1599M, I1659M, I1636M	not provided|Tuberous sclerosis 2	VCV000535885	16	2138086	16	2088085	535885	529788	rs45483700	NC_000016.10:2088084:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5106C>T (p.Ile1702=)	PKD1|TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Polycystic kidney disease, adult type	VCV000378793	16	2138086	16	2088085	378793	374860	rs45483700	NC_000016.10:2088084:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5106C>A (p.Ile1702=)	TSC2		Tuberous sclerosis 2|not specified|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000050068	16	2138086	16	2088085	50068	59230	rs45483700	NC_000016.10:2088084:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Aug 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5107G>C (p.Val1703Leu)	TSC2	V1189L, V1211L, V1459L, V1588L, V1600L, V1617L, V1636L, V1647L, V1666L, V1680L, V1212L, V1437L, V1587L, V1632L, V1667L, V1702L, V1599L, V1633L, V1637L, V1643L, V1659L, V1677L, V1679L, V1703L, V1102L, V1188L, V1232L, V1436L, V1479L, V1480L, V1483L, V1503L, V1630L, V1631L, V1660L	Tuberous sclerosis 2|not provided	VCV002101281	16	2138087	16	2088086	2101281	2151301	rs2091092273	NC_000016.10:2088085:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5107G>A (p.Val1703Met)	TSC2	V1600M, V1637M, V1680M, V1459M, V1659M, V1588M, V1636M, V1647M, V1660M, V1703M	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000934049	16	2138087	16	2088086	934049	937349	rs2091092273	NC_000016.10:2088085:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5108T>C (p.Val1703Ala)	TSC2	V1703A, V1459A, V1588A, V1637A, V1600A, V1636A, V1647A, V1680A, V1659A, V1660A	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000468138	16	2138088	16	2088087	468138	466052	rs45498401	NC_000016.10:2088086:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5109G>A (p.Val1703=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000705529	16	2138089	16	2088088	705529	693824	rs770413433	NC_000016.10:2088087:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5109G>C (p.Val1703=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000413715	16	2138089	16	2088088	413715	400971	rs770413433	NC_000016.10:2088087:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5110T>G (p.Ser1704Ala)	TSC2	S1103A, S1212A, S1437A, S1484A, S1504A, S1589A, S1631A, S1632A, S1633A, S1634A, S1644A, S1660A, S1661A, S1668A, S1681A, S1703A, S1233A, S1588A, S1618A, S1637A, S1667A, S1678A, S1680A, S1190A, S1438A, S1600A, S1601A, S1638A, S1704A, S1189A, S1213A, S1460A, S1480A, S1481A, S1648A	Tuberous sclerosis 2	VCV003671321	16	2138090	16	2088089	3671321	3793224		NC_000016.10:2088088:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Mar 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5110T>C (p.Ser1704Pro)	TSC2	S1637P, S1638P, S1660P, S1681P, S1601P, S1704P, S1589P, S1661P, S1460P, S1648P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000840043	16	2138090	16	2088089	840043	843537	rs45474691	NC_000016.10:2088088:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5110T>A (p.Ser1704Thr)	TSC2	S1704T, S1601T, S1637T, S1638T, S1648T, S1660T, S1681T, S1460T, S1589T, S1661T	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000049348	16	2138090	16	2088089	49348	58510	rs45474691	NC_000016.10:2088088:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5112T>A (p.Ser1704=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000707668	16	2138092	16	2088091	707668	693825	rs769158004	NC_000016.10:2088090:T:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5115C>T (p.Asp1705=)	TSC2		Tuberous sclerosis 2	VCV001156078	16	2138095	16	2088094	1156078	1145985	rs1385591764	NC_000016.10:2088093:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5115C>G (p.Asp1705Glu)	TSC2	D1602E, D1639E, D1661E, D1590E, D1682E, D1461E, D1638E, D1662E, D1649E, D1705E	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000663333	16	2138095	16	2088094	663333	644354	rs1385591764	NC_000016.10:2088093:C:G	single nucleotide variant	missense variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5115C>A (p.Asp1705Glu)	TSC2	D1705E, D1649E, D1461E, D1590E, D1602E, D1638E, D1662E, D1639E, D1682E, D1661E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468139	16	2138095	16	2088094	468139	465403	rs1385591764	NC_000016.10:2088093:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5116C>A (p.Arg1706Ser)	TSC2	R1214S, R1235S, R1439S, R1440S, R1482S, R1635S, R1639S, R1646S, R1663S, R1669S, R1680S, R1705S, R1105S, R1191S, R1462S, R1486S, R1591S, R1640S, R1650S, R1670S, R1215S, R1506S, R1602S, R1620S, R1633S, R1636S, R1662S, R1682S, R1683S, R1706S, R1192S, R1483S, R1590S, R1603S, R1634S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001745435	16	2138096	16	2088095	1745435	1802487	rs45517391	NC_000016.10:2088094:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5116C>G (p.Arg1706Gly)	TSC2	R1462G, R1591G, R1603G, R1639G, R1640G, R1650G, R1662G, R1663G, R1683G, R1706G	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001054766	16	2138096	16	2088095	1054766	1049499	rs45517391	NC_000016.10:2088094:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5116C>T (p.Arg1706Cys)	TSC2	R1706C, R1662C, R1663C, R1639C, R1640C, R1683C, R1462C, R1591C, R1603C, R1650C	not provided|Hereditary cancer-predisposing syndrome|not specified|See cases|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049912	16	2138096	16	2088095	49912	59074	rs45517391	NC_000016.10:2088094:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5117G>T (p.Arg1706Leu)	TSC2	R1650L, R1663L, R1639L, R1640L, R1683L, R1462L, R1591L, R1603L, R1662L, R1706L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000845057	16	2138097	16	2088096	845057	843538	rs45517392	NC_000016.10:2088095:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5117G>A (p.Arg1706His)	PKD1|TSC2	R1706H, R1662H, R1683H, R1462H, R1640H, R1650H, R1591H, R1603H, R1639H, R1663H	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type|Ovarian cancer|Tuberous sclerosis 2	VCV000049456	16	2138097	16	2088096	49456	58618	rs45517392	NC_000016.10:2088095:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5118C>G (p.Arg1706=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001745444	16	2138098	16	2088097	1745444	1802496	rs397515079	NC_000016.10:2088096:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 12, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5118C>T (p.Arg1706=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000065106	16	2138098	16	2088097	65106	76037	rs397515079	NC_000016.10:2088096:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5119A>C (p.Asn1707His)	TSC2	N1707H, N1604H, N1640H, N1463H, N1664H, N1684H, N1592H, N1651H, N1663H, N1641H	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535852	16	2138099	16	2088098	535852	529735	rs1300582033	NC_000016.10:2088097:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5120A>C (p.Asn1707Thr)	TSC2	N1216T, N1592T, N1604T, N1635T, N1641T, N1647T, N1651T, N1683T, N1684T, N1236T, N1484T, N1507T, N1640T, N1663T, N1106T, N1193T, N1440T, N1441T, N1463T, N1483T, N1487T, N1603T, N1621T, N1664T, N1681T, N1707T, N1192T, N1215T, N1591T, N1634T, N1636T, N1637T, N1670T, N1671T, N1706T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001745481	16	2138100	16	2088099	1745481	1802533	rs772439098	NC_000016.10:2088098:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5120A>G (p.Asn1707Ser)	TSC2	N1707S, N1663S, N1664S, N1684S, N1463S, N1604S, N1641S, N1640S, N1592S, N1651S	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207693	16	2138100	16	2088099	207693	203206	rs772439098	NC_000016.10:2088098:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5121C>A (p.Asn1707Lys)	TSC2	N1106K, N1192K, N1193K, N1215K, N1216K, N1236K, N1440K, N1441K, N1463K, N1483K, N1484K, N1487K, N1507K, N1591K, N1592K, N1603K, N1604K, N1621K, N1634K, N1635K, N1636K, N1637K, N1640K, N1641K, N1647K, N1651K, N1663K, N1664K, N1670K, N1671K, N1681K, N1683K, N1684K, N1706K, N1707K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003232184	16	2138101	16	2088100	3232184	3391985	rs2151621840	NC_000016.10:2088099:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5121C>T (p.Asn1707=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV002774667	16	2138101	16	2088100	2774667	2935394	rs2151621840	NC_000016.10:2088099:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5121C>G (p.Asn1707Lys)	TSC2	N1604K, N1684K, N1640K, N1663K, N1664K, N1592K, N1651K, N1463K, N1641K, N1707K	Tuberous sclerosis 2	VCV001484150	16	2138101	16	2088100	1484150	1455080	rs2151621840	NC_000016.10:2088099:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5122C>G (p.Leu1708Val)	TSC2	L1464V, L1593V, L1642V, L1665V, L1605V, L1641V, L1652V, L1664V, L1685V, L1708V	Tuberous sclerosis 2	VCV001478376	16	2138102	16	2088101	1478376	1351883	rs1168265181	NC_000016.10:2088100:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5122C>T (p.Leu1708=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000705353	16	2138102	16	2088101	705353	693826	rs1168265181	NC_000016.10:2088100:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5123T>C (p.Leu1708Pro)	TSC2	L1708P, L1464P, L1593P, L1665P, L1605P, L1664P, L1685P, L1641P, L1642P, L1652P	Hereditary cancer-predisposing syndrome	VCV000065364	16	2138103	16	2088102	65364	76298	rs397515274	NC_000016.10:2088101:T:C	single nucleotide variant	missense variant	Likely pathogenic	May 24, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.5124G>C (p.Leu1708=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001745502	16	2138104	16	2088103	1745502	1802554	rs2151622005	NC_000016.10:2088102:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 4, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5124G>A (p.Leu1708=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001596029	16	2138104	16	2088103	1596029	1569603	rs2151622005	NC_000016.10:2088102:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5125C>A (p.Pro1709Thr)	TSC2	P1218T, P1442T, P1489T, P1623T, P1637T, P1638T, P1673T, P1443T, P1485T, P1593T, P1605T, P1642T, P1653T, P1665T, P1666T, P1672T, P1683T, P1685T, P1686T, P1108T, P1194T, P1465T, P1486T, P1594T, P1639T, P1643T, P1649T, P1709T, P1195T, P1217T, P1238T, P1509T, P1606T, P1636T, P1708T	Tuberous sclerosis 2	VCV002115346	16	2138105	16	2088104	2115346	2161582	rs2091094853	NC_000016.10:2088103:C:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5125C>T (p.Pro1709Ser)	TSC2	P1594S, P1642S, P1643S, P1653S, P1666S, P1686S, P1465S, P1709S, P1606S, P1665S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000960849	16	2138105	16	2088104	960849	949293	rs2091094853	NC_000016.10:2088103:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5126C>T (p.Pro1709Leu)	TSC2	P1709L, P1594L, P1643L, P1653L, P1665L, P1642L, P1686L, P1465L, P1606L, P1666L	Tuberous sclerosis 2|not provided	VCV000049929	16	2138106	16	2088105	49929	59091	rs45517393	NC_000016.10:2088104:C:T	single nucleotide variant	missense variant	Pathogenic	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5126C>G (p.Pro1709Arg)	TSC2	P1709R, P1465R, P1643R, P1666R, P1653R, P1665R, P1594R, P1686R, P1606R, P1642R	not provided	VCV000049350	16	2138106	16	2088105	49350	58512	rs45517393	NC_000016.10:2088104:C:G	single nucleotide variant	missense variant	Pathogenic	Nov 21, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.5127C>G (p.Pro1709=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564746	16	2138107	16	2088106	2564746	2733902	rs200162473	NC_000016.10:2088105:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 5, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5127C>T (p.Pro1709=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001107617	16	2138107	16	2088106	1107617	1103684	rs200162473	NC_000016.10:2088105:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5127C>A (p.Pro1709=)	TSC2		Tuberous sclerosis 2	VCV000746492	16	2138107	16	2088106	746492	755008	rs200162473	NC_000016.10:2088105:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5129T>G (p.Phe1710Cys)	TSC2	F1466C, F1654C, F1687C, F1595C, F1643C, F1644C, F1607C, F1666C, F1667C, F1710C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000654934	16	2138109	16	2088108	654934	644355	rs1315439478	NC_000016.10:2088107:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5130C>G (p.Phe1710Leu)	TSC2	F1109L, F1196L, F1239L, F1486L, F1510L, F1594L, F1606L, F1607L, F1640L, F1643L, F1654L, F1667L, F1674L, F1218L, F1219L, F1443L, F1490L, F1639L, F1644L, F1666L, F1684L, F1487L, F1637L, F1638L, F1673L, F1709L, F1195L, F1444L, F1466L, F1595L, F1624L, F1650L, F1686L, F1687L, F1710L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002750802	16	2138110	16	2088109	2750802	2915865	rs760978505	NC_000016.10:2088108:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5130C>A (p.Phe1710Leu)	TSC2	F1607L, F1654L, F1666L, F1466L, F1687L, F1710L, F1595L, F1643L, F1644L, F1667L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000885963	16	2138110	16	2088109	885963	874849	rs760978505	NC_000016.10:2088108:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5130C>T (p.Phe1710=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000468140	16	2138110	16	2088109	468140	466054	rs760978505	NC_000016.10:2088108:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5131G>C (p.Val1711Leu)	TSC2	V1711L, V1667L, V1467L, V1644L, V1655L, V1688L, V1608L, V1645L, V1668L, V1596L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000468141	16	2138111	16	2088110	468141	465408	rs139779505	NC_000016.10:2088109:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5131G>A (p.Val1711Met)	PKD1|TSC2	V1711M, V1467M, V1644M, V1645M, V1655M, V1596M, V1667M, V1668M, V1608M, V1688M	Hereditary cancer-predisposing syndrome|not specified|not provided|Polycystic kidney disease, adult type|Tuberous sclerosis 2	VCV000064983	16	2138111	16	2088110	64983	75913	rs139779505	NC_000016.10:2088109:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5133G>A (p.Val1711=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000663323	16	2138113	16	2088112	663323	644356	rs1596457919	NC_000016.10:2088111:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5134G>A (p.Ala1712Thr)	TSC2	A1468T, A1645T, A1668T, A1609T, A1646T, A1656T, A1597T, A1712T, A1669T, A1689T	Tuberous sclerosis 2|Astroblastoma, MN1-altered|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000647482	16	2138114	16	2088113	647482	644357	rs1596457926	NC_000016.10:2088112:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5135C>T (p.Ala1712Val)	TSC2	A1712V, A1468V, A1645V, A1689V, A1597V, A1646V, A1656V, A1609V, A1669V, A1668V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000582682	16	2138115	16	2088114	582682	569870	rs45517394	NC_000016.10:2088113:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5136C>T (p.Ala1712=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000238074	16	2138116	16	2088115	238074	242332	rs878854114	NC_000016.10:2088114:C:T	single nucleotide variant	synonymous variant	Likely benign	May 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5137C>A (p.Arg1713Ser)	TSC2	R1713S, R1469S, R1647S, R1657S, R1669S, R1670S, R1610S, R1646S, R1598S, R1690S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000424872	16	2138117	16	2088116	424872	413206	rs759420443	NC_000016.10:2088115:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5137C>T (p.Arg1713Cys)	TSC2	R1713C, R1598C, R1646C, R1657C, R1669C, R1610C, R1690C, R1469C, R1647C, R1670C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000406029	16	2138117	16	2088116	406029	401702	rs759420443	NC_000016.10:2088115:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5138G>T (p.Arg1713Leu)	TSC2	R1112L, R1198L, R1199L, R1221L, R1222L, R1242L, R1446L, R1447L, R1469L, R1489L, R1490L, R1493L, R1513L, R1597L, R1598L, R1609L, R1610L, R1627L, R1640L, R1641L, R1642L, R1643L, R1646L, R1647L, R1653L, R1657L, R1669L, R1670L, R1676L, R1677L, R1687L, R1689L, R1690L, R1712L, R1713L	Tuberous sclerosis syndrome	VCV003070142	16	2138118	16	2088117	3070142	3231631	rs45517395	NC_000016.10:2088116:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5138G>C (p.Arg1713Pro)	TSC2	R1713P, R1469P, R1646P, R1647P, R1598P, R1610P, R1657P, R1669P, R1670P, R1690P	Tuberous sclerosis 2	VCV000049931	16	2138118	16	2088117	49931	59093	rs45517395	NC_000016.10:2088116:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 10, 2015	criteria provided, single submitter							
NM_000548.5(TSC2):c.5138G>A (p.Arg1713His)	TSC2	R1713H, R1598H, R1610H, R1657H, R1670H, R1690H, R1469H, R1646H, R1647H, R1669H	not provided|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049930	16	2138118	16	2088117	49930	59092	rs45517395	NC_000016.10:2088116:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5139C>T (p.Arg1713=)	TSC2		Tuberous sclerosis 2	VCV002843225	16	2138119	16	2088118	2843225	2994096	rs144994814	NC_000016.10:2088117:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5139C>A (p.Arg1713=)	TSC2		Tuberous sclerosis 2	VCV002812494	16	2138119	16	2088118	2812494	2965886	rs144994814	NC_000016.10:2088117:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5140C>T (p.Gln1714Ter)	TSC2	Q1714*, Q1658*, Q1691*, Q1470*, Q1611*, Q1648*, Q1670*, Q1671*, Q1599*, Q1647*	not specified|Tuberous sclerosis 2	VCV000049351	16	2138120	16	2088119	49351	58513	rs45517396	NC_000016.10:2088118:C:T	single nucleotide variant	nonsense	Pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5141A>G (p.Gln1714Arg)	TSC2	Q1200R, Q1243R, Q1490R, Q1514R, Q1599R, Q1610R, Q1628R, Q1643R, Q1654R, Q1658R, Q1688R, Q1714R, Q1199R, Q1598R, Q1641R, Q1642R, Q1648R, Q1691R, Q1113R, Q1222R, Q1448R, Q1491R, Q1494R, Q1671R, Q1677R, Q1690R, Q1223R, Q1447R, Q1470R, Q1611R, Q1644R, Q1647R, Q1670R, Q1678R, Q1713R	not provided|Tuberous sclerosis 2	VCV002836224	16	2138121	16	2088120	2836224	2992211	rs2151622840	NC_000016.10:2088119:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 22, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5142G>A (p.Gln1714=)	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|not specified	VCV000207694	16	2138122	16	2088121	207694	203207	rs147147042	NC_000016.10:2088120:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5143A>G (p.Met1715Val)	TSC2	M1715V, M1600V, M1648V, M1671V, M1612V, M1659V, M1672V, M1692V, M1471V, M1649V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000064967	16	2138123	16	2088122	64967	75897	rs397514974	NC_000016.10:2088121:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5144T>C (p.Met1715Thr)	TSC2	M1471T, M1600T, M1612T, M1648T, M1649T, M1659T, M1671T, M1672T, M1692T, M1715T	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001000279	16	2138124	16	2088123	1000279	996772	rs758246234	NC_000016.10:2088122:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5144T>A (p.Met1715Lys)	TSC2	M1671K, M1692K, M1715K, M1471K, M1612K, M1649K, M1672K, M1600K, M1648K, M1659K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000642467	16	2138124	16	2088123	642467	644358	rs758246234	NC_000016.10:2088122:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5145G>A (p.Met1715Ile)	TSC2	M1114I, M1471I, M1492I, M1495I, M1611I, M1612I, M1645I, M1649I, M1659I, M1223I, M1224I, M1515I, M1599I, M1642I, M1644I, M1648I, M1655I, M1671I, M1679I, M1691I, M1715I, M1201I, M1448I, M1629I, M1643I, M1672I, M1692I, M1200I, M1244I, M1449I, M1491I, M1600I, M1678I, M1689I, M1714I	Tuberous sclerosis 2	VCV002771708	16	2138125	16	2088124	2771708	2927694	rs2544481351	NC_000016.10:2088123:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5147C>A (p.Ala1716Asp)	TSC2	A1224D, A1472D, A1492D, A1493D, A1600D, A1644D, A1646D, A1650D, A1672D, A1673D, A1693D, A1115D, A1201D, A1245D, A1516D, A1613D, A1645D, A1649D, A1656D, A1680D, A1715D, A1716D, A1225D, A1450D, A1496D, A1601D, A1612D, A1690D, A1692D, A1202D, A1449D, A1630D, A1643D, A1660D, A1679D	Tuberous sclerosis 2	VCV003637260	16	2138127	16	2088126	3637260	3771414		NC_000016.10:2088125:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5147C>T (p.Ala1716Val)	TSC2	A1472V, A1601V, A1673V, A1650V, A1660V, A1716V, A1613V, A1693V, A1649V, A1672V	Tuberous sclerosis 2|not provided	VCV001039113	16	2138127	16	2088126	1039113	1032504	rs1420725409	NC_000016.10:2088125:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5148C>T (p.Ala1716=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000049885	16	2138128	16	2088127	49885	59047	rs45482604	NC_000016.10:2088126:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5149C>G (p.Leu1717Val)	TSC2	L1650V, L1651V, L1674V, L1717V, L1614V, L1673V, L1602V, L1661V, L1473V, L1694V	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000962626	16	2138129	16	2088128	962626	949294	rs1555440199	NC_000016.10:2088127:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5149C>T (p.Leu1717=)	PKD1|TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Polycystic kidney disease, adult type	VCV000468142	16	2138129	16	2088128	468142	465410	rs1555440199	NC_000016.10:2088127:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5150T>A (p.Leu1717Gln)	TSC2	L1202Q, L1246Q, L1450Q, L1601Q, L1614Q, L1650Q, L1681Q, L1225Q, L1493Q, L1497Q, L1644Q, L1651Q, L1674Q, L1694Q, L1116Q, L1226Q, L1473Q, L1631Q, L1646Q, L1647Q, L1657Q, L1680Q, L1691Q, L1693Q, L1203Q, L1451Q, L1494Q, L1517Q, L1602Q, L1613Q, L1645Q, L1661Q, L1673Q, L1716Q, L1717Q	Hereditary cancer-predisposing syndrome	VCV003974623	16	2138130	16	2088129	3974623	4086446		NC_000016.10:2088128:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 22, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5150T>G (p.Leu1717Arg)	TSC2	L1717R, L1650R, L1473R, L1661R, L1674R, L1694R, L1602R, L1673R, L1614R, L1651R	Tuberous sclerosis 2	VCV000568630	16	2138130	16	2088129	568630	569874	rs45517398	NC_000016.10:2088128:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.5150T>C (p.Leu1717Pro)	TSC2	L1717P, L1473P, L1651P, L1694P, L1614P, L1661P, L1673P, L1602P, L1650P, L1674P	not provided|Tuberous sclerosis 2	VCV000049352	16	2138130	16	2088129	49352	58514	rs45517398	NC_000016.10:2088128:T:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5151G>A (p.Leu1717=)	TSC2		Tuberous sclerosis 2	VCV000760624	16	2138131	16	2088130	760624	770749	rs1159550965	NC_000016.10:2088129:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5152C>T (p.His1718Tyr)	TSC2	H1474Y, H1615Y, H1674Y, H1675Y, H1718Y, H1603Y, H1652Y, H1662Y, H1695Y, H1651Y	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825483	16	2138132	16	2088131	825483	812625	rs1567130289	NC_000016.10:2088130:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5152C>G (p.His1718Asp)	TSC2	H1718D, H1652D, H1615D, H1651D, H1674D, H1675D, H1695D, H1662D, H1474D, H1603D	Tuberous sclerosis 2	VCV000575650	16	2138132	16	2088131	575650	573888	rs1567130289	NC_000016.10:2088130:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.5153A>G (p.His1718Arg)	TSC2	H1204R, H1451R, H1603R, H1614R, H1648R, H1692R, H1695R, H1117R, H1226R, H1227R, H1452R, H1474R, H1602R, H1646R, H1647R, H1652R, H1658R, H1674R, H1203R, H1494R, H1495R, H1518R, H1632R, H1645R, H1675R, H1694R, H1717R, H1718R, H1247R, H1498R, H1615R, H1651R, H1662R, H1681R, H1682R	Tuberous sclerosis 2|not provided	VCV002114132	16	2138133	16	2088132	2114132	2172027	rs2151623402	NC_000016.10:2088131:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5153A>T (p.His1718Leu)	TSC2	H1451L, H1602L, H1615L, H1647L, H1651L, H1652L, H1658L, H1674L, H1681L, H1695L, H1204L, H1247L, H1474L, H1632L, H1682L, H1717L, H1203L, H1494L, H1495L, H1603L, H1648L, H1675L, H1692L, H1718L, H1117L, H1226L, H1227L, H1452L, H1498L, H1518L, H1614L, H1645L, H1646L, H1662L, H1694L	Hereditary cancer-predisposing syndrome	VCV001745682	16	2138133	16	2088132	1745682	1799283	rs2151623402	NC_000016.10:2088131:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5154C>T (p.His1718=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000413721	16	2138134	16	2088133	413721	401441	rs370338085	NC_000016.10:2088132:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5155G>A (p.Ala1719Thr)	TSC2	A1719T, A1604T, A1663T, A1696T, A1475T, A1616T, A1652T, A1653T, A1675T, A1676T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000065216	16	2138135	16	2088134	65216	76148	rs201206500	NC_000016.10:2088133:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5156C>T (p.Ala1719Val)	TSC2	A1205V, A1495V, A1615V, A1693V, A1695V, A1696V, A1118V, A1227V, A1499V, A1653V, A1675V, A1676V, A1682V, A1683V, A1228V, A1248V, A1496V, A1604V, A1646V, A1648V, A1649V, A1659V, A1663V, A1718V, A1204V, A1452V, A1453V, A1475V, A1519V, A1603V, A1616V, A1633V, A1647V, A1652V, A1719V	Hereditary cancer-predisposing syndrome	VCV003462578	16	2138136	16	2088135	3462578	3621597		NC_000016.10:2088134:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 5, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5156C>A (p.Ala1719Glu)	TSC2	A1118E, A1228E, A1453E, A1499E, A1519E, A1603E, A1648E, A1653E, A1676E, A1718E, A1495E, A1604E, A1616E, A1652E, A1682E, A1696E, A1204E, A1205E, A1452E, A1615E, A1647E, A1659E, A1663E, A1675E, A1683E, A1693E, A1719E, A1227E, A1248E, A1475E, A1496E, A1633E, A1646E, A1649E, A1695E	Tuberous sclerosis 2|not specified	VCV002740269	16	2138136	16	2088135	2740269	2906210	rs2091100543	NC_000016.10:2088134:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	May 27, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5156C>G (p.Ala1719Gly)	TSC2	A1475G, A1604G, A1616G, A1652G, A1653G, A1663G, A1675G, A1676G, A1696G, A1719G	Tuberous sclerosis 2	VCV001002845	16	2138136	16	2088135	1002845	996773	rs2091100543	NC_000016.10:2088134:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5157A>G (p.Ala1719=)	TSC2		Tuberous sclerosis 2	VCV002715086	16	2138137	16	2088136	2715086	2876085	rs1555440217	NC_000016.10:2088135:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5157A>C (p.Ala1719=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536048	16	2138137	16	2088136	536048	529798	rs1555440217	NC_000016.10:2088135:A:C	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5158A>C (p.Asn1720His)	TSC2	N1228H, N1497H, N1500H, N1634H, N1650H, N1653H, N1654H, N1676H, N1684H, N1696H, N1719H, N1249H, N1453H, N1496H, N1616H, N1649H, N1677H, N1683H, N1205H, N1206H, N1229H, N1476H, N1605H, N1617H, N1647H, N1660H, N1720H, N1119H, N1454H, N1520H, N1604H, N1648H, N1664H, N1694H, N1697H	Tuberous sclerosis 2	VCV002122959	16	2138138	16	2088137	2122959	2180853	rs1555440225	NC_000016.10:2088136:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5158A>G (p.Asn1720Asp)	TSC2	N1720D, N1677D, N1476D, N1653D, N1654D, N1676D, N1605D, N1617D, N1664D, N1697D	Tuberous sclerosis 2	VCV000468143	16	2138138	16	2088137	468143	466125	rs1555440225	NC_000016.10:2088136:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5159A>C (p.Asn1720Thr)	TSC2	N1720T, N1664T, N1617T, N1676T, N1697T, N1654T, N1476T, N1605T, N1653T, N1677T	not provided	VCV000207759	16	2138139	16	2088138	207759	203208	rs796053500	NC_000016.10:2088137:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2013	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160T>C (p.Asn1720=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000406075	16	2138140	16	2088139	406075	400974	rs137854883	NC_000016.10:2088138:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160T>A (p.Asn1720Lys)	TSC2	N1720K, N1476K, N1605K, N1677K, N1617K, N1676K, N1697K, N1653K, N1654K, N1664K	Tuberous sclerosis 2	VCV000049356	16	2138140	16	2088139	49356	58518	rs137854883	NC_000016.10:2088138:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+1G>T	TSC2		not provided|Hereditary cancer-predisposing syndrome	VCV000049427	16	2138141	16	2088140	49427	58589	rs45517399	NC_000016.10:2088139:G:T	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	May 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+1G>A	TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000049425	16	2138141	16	2088140	49425	58587	rs45517399	NC_000016.10:2088139:G:A	single nucleotide variant	splice donor variant	Pathogenic	Nov 7, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+2T>C	TSC2		Tuberous sclerosis 2|not provided	VCV000065234	16	2138142	16	2088141	65234	76166	rs397515170	NC_000016.10:2088140:T:C	single nucleotide variant	splice donor variant	Pathogenic	Dec 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+3G>T	TSC2		Tuberous sclerosis 2	VCV001476749	16	2138143	16	2088142	1476749	1416814	rs45517401	NC_000016.10:2088141:G:T	single nucleotide variant	intron variant	Pathogenic	Feb 17, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+3G>A	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000574640	16	2138143	16	2088142	574640	573891	rs45517401	NC_000016.10:2088141:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5160+3G>C	TSC2		Tuberous sclerosis 2|TSC2-related disorder	VCV000049938	16	2138143	16	2088142	49938	59100	rs45517401	NC_000016.10:2088141:G:C	single nucleotide variant	intron variant	Uncertain significance	Feb 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+4A>T	TSC2		Tuberous sclerosis 2	VCV003704471	16	2138144	16	2088143	3704471	3839220		NC_000016.10:2088142:A:T	single nucleotide variant	intron variant	Pathogenic	Jun 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+4A>C	TSC2		Lymphangiomyomatosis	VCV000373972	16	2138144	16	2088143	373972	360986	rs45517403	NC_000016.10:2088142:A:C	single nucleotide variant	intron variant	Pathogenic	Jan 1, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+5G>A	TSC2		Tuberous sclerosis 2	VCV000049429	16	2138145	16	2088144	49429	58591	rs45515392	NC_000016.10:2088143:G:A	single nucleotide variant	intron variant	Pathogenic	Jan 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+6T>G	TSC2		Tuberous sclerosis 2|not provided	VCV001331334	16	2138146	16	2088145	1331334	1322009	rs1567130441	NC_000016.10:2088144:T:G	single nucleotide variant	intron variant	Uncertain significance	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+6T>A	TSC2		Tuberous sclerosis 2	VCV000999054	16	2138146	16	2088145	999054	996774	rs1567130441	NC_000016.10:2088144:T:A	single nucleotide variant	intron variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+6T>C	TSC2		Tuberous sclerosis 2	VCV000582632	16	2138146	16	2088145	582632	569877	rs1567130441	NC_000016.10:2088144:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 13, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+7G>T	TSC2		Tuberous sclerosis 2	VCV001103864	16	2138147	16	2088146	1103864	1103685	rs45506600	NC_000016.10:2088145:G:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+7G>A	TSC2		Tuberous sclerosis 2	VCV000748667	16	2138147	16	2088146	748667	760431	rs45506600	NC_000016.10:2088145:G:A	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+7G>C	TSC2		not specified|Tuberous sclerosis 2	VCV000049355	16	2138147	16	2088146	49355	58517	rs45506600	NC_000016.10:2088145:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+8G>A	TSC2		Tuberous sclerosis 2	VCV002903773	16	2138148	16	2088147	2903773	3061520	rs2151624247	NC_000016.10:2088146:G:A	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+8G>C	TSC2		Tuberous sclerosis 2	VCV001082604	16	2138148	16	2088147	1082604	1081870	rs2151624247	NC_000016.10:2088146:G:C	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+9G>C	TSC2		Tuberous sclerosis 2	VCV002032064	16	2138149	16	2088148	2032064	2086124	rs1445593661	NC_000016.10:2088147:G:C	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+9G>T	TSC2		Tuberous sclerosis 2	VCV001150597	16	2138149	16	2088148	1150597	1145986	rs1445593661	NC_000016.10:2088147:G:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5160+10G>T	TSC2		Tuberous sclerosis 2	VCV003727735	16	2138150	16	2088149	3727735	3858358		NC_000016.10:2088148:G:T	single nucleotide variant	intron variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+11G>C	TSC2		Tuberous sclerosis 2	VCV001590965	16	2138151	16	2088150	1590965	1555443	rs374737278	NC_000016.10:2088149:G:C	single nucleotide variant	intron variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+11G>A	TSC2		Tuberous sclerosis 2	VCV001575172	16	2138151	16	2088150	1575172	1638457	rs374737278	NC_000016.10:2088149:G:A	single nucleotide variant	intron variant	Likely benign	Aug 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+12T>G	TSC2		Tuberous sclerosis 2	VCV002991454	16	2138152	16	2088151	2991454	3147887	rs2151624416	NC_000016.10:2088150:T:G	single nucleotide variant	intron variant	Likely benign	Jan 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+14G>C	TSC2		Tuberous sclerosis 2	VCV001650010	16	2138154	16	2088153	1650010	1536265	rs1225889890	NC_000016.10:2088152:G:C	single nucleotide variant	intron variant	Likely benign	Oct 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+14G>A	TSC2		Tuberous sclerosis 2	VCV001565117	16	2138154	16	2088153	1565117	1568071	rs1225889890	NC_000016.10:2088152:G:A	single nucleotide variant	intron variant	Likely benign	Aug 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+16T>C	TSC2		Tuberous sclerosis 2	VCV001604814	16	2138156	16	2088155	1604814	1623968	rs745343792	NC_000016.10:2088154:T:C	single nucleotide variant	intron variant	Likely benign	Aug 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+17C>A	TSC2		Tuberous sclerosis 2	VCV002177218	16	2138157	16	2088156	2177218	1898299	rs2151624592	NC_000016.10:2088155:C:A	single nucleotide variant	intron variant	Likely benign	Nov 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+17C>G	TSC2		Tuberous sclerosis 2	VCV001647482	16	2138157	16	2088156	1647482	1653905	rs2151624592	NC_000016.10:2088155:C:G	single nucleotide variant	intron variant	Likely benign	May 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+18C>T	TSC2		Tuberous sclerosis 2	VCV002957156	16	2138158	16	2088157	2957156	3125760	rs755447030	NC_000016.10:2088156:C:T	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+19A>G	TSC2		Tuberous sclerosis 2	VCV002414154	16	2138159	16	2088158	2414154	1936785	rs1231954434	NC_000016.10:2088157:A:G	single nucleotide variant	intron variant	Likely benign	May 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+20G>T	TSC2		Tuberous sclerosis 2	VCV002721597	16	2138160	16	2088159	2721597	2884686	rs779507492	NC_000016.10:2088158:G:T	single nucleotide variant	intron variant	Likely benign	Oct 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+20G>A	TSC2		Tuberous sclerosis 2	VCV001959577	16	2138160	16	2088159	1959577	2019711	rs779507492	NC_000016.10:2088158:G:A	single nucleotide variant	intron variant	Likely benign	Sep 3, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+23G>A	TSC2		not provided	VCV000065187	16	2138163	16	2088162	65187	76119	rs368565375	NC_000016.10:2088161:G:A	single nucleotide variant	intron variant	Likely benign	Apr 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5160+37C>T	TSC2		not provided	VCV000049937	16	2138177	16	2088176	49937	59099	rs45517400	NC_000016.10:2088175:C:T	single nucleotide variant	intron variant	Benign	Aug 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-22C>A	TSC2		not provided	VCV003054436	16	2138206	16	2088205	3054436	3220129	rs376267429	NC_000016.10:2088204:C:A	single nucleotide variant	intron variant	Likely benign	Apr 1, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-20C>G	TSC2		Tuberous sclerosis 2	VCV001565596	16	2138208	16	2088207	1565596	1590186	rs200315428	NC_000016.10:2088206:C:G	single nucleotide variant	intron variant	Likely benign	Aug 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-20C>T	TSC2		not provided|not specified|Tuberous sclerosis 2	VCV000516243	16	2138208	16	2088207	516243	505234	rs200315428	NC_000016.10:2088206:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-19C>A	TSC2		Tuberous sclerosis 2	VCV002050098	16	2138209	16	2088208	2050098	2104102	rs778290482	NC_000016.10:2088207:C:A	single nucleotide variant	intron variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-19C>T	TSC2		Tuberous sclerosis 2	VCV002040634	16	2138209	16	2088208	2040634	2098527	rs778290482	NC_000016.10:2088207:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-19C>G	TSC2		Tuberous sclerosis 2	VCV001577869	16	2138209	16	2088208	1577869	1522297	rs778290482	NC_000016.10:2088207:C:G	single nucleotide variant	intron variant	Likely benign	Jun 11, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-18C>G	TSC2		Tuberous sclerosis 2	VCV002829784	16	2138210	16	2088209	2829784	2990446	rs747362965	NC_000016.10:2088208:C:G	single nucleotide variant	intron variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-18C>T	TSC2		Tuberous sclerosis 2	VCV001629937	16	2138210	16	2088209	1629937	1596460	rs747362965	NC_000016.10:2088208:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-17C>G	TSC2		Tuberous sclerosis 2	VCV002806832	16	2138211	16	2088210	2806832	2967921	rs1256554136	NC_000016.10:2088209:C:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-17C>T	TSC2		Tuberous sclerosis 2	VCV001546035	16	2138211	16	2088210	1546035	1623102	rs1256554136	NC_000016.10:2088209:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-16C>T	TSC2		Tuberous sclerosis 2	VCV001613913	16	2138212	16	2088211	1613913	1536668	rs2151626858	NC_000016.10:2088210:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-15T>C	TSC2		Tuberous sclerosis 2	VCV000065370	16	2138213	16	2088212	65370	76304	rs397515279	NC_000016.10:2088211:T:C	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-14G>A	TSC2		Tuberous sclerosis 2	VCV002796601	16	2138214	16	2088213	2796601	2955139	rs2151626974	NC_000016.10:2088212:G:A	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-14G>T	TSC2		Tuberous sclerosis 2	VCV001579539	16	2138214	16	2088213	1579539	1533497	rs2151626974	NC_000016.10:2088212:G:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-13C>T	TSC2		Tuberous sclerosis 2	VCV001959397	16	2138215	16	2088214	1959397	2019531	rs45517405	NC_000016.10:2088213:C:T	single nucleotide variant	intron variant	Likely benign	Apr 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-12C>T	TSC2		Tuberous sclerosis 2	VCV001627115	16	2138216	16	2088215	1627115	1616140	rs1555440351	NC_000016.10:2088214:C:T	single nucleotide variant	intron variant	Likely benign	Sep 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-12C>G	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified	VCV000514506	16	2138216	16	2088215	514506	506184	rs1555440351	NC_000016.10:2088214:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5161-10A>G	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001089485	16	2138218	16	2088217	1089485	1081871	rs1800718	NC_000016.10:2088216:A:G	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-10A>C	PKD1|TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not specified|not provided|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type|Tuberous sclerosis 2	VCV000049431	16	2138218	16	2088217	49431	58593	rs1800718	NC_000016.10:2088216:A:C	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-9C>T	PKD1|TSC2		not specified|not provided|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type|Tuberous sclerosis 2	VCV000049854	16	2138219	16	2088218	49854	59016	rs45515893	NC_000016.10:2088217:C:T	single nucleotide variant	intron variant	Benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-9C>A	TSC2		Tuberous sclerosis 2	VCV000049853	16	2138219	16	2088218	49853	59015	rs45515893	NC_000016.10:2088217:C:A	single nucleotide variant	intron variant	Uncertain significance	Oct 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-8G>C	TSC2		Tuberous sclerosis 2	VCV001530580	16	2138220	16	2088219	1530580	1635052	rs374674097	NC_000016.10:2088218:G:C	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-8G>T	TSC2		Tuberous sclerosis 2	VCV001129231	16	2138220	16	2088219	1129231	1125101	rs374674097	NC_000016.10:2088218:G:T	single nucleotide variant	intron variant	Likely benign	Aug 31, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-8G>A	TSC2		not specified|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000378794	16	2138220	16	2088219	378794	374171	rs374674097	NC_000016.10:2088218:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-6C>G	TSC2		Tuberous sclerosis 2	VCV002026456	16	2138222	16	2088221	2026456	2088212	rs1475029652	NC_000016.10:2088220:C:G	single nucleotide variant	intron variant	Likely benign	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-6C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000696569	16	2138222	16	2088221	696569	685416	rs1475029652	NC_000016.10:2088220:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-5C>T	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825495	16	2138223	16	2088222	825495	815620	rs775534948	NC_000016.10:2088221:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5161-5C>G	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000825494	16	2138223	16	2088222	825494	815619	rs775534948	NC_000016.10:2088221:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 19, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5161-5C>A	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000576992	16	2138223	16	2088222	576992	569880	rs775534948	NC_000016.10:2088221:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5161-4C>A	TSC2		Tuberous sclerosis 2	VCV000795292	16	2138224	16	2088223	795292	787923	rs45517406	NC_000016.10:2088222:C:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161-4C>G	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049359	16	2138224	16	2088223	49359	58521	rs45517406	NC_000016.10:2088222:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-3C>T	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001051436	16	2138225	16	2088224	1051436	1049500	rs1410204953	NC_000016.10:2088223:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-2A>G	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000427999	16	2138226	16	2088225	427999	419879	rs1114167468	NC_000016.10:2088224:A:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	May 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-1G>C	TSC2		not provided|Tuberous sclerosis 2	VCV000049944	16	2138227	16	2088226	49944	59106	rs45517404	NC_000016.10:2088225:G:C	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-1G>A	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000049943	16	2138227	16	2088226	49943	59105	rs45517404	NC_000016.10:2088225:G:A	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5161-1G>T	TSC2		Tuberous sclerosis 2	VCV000049848	16	2138227	16	2088226	49848	59010	rs45517404	NC_000016.10:2088225:G:T	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic	Dec 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5161A>G (p.Met1721Val)	TSC2	M1721V, M1606V, M1655V, M1678V, M1618V, M1654V, M1665V, M1677V, M1698V, M1477V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000406062	16	2138228	16	2088227	406062	401020	rs45517407	NC_000016.10:2088226:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 25, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5163G>A (p.Met1721Ile)	TSC2	M1250I, M1455I, M1498I, M1521I, M1605I, M1649I, M1684I, M1720I, M1207I, M1229I, M1230I, M1477I, M1497I, M1635I, M1654I, M1454I, M1501I, M1618I, M1648I, M1651I, M1665I, M1677I, M1678I, M1698I, M1120I, M1206I, M1606I, M1617I, M1650I, M1655I, M1661I, M1685I, M1695I, M1697I, M1721I	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001745741	16	2138230	16	2088229	1745741	1799341	rs2544490838	NC_000016.10:2088228:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5164G>T (p.Ala1722Ser)	TSC2	A1478S, A1679S, A1619S, A1678S, A1655S, A1656S, A1666S, A1699S, A1722S, A1607S	Tuberous sclerosis 2	VCV000661115	16	2138231	16	2088230	661115	644360	rs397515270	NC_000016.10:2088229:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 24, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.5164G>A (p.Ala1722Thr)	TSC2	A1656T, A1666T, A1679T, A1699T, A1478T, A1655T, A1678T, A1607T, A1619T, A1722T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000652844	16	2138231	16	2088230	652844	644359	rs397515270	NC_000016.10:2088229:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5164G>C (p.Ala1722Pro)	TSC2	A1722P, A1655P, A1679P, A1478P, A1678P, A1619P, A1656P, A1699P, A1607P, A1666P	Tuberous sclerosis 2	VCV000065360	16	2138231	16	2088230	65360	76294	rs397515270	NC_000016.10:2088229:G:C	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Dec 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5165C>A (p.Ala1722Asp)	TSC2	A1478D, A1607D, A1619D, A1655D, A1656D, A1666D, A1678D, A1679D, A1699D, A1722D	Tuberous sclerosis 2	VCV001700570	16	2138232	16	2088231	1700570	1692963	rs1373235682	NC_000016.10:2088230:C:A	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5165C>T (p.Ala1722Val)	TSC2	A1722V, A1655V, A1678V, A1619V, A1607V, A1478V, A1656V, A1666V, A1679V, A1699V	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000578447	16	2138232	16	2088231	578447	573895	rs1373235682	NC_000016.10:2088230:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5166C>G (p.Ala1722=)	TSC2		Tuberous sclerosis 2	VCV004071144	16	2138233	16	2088232	4071144	4184992		NC_000016.10:2088231:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	Jun 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5166C>A (p.Ala1722=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001745749	16	2138233	16	2088232	1745749	1799349	rs2151627785	NC_000016.10:2088231:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Nov 2, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5167T>C (p.Ser1723Pro)	TSC2	S1723P, S1667P, S1680P, S1656P, S1657P, S1479P, S1608P, S1620P, S1679P, S1700P	not specified|Tuberous sclerosis 2	VCV000049949	16	2138234	16	2088233	49949	59111	rs45517408	NC_000016.10:2088232:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 4, 2022	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5168C>T (p.Ser1723Leu)	TSC2	S1209L, S1456L, S1457L, S1686L, S1697L, S1700L, S1723L, S1208L, S1608L, S1619L, S1650L, S1651L, S1656L, S1667L, S1679L, S1680L, S1231L, S1500L, S1503L, S1637L, S1699L, S1722L, S1122L, S1232L, S1252L, S1479L, S1499L, S1523L, S1607L, S1620L, S1652L, S1653L, S1657L, S1663L, S1687L	Hereditary cancer-predisposing syndrome	VCV002449978	16	2138235	16	2088234	2449978	2429603	rs1060499676	NC_000016.10:2088233:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5168C>G (p.Ser1723Ter)	TSC2	S1723*, S1479*, S1608*, S1667*, S1620*, S1679*, S1680*, S1656*, S1657*, S1700*	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000397548	16	2138235	16	2088234	397548	384442	rs1060499676	NC_000016.10:2088233:C:G	single nucleotide variant	nonsense|intron variant	Pathogenic/Likely pathogenic	Jul 6, 2021	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5169A>G (p.Ser1723=)	TSC2		Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001143681	16	2138236	16	2088235	1143681	1145987	rs1567131059	NC_000016.10:2088234:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5170C>A (p.Gln1724Lys)	TSC2	Q1658K, Q1681K, Q1724K, Q1621K, Q1701K, Q1657K, Q1668K, Q1680K, Q1480K, Q1609K	Tuberous sclerosis 2	VCV001436299	16	2138237	16	2088236	1436299	1497414	rs45472701	NC_000016.10:2088235:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 15, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5170C>G (p.Gln1724Glu)	TSC2	Q1609E, Q1701E, Q1724E, Q1480E, Q1621E, Q1658E, Q1668E, Q1657E, Q1680E, Q1681E	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001395605	16	2138237	16	2088236	1395605	1425004	rs45472701	NC_000016.10:2088235:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5170C>T (p.Gln1724Ter)	TSC2	Q1724*, Q1609*, Q1657*, Q1480*, Q1658*, Q1621*, Q1668*, Q1680*, Q1681*, Q1701*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000049950	16	2138237	16	2088236	49950	59112	rs45472701	NC_000016.10:2088235:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5171A>C (p.Gln1724Pro)	TSC2	Q1480P, Q1609P, Q1621P, Q1657P, Q1658P, Q1668P, Q1680P, Q1681P, Q1701P, Q1724P, Q1123P, Q1209P, Q1210P, Q1232P, Q1233P, Q1253P, Q1457P, Q1458P, Q1500P, Q1501P, Q1504P, Q1524P, Q1608P, Q1620P, Q1638P, Q1651P, Q1652P, Q1653P, Q1654P, Q1664P, Q1687P, Q1688P, Q1698P, Q1700P, Q1723P	not provided	VCV001686734	16	2138238	16	2088237	1686734	1678851	rs923367492	NC_000016.10:2088236:A:C	single nucleotide variant	missense variant|non-coding transcript variant|splice acceptor variant	Uncertain significance	May 19, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5171A>G (p.Gln1724Arg)	TSC2	Q1609R, Q1621R, Q1680R, Q1668R, Q1681R, Q1657R, Q1701R, Q1724R, Q1480R, Q1658R, Q1123R, Q1209R, Q1210R, Q1232R, Q1233R, Q1253R, Q1457R, Q1458R, Q1500R, Q1501R, Q1504R, Q1524R, Q1608R, Q1620R, Q1638R, Q1651R, Q1652R, Q1653R, Q1654R, Q1664R, Q1687R, Q1688R, Q1698R, Q1700R, Q1723R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000947691	16	2138238	16	2088237	947691	927690	rs923367492	NC_000016.10:2088236:A:G	single nucleotide variant	missense variant|non-coding transcript variant|splice acceptor variant	Uncertain significance	Mar 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5172G>A (p.Gln1724=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002449984	16	2138239	16	2088238	2449984	2425941	rs774044431	NC_000016.10:2088237:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|splice acceptor variant	Benign/Likely benign	May 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5172G>T (p.Gln1724His)	TSC2	Q1621H, Q1658H, Q1681H, Q1480H, Q1609H, Q1657H, Q1668H, Q1701H, Q1680H, Q1724H, Q1123H, Q1209H, Q1210H, Q1232H, Q1233H, Q1253H, Q1457H, Q1458H, Q1500H, Q1501H, Q1504H, Q1524H, Q1608H, Q1620H, Q1638H, Q1651H, Q1652H, Q1653H, Q1654H, Q1664H, Q1687H, Q1688H, Q1698H, Q1700H, Q1723H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000646530	16	2138239	16	2088238	646530	644361	rs774044431	NC_000016.10:2088237:G:T	single nucleotide variant	missense variant|non-coding transcript variant|splice acceptor variant	Uncertain significance	Jul 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5173G>A (p.Val1725Met)	TSC2	V1124M, V1210M, V1211M, V1233M, V1234M, V1254M, V1458M, V1459M, V1481M, V1501M, V1502M, V1505M, V1525M, V1609M, V1610M, V1621M, V1622M, V1639M, V1652M, V1653M, V1654M, V1655M, V1658M, V1659M, V1665M, V1669M, V1678M, V1681M, V1682M, V1688M, V1689M, V1699M, V1701M, V1702M, V1724M, V1725M	Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003070177	16	2138240	16	2088239	3070177	3231665	rs2151628159	NC_000016.10:2088238:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5173G>T (p.Val1725Leu)	TSC2	V1210L, V1234L, V1505L, V1525L, V1609L, V1610L, V1658L, V1659L, V1678L, V1689L, V1701L, V1724L, V1725L, V1254L, V1458L, V1459L, V1621L, V1639L, V1653L, V1682L, V1688L, V1699L, V1124L, V1211L, V1233L, V1481L, V1501L, V1502L, V1654L, V1655L, V1665L, V1669L, V1622L, V1652L, V1681L, V1702L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002121729	16	2138240	16	2088239	2121729	2176923	rs2151628159	NC_000016.10:2088238:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5174T>C (p.Val1725Ala)	TSC2	V1124A, V1210A, V1211A, V1233A, V1234A, V1254A, V1458A, V1459A, V1481A, V1501A, V1502A, V1505A, V1525A, V1609A, V1610A, V1621A, V1622A, V1639A, V1652A, V1653A, V1654A, V1655A, V1658A, V1659A, V1665A, V1669A, V1678A, V1681A, V1682A, V1688A, V1689A, V1699A, V1701A, V1702A, V1724A, V1725A	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV002679326	16	2138241	16	2088240	2679326	2836903	rs2151628234	NC_000016.10:2088239:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5175G>A (p.Val1725=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000256632	16	2138242	16	2088241	256632	255500	rs886038357	NC_000016.10:2088240:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5176C>G (p.His1726Asp)	TSC2	H1703D, H1726D, H1482D, H1611D, H1623D, H1659D, H1660D, H1670D, H1679D, H1682D, H1683D	Tuberous sclerosis 2	VCV001007270	16	2138243	16	2088242	1007270	996775	rs761618860	NC_000016.10:2088241:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5176C>T (p.His1726Tyr)	TSC2	H1726Y, H1660Y, H1683Y, H1670Y, H1679Y, H1682Y, H1703Y, H1482Y, H1659Y, H1611Y, H1623Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535931	16	2138243	16	2088242	535931	529736	rs761618860	NC_000016.10:2088241:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 19, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5177A>T (p.His1726Leu)	TSC2	H1125L, H1211L, H1212L, H1234L, H1235L, H1255L, H1459L, H1460L, H1482L, H1502L, H1503L, H1506L, H1526L, H1610L, H1611L, H1622L, H1623L, H1640L, H1653L, H1654L, H1655L, H1656L, H1659L, H1660L, H1666L, H1670L, H1679L, H1682L, H1683L, H1689L, H1690L, H1700L, H1702L, H1703L, H1725L, H1726L	not provided	VCV002505031	16	2138244	16	2088243	2505031	2669998	rs1555440475	NC_000016.10:2088242:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5177A>C (p.His1726Pro)	TSC2	H1726P, H1611P, H1623P, H1659P, H1660P, H1670P, H1682P, H1683P, H1703P, H1482P, H1679P	Tuberous sclerosis 2|TSC2-related disorder|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II	VCV000468144	16	2138244	16	2088243	468144	466057	rs1555440475	NC_000016.10:2088242:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5180A>T (p.His1727Leu)	TSC2	H1483L, H1612L, H1624L, H1660L, H1661L, H1671L, H1680L, H1683L, H1684L, H1704L, H1727L	Tuberous sclerosis 2	VCV001056977	16	2138247	16	2088246	1056977	1049501	rs1596460080	NC_000016.10:2088245:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5180A>G (p.His1727Arg)	TSC2	H1483R, H1612R, H1683R, H1684R, H1624R, H1660R, H1661R, H1671R, H1680R, H1704R, H1727R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000659658	16	2138247	16	2088246	659658	644362	rs1596460080	NC_000016.10:2088245:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5181T>C (p.His1727=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001594587	16	2138248	16	2088247	1594587	1621711	rs767191593	NC_000016.10:2088246:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5183G>T (p.Ser1728Ile)	TSC2	S1484I, S1613I, S1625I, S1662I, S1685I, S1705I, S1728I, S1661I, S1672I, S1681I, S1684I	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000935997	16	2138250	16	2088249	935997	937350	rs1596460117	NC_000016.10:2088248:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5183G>A (p.Ser1728Asn)	TSC2	S1625N, S1672N, S1681N, S1685N, S1613N, S1661N, S1728N, S1484N, S1705N, S1662N, S1684N	Tuberous sclerosis 2	VCV000663492	16	2138250	16	2088249	663492	644363	rs1596460117	NC_000016.10:2088248:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5184C>G (p.Ser1728Arg)	TSC2	S1681R, S1705R, S1484R, S1625R, S1662R, S1613R, S1672R, S1684R, S1728R, S1661R, S1685R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001477932	16	2138251	16	2088250	1477932	1436810	rs397514955	NC_000016.10:2088249:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5184C>T (p.Ser1728=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000064939	16	2138251	16	2088250	64939	75869	rs397514955	NC_000016.10:2088249:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5185C>G (p.Arg1729Gly)	TSC2	R1614G, R1662G, R1682G, R1706G, R1729G, R1626G, R1673G, R1685G, R1485G, R1686G, R1663G	Tuberous sclerosis 2	VCV000961310	16	2138252	16	2088251	961310	949295	rs45517409	NC_000016.10:2088250:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5185C>T (p.Arg1729Cys)	TSC2	R1729C, R1626C, R1673C, R1614C, R1685C, R1686C, R1682C, R1485C, R1662C, R1663C, R1706C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000049867	16	2138252	16	2088251	49867	59029	rs45517409	NC_000016.10:2088250:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5186G>A (p.Arg1729His)	TSC2	R1729H, R1485H, R1663H, R1673H, R1685H, R1614H, R1662H, R1706H, R1626H, R1682H, R1686H	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207786	16	2138253	16	2088252	207786	203209	rs760395277	NC_000016.10:2088251:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5187C>T (p.Arg1729=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001634979	16	2138254	16	2088253	1634979	1610705	rs2091133958	NC_000016.10:2088252:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5187C>G (p.Arg1729=)	TSC2		Tuberous sclerosis 2	VCV001081424	16	2138254	16	2088253	1081424	1081872	rs2091133958	NC_000016.10:2088252:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5188T>C (p.Ser1730Pro)	TSC2	S1615P, S1663P, S1674P, S1664P, S1683P, S1707P, S1730P, S1486P, S1627P, S1686P, S1687P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001499281	16	2138255	16	2088254	1499281	1388984	rs2151628975	NC_000016.10:2088253:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5189C>T (p.Ser1730Phe)	TSC2	S1239F, S1463F, S1506F, S1510F, S1530F, S1615F, S1663F, S1664F, S1686F, S1687F, S1729F, S1215F, S1238F, S1259F, S1486F, S1657F, S1693F, S1730F, S1216F, S1464F, S1614F, S1626F, S1627F, S1658F, S1129F, S1507F, S1644F, S1659F, S1660F, S1670F, S1674F, S1683F, S1694F, S1704F, S1706F, S1707F	Tuberous sclerosis 2	VCV002115345	16	2138256	16	2088255	2115345	2161581	rs2091134565	NC_000016.10:2088254:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5189C>G (p.Ser1730Cys)	TSC2	S1486C, S1674C, S1683C, S1627C, S1663C, S1730C, S1615C, S1664C, S1686C, S1687C, S1707C	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000959546	16	2138256	16	2088255	959546	949296	rs2091134565	NC_000016.10:2088254:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5190C>T (p.Ser1730=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825527	16	2138257	16	2088256	825527	812626	rs1305025066	NC_000016.10:2088255:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5190C>A (p.Ser1730=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000536041	16	2138257	16	2088256	536041	530065	rs1305025066	NC_000016.10:2088255:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5191A>C (p.Asn1731His)	TSC2	N1628H, N1675H, N1687H, N1688H, N1665H, N1487H, N1684H, N1708H, N1616H, N1664H, N1731H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000968885	16	2138258	16	2088257	968885	957692	rs1555440500	NC_000016.10:2088256:A:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5191A>G (p.Asn1731Asp)	TSC2	N1731D, N1487D, N1616D, N1665D, N1688D, N1628D, N1675D, N1664D, N1708D, N1684D, N1687D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000449584	16	2138258	16	2088257	449584	445528	rs1555440500	NC_000016.10:2088256:A:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5192A>G (p.Asn1731Ser)	TSC2	N1487S, N1616S, N1628S, N1664S, N1665S, N1675S, N1684S, N1687S, N1688S, N1708S, N1731S	Tuberous sclerosis 2	VCV001025177	16	2138259	16	2088258	1025177	1012012	rs766040643	NC_000016.10:2088257:A:G	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5193C>T (p.Asn1731=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825528	16	2138260	16	2088259	825528	812627	rs753336580	NC_000016.10:2088258:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5193C>A (p.Asn1731Lys)	TSC2	N1731K, N1664K, N1665K, N1684K, N1628K, N1688K, N1616K, N1675K, N1708K, N1487K, N1687K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468145	16	2138260	16	2088259	468145	465413	rs753336580	NC_000016.10:2088258:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5194C>T (p.Pro1732Ser)	TSC2	P1131S, P1217S, P1218S, P1240S, P1241S, P1261S, P1465S, P1466S, P1488S, P1508S, P1509S, P1512S, P1532S, P1616S, P1617S, P1628S, P1629S, P1646S, P1659S, P1660S, P1661S, P1662S, P1665S, P1666S, P1672S, P1676S, P1685S, P1688S, P1689S, P1695S, P1696S, P1706S, P1708S, P1709S, P1731S, P1732S	Hereditary cancer-predisposing syndrome	VCV003232186	16	2138261	16	2088260	3232186	3391987	rs759007975	NC_000016.10:2088259:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5194C>A (p.Pro1732Thr)	TSC2	P1488T, P1665T, P1685T, P1688T, P1617T, P1666T, P1709T, P1629T, P1676T, P1689T, P1732T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001385363	16	2138261	16	2088260	1385363	1368108	rs759007975	NC_000016.10:2088259:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5194C>G (p.Pro1732Ala)	TSC2	P1732A, P1676A, P1629A, P1665A, P1688A, P1617A, P1709A, P1488A, P1666A, P1685A, P1689A	Tuberous sclerosis 2|Hyperextensibility at elbow|Cafe-au-lait spot|Hyperextensible hand joints|Joint hypermobility|Arthralgia|Tall stature|Hereditary cancer-predisposing syndrome	VCV000575511	16	2138261	16	2088260	575511	570147	rs759007975	NC_000016.10:2088259:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5195C>T (p.Pro1732Leu)	TSC2	P1217L, P1218L, P1241L, P1261L, P1508L, P1509L, P1512L, P1629L, P1662L, P1672L, P1685L, P1689L, P1708L, P1488L, P1617L, P1646L, P1660L, P1661L, P1696L, P1706L, P1731L, P1131L, P1628L, P1665L, P1695L, P1732L, P1240L, P1465L, P1466L, P1532L, P1616L, P1659L, P1666L, P1676L, P1688L, P1709L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV001745939	16	2138262	16	2088261	1745939	1799536	rs1446388626	NC_000016.10:2088260:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5195C>G (p.Pro1732Arg)	TSC2	P1732R, P1629R, P1676R, P1685R, P1617R, P1665R, P1688R, P1689R, P1488R, P1666R, P1709R	Tuberous sclerosis 2	VCV000535850	16	2138262	16	2088261	535850	529740	rs1446388626	NC_000016.10:2088260:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5196C>G (p.Pro1732=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003329519	16	2138263	16	2088262	3329519	3489111		NC_000016.10:2088261:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5196C>T (p.Pro1732=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000486603	16	2138263	16	2088262	486603	477522	rs910514279	NC_000016.10:2088261:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5197A>C (p.Thr1733Pro)	TSC2	T1489P, T1630P, T1666P, T1667P, T1686P, T1689P, T1618P, T1690P, T1677P, T1710P, T1733P	not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000951296	16	2138264	16	2088263	951296	927691	rs1596460327	NC_000016.10:2088262:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5197A>G (p.Thr1733Ala)	TSC2	T1690A, T1710A, T1489A, T1618A, T1666A, T1677A, T1686A, T1733A, T1630A, T1667A, T1689A	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not provided	VCV000651314	16	2138264	16	2088263	651314	644364	rs1596460327	NC_000016.10:2088262:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5198C>G (p.Thr1733Ser)	TSC2	T1219S, T1489S, T1617S, T1629S, T1661S, T1666S, T1673S, T1710S, T1733S, T1218S, T1509S, T1510S, T1533S, T1618S, T1647S, T1677S, T1689S, T1696S, T1732S, T1132S, T1262S, T1513S, T1660S, T1662S, T1686S, T1690S, T1707S, T1241S, T1242S, T1466S, T1467S, T1630S, T1663S, T1667S, T1697S, T1709S	Tuberous sclerosis 2	VCV003637261	16	2138265	16	2088264	3637261	3771415		NC_000016.10:2088263:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Jul 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5198C>A (p.Thr1733Asn)	TSC2	T1219N, T1510N, T1618N, T1667N, T1689N, T1709N, T1732N, T1733N, T1132N, T1218N, T1489N, T1509N, T1513N, T1533N, T1661N, T1686N, T1696N, T1707N, T1262N, T1630N, T1660N, T1662N, T1663N, T1666N, T1673N, T1677N, T1697N, T1710N, T1241N, T1242N, T1466N, T1467N, T1617N, T1629N, T1647N, T1690N	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578807	16	2138265	16	2088264	3578807	3708227		NC_000016.10:2088263:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5199C>G (p.Thr1733=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001992719	16	2138266	16	2088265	1992719	2059240	rs778378296	NC_000016.10:2088264:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5199C>A (p.Thr1733=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406084	16	2138266	16	2088265	406084	401037	rs778378296	NC_000016.10:2088264:C:A	single nucleotide variant	synonymous variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5199C>T (p.Thr1733=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000256633	16	2138266	16	2088265	256633	255501	rs778378296	NC_000016.10:2088264:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5200G>A (p.Asp1734Asn)	TSC2	D1734N, D1619N, D1668N, D1678N, D1687N, D1690N, D1490N, D1667N, D1691N, D1711N, D1631N	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536037	16	2138267	16	2088266	536037	530069	rs751990617	NC_000016.10:2088265:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5201A>C (p.Asp1734Ala)	TSC2	D1734A, D1668A, D1687A, D1711A, D1667A, D1678A, D1490A, D1690A, D1691A, D1619A, D1631A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000468146	16	2138268	16	2088267	468146	465417	rs878854117	NC_000016.10:2088266:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5201A>G (p.Asp1734Gly)	TSC2	D1734G, D1619G, D1668G, D1711G, D1631G, D1678G, D1690G, D1691G, D1490G, D1667G, D1687G	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405986	16	2138268	16	2088267	405986	400975	rs878854117	NC_000016.10:2088266:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5201A>T (p.Asp1734Val)	TSC2	D1734V, D1668V, D1678V, D1711V, D1490V, D1631V, D1667V, D1691V, D1690V, D1619V, D1687V	Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000238077	16	2138268	16	2088267	238077	242335	rs878854117	NC_000016.10:2088266:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5202T>G (p.Asp1734Glu)	TSC2	D1133E, D1219E, D1220E, D1242E, D1243E, D1263E, D1467E, D1468E, D1490E, D1510E, D1511E, D1514E, D1534E, D1618E, D1619E, D1630E, D1631E, D1648E, D1661E, D1662E, D1663E, D1664E, D1667E, D1668E, D1674E, D1678E, D1687E, D1690E, D1691E, D1697E, D1698E, D1708E, D1710E, D1711E, D1733E, D1734E	Intellectual disability	VCV004072100	16	2138269	16	2088268	4072100	4185972		NC_000016.10:2088267:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 20, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5202T>C (p.Asp1734=)	PKD1|TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Polycystic kidney disease, adult type|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000049895	16	2138269	16	2088268	49895	59057	rs1748	NC_000016.10:2088267:T:C	single nucleotide variant	synonymous variant	Benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5203A>G (p.Ile1735Val)	TSC2	I1735V, I1692V, I1620V, I1688V, I1691V, I1632V, I1491V, I1668V, I1669V, I1679V, I1712V	TSC2-related disorder|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified	VCV000468147	16	2138270	16	2088269	468147	466059	rs781407050	NC_000016.10:2088268:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5204T>C (p.Ile1735Thr)	TSC2	I1491T, I1668T, I1735T, I1620T, I1669T, I1691T, I1712T, I1632T, I1679T, I1688T, I1692T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000661952	16	2138271	16	2088270	661952	644365	rs786203769	NC_000016.10:2088269:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5204T>G (p.Ile1735Ser)	TSC2	I1735S, I1491S, I1620S, I1669S, I1688S, I1691S, I1692S, I1679S, I1632S, I1668S, I1712S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided	VCV000187484	16	2138271	16	2088270	187484	184146	rs786203769	NC_000016.10:2088269:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5205C>T (p.Ile1735=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000486672	16	2138272	16	2088271	486672	477999	rs1308899138	NC_000016.10:2088270:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5207A>G (p.Tyr1736Cys)	TSC2	Y1135C, Y1221C, Y1222C, Y1244C, Y1245C, Y1265C, Y1469C, Y1470C, Y1492C, Y1512C, Y1513C, Y1516C, Y1536C, Y1620C, Y1621C, Y1632C, Y1633C, Y1650C, Y1663C, Y1664C, Y1665C, Y1666C, Y1669C, Y1670C, Y1676C, Y1680C, Y1689C, Y1692C, Y1693C, Y1699C, Y1700C, Y1710C, Y1712C, Y1713C, Y1735C, Y1736C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002416226	16	2138274	16	2088273	2416226	1947445	rs746160626	NC_000016.10:2088272:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 4, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5207A>C (p.Tyr1736Ser)	TSC2	Y1633S, Y1669S, Y1693S, Y1492S, Y1680S, Y1621S, Y1736S, Y1670S, Y1689S, Y1692S, Y1713S	Tuberous sclerosis 2	VCV001427563	16	2138274	16	2088273	1427563	1441097	rs746160626	NC_000016.10:2088272:A:C	single nucleotide variant	missense variant	Likely benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5208C>T (p.Tyr1736=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000536053	16	2138275	16	2088274	536053	530297	rs45517410	NC_000016.10:2088273:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5208C>A (p.Tyr1736Ter)	TSC2	Y1736*, Y1492*, Y1689*, Y1669*, Y1692*, Y1693*, Y1713*, Y1621*, Y1633*, Y1670*, Y1680*	Tuberous sclerosis 2	VCV000049453	16	2138275	16	2088274	49453	58615	rs45517410	NC_000016.10:2088273:C:A	single nucleotide variant	nonsense	Pathogenic	Oct 1, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5209C>G (p.Pro1737Ala)	TSC2	P1634A, P1694A, P1493A, P1690A, P1714A, P1737A, P1622A, P1670A, P1671A, P1681A, P1693A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825547	16	2138276	16	2088275	825547	812629	rs780112037	NC_000016.10:2088274:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5209C>T (p.Pro1737Ser)	TSC2	P1737S, P1622S, P1671S, P1681S, P1693S, P1714S, P1493S, P1634S, P1690S, P1694S, P1670S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000238078	16	2138276	16	2088275	238078	242336	rs780112037	NC_000016.10:2088274:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5210C>T (p.Pro1737Leu)	TSC2	P1737L, P1493L, P1634L, P1693L, P1694L, P1671L, P1681L, P1690L, P1714L, P1622L, P1670L	Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000406050	16	2138277	16	2088276	406050	401709	rs749326176	NC_000016.10:2088275:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5211C>A (p.Pro1737=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000757071	16	2138278	16	2088277	757071	770750	rs151298910	NC_000016.10:2088276:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5211C>T (p.Pro1737=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468148	16	2138278	16	2088277	468148	466126	rs151298910	NC_000016.10:2088276:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5213C>T (p.Ser1738Phe)	TSC2	S1224F, S1538F, S1622F, S1652F, S1667F, S1691F, S1701F, S1712F, S1137F, S1246F, S1267F, S1623F, S1714F, S1738F, S1223F, S1247F, S1471F, S1472F, S1518F, S1671F, S1672F, S1702F, S1715F, S1494F, S1514F, S1515F, S1634F, S1635F, S1665F, S1666F, S1668F, S1678F, S1682F, S1694F, S1695F, S1737F	Tuberous sclerosis 2	VCV003637262	16	2138280	16	2088279	3637262	3771416		NC_000016.10:2088278:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5213C>G (p.Ser1738Cys)	TSC2	S1694C, S1738C, S1494C, S1623C, S1671C, S1672C, S1682C, S1691C, S1635C, S1695C, S1715C	Tuberous sclerosis 2	VCV001469824	16	2138280	16	2088279	1469824	1375667	rs2151630518	NC_000016.10:2088278:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5214C>A (p.Ser1738=)	TSC2		Tuberous sclerosis 2	VCV001633451	16	2138281	16	2088280	1633451	1598376	rs761621735	NC_000016.10:2088279:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5214C>G (p.Ser1738=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000793723	16	2138281	16	2088280	793723	785210	rs761621735	NC_000016.10:2088279:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5214C>T (p.Ser1738=)	TSC2		Tuberous sclerosis 2	VCV000413732	16	2138281	16	2088280	413732	401711	rs761621735	NC_000016.10:2088279:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5215A>G (p.Lys1739Glu)	TSC2	K1224E, K1247E, K1268E, K1495E, K1519E, K1635E, K1666E, K1667E, K1668E, K1683E, K1716E, K1138E, K1248E, K1472E, K1516E, K1623E, K1636E, K1673E, K1679E, K1695E, K1473E, K1515E, K1624E, K1653E, K1703E, K1715E, K1738E, K1225E, K1539E, K1669E, K1672E, K1692E, K1696E, K1702E, K1713E, K1739E	Tuberous sclerosis 2	VCV002822987	16	2138282	16	2088281	2822987	2988775	rs2151630676	NC_000016.10:2088280:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 21, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5216A>C (p.Lys1739Thr)	TSC2	K1495T, K1624T, K1636T, K1672T, K1673T, K1683T, K1692T, K1695T, K1696T, K1716T, K1739T	Tuberous sclerosis 2	VCV001058272	16	2138283	16	2088282	1058272	1049502	rs2151630716	NC_000016.10:2088281:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5217G>A (p.Lys1739=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000669066	16	2138284	16	2088283	669066	656347	rs1596460659	NC_000016.10:2088282:G:A	single nucleotide variant	synonymous variant	Likely benign	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5218T>A (p.Trp1740Arg)	TSC2	W1249R, W1269R, W1474R, W1624R, W1637R, W1654R, W1668R, W1674R, W1684R, W1714R, W1717R, W1740R, W1496R, W1516R, W1520R, W1540R, W1625R, W1673R, W1697R, W1703R, W1704R, W1226R, W1248R, W1473R, W1517R, W1636R, W1667R, W1693R, W1696R, W1139R, W1225R, W1669R, W1670R, W1680R, W1716R, W1739R	Tuberous sclerosis 2	VCV003637263	16	2138285	16	2088284	3637263	3771417		NC_000016.10:2088283:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5219G>C (p.Trp1740Ser)	TSC2	W1693S, W1740S, W1674S, W1684S, W1696S, W1637S, W1697S, W1496S, W1625S, W1673S, W1717S	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000825558	16	2138286	16	2088285	825558	812630	rs137854219	NC_000016.10:2088284:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5219G>A (p.Trp1740Ter)	TSC2	W1740*, W1684*, W1717*, W1674*, W1496*, W1673*, W1696*, W1625*, W1637*, W1693*, W1697*	not provided|Tuberous sclerosis 2	VCV000049362	16	2138286	16	2088285	49362	58524	rs137854219	NC_000016.10:2088284:G:A	single nucleotide variant	nonsense	Pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5220G>T (p.Trp1740Cys)	TSC2	W1740C, W1496C, W1673C, W1717C, W1625C, W1674C, W1684C, W1696C, W1637C, W1693C, W1697C	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000486653	16	2138287	16	2088286	486653	478001	rs45517411	NC_000016.10:2088285:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5220G>A (p.Trp1740Ter)	TSC2	W1740*, W1684*, W1693*, W1717*, W1625*, W1637*, W1697*, W1496*, W1673*, W1696*, W1674*	Tuberous sclerosis 2|not provided	VCV000049363	16	2138287	16	2088286	49363	58525	rs45517411	NC_000016.10:2088285:G:A	single nucleotide variant	nonsense	Pathogenic	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5221A>T (p.Ile1741Phe)	TSC2	I1226F, I1475F, I1518F, I1541F, I1626F, I1655F, I1669F, I1670F, I1674F, I1675F, I1681F, I1697F, I1718F, I1740F, I1227F, I1249F, I1625F, I1671F, I1250F, I1270F, I1474F, I1497F, I1638F, I1685F, I1705F, I1717F, I1741F, I1140F, I1517F, I1521F, I1637F, I1668F, I1694F, I1698F, I1704F, I1715F	Hereditary cancer-predisposing syndrome	VCV002564708	16	2138288	16	2088287	2564708	2733864	rs140526185	NC_000016.10:2088286:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5221A>G (p.Ile1741Val)	TSC2	I1741V, I1675V, I1697V, I1698V, I1638V, I1718V, I1674V, I1497V, I1626V, I1685V, I1694V	Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000406082	16	2138288	16	2088287	406082	400977	rs140526185	NC_000016.10:2088286:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5222T>C (p.Ile1741Thr)	TSC2	I1741T, I1674T, I1675T, I1697T, I1698T, I1497T, I1718T, I1626T, I1685T, I1694T, I1638T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000574623	16	2138289	16	2088288	574623	567913	rs935521633	NC_000016.10:2088287:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5224G>C (p.Ala1742Pro)	TSC2	A1227P, A1251P, A1271P, A1498P, A1518P, A1522P, A1627P, A1638P, A1670P, A1706P, A1741P, A1141P, A1475P, A1519P, A1542P, A1669P, A1695P, A1718P, A1719P, A1742P, A1250P, A1626P, A1639P, A1656P, A1671P, A1672P, A1675P, A1686P, A1699P, A1705P, A1228P, A1476P, A1676P, A1682P, A1698P, A1716P	Hereditary cancer-predisposing syndrome	VCV003462676	16	2138291	16	2088290	3462676	3621695		NC_000016.10:2088289:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5225C>G (p.Ala1742Gly)	TSC2	A1228G, A1518G, A1519G, A1542G, A1670G, A1682G, A1695G, A1698G, A1699G, A1705G, A1227G, A1250G, A1251G, A1476G, A1638G, A1676G, A1686G, A1141G, A1271G, A1475G, A1498G, A1656G, A1669G, A1672G, A1675G, A1706G, A1716G, A1718G, A1719G, A1522G, A1626G, A1627G, A1639G, A1671G, A1741G, A1742G	Tuberous sclerosis 2	VCV002847716	16	2138292	16	2088291	2847716	3008788	rs1369101862	NC_000016.10:2088290:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5225C>T (p.Ala1742Val)	TSC2	A1498V, A1698V, A1719V, A1742V, A1675V, A1695V, A1627V, A1686V, A1639V, A1676V, A1699V	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001503018	16	2138292	16	2088291	1503018	1404611	rs1369101862	NC_000016.10:2088290:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5226C>T (p.Ala1742=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002564644	16	2138293	16	2088292	2564644	2733800	rs2091144761	NC_000016.10:2088291:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5226C>G (p.Ala1742=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001746177	16	2138293	16	2088292	1746177	1809666	rs2091144761	NC_000016.10:2088291:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5227C>G (p.Arg1743Gly)	TSC2	R1743G, R1677G, R1687G, R1699G, R1700G, R1720G, R1499G, R1628G, R1640G, R1676G, R1696G	Tuberous sclerosis 2	VCV000049834	16	2138294	16	2088293	49834	58996	rs45517412	NC_000016.10:2088292:C:G	single nucleotide variant	missense variant	Likely pathogenic	Jul 10, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5227C>T (p.Arg1743Trp)	TSC2	R1743W, R1499W, R1696W, R1640W, R1677W, R1720W, R1628W, R1676W, R1699W, R1687W, R1700W	not provided|TSC2-related disorder|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000049471	16	2138294	16	2088293	49471	58633	rs45517412	NC_000016.10:2088292:C:T	single nucleotide variant	missense variant	Pathogenic	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5228G>T (p.Arg1743Leu)	TSC2	R1743L, R1499L, R1640L, R1676L, R1720L, R1677L, R1687L, R1699L, R1628L, R1696L, R1700L	Tuberous sclerosis 2	VCV000065291	16	2138295	16	2088294	65291	76223	rs45507199	NC_000016.10:2088293:G:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 25, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5228G>C (p.Arg1743Pro)	TSC2	R1743P, R1640P, R1699P, R1720P, R1499P, R1628P, R1677P, R1687P, R1700P, R1676P, R1696P	Tuberous sclerosis 2	VCV000049961	16	2138295	16	2088294	49961	59123	rs45507199	NC_000016.10:2088293:G:C	single nucleotide variant	missense variant	Pathogenic	Nov 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5228G>A (p.Arg1743Gln)	TSC2	R1743Q, R1687Q, R1700Q, R1696Q, R1699Q, R1677Q, R1720Q, R1499Q, R1628Q, R1640Q, R1676Q	Tuberous sclerosis 2|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000049960	16	2138295	16	2088294	49960	59122	rs45507199	NC_000016.10:2088293:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5229G>A (p.Arg1743=)	TSC2		Tuberous sclerosis syndrome	VCV003386186	16	2138296	16	2088295	3386186	3545327		NC_000016.10:2088294:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5230C>A (p.Leu1744Ile)	TSC2	L1229I, L1252I, L1253I, L1500I, L1520I, L1641I, L1678I, L1230I, L1273I, L1521I, L1628I, L1640I, L1673I, L1684I, L1688I, L1697I, L1700I, L1701I, L1707I, L1708I, L1720I, L1743I, L1744I, L1143I, L1524I, L1544I, L1629I, L1672I, L1721I, L1477I, L1478I, L1658I, L1671I, L1674I, L1677I, L1718I	Hereditary cancer-predisposing syndrome	VCV003462538	16	2138297	16	2088296	3462538	3621558		NC_000016.10:2088295:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 26, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5230C>G (p.Leu1744Val)	TSC2	L1143V, L1229V, L1230V, L1252V, L1253V, L1273V, L1477V, L1478V, L1500V, L1520V, L1521V, L1524V, L1544V, L1628V, L1629V, L1640V, L1641V, L1658V, L1671V, L1672V, L1673V, L1674V, L1677V, L1678V, L1684V, L1688V, L1697V, L1700V, L1701V, L1707V, L1708V, L1718V, L1720V, L1721V, L1743V, L1744V	Tuberous sclerosis 2	VCV001721813	16	2138297	16	2088296	1721813	1779531	rs1567132207	NC_000016.10:2088295:C:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5230C>T (p.Leu1744Phe)	TSC2	L1744F, L1629F, L1721F, L1500F, L1701F, L1641F, L1688F, L1697F, L1677F, L1678F, L1700F	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000592015	16	2138297	16	2088296	592015	583004	rs1567132207	NC_000016.10:2088295:C:T	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5231T>C (p.Leu1744Pro)	TSC2	L1744P, L1677P, L1678P, L1701P, L1641P, L1721P, L1500P, L1629P, L1688P, L1700P, L1697P	not provided	VCV000049962	16	2138298	16	2088297	49962	59124	rs45517413	NC_000016.10:2088296:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jul 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5232C>A (p.Leu1744=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003811347	16	2138299	16	2088298	3811347	3928588		NC_000016.10:2088297:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5232C>G (p.Leu1744=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001967757	16	2138299	16	2088298	1967757	2021856	rs772865175	NC_000016.10:2088297:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5232C>T (p.Leu1744=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000468150	16	2138299	16	2088298	468150	466130	rs772865175	NC_000016.10:2088297:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5233C>T (p.Arg1745Cys)	TSC2	R1745C, R1501C, R1630C, R1678C, R1689C, R1701C, R1702C, R1722C, R1642C, R1679C, R1698C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not provided	VCV000405943	16	2138300	16	2088299	405943	400979	rs760413281	NC_000016.10:2088298:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 25, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5234G>T (p.Arg1745Leu)	TSC2	R1678L, R1722L, R1630L, R1642L, R1679L, R1698L, R1701L, R1501L, R1689L, R1702L, R1745L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000837725	16	2138301	16	2088300	837725	843540	rs766093661	NC_000016.10:2088299:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5234G>A (p.Arg1745His)	TSC2	R1745H, R1642H, R1630H, R1679H, R1698H, R1701H, R1722H, R1501H, R1678H, R1689H, R1702H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV000372688	16	2138301	16	2088300	372688	360264	rs766093661	NC_000016.10:2088299:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5236C>T (p.His1746Tyr)	TSC2	H1145Y, H1231Y, H1232Y, H1254Y, H1255Y, H1275Y, H1479Y, H1480Y, H1502Y, H1522Y, H1523Y, H1526Y, H1546Y, H1630Y, H1631Y, H1642Y, H1643Y, H1660Y, H1673Y, H1674Y, H1675Y, H1676Y, H1679Y, H1680Y, H1686Y, H1690Y, H1699Y, H1702Y, H1703Y, H1709Y, H1710Y, H1720Y, H1722Y, H1723Y, H1745Y, H1746Y	Hereditary cancer-predisposing syndrome	VCV003232189	16	2138303	16	2088302	3232189	3391990	rs2151631784	NC_000016.10:2088301:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5237A>T (p.His1746Leu)	TSC2	H1231L, H1232L, H1255L, H1523L, H1630L, H1676L, H1709L, H1710L, H1746L, H1254L, H1479L, H1480L, H1522L, H1631L, H1679L, H1680L, H1686L, H1702L, H1745L, H1145L, H1502L, H1642L, H1660L, H1674L, H1675L, H1703L, H1275L, H1526L, H1546L, H1643L, H1673L, H1690L, H1699L, H1720L, H1722L, H1723L	Tuberous sclerosis 2	VCV003637264	16	2138304	16	2088303	3637264	3771418		NC_000016.10:2088302:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5237A>C (p.His1746Pro)	TSC2	H1679P, H1703P, H1680P, H1723P, H1643P, H1690P, H1702P, H1746P, H1502P, H1631P, H1699P	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001473495	16	2138304	16	2088303	1473495	1391374	rs2151631825	NC_000016.10:2088302:A:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5237A>G (p.His1746Arg)	TSC2	H1631R, H1680R, H1690R, H1699R, H1746R, H1643R, H1703R, H1679R, H1723R, H1502R, H1702R	Tuberous sclerosis 2	VCV001359198	16	2138304	16	2088303	1359198	1357474	rs2151631825	NC_000016.10:2088302:A:G	single nucleotide variant	missense variant	Uncertain significance	May 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5238C>A (p.His1746Gln)	TSC2	H1643Q, H1690Q, H1723Q, H1631Q, H1680Q, H1702Q, H1502Q, H1679Q, H1699Q, H1703Q, H1746Q	Tuberous sclerosis 2|not provided	VCV001352113	16	2138305	16	2088304	1352113	1482649	rs1060504084	NC_000016.10:2088303:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5238C>T (p.His1746=)	TSC2		not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413631	16	2138305	16	2088304	413631	401443	rs1060504084	NC_000016.10:2088303:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5239A>G (p.Ile1747Val)	TSC2	I1232V, I1255V, I1481V, I1523V, I1524V, I1632V, I1674V, I1700V, I1711V, I1747V, I1276V, I1631V, I1643V, I1676V, I1677V, I1691V, I1704V, I1724V, I1746V, I1146V, I1480V, I1527V, I1644V, I1661V, I1680V, I1681V, I1687V, I1710V, I1721V, I1233V, I1256V, I1503V, I1547V, I1675V, I1703V, I1723V	Hereditary cancer-predisposing syndrome	VCV001746268	16	2138306	16	2088305	1746268	1809757	rs2151631966	NC_000016.10:2088304:A:G	single nucleotide variant	missense variant	Uncertain significance	May 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5239A>T (p.Ile1747Phe)	TSC2	I1681F, I1691F, I1680F, I1503F, I1644F, I1703F, I1704F, I1747F, I1632F, I1700F, I1724F	Tuberous sclerosis 2	VCV001517318	16	2138306	16	2088305	1517318	1515477	rs2151631966	NC_000016.10:2088304:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5240T>A (p.Ile1747Asn)	TSC2	I1146N, I1232N, I1233N, I1255N, I1256N, I1276N, I1480N, I1481N, I1503N, I1523N, I1524N, I1527N, I1547N, I1631N, I1632N, I1643N, I1644N, I1661N, I1674N, I1675N, I1676N, I1677N, I1680N, I1681N, I1687N, I1691N, I1700N, I1703N, I1704N, I1710N, I1711N, I1721N, I1723N, I1724N, I1746N, I1747N	not provided|Tuberous sclerosis 2	VCV003372115	16	2138307	16	2088306	3372115	3531305		NC_000016.10:2088305:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5241C>T (p.Ile1747=)	TSC2		Tuberous sclerosis 2	VCV003615741	16	2138308	16	2088307	3615741	3749572		NC_000016.10:2088306:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5241C>A (p.Ile1747=)	TSC2		Tuberous sclerosis 2	VCV002979746	16	2138308	16	2088307	2979746	3134510	rs2151632082	NC_000016.10:2088306:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5241C>G (p.Ile1747Met)	TSC2	I1524M, I1631M, I1676M, I1677M, I1711M, I1721M, I1146M, I1255M, I1480M, I1523M, I1547M, I1632M, I1643M, I1680M, I1700M, I1704M, I1723M, I1724M, I1232M, I1233M, I1256M, I1276M, I1503M, I1644M, I1674M, I1691M, I1746M, I1747M, I1481M, I1527M, I1661M, I1675M, I1681M, I1687M, I1703M, I1710M	Tuberous sclerosis 2	VCV002151949	16	2138308	16	2088307	2151949	1892027	rs2151632082	NC_000016.10:2088306:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5243A>C (p.Lys1748Thr)	TSC2	K1257T, K1548T, K1644T, K1682T, K1748T, K1525T, K1528T, K1633T, K1662T, K1688T, K1705T, K1712T, K1724T, K1725T, K1147T, K1233T, K1234T, K1256T, K1524T, K1632T, K1675T, K1676T, K1677T, K1681T, K1692T, K1701T, K1711T, K1722T, K1277T, K1481T, K1482T, K1504T, K1645T, K1678T, K1704T, K1747T	Hereditary cancer-predisposing syndrome	VCV002564709	16	2138310	16	2088309	2564709	2733865	rs753424501	NC_000016.10:2088308:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5243A>G (p.Lys1748Arg)	TSC2	K1504R, K1633R, K1645R, K1681R, K1682R, K1692R, K1701R, K1704R, K1705R, K1725R, K1748R	Hereditary cancer-predisposing syndrome|not provided	VCV001306138	16	2138310	16	2088309	1306138	1297409	rs753424501	NC_000016.10:2088308:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5244G>A (p.Lys1748=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000468152	16	2138311	16	2088310	468152	466146	rs150038278	NC_000016.10:2088309:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5245C>T (p.Arg1749Trp)	TSC2	R1505W, R1634W, R1646W, R1682W, R1683W, R1693W, R1702W, R1705W, R1706W, R1726W, R1749W	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided	VCV001013629	16	2138312	16	2088311	1013629	1012013	rs1193817827	NC_000016.10:2088310:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 2, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5246G>C (p.Arg1749Pro)	TSC2	R1234P, R1235P, R1482P, R1549P, R1645P, R1677P, R1679P, R1682P, R1683P, R1712P, R1725P, R1726P, R1257P, R1529P, R1676P, R1678P, R1749P, R1148P, R1258P, R1483P, R1505P, R1526P, R1663P, R1702P, R1705P, R1713P, R1723P, R1748P, R1278P, R1525P, R1633P, R1634P, R1646P, R1689P, R1693P, R1706P	Tuberous sclerosis 2|not provided	VCV002099933	16	2138313	16	2088312	2099933	2147491	rs1555440785	NC_000016.10:2088311:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5246G>A (p.Arg1749Gln)	TSC2	R1749Q, R1683Q, R1705Q, R1505Q, R1646Q, R1682Q, R1693Q, R1706Q, R1634Q, R1702Q, R1726Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000535984	16	2138313	16	2088312	535984	529803	rs1555440785	NC_000016.10:2088311:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5247G>A (p.Arg1749=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001083249	16	2138314	16	2088313	1083249	1081873	rs2151632398	NC_000016.10:2088312:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5248C>T (p.Leu1750Phe)	TSC2	L1750F, L1635F, L1647F, L1707F, L1727F, L1684F, L1694F, L1703F, L1683F, L1706F, L1506F	Tuberous sclerosis 2	VCV000049365	16	2138315	16	2088314	49365	58527	rs45459299	NC_000016.10:2088313:C:T	single nucleotide variant	missense variant	Benign	Sep 26, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5250C>T (p.Leu1750=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001967322	16	2138317	16	2088316	1967322	2024750	rs370353005	NC_000016.10:2088315:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5250C>A (p.Leu1750=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413731	16	2138317	16	2088316	413731	401716	rs370353005	NC_000016.10:2088315:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5250C>G (p.Leu1750=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413719	16	2138317	16	2088316	413719	401040	rs370353005	NC_000016.10:2088315:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5251C>T (p.Arg1751Cys)	TSC2	R1751C, R1636C, R1708C, R1507C, R1685C, R1707C, R1648C, R1684C, R1695C, R1728C, R1704C	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	VCV000406048	16	2138318	16	2088317	406048	401445	rs781630603	NC_000016.10:2088316:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5252G>C (p.Arg1751Pro)	TSC2	R1751P, R1685P, R1507P, R1707P, R1708P, R1684P, R1695P, R1636P, R1648P, R1704P, R1728P	Tuberous sclerosis 2	VCV000574061	16	2138319	16	2088318	574061	570148	rs373365980	NC_000016.10:2088317:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5252G>A (p.Arg1751His)	TSC2	R1751H, R1507H, R1636H, R1707H, R1708H, R1685H, R1648H, R1704H, R1728H, R1684H, R1695H	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000207760	16	2138319	16	2088318	207760	203210	rs373365980	NC_000016.10:2088317:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5253C>T (p.Arg1751=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001116525	16	2138320	16	2088319	1116525	1103686	rs1567132521	NC_000016.10:2088318:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5253C>G (p.Arg1751=)	TSC2		Hereditary cancer-predisposing syndrome	VCV000825589	16	2138320	16	2088319	825589	812631	rs1567132521	NC_000016.10:2088318:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5254C>G (p.Gln1752Glu)	TSC2	Q1752E, Q1508E, Q1637E, Q1705E, Q1685E, Q1709E, Q1649E, Q1686E, Q1696E, Q1708E, Q1729E	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000535883	16	2138321	16	2088320	535883	530074	rs45517414	NC_000016.10:2088319:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 11, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5254C>T (p.Gln1752Ter)	TSC2	Q1752*, Q1637*, Q1685*, Q1508*, Q1686*, Q1729*, Q1649*, Q1708*, Q1696*, Q1705*, Q1709*	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000049367	16	2138321	16	2088320	49367	58529	rs45517414	NC_000016.10:2088319:C:T	single nucleotide variant	nonsense	Conflicting classifications of pathogenicity	Mar 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5255A>G (p.Gln1752Arg)	TSC2	Q1151R, Q1238R, Q1261R, Q1486R, Q1552R, Q1679R, Q1682R, Q1692R, Q1708R, Q1715R, Q1728R, Q1751R, Q1281R, Q1528R, Q1666R, Q1680R, Q1685R, Q1485R, Q1529R, Q1532R, Q1637R, Q1705R, Q1709R, Q1729R, Q1752R, Q1237R, Q1260R, Q1508R, Q1636R, Q1648R, Q1649R, Q1681R, Q1686R, Q1696R, Q1716R, Q1726R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002858176	16	2138322	16	2088321	2858176	3018222	rs2151632821	NC_000016.10:2088320:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5255A>C (p.Gln1752Pro)	TSC2	Q1237P, Q1281P, Q1529P, Q1552P, Q1679P, Q1685P, Q1715P, Q1726P, Q1485P, Q1486P, Q1682P, Q1709P, Q1716P, Q1751P, Q1261P, Q1508P, Q1636P, Q1637P, Q1680P, Q1681P, Q1708P, Q1728P, Q1752P, Q1151P, Q1238P, Q1260P, Q1528P, Q1532P, Q1648P, Q1649P, Q1666P, Q1686P, Q1692P, Q1696P, Q1705P, Q1729P	Hereditary cancer-predisposing syndrome	VCV002564710	16	2138322	16	2088321	2564710	2733866	rs2151632821	NC_000016.10:2088320:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5256G>C (p.Gln1752His)	TSC2	Q1485H, Q1486H, Q1637H, Q1680H, Q1716H, Q1728H, Q1715H, Q1151H, Q1238H, Q1281H, Q1508H, Q1532H, Q1649H, Q1696H, Q1260H, Q1261H, Q1529H, Q1648H, Q1666H, Q1679H, Q1692H, Q1709H, Q1726H, Q1237H, Q1528H, Q1552H, Q1636H, Q1681H, Q1682H, Q1685H, Q1686H, Q1705H, Q1708H, Q1729H, Q1751H, Q1752H	Hereditary cancer-predisposing syndrome	VCV003811323	16	2138323	16	2088322	3811323	3928564		NC_000016.10:2088321:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5256G>A (p.Gln1752=)	TSC2		Tuberous sclerosis 2	VCV001946982	16	2138323	16	2088322	1946982	1995946	rs2151632872	NC_000016.10:2088321:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 16, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5257C>G (p.Arg1753Gly)	TSC2	R1261G, R1282G, R1486G, R1529G, R1530G, R1649G, R1650G, R1681G, R1716G, R1238G, R1262G, R1487G, R1638G, R1682G, R1683G, R1697G, R1706G, R1709G, R1752G, R1239G, R1509G, R1553G, R1667G, R1687G, R1693G, R1717G, R1729G, R1730G, R1152G, R1533G, R1637G, R1680G, R1686G, R1710G, R1727G, R1753G	Tuberous sclerosis 2	VCV002814113	16	2138324	16	2088323	2814113	2966227	rs756358402	NC_000016.10:2088322:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 14, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5257C>T (p.Arg1753Trp)	TSC2	R1753W, R1509W, R1638W, R1697W, R1730W, R1650W, R1686W, R1687W, R1706W, R1709W, R1710W	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000565761	16	2138324	16	2088323	565761	569885	rs756358402	NC_000016.10:2088322:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5257C>A (p.Arg1753=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000413632	16	2138324	16	2088323	413632	401447	rs756358402	NC_000016.10:2088322:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5258G>T (p.Arg1753Leu)	TSC2	R1239L, R1261L, R1486L, R1509L, R1649L, R1680L, R1687L, R1697L, R1706L, R1727L, R1152L, R1487L, R1529L, R1533L, R1650L, R1681L, R1683L, R1716L, R1752L, R1753L, R1553L, R1637L, R1693L, R1717L, R1730L, R1238L, R1262L, R1282L, R1530L, R1638L, R1667L, R1682L, R1686L, R1709L, R1710L, R1729L	Hereditary cancer-predisposing syndrome	VCV003974603	16	2138325	16	2088324	3974603	4086426		NC_000016.10:2088323:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 25, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5258G>C (p.Arg1753Pro)	TSC2	R1686P, R1687P, R1730P, R1753P, R1638P, R1697P, R1706P, R1709P, R1509P, R1650P, R1710P	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001505927	16	2138325	16	2088324	1505927	1339657	rs749487441	NC_000016.10:2088323:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5258G>A (p.Arg1753Gln)	TSC2	R1753Q, R1509Q, R1638Q, R1697Q, R1686Q, R1706Q, R1709Q, R1730Q, R1650Q, R1687Q, R1710Q	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000233437	16	2138325	16	2088324	233437	235145	rs749487441	NC_000016.10:2088323:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5259G>T (p.Arg1753=)	TSC2		Hereditary cancer-predisposing syndrome	VCV003462560	16	2138326	16	2088325	3462560	3621580		NC_000016.10:2088324:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Sep 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259G>C (p.Arg1753=)	TSC2		Tuberous sclerosis 2	VCV000844102	16	2138326	16	2088325	844102	843541	rs1060500945	NC_000016.10:2088324:G:C	single nucleotide variant	synonymous variant	Uncertain significance	Feb 14, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259G>A (p.Arg1753=)	TSC2		Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000406042	16	2138326	16	2088325	406042	400981	rs1060500945	NC_000016.10:2088324:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5259+1G>A	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002497452	16	2138327	16	2088326	2497452	2472535	rs1567132625	NC_000016.10:2088325:G:A	single nucleotide variant	splice donor variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5259+2T>A	TSC2		Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV003895996	16	2138328	16	2088327	3895996	4011869		NC_000016.10:2088326:T:A	single nucleotide variant	splice donor variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5259+2T>C	TSC2		Tuberous sclerosis 2	VCV001483596	16	2138328	16	2088327	1483596	1380713	rs1555440894	NC_000016.10:2088326:T:C	single nucleotide variant	splice donor variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+2T>G	TSC2		not provided	VCV000432820	16	2138328	16	2088327	432820	426157	rs1555440894	NC_000016.10:2088326:T:G	single nucleotide variant	splice donor variant	Likely pathogenic	Jun 21, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+3A>G	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001017830	16	2138329	16	2088328	1017830	1012014	rs1555440897	NC_000016.10:2088327:A:G	single nucleotide variant	intron variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5259+3A>C	TSC2		Tuberous sclerosis 2	VCV000535991	16	2138329	16	2088328	535991	530301	rs1555440897	NC_000016.10:2088327:A:C	single nucleotide variant	intron variant	Uncertain significance	Apr 24, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+4G>C	TSC2		Tuberous sclerosis 2	VCV003659848	16	2138330	16	2088329	3659848	3800796		NC_000016.10:2088328:G:C	single nucleotide variant	intron variant	Uncertain significance	Jul 19, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+4G>A	TSC2		Tuberous sclerosis 2|not provided	VCV000859505	16	2138330	16	2088329	859505	852809	rs2091153561	NC_000016.10:2088328:G:A	single nucleotide variant	intron variant	Uncertain significance	Jul 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5259+5G>A	TSC2		Tuberous sclerosis 2	VCV002833067	16	2138331	16	2088330	2833067	3001394	rs768760778	NC_000016.10:2088329:G:A	single nucleotide variant	intron variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+6G>A	TSC2		Tuberous sclerosis 2	VCV000535988	16	2138332	16	2088331	535988	529813	rs1555440900	NC_000016.10:2088330:G:A	single nucleotide variant	intron variant	Likely benign	Sep 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+7A>T	TSC2		Tuberous sclerosis 2	VCV000858268	16	2138333	16	2088332	858268	852646	rs1060504122	NC_000016.10:2088331:A:T	single nucleotide variant	intron variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+7A>G	TSC2		Tuberous sclerosis 2	VCV000413754	16	2138333	16	2088332	413754	401717	rs1060504122	NC_000016.10:2088331:A:G	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5259+8A>G	TSC2		Tuberous sclerosis 2	VCV000854770	16	2138334	16	2088333	854770	852647	rs912835683	NC_000016.10:2088332:A:G	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5259+8A>C	TSC2		Tuberous sclerosis 2	VCV000703705	16	2138334	16	2088333	703705	695685	rs912835683	NC_000016.10:2088332:A:C	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5259+9T>C	TSC2		Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|not specified|Tuberous sclerosis 2	VCV000384637	16	2138335	16	2088334	384637	374174	rs1057522018	NC_000016.10:2088333:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5259+10A>C	TSC2		Tuberous sclerosis 2	VCV001142736	16	2138336	16	2088335	1142736	1145988	rs200725584	NC_000016.10:2088334:A:C	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5259+10A>G	TSC2		Tuberous sclerosis 2	VCV001098977	16	2138336	16	2088335	1098977	1103687	rs200725584	NC_000016.10:2088334:A:G	single nucleotide variant	intron variant	Likely benign	Mar 19, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+11T>C	TSC2		Tuberous sclerosis 2	VCV002141612	16	2138337	16	2088336	2141612	1869148	rs2091156218	NC_000016.10:2088335:T:C	single nucleotide variant	intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+12G>A	TSC2		Tuberous sclerosis 2	VCV002791337	16	2138338	16	2088337	2791337	2953768	rs1329810712	NC_000016.10:2088336:G:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+14G>C	TSC2		Tuberous sclerosis 2	VCV002974209	16	2138340	16	2088339	2974209	3136693	rs1002586051	NC_000016.10:2088338:G:C	single nucleotide variant	intron variant	Likely benign	Nov 2, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+15G>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000885964	16	2138341	16	2088340	885964	876637	rs373209496	NC_000016.10:2088339:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5259+16C>A	TSC2		Tuberous sclerosis 2	VCV002864703	16	2138342	16	2088341	2864703	3019601	rs2151633732	NC_000016.10:2088340:C:A	single nucleotide variant	intron variant	Likely benign	May 16, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+16C>T	TSC2		Tuberous sclerosis 2	VCV002062309	16	2138342	16	2088341	2062309	2117582	rs2151633732	NC_000016.10:2088340:C:T	single nucleotide variant	intron variant	Likely benign	Nov 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+17T>C	TSC2		Tuberous sclerosis 2	VCV001648903	16	2138343	16	2088342	1648903	1662555	rs2091158241	NC_000016.10:2088341:T:C	single nucleotide variant	intron variant	Likely benign	May 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+18C>G	TSC2		Tuberous sclerosis 2	VCV002037249	16	2138344	16	2088343	2037249	2097741	rs1469369674	NC_000016.10:2088342:C:G	single nucleotide variant	intron variant	Likely benign	Apr 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+18C>T	TSC2		Tuberous sclerosis 2	VCV001612865	16	2138344	16	2088343	1612865	1663016	rs1469369674	NC_000016.10:2088342:C:T	single nucleotide variant	intron variant	Likely benign	Apr 8, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+19C>T	TSC2		Tuberous sclerosis 2	VCV001460579	16	2138345	16	2088344	1460579	1504628	rs753175884	NC_000016.10:2088343:C:T	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+20C>G	TSC2		Tuberous sclerosis 2	VCV002732627	16	2138346	16	2088345	2732627	2893955	rs879247127	NC_000016.10:2088344:C:G	single nucleotide variant	intron variant	Likely benign	Apr 15, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+20C>T	TSC2		Tuberous sclerosis 2	VCV001564620	16	2138346	16	2088345	1564620	1654989	rs879247127	NC_000016.10:2088344:C:T	single nucleotide variant	intron variant	Likely benign	Nov 16, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5259+25C>T	PKD1|TSC2		not specified|Polycystic kidney disease, adult type	VCV000256634	16	2138351	16	2088350	256634	255502	rs201329593	NC_000016.10:2088349:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5259+34C>T	TSC2		Isolated focal cortical dysplasia type II	VCV003240655	16	2138360	16	2088359	3240655	3399641	rs898489381	NC_000016.10:2088358:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 6, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-49C>T	PKD1|TSC2		not specified|not provided|Polycystic kidney disease, adult type|Tuberous sclerosis 2	VCV000049420	16	2138398	16	2088397	49420	58582	rs13332221	NC_000016.10:2088396:C:T	single nucleotide variant	intron variant	Benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-48G>A	TSC2		Tuberous sclerosis 2	VCV002573223	16	2138399	16	2088398	2573223	2738172	rs550230895	NC_000016.10:2088397:G:A	single nucleotide variant	intron variant	Benign	Jul 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-40C>T	TSC2		not specified	VCV000256635	16	2138407	16	2088406	256635	255503	rs200623674	NC_000016.10:2088405:C:T	single nucleotide variant	intron variant	Likely benign		criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-39G>A	TSC2		not provided	VCV002570924	16	2138408	16	2088407	2570924	2735882	rs532413089	NC_000016.10:2088406:G:A	single nucleotide variant	intron variant	Benign	Apr 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-25C>G	PKD1|TSC2		not specified|not provided|Polycystic kidney disease, adult type|Tuberous sclerosis 2	VCV000049976	16	2138422	16	2088421	49976	59138	rs13332222	NC_000016.10:2088420:C:G	single nucleotide variant	intron variant	Benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-20C>T	TSC2		Tuberous sclerosis 2	VCV001607589	16	2138427	16	2088426	1607589	1637544	rs2091180250	NC_000016.10:2088425:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-18A>G	TSC2		Isolated focal cortical dysplasia type II	VCV002679349	16	2138429	16	2088428	2679349	2836926	rs2544508284	NC_000016.10:2088427:A:G	single nucleotide variant	intron variant	Uncertain significance	May 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-17G>A	TSC2		Tuberous sclerosis 2	VCV001535141	16	2138430	16	2088429	1535141	1531853	rs1476456008	NC_000016.10:2088428:G:A	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-16C>T	TSC2		Tuberous sclerosis 2	VCV002728810	16	2138431	16	2088430	2728810	2882836	rs1358961035	NC_000016.10:2088429:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-16C>G	TSC2		Tuberous sclerosis 2	VCV002186295	16	2138431	16	2088430	2186295	1921507	rs1358961035	NC_000016.10:2088429:C:G	single nucleotide variant	intron variant	Likely benign	Feb 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-15C>T	PKD1|TSC2		not specified|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type	VCV000049975	16	2138432	16	2088431	49975	59137	rs45517416	NC_000016.10:2088430:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-14G>A	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV001593228	16	2138433	16	2088432	1593228	1589300	rs745529697	NC_000016.10:2088431:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-14G>T	TSC2		Tuberous sclerosis 2	VCV001589202	16	2138433	16	2088432	1589202	1554110	rs745529697	NC_000016.10:2088431:G:T	single nucleotide variant	intron variant	Likely benign	Mar 2, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-13C>A	TSC2		Tuberous sclerosis 2	VCV001533007	16	2138434	16	2088433	1533007	1605561	rs1413775764	NC_000016.10:2088432:C:A	single nucleotide variant	intron variant	Likely benign	Aug 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-13C>T	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001178192	16	2138434	16	2088433	1178192	1167654	rs1413775764	NC_000016.10:2088432:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5260-12C>T	PKD1|TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Polycystic kidney disease, adult type|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207695	16	2138435	16	2088434	207695	203211	rs769264472	NC_000016.10:2088433:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-11T>C	TSC2		Tuberous sclerosis 2	VCV004071114	16	2138436	16	2088435	4071114	4184962		NC_000016.10:2088434:T:C	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-11T>A	TSC2		Tuberous sclerosis 2	VCV002131503	16	2138436	16	2088435	2131503	2189491	rs2544508736	NC_000016.10:2088434:T:A	single nucleotide variant	intron variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-10C>G	TSC2		Tuberous sclerosis 2	VCV001528911	16	2138437	16	2088436	1528911	1634680	rs2091183190	NC_000016.10:2088435:C:G	single nucleotide variant	intron variant	Likely benign	Jul 19, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-10C>T	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001132430	16	2138437	16	2088436	1132430	1125102	rs2091183190	NC_000016.10:2088435:C:T	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-9T>C	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000536103	16	2138438	16	2088437	536103	529744	rs775095745	NC_000016.10:2088436:T:C	single nucleotide variant	intron variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-8G>A	TSC2		Tuberous sclerosis 2	VCV002046633	16	2138439	16	2088438	2046633	2092910	rs2151637283	NC_000016.10:2088437:G:A	single nucleotide variant	intron variant	Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-7C>G	TSC2		Hereditary cancer-predisposing syndrome	VCV001692509	16	2138440	16	2088439	1692509	1684949	rs1596462958	NC_000016.10:2088438:C:G	single nucleotide variant	intron variant	Uncertain significance	Mar 18, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-7C>T	TSC2		Tuberous sclerosis 2	VCV001672606	16	2138440	16	2088439	1672606	1616861	rs1596462958	NC_000016.10:2088438:C:T	single nucleotide variant	intron variant	Likely benign	Jan 18, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-7C>A	TSC2		Tuberous sclerosis 2	VCV000644670	16	2138440	16	2088439	644670	652539	rs1596462958	NC_000016.10:2088438:C:A	single nucleotide variant	intron variant	Uncertain significance	Nov 20, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-6C>T	TSC2		Tuberous sclerosis 2	VCV001935531	16	2138441	16	2088440	1935531	1993118	rs2544509462	NC_000016.10:2088439:C:T	single nucleotide variant	intron variant	Likely benign	Aug 27, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-5T>C	TSC2		Tuberous sclerosis 2	VCV002863381	16	2138442	16	2088441	2863381	3029457	rs2544509528	NC_000016.10:2088440:T:C	single nucleotide variant	intron variant	Likely benign	May 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-4T>G	TSC2		Tuberous sclerosis 2	VCV003683834	16	2138443	16	2088442	3683834	3808683		NC_000016.10:2088441:T:G	single nucleotide variant	intron variant	Likely benign	Mar 24, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-3C>A	TSC2		Tuberous sclerosis 2	VCV003701228	16	2138444	16	2088443	3701228	3834698		NC_000016.10:2088442:C:A	single nucleotide variant	intron variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5260-3C>T	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001746442	16	2138444	16	2088443	1746442	1809930	rs2151637431	NC_000016.10:2088442:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-2A>C	TSC2		Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis 2|not provided	VCV001493658	16	2138445	16	2088444	1493658	1449161	rs1374323400	NC_000016.10:2088443:A:C	single nucleotide variant	splice acceptor variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5260-1G>A	TSC2		Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000825595	16	2138446	16	2088445	825595	815621	rs1057518103	NC_000016.10:2088444:G:A	single nucleotide variant	splice acceptor variant	Uncertain significance	Apr 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5260-1G>C	TSC2		Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|not provided|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000372963	16	2138446	16	2088445	372963	360267	rs1057518103	NC_000016.10:2088444:G:C	single nucleotide variant	splice acceptor variant	Conflicting classifications of pathogenicity	Mar 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5260A>G (p.Ile1754Val)	TSC2	I1698V, I1639V, I1687V, I1688V, I1731V, I1710V, I1711V, I1754V, I1510V, I1651V, I1707V	Tuberous sclerosis 2	VCV001356594	16	2138447	16	2088446	1356594	1447343	rs2151637498	NC_000016.10:2088445:A:G	single nucleotide variant	missense variant	Uncertain significance	May 27, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5261T>C (p.Ile1754Thr)	TSC2	I1488T, I1530T, I1651T, I1681T, I1707T, I1717T, I1730T, I1753T, I1239T, I1283T, I1534T, I1554T, I1668T, I1683T, I1684T, I1687T, I1694T, I1698T, I1731T, I1754T, I1510T, I1638T, I1639T, I1650T, I1718T, I1728T, I1153T, I1240T, I1262T, I1263T, I1487T, I1531T, I1682T, I1688T, I1710T, I1711T	Tuberous sclerosis 2	VCV002761663	16	2138448	16	2088447	2761663	2911192	rs762320484	NC_000016.10:2088446:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5261T>G (p.Ile1754Ser)	TSC2	I1754S, I1510S, I1687S, I1710S, I1711S, I1639S, I1731S, I1688S, I1651S, I1698S, I1707S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000207761	16	2138448	16	2088447	207761	203212	rs762320484	NC_000016.10:2088446:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 20, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5262C>A (p.Ile1754=)	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468153	16	2138449	16	2088448	468153	466061	rs397515318	NC_000016.10:2088447:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5262C>G (p.Ile1754Met)	TSC2	I1754M, I1510M, I1651M, I1687M, I1707M, I1710M, I1711M, I1698M, I1688M, I1639M, I1731M	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000406068	16	2138449	16	2088448	406068	400985	rs397515318	NC_000016.10:2088447:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5262C>T (p.Ile1754=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000065297	16	2138449	16	2088448	65297	76229	rs397515318	NC_000016.10:2088447:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5263T>C (p.Cys1755Arg)	TSC2	C1640R, C1652R, C1688R, C1689R, C1712R, C1699R, C1755R, C1511R, C1708R, C1711R, C1732R	Tuberous sclerosis 2	VCV001502933	16	2138450	16	2088449	1502933	1404526	rs2151637657	NC_000016.10:2088448:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5264G>T (p.Cys1755Phe)	TSC2	C1755F, C1688F, C1732F, C1640F, C1511F, C1689F, C1708F, C1652F, C1699F, C1711F, C1712F	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535948	16	2138451	16	2088450	535948	529748	rs761162904	NC_000016.10:2088449:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 3, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5265C>G (p.Cys1755Trp)	TSC2	C1511W, C1640W, C1652W, C1688W, C1689W, C1699W, C1708W, C1711W, C1712W, C1732W, C1755W	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001017532	16	2138452	16	2088451	1017532	1012015	rs141449031	NC_000016.10:2088450:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5265C>T (p.Cys1755=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000184400	16	2138452	16	2088451	184400	184147	rs141449031	NC_000016.10:2088450:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5266G>T (p.Glu1756Ter)	TSC2	E1241*, E1285*, E1532*, E1536*, E1556*, E1653*, E1689*, E1690*, E1709*, E1712*, E1755*, E1490*, E1512*, E1533*, E1640*, E1683*, E1686*, E1730*, E1733*, E1264*, E1670*, E1685*, E1696*, E1713*, E1720*, E1756*, E1155*, E1242*, E1265*, E1489*, E1641*, E1652*, E1684*, E1700*, E1719*, E1732*	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001746469	16	2138453	16	2088452	1746469	1809957	rs375075952	NC_000016.10:2088451:G:T	single nucleotide variant	nonsense	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5266G>C (p.Glu1756Gln)	TSC2	E1512Q, E1641Q, E1713Q, E1689Q, E1709Q, E1756Q, E1653Q, E1712Q, E1690Q, E1700Q, E1733Q	Tuberous sclerosis 2	VCV000656781	16	2138453	16	2088452	656781	644366	rs375075952	NC_000016.10:2088451:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.5266G>A (p.Glu1756Lys)	TSC2	E1756K, E1653K, E1733K, E1641K, E1690K, E1713K, E1512K, E1712K, E1689K, E1700K, E1709K	Hereditary cancer-predisposing syndrome|not provided|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000207762	16	2138453	16	2088452	207762	203214	rs375075952	NC_000016.10:2088451:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5267A>G (p.Glu1756Gly)	TSC2	E1756G, E1512G, E1653G, E1690G, E1709G, E1712G, E1733G, E1641G, E1689G, E1700G, E1713G	Tuberous sclerosis syndrome	VCV000318336	16	2138454	16	2088453	318336	334175	rs886051797	NC_000016.10:2088452:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.5268G>A (p.Glu1756=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001128591	16	2138455	16	2088454	1128591	1125103	rs755229386	NC_000016.10:2088453:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5268G>C (p.Glu1756Asp)	TSC2	E1700D, E1709D, E1713D, E1733D, E1756D, E1641D, E1653D, E1689D, E1512D, E1690D, E1712D	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000680371	16	2138455	16	2088454	680371	656348	rs755229386	NC_000016.10:2088453:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5269G>A (p.Glu1757Lys)	TSC2	E1757K, E1690K, E1713K, E1734K, E1513K, E1642K, E1691K, E1701K, E1710K, E1714K, E1654K	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000406083	16	2138456	16	2088455	406083	401449	rs1060500957	NC_000016.10:2088454:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5270A>C (p.Glu1757Ala)	TSC2	E1513A, E1714A, E1642A, E1691A, E1757A, E1690A, E1701A, E1710A, E1654A, E1713A, E1734A	Tuberous sclerosis 2	VCV001369830	16	2138457	16	2088456	1369830	1437536	rs2151637961	NC_000016.10:2088455:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5271A>C (p.Glu1757Asp)	TSC2	E1757D, E1710D, E1734D, E1513D, E1642D, E1690D, E1691D, E1654D, E1701D, E1713D, E1714D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406110	16	2138458	16	2088457	406110	400987	rs1060500967	NC_000016.10:2088456:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5272G>A (p.Ala1758Thr)	TSC2	A1655T, A1702T, A1715T, A1514T, A1692T, A1711T, A1714T, A1758T, A1691T, A1643T, A1735T	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001347802	16	2138459	16	2088458	1347802	1391718	rs1555441169	NC_000016.10:2088457:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5272G>C (p.Ala1758Pro)	TSC2	A1758P, A1715P, A1514P, A1692P, A1702P, A1711P, A1735P, A1643P, A1655P, A1691P, A1714P	not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000486648	16	2138459	16	2088458	486648	477455	rs1555441169	NC_000016.10:2088457:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5273C>T (p.Ala1758Val)	TSC2	A1691V, A1702V, A1758V, A1655V, A1711V, A1715V, A1735V, A1714V, A1514V, A1643V, A1692V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001413396	16	2138460	16	2088459	1413396	1461437	rs547597044	NC_000016.10:2088458:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5274C>A (p.Ala1758=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001943939	16	2138461	16	2088460	1943939	2005377	rs752945858	NC_000016.10:2088459:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5274C>T (p.Ala1758=)	TSC2		not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000238081	16	2138461	16	2088460	238081	242339	rs752945858	NC_000016.10:2088459:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5275G>C (p.Ala1759Pro)	TSC2	A1656P, A1712P, A1715P, A1716P, A1515P, A1644P, A1693P, A1703P, A1759P, A1692P, A1736P	Tuberous sclerosis 2	VCV000951509	16	2138462	16	2088461	951509	927692	rs758450326	NC_000016.10:2088460:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5275G>A (p.Ala1759Thr)	TSC2	A1759T, A1656T, A1715T, A1716T, A1692T, A1703T, A1712T, A1515T, A1644T, A1693T, A1736T	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000184396	16	2138462	16	2088461	184396	184148	rs758450326	NC_000016.10:2088460:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5276C>T (p.Ala1759Val)	TSC2	A1759V, A1656V, A1703V, A1712V, A1715V, A1716V, A1736V, A1692V, A1693V, A1515V, A1644V	Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536110	16	2138463	16	2088462	536110	529750	rs45477298	NC_000016.10:2088461:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5277C>G (p.Ala1759=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001152651	16	2138464	16	2088463	1152651	1145989	rs2151638252	NC_000016.10:2088462:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5277C>T (p.Ala1759=)	TSC2		Tuberous sclerosis 2	VCV001147395	16	2138464	16	2088463	1147395	1145990	rs2151638252	NC_000016.10:2088462:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5278T>C (p.Tyr1760His)	TSC2	Y1645H, Y1694H, Y1716H, Y1657H, Y1693H, Y1704H, Y1717H, Y1760H, Y1713H, Y1737H, Y1516H	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001470851	16	2138465	16	2088464	1470851	1395078	rs2151638289	NC_000016.10:2088463:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5279A>G (p.Tyr1760Cys)	TSC2	Y1716C, Y1516C, Y1693C, Y1694C, Y1704C, Y1713C, Y1717C, Y1657C, Y1645C, Y1737C, Y1760C	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000825610	16	2138466	16	2088465	825610	812632	rs1261020269	NC_000016.10:2088464:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5279A>C (p.Tyr1760Ser)	TSC2	Y1760S, Y1516S, Y1737S, Y1657S, Y1694S, Y1693S, Y1704S, Y1713S, Y1717S, Y1645S, Y1716S	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000581066	16	2138466	16	2088465	581066	570150	rs1261020269	NC_000016.10:2088464:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 7, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5280C>T (p.Tyr1760=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468154	16	2138467	16	2088466	468154	466062	rs1555441203	NC_000016.10:2088465:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5282C>G (p.Ser1761Cys)	TSC2	S1160C, S1246C, S1247C, S1269C, S1270C, S1290C, S1494C, S1495C, S1517C, S1537C, S1538C, S1541C, S1561C, S1645C, S1646C, S1657C, S1658C, S1675C, S1688C, S1689C, S1690C, S1691C, S1694C, S1695C, S1701C, S1705C, S1714C, S1717C, S1718C, S1724C, S1725C, S1735C, S1737C, S1738C, S1760C, S1761C	Hereditary cancer-predisposing syndrome	VCV003232191	16	2138469	16	2088468	3232191	3391992	rs2151638394	NC_000016.10:2088467:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5282C>A (p.Ser1761Tyr)	TSC2	S1246Y, S1247Y, S1517Y, S1537Y, S1541Y, S1646Y, S1675Y, S1691Y, S1701Y, S1718Y, S1724Y, S1269Y, S1290Y, S1495Y, S1657Y, S1688Y, S1689Y, S1695Y, S1725Y, S1737Y, S1160Y, S1494Y, S1645Y, S1690Y, S1705Y, S1714Y, S1735Y, S1738Y, S1270Y, S1538Y, S1561Y, S1658Y, S1694Y, S1717Y, S1760Y, S1761Y	Tuberous sclerosis 2	VCV002704096	16	2138469	16	2088468	2704096	2856522	rs2151638394	NC_000016.10:2088467:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5283C>T (p.Ser1761=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV001144260	16	2138470	16	2088469	1144260	1145991	rs747002312	NC_000016.10:2088468:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5284A>C (p.Asn1762His)	TSC2	N1248H, N1291H, N1496H, N1518H, N1562H, N1646H, N1689H, N1725H, N1736H, N1738H, N1761H, N1762H, N1247H, N1270H, N1539H, N1647H, N1690H, N1695H, N1696H, N1715H, N1718H, N1161H, N1538H, N1542H, N1676H, N1702H, N1706H, N1726H, N1739H, N1271H, N1495H, N1658H, N1659H, N1691H, N1692H, N1719H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001746585	16	2138471	16	2088470	1746585	1806132	rs1567133600	NC_000016.10:2088469:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5284A>G (p.Asn1762Asp)	TSC2	N1762D, N1518D, N1706D, N1719D, N1696D, N1739D, N1647D, N1659D, N1695D, N1715D, N1718D	Tuberous sclerosis 2	VCV000574514	16	2138471	16	2088470	574514	569901	rs1567133600	NC_000016.10:2088469:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5285A>T (p.Asn1762Ile)	TSC2	N1270I, N1291I, N1496I, N1518I, N1647I, N1695I, N1706I, N1715I, N1719I, N1762I, N1161I, N1538I, N1562I, N1659I, N1676I, N1689I, N1692I, N1718I, N1247I, N1248I, N1495I, N1658I, N1690I, N1736I, N1761I, N1271I, N1539I, N1542I, N1646I, N1691I, N1696I, N1702I, N1725I, N1726I, N1738I, N1739I	Hereditary cancer-predisposing syndrome	VCV003974643	16	2138472	16	2088471	3974643	4086466		NC_000016.10:2088470:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 2, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5286C>A (p.Asn1762Lys)	TSC2	N1647K, N1715K, N1739K, N1762K, N1518K, N1659K, N1718K, N1695K, N1696K, N1706K, N1719K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000945934	16	2138473	16	2088472	945934	927693	rs757204634	NC_000016.10:2088471:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5286C>T (p.Asn1762=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000413700	16	2138473	16	2088472	413700	401721	rs757204634	NC_000016.10:2088471:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5287C>T (p.Pro1763Ser)	TSC2	P1716S, P1740S, P1660S, P1720S, P1519S, P1696S, P1697S, P1719S, P1648S, P1707S, P1763S	Tuberous sclerosis 2	VCV001382198	16	2138474	16	2088473	1382198	1434627	rs2151638570	NC_000016.10:2088472:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5288C>T (p.Pro1763Leu)	TSC2	P1648L, P1696L, P1697L, P1719L, P1763L, P1660L, P1519L, P1720L, P1740L, P1707L, P1716L	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000945935	16	2138475	16	2088474	945935	927694	rs781139561	NC_000016.10:2088473:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5288C>G (p.Pro1763Arg)	TSC2	P1763R, P1648R, P1720R, P1519R, P1660R, P1697R, P1740R, P1696R, P1719R, P1707R, P1716R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000405947	16	2138475	16	2088474	405947	401723	rs781139561	NC_000016.10:2088473:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5289C>T (p.Pro1763=)	PKD1|TSC2		Polycystic kidney disease, adult type|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000413718	16	2138476	16	2088475	413718	400992	rs144965811	NC_000016.10:2088474:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5290A>G (p.Ser1764Gly)	TSC2	S1249G, S1272G, S1273G, S1497G, S1541G, S1564G, S1648G, S1691G, S1698G, S1704G, S1708G, S1717G, S1498G, S1540G, S1693G, S1728G, S1764G, S1163G, S1293G, S1520G, S1544G, S1660G, S1661G, S1692G, S1697G, S1720G, S1738G, S1763G, S1250G, S1649G, S1678G, S1694G, S1721G, S1727G, S1740G, S1741G	Hereditary cancer-predisposing syndrome	VCV003974628	16	2138477	16	2088476	3974628	4086451		NC_000016.10:2088475:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 19, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5290A>C (p.Ser1764Arg)	TSC2	S1272R, S1520R, S1544R, S1648R, S1661R, S1692R, S1717R, S1727R, S1250R, S1564R, S1678R, S1694R, S1697R, S1704R, S1728R, S1740R, S1741R, S1163R, S1273R, S1497R, S1540R, S1541R, S1649R, S1660R, S1693R, S1698R, S1720R, S1738R, S1763R, S1249R, S1293R, S1498R, S1691R, S1708R, S1721R, S1764R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001997198	16	2138477	16	2088476	1997198	2060280	rs2151638672	NC_000016.10:2088475:A:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5291G>C (p.Ser1764Thr)	TSC2	S1520T, S1649T, S1661T, S1697T, S1698T, S1708T, S1717T, S1720T, S1721T, S1741T, S1764T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001005314	16	2138478	16	2088477	1005314	996777	rs138831802	NC_000016.10:2088476:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5291G>A (p.Ser1764Asn)	TSC2	S1764N, S1649N, S1717N, S1698N, S1708N, S1520N, S1720N, S1661N, S1697N, S1721N, S1741N	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000448738	16	2138478	16	2088477	448738	441798	rs138831802	NC_000016.10:2088476:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 5, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5292C>G (p.Ser1764Arg)	TSC2	S1163R, S1498R, S1564R, S1648R, S1660R, S1692R, S1693R, S1720R, S1721R, S1728R, S1763R, S1250R, S1540R, S1649R, S1697R, S1708R, S1738R, S1740R, S1741R, S1249R, S1293R, S1497R, S1520R, S1541R, S1661R, S1678R, S1717R, S1727R, S1272R, S1273R, S1544R, S1691R, S1694R, S1698R, S1704R, S1764R	Tuberous sclerosis 2	VCV002705988	16	2138479	16	2088478	2705988	2877313	rs769507440	NC_000016.10:2088477:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Dec 28, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5292C>T (p.Ser1764=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000238082	16	2138479	16	2088478	238082	242340	rs769507440	NC_000016.10:2088477:C:T	single nucleotide variant	synonymous variant	Benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5293C>T (p.Leu1765=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001141180	16	2138480	16	2088479	1141180	1145992	rs1060500954	NC_000016.10:2088478:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5293C>A (p.Leu1765Ile)	TSC2	L1765I, L1698I, L1699I, L1650I, L1709I, L1521I, L1662I, L1742I, L1718I, L1721I, L1722I	Tuberous sclerosis 2	VCV000569854	16	2138480	16	2088479	569854	569907	rs1060500954	NC_000016.10:2088478:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5293C>G (p.Leu1765Val)	TSC2	L1765V, L1650V, L1718V, L1721V, L1742V, L1699V, L1662V, L1698V, L1722V, L1521V, L1709V	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000406061	16	2138480	16	2088479	406061	401724	rs1060500954	NC_000016.10:2088478:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5294T>C (p.Leu1765Pro)	TSC2	L1521P, L1650P, L1662P, L1698P, L1699P, L1709P, L1718P, L1721P, L1722P, L1742P, L1765P	Tuberous sclerosis 2	VCV001055867	16	2138481	16	2088480	1055867	1049503	rs2151638859	NC_000016.10:2088479:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5295A>C (p.Leu1765=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002108105	16	2138482	16	2088481	2108105	2163278	rs2151638899	NC_000016.10:2088480:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5295A>G (p.Leu1765=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001551521	16	2138482	16	2088481	1551521	1551300	rs2151638899	NC_000016.10:2088480:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5296C>T (p.Pro1766Ser)	TSC2	P1766S, P1710S, P1651S, P1700S, P1719S, P1722S, P1723S, P1522S, P1663S, P1743S, P1699S	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486634	16	2138483	16	2088482	486634	478002	rs779621136	NC_000016.10:2088481:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 13, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5297C>T (p.Pro1766Leu)	TSC2	P1766L, P1651L, P1699L, P1700L, P1722L, P1663L, P1719L, P1723L, P1522L, P1710L, P1743L	not provided|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000535888	16	2138484	16	2088483	535888	529815	rs748936673	NC_000016.10:2088482:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 17, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5298T>G (p.Pro1766=)	TSC2		Tuberous sclerosis 2	VCV004071331	16	2138485	16	2088484	4071331	4185179		NC_000016.10:2088483:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 6, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5298T>A (p.Pro1766=)	TSC2		Tuberous sclerosis 2	VCV001151320	16	2138485	16	2088484	1151320	1145993	rs2151638999	NC_000016.10:2088483:T:A	single nucleotide variant	synonymous variant	Likely benign	Nov 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5299C>A (p.Leu1767Met)	TSC2	L1664M, L1767M, L1720M, L1744M, L1523M, L1711M, L1723M, L1724M, L1652M, L1700M, L1701M	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV001516408	16	2138486	16	2088485	1516408	1499062	rs1051758	NC_000016.10:2088484:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5299C>T (p.Leu1767=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000798737	16	2138486	16	2088485	798737	785211	rs1051758	NC_000016.10:2088484:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5299C>G (p.Leu1767Val)	TSC2	L1767V, L1652V, L1720V, L1744V, L1664V, L1701V, L1711V, L1523V, L1700V, L1724V, L1723V	Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000468155	16	2138486	16	2088485	468155	466066	rs1051758	NC_000016.10:2088484:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5300T>A (p.Leu1767Gln)	TSC2	L1252Q, L1253Q, L1547Q, L1567Q, L1663Q, L1681Q, L1700Q, L1744Q, L1276Q, L1296Q, L1651Q, L1694Q, L1724Q, L1730Q, L1741Q, L1743Q, L1766Q, L1166Q, L1275Q, L1523Q, L1544Q, L1695Q, L1697Q, L1701Q, L1707Q, L1767Q, L1500Q, L1501Q, L1543Q, L1652Q, L1664Q, L1696Q, L1711Q, L1720Q, L1723Q, L1731Q	Tuberous sclerosis 2	VCV002822560	16	2138487	16	2088486	2822560	2978519	rs2544512897	NC_000016.10:2088485:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 20, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5301G>A (p.Leu1767=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV002062026	16	2138488	16	2088487	2062026	2121174	rs886051798	NC_000016.10:2088486:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5301G>C (p.Leu1767=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000318337	16	2138488	16	2088487	318337	324639	rs886051798	NC_000016.10:2088486:G:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5302G>C (p.Val1768Leu)	TSC2	V1167L, V1253L, V1254L, V1276L, V1277L, V1297L, V1501L, V1502L, V1524L, V1544L, V1545L, V1548L, V1568L, V1652L, V1653L, V1664L, V1665L, V1682L, V1695L, V1696L, V1697L, V1698L, V1701L, V1702L, V1708L, V1712L, V1721L, V1724L, V1725L, V1731L, V1732L, V1742L, V1744L, V1745L, V1767L, V1768L	Isolated focal cortical dysplasia type II	VCV002679334	16	2138489	16	2088488	2679334	2836911	rs2151639120	NC_000016.10:2088487:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 11, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5302G>A (p.Val1768Met)	TSC2	V1524M, V1653M, V1665M, V1701M, V1702M, V1712M, V1721M, V1724M, V1725M, V1745M, V1768M	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001303839	16	2138489	16	2088488	1303839	1294114	rs2151639120	NC_000016.10:2088487:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5303T>G (p.Val1768Gly)	TSC2	V1253G, V1297G, V1568G, V1665G, V1698G, V1712G, V1254G, V1277G, V1501G, V1544G, V1653G, V1664G, V1708G, V1724G, V1744G, V1524G, V1652G, V1695G, V1696G, V1702G, V1721G, V1731G, V1742G, V1745G, V1768G, V1167G, V1276G, V1502G, V1545G, V1548G, V1682G, V1697G, V1701G, V1725G, V1732G, V1767G	Hereditary cancer-predisposing syndrome	VCV003462576	16	2138490	16	2088489	3462576	3621595		NC_000016.10:2088488:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5303T>C (p.Val1768Ala)	TSC2	V1653A, V1665A, V1725A, V1701A, V1724A, V1702A, V1712A, V1721A, V1524A, V1745A, V1768A	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV001433456	16	2138490	16	2088489	1433456	1419129	rs1171556696	NC_000016.10:2088488:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5303T>A (p.Val1768Glu)	TSC2	V1524E, V1653E, V1665E, V1701E, V1702E, V1712E, V1721E, V1724E, V1725E, V1745E, V1768E	Hereditary cancer-predisposing syndrome|not specified	VCV000811117	16	2138490	16	2088489	811117	799860	rs1171556696	NC_000016.10:2088488:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5304G>A (p.Val1768=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825628	16	2138491	16	2088490	825628	812633	rs1596463459	NC_000016.10:2088489:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5305C>T (p.His1769Tyr)	TSC2	H1769Y, H1525Y, H1725Y, H1654Y, H1666Y, H1702Y, H1722Y, H1746Y, H1703Y, H1713Y, H1726Y	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000486631	16	2138492	16	2088491	486631	477532	rs1555441265	NC_000016.10:2088490:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5306A>G (p.His1769Arg)	TSC2	H1769R, H1654R, H1666R, H1713R, H1722R, H1725R, H1726R, H1746R, H1525R, H1702R, H1703R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000573956	16	2138493	16	2088492	573956	573898	rs1567133809	NC_000016.10:2088491:A:G	single nucleotide variant	missense variant	Uncertain significance	May 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5307C>G (p.His1769Gln)	TSC2	H1525Q, H1654Q, H1666Q, H1702Q, H1703Q, H1713Q, H1722Q, H1725Q, H1726Q, H1746Q, H1769Q	Tuberous sclerosis 2	VCV001006099	16	2138494	16	2088493	1006099	996778	rs562220073	NC_000016.10:2088492:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5307C>T (p.His1769=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000388362	16	2138494	16	2088493	388362	374175	rs562220073	NC_000016.10:2088492:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5308C>G (p.Pro1770Ala)	TSC2	P1698A, P1699A, P1700A, P1703A, P1704A, P1710A, P1714A, P1723A, P1726A, P1727A, P1733A, P1734A, P1744A, P1746A, P1747A, P1769A, P1770A, P1169A, P1255A, P1256A, P1278A, P1279A, P1299A, P1503A, P1504A, P1526A, P1546A, P1547A, P1550A, P1570A, P1654A, P1655A, P1666A, P1667A, P1684A, P1697A	not provided	VCV003367998	16	2138495	16	2088494	3367998	3527197		NC_000016.10:2088493:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5308C>A (p.Pro1770Thr)	TSC2	P1169T, P1255T, P1256T, P1278T, P1279T, P1299T, P1503T, P1504T, P1526T, P1546T, P1547T, P1550T, P1570T, P1654T, P1655T, P1666T, P1667T, P1684T, P1697T, P1698T, P1699T, P1700T, P1703T, P1704T, P1710T, P1714T, P1723T, P1726T, P1727T, P1733T, P1734T, P1744T, P1746T, P1747T, P1769T, P1770T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003232192	16	2138495	16	2088494	3232192	3391993	rs761181064	NC_000016.10:2088493:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5308C>T (p.Pro1770Ser)	TSC2	P1770S, P1667S, P1703S, P1704S, P1714S, P1747S, P1727S, P1723S, P1526S, P1655S, P1726S	not specified|not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000318338	16	2138495	16	2088494	318338	340865	rs761181064	NC_000016.10:2088493:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5309C>G (p.Pro1770Arg)	TSC2	P1704R, P1747R, P1770R, P1667R, P1526R, P1703R, P1723R, P1726R, P1727R, P1655R, P1714R	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II	VCV000944222	16	2138496	16	2088495	944222	927695	rs771357054	NC_000016.10:2088494:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 29, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5309C>T (p.Pro1770Leu)	TSC2	P1526L, P1703L, P1704L, P1747L, P1770L, P1723L, P1655L, P1667L, P1726L, P1727L, P1714L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000854555	16	2138496	16	2088495	854555	843542	rs771357054	NC_000016.10:2088494:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5311C>A (p.Pro1771Thr)	TSC2	P1527T, P1705T, P1727T, P1656T, P1668T, P1715T, P1728T, P1771T, P1704T, P1724T, P1748T	Tuberous sclerosis 2	VCV001351228	16	2138498	16	2088497	1351228	1407578	rs777006583	NC_000016.10:2088496:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5311C>T (p.Pro1771Ser)	TSC2	P1715S, P1668S, P1727S, P1771S, P1527S, P1704S, P1705S, P1748S, P1656S, P1724S, P1728S	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000655006	16	2138498	16	2088497	655006	644367	rs777006583	NC_000016.10:2088496:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5311C>G (p.Pro1771Ala)	TSC2	P1771A, P1656A, P1527A, P1668A, P1704A, P1715A, P1748A, P1727A, P1705A, P1724A, P1728A	not provided|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000486616	16	2138498	16	2088497	486616	477456	rs777006583	NC_000016.10:2088496:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5312C>A (p.Pro1771Gln)	TSC2	P1771Q, P1527Q, P1715Q, P1656Q, P1727Q, P1668Q, P1704Q, P1705Q, P1724Q, P1728Q, P1748Q	Tuberous sclerosis 2	VCV000536004	16	2138499	16	2088498	536004	530077	rs137854214	NC_000016.10:2088497:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.5312C>T (p.Pro1771Leu)	PKD1|TSC2	P1771L, P1668L, P1704L, P1724L, P1728L, P1705L, P1715L, P1527L, P1656L, P1748L, P1727L	not provided|Tuberous sclerosis 2|not specified|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Polycystic kidney disease, adult type	VCV000049370	16	2138499	16	2088498	49370	58532	rs137854214	NC_000016.10:2088497:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5313G>C (p.Pro1771=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000468156	16	2138500	16	2088499	468156	466333	rs765607686	NC_000016.10:2088498:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5313G>A (p.Pro1771=)	TSC2		not specified|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000413716	16	2138500	16	2088499	413716	401453	rs765607686	NC_000016.10:2088498:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5314T>G (p.Ser1772Ala)	TSC2	S1772A, S1528A, S1729A, S1725A, S1669A, S1716A, S1657A, S1705A, S1706A, S1728A, S1749A	Tuberous sclerosis 2	VCV000406120	16	2138501	16	2088500	406120	401457	rs1060500973	NC_000016.10:2088499:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.5315C>G (p.Ser1772Cys)	TSC2	S1171C, S1257C, S1258C, S1280C, S1281C, S1301C, S1505C, S1506C, S1528C, S1548C, S1549C, S1552C, S1572C, S1656C, S1657C, S1668C, S1669C, S1686C, S1699C, S1700C, S1701C, S1702C, S1705C, S1706C, S1712C, S1716C, S1725C, S1728C, S1729C, S1735C, S1736C, S1746C, S1748C, S1749C, S1771C, S1772C	not provided	VCV002662458	16	2138502	16	2088501	2662458	2829909	rs2151639562	NC_000016.10:2088500:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5315C>T (p.Ser1772Phe)	TSC2	S1706F, S1725F, S1705F, S1729F, S1749F, S1528F, S1657F, S1669F, S1716F, S1728F, S1772F	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Lymphangiomyomatosis	VCV001460617	16	2138502	16	2088501	1460617	1504665	rs2151639562	NC_000016.10:2088500:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5316C>T (p.Ser1772=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001746786	16	2138503	16	2088502	1746786	1806331	rs2151639594	NC_000016.10:2088501:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Oct 5, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5316C>G (p.Ser1772=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV001148037	16	2138503	16	2088502	1148037	1145994	rs2151639594	NC_000016.10:2088501:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5317C>T (p.His1773Tyr)	TSC2	H1259Y, H1281Y, H1549Y, H1669Y, H1713Y, H1717Y, H1747Y, H1302Y, H1507Y, H1553Y, H1573Y, H1700Y, H1707Y, H1730Y, H1736Y, H1772Y, H1172Y, H1258Y, H1529Y, H1657Y, H1670Y, H1687Y, H1701Y, H1702Y, H1703Y, H1729Y, H1749Y, H1282Y, H1506Y, H1550Y, H1658Y, H1706Y, H1726Y, H1737Y, H1750Y, H1773Y	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV002092994	16	2138504	16	2088503	2092994	2145737	rs1030998097	NC_000016.10:2088502:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5317C>A (p.His1773Asn)	TSC2	H1670N, H1706N, H1773N, H1707N, H1717N, H1726N, H1730N, H1529N, H1658N, H1729N, H1750N	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000949721	16	2138504	16	2088503	949721	927696	rs1030998097	NC_000016.10:2088502:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5318A>T (p.His1773Leu)	TSC2	H1707L, H1717L, H1729L, H1730L, H1706L, H1726L, H1529L, H1773L, H1658L, H1670L, H1750L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000661272	16	2138505	16	2088504	661272	644368	rs45517418	NC_000016.10:2088503:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5318A>G (p.His1773Arg)	TSC2	H1773R, H1658R, H1670R, H1706R, H1729R, H1726R, H1730R, H1707R, H1717R, H1750R, H1529R	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238083	16	2138505	16	2088504	238083	242341	rs45517418	NC_000016.10:2088503:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5318A>C (p.His1773Pro)	TSC2	H1773P, H1750P, H1529P, H1670P, H1730P, H1658P, H1706P, H1707P, H1717P, H1726P, H1729P	Tuberous sclerosis 2	VCV000049920	16	2138505	16	2088504	49920	59082	rs45517418	NC_000016.10:2088503:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5319T>C (p.His1773=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not specified	VCV000238084	16	2138506	16	2088505	238084	242342	rs536518032	NC_000016.10:2088504:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5320A>C (p.Ser1774Arg)	TSC2	S1259R, S1260R, S1283R, S1574R, S1659R, S1671R, S1707R, S1738R, S1751R, S1773R, S1173R, S1282R, S1303R, S1507R, S1550R, S1551R, S1670R, S1702R, S1703R, S1727R, S1750R, S1554R, S1701R, S1730R, S1737R, S1774R, S1508R, S1530R, S1658R, S1688R, S1704R, S1708R, S1714R, S1718R, S1731R, S1748R	Hereditary cancer-predisposing syndrome	VCV002564711	16	2138507	16	2088506	2564711	2733867	rs368083145	NC_000016.10:2088505:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5320A>G (p.Ser1774Gly)	TSC2	S1774G, S1530G, S1708G, S1731G, S1751G, S1707G, S1718G, S1730G, S1659G, S1671G, S1727G	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not specified	VCV000468157	16	2138507	16	2088506	468157	466071	rs368083145	NC_000016.10:2088505:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5321G>A (p.Ser1774Asn)	TSC2	S1260N, S1283N, S1303N, S1508N, S1530N, S1554N, S1670N, S1702N, S1708N, S1738N, S1750N, S1574N, S1658N, S1671N, S1703N, S1173N, S1550N, S1551N, S1701N, S1704N, S1707N, S1718N, S1737N, S1748N, S1751N, S1259N, S1282N, S1507N, S1659N, S1688N, S1714N, S1727N, S1730N, S1731N, S1773N, S1774N	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV003578810	16	2138508	16	2088507	3578810	3708228		NC_000016.10:2088506:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5321G>T (p.Ser1774Ile)	TSC2	S1173I, S1259I, S1260I, S1282I, S1283I, S1303I, S1507I, S1508I, S1530I, S1550I, S1551I, S1554I, S1574I, S1658I, S1659I, S1670I, S1671I, S1688I, S1701I, S1702I, S1703I, S1704I, S1707I, S1708I, S1714I, S1718I, S1727I, S1730I, S1731I, S1737I, S1738I, S1748I, S1750I, S1751I, S1773I, S1774I	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV001719840	16	2138508	16	2088507	1719840	1772496	rs9209	NC_000016.10:2088506:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5321G>C (p.Ser1774Thr)	PKD1|TSC2	S1774T, S1659T, S1671T, S1708T, S1718T, S1727T, S1530T, S1707T, S1730T, S1731T, S1751T	not provided|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|not specified|Hereditary cancer-predisposing syndrome	VCV000041745	16	2138508	16	2088507	41745	50184	rs9209	NC_000016.10:2088506:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Jul 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5322C>G (p.Ser1774Arg)	TSC2	S1507R, S1530R, S1574R, S1658R, S1703R, S1704R, S1731R, S1748R, S1173R, S1282R, S1283R, S1508R, S1554R, S1659R, S1688R, S1708R, S1718R, S1738R, S1260R, S1551R, S1670R, S1702R, S1707R, S1727R, S1730R, S1737R, S1750R, S1751R, S1259R, S1303R, S1550R, S1671R, S1701R, S1714R, S1773R, S1774R	Tuberous sclerosis 2	VCV002976828	16	2138509	16	2088508	2976828	3130728	rs751622894	NC_000016.10:2088507:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Nov 29, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5322C>T (p.Ser1774=)	TSC2		not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000511981	16	2138509	16	2088508	511981	505707	rs751622894	NC_000016.10:2088507:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5325A>C (p.Lys1775Asn)	TSC2	K1174N, K1551N, K1671N, K1702N, K1709N, K1731N, K1732N, K1304N, K1531N, K1575N, K1703N, K1705N, K1719N, K1738N, K1260N, K1261N, K1284N, K1552N, K1672N, K1689N, K1715N, K1739N, K1749N, K1751N, K1775N, K1283N, K1508N, K1509N, K1555N, K1659N, K1660N, K1704N, K1708N, K1728N, K1752N, K1774N	Hereditary cancer-predisposing syndrome	VCV002564712	16	2138512	16	2088511	2564712	2733868	rs2151639935	NC_000016.10:2088510:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5326G>T (p.Ala1776Ser)	TSC2	A1285S, A1509S, A1660S, A1690S, A1752S, A1175S, A1556S, A1576S, A1661S, A1706S, A1720S, A1732S, A1750S, A1753S, A1776S, A1305S, A1532S, A1703S, A1710S, A1733S, A1740S, A1261S, A1262S, A1284S, A1510S, A1552S, A1553S, A1672S, A1673S, A1704S, A1705S, A1709S, A1716S, A1729S, A1739S, A1775S	Tuberous sclerosis 2	VCV002861852	16	2138513	16	2088512	2861852	3029214	rs2151639960	NC_000016.10:2088511:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5326G>C (p.Ala1776Pro)	TSC2	A1262P, A1284P, A1660P, A1690P, A1705P, A1709P, A1716P, A1733P, A1750P, A1752P, A1776P, A1261P, A1285P, A1553P, A1556P, A1576P, A1673P, A1704P, A1706P, A1175P, A1509P, A1552P, A1661P, A1720P, A1739P, A1740P, A1305P, A1510P, A1532P, A1672P, A1703P, A1710P, A1729P, A1732P, A1753P, A1775P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002109597	16	2138513	16	2088512	2109597	2163472	rs2151639960	NC_000016.10:2088511:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5327C>T (p.Ala1776Val)	TSC2	A1175V, A1261V, A1262V, A1284V, A1285V, A1305V, A1509V, A1510V, A1532V, A1552V, A1553V, A1556V, A1576V, A1660V, A1661V, A1672V, A1673V, A1690V, A1703V, A1704V, A1705V, A1706V, A1709V, A1710V, A1716V, A1720V, A1729V, A1732V, A1733V, A1739V, A1740V, A1750V, A1752V, A1753V, A1775V, A1776V	not provided	VCV002430885	16	2138514	16	2088513	2430885	2404392	rs1260718488	NC_000016.10:2088512:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5328C>A (p.Ala1776=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002626429	16	2138515	16	2088514	2626429	2794195	rs757292336	NC_000016.10:2088513:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5328C>G (p.Ala1776=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000761871	16	2138515	16	2088514	761871	770751	rs757292336	NC_000016.10:2088513:C:G	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5328C>T (p.Ala1776=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000704130	16	2138515	16	2088514	704130	693827	rs757292336	NC_000016.10:2088513:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5329C>T (p.Pro1777Ser)	TSC2	P1777S, P1533S, P1711S, P1734S, P1733S, P1662S, P1721S, P1754S, P1674S, P1710S, P1730S	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000575848	16	2138516	16	2088515	575848	567914	rs781226141	NC_000016.10:2088514:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 27, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5329C>G (p.Pro1777Ala)	TSC2	P1777A, P1533A, P1674A, P1710A, P1734A, P1754A, P1662A, P1711A, P1721A, P1730A, P1733A	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000231259	16	2138516	16	2088515	231259	235146	rs781226141	NC_000016.10:2088514:C:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5330C>T (p.Pro1777Leu)	TSC2	P1285L, P1510L, P1673L, P1674L, P1706L, P1740L, P1753L, P1262L, P1557L, P1661L, P1662L, P1705L, P1710L, P1751L, P1176L, P1263L, P1286L, P1577L, P1704L, P1707L, P1717L, P1733L, P1734L, P1741L, P1777L, P1306L, P1511L, P1533L, P1553L, P1554L, P1691L, P1711L, P1721L, P1730L, P1754L, P1776L	Hereditary cancer-predisposing syndrome	VCV002316507	16	2138517	16	2088516	2316507	2313192	rs1555441353	NC_000016.10:2088515:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5330C>A (p.Pro1777His)	TSC2	P1721H, P1777H, P1674H, P1711H, P1662H, P1710H, P1730H, P1734H, P1754H, P1533H, P1733H	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome	VCV000871743	16	2138517	16	2088516	871743	860219	rs1555441353	NC_000016.10:2088515:C:A	single nucleotide variant	missense variant	Uncertain significance	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5330C>G (p.Pro1777Arg)	TSC2	P1777R, P1533R, P1711R, P1730R, P1662R, P1721R, P1734R, P1674R, P1710R, P1754R, P1733R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535891	16	2138517	16	2088516	535891	530080	rs1555441353	NC_000016.10:2088515:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5331T>C (p.Pro1777=)	TSC2		Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000065127	16	2138518	16	2088517	65127	76058	rs370820622	NC_000016.10:2088516:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5332G>A (p.Ala1778Thr)	TSC2	A1778T, A1663T, A1711T, A1534T, A1712T, A1735T, A1755T, A1675T, A1722T, A1731T, A1734T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided|Tuberous sclerosis syndrome	VCV000571016	16	2138519	16	2088518	571016	567919	rs1245934608	NC_000016.10:2088517:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5333C>A (p.Ala1778Glu)	TSC2	A1177E, A1263E, A1307E, A1558E, A1578E, A1708E, A1711E, A1712E, A1741E, A1742E, A1752E, A1755E, A1534E, A1555E, A1662E, A1675E, A1705E, A1734E, A1264E, A1287E, A1512E, A1554E, A1663E, A1692E, A1707E, A1731E, A1735E, A1778E, A1286E, A1511E, A1674E, A1706E, A1718E, A1722E, A1754E, A1777E	Tuberous sclerosis 2	VCV002757633	16	2138520	16	2088519	2757633	2917505	rs755900742	NC_000016.10:2088518:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Sep 3, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5333C>T (p.Ala1778Val)	TSC2	A1778V, A1663V, A1675V, A1712V, A1722V, A1731V, A1755V, A1711V, A1734V, A1735V, A1534V	TSC2-related disorder|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000468159	16	2138520	16	2088519	468159	466157	rs755900742	NC_000016.10:2088518:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5334A>C (p.Ala1778=)	TSC2		Tuberous sclerosis 2	VCV004071166	16	2138521	16	2088520	4071166	4185014		NC_000016.10:2088519:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5334A>G (p.Ala1778=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome	VCV000468160	16	2138521	16	2088520	468160	465422	rs371580877	NC_000016.10:2088519:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5335C>G (p.Gln1779Glu)	TSC2	Q1178E, Q1288E, Q1287E, Q1555E, Q1676E, Q1712E, Q1723E, Q1753E, Q1264E, Q1265E, Q1559E, Q1709E, Q1742E, Q1755E, Q1779E, Q1308E, Q1556E, Q1579E, Q1663E, Q1693E, Q1706E, Q1707E, Q1708E, Q1735E, Q1736E, Q1756E, Q1778E, Q1512E, Q1513E, Q1535E, Q1664E, Q1675E, Q1713E, Q1719E, Q1732E, Q1743E	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001746897	16	2138522	16	2088521	1746897	1806442	rs1396666232	NC_000016.10:2088520:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5335C>A (p.Gln1779Lys)	TSC2	Q1664K, Q1713K, Q1756K, Q1535K, Q1676K, Q1712K, Q1735K, Q1736K, Q1779K, Q1723K, Q1732K	Tuberous sclerosis 2	VCV000864247	16	2138522	16	2088521	864247	843544	rs1396666232	NC_000016.10:2088520:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5336A>C (p.Gln1779Pro)	TSC2	Q1288P, Q1512P, Q1663P, Q1675P, Q1713P, Q1723P, Q1736P, Q1287P, Q1513P, Q1559P, Q1664P, Q1676P, Q1706P, Q1719P, Q1742P, Q1264P, Q1265P, Q1708P, Q1743P, Q1778P, Q1779P, Q1178P, Q1308P, Q1535P, Q1555P, Q1556P, Q1579P, Q1693P, Q1707P, Q1709P, Q1712P, Q1732P, Q1735P, Q1753P, Q1755P, Q1756P	Hereditary cancer-predisposing syndrome	VCV003974645	16	2138523	16	2088522	3974645	4086468		NC_000016.10:2088521:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 4, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5336A>G (p.Gln1779Arg)	TSC2	Q1779R, Q1664R, Q1676R, Q1732R, Q1736R, Q1713R, Q1723R, Q1535R, Q1712R, Q1735R, Q1756R	not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000514715	16	2138523	16	2088522	514715	505236	rs748947919	NC_000016.10:2088521:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5337G>C (p.Gln1779His)	TSC2	Q1664H, Q1732H, Q1535H, Q1712H, Q1736H, Q1713H, Q1723H, Q1735H, Q1756H, Q1676H, Q1779H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001507258	16	2138524	16	2088523	1507258	1449548	rs768237144	NC_000016.10:2088522:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 27, 2023	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5337G>A (p.Gln1779=)	TSC2		not provided|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000668419	16	2138524	16	2088523	668419	656349	rs768237144	NC_000016.10:2088522:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5338A>G (p.Thr1780Ala)	TSC2	T1266A, T1289A, T1309A, T1513A, T1556A, T1557A, T1664A, T1665A, T1707A, T1709A, T1710A, T1733A, T1736A, T1737A, T1756A, T1265A, T1708A, T1713A, T1743A, T1757A, T1179A, T1514A, T1536A, T1694A, T1779A, T1677A, T1714A, T1720A, T1724A, T1744A, T1754A, T1780A, T1288A, T1560A, T1580A, T1676A	Tuberous sclerosis 2	VCV002840486	16	2138525	16	2088524	2840486	3000310	rs989487316	NC_000016.10:2088523:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5338A>C (p.Thr1780Pro)	TSC2	T1780P, T1677P, T1736P, T1737P, T1757P, T1665P, T1724P, T1536P, T1713P, T1714P, T1733P	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000468161	16	2138525	16	2088524	468161	466334	rs989487316	NC_000016.10:2088523:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5339C>T (p.Thr1780Ile)	TSC2	T1780I, T1536I, T1714I, T1737I, T1677I, T1736I, T1757I, T1665I, T1713I, T1724I, T1733I	not provided|Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000405968	16	2138526	16	2088525	405968	401725	rs778395191	NC_000016.10:2088524:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5340T>G (p.Thr1780=)	TSC2		Tuberous sclerosis 2	VCV001567520	16	2138527	16	2088526	1567520	1591680	rs1455248686	NC_000016.10:2088525:T:G	single nucleotide variant	synonymous variant	Likely benign	May 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5340T>A (p.Thr1780=)	TSC2		Tuberous sclerosis 2	VCV001107374	16	2138527	16	2088526	1107374	1103688	rs1455248686	NC_000016.10:2088525:T:A	single nucleotide variant	synonymous variant	Likely benign	May 12, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5340T>C (p.Thr1780=)	TSC2		Hereditary cancer-predisposing syndrome	VCV000825664	16	2138527	16	2088526	825664	812634	rs1455248686	NC_000016.10:2088525:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5341C>A (p.Pro1781Thr)	TSC2	P1715T, P1714T, P1725T, P1738T, P1781T, P1537T, P1666T, P1678T, P1737T, P1734T, P1758T	Tuberous sclerosis 2	VCV001440541	16	2138528	16	2088527	1440541	1461826	rs1555441410	NC_000016.10:2088526:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5341C>G (p.Pro1781Ala)	TSC2	P1781A, P1678A, P1734A, P1758A, P1537A, P1737A, P1714A, P1715A, P1738A, P1666A, P1725A	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000535864	16	2138528	16	2088527	535864	530305	rs1555441410	NC_000016.10:2088526:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5342C>T (p.Pro1781Leu)	TSC2	P1781L, P1537L, P1758L, P1714L, P1678L, P1715L, P1725L, P1734L, P1737L, P1738L, P1666L	not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238085	16	2138529	16	2088528	238085	242343	rs878854119	NC_000016.10:2088527:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5343A>C (p.Pro1781=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564713	16	2138530	16	2088529	2564713	2733869	rs747614356	NC_000016.10:2088528:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5343A>G (p.Pro1781=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not specified	VCV000468162	16	2138530	16	2088529	468162	466074	rs747614356	NC_000016.10:2088528:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5344G>A (p.Ala1782Thr)	TSC2	A1667T, A1759T, A1716T, A1735T, A1738T, A1679T, A1739T, A1782T, A1538T, A1715T, A1726T	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001478025	16	2138531	16	2088530	1478025	1351533	rs1405712076	NC_000016.10:2088529:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5344G>T (p.Ala1782Ser)	TSC2	A1782S, A1679S, A1716S, A1735S, A1739S, A1538S, A1726S, A1738S, A1667S, A1715S, A1759S	Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000574864	16	2138531	16	2088530	574864	573899	rs1405712076	NC_000016.10:2088529:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5345C>T (p.Ala1782Val)	TSC2	A1268V, A1311V, A1558V, A1582V, A1667V, A1679V, A1709V, A1710V, A1716V, A1735V, A1756V, A1758V, A1759V, A1181V, A1290V, A1291V, A1516V, A1562V, A1678V, A1711V, A1715V, A1738V, A1739V, A1782V, A1515V, A1666V, A1712V, A1722V, A1745V, A1781V, A1267V, A1538V, A1559V, A1696V, A1726V, A1746V	Tuberous sclerosis 2	VCV002039590	16	2138532	16	2088531	2039590	2094911	rs2091206453	NC_000016.10:2088530:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5345C>G (p.Ala1782Gly)	TSC2	A1538G, A1715G, A1726G, A1759G, A1679G, A1735G, A1782G, A1667G, A1738G, A1739G, A1716G	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000840454	16	2138532	16	2088531	840454	843545	rs2091206453	NC_000016.10:2088530:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5346C>A (p.Ala1782=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001656840	16	2138533	16	2088532	1656840	1562224	rs557200243	NC_000016.10:2088531:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5346C>G (p.Ala1782=)	TSC2		Tuberous sclerosis 2	VCV000536016	16	2138533	16	2088532	536016	529824	rs557200243	NC_000016.10:2088531:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5346C>T (p.Ala1782=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000238086	16	2138533	16	2088532	238086	242344	rs557200243	NC_000016.10:2088531:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5347G>C (p.Glu1783Gln)	TSC2	E1583Q, E1668Q, E1680Q, E1710Q, E1716Q, E1727Q, E1269Q, E1291Q, E1292Q, E1312Q, E1713Q, E1740Q, E1757Q, E1783Q, E1517Q, E1539Q, E1560Q, E1563Q, E1697Q, E1717Q, E1723Q, E1736Q, E1739Q, E1746Q, E1759Q, E1182Q, E1268Q, E1516Q, E1559Q, E1667Q, E1679Q, E1711Q, E1712Q, E1747Q, E1760Q, E1782Q	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001746958	16	2138534	16	2088533	1746958	1806502	rs777166275	NC_000016.10:2088532:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5347G>T (p.Glu1783Ter)	TSC2	E1539*, E1717*, E1727*, E1736*, E1739*, E1668*, E1716*, E1760*, E1783*, E1680*, E1740*	Tuberous sclerosis 2	VCV001433454	16	2138534	16	2088533	1433454	1419127	rs777166275	NC_000016.10:2088532:G:T	single nucleotide variant	nonsense	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5347G>A (p.Glu1783Lys)	TSC2	E1783K, E1717K, E1736K, E1739K, E1539K, E1668K, E1680K, E1727K, E1740K, E1760K, E1716K	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000207763	16	2138534	16	2088533	207763	203215	rs777166275	NC_000016.10:2088532:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5348A>C (p.Glu1783Ala)	TSC2	E1268A, E1292A, E1563A, E1583A, E1679A, E1711A, E1727A, E1182A, E1269A, E1539A, E1559A, E1680A, E1697A, E1712A, E1760A, E1668A, E1716A, E1736A, E1739A, E1746A, E1759A, E1782A, E1291A, E1312A, E1516A, E1517A, E1560A, E1667A, E1710A, E1713A, E1717A, E1723A, E1740A, E1747A, E1757A, E1783A	Hereditary cancer-predisposing syndrome	VCV002560704	16	2138535	16	2088534	2560704	2716864	rs1555441444	NC_000016.10:2088533:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5348A>G (p.Glu1783Gly)	TSC2	E1783G, E1740G, E1760G, E1668G, E1716G, E1727G, E1736G, E1539G, E1680G, E1717G, E1739G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000468163	16	2138535	16	2088534	468163	466335	rs1555441444	NC_000016.10:2088533:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5349G>T (p.Glu1783Asp)	TSC2	E1516D, E1668D, E1717D, E1736D, E1739D, E1757D, E1759D, E1760D, E1312D, E1539D, E1563D, E1680D, E1697D, E1711D, E1716D, E1783D, E1182D, E1268D, E1291D, E1292D, E1559D, E1667D, E1712D, E1713D, E1740D, E1782D, E1269D, E1517D, E1560D, E1583D, E1679D, E1710D, E1723D, E1727D, E1746D, E1747D	Tuberous sclerosis 2	VCV002884748	16	2138536	16	2088535	2884748	3050092	rs2151640927	NC_000016.10:2088534:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5349G>A (p.Glu1783=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001127389	16	2138536	16	2088535	1127389	1125104	rs2151640927	NC_000016.10:2088534:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5350C>T (p.Pro1784Ser)	TSC2	P1183S, P1269S, P1270S, P1292S, P1293S, P1313S, P1517S, P1518S, P1540S, P1560S, P1561S, P1564S, P1584S, P1668S, P1669S, P1680S, P1681S, P1698S, P1711S, P1712S, P1713S, P1714S, P1717S, P1718S, P1724S, P1728S, P1737S, P1740S, P1741S, P1747S, P1748S, P1758S, P1760S, P1761S, P1783S, P1784S	Tuberous sclerosis 2	VCV001714987	16	2138537	16	2088536	1714987	1777988	rs1327577470	NC_000016.10:2088535:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5352C>A (p.Pro1784=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001158466	16	2138539	16	2088538	1158466	1145995	rs1367848310	NC_000016.10:2088537:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5352C>G (p.Pro1784=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001102813	16	2138539	16	2088538	1102813	1103689	rs1367848310	NC_000016.10:2088537:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5352C>T (p.Pro1784=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825675	16	2138539	16	2088538	825675	812635	rs1367848310	NC_000016.10:2088537:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5353A>G (p.Thr1785Ala)	TSC2	T1541A, T1670A, T1682A, T1718A, T1719A, T1729A, T1738A, T1741A, T1742A, T1762A, T1785A	Tuberous sclerosis 2	VCV001019286	16	2138540	16	2088539	1019286	1012016	rs1555441455	NC_000016.10:2088538:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5353A>C (p.Thr1785Pro)	TSC2	T1541P, T1682P, T1738P, T1670P, T1719P, T1741P, T1718P, T1729P, T1742P, T1762P, T1785P	Tuberous sclerosis 2	VCV000855031	16	2138540	16	2088539	855031	843546	rs1555441455	NC_000016.10:2088538:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5353A>T (p.Thr1785Ser)	TSC2	T1785S, T1762S, T1541S, T1670S, T1729S, T1741S, T1742S, T1682S, T1718S, T1719S, T1738S	Tuberous sclerosis 2	VCV000468164	16	2138540	16	2088539	468164	466080	rs1555441455	NC_000016.10:2088538:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5355A>G (p.Thr1785=)	TSC2		not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000387753	16	2138542	16	2088541	387753	377294	rs1057522896	NC_000016.10:2088540:A:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5356C>T (p.Pro1786Ser)	TSC2	P1786S, P1743S, P1671S, P1683S, P1719S, P1730S, P1542S, P1720S, P1739S, P1742S, P1763S	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|not provided	VCV000583381	16	2138543	16	2088542	583381	570151	rs371543182	NC_000016.10:2088541:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5357C>T (p.Pro1786Leu)	TSC2	P1542L, P1671L, P1683L, P1719L, P1720L, P1730L, P1739L, P1742L, P1743L, P1763L, P1786L	Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV001010291	16	2138544	16	2088543	1010291	996779	rs770117004	NC_000016.10:2088542:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 29, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5357C>G (p.Pro1786Arg)	TSC2	P1786R, P1542R, P1730R, P1671R, P1683R, P1719R, P1742R, P1720R, P1743R, P1739R, P1763R	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000207764	16	2138544	16	2088543	207764	203216	rs770117004	NC_000016.10:2088542:C:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5358T>G (p.Pro1786=)	TSC2		Hereditary cancer-predisposing syndrome	VCV002564714	16	2138545	16	2088544	2564714	2733870	rs1230726900	NC_000016.10:2088543:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5358T>C (p.Pro1786=)	TSC2		Tuberous sclerosis 2	VCV000536072	16	2138545	16	2088544	536072	530081	rs1230726900	NC_000016.10:2088543:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 15, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5359G>C (p.Gly1787Arg)	TSC2	G1186R, G1272R, G1273R, G1295R, G1296R, G1316R, G1520R, G1521R, G1543R, G1563R, G1564R, G1567R, G1587R, G1671R, G1672R, G1683R, G1684R, G1701R, G1714R, G1715R, G1716R, G1717R, G1720R, G1721R, G1727R, G1731R, G1740R, G1743R, G1744R, G1750R, G1751R, G1761R, G1763R, G1764R, G1786R, G1787R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV003075067	16	2138546	16	2088545	3075067	3234719	rs45517419	NC_000016.10:2088544:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5359G>A (p.Gly1787Ser)	TSC2	G1787S, G1543S, G1672S, G1684S, G1720S, G1764S, G1721S, G1731S, G1740S, G1744S, G1743S	not provided|Tuberous sclerosis syndrome|not specified|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000041746	16	2138546	16	2088545	41746	50185	rs45517419	NC_000016.10:2088544:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 1, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5360G>A (p.Gly1787Asp)	TSC2	G1295D, G1316D, G1520D, G1543D, G1587D, G1683D, G1716D, G1717D, G1720D, G1740D, G1743D, G1763D, G1272D, G1567D, G1671D, G1721D, G1764D, G1786D, G1521D, G1563D, G1714D, G1715D, G1744D, G1750D, G1761D, G1186D, G1273D, G1296D, G1564D, G1672D, G1684D, G1701D, G1727D, G1731D, G1751D, G1787D	Tuberous sclerosis 2	VCV002734580	16	2138547	16	2088546	2734580	2894608	rs2544517156	NC_000016.10:2088545:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5361C>T (p.Gly1787=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000977135	16	2138548	16	2088547	977135	965266	rs1334165353	NC_000016.10:2088546:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5361C>G (p.Gly1787=)	TSC2		Tuberous sclerosis 2	VCV000644856	16	2138548	16	2088547	644856	644369	rs1334165353	NC_000016.10:2088546:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5361C>A (p.Gly1787=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000536058	16	2138548	16	2088547	536058	529751	rs1334165353	NC_000016.10:2088546:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5362T>G (p.Tyr1788Asp)	TSC2	Y1788D, Y1544D, Y1685D, Y1721D, Y1722D, Y1744D, Y1745D, Y1673D, Y1732D, Y1741D, Y1765D	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|not provided	VCV000572324	16	2138549	16	2088548	572324	573900	rs904411432	NC_000016.10:2088547:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5362T>C (p.Tyr1788His)	TSC2	Y1788H, Y1722H, Y1741H, Y1765H, Y1732H, Y1744H, Y1745H, Y1721H, Y1544H, Y1673H, Y1685H	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000406106	16	2138549	16	2088548	406106	401460	rs904411432	NC_000016.10:2088547:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5363A>C (p.Tyr1788Ser)	TSC2	Y1544S, Y1673S, Y1685S, Y1721S, Y1722S, Y1732S, Y1741S, Y1744S, Y1745S, Y1765S, Y1788S	Tuberous sclerosis 2	VCV001002416	16	2138550	16	2088549	1002416	996780	rs397515221	NC_000016.10:2088548:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5363A>G (p.Tyr1788Cys)	TSC2	Y1788C, Y1744C, Y1544C, Y1721C, Y1722C, Y1765C, Y1673C, Y1732C, Y1745C, Y1685C, Y1741C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2	VCV000449819	16	2138550	16	2088549	449819	445529	rs397515221	NC_000016.10:2088548:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5363A>T (p.Tyr1788Phe)	TSC2	Y1788F, Y1673F, Y1685F, Y1721F, Y1722F, Y1765F, Y1544F, Y1732F, Y1744F, Y1741F, Y1745F	Hereditary cancer-predisposing syndrome	VCV000065302	16	2138550	16	2088549	65302	76234	rs397515221	NC_000016.10:2088548:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5364T>A (p.Tyr1788Ter)	TSC2	Y1274*, Y1296*, Y1522*, Y1588*, Y1672*, Y1732*, Y1744*, Y1788*, Y1187*, Y1297*, Y1564*, Y1565*, Y1568*, Y1718*, Y1722*, Y1728*, Y1745*, Y1752*, Y1762*, Y1765*, Y1787*, Y1273*, Y1521*, Y1684*, Y1702*, Y1716*, Y1717*, Y1721*, Y1741*, Y1751*, Y1764*, Y1317*, Y1544*, Y1673*, Y1685*, Y1715*	Hereditary cancer-predisposing syndrome	VCV001747080	16	2138551	16	2088550	1747080	1802831	rs367703283	NC_000016.10:2088549:T:A	single nucleotide variant	nonsense	Uncertain significance	Nov 17, 2016	criteria provided, single submitter							
NM_000548.5(TSC2):c.5364T>G (p.Tyr1788Ter)	TSC2	Y1673*, Y1685*, Y1744*, Y1765*, Y1788*, Y1722*, Y1741*, Y1544*, Y1721*, Y1732*, Y1745*	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000641900	16	2138551	16	2088550	641900	644370	rs367703283	NC_000016.10:2088549:T:G	single nucleotide variant	nonsense	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5364T>C (p.Tyr1788=)	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000238087	16	2138551	16	2088550	238087	242345	rs367703283	NC_000016.10:2088549:T:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5365G>A (p.Glu1789Lys)	TSC2	E1545K, E1686K, E1746K, E1722K, E1723K, E1742K, E1674K, E1733K, E1745K, E1766K, E1789K	Tuberous sclerosis 2	VCV000941665	16	2138552	16	2088551	941665	937352	rs45517420	NC_000016.10:2088550:G:A	single nucleotide variant	missense variant	Benign	Apr 2, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5367G>A (p.Glu1789=)	TSC2		not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000714193	16	2138554	16	2088553	714193	726495	rs966695764	NC_000016.10:2088552:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5367G>C (p.Glu1789Asp)	TSC2	E1789D, E1733D, E1742D, E1746D, E1545D, E1686D, E1723D, E1722D, E1674D, E1745D, E1766D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV000568482	16	2138554	16	2088553	568482	569908	rs966695764	NC_000016.10:2088552:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5368G>C (p.Val1790Leu)	TSC2	V1189L, V1275L, V1276L, V1298L, V1299L, V1319L, V1523L, V1524L, V1546L, V1566L, V1567L, V1570L, V1590L, V1674L, V1675L, V1686L, V1687L, V1704L, V1717L, V1718L, V1719L, V1720L, V1723L, V1724L, V1730L, V1734L, V1743L, V1746L, V1747L, V1753L, V1754L, V1764L, V1766L, V1767L, V1789L, V1790L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV003232193	16	2138555	16	2088554	3232193	3391994	rs200140994	NC_000016.10:2088553:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5368G>A (p.Val1790Met)	TSC2	V1790M, V1687M, V1746M, V1767M, V1743M, V1546M, V1747M, V1675M, V1723M, V1724M, V1734M	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not provided	VCV000041747	16	2138555	16	2088554	41747	50186	rs200140994	NC_000016.10:2088553:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5369T>A (p.Val1790Glu)	TSC2	V1546E, V1743E, V1767E, V1790E, V1675E, V1687E, V1723E, V1724E, V1746E, V1747E, V1734E	Tuberous sclerosis 2	VCV001492857	16	2138556	16	2088555	1492857	1515693	rs1596464243	NC_000016.10:2088554:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5369T>G (p.Val1790Gly)	TSC2	V1675G, V1724G, V1734G, V1746G, V1767G, V1546G, V1747G, V1790G, V1723G, V1743G, V1687G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000647072	16	2138556	16	2088555	647072	644371	rs1596464243	NC_000016.10:2088554:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5370G>A (p.Val1790=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000763866	16	2138557	16	2088556	763866	770752	rs762032752	NC_000016.10:2088555:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5370G>C (p.Val1790=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|not provided	VCV000380326	16	2138557	16	2088556	380326	377299	rs762032752	NC_000016.10:2088555:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5371G>A (p.Gly1791Ser)	TSC2	G1791S, G1688S, G1725S, G1744S, G1748S, G1768S, G1735S, G1547S, G1676S, G1724S, G1747S	Tuberous sclerosis 2	VCV000049998	16	2138558	16	2088557	49998	59160	rs45517421	NC_000016.10:2088556:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5372G>C (p.Gly1791Ala)	TSC2	G1547A, G1676A, G1724A, G1735A, G1791A, G1688A, G1725A, G1747A, G1768A, G1744A, G1748A	Tuberous sclerosis 2	VCV001461231	16	2138559	16	2088558	1461231	1498062	rs2091211512	NC_000016.10:2088557:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5372G>A (p.Gly1791Asp)	TSC2	G1547D, G1724D, G1747D, G1748D, G1791D, G1676D, G1688D, G1725D, G1735D, G1744D, G1768D	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000962136	16	2138559	16	2088558	962136	949298	rs2091211512	NC_000016.10:2088557:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5373C>T (p.Gly1791=)	TSC2		Tuberous sclerosis 2	VCV002066591	16	2138560	16	2088559	2066591	2125404	rs1555441528	NC_000016.10:2088558:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 10, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5373C>G (p.Gly1791=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000468166	16	2138560	16	2088559	468166	466158	rs1555441528	NC_000016.10:2088558:C:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5374C>T (p.Gln1792Ter)	TSC2	Q1277*, Q1300*, Q1525*, Q1676*, Q1677*, Q1688*, Q1722*, Q1748*, Q1766*, Q1768*, Q1301*, Q1569*, Q1732*, Q1756*, Q1769*, Q1792*, Q1278*, Q1568*, Q1572*, Q1592*, Q1689*, Q1706*, Q1726*, Q1191*, Q1321*, Q1526*, Q1548*, Q1719*, Q1720*, Q1721*, Q1725*, Q1736*, Q1745*, Q1749*, Q1755*, Q1791*	Tuberous sclerosis 2|not provided	VCV002020349	16	2138561	16	2088560	2020349	2079534	rs201916931	NC_000016.10:2088559:C:T	single nucleotide variant	nonsense	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5374C>A (p.Gln1792Lys)	TSC2	Q1792K, Q1726K, Q1745K, Q1769K, Q1548K, Q1677K, Q1689K, Q1725K, Q1736K, Q1748K, Q1749K	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405999	16	2138561	16	2088560	405999	401726	rs201916931	NC_000016.10:2088559:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5375A>G (p.Gln1792Arg)	TSC2	Q1191R, Q1525R, Q1526R, Q1572R, Q1676R, Q1677R, Q1719R, Q1736R, Q1755R, Q1768R, Q1791R, Q1792R, Q1277R, Q1321R, Q1548R, Q1721R, Q1725R, Q1745R, Q1278R, Q1568R, Q1592R, Q1688R, Q1689R, Q1720R, Q1732R, Q1749R, Q1300R, Q1301R, Q1569R, Q1706R, Q1722R, Q1726R, Q1748R, Q1756R, Q1766R, Q1769R	Hereditary cancer-predisposing syndrome	VCV001747118	16	2138562	16	2088561	1747118	1802869	rs2544518249	NC_000016.10:2088560:A:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5376G>C (p.Gln1792His)	TSC2	Q1792H, Q1677H, Q1725H, Q1726H, Q1736H, Q1748H, Q1548H, Q1689H, Q1769H, Q1745H, Q1749H	Tuberous sclerosis 2	VCV000049940	16	2138563	16	2088562	49940	59102	rs45517422	NC_000016.10:2088561:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5377C>A (p.Arg1793=)	TSC2		Hereditary cancer-predisposing syndrome	VCV001747130	16	2138564	16	2088563	1747130	1802881	rs1473538868	NC_000016.10:2088562:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 3, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5377C>T (p.Arg1793Trp)	TSC2	R1793W, R1549W, R1690W, R1770W, R1746W, R1678W, R1726W, R1727W, R1737W, R1749W, R1750W	not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000860324	16	2138564	16	2088563	860324	843547	rs1473538868	NC_000016.10:2088562:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 28, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5377C>G (p.Arg1793Gly)	TSC2	R1549G, R1690G, R1749G, R1750G, R1793G, R1726G, R1727G, R1737G, R1746G, R1678G, R1770G	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000640503	16	2138564	16	2088563	640503	644372	rs1473538868	NC_000016.10:2088562:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 23, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5378G>C (p.Arg1793Pro)	TSC2	R1793P, R1678P, R1690P, R1727P, R1746P, R1726P, R1750P, R1549P, R1737P, R1770P, R1749P	Tuberous sclerosis 2	VCV000580896	16	2138565	16	2088564	580896	569910	rs45506695	NC_000016.10:2088563:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5378G>A (p.Arg1793Gln)	TSC2	R1793Q, R1690Q, R1750Q, R1770Q, R1549Q, R1727Q, R1746Q, R1678Q, R1726Q, R1737Q, R1749Q	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis 2	VCV000049941	16	2138565	16	2088564	49941	59103	rs45506695	NC_000016.10:2088563:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5379G>A (p.Arg1793=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001152192	16	2138566	16	2088565	1152192	1145996	rs750392366	NC_000016.10:2088564:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5380A>C (p.Lys1794Gln)	TSC2	K1323Q, K1570Q, K1679Q, K1691Q, K1722Q, K1723Q, K1734Q, K1768Q, K1193Q, K1280Q, K1302Q, K1528Q, K1724Q, K1758Q, K1771Q, K1793Q, K1303Q, K1550Q, K1574Q, K1690Q, K1721Q, K1727Q, K1738Q, K1747Q, K1757Q, K1794Q, K1279Q, K1527Q, K1571Q, K1594Q, K1678Q, K1708Q, K1728Q, K1750Q, K1751Q, K1770Q	Tuberous sclerosis 2	VCV001973491	16	2138567	16	2088566	1973491	2030057	rs2544518554	NC_000016.10:2088565:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5381A>C (p.Lys1794Thr)	TSC2	K1193T, K1279T, K1303T, K1571T, K1678T, K1690T, K1708T, K1721T, K1734T, K1738T, K1747T, K1280T, K1527T, K1528T, K1679T, K1722T, K1727T, K1751T, K1793T, K1323T, K1550T, K1570T, K1691T, K1728T, K1750T, K1794T, K1302T, K1574T, K1594T, K1723T, K1724T, K1757T, K1758T, K1768T, K1770T, K1771T	Hereditary cancer-predisposing syndrome	VCV002564715	16	2138568	16	2088567	2564715	2733871	rs756064266	NC_000016.10:2088566:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5381A>G (p.Lys1794Arg)	TSC2	K1550R, K1679R, K1728R, K1747R, K1727R, K1691R, K1751R, K1794R, K1738R, K1750R, K1771R	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000858649	16	2138568	16	2088567	858649	843548	rs756064266	NC_000016.10:2088566:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 21, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5383C>A (p.Arg1795Ser)	TSC2	R1194S, R1280S, R1281S, R1303S, R1304S, R1324S, R1528S, R1529S, R1551S, R1571S, R1572S, R1575S, R1595S, R1679S, R1680S, R1691S, R1692S, R1709S, R1722S, R1723S, R1724S, R1725S, R1728S, R1729S, R1735S, R1739S, R1748S, R1751S, R1752S, R1758S, R1759S, R1769S, R1771S, R1772S, R1794S, R1795S	Hereditary cancer-predisposing syndrome	VCV003232195	16	2138570	16	2088569	3232195	3391996	rs45517423	NC_000016.10:2088568:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5383C>G (p.Arg1795Gly)	TSC2	R1748G, R1751G, R1772G, R1551G, R1680G, R1728G, R1729G, R1692G, R1752G, R1795G, R1739G	Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000663278	16	2138570	16	2088569	663278	644373	rs45517423	NC_000016.10:2088568:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5383C>T (p.Arg1795Cys)	TSC2	R1795C, R1728C, R1752C, R1692C, R1729C, R1772C, R1551C, R1739C, R1680C, R1748C, R1751C	Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Lymphangiomyomatosis|not provided|not specified|Tuberous sclerosis 2|Tuberous sclerosis 2|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II	VCV000041748	16	2138570	16	2088569	41748	50187	rs45517423	NC_000016.10:2088568:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5384G>A (p.Arg1795His)	TSC2	R1795H, R1752H, R1739H, R1748H, R1751H, R1772H, R1551H, R1680H, R1692H, R1728H, R1729H	Hereditary cancer-predisposing syndrome|not specified|Tuberous sclerosis syndrome|Tuberous sclerosis 2|not provided	VCV000381472	16	2138571	16	2088570	381472	377307	rs137854288	NC_000016.10:2088569:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5385C>A (p.Arg1795=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002840358	16	2138572	16	2088571	2840358	3000182	rs2544518822	NC_000016.10:2088570:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5386C>G (p.Leu1796Val)	TSC2	L1282V, L1529V, L1572V, L1576V, L1693V, L1726V, L1730V, L1759V, L1760V, L1195V, L1596V, L1680V, L1710V, L1723V, L1725V, L1736V, L1740V, L1752V, L1773V, L1795V, L1304V, L1305V, L1552V, L1681V, L1692V, L1724V, L1753V, L1796V, L1281V, L1325V, L1530V, L1573V, L1729V, L1749V, L1770V, L1772V	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002454683	16	2138573	16	2088572	2454683	2434352	rs45455398	NC_000016.10:2088571:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5386C>T (p.Leu1796Phe)	TSC2	L1796F, L1552F, L1681F, L1730F, L1693F, L1740F, L1752F, L1753F, L1729F, L1749F, L1773F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000570788	16	2138573	16	2088572	570788	569914	rs45455398	NC_000016.10:2088571:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5388C>T (p.Leu1796=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000771680	16	2138575	16	2088574	771680	703555	rs1412229429	NC_000016.10:2088573:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5389A>C (p.Ile1797Leu)	TSC2	I1797L, I1730L, I1731L, I1553L, I1741L, I1750L, I1682L, I1754L, I1694L, I1753L, I1774L	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II	VCV000207696	16	2138576	16	2088575	207696	203217	rs796053479	NC_000016.10:2088574:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5390T>G (p.Ile1797Ser)	TSC2	I1577S, I1597S, I1681S, I1726S, I1741S, I1753S, I1771S, I1773S, I1306S, I1326S, I1530S, I1531S, I1553S, I1693S, I1694S, I1725S, I1727S, I1730S, I1731S, I1737S, I1750S, I1796S, I1196S, I1282S, I1574S, I1682S, I1754S, I1760S, I1283S, I1305S, I1573S, I1711S, I1724S, I1761S, I1774S, I1797S	Hereditary cancer-predisposing syndrome	VCV002626457	16	2138577	16	2088576	2626457	2794223	rs2151642406	NC_000016.10:2088575:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5390T>C (p.Ile1797Thr)	TSC2	I1682T, I1731T, I1741T, I1797T, I1553T, I1694T, I1754T, I1753T, I1730T, I1750T, I1774T	Tuberous sclerosis 2	VCV001522223	16	2138577	16	2088576	1522223	1369167	rs2151642406	NC_000016.10:2088575:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5391C>G (p.Ile1797Met)	TSC2	I1196M, I1282M, I1283M, I1305M, I1306M, I1326M, I1530M, I1531M, I1553M, I1573M, I1574M, I1577M, I1597M, I1681M, I1682M, I1693M, I1694M, I1711M, I1724M, I1725M, I1726M, I1727M, I1730M, I1731M, I1737M, I1741M, I1750M, I1753M, I1754M, I1760M, I1761M, I1771M, I1773M, I1774M, I1796M, I1797M	Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002679333	16	2138578	16	2088577	2679333	2836910	rs571792728	NC_000016.10:2088576:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 2, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5391C>T (p.Ile1797=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001132455	16	2138578	16	2088577	1132455	1125105	rs571792728	NC_000016.10:2088576:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5392T>G (p.Ser1798Ala)	TSC2	S1197A, S1283A, S1284A, S1306A, S1307A, S1327A, S1531A, S1532A, S1554A, S1574A, S1575A, S1578A, S1598A, S1682A, S1683A, S1694A, S1695A, S1712A, S1725A, S1726A, S1727A, S1728A, S1731A, S1732A, S1738A, S1742A, S1751A, S1754A, S1755A, S1761A, S1762A, S1772A, S1774A, S1775A, S1797A, S1798A	not provided	VCV002645973	16	2138579	16	2088578	2645973	2810854	rs2091216026	NC_000016.10:2088577:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 1, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5392T>A (p.Ser1798Thr)	TSC2	S1284T, S1306T, S1694T, S1731T, S1761T, S1772T, S1774T, S1775T, S1798T, S1197T, S1307T, S1682T, S1725T, S1727T, S1728T, S1742T, S1283T, S1327T, S1532T, S1554T, S1575T, S1695T, S1712T, S1726T, S1732T, S1751T, S1754T, S1755T, S1797T, S1531T, S1574T, S1578T, S1598T, S1683T, S1738T, S1762T	not provided|Hereditary cancer-predisposing syndrome	VCV001747236	16	2138579	16	2088578	1747236	1802987	rs2091216026	NC_000016.10:2088577:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5393C>G (p.Ser1798Cys)	TSC2	S1307C, S1327C, S1532C, S1575C, S1726C, S1732C, S1772C, S1197C, S1283C, S1284C, S1306C, S1531C, S1554C, S1578C, S1598C, S1682C, S1683C, S1742C, S1751C, S1754C, S1762C, S1798C, S1574C, S1694C, S1712C, S1727C, S1728C, S1738C, S1755C, S1775C, S1797C, S1695C, S1725C, S1731C, S1761C, S1774C	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV003462694	16	2138580	16	2088579	3462694	3621713		NC_000016.10:2088578:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5393C>T (p.Ser1798Phe)	TSC2	S1695F, S1754F, S1554F, S1731F, S1683F, S1742F, S1751F, S1775F, S1732F, S1755F, S1798F	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000838366	16	2138580	16	2088579	838366	843549	rs2091216208	NC_000016.10:2088578:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5394C>G (p.Ser1798=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001747242	16	2138581	16	2088580	1747242	1802993	rs2151642575	NC_000016.10:2088579:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5394C>T (p.Ser1798=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001079904	16	2138581	16	2088580	1079904	1081874	rs2151642575	NC_000016.10:2088579:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5395T>G (p.Ser1799Ala)	TSC2	S1555A, S1733A, S1743A, S1732A, S1752A, S1756A, S1755A, S1776A, S1799A, S1684A, S1696A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001379364	16	2138582	16	2088581	1379364	1486592	rs1231583517	NC_000016.10:2088580:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5395T>C (p.Ser1799Pro)	TSC2	S1799P, S1733P, S1776P, S1684P, S1696P, S1732P, S1555P, S1755P, S1756P, S1743P, S1752P	Tuberous sclerosis 2	VCV000468167	16	2138582	16	2088581	468167	466081	rs1231583517	NC_000016.10:2088580:T:C	single nucleotide variant	missense variant	Benign	Dec 6, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5396C>G (p.Ser1799Trp)	TSC2	S1555W, S1684W, S1696W, S1732W, S1733W, S1743W, S1752W, S1755W, S1756W, S1776W, S1799W	Tuberous sclerosis 2	VCV001053455	16	2138583	16	2088582	1053455	1049504	rs778484981	NC_000016.10:2088581:C:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2021	criteria provided, single submitter							
NM_000548.5(TSC2):c.5396C>T (p.Ser1799Leu)	TSC2	S1799L, S1743L, S1684L, S1696L, S1555L, S1733L, S1755L, S1732L, S1752L, S1756L, S1776L	not specified|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000450528	16	2138583	16	2088582	450528	445530	rs778484981	NC_000016.10:2088581:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5397G>T (p.Ser1799=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001118494	16	2138584	16	2088583	1118494	1103690	rs1051771	NC_000016.10:2088582:G:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5397G>A (p.Ser1799=)	TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000185225	16	2138584	16	2088583	185225	184149	rs1051771	NC_000016.10:2088582:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5397G>C (p.Ser1799=)	PKD1|TSC2		Hereditary cancer-predisposing syndrome|not specified|not provided|Tuberous sclerosis syndrome|Polycystic kidney disease, adult type|Tuberous sclerosis 2	VCV000049847	16	2138584	16	2088583	49847	59009	rs1051771	NC_000016.10:2088582:G:C	single nucleotide variant	synonymous variant	Benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5398G>A (p.Val1800Met)	TSC2	V1308M, V1309M, V1329M, V1534M, V1556M, V1576M, V1600M, V1684M, V1714M, V1729M, V1764M, V1777M, V1800M, V1533M, V1580M, V1697M, V1734M, V1753M, V1756M, V1776M, V1286M, V1696M, V1728M, V1733M, V1757M, V1799M, V1199M, V1285M, V1577M, V1685M, V1727M, V1730M, V1740M, V1744M, V1763M, V1774M	Hereditary cancer-predisposing syndrome	VCV002624600	16	2138585	16	2088584	2624600	2793689	rs2151642819	NC_000016.10:2088583:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 7, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5399T>C (p.Val1800Ala)	TSC2	V1744A, V1800A, V1556A, V1753A, V1697A, V1756A, V1685A, V1733A, V1734A, V1757A, V1777A	Tuberous sclerosis 2	VCV000949798	16	2138586	16	2088585	949798	927697	rs2091217625	NC_000016.10:2088584:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5400G>C (p.Val1800=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2	VCV001096334	16	2138587	16	2088586	1096334	1081875	rs777327091	NC_000016.10:2088585:G:C	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5400G>A (p.Val1800=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001011359	16	2138587	16	2088586	1011359	996781	rs777327091	NC_000016.10:2088585:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5401G>A (p.Glu1801Lys)	TSC2	E1801K, E1557K, E1754K, E1734K, E1735K, E1758K, E1778K, E1686K, E1698K, E1745K, E1757K	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000575239	16	2138588	16	2088587	575239	570156	rs1249406161	NC_000016.10:2088586:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 25, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5403G>A (p.Glu1801=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000578157	16	2138590	16	2088589	578157	569916	rs1060500918	NC_000016.10:2088588:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5403G>T (p.Glu1801Asp)	TSC2	E1801D, E1698D, E1745D, E1757D, E1758D, E1778D, E1557D, E1735D, E1686D, E1734D, E1754D	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000405970	16	2138590	16	2088589	405970	401727	rs1060500918	NC_000016.10:2088588:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 8, 2024	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5404G>T (p.Asp1802Tyr)	TSC2	D1201Y, D1288Y, D1310Y, D1578Y, D1582Y, D1729Y, D1731Y, D1735Y, D1742Y, D1759Y, D1776Y, D1311Y, D1558Y, D1579Y, D1686Y, D1736Y, D1766Y, D1801Y, D1536Y, D1699Y, D1716Y, D1732Y, D1755Y, D1802Y, D1287Y, D1331Y, D1535Y, D1602Y, D1687Y, D1698Y, D1730Y, D1746Y, D1758Y, D1765Y, D1778Y, D1779Y	Hereditary cancer-predisposing syndrome	VCV001747325	16	2138591	16	2088590	1747325	1803076	rs1596464614	NC_000016.10:2088589:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5404G>A (p.Asp1802Asn)	TSC2	D1687N, D1758N, D1699N, D1735N, D1746N, D1558N, D1755N, D1736N, D1759N, D1779N, D1802N	Hereditary cancer-predisposing syndrome	VCV000825707	16	2138591	16	2088590	825707	812636	rs1596464614	NC_000016.10:2088589:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2019	criteria provided, single submitter							
NM_000548.5(TSC2):c.5405A>T (p.Asp1802Val)	TSC2	D1201V, D1287V, D1288V, D1310V, D1311V, D1331V, D1535V, D1536V, D1558V, D1578V, D1579V, D1582V, D1602V, D1686V, D1687V, D1698V, D1699V, D1716V, D1729V, D1730V, D1731V, D1732V, D1735V, D1736V, D1742V, D1746V, D1755V, D1758V, D1759V, D1765V, D1766V, D1776V, D1778V, D1779V, D1801V, D1802V	Hereditary cancer-predisposing syndrome	VCV003232196	16	2138592	16	2088591	3232196	3391997	rs2091218851	NC_000016.10:2088590:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 23, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5405A>C (p.Asp1802Ala)	TSC2	D1201A, D1287A, D1535A, D1602A, D1698A, D1729A, D1731A, D1778A, D1311A, D1331A, D1558A, D1686A, D1687A, D1699A, D1730A, D1735A, D1742A, D1765A, D1776A, D1758A, D1779A, D1802A, D1288A, D1310A, D1578A, D1579A, D1732A, D1736A, D1746A, D1755A, D1759A, D1766A, D1801A, D1536A, D1582A, D1716A	Hereditary cancer-predisposing syndrome	VCV001747326	16	2138592	16	2088591	1747326	1803077	rs2091218851	NC_000016.10:2088590:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5406C>G (p.Asp1802Glu)	TSC2	D1287E, D1311E, D1331E, D1558E, D1602E, D1699E, D1729E, D1746E, D1765E, D1801E, D1288E, D1578E, D1579E, D1698E, D1716E, D1731E, D1735E, D1755E, D1758E, D1776E, D1802E, D1201E, D1310E, D1535E, D1582E, D1686E, D1687E, D1759E, D1779E, D1536E, D1730E, D1732E, D1736E, D1742E, D1766E, D1778E	Hereditary cancer-predisposing syndrome	VCV002303883	16	2138593	16	2088592	2303883	2293234	rs746376375	NC_000016.10:2088591:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5406C>T (p.Asp1802=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000536025	16	2138593	16	2088592	536025	530306	rs746376375	NC_000016.10:2088591:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5407T>C (p.Phe1803Leu)	TSC2	F1731L, F1732L, F1760L, F1766L, F1777L, F1559L, F1579L, F1583L, F1737L, F1743L, F1756L, F1779L, F1780L, F1202L, F1536L, F1537L, F1580L, F1700L, F1733L, F1736L, F1767L, F1803L, F1289L, F1311L, F1603L, F1687L, F1699L, F1730L, F1747L, F1759L, F1802L, F1288L, F1312L, F1332L, F1688L, F1717L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002564633	16	2138594	16	2088593	2564633	2733789	rs2544521045	NC_000016.10:2088592:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5408T>C (p.Phe1803Ser)	TSC2	F1559S, F1688S, F1700S, F1736S, F1737S, F1747S, F1756S, F1759S, F1760S, F1780S, F1803S	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001692510	16	2138595	16	2088594	1692510	1684950	rs2151643160	NC_000016.10:2088593:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5409C>T (p.Phe1803=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000468168	16	2138596	16	2088595	468168	466163	rs770270816	NC_000016.10:2088594:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5410A>G (p.Thr1804Ala)	TSC2	T1538A, T1700A, T1718A, T1731A, T1733A, T1748A, T1760A, T1778A, T1290A, T1537A, T1560A, T1734A, T1768A, T1780A, T1803A, T1804A, T1203A, T1289A, T1581A, T1584A, T1701A, T1737A, T1738A, T1757A, T1761A, T1767A, T1312A, T1313A, T1333A, T1580A, T1604A, T1688A, T1689A, T1732A, T1744A, T1781A	Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001747378	16	2138597	16	2088596	1747378	1803129	rs372918437	NC_000016.10:2088595:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5411C>A (p.Thr1804Asn)	TSC2	T1289N, T1312N, T1538N, T1560N, T1584N, T1718N, T1732N, T1738N, T1744N, T1748N, T1757N, T1760N, T1780N, T1804N, T1290N, T1313N, T1688N, T1733N, T1737N, T1767N, T1803N, T1333N, T1689N, T1731N, T1761N, T1778N, T1203N, T1537N, T1580N, T1581N, T1604N, T1700N, T1701N, T1734N, T1768N, T1781N	Hereditary cancer-predisposing syndrome	VCV003974705	16	2138598	16	2088597	3974705	4086528		NC_000016.10:2088596:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.5411C>T (p.Thr1804Ile)	TSC2	T1560I, T1737I, T1738I, T1761I, T1689I, T1804I, T1701I, T1748I, T1757I, T1760I, T1781I	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV001499063	16	2138598	16	2088597	1499063	1488808	rs2151643245	NC_000016.10:2088596:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5412C>G (p.Thr1804=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002626416	16	2138599	16	2088598	2626416	2794182	rs397515252	NC_000016.10:2088597:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5412C>A (p.Thr1804=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV001640279	16	2138599	16	2088598	1640279	1625957	rs397515252	NC_000016.10:2088597:C:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5412C>T (p.Thr1804=)	TSC2		Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	VCV000065340	16	2138599	16	2088598	65340	76273	rs397515252	NC_000016.10:2088597:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5413G>T (p.Glu1805Ter)	TSC2	E1204*, E1582*, E1690*, E1719*, E1732*, E1733*, E1745*, E1781*, E1291*, E1585*, E1605*, E1739*, E1779*, E1782*, E1804*, E1290*, E1313*, E1539*, E1561*, E1581*, E1738*, E1758*, E1762*, E1769*, E1805*, E1314*, E1334*, E1538*, E1689*, E1701*, E1702*, E1734*, E1735*, E1749*, E1761*, E1768*	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV002626437	16	2138600	16	2088599	2626437	2794203	rs376017665	NC_000016.10:2088598:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Aug 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5413G>C (p.Glu1805Gln)	TSC2	E1561Q, E1690Q, E1702Q, E1738Q, E1739Q, E1749Q, E1758Q, E1761Q, E1762Q, E1782Q, E1805Q	Tuberous sclerosis 2	VCV001027245	16	2138600	16	2088599	1027245	1012017	rs376017665	NC_000016.10:2088598:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2020	criteria provided, single submitter							
NM_000548.5(TSC2):c.5413G>A (p.Glu1805Lys)	TSC2	E1805K, E1690K, E1762K, E1738K, E1739K, E1782K, E1561K, E1758K, E1761K, E1702K, E1749K	TSC2-related disorder|Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000536087	16	2138600	16	2088599	536087	530083	rs376017665	NC_000016.10:2088598:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5414A>G (p.Glu1805Gly)	TSC2	E1561G, E1702G, E1749G, E1761G, E1762G, E1758G, E1690G, E1738G, E1739G, E1782G, E1805G	Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2|Tuberous sclerosis 2	VCV000959264	16	2138601	16	2088600	959264	949299	rs2091219993	NC_000016.10:2088599:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5415G>C (p.Glu1805Asp)	TSC2	E1761D, E1782D, E1561D, E1702D, E1738D, E1690D, E1758D, E1762D, E1805D, E1739D, E1749D	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000825713	16	2138602	16	2088601	825713	812637	rs982803529	NC_000016.10:2088600:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5415G>A (p.Glu1805=)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis|Tuberous sclerosis 2|Isolated focal cortical dysplasia type II|Hereditary cancer-predisposing syndrome	VCV000536080	16	2138602	16	2088601	536080	530319	rs982803529	NC_000016.10:2088600:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5416T>C (p.Phe1806Leu)	TSC2	F1806L, F1562L, F1739L, F1759L, F1740L, F1762L, F1763L, F1691L, F1703L, F1750L, F1783L	Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2	VCV000405942	16	2138603	16	2088602	405942	401462	rs1060500910	NC_000016.10:2088601:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5417T>G (p.Phe1806Cys)	TSC2	F1292C, F1335C, F1540C, F1582C, F1720C, F1734C, F1740C, F1746C, F1750C, F1759C, F1805C, F1806C, F1315C, F1583C, F1702C, F1733C, F1735C, F1739C, F1762C, F1763C, F1769C, F1780C, F1205C, F1291C, F1314C, F1562C, F1690C, F1782C, F1783C, F1539C, F1586C, F1606C, F1691C, F1703C, F1736C, F1770C	Hereditary cancer-predisposing syndrome	VCV001747397	16	2138604	16	2088603	1747397	1803148	rs2544521838	NC_000016.10:2088602:T:G	single nucleotide variant	missense variant	Uncertain significance	May 28, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5418T>G (p.Phe1806Leu)	TSC2	F1806L, F1691L, F1740L, F1759L, F1703L, F1750L, F1763L, F1783L, F1762L, F1562L, F1739L	Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2	VCV000041749	16	2138605	16	2088604	41749	50188	rs200004126	NC_000016.10:2088603:T:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.5419G>A (p.Val1807Met)	TSC2	V1540M, V1541M, V1587M, V1721M, V1741M, V1747M, V1783M, V1806M, V1807M, V1206M, V1293M, V1584M, V1607M, V1692M, V1704M, V1734M, V1735M, V1751M, V1760M, V1770M, V1315M, V1336M, V1583M, V1703M, V1764M, V1781M, V1292M, V1316M, V1563M, V1691M, V1736M, V1737M, V1740M, V1763M, V1771M, V1784M	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV002131334	16	2138606	16	2088605	2131334	2191469	rs45486402	NC_000016.10:2088604:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5419G>T (p.Val1807Leu)	TSC2	V1807L, V1692L, V1741L, V1763L, V1784L, V1751L, V1704L, V1760L, V1764L, V1563L, V1740L	Tuberous sclerosis 2	VCV000049374	16	2138606	16	2088605	49374	58536	rs45486402	NC_000016.10:2088604:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5420T>C (p.Val1807Ala)	TSC2	V1206A, V1292A, V1293A, V1315A, V1316A, V1336A, V1540A, V1541A, V1563A, V1583A, V1584A, V1587A, V1607A, V1691A, V1692A, V1703A, V1704A, V1721A, V1734A, V1735A, V1736A, V1737A, V1740A, V1741A, V1747A, V1751A, V1760A, V1763A, V1764A, V1770A, V1771A, V1781A, V1783A, V1784A, V1806A, V1807A	Tuberous sclerosis syndrome	VCV003073336	16	2138607	16	2088606	3073336	3234292	rs2544522065	NC_000016.10:2088605:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 4, 2023	criteria provided, single submitter							
NM_000548.5(TSC2):c.5421G>T (p.Val1807=)	TSC2		Tuberous sclerosis 2	VCV002020090	16	2138608	16	2088607	2020090	2083130	rs1596464773	NC_000016.10:2088606:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 4, 2024	criteria provided, single submitter							
NM_000548.5(TSC2):c.5421G>A (p.Val1807=)	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	VCV000752092	16	2138608	16	2088607	752092	770753	rs1596464773	NC_000016.10:2088606:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5422T>C (p.Ter1808Arg)	TSC2		Hereditary cancer-predisposing syndrome	VCV001747449	16	2138609	16	2088608	1747449	1799747	rs1567135442	NC_000016.10:2088607:T:C	single nucleotide variant	stop lost	Uncertain significance	Oct 25, 2022	criteria provided, single submitter							
NM_000548.5(TSC2):c.5422T>A (p.Ter1808Arg)	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	VCV000573246	16	2138609	16	2088608	573246	573901	rs1567135442	NC_000016.10:2088607:T:A	single nucleotide variant	stop lost	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.5423G>A (p.Ter1808=)	TSC2		Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV000766318	16	2138610	16	2088609	766318	770754	rs762120606	NC_000016.10:2088608:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.*1G>A	TSC2		Tuberous sclerosis 2	VCV004071065	16	2138612	16	2088611	4071065	4184913		NC_000016.10:2088610:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*1G>C	TSC2		Tuberous sclerosis 2	VCV004071031	16	2138612	16	2088611	4071031	4184879		NC_000016.10:2088610:G:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*3C>T	TSC2		Tuberous sclerosis 2	VCV004071101	16	2138614	16	2088613	4071101	4184949		NC_000016.10:2088612:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*4C>G	TSC2		Tuberous sclerosis 2	VCV004071452	16	2138615	16	2088614	4071452	4185299		NC_000016.10:2088613:C:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*4C>T	TSC2		Tuberous sclerosis syndrome|not provided|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome|not specified	VCV000486611	16	2138615	16	2088614	486611	478005	rs368282661	NC_000016.10:2088613:C:T	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.*5G>T	TSC2		Tuberous sclerosis 2|Tuberous sclerosis syndrome	VCV003070696	16	2138616	16	2088615	3070696	3230453	rs201342697	NC_000016.10:2088614:G:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.*5G>A	TSC2		Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000184450	16	2138616	16	2088615	184450	184150	rs201342697	NC_000016.10:2088614:G:A	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.*6G>C	TSC2		Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV003072332	16	2138617	16	2088616	3072332	3230775	rs397515008	NC_000016.10:2088615:G:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.*6G>A	TSC2		Tuberous sclerosis 2	VCV000065017	16	2138617	16	2088616	65017	75947	rs397515008	NC_000016.10:2088615:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*7G>C	TSC2		Tuberous sclerosis 2	VCV004071206	16	2138618	16	2088617	4071206	4185054		NC_000016.10:2088616:G:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*7G>T	TSC2		Tuberous sclerosis 2	VCV004071156	16	2138618	16	2088617	4071156	4185004		NC_000016.10:2088616:G:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*7G>A	TSC2		not provided|Tuberous sclerosis syndrome|Tuberous sclerosis 2	VCV000379639	16	2138618	16	2088617	379639	377309	rs765016970	NC_000016.10:2088616:G:A	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jun 9, 2025	criteria provided, conflicting classifications							
NM_000548.5(TSC2):c.*8G>A	TSC2		Tuberous sclerosis 2	VCV004071034	16	2138619	16	2088618	4071034	4184882		NC_000016.10:2088617:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*9C>T	TSC2		Tuberous sclerosis 2	VCV004071046	16	2138620	16	2088619	4071046	4184894		NC_000016.10:2088618:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*10C>G	TSC2		Tuberous sclerosis 2	VCV004071451	16	2138621	16	2088620	4071451	4185298		NC_000016.10:2088619:C:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*10C>T	TSC2		Tuberous sclerosis 2	VCV004071122	16	2138621	16	2088620	4071122	4184970		NC_000016.10:2088619:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 9, 2025	criteria provided, single submitter							
NM_000548.5(TSC2):c.*12T>G	TSC2		not provided	VCV001204303	16	2138623	16	2088622	1204303	1195036	rs544055911	NC_000016.10:2088621:T:G	single nucleotide variant	3 prime UTR variant	Likely benign	Sep 6, 2017	criteria provided, single submitter							
NM_000548.5(TSC2):c.*23C>T	TSC2		Tuberous sclerosis syndrome	VCV000318339	16	2138634	16	2088633	318339	342276	rs774841226	NC_000016.10:2088632:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.*26G>A	TSC2		not provided|Tuberous sclerosis syndrome|not specified	VCV000049662	16	2138637	16	2088636	49662	58824	rs13332015	NC_000016.10:2088635:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.*35G>A	TSC2		not provided|Tuberous sclerosis syndrome|not specified	VCV000256617	16	2138646	16	2088645	256617	255504	rs200025534	NC_000016.10:2088644:G:A	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.*44T>C	TSC2		not provided|Tuberous sclerosis syndrome	VCV000318340	16	2138655	16	2088654	318340	342277	rs188991734	NC_000016.10:2088653:T:C	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.*71C>T	TSC2		not provided|Tuberous sclerosis syndrome	VCV000318341	16	2138682	16	2088681	318341	340867	rs45498900	NC_000016.10:2088680:C:T	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jan 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.*77G>A	TSC2		Tuberous sclerosis syndrome	VCV000318342	16	2138688	16	2088687	318342	342282	rs886051799	NC_000016.10:2088686:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.*86T>G	TSC2		Tuberous sclerosis syndrome	VCV000885118	16	2138697	16	2088696	885118	874850	rs915706457	NC_000016.10:2088695:T:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000548.5(TSC2):c.*127T>C	PKD1|TSC2		not provided	VCV000065144	16	2138738	16	2088737	65144	76075	rs34379884	NC_000016.10:2088736:T:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Likely benign	Jun 18, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.*256C>T	PKD1|TSC2		not provided	VCV001230996	16	2138867	16	2088866	1230996	1222245	rs78282474	NC_000016.10:2088865:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 19, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.*258C>T	PKD1|TSC2		not provided	VCV001245044	16	2138869	16	2088868	1245044	1236281	rs13332377	NC_000016.10:2088867:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 14, 2018	criteria provided, multiple submitters, no conflicts							
NM_000548.5(TSC2):c.*275A>G	PKD1|TSC2		not provided	VCV001216114	16	2138886	16	2088885	1216114	1206095	rs549700419	NC_000016.10:2088884:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Likely benign	Aug 6, 2019	criteria provided, single submitter							
NM_001009944.3(PKD1):c.*601T>A	PKD1|TSC2		Autosomal dominant polycystic kidney disease	VCV003780389	16	2139127	16	2089126	3780389	3896355		NC_000016.10:2089125:A:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Feb 19, 2016	criteria provided, single submitter							
NM_001009944.3(PKD1):c.*244C>A	PKD1|TSC2		Autosomal dominant polycystic kidney disease	VCV003780140	16	2139484	16	2089483	3780140	3896106		NC_000016.10:2089482:G:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Mar 22, 2016	criteria provided, single submitter							
NM_001009944.3(PKD1):c.11858T>C (p.Leu3953Pro)	PKD1|TSC2	L3952P, L3953P	not provided|Lymphangiomyomatosis|Isolated focal cortical dysplasia type II|Tuberous sclerosis 2	VCV000829953	16	2141030	16	2091029	829953	818314	rs1596476599	NC_000016.10:2091028:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_001009944.3(PKD1):c.11412-2A>G	MIR1225|PKD1|PKD1-AS1|TSC2		Polycystic kidney disease, adult type	VCV003335929	16	2141909	16	2091908	3335929	3494623		NC_000016.10:2091907:T:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Aug 8, 2024	criteria provided, single submitter							
NM_001009944.3(PKD1):c.11249G>A (p.Arg3750Gln)	MIR1225|PKD1|PKD1-AS1|TSC2	R3750Q, R3749Q	not provided|Autosomal dominant polycystic kidney disease|Polycystic kidney disease, adult type	VCV000636966	16	2142501	16	2092500	636966	624552	rs1327414405	NC_000016.10:2092499:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 1, 2024	criteria provided, conflicting classifications							
